
### [MONDO:0003847](http://purl.obolibrary.org/obo/MONDO_0003847)
**Label:** inherited genetic disease

**Subclasses:** [MONDO:0008300](http://purl.obolibrary.org/obo/MONDO_0008300) (Prader-Willi syndrome), [MONDO:0009632](http://purl.obolibrary.org/obo/MONDO_0009632) (microphthalmia with hyperopia, retinal degeneration, Macrophakia, and dental anomalies), [MONDO:0018581](http://purl.obolibrary.org/obo/MONDO_0018581) (progressive encephalomyelitis with rigidity and myoclonus), [MONDO:0009633](http://purl.obolibrary.org/obo/MONDO_0009633) (microspherophakia and/or megalocornea, with ectopia lentis and With or without secondary glaucoma), [MONDO:0009634](http://purl.obolibrary.org/obo/MONDO_0009634) (microtia with meatal atresia and conductive deafness), [MONDO:0008304](http://purl.obolibrary.org/obo/MONDO_0008304) (premature Chromatid separation trait), [MONDO:0009636](http://purl.obolibrary.org/obo/MONDO_0009636) (mitochondrial DNA depletion syndrome 3), [MONDO:0008306](http://purl.obolibrary.org/obo/MONDO_0008306) (ABri amyloidosis), [MONDO:0008307](http://purl.obolibrary.org/obo/MONDO_0008307) (presenile dementia, Kraepelin type), [MONDO:0010628](http://purl.obolibrary.org/obo/MONDO_0010628) (immunoglobulin M, level of), [MONDO:0008308](http://purl.obolibrary.org/obo/MONDO_0008308) (priapism, familial idiopathic), [MONDO:0008309](http://purl.obolibrary.org/obo/MONDO_0008309) (primary release disorder of platelets), [MONDO:0010629](http://purl.obolibrary.org/obo/MONDO_0010629) (impacted teeth, multiple), [MONDO:0011958](http://purl.obolibrary.org/obo/MONDO_0011958) (bile and pancreatic ducts, complete absence of), [MONDO:0010626](http://purl.obolibrary.org/obo/MONDO_0010626) (X-linked hyper-IgM syndrome), [MONDO:0010627](http://purl.obolibrary.org/obo/MONDO_0010627) (X-linked lymphoproliferative syndrome), [MONDO:0010621](http://purl.obolibrary.org/obo/MONDO_0010621) (child syndrome), [MONDO:0011950](http://purl.obolibrary.org/obo/MONDO_0011950) (infantile-onset autosomal recessive nonprogressive cerebellar ataxia), [MONDO:0010624](http://purl.obolibrary.org/obo/MONDO_0010624) (ichthyosis follicularis-alopecia-photophobia syndrome), [MONDO:0010625](http://purl.obolibrary.org/obo/MONDO_0010625) (immunodeficiency, X-linked, with deficiency of 115,000 Dalton surface glycoprotein), [MONDO:0011955](http://purl.obolibrary.org/obo/MONDO_0011955) (diabetes mellitus, Noninsulin-dependent, 4), [MONDO:0010622](http://purl.obolibrary.org/obo/MONDO_0010622) (recessive X-linked ichthyosis), [MONDO:0011954](http://purl.obolibrary.org/obo/MONDO_0011954) (CMM4), [MONDO:0010623](http://purl.obolibrary.org/obo/MONDO_0010623) (ichthyosis and male hypogonadism), [MONDO:0018579](http://purl.obolibrary.org/obo/MONDO_0018579) (disorder of ketone body transport), [MONDO:0018576](http://purl.obolibrary.org/obo/MONDO_0018576) (non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy), [MONDO:0018575](http://purl.obolibrary.org/obo/MONDO_0018575) (microcephalic primordial dwarfism-insulin resistance syndrome), [MONDO:0018573](http://purl.obolibrary.org/obo/MONDO_0018573) (intrauterine growth restriction-short stature-early adult-onset diabetes syndrome), [MONDO:0018570](http://purl.obolibrary.org/obo/MONDO_0018570) (hypophosphatasia), [MONDO:0017241](http://purl.obolibrary.org/obo/MONDO_0017241) (severe intellectual disability and progressive spastic paraplegia), [MONDO:0009623](http://purl.obolibrary.org/obo/MONDO_0009623) (Nijmegen breakage syndrome), [MONDO:0009625](http://purl.obolibrary.org/obo/MONDO_0009625) (microcephaly with spastic quadriplegia), [MONDO:0009626](http://purl.obolibrary.org/obo/MONDO_0009626) (pseudo-TORCH syndrome), [MONDO:0009627](http://purl.obolibrary.org/obo/MONDO_0009627) (Galloway-Mowat syndrome), [MONDO:0009628](http://purl.obolibrary.org/obo/MONDO_0009628) (microcolon (disease)), [MONDO:0011949](http://purl.obolibrary.org/obo/MONDO_0011949) (Thai symphalangism syndrome), [MONDO:0011947](http://purl.obolibrary.org/obo/MONDO_0011947) (HNP1), [MONDO:0010619](http://purl.obolibrary.org/obo/MONDO_0010619) (X-linked hypophosphatemic rickets), [MONDO:0011941](http://purl.obolibrary.org/obo/MONDO_0011941) (mycobacterium tuberculosis, susceptibility to, 1), [MONDO:0011940](http://purl.obolibrary.org/obo/MONDO_0011940) (mycobacterium tuberculosis, susceptibility to), [MONDO:0011945](http://purl.obolibrary.org/obo/MONDO_0011945) (Gaucher's disease perinatal lethal), [MONDO:0010613](http://purl.obolibrary.org/obo/MONDO_0010613) (glycerol kinase deficiency), [MONDO:0010611](http://purl.obolibrary.org/obo/MONDO_0010611) (hydrocephalus with stenosis of the aqueduct of sylvius), [MONDO:0010612](http://purl.obolibrary.org/obo/MONDO_0010612) (hydrocephaly-cerebellar agenesis syndrome), [MONDO:0018569](http://purl.obolibrary.org/obo/MONDO_0018569) (X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndrome), [MONDO:0018568](http://purl.obolibrary.org/obo/MONDO_0018568) (COG2-CDG), [MONDO:0017238](http://purl.obolibrary.org/obo/MONDO_0017238) (hemoglobinopathy Toms River), [MONDO:0019896](http://purl.obolibrary.org/obo/MONDO_0019896) (Kleefstra syndrome due to 9q34 microdeletion), [MONDO:0017233](http://purl.obolibrary.org/obo/MONDO_0017233) (familial Alzheimer-like prion disease), [MONDO:0017234](http://purl.obolibrary.org/obo/MONDO_0017234) (inherited prion disease), [MONDO:0009610](http://purl.obolibrary.org/obo/MONDO_0009610) (3-methylglutaconic aciduria type 1), [MONDO:0017231](http://purl.obolibrary.org/obo/MONDO_0017231) (erythropoietic uroporphyria associated with myeloid malignancy), [MONDO:0009611](http://purl.obolibrary.org/obo/MONDO_0009611) (3-methylglutaconic aciduria type 4), [MONDO:0017230](http://purl.obolibrary.org/obo/MONDO_0017230) (autosomal semi-dominant severe lipodystrophic laminopathy), [MONDO:0009612](http://purl.obolibrary.org/obo/MONDO_0009612) (methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency), [MONDO:0009613](http://purl.obolibrary.org/obo/MONDO_0009613) (methylmalonic acidemia cb1A type), [MONDO:0009614](http://purl.obolibrary.org/obo/MONDO_0009614) (methylmalonic acidemia cb1B type), [MONDO:0009615](http://purl.obolibrary.org/obo/MONDO_0009615) (methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency), [MONDO:0011937](http://purl.obolibrary.org/obo/MONDO_0011937) (peeling skin syndrome 4), [MONDO:0009618](http://purl.obolibrary.org/obo/MONDO_0009618) (microcephaly-cardiomyopathy syndrome), [MONDO:0006579](http://purl.obolibrary.org/obo/MONDO_0006579) (melanoacanthoma), [MONDO:0009619](http://purl.obolibrary.org/obo/MONDO_0009619) (microcephaly-micromelia syndrome), [MONDO:0010605](http://purl.obolibrary.org/obo/MONDO_0010605) (hemopoietic proliferation), [MONDO:0010608](http://purl.obolibrary.org/obo/MONDO_0010608) (Hhhh syndrome), [MONDO:0011939](http://purl.obolibrary.org/obo/MONDO_0011939) (Spondyloenchondrodysplasia with immune dysregulation), [MONDO:0011930](http://purl.obolibrary.org/obo/MONDO_0011930) (epilepsy, familial adult myoclonic, 2), [MONDO:0010602](http://purl.obolibrary.org/obo/MONDO_0010602) (hemophilia A), [MONDO:0011933](http://purl.obolibrary.org/obo/MONDO_0011933) (ALG2-CDG), [MONDO:0010603](http://purl.obolibrary.org/obo/MONDO_0010603) (hemophilia A with vascular abnormality), [MONDO:0010601](http://purl.obolibrary.org/obo/MONDO_0010601) (gynecomastia, familial), [MONDO:0017225](http://purl.obolibrary.org/obo/MONDO_0017225) (null syndrome), [MONDO:0017222](http://purl.obolibrary.org/obo/MONDO_0017222) (Pelizaeus-Merzbacher disease, classic form), [MONDO:0017221](http://purl.obolibrary.org/obo/MONDO_0017221) (Pelizaeus-Merzbacher disease, connatal form), [MONDO:0014197](http://purl.obolibrary.org/obo/MONDO_0014197) (combined immunodeficiency due to MALT1 deficiency), [MONDO:0017224](http://purl.obolibrary.org/obo/MONDO_0017224) (Pelizaeus-Merzbacher disease in female carriers), [MONDO:0014198](http://purl.obolibrary.org/obo/MONDO_0014198) (mitochondrial DNA depletion syndrome 13), [MONDO:0017223](http://purl.obolibrary.org/obo/MONDO_0017223) (Pelizaeus-Merzbacher disease, transitional form), [MONDO:0014199](http://purl.obolibrary.org/obo/MONDO_0014199) (epileptic encephalopathy, early infantile, 17), [MONDO:0014192](http://purl.obolibrary.org/obo/MONDO_0014192) (primary ciliary dyskinesia 22), [MONDO:0018550](http://purl.obolibrary.org/obo/MONDO_0018550) (spastic paraplegia-optic atrophy-neuropathy and spastic paraplegia-optic atrophy-neuropathy-related disorder), [MONDO:0014193](http://purl.obolibrary.org/obo/MONDO_0014193) (primary ciliary dyskinesia 23), [MONDO:0009600](http://purl.obolibrary.org/obo/MONDO_0009600) (metaphyseal dysplasia, anetoderma, and optic atrophy), [MONDO:0014194](http://purl.obolibrary.org/obo/MONDO_0014194) (mitochondrial complex III deficiency nuclear type 6), [MONDO:0009601](http://purl.obolibrary.org/obo/MONDO_0009601) (metaphyseal dysplasia without hypotrichosis), [MONDO:0009602](http://purl.obolibrary.org/obo/MONDO_0009602) (metaphyseal modeling abnormality, skin lesions, and spastic paraplegia), [MONDO:0009603](http://purl.obolibrary.org/obo/MONDO_0009603) (neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency), [MONDO:0009604](http://purl.obolibrary.org/obo/MONDO_0009604) (methemoglobin reductase deficiency), [MONDO:0014190](http://purl.obolibrary.org/obo/MONDO_0014190) (combined oxidative phosphorylation defect type 17), [MONDO:0009605](http://purl.obolibrary.org/obo/MONDO_0009605) (methemoglobinemia type 4), [MONDO:0009606](http://purl.obolibrary.org/obo/MONDO_0009606) (methemoglobinemia due to deficiency of methemoglobin reductase), [MONDO:0009607](http://purl.obolibrary.org/obo/MONDO_0009607) (brain demyelination due to methionine adenosyltransferase deficiency), [MONDO:0011926](http://purl.obolibrary.org/obo/MONDO_0011926) (PSORS9), [MONDO:0009608](http://purl.obolibrary.org/obo/MONDO_0009608) (methionine malabsorption syndrome), [MONDO:0011924](http://purl.obolibrary.org/obo/MONDO_0011924) (panic disorder 2), [MONDO:0009609](http://purl.obolibrary.org/obo/MONDO_0009609) (methylcobalamin deficiency type cblG), [MONDO:0006588](http://purl.obolibrary.org/obo/MONDO_0006588) (nonepidermolytic palmoplantar keratoderma), [MONDO:0011929](http://purl.obolibrary.org/obo/MONDO_0011929) (chromosome 1p36 deletion syndrome), [MONDO:0011920](http://purl.obolibrary.org/obo/MONDO_0011920) (autosomal dominant nonsyndromic deafness 48), [MONDO:0011992](http://purl.obolibrary.org/obo/MONDO_0011992) (hereditary spastic paraplegia 25), [MONDO:0010661](http://purl.obolibrary.org/obo/MONDO_0010661) (severe X-linked intellectual disability, Gustavson type), [MONDO:0011991](http://purl.obolibrary.org/obo/MONDO_0011991) (autosomal recessive nonsyndromic deafness 38), [MONDO:0008342](http://purl.obolibrary.org/obo/MONDO_0008342) (pubic bone dysplasia), [MONDO:0009674](http://purl.obolibrary.org/obo/MONDO_0009674) (muscular dystrophy, adult-onset, with leukoencephalopathy), [MONDO:0008343](http://purl.obolibrary.org/obo/MONDO_0008343) (pulmonary atresia with ventricular septal defect), [MONDO:0009675](http://purl.obolibrary.org/obo/MONDO_0009675) (autosomal recessive limb-girdle muscular dystrophy type 2A), [MONDO:0008344](http://purl.obolibrary.org/obo/MONDO_0008344) (pulmonary edema of mountaineers, susceptibility to), [MONDO:0017295](http://purl.obolibrary.org/obo/MONDO_0017295) (glycerol kinase deficiency, juvenile form), [MONDO:0017294](http://purl.obolibrary.org/obo/MONDO_0017294) (glycerol kinase deficiency, infantile form), [MONDO:0009676](http://purl.obolibrary.org/obo/MONDO_0009676) (autosomal recessive limb-girdle muscular dystrophy type 2B), [MONDO:0008346](http://purl.obolibrary.org/obo/MONDO_0008346) (pulmonary hemosiderosis), [MONDO:0009677](http://purl.obolibrary.org/obo/MONDO_0009677) (autosomal recessive limb-girdle muscular dystrophy type 2C), [MONDO:0017296](http://purl.obolibrary.org/obo/MONDO_0017296) (glycerol kinase deficiency, adult form), [MONDO:0009678](http://purl.obolibrary.org/obo/MONDO_0009678) (Fukuyama congenital muscular dystrophy), [MONDO:0008349](http://purl.obolibrary.org/obo/MONDO_0008349) (pulmonic stenosis, atrial septal defect, and Unique Electrocardiographic abnormalities), [MONDO:0017290](http://purl.obolibrary.org/obo/MONDO_0017290) (familial intrahepatic cholestasis), [MONDO:0010664](http://purl.obolibrary.org/obo/MONDO_0010664) (syndromic X-linked intellectual disability Snyder type), [MONDO:0010665](http://purl.obolibrary.org/obo/MONDO_0010665) (Wilson-Turner syndrome), [MONDO:0010662](http://purl.obolibrary.org/obo/MONDO_0010662) (paraplegia-intellectual disability-hyperkeratosis syndrome), [MONDO:0011994](http://purl.obolibrary.org/obo/MONDO_0011994) (autosomal dominant nonsyndromic deafness 41), [MONDO:0011993](http://purl.obolibrary.org/obo/MONDO_0011993) (Aspirin resistance), [MONDO:0010663](http://purl.obolibrary.org/obo/MONDO_0010663) (X-linked intellectual disability-hypotonic face syndrome), [MONDO:0010668](http://purl.obolibrary.org/obo/MONDO_0010668) (skeletal dysplasia-intellectual disability syndrome), [MONDO:0011999](http://purl.obolibrary.org/obo/MONDO_0011999) (OTSC3), [MONDO:0010666](http://purl.obolibrary.org/obo/MONDO_0010666) (Miles-Carpenter syndrome), [MONDO:0011997](http://purl.obolibrary.org/obo/MONDO_0011997) (Hermansky-Pudlak syndrome 2), [MONDO:0010667](http://purl.obolibrary.org/obo/MONDO_0010667) (Prieto syndrome), [MONDO:0009660](http://purl.obolibrary.org/obo/MONDO_0009660) (mucopolysaccharidosis type 4B), [MONDO:0011981](http://purl.obolibrary.org/obo/MONDO_0011981) (autoimmune thyroid disease, susceptibility to, 2), [MONDO:0010650](http://purl.obolibrary.org/obo/MONDO_0010650) (Melnick-Needles syndrome), [MONDO:0009661](http://purl.obolibrary.org/obo/MONDO_0009661) (mucopolysaccharidosis type 6), [MONDO:0008330](http://purl.obolibrary.org/obo/MONDO_0008330) (Pseudomonilethrix), [MONDO:0011980](http://purl.obolibrary.org/obo/MONDO_0011980) (autoimmune thyroid disease, susceptibility to, 1), [MONDO:0009662](http://purl.obolibrary.org/obo/MONDO_0009662) (mucopolysaccharidosis type 7), [MONDO:0008331](http://purl.obolibrary.org/obo/MONDO_0008331) (pseudopapilledema (disease)), [MONDO:0009663](http://purl.obolibrary.org/obo/MONDO_0009663) (mucus inspissation of respiratory tract), [MONDO:0009664](http://purl.obolibrary.org/obo/MONDO_0009664) (mulibrey nanism), [MONDO:0008333](http://purl.obolibrary.org/obo/MONDO_0008333) (pseudoxanthoma elasticum, Forme Fruste), [MONDO:0009665](http://purl.obolibrary.org/obo/MONDO_0009665) (biotinidase deficiency), [MONDO:0008334](http://purl.obolibrary.org/obo/MONDO_0008334) (psoriasis 1, susceptibility to), [MONDO:0009666](http://purl.obolibrary.org/obo/MONDO_0009666) (holocarboxylase synthetase deficiency), [MONDO:0009667](http://purl.obolibrary.org/obo/MONDO_0009667) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3), [MONDO:0008336](http://purl.obolibrary.org/obo/MONDO_0008336) (pterygium colli, isolated), [MONDO:0008338](http://purl.obolibrary.org/obo/MONDO_0008338) (autosomal dominant multiple pterygium syndrome), [MONDO:0010659](http://purl.obolibrary.org/obo/MONDO_0010659) (FRAXE intellectual disability), [MONDO:0010653](http://purl.obolibrary.org/obo/MONDO_0010653) (Renpenning syndrome), [MONDO:0011985](http://purl.obolibrary.org/obo/MONDO_0011985) (hyper-IgM syndrome type 4), [MONDO:0010654](http://purl.obolibrary.org/obo/MONDO_0010654) (Partington syndrome), [MONDO:0010651](http://purl.obolibrary.org/obo/MONDO_0010651) (Menkes disease), [MONDO:0011983](http://purl.obolibrary.org/obo/MONDO_0011983) (autoimmune thyroid disease, susceptibility to, 4), [MONDO:0011982](http://purl.obolibrary.org/obo/MONDO_0011982) (autoimmune thyroid disease, susceptibility to, 3), [MONDO:0010652](http://purl.obolibrary.org/obo/MONDO_0010652) (X-linked intellectual disability-seizures-psoriasis syndrome), [MONDO:0010657](http://purl.obolibrary.org/obo/MONDO_0010657) (methylmalonic acidemia with homocystinuria, type cblX), [MONDO:0010658](http://purl.obolibrary.org/obo/MONDO_0010658) (syndromic X-linked intellectual disability 12), [MONDO:0010655](http://purl.obolibrary.org/obo/MONDO_0010655) (X-linked intellectual disability with marfanoid habitus), [MONDO:0011986](http://purl.obolibrary.org/obo/MONDO_0011986) (tropical pancreatitis), [MONDO:0009650](http://purl.obolibrary.org/obo/MONDO_0009650) (inclusion-cell disease), [MONDO:0008320](http://purl.obolibrary.org/obo/MONDO_0008320) (Protrusio Acetabuli (disease)), [MONDO:0009651](http://purl.obolibrary.org/obo/MONDO_0009651) (pseudo-Hurler polydystrophy), [MONDO:0008321](http://purl.obolibrary.org/obo/MONDO_0008321) (Pruritus, hereditary localized), [MONDO:0009652](http://purl.obolibrary.org/obo/MONDO_0009652) (mucolipidosis type III gamma), [MONDO:0017273](http://purl.obolibrary.org/obo/MONDO_0017273) (autosomal ichthyosis syndrome with fatal disease course), [MONDO:0009653](http://purl.obolibrary.org/obo/MONDO_0009653) (mucolipidosis type IV), [MONDO:0017272](http://purl.obolibrary.org/obo/MONDO_0017272) (autosomal ichthyosis syndrome with prominent neurologics signs), [MONDO:0008323](http://purl.obolibrary.org/obo/MONDO_0008323) (Liddle syndrome), [MONDO:0009654](http://purl.obolibrary.org/obo/MONDO_0009654) (Mucopolysaccharidoses, unclassified types), [MONDO:0008324](http://purl.obolibrary.org/obo/MONDO_0008324) (Pseudoarthrogryposis), [MONDO:0017275](http://purl.obolibrary.org/obo/MONDO_0017275) (spastic paraplegia-facial-cutaneous lesions syndrome), [MONDO:0009655](http://purl.obolibrary.org/obo/MONDO_0009655) (Sanfilippo syndrome type A), [MONDO:0017274](http://purl.obolibrary.org/obo/MONDO_0017274) (autosomal ichthyosis syndrome with other associated signs), [MONDO:0008325](http://purl.obolibrary.org/obo/MONDO_0008325) (Pseudoatrophoderma colli), [MONDO:0009656](http://purl.obolibrary.org/obo/MONDO_0009656) (Sanfilippo syndrome type B), [MONDO:0008326](http://purl.obolibrary.org/obo/MONDO_0008326) (Pseudocholinesterase, Increase 1N plasma level of), [MONDO:0009657](http://purl.obolibrary.org/obo/MONDO_0009657) (Sanfilippo syndrome type C), [MONDO:0009658](http://purl.obolibrary.org/obo/MONDO_0009658) (Sanfilippo syndrome type D), [MONDO:0008327](http://purl.obolibrary.org/obo/MONDO_0008327) (exfoliation syndrome), [MONDO:0009659](http://purl.obolibrary.org/obo/MONDO_0009659) (mucopolysaccharidosis type 4A), [MONDO:0017271](http://purl.obolibrary.org/obo/MONDO_0017271) (autosomal ichthyosis syndrome with prominent hair abnormalities), [MONDO:0008328](http://purl.obolibrary.org/obo/MONDO_0008328) (glaucoma 1, open angle, P), [MONDO:0008329](http://purl.obolibrary.org/obo/MONDO_0008329) (autosomal dominant pseudohypoaldosteronism type 1), [MONDO:0017270](http://purl.obolibrary.org/obo/MONDO_0017270) (autosomal ichthyosis syndrome), [MONDO:0010648](http://purl.obolibrary.org/obo/MONDO_0010648) (MAFD2), [MONDO:0010649](http://purl.obolibrary.org/obo/MONDO_0010649) (isolated congenital megalocornea), [MONDO:0010642](http://purl.obolibrary.org/obo/MONDO_0010642) (Lesch-Nyhan phenotype with normal Hgprt), [MONDO:0011973](http://purl.obolibrary.org/obo/MONDO_0011973) (zinc deficiency, transient neonatal), [MONDO:0005285](http://purl.obolibrary.org/obo/MONDO_0005285) (kidney stone), [MONDO:0010640](http://purl.obolibrary.org/obo/MONDO_0010640) (Leber optic atrophy, susceptibility to), [MONDO:0011971](http://purl.obolibrary.org/obo/MONDO_0011971) (hyper-IgM syndrome type 5), [MONDO:0011978](http://purl.obolibrary.org/obo/MONDO_0011978) (Coq-responsive Oxphos deficiency), [MONDO:0010645](http://purl.obolibrary.org/obo/MONDO_0010645) (oculocerebrorenal syndrome), [MONDO:0017269](http://purl.obolibrary.org/obo/MONDO_0017269) (X-linked ichthyosis syndrome), [MONDO:0017266](http://purl.obolibrary.org/obo/MONDO_0017266) (keratinopathic ichthyosis), [MONDO:0018598](http://purl.obolibrary.org/obo/MONDO_0018598) (neonatal adrenoleukodystrophy), [MONDO:0017265](http://purl.obolibrary.org/obo/MONDO_0017265) (autosomal recessive congenital ichthyosis), [MONDO:0009640](http://purl.obolibrary.org/obo/MONDO_0009640) (mitochondrial complex I deficiency), [MONDO:0018596](http://purl.obolibrary.org/obo/MONDO_0018596) (systemic polyarteritis nodosa), [MONDO:0017268](http://purl.obolibrary.org/obo/MONDO_0017268) (acral self-healing collodion baby), [MONDO:0008310](http://purl.obolibrary.org/obo/MONDO_0008310) (progeria), [MONDO:0009641](http://purl.obolibrary.org/obo/MONDO_0009641) (mitochondrial complex II deficiency), [MONDO:0017267](http://purl.obolibrary.org/obo/MONDO_0017267) (self-healing collodion baby), [MONDO:0017262](http://purl.obolibrary.org/obo/MONDO_0017262) (inherited non-syndromic ichthyosis), [MONDO:0018594](http://purl.obolibrary.org/obo/MONDO_0018594) (secondary polyarteritis nodosa), [MONDO:0018595](http://purl.obolibrary.org/obo/MONDO_0018595) (single-organ polyarteritis nodosa), [MONDO:0009643](http://purl.obolibrary.org/obo/MONDO_0009643) (sulfite oxidase deficiency due to molybdenum cofactor deficiency type a), [MONDO:0018592](http://purl.obolibrary.org/obo/MONDO_0018592) (cutaneous polyarteritis nodosa), [MONDO:0017264](http://purl.obolibrary.org/obo/MONDO_0017264) (syndromic recessive X-linked ichthyosis), [MONDO:0008313](http://purl.obolibrary.org/obo/MONDO_0008313) (pelvic organ prolapse, susceptibility to), [MONDO:0009644](http://purl.obolibrary.org/obo/MONDO_0009644) (sulfite oxidase deficiency due to molybdenum cofactor deficiency type b), [MONDO:0008314](http://purl.obolibrary.org/obo/MONDO_0008314) (Pronation-Supination of the forearm, impairment of), [MONDO:0017263](http://purl.obolibrary.org/obo/MONDO_0017263) (inherited ichthyosis syndromic form), [MONDO:0018593](http://purl.obolibrary.org/obo/MONDO_0018593) (primary polyarteritis nodosa), [MONDO:0009646](http://purl.obolibrary.org/obo/MONDO_0009646) (monosomy 7 of bone marrow), [MONDO:0018591](http://purl.obolibrary.org/obo/MONDO_0018591) (ITM2B amyloidosis), [MONDO:0009647](http://purl.obolibrary.org/obo/MONDO_0009647) (Morquio syndrome C), [MONDO:0008317](http://purl.obolibrary.org/obo/MONDO_0008317) (proteolytic capacity of plasma), [MONDO:0008318](http://purl.obolibrary.org/obo/MONDO_0008318) (Proteus syndrome), [MONDO:0010639](http://purl.obolibrary.org/obo/MONDO_0010639) (laryngeal abductor paralysis-intellectual disability syndrome), [MONDO:0008319](http://purl.obolibrary.org/obo/MONDO_0008319) (protoporphyria, erythropoietic), [MONDO:0011969](http://purl.obolibrary.org/obo/MONDO_0011969) (ALG8-CDG), [MONDO:0011968](http://purl.obolibrary.org/obo/MONDO_0011968) (autosomal recessive limb-girdle muscular dystrophy type 2D), [MONDO:0010638](http://purl.obolibrary.org/obo/MONDO_0010638) (keratosis follicularis-dwarfism-cerebral atrophy syndrome), [MONDO:0010631](http://purl.obolibrary.org/obo/MONDO_0010631) (Bloch-Sulzberger syndrome), [MONDO:0011963](http://purl.obolibrary.org/obo/MONDO_0011963) (Joubert syndrome 2), [MONDO:0010632](http://purl.obolibrary.org/obo/MONDO_0010632) (epileptic encephalopathy, early infantile, 1), [MONDO:0011961](http://purl.obolibrary.org/obo/MONDO_0011961) (hereditary sensory and autonomic neuropathy type 1B), [MONDO:0010630](http://purl.obolibrary.org/obo/MONDO_0010630) (imprinting gene related to retinoblastoma), [MONDO:0010636](http://purl.obolibrary.org/obo/MONDO_0010636) (Kallmann syndrome with spastic paraplegia), [MONDO:0011965](http://purl.obolibrary.org/obo/MONDO_0011965) (familial temporal lobe epilepsy 2), [MONDO:0010633](http://purl.obolibrary.org/obo/MONDO_0010633) (iris hypoplasia with glaucoma), [MONDO:0011964](http://purl.obolibrary.org/obo/MONDO_0011964) (DPAGT1-CDG), [MONDO:0010634](http://purl.obolibrary.org/obo/MONDO_0010634) (jaundice, familial obstructive, of infancy), [MONDO:0008382](http://purl.obolibrary.org/obo/MONDO_0008382) (retinoschisis, autosomal dominant), [MONDO:0008384](http://purl.obolibrary.org/obo/MONDO_0008384) (rheumatoid Nodulosis), [MONDO:0008385](http://purl.obolibrary.org/obo/MONDO_0008385) (Rhiny), [MONDO:0008386](http://purl.obolibrary.org/obo/MONDO_0008386) (Axenfeld-Rieger syndrome type 1), [MONDO:0001745](http://purl.obolibrary.org/obo/MONDO_0001745) (subserous uterine fibroid), [MONDO:0019032](http://purl.obolibrary.org/obo/MONDO_0019032) (X-linked intellectual disability with isolated growth hormone deficiency), [MONDO:0019031](http://purl.obolibrary.org/obo/MONDO_0019031) (thrombocytopenia with congenital dyserythropoietic anemia), [MONDO:0007049](http://purl.obolibrary.org/obo/MONDO_0007049) (acroleukopathy, symmetric), [MONDO:0007047](http://purl.obolibrary.org/obo/MONDO_0007047) (punctate palmoplantar keratoderma type III), [MONDO:0007046](http://purl.obolibrary.org/obo/MONDO_0007046) (hereditary papulotranslucent acrokeratoderma), [MONDO:0013736](http://purl.obolibrary.org/obo/MONDO_0013736) (myopathy, centronuclear, 3), [MONDO:0012402](http://purl.obolibrary.org/obo/MONDO_0012402) (opioid dependence, susceptibility to, 1), [MONDO:0013737](http://purl.obolibrary.org/obo/MONDO_0013737) (hereditary spastic paraplegia 46), [MONDO:0007042](http://purl.obolibrary.org/obo/MONDO_0007042) (Saethre-Chotzen syndrome), [MONDO:0013738](http://purl.obolibrary.org/obo/MONDO_0013738) (autosomal recessive nonsyndromic deafness 96), [MONDO:0012407](http://purl.obolibrary.org/obo/MONDO_0012407) (Pyridoxal phosphate-responsive seizures), [MONDO:0013731](http://purl.obolibrary.org/obo/MONDO_0013731) (early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome), [MONDO:0012406](http://purl.obolibrary.org/obo/MONDO_0012406) (HRPT3), [MONDO:0013732](http://purl.obolibrary.org/obo/MONDO_0013732) (glucocorticoid Therapy, response to), [MONDO:0012405](http://purl.obolibrary.org/obo/MONDO_0012405) (polyposis syndrome, hereditary mixed, 2), [MONDO:0013733](http://purl.obolibrary.org/obo/MONDO_0013733) (accelerated tumor formation, susceptibility to), [MONDO:0008371](http://purl.obolibrary.org/obo/MONDO_0008371) (Dowling-Degos disease), [MONDO:0019027](http://purl.obolibrary.org/obo/MONDO_0019027) (otopalatodigital syndrome), [MONDO:0000429](http://purl.obolibrary.org/obo/MONDO_0000429) (autosomal genetic disease), [MONDO:0008374](http://purl.obolibrary.org/obo/MONDO_0008374) (retinal cone dystrophy type 1), [MONDO:0010694](http://purl.obolibrary.org/obo/MONDO_0010694) (nystagmus, myoclonic), [MONDO:0010691](http://purl.obolibrary.org/obo/MONDO_0010691) (Norrie disease), [MONDO:0008375](http://purl.obolibrary.org/obo/MONDO_0008375) (retinal detachment), [MONDO:0008376](http://purl.obolibrary.org/obo/MONDO_0008376) (retinal venous Beading), [MONDO:0010692](http://purl.obolibrary.org/obo/MONDO_0010692) (nuclear Ribonucleic acid), [MONDO:0000425](http://purl.obolibrary.org/obo/MONDO_0000425) (X-linked disease), [MONDO:0000426](http://purl.obolibrary.org/obo/MONDO_0000426) (autosomal dominant disease), [MONDO:0000428](http://purl.obolibrary.org/obo/MONDO_0000428) (Y-linked disease), [MONDO:0000421](http://purl.obolibrary.org/obo/MONDO_0000421) (inborn serine deficiency), [MONDO:0000422](http://purl.obolibrary.org/obo/MONDO_0000422) (inborn glycogen metabolism disorder), [MONDO:0000424](http://purl.obolibrary.org/obo/MONDO_0000424) (inborn vitamin B12 deficiency (disease)), [MONDO:0000420](http://purl.obolibrary.org/obo/MONDO_0000420) (cerebral folate receptor alpha deficiency), [MONDO:0013728](http://purl.obolibrary.org/obo/MONDO_0013728) (pregnancy loss, recurrent, susceptibility to, 2), [MONDO:0013729](http://purl.obolibrary.org/obo/MONDO_0013729) (pregnancy loss, recurrent, susceptibility to, 3), [MONDO:0007057](http://purl.obolibrary.org/obo/MONDO_0007057) (acroosteolysis dominant type), [MONDO:0013724](http://purl.obolibrary.org/obo/MONDO_0013724) (bacteremia, susceptibility to, 2), [MONDO:0010697](http://purl.obolibrary.org/obo/MONDO_0010697) (OPEM), [MONDO:0013725](http://purl.obolibrary.org/obo/MONDO_0013725) (colorectal cancer, hereditary nonpolyposis, type 7), [MONDO:0010698](http://purl.obolibrary.org/obo/MONDO_0010698) (early-onset X-linked optic atrophy), [MONDO:0013726](http://purl.obolibrary.org/obo/MONDO_0013726) (lethal encephalopathy due to mitochondrial and peroxisomal fission defect), [MONDO:0007054](http://purl.obolibrary.org/obo/MONDO_0007054) (acromial dimples), [MONDO:0010695](http://purl.obolibrary.org/obo/MONDO_0010695) (occipital hair, white Lock of), [MONDO:0010696](http://purl.obolibrary.org/obo/MONDO_0010696) (omphalocele, X-linked), [MONDO:0007053](http://purl.obolibrary.org/obo/MONDO_0007053) (restless legs syndrome 1), [MONDO:0013727](http://purl.obolibrary.org/obo/MONDO_0013727) (pregnancy loss, recurrent, susceptibility to, 1), [MONDO:0010699](http://purl.obolibrary.org/obo/MONDO_0010699) (Charcot-Marie-tooth disease X-linked recessive 5), [MONDO:0007050](http://purl.obolibrary.org/obo/MONDO_0007050) (acromegaloid changes, cutis verticis gyrata, and corneal leukoma), [MONDO:0013723](http://purl.obolibrary.org/obo/MONDO_0013723) (bacteremia, susceptibility to, 1), [MONDO:0008361](http://purl.obolibrary.org/obo/MONDO_0008361) (radius, aplasia of, with cleft lip/palate), [MONDO:0019016](http://purl.obolibrary.org/obo/MONDO_0019016) (maternally-inherited progressive external ophthalmoplegia), [MONDO:0010682](http://purl.obolibrary.org/obo/MONDO_0010682) (myoclonic epilepsy, progressive), [MONDO:0008362](http://purl.obolibrary.org/obo/MONDO_0008362) (Ragweed sensitivity), [MONDO:0001728](http://purl.obolibrary.org/obo/MONDO_0001728) (active vestibular Meniere's disease), [MONDO:0010683](http://purl.obolibrary.org/obo/MONDO_0010683) (X-linked centronuclear myopathy), [MONDO:0008363](http://purl.obolibrary.org/obo/MONDO_0008363) (Raindrop hypopigmentation), [MONDO:0001727](http://purl.obolibrary.org/obo/MONDO_0001727) (active cochleovestibular Meniere's disease), [MONDO:0019017](http://purl.obolibrary.org/obo/MONDO_0019017) (short fifth metacarpals-insulin resistance syndrome), [MONDO:0008364](http://purl.obolibrary.org/obo/MONDO_0008364) (Raynaud disease), [MONDO:0019014](http://purl.obolibrary.org/obo/MONDO_0019014) (mutilating palmoplantar keratoderma with periorificial keratotic plaques), [MONDO:0010680](http://purl.obolibrary.org/obo/MONDO_0010680) (X-linked Emery-Dreifuss muscular dystrophy), [MONDO:0008365](http://purl.obolibrary.org/obo/MONDO_0008365) (recombinant 8 syndrome), [MONDO:0001729](http://purl.obolibrary.org/obo/MONDO_0001729) (active cochlear Meniere's disease), [MONDO:0010681](http://purl.obolibrary.org/obo/MONDO_0010681) (Myelolymphatic insufficiency), [MONDO:0009696](http://purl.obolibrary.org/obo/MONDO_0009696) (juvenile myoclonic epilepsy), [MONDO:0019012](http://purl.obolibrary.org/obo/MONDO_0019012) (Carpenter syndrome), [MONDO:0008366](http://purl.obolibrary.org/obo/MONDO_0008366) (red cell Permeability defect), [MONDO:0008367](http://purl.obolibrary.org/obo/MONDO_0008367) (red cell phospholipid defect with hemolysis), [MONDO:0019010](http://purl.obolibrary.org/obo/MONDO_0019010) (congenital isolated hyperinsulinism), [MONDO:0008368](http://purl.obolibrary.org/obo/MONDO_0008368) (autosomal dominant distal renal tubular acidosis), [MONDO:0008369](http://purl.obolibrary.org/obo/MONDO_0008369) (proximal renal tubular acidosis), [MONDO:0007029](http://purl.obolibrary.org/obo/MONDO_0007029) (branchio-oto-renal syndrome), [MONDO:0013717](http://purl.obolibrary.org/obo/MONDO_0013717) (asphyxiating thoracic dystrophy 5), [MONDO:0013718](http://purl.obolibrary.org/obo/MONDO_0013718) (nephronophthisis 13), [MONDO:0013719](http://purl.obolibrary.org/obo/MONDO_0013719) (cranioectodermal dysplasia 4), [MONDO:0010686](http://purl.obolibrary.org/obo/MONDO_0010686) (N syndrome), [MONDO:0013713](http://purl.obolibrary.org/obo/MONDO_0013713) (dengue virus, susceptibility to), [MONDO:0013714](http://purl.obolibrary.org/obo/MONDO_0013714) (Mannose-Binding protein deficiency), [MONDO:0010687](http://purl.obolibrary.org/obo/MONDO_0010687) (nephrolithiasis, X-linked recessive, with renal failure), [MONDO:0013715](http://purl.obolibrary.org/obo/MONDO_0013715) (amyotrophic lateral sclerosis type 16), [MONDO:0010685](http://purl.obolibrary.org/obo/MONDO_0010685) (MYP1), [MONDO:0013716](http://purl.obolibrary.org/obo/MONDO_0013716) (AAA4), [MONDO:0013710](http://purl.obolibrary.org/obo/MONDO_0013710) (colorectal cancer, hereditary nonpolyposis, type 5), [MONDO:0013711](http://purl.obolibrary.org/obo/MONDO_0013711) (peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome), [MONDO:0010688](http://purl.obolibrary.org/obo/MONDO_0010688) (neuropathy, hereditary sensory, X-linked), [MONDO:0010689](http://purl.obolibrary.org/obo/MONDO_0010689) (Charcot-Marie-tooth disease X-linked recessive 4), [MONDO:0013712](http://purl.obolibrary.org/obo/MONDO_0013712) (surfactant metabolism dysfunction, pulmonary, 5), [MONDO:0019008](http://purl.obolibrary.org/obo/MONDO_0019008) (benign recurrent intrahepatic cholestasis), [MONDO:0008350](http://purl.obolibrary.org/obo/MONDO_0008350) (pulmonic stenosis and deafness), [MONDO:0019005](http://purl.obolibrary.org/obo/MONDO_0019005) (nephronophthisis (disease)), [MONDO:0010671](http://purl.obolibrary.org/obo/MONDO_0010671) (microphthalmia, syndromic 1), [MONDO:0008351](http://purl.obolibrary.org/obo/MONDO_0008351) (pupil, egg-shaped), [MONDO:0010672](http://purl.obolibrary.org/obo/MONDO_0010672) (microphthalmia with linear skin defects syndrome), [MONDO:0009683](http://purl.obolibrary.org/obo/MONDO_0009683) (autosomal recessive limb-girdle muscular dystrophy type 2H), [MONDO:0008352](http://purl.obolibrary.org/obo/MONDO_0008352) (pupillary membrane, persistence of), [MONDO:0019003](http://purl.obolibrary.org/obo/MONDO_0019003) (multiple endocrine neoplasia type 2), [MONDO:0009684](http://purl.obolibrary.org/obo/MONDO_0009684) (muscular hypertonia, lethal), [MONDO:0010670](http://purl.obolibrary.org/obo/MONDO_0010670) (X-linked intellectual disability-spastic quadriparesis syndrome), [MONDO:0008354](http://purl.obolibrary.org/obo/MONDO_0008354) (purpura simplex), [MONDO:0009685](http://purl.obolibrary.org/obo/MONDO_0009685) (Miyoshi myopathy), [MONDO:0008355](http://purl.obolibrary.org/obo/MONDO_0008355) (IHPS1), [MONDO:0009686](http://purl.obolibrary.org/obo/MONDO_0009686) (musk, inability to smell), [MONDO:0001734](http://purl.obolibrary.org/obo/MONDO_0001734) (tuberous sclerosis), [MONDO:0008356](http://purl.obolibrary.org/obo/MONDO_0008356) (radial Heads, posterior dislocation of), [MONDO:0000406](http://purl.obolibrary.org/obo/MONDO_0000406) (brown-Vialetto-van Laere syndrome), [MONDO:0007039](http://purl.obolibrary.org/obo/MONDO_0007039) (neurofibromatosis type 2), [MONDO:0013706](http://purl.obolibrary.org/obo/MONDO_0013706) (MRT23), [MONDO:0007038](http://purl.obolibrary.org/obo/MONDO_0007038) (Achoo syndrome), [MONDO:0013707](http://purl.obolibrary.org/obo/MONDO_0013707) (MRT24), [MONDO:0013708](http://purl.obolibrary.org/obo/MONDO_0013708) (MRT25), [MONDO:0007036](http://purl.obolibrary.org/obo/MONDO_0007036) (Achard syndrome), [MONDO:0013709](http://purl.obolibrary.org/obo/MONDO_0013709) (MRT28), [MONDO:0007035](http://purl.obolibrary.org/obo/MONDO_0007035) (acanthosis nigricans (disease)), [MONDO:0013702](http://purl.obolibrary.org/obo/MONDO_0013702) (mental retardation, autosomal recessive 27), [MONDO:0013703](http://purl.obolibrary.org/obo/MONDO_0013703) (MRT33), [MONDO:0013704](http://purl.obolibrary.org/obo/MONDO_0013704) (MRT30), [MONDO:0010673](http://purl.obolibrary.org/obo/MONDO_0010673) (Modifier, X-linked, for Neurofunctional defects), [MONDO:0010674](http://purl.obolibrary.org/obo/MONDO_0010674) (mucopolysaccharidosis type 2), [MONDO:0013705](http://purl.obolibrary.org/obo/MONDO_0013705) (MRT19), [MONDO:0007031](http://purl.obolibrary.org/obo/MONDO_0007031) (familial abdominal aortic aneurysm), [MONDO:0010679](http://purl.obolibrary.org/obo/MONDO_0010679) (Duchenne muscular dystrophy), [MONDO:0007030](http://purl.obolibrary.org/obo/MONDO_0007030) (autosomal dominant Aarskog syndrome), [MONDO:0013700](http://purl.obolibrary.org/obo/MONDO_0013700) (pancreatic triacylglycerol lipase deficiency), [MONDO:0013701](http://purl.obolibrary.org/obo/MONDO_0013701) (MRT32), [MONDO:0007092](http://purl.obolibrary.org/obo/MONDO_0007092) (amelogenesis imperfecta type 1B), [MONDO:0007091](http://purl.obolibrary.org/obo/MONDO_0007091) (amelia and terminal transverse hemimelia), [MONDO:0013773](http://purl.obolibrary.org/obo/MONDO_0013773) (porencephaly 2), [MONDO:0007090](http://purl.obolibrary.org/obo/MONDO_0007090) (amastia, bilateral, with ureteral triplication and dysmorphism), [MONDO:0012442](http://purl.obolibrary.org/obo/MONDO_0012442) (autosomal recessive nonsyndromic deafness 66), [MONDO:0011111](http://purl.obolibrary.org/obo/MONDO_0011111) (Horns 1N sheep), [MONDO:0019075](http://purl.obolibrary.org/obo/MONDO_0019075) (Bosley-Salih-Alorainy syndrome), [MONDO:0000455](http://purl.obolibrary.org/obo/MONDO_0000455) (cone dystrophy), [MONDO:0000456](http://purl.obolibrary.org/obo/MONDO_0000456) (cerebral creatine deficiency syndrome), [MONDO:0016809](http://purl.obolibrary.org/obo/MONDO_0016809) (spinocerebellar ataxia with epilepsy), [MONDO:0016808](http://purl.obolibrary.org/obo/MONDO_0016808) (mitochondrial DNA depletion syndrome, hepatocerebral form), [MONDO:0016805](http://purl.obolibrary.org/obo/MONDO_0016805) (isolated oxidative phosphorylation complex disorder), [MONDO:0013779](http://purl.obolibrary.org/obo/MONDO_0013779) (Wiskott-Aldrich syndrome 2), [MONDO:0016804](http://purl.obolibrary.org/obo/MONDO_0016804) (exercise intolerance with lactic acidosis), [MONDO:0011115](http://purl.obolibrary.org/obo/MONDO_0011115) (spastic paraplegia and Evans syndrome), [MONDO:0016807](http://purl.obolibrary.org/obo/MONDO_0016807) (pure mitochondrial myopathy), [MONDO:0011114](http://purl.obolibrary.org/obo/MONDO_0011114) (familial multiple trichoepithelioma), [MONDO:0012445](http://purl.obolibrary.org/obo/MONDO_0012445) (autosomal recessive nonsyndromic deafness 59), [MONDO:0012444](http://purl.obolibrary.org/obo/MONDO_0012444) (neurodegeneration with brain iron accumulation 2b), [MONDO:0007086](http://purl.obolibrary.org/obo/MONDO_0007086) (autosomal dominant Alport syndrome), [MONDO:0016806](http://purl.obolibrary.org/obo/MONDO_0016806) (maternally-inherited mitochondrial dystonia), [MONDO:0016801](http://purl.obolibrary.org/obo/MONDO_0016801) (mitochondrial substrate carrier disorder), [MONDO:0016800](http://purl.obolibrary.org/obo/MONDO_0016800) (mitochondrial membrane transport disorder), [MONDO:0011119](http://purl.obolibrary.org/obo/MONDO_0011119) (iridogoniodysgenesis), [MONDO:0013776](http://purl.obolibrary.org/obo/MONDO_0013776) (spastic ataxia 5), [MONDO:0013777](http://purl.obolibrary.org/obo/MONDO_0013777) (pseudohypoaldosteronism type 2B), [MONDO:0012449](http://purl.obolibrary.org/obo/MONDO_0012449) (spinocerebellar ataxia type 23), [MONDO:0007083](http://purl.obolibrary.org/obo/MONDO_0007083) (autosomal dominant palmoplantar keratoderma and congenital alopecia), [MONDO:0016803](http://purl.obolibrary.org/obo/MONDO_0016803) (unspecified mitochondrial disorder), [MONDO:0013778](http://purl.obolibrary.org/obo/MONDO_0013778) (pseudohypoaldosteronism type 2C), [MONDO:0016802](http://purl.obolibrary.org/obo/MONDO_0016802) (mitochondrial protein import disorder), [MONDO:0011117](http://purl.obolibrary.org/obo/MONDO_0011117) (iris pigment epithelium anomalies), [MONDO:0013760](http://purl.obolibrary.org/obo/MONDO_0013760) (congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome), [MONDO:0013761](http://purl.obolibrary.org/obo/MONDO_0013761) (childhood encephalopathy due to thiamine pyrophosphokinase deficiency), [MONDO:0013762](http://purl.obolibrary.org/obo/MONDO_0013762) (Lipoic acid synthetase deficiency), [MONDO:0013763](http://purl.obolibrary.org/obo/MONDO_0013763) (Joubert syndrome 15), [MONDO:0011101](http://purl.obolibrary.org/obo/MONDO_0011101) (peroxisome biogenesis disorder 1B), [MONDO:0012432](http://purl.obolibrary.org/obo/MONDO_0012432) (Joubert syndrome 5), [MONDO:0011100](http://purl.obolibrary.org/obo/MONDO_0011100) (microcephaly, retinitis pigmentosa, and sutural cataract), [MONDO:0012430](http://purl.obolibrary.org/obo/MONDO_0012430) (cerebellar ataxia, mental retardation, and Dysequilibrium syndrome 2), [MONDO:0000463](http://purl.obolibrary.org/obo/MONDO_0000463) (urofacial syndrome), [MONDO:0013768](http://purl.obolibrary.org/obo/MONDO_0013768) (arterial calcification, generalized, of infancy, 2), [MONDO:0012436](http://purl.obolibrary.org/obo/MONDO_0012436) (neonatal diabetes mellitus with congenital hypothyroidism), [MONDO:0013769](http://purl.obolibrary.org/obo/MONDO_0013769) (atrioventricular septal defect 5), [MONDO:0007099](http://purl.obolibrary.org/obo/MONDO_0007099) (familial visceral amyloidosis), [MONDO:0012435](http://purl.obolibrary.org/obo/MONDO_0012435) (3-methylglutaconic aciduria type 5), [MONDO:0011103](http://purl.obolibrary.org/obo/MONDO_0011103) (autosomal dominant nonsyndromic deafness 3A), [MONDO:0007098](http://purl.obolibrary.org/obo/MONDO_0007098) (ACys amyloidosis), [MONDO:0007097](http://purl.obolibrary.org/obo/MONDO_0007097) (Finnish type amyloidosis), [MONDO:0011102](http://purl.obolibrary.org/obo/MONDO_0011102) (autosomal dominant nonsyndromic deafness 12), [MONDO:0012433](http://purl.obolibrary.org/obo/MONDO_0012433) (Senior-Loken syndrome 6), [MONDO:0013764](http://purl.obolibrary.org/obo/MONDO_0013764) (Joubert syndrome 16), [MONDO:0007096](http://purl.obolibrary.org/obo/MONDO_0007096) (amenorrhea-galactorrhea syndrome), [MONDO:0013765](http://purl.obolibrary.org/obo/MONDO_0013765) (coronary heart disease, susceptibility to, 6), [MONDO:0012439](http://purl.obolibrary.org/obo/MONDO_0012439) (Alagille syndrome due to a NOTCH2 point mutation), [MONDO:0013766](http://purl.obolibrary.org/obo/MONDO_0013766) (familial cold autoinflammatory syndrome 3), [MONDO:0007094](http://purl.obolibrary.org/obo/MONDO_0007094) (amelogenesis imperfecta type 1A), [MONDO:0013767](http://purl.obolibrary.org/obo/MONDO_0013767) (autoimmune lymphoproliferative syndrome type 4), [MONDO:0007093](http://purl.obolibrary.org/obo/MONDO_0007093) (hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism), [MONDO:0013751](http://purl.obolibrary.org/obo/MONDO_0013751) (cutis laxa, autosomal dominant 2), [MONDO:0012421](http://purl.obolibrary.org/obo/MONDO_0012421) (autosomal recessive nonsyndromic deafness 44), [MONDO:0012420](http://purl.obolibrary.org/obo/MONDO_0012420) (autosomal recessive nonsyndromic deafness 49), [MONDO:0020045](http://purl.obolibrary.org/obo/MONDO_0020045) (autosomal recessive cerebellar ataxia due to a DNA repair defect), [MONDO:0020046](http://purl.obolibrary.org/obo/MONDO_0020046) (autosomal recessive degenerative and progressive cerebellar ataxia), [MONDO:0020047](http://purl.obolibrary.org/obo/MONDO_0020047) (autosomal recessive syndromic cerebellar ataxia), [MONDO:0000438](http://purl.obolibrary.org/obo/MONDO_0000438) (ataxia with oculomotor apraxia type 2), [MONDO:0019052](http://purl.obolibrary.org/obo/MONDO_0019052) (inborn errors of metabolism), [MONDO:0019053](http://purl.obolibrary.org/obo/MONDO_0019053) (peroxisomal disease), [MONDO:0001761](http://purl.obolibrary.org/obo/MONDO_0001761) (favism), [MONDO:0020043](http://purl.obolibrary.org/obo/MONDO_0020043) (autosomal recessive congenital cerebellar ataxia), [MONDO:0007068](http://purl.obolibrary.org/obo/MONDO_0007068) (Adenylosuccinate lyase deficiency), [MONDO:0020044](http://purl.obolibrary.org/obo/MONDO_0020044) (autosomal recessive metabolic cerebellar ataxia), [MONDO:0007067](http://purl.obolibrary.org/obo/MONDO_0007067) (pyruvate kinase hyperactivity), [MONDO:0007066](http://purl.obolibrary.org/obo/MONDO_0007066) (adenosine triphosphatase deficiency, anemia due to), [MONDO:0013758](http://purl.obolibrary.org/obo/MONDO_0013758) (Charcot-Marie-tooth disease dominant intermediate E), [MONDO:0012424](http://purl.obolibrary.org/obo/MONDO_0012424) (heat-shock Rna 1), [MONDO:0013759](http://purl.obolibrary.org/obo/MONDO_0013759) (MITF-related melanoma and renal cell carcinoma predisposition syndrome), [MONDO:0012423](http://purl.obolibrary.org/obo/MONDO_0012423) (MORM syndrome), [MONDO:0007065](http://purl.obolibrary.org/obo/MONDO_0007065) (adenosine deaminase, elevated, hemolytic anemia due to), [MONDO:0007064](http://purl.obolibrary.org/obo/MONDO_0007064) (adenosine deaminase deficiency), [MONDO:0013753](http://purl.obolibrary.org/obo/MONDO_0013753) (Charcot-Marie-tooth disease axonal type 2P), [MONDO:0012429](http://purl.obolibrary.org/obo/MONDO_0012429) (Aicardi-Goutieres syndrome 2), [MONDO:0012428](http://purl.obolibrary.org/obo/MONDO_0012428) (KYPSC1), [MONDO:0013755](http://purl.obolibrary.org/obo/MONDO_0013755) (PYCR1-related de Barsy syndrome), [MONDO:0012427](http://purl.obolibrary.org/obo/MONDO_0012427) (Loeys-Dietz syndrome 2), [MONDO:0007061](http://purl.obolibrary.org/obo/MONDO_0007061) (acylase, cobalt-activated), [MONDO:0012426](http://purl.obolibrary.org/obo/MONDO_0012426) (immunodeficiency 25), [MONDO:0008391](http://purl.obolibrary.org/obo/MONDO_0008391) (Robinow-Sorauf syndrome), [MONDO:0007080](http://purl.obolibrary.org/obo/MONDO_0007080) (glucocorticoid-remediable aldosteronism), [MONDO:0008393](http://purl.obolibrary.org/obo/MONDO_0008393) (Rubinstein-Taybi syndrome due to CREBBP mutations), [MONDO:0008394](http://purl.obolibrary.org/obo/MONDO_0008394) (Silver-Russell syndrome), [MONDO:0013741](http://purl.obolibrary.org/obo/MONDO_0013741) (familial temporal lobe epilepsy 5), [MONDO:0008395](http://purl.obolibrary.org/obo/MONDO_0008395) (Ruvalcaba syndrome), [MONDO:0012410](http://purl.obolibrary.org/obo/MONDO_0012410) (finnish upper limb-onset distal myopathy), [MONDO:0008398](http://purl.obolibrary.org/obo/MONDO_0008398) (salivary substance, clostridium botulinum type), [MONDO:0000447](http://purl.obolibrary.org/obo/MONDO_0000447) (polycystic liver disease (disease)), [MONDO:0000443](http://purl.obolibrary.org/obo/MONDO_0000443) (adenylosuccinase lyase deficiency), [MONDO:0012419](http://purl.obolibrary.org/obo/MONDO_0012419) (age related macular degeneration 7), [MONDO:0007078](http://purl.obolibrary.org/obo/MONDO_0007078) (Albright's hereditary osteodystrophy), [MONDO:0013746](http://purl.obolibrary.org/obo/MONDO_0013746) (ventricular septal defect 1), [MONDO:0012414](http://purl.obolibrary.org/obo/MONDO_0012414) (neuronal ceroid lipofuscinosis 10), [MONDO:0013747](http://purl.obolibrary.org/obo/MONDO_0013747) (atrioventricular septal defect 4), [MONDO:0007077](http://purl.obolibrary.org/obo/MONDO_0007077) (Tietz syndrome), [MONDO:0013748](http://purl.obolibrary.org/obo/MONDO_0013748) (ventricular septal defect 2), [MONDO:0013749](http://purl.obolibrary.org/obo/MONDO_0013749) (ventricular septal defect 3), [MONDO:0012418](http://purl.obolibrary.org/obo/MONDO_0012418) (autosomal recessive nonsyndromic deafness 62), [MONDO:0013742](http://purl.obolibrary.org/obo/MONDO_0013742) (familial mesial temporal lobe epilepsy with febrile seizures), [MONDO:0007074](http://purl.obolibrary.org/obo/MONDO_0007074) (ainhum (disease)), [MONDO:0012417](http://purl.obolibrary.org/obo/MONDO_0012417) (heart-hand syndrome, Slovenian type), [MONDO:0007072](http://purl.obolibrary.org/obo/MONDO_0007072) (adult syndrome), [MONDO:0012416](http://purl.obolibrary.org/obo/MONDO_0012416) (Devriendt syndrome), [MONDO:0013745](http://purl.obolibrary.org/obo/MONDO_0013745) (Joubert syndrome 14), [MONDO:0012415](http://purl.obolibrary.org/obo/MONDO_0012415) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal dominant 4), [MONDO:0011152](http://purl.obolibrary.org/obo/MONDO_0011152) (PHGDH deficiency), [MONDO:0012481](http://purl.obolibrary.org/obo/MONDO_0012481) (mevalonic aciduria), [MONDO:0012480](http://purl.obolibrary.org/obo/MONDO_0012480) (diabetes mellitus, transient neonatal, 2), [MONDO:0011156](http://purl.obolibrary.org/obo/MONDO_0011156) (progressive familial intrahepatic cholestasis type 2), [MONDO:0011155](http://purl.obolibrary.org/obo/MONDO_0011155) (vacuolar Neuromyopathy), [MONDO:0012486](http://purl.obolibrary.org/obo/MONDO_0012486) (preauricular tag, isolated, autosomal dominant, 1), [MONDO:0012485](http://purl.obolibrary.org/obo/MONDO_0012485) (autosomal recessive nonsyndromic deafness 68), [MONDO:0011153](http://purl.obolibrary.org/obo/MONDO_0011153) (hyperinsulinemic hypoglycemia, familial, 2), [MONDO:0012484](http://purl.obolibrary.org/obo/MONDO_0012484) (prosopagnosia, hereditary), [MONDO:0003527](http://purl.obolibrary.org/obo/MONDO_0003527) (Ferguson-Smith tumor), [MONDO:0011159](http://purl.obolibrary.org/obo/MONDO_0011159) (autosomal dominant nonsyndromic deafness 13), [MONDO:0015517](http://purl.obolibrary.org/obo/MONDO_0015517) (common variable immunodeficiency), [MONDO:0011158](http://purl.obolibrary.org/obo/MONDO_0011158) (autoimmune lymphoproliferative syndrome type 1), [MONDO:0012488](http://purl.obolibrary.org/obo/MONDO_0012488) (hepatitis b virus, susceptibility to), [MONDO:0015515](http://purl.obolibrary.org/obo/MONDO_0015515) (carnitine palmitoyltransferase II deficiency), [MONDO:0011141](http://purl.obolibrary.org/obo/MONDO_0011141) (folate level 1N erythrocytes), [MONDO:0016830](http://purl.obolibrary.org/obo/MONDO_0016830) (Emery-Dreifuss muscular dystrophy), [MONDO:0012472](http://purl.obolibrary.org/obo/MONDO_0012472) (Aicardi-Goutieres syndrome 4), [MONDO:0012471](http://purl.obolibrary.org/obo/MONDO_0012471) (Aicardi-Goutieres syndrome 3), [MONDO:0011145](http://purl.obolibrary.org/obo/MONDO_0011145) (colobomatous microphthalmia-obesity-hypogenitalism-intellectual disability syndrome), [MONDO:0011144](http://purl.obolibrary.org/obo/MONDO_0011144) (neuronal ceroid lipofuscinosis 6), [MONDO:0012475](http://purl.obolibrary.org/obo/MONDO_0012475) (cone dystrophy with supernormal rod response), [MONDO:0012474](http://purl.obolibrary.org/obo/MONDO_0012474) (autosomal dominant nocturnal frontal lobe epilepsy 4), [MONDO:0011142](http://purl.obolibrary.org/obo/MONDO_0011142) (Ehlers-Danlos syndrome, musculocontractural type), [MONDO:0012473](http://purl.obolibrary.org/obo/MONDO_0012473) (right pulmonary artery, anomalous origin of, familial), [MONDO:0020093](http://purl.obolibrary.org/obo/MONDO_0020093) (autosomal dominant isolated diffuse palmoplantar keratoderma), [MONDO:0020094](http://purl.obolibrary.org/obo/MONDO_0020094) (autosomal dominant disease with diffuse palmoplantar keratoderma as a major feature), [MONDO:0020095](http://purl.obolibrary.org/obo/MONDO_0020095) (autosomal dominant disease associated with focal palmoplantar keratoderma as a major feature), [MONDO:0020096](http://purl.obolibrary.org/obo/MONDO_0020096) (autosomal recessive isolated diffuse palmoplantar keratoderma), [MONDO:0020097](http://purl.obolibrary.org/obo/MONDO_0020097) (autosomal recessive disease with focal palmoplantar keratoderma as a major feature), [MONDO:0011148](http://purl.obolibrary.org/obo/MONDO_0011148) (Spondylospinal thoracic dysostosis), [MONDO:0011147](http://purl.obolibrary.org/obo/MONDO_0011147) (chromosome 18q deletion syndrome), [MONDO:0011146](http://purl.obolibrary.org/obo/MONDO_0011146) (tetrasomy 12p), [MONDO:0012461](http://purl.obolibrary.org/obo/MONDO_0012461) (bulimia nervosa, susceptibility to, 2), [MONDO:0011130](http://purl.obolibrary.org/obo/MONDO_0011130) (sebaceous gland hyperplasia, familial presenile), [MONDO:0013793](http://purl.obolibrary.org/obo/MONDO_0013793) (encephalomyopathy, mitochondrial, due to Voltage-dependent Anion channel deficiency), [MONDO:0012460](http://purl.obolibrary.org/obo/MONDO_0012460) (autosomal recessive nonsyndromic deafness 67), [MONDO:0013796](http://purl.obolibrary.org/obo/MONDO_0013796) (chromosome 17q12 duplication syndrome), [MONDO:0012465](http://purl.obolibrary.org/obo/MONDO_0012465) (hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency), [MONDO:0011132](http://purl.obolibrary.org/obo/MONDO_0011132) (T-cell immunodeficiency, congenital alopecia, and nail dystrophy), [MONDO:0020088](http://purl.obolibrary.org/obo/MONDO_0020088) (familial partial lipodystrophy), [MONDO:0012469](http://purl.obolibrary.org/obo/MONDO_0012469) (MYP14), [MONDO:0012468](http://purl.obolibrary.org/obo/MONDO_0012468) (rhizomelic dysplasia, scoliosis, and retinitis pigmentosa), [MONDO:0016826](http://purl.obolibrary.org/obo/MONDO_0016826) (methylmalonic acidemia with homocystinuria), [MONDO:0012467](http://purl.obolibrary.org/obo/MONDO_0012467) (cold-induced sweating syndrome 2), [MONDO:0016828](http://purl.obolibrary.org/obo/MONDO_0016828) (autosomal recessive sideroblastic anemia), [MONDO:0011135](http://purl.obolibrary.org/obo/MONDO_0011135) (superior transverse scapular ligament, calcification of, familial), [MONDO:0013797](http://purl.obolibrary.org/obo/MONDO_0013797) (chromosome 17q12 deletion syndrome), [MONDO:0013798](http://purl.obolibrary.org/obo/MONDO_0013798) (chromosome 16q22 deletion syndrome), [MONDO:0013799](http://purl.obolibrary.org/obo/MONDO_0013799) (Efavirenz, poor metabolism of), [MONDO:0013782](http://purl.obolibrary.org/obo/MONDO_0013782) (pseudohypoaldosteronism type 2E), [MONDO:0012450](http://purl.obolibrary.org/obo/MONDO_0012450) (spinocerebellar ataxia type 28), [MONDO:0016810](http://purl.obolibrary.org/obo/MONDO_0016810) (autosomal recessive progressive external ophthalmoplegia), [MONDO:0013784](http://purl.obolibrary.org/obo/MONDO_0013784) (lethal neonatal spasticity-epileptic encephalopathy syndrome), [MONDO:0013785](http://purl.obolibrary.org/obo/MONDO_0013785) (mental retardation, autosomal recessive 34), [MONDO:0012454](http://purl.obolibrary.org/obo/MONDO_0012454) (alcohol sensitivity, acute), [MONDO:0012452](http://purl.obolibrary.org/obo/MONDO_0012452) (autosomal recessive nonsyndromic deafness 65), [MONDO:0013781](http://purl.obolibrary.org/obo/MONDO_0013781) (pseudohypoaldosteronism type 2D), [MONDO:0012451](http://purl.obolibrary.org/obo/MONDO_0012451) (EOE1), [MONDO:0019083](http://purl.obolibrary.org/obo/MONDO_0019083) (Leigh syndrome with cardiomyopathy), [MONDO:0020075](http://purl.obolibrary.org/obo/MONDO_0020075) (genetic non-syndromic obesity), [MONDO:0011127](http://purl.obolibrary.org/obo/MONDO_0011127) (Bartter disease type 1), [MONDO:0016816](http://purl.obolibrary.org/obo/MONDO_0016816) (Leigh syndrome with nephrotic syndrome), [MONDO:0011126](http://purl.obolibrary.org/obo/MONDO_0011126) (acute insulin response), [MONDO:0012457](http://purl.obolibrary.org/obo/MONDO_0012457) (IHPS2), [MONDO:0016815](http://purl.obolibrary.org/obo/MONDO_0016815) (Leigh syndrome with leukodystrophy), [MONDO:0011125](http://purl.obolibrary.org/obo/MONDO_0011125) (trichothiodystrophy 1, photosensitive), [MONDO:0016817](http://purl.obolibrary.org/obo/MONDO_0016817) (Meier-Gorlin syndrome), [MONDO:0016811](http://purl.obolibrary.org/obo/MONDO_0016811) (renal tubulopathy-encephalopathy-liver failure syndrome), [MONDO:0013787](http://purl.obolibrary.org/obo/MONDO_0013787) (psychomotor retardation, epilepsy, and craniofacial dysmorphism), [MONDO:0011129](http://purl.obolibrary.org/obo/MONDO_0011129) (GLC1C), [MONDO:0016814](http://purl.obolibrary.org/obo/MONDO_0016814) (maternally-inherited Leigh syndrome), [MONDO:0013788](http://purl.obolibrary.org/obo/MONDO_0013788) (Usher syndrome type 3B), [MONDO:0013789](http://purl.obolibrary.org/obo/MONDO_0013789) (DDOST-CDG), [MONDO:0011128](http://purl.obolibrary.org/obo/MONDO_0011128) (Sheldon-hall syndrome), [MONDO:0015553](http://purl.obolibrary.org/obo/MONDO_0015553) (dystrophic epidermolysis bullosa, nails only), [MONDO:0011195](http://purl.obolibrary.org/obo/MONDO_0011195) (Usher syndrome type 1E), [MONDO:0014223](http://purl.obolibrary.org/obo/MONDO_0014223) (amyotrophic lateral sclerosis type 19), [MONDO:0014224](http://purl.obolibrary.org/obo/MONDO_0014224) (developmental delay with autism spectrum disorder and gait instability), [MONDO:0011193](http://purl.obolibrary.org/obo/MONDO_0011193) (cone dystrophy 3), [MONDO:0014225](http://purl.obolibrary.org/obo/MONDO_0014225) (hemochromatosis type 5), [MONDO:0015550](http://purl.obolibrary.org/obo/MONDO_0015550) (suprabasal epidermolysis bullosa simplex), [MONDO:0015552](http://purl.obolibrary.org/obo/MONDO_0015552) (acral dystrophic epidermolysis bullosa), [MONDO:0014220](http://purl.obolibrary.org/obo/MONDO_0014220) (myopathy due to Myoadenylate deaminase deficiency), [MONDO:0014221](http://purl.obolibrary.org/obo/MONDO_0014221) (triosephosphate isomerase deficiency), [MONDO:0015551](http://purl.obolibrary.org/obo/MONDO_0015551) (basal epidermolysis bullosa simplex), [MONDO:0011192](http://purl.obolibrary.org/obo/MONDO_0011192) (autosomal recessive nonsyndromic deafness 18A), [MONDO:0007926](http://purl.obolibrary.org/obo/MONDO_0007926) (Waldenstrom macroglobulinemia), [MONDO:0011191](http://purl.obolibrary.org/obo/MONDO_0011191) (hemangioma, capillary infantile), [MONDO:0007924](http://purl.obolibrary.org/obo/MONDO_0007924) (Bannayan-Riley-Ruvalcaba syndrome), [MONDO:0011190](http://purl.obolibrary.org/obo/MONDO_0011190) (nephronophthisis 2), [MONDO:0007923](http://purl.obolibrary.org/obo/MONDO_0007923) (macrocephaly, benign familial), [MONDO:0007920](http://purl.obolibrary.org/obo/MONDO_0007920) (Meige disease), [MONDO:0014226](http://purl.obolibrary.org/obo/MONDO_0014226) (idiopathic CD4 lymphocytopenia), [MONDO:0019915](http://purl.obolibrary.org/obo/MONDO_0019915) (maternal uniparental disomy of chromosome 14), [MONDO:0014227](http://purl.obolibrary.org/obo/MONDO_0014227) (hypopigmentation-punctate palmoplantar keratoderma syndrome), [MONDO:0019913](http://purl.obolibrary.org/obo/MONDO_0019913) (silver-Russell syndrome due to maternal uniparental disomy of chromosome 7), [MONDO:0014211](http://purl.obolibrary.org/obo/MONDO_0014211) (primary ciliary dyskinesia 26), [MONDO:0014212](http://purl.obolibrary.org/obo/MONDO_0014212) (sulfite oxidase deficiency due to molybdenum cofactor deficiency type c), [MONDO:0011183](http://purl.obolibrary.org/obo/MONDO_0011183) (Paget disease of bone 2, early-onset), [MONDO:0011182](http://purl.obolibrary.org/obo/MONDO_0011182) (trimethylaminuria (disease)), [MONDO:0014214](http://purl.obolibrary.org/obo/MONDO_0014214) (short-rib thoracic dysplasia 8 with or without polydactyly), [MONDO:0011186](http://purl.obolibrary.org/obo/MONDO_0011186) (Usher syndrome type 1F), [MONDO:0007937](http://purl.obolibrary.org/obo/MONDO_0007937) (renal hypomagnesemia 2), [MONDO:0011180](http://purl.obolibrary.org/obo/MONDO_0011180) (broad terminal phalanges, familial), [MONDO:0007932](http://purl.obolibrary.org/obo/MONDO_0007932) (age related macular degeneration 2), [MONDO:0014219](http://purl.obolibrary.org/obo/MONDO_0014219) (alacrima, achalasia, and mental retardation syndrome), [MONDO:0014215](http://purl.obolibrary.org/obo/MONDO_0014215) (primary ciliary dyskinesia 27), [MONDO:0014216](http://purl.obolibrary.org/obo/MONDO_0014216) (primary ciliary dyskinesia 28), [MONDO:0014217](http://purl.obolibrary.org/obo/MONDO_0014217) (telangiectasia, hereditary hemorrhagic, type 5), [MONDO:0016863](http://purl.obolibrary.org/obo/MONDO_0016863) (Okihiro syndrome due to 20q13 microdeletion), [MONDO:0011174](http://purl.obolibrary.org/obo/MONDO_0011174) (Hyperzincemia with functional zinc depletion), [MONDO:0014201](http://purl.obolibrary.org/obo/MONDO_0014201) (early infantile epileptic encephalopathy without suppression burst), [MONDO:0016862](http://purl.obolibrary.org/obo/MONDO_0016862) (Alagille syndrome due to a JAG1 point mutation), [MONDO:0011172](http://purl.obolibrary.org/obo/MONDO_0011172) (Otofacioosseous-gonadal syndrome), [MONDO:0014202](http://purl.obolibrary.org/obo/MONDO_0014202) (primary ciliary dyskinesia 24), [MONDO:0016864](http://purl.obolibrary.org/obo/MONDO_0016864) (Okihiro syndrome due to a point mutation), [MONDO:0014203](http://purl.obolibrary.org/obo/MONDO_0014203) (primary ciliary dyskinesia 25), [MONDO:0016861](http://purl.obolibrary.org/obo/MONDO_0016861) (Alagille syndrome due to 20p12 microdeletion), [MONDO:0011176](http://purl.obolibrary.org/obo/MONDO_0011176) (intestinal hypomagnesemia 1), [MONDO:0016860](http://purl.obolibrary.org/obo/MONDO_0016860) (familial adenomatous polyposis due to 5q22.2 microdeletion), [MONDO:0011175](http://purl.obolibrary.org/obo/MONDO_0011175) (FRDA2), [MONDO:0007906](http://purl.obolibrary.org/obo/MONDO_0007906) (familial partial lipodystrophy, Dunnigan type), [MONDO:0007905](http://purl.obolibrary.org/obo/MONDO_0007905) (lip, hamartomatous), [MONDO:0011170](http://purl.obolibrary.org/obo/MONDO_0011170) (autosomal recessive limb-girdle muscular dystrophy type 2G), [MONDO:0007903](http://purl.obolibrary.org/obo/MONDO_0007903) (Li-Fraumeni syndrome 1), [MONDO:0007902](http://purl.obolibrary.org/obo/MONDO_0007902) (lichen planus, familial), [MONDO:0007901](http://purl.obolibrary.org/obo/MONDO_0007901) (Levator-medial rectus synkinesis), [MONDO:0007900](http://purl.obolibrary.org/obo/MONDO_0007900) (nonsyndromic congenital nail disorder 3), [MONDO:0014208](http://purl.obolibrary.org/obo/MONDO_0014208) (Charcot-Marie-tooth disease type 2R), [MONDO:0011179](http://purl.obolibrary.org/obo/MONDO_0011179) (leishmaniasis, Tegumentary, susceptibility to), [MONDO:0014207](http://purl.obolibrary.org/obo/MONDO_0014207) (age related macular degeneration 14), [MONDO:0012494](http://purl.obolibrary.org/obo/MONDO_0012494) (testicular microlithiasis (disease)), [MONDO:0012493](http://purl.obolibrary.org/obo/MONDO_0012493) (RLS4), [MONDO:0011161](http://purl.obolibrary.org/obo/MONDO_0011161) (sperm-specific antigen 1), [MONDO:0012492](http://purl.obolibrary.org/obo/MONDO_0012492) (RLS3), [MONDO:0012491](http://purl.obolibrary.org/obo/MONDO_0012491) (WM2), [MONDO:0011160](http://purl.obolibrary.org/obo/MONDO_0011160) (autosomal recessive nonsyndromic deafness 15), [MONDO:0007919](http://purl.obolibrary.org/obo/MONDO_0007919) (lymphedema, hereditary, 1A), [MONDO:0007914](http://purl.obolibrary.org/obo/MONDO_0007914) (lumbar stenosis, familial), [MONDO:0007913](http://purl.obolibrary.org/obo/MONDO_0007913) (low density lipoprotein, variation 1N molecular weight of), [MONDO:0007912](http://purl.obolibrary.org/obo/MONDO_0007912) (Lithium transport), [MONDO:0007911](http://purl.obolibrary.org/obo/MONDO_0007911) (lipoprotein, variant of beta), [MONDO:0007910](http://purl.obolibrary.org/obo/MONDO_0007910) (lipoprotein types--Lt system), [MONDO:0004882](http://purl.obolibrary.org/obo/MONDO_0004882) (angioid streaks of choroid), [MONDO:0016859](http://purl.obolibrary.org/obo/MONDO_0016859) (blepharophimosis-epicanthus inversus-ptosis due to copy number variations), [MONDO:0011169](http://purl.obolibrary.org/obo/MONDO_0011169) (keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome), [MONDO:0012499](http://purl.obolibrary.org/obo/MONDO_0012499) (Buruli ulcer, susceptibility to), [MONDO:0015524](http://purl.obolibrary.org/obo/MONDO_0015524) (hyperplastic polyposis syndrome), [MONDO:0016858](http://purl.obolibrary.org/obo/MONDO_0016858) (blepharophimosis-epicanthus inversus-ptosis due to a point mutation syndrome), [MONDO:0015526](http://purl.obolibrary.org/obo/MONDO_0015526) (cold-induced sweating syndrome), [MONDO:0016857](http://purl.obolibrary.org/obo/MONDO_0016857) (blepharophimosis-epicanthus inversus-ptosis due to 3q23 rearrangement syndrome), [MONDO:0014266](http://purl.obolibrary.org/obo/MONDO_0014266) (age related macular degeneration 15), [MONDO:0014267](http://purl.obolibrary.org/obo/MONDO_0014267) (severe combined immunodeficiency due to IKK2 deficiency), [MONDO:0018625](http://purl.obolibrary.org/obo/MONDO_0018625) (classic stiff person syndrome), [MONDO:0014268](http://purl.obolibrary.org/obo/MONDO_0014268) (combined immunodeficiency due to OX40 deficiency), [MONDO:0014269](http://purl.obolibrary.org/obo/MONDO_0014269) (combined oxidative phosphorylation deficiency 19), [MONDO:0014262](http://purl.obolibrary.org/obo/MONDO_0014262) (Rienhoff syndrome), [MONDO:0014263](http://purl.obolibrary.org/obo/MONDO_0014263) (Verheij syndrome), [MONDO:0014264](http://purl.obolibrary.org/obo/MONDO_0014264) (OTSC10), [MONDO:0014260](http://purl.obolibrary.org/obo/MONDO_0014260) (immunodeficiency, common variable, 10), [MONDO:0014261](http://purl.obolibrary.org/obo/MONDO_0014261) (growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome), [MONDO:0005308](http://purl.obolibrary.org/obo/MONDO_0005308) (ciliopathy), [MONDO:0007968](http://purl.obolibrary.org/obo/MONDO_0007968) (melanoma tumor antigen Gp90), [MONDO:0007967](http://purl.obolibrary.org/obo/MONDO_0007967) (melanoma and neural system tumor syndrome), [MONDO:0007965](http://purl.obolibrary.org/obo/MONDO_0007965) (melanoma, malignant familial intraocular), [MONDO:0007964](http://purl.obolibrary.org/obo/MONDO_0007964) (dysplastic nevus syndrome), [MONDO:0007963](http://purl.obolibrary.org/obo/MONDO_0007963) (CMM1), [MONDO:0007962](http://purl.obolibrary.org/obo/MONDO_0007962) (Megalodactyly), [MONDO:0002273](http://purl.obolibrary.org/obo/MONDO_0002273) (plasma protein metabolism disease), [MONDO:0002272](http://purl.obolibrary.org/obo/MONDO_0002272) (polyclonal hypergammaglobulinemia), [MONDO:0002274](http://purl.obolibrary.org/obo/MONDO_0002274) (monoclonal paraproteinemia), [MONDO:0018629](http://purl.obolibrary.org/obo/MONDO_0018629) (focal stiff limb syndrome), [MONDO:0015587](http://purl.obolibrary.org/obo/MONDO_0015587) (rolandic epilepsy-speech dyspraxia syndrome), [MONDO:0014255](http://purl.obolibrary.org/obo/MONDO_0014255) (complement factor b deficiency), [MONDO:0015586](http://purl.obolibrary.org/obo/MONDO_0015586) (benign familial mesial temporal lobe epilepsy), [MONDO:0014258](http://purl.obolibrary.org/obo/MONDO_0014258) (congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome), [MONDO:0014251](http://purl.obolibrary.org/obo/MONDO_0014251) (melioidosis, susceptibility to), [MONDO:0015583](http://purl.obolibrary.org/obo/MONDO_0015583) (2p21 microdeletion syndrome), [MONDO:0014252](http://purl.obolibrary.org/obo/MONDO_0014252) (familial hypobetalipoproteinemia 1), [MONDO:0019941](http://purl.obolibrary.org/obo/MONDO_0019941) (hereditary sensory and autonomic neuropathy type 2), [MONDO:0014253](http://purl.obolibrary.org/obo/MONDO_0014253) (autoimmune lymphoproliferative syndrome type 3), [MONDO:0015581](http://purl.obolibrary.org/obo/MONDO_0015581) (bile acid synthesis defect with cholestasis and malabsorption), [MONDO:0014250](http://purl.obolibrary.org/obo/MONDO_0014250) (familial  hyperprolactinemia), [MONDO:0007976](http://purl.obolibrary.org/obo/MONDO_0007976) (mesomelic dwarfism of hypoplastic tibia and radius type), [MONDO:0007975](http://purl.obolibrary.org/obo/MONDO_0007975) (meralgia paraesthetica, familial), [MONDO:0005313](http://purl.obolibrary.org/obo/MONDO_0005313) (necrotizing enterocolitis), [MONDO:0007974](http://purl.obolibrary.org/obo/MONDO_0007974) (mental retardation, autosomal dominant 1), [MONDO:0007973](http://purl.obolibrary.org/obo/MONDO_0007973) (mental and growth retardation with amblyopia), [MONDO:0007972](http://purl.obolibrary.org/obo/MONDO_0007972) (Meniere disease), [MONDO:0014259](http://purl.obolibrary.org/obo/MONDO_0014259) (neuronopathy, distal hereditary motor, type 2D), [MONDO:0014244](http://purl.obolibrary.org/obo/MONDO_0014244) (hereditary sensory and autonomic neuropathy type 7), [MONDO:0014245](http://purl.obolibrary.org/obo/MONDO_0014245) (Diamond-Blackfan anemia 12), [MONDO:0018603](http://purl.obolibrary.org/obo/MONDO_0018603) (interstitial lung disease due to SP-c deficiency), [MONDO:0014246](http://purl.obolibrary.org/obo/MONDO_0014246) (episodic pain syndrome, familial, 2), [MONDO:0014243](http://purl.obolibrary.org/obo/MONDO_0014243) (Prader-Willi syndrome due to point mutation), [MONDO:0007948](http://purl.obolibrary.org/obo/MONDO_0007948) (marfanoid hypermobility syndrome), [MONDO:0007947](http://purl.obolibrary.org/obo/MONDO_0007947) (Marfan syndrome), [MONDO:0007945](http://purl.obolibrary.org/obo/MONDO_0007945) (mannose 6-phosphate receptor recognition defect, Lebanese type), [MONDO:0007944](http://purl.obolibrary.org/obo/MONDO_0007944) (Treacher-Collins syndrome 1), [MONDO:0007942](http://purl.obolibrary.org/obo/MONDO_0007942) (Mammastatin), [MONDO:0007941](http://purl.obolibrary.org/obo/MONDO_0007941) (malocclusion due to Protuberant upper Front teeth), [MONDO:0003582](http://purl.obolibrary.org/obo/MONDO_0003582) (hereditary breast ovarian cancer), [MONDO:0014248](http://purl.obolibrary.org/obo/MONDO_0014248) (autism spectrum disorder-epilepsy-arthrogryposis syndrome), [MONDO:0015579](http://purl.obolibrary.org/obo/MONDO_0015579) (Hb Bart's hydrops fetalis), [MONDO:0018604](http://purl.obolibrary.org/obo/MONDO_0018604) (familial colorectal cancer type X), [MONDO:0018605](http://purl.obolibrary.org/obo/MONDO_0018605) (disorders of pentose/polyol metabolism), [MONDO:0019923](http://purl.obolibrary.org/obo/MONDO_0019923) (Beckwith-Wiedemann syndrome due to paternal uniparental disomy of chromosome 11), [MONDO:0014235](http://purl.obolibrary.org/obo/MONDO_0014235) (chromosome 22q13 duplication syndrome), [MONDO:0014236](http://purl.obolibrary.org/obo/MONDO_0014236) (Ehlers-Danlos syndrome, musculocontractural type 2), [MONDO:0007958](http://purl.obolibrary.org/obo/MONDO_0007958) (familial medullary thyroid carcinoma), [MONDO:0007957](http://purl.obolibrary.org/obo/MONDO_0007957) (Mediosternal depigmentation line), [MONDO:0007955](http://purl.obolibrary.org/obo/MONDO_0007955) (Meckel's diverticulum), [MONDO:0006622](http://purl.obolibrary.org/obo/MONDO_0006622) (vulvar seborrheic keratosis), [MONDO:0006621](http://purl.obolibrary.org/obo/MONDO_0006621) (vulvar inverted follicular keratosis), [MONDO:0007952](http://purl.obolibrary.org/obo/MONDO_0007952) (maxillofacial dysostosis), [MONDO:0007951](http://purl.obolibrary.org/obo/MONDO_0007951) (Masticatory muscles, hypertrophy of), [MONDO:0014237](http://purl.obolibrary.org/obo/MONDO_0014237) (autosomal recessive nonsyndromic deafness 76), [MONDO:0016899](http://purl.obolibrary.org/obo/MONDO_0016899) (Duchenne and Becker muscular dystrophy), [MONDO:0017336](http://purl.obolibrary.org/obo/MONDO_0017336) (fatal infantile hypertrophic cardiomyopathy due to mitochondrial complex i deficiency), [MONDO:0017338](http://purl.obolibrary.org/obo/MONDO_0017338) (fatal multiple mitochondrial dysfunctions syndrome), [MONDO:0016006](http://purl.obolibrary.org/obo/MONDO_0016006) (Cockayne syndrome), [MONDO:0016001](http://purl.obolibrary.org/obo/MONDO_0016001) (2-hydroxyglutaric aciduria), [MONDO:0018662](http://purl.obolibrary.org/obo/MONDO_0018662) (autosomal recessive brachyolmia), [MONDO:0019992](http://purl.obolibrary.org/obo/MONDO_0019992) (pseudohypoparathyroidism), [MONDO:0009713](http://purl.obolibrary.org/obo/MONDO_0009713) (MYP18), [MONDO:0009715](http://purl.obolibrary.org/obo/MONDO_0009715) (myotonia congenita, autosomal recessive), [MONDO:0010705](http://purl.obolibrary.org/obo/MONDO_0010705) (Ouabain resistance), [MONDO:0009717](http://purl.obolibrary.org/obo/MONDO_0009717) (Schwartz-Jampel syndrome), [MONDO:0010706](http://purl.obolibrary.org/obo/MONDO_0010706) (premature ovarian failure 1), [MONDO:0010703](http://purl.obolibrary.org/obo/MONDO_0010703) (ornithine carbamoyltransferase deficiency), [MONDO:0010704](http://purl.obolibrary.org/obo/MONDO_0010704) (Otopalatodigital syndrome type 1), [MONDO:0010709](http://purl.obolibrary.org/obo/MONDO_0010709) (early-onset parkinsonism-intellectual disability syndrome), [MONDO:0010707](http://purl.obolibrary.org/obo/MONDO_0010707) (Paine syndrome), [MONDO:0010708](http://purl.obolibrary.org/obo/MONDO_0010708) (W syndrome), [MONDO:0017339](http://purl.obolibrary.org/obo/MONDO_0017339) (exfoliative ichthyosis), [MONDO:0010702](http://purl.obolibrary.org/obo/MONDO_0010702) (orofaciodigital syndrome I), [MONDO:0010700](http://purl.obolibrary.org/obo/MONDO_0010700) (optic atrophy--spastic paraplegia syndrome), [MONDO:0018657](http://purl.obolibrary.org/obo/MONDO_0018657) (pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome), [MONDO:0014299](http://purl.obolibrary.org/obo/MONDO_0014299) (Schwannomatosis 2), [MONDO:0018658](http://purl.obolibrary.org/obo/MONDO_0018658) (19p13.3 microduplication syndrome), [MONDO:0017324](http://purl.obolibrary.org/obo/MONDO_0017324) (autosomal recessive hypophosphatemic rickets), [MONDO:0018653](http://purl.obolibrary.org/obo/MONDO_0018653) (Polymerase proofreading-related adenomatous polyposis), [MONDO:0014295](http://purl.obolibrary.org/obo/MONDO_0014295) (hereditary spastic paraplegia 57), [MONDO:0014296](http://purl.obolibrary.org/obo/MONDO_0014296) (Warburg micro syndrome 4), [MONDO:0017320](http://purl.obolibrary.org/obo/MONDO_0017320) (Phosphoenolpyruvate carboxykinase deficiency), [MONDO:0014297](http://purl.obolibrary.org/obo/MONDO_0014297) (Joubert syndrome 22), [MONDO:0014298](http://purl.obolibrary.org/obo/MONDO_0014298) (chromosome 5q12 deletion syndrome), [MONDO:0014291](http://purl.obolibrary.org/obo/MONDO_0014291) (autosomal dominant nonsyndromic deafness 54), [MONDO:0014293](http://purl.obolibrary.org/obo/MONDO_0014293) (autosomal dominant nonsyndromic deafness 58), [MONDO:0014294](http://purl.obolibrary.org/obo/MONDO_0014294) (chromosome 15q11.2 deletion syndrome), [MONDO:0009701](http://purl.obolibrary.org/obo/MONDO_0009701) (myopathy, granulovacuolar lobular, with Electrical myotonia), [MONDO:0009702](http://purl.obolibrary.org/obo/MONDO_0009702) (myopathy due to malate-aspartate Shuttle defect), [MONDO:0009704](http://purl.obolibrary.org/obo/MONDO_0009704) (carnitine palmitoyl transferase II deficiency, myopathic form), [MONDO:0009705](http://purl.obolibrary.org/obo/MONDO_0009705) (carnitine palmitoyltransferase i deficiency), [MONDO:0009706](http://purl.obolibrary.org/obo/MONDO_0009706) (hereditary myopathy with lactic acidosis due to ISCU deficiency), [MONDO:0009707](http://purl.obolibrary.org/obo/MONDO_0009707) (myopathy with giant abnormal mitochondria), [MONDO:0009709](http://purl.obolibrary.org/obo/MONDO_0009709) (myopathy, centronuclear, 2), [MONDO:0017329](http://purl.obolibrary.org/obo/MONDO_0017329) (familial vesicoureteral reflux), [MONDO:0014288](http://purl.obolibrary.org/obo/MONDO_0014288) (Joubert syndrome 21), [MONDO:0017313](http://purl.obolibrary.org/obo/MONDO_0017313) (disorder of folate metabolism and transport), [MONDO:0019975](http://purl.obolibrary.org/obo/MONDO_0019975) (pellagra), [MONDO:0018644](http://purl.obolibrary.org/obo/MONDO_0018644) (autosomal dominant complex spastic paraplegia type 9B), [MONDO:0018642](http://purl.obolibrary.org/obo/MONDO_0018642) (NIK deficiency), [MONDO:0014284](http://purl.obolibrary.org/obo/MONDO_0014284) (short-rib thoracic dysplasia 10 with or without polydactyly), [MONDO:0017312](http://purl.obolibrary.org/obo/MONDO_0017312) (Perrault syndrome), [MONDO:0014286](http://purl.obolibrary.org/obo/MONDO_0014286) (neuropathy, hereditary sensory, type 1F), [MONDO:0018641](http://purl.obolibrary.org/obo/MONDO_0018641) (paroxysmal nocturnal hemoglobinuria), [MONDO:0014287](http://purl.obolibrary.org/obo/MONDO_0014287) (short-rib thoracic dysplasia 11 with or without polydactyly), [MONDO:0014280](http://purl.obolibrary.org/obo/MONDO_0014280) (immunodeficiency 19), [MONDO:0014283](http://purl.obolibrary.org/obo/MONDO_0014283) (autosomal dominant nonsyndromic deafness 56), [MONDO:0007989](http://purl.obolibrary.org/obo/MONDO_0007989) (congenital microcoria), [MONDO:0006657](http://purl.obolibrary.org/obo/MONDO_0006657) (apparent mineralocorticoid excess syndrome), [MONDO:0007988](http://purl.obolibrary.org/obo/MONDO_0007988) (autosomal dominant microcephaly), [MONDO:0007985](http://purl.obolibrary.org/obo/MONDO_0007985) (Metatarsus varus, type 1), [MONDO:0007981](http://purl.obolibrary.org/obo/MONDO_0007981) (metachromatic leukodystrophy, adult-onset, with normal arylsulfatase a), [MONDO:0007980](http://purl.obolibrary.org/obo/MONDO_0007980) (Metachromasia of Fibroblasts), [MONDO:0014277](http://purl.obolibrary.org/obo/MONDO_0014277) (DDH2), [MONDO:0014278](http://purl.obolibrary.org/obo/MONDO_0014278) (immunodeficiency 18), [MONDO:0017305](http://purl.obolibrary.org/obo/MONDO_0017305) (syndromic oculocutaneous albinism), [MONDO:0017304](http://purl.obolibrary.org/obo/MONDO_0017304) (ocular albinism (disease)), [MONDO:0018634](http://purl.obolibrary.org/obo/MONDO_0018634) (hereditary amyloidosis), [MONDO:0014275](http://purl.obolibrary.org/obo/MONDO_0014275) (Fanconi renotubular syndrome 3), [MONDO:0014276](http://purl.obolibrary.org/obo/MONDO_0014276) (combined immunodeficiency due to CD3gamma deficiency), [MONDO:0018630](http://purl.obolibrary.org/obo/MONDO_0018630) (hereditary nonpolyposis colon cancer), [MONDO:0014270](http://purl.obolibrary.org/obo/MONDO_0014270) (STT3A-CDG), [MONDO:0014271](http://purl.obolibrary.org/obo/MONDO_0014271) (STT3B-CDG), [MONDO:0014272](http://purl.obolibrary.org/obo/MONDO_0014272) (palmoplantar keratoderma, Nagashima type), [MONDO:0005334](http://purl.obolibrary.org/obo/MONDO_0005334) (nephritis, hereditary), [MONDO:0007997](http://purl.obolibrary.org/obo/MONDO_0007997) (Microspherophakia with hernia), [MONDO:0007996](http://purl.obolibrary.org/obo/MONDO_0007996) (microphthalmia, isolated, with corectopia), [MONDO:0017307](http://purl.obolibrary.org/obo/MONDO_0017307) (disorder of tyrosine metabolism), [MONDO:0017306](http://purl.obolibrary.org/obo/MONDO_0017306) (disorder of phenylalanine metabolism), [MONDO:0018637](http://purl.obolibrary.org/obo/MONDO_0018637) (familial chylomicronemia syndrome), [MONDO:0017308](http://purl.obolibrary.org/obo/MONDO_0017308) (Marfan syndrome type 2), [MONDO:0018638](http://purl.obolibrary.org/obo/MONDO_0018638) (pseudohypoaldosteronism), [MONDO:0016048](http://purl.obolibrary.org/obo/MONDO_0016048) (isolated autosomal dominant hypomagnesemia, Glaudemans type), [MONDO:0009750](http://purl.obolibrary.org/obo/MONDO_0009750) (neuropathy, hereditary motor and sensory, with excessive myelin Folding complex, autosomal recessive), [MONDO:0008420](http://purl.obolibrary.org/obo/MONDO_0008420) (seborrheic keratosis), [MONDO:0009751](http://purl.obolibrary.org/obo/MONDO_0009751) (neuropathy, hereditary sensory, atypical), [MONDO:0009752](http://purl.obolibrary.org/obo/MONDO_0009752) (neuropathy, painful), [MONDO:0008422](http://purl.obolibrary.org/obo/MONDO_0008422) (autosomal dominant sideroblastic anemia), [MONDO:0009753](http://purl.obolibrary.org/obo/MONDO_0009753) (Neurovisceral storage disease with Curvilinear bodies), [MONDO:0008423](http://purl.obolibrary.org/obo/MONDO_0008423) (sinus node disease and myopia), [MONDO:0009754](http://purl.obolibrary.org/obo/MONDO_0009754) (neutropenia, lethal congenital, with eosinophilia), [MONDO:0009755](http://purl.obolibrary.org/obo/MONDO_0009755) (neutrophil actin dysfunction), [MONDO:0008424](http://purl.obolibrary.org/obo/MONDO_0008424) (sella turcica, Bridged), [MONDO:0009756](http://purl.obolibrary.org/obo/MONDO_0009756) (Niemann-Pick disease type A), [MONDO:0009757](http://purl.obolibrary.org/obo/MONDO_0009757) (Niemann-Pick disease, type C1), [MONDO:0008427](http://purl.obolibrary.org/obo/MONDO_0008427) (Sister Chromatid exchange, frequency of), [MONDO:0008428](http://purl.obolibrary.org/obo/MONDO_0008428) (septooptic dysplasia), [MONDO:0009759](http://purl.obolibrary.org/obo/MONDO_0009759) (mosaic variegated aneuploidy syndrome 1), [MONDO:0010749](http://purl.obolibrary.org/obo/MONDO_0010749) (trigonocephaly-short stature-developmental delay syndrome), [MONDO:0010741](http://purl.obolibrary.org/obo/MONDO_0010741) (tooth agenesis, selective, X-linked, 1), [MONDO:0010740](http://purl.obolibrary.org/obo/MONDO_0010740) (taurodontism, microdontia, and dens invaginatus), [MONDO:0010746](http://purl.obolibrary.org/obo/MONDO_0010746) (thumbs, congenital Clasped), [MONDO:0010744](http://purl.obolibrary.org/obo/MONDO_0010744) (thrombocytopenia with elevated serum Iga and renal disease), [MONDO:0018699](http://purl.obolibrary.org/obo/MONDO_0018699) (pseudohypoparathyroidism with Albright hereditary osteodystrophy), [MONDO:0017365](http://purl.obolibrary.org/obo/MONDO_0017365) (hereditary acrokeratotic poikiloderma, weary type), [MONDO:0018698](http://purl.obolibrary.org/obo/MONDO_0018698) (hereditary neuroendocrine tumor of small intestine), [MONDO:0017360](http://purl.obolibrary.org/obo/MONDO_0017360) (vitamin B12-unresponsive methylmalonic acidemia type mut0), [MONDO:0008412](http://purl.obolibrary.org/obo/MONDO_0008412) (intestinal schistosomiasis), [MONDO:0009743](http://purl.obolibrary.org/obo/MONDO_0009743) (neurologic disease, infantile multisystem, with osseous fragility), [MONDO:0009744](http://purl.obolibrary.org/obo/MONDO_0009744) (neuronal ceroid lipofuscinosis 1), [MONDO:0009745](http://purl.obolibrary.org/obo/MONDO_0009745) (neuronal ceroid lipofuscinosis 5), [MONDO:0009746](http://purl.obolibrary.org/obo/MONDO_0009746) (hereditary sensory and autonomic neuropathy type 4), [MONDO:0009747](http://purl.obolibrary.org/obo/MONDO_0009747) (Navajo neurohepatopathy), [MONDO:0008416](http://purl.obolibrary.org/obo/MONDO_0008416) (palmoplantar keratoderma-sclerodactyly syndrome), [MONDO:0009748](http://purl.obolibrary.org/obo/MONDO_0009748) (hereditary sensory and autonomic neuropathy with spastic paraplegia), [MONDO:0008417](http://purl.obolibrary.org/obo/MONDO_0008417) (sclerocornea, autosomal dominant), [MONDO:0008419](http://purl.obolibrary.org/obo/MONDO_0008419) (IS1), [MONDO:0010739](http://purl.obolibrary.org/obo/MONDO_0010739) (Taqi Polymorphism), [MONDO:0004069](http://purl.obolibrary.org/obo/MONDO_0004069) (inborn mitochondrial metabolism disorder), [MONDO:0010737](http://purl.obolibrary.org/obo/MONDO_0010737) (spondyloepiphyseal dysplasia tarda, X-linked), [MONDO:0010730](http://purl.obolibrary.org/obo/MONDO_0010730) (combined immunodeficiency, X-linked), [MONDO:0010731](http://purl.obolibrary.org/obo/MONDO_0010731) (Simpson-Golabi-Behmel syndrome), [MONDO:0010734](http://purl.obolibrary.org/obo/MONDO_0010734) (Spatial Visualization, Aptitude for), [MONDO:0010732](http://purl.obolibrary.org/obo/MONDO_0010732) (spastic paraparesis-deafness syndrome), [MONDO:0017359](http://purl.obolibrary.org/obo/MONDO_0017359) (3-methylglutaconic aciduria), [MONDO:0016028](http://purl.obolibrary.org/obo/MONDO_0016028) (erythromelalgia), [MONDO:0018686](http://purl.obolibrary.org/obo/MONDO_0018686) (acquired Creutzfeldt-Jakob disease), [MONDO:0017354](http://purl.obolibrary.org/obo/MONDO_0017354) (infantile glycine encephalopathy), [MONDO:0016022](http://purl.obolibrary.org/obo/MONDO_0016022) (early myoclonic encephalopathy), [MONDO:0017353](http://purl.obolibrary.org/obo/MONDO_0017353) (neonatal glycine encephalopathy), [MONDO:0017356](http://purl.obolibrary.org/obo/MONDO_0017356) (disorder of ornithine metabolism), [MONDO:0017355](http://purl.obolibrary.org/obo/MONDO_0017355) (disorder of proline metabolism), [MONDO:0018682](http://purl.obolibrary.org/obo/MONDO_0018682) (congenital insensitivity to pain with severe intellectual disability), [MONDO:0009730](http://purl.obolibrary.org/obo/MONDO_0009730) (Nephrosialidosis), [MONDO:0017350](http://purl.obolibrary.org/obo/MONDO_0017350) (disorder of tryptophan metabolism), [MONDO:0018683](http://purl.obolibrary.org/obo/MONDO_0018683) (acquired ichthyosis), [MONDO:0008400](http://purl.obolibrary.org/obo/MONDO_0008400) (salivary duct Calculi), [MONDO:0017352](http://purl.obolibrary.org/obo/MONDO_0017352) (disorder of glutamine metabolism), [MONDO:0016021](http://purl.obolibrary.org/obo/MONDO_0016021) (early infantile epileptic encephalopathy), [MONDO:0017351](http://purl.obolibrary.org/obo/MONDO_0017351) (disorder of lysine and hydroxylysine metabolism), [MONDO:0009734](http://purl.obolibrary.org/obo/MONDO_0009734) (hyperinsulinemic hypoglycemia, familial, 1), [MONDO:0009735](http://purl.obolibrary.org/obo/MONDO_0009735) (Netherton syndrome), [MONDO:0009736](http://purl.obolibrary.org/obo/MONDO_0009736) (Neu-Laxova syndrome 1), [MONDO:0008405](http://purl.obolibrary.org/obo/MONDO_0008405) (scapula, contour of vertebral border of), [MONDO:0009737](http://purl.obolibrary.org/obo/MONDO_0009737) (Galactosialidosis), [MONDO:0008406](http://purl.obolibrary.org/obo/MONDO_0008406) (autosomal recessive Emery-Dreifuss muscular dystrophy), [MONDO:0009738](http://purl.obolibrary.org/obo/MONDO_0009738) (sialidosis type 2), [MONDO:0010727](http://purl.obolibrary.org/obo/MONDO_0010727) (Russell-silver syndrome, X-linked), [MONDO:0010728](http://purl.obolibrary.org/obo/MONDO_0010728) (SCARF syndrome), [MONDO:0009739](http://purl.obolibrary.org/obo/MONDO_0009739) (neurodegeneration with brain iron accumulation 2a), [MONDO:0008409](http://purl.obolibrary.org/obo/MONDO_0008409) (MYH7-related late-onset scapuloperoneal muscular dystrophy), [MONDO:0010726](http://purl.obolibrary.org/obo/MONDO_0010726) (Rett syndrome), [MONDO:0010729](http://purl.obolibrary.org/obo/MONDO_0010729) (X-linked intellectual disability, Schimke type), [MONDO:0004033](http://purl.obolibrary.org/obo/MONDO_0004033) (familial ovarian carcinoma), [MONDO:0010721](http://purl.obolibrary.org/obo/MONDO_0010721) (reticuloendotheliosis, X-linked), [MONDO:0018670](http://purl.obolibrary.org/obo/MONDO_0018670) (symptomatic form of fragile X syndrome in female carrier), [MONDO:0009723](http://purl.obolibrary.org/obo/MONDO_0009723) (Leigh syndrome), [MONDO:0010716](http://purl.obolibrary.org/obo/MONDO_0010716) (X-linked lethal multiple pterygium syndrome), [MONDO:0010717](http://purl.obolibrary.org/obo/MONDO_0010717) (pyruvate dehydrogenase E1-alpha deficiency), [MONDO:0009728](http://purl.obolibrary.org/obo/MONDO_0009728) (nephronophthisis 1), [MONDO:0009729](http://purl.obolibrary.org/obo/MONDO_0009729) (nephropathy-deafness-hyperparathyroidism syndrome), [MONDO:0010714](http://purl.obolibrary.org/obo/MONDO_0010714) (Pelizaeus-Merzbacher disease), [MONDO:0010715](http://purl.obolibrary.org/obo/MONDO_0010715) (pseudohermaphroditism, incomplete male, type 1), [MONDO:0010719](http://purl.obolibrary.org/obo/MONDO_0010719) (radiation sensitivity of natural killer activity), [MONDO:0009790](http://purl.obolibrary.org/obo/MONDO_0009790) (Opticocochleodentate degeneration), [MONDO:0009791](http://purl.obolibrary.org/obo/MONDO_0009791) (oral Sensibility, disturbance of), [MONDO:0009792](http://purl.obolibrary.org/obo/MONDO_0009792) (ichthyosis-oral and digital anomalies syndrome), [MONDO:0008461](http://purl.obolibrary.org/obo/MONDO_0008461) (splenomegaly syndrome with splenic Germinal center hypoplasia and reduced Circulating T Helper cells), [MONDO:0010781](http://purl.obolibrary.org/obo/MONDO_0010781) (ataxia and polyneuropathy, adult-onset), [MONDO:0019115](http://purl.obolibrary.org/obo/MONDO_0019115) (obesity due to melanocortin 4 receptor deficiency), [MONDO:0016089](http://purl.obolibrary.org/obo/MONDO_0016089) (infantile Krabbe disease), [MONDO:0016088](http://purl.obolibrary.org/obo/MONDO_0016088) (hypoxanthine-guanine phosphoribosyltransferase deficiency), [MONDO:0008462](http://purl.obolibrary.org/obo/MONDO_0008462) (split lower 51P), [MONDO:0010782](http://purl.obolibrary.org/obo/MONDO_0010782) (myopathy, lactic acidosis, and sideroblastic anemia 3), [MONDO:0008463](http://purl.obolibrary.org/obo/MONDO_0008463) (split-hand and Split-foot with hypodontia), [MONDO:0010780](http://purl.obolibrary.org/obo/MONDO_0010780) (mitochondrial myopathy with reversible cytochrome c oxidase deficiency), [MONDO:0009796](http://purl.obolibrary.org/obo/MONDO_0009796) (gyrate atrophy), [MONDO:0019111](http://purl.obolibrary.org/obo/MONDO_0019111) (familial thrombocytosis), [MONDO:0001822](http://purl.obolibrary.org/obo/MONDO_0001822) (hypolipoproteinemia (disease)), [MONDO:0009797](http://purl.obolibrary.org/obo/MONDO_0009797) (orotic aciduria), [MONDO:0008468](http://purl.obolibrary.org/obo/MONDO_0008468) (SPDA2), [MONDO:0007129](http://purl.obolibrary.org/obo/MONDO_0007129) (tooth agenesis, selective, 1), [MONDO:0007128](http://purl.obolibrary.org/obo/MONDO_0007128) (annular erythema), [MONDO:0016090](http://purl.obolibrary.org/obo/MONDO_0016090) (late-infantile/juvenile Krabbe disease), [MONDO:0007127](http://purl.obolibrary.org/obo/MONDO_0007127) (diffuse idiopathic skeletal hyperostosis), [MONDO:0013816](http://purl.obolibrary.org/obo/MONDO_0013816) (palmoplantar keratoderma, mutilating, with periorificial keratotic plaques), [MONDO:0007126](http://purl.obolibrary.org/obo/MONDO_0007126) (spondyloarthropathy, susceptibility to, 1), [MONDO:0007125](http://purl.obolibrary.org/obo/MONDO_0007125) (ankyloglossia), [MONDO:0010785](http://purl.obolibrary.org/obo/MONDO_0010785) (maternally-inherited diabetes and deafness), [MONDO:0007122](http://purl.obolibrary.org/obo/MONDO_0007122) (anisocoria (disease)), [MONDO:0007121](http://purl.obolibrary.org/obo/MONDO_0007121) (aniridia, microcornea, and Spontaneously Reabsorbed cataract), [MONDO:0010786](http://purl.obolibrary.org/obo/MONDO_0010786) (chronic diarrhea with villous atrophy), [MONDO:0007120](http://purl.obolibrary.org/obo/MONDO_0007120) (aniridia-absent patella syndrome), [MONDO:0013814](http://purl.obolibrary.org/obo/MONDO_0013814) (PDCOS), [MONDO:0010784](http://purl.obolibrary.org/obo/MONDO_0010784) (Chloramphenicol toxicity), [MONDO:0010789](http://purl.obolibrary.org/obo/MONDO_0010789) (MELAS syndrome), [MONDO:0010787](http://purl.obolibrary.org/obo/MONDO_0010787) (Kearns-Sayre syndrome), [MONDO:0013810](http://purl.obolibrary.org/obo/MONDO_0013810) (COG6-CGD), [MONDO:0010788](http://purl.obolibrary.org/obo/MONDO_0010788) (Leber hereditary optic neuropathy), [MONDO:0013811](http://purl.obolibrary.org/obo/MONDO_0013811) (combined oxidative phosphorylation defect type 9), [MONDO:0009781](http://purl.obolibrary.org/obo/MONDO_0009781) (Onychotrichodysplasia and neutropenia), [MONDO:0010770](http://purl.obolibrary.org/obo/MONDO_0010770) (ubiquitin-activating enzyme, Y-linked), [MONDO:0008451](http://purl.obolibrary.org/obo/MONDO_0008451) (distal hereditary motor neuropathy type 1), [MONDO:0010771](http://purl.obolibrary.org/obo/MONDO_0010771) (histiocytoid cardiomyopathy), [MONDO:0009782](http://purl.obolibrary.org/obo/MONDO_0009782) (ophthalmoplegia totalis with ptosis and miosis), [MONDO:0009783](http://purl.obolibrary.org/obo/MONDO_0009783) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal recessive 1), [MONDO:0016079](http://purl.obolibrary.org/obo/MONDO_0016079) (sporadic Creutzfeldt-Jakob disease), [MONDO:0008453](http://purl.obolibrary.org/obo/MONDO_0008453) (adult-onset proximal spinal muscular atrophy, autosomal dominant), [MONDO:0009784](http://purl.obolibrary.org/obo/MONDO_0009784) (Ophthalmoplegic neuromuscular disorder with abnormal mitochondria), [MONDO:0009787](http://purl.obolibrary.org/obo/MONDO_0009787) (3-methylglutaconic aciduria type 3), [MONDO:0008456](http://purl.obolibrary.org/obo/MONDO_0008456) (spinocerebellar ataxia with rigidity and peripheral neuropathy), [MONDO:0009788](http://purl.obolibrary.org/obo/MONDO_0009788) (optic atrophy, hearing loss, and peripheral neuropathy, autosomal recessive), [MONDO:0008457](http://purl.obolibrary.org/obo/MONDO_0008457) (spinocerebellar ataxia type 6), [MONDO:0008458](http://purl.obolibrary.org/obo/MONDO_0008458) (spinocerebellar ataxia type 2), [MONDO:0009789](http://purl.obolibrary.org/obo/MONDO_0009789) (nonarteritic anterior ischemic optic neuropathy, susceptibility to), [MONDO:0008459](http://purl.obolibrary.org/obo/MONDO_0008459) (spinocerebellar atrophy with pupillary paralysis), [MONDO:0016071](http://purl.obolibrary.org/obo/MONDO_0016071) (juvenile hyaline fibromatosis), [MONDO:0000501](http://purl.obolibrary.org/obo/MONDO_0000501) (Jensen syndrome), [MONDO:0013809](http://purl.obolibrary.org/obo/MONDO_0013809) (CANVAS), [MONDO:0007139](http://purl.obolibrary.org/obo/MONDO_0007139) (antipyrine metabolism), [MONDO:0007137](http://purl.obolibrary.org/obo/MONDO_0007137) (isolated congenital anosmia), [MONDO:0013805](http://purl.obolibrary.org/obo/MONDO_0013805) (mental retardation, autosomal dominant 13), [MONDO:0013806](http://purl.obolibrary.org/obo/MONDO_0013806) (familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome), [MONDO:0013808](http://purl.obolibrary.org/obo/MONDO_0013808) (Maffucci syndrome), [MONDO:0013801](http://purl.obolibrary.org/obo/MONDO_0013801) (epileptic encephalopathy, early infantile, 13), [MONDO:0010774](http://purl.obolibrary.org/obo/MONDO_0010774) (striatonigral degeneration, infantile, mitochondrial), [MONDO:0007133](http://purl.obolibrary.org/obo/MONDO_0007133) (anonychia-onychodystrophy with brachydactyly type b and ectrodactyly), [MONDO:0013802](http://purl.obolibrary.org/obo/MONDO_0013802) (infantile cerebellar-retinal degeneration), [MONDO:0010775](http://purl.obolibrary.org/obo/MONDO_0010775) (retinitis pigmentosa-deafness syndrome), [MONDO:0007132](http://purl.obolibrary.org/obo/MONDO_0007132) (anonychia-ectrodactyly), [MONDO:0010772](http://purl.obolibrary.org/obo/MONDO_0010772) (Leber optic atrophy and dystonia), [MONDO:0013803](http://purl.obolibrary.org/obo/MONDO_0013803) (LCC), [MONDO:0010773](http://purl.obolibrary.org/obo/MONDO_0010773) (myopathy and diabetes mellitus), [MONDO:0010778](http://purl.obolibrary.org/obo/MONDO_0010778) (cyclic vomiting syndrome), [MONDO:0010779](http://purl.obolibrary.org/obo/MONDO_0010779) (mitochondrial non-syndromic sensorineural deafness), [MONDO:0010776](http://purl.obolibrary.org/obo/MONDO_0010776) (hypomagnesemia, hypertension, and hypercholesterolemia, mitochondrial), [MONDO:0010777](http://purl.obolibrary.org/obo/MONDO_0010777) (cardiomyopathy, infantile hypertrophic), [MONDO:0010760](http://purl.obolibrary.org/obo/MONDO_0010760) (Xh antigen), [MONDO:0008440](http://purl.obolibrary.org/obo/MONDO_0008440) (spastic paraplegia-nephritis-deafness syndrome), [MONDO:0009772](http://purl.obolibrary.org/obo/MONDO_0009772) (Oculorenocerebellar syndrome), [MONDO:0008441](http://purl.obolibrary.org/obo/MONDO_0008441) (spastic paraplegia with associated extrapyramidal signs), [MONDO:0001807](http://purl.obolibrary.org/obo/MONDO_0001807) (familial combined hyperlipidemia), [MONDO:0009773](http://purl.obolibrary.org/obo/MONDO_0009773) (Odonto-onycho-dermal dysplasia), [MONDO:0008442](http://purl.obolibrary.org/obo/MONDO_0008442) (spastic paraplegia-neuropathy-poikiloderma syndrome), [MONDO:0016063](http://purl.obolibrary.org/obo/MONDO_0016063) (Cowden disease), [MONDO:0008443](http://purl.obolibrary.org/obo/MONDO_0008443) (spastic paraplegia-precocious puberty syndrome), [MONDO:0009775](http://purl.obolibrary.org/obo/MONDO_0009775) (Oguchi disease-1), [MONDO:0008444](http://purl.obolibrary.org/obo/MONDO_0008444) (spastic paraplegia, optic atrophy, and dementia), [MONDO:0008446](http://purl.obolibrary.org/obo/MONDO_0008446) (sperm Protamine P4), [MONDO:0009778](http://purl.obolibrary.org/obo/MONDO_0009778) (olivopontocerebellar atrophy Ii, autosomal recessive), [MONDO:0017390](http://purl.obolibrary.org/obo/MONDO_0017390) (methylmalonic acidemia without homocystinuria), [MONDO:0009779](http://purl.obolibrary.org/obo/MONDO_0009779) (autosomal recessive omodysplasia), [MONDO:0007107](http://purl.obolibrary.org/obo/MONDO_0007107) (anal sphincter myopathy, internal), [MONDO:0007106](http://purl.obolibrary.org/obo/MONDO_0007106) (anal sphincter dysplasia), [MONDO:0010769](http://purl.obolibrary.org/obo/MONDO_0010769) (hairy ears, Y-linked), [MONDO:0007103](http://purl.obolibrary.org/obo/MONDO_0007103) (amyotrophic lateral sclerosis type 1), [MONDO:0007102](http://purl.obolibrary.org/obo/MONDO_0007102) (amyotrophic dystonic paraplegia), [MONDO:0007101](http://purl.obolibrary.org/obo/MONDO_0007101) (familial primary localized cutaneous amyloidosis), [MONDO:0007100](http://purl.obolibrary.org/obo/MONDO_0007100) (familial amyloid neuropathy), [MONDO:0010764](http://purl.obolibrary.org/obo/MONDO_0010764) (DFNY1), [MONDO:0010761](http://purl.obolibrary.org/obo/MONDO_0010761) (retinitis pigmentosa Y-linked), [MONDO:0008430](http://purl.obolibrary.org/obo/MONDO_0008430) (skeletal dysplasia with delayed epiphyseal and carpal bone ossification), [MONDO:0017389](http://purl.obolibrary.org/obo/MONDO_0017389) (tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria), [MONDO:0008431](http://purl.obolibrary.org/obo/MONDO_0008431) (Slipped femoral capital epiphyses), [MONDO:0009763](http://purl.obolibrary.org/obo/MONDO_0009763) (obesity-hypoventilation syndrome), [MONDO:0008432](http://purl.obolibrary.org/obo/MONDO_0008432) (ketone Compounds, Ability to smell), [MONDO:0008434](http://purl.obolibrary.org/obo/MONDO_0008434) (Smith-Magenis syndrome), [MONDO:0017385](http://purl.obolibrary.org/obo/MONDO_0017385) (malignant migrating partial seizures of infancy), [MONDO:0009765](http://purl.obolibrary.org/obo/MONDO_0009765) (ocular myopathy with Curare sensitivity), [MONDO:0009766](http://purl.obolibrary.org/obo/MONDO_0009766) (oculocerebral hypopigmentation syndrome of Preus), [MONDO:0008435](http://purl.obolibrary.org/obo/MONDO_0008435) (Somatomedin, embryonic), [MONDO:0009767](http://purl.obolibrary.org/obo/MONDO_0009767) (oculocerebral hypopigmentation syndrome, cross type), [MONDO:0009768](http://purl.obolibrary.org/obo/MONDO_0009768) (oculodentodigital dysplasia, autosomal recessive), [MONDO:0016050](http://purl.obolibrary.org/obo/MONDO_0016050) (thiamine-responsive encephalopathy), [MONDO:0008439](http://purl.obolibrary.org/obo/MONDO_0008439) (spastic paraplegia-epilepsy-intellectual disability syndrome), [MONDO:0017380](http://purl.obolibrary.org/obo/MONDO_0017380) (juvenile polyposis syndrome), [MONDO:0010758](http://purl.obolibrary.org/obo/MONDO_0010758) (intellectual disability-developmental delay-contractures syndrome), [MONDO:0007117](http://purl.obolibrary.org/obo/MONDO_0007117) (angioedema, hereditary, type 1/2), [MONDO:0007113](http://purl.obolibrary.org/obo/MONDO_0007113) (Angelman syndrome), [MONDO:0010752](http://purl.obolibrary.org/obo/MONDO_0010752) (Vacterl association, X-linked, with or without hydrocephalus), [MONDO:0007110](http://purl.obolibrary.org/obo/MONDO_0007110) (Diamond-Blackfan anemia 1), [MONDO:0010751](http://purl.obolibrary.org/obo/MONDO_0010751) (Unique green phenomenon), [MONDO:0010757](http://purl.obolibrary.org/obo/MONDO_0010757) (Widow'S Peak syndrome), [MONDO:0010754](http://purl.obolibrary.org/obo/MONDO_0010754) (van den Bosch syndrome), [MONDO:0010755](http://purl.obolibrary.org/obo/MONDO_0010755) (vesicoureteral reflux, X-linked), [MONDO:0013850](http://purl.obolibrary.org/obo/MONDO_0013850) (periodic fever, menstrual cycle-dependent), [MONDO:0012520](http://purl.obolibrary.org/obo/MONDO_0012520) (insulin-resistance syndrome type A), [MONDO:0020148](http://purl.obolibrary.org/obo/MONDO_0020148) (syndromic aniridia), [MONDO:0019150](http://purl.obolibrary.org/obo/MONDO_0019150) (familial isolated restrictive cardiomyopathy), [MONDO:0012529](http://purl.obolibrary.org/obo/MONDO_0012529) (Diamond-Blackfan anemia 3), [MONDO:0007169](http://purl.obolibrary.org/obo/MONDO_0007169) (ATHS), [MONDO:0020142](http://purl.obolibrary.org/obo/MONDO_0020142) (metabolic disease with dementia), [MONDO:0020143](http://purl.obolibrary.org/obo/MONDO_0020143) (cerebral lipidosis with dementia), [MONDO:0007166](http://purl.obolibrary.org/obo/MONDO_0007166) (ataxia with Fasciculations), [MONDO:0013856](http://purl.obolibrary.org/obo/MONDO_0013856) (hypertelorism and other facial dysmorphism, brachydactyly, genital abnormalities, mental retardation, and recurrent inflammatory episodes), [MONDO:0007165](http://purl.obolibrary.org/obo/MONDO_0007165) (spastic ataxia 7), [MONDO:0013857](http://purl.obolibrary.org/obo/MONDO_0013857) (alar cleft, isolated), [MONDO:0012522](http://purl.obolibrary.org/obo/MONDO_0012522) (diabetes mellitus, transient neonatal, 3), [MONDO:0007164](http://purl.obolibrary.org/obo/MONDO_0007164) (spastic ataxia 1), [MONDO:0007162](http://purl.obolibrary.org/obo/MONDO_0007162) (asymmetric short stature syndrome), [MONDO:0013854](http://purl.obolibrary.org/obo/MONDO_0013854) (primary ciliary dyskinesia 17), [MONDO:0012526](http://purl.obolibrary.org/obo/MONDO_0012526) (hereditary angioedema type 3), [MONDO:0013855](http://purl.obolibrary.org/obo/MONDO_0013855) (influenza, severe, susceptibility to), [MONDO:0007180](http://purl.obolibrary.org/obo/MONDO_0007180) (Axenfeld-Rieger anomaly with partially absent eye muscles, distinctive face, hydrocephaly, and skeletal abnormalities), [MONDO:0008491](http://purl.obolibrary.org/obo/MONDO_0008491) (stiff-person syndrome), [MONDO:0013840](http://purl.obolibrary.org/obo/MONDO_0013840) (encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome), [MONDO:0019148](http://purl.obolibrary.org/obo/MONDO_0019148) (Wolman disease), [MONDO:0019149](http://purl.obolibrary.org/obo/MONDO_0019149) (cholesteryl ester storage disease), [MONDO:0008496](http://purl.obolibrary.org/obo/MONDO_0008496) (storm syndrome), [MONDO:0008498](http://purl.obolibrary.org/obo/MONDO_0008498) (strabismus, susceptibility to), [MONDO:0004905](http://purl.obolibrary.org/obo/MONDO_0004905) (intestinal disaccharidase deficiency), [MONDO:0019142](http://purl.obolibrary.org/obo/MONDO_0019142) (porphyria), [MONDO:0012519](http://purl.obolibrary.org/obo/MONDO_0012519) (Rubinstein-Taybi syndrome due to 16p13.3 microdeletion), [MONDO:0012518](http://purl.obolibrary.org/obo/MONDO_0012518) (congenital myasthenic syndrome 12), [MONDO:0007178](http://purl.obolibrary.org/obo/MONDO_0007178) (aurocephalosyndactyly), [MONDO:0012513](http://purl.obolibrary.org/obo/MONDO_0012513) (maturity-onset diabetes of the young type 7), [MONDO:0012512](http://purl.obolibrary.org/obo/MONDO_0012512) (fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3), [MONDO:0013846](http://purl.obolibrary.org/obo/MONDO_0013846) (peripartum cardiomyopathy, susceptibility to), [MONDO:0013847](http://purl.obolibrary.org/obo/MONDO_0013847) (chromosome 16p11.2 duplication syndrome), [MONDO:0007175](http://purl.obolibrary.org/obo/MONDO_0007175) (Pr interval, variation 1N), [MONDO:0012511](http://purl.obolibrary.org/obo/MONDO_0012511) (Preterm premature rupture of the membranes), [MONDO:0012510](http://purl.obolibrary.org/obo/MONDO_0012510) (combined oxidative phosphorylation defect type 2), [MONDO:0013848](http://purl.obolibrary.org/obo/MONDO_0013848) (dilated cardiomyopathy 2B), [MONDO:0013841](http://purl.obolibrary.org/obo/MONDO_0013841) (STUT3), [MONDO:0012517](http://purl.obolibrary.org/obo/MONDO_0012517) (atypical Gaucher's disease due to saposin c deficiency), [MONDO:0007171](http://purl.obolibrary.org/obo/MONDO_0007171) (atrial standstill 1), [MONDO:0012515](http://purl.obolibrary.org/obo/MONDO_0012515) (GLC1M), [MONDO:0013844](http://purl.obolibrary.org/obo/MONDO_0013844) (STUT4), [MONDO:0008481](http://purl.obolibrary.org/obo/MONDO_0008481) (spondylosis, cervical), [MONDO:0008483](http://purl.obolibrary.org/obo/MONDO_0008483) (STUT1), [MONDO:0008484](http://purl.obolibrary.org/obo/MONDO_0008484) (stapes ankylosis with broad thumbs and toes), [MONDO:0001845](http://purl.obolibrary.org/obo/MONDO_0001845) (uterine corpus lipoleiomyoma), [MONDO:0008487](http://purl.obolibrary.org/obo/MONDO_0008487) (polycystic ovary syndrome), [MONDO:0001844](http://purl.obolibrary.org/obo/MONDO_0001844) (uterine corpus myxoid leiomyoma), [MONDO:0008489](http://purl.obolibrary.org/obo/MONDO_0008489) (sternum, premature Obliteration of sutures of), [MONDO:0001846](http://purl.obolibrary.org/obo/MONDO_0001846) (uterine corpus bizarre leiomyoma), [MONDO:0001841](http://purl.obolibrary.org/obo/MONDO_0001841) (uterine corpus epithelioid leiomyoma), [MONDO:0019130](http://purl.obolibrary.org/obo/MONDO_0019130) (tubular renal disease-cardiomyopathy syndrome), [MONDO:0001843](http://purl.obolibrary.org/obo/MONDO_0001843) (uterus interstitial leiomyoma), [MONDO:0001842](http://purl.obolibrary.org/obo/MONDO_0001842) (uterine corpus dissecting leiomyoma), [MONDO:0012507](http://purl.obolibrary.org/obo/MONDO_0012507) (retinal cone dystrophy 4), [MONDO:0007149](http://purl.obolibrary.org/obo/MONDO_0007149) (arbitrary restriction Polymorphism 1), [MONDO:0007148](http://purl.obolibrary.org/obo/MONDO_0007148) (appendicitis, proneness to), [MONDO:0013838](http://purl.obolibrary.org/obo/MONDO_0013838) (coenzyme Q10 deficiency, primary, 3), [MONDO:0013839](http://purl.obolibrary.org/obo/MONDO_0013839) (hereditary sensory and autonomic neuropathy type 6), [MONDO:0007144](http://purl.obolibrary.org/obo/MONDO_0007144) (aortic arch interruption, facial palsy, and retinal coloboma), [MONDO:0013834](http://purl.obolibrary.org/obo/MONDO_0013834) (UV-Sensitive syndrome 3), [MONDO:0012502](http://purl.obolibrary.org/obo/MONDO_0012502) (normophosphatemic familial tumoral calcinosis), [MONDO:0012501](http://purl.obolibrary.org/obo/MONDO_0012501) (Mutagen sensitivity), [MONDO:0013835](http://purl.obolibrary.org/obo/MONDO_0013835) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 7), [MONDO:0007142](http://purl.obolibrary.org/obo/MONDO_0007142) (Townes-Brocks syndrome), [MONDO:0013836](http://purl.obolibrary.org/obo/MONDO_0013836) (familial steroid-resistant nephrotic syndrome with sensorineural deafness), [MONDO:0007141](http://purl.obolibrary.org/obo/MONDO_0007141) (antiviral state repressor, regulator of), [MONDO:0013837](http://purl.obolibrary.org/obo/MONDO_0013837) (deafness-encephaloneuropathy-obesity-valvulopathy syndrome), [MONDO:0012503](http://purl.obolibrary.org/obo/MONDO_0012503) (thiopurine S-methyltransferase deficiency), [MONDO:0020119](http://purl.obolibrary.org/obo/MONDO_0020119) (X-linked syndromic intellectual disability), [MONDO:0008470](http://purl.obolibrary.org/obo/MONDO_0008470) (spondyloepiphyseal dysplasia with punctate corneal dystrophy), [MONDO:0008471](http://purl.obolibrary.org/obo/MONDO_0008471) (spondyloepiphyseal dysplasia congenita), [MONDO:0010792](http://purl.obolibrary.org/obo/MONDO_0010792) (lethal infantile mitochondrial myopathy), [MONDO:0010793](http://purl.obolibrary.org/obo/MONDO_0010793) (nephropathy, chronic tubulointerstitial), [MONDO:0008473](http://purl.obolibrary.org/obo/MONDO_0008473) (spondyloepiphyseal dysplasia, Maroteaux type), [MONDO:0008474](http://purl.obolibrary.org/obo/MONDO_0008474) (spondyloepiphyseal dysplasia tarda, autosomal dominant), [MONDO:0010790](http://purl.obolibrary.org/obo/MONDO_0010790) (MERRF syndrome), [MONDO:0008475](http://purl.obolibrary.org/obo/MONDO_0008475) (spondylolisthesis (disease)), [MONDO:0010791](http://purl.obolibrary.org/obo/MONDO_0010791) (myoglobinuria, recurrent), [MONDO:0016097](http://purl.obolibrary.org/obo/MONDO_0016097) (symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers), [MONDO:0016091](http://purl.obolibrary.org/obo/MONDO_0016091) (adult Krabbe disease), [MONDO:0013827](http://purl.obolibrary.org/obo/MONDO_0013827) (hyperekplexia 3), [MONDO:0013828](http://purl.obolibrary.org/obo/MONDO_0013828) (hyperekplexia 2), [MONDO:0013829](http://purl.obolibrary.org/obo/MONDO_0013829) (UV-Sensitive syndrome 2), [MONDO:0007156](http://purl.obolibrary.org/obo/MONDO_0007156) (arthritis, Sacroiliac), [MONDO:0013823](http://purl.obolibrary.org/obo/MONDO_0013823) (autosomal dominant nonsyndromic deafness 4B), [MONDO:0007155](http://purl.obolibrary.org/obo/MONDO_0007155) (arteritis, familial granulomatous, with juvenile polyarthritis), [MONDO:0010797](http://purl.obolibrary.org/obo/MONDO_0010797) (Pearson syndrome), [MONDO:0013824](http://purl.obolibrary.org/obo/MONDO_0013824) (Joubert syndrome 17), [MONDO:0010794](http://purl.obolibrary.org/obo/MONDO_0010794) (NARP syndrome), [MONDO:0007153](http://purl.obolibrary.org/obo/MONDO_0007153) (arteries, anomalies of), [MONDO:0013826](http://purl.obolibrary.org/obo/MONDO_0013826) (autosomal recessive nonsyndromic deafness 86), [MONDO:0007151](http://purl.obolibrary.org/obo/MONDO_0007151) (Arms, malformation of), [MONDO:0007150](http://purl.obolibrary.org/obo/MONDO_0007150) (arcus senilis), [MONDO:0010798](http://purl.obolibrary.org/obo/MONDO_0010798) (proximal tubulopathy-diabetes mellitus-cerebellar ataxia syndrome), [MONDO:0010799](http://purl.obolibrary.org/obo/MONDO_0010799) (mitochondrial non-syndromic sensorineural deafness with susceptibility to aminoglycoside exposure), [MONDO:0012560](http://purl.obolibrary.org/obo/MONDO_0012560) (invasive pneumococcal disease, recurrent isolated, 1), [MONDO:0012564](http://purl.obolibrary.org/obo/MONDO_0012564) (Polyosteolysis-hyperostosis syndrome), [MONDO:0011233](http://purl.obolibrary.org/obo/MONDO_0011233) (Axenfeld-Rieger syndrome type 3), [MONDO:0011231](http://purl.obolibrary.org/obo/MONDO_0011231) (FEB2), [MONDO:0012561](http://purl.obolibrary.org/obo/MONDO_0012561) (congenital anomalies of kidney and urinary tract 1, susceptibility to), [MONDO:0011230](http://purl.obolibrary.org/obo/MONDO_0011230) (ossification of the posterior longitudinal ligament of the spine), [MONDO:0013891](http://purl.obolibrary.org/obo/MONDO_0013891) (amyotrophic lateral sclerosis type 18), [MONDO:0000579](http://purl.obolibrary.org/obo/MONDO_0000579) (coronin-1A deficiency), [MONDO:0019197](http://purl.obolibrary.org/obo/MONDO_0019197) (Folinic acid-responsive seizures), [MONDO:0000575](http://purl.obolibrary.org/obo/MONDO_0000575) (interleukin-7 receptor alpha deficiency), [MONDO:0019193](http://purl.obolibrary.org/obo/MONDO_0019193) (acquired generalized lipodystrophy), [MONDO:0000572](http://purl.obolibrary.org/obo/MONDO_0000572) (recombinase activating gene 1 deficiency), [MONDO:0000573](http://purl.obolibrary.org/obo/MONDO_0000573) (recombinase activating gene 2 deficiency), [MONDO:0000570](http://purl.obolibrary.org/obo/MONDO_0000570) (severe combined immunodeficiency due to artemis deficiency), [MONDO:0011237](http://purl.obolibrary.org/obo/MONDO_0011237) (hyperlipidemia, combined, 1), [MONDO:0011236](http://purl.obolibrary.org/obo/MONDO_0011236) (hyperinsulinism due to glucokinase deficiency), [MONDO:0012565](http://purl.obolibrary.org/obo/MONDO_0012565) (Fanconi anemia complementation group N), [MONDO:0013896](http://purl.obolibrary.org/obo/MONDO_0013896) (Joubert syndrome 18), [MONDO:0013897](http://purl.obolibrary.org/obo/MONDO_0013897) (Loeys-Dietz syndrome 4), [MONDO:0012569](http://purl.obolibrary.org/obo/MONDO_0012569) (MMVP3), [MONDO:0011238](http://purl.obolibrary.org/obo/MONDO_0011238) (chondrodysplasia punctata, brachytelephalangic, autosomal), [MONDO:0013899](http://purl.obolibrary.org/obo/MONDO_0013899) (Weill-Marchesani syndrome 3), [MONDO:0013881](http://purl.obolibrary.org/obo/MONDO_0013881) (congenital nephrotic syndrome-interstitial lung disease-epidermolysis bullosa syndrome), [MONDO:0013882](http://purl.obolibrary.org/obo/MONDO_0013882) (hyperphosphatasia with mental retardation syndrome 2), [MONDO:0013883](http://purl.obolibrary.org/obo/MONDO_0013883) (congenital myasthenic syndrome 13), [MONDO:0013884](http://purl.obolibrary.org/obo/MONDO_0013884) (neuronopathy, distal hereditary motor, type 5B), [MONDO:0012553](http://purl.obolibrary.org/obo/MONDO_0012553) (Cerebrooculofacioskeletal syndrome 2), [MONDO:0011222](http://purl.obolibrary.org/obo/MONDO_0011222) (GLC1D), [MONDO:0012552](http://purl.obolibrary.org/obo/MONDO_0012552) (multiple endocrine neoplasia type 4), [MONDO:0011221](http://purl.obolibrary.org/obo/MONDO_0011221) (Weyers ulnar ray/oligodactyly syndrome), [MONDO:0012550](http://purl.obolibrary.org/obo/MONDO_0012550) (iris pattern), [MONDO:0019188](http://purl.obolibrary.org/obo/MONDO_0019188) (Rubinstein-Taybi syndrome), [MONDO:0019189](http://purl.obolibrary.org/obo/MONDO_0019189) (disorder of amino acid and other organic acid metabolism), [MONDO:0019187](http://purl.obolibrary.org/obo/MONDO_0019187) (Axenfeld-Rieger syndrome), [MONDO:0019182](http://purl.obolibrary.org/obo/MONDO_0019182) (genetic obesity), [MONDO:0019192](http://purl.obolibrary.org/obo/MONDO_0019192) (AKT2-related familial partial lipodystrophy), [MONDO:0019190](http://purl.obolibrary.org/obo/MONDO_0019190) (juvenile polyposis of infancy), [MONDO:0012557](http://purl.obolibrary.org/obo/MONDO_0012557) (cardiomyopathy-hypotonia-lactic acidosis syndrome), [MONDO:0011226](http://purl.obolibrary.org/obo/MONDO_0011226) (autosomal dominant nonsyndromic deafness 15), [MONDO:0011225](http://purl.obolibrary.org/obo/MONDO_0011225) (severe combined immunodeficiency with sensitivity to ionizing radiation), [MONDO:0012556](http://purl.obolibrary.org/obo/MONDO_0012556) (DK1-CDG), [MONDO:0012554](http://purl.obolibrary.org/obo/MONDO_0012554) (Cerebrooculofacioskeletal syndrome 4), [MONDO:0013885](http://purl.obolibrary.org/obo/MONDO_0013885) (Malan overgrowth syndrome), [MONDO:0013886](http://purl.obolibrary.org/obo/MONDO_0013886) (nonprogressive cerebellar atxia with mental retardation), [MONDO:0011229](http://purl.obolibrary.org/obo/MONDO_0011229) (ethylmalonic encephalopathy), [MONDO:0013887](http://purl.obolibrary.org/obo/MONDO_0013887) (heterotaxy, visceral, 6, autosomal), [MONDO:0011228](http://purl.obolibrary.org/obo/MONDO_0011228) (creases, Infra-auricular cutaneous, with tall stature and advanced bone age), [MONDO:0013888](http://purl.obolibrary.org/obo/MONDO_0013888) (tremor, hereditary essential, 4), [MONDO:0012558](http://purl.obolibrary.org/obo/MONDO_0012558) (epiphyseal dysplasia, Baumann type), [MONDO:0013870](http://purl.obolibrary.org/obo/MONDO_0013870) (TMEM165-CDG), [MONDO:0007190](http://purl.obolibrary.org/obo/MONDO_0007190) (leukemia, chronic lymphocytic, susceptibility to, 2), [MONDO:0013871](http://purl.obolibrary.org/obo/MONDO_0013871) (Seckel syndrome 6), [MONDO:0012542](http://purl.obolibrary.org/obo/MONDO_0012542) (PSORS8), [MONDO:0012541](http://purl.obolibrary.org/obo/MONDO_0012541) (deafness with labyrinthine aplasia, microtia, and microdontia), [MONDO:0011210](http://purl.obolibrary.org/obo/MONDO_0011210) (mitochondrial Intermembrane space protein Tim12, Yeast, Homolog of), [MONDO:0012540](http://purl.obolibrary.org/obo/MONDO_0012540) (age related macular degeneration 4), [MONDO:0000559](http://purl.obolibrary.org/obo/MONDO_0000559) (X-linked hereditary ataxia), [MONDO:0019176](http://purl.obolibrary.org/obo/MONDO_0019176) (trichorhinophalangeal syndrome type 1 and 3), [MONDO:0019174](http://purl.obolibrary.org/obo/MONDO_0019174) (infantile Refsum disease), [MONDO:0019171](http://purl.obolibrary.org/obo/MONDO_0019171) (familial long QT syndrome), [MONDO:0019180](http://purl.obolibrary.org/obo/MONDO_0019180) (hereditary hemorrhagic telangiectasia), [MONDO:0007189](http://purl.obolibrary.org/obo/MONDO_0007189) (b-cell growth factor), [MONDO:0007187](http://purl.obolibrary.org/obo/MONDO_0007187) (nevoid basal cell carcinoma syndrome), [MONDO:0012545](http://purl.obolibrary.org/obo/MONDO_0012545) (neutral lipid storage myopathy), [MONDO:0011214](http://purl.obolibrary.org/obo/MONDO_0011214) (progressive familial intrahepatic cholestasis type 3), [MONDO:0011213](http://purl.obolibrary.org/obo/MONDO_0011213) (plantar lipomatosis, unusual facies, and developmental delay), [MONDO:0007186](http://purl.obolibrary.org/obo/MONDO_0007186) (gastroesophageal reflux disease), [MONDO:0012544](http://purl.obolibrary.org/obo/MONDO_0012544) (brachydactyly-syndactyly syndrome), [MONDO:0012543](http://purl.obolibrary.org/obo/MONDO_0012543) (OPA5), [MONDO:0011212](http://purl.obolibrary.org/obo/MONDO_0011212) (sensorineural hearing loss, retinal pigment epithelium lesions, Discolored teeth), [MONDO:0007183](http://purl.obolibrary.org/obo/MONDO_0007183) (azotemia, familial), [MONDO:0011218](http://purl.obolibrary.org/obo/MONDO_0011218) (autosomal recessive congenital ichthyosis 11), [MONDO:0013875](http://purl.obolibrary.org/obo/MONDO_0013875) (3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome), [MONDO:0012549](http://purl.obolibrary.org/obo/MONDO_0012549) (autosomal recessive ataxia, Beauce type), [MONDO:0007182](http://purl.obolibrary.org/obo/MONDO_0007182) (Machado-Joseph disease), [MONDO:0013876](http://purl.obolibrary.org/obo/MONDO_0013876) (basal cell carcinoma, susceptibility to, 7), [MONDO:0011217](http://purl.obolibrary.org/obo/MONDO_0011217) (Desmosterolosis), [MONDO:0012548](http://purl.obolibrary.org/obo/MONDO_0012548) (Kostmann syndrome), [MONDO:0007181](http://purl.obolibrary.org/obo/MONDO_0007181) (axial osteomalacia), [MONDO:0013877](http://purl.obolibrary.org/obo/MONDO_0013877) (mitochondrial pyruvate carrier deficiency), [MONDO:0011216](http://purl.obolibrary.org/obo/MONDO_0011216) (hemochromatosis type 2A), [MONDO:0012547](http://purl.obolibrary.org/obo/MONDO_0012547) (Noonan syndrome 4), [MONDO:0013861](http://purl.obolibrary.org/obo/MONDO_0013861) (amyotrophic lateral sclerosis type 17), [MONDO:0013862](http://purl.obolibrary.org/obo/MONDO_0013862) (immunodeficiency, common variable, 7), [MONDO:0011200](http://purl.obolibrary.org/obo/MONDO_0011200) (torsion dystonia 7), [MONDO:0012531](http://purl.obolibrary.org/obo/MONDO_0012531) (xeroderma pigmentosum group B), [MONDO:0012530](http://purl.obolibrary.org/obo/MONDO_0012530) (palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome), [MONDO:0019169](http://purl.obolibrary.org/obo/MONDO_0019169) (pyruvate dehydrogenase deficiency), [MONDO:0019162](http://purl.obolibrary.org/obo/MONDO_0019162) (pseudohypoaldosteronism type 2), [MONDO:0019161](http://purl.obolibrary.org/obo/MONDO_0019161) (pseudohypoaldosteronism type 1), [MONDO:0019170](http://purl.obolibrary.org/obo/MONDO_0019170) (polyarteritis nodosa), [MONDO:0000561](http://purl.obolibrary.org/obo/MONDO_0000561) (spinocerebellar ataxia type 16), [MONDO:0000563](http://purl.obolibrary.org/obo/MONDO_0000563) (GRID2-related autosomal dominant spinocerebellar ataxia), [MONDO:0011209](http://purl.obolibrary.org/obo/MONDO_0011209) (progeroid facial appearance with hand anomalies), [MONDO:0013867](http://purl.obolibrary.org/obo/MONDO_0013867) (brown-Vialetto-van Laere syndrome 2), [MONDO:0012535](http://purl.obolibrary.org/obo/MONDO_0012535) (holoprosencephaly, recurrent infections, and monocytosis), [MONDO:0011204](http://purl.obolibrary.org/obo/MONDO_0011204) (cerebellar degeneration-related Autoantigen 3), [MONDO:0007199](http://purl.obolibrary.org/obo/MONDO_0007199) (blepharochalasis, superior), [MONDO:0012534](http://purl.obolibrary.org/obo/MONDO_0012534) (combined oxidative phosphorylation defect type 4), [MONDO:0007197](http://purl.obolibrary.org/obo/MONDO_0007197) (bladder diverticulum (disease)), [MONDO:0013869](http://purl.obolibrary.org/obo/MONDO_0013869) (adenine phosphoribosyltransferase deficiency), [MONDO:0011201](http://purl.obolibrary.org/obo/MONDO_0011201) (ETM2), [MONDO:0012532](http://purl.obolibrary.org/obo/MONDO_0012532) (HHT4), [MONDO:0013863](http://purl.obolibrary.org/obo/MONDO_0013863) (combined immunodeficiency due to LRBA deficiency), [MONDO:0012539](http://purl.obolibrary.org/obo/MONDO_0012539) (Joubert syndrome 6), [MONDO:0011207](http://purl.obolibrary.org/obo/MONDO_0011207) (xanthomatosis, susceptibility to), [MONDO:0013865](http://purl.obolibrary.org/obo/MONDO_0013865) (mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency), [MONDO:0011206](http://purl.obolibrary.org/obo/MONDO_0011206) (ventriculomegaly with defects of the radius and kidney), [MONDO:0007192](http://purl.obolibrary.org/obo/MONDO_0007192) (AABT), [MONDO:0013866](http://purl.obolibrary.org/obo/MONDO_0013866) (neuronal ceroid lipofuscinosis 11), [MONDO:0011205](http://purl.obolibrary.org/obo/MONDO_0011205) (medium chain 3-Ketoacyl-Coa thiolase deficiency), [MONDO:0011273](http://purl.obolibrary.org/obo/MONDO_0011273) (H syndrome), [MONDO:0015633](http://purl.obolibrary.org/obo/MONDO_0015633) (Bazex syndrome), [MONDO:0014301](http://purl.obolibrary.org/obo/MONDO_0014301) (DDD3), [MONDO:0015632](http://purl.obolibrary.org/obo/MONDO_0015632) (FASTKD2-related infantile mitochondrial encephalomyopathy), [MONDO:0014302](http://purl.obolibrary.org/obo/MONDO_0014302) (hereditary spastic paraplegia 62), [MONDO:0011277](http://purl.obolibrary.org/obo/MONDO_0011277) (Leukoregulin), [MONDO:0003640](http://purl.obolibrary.org/obo/MONDO_0003640) (verruciform xanthoma of skin), [MONDO:0014307](http://purl.obolibrary.org/obo/MONDO_0014307) (Dowling-Degos disease 4), [MONDO:0014308](http://purl.obolibrary.org/obo/MONDO_0014308) (familial temporal lobe epilepsy 6), [MONDO:0014309](http://purl.obolibrary.org/obo/MONDO_0014309) (obesity due to CEP19 deficiency), [MONDO:0011279](http://purl.obolibrary.org/obo/MONDO_0011279) (autosomal recessive nonsyndromic deafness 17), [MONDO:0011278](http://purl.obolibrary.org/obo/MONDO_0011278) (bile duct cysts), [MONDO:0014303](http://purl.obolibrary.org/obo/MONDO_0014303) (hereditary spastic paraplegia 64), [MONDO:0015634](http://purl.obolibrary.org/obo/MONDO_0015634) (isolated osteopoikilosis), [MONDO:0014304](http://purl.obolibrary.org/obo/MONDO_0014304) (hereditary spastic paraplegia 61), [MONDO:0014305](http://purl.obolibrary.org/obo/MONDO_0014305) (hereditary spastic paraplegia 63), [MONDO:0011262](http://purl.obolibrary.org/obo/MONDO_0011262) (camptodactyly, myopia, and fibrosis of the medial rectus muscle of eye), [MONDO:0011260](http://purl.obolibrary.org/obo/MONDO_0011260) (pancreatic lymphoma, familial), [MONDO:0012590](http://purl.obolibrary.org/obo/MONDO_0012590) (XFE progeroid syndrome), [MONDO:0011265](http://purl.obolibrary.org/obo/MONDO_0011265) (STHAG2), [MONDO:0012596](http://purl.obolibrary.org/obo/MONDO_0012596) (PSAT deficiency), [MONDO:0011263](http://purl.obolibrary.org/obo/MONDO_0011263) (skeletal dysplasia and progressive central nervous system degeneration, lethal), [MONDO:0011269](http://purl.obolibrary.org/obo/MONDO_0011269) (psoriasis 2), [MONDO:0011268](http://purl.obolibrary.org/obo/MONDO_0011268) (renal tubular acidosis, distal, autosomal recessive), [MONDO:0011267](http://purl.obolibrary.org/obo/MONDO_0011267) (mental retardation, severe, with spasticity and pigmentary tapetoretinal degeneration), [MONDO:0015624](http://purl.obolibrary.org/obo/MONDO_0015624) (Diazoxide-sensitive diffuse hyperinsulinism), [MONDO:0015625](http://purl.obolibrary.org/obo/MONDO_0015625) (Diazoxide-resistant diffuse hyperinsulinism), [MONDO:0011251](http://purl.obolibrary.org/obo/MONDO_0011251) (facial dysmorphism, cleft palate, hearing loss, and camptodactyly), [MONDO:0012582](http://purl.obolibrary.org/obo/MONDO_0012582) (interstitial lung disease due to ABCA3 deficiency), [MONDO:0011250](http://purl.obolibrary.org/obo/MONDO_0011250) (microcephaly, Macrotia, and mental retardation), [MONDO:0012580](http://purl.obolibrary.org/obo/MONDO_0012580) (hereditary pulmonary alveolar proteinosis), [MONDO:0015611](http://purl.obolibrary.org/obo/MONDO_0015611) (neutral lipid storage disease), [MONDO:0012586](http://purl.obolibrary.org/obo/MONDO_0012586) (coronary artery disease, autosomal dominant 2), [MONDO:0012585](http://purl.obolibrary.org/obo/MONDO_0012585) (coronary heart disease, susceptibility to, 7), [MONDO:0011254](http://purl.obolibrary.org/obo/MONDO_0011254) (brachydactyly, intraventricular septal defect, and deafness), [MONDO:0012583](http://purl.obolibrary.org/obo/MONDO_0012583) (STHAG5), [MONDO:0011257](http://purl.obolibrary.org/obo/MONDO_0011257) (MPI-CDG), [MONDO:0012588](http://purl.obolibrary.org/obo/MONDO_0012588) (neuronal ceroid lipofuscinosis 7), [MONDO:0011256](http://purl.obolibrary.org/obo/MONDO_0011256) (emphysema, congenital, with deafness, penoscrotal web, and mental retardation), [MONDO:0015612](http://purl.obolibrary.org/obo/MONDO_0015612) (Dent disease), [MONDO:0011240](http://purl.obolibrary.org/obo/MONDO_0011240) (megalencephaly-capillary malformation-polymicrogyria syndrome), [MONDO:0012571](http://purl.obolibrary.org/obo/MONDO_0012571) (primary ciliary dyskinesia 6), [MONDO:0015600](http://purl.obolibrary.org/obo/MONDO_0015600) (X-linked intellectual disability, Cilliers type), [MONDO:0012575](http://purl.obolibrary.org/obo/MONDO_0012575) (branchiootorenal syndrome 2), [MONDO:0012574](http://purl.obolibrary.org/obo/MONDO_0012574) (Potocki-Luspski syndrome), [MONDO:0012573](http://purl.obolibrary.org/obo/MONDO_0012573) (vesicoureteral reflux 2), [MONDO:0011242](http://purl.obolibrary.org/obo/MONDO_0011242) (Bartter disease type 4a), [MONDO:0012572](http://purl.obolibrary.org/obo/MONDO_0012572) (Sakoda complex), [MONDO:0011241](http://purl.obolibrary.org/obo/MONDO_0011241) (Pseudoacromegaly with severe insulin resistance), [MONDO:0003638](http://purl.obolibrary.org/obo/MONDO_0003638) (lung meningioma), [MONDO:0011247](http://purl.obolibrary.org/obo/MONDO_0011247) (jejunal atresia with renal adysplasia), [MONDO:0011246](http://purl.obolibrary.org/obo/MONDO_0011246) (megaconial type congenital muscular dystrophy), [MONDO:0012577](http://purl.obolibrary.org/obo/MONDO_0012577) (asthma-related Traits, susceptibility to, 4), [MONDO:0011245](http://purl.obolibrary.org/obo/MONDO_0011245) (ichthyosis, hystrix-like, with deafness), [MONDO:0015602](http://purl.obolibrary.org/obo/MONDO_0015602) (developmental delay-deafness syndrome, Hildebrand type), [MONDO:0015601](http://purl.obolibrary.org/obo/MONDO_0015601) (X-linked intellectual disability, van Esch type), [MONDO:0014344](http://purl.obolibrary.org/obo/MONDO_0014344) (congenital heart defects, multiple types, 4), [MONDO:0015674](http://purl.obolibrary.org/obo/MONDO_0015674) (late infantile neuronal ceroid lipofuscinosis), [MONDO:0018700](http://purl.obolibrary.org/obo/MONDO_0018700) (pseudohypoparathyroidism without Albright hereditary osteodystrophy), [MONDO:0014340](http://purl.obolibrary.org/obo/MONDO_0014340) (atrial fibrillation, familial, 15), [MONDO:0013010](http://purl.obolibrary.org/obo/MONDO_0013010) (autosomal recessive nonsyndromic deafness 71), [MONDO:0014341](http://purl.obolibrary.org/obo/MONDO_0014341) (complex cortical dysplasia with other brain malformations 6), [MONDO:0014342](http://purl.obolibrary.org/obo/MONDO_0014342) (female infertility due to zona pellucida defect), [MONDO:0002350](http://purl.obolibrary.org/obo/MONDO_0002350) (familial nephrotic syndrome), [MONDO:0018709](http://purl.obolibrary.org/obo/MONDO_0018709) (X-linked intellectual disability-hypotonia-movement disorder syndrome), [MONDO:0018705](http://purl.obolibrary.org/obo/MONDO_0018705) (infantile-onset axonal motor and sensory neuropathy-optic atrophy-neurodegenerative syndrome), [MONDO:0013016](http://purl.obolibrary.org/obo/MONDO_0013016) (leukocyte adhesion deficiency 3), [MONDO:0014347](http://purl.obolibrary.org/obo/MONDO_0014347) (short stature with microcephaly and distinctive facies), [MONDO:0014348](http://purl.obolibrary.org/obo/MONDO_0014348) (mental retardation, autosomal recessive 42), [MONDO:0018706](http://purl.obolibrary.org/obo/MONDO_0018706) (syndromic sensorineural deafness due to combined oxidative phosphorylation defect), [MONDO:0013019](http://purl.obolibrary.org/obo/MONDO_0013019) (spondyloepimetaphyseal dysplasia, Pakistani type), [MONDO:0013001](http://purl.obolibrary.org/obo/MONDO_0013001) (Synesthesia), [MONDO:0014332](http://purl.obolibrary.org/obo/MONDO_0014332) (Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency), [MONDO:0014334](http://purl.obolibrary.org/obo/MONDO_0014334) (severe combined immunodeficiency due to LCK deficiency), [MONDO:0013004](http://purl.obolibrary.org/obo/MONDO_0013004) (hypotonia, seizures, and precocious puberty), [MONDO:0016990](http://purl.obolibrary.org/obo/MONDO_0016990) (acquired prothrombin deficiency), [MONDO:0016993](http://purl.obolibrary.org/obo/MONDO_0016993) (generalized peeling skin syndrome type c), [MONDO:0014330](http://purl.obolibrary.org/obo/MONDO_0014330) (Eculizumab, poor response to), [MONDO:0016992](http://purl.obolibrary.org/obo/MONDO_0016992) (peeling skin syndrome type b), [MONDO:0013000](http://purl.obolibrary.org/obo/MONDO_0013000) (porphyria due to ALA dehydratase deficiency), [MONDO:0013009](http://purl.obolibrary.org/obo/MONDO_0013009) (Megarbane-Jalkh syndrome), [MONDO:0013005](http://purl.obolibrary.org/obo/MONDO_0013005) (EAST syndrome), [MONDO:0014337](http://purl.obolibrary.org/obo/MONDO_0014337) (complex cortical dysplasia with other brain malformations 5), [MONDO:0014338](http://purl.obolibrary.org/obo/MONDO_0014338) (IL21-related infantile inflammatory bowel disease), [MONDO:0014339](http://purl.obolibrary.org/obo/MONDO_0014339) (autosomal recessive spinocerebellar ataxia 16), [MONDO:0015653](http://purl.obolibrary.org/obo/MONDO_0015653) (monogenic disease with epilepsy), [MONDO:0014321](http://purl.obolibrary.org/obo/MONDO_0014321) (premature ovarian failure 8), [MONDO:0014322](http://purl.obolibrary.org/obo/MONDO_0014322) (premature ovarian failure 9), [MONDO:0016983](http://purl.obolibrary.org/obo/MONDO_0016983) (Bartter syndrome with hypocalcemia), [MONDO:0011293](http://purl.obolibrary.org/obo/MONDO_0011293) (Homocysteinemia), [MONDO:0014324](http://purl.obolibrary.org/obo/MONDO_0014324) (pachyonychia congenita 3), [MONDO:0011292](http://purl.obolibrary.org/obo/MONDO_0011292) (dermatitis, atopic), [MONDO:0011299](http://purl.obolibrary.org/obo/MONDO_0011299) (Huntington disease-like 1), [MONDO:0016980](http://purl.obolibrary.org/obo/MONDO_0016980) (ATR-X-related syndrome), [MONDO:0011297](http://purl.obolibrary.org/obo/MONDO_0011297) (autosomal dominant nocturnal frontal lobe epilepsy 2), [MONDO:0011296](http://purl.obolibrary.org/obo/MONDO_0011296) (Meckel syndrome, type 2), [MONDO:0016981](http://purl.obolibrary.org/obo/MONDO_0016981) (infantile spams-psychomotor retardation-progressive brain atrophy-basal ganglia disease syndrome), [MONDO:0011291](http://purl.obolibrary.org/obo/MONDO_0011291) (congenital disorder of glycosylation type 1C), [MONDO:0011290](http://purl.obolibrary.org/obo/MONDO_0011290) (Dislocated elbows, bowed tibias, scoliosis, deafness, cataract, microcephaly, and mental retardation), [MONDO:0014329](http://purl.obolibrary.org/obo/MONDO_0014329) (atrial standstill 2), [MONDO:0016988](http://purl.obolibrary.org/obo/MONDO_0016988) (hyperinsulinism due to HNF4A deficiency), [MONDO:0014325](http://purl.obolibrary.org/obo/MONDO_0014325) (pachyonychia congenita 4), [MONDO:0014327](http://purl.obolibrary.org/obo/MONDO_0014327) (autosomal dominant focal non-epidermolytic palmoplantar keratoderma with plantar blistering), [MONDO:0014328](http://purl.obolibrary.org/obo/MONDO_0014328) (epileptic encephalopathy, early infantile, 19), [MONDO:0011283](http://purl.obolibrary.org/obo/MONDO_0011283) (mitochondrial DNA depletion syndrome 1), [MONDO:0014311](http://purl.obolibrary.org/obo/MONDO_0014311) (autosomal recessive spinocerebellar ataxia 15), [MONDO:0011282](http://purl.obolibrary.org/obo/MONDO_0011282) (tumor suppressor gene on chromosome 11), [MONDO:0011288](http://purl.obolibrary.org/obo/MONDO_0011288) (spastic paraplegia, optic atrophy, microcephaly, and 10Y sex reversal), [MONDO:0011286](http://purl.obolibrary.org/obo/MONDO_0011286) (autosomal recessive nonsyndromic deafness 13), [MONDO:0011285](http://purl.obolibrary.org/obo/MONDO_0011285) (age related macular degeneration 1), [MONDO:0014318](http://purl.obolibrary.org/obo/MONDO_0014318) (hyperphosphatasia with mental retardation syndrome 4), [MONDO:0011289](http://purl.obolibrary.org/obo/MONDO_0011289) (apraxia of eyelid Opening), [MONDO:0013056](http://purl.obolibrary.org/obo/MONDO_0013056) (epileptic encephalopathy with global cerebral demyelination), [MONDO:0017413](http://purl.obolibrary.org/obo/MONDO_0017413) (Reunion island larsen syndrome), [MONDO:0013057](http://purl.obolibrary.org/obo/MONDO_0013057) (PSORS12), [MONDO:0014389](http://purl.obolibrary.org/obo/MONDO_0014389) (polyglucosan body myopathy 1 with or without immunodeficiency), [MONDO:0013059](http://purl.obolibrary.org/obo/MONDO_0013059) (Aicardi-Goutieres syndrome 5), [MONDO:0014385](http://purl.obolibrary.org/obo/MONDO_0014385) (amelogenesis imperfecta hypomaturation type 2A5), [MONDO:0013054](http://purl.obolibrary.org/obo/MONDO_0013054) (microcephaly, growth retardation, cataract, hearing loss, and unusual appearance), [MONDO:0013055](http://purl.obolibrary.org/obo/MONDO_0013055) (Stargardt macular degeneration, absent or hypoplastic corpus callosum, mental retardation, and dysmorphic features), [MONDO:0014381](http://purl.obolibrary.org/obo/MONDO_0014381) (cholestasis, progressive familial intrahepatic, 4), [MONDO:0013051](http://purl.obolibrary.org/obo/MONDO_0013051) (autosomal recessive cutis laxa type 2B), [MONDO:0013045](http://purl.obolibrary.org/obo/MONDO_0013045) (mycobacterium tuberculosis, susceptibility to, 3), [MONDO:0013046](http://purl.obolibrary.org/obo/MONDO_0013046) (glycogen storage disease due to muscle beta-enolase deficiency), [MONDO:0014377](http://purl.obolibrary.org/obo/MONDO_0014377) (epileptic encephalopathy, early infantile, 24), [MONDO:0014378](http://purl.obolibrary.org/obo/MONDO_0014378) (primary ciliary dyskinesia 29), [MONDO:0013047](http://purl.obolibrary.org/obo/MONDO_0013047) (glycogen storage disease due to lactate dehydrogenase M-subunit deficiency), [MONDO:0013048](http://purl.obolibrary.org/obo/MONDO_0013048) (hereditary spastic paraplegia 50), [MONDO:0014374](http://purl.obolibrary.org/obo/MONDO_0014374) (nephronophthisis 18), [MONDO:0014371](http://purl.obolibrary.org/obo/MONDO_0014371) (early-onset epileptic encephalopathy-cortical blindness-intellectual disability-facial dysmorphism syndrome), [MONDO:0005439](http://purl.obolibrary.org/obo/MONDO_0005439) (familial hypercholesterolemia), [MONDO:0013049](http://purl.obolibrary.org/obo/MONDO_0013049) (DPM3-CDG), [MONDO:0017408](http://purl.obolibrary.org/obo/MONDO_0017408) (Rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome), [MONDO:0017407](http://purl.obolibrary.org/obo/MONDO_0017407) (deficiency in anterior pituitary function-variable immunodeficiency syndrome), [MONDO:0013034](http://purl.obolibrary.org/obo/MONDO_0013034) (keratosis palmoplantaris striata 2), [MONDO:0014367](http://purl.obolibrary.org/obo/MONDO_0014367) (Aicardi-Goutieres syndrome 7), [MONDO:0014368](http://purl.obolibrary.org/obo/MONDO_0014368) (melanoma, cutaneous malignant, susceptibility to, 10), [MONDO:0013037](http://purl.obolibrary.org/obo/MONDO_0013037) (Giacheti syndrome), [MONDO:0013030](http://purl.obolibrary.org/obo/MONDO_0013030) (dilated cardiomyopathy 1BB), [MONDO:0014362](http://purl.obolibrary.org/obo/MONDO_0014362) (chromosome 16 inversion, 0.45-Mb), [MONDO:0014363](http://purl.obolibrary.org/obo/MONDO_0014363) (autosomal recessive nonsyndromic deafness 101), [MONDO:0013032](http://purl.obolibrary.org/obo/MONDO_0013032) (epilepsy, idiopathic generalized, susceptibility to, 8), [MONDO:0014364](http://purl.obolibrary.org/obo/MONDO_0014364) (mitochondrial complex III deficiency nuclear type 8), [MONDO:0014360](http://purl.obolibrary.org/obo/MONDO_0014360) (epileptic encephalopathy, early infantile, 21), [MONDO:0006735](http://purl.obolibrary.org/obo/MONDO_0006735) (duodenogastric reflux), [MONDO:0013039](http://purl.obolibrary.org/obo/MONDO_0013039) (three M syndrome 2), [MONDO:0014354](http://purl.obolibrary.org/obo/MONDO_0014354) (mental retardation, autosomal recessive 43), [MONDO:0014355](http://purl.obolibrary.org/obo/MONDO_0014355) (cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis), [MONDO:0018710](http://purl.obolibrary.org/obo/MONDO_0018710) (megalencephaly-severe kyphoscoliosis-overgrowth syndrome), [MONDO:0013025](http://purl.obolibrary.org/obo/MONDO_0013025) (chromosome 6q24-q25 deletion syndrome), [MONDO:0014356](http://purl.obolibrary.org/obo/MONDO_0014356) (mitochondrial complex III deficiency nuclear type 7), [MONDO:0014357](http://purl.obolibrary.org/obo/MONDO_0014357) (mental retardation, autosomal dominant 24), [MONDO:0014350](http://purl.obolibrary.org/obo/MONDO_0014350) (Seckel syndrome 8), [MONDO:0014352](http://purl.obolibrary.org/obo/MONDO_0014352) (abdominal obesity-metabolic syndrome 3), [MONDO:0014353](http://purl.obolibrary.org/obo/MONDO_0014353) (PGM3-CDG), [MONDO:0013022](http://purl.obolibrary.org/obo/MONDO_0013022) (RLS7), [MONDO:0005413](http://purl.obolibrary.org/obo/MONDO_0005413) (cystic fibrosis associated meconium ileum), [MONDO:0013028](http://purl.obolibrary.org/obo/MONDO_0013028) (adenosine monophosphate deaminase deficiency), [MONDO:0013029](http://purl.obolibrary.org/obo/MONDO_0013029) (cerebellar ataxia type 9), [MONDO:0013098](http://purl.obolibrary.org/obo/MONDO_0013098) (noise induced hearing loss), [MONDO:0018781](http://purl.obolibrary.org/obo/MONDO_0018781) (KID syndrome), [MONDO:0008500](http://purl.obolibrary.org/obo/MONDO_0008500) (striae Distensae, familial), [MONDO:0009833](http://purl.obolibrary.org/obo/MONDO_0009833) (Shwachman-Diamond syndrome), [MONDO:0008502](http://purl.obolibrary.org/obo/MONDO_0008502) (sulfhemoglobinemia, congenital), [MONDO:0009834](http://purl.obolibrary.org/obo/MONDO_0009834) (pancreatic insufficiency, combined exocrine), [MONDO:0013090](http://purl.obolibrary.org/obo/MONDO_0013090) (chromosome 19q13.11 deletion syndrome), [MONDO:0013091](http://purl.obolibrary.org/obo/MONDO_0013091) (glycogen storage disease IXc), [MONDO:0009836](http://purl.obolibrary.org/obo/MONDO_0009836) (pancreatitis, sclerosing cholangitis, and sicca complex), [MONDO:0008505](http://purl.obolibrary.org/obo/MONDO_0008505) (surface antigen, glycoprotein 75), [MONDO:0004137](http://purl.obolibrary.org/obo/MONDO_0004137) (hereditary conventional renal cell carcinoma), [MONDO:0008506](http://purl.obolibrary.org/obo/MONDO_0008506) (symphalangism of toes), [MONDO:0008507](http://purl.obolibrary.org/obo/MONDO_0008507) (surface Polypeptides, Anonymous), [MONDO:0008508](http://purl.obolibrary.org/obo/MONDO_0008508) (symphalangism, C. S. Lewis type), [MONDO:0005464](http://purl.obolibrary.org/obo/MONDO_0005464) (rhegmatogenous retinal detachment), [MONDO:0010822](http://purl.obolibrary.org/obo/MONDO_0010822) (Warburg micro syndrome 1), [MONDO:0010823](http://purl.obolibrary.org/obo/MONDO_0010823) (rhizomelic chondrodysplasia punctata type 3), [MONDO:0018774](http://purl.obolibrary.org/obo/MONDO_0018774) (erythrokeratodermia-cardiomyopathy syndrome), [MONDO:0018772](http://purl.obolibrary.org/obo/MONDO_0018772) (Joubert syndrome), [MONDO:0018773](http://purl.obolibrary.org/obo/MONDO_0018773) (autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome), [MONDO:0013081](http://purl.obolibrary.org/obo/MONDO_0013081) (lymphoproliferative syndrome 1), [MONDO:0018770](http://purl.obolibrary.org/obo/MONDO_0018770) (Jeune syndrome), [MONDO:0009820](http://purl.obolibrary.org/obo/MONDO_0009820) (osteoporosis-pseudoglioma syndrome), [MONDO:0009823](http://purl.obolibrary.org/obo/MONDO_0009823) (primary hyperoxaluria type 1), [MONDO:0009824](http://purl.obolibrary.org/obo/MONDO_0009824) (primary hyperoxaluria type 2), [MONDO:0009825](http://purl.obolibrary.org/obo/MONDO_0009825) (5-oxoprolinase deficiency (disease)), [MONDO:0009826](http://purl.obolibrary.org/obo/MONDO_0009826) (Pa Polymorphism of alpha-2-globulin), [MONDO:0010815](http://purl.obolibrary.org/obo/MONDO_0010815) (spondyloepiphyseal dysplasia tarda with characteristic facies), [MONDO:0009827](http://purl.obolibrary.org/obo/MONDO_0009827) (pachyonychia congenita, autosomal recessive), [MONDO:0009828](http://purl.obolibrary.org/obo/MONDO_0009828) (Palant cleft palate syndrome), [MONDO:0010813](http://purl.obolibrary.org/obo/MONDO_0010813) (pancreatic beta cell agenesis with neonatal diabetes mellitus), [MONDO:0009829](http://purl.obolibrary.org/obo/MONDO_0009829) (pallidal degeneration, progressive, with retinitis pigmentosa), [MONDO:0010817](http://purl.obolibrary.org/obo/MONDO_0010817) (autosomal dominant nonsyndromic deafness 2A), [MONDO:0010812](http://purl.obolibrary.org/obo/MONDO_0010812) (macrocytosis, familial), [MONDO:0018767](http://purl.obolibrary.org/obo/MONDO_0018767) (severe primary trimethylaminuria), [MONDO:0018768](http://purl.obolibrary.org/obo/MONDO_0018768) (familial cold autoinflammatory syndrome), [MONDO:0013076](http://purl.obolibrary.org/obo/MONDO_0013076) (attention deficit-hyperactivity disorder, susceptibility to, 7), [MONDO:0013077](http://purl.obolibrary.org/obo/MONDO_0013077) (Santos syndrome), [MONDO:0013071](http://purl.obolibrary.org/obo/MONDO_0013071) (Emery-Dreifuss muscular dystrophy 4, autosomal dominant), [MONDO:0013072](http://purl.obolibrary.org/obo/MONDO_0013072) (Emery-Dreifuss muscular dystrophy 5, autosomal dominant), [MONDO:0013073](http://purl.obolibrary.org/obo/MONDO_0013073) (palmoplantar keratoderma, nonepidermolytic, focal 1), [MONDO:0009811](http://purl.obolibrary.org/obo/MONDO_0009811) (Osteoma of middle ear), [MONDO:0009812](http://purl.obolibrary.org/obo/MONDO_0009812) (osteomalacia, sclerosing, with cerebral calcification), [MONDO:0010804](http://purl.obolibrary.org/obo/MONDO_0010804) (BRCATA), [MONDO:0010802](http://purl.obolibrary.org/obo/MONDO_0010802) (pancreatic hypoplasia-diabetes-congenital heart disease syndrome), [MONDO:0010808](http://purl.obolibrary.org/obo/MONDO_0010808) (fatal familial insomnia), [MONDO:0006772](http://purl.obolibrary.org/obo/MONDO_0006772) (glycogen storage disease VIII), [MONDO:0010807](http://purl.obolibrary.org/obo/MONDO_0010807) (autosomal recessive nonsyndromic deafness 2), [MONDO:0001083](http://purl.obolibrary.org/obo/MONDO_0001083) (Fanconi syndrome), [MONDO:0010800](http://purl.obolibrary.org/obo/MONDO_0010800) (Wolfram syndrome, mitochondrial form), [MONDO:0016108](http://purl.obolibrary.org/obo/MONDO_0016108) (autosomal dominant distal myopathy), [MONDO:0016109](http://purl.obolibrary.org/obo/MONDO_0016109) (autosomal recessive distal myopathy), [MONDO:0014398](http://purl.obolibrary.org/obo/MONDO_0014398) (combined oxidative phosphorylation defect type 21), [MONDO:0014399](http://purl.obolibrary.org/obo/MONDO_0014399) (PCNA-related progressive neurodegenerative photosensitivy syndrome), [MONDO:0013068](http://purl.obolibrary.org/obo/MONDO_0013068) (ARHI2), [MONDO:0013069](http://purl.obolibrary.org/obo/MONDO_0013069) (autosomal recessive optic atrophy, OPA7 type), [MONDO:0014394](http://purl.obolibrary.org/obo/MONDO_0014394) (Diamond-Blackfan anemia 13), [MONDO:0014396](http://purl.obolibrary.org/obo/MONDO_0014396) (dilated cardiomyopathy 1NN), [MONDO:0013065](http://purl.obolibrary.org/obo/MONDO_0013065) (premature ovarian failure 7), [MONDO:0014397](http://purl.obolibrary.org/obo/MONDO_0014397) (combined oxidative phosphorylation defect type 20), [MONDO:0013060](http://purl.obolibrary.org/obo/MONDO_0013060) (autosomal recessive Parkinson disease 14), [MONDO:0014391](http://purl.obolibrary.org/obo/MONDO_0014391) (severe combined immunodeficiency due to CTPS1 deficiency), [MONDO:0014392](http://purl.obolibrary.org/obo/MONDO_0014392) (epileptic encephalopathy, early infantile, 25), [MONDO:0013062](http://purl.obolibrary.org/obo/MONDO_0013062) (long QT syndrome 12), [MONDO:0014393](http://purl.obolibrary.org/obo/MONDO_0014393) (lymphedema, hereditary, 1D), [MONDO:0009802](http://purl.obolibrary.org/obo/MONDO_0009802) (osteodysplasty, precocious, of Danks, Mayne, and Kozlowski), [MONDO:0006788](http://purl.obolibrary.org/obo/MONDO_0006788) (hydrophthalmos), [MONDO:0009808](http://purl.obolibrary.org/obo/MONDO_0009808) (osteoid Osteoma (disease)), [MONDO:0018349](http://purl.obolibrary.org/obo/MONDO_0018349) (MAN1B1-CDG), [MONDO:0018347](http://purl.obolibrary.org/obo/MONDO_0018347) (severe intellectual disability-progressive postnatal microcephaly- midline stereotypic hand movements syndrome), [MONDO:0018348](http://purl.obolibrary.org/obo/MONDO_0018348) (polyglucosan body myopathy type 1), [MONDO:0018345](http://purl.obolibrary.org/obo/MONDO_0018345) (T+ b+ severe combined immunodeficiency), [MONDO:0018343](http://purl.obolibrary.org/obo/MONDO_0018343) (periodic paralysis with later-onset distal motor neuropathy), [MONDO:0019675](http://purl.obolibrary.org/obo/MONDO_0019675) (spondyloepimetaphyseal dysplasia with joint laxity), [MONDO:0018342](http://purl.obolibrary.org/obo/MONDO_0018342) (Joubert syndrome with Jeune asphyxiating thoracic dystrophy), [MONDO:0011718](http://purl.obolibrary.org/obo/MONDO_0011718) (primary ciliary dyskinesia 2), [MONDO:0011717](http://purl.obolibrary.org/obo/MONDO_0011717) (hyperinsulinism-hyperammonemia syndrome), [MONDO:0007689](http://purl.obolibrary.org/obo/MONDO_0007689) (guanylate kinase 3), [MONDO:0011715](http://purl.obolibrary.org/obo/MONDO_0011715) (Seckel syndrome 2), [MONDO:0007687](http://purl.obolibrary.org/obo/MONDO_0007687) (graying of hair, precocious), [MONDO:0007685](http://purl.obolibrary.org/obo/MONDO_0007685) (Granulosis rubra Nasi), [MONDO:0011710](http://purl.obolibrary.org/obo/MONDO_0011710) (SLI1), [MONDO:0007682](http://purl.obolibrary.org/obo/MONDO_0007682) (Granddad syndrome), [MONDO:0007681](http://purl.obolibrary.org/obo/MONDO_0007681) (familial multinodular goiter), [MONDO:0011714](http://purl.obolibrary.org/obo/MONDO_0011714) (partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome), [MONDO:0011713](http://purl.obolibrary.org/obo/MONDO_0011713) (melanoma-pancreatic cancer syndrome), [MONDO:0011711](http://purl.obolibrary.org/obo/MONDO_0011711) (SLI2), [MONDO:0018339](http://purl.obolibrary.org/obo/MONDO_0018339) (PrP systemic amyloidosis), [MONDO:0018336](http://purl.obolibrary.org/obo/MONDO_0018336) (silver-Russell syndrome due to a point mutation), [MONDO:0018337](http://purl.obolibrary.org/obo/MONDO_0018337) (severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency), [MONDO:0019666](http://purl.obolibrary.org/obo/MONDO_0019666) (spondyloepimetaphyseal dysplasia, PAPSS2 type), [MONDO:0018332](http://purl.obolibrary.org/obo/MONDO_0018332) (multiple acyl-CoA dehydrogenase deficiency, severe neonatal type), [MONDO:0018333](http://purl.obolibrary.org/obo/MONDO_0018333) (multiple acyl-CoA dehydrogenase deficiency, mild type), [MONDO:0011704](http://purl.obolibrary.org/obo/MONDO_0011704) (GLC1B), [MONDO:0007698](http://purl.obolibrary.org/obo/MONDO_0007698) (hand-foot-genital syndrome), [MONDO:0006366](http://purl.obolibrary.org/obo/MONDO_0006366) (Peutz-Jeghers polyp of the stomach), [MONDO:0007697](http://purl.obolibrary.org/obo/MONDO_0007697) (hand Clasping pattern), [MONDO:0007695](http://purl.obolibrary.org/obo/MONDO_0007695) (hairy palms and soles), [MONDO:0011708](http://purl.obolibrary.org/obo/MONDO_0011708) (autosomal dominant nonsyndromic deafness 36), [MONDO:0007694](http://purl.obolibrary.org/obo/MONDO_0007694) (hairy nose tip), [MONDO:0007692](http://purl.obolibrary.org/obo/MONDO_0007692) (hairy ears), [MONDO:0011703](http://purl.obolibrary.org/obo/MONDO_0011703) (spongiform encephalopathy with neuropsychiatric features), [MONDO:0011702](http://purl.obolibrary.org/obo/MONDO_0011702) (dilated cardiomyopathy 1L), [MONDO:0018328](http://purl.obolibrary.org/obo/MONDO_0018328) (homozygous familial hypercholesterolemia), [MONDO:0018323](http://purl.obolibrary.org/obo/MONDO_0018323) (HSD10 disease, neonatal type), [MONDO:0018322](http://purl.obolibrary.org/obo/MONDO_0018322) (HSD10 disease, infantile type), [MONDO:0015293](http://purl.obolibrary.org/obo/MONDO_0015293) (segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome), [MONDO:0018320](http://purl.obolibrary.org/obo/MONDO_0018320) (primary microcephaly-mild intellectual disability-young-onset diabetes syndrome), [MONDO:0007669](http://purl.obolibrary.org/obo/MONDO_0007669) (renal cysts and diabetes syndrome), [MONDO:0007668](http://purl.obolibrary.org/obo/MONDO_0007668) (globulin anomaly involving beta (2A)-Globulin), [MONDO:0006335](http://purl.obolibrary.org/obo/MONDO_0006335) (ovarian endometrioid adenocarcinoma), [MONDO:0007665](http://purl.obolibrary.org/obo/MONDO_0007665) (primary open angle glaucoma), [MONDO:0007664](http://purl.obolibrary.org/obo/MONDO_0007664) (glaucoma 1, open angle, a), [MONDO:0007663](http://purl.obolibrary.org/obo/MONDO_0007663) (glaucoma with elevated episcleral venous pressure), [MONDO:0007662](http://purl.obolibrary.org/obo/MONDO_0007662) (iridogoniodysgenesis, type 2), [MONDO:0007661](http://purl.obolibrary.org/obo/MONDO_0007661) (Tourette syndrome), [MONDO:0007660](http://purl.obolibrary.org/obo/MONDO_0007660) (familial ossifying fibroma), [MONDO:0018314](http://purl.obolibrary.org/obo/MONDO_0018314) (infantile-onset mesial temporal lobe epilepsy with severe cognitive regression), [MONDO:0015286](http://purl.obolibrary.org/obo/MONDO_0015286) (congenital disorder of glycosylation), [MONDO:0019643](http://purl.obolibrary.org/obo/MONDO_0019643) (transient pseudohypoaldosteronism), [MONDO:0015285](http://purl.obolibrary.org/obo/MONDO_0015285) (Carney complex), [MONDO:0015282](http://purl.obolibrary.org/obo/MONDO_0015282) (cardiomyopathy-cataract-hip spine disease syndrome), [MONDO:0015281](http://purl.obolibrary.org/obo/MONDO_0015281) (atrial standstill), [MONDO:0008996](http://purl.obolibrary.org/obo/MONDO_0008996) (Joubert syndrome with hepatic defect), [MONDO:0015283](http://purl.obolibrary.org/obo/MONDO_0015283) (maternally-inherited cardiomyopathy and hearing loss), [MONDO:0008998](http://purl.obolibrary.org/obo/MONDO_0008998) (Cockayne syndrome type 3), [MONDO:0008999](http://purl.obolibrary.org/obo/MONDO_0008999) (Cohen syndrome), [MONDO:0007679](http://purl.obolibrary.org/obo/MONDO_0007679) (GMS syndrome), [MONDO:0006347](http://purl.obolibrary.org/obo/MONDO_0006347) (pancreatic large cell neuroendocrine carcinoma), [MONDO:0007678](http://purl.obolibrary.org/obo/MONDO_0007678) (glycoprotein, renal), [MONDO:0007677](http://purl.obolibrary.org/obo/MONDO_0007677) (hyperglycinuria (disease)), [MONDO:0007676](http://purl.obolibrary.org/obo/MONDO_0007676) (glutathione transferase activity Toward Trans-Stilbene Oxide), [MONDO:0007675](http://purl.obolibrary.org/obo/MONDO_0007675) (glutamic acid decarboxylase, brain, membrane form), [MONDO:0007674](http://purl.obolibrary.org/obo/MONDO_0007674) (glucose-6-phosphate dehydrogenase-like), [MONDO:0007673](http://purl.obolibrary.org/obo/MONDO_0007673) (Glucoglycinuria), [MONDO:0018318](http://purl.obolibrary.org/obo/MONDO_0018318) (disorder of asparagine metabolism), [MONDO:0011750](http://purl.obolibrary.org/obo/MONDO_0011750) (insulinoma tumor suppressor gene locus), [MONDO:0009430](http://purl.obolibrary.org/obo/MONDO_0009430) (hypophosphatemic rickets, autosomal recessive, 1), [MONDO:0008100](http://purl.obolibrary.org/obo/MONDO_0008100) (nipples inverted), [MONDO:0008101](http://purl.obolibrary.org/obo/MONDO_0008101) (familial supernumerary nipples), [MONDO:0017058](http://purl.obolibrary.org/obo/MONDO_0017058) (autosomal recessive intermediate Charcot-Marie-tooth disease), [MONDO:0009432](http://purl.obolibrary.org/obo/MONDO_0009432) (hypopituitarism, congenital, with central diabetes insipidus), [MONDO:0017053](http://purl.obolibrary.org/obo/MONDO_0017053) (intermittent maple syrup urine disease), [MONDO:0008102](http://purl.obolibrary.org/obo/MONDO_0008102) (sick sinus syndrome 2, autosomal dominant), [MONDO:0009434](http://purl.obolibrary.org/obo/MONDO_0009434) (hypoproteinemia, Hypercatabolic), [MONDO:0008103](http://purl.obolibrary.org/obo/MONDO_0008103) (Noduli Cutanei, multiple, with urinary tract abnormalities), [MONDO:0017052](http://purl.obolibrary.org/obo/MONDO_0017052) (intermediate maple syrup urine disease), [MONDO:0008104](http://purl.obolibrary.org/obo/MONDO_0008104) (Noonan syndrome 1), [MONDO:0008105](http://purl.obolibrary.org/obo/MONDO_0008105) (nose, anomalous shape of), [MONDO:0017054](http://purl.obolibrary.org/obo/MONDO_0017054) (thiamine-responsive maple syrup urine disease), [MONDO:0008107](http://purl.obolibrary.org/obo/MONDO_0008107) (nystagmus, hereditary vertical), [MONDO:0009439](http://purl.obolibrary.org/obo/MONDO_0009439) (autosomal recessive congenital ichthyosis 2), [MONDO:0017051](http://purl.obolibrary.org/obo/MONDO_0017051) (classic maple syrup urine disease), [MONDO:0010428](http://purl.obolibrary.org/obo/MONDO_0010428) (chromosome Xp11.23-p11.22 duplication syndrome), [MONDO:0011759](http://purl.obolibrary.org/obo/MONDO_0011759) (Hurler-Scheie syndrome), [MONDO:0011753](http://purl.obolibrary.org/obo/MONDO_0011753) (EIG2), [MONDO:0010420](http://purl.obolibrary.org/obo/MONDO_0010420) (X-linked erythropoietic protoporphyria), [MONDO:0011752](http://purl.obolibrary.org/obo/MONDO_0011752) (nephronophthisis 4), [MONDO:0011751](http://purl.obolibrary.org/obo/MONDO_0011751) (COPD, severe early onset), [MONDO:0011758](http://purl.obolibrary.org/obo/MONDO_0011758) (Hurler syndrome), [MONDO:0010427](http://purl.obolibrary.org/obo/MONDO_0010427) (syndromic X-linked intellectual disability Raymond type), [MONDO:0006391](http://purl.obolibrary.org/obo/MONDO_0006391) (pyloric gland adenoma), [MONDO:0010424](http://purl.obolibrary.org/obo/MONDO_0010424) (surfactant metabolism dysfunction, pulmonary, 4), [MONDO:0011756](http://purl.obolibrary.org/obo/MONDO_0011756) (Senior-Loken syndrome 4), [MONDO:0011755](http://purl.obolibrary.org/obo/MONDO_0011755) (SLSN3), [MONDO:0009421](http://purl.obolibrary.org/obo/MONDO_0009421) (hypogonadism, male), [MONDO:0009422](http://purl.obolibrary.org/obo/MONDO_0009422) (hypohidrosis with abnormal palmar dermal Ridges), [MONDO:0009423](http://purl.obolibrary.org/obo/MONDO_0009423) (hypokalemic alkalosis, familial, with specific renal tubulopathy), [MONDO:0009424](http://purl.obolibrary.org/obo/MONDO_0009424) (Bartter disease type 2), [MONDO:0009426](http://purl.obolibrary.org/obo/MONDO_0009426) (hypoparathyroidism-retardation-dysmorphism syndrome), [MONDO:0018370](http://purl.obolibrary.org/obo/MONDO_0018370) (KLHL9-related early-onset distal myopathy), [MONDO:0018371](http://purl.obolibrary.org/obo/MONDO_0018371) (nebulin-related early-onset distal myopathy), [MONDO:0009427](http://purl.obolibrary.org/obo/MONDO_0009427) (infantile hypophosphatasia), [MONDO:0009428](http://purl.obolibrary.org/obo/MONDO_0009428) (childhood hypophosphatasia), [MONDO:0009429](http://purl.obolibrary.org/obo/MONDO_0009429) (hypophosphatemia, renal, with intracerebral calcifications), [MONDO:0010419](http://purl.obolibrary.org/obo/MONDO_0010419) (X-linked sideroblastic anemia), [MONDO:0011749](http://purl.obolibrary.org/obo/MONDO_0011749) (oculocutaneous albinism type 1B), [MONDO:0010417](http://purl.obolibrary.org/obo/MONDO_0010417) (syndromic X-linked intellectual disability Najm type), [MONDO:0011748](http://purl.obolibrary.org/obo/MONDO_0011748) (Usher syndrome type 1G), [MONDO:0010411](http://purl.obolibrary.org/obo/MONDO_0010411) (IHPS4), [MONDO:0010412](http://purl.obolibrary.org/obo/MONDO_0010412) (X-linked intellectual disability-craniofacioskeletal syndrome), [MONDO:0011740](http://purl.obolibrary.org/obo/MONDO_0011740) (Carney-Stratakis syndrome), [MONDO:0011747](http://purl.obolibrary.org/obo/MONDO_0011747) (DYX5), [MONDO:0011746](http://purl.obolibrary.org/obo/MONDO_0011746) (symphalangism, distal, with microdontia, dental pulp stones, and narrowed zygomatic arch), [MONDO:0010416](http://purl.obolibrary.org/obo/MONDO_0010416) (deafness, cataract, retinitis pigmentosa, and sperm abnormalities), [MONDO:0011745](http://purl.obolibrary.org/obo/MONDO_0011745) (Duodenojejunal atresia with volvulus, absent dorsal mesentery, and Absent superior mesenteric artery), [MONDO:0009412](http://purl.obolibrary.org/obo/MONDO_0009412) (scurvy), [MONDO:0009413](http://purl.obolibrary.org/obo/MONDO_0009413) (immunodeficiency, common variable, 2), [MONDO:0009414](http://purl.obolibrary.org/obo/MONDO_0009414) (glycogen storage disease due to hepatic glycogen synthase deficiency), [MONDO:0009415](http://purl.obolibrary.org/obo/MONDO_0009415) (hypoglycemia, Leucine-induced), [MONDO:0009418](http://purl.obolibrary.org/obo/MONDO_0009418) (hypogonadism with low-grade mental deficiency and microcephaly), [MONDO:0009419](http://purl.obolibrary.org/obo/MONDO_0009419) (Woodhouse-Sakati syndrome), [MONDO:0010409](http://purl.obolibrary.org/obo/MONDO_0010409) (syndromic X-linked intellectual disability Shrimpton type), [MONDO:0011739](http://purl.obolibrary.org/obo/MONDO_0011739) (pancreatic cancer, susceptibility to, 1), [MONDO:0010407](http://purl.obolibrary.org/obo/MONDO_0010407) (syndromic X-linked intellectual disability Turner type), [MONDO:0011731](http://purl.obolibrary.org/obo/MONDO_0011731) (glucose-galactose malabsorption), [MONDO:0010401](http://purl.obolibrary.org/obo/MONDO_0010401) (X-linked myopathy with postural muscle atrophy), [MONDO:0011730](http://purl.obolibrary.org/obo/MONDO_0011730) (Fumaric aciduria), [MONDO:0010404](http://purl.obolibrary.org/obo/MONDO_0010404) (X-linked non progressive cerebellar ataxia), [MONDO:0011736](http://purl.obolibrary.org/obo/MONDO_0011736) (Cree mental retardation syndrome), [MONDO:0011735](http://purl.obolibrary.org/obo/MONDO_0011735) (hyper-IgM syndrome type 3), [MONDO:0011734](http://purl.obolibrary.org/obo/MONDO_0011734) (Cardioneuromyopathy with hyaline Masses and nemaline rods), [MONDO:0010402](http://purl.obolibrary.org/obo/MONDO_0010402) (syndromic X-linked intellectual disability 94), [MONDO:0011733](http://purl.obolibrary.org/obo/MONDO_0011733) (PSMNSB), [MONDO:0018354](http://purl.obolibrary.org/obo/MONDO_0018354) (Prader-Willi-like syndrome), [MONDO:0018355](http://purl.obolibrary.org/obo/MONDO_0018355) (Prader-Willi-like syndrome due to point mutation), [MONDO:0009400](http://purl.obolibrary.org/obo/MONDO_0009400) (hyperprolinemia type 1), [MONDO:0009401](http://purl.obolibrary.org/obo/MONDO_0009401) (hyperprolinemia type 2), [MONDO:0019681](http://purl.obolibrary.org/obo/MONDO_0019681) (juvenile sialidosis type 2), [MONDO:0009403](http://purl.obolibrary.org/obo/MONDO_0009403) (hypertelorism and tetralogy of fallot), [MONDO:0019682](http://purl.obolibrary.org/obo/MONDO_0019682) (congenital sialidosis type 2), [MONDO:0009404](http://purl.obolibrary.org/obo/MONDO_0009404) (hypertelorism, microtia, facial clefting syndrome), [MONDO:0019680](http://purl.obolibrary.org/obo/MONDO_0019680) (genochondromatosis type 2), [MONDO:0009407](http://purl.obolibrary.org/obo/MONDO_0009407) (hypertrophic neuropathy and cataract), [MONDO:0009408](http://purl.obolibrary.org/obo/MONDO_0009408) (hyperuricemia, infantile, with abnormal behavior and normal hypoxanthine guanine phosphoribosyltransferase), [MONDO:0011729](http://purl.obolibrary.org/obo/MONDO_0011729) (stroke, susceptibility to, 1), [MONDO:0011728](http://purl.obolibrary.org/obo/MONDO_0011728) (blepharospasm), [MONDO:0009409](http://purl.obolibrary.org/obo/MONDO_0009409) (hypervitaminosis a, susceptibility to), [MONDO:0011727](http://purl.obolibrary.org/obo/MONDO_0011727) (ANON1), [MONDO:0011726](http://purl.obolibrary.org/obo/MONDO_0011726) (peripheral arterial occlusive disease 1), [MONDO:0011721](http://purl.obolibrary.org/obo/MONDO_0011721) (distal myopathy with anterior tibial onset), [MONDO:0011725](http://purl.obolibrary.org/obo/MONDO_0011725) (Crigler-Najjar syndrome type 2), [MONDO:0011724](http://purl.obolibrary.org/obo/MONDO_0011724) (encephalopathy due to GLUT1 deficiency), [MONDO:0011722](http://purl.obolibrary.org/obo/MONDO_0011722) (intellectual disability-obesity-prognathism-eye and skin anomalies syndrome), [MONDO:0011790](http://purl.obolibrary.org/obo/MONDO_0011790) (Amish lethal microcephaly), [MONDO:0009471](http://purl.obolibrary.org/obo/MONDO_0009471) (intrinsic factor and r binder, combined congenital deficiency of), [MONDO:0008140](http://purl.obolibrary.org/obo/MONDO_0008140) (Ossified ear cartilages), [MONDO:0008141](http://purl.obolibrary.org/obo/MONDO_0008141) (ossicular malformations, familial), [MONDO:0009472](http://purl.obolibrary.org/obo/MONDO_0009472) (acetylation, slow), [MONDO:0011794](http://purl.obolibrary.org/obo/MONDO_0011794) (Dravet syndrome), [MONDO:0010462](http://purl.obolibrary.org/obo/MONDO_0010462) (syndromic X-linked intellectual disability Chudley-Schwartz type), [MONDO:0009474](http://purl.obolibrary.org/obo/MONDO_0009474) (isovaleric acid, Inability to smell), [MONDO:0010463](http://purl.obolibrary.org/obo/MONDO_0010463) (X-linked dominant chondrodysplasia, Chassaing-Lacombe type), [MONDO:0009475](http://purl.obolibrary.org/obo/MONDO_0009475) (isovaleric acidemia), [MONDO:0010460](http://purl.obolibrary.org/obo/MONDO_0010460) (syndromic X-linked intellectual disability 17), [MONDO:0008145](http://purl.obolibrary.org/obo/MONDO_0008145) (Ollier disease), [MONDO:0010461](http://purl.obolibrary.org/obo/MONDO_0010461) (syndromic X-linked intellectual disability Nascimento type), [MONDO:0009477](http://purl.obolibrary.org/obo/MONDO_0009477) (Stromme syndrome), [MONDO:0009478](http://purl.obolibrary.org/obo/MONDO_0009478) (combined immunodeficiency due to DOCK8 deficiency), [MONDO:0009479](http://purl.obolibrary.org/obo/MONDO_0009479) (Johanson-Blizzard syndrome), [MONDO:0014828](http://purl.obolibrary.org/obo/MONDO_0014828) (immunodeficiency-centromeric instability-facial anomalies syndrome 3), [MONDO:0014829](http://purl.obolibrary.org/obo/MONDO_0014829) (immunodeficiency-centromeric instability-facial anomalies syndrome 4), [MONDO:0010466](http://purl.obolibrary.org/obo/MONDO_0010466) (multiple congenital anomalies-hypotonia-seizures syndrome 2), [MONDO:0011798](http://purl.obolibrary.org/obo/MONDO_0011798) (Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration), [MONDO:0010467](http://purl.obolibrary.org/obo/MONDO_0010467) (Xq27.3q28 duplication syndrome), [MONDO:0014825](http://purl.obolibrary.org/obo/MONDO_0014825) (chromosome 11p13 deletion syndrome, distal), [MONDO:0014826](http://purl.obolibrary.org/obo/MONDO_0014826) (nucleoside diphosphate-linked Moiety X Motif 15 deficiency; NUDT15D), [MONDO:0011796](http://purl.obolibrary.org/obo/MONDO_0011796) (PEPS), [MONDO:0010464](http://purl.obolibrary.org/obo/MONDO_0010464) (X-linked cerebral-cerebellar-coloboma syndrome syndrome), [MONDO:0014820](http://purl.obolibrary.org/obo/MONDO_0014820) (mitochondrial DNA depletion syndrome 14 (cardioencephalomyopathic type); MTDPS14), [MONDO:0014822](http://purl.obolibrary.org/obo/MONDO_0014822) (15q14 microdeletion syndrome), [MONDO:0011799](http://purl.obolibrary.org/obo/MONDO_0011799) (autosomal recessive nonsyndromic deafness 33), [MONDO:0009460](http://purl.obolibrary.org/obo/MONDO_0009460) (Indolylacroyl Glycinuria with mental retardation), [MONDO:0009462](http://purl.obolibrary.org/obo/MONDO_0009462) (inosine phosphorylase deficiency, immune defect due to), [MONDO:0011783](http://purl.obolibrary.org/obo/MONDO_0011783) (ALG12-CDG), [MONDO:0008131](http://purl.obolibrary.org/obo/MONDO_0008131) (optic atrophy, hearing loss, and peripheral neuropathy, autosomal dominant), [MONDO:0011782](http://purl.obolibrary.org/obo/MONDO_0011782) (angioid streaks), [MONDO:0009463](http://purl.obolibrary.org/obo/MONDO_0009463) (internal carotid arteries, hypoplasia of), [MONDO:0008132](http://purl.obolibrary.org/obo/MONDO_0008132) (optic atrophy with demyelinating disease of CNS), [MONDO:0009464](http://purl.obolibrary.org/obo/MONDO_0009464) (immunodeficiency with defective T-cell response to interleukin 1), [MONDO:0011781](http://purl.obolibrary.org/obo/MONDO_0011781) (spinocerebellar ataxia type 17), [MONDO:0008133](http://purl.obolibrary.org/obo/MONDO_0008133) (autosomal dominant optic atrophy and cataract), [MONDO:0011780](http://purl.obolibrary.org/obo/MONDO_0011780) (SLI3), [MONDO:0009465](http://purl.obolibrary.org/obo/MONDO_0009465) (multiple intestinal atresia), [MONDO:0008134](http://purl.obolibrary.org/obo/MONDO_0008134) (autosomal dominant optic atrophy, classic form), [MONDO:0008135](http://purl.obolibrary.org/obo/MONDO_0008135) (optic atrophy with negative Electroretinograms), [MONDO:0009469](http://purl.obolibrary.org/obo/MONDO_0009469) (benign recurrent intrahepatic cholestasis type 1), [MONDO:0021106](http://purl.obolibrary.org/obo/MONDO_0021106) (laminopathy), [MONDO:0011787](http://purl.obolibrary.org/obo/MONDO_0011787) (autosomal recessive limb-girdle muscular dystrophy type 2I), [MONDO:0010455](http://purl.obolibrary.org/obo/MONDO_0010455) (X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia), [MONDO:0014815](http://purl.obolibrary.org/obo/MONDO_0014815) (mental retardation, autosomal recessive 52), [MONDO:0011785](http://purl.obolibrary.org/obo/MONDO_0011785) (hereditary spastic paraplegia 19), [MONDO:0014816](http://purl.obolibrary.org/obo/MONDO_0014816) (split-foot malformation with Mesoaxial polydactyly; SFMMP), [MONDO:0010459](http://purl.obolibrary.org/obo/MONDO_0010459) (amyotrophic lateral sclerosis type 15), [MONDO:0014810](http://purl.obolibrary.org/obo/MONDO_0014810) (pancytopenia due to IKZF1 mutations), [MONDO:0011789](http://purl.obolibrary.org/obo/MONDO_0011789) (familial meningioma), [MONDO:0010457](http://purl.obolibrary.org/obo/MONDO_0010457) (Ogden syndrome), [MONDO:0014811](http://purl.obolibrary.org/obo/MONDO_0014811) (cerebellar atrophy, visual impairment, and psychomotor retardation;), [MONDO:0014812](http://purl.obolibrary.org/obo/MONDO_0014812) (metabolic encephalomyopathic Crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration; MECRCN), [MONDO:0009450](http://purl.obolibrary.org/obo/MONDO_0009450) (ciliary dyskinesia with excessively long cilia), [MONDO:0011772](http://purl.obolibrary.org/obo/MONDO_0011772) (B4GALT1-CDG), [MONDO:0010440](http://purl.obolibrary.org/obo/MONDO_0010440) (autism, susceptibility to, X-linked 4), [MONDO:0008120](http://purl.obolibrary.org/obo/MONDO_0008120) (spinocerebellar ataxia type 7), [MONDO:0009451](http://purl.obolibrary.org/obo/MONDO_0009451) (Nezelof syndrome), [MONDO:0009452](http://purl.obolibrary.org/obo/MONDO_0009452) (Vici syndrome), [MONDO:0008121](http://purl.obolibrary.org/obo/MONDO_0008121) (onychogryposis, Pedal, with keratosis plantaris and coarse hair), [MONDO:0011771](http://purl.obolibrary.org/obo/MONDO_0011771) (distal spinal muscular atrophy type 3), [MONDO:0009453](http://purl.obolibrary.org/obo/MONDO_0009453) (immune deficiency disease), [MONDO:0008122](http://purl.obolibrary.org/obo/MONDO_0008122) (olivopontocerebellar atrophy 5), [MONDO:0009454](http://purl.obolibrary.org/obo/MONDO_0009454) (immunodeficiency-centromeric instability-facial anomalies syndrome 1), [MONDO:0008123](http://purl.obolibrary.org/obo/MONDO_0008123) (autosomal dominant omodysplasia), [MONDO:0008124](http://purl.obolibrary.org/obo/MONDO_0008124) (omphalocele, autosomal), [MONDO:0009455](http://purl.obolibrary.org/obo/MONDO_0009455) (immunodeficiency, partial combined, with absence of Hla Determinants and beta-2-Microglobulin from lymphocytes), [MONDO:0008125](http://purl.obolibrary.org/obo/MONDO_0008125) (nonsyndromic congenital nail disorder 5), [MONDO:0009456](http://purl.obolibrary.org/obo/MONDO_0009456) (Immunoerythromyeloid hypoplasia), [MONDO:0008126](http://purl.obolibrary.org/obo/MONDO_0008126) (Oncogene Yuasa), [MONDO:0009457](http://purl.obolibrary.org/obo/MONDO_0009457) (immunoglobulin d level 1N plasma, low), [MONDO:0009459](http://purl.obolibrary.org/obo/MONDO_0009459) (channelopathy-associated congenital insensitivity to pain), [MONDO:0008128](http://purl.obolibrary.org/obo/MONDO_0008128) (ophthalmoplegia, familial static), [MONDO:0008129](http://purl.obolibrary.org/obo/MONDO_0008129) (ophthalmoplegia, familial total, with iris Transillumination), [MONDO:0014809](http://purl.obolibrary.org/obo/MONDO_0014809) (myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to; MPLPF), [MONDO:0011776](http://purl.obolibrary.org/obo/MONDO_0011776) (CINCA syndrome), [MONDO:0014802](http://purl.obolibrary.org/obo/MONDO_0014802) (Cowden syndrome 7), [MONDO:0014803](http://purl.obolibrary.org/obo/MONDO_0014803) (spasticity-ataxia-gait anomalies syndrome), [MONDO:0011774](http://purl.obolibrary.org/obo/MONDO_0011774) (autosomal recessive nonsyndromic deafness 30), [MONDO:0014804](http://purl.obolibrary.org/obo/MONDO_0014804) (adult-onset autosomal recessive sideroblastic anemia), [MONDO:0014805](http://purl.obolibrary.org/obo/MONDO_0014805) (chromosome 16p13.2 deletion syndrome), [MONDO:0011779](http://purl.obolibrary.org/obo/MONDO_0011779) (laryngeal atresia, encephalocele, and limb deformities), [MONDO:0014801](http://purl.obolibrary.org/obo/MONDO_0014801) (even-plus syndrome), [MONDO:0011761](http://purl.obolibrary.org/obo/MONDO_0011761) (autosomal dominant nonsyndromic deafness 21), [MONDO:0009440](http://purl.obolibrary.org/obo/MONDO_0009440) (ichthyosiform erythroderma, corneal involvement, and deafness), [MONDO:0009441](http://purl.obolibrary.org/obo/MONDO_0009441) (autosomal recessive congenital ichthyosis 1), [MONDO:0011760](http://purl.obolibrary.org/obo/MONDO_0011760) (Scheie syndrome), [MONDO:0008110](http://purl.obolibrary.org/obo/MONDO_0008110) (ocular Dominance), [MONDO:0009442](http://purl.obolibrary.org/obo/MONDO_0009442) (ichthyosis congenita with biliary atresia), [MONDO:0009443](http://purl.obolibrary.org/obo/MONDO_0009443) (autosomal recessive congenital ichthyosis 4B), [MONDO:0009444](http://purl.obolibrary.org/obo/MONDO_0009444) (ichthyosis-alopecia-eclabion-ectropion-intellectual disability syndrome), [MONDO:0009445](http://purl.obolibrary.org/obo/MONDO_0009445) (ichthyosis-hepatosplenomegaly-cerebellar degeneration syndrome), [MONDO:0008114](http://purl.obolibrary.org/obo/MONDO_0008114) (obsessive-compulsive disorder), [MONDO:0009446](http://purl.obolibrary.org/obo/MONDO_0009446) (ichthyosis-intellectual disability-dwarfism-renal impairment syndrome), [MONDO:0008115](http://purl.obolibrary.org/obo/MONDO_0008115) (Feingold syndrome type 1), [MONDO:0009447](http://purl.obolibrary.org/obo/MONDO_0009447) (ichthyosis, split hairs, and amino aciduria), [MONDO:0009448](http://purl.obolibrary.org/obo/MONDO_0009448) (Iminoglycinuria), [MONDO:0009449](http://purl.obolibrary.org/obo/MONDO_0009449) (ciliary dyskinesia with defective radial spokes), [MONDO:0008119](http://purl.obolibrary.org/obo/MONDO_0008119) (spinocerebellar ataxia type 1), [MONDO:0010439](http://purl.obolibrary.org/obo/MONDO_0010439) (cardiomyopathy, fatal fetal, due to myocardial calcification), [MONDO:0010431](http://purl.obolibrary.org/obo/MONDO_0010431) (Joubert syndrome 10), [MONDO:0011763](http://purl.obolibrary.org/obo/MONDO_0011763) (T-Box 24), [MONDO:0010432](http://purl.obolibrary.org/obo/MONDO_0010432) (thrombophilia, X-linked, due to factor 9 defect), [MONDO:0011762](http://purl.obolibrary.org/obo/MONDO_0011762) (autosomal recessive nonsyndromic deafness 22), [MONDO:0010437](http://purl.obolibrary.org/obo/MONDO_0010437) (severe X-linked mitochondrial encephalomyopathy), [MONDO:0010438](http://purl.obolibrary.org/obo/MONDO_0010438) (paroxysmal nocturnal hemoglobinuria 1), [MONDO:0011767](http://purl.obolibrary.org/obo/MONDO_0011767) (autosomal recessive nonsyndromic deafness 31), [MONDO:0010436](http://purl.obolibrary.org/obo/MONDO_0010436) (chromosome Xq28 duplication syndrome), [MONDO:0014860](http://purl.obolibrary.org/obo/MONDO_0014860) (polycystic liver disease 2; PCLD2), [MONDO:0013530](http://purl.obolibrary.org/obo/MONDO_0013530) (atrial fibrillation, familial, 10), [MONDO:0013531](http://purl.obolibrary.org/obo/MONDO_0013531) (PSPH deficiency), [MONDO:0013532](http://purl.obolibrary.org/obo/MONDO_0013532) (protein Z deficiency), [MONDO:0008185](http://purl.obolibrary.org/obo/MONDO_0008185) (hereditary chronic pancreatitis), [MONDO:0014863](http://purl.obolibrary.org/obo/MONDO_0014863) (macrocephaly, dysmorphic facies, and psychomotor retardation; MDFPMR), [MONDO:0008186](http://purl.obolibrary.org/obo/MONDO_0008186) (pancytopenia and occlusive vascular disease), [MONDO:0008187](http://purl.obolibrary.org/obo/MONDO_0008187) (PAND1), [MONDO:0012200](http://purl.obolibrary.org/obo/MONDO_0012200) (posterior polymorphous corneal dystrophy 3), [MONDO:0008188](http://purl.obolibrary.org/obo/MONDO_0008188) (papillomatosis, confluent and reticulated), [MONDO:0008189](http://purl.obolibrary.org/obo/MONDO_0008189) (papillomatosis, florid, of nipple), [MONDO:0000215](http://purl.obolibrary.org/obo/MONDO_0000215) (epilepsy, familial focal, with variable foci), [MONDO:0021155](http://purl.obolibrary.org/obo/MONDO_0021155) (X-linked cone-rod dystrophy), [MONDO:0014868](http://purl.obolibrary.org/obo/MONDO_0014868) (epileptic encephalopathy, early infantile, 38; EIEE38), [MONDO:0013537](http://purl.obolibrary.org/obo/MONDO_0013537) (autosomal recessive nonsyndromic deafness 29), [MONDO:0013538](http://purl.obolibrary.org/obo/MONDO_0013538) (alpha-2-Macroglobulin deficiency), [MONDO:0014869](http://purl.obolibrary.org/obo/MONDO_0014869) (hydrops, lactic acidosis, and sideroblastic anemia), [MONDO:0013539](http://purl.obolibrary.org/obo/MONDO_0013539) (hypotonia-failure to thrive-microcephaly syndrome), [MONDO:0013533](http://purl.obolibrary.org/obo/MONDO_0013533) (hyperlipidemia due to hepatic triglyceride lipase deficiency), [MONDO:0014864](http://purl.obolibrary.org/obo/MONDO_0014864) (Hypermanganesemia with dystonia 2; HMNDYT2), [MONDO:0012208](http://purl.obolibrary.org/obo/MONDO_0012208) (congenital reticular ichthyosiform erythroderma), [MONDO:0013534](http://purl.obolibrary.org/obo/MONDO_0013534) (apolipoprotein c-Iii deficiency), [MONDO:0008190](http://purl.obolibrary.org/obo/MONDO_0008190) (human papillomavirus type 18 Integration site 1), [MONDO:0008191](http://purl.obolibrary.org/obo/MONDO_0008191) (human papillomavirus type 18 Integration site 2), [MONDO:0014866](http://purl.obolibrary.org/obo/MONDO_0014866) (Charcot-Marie-tooth disease axonal type 2T), [MONDO:0013535](http://purl.obolibrary.org/obo/MONDO_0013535) (Hydroxyacyl glutathione hydrolase deficiency), [MONDO:0012207](http://purl.obolibrary.org/obo/MONDO_0012207) (umbilicus, familial flat), [MONDO:0013536](http://purl.obolibrary.org/obo/MONDO_0013536) (Heme oxygenase 1 deficiency), [MONDO:0014867](http://purl.obolibrary.org/obo/MONDO_0014867) (spinocerebellar ataxia 43; SCA43), [MONDO:0008171](http://purl.obolibrary.org/obo/MONDO_0008171) (nephrolithiasis), [MONDO:0010491](http://purl.obolibrary.org/obo/MONDO_0010491) (X-linked acrogigantism due to Xq26 microduplication), [MONDO:0014850](http://purl.obolibrary.org/obo/MONDO_0014850) (retinitis pigmentosa and Erythrocytic Microcytosis; RPEM), [MONDO:0008173](http://purl.obolibrary.org/obo/MONDO_0008173) (pachyonychia congenita 1), [MONDO:0013520](http://purl.obolibrary.org/obo/MONDO_0013520) (dyskeratosis congenita, autosomal recessive 3), [MONDO:0014851](http://purl.obolibrary.org/obo/MONDO_0014851) (hypercalcemia, infantile, 2; HCINF2), [MONDO:0010490](http://purl.obolibrary.org/obo/MONDO_0010490) (SSR4-CDG), [MONDO:0008174](http://purl.obolibrary.org/obo/MONDO_0008174) (pachyonychia congenita 2), [MONDO:0013521](http://purl.obolibrary.org/obo/MONDO_0013521) (dyskeratosis congenita, autosomal dominant 2), [MONDO:0014852](http://purl.obolibrary.org/obo/MONDO_0014852) (palmoplantar carcinoma, multiple Self-healing; MSPC), [MONDO:0010495](http://purl.obolibrary.org/obo/MONDO_0010495) (trichothiodystrophy 5, nonphotosensitive), [MONDO:0008176](http://purl.obolibrary.org/obo/MONDO_0008176) (Paget disease of bone 3), [MONDO:0010496](http://purl.obolibrary.org/obo/MONDO_0010496) (X-linked intellectual disability-short stature-overweight syndrome), [MONDO:0010493](http://purl.obolibrary.org/obo/MONDO_0010493) (Diamond-Blackfan anemia 14 with mandibulofacial dysostosis), [MONDO:0010494](http://purl.obolibrary.org/obo/MONDO_0010494) (linear skin defects with multiple congenital anomalies 3), [MONDO:0014857](http://purl.obolibrary.org/obo/MONDO_0014857) (neurodevelopmental disorder with or without anomalies of the brain, eye, or heart; NEDBEH), [MONDO:0014858](http://purl.obolibrary.org/obo/MONDO_0014858) (mental retardation, autosomal dominant 43; MRD43), [MONDO:0013528](http://purl.obolibrary.org/obo/MONDO_0013528) (mental retardation, autosomal recessive 14), [MONDO:0010497](http://purl.obolibrary.org/obo/MONDO_0010497) (mental retardation, X-linked 102), [MONDO:0014859](http://purl.obolibrary.org/obo/MONDO_0014859) (epileptic encephalopathy, early infantile, 37; EIEE37), [MONDO:0010498](http://purl.obolibrary.org/obo/MONDO_0010498) (MEND syndrome), [MONDO:0014853](http://purl.obolibrary.org/obo/MONDO_0014853) (autosomal dominant nonsyndromic deafness 70), [MONDO:0013522](http://purl.obolibrary.org/obo/MONDO_0013522) (dyskeratosis congenita, autosomal dominant 3), [MONDO:0014854](http://purl.obolibrary.org/obo/MONDO_0014854) (autosomal dominant nonsyndromic deafness 66), [MONDO:0013523](http://purl.obolibrary.org/obo/MONDO_0013523) (Nestor-Guillermo progeria syndrome), [MONDO:0014855](http://purl.obolibrary.org/obo/MONDO_0014855) (mental retardation, autosomal dominant 42; MRD42), [MONDO:0013525](http://purl.obolibrary.org/obo/MONDO_0013525) (primary ciliary dyskinesia 16), [MONDO:0014856](http://purl.obolibrary.org/obo/MONDO_0014856) (combined oxidative phosphorylation defect type 30), [MONDO:0008181](http://purl.obolibrary.org/obo/MONDO_0008181) (palmaris Longus muscle, absence of), [MONDO:0009491](http://purl.obolibrary.org/obo/MONDO_0009491) (Haim-Munk syndrome), [MONDO:0008160](http://purl.obolibrary.org/obo/MONDO_0008160) (osteosclerosis with ichthyosis and fractures), [MONDO:0009492](http://purl.obolibrary.org/obo/MONDO_0009492) (Succinyl-CoA:3-ketoacid CoA transferase deficiency), [MONDO:0008162](http://purl.obolibrary.org/obo/MONDO_0008162) (otitis media, susceptibility to), [MONDO:0013510](http://purl.obolibrary.org/obo/MONDO_0013510) (melanoma, cutaneous malignant, susceptibility to, 6), [MONDO:0014841](http://purl.obolibrary.org/obo/MONDO_0014841) (trichothiodystrophy 6, nonphotosensitive; TTD6), [MONDO:0009494](http://purl.obolibrary.org/obo/MONDO_0009494) (Ketoadipicaciduria), [MONDO:0010484](http://purl.obolibrary.org/obo/MONDO_0010484) (deafness, X-linked 6), [MONDO:0008164](http://purl.obolibrary.org/obo/MONDO_0008164) (OTSC1), [MONDO:0010485](http://purl.obolibrary.org/obo/MONDO_0010485) (X-linked colobomatous microphthalmia-microcephaly-intellectual disability-short stature syndrome), [MONDO:0009496](http://purl.obolibrary.org/obo/MONDO_0009496) (Kniest-like dysplasia with Pursed lips and ectopia lentis), [MONDO:0008166](http://purl.obolibrary.org/obo/MONDO_0008166) (ovalocytosis, hereditary hemolytic, with defective Erythropoiesis), [MONDO:0009497](http://purl.obolibrary.org/obo/MONDO_0009497) (Kifafa seizure disorder), [MONDO:0010483](http://purl.obolibrary.org/obo/MONDO_0010483) (X-linked intellectual disability, Cantagrel type), [MONDO:0009499](http://purl.obolibrary.org/obo/MONDO_0009499) (Krabbe disease), [MONDO:0008169](http://purl.obolibrary.org/obo/MONDO_0008169) (osteochondrodysplasia, rhizomelic, with Callosal agenesis, thrombocytopenia, hydrocephalus, and hypertension), [MONDO:0013519](http://purl.obolibrary.org/obo/MONDO_0013519) (dyskeratosis congenita, autosomal recessive 2), [MONDO:0021130](http://purl.obolibrary.org/obo/MONDO_0021130) (disorder of sphingolipid biosynthesis), [MONDO:0014846](http://purl.obolibrary.org/obo/MONDO_0014846) (autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency), [MONDO:0013517](http://purl.obolibrary.org/obo/MONDO_0013517) (beta-thalassemia HBB/LCRB), [MONDO:0014848](http://purl.obolibrary.org/obo/MONDO_0014848) (You-Hoover-Fong syndrome; YHFS), [MONDO:0010486](http://purl.obolibrary.org/obo/MONDO_0010486) (palmoplantar keratoderma, mutilating, with periorificial keratotic plaques, X-linked), [MONDO:0014849](http://purl.obolibrary.org/obo/MONDO_0014849) (autosomal recessive nonsyndromic deafness 105), [MONDO:0013511](http://purl.obolibrary.org/obo/MONDO_0013511) (cyanosis, transient neonatal), [MONDO:0014842](http://purl.obolibrary.org/obo/MONDO_0014842) (mental retardation, autosomal dominant 41; MRD41), [MONDO:0013512](http://purl.obolibrary.org/obo/MONDO_0013512) (hemoglobin H disease), [MONDO:0014843](http://purl.obolibrary.org/obo/MONDO_0014843) (premature ovarian failure 11; POF11), [MONDO:0013513](http://purl.obolibrary.org/obo/MONDO_0013513) (atrial fibrillation, familial, 9), [MONDO:0014844](http://purl.obolibrary.org/obo/MONDO_0014844) (premature ovarian failure 12; POF12), [MONDO:0014845](http://purl.obolibrary.org/obo/MONDO_0014845) (spinocerebellar ataxia, autosomal recessive 22; SCAR22), [MONDO:0009480](http://purl.obolibrary.org/obo/MONDO_0009480) (Joubert syndrome with oculorenal defect), [MONDO:0009481](http://purl.obolibrary.org/obo/MONDO_0009481) (Jumping Frenchmen of Maine), [MONDO:0010473](http://purl.obolibrary.org/obo/MONDO_0010473) (X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome), [MONDO:0009484](http://purl.obolibrary.org/obo/MONDO_0009484) (primary ciliary dyskinesia 1), [MONDO:0010474](http://purl.obolibrary.org/obo/MONDO_0010474) (linear skin defects with multiple congenital anomalies 2), [MONDO:0009486](http://purl.obolibrary.org/obo/MONDO_0009486) (autosomal recessive Kenny-Caffey syndrome), [MONDO:0010472](http://purl.obolibrary.org/obo/MONDO_0010472) (ALG13-CDG), [MONDO:0009487](http://purl.obolibrary.org/obo/MONDO_0009487) (keratoconus and congenital hip dysplasia), [MONDO:0008157](http://purl.obolibrary.org/obo/MONDO_0008157) (Buschke-Ollendorff syndrome), [MONDO:0009488](http://purl.obolibrary.org/obo/MONDO_0009488) (keratoconus posticus circumscriptus), [MONDO:0009489](http://purl.obolibrary.org/obo/MONDO_0009489) (hereditary palmoplantar keratoderma, Gamborg-Nielsen type), [MONDO:0001539](http://purl.obolibrary.org/obo/MONDO_0001539) (retinal perforation), [MONDO:0000208](http://purl.obolibrary.org/obo/MONDO_0000208) (microcephaly, short stature, and impaired glucose metabolism), [MONDO:0013508](http://purl.obolibrary.org/obo/MONDO_0013508) (MYP19), [MONDO:0014839](http://purl.obolibrary.org/obo/MONDO_0014839) (chorea, childhood-onset, with psychomotor retardation; COCPMR), [MONDO:0013509](http://purl.obolibrary.org/obo/MONDO_0013509) (mental retardation, autosomal dominant 6), [MONDO:0010478](http://purl.obolibrary.org/obo/MONDO_0010478) (SLC35A2-CDG), [MONDO:0014831](http://purl.obolibrary.org/obo/MONDO_0014831) (progeroid and marfanoid aspect-lipodystrophy syndrome), [MONDO:0013501](http://purl.obolibrary.org/obo/MONDO_0013501) (amyotrophic lateral sclerosis type 14), [MONDO:0014832](http://purl.obolibrary.org/obo/MONDO_0014832) (mental retardation, autosomal recessive 53; MRT53), [MONDO:0013502](http://purl.obolibrary.org/obo/MONDO_0013502) (amyloidosis, primary localized cutaneous, 2), [MONDO:0010479](http://purl.obolibrary.org/obo/MONDO_0010479) (Charcot-Marie-tooth disease X-linked dominant 6), [MONDO:0014833](http://purl.obolibrary.org/obo/MONDO_0014833) (heart and brain malformation syndrome; HBMS), [MONDO:0009490](http://purl.obolibrary.org/obo/MONDO_0009490) (Papillon-Lefevre disease), [MONDO:0014834](http://purl.obolibrary.org/obo/MONDO_0014834) (dyskinesia, limb and orofacial, infantile-onset; IOLOD), [MONDO:0012241](http://purl.obolibrary.org/obo/MONDO_0012241) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal dominant 3), [MONDO:0013573](http://purl.obolibrary.org/obo/MONDO_0013573) (cranioectodermal dysplasia 3), [MONDO:0016601](http://purl.obolibrary.org/obo/MONDO_0016601) (adult-onset citrullinemia type i), [MONDO:0013575](http://purl.obolibrary.org/obo/MONDO_0013575) (plasma fibronectin deficiency), [MONDO:0016600](http://purl.obolibrary.org/obo/MONDO_0016600) (acute neonatal citrullinemia type i), [MONDO:0012245](http://purl.obolibrary.org/obo/MONDO_0012245) (epileptic encephalopathy, early infantile, 3), [MONDO:0013570](http://purl.obolibrary.org/obo/MONDO_0013570) (combined oxidative phosphorylation defect type 8), [MONDO:0012243](http://purl.obolibrary.org/obo/MONDO_0012243) (b-cell immunodeficiency, distal limb anomalies, and urogenital malformations), [MONDO:0013571](http://purl.obolibrary.org/obo/MONDO_0013571) (acatalasia), [MONDO:0012242](http://purl.obolibrary.org/obo/MONDO_0012242) (VVS), [MONDO:0001586](http://purl.obolibrary.org/obo/MONDO_0001586) (mucopolysaccharidosis type 1), [MONDO:0016607](http://purl.obolibrary.org/obo/MONDO_0016607) (Odontohypophosphatasia), [MONDO:0012249](http://purl.obolibrary.org/obo/MONDO_0012249) (colorectal cancer, hereditary nonpolyposis, type 2), [MONDO:0012248](http://purl.obolibrary.org/obo/MONDO_0012248) (autosomal recessive limb-girdle muscular dystrophy type 2K), [MONDO:0016606](http://purl.obolibrary.org/obo/MONDO_0016606) (Prenatal benign hypophosphatasia), [MONDO:0017937](http://purl.obolibrary.org/obo/MONDO_0017937) (autosomal dominant intermediate Charcot-Marie-tooth disease with neuropathic pain), [MONDO:0012247](http://purl.obolibrary.org/obo/MONDO_0012247) (spinocerebellar ataxia type 27), [MONDO:0017938](http://purl.obolibrary.org/obo/MONDO_0017938) (X-linked cleft palate with or without ankyloglossia), [MONDO:0012246](http://purl.obolibrary.org/obo/MONDO_0012246) (spinocerebellar ataxia type 26), [MONDO:0016603](http://purl.obolibrary.org/obo/MONDO_0016603) (citrullinemia type II), [MONDO:0017935](http://purl.obolibrary.org/obo/MONDO_0017935) (hyperinsulinism due to HNF1A deficiency), [MONDO:0016602](http://purl.obolibrary.org/obo/MONDO_0016602) (citrin deficiency), [MONDO:0013579](http://purl.obolibrary.org/obo/MONDO_0013579) (developmental delay due to methylmalonate semialdehyde dehydrogenase deficiency), [MONDO:0017933](http://purl.obolibrary.org/obo/MONDO_0017933) (hypertrophic cardiomyopathy and renal tubular disease due to mitochondrial DNA mutation), [MONDO:0016605](http://purl.obolibrary.org/obo/MONDO_0016605) (perinatal lethal hypophosphatasia), [MONDO:0012230](http://purl.obolibrary.org/obo/MONDO_0012230) (MYP10), [MONDO:0014893](http://purl.obolibrary.org/obo/MONDO_0014893) (Okur-Chung neurodevelopmental syndrome; OCNDS), [MONDO:0013563](http://purl.obolibrary.org/obo/MONDO_0013563) (multiple congenital anomalies-hypotonia-seizures syndrome 1), [MONDO:0014894](http://purl.obolibrary.org/obo/MONDO_0014894) (Meier-Gorlin syndrome 7; MGORS7), [MONDO:0013564](http://purl.obolibrary.org/obo/MONDO_0013564) (Anhaptoglobinemia), [MONDO:0014895](http://purl.obolibrary.org/obo/MONDO_0014895) (epileptic encephalopathy, early infantile, 40; EIEE40), [MONDO:0013565](http://purl.obolibrary.org/obo/MONDO_0013565) (Fanconi anemia complementation group G), [MONDO:0012234](http://purl.obolibrary.org/obo/MONDO_0012234) (LFS3), [MONDO:0012233](http://purl.obolibrary.org/obo/MONDO_0012233) (Li-Fraumeni syndrome 2), [MONDO:0014890](http://purl.obolibrary.org/obo/MONDO_0014890) (cold-induced sweating syndrome 3; CISS3), [MONDO:0012232](http://purl.obolibrary.org/obo/MONDO_0012232) (STUT2), [MONDO:0013560](http://purl.obolibrary.org/obo/MONDO_0013560) (Hermansky-Pudlak syndrome 8), [MONDO:0014891](http://purl.obolibrary.org/obo/MONDO_0014891) (hyperuricemic nephropathy, familial juvenile, 4; HNFJ4), [MONDO:0021181](http://purl.obolibrary.org/obo/MONDO_0021181) (inherited blood coagulation disorder), [MONDO:0000260](http://purl.obolibrary.org/obo/MONDO_0000260) (Kartagener syndrome), [MONDO:0012238](http://purl.obolibrary.org/obo/MONDO_0012238) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal dominant 2), [MONDO:0012235](http://purl.obolibrary.org/obo/MONDO_0012235) (autosomal recessive spinocerebellar ataxia 7), [MONDO:0014897](http://purl.obolibrary.org/obo/MONDO_0014897) (portal hypertension, Noncirrhotic; NCPH), [MONDO:0013566](http://purl.obolibrary.org/obo/MONDO_0013566) (Fanconi anemia complementation group L), [MONDO:0014898](http://purl.obolibrary.org/obo/MONDO_0014898) (progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3; PEOB3), [MONDO:0013568](http://purl.obolibrary.org/obo/MONDO_0013568) (sick sinus syndrome 3, susceptibility to), [MONDO:0014899](http://purl.obolibrary.org/obo/MONDO_0014899) (adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency), [MONDO:0013569](http://purl.obolibrary.org/obo/MONDO_0013569) (short-rib thoracic dysplasia 7 with or without polydactyly), [MONDO:0014882](http://purl.obolibrary.org/obo/MONDO_0014882) (hereditary spastic paraplegia 77), [MONDO:0013551](http://purl.obolibrary.org/obo/MONDO_0013551) (hereditary spastic paraplegia 47), [MONDO:0013552](http://purl.obolibrary.org/obo/MONDO_0013552) (hereditary spastic paraplegia 52), [MONDO:0013553](http://purl.obolibrary.org/obo/MONDO_0013553) (immunodeficiency-centromeric instability-facial anomalies syndrome 2), [MONDO:0014884](http://purl.obolibrary.org/obo/MONDO_0014884) (cholestasis, progressive familial intrahepatic, 5; PFIC5), [MONDO:0014885](http://purl.obolibrary.org/obo/MONDO_0014885) (Hermansky-Pudlak syndrome 10; HPS10), [MONDO:0013554](http://purl.obolibrary.org/obo/MONDO_0013554) (psoriasis 13, susceptibility to), [MONDO:0012223](http://purl.obolibrary.org/obo/MONDO_0012223) (hypotrichosis, progressive patterned scalp, with Wiry hair, onycholysis, and cleft lip/palate), [MONDO:0012222](http://purl.obolibrary.org/obo/MONDO_0012222) (alpha-N-acetylgalactosaminidase deficiency type 2), [MONDO:0012221](http://purl.obolibrary.org/obo/MONDO_0012221) (alpha-N-acetylgalactosaminidase deficiency type 1), [MONDO:0014881](http://purl.obolibrary.org/obo/MONDO_0014881) (short stature, developmental delay, and congenital heart defects;), [MONDO:0013550](http://purl.obolibrary.org/obo/MONDO_0013550) (distal myopathy with posterior leg and anterior hand involvement), [MONDO:0012220](http://purl.obolibrary.org/obo/MONDO_0012220) (Griscelli syndrome type 3), [MONDO:0005929](http://purl.obolibrary.org/obo/MONDO_0005929) (postpartum depression), [MONDO:0021171](http://purl.obolibrary.org/obo/MONDO_0021171) (Timothy syndrome type 1 (disorder)), [MONDO:0001562](http://purl.obolibrary.org/obo/MONDO_0001562) (displacement of cardia through esophageal hiatus), [MONDO:0021172](http://purl.obolibrary.org/obo/MONDO_0021172) (Timothy syndrome type 2 (disorder)), [MONDO:0012227](http://purl.obolibrary.org/obo/MONDO_0012227) (MYP7), [MONDO:0013559](http://purl.obolibrary.org/obo/MONDO_0013559) (Hermansky-Pudlak syndrome 7), [MONDO:0012226](http://purl.obolibrary.org/obo/MONDO_0012226) (FEB5), [MONDO:0012225](http://purl.obolibrary.org/obo/MONDO_0012225) (Senior-Loken syndrome 5), [MONDO:0012224](http://purl.obolibrary.org/obo/MONDO_0012224) (FEB6), [MONDO:0014886](http://purl.obolibrary.org/obo/MONDO_0014886) (mental retardation, autosomal recessive 55; MRT55), [MONDO:0013555](http://purl.obolibrary.org/obo/MONDO_0013555) (Hermansky-Pudlak syndrome 3), [MONDO:0014887](http://purl.obolibrary.org/obo/MONDO_0014887) (bone marrow failure syndrome 3; BMFS3), [MONDO:0013556](http://purl.obolibrary.org/obo/MONDO_0013556) (Hermansky-Pudlak syndrome 4), [MONDO:0012229](http://purl.obolibrary.org/obo/MONDO_0012229) (MYP9), [MONDO:0014888](http://purl.obolibrary.org/obo/MONDO_0014888) (Mirage syndrome; MIRAGE), [MONDO:0013557](http://purl.obolibrary.org/obo/MONDO_0013557) (Hermansky-Pudlak syndrome 5), [MONDO:0012228](http://purl.obolibrary.org/obo/MONDO_0012228) (MYP8), [MONDO:0014889](http://purl.obolibrary.org/obo/MONDO_0014889) (striatonigral degeneration, childhood-onset; SNDC), [MONDO:0013558](http://purl.obolibrary.org/obo/MONDO_0013558) (Hermansky-Pudlak syndrome 6), [MONDO:0008194](http://purl.obolibrary.org/obo/MONDO_0008194) (Paramolar tubercle of Bolk), [MONDO:0013543](http://purl.obolibrary.org/obo/MONDO_0013543) (Trypsinogen deficiency), [MONDO:0012212](http://purl.obolibrary.org/obo/MONDO_0012212) (Loeys-Dietz syndrome 1), [MONDO:0012211](http://purl.obolibrary.org/obo/MONDO_0012211) (MPDU1-CDG), [MONDO:0017909](http://purl.obolibrary.org/obo/MONDO_0017909) (glutathione synthetase deficiency), [MONDO:0013548](http://purl.obolibrary.org/obo/MONDO_0013548) (Acetyl-Coa acetyltransferase-2 deficiency), [MONDO:0012215](http://purl.obolibrary.org/obo/MONDO_0012215) (myofibrillar myopathy 3), [MONDO:0013549](http://purl.obolibrary.org/obo/MONDO_0013549) (N-Acetylaspartate deficiency), [MONDO:0017905](http://purl.obolibrary.org/obo/MONDO_0017905) (X-linked mendelian susceptibility to mycobacterial diseases), [MONDO:0012213](http://purl.obolibrary.org/obo/MONDO_0012213) (hereditary spastic paraplegia 26), [MONDO:0017902](http://purl.obolibrary.org/obo/MONDO_0017902) (autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency), [MONDO:0014875](http://purl.obolibrary.org/obo/MONDO_0014875) (hyperaldosteronism, familial, type IV; HALD4), [MONDO:0013544](http://purl.obolibrary.org/obo/MONDO_0013544) (atrial fibrillation, familial, 11), [MONDO:0012219](http://purl.obolibrary.org/obo/MONDO_0012219) (spondyloepiphyseal dysplasia tarda, autosomal recessive, Leroy-Spranger type), [MONDO:0014876](http://purl.obolibrary.org/obo/MONDO_0014876) (mental retardation, autosomal recessive 54; MRT54), [MONDO:0013545](http://purl.obolibrary.org/obo/MONDO_0013545) (atrial fibrillation, familial, 12), [MONDO:0017900](http://purl.obolibrary.org/obo/MONDO_0017900) (mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency), [MONDO:0013546](http://purl.obolibrary.org/obo/MONDO_0013546) (mitochondrial complex v (ATP synthase) deficiency nuclear type 2), [MONDO:0012218](http://purl.obolibrary.org/obo/MONDO_0012218) (ADDWOC), [MONDO:0013547](http://purl.obolibrary.org/obo/MONDO_0013547) (mitochondrial complex v (ATP synthase) deficiency nuclear type 3), [MONDO:0015312](http://purl.obolibrary.org/obo/MONDO_0015312) (choanal atresia, unilateral), [MONDO:0012284](http://purl.obolibrary.org/obo/MONDO_0012284) (nephropathy, progressive, with deafness), [MONDO:0017973](http://purl.obolibrary.org/obo/MONDO_0017973) (non-classic congenital lipoid adrenal hyperplasia due to STAR deficency), [MONDO:0012283](http://purl.obolibrary.org/obo/MONDO_0012283) (cleft palate, midfacial hypoplasia, triangular facies, and sensorineural hearing loss), [MONDO:0012282](http://purl.obolibrary.org/obo/MONDO_0012282) (Al-Gazali syndrome), [MONDO:0015313](http://purl.obolibrary.org/obo/MONDO_0015313) (choanal atresia, bilateral), [MONDO:0017972](http://purl.obolibrary.org/obo/MONDO_0017972) (classic congenital lipoid adrenal hyperplasia due to STAR deficency), [MONDO:0012288](http://purl.obolibrary.org/obo/MONDO_0012288) (iridogoniodysgenesis and skeletal anomalies), [MONDO:0003321](http://purl.obolibrary.org/obo/MONDO_0003321) (hereditary wilms' tumor), [MONDO:0017979](http://purl.obolibrary.org/obo/MONDO_0017979) (autoimmune lymphoproliferative syndrome), [MONDO:0016647](http://purl.obolibrary.org/obo/MONDO_0016647) (autosomal recessive Stickler syndrome), [MONDO:0016646](http://purl.obolibrary.org/obo/MONDO_0016646) (autosomal dominant optic atrophy and peripheral neuropathy), [MONDO:0016649](http://purl.obolibrary.org/obo/MONDO_0016649) (Warburg micro syndrome), [MONDO:0012274](http://purl.obolibrary.org/obo/MONDO_0012274) (acromesomelic dysplasia, Demirhan type), [MONDO:0012273](http://purl.obolibrary.org/obo/MONDO_0012273) (autosomal recessive nonsyndromic deafness 48), [MONDO:0012272](http://purl.obolibrary.org/obo/MONDO_0012272) (mental retardation, keratoconus, febrile seizures, and sinoatrial block), [MONDO:0012277](http://purl.obolibrary.org/obo/MONDO_0012277) (myofibrillar myopathy 4), [MONDO:0012276](http://purl.obolibrary.org/obo/MONDO_0012276) (generalized epilepsy-paroxysmal dyskinesia syndrome), [MONDO:0015308](http://purl.obolibrary.org/obo/MONDO_0015308) (laminopathy type Decaudain-Vigouroux), [MONDO:0017953](http://purl.obolibrary.org/obo/MONDO_0017953) (hereditary periodic fever syndrome), [MONDO:0013597](http://purl.obolibrary.org/obo/MONDO_0013597) (platelet-type bleeding disorder 14), [MONDO:0013598](http://purl.obolibrary.org/obo/MONDO_0013598) (myostatin-related muscle hypertrophy), [MONDO:0013593](http://purl.obolibrary.org/obo/MONDO_0013593) (autosomal dominant nonsyndromic deafness 64), [MONDO:0013594](http://purl.obolibrary.org/obo/MONDO_0013594) (spinocerebellar ataxia type 36), [MONDO:0004639](http://purl.obolibrary.org/obo/MONDO_0004639) (perinatal necrotizing enterocolitis), [MONDO:0013590](http://purl.obolibrary.org/obo/MONDO_0013590) (Stickler syndrome, type 4), [MONDO:0000275](http://purl.obolibrary.org/obo/MONDO_0000275) (monogenic disease), [MONDO:0017959](http://purl.obolibrary.org/obo/MONDO_0017959) (JMP syndrome), [MONDO:0012269](http://purl.obolibrary.org/obo/MONDO_0012269) (chromosome 3q29 microdeletion syndrome), [MONDO:0013584](http://purl.obolibrary.org/obo/MONDO_0013584) (hereditary sensory neuropathy-deafness-dementia syndrome), [MONDO:0012252](http://purl.obolibrary.org/obo/MONDO_0012252) (rhabdoid tumor predisposition syndrome 1), [MONDO:0012251](http://purl.obolibrary.org/obo/MONDO_0012251) (MEDNIK syndrome), [MONDO:0013585](http://purl.obolibrary.org/obo/MONDO_0013585) (hydrolethalus syndrome 2), [MONDO:0016612](http://purl.obolibrary.org/obo/MONDO_0016612) (X-linked cerebellar ataxia), [MONDO:0013586](http://purl.obolibrary.org/obo/MONDO_0013586) (Chitotriosidase deficiency), [MONDO:0013587](http://purl.obolibrary.org/obo/MONDO_0013587) (glycogen storage disease due to lactate dehydrogenase H-subunit deficiency), [MONDO:0013580](http://purl.obolibrary.org/obo/MONDO_0013580) (pyruvate dehydrogenase E1-beta deficiency), [MONDO:0012256](http://purl.obolibrary.org/obo/MONDO_0012256) (hereditary spastic paraplegia 28), [MONDO:0013581](http://purl.obolibrary.org/obo/MONDO_0013581) (mental retardation, autosomal dominant 2), [MONDO:0012255](http://purl.obolibrary.org/obo/MONDO_0012255) (chromosome 18 Pericentric inversion), [MONDO:0013582](http://purl.obolibrary.org/obo/MONDO_0013582) (mosaic variegated aneuploidy syndrome 2), [MONDO:0012259](http://purl.obolibrary.org/obo/MONDO_0012259) (colloid cysts of third ventricle), [MONDO:0017948](http://purl.obolibrary.org/obo/MONDO_0017948) (ABetaA21G amyloidosis), [MONDO:0012258](http://purl.obolibrary.org/obo/MONDO_0012258) (epidermolysis bullosa simplex with circinate migratory erythema), [MONDO:0016619](http://purl.obolibrary.org/obo/MONDO_0016619) (autosomal recessive hypohidrotic ectodermal dysplasia), [MONDO:0017949](http://purl.obolibrary.org/obo/MONDO_0017949) (ABeta amyloidosis, Arctic type), [MONDO:0017946](http://purl.obolibrary.org/obo/MONDO_0017946) (ABeta amyloidosis, Iowa type), [MONDO:0013588](http://purl.obolibrary.org/obo/MONDO_0013588) (Perrault syndrome 3), [MONDO:0016614](http://purl.obolibrary.org/obo/MONDO_0016614) (autosomal recessive ataxia due to PEX10 deficiency), [MONDO:0016613](http://purl.obolibrary.org/obo/MONDO_0016613) (APC-related attenuated familial adenomatous polyposis), [MONDO:0017947](http://purl.obolibrary.org/obo/MONDO_0017947) (ABeta amyloidosis, Italian type), [MONDO:0017945](http://purl.obolibrary.org/obo/MONDO_0017945) (ABetaL34V amyloidosis), [MONDO:0014024](http://purl.obolibrary.org/obo/MONDO_0014024) (hereditary spastic paraplegia 43), [MONDO:0015356](http://purl.obolibrary.org/obo/MONDO_0015356) (hereditary neoplastic syndrome), [MONDO:0014025](http://purl.obolibrary.org/obo/MONDO_0014025) (lower motor neuron syndrome with late-adult onset), [MONDO:0015355](http://purl.obolibrary.org/obo/MONDO_0015355) (distal hereditary motor neuropathy type 7), [MONDO:0014020](http://purl.obolibrary.org/obo/MONDO_0014020) (hereditary spastic paraplegia 55), [MONDO:0015352](http://purl.obolibrary.org/obo/MONDO_0015352) (distal hereditary motor neuropathy type 2), [MONDO:0014022](http://purl.obolibrary.org/obo/MONDO_0014022) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10), [MONDO:0015354](http://purl.obolibrary.org/obo/MONDO_0015354) (hereditary sensory and autonomic neuropathy with deafness and global delay), [MONDO:0015353](http://purl.obolibrary.org/obo/MONDO_0015353) (distal hereditary motor neuropathy type 5), [MONDO:0014023](http://purl.obolibrary.org/obo/MONDO_0014023) (congenital muscular dystrophy with intellectual disability and severe epilepsy), [MONDO:0007729](http://purl.obolibrary.org/obo/MONDO_0007729) (DDH1), [MONDO:0007728](http://purl.obolibrary.org/obo/MONDO_0007728) (acne inversa, familial, 1), [MONDO:0007727](http://purl.obolibrary.org/obo/MONDO_0007727) (autosomal dominant familial periodic fever), [MONDO:0007722](http://purl.obolibrary.org/obo/MONDO_0007722) (Heterochromia iridis (disease)), [MONDO:0007721](http://purl.obolibrary.org/obo/MONDO_0007721) (hiatus hernia (disease)), [MONDO:0007720](http://purl.obolibrary.org/obo/MONDO_0007720) (hernia, double inguinal), [MONDO:0004691](http://purl.obolibrary.org/obo/MONDO_0004691) (autosomal dominant polycystic kidney disease), [MONDO:0019717](http://purl.obolibrary.org/obo/MONDO_0019717) (chromosomal disease with overgrowth), [MONDO:0016676](http://purl.obolibrary.org/obo/MONDO_0016676) (recurrent infections-inflammatory syndrome due to zinc metabolism disorder syndrome), [MONDO:0014013](http://purl.obolibrary.org/obo/MONDO_0014013) (maternal riboflavin deficiency), [MONDO:0014014](http://purl.obolibrary.org/obo/MONDO_0014014) (epidermolysis bullosa simplex due to exophilin 5 deficiency), [MONDO:0014016](http://purl.obolibrary.org/obo/MONDO_0014016) (hereditary spastic paraplegia 49), [MONDO:0014010](http://purl.obolibrary.org/obo/MONDO_0014010) (autosomal recessive congenital ichthyosis 9), [MONDO:0014011](http://purl.obolibrary.org/obo/MONDO_0014011) (autosomal recessive congenital ichthyosis 10), [MONDO:0016673](http://purl.obolibrary.org/obo/MONDO_0016673) (localized junctional epidermolysis bullosa, non-Herlitz type), [MONDO:0007738](http://purl.obolibrary.org/obo/MONDO_0007738) (spondyloepiphyseal dysplasia with congenital joint dislocations), [MONDO:0007736](http://purl.obolibrary.org/obo/MONDO_0007736) (Hpa 1 Recognition Polymorphism, beta-Globin-related), [MONDO:0007732](http://purl.obolibrary.org/obo/MONDO_0007732) (Holt-Oram syndrome), [MONDO:0007731](http://purl.obolibrary.org/obo/MONDO_0007731) (Hla Modifier), [MONDO:0007730](http://purl.obolibrary.org/obo/MONDO_0007730) (histiocytic dermatoarthritis), [MONDO:0014018](http://purl.obolibrary.org/obo/MONDO_0014018) (hereditary spastic paraplegia 54), [MONDO:0014002](http://purl.obolibrary.org/obo/MONDO_0014002) (autosomal dominant nocturnal frontal lobe epilepsy 5), [MONDO:0017998](http://purl.obolibrary.org/obo/MONDO_0017998) (PLA2G6-associated neurodegeneration), [MONDO:0014003](http://purl.obolibrary.org/obo/MONDO_0014003) (epileptic encephalopathy, early infantile, 15), [MONDO:0017994](http://purl.obolibrary.org/obo/MONDO_0017994) (severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency), [MONDO:0014001](http://purl.obolibrary.org/obo/MONDO_0014001) (Usher syndrome type 1K), [MONDO:0017992](http://purl.obolibrary.org/obo/MONDO_0017992) (autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis), [MONDO:0007709](http://purl.obolibrary.org/obo/MONDO_0007709) (Hematuria, benign familial), [MONDO:0007708](http://purl.obolibrary.org/obo/MONDO_0007708) (Kasabach-Merritt syndrome), [MONDO:0007702](http://purl.obolibrary.org/obo/MONDO_0007702) (heart-hand syndrome type 3), [MONDO:0002012](http://purl.obolibrary.org/obo/MONDO_0002012) (methylmalonic acidemia), [MONDO:0007700](http://purl.obolibrary.org/obo/MONDO_0007700) (Hawkinsinuria), [MONDO:0002014](http://purl.obolibrary.org/obo/MONDO_0002014) (autosomal recessive Ehlers-Danlos syndrome, vascular type), [MONDO:0014007](http://purl.obolibrary.org/obo/MONDO_0014007) (Aicardi-Goutieres syndrome 6), [MONDO:0017999](http://purl.obolibrary.org/obo/MONDO_0017999) (fatty acid hydroxylase-associated neurodegeneration), [MONDO:0014008](http://purl.obolibrary.org/obo/MONDO_0014008) (Phosphohydroxylysinuria), [MONDO:0014009](http://purl.obolibrary.org/obo/MONDO_0014009) (autosomal recessive congenital ichthyosis 7), [MONDO:0015339](http://purl.obolibrary.org/obo/MONDO_0015339) (adrenomyeloneuropathy), [MONDO:0017986](http://purl.obolibrary.org/obo/MONDO_0017986) (disorder of plasmalogens biosynthesis), [MONDO:0012294](http://purl.obolibrary.org/obo/MONDO_0012294) (drug metabolism, poor, Cyp2C19-related), [MONDO:0012293](http://purl.obolibrary.org/obo/MONDO_0012293) (autosomal recessive nonsyndromic deafness 23), [MONDO:0012298](http://purl.obolibrary.org/obo/MONDO_0012298) (omphalocele, diaphragmatic hernia, and radial ray defects), [MONDO:0012297](http://purl.obolibrary.org/obo/MONDO_0012297) (SPOAN syndrome), [MONDO:0007717](http://purl.obolibrary.org/obo/MONDO_0007717) (hemoglobin--variants for which the chain Carrying the mutation 1S unknown or uncertain), [MONDO:0012292](http://purl.obolibrary.org/obo/MONDO_0012292) (hepatitis c virus, susceptibility to), [MONDO:0012291](http://purl.obolibrary.org/obo/MONDO_0012291) (immunoglobulin a deficiency 2), [MONDO:0012290](http://purl.obolibrary.org/obo/MONDO_0012290) (CEDNIK syndrome), [MONDO:0007715](http://purl.obolibrary.org/obo/MONDO_0007715) (hemolytic Poikilocytic anemia due to reduced Ankyrin Binding sites), [MONDO:0004689](http://purl.obolibrary.org/obo/MONDO_0004689) (metal metabolism disorder), [MONDO:0018426](http://purl.obolibrary.org/obo/MONDO_0018426) (AXIN2-related attenuated familial adenomatous polyposis), [MONDO:0018424](http://purl.obolibrary.org/obo/MONDO_0018424) (Lipoic acid biosynthesis defect), [MONDO:0018422](http://purl.obolibrary.org/obo/MONDO_0018422) (autosomal recessive spastic paraplegia type 70), [MONDO:0014064](http://purl.obolibrary.org/obo/MONDO_0014064) (mitochondrial complex III deficiency nuclear type 3), [MONDO:0018423](http://purl.obolibrary.org/obo/MONDO_0018423) (autosomal recessive spastic paraplegia type 71), [MONDO:0014065](http://purl.obolibrary.org/obo/MONDO_0014065) (mitochondrial complex III deficiency nuclear type 4), [MONDO:0018420](http://purl.obolibrary.org/obo/MONDO_0018420) (autosomal recessive spastic paraplegia type 68), [MONDO:0014066](http://purl.obolibrary.org/obo/MONDO_0014066) (mitochondrial complex III deficiency nuclear type 5), [MONDO:0018421](http://purl.obolibrary.org/obo/MONDO_0018421) (autosomal recessive spastic paraplegia type 69), [MONDO:0014060](http://purl.obolibrary.org/obo/MONDO_0014060) (progressive retinal dystrophy due to retinol transport defect), [MONDO:0014062](http://purl.obolibrary.org/obo/MONDO_0014062) (mitochondrial DNA deletion syndrome with progressive myopathy), [MONDO:0014063](http://purl.obolibrary.org/obo/MONDO_0014063) (mitochondrial complex III deficiency nuclear type 2), [MONDO:0007769](http://purl.obolibrary.org/obo/MONDO_0007769) (hyperpigmentation of eyelid), [MONDO:0007768](http://purl.obolibrary.org/obo/MONDO_0007768) (hyperparathyroidism-jaw tumor syndrome), [MONDO:0007767](http://purl.obolibrary.org/obo/MONDO_0007767) (hyperparathyroidism 1), [MONDO:0007762](http://purl.obolibrary.org/obo/MONDO_0007762) (hyperlipoproteinemia type V), [MONDO:0007761](http://purl.obolibrary.org/obo/MONDO_0007761) (hyperlipoproteinemia type IV), [MONDO:0007760](http://purl.obolibrary.org/obo/MONDO_0007760) (hyperlipoproteinemia, type II, and deafness), [MONDO:0019746](http://purl.obolibrary.org/obo/MONDO_0019746) (cystinuria type B), [MONDO:0014057](http://purl.obolibrary.org/obo/MONDO_0014057) (maple syrup urine disease, mild variant), [MONDO:0018416](http://purl.obolibrary.org/obo/MONDO_0018416) (autosomal recessive spastic paraplegia type 59), [MONDO:0019745](http://purl.obolibrary.org/obo/MONDO_0019745) (cystinuria type A), [MONDO:0014053](http://purl.obolibrary.org/obo/MONDO_0014053) (stomatin-like protein-2, Hyperphosphorylation of), [MONDO:0019742](http://purl.obolibrary.org/obo/MONDO_0019742) (late-onset nephronophthisis), [MONDO:0014054](http://purl.obolibrary.org/obo/MONDO_0014054) (lymphoproliferative syndrome 2), [MONDO:0014055](http://purl.obolibrary.org/obo/MONDO_0014055) (FAME4), [MONDO:0014056](http://purl.obolibrary.org/obo/MONDO_0014056) (melanoma, cutaneous malignant, susceptibility to, 9), [MONDO:0014051](http://purl.obolibrary.org/obo/MONDO_0014051) (cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2), [MONDO:0007779](http://purl.obolibrary.org/obo/MONDO_0007779) (autosomal dominant Opitz G/BBB syndrome), [MONDO:0007778](http://purl.obolibrary.org/obo/MONDO_0007778) (hypertelorism (disease)), [MONDO:0007777](http://purl.obolibrary.org/obo/MONDO_0007777) (Hypertaurinuric cardiomyopathy), [MONDO:0007776](http://purl.obolibrary.org/obo/MONDO_0007776) (hypersensitivity pneumonitis, familial), [MONDO:0007775](http://purl.obolibrary.org/obo/MONDO_0007775) (hypersecretion of adrenal androgens, familial), [MONDO:0007774](http://purl.obolibrary.org/obo/MONDO_0007774) (Hyperreflexia (disease)), [MONDO:0007773](http://purl.obolibrary.org/obo/MONDO_0007773) (Hyperproglucagonemia), [MONDO:0007772](http://purl.obolibrary.org/obo/MONDO_0007772) (pseudohypoaldosteronism type 2A), [MONDO:0007770](http://purl.obolibrary.org/obo/MONDO_0007770) (hyperpigmentation of Fuldauer and Kuijpers), [MONDO:0018419](http://purl.obolibrary.org/obo/MONDO_0018419) (autosomal recessive spastic paraplegia type 67), [MONDO:0018417](http://purl.obolibrary.org/obo/MONDO_0018417) (autosomal recessive spastic paraplegia type 60), [MONDO:0018418](http://purl.obolibrary.org/obo/MONDO_0018418) (autosomal recessive spastic paraplegia type 66), [MONDO:0014046](http://purl.obolibrary.org/obo/MONDO_0014046) (Cowden syndrome 4), [MONDO:0014047](http://purl.obolibrary.org/obo/MONDO_0014047) (Cowden syndrome 5), [MONDO:0019733](http://purl.obolibrary.org/obo/MONDO_0019733) (AFib amyloidosis), [MONDO:0014048](http://purl.obolibrary.org/obo/MONDO_0014048) (Cowden syndrome 6), [MONDO:0014049](http://purl.obolibrary.org/obo/MONDO_0014049) (urofacial syndrome 2), [MONDO:0019731](http://purl.obolibrary.org/obo/MONDO_0019731) (AApoAI amyloidosis), [MONDO:0019732](http://purl.obolibrary.org/obo/MONDO_0019732) (ALys amyloidosis), [MONDO:0015373](http://purl.obolibrary.org/obo/MONDO_0015373) (Saldino-Mainzer syndrome), [MONDO:0014045](http://purl.obolibrary.org/obo/MONDO_0014045) (Cowden syndrome 3), [MONDO:0007749](http://purl.obolibrary.org/obo/MONDO_0007749) (autosomal recessive infantile hypercalcemia), [MONDO:0007747](http://purl.obolibrary.org/obo/MONDO_0007747) (Hyperchlorhidrosis, isolated), [MONDO:0007746](http://purl.obolibrary.org/obo/MONDO_0007746) (orthostatic hypotensive disorder, Streeten type), [MONDO:0007745](http://purl.obolibrary.org/obo/MONDO_0007745) (Gilbert syndrome), [MONDO:0007744](http://purl.obolibrary.org/obo/MONDO_0007744) (cholesterol-ester transfer protein deficiency), [MONDO:0007743](http://purl.obolibrary.org/obo/MONDO_0007743) (attention deficit-hyperactivity disorder), [MONDO:0007742](http://purl.obolibrary.org/obo/MONDO_0007742) (5-Hydroxytryptamine oxygenase Regulator), [MONDO:0015366](http://purl.obolibrary.org/obo/MONDO_0015366) (autosomal recessive hereditary sensory and autonomic neuropathy), [MONDO:0015369](http://purl.obolibrary.org/obo/MONDO_0015369) (Joubert syndrome and related disorders), [MONDO:0014038](http://purl.obolibrary.org/obo/MONDO_0014038) (colorectal cancer, susceptibility to, 12), [MONDO:0015363](http://purl.obolibrary.org/obo/MONDO_0015363) (autosomal recessive distal hereditary motor neuropathy), [MONDO:0015362](http://purl.obolibrary.org/obo/MONDO_0015362) (autosomal dominant distal hereditary motor neuropathy), [MONDO:0015365](http://purl.obolibrary.org/obo/MONDO_0015365) (autosomal dominant hereditary sensory and autonomic neuropathy), [MONDO:0015364](http://purl.obolibrary.org/obo/MONDO_0015364) (hereditary sensory and autonomic neuropathy), [MONDO:0014030](http://purl.obolibrary.org/obo/MONDO_0014030) (primary ciliary dyskinesia 20), [MONDO:0007759](http://purl.obolibrary.org/obo/MONDO_0007759) (hyperlipidemia, familial combined, LPL related), [MONDO:0007758](http://purl.obolibrary.org/obo/MONDO_0007758) (epidermolytic palmoplantar keratoderma), [MONDO:0007757](http://purl.obolibrary.org/obo/MONDO_0007757) (hyperkeratosis-hyperpigmentation syndrome), [MONDO:0007755](http://purl.obolibrary.org/obo/MONDO_0007755) (hyperimmunoglobulin G1(A1) syndrome), [MONDO:0007754](http://purl.obolibrary.org/obo/MONDO_0007754) (HYPRPP), [MONDO:0007753](http://purl.obolibrary.org/obo/MONDO_0007753) (Frey syndrome), [MONDO:0007752](http://purl.obolibrary.org/obo/MONDO_0007752) (Hyperheparinemia), [MONDO:0007751](http://purl.obolibrary.org/obo/MONDO_0007751) (hypercholesterolemia, autosomal dominant, type b), [MONDO:0007750](http://purl.obolibrary.org/obo/MONDO_0007750) (hypercholesterolemia, familial), [MONDO:0014039](http://purl.obolibrary.org/obo/MONDO_0014039) (mitochondrial DNA depletion syndrome 11), [MONDO:0017138](http://purl.obolibrary.org/obo/MONDO_0017138) (Opitz G/BBB syndrome), [MONDO:0019799](http://purl.obolibrary.org/obo/MONDO_0019799) (hepatoerythropoietic porphyria), [MONDO:0018467](http://purl.obolibrary.org/obo/MONDO_0018467) (nephropathic infantile cystinosis), [MONDO:0019798](http://purl.obolibrary.org/obo/MONDO_0019798) (acute hepatic porphyria), [MONDO:0018464](http://purl.obolibrary.org/obo/MONDO_0018464) (severe phosphoribosylpyrophosphate synthetase superactivity), [MONDO:0018462](http://purl.obolibrary.org/obo/MONDO_0018462) (Angelman syndrome due to imprinting defect in 15q11-q13), [MONDO:0019793](http://purl.obolibrary.org/obo/MONDO_0019793) (autosomal dominant cerebellar ataxia type 3), [MONDO:0009511](http://purl.obolibrary.org/obo/MONDO_0009511) (larsen-like syndrome, B3GAT3 type), [MONDO:0019794](http://purl.obolibrary.org/obo/MONDO_0019794) (autosomal dominant cerebellar ataxia type 4), [MONDO:0018463](http://purl.obolibrary.org/obo/MONDO_0018463) (mild phosphoribosylpyrophosphate synthetase superactivity), [MONDO:0017132](http://purl.obolibrary.org/obo/MONDO_0017132) (hereditary ATTR amyloidosis), [MONDO:0019791](http://purl.obolibrary.org/obo/MONDO_0019791) (recessive mitochondrial ataxia syndrome), [MONDO:0009513](http://purl.obolibrary.org/obo/MONDO_0009513) (laryngo-onycho-cutaneous syndrome), [MONDO:0018461](http://purl.obolibrary.org/obo/MONDO_0018461) (Angelman syndrome due to a point mutation), [MONDO:0019792](http://purl.obolibrary.org/obo/MONDO_0019792) (autosomal dominant cerebellar ataxia type I), [MONDO:0009514](http://purl.obolibrary.org/obo/MONDO_0009514) (Laurence-Moon syndrome), [MONDO:0009515](http://purl.obolibrary.org/obo/MONDO_0009515) (Norum disease), [MONDO:0009517](http://purl.obolibrary.org/obo/MONDO_0009517) (Donohue syndrome), [MONDO:0010507](http://purl.obolibrary.org/obo/MONDO_0010507) (Xq25 duplication syndrome), [MONDO:0010508](http://purl.obolibrary.org/obo/MONDO_0010508) (mental retardation, X-linked 103; MRX103), [MONDO:0005144](http://purl.obolibrary.org/obo/MONDO_0005144) (familial amyotrophic lateral sclerosis), [MONDO:0010500](http://purl.obolibrary.org/obo/MONDO_0010500) (mental retardation, X-linked, syndromic 33), [MONDO:0011835](http://purl.obolibrary.org/obo/MONDO_0011835) (sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome), [MONDO:0010503](http://purl.obolibrary.org/obo/MONDO_0010503) (Bartter disease type 5), [MONDO:0011834](http://purl.obolibrary.org/obo/MONDO_0011834) (spinocerebellar ataxia type 18), [MONDO:0010504](http://purl.obolibrary.org/obo/MONDO_0010504) (immunodeficiency 47; IMD47), [MONDO:0011833](http://purl.obolibrary.org/obo/MONDO_0011833) (spinocerebellar ataxia type 21), [MONDO:0010501](http://purl.obolibrary.org/obo/MONDO_0010501) (syndromic X-linked intellectual disability 34), [MONDO:0011832](http://purl.obolibrary.org/obo/MONDO_0011832) (autosomal dominant nonsyndromic deafness 44), [MONDO:0010502](http://purl.obolibrary.org/obo/MONDO_0010502) (mental retardation, X-linked 99, syndromic, female-restricted; MRXS99F), [MONDO:0018459](http://purl.obolibrary.org/obo/MONDO_0018459) (isolated glycerol kinase deficiency), [MONDO:0018458](http://purl.obolibrary.org/obo/MONDO_0018458) (familial hypocalciuric hypercalcemia), [MONDO:0017123](http://purl.obolibrary.org/obo/MONDO_0017123) (arthrogryposis-renal dysfunction-cholestasis syndrome), [MONDO:0014098](http://purl.obolibrary.org/obo/MONDO_0014098) (CIDEC-related familial partial lipodystrophy), [MONDO:0017125](http://purl.obolibrary.org/obo/MONDO_0017125) (oculofaciocardiodental syndrome), [MONDO:0018453](http://purl.obolibrary.org/obo/MONDO_0018453) (familial atypical multiple mole melanoma syndrome), [MONDO:0018451](http://purl.obolibrary.org/obo/MONDO_0018451) (X-linked distal hereditary motor neuropathy), [MONDO:0014095](http://purl.obolibrary.org/obo/MONDO_0014095) (dilated cardiomyopathy 1JJ), [MONDO:0018450](http://purl.obolibrary.org/obo/MONDO_0018450) (spinal muscular atrophy with respiratory distress type 2), [MONDO:0009502](http://purl.obolibrary.org/obo/MONDO_0009502) (pyruvate dehydrogenase E2 deficiency), [MONDO:0009503](http://purl.obolibrary.org/obo/MONDO_0009503) (pyruvate dehydrogenase E3-binding protein deficiency), [MONDO:0009504](http://purl.obolibrary.org/obo/MONDO_0009504) (mitochondrial DNA depletion syndrome 9), [MONDO:0009505](http://purl.obolibrary.org/obo/MONDO_0009505) (lactic aciduria due to d-Lactic acid), [MONDO:0014091](http://purl.obolibrary.org/obo/MONDO_0014091) (mitochondrial complex v (ATP synthase) deficiency nuclear type 4), [MONDO:0011828](http://purl.obolibrary.org/obo/MONDO_0011828) (mental retardation, autosomal recessive 2), [MONDO:0009508](http://purl.obolibrary.org/obo/MONDO_0009508) (Lambotte syndrome), [MONDO:0011825](http://purl.obolibrary.org/obo/MONDO_0011825) (streptococcus, group a, Severity of infection by), [MONDO:0011829](http://purl.obolibrary.org/obo/MONDO_0011829) (coenzyme Q10 deficiency, primary, 1), [MONDO:0011820](http://purl.obolibrary.org/obo/MONDO_0011820) (IS2), [MONDO:0011822](http://purl.obolibrary.org/obo/MONDO_0011822) (Bartter disease type 3), [MONDO:0011821](http://purl.obolibrary.org/obo/MONDO_0011821) (Meckel syndrome, type 3), [MONDO:0019779](http://purl.obolibrary.org/obo/MONDO_0019779) (Renier-Gabreels-Jasper syndrome), [MONDO:0018446](http://purl.obolibrary.org/obo/MONDO_0018446) (autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome), [MONDO:0019777](http://purl.obolibrary.org/obo/MONDO_0019777) (Carpenter-Waziri syndrome), [MONDO:0019778](http://purl.obolibrary.org/obo/MONDO_0019778) (Smith-Fineman-Myers syndrome), [MONDO:0019775](http://purl.obolibrary.org/obo/MONDO_0019775) (Chudley-Lowry-Hoar syndrome), [MONDO:0019776](http://purl.obolibrary.org/obo/MONDO_0019776) (Juberg-Marsidi syndrome), [MONDO:0018445](http://purl.obolibrary.org/obo/MONDO_0018445) (global developmental delay-lung cysts-overgrowth-wilms tumor syndrome), [MONDO:0019774](http://purl.obolibrary.org/obo/MONDO_0019774) (Holmes-Gang syndrome), [MONDO:0014089](http://purl.obolibrary.org/obo/MONDO_0014089) (corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome), [MONDO:0018440](http://purl.obolibrary.org/obo/MONDO_0018440) (autosomal recessive distal renal tubular acidosis), [MONDO:0014082](http://purl.obolibrary.org/obo/MONDO_0014082) (cryptosporidiosis-chronic cholangitis-liver disease syndrome), [MONDO:0014084](http://purl.obolibrary.org/obo/MONDO_0014084) (ataxia with oculomotor apraxia type 3), [MONDO:0019770](http://purl.obolibrary.org/obo/MONDO_0019770) (X-linked dominant intellectual disability-epilepsy syndrome), [MONDO:0014080](http://purl.obolibrary.org/obo/MONDO_0014080) (OSMD), [MONDO:0014081](http://purl.obolibrary.org/obo/MONDO_0014081) (severe combined immunodeficiency due to CARD11 deficiency), [MONDO:0011817](http://purl.obolibrary.org/obo/MONDO_0011817) (coronary heart disease, susceptibility to, 1), [MONDO:0007789](http://purl.obolibrary.org/obo/MONDO_0007789) (Hypertrophia musculorum vera), [MONDO:0011816](http://purl.obolibrary.org/obo/MONDO_0011816) (Lathosterolosis), [MONDO:0007788](http://purl.obolibrary.org/obo/MONDO_0007788) (hypertriglyceridemia, familial), [MONDO:0007785](http://purl.obolibrary.org/obo/MONDO_0007785) (hyperthyroxinemia, Dystransthyretinemic), [MONDO:0011819](http://purl.obolibrary.org/obo/MONDO_0011819) (spinocerebellar ataxia type 19/22), [MONDO:0007782](http://purl.obolibrary.org/obo/MONDO_0007782) (hyperthermia, cutaneous, with Headaches and Nausea), [MONDO:0011812](http://purl.obolibrary.org/obo/MONDO_0011812) (Duane-radial ray syndrome), [MONDO:0011811](http://purl.obolibrary.org/obo/MONDO_0011811) (autosomal recessive cerebellar ataxia-saccadic intrusion syndrome), [MONDO:0014079](http://purl.obolibrary.org/obo/MONDO_0014079) (RLS8), [MONDO:0019768](http://purl.obolibrary.org/obo/MONDO_0019768) (X-linked intellectual disability, Golabi-Ito-hall type), [MONDO:0019769](http://purl.obolibrary.org/obo/MONDO_0019769) (X-linked intellectual disability, Sutherland-Haan type), [MONDO:0019766](http://purl.obolibrary.org/obo/MONDO_0019766) (X-linked intellectual disability, Porteous type), [MONDO:0019767](http://purl.obolibrary.org/obo/MONDO_0019767) (Hamel cerebro-palato-cardiac syndrome), [MONDO:0014076](http://purl.obolibrary.org/obo/MONDO_0014076) (dyskeratosis congenita, autosomal recessive 5), [MONDO:0018431](http://purl.obolibrary.org/obo/MONDO_0018431) (cold-induced sweating syndrome-hyperthermia spectrum), [MONDO:0014071](http://purl.obolibrary.org/obo/MONDO_0014071) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11), [MONDO:0014072](http://purl.obolibrary.org/obo/MONDO_0014072) (d,L-2-hydroxyglutaric aciduria), [MONDO:0014073](http://purl.obolibrary.org/obo/MONDO_0014073) (dilated cardiomyopathy 1II), [MONDO:0014074](http://purl.obolibrary.org/obo/MONDO_0014074) (Charcot-Marie-tooth disease dominant intermediate f), [MONDO:0014070](http://purl.obolibrary.org/obo/MONDO_0014070) (oculocutaneous albinism type 7), [MONDO:0011806](http://purl.obolibrary.org/obo/MONDO_0011806) (osteofibrous dysplasia), [MONDO:0011805](http://purl.obolibrary.org/obo/MONDO_0011805) (asthma-related Traits, susceptibility to, 1), [MONDO:0007799](http://purl.obolibrary.org/obo/MONDO_0007799) (HBD), [MONDO:0011804](http://purl.obolibrary.org/obo/MONDO_0011804) (autoimmune lymphoproliferative syndrome type 2B), [MONDO:0011803](http://purl.obolibrary.org/obo/MONDO_0011803) (hereditary spastic paraplegia 7), [MONDO:0007798](http://purl.obolibrary.org/obo/MONDO_0007798) (adult hypophosphatasia), [MONDO:0007797](http://purl.obolibrary.org/obo/MONDO_0007797) (hypoparathyroidism-deafness-renal disease syndrome), [MONDO:0011809](http://purl.obolibrary.org/obo/MONDO_0011809) (Mammographic density), [MONDO:0007792](http://purl.obolibrary.org/obo/MONDO_0007792) (familial hypocalciuric hypercalcemia 2), [MONDO:0007791](http://purl.obolibrary.org/obo/MONDO_0007791) (familial hypocalciuric hypercalcemia 1), [MONDO:0011801](http://purl.obolibrary.org/obo/MONDO_0011801) (spinocerebellar ataxia type 1 with axonal neuropathy), [MONDO:0011871](http://purl.obolibrary.org/obo/MONDO_0011871) (Niemann-Pick disease type B), [MONDO:0009550](http://purl.obolibrary.org/obo/MONDO_0009550) (renal hypomagnesemia 3), [MONDO:0011870](http://purl.obolibrary.org/obo/MONDO_0011870) (annular epidermolytic ichthyosis), [MONDO:0009551](http://purl.obolibrary.org/obo/MONDO_0009551) (magnesium, elevated red cell), [MONDO:0010540](http://purl.obolibrary.org/obo/MONDO_0010540) (bullous dystrophy, macular type), [MONDO:0008220](http://purl.obolibrary.org/obo/MONDO_0008220) (Pepsinogen 3, group 1), [MONDO:0008221](http://purl.obolibrary.org/obo/MONDO_0008221) (Prolidase deficiency), [MONDO:0009552](http://purl.obolibrary.org/obo/MONDO_0009552) (mal de Meleda), [MONDO:0017174](http://purl.obolibrary.org/obo/MONDO_0017174) (Machado-Joseph disease type 1), [MONDO:0008223](http://purl.obolibrary.org/obo/MONDO_0008223) (hypokalemic periodic paralysis), [MONDO:0009555](http://purl.obolibrary.org/obo/MONDO_0009555) (malocclusion and short stature), [MONDO:0008224](http://purl.obolibrary.org/obo/MONDO_0008224) (hyperkalemic periodic paralysis), [MONDO:0017176](http://purl.obolibrary.org/obo/MONDO_0017176) (Machado-Joseph disease type 3), [MONDO:0009556](http://purl.obolibrary.org/obo/MONDO_0009556) (malonic aciduria), [MONDO:0008225](http://purl.obolibrary.org/obo/MONDO_0008225) (normokalemic periodic paralysis), [MONDO:0009557](http://purl.obolibrary.org/obo/MONDO_0009557) (mandibuloacral dysplasia with type A lipodystrophy), [MONDO:0017175](http://purl.obolibrary.org/obo/MONDO_0017175) (Machado-Joseph disease type 2), [MONDO:0008226](http://purl.obolibrary.org/obo/MONDO_0008226) (aggressive periodontitis), [MONDO:0009558](http://purl.obolibrary.org/obo/MONDO_0009558) (Treacher Collins syndrome 3), [MONDO:0008228](http://purl.obolibrary.org/obo/MONDO_0008228) (pernicious anemia), [MONDO:0009559](http://purl.obolibrary.org/obo/MONDO_0009559) (mandibulofacial dysostosis with mental deficiency), [MONDO:0017172](http://purl.obolibrary.org/obo/MONDO_0017172) (mucopolysaccharidosis type 6, slowly progressing), [MONDO:0008229](http://purl.obolibrary.org/obo/MONDO_0008229) (peroneal nerve, accessory deep), [MONDO:0017171](http://purl.obolibrary.org/obo/MONDO_0017171) (mucopolysaccharidosis type 6, rapidly progressing), [MONDO:0014909](http://purl.obolibrary.org/obo/MONDO_0014909) (primary ciliary dyskinesia 34), [MONDO:0010549](http://purl.obolibrary.org/obo/MONDO_0010549) (Charcot-Marie-tooth disease X-linked dominant 1), [MONDO:0014905](http://purl.obolibrary.org/obo/MONDO_0014905) (encephalopathy due to defective mitochondrial and peroxisomal fission 2; EMPF2), [MONDO:0014907](http://purl.obolibrary.org/obo/MONDO_0014907) (short-rib thoracic dysplasia 15 with polydactyly; SRTD15), [MONDO:0010543](http://purl.obolibrary.org/obo/MONDO_0010543) (Barth syndrome), [MONDO:0014901](http://purl.obolibrary.org/obo/MONDO_0014901) (tooth agenesis, selective, 8; STHAG8), [MONDO:0011875](http://purl.obolibrary.org/obo/MONDO_0011875) (epilepsy, idiopathic generalized, susceptibility to, 11), [MONDO:0011874](http://purl.obolibrary.org/obo/MONDO_0011874) (neonatal ichthyosis-sclerosing cholangitis syndrome), [MONDO:0011873](http://purl.obolibrary.org/obo/MONDO_0011873) (Niemann-Pick disease, type C2), [MONDO:0010542](http://purl.obolibrary.org/obo/MONDO_0010542) (dilated cardiomyopathy 3B), [MONDO:0011872](http://purl.obolibrary.org/obo/MONDO_0011872) (Griscelli syndrome type 2), [MONDO:0014904](http://purl.obolibrary.org/obo/MONDO_0014904) (congenital disorder of glycosylation, type Iaa; CDG1AA), [MONDO:0010547](http://purl.obolibrary.org/obo/MONDO_0010547) (X-linked progressive cerebellar ataxia), [MONDO:0011879](http://purl.obolibrary.org/obo/MONDO_0011879) (neuronopathy, distal hereditary motor, type 7B), [MONDO:0010548](http://purl.obolibrary.org/obo/MONDO_0010548) (spinocerebellar ataxia, X-linked 2), [MONDO:0010545](http://purl.obolibrary.org/obo/MONDO_0010545) (Nance-Horan syndrome), [MONDO:0010546](http://purl.obolibrary.org/obo/MONDO_0010546) (central incisors, absence of), [MONDO:0011876](http://purl.obolibrary.org/obo/MONDO_0011876) (juvenile absence epilepsy), [MONDO:0014900](http://purl.obolibrary.org/obo/MONDO_0014900) (autosomal recessive limb-girdle muscular dystrophy type 2Y), [MONDO:0009541](http://purl.obolibrary.org/obo/MONDO_0009541) (Lymphopenic hypergammaglobulinemia, antibody deficiency, autoimmune hemolytic anemia, and glomerulonephritis), [MONDO:0009542](http://purl.obolibrary.org/obo/MONDO_0009542) (lysine malabsorption syndrome), [MONDO:0018495](http://purl.obolibrary.org/obo/MONDO_0018495) (X-linked intellectual disability-limb spasticity-retinal dystrophy-diabetes insipidus syndrome), [MONDO:0008212](http://purl.obolibrary.org/obo/MONDO_0008212) (Pechet factor deficiency), [MONDO:0018496](http://purl.obolibrary.org/obo/MONDO_0018496) (ARX-related encephalopathy-brain malformation spectrum), [MONDO:0008213](http://purl.obolibrary.org/obo/MONDO_0008213) (pectus excavatum (disease)), [MONDO:0009545](http://purl.obolibrary.org/obo/MONDO_0009545) (Macroepiphyseal dysplasia with osteoporosis, wrinkled skin, and Aged appearance), [MONDO:0008214](http://purl.obolibrary.org/obo/MONDO_0008214) (Pelger-Huet anomaly), [MONDO:0017165](http://purl.obolibrary.org/obo/MONDO_0017165) (bile acid CoA ligase deficiency and defective amidation), [MONDO:0009546](http://purl.obolibrary.org/obo/MONDO_0009546) (macrosomia Adiposa congenita), [MONDO:0008215](http://purl.obolibrary.org/obo/MONDO_0008215) (adult-onset autosomal dominant demyelinating leukodystrophy), [MONDO:0008216](http://purl.obolibrary.org/obo/MONDO_0008216) (pelvic lipomatosis with crossed renal ectopia), [MONDO:0018491](http://purl.obolibrary.org/obo/MONDO_0018491) (3-phosphoglycerate dehydrogenase deficiency), [MONDO:0018492](http://purl.obolibrary.org/obo/MONDO_0018492) (hereditary clear cell renal cell carcinoma), [MONDO:0009548](http://purl.obolibrary.org/obo/MONDO_0009548) (renal hypomagnesemia 5 with ocular involvement), [MONDO:0010539](http://purl.obolibrary.org/obo/MONDO_0010539) (X-linked mandibulofacial dysostosis), [MONDO:0011869](http://purl.obolibrary.org/obo/MONDO_0011869) (epidermolysis bullosa simplex superficialis), [MONDO:0011864](http://purl.obolibrary.org/obo/MONDO_0011864) (immunodeficiency, common variable, 1), [MONDO:0010533](http://purl.obolibrary.org/obo/MONDO_0010533) (Arts syndrome), [MONDO:0011863](http://purl.obolibrary.org/obo/MONDO_0011863) (prostate cancer Aggressiveness quantitative trait locus on chromosome 19), [MONDO:0011862](http://purl.obolibrary.org/obo/MONDO_0011862) (hereditary spastic paraplegia 24), [MONDO:0011861](http://purl.obolibrary.org/obo/MONDO_0011861) (Breath-Holding Spells), [MONDO:0010536](http://purl.obolibrary.org/obo/MONDO_0010536) (Tubulin, beta), [MONDO:0010537](http://purl.obolibrary.org/obo/MONDO_0010537) (Borjeson-Forssman-Lehmann syndrome), [MONDO:0011867](http://purl.obolibrary.org/obo/MONDO_0011867) (microphthalmia with cyst, bilateral facial clefts, and limb anomalies), [MONDO:0005190](http://purl.obolibrary.org/obo/MONDO_0005190) (macroglobulinemia), [MONDO:0010534](http://purl.obolibrary.org/obo/MONDO_0010534) (X-linked spinocerebellar ataxia type 4), [MONDO:0009530](http://purl.obolibrary.org/obo/MONDO_0009530) (lipoid proteinosis), [MONDO:0009531](http://purl.obolibrary.org/obo/MONDO_0009531) (lip Prints), [MONDO:0018485](http://purl.obolibrary.org/obo/MONDO_0018485) (glycogen storage disease due to acid maltase deficiency, late-onset), [MONDO:0008202](http://purl.obolibrary.org/obo/MONDO_0008202) (Parotidomegaly, hereditary bilateral), [MONDO:0009534](http://purl.obolibrary.org/obo/MONDO_0009534) (lymphoblastic transformation, Inhibition of), [MONDO:0008203](http://purl.obolibrary.org/obo/MONDO_0008203) (Passovoy factor defect), [MONDO:0009535](http://purl.obolibrary.org/obo/MONDO_0009535) (lymphedema, congenital recessive), [MONDO:0009536](http://purl.obolibrary.org/obo/MONDO_0009536) (lymphoblastic transformation, intrinsic defect 1N), [MONDO:0009538](http://purl.obolibrary.org/obo/MONDO_0009538) (lymphoid system deterioration, progressive), [MONDO:0008208](http://purl.obolibrary.org/obo/MONDO_0008208) (patella, familial recurrent dislocation of), [MONDO:0010529](http://purl.obolibrary.org/obo/MONDO_0010529) (X-linked spinocerebellar ataxia type 3), [MONDO:0010527](http://purl.obolibrary.org/obo/MONDO_0010527) (microphthalmia-ankyloblepharon-intellectual disability syndrome), [MONDO:0011859](http://purl.obolibrary.org/obo/MONDO_0011859) (distal myopathy with early respiratory muscle involvement), [MONDO:0011858](http://purl.obolibrary.org/obo/MONDO_0011858) (spastic paraplegia, ataxia, and mental retardation), [MONDO:0010528](http://purl.obolibrary.org/obo/MONDO_0010528) (anosmia (disease)), [MONDO:0010521](http://purl.obolibrary.org/obo/MONDO_0010521) (amelogenesis imperfecta type 1E), [MONDO:0011853](http://purl.obolibrary.org/obo/MONDO_0011853) (Camptosynpolydactyly, complex), [MONDO:0010522](http://purl.obolibrary.org/obo/MONDO_0010522) (X-linked amelogenesis imperfecta hypoplastic/hypomaturation 2), [MONDO:0011852](http://purl.obolibrary.org/obo/MONDO_0011852) (nonsyndromic congenital nail disorder 8), [MONDO:0010520](http://purl.obolibrary.org/obo/MONDO_0010520) (X-linked Alport syndrome), [MONDO:0011857](http://purl.obolibrary.org/obo/MONDO_0011857) (atrial fibrillation, familial, 3), [MONDO:0006491](http://purl.obolibrary.org/obo/MONDO_0006491) (vulvar lichen sclerosus), [MONDO:0010526](http://purl.obolibrary.org/obo/MONDO_0010526) (Fabry disease), [MONDO:0010524](http://purl.obolibrary.org/obo/MONDO_0010524) (X-linked sideroblastic anemia with ataxia), [MONDO:0011854](http://purl.obolibrary.org/obo/MONDO_0011854) (secretory diarrhea, myopathy, and deafness), [MONDO:0017148](http://purl.obolibrary.org/obo/MONDO_0017148) (heritable pulmonary arterial hypertension), [MONDO:0018479](http://purl.obolibrary.org/obo/MONDO_0018479) (congenital adrenal hyperplasia), [MONDO:0018477](http://purl.obolibrary.org/obo/MONDO_0018477) (bilirubin encephalopathy), [MONDO:0009520](http://purl.obolibrary.org/obo/MONDO_0009520) (3-hydroxy-3-methylglutaric aciduria), [MONDO:0009521](http://purl.obolibrary.org/obo/MONDO_0009521) (leukemia, acute myelocytic, with polyposis coli and colon cancer), [MONDO:0018473](http://purl.obolibrary.org/obo/MONDO_0018473) (hyperlipoproteinemia type 3), [MONDO:0017140](http://purl.obolibrary.org/obo/MONDO_0017140) (L1 syndrome), [MONDO:0018472](http://purl.obolibrary.org/obo/MONDO_0018472) (familial isolated trichomegaly), [MONDO:0009526](http://purl.obolibrary.org/obo/MONDO_0009526) (fibular aplasia, tibial Campomelia, and Oligosyndactyly syndrome), [MONDO:0009527](http://purl.obolibrary.org/obo/MONDO_0009527) (lipase deficiency, combined), [MONDO:0009528](http://purl.obolibrary.org/obo/MONDO_0009528) (chylomicron retention disease), [MONDO:0010518](http://purl.obolibrary.org/obo/MONDO_0010518) (Wiskott-Aldrich syndrome), [MONDO:0009529](http://purl.obolibrary.org/obo/MONDO_0009529) (pyruvate dehydrogenase E3 deficiency), [MONDO:0010519](http://purl.obolibrary.org/obo/MONDO_0010519) (alpha thalassemia-X-linked intellectual disability syndrome), [MONDO:0011849](http://purl.obolibrary.org/obo/MONDO_0011849) (psoriatic arthritis), [MONDO:0011848](http://purl.obolibrary.org/obo/MONDO_0011848) (headache associated with sexual activity), [MONDO:0010516](http://purl.obolibrary.org/obo/MONDO_0010516) (midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis; MFHIEN), [MONDO:0010517](http://purl.obolibrary.org/obo/MONDO_0010517) (ciliary dyskinesia, primary, 36, X-linked; CILD36), [MONDO:0011841](http://purl.obolibrary.org/obo/MONDO_0011841) (biotin-responsive basal ganglia disease), [MONDO:0011840](http://purl.obolibrary.org/obo/MONDO_0011840) (dilated cardiomyopathy 1M), [MONDO:0010514](http://purl.obolibrary.org/obo/MONDO_0010514) (immunodeficiency 50; IMD50), [MONDO:0011846](http://purl.obolibrary.org/obo/MONDO_0011846) (bulimia nervosa, susceptibility to, 1), [MONDO:0010515](http://purl.obolibrary.org/obo/MONDO_0010515) (Meester-Loeys syndrome; MRLS), [MONDO:0010512](http://purl.obolibrary.org/obo/MONDO_0010512) (mental retardation, X-linked, syndromic, Bain type; MRXSB), [MONDO:0010513](http://purl.obolibrary.org/obo/MONDO_0010513) (mental retardation, X-linked, syndromic, Borck type; MRXSBRK), [MONDO:0009590](http://purl.obolibrary.org/obo/MONDO_0009590) (metachromatic leukodystrophy due to saposin b deficiency), [MONDO:0008260](http://purl.obolibrary.org/obo/MONDO_0008260) (Kindler syndrome), [MONDO:0009591](http://purl.obolibrary.org/obo/MONDO_0009591) (metachromatic leukodystrophy, juvenile form), [MONDO:0014940](http://purl.obolibrary.org/obo/MONDO_0014940) (neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset; NADGP), [MONDO:0008263](http://purl.obolibrary.org/obo/MONDO_0008263) (polycystic kidney disease 1), [MONDO:0010584](http://purl.obolibrary.org/obo/MONDO_0010584) (dyskeratosis congenita, X-linked), [MONDO:0009595](http://purl.obolibrary.org/obo/MONDO_0009595) (cartilage-hair hypoplasia), [MONDO:0009596](http://purl.obolibrary.org/obo/MONDO_0009596) (metaphyseal chondrodysplasia, Pena type), [MONDO:0008265](http://purl.obolibrary.org/obo/MONDO_0008265) (isolated polycystic liver disease), [MONDO:0014949](http://purl.obolibrary.org/obo/MONDO_0014949) (epileptic encephalopathy, early infantile, 47; EIEE47), [MONDO:0013618](http://purl.obolibrary.org/obo/MONDO_0013618) (craniofacial anomalies and anterior segment dysgenesis syndrome), [MONDO:0013614](http://purl.obolibrary.org/obo/MONDO_0013614) (hypertelorism-preauricular sinus-punctual pits-deafness syndrome), [MONDO:0014945](http://purl.obolibrary.org/obo/MONDO_0014945) (myopathy, distal, with rimmed vacuoles; DMRV), [MONDO:0010587](http://purl.obolibrary.org/obo/MONDO_0010587) (epidermodysplasia verruciformis, X-linked), [MONDO:0014946](http://purl.obolibrary.org/obo/MONDO_0014946) (Sifrim-Hitz-Weiss syndrome; SIHIWES), [MONDO:0014947](http://purl.obolibrary.org/obo/MONDO_0014947) (epileptic encephalopathy, early infantile, 46; EIEE46), [MONDO:0010585](http://purl.obolibrary.org/obo/MONDO_0010585) (X-linked hypohidrotic ectodermal dysplasia), [MONDO:0014948](http://purl.obolibrary.org/obo/MONDO_0014948) (short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay; SRMMD), [MONDO:0010586](http://purl.obolibrary.org/obo/MONDO_0010586) (X-linked Ehlers-Danlos syndrome), [MONDO:0014941](http://purl.obolibrary.org/obo/MONDO_0014941) (arthrogryposis, distal, with impaired Proprioception and Touch; DAIPT), [MONDO:0014942](http://purl.obolibrary.org/obo/MONDO_0014942) (epileptic encephalopathy, early infantile, 45; EIEE45), [MONDO:0010589](http://purl.obolibrary.org/obo/MONDO_0010589) (Aarskog-Scott syndrome, X-linked), [MONDO:0014943](http://purl.obolibrary.org/obo/MONDO_0014943) (mitochondrial DNA depletion syndrome 15 (hepatocerebral type);), [MONDO:0014944](http://purl.obolibrary.org/obo/MONDO_0014944) (short stature-brachydactyly-obesity-global developmental delay syndrome), [MONDO:0009580](http://purl.obolibrary.org/obo/MONDO_0009580) (mental retardation, autosomal recessive 1), [MONDO:0010572](http://purl.obolibrary.org/obo/MONDO_0010572) (occipital horn syndrome), [MONDO:0008252](http://purl.obolibrary.org/obo/MONDO_0008252) (platelet adenylate cyclase activity), [MONDO:0008253](http://purl.obolibrary.org/obo/MONDO_0008253) (platelet aggregation, spontaneous), [MONDO:0010573](http://purl.obolibrary.org/obo/MONDO_0010573) (cutis verticis gyrata, thyroid aplasia, and mental retardation), [MONDO:0010570](http://purl.obolibrary.org/obo/MONDO_0010570) (craniofrontonasal syndrome), [MONDO:0008254](http://purl.obolibrary.org/obo/MONDO_0008254) (platelet disorder, undefined), [MONDO:0009586](http://purl.obolibrary.org/obo/MONDO_0009586) (mesangial sclerosis, diffuse renal, with ocular abnormalities), [MONDO:0008255](http://purl.obolibrary.org/obo/MONDO_0008255) (platelet factor 3 deficiency), [MONDO:0010571](http://purl.obolibrary.org/obo/MONDO_0010571) (Otopalatodigital syndrome type 2), [MONDO:0009587](http://purl.obolibrary.org/obo/MONDO_0009587) (Mesoaxial Hexadactyly and cardiac malformation), [MONDO:0008256](http://purl.obolibrary.org/obo/MONDO_0008256) (platelet membrane fluidity), [MONDO:0008257](http://purl.obolibrary.org/obo/MONDO_0008257) (platelet responsiveness to adrenaline, depressed), [MONDO:0008258](http://purl.obolibrary.org/obo/MONDO_0008258) (platelet signal processing defect), [MONDO:0013608](http://purl.obolibrary.org/obo/MONDO_0013608) (Joubert syndrome 13), [MONDO:0013609](http://purl.obolibrary.org/obo/MONDO_0013609) (Meckel syndrome, type 10), [MONDO:0010576](http://purl.obolibrary.org/obo/MONDO_0010576) (X-linked mixed deafness with perilymphatic gusher), [MONDO:0013603](http://purl.obolibrary.org/obo/MONDO_0013603) (MYP20), [MONDO:0014934](http://purl.obolibrary.org/obo/MONDO_0014934) (spinocerebellar ataxia, autosomal recessive 24; SCAR24), [MONDO:0010577](http://purl.obolibrary.org/obo/MONDO_0010577) (deafness, X-linked 1), [MONDO:0013604](http://purl.obolibrary.org/obo/MONDO_0013604) (myopia 21, autosomal dominant), [MONDO:0014935](http://purl.obolibrary.org/obo/MONDO_0014935) (Frontometaphyseal dysplasia 2; FMD2), [MONDO:0010574](http://purl.obolibrary.org/obo/MONDO_0010574) (syndromic X-linked intellectual disability 5), [MONDO:0014936](http://purl.obolibrary.org/obo/MONDO_0014936) (Tokita-Kim syndrome; TOKIMS), [MONDO:0013606](http://purl.obolibrary.org/obo/MONDO_0013606) (Hermansky-Pudlak syndrome 9), [MONDO:0014930](http://purl.obolibrary.org/obo/MONDO_0014930) (mental retardation, autosomal recessive 56; MRT56), [MONDO:0014931](http://purl.obolibrary.org/obo/MONDO_0014931) (Alazami-Yuan syndrome; ALYUS), [MONDO:0010578](http://purl.obolibrary.org/obo/MONDO_0010578) (deafness dystonia syndrome), [MONDO:0013601](http://purl.obolibrary.org/obo/MONDO_0013601) (GPXD), [MONDO:0014932](http://purl.obolibrary.org/obo/MONDO_0014932) (orofaciodigital syndrome XV), [MONDO:0014933](http://purl.obolibrary.org/obo/MONDO_0014933) (epileptic encephalopathy, early infantile, 44; EIEE44), [MONDO:0008240](http://purl.obolibrary.org/obo/MONDO_0008240) (6-Phosphogluconolactonase deficiency), [MONDO:0009571](http://purl.obolibrary.org/obo/MONDO_0009571) (Meckel syndrome, type 1), [MONDO:0010561](http://purl.obolibrary.org/obo/MONDO_0010561) (Coffin-Lowry syndrome), [MONDO:0009572](http://purl.obolibrary.org/obo/MONDO_0009572) (autosomal recessive familial Mediterranean fever), [MONDO:0008241](http://purl.obolibrary.org/obo/MONDO_0008241) (Phosphoglycoprotein 1), [MONDO:0011893](http://purl.obolibrary.org/obo/MONDO_0011893) (autosomal dominant nonsyndromic deafness 52), [MONDO:0011892](http://purl.obolibrary.org/obo/MONDO_0011892) (epilepsy, idiopathic generalized, susceptibility to, 9), [MONDO:0009573](http://purl.obolibrary.org/obo/MONDO_0009573) (megaepiphyseal dwarfism), [MONDO:0008242](http://purl.obolibrary.org/obo/MONDO_0008242) (photomyoclonus, diabetes mellitus, deafness, nephropathy, and cerebral dysfunction), [MONDO:0009574](http://purl.obolibrary.org/obo/MONDO_0009574) (megalencephaly with dysmyelination), [MONDO:0009575](http://purl.obolibrary.org/obo/MONDO_0009575) (thiamine-responsive megaloblastic anemia syndrome), [MONDO:0008244](http://purl.obolibrary.org/obo/MONDO_0008244) (piebaldism), [MONDO:0010560](http://purl.obolibrary.org/obo/MONDO_0010560) (cleft palate with or without ankyloglossia, X-linked), [MONDO:0009576](http://purl.obolibrary.org/obo/MONDO_0009576) (megalocornea (disease)), [MONDO:0008248](http://purl.obolibrary.org/obo/MONDO_0008248) (pigmented purpuric eruption), [MONDO:0008249](http://purl.obolibrary.org/obo/MONDO_0008249) (Pilonidal sinus (disease)), [MONDO:0014927](http://purl.obolibrary.org/obo/MONDO_0014927) (Joubert syndrome 27), [MONDO:0014928](http://purl.obolibrary.org/obo/MONDO_0014928) (Joubert syndrome 28), [MONDO:0014923](http://purl.obolibrary.org/obo/MONDO_0014923) (peeling skin syndrome 5; PSS5), [MONDO:0010565](http://purl.obolibrary.org/obo/MONDO_0010565) (red color blindness), [MONDO:0010566](http://purl.obolibrary.org/obo/MONDO_0010566) (X-linked cone-rod dystrophy 1), [MONDO:0014924](http://purl.obolibrary.org/obo/MONDO_0014924) (epilepsy, familial focal, with variable foci 2; FFEVF2), [MONDO:0014925](http://purl.obolibrary.org/obo/MONDO_0014925) (epilepsy, familial focal, with variable foci 3; FFEVF3), [MONDO:0010564](http://purl.obolibrary.org/obo/MONDO_0010564) (red-green color blindness), [MONDO:0014926](http://purl.obolibrary.org/obo/MONDO_0014926) (Bardet-Biedl syndrome 20; BBS20), [MONDO:0010569](http://purl.obolibrary.org/obo/MONDO_0010569) (X-linked complicated corpus callosum dysgenesis), [MONDO:0010567](http://purl.obolibrary.org/obo/MONDO_0010567) (cone dystrophy, X-linked, with Tapetal-like sheen), [MONDO:0014921](http://purl.obolibrary.org/obo/MONDO_0014921) (epileptic encephalopathy, early infantile, 43; EIEE43), [MONDO:0010568](http://purl.obolibrary.org/obo/MONDO_0010568) (Aicardi syndrome), [MONDO:0011898](http://purl.obolibrary.org/obo/MONDO_0011898) (Charcot-Marie-tooth disease, axonal, with vocal cord paresis, autosomal recessive), [MONDO:0017189](http://purl.obolibrary.org/obo/MONDO_0017189) (adult-onset non-insulinoma persistent hyperinsulinemic hypoglycemia), [MONDO:0011882](http://purl.obolibrary.org/obo/MONDO_0011882) (skin fragility-woolly hair-palmoplantar keratoderma syndrome), [MONDO:0008230](http://purl.obolibrary.org/obo/MONDO_0008230) (Peroxidase, salivary), [MONDO:0009561](http://purl.obolibrary.org/obo/MONDO_0009561) (alpha-mannosidosis), [MONDO:0010550](http://purl.obolibrary.org/obo/MONDO_0010550) (Charcot-Marie-tooth disease X-linked recessive 2), [MONDO:0009562](http://purl.obolibrary.org/obo/MONDO_0009562) (beta-mannosidosis), [MONDO:0017188](http://purl.obolibrary.org/obo/MONDO_0017188) (Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency), [MONDO:0008231](http://purl.obolibrary.org/obo/MONDO_0008231) (Peyronie's disease), [MONDO:0010551](http://purl.obolibrary.org/obo/MONDO_0010551) (Charcot-Marie-tooth disease X-linked recessive 3), [MONDO:0011881](http://purl.obolibrary.org/obo/MONDO_0011881) (keratosis palmoplantaris striata 3), [MONDO:0009563](http://purl.obolibrary.org/obo/MONDO_0009563) (maple syrup urine disease), [MONDO:0008232](http://purl.obolibrary.org/obo/MONDO_0008232) (Phagocytosis, plasma-related defect 1N), [MONDO:0009564](http://purl.obolibrary.org/obo/MONDO_0009564) (Marden-Walker syndrome), [MONDO:0017185](http://purl.obolibrary.org/obo/MONDO_0017185) (autosomal dominant hyperinsulinism due to Kir6.2 deficiency), [MONDO:0008234](http://purl.obolibrary.org/obo/MONDO_0008234) (multiple endocrine neoplasia type 2A), [MONDO:0008235](http://purl.obolibrary.org/obo/MONDO_0008235) (pheochromocytoma--islet cell tumor syndrome), [MONDO:0017184](http://purl.obolibrary.org/obo/MONDO_0017184) (autosomal dominant hyperinsulinism due to SUR1 deficiency), [MONDO:0009567](http://purl.obolibrary.org/obo/MONDO_0009567) (Marinesco-SjC6gren syndrome), [MONDO:0017187](http://purl.obolibrary.org/obo/MONDO_0017187) (Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency), [MONDO:0008236](http://purl.obolibrary.org/obo/MONDO_0008236) (phlebectasia of lips), [MONDO:0017186](http://purl.obolibrary.org/obo/MONDO_0017186) (Diazoxide-resistant hyperinsulinism), [MONDO:0008238](http://purl.obolibrary.org/obo/MONDO_0008238) (phosphatase, acid, of tissues), [MONDO:0008239](http://purl.obolibrary.org/obo/MONDO_0008239) (Phosphoglucomutase 4), [MONDO:0017183](http://purl.obolibrary.org/obo/MONDO_0017183) (hyperinsulinism due to UCP2 deficiency), [MONDO:0017182](http://purl.obolibrary.org/obo/MONDO_0017182) (familial hyperinsulinism), [MONDO:0014916](http://purl.obolibrary.org/obo/MONDO_0014916) (epileptic encephalopathy, early infantile, 41; EIEE41), [MONDO:0014917](http://purl.obolibrary.org/obo/MONDO_0014917) (epileptic encephalopathy, early infantile, 42; EIEE42), [MONDO:0014918](http://purl.obolibrary.org/obo/MONDO_0014918) (Thauvin-Robinet-Faivre syndrome; TROFAS), [MONDO:0014919](http://purl.obolibrary.org/obo/MONDO_0014919) (Sessile Serrated polyposis cancer syndrome; SSPCS), [MONDO:0014912](http://purl.obolibrary.org/obo/MONDO_0014912) (otulipenia), [MONDO:0010555](http://purl.obolibrary.org/obo/MONDO_0010555) (X-linked chondrodysplasia punctata 1), [MONDO:0014913](http://purl.obolibrary.org/obo/MONDO_0014913) (familial adenomatous polyposis 4; FAP4), [MONDO:0014914](http://purl.obolibrary.org/obo/MONDO_0014914) (Dias-Logan syndrome; DILOS), [MONDO:0011884](http://purl.obolibrary.org/obo/MONDO_0011884) (hypotrichosis-osteolysis-periodontitis-palmoplantar keratoderma syndrome), [MONDO:0010552](http://purl.obolibrary.org/obo/MONDO_0010552) (Charcot-Marie-tooth peroneal muscular atrophy, X-linked, with aplasia cutis congenita), [MONDO:0011883](http://purl.obolibrary.org/obo/MONDO_0011883) (curly hair-acral keratoderma-caries syndrome), [MONDO:0014915](http://purl.obolibrary.org/obo/MONDO_0014915) (short-rib thoracic dysplasia 16 with or without polydactyly; SRTD16), [MONDO:0010553](http://purl.obolibrary.org/obo/MONDO_0010553) (Charcot-Marie-tooth peroneal muscular atrophy and Friedreich ataxia, combined), [MONDO:0010558](http://purl.obolibrary.org/obo/MONDO_0010558) (choroideremia-deafness-obesity syndrome), [MONDO:0010559](http://purl.obolibrary.org/obo/MONDO_0010559) (MASA syndrome), [MONDO:0010556](http://purl.obolibrary.org/obo/MONDO_0010556) (X-linked chondrodysplasia punctata), [MONDO:0014910](http://purl.obolibrary.org/obo/MONDO_0014910) (primary ciliary dyskinesia 35), [MONDO:0014911](http://purl.obolibrary.org/obo/MONDO_0014911) (growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy; GRIDHH), [MONDO:0010557](http://purl.obolibrary.org/obo/MONDO_0010557) (choroideremia), [MONDO:0011887](http://purl.obolibrary.org/obo/MONDO_0011887) (cataract, congenital, with mental impairment and Dentate gyrus atrophy), [MONDO:0014981](http://purl.obolibrary.org/obo/MONDO_0014981) (immunodeficiency 49; IMD49), [MONDO:0013651](http://purl.obolibrary.org/obo/MONDO_0013651) (mental retardation, autosomal recessive 18), [MONDO:0014982](http://purl.obolibrary.org/obo/MONDO_0014982) (myopia 25, autosomal dominant; MYP25), [MONDO:0014984](http://purl.obolibrary.org/obo/MONDO_0014984) (lung disease, immunodeficiency, and chromosome breakage syndrome;), [MONDO:0014980](http://purl.obolibrary.org/obo/MONDO_0014980) (cone-rod dystrophy and hearing loss; CRDHL), [MONDO:0001664](http://purl.obolibrary.org/obo/MONDO_0001664) (submucous uterine fibroid), [MONDO:0013658](http://purl.obolibrary.org/obo/MONDO_0013658) (mental retardation, autosomal dominant 11), [MONDO:0012326](http://purl.obolibrary.org/obo/MONDO_0012326) (autosomal recessive nonsyndromic deafness 42), [MONDO:0012325](http://purl.obolibrary.org/obo/MONDO_0012325) (Nguyen syndrome), [MONDO:0012323](http://purl.obolibrary.org/obo/MONDO_0012323) (lethal acantholytic epidermolysis bullosa), [MONDO:0014985](http://purl.obolibrary.org/obo/MONDO_0014985) (Fanconi anemia complementation group v), [MONDO:0013655](http://purl.obolibrary.org/obo/MONDO_0013655) (mental retardation, autosomal dominant 8), [MONDO:0012329](http://purl.obolibrary.org/obo/MONDO_0012329) (short stature and Facioauriculothoracic malformations), [MONDO:0014986](http://purl.obolibrary.org/obo/MONDO_0014986) (Fanconi anemia complementation group r), [MONDO:0013656](http://purl.obolibrary.org/obo/MONDO_0013656) (mental retardation, autosomal dominant 9), [MONDO:0012328](http://purl.obolibrary.org/obo/MONDO_0012328) (trichilemmal cyst), [MONDO:0014987](http://purl.obolibrary.org/obo/MONDO_0014987) (Fanconi anemia complementation group U), [MONDO:0013657](http://purl.obolibrary.org/obo/MONDO_0013657) (mental retardation, autosomal dominant 10), [MONDO:0014988](http://purl.obolibrary.org/obo/MONDO_0014988) (3-methylglutaconic aciduria, type Viii; MGCA8), [MONDO:0012327](http://purl.obolibrary.org/obo/MONDO_0012327) (autosomal recessive nonsyndromic deafness 46), [MONDO:0008292](http://purl.obolibrary.org/obo/MONDO_0008292) (punctate palmoplantar keratoderma type 2), [MONDO:0014971](http://purl.obolibrary.org/obo/MONDO_0014971) (amelogenesis imperfecta, hypomaturation type, Iia6; AI2A6), [MONDO:0013641](http://purl.obolibrary.org/obo/MONDO_0013641) (Warburg micro syndrome 2), [MONDO:0014972](http://purl.obolibrary.org/obo/MONDO_0014972) (chromosome 19q13.11 deletion syndrome, proximal), [MONDO:0008294](http://purl.obolibrary.org/obo/MONDO_0008294) (acute intermittent porphyria), [MONDO:0008295](http://purl.obolibrary.org/obo/MONDO_0008295) (sporadic porphyria cutanea tarda), [MONDO:0014973](http://purl.obolibrary.org/obo/MONDO_0014973) (sudden cardiac failure, infantile; SCFI), [MONDO:0012311](http://purl.obolibrary.org/obo/MONDO_0012311) (Spondylomegaepiphyseal dysplasia with upper limb Mesomelia, punctate calcifications, and deafness), [MONDO:0008296](http://purl.obolibrary.org/obo/MONDO_0008296) (familial porphyria cutanea tarda), [MONDO:0008297](http://purl.obolibrary.org/obo/MONDO_0008297) (variegate porphyria), [MONDO:0008299](http://purl.obolibrary.org/obo/MONDO_0008299) (posterior column ataxia), [MONDO:0001676](http://purl.obolibrary.org/obo/MONDO_0001676) (erythropoietic protoporphyria), [MONDO:0014978](http://purl.obolibrary.org/obo/MONDO_0014978) (preimplantation embryonic lethality 2; PREMBL2), [MONDO:0012315](http://purl.obolibrary.org/obo/MONDO_0012315) (distal 10q deletion syndrome), [MONDO:0013647](http://purl.obolibrary.org/obo/MONDO_0013647) (primary microcephaly-epilepsy-permanent neonatal diabetes syndrome), [MONDO:0014979](http://purl.obolibrary.org/obo/MONDO_0014979) (myoclonus, intractable, neonatal; NEIMY), [MONDO:0014974](http://purl.obolibrary.org/obo/MONDO_0014974) (sudden cardiac failure, alcohol-induced; SCFAI), [MONDO:0013643](http://purl.obolibrary.org/obo/MONDO_0013643) (HNFJ3), [MONDO:0012319](http://purl.obolibrary.org/obo/MONDO_0012319) (MAFD3), [MONDO:0014976](http://purl.obolibrary.org/obo/MONDO_0014976) (lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome), [MONDO:0013645](http://purl.obolibrary.org/obo/MONDO_0013645) (autosomal recessive spinocerebellar ataxia 11), [MONDO:0014977](http://purl.obolibrary.org/obo/MONDO_0014977) (muscular dystrophy, limb-girdle, type 2z; LGMD2Z), [MONDO:0013646](http://purl.obolibrary.org/obo/MONDO_0013646) (chromosome 8q21.11 deletion syndrome), [MONDO:0008281](http://purl.obolibrary.org/obo/MONDO_0008281) (polyposis, intestinal, Scattered and discrete), [MONDO:0014960](http://purl.obolibrary.org/obo/MONDO_0014960) (encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy; PEBEL), [MONDO:0008282](http://purl.obolibrary.org/obo/MONDO_0008282) (polyposis, intestinal, with multiple exostoses), [MONDO:0008283](http://purl.obolibrary.org/obo/MONDO_0008283) (Cronkhite-Canada syndrome), [MONDO:0013630](http://purl.obolibrary.org/obo/MONDO_0013630) (Meckel syndrome, type 9), [MONDO:0008284](http://purl.obolibrary.org/obo/MONDO_0008284) (polyposis of gastric fundus without Polyposis coli), [MONDO:0014962](http://purl.obolibrary.org/obo/MONDO_0014962) (mental retardation, autosomal recessive 57; MRT57), [MONDO:0008285](http://purl.obolibrary.org/obo/MONDO_0008285) (polyps, multiple and recurrent inflammatory fibroid, gastrointestinal), [MONDO:0008288](http://purl.obolibrary.org/obo/MONDO_0008288) (popliteal cyst), [MONDO:0008289](http://purl.obolibrary.org/obo/MONDO_0008289) (porencephaly 1), [MONDO:0014967](http://purl.obolibrary.org/obo/MONDO_0014967) (heterotaxy, visceral, 8, autosomal; HTX8), [MONDO:0014968](http://purl.obolibrary.org/obo/MONDO_0014968) (encephalopathy, progressive, with amyotrophy and optic atrophy; PEAMO), [MONDO:0013638](http://purl.obolibrary.org/obo/MONDO_0013638) (Warburg micro syndrome 3), [MONDO:0014969](http://purl.obolibrary.org/obo/MONDO_0014969) (isolated sedoheptulokinase deficiency), [MONDO:0012301](http://purl.obolibrary.org/obo/MONDO_0012301) (mitochondrial dna depletion syndrome, myopathic form), [MONDO:0013632](http://purl.obolibrary.org/obo/MONDO_0013632) (autosomal dominant nonsyndromic deafness 33), [MONDO:0012308](http://purl.obolibrary.org/obo/MONDO_0012308) (Joubert syndrome 4), [MONDO:0014963](http://purl.obolibrary.org/obo/MONDO_0014963) (Shashi-Pena syndrome; SHAPNS), [MONDO:0014964](http://purl.obolibrary.org/obo/MONDO_0014964) (encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum; PEBAT), [MONDO:0012306](http://purl.obolibrary.org/obo/MONDO_0012306) (cardiomyopathy, familial restrictive, 2), [MONDO:0013634](http://purl.obolibrary.org/obo/MONDO_0013634) (neuropathy, hereditary sensory, type 2C), [MONDO:0008291](http://purl.obolibrary.org/obo/MONDO_0008291) (porokeratosis plantaris palmaris et disseminata), [MONDO:0010590](http://purl.obolibrary.org/obo/MONDO_0010590) (FG syndrome 1), [MONDO:0014951](http://purl.obolibrary.org/obo/MONDO_0014951) (Sotos syndrome 3; SOTOS3), [MONDO:0008274](http://purl.obolibrary.org/obo/MONDO_0008274) (polyostotic fibrous dysplasia), [MONDO:0010594](http://purl.obolibrary.org/obo/MONDO_0010594) (genitourinary tract anomalies (disease)), [MONDO:0010592](http://purl.obolibrary.org/obo/MONDO_0010592) (focal dermal hypoplasia), [MONDO:0008276](http://purl.obolibrary.org/obo/MONDO_0008276) (generalized juvenile polyposis/juvenile polyposis coli), [MONDO:0008277](http://purl.obolibrary.org/obo/MONDO_0008277) (polyposis, gastric), [MONDO:0008278](http://purl.obolibrary.org/obo/MONDO_0008278) (juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome), [MONDO:0013629](http://purl.obolibrary.org/obo/MONDO_0013629) (MRT16), [MONDO:0010598](http://purl.obolibrary.org/obo/MONDO_0010598) (glycogen storage disease IXa), [MONDO:0014956](http://purl.obolibrary.org/obo/MONDO_0014956) (Chitayat syndrome; CHYTS), [MONDO:0013626](http://purl.obolibrary.org/obo/MONDO_0013626) (psoriasis 14, pustular), [MONDO:0010599](http://purl.obolibrary.org/obo/MONDO_0010599) (granulomas, congenital cerebral), [MONDO:0014957](http://purl.obolibrary.org/obo/MONDO_0014957) (language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia; LADCI), [MONDO:0013627](http://purl.obolibrary.org/obo/MONDO_0013627) (three M syndrome 3), [MONDO:0014958](http://purl.obolibrary.org/obo/MONDO_0014958) (Harel-Yoon syndrome; HAYOS), [MONDO:0013628](http://purl.obolibrary.org/obo/MONDO_0013628) (hyperphosphatasia with mental retardation syndrome 3), [MONDO:0010597](http://purl.obolibrary.org/obo/MONDO_0010597) (Glutamyl Ribose-5-phosphate storage disease), [MONDO:0014959](http://purl.obolibrary.org/obo/MONDO_0014959) (mitochondrial DNA depletion syndrome 12a (cardiomyopathic type), autosomal dominant; MTDPS12A), [MONDO:0014953](http://purl.obolibrary.org/obo/MONDO_0014953) (intellectual developmental disorder with cardiac arrhythmia; IDDCA), [MONDO:0008280](http://purl.obolibrary.org/obo/MONDO_0008280) (Peutz-Jeghers syndrome), [MONDO:0013624](http://purl.obolibrary.org/obo/MONDO_0013624) (mental retardation, autosomal recessive 15), [MONDO:0012362](http://purl.obolibrary.org/obo/MONDO_0012362) (dilated cardiomyopathy 1P), [MONDO:0013694](http://purl.obolibrary.org/obo/MONDO_0013694) (MRT31), [MONDO:0011031](http://purl.obolibrary.org/obo/MONDO_0011031) (autosomal dominant nonsyndromic deafness 10), [MONDO:0013695](http://purl.obolibrary.org/obo/MONDO_0013695) (colorectal cancer, hereditary nonpolyposis, type 6), [MONDO:0011030](http://purl.obolibrary.org/obo/MONDO_0011030) (epithelial Basolateral chloride Conductance Regulator, rabbit, Homolog of), [MONDO:0013696](http://purl.obolibrary.org/obo/MONDO_0013696) (chromosome 2P16.3 deletion syndrome), [MONDO:0013697](http://purl.obolibrary.org/obo/MONDO_0013697) (MRT29), [MONDO:0012366](http://purl.obolibrary.org/obo/MONDO_0012366) (GBD3), [MONDO:0013691](http://purl.obolibrary.org/obo/MONDO_0013691) (Feingold syndrome type 2), [MONDO:0012365](http://purl.obolibrary.org/obo/MONDO_0012365) (GBD2), [MONDO:0012364](http://purl.obolibrary.org/obo/MONDO_0012364) (dilated cardiomyopathy 1Q), [MONDO:0013692](http://purl.obolibrary.org/obo/MONDO_0013692) (BAP1-related tumor predisposition syndrome), [MONDO:0011032](http://purl.obolibrary.org/obo/MONDO_0011032) (autosomal dominant nonsyndromic deafness 11), [MONDO:0004739](http://purl.obolibrary.org/obo/MONDO_0004739) (urea cycle disorder), [MONDO:0004737](http://purl.obolibrary.org/obo/MONDO_0004737) (homocystinuria (disease)), [MONDO:0004738](http://purl.obolibrary.org/obo/MONDO_0004738) (histidine metabolism disease), [MONDO:0004736](http://purl.obolibrary.org/obo/MONDO_0004736) (amino acid metabolic disorder), [MONDO:0011039](http://purl.obolibrary.org/obo/MONDO_0011039) (atrophia maculosa varioliformis cutis, familial), [MONDO:0011038](http://purl.obolibrary.org/obo/MONDO_0011038) (cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome), [MONDO:0011037](http://purl.obolibrary.org/obo/MONDO_0011037) (renal dysplasia, cystic, susceptibility to), [MONDO:0012368](http://purl.obolibrary.org/obo/MONDO_0012368) (neurological conditions associated with aminoacylase 1 deficiency), [MONDO:0013699](http://purl.obolibrary.org/obo/MONDO_0013699) (colorectal cancer, hereditary nonpolyposis, type 4), [MONDO:0013683](http://purl.obolibrary.org/obo/MONDO_0013683) (VUR5), [MONDO:0012351](http://purl.obolibrary.org/obo/MONDO_0012351) (Zygodactyly type 1), [MONDO:0013684](http://purl.obolibrary.org/obo/MONDO_0013684) (VUR6), [MONDO:0013685](http://purl.obolibrary.org/obo/MONDO_0013685) (pancreatic cancer, susceptibility to, 4), [MONDO:0011024](http://purl.obolibrary.org/obo/MONDO_0011024) (dermatitis herpetiformis, familial), [MONDO:0012355](http://purl.obolibrary.org/obo/MONDO_0012355) (autosomal recessive nonsyndromic deafness 28), [MONDO:0011023](http://purl.obolibrary.org/obo/MONDO_0011023) (hereditary mixed polyposis syndrome), [MONDO:0013680](http://purl.obolibrary.org/obo/MONDO_0013680) (cognitive impairment with or without cerebellar ataxia), [MONDO:0012353](http://purl.obolibrary.org/obo/MONDO_0012353) (erythrocytosis, familial, 3), [MONDO:0013681](http://purl.obolibrary.org/obo/MONDO_0013681) (alpha-methylacyl-CoA racemase deficiency), [MONDO:0013682](http://purl.obolibrary.org/obo/MONDO_0013682) (VUR4), [MONDO:0012352](http://purl.obolibrary.org/obo/MONDO_0012352) (vasculitis, lymphocytic, cutaneous small vessel), [MONDO:0004743](http://purl.obolibrary.org/obo/MONDO_0004743) (hyperhomocysteinemia), [MONDO:0004741](http://purl.obolibrary.org/obo/MONDO_0004741) (tyrosinemia), [MONDO:0011028](http://purl.obolibrary.org/obo/MONDO_0011028) (autosomal recessive limb-girdle muscular dystrophy type 2F), [MONDO:0012359](http://purl.obolibrary.org/obo/MONDO_0012359) (combined immunodeficiency due to partial RAG1 deficiency), [MONDO:0011027](http://purl.obolibrary.org/obo/MONDO_0011027) (diabetes mellitus, Noninsulin-dependent, 1), [MONDO:0011026](http://purl.obolibrary.org/obo/MONDO_0011026) (autosomal recessive congenital ichthyosis 4A), [MONDO:0012357](http://purl.obolibrary.org/obo/MONDO_0012357) (glaucoma 1, open angle, G), [MONDO:0011025](http://purl.obolibrary.org/obo/MONDO_0011025) (Cayman type cerebellar ataxia), [MONDO:0013687](http://purl.obolibrary.org/obo/MONDO_0013687) (autosomal recessive spinocerebellar ataxia 12), [MONDO:0011029](http://purl.obolibrary.org/obo/MONDO_0011029) (myeloid tumor suppressor), [MONDO:0013672](http://purl.obolibrary.org/obo/MONDO_0013672) (chromosome 15q25 deletion syndrome), [MONDO:0013673](http://purl.obolibrary.org/obo/MONDO_0013673) (Wolfram-like syndrome), [MONDO:0013675](http://purl.obolibrary.org/obo/MONDO_0013675) (multiple mitochondrial dysfunctions syndrome 2), [MONDO:0011013](http://purl.obolibrary.org/obo/MONDO_0011013) (autosomal dominant hypocalcemia 1), [MONDO:0012343](http://purl.obolibrary.org/obo/MONDO_0012343) (AAA2), [MONDO:0011012](http://purl.obolibrary.org/obo/MONDO_0011012) (african iron overload), [MONDO:0012342](http://purl.obolibrary.org/obo/MONDO_0012342) (7q11.23 microduplication syndrome), [MONDO:0000351](http://purl.obolibrary.org/obo/MONDO_0000351) (hypermethioninemia (disease)), [MONDO:0011017](http://purl.obolibrary.org/obo/MONDO_0011017) (Naxos disease), [MONDO:0012348](http://purl.obolibrary.org/obo/MONDO_0012348) (maturity-onset diabetes of the young type 8), [MONDO:0012347](http://purl.obolibrary.org/obo/MONDO_0012347) (hamartoma, Precalcaneal congenital fibrolipomatous), [MONDO:0012345](http://purl.obolibrary.org/obo/MONDO_0012345) (acral peeling skin syndrome), [MONDO:0013676](http://purl.obolibrary.org/obo/MONDO_0013676) (hypermethioninemia due to adenosine kinase deficiency), [MONDO:0013677](http://purl.obolibrary.org/obo/MONDO_0013677) (Emery-Dreifuss muscular dystrophy 7, autosomal dominant), [MONDO:0011018](http://purl.obolibrary.org/obo/MONDO_0011018) (brachyolmia-amelogenesis imperfecta syndrome), [MONDO:0012349](http://purl.obolibrary.org/obo/MONDO_0012349) (spondylocostal dysostosis 3, autosomal recessive), [MONDO:0013661](http://purl.obolibrary.org/obo/MONDO_0013661) (combined malonic and methylmalonic acidemia), [MONDO:0014994](http://purl.obolibrary.org/obo/MONDO_0014994) (global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies; GDACCF), [MONDO:0013663](http://purl.obolibrary.org/obo/MONDO_0013663) (platelet-activating factor Acetylhydrolase deficiency (disease)), [MONDO:0014995](http://purl.obolibrary.org/obo/MONDO_0014995) (neurodevelopmental disorder with hypotonia, seizures, and absent language; NDHSAL), [MONDO:0013664](http://purl.obolibrary.org/obo/MONDO_0013664) (46,XY disorder of sex development due to testicular 17,20-desmolase deficiency), [MONDO:0012333](http://purl.obolibrary.org/obo/MONDO_0012333) (autosomal recessive nonsyndromic deafness 53), [MONDO:0011000](http://purl.obolibrary.org/obo/MONDO_0011000) (guanylate cyclase 2E), [MONDO:0013660](http://purl.obolibrary.org/obo/MONDO_0013660) (arthrogryposis, Perthes disease, and Upward gaze palsy), [MONDO:0014991](http://purl.obolibrary.org/obo/MONDO_0014991) (Seckel syndrome 10; SCKL10), [MONDO:0000366](http://purl.obolibrary.org/obo/MONDO_0000366) (glycogen storage disease IX), [MONDO:0000365](http://purl.obolibrary.org/obo/MONDO_0000365) (primary congenital glaucoma (disease)), [MONDO:0013669](http://purl.obolibrary.org/obo/MONDO_0013669) (breast-ovarian cancer, familial, susceptibility to, 4), [MONDO:0011006](http://purl.obolibrary.org/obo/MONDO_0011006) (hereditary spastic paraplegia 9A), [MONDO:0012337](http://purl.obolibrary.org/obo/MONDO_0012337) (GLC1I), [MONDO:0011005](http://purl.obolibrary.org/obo/MONDO_0011005) (trisomy 18-like syndrome), [MONDO:0012335](http://purl.obolibrary.org/obo/MONDO_0012335) (obesity due to pro-opiomelanocortin deficiency), [MONDO:0011003](http://purl.obolibrary.org/obo/MONDO_0011003) (dilated cardiomyopathy 1E), [MONDO:0012334](http://purl.obolibrary.org/obo/MONDO_0012334) (hereditary spastic paraplegia 29), [MONDO:0014996](http://purl.obolibrary.org/obo/MONDO_0014996) (mental retardation, autosomal recessive 58; MRT58), [MONDO:0013665](http://purl.obolibrary.org/obo/MONDO_0013665) (EJM9), [MONDO:0014997](http://purl.obolibrary.org/obo/MONDO_0014997) (nephronophthisis 20), [MONDO:0011009](http://purl.obolibrary.org/obo/MONDO_0011009) (muscular dystrophy, congenital, with severe central nervous system atrophy and absence of large myelinated fibers), [MONDO:0013666](http://purl.obolibrary.org/obo/MONDO_0013666) (Stickler syndrome, type 5), [MONDO:0014998](http://purl.obolibrary.org/obo/MONDO_0014998) (glaucoma 3, primary congenital, E; GLC3E), [MONDO:0014999](http://purl.obolibrary.org/obo/MONDO_0014999) (tooth agenesis, selective, 9; STHAG9), [MONDO:0013668](http://purl.obolibrary.org/obo/MONDO_0013668) (tetrasomy 18p), [MONDO:0012338](http://purl.obolibrary.org/obo/MONDO_0012338) (EIG4), [MONDO:0014101](http://purl.obolibrary.org/obo/MONDO_0014101) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12), [MONDO:0011074](http://purl.obolibrary.org/obo/MONDO_0011074) (autosomal dominant nonsyndromic deafness 7), [MONDO:0011073](http://purl.obolibrary.org/obo/MONDO_0011073) (diabetes mellitus, transient neonatal, 1), [MONDO:0011072](http://purl.obolibrary.org/obo/MONDO_0011072) (NIDDM2), [MONDO:0014104](http://purl.obolibrary.org/obo/MONDO_0014104) (cerebellar ataxia, mental retardation, and Dysequilibrium syndrome 4), [MONDO:0011078](http://purl.obolibrary.org/obo/MONDO_0011078) (anterior chamber cleavage disorder, cerebellar hypoplasia, hypothyroidism, and tracheal stenosis), [MONDO:0011077](http://purl.obolibrary.org/obo/MONDO_0011077) (microcephaly, corpus callosum dysgenesis, and cleft lip/palate), [MONDO:0011076](http://purl.obolibrary.org/obo/MONDO_0011076) (myofibrillar myopathy 1), [MONDO:0007809](http://purl.obolibrary.org/obo/MONDO_0007809) (ichthyosis hystrix gravior), [MONDO:0007808](http://purl.obolibrary.org/obo/MONDO_0007808) (ichthyosis hystrix of Curth-Macklin), [MONDO:0007807](http://purl.obolibrary.org/obo/MONDO_0007807) (hypoxanthine guanine phosphoribosyltransferase suppressor), [MONDO:0011071](http://purl.obolibrary.org/obo/MONDO_0011071) (hereditary thrombocytopenia with normal platelets-hematological cancer predisposition syndrome), [MONDO:0007800](http://purl.obolibrary.org/obo/MONDO_0007800) (chromosome 18p deletion syndrome), [MONDO:0014109](http://purl.obolibrary.org/obo/MONDO_0014109) (NGLY1-deficiency), [MONDO:0014108](http://purl.obolibrary.org/obo/MONDO_0014108) (Fanconi anemia complementation group Q), [MONDO:0012393](http://purl.obolibrary.org/obo/MONDO_0012393) (congenital brain dysgenesis due to glutamine synthetase deficiency), [MONDO:0011061](http://purl.obolibrary.org/obo/MONDO_0011061) (chorea, remitting, with nystagmus and cataract), [MONDO:0012392](http://purl.obolibrary.org/obo/MONDO_0012392) (2-methylbutyryl-CoA dehydrogenase deficiency), [MONDO:0011067](http://purl.obolibrary.org/obo/MONDO_0011067) (autosomal recessive nonsyndromic deafness 12), [MONDO:0012397](http://purl.obolibrary.org/obo/MONDO_0012397) (brachydactyly, coloboma, and anterior segment dysgenesis), [MONDO:0012396](http://purl.obolibrary.org/obo/MONDO_0012396) (exercise-induced hyperinsulinism), [MONDO:0007818](http://purl.obolibrary.org/obo/MONDO_0007818) (Job's syndrome), [MONDO:0007817](http://purl.obolibrary.org/obo/MONDO_0007817) (Ige responsiveness, atopic), [MONDO:0012391](http://purl.obolibrary.org/obo/MONDO_0012391) (neuronal ceroid lipofuscinosis 8 northern epilepsy variant), [MONDO:0007816](http://purl.obolibrary.org/obo/MONDO_0007816) (immune suppression), [MONDO:0007815](http://purl.obolibrary.org/obo/MONDO_0007815) (immunodeficiency with defective leukocyte and lymphocyte function and With response to Histamine-1 antagonist), [MONDO:0012390](http://purl.obolibrary.org/obo/MONDO_0012390) (arthrogryposis multiplex with deafness, inguinal hernias, and early death), [MONDO:0007814](http://purl.obolibrary.org/obo/MONDO_0007814) (immune deficiency, familial variable), [MONDO:0003458](http://purl.obolibrary.org/obo/MONDO_0003458) (uterine corpus adenofibroma), [MONDO:0007813](http://purl.obolibrary.org/obo/MONDO_0007813) (ichthyosis bullosa of Siemens), [MONDO:0007811](http://purl.obolibrary.org/obo/MONDO_0007811) (ichthyosis-cheek-eyebrow syndrome), [MONDO:0007810](http://purl.obolibrary.org/obo/MONDO_0007810) (ichthyosis vulgaris), [MONDO:0011069](http://purl.obolibrary.org/obo/MONDO_0011069) (cervical ribs, sprengel anomaly, anal atresia, and urethral obstruction), [MONDO:0012384](http://purl.obolibrary.org/obo/MONDO_0012384) (panic disorder 3), [MONDO:0011052](http://purl.obolibrary.org/obo/MONDO_0011052) (ACLH), [MONDO:0012382](http://purl.obolibrary.org/obo/MONDO_0012382) (hyperinsulinemic hypoglycemia, familial, 4), [MONDO:0011051](http://purl.obolibrary.org/obo/MONDO_0011051) (lethal short-limb skeletal dysplasia, Al Gazali type), [MONDO:0012381](http://purl.obolibrary.org/obo/MONDO_0012381) (hyperinsulinism due to INSR deficiency), [MONDO:0012388](http://purl.obolibrary.org/obo/MONDO_0012388) (MYP11), [MONDO:0012387](http://purl.obolibrary.org/obo/MONDO_0012387) (osteosclerosis-ichthyosis-premature ovarian failure syndrome), [MONDO:0011055](http://purl.obolibrary.org/obo/MONDO_0011055) (distal monosomy 10p), [MONDO:0012386](http://purl.obolibrary.org/obo/MONDO_0012386) (Trichoscyphodysplasia), [MONDO:0011054](http://purl.obolibrary.org/obo/MONDO_0011054) (autosomal recessive amelia), [MONDO:0012385](http://purl.obolibrary.org/obo/MONDO_0012385) (metaphyseal chondrodysplasia with cone-shaped epiphyses, normal hair, and Normal hands), [MONDO:0012380](http://purl.obolibrary.org/obo/MONDO_0012380) (autosomal dominant nonsyndromic deafness 53), [MONDO:0011058](http://purl.obolibrary.org/obo/MONDO_0011058) (autosomal dominant nonsyndromic deafness 9), [MONDO:0012389](http://purl.obolibrary.org/obo/MONDO_0012389) (MYP12), [MONDO:0015414](http://purl.obolibrary.org/obo/MONDO_0015414) (paramedian nasal cleft), [MONDO:0012373](http://purl.obolibrary.org/obo/MONDO_0012373) (ectodermal dysplasia, sensorineural hearing loss, and distinctive facial features), [MONDO:0011042](http://purl.obolibrary.org/obo/MONDO_0011042) (Martinez-Frias syndrome), [MONDO:0012372](http://purl.obolibrary.org/obo/MONDO_0012372) (hypertrichosis, hyperkeratosis, mental retardation, and distinctive facial features), [MONDO:0011040](http://purl.obolibrary.org/obo/MONDO_0011040) (spinal dysplasia, Anhalt type), [MONDO:0012371](http://purl.obolibrary.org/obo/MONDO_0012371) (Noonan syndrome 3), [MONDO:0012370](http://purl.obolibrary.org/obo/MONDO_0012370) (autosomal recessive nonsyndromic deafness 51), [MONDO:0012377](http://purl.obolibrary.org/obo/MONDO_0012377) (ASPG4), [MONDO:0012376](http://purl.obolibrary.org/obo/MONDO_0012376) (autosomal recessive nonsyndromic deafness 55), [MONDO:0011044](http://purl.obolibrary.org/obo/MONDO_0011044) (ectrodactyly of lower limbs, congenital heart defect, and micrognathia), [MONDO:0012375](http://purl.obolibrary.org/obo/MONDO_0012375) (autosomal recessive nonsyndromic deafness 47), [MONDO:0012374](http://purl.obolibrary.org/obo/MONDO_0012374) (brachyphalangy, polydactyly, and tibial aplasia/hypoplasia), [MONDO:0011043](http://purl.obolibrary.org/obo/MONDO_0011043) (myelodysplasia, immunodeficiency, facial dysmorphism, short stature, and psychomotor delay), [MONDO:0012379](http://purl.obolibrary.org/obo/MONDO_0012379) (asthma-related Traits, susceptibility to, 3), [MONDO:0011047](http://purl.obolibrary.org/obo/MONDO_0011047) (deafness-epiphyseal dysplasia-short stature syndrome), [MONDO:0014146](http://purl.obolibrary.org/obo/MONDO_0014146) (autosomal dominant hypocalcemia 2), [MONDO:0014147](http://purl.obolibrary.org/obo/MONDO_0014147) (neuronal ceroid lipofuscinosis 13), [MONDO:0018502](http://purl.obolibrary.org/obo/MONDO_0018502) (hereditary gastric cancer), [MONDO:0014142](http://purl.obolibrary.org/obo/MONDO_0014142) (autosomal recessive limb-girdle muscular dystrophy type 2T), [MONDO:0014143](http://purl.obolibrary.org/obo/MONDO_0014143) (Noonan syndrome 8), [MONDO:0014144](http://purl.obolibrary.org/obo/MONDO_0014144) (autosomal recessive limb-girdle muscular dystrophy type 2S), [MONDO:0014140](http://purl.obolibrary.org/obo/MONDO_0014140) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14), [MONDO:0015470](http://purl.obolibrary.org/obo/MONDO_0015470) (familial isolated dilated cardiomyopathy), [MONDO:0007849](http://purl.obolibrary.org/obo/MONDO_0007849) (keratitis fugax hereditaria), [MONDO:0007848](http://purl.obolibrary.org/obo/MONDO_0007848) (autosomal dominant keratitis), [MONDO:0007847](http://purl.obolibrary.org/obo/MONDO_0007847) (Keloid formation), [MONDO:0006510](http://purl.obolibrary.org/obo/MONDO_0006510) (renal tubular transport disease), [MONDO:0007840](http://purl.obolibrary.org/obo/MONDO_0007840) (internal carotid artery, spontaneous dissection of), [MONDO:0018507](http://purl.obolibrary.org/obo/MONDO_0018507) (microcephaly-complex motor and sensory axonal neuropathy syndrome), [MONDO:0016797](http://purl.obolibrary.org/obo/MONDO_0016797) (multiple mitochondrial DNA deletion syndrome), [MONDO:0016796](http://purl.obolibrary.org/obo/MONDO_0016796) (mitochondrial DNA depletion syndrome, encephalomyopathic form), [MONDO:0016799](http://purl.obolibrary.org/obo/MONDO_0016799) (mitochondrial oxidative phosphorylation disorder with no known mechanism), [MONDO:0016798](http://purl.obolibrary.org/obo/MONDO_0016798) (ataxia neuropathy spectrum), [MONDO:0014130](http://purl.obolibrary.org/obo/MONDO_0014130) (Dowling-Degos disease 2), [MONDO:0016793](http://purl.obolibrary.org/obo/MONDO_0016793) (mitochondrial oxidative phosphorylation disorder due to a point mutation of mitochondrial DNA), [MONDO:0014131](http://purl.obolibrary.org/obo/MONDO_0014131) (hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome), [MONDO:0016792](http://purl.obolibrary.org/obo/MONDO_0016792) (mitochondrial oxidative phosphorylation disorder due to a large-scale single deletion of mitochondrial DNA), [MONDO:0016795](http://purl.obolibrary.org/obo/MONDO_0016795) (mitochondrial oxidative phosphorylation disorder due to a duplication of mitochondrial DNA), [MONDO:0014132](http://purl.obolibrary.org/obo/MONDO_0014132) (multiple mitochondrial dysfunctions syndrome 3), [MONDO:0014133](http://purl.obolibrary.org/obo/MONDO_0014133) (epileptic encephalopathy, early infantile, 16), [MONDO:0016794](http://purl.obolibrary.org/obo/MONDO_0016794) (maternally-inherited mitochondrial myopathy), [MONDO:0016791](http://purl.obolibrary.org/obo/MONDO_0016791) (mitochondrial oxidative phosphorylation disorder due to mitochondrial DNA anomalies), [MONDO:0016790](http://purl.obolibrary.org/obo/MONDO_0016790) (tricarboxylic acid cycle disorder), [MONDO:0007859](http://purl.obolibrary.org/obo/MONDO_0007859) (palmoplantar keratoderma i, striate, focal, or diffuse), [MONDO:0007858](http://purl.obolibrary.org/obo/MONDO_0007858) (palmoplantar keratoderma, punctate type 1A), [MONDO:0007857](http://purl.obolibrary.org/obo/MONDO_0007857) (keratosis palmaris et plantaris-clinodactyly syndrome), [MONDO:0007856](http://purl.obolibrary.org/obo/MONDO_0007856) (palmoplantar keratoderma-esophageal carcinoma syndrome), [MONDO:0007855](http://purl.obolibrary.org/obo/MONDO_0007855) (keratosis, familial actinic), [MONDO:0007853](http://purl.obolibrary.org/obo/MONDO_0007853) (keratoderma, palmoplantar, with nail dystrophy and hereditary motor-sensory neuropathy), [MONDO:0007852](http://purl.obolibrary.org/obo/MONDO_0007852) (palmoplantar keratoderma-deafness syndrome), [MONDO:0007850](http://purl.obolibrary.org/obo/MONDO_0007850) (autosomal dominant keratitis-ichthyosis-deafness syndrome), [MONDO:0014139](http://purl.obolibrary.org/obo/MONDO_0014139) (Ehlers-Danlos syndrome, progeroid type, 2), [MONDO:0014123](http://purl.obolibrary.org/obo/MONDO_0014123) (primary ciliary dyskinesia 21), [MONDO:0011097](http://purl.obolibrary.org/obo/MONDO_0011097) (Axenfeld-Rieger syndrome type 2), [MONDO:0015454](http://purl.obolibrary.org/obo/MONDO_0015454) (multiple carboxylase deficiency), [MONDO:0011095](http://purl.obolibrary.org/obo/MONDO_0011095) (dilated cardiomyopathy 1D), [MONDO:0014125](http://purl.obolibrary.org/obo/MONDO_0014125) (symphalangism, proximal, 1B), [MONDO:0014126](http://purl.obolibrary.org/obo/MONDO_0014126) (Perrault syndrome 4), [MONDO:0011094](http://purl.obolibrary.org/obo/MONDO_0011094) (dilated cardiomyopathy 1C), [MONDO:0016782](http://purl.obolibrary.org/obo/MONDO_0016782) (paternal 14q32.2 hypomethylation syndrome), [MONDO:0014120](http://purl.obolibrary.org/obo/MONDO_0014120) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13), [MONDO:0014121](http://purl.obolibrary.org/obo/MONDO_0014121) (autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures), [MONDO:0011099](http://purl.obolibrary.org/obo/MONDO_0011099) (Athabaskan brainstem dysgenesis syndrome), [MONDO:0016780](http://purl.obolibrary.org/obo/MONDO_0016780) (paternal 14q32.2 microdeletion syndrome), [MONDO:0007828](http://purl.obolibrary.org/obo/MONDO_0007828) (indifference to pain, congenital, autosomal dominant), [MONDO:0011093](http://purl.obolibrary.org/obo/MONDO_0011093) (mucopolysaccharidosis type 9), [MONDO:0011092](http://purl.obolibrary.org/obo/MONDO_0011092) (Ribbing disease), [MONDO:0007826](http://purl.obolibrary.org/obo/MONDO_0007826) (incisors, Shovel-shaped), [MONDO:0007825](http://purl.obolibrary.org/obo/MONDO_0007825) (incisors, Rotation of upper central), [MONDO:0007824](http://purl.obolibrary.org/obo/MONDO_0007824) (incisors, lower central, absence of), [MONDO:0007823](http://purl.obolibrary.org/obo/MONDO_0007823) (insulin receptors, familial Increase 1N), [MONDO:0007822](http://purl.obolibrary.org/obo/MONDO_0007822) (incisors, long upper central), [MONDO:0007821](http://purl.obolibrary.org/obo/MONDO_0007821) (immunoglobulin Switch sequences), [MONDO:0007820](http://purl.obolibrary.org/obo/MONDO_0007820) (fused mandibular incisors), [MONDO:0014127](http://purl.obolibrary.org/obo/MONDO_0014127) (oculocutaneous albinism type 5), [MONDO:0016789](http://purl.obolibrary.org/obo/MONDO_0016789) (pyruvate metabolism disorder), [MONDO:0014129](http://purl.obolibrary.org/obo/MONDO_0014129) (autosomal recessive limb-girdle muscular dystrophy type 2R), [MONDO:0011086](http://purl.obolibrary.org/obo/MONDO_0011086) (severe combined immunodeficiency, autosomal recessive, T cell-negative, b cell-negative, Nk cell-positive), [MONDO:0011084](http://purl.obolibrary.org/obo/MONDO_0011084) (PSORS3), [MONDO:0015446](http://purl.obolibrary.org/obo/MONDO_0015446) (atypical coarctation of aorta), [MONDO:0019800](http://purl.obolibrary.org/obo/MONDO_0019800) (chronic hepatic porphyria), [MONDO:0015445](http://purl.obolibrary.org/obo/MONDO_0015445) (autosomal dominant coarctation of aorta), [MONDO:0011089](http://purl.obolibrary.org/obo/MONDO_0011089) (patent ductus venosus), [MONDO:0015442](http://purl.obolibrary.org/obo/MONDO_0015442) (hereditary breast and ovarian cancer syndrome), [MONDO:0006507](http://purl.obolibrary.org/obo/MONDO_0006507) (hereditary hemochromatosis), [MONDO:0011080](http://purl.obolibrary.org/obo/MONDO_0011080) (progressive deafness with stapes fixation), [MONDO:0007835](http://purl.obolibrary.org/obo/MONDO_0007835) (intussusception), [MONDO:0007834](http://purl.obolibrary.org/obo/MONDO_0007834) (islet cell adenomatosis), [MONDO:0007833](http://purl.obolibrary.org/obo/MONDO_0007833) (iris pigment layer, cleavage of), [MONDO:0007832](http://purl.obolibrary.org/obo/MONDO_0007832) (interferon Antiviral depressor), [MONDO:0007831](http://purl.obolibrary.org/obo/MONDO_0007831) (Insect Stings, hypersensitivity to), [MONDO:0007830](http://purl.obolibrary.org/obo/MONDO_0007830) (insensitivity to pain with hyperplastic Myelinopathy), [MONDO:0014116](http://purl.obolibrary.org/obo/MONDO_0014116) (complex cortical dysplasia with other brain malformations 2), [MONDO:0015448](http://purl.obolibrary.org/obo/MONDO_0015448) (isolated CoQ-cytochrome c reductase deficiency), [MONDO:0014189](http://purl.obolibrary.org/obo/MONDO_0014189) (age related macular degeneration 13), [MONDO:0017214](http://purl.obolibrary.org/obo/MONDO_0017214) (vitamin B12-responsive methylmalonic acidemia), [MONDO:0017216](http://purl.obolibrary.org/obo/MONDO_0017216) (calciphylaxis cutis), [MONDO:0014185](http://purl.obolibrary.org/obo/MONDO_0014185) (chromosome 3q13.31 deletion syndrome), [MONDO:0018543](http://purl.obolibrary.org/obo/MONDO_0018543) (autosomal dominant hypocalcemia), [MONDO:0019875](http://purl.obolibrary.org/obo/MONDO_0019875) (Beckwith-Wiedemann syndrome due to 11p15 microduplication), [MONDO:0018544](http://purl.obolibrary.org/obo/MONDO_0018544) (X-linked adrenoleukodystrophy), [MONDO:0019873](http://purl.obolibrary.org/obo/MONDO_0019873) (4p16.3 microduplication syndrome), [MONDO:0014181](http://purl.obolibrary.org/obo/MONDO_0014181) (amyotrophic lateral sclerosis type 20), [MONDO:0014182](http://purl.obolibrary.org/obo/MONDO_0014182) (autosomal recessive nonsyndromic deafness 88), [MONDO:0014184](http://purl.obolibrary.org/obo/MONDO_0014184) (language impairment (disease)), [MONDO:0014180](http://purl.obolibrary.org/obo/MONDO_0014180) (epidermolysis bullosa simplex due to BP230 deficiency), [MONDO:0011916](http://purl.obolibrary.org/obo/MONDO_0011916) (Charcot-Marie-tooth disease axonal type 2K), [MONDO:0007889](http://purl.obolibrary.org/obo/MONDO_0007889) (lentigines), [MONDO:0007888](http://purl.obolibrary.org/obo/MONDO_0007888) (hereditary leiomyomatosis and renal cell cancer), [MONDO:0011915](http://purl.obolibrary.org/obo/MONDO_0011915) (MMVP2), [MONDO:0007886](http://purl.obolibrary.org/obo/MONDO_0007886) (uterine corpus leiomyoma), [MONDO:0007884](http://purl.obolibrary.org/obo/MONDO_0007884) (leg ulcers, familial, of juvenile onset), [MONDO:0011918](http://purl.obolibrary.org/obo/MONDO_0011918) (anxiety), [MONDO:0007883](http://purl.obolibrary.org/obo/MONDO_0007883) (Lazy leukocyte syndrome), [MONDO:0007882](http://purl.obolibrary.org/obo/MONDO_0007882) (lattice degeneration of retina Leading to retinal detachment), [MONDO:0007881](http://purl.obolibrary.org/obo/MONDO_0007881) (tooth agenesis, selective, 4), [MONDO:0011912](http://purl.obolibrary.org/obo/MONDO_0011912) (autosomal recessive nonsyndromic deafness 37), [MONDO:0011910](http://purl.obolibrary.org/obo/MONDO_0011910) (autosomal dominant limb-girdle muscular dystrophy type 1C), [MONDO:0019863](http://purl.obolibrary.org/obo/MONDO_0019863) (Acro-renal-ocular syndrome), [MONDO:0014175](http://purl.obolibrary.org/obo/MONDO_0014175) (mitochondrial DNA depletion syndrome 12), [MONDO:0014177](http://purl.obolibrary.org/obo/MONDO_0014177) (myopia 22, autosomal dominant), [MONDO:0014170](http://purl.obolibrary.org/obo/MONDO_0014170) (complex cortical dysplasia with other brain malformations 3), [MONDO:0014171](http://purl.obolibrary.org/obo/MONDO_0014171) (complex cortical dysplasia with other brain malformations 4), [MONDO:0011905](http://purl.obolibrary.org/obo/MONDO_0011905) (familial hypercholanemia), [MONDO:0007899](http://purl.obolibrary.org/obo/MONDO_0007899) (lichen sclerosus et atrophicus), [MONDO:0007898](http://purl.obolibrary.org/obo/MONDO_0007898) (leukocyte nuclear appendages, hereditary Prevalence of), [MONDO:0011909](http://purl.obolibrary.org/obo/MONDO_0011909) (Charcot-Marie-tooth disease dominant intermediate d), [MONDO:0006563](http://purl.obolibrary.org/obo/MONDO_0006563) (inverted follicular keratosis), [MONDO:0007893](http://purl.obolibrary.org/obo/MONDO_0007893) (Noonan syndrome with multiple lentigines), [MONDO:0011906](http://purl.obolibrary.org/obo/MONDO_0011906) (congenital bile acid synthesis defect 1), [MONDO:0007890](http://purl.obolibrary.org/obo/MONDO_0007890) (lentiginosis, centrofacial neurodysraphic), [MONDO:0011901](http://purl.obolibrary.org/obo/MONDO_0011901) (Charcot-Marie-tooth disease axonal type 2H), [MONDO:0018538](http://purl.obolibrary.org/obo/MONDO_0018538) (inherited digestive cancer-predisposing syndrome), [MONDO:0014167](http://purl.obolibrary.org/obo/MONDO_0014167) (epilepsy, familial adult myoclonic, 5), [MONDO:0014168](http://purl.obolibrary.org/obo/MONDO_0014168) (severe combined immunodeficiency due to CORO1A deficiency), [MONDO:0014163](http://purl.obolibrary.org/obo/MONDO_0014163) (left ventricular noncompaction 10), [MONDO:0014164](http://purl.obolibrary.org/obo/MONDO_0014164) (Meckel syndrome, type 11), [MONDO:0014166](http://purl.obolibrary.org/obo/MONDO_0014166) (paroxysmal nocturnal hemoglobinuria 2), [MONDO:0014160](http://purl.obolibrary.org/obo/MONDO_0014160) (TCR-alpha-beta-positive T-cell deficiency), [MONDO:0014161](http://purl.obolibrary.org/obo/MONDO_0014161) (VUR7), [MONDO:0014162](http://purl.obolibrary.org/obo/MONDO_0014162) (infantile hypertrophic cardiomyopathy due to MRPL44 deficiency), [MONDO:0007869](http://purl.obolibrary.org/obo/MONDO_0007869) (Kyrle disease), [MONDO:0007868](http://purl.obolibrary.org/obo/MONDO_0007868) (hyperekplexia 1), [MONDO:0007867](http://purl.obolibrary.org/obo/MONDO_0007867) (nonsyndromic congenital nail disorder 2), [MONDO:0007866](http://purl.obolibrary.org/obo/MONDO_0007866) (Bart-Pumphrey syndrome), [MONDO:0007865](http://purl.obolibrary.org/obo/MONDO_0007865) (Knuckle pads), [MONDO:0007862](http://purl.obolibrary.org/obo/MONDO_0007862) (Waardenburg syndrome type 3), [MONDO:0007860](http://purl.obolibrary.org/obo/MONDO_0007860) (focal palmoplantar and gingival keratoderma), [MONDO:0014156](http://purl.obolibrary.org/obo/MONDO_0014156) (atrial fibrillation, familial, 14), [MONDO:0015487](http://purl.obolibrary.org/obo/MONDO_0015487) (fatal infantile encephalocardiomyopathy), [MONDO:0014158](http://purl.obolibrary.org/obo/MONDO_0014158) (nephronophthisis 16), [MONDO:0014159](http://purl.obolibrary.org/obo/MONDO_0014159) (autosomal recessive spinocerebellar ataxia 14), [MONDO:0014152](http://purl.obolibrary.org/obo/MONDO_0014152) (left ventricular noncompaction 8), [MONDO:0014154](http://purl.obolibrary.org/obo/MONDO_0014154) (Charcot-Marie-tooth disease recessive intermediate c), [MONDO:0014155](http://purl.obolibrary.org/obo/MONDO_0014155) (atrial fibrillation, familial, 13), [MONDO:0015485](http://purl.obolibrary.org/obo/MONDO_0015485) (primary glaucoma), [MONDO:0005217](http://purl.obolibrary.org/obo/MONDO_0005217) (familial cardiomyopathy), [MONDO:0007877](http://purl.obolibrary.org/obo/MONDO_0007877) (LAP), [MONDO:0007876](http://purl.obolibrary.org/obo/MONDO_0007876) (laryngeal abductor paralysis), [MONDO:0007875](http://purl.obolibrary.org/obo/MONDO_0007875) (larsen syndrome), [MONDO:0007874](http://purl.obolibrary.org/obo/MONDO_0007874) (trichorhinophalangeal syndrome type II), [MONDO:0007873](http://purl.obolibrary.org/obo/MONDO_0007873) (lactic acidosis, chronic adult form), [MONDO:0007872](http://purl.obolibrary.org/obo/MONDO_0007872) (LADD syndrome), [MONDO:0007870](http://purl.obolibrary.org/obo/MONDO_0007870) (labia minora, incomplete adhesion of), [MONDO:0019438](http://purl.obolibrary.org/obo/MONDO_0019438) (AL amyloidosis), [MONDO:0018105](http://purl.obolibrary.org/obo/MONDO_0018105) (Wolfram syndrome), [MONDO:0019436](http://purl.obolibrary.org/obo/MONDO_0019436) (psoriasis-related juvenile idiopathic arthritis), [MONDO:0018106](http://purl.obolibrary.org/obo/MONDO_0018106) (hereditary xanthinuria), [MONDO:0008780](http://purl.obolibrary.org/obo/MONDO_0008780) (amyotrophic lateral sclerosis type 2), [MONDO:0018101](http://purl.obolibrary.org/obo/MONDO_0018101) (familial primary hypomagnesemia with normocalciuria and normocalcemia), [MONDO:0008783](http://purl.obolibrary.org/obo/MONDO_0008783) (Tangier disease), [MONDO:0000817](http://purl.obolibrary.org/obo/MONDO_0000817) (corneal opacification and other ocular anomalies), [MONDO:0019430](http://purl.obolibrary.org/obo/MONDO_0019430) (X-linked intellectual disability-ataxia-apraxia syndrome), [MONDO:0008785](http://purl.obolibrary.org/obo/MONDO_0008785) (pyridoxine-refractory autosomal recessive sideroblastic anemia), [MONDO:0018100](http://purl.obolibrary.org/obo/MONDO_0018100) (primary hypomagnesemia), [MONDO:0008787](http://purl.obolibrary.org/obo/MONDO_0008787) (microcytic anemia with liver iron overload), [MONDO:0012807](http://purl.obolibrary.org/obo/MONDO_0012807) (epidermolysis bullosa simplex with pyloric atresia), [MONDO:0007448](http://purl.obolibrary.org/obo/MONDO_0007448) (dermatographia), [MONDO:0012805](http://purl.obolibrary.org/obo/MONDO_0012805) (childhood onset GLUT1 deficiency syndrome 2), [MONDO:0007447](http://purl.obolibrary.org/obo/MONDO_0007447) (dermodistortive urticaria), [MONDO:0007446](http://purl.obolibrary.org/obo/MONDO_0007446) (dermatosis papulosa nigra), [MONDO:0007445](http://purl.obolibrary.org/obo/MONDO_0007445) (Dermatopathia pigmentosa reticularis), [MONDO:0007444](http://purl.obolibrary.org/obo/MONDO_0007444) (dermal Ridges, Patternless), [MONDO:0012809](http://purl.obolibrary.org/obo/MONDO_0012809) (histiocytoma, Angiomatoid fibrous), [MONDO:0012808](http://purl.obolibrary.org/obo/MONDO_0012808) (dilated cardiomyopathy 1AA), [MONDO:0007442](http://purl.obolibrary.org/obo/MONDO_0007442) (dentinogenesis imperfecta type 3), [MONDO:0007441](http://purl.obolibrary.org/obo/MONDO_0007441) (dentinogenesis imperfecta type 2), [MONDO:0007440](http://purl.obolibrary.org/obo/MONDO_0007440) (MAFD1), [MONDO:0012803](http://purl.obolibrary.org/obo/MONDO_0012803) (diarrhea-vomiting due to trehalase deficiency), [MONDO:0012800](http://purl.obolibrary.org/obo/MONDO_0012800) (trichoepithelioma, multiple familial, 2), [MONDO:0019427](http://purl.obolibrary.org/obo/MONDO_0019427) (X-linked neurodegenerative syndrome, Bertini type), [MONDO:0019425](http://purl.obolibrary.org/obo/MONDO_0019425) (X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome), [MONDO:0019426](http://purl.obolibrary.org/obo/MONDO_0019426) (X-linked intellectual disability-corpus callosum agenesis-spastic quadriparesis syndrome), [MONDO:0019423](http://purl.obolibrary.org/obo/MONDO_0019423) (X-linked intellectual disability, Stoll type), [MONDO:0008770](http://purl.obolibrary.org/obo/MONDO_0008770) (amelogenesis imperfecta type 1C), [MONDO:0019424](http://purl.obolibrary.org/obo/MONDO_0019424) (X-linked intellectual disability-acromegaly-hyperactivity syndrome), [MONDO:0019421](http://purl.obolibrary.org/obo/MONDO_0019421) (X-linked intellectual disability, Seemanova type), [MONDO:0008772](http://purl.obolibrary.org/obo/MONDO_0008772) (amelogenesis imperfecta type 2A1), [MONDO:0019422](http://purl.obolibrary.org/obo/MONDO_0019422) (X-linked intellectual disability, Stevenson type), [MONDO:0008773](http://purl.obolibrary.org/obo/MONDO_0008773) (amino aciduria with mental deficiency, dwarfism, muscular dystrophy, osteoporosis, and acidosis), [MONDO:0016393](http://purl.obolibrary.org/obo/MONDO_0016393) (Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndrome), [MONDO:0000821](http://purl.obolibrary.org/obo/MONDO_0000821) (cerebral cavernous malformation 3), [MONDO:0019420](http://purl.obolibrary.org/obo/MONDO_0019420) (X-linked intellectual disability, Pai type), [MONDO:0008774](http://purl.obolibrary.org/obo/MONDO_0008774) (2-aminoadipic 2-oxoadipic aciduria), [MONDO:0008775](http://purl.obolibrary.org/obo/MONDO_0008775) (Amobarbital, deficient N-Hydroxylation of), [MONDO:0016395](http://purl.obolibrary.org/obo/MONDO_0016395) (foveal hypoplasia-presenile cataract syndrome), [MONDO:0008776](http://purl.obolibrary.org/obo/MONDO_0008776) (amyloidosis of gingiva and conjunctiva, with mental retardation), [MONDO:0008778](http://purl.obolibrary.org/obo/MONDO_0008778) (amyloidosis, cutaneous bullous), [MONDO:0008779](http://purl.obolibrary.org/obo/MONDO_0008779) (arthrogryposis), [MONDO:0016391](http://purl.obolibrary.org/obo/MONDO_0016391) (neonatal diabetes mellitus), [MONDO:0007459](http://purl.obolibrary.org/obo/MONDO_0007459) (dilution, pigmentary), [MONDO:0007457](http://purl.obolibrary.org/obo/MONDO_0007457) (diastema, dental medial), [MONDO:0007456](http://purl.obolibrary.org/obo/MONDO_0007456) (diarrhea, glucose-Stimulated secretory, with common variable immunodeficiency), [MONDO:0007455](http://purl.obolibrary.org/obo/MONDO_0007455) (diabetes mellitus, Noninsulin-dependent), [MONDO:0007453](http://purl.obolibrary.org/obo/MONDO_0007453) (maturity-onset diabetes of the young type 2), [MONDO:0007452](http://purl.obolibrary.org/obo/MONDO_0007452) (maturity-onset diabetes of the young type 1), [MONDO:0019429](http://purl.obolibrary.org/obo/MONDO_0019429) (X-linked neurodegenerative syndrome, Hamel type), [MONDO:0019416](http://purl.obolibrary.org/obo/MONDO_0019416) (X-linked intellectual disability-hypogammaglobulinemia-progressive neurological deterioration syndrome), [MONDO:0019417](http://purl.obolibrary.org/obo/MONDO_0019417) (X-linked intellectual disability-precocious puberty-obesity syndrome), [MONDO:0019414](http://purl.obolibrary.org/obo/MONDO_0019414) (BRESEK syndrome), [MONDO:0015054](http://purl.obolibrary.org/obo/MONDO_0015054) (hereditary angioedema type 2), [MONDO:0008760](http://purl.obolibrary.org/obo/MONDO_0008760) (beta-ketothiolase deficiency), [MONDO:0008761](http://purl.obolibrary.org/obo/MONDO_0008761) (alpha-2-deficient collagen disease), [MONDO:0019411](http://purl.obolibrary.org/obo/MONDO_0019411) (genochondromatosis type 1), [MONDO:0016387](http://purl.obolibrary.org/obo/MONDO_0016387) (mitochondrial oxidative phosphorylation disorder), [MONDO:0008762](http://purl.obolibrary.org/obo/MONDO_0008762) (autosomal recessive Alport syndrome), [MONDO:0008763](http://purl.obolibrary.org/obo/MONDO_0008763) (Alstrom syndrome), [MONDO:0015053](http://purl.obolibrary.org/obo/MONDO_0015053) (hereditary angioedema type 1), [MONDO:0008767](http://purl.obolibrary.org/obo/MONDO_0008767) (neuronal ceroid lipofuscinosis 3), [MONDO:0008768](http://purl.obolibrary.org/obo/MONDO_0008768) (neuronal ceroid lipofuscinosis 4A), [MONDO:0007429](http://purl.obolibrary.org/obo/MONDO_0007429) (optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy), [MONDO:0008769](http://purl.obolibrary.org/obo/MONDO_0008769) (neuronal ceroid lipofuscinosis 2), [MONDO:0007427](http://purl.obolibrary.org/obo/MONDO_0007427) (deafness with anhidrotic ectodermal dysplasia), [MONDO:0007426](http://purl.obolibrary.org/obo/MONDO_0007426) (deafness, unilateral), [MONDO:0007425](http://purl.obolibrary.org/obo/MONDO_0007425) (deafness, sensorineural, with peripheral neuropathy and arterial disease), [MONDO:0007424](http://purl.obolibrary.org/obo/MONDO_0007424) (autosomal dominant nonsyndromic deafness 1), [MONDO:0007423](http://purl.obolibrary.org/obo/MONDO_0007423) (deafness, mid-tone neural), [MONDO:0007422](http://purl.obolibrary.org/obo/MONDO_0007422) (keratoderma hereditarium mutilans), [MONDO:0007421](http://purl.obolibrary.org/obo/MONDO_0007421) (deafness-ear malformation-facial palsy syndrome), [MONDO:0007420](http://purl.obolibrary.org/obo/MONDO_0007420) (autosomal dominant deafness-onychodystrophy syndrome), [MONDO:0019418](http://purl.obolibrary.org/obo/MONDO_0019418) (X-linked intellectual disability-epilepsy-progressive joint contractures-dysmorphism syndrome), [MONDO:0019419](http://purl.obolibrary.org/obo/MONDO_0019419) (X-linked intellectual disability-macrocephaly-macroorchidism syndrome), [MONDO:0019402](http://purl.obolibrary.org/obo/MONDO_0019402) (beta thalassemia), [MONDO:0008753](http://purl.obolibrary.org/obo/MONDO_0008753) (alkaptonuria), [MONDO:0008758](http://purl.obolibrary.org/obo/MONDO_0008758) (mitochondrial DNA depletion syndrome 4a), [MONDO:0007439](http://purl.obolibrary.org/obo/MONDO_0007439) (Deoxyribose-5-phosphate aldolase deficiency), [MONDO:0008759](http://purl.obolibrary.org/obo/MONDO_0008759) (Oxoglutaricaciduria), [MONDO:0007438](http://purl.obolibrary.org/obo/MONDO_0007438) (dentin dysplasia-sclerotic bones syndrome), [MONDO:0007437](http://purl.obolibrary.org/obo/MONDO_0007437) (dentin dysplasia type II), [MONDO:0007436](http://purl.obolibrary.org/obo/MONDO_0007436) (dentin dysplasia type I), [MONDO:0007435](http://purl.obolibrary.org/obo/MONDO_0007435) (dentatorubral-pallidoluysian atrophy), [MONDO:0007434](http://purl.obolibrary.org/obo/MONDO_0007434) (primary failure of tooth eruption), [MONDO:0007433](http://purl.obolibrary.org/obo/MONDO_0007433) (dementia/parkinsonism with non-Alzheimer amyloid plaques), [MONDO:0007431](http://purl.obolibrary.org/obo/MONDO_0007431) (dens 1N dente and palatal invaginations), [MONDO:0007430](http://purl.obolibrary.org/obo/MONDO_0007430) (dens Evaginatus), [MONDO:0018149](http://purl.obolibrary.org/obo/MONDO_0018149) (GM1 gangliosidosis), [MONDO:0018143](http://purl.obolibrary.org/obo/MONDO_0018143) (pyruvate carboxylase deficiency, benign type), [MONDO:0018144](http://purl.obolibrary.org/obo/MONDO_0018144) (congenital myasthenic syndromes with glycosylation defect), [MONDO:0018141](http://purl.obolibrary.org/obo/MONDO_0018141) (pyruvate carboxylase deficiency, infantile form), [MONDO:0018142](http://purl.obolibrary.org/obo/MONDO_0018142) (pyruvate carboxylase deficiency, severe neonatal type), [MONDO:0011519](http://purl.obolibrary.org/obo/MONDO_0011519) (autosomal dominant nonsyndromic deafness 23), [MONDO:0012849](http://purl.obolibrary.org/obo/MONDO_0012849) (Joubert syndrome 9), [MONDO:0012848](http://purl.obolibrary.org/obo/MONDO_0012848) (Meckel syndrome, type 6), [MONDO:0007487](http://purl.obolibrary.org/obo/MONDO_0007487) (dyslexia, susceptibility to, 1), [MONDO:0011512](http://purl.obolibrary.org/obo/MONDO_0011512) (Brooke-Spiegler syndrome), [MONDO:0007485](http://purl.obolibrary.org/obo/MONDO_0007485) (dyskeratosis congenita, autosomal dominant 1), [MONDO:0012842](http://purl.obolibrary.org/obo/MONDO_0012842) (CMM7), [MONDO:0011511](http://purl.obolibrary.org/obo/MONDO_0011511) (clavicular hypoplasia, zygomatic arch Hypoplasia, and micrognathia), [MONDO:0012847](http://purl.obolibrary.org/obo/MONDO_0012847) (autosomal recessive congenital ichthyosis 6), [MONDO:0011516](http://purl.obolibrary.org/obo/MONDO_0011516) (early response to neural induction gene), [MONDO:0007480](http://purl.obolibrary.org/obo/MONDO_0007480) (dwarfism with stiff joints and ocular abnormalities), [MONDO:0011514](http://purl.obolibrary.org/obo/MONDO_0011514) (tricuspid atresia (disease)), [MONDO:0012844](http://purl.obolibrary.org/obo/MONDO_0012844) (primary ciliary dyskinesia 8), [MONDO:0018138](http://purl.obolibrary.org/obo/MONDO_0018138) (ocular albinism with congenital sensorineural deafness), [MONDO:0018136](http://purl.obolibrary.org/obo/MONDO_0018136) (minimal pigment oculocutaneous albinism type 1), [MONDO:0018137](http://purl.obolibrary.org/obo/MONDO_0018137) (temperature-sensitive oculocutaneous albinism type 1), [MONDO:0018134](http://purl.obolibrary.org/obo/MONDO_0018134) (disorder of melanin metabolism), [MONDO:0018135](http://purl.obolibrary.org/obo/MONDO_0018135) (oculocutaneous albinism type 1), [MONDO:0018130](http://purl.obolibrary.org/obo/MONDO_0018130) (brain dopamine-serotonin vesicular transport disease), [MONDO:0020458](http://purl.obolibrary.org/obo/MONDO_0020458) (hemolytic anemia due to erythrocyte adenosine deaminase overproduction), [MONDO:0011509](http://purl.obolibrary.org/obo/MONDO_0011509) (low density lipoprotein cholesterol, mild elevation of), [MONDO:0011507](http://purl.obolibrary.org/obo/MONDO_0011507) (diabetes mellitus, congenital autoimmune), [MONDO:0011506](http://purl.obolibrary.org/obo/MONDO_0011506) (familial infantile myoclonic epilepsy), [MONDO:0007499](http://purl.obolibrary.org/obo/MONDO_0007499) (ear Folding), [MONDO:0007498](http://purl.obolibrary.org/obo/MONDO_0007498) (ear exostoses), [MONDO:0007497](http://purl.obolibrary.org/obo/MONDO_0007497) (ear Antitragus, tag at base of), [MONDO:0007495](http://purl.obolibrary.org/obo/MONDO_0007495) (dystonia 5), [MONDO:0012830](http://purl.obolibrary.org/obo/MONDO_0012830) (chromosome 10q23 deletion syndrome), [MONDO:0011505](http://purl.obolibrary.org/obo/MONDO_0011505) (familial hypobetalipoproteinemia 2), [MONDO:0007491](http://purl.obolibrary.org/obo/MONDO_0007491) (Dystelephalangy), [MONDO:0011502](http://purl.obolibrary.org/obo/MONDO_0011502) (Wolfram syndrome 2), [MONDO:0018129](http://purl.obolibrary.org/obo/MONDO_0018129) (autosomal recessive cerebellar ataxia with late-onset spasticity), [MONDO:0018125](http://purl.obolibrary.org/obo/MONDO_0018125) (focal epilepsy-intellectual disability-cerebro-cerebellar malformation), [MONDO:0000838](http://purl.obolibrary.org/obo/MONDO_0000838) (chromosomal disease), [MONDO:0018123](http://purl.obolibrary.org/obo/MONDO_0018123) (intellectual disability-obesity-brain malformations-facial dysmorphism syndrome), [MONDO:0018121](http://purl.obolibrary.org/obo/MONDO_0018121) (mitochondrial DNA maintenance syndrome), [MONDO:0018122](http://purl.obolibrary.org/obo/MONDO_0018122) (digital anomalies-intellectual disability-short stature syndrome), [MONDO:0015095](http://purl.obolibrary.org/obo/MONDO_0015095) (Peters anomaly-cataract syndrome), [MONDO:0018120](http://purl.obolibrary.org/obo/MONDO_0018120) (disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement), [MONDO:0015090](http://purl.obolibrary.org/obo/MONDO_0015090) (autosomal recessive pure spastic paraplegia), [MONDO:0015091](http://purl.obolibrary.org/obo/MONDO_0015091) (autosomal dominant spastic paraplegia type 9), [MONDO:0012828](http://purl.obolibrary.org/obo/MONDO_0012828) (atrial fibrillation, familial, 7), [MONDO:0012827](http://purl.obolibrary.org/obo/MONDO_0012827) (IS5), [MONDO:0007469](http://purl.obolibrary.org/obo/MONDO_0007469) (double nail for fifth toe), [MONDO:0012826](http://purl.obolibrary.org/obo/MONDO_0012826) (IS4), [MONDO:0007468](http://purl.obolibrary.org/obo/MONDO_0007468) (Dna, Satellite, alpha type), [MONDO:0007467](http://purl.obolibrary.org/obo/MONDO_0007467) (Dna, low-repetitive sequences of), [MONDO:0007466](http://purl.obolibrary.org/obo/MONDO_0007466) (Dna, Satellite, 3), [MONDO:0007465](http://purl.obolibrary.org/obo/MONDO_0007465) (distichiasis with congenital anomalies of the heart and peripheral vasculature), [MONDO:0007463](http://purl.obolibrary.org/obo/MONDO_0007463) (distal osteosclerosis), [MONDO:0007460](http://purl.obolibrary.org/obo/MONDO_0007460) (discrimination, Two-point, reduction 1N), [MONDO:0018118](http://purl.obolibrary.org/obo/MONDO_0018118) (disorder of phospholipids, sphingolipids and fatty acids biosynthesis with central nervous system predominant involvement), [MONDO:0018119](http://purl.obolibrary.org/obo/MONDO_0018119) (disorder of phospholipids, sphingolipids and fatty acids biosynthesis with peripheral nerves predominant involvement), [MONDO:0018116](http://purl.obolibrary.org/obo/MONDO_0018116) (galactosemia), [MONDO:0018117](http://purl.obolibrary.org/obo/MONDO_0018117) (disorder of phospholipids, sphingolipids and fatty acids biosynthesis), [MONDO:0015087](http://purl.obolibrary.org/obo/MONDO_0015087) (autosomal dominant complex spastic paraplegia), [MONDO:0015088](http://purl.obolibrary.org/obo/MONDO_0015088) (autosomal dominant pure spastic paraplegia), [MONDO:0008793](http://purl.obolibrary.org/obo/MONDO_0008793) (angiomatosis, diffuse Corticomeningeal, of Divry and van Bogaert), [MONDO:0015089](http://purl.obolibrary.org/obo/MONDO_0015089) (autosomal recessive complex spastic paraplegia), [MONDO:0008794](http://purl.obolibrary.org/obo/MONDO_0008794) (anhidrosis, familial generalized, with abnormal or absent sweat glands), [MONDO:0019441](http://purl.obolibrary.org/obo/MONDO_0019441) (ATTRV122I amyloidosis), [MONDO:0008795](http://purl.obolibrary.org/obo/MONDO_0008795) (aniridia-cerebellar ataxia-intellectual disability syndrome), [MONDO:0015084](http://purl.obolibrary.org/obo/MONDO_0015084) (FRAXF syndrome), [MONDO:0008796](http://purl.obolibrary.org/obo/MONDO_0008796) (aniridia-renal agenesis-psychomotor retardation syndrome), [MONDO:0008797](http://purl.obolibrary.org/obo/MONDO_0008797) (anodontia), [MONDO:0015085](http://purl.obolibrary.org/obo/MONDO_0015085) (bathing suit ichthyosis), [MONDO:0012818](http://purl.obolibrary.org/obo/MONDO_0012818) (maturity-onset diabetes of the young type 9), [MONDO:0012816](http://purl.obolibrary.org/obo/MONDO_0012816) (atrial fibrillation, familial, 6), [MONDO:0007479](http://purl.obolibrary.org/obo/MONDO_0007479) (dwarfism, Levi type), [MONDO:0007478](http://purl.obolibrary.org/obo/MONDO_0007478) (autosomal dominant Kenny-Caffey syndrome), [MONDO:0007477](http://purl.obolibrary.org/obo/MONDO_0007477) (3-M syndrome), [MONDO:0007475](http://purl.obolibrary.org/obo/MONDO_0007475) (duodenal ulcer, hyperpepsinogenemic 1), [MONDO:0012819](http://purl.obolibrary.org/obo/MONDO_0012819) (diabetic ketoacidosis), [MONDO:0007474](http://purl.obolibrary.org/obo/MONDO_0007474) (duodenal ulcer due to antral G-cell hyperfunction), [MONDO:0012814](http://purl.obolibrary.org/obo/MONDO_0012814) (diastasis recti and weakness of the Linea Alba), [MONDO:0012812](http://purl.obolibrary.org/obo/MONDO_0012812) (epileptic encephalopathy, early infantile, 4), [MONDO:0009230](http://purl.obolibrary.org/obo/MONDO_0009230) (fibrosclerosis, multifocal), [MONDO:0009231](http://purl.obolibrary.org/obo/MONDO_0009231) (fibular hypoplasia and complex brachydactyly), [MONDO:0011551](http://purl.obolibrary.org/obo/MONDO_0011551) (autosomal recessive dopa-responsive dystonia), [MONDO:0012882](http://purl.obolibrary.org/obo/MONDO_0012882) (MAFD9), [MONDO:0010221](http://purl.obolibrary.org/obo/MONDO_0010221) (CHIME syndrome), [MONDO:0012881](http://purl.obolibrary.org/obo/MONDO_0012881) (major affective disorder 7), [MONDO:0018189](http://purl.obolibrary.org/obo/MONDO_0018189) (autosomal recessive cerebellar ataxia-pyramidal signs-nystagmus-oculomotor apraxia syndrome), [MONDO:0011550](http://purl.obolibrary.org/obo/MONDO_0011550) (fibromatosis, gingival, with hypertrichosis and mental retardation), [MONDO:0009237](http://purl.obolibrary.org/obo/MONDO_0009237) (focal epithelial hyperplasia), [MONDO:0009238](http://purl.obolibrary.org/obo/MONDO_0009238) (hereditary folate malabsorption), [MONDO:0018190](http://purl.obolibrary.org/obo/MONDO_0018190) (autosomal dominant childhood-onset proximal spinal muscular atrophy), [MONDO:0011556](http://purl.obolibrary.org/obo/MONDO_0011556) (BCC1), [MONDO:0010224](http://purl.obolibrary.org/obo/MONDO_0010224) (corpus callosum agenesis-abnormal genitalia syndrome), [MONDO:0010225](http://purl.obolibrary.org/obo/MONDO_0010225) (Dent disease type 1), [MONDO:0011554](http://purl.obolibrary.org/obo/MONDO_0011554) (DFNM1), [MONDO:0012885](http://purl.obolibrary.org/obo/MONDO_0012885) (SRD5A3-CDG), [MONDO:0010222](http://purl.obolibrary.org/obo/MONDO_0010222) (X-linked Opitz G/BBB syndrome), [MONDO:0010223](http://purl.obolibrary.org/obo/MONDO_0010223) (ichthyosis, X-linked, without steroid sulfatase deficiency), [MONDO:0011553](http://purl.obolibrary.org/obo/MONDO_0011553) (autosomal recessive nonsyndromic deafness 26), [MONDO:0010228](http://purl.obolibrary.org/obo/MONDO_0010228) (DFNX3), [MONDO:0011559](http://purl.obolibrary.org/obo/MONDO_0011559) (benign recurrent intrahepatic cholestasis type 2), [MONDO:0011558](http://purl.obolibrary.org/obo/MONDO_0011558) (Usher syndrome type 2C), [MONDO:0011557](http://purl.obolibrary.org/obo/MONDO_0011557) (radiation sensitivity/chromosome instability syndrome, autosomal dominant), [MONDO:0011541](http://purl.obolibrary.org/obo/MONDO_0011541) (dilated cardiomyopathy 1J), [MONDO:0012872](http://purl.obolibrary.org/obo/MONDO_0012872) (THPH9), [MONDO:0010210](http://purl.obolibrary.org/obo/MONDO_0010210) (xeroderma pigmentosum group A), [MONDO:0012871](http://purl.obolibrary.org/obo/MONDO_0012871) (Jervell and Lange-Nielsen syndrome 2), [MONDO:0011540](http://purl.obolibrary.org/obo/MONDO_0011540) (spinocerebellar ataxia type 14), [MONDO:0012870](http://purl.obolibrary.org/obo/MONDO_0012870) (chromosome 2q31.2 deletion syndrome), [MONDO:0020496](http://purl.obolibrary.org/obo/MONDO_0020496) (familial porencephaly), [MONDO:0020497](http://purl.obolibrary.org/obo/MONDO_0020497) (Turcot syndrome with polyposis), [MONDO:0009225](http://purl.obolibrary.org/obo/MONDO_0009225) (fever, familial Lifelong persistent), [MONDO:0018174](http://purl.obolibrary.org/obo/MONDO_0018174) (hereditary glaucoma), [MONDO:0009229](http://purl.obolibrary.org/obo/MONDO_0009229) (hyaline fibromatosis syndrome), [MONDO:0010219](http://purl.obolibrary.org/obo/MONDO_0010219) (xylosidase deficiency), [MONDO:0020491](http://purl.obolibrary.org/obo/MONDO_0020491) (subcortical band heterotopia), [MONDO:0012876](http://purl.obolibrary.org/obo/MONDO_0012876) (heparin cofactor 2 deficiency), [MONDO:0011545](http://purl.obolibrary.org/obo/MONDO_0011545) (autosomal dominant nocturnal frontal lobe epilepsy 3), [MONDO:0010213](http://purl.obolibrary.org/obo/MONDO_0010213) (xeroderma pigmentosum group E), [MONDO:0015903](http://purl.obolibrary.org/obo/MONDO_0015903) (hyperalphalipoproteinemia), [MONDO:0010214](http://purl.obolibrary.org/obo/MONDO_0010214) (xeroderma pigmentosum variant type), [MONDO:0015902](http://purl.obolibrary.org/obo/MONDO_0015902) (major hypertriglyceridemia), [MONDO:0010211](http://purl.obolibrary.org/obo/MONDO_0010211) (xeroderma pigmentosum group C), [MONDO:0015905](http://purl.obolibrary.org/obo/MONDO_0015905) (rare syndromic dyslipidemia), [MONDO:0011543](http://purl.obolibrary.org/obo/MONDO_0011543) (BRCA3), [MONDO:0010212](http://purl.obolibrary.org/obo/MONDO_0010212) (xeroderma pigmentosum group D), [MONDO:0011542](http://purl.obolibrary.org/obo/MONDO_0011542) (PSORS6), [MONDO:0015904](http://purl.obolibrary.org/obo/MONDO_0015904) (rare hypolipidemia), [MONDO:0010217](http://purl.obolibrary.org/obo/MONDO_0010217) (de Sanctis-Cacchione syndrome), [MONDO:0011548](http://purl.obolibrary.org/obo/MONDO_0011548) (cerebral palsy, ataxic, autosomal recessive), [MONDO:0015901](http://purl.obolibrary.org/obo/MONDO_0015901) (rare hyperlipidemia), [MONDO:0010215](http://purl.obolibrary.org/obo/MONDO_0010215) (xeroderma pigmentosum group F), [MONDO:0012878](http://purl.obolibrary.org/obo/MONDO_0012878) (Cowden syndrome 2), [MONDO:0010216](http://purl.obolibrary.org/obo/MONDO_0010216) (xeroderma pigmentosum group G), [MONDO:0011546](http://purl.obolibrary.org/obo/MONDO_0011546) (heterotaxy, visceral, 2, autosomal), [MONDO:0012877](http://purl.obolibrary.org/obo/MONDO_0012877) (MAFD8), [MONDO:0018169](http://purl.obolibrary.org/obo/MONDO_0018169) (morning glory syndrome), [MONDO:0012861](http://purl.obolibrary.org/obo/MONDO_0012861) (premature ovarian failure 6), [MONDO:0009213](http://purl.obolibrary.org/obo/MONDO_0009213) (Fanconi anemia complementation group C), [MONDO:0009214](http://purl.obolibrary.org/obo/MONDO_0009214) (Fanconi anemia complementation group D2), [MONDO:0018163](http://purl.obolibrary.org/obo/MONDO_0018163) (autosomal recessive cutis laxa type 2A), [MONDO:0009215](http://purl.obolibrary.org/obo/MONDO_0009215) (Fanconi anemia complementation group a), [MONDO:0009216](http://purl.obolibrary.org/obo/MONDO_0009216) (glycogen storage disease due to GLUT2 deficiency), [MONDO:0009217](http://purl.obolibrary.org/obo/MONDO_0009217) (Fanconi-like syndrome), [MONDO:0009218](http://purl.obolibrary.org/obo/MONDO_0009218) (Farber lipogranulomatosis), [MONDO:0018162](http://purl.obolibrary.org/obo/MONDO_0018162) (neurometabolic disorder due to serine deficiency), [MONDO:0018160](http://purl.obolibrary.org/obo/MONDO_0018160) (hereditary retinoblastoma), [MONDO:0010208](http://purl.obolibrary.org/obo/MONDO_0010208) (Wrinkly skin syndrome), [MONDO:0010209](http://purl.obolibrary.org/obo/MONDO_0010209) (xanthinuria type I), [MONDO:0020480](http://purl.obolibrary.org/obo/MONDO_0020480) (sulfite oxidase deficiency due to molybdenum cofactor deficiency), [MONDO:0012865](http://purl.obolibrary.org/obo/MONDO_0012865) (Pseudofolliculitis barbae), [MONDO:0012864](http://purl.obolibrary.org/obo/MONDO_0012864) (chromosome 2q32-q33 deletion syndrome), [MONDO:0011533](http://purl.obolibrary.org/obo/MONDO_0011533) (temtamy preaxial brachydactyly syndrome), [MONDO:0012863](http://purl.obolibrary.org/obo/MONDO_0012863) (attention deficit-hyperactivity disorder, susceptibility to, 6), [MONDO:0010200](http://purl.obolibrary.org/obo/MONDO_0010200) (Wilson disease), [MONDO:0011531](http://purl.obolibrary.org/obo/MONDO_0011531) (Noonan syndrome 2), [MONDO:0012862](http://purl.obolibrary.org/obo/MONDO_0012862) (attention deficit-hyperactivity disorder, susceptibility to, 5), [MONDO:0012869](http://purl.obolibrary.org/obo/MONDO_0012869) (mental retardation, autosomal dominant 22), [MONDO:0011538](http://purl.obolibrary.org/obo/MONDO_0011538) (frontoocular syndrome), [MONDO:0011537](http://purl.obolibrary.org/obo/MONDO_0011537) (macrocephaly-autism syndrome), [MONDO:0011536](http://purl.obolibrary.org/obo/MONDO_0011536) (OPA4), [MONDO:0010204](http://purl.obolibrary.org/obo/MONDO_0010204) (lysosomal acid lipase deficiency), [MONDO:0012867](http://purl.obolibrary.org/obo/MONDO_0012867) (hereditary spastic paraplegia 38), [MONDO:0010205](http://purl.obolibrary.org/obo/MONDO_0010205) (Wolman disease with hypolipoproteinemia and acanthocytosis), [MONDO:0018158](http://purl.obolibrary.org/obo/MONDO_0018158) (mitochondrial DNA depletion syndrome), [MONDO:0019489](http://purl.obolibrary.org/obo/MONDO_0019489) (diffuse palmoplantar keratoderma-acrocyanosis syndrome), [MONDO:0018157](http://purl.obolibrary.org/obo/MONDO_0018157) (mitochondrial disorder due to a defect in mitochondrial protein synthesis), [MONDO:0009201](http://purl.obolibrary.org/obo/MONDO_0009201) (facial abnormalities, kyphoscoliosis, and mental retardation), [MONDO:0003914](http://purl.obolibrary.org/obo/MONDO_0003914) (inborn purine-pyrimidine metabolic disorder), [MONDO:0020476](http://purl.obolibrary.org/obo/MONDO_0020476) (mesial temporal lobe epilepsy with hippocampal sclerosis), [MONDO:0018150](http://purl.obolibrary.org/obo/MONDO_0018150) (Gaucher disease), [MONDO:0020478](http://purl.obolibrary.org/obo/MONDO_0020478) (Leber plus disease), [MONDO:0018151](http://purl.obolibrary.org/obo/MONDO_0018151) (coenzyme Q10 deficiency), [MONDO:0009208](http://purl.obolibrary.org/obo/MONDO_0009208) (Faciothoracogenital syndrome), [MONDO:0009209](http://purl.obolibrary.org/obo/MONDO_0009209) (autosomal recessive faciodigitogenital syndrome), [MONDO:0011529](http://purl.obolibrary.org/obo/MONDO_0011529) (spinocerebellar ataxia type 13), [MONDO:0011528](http://purl.obolibrary.org/obo/MONDO_0011528) (hyper-IgM syndrome type 2), [MONDO:0011523](http://purl.obolibrary.org/obo/MONDO_0011523) (Bardet-Biedl syndrome 6), [MONDO:0012856](http://purl.obolibrary.org/obo/MONDO_0012856) (Birk-Barel syndrome), [MONDO:0011525](http://purl.obolibrary.org/obo/MONDO_0011525) (Carney complex type 2), [MONDO:0011524](http://purl.obolibrary.org/obo/MONDO_0011524) (Dianzani autoimmune lymphoproliferative disease), [MONDO:0012855](http://purl.obolibrary.org/obo/MONDO_0012855) (Joubert syndrome 8), [MONDO:0010260](http://purl.obolibrary.org/obo/MONDO_0010260) (ACLLX), [MONDO:0011590](http://purl.obolibrary.org/obo/MONDO_0011590) (anisomastia), [MONDO:0009275](http://purl.obolibrary.org/obo/MONDO_0009275) (neonatal hemochromatosis), [MONDO:0011596](http://purl.obolibrary.org/obo/MONDO_0011596) (atopic dermatitis 2), [MONDO:0010265](http://purl.obolibrary.org/obo/MONDO_0010265) (Simpson-Golabi-Behmel syndrome type 2), [MONDO:0009277](http://purl.obolibrary.org/obo/MONDO_0009277) (glaucoma 3A), [MONDO:0011594](http://purl.obolibrary.org/obo/MONDO_0011594) (ovarian dysgenesis, hypergonadotropic, with short stature and recurrent metabolic acidosis), [MONDO:0010262](http://purl.obolibrary.org/obo/MONDO_0010262) (hypotonia, congenital nystagmus, ataxia, and abnormal auditory brainstem Responses), [MONDO:0009278](http://purl.obolibrary.org/obo/MONDO_0009278) (hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency), [MONDO:0010263](http://purl.obolibrary.org/obo/MONDO_0010263) (Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome), [MONDO:0009279](http://purl.obolibrary.org/obo/MONDO_0009279) (triple-a syndrome), [MONDO:0010268](http://purl.obolibrary.org/obo/MONDO_0010268) (X-linked lissencephaly with abnormal genitalia), [MONDO:0014626](http://purl.obolibrary.org/obo/MONDO_0014626) (spinocerebellar ataxia type 41), [MONDO:0010269](http://purl.obolibrary.org/obo/MONDO_0010269) (Coats disease), [MONDO:0011598](http://purl.obolibrary.org/obo/MONDO_0011598) (atopic dermatitis 4), [MONDO:0011597](http://purl.obolibrary.org/obo/MONDO_0011597) (atopic dermatitis 3), [MONDO:0010267](http://purl.obolibrary.org/obo/MONDO_0010267) (EMWX), [MONDO:0014622](http://purl.obolibrary.org/obo/MONDO_0014622) (isolated focal non-epidermolytic palmoplantar keratoderma), [MONDO:0009280](http://purl.obolibrary.org/obo/MONDO_0009280) (Monosodium glutamate sensitivity), [MONDO:0014624](http://purl.obolibrary.org/obo/MONDO_0014624) (BRWNS), [MONDO:0009281](http://purl.obolibrary.org/obo/MONDO_0009281) (Glutaryl-CoA dehydrogenase deficiency), [MONDO:0014625](http://purl.obolibrary.org/obo/MONDO_0014625) (epileptic encephalopathy, early infantile, 33), [MONDO:0011581](http://purl.obolibrary.org/obo/MONDO_0011581) (dilated cardiomyopathy with woolly hair and keratoderma), [MONDO:0009260](http://purl.obolibrary.org/obo/MONDO_0009260) (GM1 gangliosidosis type 1), [MONDO:0009261](http://purl.obolibrary.org/obo/MONDO_0009261) (GM1 gangliosidosis type 2), [MONDO:0009262](http://purl.obolibrary.org/obo/MONDO_0009262) (GM1 gangliosidosis type 3), [MONDO:0014610](http://purl.obolibrary.org/obo/MONDO_0014610) (lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome), [MONDO:0011585](http://purl.obolibrary.org/obo/MONDO_0011585) (autosomal recessive distal spinal muscular atrophy 2), [MONDO:0011584](http://purl.obolibrary.org/obo/MONDO_0011584) (Fanconi anemia complementation group D1), [MONDO:0010254](http://purl.obolibrary.org/obo/MONDO_0010254) (hematopoietic stem cell Kinetics, control of), [MONDO:0009265](http://purl.obolibrary.org/obo/MONDO_0009265) (Gaucher's disease type I), [MONDO:0009266](http://purl.obolibrary.org/obo/MONDO_0009266) (Gaucher's disease type II), [MONDO:0011583](http://purl.obolibrary.org/obo/MONDO_0011583) (cerebral amyloid angiopathy, App-related), [MONDO:0009267](http://purl.obolibrary.org/obo/MONDO_0009267) (Gaucher's disease type III), [MONDO:0011582](http://purl.obolibrary.org/obo/MONDO_0011582) (multiple mitochondrial dysfunctions syndrome 1), [MONDO:0009268](http://purl.obolibrary.org/obo/MONDO_0009268) (Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome), [MONDO:0014619](http://purl.obolibrary.org/obo/MONDO_0014619) (trichothiodystrophy 3, photosensitive), [MONDO:0014615](http://purl.obolibrary.org/obo/MONDO_0014615) (trichothiodystrophy 2, photosensitive), [MONDO:0015947](http://purl.obolibrary.org/obo/MONDO_0015947) (inherited ichthyosis), [MONDO:0010258](http://purl.obolibrary.org/obo/MONDO_0010258) (MEHMO syndrome), [MONDO:0011588](http://purl.obolibrary.org/obo/MONDO_0011588) (platelet-type bleeding disorder 12), [MONDO:0014616](http://purl.obolibrary.org/obo/MONDO_0014616) (Skint1-like Pseudogene), [MONDO:0014617](http://purl.obolibrary.org/obo/MONDO_0014617) (mental retardation, autosomal dominant 38), [MONDO:0011586](http://purl.obolibrary.org/obo/MONDO_0011586) (OTSC2), [MONDO:0014611](http://purl.obolibrary.org/obo/MONDO_0014611) (multiple mitochondrial dysfunctions syndrome 4), [MONDO:0015942](http://purl.obolibrary.org/obo/MONDO_0015942) (frontometaphyseal dysplasia), [MONDO:0015945](http://purl.obolibrary.org/obo/MONDO_0015945) (polymalformative genetic syndrome with increased risk of developing cancer), [MONDO:0011570](http://purl.obolibrary.org/obo/MONDO_0011570) (Charcot-Marie-tooth disease type 2B2), [MONDO:0009250](http://purl.obolibrary.org/obo/MONDO_0009250) (fructose utilization), [MONDO:0009251](http://purl.obolibrary.org/obo/MONDO_0009251) (fructose-1,6-bisphosphatase deficiency), [MONDO:0009252](http://purl.obolibrary.org/obo/MONDO_0009252) (essential fructosuria), [MONDO:0011574](http://purl.obolibrary.org/obo/MONDO_0011574) (tetralogy of fallot syndrome, autosomal recessive), [MONDO:0011573](http://purl.obolibrary.org/obo/MONDO_0011573) (PSORS7), [MONDO:0009254](http://purl.obolibrary.org/obo/MONDO_0009254) (fucosidosis), [MONDO:0009255](http://purl.obolibrary.org/obo/MONDO_0009255) (galactokinase deficiency), [MONDO:0009256](http://purl.obolibrary.org/obo/MONDO_0009256) (galactorrhea (disease)), [MONDO:0011571](http://purl.obolibrary.org/obo/MONDO_0011571) (deafness, autosomal dominant 39, with dentinogenesis imperfecta 1), [MONDO:0002615](http://purl.obolibrary.org/obo/MONDO_0002615) (xanthomatosis (disease)), [MONDO:0003947](http://purl.obolibrary.org/obo/MONDO_0003947) (hyper-IgM syndrome), [MONDO:0009257](http://purl.obolibrary.org/obo/MONDO_0009257) (galactose epimerase deficiency), [MONDO:0009258](http://purl.obolibrary.org/obo/MONDO_0009258) (classic galactosemia), [MONDO:0009259](http://purl.obolibrary.org/obo/MONDO_0009259) (gamma-glutamylcysteine synthetase deficiency), [MONDO:0014609](http://purl.obolibrary.org/obo/MONDO_0014609) (cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome), [MONDO:0011578](http://purl.obolibrary.org/obo/MONDO_0011578) (familial papillary thyroid carcinoma with renal papillary neoplasia), [MONDO:0010246](http://purl.obolibrary.org/obo/MONDO_0010246) (early infantile epileptic encephalopathy 9), [MONDO:0010247](http://purl.obolibrary.org/obo/MONDO_0010247) (X-linked cerebral adrenoleukodystrophy), [MONDO:0010244](http://purl.obolibrary.org/obo/MONDO_0010244) (CGF1), [MONDO:0011576](http://purl.obolibrary.org/obo/MONDO_0011576) (familial hyperaldosteronism type II), [MONDO:0010245](http://purl.obolibrary.org/obo/MONDO_0010245) (X-linked cone-rod dystrophy 2), [MONDO:0014607](http://purl.obolibrary.org/obo/MONDO_0014607) (epileptic encephalopathy, early infantile, 32), [MONDO:0014600](http://purl.obolibrary.org/obo/MONDO_0014600) (dyskeratosis congenita, autosomal recessive 6), [MONDO:0014601](http://purl.obolibrary.org/obo/MONDO_0014601) (autosomal recessive spinocerebellar ataxia 20), [MONDO:0010248](http://purl.obolibrary.org/obo/MONDO_0010248) (X-linked spondyloepimetaphyseal dysplasia), [MONDO:0010249](http://purl.obolibrary.org/obo/MONDO_0010249) (X-linked b cell surface antigen, mouse, Homolog-like 1), [MONDO:0014603](http://purl.obolibrary.org/obo/MONDO_0014603) (autosomal dominant nonsyndromic deafness 40), [MONDO:0009240](http://purl.obolibrary.org/obo/MONDO_0009240) (Formiminoglutamic aciduria), [MONDO:0009243](http://purl.obolibrary.org/obo/MONDO_0009243) (Fraser-like syndrome), [MONDO:0009244](http://purl.obolibrary.org/obo/MONDO_0009244) (Freesia Flowers, Inability to smell), [MONDO:0009245](http://purl.obolibrary.org/obo/MONDO_0009245) (Friedreich ataxia), [MONDO:0009246](http://purl.obolibrary.org/obo/MONDO_0009246) (Friedreich ataxia and congenital glaucoma), [MONDO:0003959](http://purl.obolibrary.org/obo/MONDO_0003959) (breast large cell neuroendocrine carcinoma), [MONDO:0009248](http://purl.obolibrary.org/obo/MONDO_0009248) (fructose and galactose intolerance), [MONDO:0018197](http://purl.obolibrary.org/obo/MONDO_0018197) (mitochondrial DNA depletion syndrome, hepatocerebrorenal form), [MONDO:0009249](http://purl.obolibrary.org/obo/MONDO_0009249) (hereditary fructose intolerance), [MONDO:0011567](http://purl.obolibrary.org/obo/MONDO_0011567) (dilated cardiomyopathy 1K), [MONDO:0010235](http://purl.obolibrary.org/obo/MONDO_0010235) (X-linked intellectual disability-psychosis-macroorchidism syndrome), [MONDO:0012897](http://purl.obolibrary.org/obo/MONDO_0012897) (congenital factor XI deficiency), [MONDO:0011566](http://purl.obolibrary.org/obo/MONDO_0011566) (abdominal obesity-metabolic syndrome quantitative trait locus 2), [MONDO:0011565](http://purl.obolibrary.org/obo/MONDO_0011565) (metabolic syndrome X), [MONDO:0012896](http://purl.obolibrary.org/obo/MONDO_0012896) (PSORS10), [MONDO:0010239](http://purl.obolibrary.org/obo/MONDO_0010239) (lissencephaly type 1 due to doublecortin gene mutation), [MONDO:0015921](http://purl.obolibrary.org/obo/MONDO_0015921) (ARX-related epileptic encephalopathy), [MONDO:0015920](http://purl.obolibrary.org/obo/MONDO_0015920) (syndromic neurometabolic disease with X-linked intellectual disability), [MONDO:0011569](http://purl.obolibrary.org/obo/MONDO_0011569) (Charcot-Marie-tooth disease type 2B1), [MONDO:0010237](http://purl.obolibrary.org/obo/MONDO_0010237) (X-linked intellectual disability-plagiocephaly syndrome), [MONDO:0011568](http://purl.obolibrary.org/obo/MONDO_0011568) (autosomal dominant nonsyndromic deafness 25), [MONDO:0010238](http://purl.obolibrary.org/obo/MONDO_0010238) (deafness, X-linked 4), [MONDO:0015922](http://purl.obolibrary.org/obo/MONDO_0015922) (channelopathy with epilepsy), [MONDO:0014662](http://purl.obolibrary.org/obo/MONDO_0014662) (congenital insensitivity to pain-hypohidrosis syndrome), [MONDO:0014663](http://purl.obolibrary.org/obo/MONDO_0014663) (growth restriction, severe, with distinctive facies), [MONDO:0013332](http://purl.obolibrary.org/obo/MONDO_0013332) (brachydactyly, type A1, with short stature, scoliosis, microcephaly, ptosis, hearing loss, and mental retardation), [MONDO:0014664](http://purl.obolibrary.org/obo/MONDO_0014664) (Joubert syndrome 23), [MONDO:0013333](http://purl.obolibrary.org/obo/MONDO_0013333) (Odontoid hypoplasia), [MONDO:0015995](http://purl.obolibrary.org/obo/MONDO_0015995) (melorheostosis with osteopoikilosis), [MONDO:0012003](http://purl.obolibrary.org/obo/MONDO_0012003) (autosomal recessive nonsyndromic deafness 39), [MONDO:0012002](http://purl.obolibrary.org/obo/MONDO_0012002) (autosomal recessive nonsyndromic deafness 40), [MONDO:0012001](http://purl.obolibrary.org/obo/MONDO_0012001) (mandibulofacial dysostosis with ptosis, autosomal dominant), [MONDO:0012000](http://purl.obolibrary.org/obo/MONDO_0012000) (specific phobia), [MONDO:0015991](http://purl.obolibrary.org/obo/MONDO_0015991) (citrullinemia), [MONDO:0014661](http://purl.obolibrary.org/obo/MONDO_0014661) (epidermolysis bullosa simplex with nail dystrophy), [MONDO:0013330](http://purl.obolibrary.org/obo/MONDO_0013330) (agenesis of the corpus callosum and congenital lymphedema), [MONDO:0012007](http://purl.obolibrary.org/obo/MONDO_0012007) (scimitar anomaly, multiple cardiac malformations, and craniofacial and central nervous system abnormalities), [MONDO:0013339](http://purl.obolibrary.org/obo/MONDO_0013339) (dilated cardiomyopathy 1GG), [MONDO:0012005](http://purl.obolibrary.org/obo/MONDO_0012005) (growth failure, microcephaly, mental retardation, cataracts, large joint contractures, osteoporosis, cortical dysplasia, and cerebellar atrophy), [MONDO:0013335](http://purl.obolibrary.org/obo/MONDO_0013335) (Tuberculin skin test reactivity, absence of), [MONDO:0014667](http://purl.obolibrary.org/obo/MONDO_0014667) (cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3), [MONDO:0013336](http://purl.obolibrary.org/obo/MONDO_0013336) (chromosome 19p13.13 deletion syndrome), [MONDO:0012009](http://purl.obolibrary.org/obo/MONDO_0012009) (coronary heart disease, susceptibility to, 2), [MONDO:0014668](http://purl.obolibrary.org/obo/MONDO_0014668) (cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4), [MONDO:0013337](http://purl.obolibrary.org/obo/MONDO_0013337) (neuropathy, hereditary sensory and autonomic, type 1C), [MONDO:0013338](http://purl.obolibrary.org/obo/MONDO_0013338) (Charcot-Marie-tooth disease recessive intermediate b), [MONDO:0013320](http://purl.obolibrary.org/obo/MONDO_0013320) (chromosome 16p12.2-p11.2 deletion syndrome), [MONDO:0010294](http://purl.obolibrary.org/obo/MONDO_0010294) (X-linked severe congenital neutropenia), [MONDO:0013321](http://purl.obolibrary.org/obo/MONDO_0013321) (FWS), [MONDO:0013322](http://purl.obolibrary.org/obo/MONDO_0013322) (FAME3), [MONDO:0013323](http://purl.obolibrary.org/obo/MONDO_0013323) (cranioectodermal dysplasia 2), [MONDO:0010292](http://purl.obolibrary.org/obo/MONDO_0010292) (Uruguay Faciocardiomusculoskeletal syndrome), [MONDO:0010298](http://purl.obolibrary.org/obo/MONDO_0010298) (Lesch-Nyhan syndrome), [MONDO:0014650](http://purl.obolibrary.org/obo/MONDO_0014650) (familial temporal lobe epilepsy 8), [MONDO:0000026](http://purl.obolibrary.org/obo/MONDO_0000026) (Fanconi renotubular syndrome), [MONDO:0010290](http://purl.obolibrary.org/obo/MONDO_0010290) (MNG2), [MONDO:0000024](http://purl.obolibrary.org/obo/MONDO_0000024) (exostoses, multiple), [MONDO:0013329](http://purl.obolibrary.org/obo/MONDO_0013329) (familial clubfoot due to 17q23.1q23.2 microduplication), [MONDO:0010299](http://purl.obolibrary.org/obo/MONDO_0010299) (hypoxanthine guanine phosphoribosyltransferase partial deficiency), [MONDO:0013325](http://purl.obolibrary.org/obo/MONDO_0013325) (COG5-CDG), [MONDO:0014656](http://purl.obolibrary.org/obo/MONDO_0014656) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal recessive 2), [MONDO:0013326](http://purl.obolibrary.org/obo/MONDO_0013326) (Senior-Loken syndrome 7), [MONDO:0014657](http://purl.obolibrary.org/obo/MONDO_0014657) (primary ciliary dyskinesia 32), [MONDO:0013327](http://purl.obolibrary.org/obo/MONDO_0013327) (primary hyperoxaluria type 3), [MONDO:0009293](http://purl.obolibrary.org/obo/MONDO_0009293) (glycogen storage disease V), [MONDO:0010282](http://purl.obolibrary.org/obo/MONDO_0010282) (mycobacterium tuberculosis, susceptibility to, X-linked), [MONDO:0009294](http://purl.obolibrary.org/obo/MONDO_0009294) (glycogen storage disease VI), [MONDO:0010283](http://purl.obolibrary.org/obo/MONDO_0010283) (syndromic X-linked intellectual disability Lubs type), [MONDO:0013310](http://purl.obolibrary.org/obo/MONDO_0013310) (congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency), [MONDO:0009295](http://purl.obolibrary.org/obo/MONDO_0009295) (glycogen storage disease VII), [MONDO:0015974](http://purl.obolibrary.org/obo/MONDO_0015974) (severe combined immunodeficiency (disease)), [MONDO:0010281](http://purl.obolibrary.org/obo/MONDO_0010281) (Danon disease), [MONDO:0009296](http://purl.obolibrary.org/obo/MONDO_0009296) (glycoprotein storage disease), [MONDO:0010286](http://purl.obolibrary.org/obo/MONDO_0010286) (syndromic X-linked intellectual disability Siderius type), [MONDO:0009297](http://purl.obolibrary.org/obo/MONDO_0009297) (renal glycosuria), [MONDO:0009298](http://purl.obolibrary.org/obo/MONDO_0009298) (Gombo syndrome), [MONDO:0010284](http://purl.obolibrary.org/obo/MONDO_0010284) (Armfield syndrome), [MONDO:0010285](http://purl.obolibrary.org/obo/MONDO_0010285) (syndromic X-linked intellectual disability Abidi type), [MONDO:0014648](http://purl.obolibrary.org/obo/MONDO_0014648) (Al-Raqad syndrome), [MONDO:0014649](http://purl.obolibrary.org/obo/MONDO_0014649) (mental retardation, autosomal recessive 50), [MONDO:0013318](http://purl.obolibrary.org/obo/MONDO_0013318) (early Repolarization associated with ventricular fibrillation), [MONDO:0013319](http://purl.obolibrary.org/obo/MONDO_0013319) (chromosome 4Q32.1-Q32.2 Triplication syndrome), [MONDO:0015976](http://purl.obolibrary.org/obo/MONDO_0015976) (hyper-IgM syndrome without susceptibility to opportunistic infections), [MONDO:0014644](http://purl.obolibrary.org/obo/MONDO_0014644) (hereditary spastic paraplegia 74), [MONDO:0015975](http://purl.obolibrary.org/obo/MONDO_0015975) (hyper-IgM syndrome with susceptibility to opportunistic infections), [MONDO:0014645](http://purl.obolibrary.org/obo/MONDO_0014645) (BENTA disease), [MONDO:0014647](http://purl.obolibrary.org/obo/MONDO_0014647) (CAD-CDG), [MONDO:0009282](http://purl.obolibrary.org/obo/MONDO_0009282) (multiple acyl-CoA dehydrogenase deficiency), [MONDO:0010271](http://purl.obolibrary.org/obo/MONDO_0010271) (X-linked myotubular myopathy-abnormal genitalia syndrome), [MONDO:0009283](http://purl.obolibrary.org/obo/MONDO_0009283) (glutaric acidemia type 3), [MONDO:0014630](http://purl.obolibrary.org/obo/MONDO_0014630) (NTHL1-related attenuated familial adenomatous polyposis), [MONDO:0010272](http://purl.obolibrary.org/obo/MONDO_0010272) (syndromic X-linked intellectual disability type 10), [MONDO:0014631](http://purl.obolibrary.org/obo/MONDO_0014631) (hypomagnesemia, seizures, and mental retardation), [MONDO:0009284](http://purl.obolibrary.org/obo/MONDO_0009284) (glutathione synthetase deficiency without 5-oxoprolinuria), [MONDO:0010270](http://purl.obolibrary.org/obo/MONDO_0010270) (syndromic X-linked intellectual disability 7), [MONDO:0009285](http://purl.obolibrary.org/obo/MONDO_0009285) (gamma-glutamyl transpeptidase deficiency), [MONDO:0009286](http://purl.obolibrary.org/obo/MONDO_0009286) (gluteal muscles, absence of), [MONDO:0009287](http://purl.obolibrary.org/obo/MONDO_0009287) (glycogen storage disease due to glucose-6-phosphatase deficiency type Ia), [MONDO:0010276](http://purl.obolibrary.org/obo/MONDO_0010276) (radioulnar synostosis, radial ray abnormalities, and severe malformations 1N the male), [MONDO:0009288](http://purl.obolibrary.org/obo/MONDO_0009288) (glycogen storage disease due to glucose-6-phosphatase deficiency type ib), [MONDO:0009289](http://purl.obolibrary.org/obo/MONDO_0009289) (glycogen storage disease Ic), [MONDO:0001337](http://purl.obolibrary.org/obo/MONDO_0001337) (inflamed seborrheic keratosis), [MONDO:0001336](http://purl.obolibrary.org/obo/MONDO_0001336) (familial hyperlipidemia), [MONDO:0001333](http://purl.obolibrary.org/obo/MONDO_0001333) (Patau syndrome), [MONDO:0014637](http://purl.obolibrary.org/obo/MONDO_0014637) (DOCK2 deficiency), [MONDO:0013306](http://purl.obolibrary.org/obo/MONDO_0013306) (combined oxidative phosphorylation defect type 7), [MONDO:0014638](http://purl.obolibrary.org/obo/MONDO_0014638) (Fanconi anemia complementation group T), [MONDO:0013307](http://purl.obolibrary.org/obo/MONDO_0013307) (myopathy, lactic acidosis, and sideroblastic anemia 2), [MONDO:0013308](http://purl.obolibrary.org/obo/MONDO_0013308) (Noonan syndrome-like disorder with juvenile myelomonocytic leukemia), [MONDO:0010277](http://purl.obolibrary.org/obo/MONDO_0010277) (syndromic X-linked intellectual disability Shashi type), [MONDO:0014639](http://purl.obolibrary.org/obo/MONDO_0014639) (familial temporal lobe epilepsy 7), [MONDO:0013309](http://purl.obolibrary.org/obo/MONDO_0013309) (chromosome 2p12-p11.2 deletion syndrome), [MONDO:0010278](http://purl.obolibrary.org/obo/MONDO_0010278) (Christianson syndrome), [MONDO:0013302](http://purl.obolibrary.org/obo/MONDO_0013302) (nephronophthisis 11), [MONDO:0009290](http://purl.obolibrary.org/obo/MONDO_0009290) (glycogen storage disease II), [MONDO:0015967](http://purl.obolibrary.org/obo/MONDO_0015967) (rare genetic diabetes mellitus), [MONDO:0009291](http://purl.obolibrary.org/obo/MONDO_0009291) (glycogen storage disease III), [MONDO:0009292](http://purl.obolibrary.org/obo/MONDO_0009292) (glycogen storage disease due to glycogen branching enzyme deficiency), [MONDO:0014636](http://purl.obolibrary.org/obo/MONDO_0014636) (combined oxidative phosphorylation defect type 25), [MONDO:0013305](http://purl.obolibrary.org/obo/MONDO_0013305) (autosomal dominant nonsyndromic deafness 51), [MONDO:0016401](http://purl.obolibrary.org/obo/MONDO_0016401) (energy metabolism disorder with epilepsy), [MONDO:0017732](http://purl.obolibrary.org/obo/MONDO_0017732) (alpha-mannosidosis, infantile form), [MONDO:0017731](http://purl.obolibrary.org/obo/MONDO_0017731) (glycoproteinosis), [MONDO:0016403](http://purl.obolibrary.org/obo/MONDO_0016403) (mitochondrial disease with peripheral neuropathy), [MONDO:0017734](http://purl.obolibrary.org/obo/MONDO_0017734) (sialidosis), [MONDO:0012041](http://purl.obolibrary.org/obo/MONDO_0012041) (MUTYH-related attenuated familial adenomatous polyposis), [MONDO:0016402](http://purl.obolibrary.org/obo/MONDO_0016402) (mitochondrial disease with epilepsy), [MONDO:0017733](http://purl.obolibrary.org/obo/MONDO_0017733) (alpha-mannosidosis, adult form), [MONDO:0012047](http://purl.obolibrary.org/obo/MONDO_0012047) (alopecia universalis congenita, 10Y gonadal dysgenesis, and laryngomalacia), [MONDO:0013371](http://purl.obolibrary.org/obo/MONDO_0013371) (dilated cardiomyopathy 1U), [MONDO:0013372](http://purl.obolibrary.org/obo/MONDO_0013372) (long QT syndrome 5), [MONDO:0012046](http://purl.obolibrary.org/obo/MONDO_0012046) (congenital corneal opacities, cornea guttata, and corectopia), [MONDO:0012045](http://purl.obolibrary.org/obo/MONDO_0012045) (MYP5), [MONDO:0017730](http://purl.obolibrary.org/obo/MONDO_0017730) (metachromatic leukodystrophy, adult form), [MONDO:0013373](http://purl.obolibrary.org/obo/MONDO_0013373) (dilated cardiomyopathy 1V), [MONDO:0013374](http://purl.obolibrary.org/obo/MONDO_0013374) (supernumerary der(22)T(8), [MONDO:0013370](http://purl.obolibrary.org/obo/MONDO_0013370) (long QT syndrome 6), [MONDO:0017739](http://purl.obolibrary.org/obo/MONDO_0017739) (disorder of lysosomal-related organelles), [MONDO:0012048](http://purl.obolibrary.org/obo/MONDO_0012048) (endogenous depression), [MONDO:0013379](http://purl.obolibrary.org/obo/MONDO_0013379) (Noonan syndrome 7), [MONDO:0016405](http://purl.obolibrary.org/obo/MONDO_0016405) (sterol metabolism disorder with epilepsy), [MONDO:0017736](http://purl.obolibrary.org/obo/MONDO_0017736) (disorder of sialic acid metabolism), [MONDO:0017738](http://purl.obolibrary.org/obo/MONDO_0017738) (lysosomal glycogen storage disease), [MONDO:0017737](http://purl.obolibrary.org/obo/MONDO_0017737) (intermediate severe Salla disease), [MONDO:0013364](http://purl.obolibrary.org/obo/MONDO_0013364) (Rubinstein-Taybi syndrome due to EP300 haploinsufficiency), [MONDO:0017721](http://purl.obolibrary.org/obo/MONDO_0017721) (Sandhoff disease, infantile form), [MONDO:0017720](http://purl.obolibrary.org/obo/MONDO_0017720) (GM2 gangliosidosis), [MONDO:0014696](http://purl.obolibrary.org/obo/MONDO_0014696) (Cerebrooculofacioskeletal syndrome 3), [MONDO:0012031](http://purl.obolibrary.org/obo/MONDO_0012031) (platelet-type bleeding disorder 10), [MONDO:0013365](http://purl.obolibrary.org/obo/MONDO_0013365) (autosomal recessive nonsyndromic deafness 83), [MONDO:0014697](http://purl.obolibrary.org/obo/MONDO_0014697) (immunodeficiency, common variable, 12), [MONDO:0017723](http://purl.obolibrary.org/obo/MONDO_0017723) (Sandhoff disease, adult form), [MONDO:0013366](http://purl.obolibrary.org/obo/MONDO_0013366) (spondylocostal dysostosis 4, autosomal recessive), [MONDO:0012030](http://purl.obolibrary.org/obo/MONDO_0012030) (autosomal dominant nonsyndromic deafness 43), [MONDO:0013367](http://purl.obolibrary.org/obo/MONDO_0013367) (long QT syndrome 2), [MONDO:0017722](http://purl.obolibrary.org/obo/MONDO_0017722) (Sandhoff disease, juvenile form), [MONDO:0014691](http://purl.obolibrary.org/obo/MONDO_0014691) (Noonan syndrome 9), [MONDO:0013361](http://purl.obolibrary.org/obo/MONDO_0013361) (prothrombin deficiency), [MONDO:0012034](http://purl.obolibrary.org/obo/MONDO_0012034) (autosomal dominant limb-girdle muscular dystrophy type 1F), [MONDO:0014693](http://purl.obolibrary.org/obo/MONDO_0014693) (Noonan syndrome 10), [MONDO:0013363](http://purl.obolibrary.org/obo/MONDO_0013363) (chromosome 2q31.1 duplication syndrome), [MONDO:0014694](http://purl.obolibrary.org/obo/MONDO_0014694) (spondylocostal dysostosis 6, autosomal recessive), [MONDO:0014690](http://purl.obolibrary.org/obo/MONDO_0014690) (dyskeratosis congenita, autosomal dominant 6), [MONDO:0000065](http://purl.obolibrary.org/obo/MONDO_0000065) (microvascular complications of diabetes, susceptibility), [MONDO:0004424](http://purl.obolibrary.org/obo/MONDO_0004424) (familial glomangioma), [MONDO:0000066](http://purl.obolibrary.org/obo/MONDO_0000066) (mitochondrial complex deficiency), [MONDO:0017729](http://purl.obolibrary.org/obo/MONDO_0017729) (metachromatic leukodystrophy, late infantile form), [MONDO:0017728](http://purl.obolibrary.org/obo/MONDO_0017728) (Tay-Sachs disease, B1 variant), [MONDO:0012039](http://purl.obolibrary.org/obo/MONDO_0012039) (myocardial infarction, susceptibility to), [MONDO:0012038](http://purl.obolibrary.org/obo/MONDO_0012038) (speech-Sound disorder), [MONDO:0012037](http://purl.obolibrary.org/obo/MONDO_0012037) (mental retardation, autosomal recessive 3), [MONDO:0017725](http://purl.obolibrary.org/obo/MONDO_0017725) (Tay-Sachs disease, b variant, juvenile form), [MONDO:0014699](http://purl.obolibrary.org/obo/MONDO_0014699) (mental retardation, autosomal dominant 40), [MONDO:0017724](http://purl.obolibrary.org/obo/MONDO_0017724) (Tay-Sachs disease, b variant, infantile form), [MONDO:0017726](http://purl.obolibrary.org/obo/MONDO_0017726) (Tay-Sachs disease, b variant, adult form), [MONDO:0012021](http://purl.obolibrary.org/obo/MONDO_0012021) (MYP17), [MONDO:0014684](http://purl.obolibrary.org/obo/MONDO_0014684) (combined oxidative phosphorylation defect type 26), [MONDO:0013353](http://purl.obolibrary.org/obo/MONDO_0013353) (mental retardation, anterior maxillary Protrusion, and strabismus), [MONDO:0013354](http://purl.obolibrary.org/obo/MONDO_0013354) (spastic ataxia 4), [MONDO:0012020](http://purl.obolibrary.org/obo/MONDO_0012020) (chromosome 22q11.2 microduplication syndrome), [MONDO:0014686](http://purl.obolibrary.org/obo/MONDO_0014686) (short stature, microcephaly, and endocrine dysfunction), [MONDO:0017712](http://purl.obolibrary.org/obo/MONDO_0017712) (combined pancreatic lipase-colipase deficiency), [MONDO:0013356](http://purl.obolibrary.org/obo/MONDO_0013356) (vesicoureteral reflux 3), [MONDO:0017711](http://purl.obolibrary.org/obo/MONDO_0017711) (pancreatic colipase deficiency), [MONDO:0013350](http://purl.obolibrary.org/obo/MONDO_0013350) (mitochondrial DNA depletion syndrome 4b), [MONDO:0012023](http://purl.obolibrary.org/obo/MONDO_0012023) (autosomal dominant nonsyndromic deafness 49), [MONDO:0014683](http://purl.obolibrary.org/obo/MONDO_0014683) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9), [MONDO:0000032](http://purl.obolibrary.org/obo/MONDO_0000032) (febrile seizures, familial), [MONDO:0017718](http://purl.obolibrary.org/obo/MONDO_0017718) (mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes), [MONDO:0017717](http://purl.obolibrary.org/obo/MONDO_0017717) (metabolic disease due to other fatty acid oxidation disorder), [MONDO:0017719](http://purl.obolibrary.org/obo/MONDO_0017719) (gangliosidosis), [MONDO:0017714](http://purl.obolibrary.org/obo/MONDO_0017714) (acyl-CoA dehydrogenase deficiency), [MONDO:0013357](http://purl.obolibrary.org/obo/MONDO_0013357) (chromosome 17q11.2 deletion syndrome, 1.4Mb), [MONDO:0014688](http://purl.obolibrary.org/obo/MONDO_0014688) (short-rib thoracic dysplasia 14 with polydactyly), [MONDO:0017713](http://purl.obolibrary.org/obo/MONDO_0017713) (disorder of fatty acid oxidation and ketogenesis), [MONDO:0013358](http://purl.obolibrary.org/obo/MONDO_0013358) (Seckel syndrome 4), [MONDO:0017716](http://purl.obolibrary.org/obo/MONDO_0017716) (disorder of carnitine cycle and carnitine transport), [MONDO:0013359](http://purl.obolibrary.org/obo/MONDO_0013359) (familial hyperaldosteronism type III), [MONDO:0017715](http://purl.obolibrary.org/obo/MONDO_0017715) (3-hydroxyacyl-CoA dehydrogenase deficiency), [MONDO:0012010](http://purl.obolibrary.org/obo/MONDO_0012010) (coronary heart disease, susceptibility to, 4), [MONDO:0013342](http://purl.obolibrary.org/obo/MONDO_0013342) (hereditary spastic paraplegia 48), [MONDO:0014674](http://purl.obolibrary.org/obo/MONDO_0014674) (maturity-onset diabetes of the young type 14), [MONDO:0014675](http://purl.obolibrary.org/obo/MONDO_0014675) (autosomal recessive nonsyndromic deafness 104), [MONDO:0017701](http://purl.obolibrary.org/obo/MONDO_0017701) (glycogen storage disease due to glycogen branching enzyme deficiency, adult neuromuscular form), [MONDO:0014676](http://purl.obolibrary.org/obo/MONDO_0014676) (Emery-Dreifuss muscular dystrophy 3, autosomal recessive), [MONDO:0013345](http://purl.obolibrary.org/obo/MONDO_0013345) (d-2-Hydroxyglutaric aciduria 2), [MONDO:0017700](http://purl.obolibrary.org/obo/MONDO_0017700) (glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form), [MONDO:0012014](http://purl.obolibrary.org/obo/MONDO_0012014) (Charcot-Marie-tooth disease recessive intermediate a), [MONDO:0012013](http://purl.obolibrary.org/obo/MONDO_0012013) (glaucoma-ectopia-microspherophakia-stiff joints-short stature syndrome), [MONDO:0012012](http://purl.obolibrary.org/obo/MONDO_0012012) (Charcot-Marie-tooth disease dominant intermediate c), [MONDO:0013341](http://purl.obolibrary.org/obo/MONDO_0013341) (methylmalonic acidemia due to transcobalamin receptor defect), [MONDO:0012011](http://purl.obolibrary.org/obo/MONDO_0012011) (coronary artery disease, autosomal dominant, 1), [MONDO:0000049](http://purl.obolibrary.org/obo/MONDO_0000049) (invasive pneumococcal disease, recurrent isolated), [MONDO:0017706](http://purl.obolibrary.org/obo/MONDO_0017706) (disorder of carbohydrate absorption and transport), [MONDO:0017709](http://purl.obolibrary.org/obo/MONDO_0017709) (disorder of lipid absorption and transport), [MONDO:0017708](http://purl.obolibrary.org/obo/MONDO_0017708) (mevalonate kinase deficiency), [MONDO:0017703](http://purl.obolibrary.org/obo/MONDO_0017703) (disorder of glyoxylate metabolism), [MONDO:0014678](http://purl.obolibrary.org/obo/MONDO_0014678) (mental retardation, autosomal dominant 39), [MONDO:0017704](http://purl.obolibrary.org/obo/MONDO_0017704) (familial partial epilepsy), [MONDO:0012019](http://purl.obolibrary.org/obo/MONDO_0012019) (spondyloepiphyseal dysplasia, Kimberley type), [MONDO:0013349](http://purl.obolibrary.org/obo/MONDO_0013349) (ALG11-CDG), [MONDO:0012087](http://purl.obolibrary.org/obo/MONDO_0012087) (primary ciliary dyskinesia 4), [MONDO:0012086](http://purl.obolibrary.org/obo/MONDO_0012086) (autosomal dominant nonsyndromic deafness 31), [MONDO:0012085](http://purl.obolibrary.org/obo/MONDO_0012085) (primary ciliary dyskinesia 3), [MONDO:0012084](http://purl.obolibrary.org/obo/MONDO_0012084) (aromatic L-amino acid decarboxylase deficiency), [MONDO:0016441](http://purl.obolibrary.org/obo/MONDO_0016441) (acquired pseudoxanthoma elasticum), [MONDO:0017774](http://purl.obolibrary.org/obo/MONDO_0017774) (hypobetalipoproteinemia), [MONDO:0012089](http://purl.obolibrary.org/obo/MONDO_0012089) (ichthyosis prematurity syndrome), [MONDO:0017773](http://purl.obolibrary.org/obo/MONDO_0017773) (hypoalphalipoproteinemia), [MONDO:0012088](http://purl.obolibrary.org/obo/MONDO_0012088) (primary ciliary dyskinesia 5), [MONDO:0008820](http://purl.obolibrary.org/obo/MONDO_0008820) (arthrogryposis, distal, with hypopituitarism, mental retardation, and facial anomalies), [MONDO:0012083](http://purl.obolibrary.org/obo/MONDO_0012083) (autosomal dominant nonsyndromic deafness 28), [MONDO:0008821](http://purl.obolibrary.org/obo/MONDO_0008821) (arthrogryposis, distal, with mental retardation and characteristic facies), [MONDO:0012082](http://purl.obolibrary.org/obo/MONDO_0012082) (ASPG1), [MONDO:0008822](http://purl.obolibrary.org/obo/MONDO_0008822) (arthrogryposis, renal dysfunction, and cholestasis 1), [MONDO:0012081](http://purl.obolibrary.org/obo/MONDO_0012081) (15q11q13 microduplication syndrome), [MONDO:0012080](http://purl.obolibrary.org/obo/MONDO_0012080) (neuronopathy, distal hereditary motor, type 2B), [MONDO:0008828](http://purl.obolibrary.org/obo/MONDO_0008828) (camptodactyly-arthropathy-coxa vara-pericarditis syndrome), [MONDO:0000093](http://purl.obolibrary.org/obo/MONDO_0000093) (schistosoma mansoni infection, susceptibility), [MONDO:0017779](http://purl.obolibrary.org/obo/MONDO_0017779) (alpha-N-acetylgalactosaminidase deficiency), [MONDO:0017765](http://purl.obolibrary.org/obo/MONDO_0017765) (disorder of magnesium transport), [MONDO:0012076](http://purl.obolibrary.org/obo/MONDO_0012076) (midface hypoplasia, obesity, developmental delay, and neonatal hypotonia), [MONDO:0012075](http://purl.obolibrary.org/obo/MONDO_0012075) (oligodontia-cancer predisposition syndrome), [MONDO:0017764](http://purl.obolibrary.org/obo/MONDO_0017764) (disorder of zinc metabolism), [MONDO:0015104](http://purl.obolibrary.org/obo/MONDO_0015104) (porphyria cutanea tarda), [MONDO:0012074](http://purl.obolibrary.org/obo/MONDO_0012074) (mandibuloacral dysplasia with type B lipodystrophy), [MONDO:0012073](http://purl.obolibrary.org/obo/MONDO_0012073) (Ribose-5-P isomerase deficiency), [MONDO:0017766](http://purl.obolibrary.org/obo/MONDO_0017766) (disorder of manganese transport), [MONDO:0017761](http://purl.obolibrary.org/obo/MONDO_0017761) (disorder of mineral absorption and transport), [MONDO:0017760](http://purl.obolibrary.org/obo/MONDO_0017760) (disorder of other vitamins and cofactors metabolism and transport), [MONDO:0012079](http://purl.obolibrary.org/obo/MONDO_0012079) (ASPG2), [MONDO:0012078](http://purl.obolibrary.org/obo/MONDO_0012078) (Joubert syndrome 3), [MONDO:0017763](http://purl.obolibrary.org/obo/MONDO_0017763) (disorder of iron metabolism and transport), [MONDO:0017762](http://purl.obolibrary.org/obo/MONDO_0017762) (disorder of copper metabolism), [MONDO:0016431](http://purl.obolibrary.org/obo/MONDO_0016431) (autosomal dominant Charcot-Marie-tooth disease type 2M), [MONDO:0008810](http://purl.obolibrary.org/obo/MONDO_0008810) (familial apolipoprotein C-II deficiency), [MONDO:0012072](http://purl.obolibrary.org/obo/MONDO_0012072) (familial partial lipodystrophy, KC6bberling type), [MONDO:0012071](http://purl.obolibrary.org/obo/MONDO_0012071) (congenital generalized lipodystrophy type 1), [MONDO:0008812](http://purl.obolibrary.org/obo/MONDO_0008812) (AREDYLD syndrome), [MONDO:0008814](http://purl.obolibrary.org/obo/MONDO_0008814) (hyperargininemia), [MONDO:0008815](http://purl.obolibrary.org/obo/MONDO_0008815) (argininosuccinic aciduria), [MONDO:0008816](http://purl.obolibrary.org/obo/MONDO_0008816) (Arnold-Chiari malformation type II), [MONDO:0008819](http://purl.obolibrary.org/obo/MONDO_0008819) (arteriosclerosis, severe juvenile), [MONDO:0017754](http://purl.obolibrary.org/obo/MONDO_0017754) (disorder of porphyrin and haem metabolism), [MONDO:0013397](http://purl.obolibrary.org/obo/MONDO_0013397) (acne inversa, familial, 2), [MONDO:0016422](http://purl.obolibrary.org/obo/MONDO_0016422) (autoimmune polyendocrinopathy type 3), [MONDO:0013398](http://purl.obolibrary.org/obo/MONDO_0013398) (acne inversa, familial, 3), [MONDO:0017753](http://purl.obolibrary.org/obo/MONDO_0017753) (disorder of peroxisomal alpha-, beta- and omega-oxidation), [MONDO:0017756](http://purl.obolibrary.org/obo/MONDO_0017756) (disorder of pterin metabolism), [MONDO:0012062](http://purl.obolibrary.org/obo/MONDO_0012062) (dilated cardiomyopathy 1O), [MONDO:0017755](http://purl.obolibrary.org/obo/MONDO_0017755) (disorder of bilirubin metabolism and excretion), [MONDO:0017750](http://purl.obolibrary.org/obo/MONDO_0017750) (defect in conserved oligomeric Golgi complex), [MONDO:0013393](http://purl.obolibrary.org/obo/MONDO_0013393) (distal 7q11.23 microdeletion syndrome), [MONDO:0012068](http://purl.obolibrary.org/obo/MONDO_0012068) (brachial palsy, familial congenital), [MONDO:0012067](http://purl.obolibrary.org/obo/MONDO_0012067) (asthma-related Traits, susceptibility to, 2), [MONDO:0017752](http://purl.obolibrary.org/obo/MONDO_0017752) (defect in v-ATPase), [MONDO:0013396](http://purl.obolibrary.org/obo/MONDO_0013396) (chromosome 1p32-p31 deletion syndrome), [MONDO:0012066](http://purl.obolibrary.org/obo/MONDO_0012066) (ATFB1), [MONDO:0013390](http://purl.obolibrary.org/obo/MONDO_0013390) (autosomal recessive limb-girdle muscular dystrophy type 2Q), [MONDO:0013391](http://purl.obolibrary.org/obo/MONDO_0013391) (leukoencephalopathy-dystonia-motor neuropathy syndrome), [MONDO:0013392](http://purl.obolibrary.org/obo/MONDO_0013392) (autosomal recessive spinocerebellar ataxia 10), [MONDO:0012061](http://purl.obolibrary.org/obo/MONDO_0012061) (familial sick sinus syndrome), [MONDO:0008800](http://purl.obolibrary.org/obo/MONDO_0008800) (microphthalmia with limb anomalies), [MONDO:0012060](http://purl.obolibrary.org/obo/MONDO_0012060) (autosomal recessive nonsyndromic deafness 35), [MONDO:0008801](http://purl.obolibrary.org/obo/MONDO_0008801) (anosmia for Isobutyric acid), [MONDO:0008802](http://purl.obolibrary.org/obo/MONDO_0008802) (antithrombin, familial hemorrhagic diathesis due to), [MONDO:0008803](http://purl.obolibrary.org/obo/MONDO_0008803) (Antley-Bixler syndrome), [MONDO:0008807](http://purl.obolibrary.org/obo/MONDO_0008807) (apnea, central sleep), [MONDO:0000070](http://purl.obolibrary.org/obo/MONDO_0000070) (mycobacterium tuberculosis, susceptibility), [MONDO:0017758](http://purl.obolibrary.org/obo/MONDO_0017758) (disorder of vitamin and non-protein cofactor absorption and transportB), [MONDO:0017757](http://purl.obolibrary.org/obo/MONDO_0017757) (disorder of metabolite absorption and transport), [MONDO:0017759](http://purl.obolibrary.org/obo/MONDO_0017759) (disorder of catecholamine synthesis), [MONDO:0013386](http://purl.obolibrary.org/obo/MONDO_0013386) (autosomal recessive nonsyndromic deafness 74), [MONDO:0017743](http://purl.obolibrary.org/obo/MONDO_0017743) (disorder of O-N-acetylgalactosaminylglycan synthesis), [MONDO:0017742](http://purl.obolibrary.org/obo/MONDO_0017742) (disorder of O-xylosylglycan synthesis), [MONDO:0013387](http://purl.obolibrary.org/obo/MONDO_0013387) (KCNQ2-related epileptic encephalopathy), [MONDO:0012052](http://purl.obolibrary.org/obo/MONDO_0012052) (ALG1-CDG), [MONDO:0017745](http://purl.obolibrary.org/obo/MONDO_0017745) (disorder of O-mannosylglycan synthesis), [MONDO:0013388](http://purl.obolibrary.org/obo/MONDO_0013388) (epileptic encephalopathy, early infantile, 11), [MONDO:0013389](http://purl.obolibrary.org/obo/MONDO_0013389) (epileptic encephalopathy, early infantile, 12), [MONDO:0017744](http://purl.obolibrary.org/obo/MONDO_0017744) (disorder of O-xylosyl/N-acetylgalactosaminylglycan synthesis), [MONDO:0012051](http://purl.obolibrary.org/obo/MONDO_0012051) (periodontitis, aggressive, 2), [MONDO:0012058](http://purl.obolibrary.org/obo/MONDO_0012058) (myocardial infarction, susceptibility to, 2), [MONDO:0013382](http://purl.obolibrary.org/obo/MONDO_0013382) (progressive demyelinating neuropathy with bilateral striatal necrosis), [MONDO:0012057](http://purl.obolibrary.org/obo/MONDO_0012057) (Legionnaire disease, susceptibility to), [MONDO:0017741](http://purl.obolibrary.org/obo/MONDO_0017741) (disorder of protein O-glycosylation), [MONDO:0017740](http://purl.obolibrary.org/obo/MONDO_0017740) (disorder of protein N-glycosylation), [MONDO:0013385](http://purl.obolibrary.org/obo/MONDO_0013385) (Treacher Collins syndrome 2), [MONDO:0013380](http://purl.obolibrary.org/obo/MONDO_0013380) (leopard syndrome 3), [MONDO:0013381](http://purl.obolibrary.org/obo/MONDO_0013381) (neuropathy, hereditary sensory, type 1D), [MONDO:0012050](http://purl.obolibrary.org/obo/MONDO_0012050) (major depressive disorder 1), [MONDO:0005775](http://purl.obolibrary.org/obo/MONDO_0005775) (glucosephosphate dehydrogenase deficiency), [MONDO:0016419](http://purl.obolibrary.org/obo/MONDO_0016419) (hereditary breast carcinoma), [MONDO:0017747](http://purl.obolibrary.org/obo/MONDO_0017747) (disorder of fucoglycosan synthesis), [MONDO:0017746](http://purl.obolibrary.org/obo/MONDO_0017746) (atypical Rett syndrome), [MONDO:0017749](http://purl.obolibrary.org/obo/MONDO_0017749) (disorder of multiple glycosylation), [MONDO:0016417](http://purl.obolibrary.org/obo/MONDO_0016417) (congenital ichthyosis-microcephalus-tetraplegia syndrome), [MONDO:0017748](http://purl.obolibrary.org/obo/MONDO_0017748) (disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation), [MONDO:0020504](http://purl.obolibrary.org/obo/MONDO_0020504) (genetic recurrent myoglobinuria), [MONDO:0016485](http://purl.obolibrary.org/obo/MONDO_0016485) (Usher syndrome type 3), [MONDO:0016484](http://purl.obolibrary.org/obo/MONDO_0016484) (Usher syndrome type 2), [MONDO:0016487](http://purl.obolibrary.org/obo/MONDO_0016487) (beta-thalassemia intermedia), [MONDO:0008860](http://purl.obolibrary.org/obo/MONDO_0008860) (beta-Aminoisobutyric acid, urinary excretion of), [MONDO:0016486](http://purl.obolibrary.org/obo/MONDO_0016486) (beta-thalassemia major), [MONDO:0016481](http://purl.obolibrary.org/obo/MONDO_0016481) (silver-Russell syndrome due to 11p15 microduplication), [MONDO:0008861](http://purl.obolibrary.org/obo/MONDO_0008861) (3-Methylcrotonyl-Coa carboxylase 1 deficiency), [MONDO:0016480](http://purl.obolibrary.org/obo/MONDO_0016480) (silver-Russell syndrome due to an imprinting defect of 11p15), [MONDO:0008862](http://purl.obolibrary.org/obo/MONDO_0008862) (3-Methylcrotonyl-Coa carboxylase 2 deficiency), [MONDO:0015151](http://purl.obolibrary.org/obo/MONDO_0015151) (autosomal dominant limb-girdle muscular dystrophy), [MONDO:0008863](http://purl.obolibrary.org/obo/MONDO_0008863) (sitosterolemia), [MONDO:0015152](http://purl.obolibrary.org/obo/MONDO_0015152) (autosomal recessive limb-girdle muscular dystrophy), [MONDO:0016482](http://purl.obolibrary.org/obo/MONDO_0016482) (silver-Russell syndrome due to maternal uniparental disomy of chromosome 11), [MONDO:0008866](http://purl.obolibrary.org/obo/MONDO_0008866) (bifid nose, autosomal recessive), [MONDO:0008868](http://purl.obolibrary.org/obo/MONDO_0008868) (biliary malformation with renal tubular insufficiency), [MONDO:0007526](http://purl.obolibrary.org/obo/MONDO_0007526) (Ehlers-Danlos syndrome progeroid type), [MONDO:0008869](http://purl.obolibrary.org/obo/MONDO_0008869) (Seckel syndrome 1), [MONDO:0007524](http://purl.obolibrary.org/obo/MONDO_0007524) (autosomal dominant Ehlers-Danlos syndrome, vascular type), [MONDO:0007521](http://purl.obolibrary.org/obo/MONDO_0007521) (Egasyn), [MONDO:0007520](http://purl.obolibrary.org/obo/MONDO_0007520) (ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 1), [MONDO:0019517](http://purl.obolibrary.org/obo/MONDO_0019517) (Waardenburg syndrome type 2), [MONDO:0016478](http://purl.obolibrary.org/obo/MONDO_0016478) (Beckwith-Wiedemann syndrome due to 11p15 translocation/inversion), [MONDO:0016477](http://purl.obolibrary.org/obo/MONDO_0016477) (Beckwith-Wiedemann syndrome due to 11p15 microdeletion), [MONDO:0019502](http://purl.obolibrary.org/obo/MONDO_0019502) (autosomal recessive non-syndromic intellectual disability), [MONDO:0016479](http://purl.obolibrary.org/obo/MONDO_0016479) (silver-Russell syndrome due to 7p11.2p13 microduplication), [MONDO:0000909](http://purl.obolibrary.org/obo/MONDO_0000909) (Bartter disease type 4b), [MONDO:0019501](http://purl.obolibrary.org/obo/MONDO_0019501) (Usher syndrome), [MONDO:0016473](http://purl.obolibrary.org/obo/MONDO_0016473) (familial rhabdoid tumor), [MONDO:0016476](http://purl.obolibrary.org/obo/MONDO_0016476) (Beckwith-Wiedemann syndrome due to CDKN1C mutation), [MONDO:0016475](http://purl.obolibrary.org/obo/MONDO_0016475) (Beckwith-Wiedemann syndrome due to imprinting defect of 11p15), [MONDO:0016471](http://purl.obolibrary.org/obo/MONDO_0016471) (pachyonychia congenita), [MONDO:0008854](http://purl.obolibrary.org/obo/MONDO_0008854) (Bardet-Biedl syndrome 1), [MONDO:0008855](http://purl.obolibrary.org/obo/MONDO_0008855) (MHC class II deficiency), [MONDO:0007539](http://purl.obolibrary.org/obo/MONDO_0007539) (encephalopathy, recurrent, of childhood), [MONDO:0007538](http://purl.obolibrary.org/obo/MONDO_0007538) (hypocalcified amelogenesis imperfecta), [MONDO:0008859](http://purl.obolibrary.org/obo/MONDO_0008859) (berry aneurysm, cirrhosis, pulmonary emphysema, and cerebral calcification), [MONDO:0007535](http://purl.obolibrary.org/obo/MONDO_0007535) (emphysema, hereditary pulmonary), [MONDO:0007534](http://purl.obolibrary.org/obo/MONDO_0007534) (Beckwith-Wiedemann syndrome), [MONDO:0007532](http://purl.obolibrary.org/obo/MONDO_0007532) (Electroencephalographic Peculiarity: occipital slow beta waves), [MONDO:0007531](http://purl.obolibrary.org/obo/MONDO_0007531) (Electroencephalographic Peculiarity: fronto-Precentral beta wave Groups), [MONDO:0007530](http://purl.obolibrary.org/obo/MONDO_0007530) (Electroencephalographic Peculiarity: 14 and 6 Per Sec. positive spike phenomenon), [MONDO:0015131](http://purl.obolibrary.org/obo/MONDO_0015131) (congenital combined immunodeficiency), [MONDO:0016464](http://purl.obolibrary.org/obo/MONDO_0016464) (insulin-resistance syndrome type b), [MONDO:0017790](http://purl.obolibrary.org/obo/MONDO_0017790) (gastric adenocarcinoma and proximal polyposis of the stomach), [MONDO:0008840](http://purl.obolibrary.org/obo/MONDO_0008840) (ataxia telangiectasia), [MONDO:0008841](http://purl.obolibrary.org/obo/MONDO_0008841) (ataxia-telangiectasia with generalized skin pigmentation and early death), [MONDO:0008842](http://purl.obolibrary.org/obo/MONDO_0008842) (ataxia with oculomotor apraxia type 1), [MONDO:0007509](http://purl.obolibrary.org/obo/MONDO_0007509) (ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant), [MONDO:0007508](http://purl.obolibrary.org/obo/MONDO_0007508) (Rapp-Hodgkin syndrome), [MONDO:0008844](http://purl.obolibrary.org/obo/MONDO_0008844) (Athrombia, essential), [MONDO:0008845](http://purl.obolibrary.org/obo/MONDO_0008845) (atonic-Astatic syndrome of Foerster), [MONDO:0007506](http://purl.obolibrary.org/obo/MONDO_0007506) (E11S), [MONDO:0008846](http://purl.obolibrary.org/obo/MONDO_0008846) (atransferrinemia), [MONDO:0007505](http://purl.obolibrary.org/obo/MONDO_0007505) (Earring holes, natural), [MONDO:0007504](http://purl.obolibrary.org/obo/MONDO_0007504) (thickened earlobes-conductive deafness syndrome), [MONDO:0008848](http://purl.obolibrary.org/obo/MONDO_0008848) (atrioventricular dissociation (disease)), [MONDO:0007502](http://purl.obolibrary.org/obo/MONDO_0007502) (ear pits, posterior Helical), [MONDO:0003147](http://purl.obolibrary.org/obo/MONDO_0003147) (space motion sickness), [MONDO:0007501](http://purl.obolibrary.org/obo/MONDO_0007501) (preauricular fistulae, congenital), [MONDO:0007500](http://purl.obolibrary.org/obo/MONDO_0007500) (ear malformation), [MONDO:0012098](http://purl.obolibrary.org/obo/MONDO_0012098) (spinocerebellar ataxia type 20), [MONDO:0012097](http://purl.obolibrary.org/obo/MONDO_0012097) (spondylocostal dysostosis 2, autosomal recessive), [MONDO:0017782](http://purl.obolibrary.org/obo/MONDO_0017782) (developmental and speech delay due to SOX5 deficiency), [MONDO:0016454](http://purl.obolibrary.org/obo/MONDO_0016454) (severe early-onset axonal neuropathy due to NEFL deficiency), [MONDO:0012099](http://purl.obolibrary.org/obo/MONDO_0012099) (AICA-ribosiduria), [MONDO:0015123](http://purl.obolibrary.org/obo/MONDO_0015123) (rare dyslipidemia), [MONDO:0012090](http://purl.obolibrary.org/obo/MONDO_0012090) (autosomal dominant nonsyndromic deafness 47), [MONDO:0017781](http://purl.obolibrary.org/obo/MONDO_0017781) (12p12.1 microdeletion syndrome), [MONDO:0008830](http://purl.obolibrary.org/obo/MONDO_0008830) (aspartylglucosaminuria), [MONDO:0008831](http://purl.obolibrary.org/obo/MONDO_0008831) (asphyxiating thoracic dystrophy 1), [MONDO:0007518](http://purl.obolibrary.org/obo/MONDO_0007518) (edema, familial idiopathic, prepubertal), [MONDO:0012092](http://purl.obolibrary.org/obo/MONDO_0012092) (hereditary sensory and autonomic neuropathy type 5), [MONDO:0008834](http://purl.obolibrary.org/obo/MONDO_0008834) (asthma, nasal polyps, and Aspirin intolerance), [MONDO:0007517](http://purl.obolibrary.org/obo/MONDO_0007517) (ectrodactyly-cleft palate syndrome), [MONDO:0007516](http://purl.obolibrary.org/obo/MONDO_0007516) (ectrodactyly and ectodermal dysplasia without cleft lip/palate), [MONDO:0008835](http://purl.obolibrary.org/obo/MONDO_0008835) (asthma, short stature, and elevated Iga), [MONDO:0012091](http://purl.obolibrary.org/obo/MONDO_0012091) (autosomal recessive nonsyndromic deafness 32), [MONDO:0007515](http://purl.obolibrary.org/obo/MONDO_0007515) (ectopia pupillae (disease)), [MONDO:0008836](http://purl.obolibrary.org/obo/MONDO_0008836) (ataxia with myoclonic epilepsy and presenile dementia), [MONDO:0008837](http://purl.obolibrary.org/obo/MONDO_0008837) (ataxia, deafness, and cardiomyopathy), [MONDO:0008838](http://purl.obolibrary.org/obo/MONDO_0008838) (ataxia-deafness-intellectual disability syndrome), [MONDO:0007513](http://purl.obolibrary.org/obo/MONDO_0007513) (ectodermal dysplasia with adrenal cyst), [MONDO:0007512](http://purl.obolibrary.org/obo/MONDO_0007512) (ectodermal dysplasia syndrome with distinctive facial appearance and preaxial polydactyly of feet), [MONDO:0008839](http://purl.obolibrary.org/obo/MONDO_0008839) (ataxia-microcephaly-cataract syndrome), [MONDO:0007510](http://purl.obolibrary.org/obo/MONDO_0007510) (Clouston syndrome), [MONDO:0018226](http://purl.obolibrary.org/obo/MONDO_0018226) (infantile epileptic-dyskinetic encephalopathy), [MONDO:0015198](http://purl.obolibrary.org/obo/MONDO_0015198) (aniridia-ptosis-intellectual disability-familial obesity syndrome), [MONDO:0015199](http://purl.obolibrary.org/obo/MONDO_0015199) (aniridia-intellectual disability syndrome), [MONDO:0018222](http://purl.obolibrary.org/obo/MONDO_0018222) (X-linked intellectual disability due to GRIA3 anomalies), [MONDO:0018220](http://purl.obolibrary.org/obo/MONDO_0018220) (glycogen storage disease due to glucose-6-phosphatase deficiency), [MONDO:0019550](http://purl.obolibrary.org/obo/MONDO_0019550) (hereditary motor and sensory neuropathy with acrodystrophy), [MONDO:0012928](http://purl.obolibrary.org/obo/MONDO_0012928) (hereditary spastic paraplegia 42), [MONDO:0012927](http://purl.obolibrary.org/obo/MONDO_0012927) (chromosome 1q41-q42 deletion syndrome), [MONDO:0007569](http://purl.obolibrary.org/obo/MONDO_0007569) (erythema nodosum, familial), [MONDO:0012926](http://purl.obolibrary.org/obo/MONDO_0012926) (amelogenesis imperfecta hypomaturation type 2A2), [MONDO:0012925](http://purl.obolibrary.org/obo/MONDO_0012925) (Diamond-Blackfan anemia 5), [MONDO:0007567](http://purl.obolibrary.org/obo/MONDO_0007567) (Epstein-Barr virus Insertion site 1), [MONDO:0007565](http://purl.obolibrary.org/obo/MONDO_0007565) (familial cylindromatosis), [MONDO:0007563](http://purl.obolibrary.org/obo/MONDO_0007563) (epistaxis, hereditary), [MONDO:0012924](http://purl.obolibrary.org/obo/MONDO_0012924) (Diamond-Blackfan anemia 4), [MONDO:0012923](http://purl.obolibrary.org/obo/MONDO_0012923) (congenital generalized lipodystrophy type 3), [MONDO:0012922](http://purl.obolibrary.org/obo/MONDO_0012922) (IHPS5), [MONDO:0019548](http://purl.obolibrary.org/obo/MONDO_0019548) (autosomal dominant intermediate Charcot-Marie-tooth disease), [MONDO:0019549](http://purl.obolibrary.org/obo/MONDO_0019549) (severe early-onset axonal neuropathy due to MFN2 deficiency), [MONDO:0008890](http://purl.obolibrary.org/obo/MONDO_0008890) (progressive bulbar palsy), [MONDO:0018213](http://purl.obolibrary.org/obo/MONDO_0018213) (hereditary sensory and autonomic neuropathy type 1), [MONDO:0008891](http://purl.obolibrary.org/obo/MONDO_0008891) (riboflavin transporter deficiency), [MONDO:0008892](http://purl.obolibrary.org/obo/MONDO_0008892) (progressive familial intrahepatic cholestasis type 1), [MONDO:0018212](http://purl.obolibrary.org/obo/MONDO_0018212) (familial cervical artery dissection), [MONDO:0020531](http://purl.obolibrary.org/obo/MONDO_0020531) (long chain acyl-CoA dehydrogenase deficiency), [MONDO:0008897](http://purl.obolibrary.org/obo/MONDO_0008897) (hyperphosphatemic familial tumoral calcinosis), [MONDO:0015185](http://purl.obolibrary.org/obo/MONDO_0015185) (intestinal polyposis syndrome), [MONDO:0008898](http://purl.obolibrary.org/obo/MONDO_0008898) (camptodactyly syndrome, Guadalajara type 1), [MONDO:0008899](http://purl.obolibrary.org/obo/MONDO_0008899) (camptodactyly syndrome, Guadalajara type 2), [MONDO:0012917](http://purl.obolibrary.org/obo/MONDO_0012917) (SLI4), [MONDO:0012916](http://purl.obolibrary.org/obo/MONDO_0012916) (chromosome 2p16.1-p15 deletion syndrome), [MONDO:0012915](http://purl.obolibrary.org/obo/MONDO_0012915) (chromosome 1q21.1 duplication syndrome), [MONDO:0007579](http://purl.obolibrary.org/obo/MONDO_0007579) (esterase C), [MONDO:0007578](http://purl.obolibrary.org/obo/MONDO_0007578) (esterase B), [MONDO:0012914](http://purl.obolibrary.org/obo/MONDO_0012914) (chromosome 1q21.1 deletion syndrome), [MONDO:0007577](http://purl.obolibrary.org/obo/MONDO_0007577) (esophageal ring, lower), [MONDO:0007574](http://purl.obolibrary.org/obo/MONDO_0007574) (spinocerebellar ataxia type 34), [MONDO:0012918](http://purl.obolibrary.org/obo/MONDO_0012918) (primary ciliary dyskinesia 10), [MONDO:0007573](http://purl.obolibrary.org/obo/MONDO_0007573) (acute erythroleukemia, familial), [MONDO:0007571](http://purl.obolibrary.org/obo/MONDO_0007571) (primary erythermalgia), [MONDO:0012913](http://purl.obolibrary.org/obo/MONDO_0012913) (wilms tumor, aniridia, genitourinary anomalies, mental retardation, and obesity syndrome), [MONDO:0012912](http://purl.obolibrary.org/obo/MONDO_0012912) (pseudopseudohypoparathyroidism), [MONDO:0012911](http://purl.obolibrary.org/obo/MONDO_0012911) (pseudohypoparathyroidism type 1C), [MONDO:0012910](http://purl.obolibrary.org/obo/MONDO_0012910) (ARHI1), [MONDO:0008880](http://purl.obolibrary.org/obo/MONDO_0008880) (Bowen syndrome of multiple malformations), [MONDO:0008883](http://purl.obolibrary.org/obo/MONDO_0008883) (brachydactyly, type A2, with microcephaly), [MONDO:0000911](http://purl.obolibrary.org/obo/MONDO_0000911) (dilated cardiomyopathy 1T), [MONDO:0000912](http://purl.obolibrary.org/obo/MONDO_0000912) (autosomal recessive nonsyndromic deafness 5), [MONDO:0008886](http://purl.obolibrary.org/obo/MONDO_0008886) (Sabinas brittle hair syndrome), [MONDO:0020523](http://purl.obolibrary.org/obo/MONDO_0020523) (familial parathyroid adenoma), [MONDO:0020525](http://purl.obolibrary.org/obo/MONDO_0020525) (transient neonatal diabetes mellitus (disease)), [MONDO:0007549](http://purl.obolibrary.org/obo/MONDO_0007549) (generalized dominant dystrophic epidermolysis bullosa), [MONDO:0007548](http://purl.obolibrary.org/obo/MONDO_0007548) (transient bullous dermolysis of the newborn), [MONDO:0012906](http://purl.obolibrary.org/obo/MONDO_0012906) (primary ciliary dyskinesia 9), [MONDO:0007547](http://purl.obolibrary.org/obo/MONDO_0007547) (epidermoid cysts), [MONDO:0012903](http://purl.obolibrary.org/obo/MONDO_0012903) (autosomal recessive nonsyndromic deafness 45), [MONDO:0007545](http://purl.obolibrary.org/obo/MONDO_0007545) (Eosinophilopenia), [MONDO:0007544](http://purl.obolibrary.org/obo/MONDO_0007544) (eosinophilia, familial), [MONDO:0012909](http://purl.obolibrary.org/obo/MONDO_0012909) (skeletal defects, genital hypoplasia, and mental retardation), [MONDO:0007543](http://purl.obolibrary.org/obo/MONDO_0007543) (enolase, sperm specific), [MONDO:0007541](http://purl.obolibrary.org/obo/MONDO_0007541) (endometriosis, susceptibility to, 1), [MONDO:0007540](http://purl.obolibrary.org/obo/MONDO_0007540) (multiple endocrine neoplasia type 1), [MONDO:0012902](http://purl.obolibrary.org/obo/MONDO_0012902) (autosomal dominant nonsyndromic deafness 27), [MONDO:0012900](http://purl.obolibrary.org/obo/MONDO_0012900) (cardiomyopathy, familial restrictive, 3), [MONDO:0018208](http://purl.obolibrary.org/obo/MONDO_0018208) (neurofibromatosis type 1 due to NF1 mutation or intragenic deletion), [MONDO:0015169](http://purl.obolibrary.org/obo/MONDO_0015169) (chronic diarrhea due to glucoamylase deficiency), [MONDO:0019524](http://purl.obolibrary.org/obo/MONDO_0019524) (infantile Bartter syndrome with sensorineural deafness), [MONDO:0019522](http://purl.obolibrary.org/obo/MONDO_0019522) (recessive dystrophic epidermolysis bullosa-generalized other), [MONDO:0019523](http://purl.obolibrary.org/obo/MONDO_0019523) (Walker-Warburg syndrome), [MONDO:0019521](http://purl.obolibrary.org/obo/MONDO_0019521) (centripetalis recessive dystrophic epidermolysis bullosa), [MONDO:0008872](http://purl.obolibrary.org/obo/MONDO_0008872) (microcephalic osteodysplastic primordial dwarfism type II), [MONDO:0008876](http://purl.obolibrary.org/obo/MONDO_0008876) (Bloom syndrome), [MONDO:0008877](http://purl.obolibrary.org/obo/MONDO_0008877) (blue diaper syndrome), [MONDO:0008879](http://purl.obolibrary.org/obo/MONDO_0008879) (Bowen-Conradi syndrome), [MONDO:0007557](http://purl.obolibrary.org/obo/MONDO_0007557) (epidermolysis bullosa with congenital localized absence of skin and deformity of nails), [MONDO:0007556](http://purl.obolibrary.org/obo/MONDO_0007556) (epidermolysis bullosa simplex with mottled pigmentation), [MONDO:0007555](http://purl.obolibrary.org/obo/MONDO_0007555) (epidermolysis bullosa simplex Ogna type), [MONDO:0007554](http://purl.obolibrary.org/obo/MONDO_0007554) (generalized epidermolysis bullosa simplex, non-Dowling-Meara type), [MONDO:0007553](http://purl.obolibrary.org/obo/MONDO_0007553) (epidermolysis bullosa with deficiency of Galactosylhydroxylysyl Glucosyltransferase), [MONDO:0006221](http://purl.obolibrary.org/obo/MONDO_0006221) (gastric adenoma), [MONDO:0007552](http://purl.obolibrary.org/obo/MONDO_0007552) (pretibial dystrophic epidermolysis bullosa), [MONDO:0007551](http://purl.obolibrary.org/obo/MONDO_0007551) (localized epidermolysis bullosa simplex), [MONDO:0007550](http://purl.obolibrary.org/obo/MONDO_0007550) (epidermolysis bullosa simplex Dowling-Meara type), [MONDO:0012960](http://purl.obolibrary.org/obo/MONDO_0012960) (mental retardation, autosomal dominant 5), [MONDO:0019597](http://purl.obolibrary.org/obo/MONDO_0019597) (46,XY disorder of sex development due to isolated 17,20-lyase deficiency), [MONDO:0009311](http://purl.obolibrary.org/obo/MONDO_0009311) (grouped pigmentation of the retina), [MONDO:0018264](http://purl.obolibrary.org/obo/MONDO_0018264) (oculocutaneous albinism type 6), [MONDO:0009314](http://purl.obolibrary.org/obo/MONDO_0009314) (GTP cyclohydrolase i deficiency), [MONDO:0009315](http://purl.obolibrary.org/obo/MONDO_0009315) (congenital factor XII deficiency), [MONDO:0009317](http://purl.obolibrary.org/obo/MONDO_0009317) (nonphotosensitive trichothiodystrophy), [MONDO:0009319](http://purl.obolibrary.org/obo/MONDO_0009319) (pantothenate kinase-associated neurodegeneration), [MONDO:0011639](http://purl.obolibrary.org/obo/MONDO_0011639) (Diamond-Blackfan anemia 15 with mandibulofacial dysostosis), [MONDO:0012969](http://purl.obolibrary.org/obo/MONDO_0012969) (Microvascular complications of diabetes, susceptibility to, 5), [MONDO:0010308](http://purl.obolibrary.org/obo/MONDO_0010308) (thrombocytopenia, X-linked, with or without dyserythropoietic anemia), [MONDO:0011638](http://purl.obolibrary.org/obo/MONDO_0011638) (neuroferritinopathy), [MONDO:0010301](http://purl.obolibrary.org/obo/MONDO_0010301) (THCYTX), [MONDO:0012964](http://purl.obolibrary.org/obo/MONDO_0012964) (chromosome 15q26-qter deletion syndrome), [MONDO:0012963](http://purl.obolibrary.org/obo/MONDO_0012963) (Microvascular complications of diabetes, susceptibility to, 3), [MONDO:0012962](http://purl.obolibrary.org/obo/MONDO_0012962) (Microvascular complications of diabetes, susceptibility to, 2), [MONDO:0011631](http://purl.obolibrary.org/obo/MONDO_0011631) (hemochromatosis type 4), [MONDO:0010305](http://purl.obolibrary.org/obo/MONDO_0010305) (creatine transporter deficiency), [MONDO:0011637](http://purl.obolibrary.org/obo/MONDO_0011637) (Sener syndrome), [MONDO:0012968](http://purl.obolibrary.org/obo/MONDO_0012968) (Usher syndrome type 1H), [MONDO:0011636](http://purl.obolibrary.org/obo/MONDO_0011636) (DBA2), [MONDO:0010306](http://purl.obolibrary.org/obo/MONDO_0010306) (X-linked intellectual disability, Cabezas type), [MONDO:0012966](http://purl.obolibrary.org/obo/MONDO_0012966) (Microvascular complications of diabetes, susceptibility to, 4), [MONDO:0011635](http://purl.obolibrary.org/obo/MONDO_0011635) (MNG3), [MONDO:0018257](http://purl.obolibrary.org/obo/MONDO_0018257) (familial syringomyelia), [MONDO:0019588](http://purl.obolibrary.org/obo/MONDO_0019588) (autosomal recessive nonsyndromic deafness), [MONDO:0019586](http://purl.obolibrary.org/obo/MONDO_0019586) (X-linked nonsyndromic deafness), [MONDO:0019587](http://purl.obolibrary.org/obo/MONDO_0019587) (autosomal dominant nonsyndromic deafness), [MONDO:0009300](http://purl.obolibrary.org/obo/MONDO_0009300) (Perrault syndrome 1), [MONDO:0020573](http://purl.obolibrary.org/obo/MONDO_0020573) (genetic predisposition to disease), [MONDO:0018251](http://purl.obolibrary.org/obo/MONDO_0018251) (glycogen storage disease due to phosphorylase kinase deficiency), [MONDO:0018252](http://purl.obolibrary.org/obo/MONDO_0018252) (focal palmoplantar keratoderma with joint keratoses), [MONDO:0009305](http://purl.obolibrary.org/obo/MONDO_0009305) (granulocytopenia with immunoglobulin abnormality), [MONDO:0009306](http://purl.obolibrary.org/obo/MONDO_0009306) (combined immunodeficiency with skin granulomas), [MONDO:0018250](http://purl.obolibrary.org/obo/MONDO_0018250) (diffuse palmoplantar keratoderma with painful fissures), [MONDO:0000984](http://purl.obolibrary.org/obo/MONDO_0000984) (thalassemia), [MONDO:0011629](http://purl.obolibrary.org/obo/MONDO_0011629) (MOGS-CDG), [MONDO:0012959](http://purl.obolibrary.org/obo/MONDO_0012959) (PSORS11), [MONDO:0011628](http://purl.obolibrary.org/obo/MONDO_0011628) (propionic acidemia), [MONDO:0012953](http://purl.obolibrary.org/obo/MONDO_0012953) (colorectal cancer, susceptibility to, 10), [MONDO:0011622](http://purl.obolibrary.org/obo/MONDO_0011622) (nephrolithiasis, Uric acid, susceptibility to), [MONDO:0011626](http://purl.obolibrary.org/obo/MONDO_0011626) (acromegaloid features, overgrowth, cleft palate, and hernia), [MONDO:0011625](http://purl.obolibrary.org/obo/MONDO_0011625) (autosomal dominant nonsyndromic deafness 18), [MONDO:0011624](http://purl.obolibrary.org/obo/MONDO_0011624) (transaldolase deficiency), [MONDO:0011623](http://purl.obolibrary.org/obo/MONDO_0011623) (spinocerebellar ataxia, autosomal recessive 1), [MONDO:0018248](http://purl.obolibrary.org/obo/MONDO_0018248) (intellectual disability-seizures-macrocephaly-obesity syndrome), [MONDO:0018247](http://purl.obolibrary.org/obo/MONDO_0018247) (CADDS), [MONDO:0018244](http://purl.obolibrary.org/obo/MONDO_0018244) (obesity due to SIM1 deficiency), [MONDO:0019573](http://purl.obolibrary.org/obo/MONDO_0019573) (autosomal recessive cutis laxa type 2), [MONDO:0019571](http://purl.obolibrary.org/obo/MONDO_0019571) (autosomal dominant cutis laxa), [MONDO:0019570](http://purl.obolibrary.org/obo/MONDO_0019570) (Cockayne syndrome type 2), [MONDO:0020569](http://purl.obolibrary.org/obo/MONDO_0020569) (intermediate DEND syndrome), [MONDO:0011619](http://purl.obolibrary.org/obo/MONDO_0011619) (crumpled helices and small mouth), [MONDO:0011618](http://purl.obolibrary.org/obo/MONDO_0011618) (liver fibrocystic disease and polydactyly), [MONDO:0012948](http://purl.obolibrary.org/obo/MONDO_0012948) (chromosome 6pter-p24 deletion syndrome), [MONDO:0011617](http://purl.obolibrary.org/obo/MONDO_0011617) (arthropathy, erosive), [MONDO:0012947](http://purl.obolibrary.org/obo/MONDO_0012947) (mental retardation, autosomal dominant 4), [MONDO:0007586](http://purl.obolibrary.org/obo/MONDO_0007586) (exostoses, multiple, type 2), [MONDO:0007585](http://purl.obolibrary.org/obo/MONDO_0007585) (exostoses, multiple, type 1), [MONDO:0011611](http://purl.obolibrary.org/obo/MONDO_0011611) (short stature, mental retardation, Callosal agenesis, Heminasal hypoplasia, microphthalmia, and atypical clefting), [MONDO:0011610](http://purl.obolibrary.org/obo/MONDO_0011610) (Dimethylglycine dehydrogenase deficiency), [MONDO:0007583](http://purl.obolibrary.org/obo/MONDO_0007583) (exostoses of heel), [MONDO:0007581](http://purl.obolibrary.org/obo/MONDO_0007581) (exchondrosis of pinna, posterior), [MONDO:0012946](http://purl.obolibrary.org/obo/MONDO_0012946) (mental retardation, autosomal dominant 3), [MONDO:0007580](http://purl.obolibrary.org/obo/MONDO_0007580) (esterase Es-2, Regulator for), [MONDO:0012945](http://purl.obolibrary.org/obo/MONDO_0012945) (amyotrophic lateral sclerosis type 11), [MONDO:0011614](http://purl.obolibrary.org/obo/MONDO_0011614) (3-hydroxy-3-methylglutaryl-CoA synthase deficiency), [MONDO:0011612](http://purl.obolibrary.org/obo/MONDO_0011612) (glycine encephalopathy), [MONDO:0019569](http://purl.obolibrary.org/obo/MONDO_0019569) (Cockayne syndrome type 1), [MONDO:0011608](http://purl.obolibrary.org/obo/MONDO_0011608) (atopic dermatitis 5), [MONDO:0012939](http://purl.obolibrary.org/obo/MONDO_0012939) (Diamond-Blackfan anemia 8), [MONDO:0012938](http://purl.obolibrary.org/obo/MONDO_0012938) (Diamond-Blackfan anemia 7), [MONDO:0011606](http://purl.obolibrary.org/obo/MONDO_0011606) (baby rattle pelvis dysplasia), [MONDO:0012937](http://purl.obolibrary.org/obo/MONDO_0012937) (Diamond-Blackfan anemia 6), [MONDO:0007599](http://purl.obolibrary.org/obo/MONDO_0007599) (factor 9 and Factor XI, combined deficiency of), [MONDO:0007598](http://purl.obolibrary.org/obo/MONDO_0007598) (factors VIII, IX and XI, combined deficiency of), [MONDO:0007597](http://purl.obolibrary.org/obo/MONDO_0007597) (factor VIII and Factor IX, combined deficiency of), [MONDO:0011609](http://purl.obolibrary.org/obo/MONDO_0011609) (atopic dermatitis 6), [MONDO:0007594](http://purl.obolibrary.org/obo/MONDO_0007594) (factor 5 excess with spontaneous thrombosis), [MONDO:0007593](http://purl.obolibrary.org/obo/MONDO_0007593) (facial spasm), [MONDO:0007591](http://purl.obolibrary.org/obo/MONDO_0007591) (facial hypertrichosis (disease)), [MONDO:0011603](http://purl.obolibrary.org/obo/MONDO_0011603) (GNE myopathy), [MONDO:0012933](http://purl.obolibrary.org/obo/MONDO_0012933) (breast-ovarian cancer, familial, susceptibility to, 2), [MONDO:0011602](http://purl.obolibrary.org/obo/MONDO_0011602) (autosomal recessive nonsyndromic deafness 27), [MONDO:0012932](http://purl.obolibrary.org/obo/MONDO_0012932) (MYP16), [MONDO:0011601](http://purl.obolibrary.org/obo/MONDO_0011601) (neonatal intrahepatic cholestasis due to citrin deficiency), [MONDO:0009351](http://purl.obolibrary.org/obo/MONDO_0009351) (homocarnosinosis), [MONDO:0008020](http://purl.obolibrary.org/obo/MONDO_0008020) (multiple exostoses with spastic Tetraparesis), [MONDO:0009352](http://purl.obolibrary.org/obo/MONDO_0009352) (classic homocystinuria), [MONDO:0011673](http://purl.obolibrary.org/obo/MONDO_0011673) (autosomal dominant nonsyndromic deafness 30), [MONDO:0008021](http://purl.obolibrary.org/obo/MONDO_0008021) (Cowden syndrome 1), [MONDO:0009353](http://purl.obolibrary.org/obo/MONDO_0009353) (homocystinuria due to methylene tetrahydrofolate reductase deficiency), [MONDO:0008022](http://purl.obolibrary.org/obo/MONDO_0008022) (muscle cramps, familial), [MONDO:0009354](http://purl.obolibrary.org/obo/MONDO_0009354) (methylcobalamin deficiency type cblE), [MONDO:0008024](http://purl.obolibrary.org/obo/MONDO_0008024) (neuronopathy, distal hereditary motor, type 7A), [MONDO:0010340](http://purl.obolibrary.org/obo/MONDO_0010340) (Asperger syndrome, X-linked, susceptibility to, 1), [MONDO:0009355](http://purl.obolibrary.org/obo/MONDO_0009355) (Hooft disease), [MONDO:0009356](http://purl.obolibrary.org/obo/MONDO_0009356) (autosomal recessive humeroradial synostosis), [MONDO:0008025](http://purl.obolibrary.org/obo/MONDO_0008025) (neuronopathy, distal hereditary motor, type 2A), [MONDO:0008026](http://purl.obolibrary.org/obo/MONDO_0008026) (autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures), [MONDO:0009358](http://purl.obolibrary.org/obo/MONDO_0009358) (Hutterite cerebroosteonephrodysplasia syndrome), [MONDO:0008027](http://purl.obolibrary.org/obo/MONDO_0008027) (muscular atrophy, malignant neurogenic), [MONDO:0009359](http://purl.obolibrary.org/obo/MONDO_0009359) (hydranencephaly with renal aplasia-dysplasia), [MONDO:0014707](http://purl.obolibrary.org/obo/MONDO_0014707) (chromosome 14Q32 duplication syndrome, 700-Kb), [MONDO:0014709](http://purl.obolibrary.org/obo/MONDO_0014709) (Heimler syndrome 2), [MONDO:0011677](http://purl.obolibrary.org/obo/MONDO_0011677) (Megarbane syndrome), [MONDO:0010343](http://purl.obolibrary.org/obo/MONDO_0010343) (Asperger syndrome, X-linked, susceptibility to, 2), [MONDO:0011675](http://purl.obolibrary.org/obo/MONDO_0011675) (Charcot-Marie-tooth disease dominant intermediate a), [MONDO:0011674](http://purl.obolibrary.org/obo/MONDO_0011674) (Charcot-Marie-tooth disease dominant intermediate b), [MONDO:0014706](http://purl.obolibrary.org/obo/MONDO_0014706) (cutis laxa, autosomal dominant 3), [MONDO:0014701](http://purl.obolibrary.org/obo/MONDO_0014701) (spondyloepiphyseal dysplasia, Stanescu type), [MONDO:0014702](http://purl.obolibrary.org/obo/MONDO_0014702) (hereditary spastic paraplegia 9B), [MONDO:0010348](http://purl.obolibrary.org/obo/MONDO_0010348) (DYX9), [MONDO:0011678](http://purl.obolibrary.org/obo/MONDO_0011678) (homozygous 11P15-P14 deletion syndrome), [MONDO:0008010](http://purl.obolibrary.org/obo/MONDO_0008010) (antigen Defined by monoclonal antibody Aj9), [MONDO:0011662](http://purl.obolibrary.org/obo/MONDO_0011662) (pathological gambling), [MONDO:0012992](http://purl.obolibrary.org/obo/MONDO_0012992) (pancreatic insufficiency-anemia-hyperostosis syndrome), [MONDO:0008011](http://purl.obolibrary.org/obo/MONDO_0008011) (antigen Defined by monoclonal antibody T87), [MONDO:0010331](http://purl.obolibrary.org/obo/MONDO_0010331) (coronary heart disease, susceptibility to, 3), [MONDO:0008012](http://purl.obolibrary.org/obo/MONDO_0008012) (Monophalangy of great toe), [MONDO:0012991](http://purl.obolibrary.org/obo/MONDO_0012991) (Kahrizi syndrome), [MONDO:0011660](http://purl.obolibrary.org/obo/MONDO_0011660) (autosomal dominant nonsyndromic deafness 22), [MONDO:0009343](http://purl.obolibrary.org/obo/MONDO_0009343) (Hirschsprung disease with ulnar polydactyly, polysyndactyly of Big toes, and ventricular septal defect), [MONDO:0008013](http://purl.obolibrary.org/obo/MONDO_0008013) (chromosome 9p deletion syndrome), [MONDO:0009345](http://purl.obolibrary.org/obo/MONDO_0009345) (histidinemia), [MONDO:0008014](http://purl.obolibrary.org/obo/MONDO_0008014) (Nondisjunction), [MONDO:0008015](http://purl.obolibrary.org/obo/MONDO_0008015) (motion sickness), [MONDO:0009346](http://purl.obolibrary.org/obo/MONDO_0009346) (histidinuria due to a renal tubular defect), [MONDO:0018295](http://purl.obolibrary.org/obo/MONDO_0018295) (congenital disorder of glycosylation with deafness as a major feature), [MONDO:0009347](http://purl.obolibrary.org/obo/MONDO_0009347) (histiocytosis, familial Lipochrome), [MONDO:0018296](http://purl.obolibrary.org/obo/MONDO_0018296) (congenital disorder of glycosylation with developmental anomaly), [MONDO:0008018](http://purl.obolibrary.org/obo/MONDO_0008018) (Muir-Torre syndrome), [MONDO:0018293](http://purl.obolibrary.org/obo/MONDO_0018293) (congenital disorder of glycosylation with skin involvement), [MONDO:0018294](http://purl.obolibrary.org/obo/MONDO_0018294) (congenital disorder of glycosylation with nephropathy as a major feature), [MONDO:0018291](http://purl.obolibrary.org/obo/MONDO_0018291) (congenital disorder of glycosylation with intestinal involvement), [MONDO:0018292](http://purl.obolibrary.org/obo/MONDO_0018292) (congenital disorder of glycosylation-related bone disorder), [MONDO:0010334](http://purl.obolibrary.org/obo/MONDO_0010334) (severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome), [MONDO:0012996](http://purl.obolibrary.org/obo/MONDO_0012996) (AGAT deficiency), [MONDO:0010335](http://purl.obolibrary.org/obo/MONDO_0010335) (X-linked cone-rod dystrophy 3), [MONDO:0012995](http://purl.obolibrary.org/obo/MONDO_0012995) (MYP15), [MONDO:0010332](http://purl.obolibrary.org/obo/MONDO_0010332) (X-linked intellectual disability-cubitus valgus-dysmorphism syndrome), [MONDO:0012994](http://purl.obolibrary.org/obo/MONDO_0012994) (Dopa-responsive dystonia due to sepiapterin reductase deficiency), [MONDO:0010333](http://purl.obolibrary.org/obo/MONDO_0010333) (corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome), [MONDO:0010338](http://purl.obolibrary.org/obo/MONDO_0010338) (X-linked distal spinal muscular atrophy type 3), [MONDO:0011669](http://purl.obolibrary.org/obo/MONDO_0011669) (hypotonia-cystinuria syndrome), [MONDO:0010339](http://purl.obolibrary.org/obo/MONDO_0010339) (X-linked epilepsy-learning disabilities-behavior disorders syndrome), [MONDO:0012999](http://purl.obolibrary.org/obo/MONDO_0012999) (guanidinoacetate methyltransferase deficiency), [MONDO:0011668](http://purl.obolibrary.org/obo/MONDO_0011668) (maturity-onset diabetes of the young type 6), [MONDO:0010337](http://purl.obolibrary.org/obo/MONDO_0010337) (X-linked intellectual disability-cerebellar hypoplasia syndrome), [MONDO:0011667](http://purl.obolibrary.org/obo/MONDO_0011667) (maturity-onset diabetes of the young type 4), [MONDO:0012998](http://purl.obolibrary.org/obo/MONDO_0012998) (faciocardiomelic syndrome), [MONDO:0011651](http://purl.obolibrary.org/obo/MONDO_0011651) (mental retardation, short stature, facial anomalies, and joint dislocations), [MONDO:0011650](http://purl.obolibrary.org/obo/MONDO_0011650) (atrioventricular septal defect, susceptibility to, 2), [MONDO:0009331](http://purl.obolibrary.org/obo/MONDO_0009331) (isolated hemihyperplasia), [MONDO:0018288](http://purl.obolibrary.org/obo/MONDO_0018288) (congenital disorder of glycosylation with hepatic involvement), [MONDO:0008001](http://purl.obolibrary.org/obo/MONDO_0008001) (milia, multiple eruptive), [MONDO:0018289](http://purl.obolibrary.org/obo/MONDO_0018289) (congenital disorder of glycosylation with dilated cardiomyopathy), [MONDO:0008003](http://purl.obolibrary.org/obo/MONDO_0008003) (autosomal dominant progressive external ophthalmoplegia), [MONDO:0018286](http://purl.obolibrary.org/obo/MONDO_0018286) (non-X-linked congenital disorder of glycosylation with intellectual disability as a major feature), [MONDO:0018287](http://purl.obolibrary.org/obo/MONDO_0018287) (congenital disorder of glycosylation with epilepsy as a major feature), [MONDO:0008004](http://purl.obolibrary.org/obo/MONDO_0008004) (familial mitral valve prolapse), [MONDO:0008005](http://purl.obolibrary.org/obo/MONDO_0008005) (Cardiospondylocarpofacial syndrome), [MONDO:0009336](http://purl.obolibrary.org/obo/MONDO_0009336) (hemosiderosis, pulmonary, with deficiency of gamma-a globulin), [MONDO:0018284](http://purl.obolibrary.org/obo/MONDO_0018284) (congenital disorder of glycosylation with neurological involvement), [MONDO:0018285](http://purl.obolibrary.org/obo/MONDO_0018285) (X-linked congenital disorder of glycosylation with intellectual disability as a major feature), [MONDO:0008007](http://purl.obolibrary.org/obo/MONDO_0008007) (tooth ankylosis), [MONDO:0008008](http://purl.obolibrary.org/obo/MONDO_0008008) (MOMO syndrome), [MONDO:0009339](http://purl.obolibrary.org/obo/MONDO_0009339) (congenital bile acid synthesis defect 2), [MONDO:0008009](http://purl.obolibrary.org/obo/MONDO_0008009) (monilethrix), [MONDO:0000995](http://purl.obolibrary.org/obo/MONDO_0000995) (familial periodic paralysis), [MONDO:0018290](http://purl.obolibrary.org/obo/MONDO_0018290) (congenital disorder of glycosylation with cardiac malformation as a major feature), [MONDO:0010323](http://purl.obolibrary.org/obo/MONDO_0010323) (Atkin-Flaitz syndrome), [MONDO:0011654](http://purl.obolibrary.org/obo/MONDO_0011654) (mental retardation, microcephaly, growth Retardation, joint contractures, and facial dysmorphism), [MONDO:0012984](http://purl.obolibrary.org/obo/MONDO_0012984) (PHARC syndrome), [MONDO:0010327](http://purl.obolibrary.org/obo/MONDO_0010327) (HSD10 disease), [MONDO:0011659](http://purl.obolibrary.org/obo/MONDO_0011659) (HTX3), [MONDO:0011657](http://purl.obolibrary.org/obo/MONDO_0011657) (autosomal dominant nonsyndromic deafness 24), [MONDO:0010325](http://purl.obolibrary.org/obo/MONDO_0010325) (X-linked intellectual disability, Stocco dos Santos type), [MONDO:0011656](http://purl.obolibrary.org/obo/MONDO_0011656) (PDB4), [MONDO:0018279](http://purl.obolibrary.org/obo/MONDO_0018279) (congenital muscular dystrophy without intellectual disability), [MONDO:0012971](http://purl.obolibrary.org/obo/MONDO_0012971) (Microvascular complications of diabetes, susceptibility to, 7), [MONDO:0012970](http://purl.obolibrary.org/obo/MONDO_0012970) (Microvascular complications of diabetes, susceptibility to, 6), [MONDO:0018277](http://purl.obolibrary.org/obo/MONDO_0018277) (congenital muscular dystrophy with cerebellar involvement), [MONDO:0018278](http://purl.obolibrary.org/obo/MONDO_0018278) (congenital muscular dystrophy with intellectual disability), [MONDO:0009322](http://purl.obolibrary.org/obo/MONDO_0009322) (halo nevi), [MONDO:0018275](http://purl.obolibrary.org/obo/MONDO_0018275) (salt and pepper syndrome), [MONDO:0009323](http://purl.obolibrary.org/obo/MONDO_0009323) (Halothane hepatitis), [MONDO:0009324](http://purl.obolibrary.org/obo/MONDO_0009324) (Hartnup disease), [MONDO:0018273](http://purl.obolibrary.org/obo/MONDO_0018273) (XYLT1-CDG), [MONDO:0009325](http://purl.obolibrary.org/obo/MONDO_0009325) (deafness-enamel hypoplasia-nail defects syndrome), [MONDO:0018274](http://purl.obolibrary.org/obo/MONDO_0018274) (GM3 synthase deficiency), [MONDO:0009327](http://purl.obolibrary.org/obo/MONDO_0009327) (heart, malformation of), [MONDO:0009328](http://purl.obolibrary.org/obo/MONDO_0009328) (hemangiomatosis, cutaneous, with associated features), [MONDO:0011649](http://purl.obolibrary.org/obo/MONDO_0011649) (AVSD 1), [MONDO:0010319](http://purl.obolibrary.org/obo/MONDO_0010319) (syndromic X-linked intellectual disability Hedera type), [MONDO:0012975](http://purl.obolibrary.org/obo/MONDO_0012975) (autosomal dominant nonsyndromic deafness 3B), [MONDO:0010312](http://purl.obolibrary.org/obo/MONDO_0010312) (radial ray deficiency, X-linked), [MONDO:0012974](http://purl.obolibrary.org/obo/MONDO_0012974) (autosomal dominant nonsyndromic deafness 59), [MONDO:0011643](http://purl.obolibrary.org/obo/MONDO_0011643) (permanent neonatal diabetes mellitus), [MONDO:0011642](http://purl.obolibrary.org/obo/MONDO_0011642) (carnitine acetyltransferase deficiency), [MONDO:0010311](http://purl.obolibrary.org/obo/MONDO_0010311) (Becker muscular dystrophy), [MONDO:0011641](http://purl.obolibrary.org/obo/MONDO_0011641) (Baculum, congenital absence of), [MONDO:0012972](http://purl.obolibrary.org/obo/MONDO_0012972) (FEB10), [MONDO:0012979](http://purl.obolibrary.org/obo/MONDO_0012979) (primary ciliary dyskinesia 12), [MONDO:0012978](http://purl.obolibrary.org/obo/MONDO_0012978) (primary ciliary dyskinesia 11), [MONDO:0011646](http://purl.obolibrary.org/obo/MONDO_0011646) (laryngeal abductor paralysis with cerebellar ataxia and motor neuropathy), [MONDO:0012977](http://purl.obolibrary.org/obo/MONDO_0012977) (autosomal recessive nonsyndromic deafness 1B), [MONDO:0012976](http://purl.obolibrary.org/obo/MONDO_0012976) (autosomal dominant nonsyndromic deafness 2B), [MONDO:0010315](http://purl.obolibrary.org/obo/MONDO_0010315) (gamma chain deficiency), [MONDO:0011645](http://purl.obolibrary.org/obo/MONDO_0011645) (aneurysmal bone cysts), [MONDO:0010381](http://purl.obolibrary.org/obo/MONDO_0010381) (Tn Polyagglutination syndrome), [MONDO:0008061](http://purl.obolibrary.org/obo/MONDO_0008061) (nail-patella syndrome), [MONDO:0009392](http://purl.obolibrary.org/obo/MONDO_0009392) (hyperopia, high), [MONDO:0009393](http://purl.obolibrary.org/obo/MONDO_0009393) (ornithine translocase deficiency), [MONDO:0010382](http://purl.obolibrary.org/obo/MONDO_0010382) (fragile X-associated tremor/ataxia syndrome), [MONDO:0014740](http://purl.obolibrary.org/obo/MONDO_0014740) (autosomal dominant nonsyndromic deafness 68), [MONDO:0008063](http://purl.obolibrary.org/obo/MONDO_0008063) (nasal alar collapse, bilateral), [MONDO:0010380](http://purl.obolibrary.org/obo/MONDO_0010380) (cataract, ataxia, short stature, and mental retardation), [MONDO:0008064](http://purl.obolibrary.org/obo/MONDO_0008064) (nasal bones, absence of), [MONDO:0009396](http://purl.obolibrary.org/obo/MONDO_0009396) (hyperparathyroidism, neonatal Self-limited primary, with hypercalciuria), [MONDO:0008065](http://purl.obolibrary.org/obo/MONDO_0008065) (nasal groove, familial transverse), [MONDO:0010385](http://purl.obolibrary.org/obo/MONDO_0010385) (X-linked lymphoproliferative syndrome 2), [MONDO:0010386](http://purl.obolibrary.org/obo/MONDO_0010386) (X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency), [MONDO:0008066](http://purl.obolibrary.org/obo/MONDO_0008066) (nasal hyperpigmentation, familial transverse), [MONDO:0009398](http://purl.obolibrary.org/obo/MONDO_0009398) (hyperphosphatasia with mental retardation syndrome 1), [MONDO:0010383](http://purl.obolibrary.org/obo/MONDO_0010383) (fragile X syndrome), [MONDO:0009399](http://purl.obolibrary.org/obo/MONDO_0009399) (hyperphosphatemia, Polyuria, and seizures), [MONDO:0008068](http://purl.obolibrary.org/obo/MONDO_0008068) (navicular bone, accessory), [MONDO:0008069](http://purl.obolibrary.org/obo/MONDO_0008069) (necrotizing encephalomyelopathy, subacute, of Leigh, adult), [MONDO:0010389](http://purl.obolibrary.org/obo/MONDO_0010389) (X-linked mendelian susceptibility to mycobacterial diseases due to CYBB deficiency), [MONDO:0013416](http://purl.obolibrary.org/obo/MONDO_0013416) (age related macular degeneration 8), [MONDO:0014747](http://purl.obolibrary.org/obo/MONDO_0014747) (retinal dystrophy and iris coloboma with or without congenital cataract;), [MONDO:0010387](http://purl.obolibrary.org/obo/MONDO_0010387) (invasive pneumococcal disease, recurrent isolated, 2), [MONDO:0014749](http://purl.obolibrary.org/obo/MONDO_0014749) (tooth agenesis, selective, 7; STHAG7), [MONDO:0010388](http://purl.obolibrary.org/obo/MONDO_0010388) (rolandic epilepsy, mental retardation, and speech dyspraxia, X-linked), [MONDO:0014743](http://purl.obolibrary.org/obo/MONDO_0014743) (rhizomelic chondrodysplasia punctata type 5), [MONDO:0014744](http://purl.obolibrary.org/obo/MONDO_0014744) (acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome), [MONDO:0013415](http://purl.obolibrary.org/obo/MONDO_0013415) (chromosome 17p13.1 deletion syndrome), [MONDO:0014746](http://purl.obolibrary.org/obo/MONDO_0014746) (SLC39A8-CDG), [MONDO:0008050](http://purl.obolibrary.org/obo/MONDO_0008050) (Laing early-onset distal myopathy), [MONDO:0009381](http://purl.obolibrary.org/obo/MONDO_0009381) (hyperbilirubinemia, Conjugated, type 3), [MONDO:0009382](http://purl.obolibrary.org/obo/MONDO_0009382) (PSHB), [MONDO:0009383](http://purl.obolibrary.org/obo/MONDO_0009383) (transient familial neonatal hyperbilirubinemia), [MONDO:0008052](http://purl.obolibrary.org/obo/MONDO_0008052) (myopathy with storage of Glycoproteins and Glycosaminoglycans), [MONDO:0014731](http://purl.obolibrary.org/obo/MONDO_0014731) (seizures-scoliosis-macrocephaly syndrome), [MONDO:0008053](http://purl.obolibrary.org/obo/MONDO_0008053) (MYP2), [MONDO:0009385](http://purl.obolibrary.org/obo/MONDO_0009385) (Hyperleucine-Isoleucinemia), [MONDO:0009386](http://purl.obolibrary.org/obo/MONDO_0009386) (Hyperlexia), [MONDO:0010375](http://purl.obolibrary.org/obo/MONDO_0010375) (hyperekplexia-epilepsy syndrome), [MONDO:0010372](http://purl.obolibrary.org/obo/MONDO_0010372) (Clark-Baraitser syndrome), [MONDO:0009387](http://purl.obolibrary.org/obo/MONDO_0009387) (familial lipoprotein lipase deficiency), [MONDO:0010373](http://purl.obolibrary.org/obo/MONDO_0010373) (premature ovarian failure 2B), [MONDO:0009388](http://purl.obolibrary.org/obo/MONDO_0009388) (hyperlysinemia (disease)), [MONDO:0008057](http://purl.obolibrary.org/obo/MONDO_0008057) (Carney complex, type 1), [MONDO:0021025](http://purl.obolibrary.org/obo/MONDO_0021025) (cirrhosis, familial, with antigenemia), [MONDO:0009389](http://purl.obolibrary.org/obo/MONDO_0009389) (hyperlysinemia due to defect 1N lysine transport into mitochondria), [MONDO:0021024](http://purl.obolibrary.org/obo/MONDO_0021024) (malaria, susceptibility to), [MONDO:0008059](http://purl.obolibrary.org/obo/MONDO_0008059) (Naegeli-Franceschetti-Jadassohn syndrome), [MONDO:0000108](http://purl.obolibrary.org/obo/MONDO_0000108) (bacteremia, susceptibility), [MONDO:0013409](http://purl.obolibrary.org/obo/MONDO_0013409) (age related macular degeneration 5), [MONDO:0021020](http://purl.obolibrary.org/obo/MONDO_0021020) (Crigler-Najjar syndrome type 1), [MONDO:0021022](http://purl.obolibrary.org/obo/MONDO_0021022) (hereditary hyperekplexia), [MONDO:0010378](http://purl.obolibrary.org/obo/MONDO_0010378) (X-linked hereditary sensory and autonomic neuropathy with deafness), [MONDO:0010379](http://purl.obolibrary.org/obo/MONDO_0010379) (Brunner syndrome), [MONDO:0013406](http://purl.obolibrary.org/obo/MONDO_0013406) (age related macular degeneration 6), [MONDO:0010376](http://purl.obolibrary.org/obo/MONDO_0010376) (Brooks-Wisniewski-brown syndrome), [MONDO:0014738](http://purl.obolibrary.org/obo/MONDO_0014738) (autosomal dominant nonsyndromic deafness 69), [MONDO:0010377](http://purl.obolibrary.org/obo/MONDO_0010377) (MYP13), [MONDO:0014739](http://purl.obolibrary.org/obo/MONDO_0014739) (autosomal recessive nonsyndromic deafness 97), [MONDO:0013401](http://purl.obolibrary.org/obo/MONDO_0013401) (hereditary spastic paraplegia 51), [MONDO:0014733](http://purl.obolibrary.org/obo/MONDO_0014733) (Charcot-Marie-tooth disease type 4K), [MONDO:0013403](http://purl.obolibrary.org/obo/MONDO_0013403) (heterotaxy, visceral, 4, autosomal), [MONDO:0009390](http://purl.obolibrary.org/obo/MONDO_0009390) (Hyperlysinuria with hyperammonemia), [MONDO:0014734](http://purl.obolibrary.org/obo/MONDO_0014734) (epilepsy, idiopathic generalized, susceptibility to, 14; EIG14), [MONDO:0013404](http://purl.obolibrary.org/obo/MONDO_0013404) (hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase), [MONDO:0009391](http://purl.obolibrary.org/obo/MONDO_0009391) (Hypermetabolism due to defect 1N mitochondria), [MONDO:0009370](http://purl.obolibrary.org/obo/MONDO_0009370) (L-2-hydroxyglutaric aciduria), [MONDO:0009371](http://purl.obolibrary.org/obo/MONDO_0009371) (3-hydroxyisobutyric aciduria), [MONDO:0009372](http://purl.obolibrary.org/obo/MONDO_0009372) (encephalopathy due to hydroxykynureninuria), [MONDO:0008041](http://purl.obolibrary.org/obo/MONDO_0008041) (myoclonic epilepsy, Hartung type), [MONDO:0014720](http://purl.obolibrary.org/obo/MONDO_0014720) (autosomal dominant optic atrophy plus syndrome), [MONDO:0008042](http://purl.obolibrary.org/obo/MONDO_0008042) (myoclonus and ataxia), [MONDO:0009373](http://purl.obolibrary.org/obo/MONDO_0009373) (seizures-intellectual disability due to hydroxylysinuria syndrome), [MONDO:0009374](http://purl.obolibrary.org/obo/MONDO_0009374) (Hydroxyprolinemia (disease)), [MONDO:0009375](http://purl.obolibrary.org/obo/MONDO_0009375) (hymen, imperforate), [MONDO:0010364](http://purl.obolibrary.org/obo/MONDO_0010364) (X-linked intellectual disability-retinitis pigmentosa syndrome), [MONDO:0011694](http://purl.obolibrary.org/obo/MONDO_0011694) (spinocerebellar ataxia type 15/16), [MONDO:0011693](http://purl.obolibrary.org/obo/MONDO_0011693) (glaucoma, normal tension, susceptibility to), [MONDO:0009376](http://purl.obolibrary.org/obo/MONDO_0009376) (carbamoyl phosphate synthetase i deficiency disease), [MONDO:0008046](http://purl.obolibrary.org/obo/MONDO_0008046) (autosomal dominant myoglobinuria), [MONDO:0010362](http://purl.obolibrary.org/obo/MONDO_0010362) (glycogen storage disease IXd), [MONDO:0009377](http://purl.obolibrary.org/obo/MONDO_0009377) (hyperammonemia due to N-acetylglutamate synthase deficiency), [MONDO:0009378](http://purl.obolibrary.org/obo/MONDO_0009378) (hyper-beta-alaninemia), [MONDO:0021013](http://purl.obolibrary.org/obo/MONDO_0021013) (trichothiodystrophy 4, nonphotosensitive), [MONDO:0008048](http://purl.obolibrary.org/obo/MONDO_0008048) (autosomal dominant centronuclear myopathy), [MONDO:0009379](http://purl.obolibrary.org/obo/MONDO_0009379) (Rotor syndrome), [MONDO:0021018](http://purl.obolibrary.org/obo/MONDO_0021018) (autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6)), [MONDO:0021019](http://purl.obolibrary.org/obo/MONDO_0021019) (X-linked recessive ocular albinism), [MONDO:0014729](http://purl.obolibrary.org/obo/MONDO_0014729) (hereditary spastic paraplegia 75), [MONDO:0014725](http://purl.obolibrary.org/obo/MONDO_0014725) (spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome), [MONDO:0011698](http://purl.obolibrary.org/obo/MONDO_0011698) (glycine N-methyltransferase deficiency), [MONDO:0014726](http://purl.obolibrary.org/obo/MONDO_0014726) (Charcot-Marie-tooth disease axonal type 2X), [MONDO:0010368](http://purl.obolibrary.org/obo/MONDO_0010368) (immunodeficiency without anhidrotic ectodermal dysplasia), [MONDO:0011697](http://purl.obolibrary.org/obo/MONDO_0011697) (Waardenburg syndrome type 2C), [MONDO:0014728](http://purl.obolibrary.org/obo/MONDO_0014728) (combined oxidative phosphorylation defect type 27), [MONDO:0014722](http://purl.obolibrary.org/obo/MONDO_0014722) (Roifman syndrome), [MONDO:0009380](http://purl.obolibrary.org/obo/MONDO_0009380) (Dubin-Johnson syndrome), [MONDO:0014724](http://purl.obolibrary.org/obo/MONDO_0014724) (Joubert syndrome 24), [MONDO:0011680](http://purl.obolibrary.org/obo/MONDO_0011680) (autosomal recessive congenital ichthyosis 3), [MONDO:0009361](http://purl.obolibrary.org/obo/MONDO_0009361) (hydrocephalus due to congenital stenosis of aqueduct of sylvius), [MONDO:0008032](http://purl.obolibrary.org/obo/MONDO_0008032) (autosomal dominant limb-girdle muscular dystrophy type 1A), [MONDO:0010353](http://purl.obolibrary.org/obo/MONDO_0010353) (deafness-intellectual disability, Martin-Probst type syndrome), [MONDO:0011683](http://purl.obolibrary.org/obo/MONDO_0011683) (oculocutaneous albinism type 4), [MONDO:0008033](http://purl.obolibrary.org/obo/MONDO_0008033) (autosomal dominant limb-girdle muscular dystrophy type 1B), [MONDO:0009365](http://purl.obolibrary.org/obo/MONDO_0009365) (hydrolethalus syndrome 1), [MONDO:0008034](http://purl.obolibrary.org/obo/MONDO_0008034) (muscular dystrophy, pseudohypertrophic, with Internalized capillaries), [MONDO:0010350](http://purl.obolibrary.org/obo/MONDO_0010350) (premature ovarian failure 2A), [MONDO:0008035](http://purl.obolibrary.org/obo/MONDO_0008035) (muscular hypoplasia, congenital universal, of Krabbe), [MONDO:0010351](http://purl.obolibrary.org/obo/MONDO_0010351) (Fanconi anemia complementation group b), [MONDO:0009368](http://purl.obolibrary.org/obo/MONDO_0009368) (Urofacial Syndrome type 1), [MONDO:0008037](http://purl.obolibrary.org/obo/MONDO_0008037) (myelinated optic nerve fibers), [MONDO:0009369](http://purl.obolibrary.org/obo/MONDO_0009369) (non-immune hydrops fetalis), [MONDO:0014718](http://purl.obolibrary.org/obo/MONDO_0014718) (epileptic encephalopathy, early infantile, 34; EIEE34), [MONDO:0014719](http://purl.obolibrary.org/obo/MONDO_0014719) (ITPA-related encephalopathy), [MONDO:0021001](http://purl.obolibrary.org/obo/MONDO_0021001) (hemochromatosis type 1), [MONDO:0010354](http://purl.obolibrary.org/obo/MONDO_0010354) (Allan-Herndon-Dudley syndrome), [MONDO:0011686](http://purl.obolibrary.org/obo/MONDO_0011686) (DNA ligase IV deficiency), [MONDO:0010355](http://purl.obolibrary.org/obo/MONDO_0010355) (syndromic X-linked intellectual disability Claes-Jensen type), [MONDO:0011685](http://purl.obolibrary.org/obo/MONDO_0011685) (Polysubstance abuse, susceptibility to), [MONDO:0010358](http://purl.obolibrary.org/obo/MONDO_0010358) (hypophosphatemic rickets, X-linked recessive), [MONDO:0014712](http://purl.obolibrary.org/obo/MONDO_0014712) (Senior-Loken syndrome 9; SLSN9), [MONDO:0010359](http://purl.obolibrary.org/obo/MONDO_0010359) (Dent disease type 2), [MONDO:0011689](http://purl.obolibrary.org/obo/MONDO_0011689) (DYX6), [MONDO:0014783](http://purl.obolibrary.org/obo/MONDO_0014783) (preimplantation embryonic lethality 1; PREMBL1), [MONDO:0012120](http://purl.obolibrary.org/obo/MONDO_0012120) (pyruvate dehydrogenase phosphatase deficiency), [MONDO:0014785](http://purl.obolibrary.org/obo/MONDO_0014785) (microcephaly, short stature, and impaired glucose metabolism 2; MSSGM2), [MONDO:0017810](http://purl.obolibrary.org/obo/MONDO_0017810) (variant ABeta2M amyloidosis), [MONDO:0012123](http://purl.obolibrary.org/obo/MONDO_0012123) (congenital disorder of glycosylation type 1E), [MONDO:0014780](http://purl.obolibrary.org/obo/MONDO_0014780) (hyperphosphatasia with mental retardation syndrome 6; HPMRS6), [MONDO:0014781](http://purl.obolibrary.org/obo/MONDO_0014781) (combined oxidative phosphorylation deficiency 29; COXPD29), [MONDO:0012121](http://purl.obolibrary.org/obo/MONDO_0012121) (OTSC5), [MONDO:0014782](http://purl.obolibrary.org/obo/MONDO_0014782) (autosomal recessive limb-girdle muscular dystrophy type 2X), [MONDO:0000133](http://purl.obolibrary.org/obo/MONDO_0000133) (immunodeficiency-centromeric instability-facial anomalies syndrome), [MONDO:0017817](http://purl.obolibrary.org/obo/MONDO_0017817) (primary localized amyloidosis), [MONDO:0017816](http://purl.obolibrary.org/obo/MONDO_0017816) (primary systemic amyloidosis), [MONDO:0012127](http://purl.obolibrary.org/obo/MONDO_0012127) (autosomal recessive limb-girdle muscular dystrophy type 2J), [MONDO:0017819](http://purl.obolibrary.org/obo/MONDO_0017819) (atypical dentin dysplasia due to SMOC2 deficiency), [MONDO:0013456](http://purl.obolibrary.org/obo/MONDO_0013456) (constitutional megaloblastic anemia with severe neurologic disease), [MONDO:0014788](http://purl.obolibrary.org/obo/MONDO_0014788) (autosomal recessive limb-girdle muscular dystrophy type 2W), [MONDO:0013458](http://purl.obolibrary.org/obo/MONDO_0013458) (hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome), [MONDO:0014789](http://purl.obolibrary.org/obo/MONDO_0014789) (CCDC115-CDG), [MONDO:0012129](http://purl.obolibrary.org/obo/MONDO_0012129) (leukoencephalopathy, arthritis, colitis, and Hypogammaglobulinema), [MONDO:0013441](http://purl.obolibrary.org/obo/MONDO_0013441) (asphyxiating thoracic dystrophy 4), [MONDO:0008095](http://purl.obolibrary.org/obo/MONDO_0008095) (nevus anemicus (disease)), [MONDO:0013442](http://purl.obolibrary.org/obo/MONDO_0013442) (nephronophthisis 12), [MONDO:0008096](http://purl.obolibrary.org/obo/MONDO_0008096) (nevus flammeus of nape of neck), [MONDO:0013443](http://purl.obolibrary.org/obo/MONDO_0013443) (Seckel syndrome 5), [MONDO:0013444](http://purl.obolibrary.org/obo/MONDO_0013444) (nephronophthisis 9), [MONDO:0014775](http://purl.obolibrary.org/obo/MONDO_0014775) (neonatal severe cardiopulmonary failure due to mitochondrial methylation defect), [MONDO:0012113](http://purl.obolibrary.org/obo/MONDO_0012113) (EIG3), [MONDO:0014770](http://purl.obolibrary.org/obo/MONDO_0014770) (Joubert syndrome 25), [MONDO:0013440](http://purl.obolibrary.org/obo/MONDO_0013440) (autosomal recessive limb-girdle muscular dystrophy type 2P), [MONDO:0014771](http://purl.obolibrary.org/obo/MONDO_0014771) (Joubert syndrome 26), [MONDO:0005835](http://purl.obolibrary.org/obo/MONDO_0005835) (Lynch syndrome), [MONDO:0021061](http://purl.obolibrary.org/obo/MONDO_0021061) (neurofibromatosis), [MONDO:0000144](http://purl.obolibrary.org/obo/MONDO_0000144) (pregnancy loss, recurrent, susceptibility), [MONDO:0017809](http://purl.obolibrary.org/obo/MONDO_0017809) (parkinsonism due to ATP13A2 deficiency), [MONDO:0000141](http://purl.obolibrary.org/obo/MONDO_0000141) (mosaic variegated aneuploidy syndrome), [MONDO:0012117](http://purl.obolibrary.org/obo/MONDO_0012117) (ALG9-CDG), [MONDO:0017806](http://purl.obolibrary.org/obo/MONDO_0017806) (15q overgrowth syndrome), [MONDO:0012116](http://purl.obolibrary.org/obo/MONDO_0012116) (spinocerebellar ataxia type 8), [MONDO:0012115](http://purl.obolibrary.org/obo/MONDO_0012115) (IS3), [MONDO:0014776](http://purl.obolibrary.org/obo/MONDO_0014776) (spinocerebellar ataxia type 42), [MONDO:0012119](http://purl.obolibrary.org/obo/MONDO_0012119) (ASPG3), [MONDO:0014778](http://purl.obolibrary.org/obo/MONDO_0014778) (lamb-Shaffer syndrome; LAMSHF), [MONDO:0012118](http://purl.obolibrary.org/obo/MONDO_0012118) (COG7-CDG), [MONDO:0014761](http://purl.obolibrary.org/obo/MONDO_0014761) (hereditary pediatric BehC'et-like disease), [MONDO:0008083](http://purl.obolibrary.org/obo/MONDO_0008083) (neuronal ceroid lipofuscinosis 4B), [MONDO:0013430](http://purl.obolibrary.org/obo/MONDO_0013430) (Meier-Gorlin syndrome 3), [MONDO:0014762](http://purl.obolibrary.org/obo/MONDO_0014762) (heterotaxy, visceral, 7, autosomal; HTX7), [MONDO:0013431](http://purl.obolibrary.org/obo/MONDO_0013431) (Meier-Gorlin syndrome 4), [MONDO:0008084](http://purl.obolibrary.org/obo/MONDO_0008084) (neuropathy, congenital, with arthrogryposis multiplex), [MONDO:0013432](http://purl.obolibrary.org/obo/MONDO_0013432) (Meier-Gorlin syndrome 5), [MONDO:0008085](http://purl.obolibrary.org/obo/MONDO_0008085) (neuropathy, hereditary sensorimotor, with upper motor neuron, visual pathway and autonomic disturbance), [MONDO:0014763](http://purl.obolibrary.org/obo/MONDO_0014763) (Bombay phenotype), [MONDO:0008086](http://purl.obolibrary.org/obo/MONDO_0008086) (neuropathy, hereditary sensory and autonomic, type 1A), [MONDO:0014764](http://purl.obolibrary.org/obo/MONDO_0014764) (spastic paraplegia-severe developmental delay-epilepsy syndrome), [MONDO:0012102](http://purl.obolibrary.org/obo/MONDO_0012102) (GLC1K), [MONDO:0012101](http://purl.obolibrary.org/obo/MONDO_0012101) (GLC1J), [MONDO:0008088](http://purl.obolibrary.org/obo/MONDO_0008088) (neuropathy, with Paraprotein 1N serum, cerebrospinal fluid and urine), [MONDO:0012100](http://purl.obolibrary.org/obo/MONDO_0012100) (major depressive disorder 2), [MONDO:0008089](http://purl.obolibrary.org/obo/MONDO_0008089) (neutropenia, chronic familial), [MONDO:0014760](http://purl.obolibrary.org/obo/MONDO_0014760) (TFRC-related combined immunodeficiency), [MONDO:0021057](http://purl.obolibrary.org/obo/MONDO_0021057) (classic or attenuated familial adenomatous polyposis), [MONDO:0005803](http://purl.obolibrary.org/obo/MONDO_0005803) (hyperinsulinemic hypoglycemia (disease)), [MONDO:0000114](http://purl.obolibrary.org/obo/MONDO_0000114) (cerebelloparenchymal disorder), [MONDO:0000115](http://purl.obolibrary.org/obo/MONDO_0000115) (Chiari malformation), [MONDO:0000111](http://purl.obolibrary.org/obo/MONDO_0000111) (camptodactyly syndrome, Guadalajara), [MONDO:0021056](http://purl.obolibrary.org/obo/MONDO_0021056) (familial adenomatous polyposis 1), [MONDO:0021055](http://purl.obolibrary.org/obo/MONDO_0021055) (classic familial adenomatous polyposis), [MONDO:0014769](http://purl.obolibrary.org/obo/MONDO_0014769) (inherited oocyte maturation defect), [MONDO:0013439](http://purl.obolibrary.org/obo/MONDO_0013439) (congenital bile acid synthesis defect 3), [MONDO:0012104](http://purl.obolibrary.org/obo/MONDO_0012104) (partial acquired lipodystrophy), [MONDO:0012103](http://purl.obolibrary.org/obo/MONDO_0012103) (spinocerebellar ataxia type 25), [MONDO:0013434](http://purl.obolibrary.org/obo/MONDO_0013434) (primary ciliary dyskinesia 14), [MONDO:0008091](http://purl.obolibrary.org/obo/MONDO_0008091) (NM), [MONDO:0013435](http://purl.obolibrary.org/obo/MONDO_0013435) (primary ciliary dyskinesia 15), [MONDO:0014766](http://purl.obolibrary.org/obo/MONDO_0014766) (leukodystrophy and acquired microcephaly with or without dystonia;), [MONDO:0014767](http://purl.obolibrary.org/obo/MONDO_0014767) (Seckel syndrome 9; SCKL9), [MONDO:0008093](http://purl.obolibrary.org/obo/MONDO_0008093) (nevus, epidermal), [MONDO:0012107](http://purl.obolibrary.org/obo/MONDO_0012107) (neuropathy, hereditary sensory and autonomic, adult-onset, with anosmia), [MONDO:0010392](http://purl.obolibrary.org/obo/MONDO_0010392) (glycogen storage disease due to phosphoglycerate kinase 1 deficiency), [MONDO:0014750](http://purl.obolibrary.org/obo/MONDO_0014750) (primary ciliary dyskinesia 33), [MONDO:0013420](http://purl.obolibrary.org/obo/MONDO_0013420) (age related macular degeneration 12), [MONDO:0008073](http://purl.obolibrary.org/obo/MONDO_0008073) (familial juvenile hyperuricemic nephropathy type 1), [MONDO:0008074](http://purl.obolibrary.org/obo/MONDO_0008074) (nerve growth factor, alpha subunit), [MONDO:0010390](http://purl.obolibrary.org/obo/MONDO_0010390) (ocular albinism with late-onset sensorineural deafness), [MONDO:0008075](http://purl.obolibrary.org/obo/MONDO_0008075) (neurofibromatosis type 3), [MONDO:0010396](http://purl.obolibrary.org/obo/MONDO_0010396) (epileptic encephalopathy, early infantile, 2), [MONDO:0010397](http://purl.obolibrary.org/obo/MONDO_0010397) (severe neonatal-onset encephalopathy with microcephaly), [MONDO:0008078](http://purl.obolibrary.org/obo/MONDO_0008078) (neurofibromatosis, familial spinal), [MONDO:0008079](http://purl.obolibrary.org/obo/MONDO_0008079) (neurofibromatosis-pheochromocytoma-duodenal carcinoid syndrome), [MONDO:0010395](http://purl.obolibrary.org/obo/MONDO_0010395) (phosphoribosylpyrophosphate synthetase superactivity), [MONDO:0014759](http://purl.obolibrary.org/obo/MONDO_0014759) (mental retardation, autosomal recessive 51; MRT51), [MONDO:0013428](http://purl.obolibrary.org/obo/MONDO_0013428) (Meier-Gorlin syndrome 2), [MONDO:0010398](http://purl.obolibrary.org/obo/MONDO_0010398) (syndromic X-linked intellectual disability 14), [MONDO:0010399](http://purl.obolibrary.org/obo/MONDO_0010399) (chromosome Xp21 deletion syndrome), [MONDO:0014754](http://purl.obolibrary.org/obo/MONDO_0014754) (coenzyme Q10 deficiency, primary, 8; COQ10D8), [MONDO:0013424](http://purl.obolibrary.org/obo/MONDO_0013424) (3p- syndrome), [MONDO:0008080](http://purl.obolibrary.org/obo/MONDO_0008080) (neurofibromatosis, type III, mixed central and peripheral), [MONDO:0014756](http://purl.obolibrary.org/obo/MONDO_0014756) (tremor, hereditary essential, 5; ETM5), [MONDO:0008081](http://purl.obolibrary.org/obo/MONDO_0008081) (neurofibromatosis, type IV, of Riccardi), [MONDO:0013426](http://purl.obolibrary.org/obo/MONDO_0013426) (aneurysm-osteoarthritis syndrome), [MONDO:0008082](http://purl.obolibrary.org/obo/MONDO_0008082) (multiple endocrine neoplasia type 2B), [MONDO:0014757](http://purl.obolibrary.org/obo/MONDO_0014757) (Takenouchi-Kosaki syndrome; TKS), [MONDO:0013497](http://purl.obolibrary.org/obo/MONDO_0013497) (Okt4 Epitope deficiency), [MONDO:0012163](http://purl.obolibrary.org/obo/MONDO_0012163) (severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive), [MONDO:0017855](http://purl.obolibrary.org/obo/MONDO_0017855) (T-b- severe combined immunodeficiency), [MONDO:0013499](http://purl.obolibrary.org/obo/MONDO_0013499) (Fanconi anemia complementation group P), [MONDO:0012161](http://purl.obolibrary.org/obo/MONDO_0012161) (susceptibility to respiratory infections associated with CD8alpha chain mutation), [MONDO:0012168](http://purl.obolibrary.org/obo/MONDO_0012168) (DYX8), [MONDO:0013493](http://purl.obolibrary.org/obo/MONDO_0013493) (ACACAD), [MONDO:0012167](http://purl.obolibrary.org/obo/MONDO_0012167) (ATFB2), [MONDO:0013494](http://purl.obolibrary.org/obo/MONDO_0013494) (PSMNSW), [MONDO:0017851](http://purl.obolibrary.org/obo/MONDO_0017851) (erythrokeratodermia variabilis), [MONDO:0012166](http://purl.obolibrary.org/obo/MONDO_0012166) (ataxia, sensory, 1, autosomal dominant), [MONDO:0013495](http://purl.obolibrary.org/obo/MONDO_0013495) (autosomal recessive congenital ichthyosis 8), [MONDO:0003205](http://purl.obolibrary.org/obo/MONDO_0003205) (renal pelvis adenocarcinoma), [MONDO:0000179](http://purl.obolibrary.org/obo/MONDO_0000179) (Neu-Laxova syndrome), [MONDO:0008900](http://purl.obolibrary.org/obo/MONDO_0008900) (camptodactyly with fibrous tissue hyperplasia and skeletal dysplasia), [MONDO:0008902](http://purl.obolibrary.org/obo/MONDO_0008902) (camptodactyly-ichthyosis syndrome), [MONDO:0008906](http://purl.obolibrary.org/obo/MONDO_0008906) (Carbimazole sensitivity), [MONDO:0008907](http://purl.obolibrary.org/obo/MONDO_0008907) (PMM2-CDG), [MONDO:0008908](http://purl.obolibrary.org/obo/MONDO_0008908) (MGAT2-CDG), [MONDO:0008909](http://purl.obolibrary.org/obo/MONDO_0008909) (congenital disorder of glycosylation, type i/Iix), [MONDO:0012169](http://purl.obolibrary.org/obo/MONDO_0012169) (premature ovarian failure 3), [MONDO:0016525](http://purl.obolibrary.org/obo/MONDO_0016525) (familial hyperaldosteronism), [MONDO:0017856](http://purl.obolibrary.org/obo/MONDO_0017856) (X-linked spasticity-intellectual disability-epilepsy syndrome), [MONDO:0016527](http://purl.obolibrary.org/obo/MONDO_0016527) (glycogen storage disease due to lactate dehydrogenase deficiency), [MONDO:0017842](http://purl.obolibrary.org/obo/MONDO_0017842) (Senior-Loken syndrome), [MONDO:0013485](http://purl.obolibrary.org/obo/MONDO_0013485) (spinocerebellar ataxia type 35), [MONDO:0012152](http://purl.obolibrary.org/obo/MONDO_0012152) (attention deficit-hyperactivity disorder, susceptibility to, 4), [MONDO:0013486](http://purl.obolibrary.org/obo/MONDO_0013486) (spinocerebellar ataxia type 32), [MONDO:0012151](http://purl.obolibrary.org/obo/MONDO_0012151) (attention deficit-hyperactivity disorder, susceptibility to, 3), [MONDO:0012150](http://purl.obolibrary.org/obo/MONDO_0012150) (attention deficit-hyperactivity disorder, susceptibility to, 2), [MONDO:0013488](http://purl.obolibrary.org/obo/MONDO_0013488) (APLDC3), [MONDO:0013481](http://purl.obolibrary.org/obo/MONDO_0013481) (chromosome 13q14 deletion syndrome), [MONDO:0013482](http://purl.obolibrary.org/obo/MONDO_0013482) (Meckel syndrome, type 8), [MONDO:0012155](http://purl.obolibrary.org/obo/MONDO_0012155) (choanal atresia), [MONDO:0017840](http://purl.obolibrary.org/obo/MONDO_0017840) (classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form), [MONDO:0013483](http://purl.obolibrary.org/obo/MONDO_0013483) (obesity, Hyperphagia, and developmental delay), [MONDO:0013484](http://purl.obolibrary.org/obo/MONDO_0013484) (cataract 36), [MONDO:0013480](http://purl.obolibrary.org/obo/MONDO_0013480) (renal hypomagnesemia 6), [MONDO:0000188](http://purl.obolibrary.org/obo/MONDO_0000188) (GLUT1 deficiency syndrome), [MONDO:0016518](http://purl.obolibrary.org/obo/MONDO_0016518) (isolated punctate palmoplantar keratoderma), [MONDO:0013489](http://purl.obolibrary.org/obo/MONDO_0013489) (autosomal recessive nonsyndromic deafness 89), [MONDO:0017846](http://purl.obolibrary.org/obo/MONDO_0017846) (autosomal dominant spastic ataxia), [MONDO:0016514](http://purl.obolibrary.org/obo/MONDO_0016514) (epidermolysis bullosa simplex with anodontia/hypodontia), [MONDO:0017847](http://purl.obolibrary.org/obo/MONDO_0017847) (autosomal recessive spastic ataxia), [MONDO:0017831](http://purl.obolibrary.org/obo/MONDO_0017831) (mild Canavan disease), [MONDO:0017830](http://purl.obolibrary.org/obo/MONDO_0017830) (severe Canavan disease), [MONDO:0016502](http://purl.obolibrary.org/obo/MONDO_0016502) (Hermansky-Pudlak syndrome without pulmonary fibrosis), [MONDO:0012140](http://purl.obolibrary.org/obo/MONDO_0012140) (pulmonary function), [MONDO:0016501](http://purl.obolibrary.org/obo/MONDO_0016501) (Hermansky-Pudlak syndrome with pulmonary fibrosis), [MONDO:0012145](http://purl.obolibrary.org/obo/MONDO_0012145) (macular degeneration, age-related, 3), [MONDO:0013471](http://purl.obolibrary.org/obo/MONDO_0013471) (autosomal recessive nonsyndromic deafness 61), [MONDO:0012144](http://purl.obolibrary.org/obo/MONDO_0012144) (Waardenburg syndrome type 2D), [MONDO:0013473](http://purl.obolibrary.org/obo/MONDO_0013473) (Hirschsprung disease, cardiac defects, and autonomic dysfunction), [MONDO:0021093](http://purl.obolibrary.org/obo/MONDO_0021093) (cranioectodermal dysplasia 1), [MONDO:0000155](http://purl.obolibrary.org/obo/MONDO_0000155) (triglyceride storage disease), [MONDO:0000152](http://purl.obolibrary.org/obo/MONDO_0000152) (thiamine-responsive dysfunction syndrome), [MONDO:0017839](http://purl.obolibrary.org/obo/MONDO_0017839) (classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form), [MONDO:0012149](http://purl.obolibrary.org/obo/MONDO_0012149) (attention deficit-hyperactivity disorder, susceptibility to, 1), [MONDO:0012148](http://purl.obolibrary.org/obo/MONDO_0012148) (drug metabolism, poor, Cyp2D6-related), [MONDO:0012147](http://purl.obolibrary.org/obo/MONDO_0012147) (coronary heart disease, susceptibility to, 5), [MONDO:0013478](http://purl.obolibrary.org/obo/MONDO_0013478) (PLIN1-related familial partial lipodystrophy), [MONDO:0013479](http://purl.obolibrary.org/obo/MONDO_0013479) (dilated cardiomyopathy 1HH), [MONDO:0017837](http://purl.obolibrary.org/obo/MONDO_0017837) (multiple sclerosis-ichthyosis-factor VIII deficiency syndrome), [MONDO:0012131](http://purl.obolibrary.org/obo/MONDO_0012131) (metaphyseal Undermodeling, spondylar dysplasia, and overgrowth), [MONDO:0014794](http://purl.obolibrary.org/obo/MONDO_0014794) (Meier-Gorlin syndrome 6; MGORS6), [MONDO:0012130](http://purl.obolibrary.org/obo/MONDO_0012130) (myofibrillar myopathy 2), [MONDO:0014795](http://purl.obolibrary.org/obo/MONDO_0014795) (exercise intolerance, riboflavin-responsive; RREI), [MONDO:0013466](http://purl.obolibrary.org/obo/MONDO_0013466) (OFC13), [MONDO:0012135](http://purl.obolibrary.org/obo/MONDO_0012135) (RLS2), [MONDO:0014790](http://purl.obolibrary.org/obo/MONDO_0014790) (TMEM199-CDG), [MONDO:0012134](http://purl.obolibrary.org/obo/MONDO_0012134) (EJM3), [MONDO:0014791](http://purl.obolibrary.org/obo/MONDO_0014791) (Luscan-Lumish syndrome; LLS), [MONDO:0012133](http://purl.obolibrary.org/obo/MONDO_0012133) (lateral semicircular canal malformation, familial, with external and middle ear abnormalities), [MONDO:0014792](http://purl.obolibrary.org/obo/MONDO_0014792) (Paget disease of bone 6; PDB6), [MONDO:0013461](http://purl.obolibrary.org/obo/MONDO_0013461) (inosine Triphosphatase deficiency), [MONDO:0014793](http://purl.obolibrary.org/obo/MONDO_0014793) (microcephaly, congenital cataract, and psoriasiform dermatitis; MCCPD), [MONDO:0013462](http://purl.obolibrary.org/obo/MONDO_0013462) (Fucosyltransferase 6 deficiency), [MONDO:0000160](http://purl.obolibrary.org/obo/MONDO_0000160) (epilepsy, familial adult myoclonic), [MONDO:0000162](http://purl.obolibrary.org/obo/MONDO_0000162) (autoimmune thyroid disease, susceptibility to), [MONDO:0000163](http://purl.obolibrary.org/obo/MONDO_0000163) (breast-ovarian cancer, familial, susceptibility to), [MONDO:0012137](http://purl.obolibrary.org/obo/MONDO_0012137) (Carney complex-trismus-pseudocamptodactyly syndrome), [MONDO:0001490](http://purl.obolibrary.org/obo/MONDO_0001490) (corneal granular dystrophy), [MONDO:0017829](http://purl.obolibrary.org/obo/MONDO_0017829) (autosomal dominant proximal renal tubular acidosis), [MONDO:0012136](http://purl.obolibrary.org/obo/MONDO_0012136) (carnitine palmitoyl transferase II deficiency, neonatal form), [MONDO:0016565](http://purl.obolibrary.org/obo/MONDO_0016565) (syndromic obesity), [MONDO:0017893](http://purl.obolibrary.org/obo/MONDO_0017893) (inherited acute myeloid leukemia), [MONDO:0015231](http://purl.obolibrary.org/obo/MONDO_0015231) (Bartter syndrome), [MONDO:0017891](http://purl.obolibrary.org/obo/MONDO_0017891) (inherited renal cancer-predisposing syndrome), [MONDO:0007607](http://purl.obolibrary.org/obo/MONDO_0007607) (Birt-Hogg-Dube syndrome), [MONDO:0008942](http://purl.obolibrary.org/obo/MONDO_0008942) (CPD2), [MONDO:0007606](http://purl.obolibrary.org/obo/MONDO_0007606) (fibrodysplasia ossificans progressiva), [MONDO:0008943](http://purl.obolibrary.org/obo/MONDO_0008943) (autosomal recessive spinocerebellar ataxia 2), [MONDO:0008944](http://purl.obolibrary.org/obo/MONDO_0008944) (Joubert syndrome 1), [MONDO:0007605](http://purl.obolibrary.org/obo/MONDO_0007605) (Fibrinolytic defect), [MONDO:0008945](http://purl.obolibrary.org/obo/MONDO_0008945) (myoclonic cerebellar dyssynergia), [MONDO:0008946](http://purl.obolibrary.org/obo/MONDO_0008946) (cerebral angiopathy, Dysphoric), [MONDO:0007602](http://purl.obolibrary.org/obo/MONDO_0007602) (favism, susceptibility to), [MONDO:0008948](http://purl.obolibrary.org/obo/MONDO_0008948) (cerebrotendinous xanthomatosis), [MONDO:0007601](http://purl.obolibrary.org/obo/MONDO_0007601) (familial Mediterranean fever, autosomal dominant), [MONDO:0007600](http://purl.obolibrary.org/obo/MONDO_0007600) (primary Fanconi syndrome), [MONDO:0008949](http://purl.obolibrary.org/obo/MONDO_0008949) (cerebral malformation, seizures, hypertrichosis, and overlapping fingers), [MONDO:0015238](http://purl.obolibrary.org/obo/MONDO_0015238) (Arrhinia-choanal atresia-microphthalmia syndrome), [MONDO:0012196](http://purl.obolibrary.org/obo/MONDO_0012196) (autosomal dominant auditory neuropathy 1), [MONDO:0012199](http://purl.obolibrary.org/obo/MONDO_0012199) (posterior polymorphous corneal dystrophy 2), [MONDO:0017884](http://purl.obolibrary.org/obo/MONDO_0017884) (papillary renal cell carcinoma), [MONDO:0012198](http://purl.obolibrary.org/obo/MONDO_0012198) (PCWH syndrome), [MONDO:0012193](http://purl.obolibrary.org/obo/MONDO_0012193) (autosomal dominant limb-girdle muscular dystrophy type 1G), [MONDO:0012192](http://purl.obolibrary.org/obo/MONDO_0012192) (permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome), [MONDO:0008932](http://purl.obolibrary.org/obo/MONDO_0008932) (PCD), [MONDO:0012191](http://purl.obolibrary.org/obo/MONDO_0012191) (Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1), [MONDO:0007616](http://purl.obolibrary.org/obo/MONDO_0007616) (fibula, recurrent dislocation of head of), [MONDO:0008933](http://purl.obolibrary.org/obo/MONDO_0008933) (Cephalin lipidosis), [MONDO:0004589](http://purl.obolibrary.org/obo/MONDO_0004589) (hereditary retinal dystrophy), [MONDO:0007613](http://purl.obolibrary.org/obo/MONDO_0007613) (fibromuscular dysplasia of arteries), [MONDO:0008936](http://purl.obolibrary.org/obo/MONDO_0008936) (cerebellar ataxia and neurosensory deafness), [MONDO:0008937](http://purl.obolibrary.org/obo/MONDO_0008937) (cerebellar ataxia, benign, with Thermoanalgesia), [MONDO:0008938](http://purl.obolibrary.org/obo/MONDO_0008938) (early-onset cerebellar ataxia with retained tendon reflexes), [MONDO:0004587](http://purl.obolibrary.org/obo/MONDO_0004587) (hereditary night blindness), [MONDO:0016559](http://purl.obolibrary.org/obo/MONDO_0016559) (glaucoma secondary to spherophakia/ectopia lentis and megalocornea), [MONDO:0015229](http://purl.obolibrary.org/obo/MONDO_0015229) (Bardet-Biedl syndrome), [MONDO:0012186](http://purl.obolibrary.org/obo/MONDO_0012186) (Fanconi anemia complementation group i), [MONDO:0016543](http://purl.obolibrary.org/obo/MONDO_0016543) (hyperphenylalaninemia), [MONDO:0012184](http://purl.obolibrary.org/obo/MONDO_0012184) (Pierson syndrome), [MONDO:0012183](http://purl.obolibrary.org/obo/MONDO_0012183) (melanoma, cutaneous malignant, susceptibility to, 3), [MONDO:0016545](http://purl.obolibrary.org/obo/MONDO_0016545) (leukoencephalopathy-palmoplantar keratoderma syndrome), [MONDO:0012189](http://purl.obolibrary.org/obo/MONDO_0012189) (Amish infantile epilepsy syndrome), [MONDO:0012188](http://purl.obolibrary.org/obo/MONDO_0012188) (neuronal ceroid lipofuscinosis 9), [MONDO:0012187](http://purl.obolibrary.org/obo/MONDO_0012187) (Fanconi anemia complementation group j), [MONDO:0012182](http://purl.obolibrary.org/obo/MONDO_0012182) (skeletal dysplasia, rhizomelic, with retinitis pigmentosa), [MONDO:0008920](http://purl.obolibrary.org/obo/MONDO_0008920) (carnitine deficiency, myopathic), [MONDO:0012181](http://purl.obolibrary.org/obo/MONDO_0012181) (hereditary spastic paraplegia 27), [MONDO:0008921](http://purl.obolibrary.org/obo/MONDO_0008921) (Carnosinemia), [MONDO:0008922](http://purl.obolibrary.org/obo/MONDO_0008922) (Sengers syndrome), [MONDO:0008923](http://purl.obolibrary.org/obo/MONDO_0008923) (autosomal recessive palmoplantar keratoderma and congenital alopecia), [MONDO:0008924](http://purl.obolibrary.org/obo/MONDO_0008924) (congenital cataract-ichthyosis syndrome), [MONDO:0008926](http://purl.obolibrary.org/obo/MONDO_0008926) (COFS syndrome), [MONDO:0016547](http://purl.obolibrary.org/obo/MONDO_0016547) (Beckwith-Wiedemann syndrome due to NSD1 mutation), [MONDO:0016533](http://purl.obolibrary.org/obo/MONDO_0016533) (apolipoprotein A-II amyloidosis), [MONDO:0012174](http://purl.obolibrary.org/obo/MONDO_0012174) (peripheral cone dystrophy), [MONDO:0012173](http://purl.obolibrary.org/obo/MONDO_0012173) (long chain 3-hydroxyacyl-CoA dehydrogenase deficiency), [MONDO:0012172](http://purl.obolibrary.org/obo/MONDO_0012172) (mitochondrial trifunctional protein deficiency), [MONDO:0012178](http://purl.obolibrary.org/obo/MONDO_0012178) (mental retardation with optic atrophy, facial dysmorphism, microcephaly, and short stature), [MONDO:0012177](http://purl.obolibrary.org/obo/MONDO_0012177) (posterior column ataxia-retinitis pigmentosa syndrome), [MONDO:0012176](http://purl.obolibrary.org/obo/MONDO_0012176) (Emanuel syndrome), [MONDO:0012171](http://purl.obolibrary.org/obo/MONDO_0012171) (marfanoid habitus with situs inversus), [MONDO:0008910](http://purl.obolibrary.org/obo/MONDO_0008910) (Carboxypeptidase N deficiency), [MONDO:0012170](http://purl.obolibrary.org/obo/MONDO_0012170) (autosomal recessive nonsyndromic deafness 36), [MONDO:0008911](http://purl.obolibrary.org/obo/MONDO_0008911) (cardiac lipidosis, familial), [MONDO:0008912](http://purl.obolibrary.org/obo/MONDO_0008912) (cardiac septal defects with coarctation of the aorta), [MONDO:0008913](http://purl.obolibrary.org/obo/MONDO_0008913) (cardiac valvular defect, developmental), [MONDO:0008914](http://purl.obolibrary.org/obo/MONDO_0008914) (cardioauditory syndrome of Sanchez Cascos), [MONDO:0008915](http://purl.obolibrary.org/obo/MONDO_0008915) (dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome), [MONDO:0008916](http://purl.obolibrary.org/obo/MONDO_0008916) (cardiomyopathy associated with myopathy and sudden death), [MONDO:0008918](http://purl.obolibrary.org/obo/MONDO_0008918) (carnitine-acylcarnitine translocase deficiency), [MONDO:0008919](http://purl.obolibrary.org/obo/MONDO_0008919) (systemic primary carnitine deficiency disease), [MONDO:0016537](http://purl.obolibrary.org/obo/MONDO_0016537) (lymphoproliferative syndrome), [MONDO:0016536](http://purl.obolibrary.org/obo/MONDO_0016536) (autosomal recessive lymphoproliferative disease), [MONDO:0016539](http://purl.obolibrary.org/obo/MONDO_0016539) (atypical hypotonia-cystinuria syndrome), [MONDO:0016538](http://purl.obolibrary.org/obo/MONDO_0016538) (hypotonia-cystinuria syndrome type 1), [MONDO:0015278](http://purl.obolibrary.org/obo/MONDO_0015278) (familial pancreatic carcinoma), [MONDO:0018306](http://purl.obolibrary.org/obo/MONDO_0018306) (Griscelli syndrome), [MONDO:0019630](http://purl.obolibrary.org/obo/MONDO_0019630) (congenital ectropion uveae), [MONDO:0015270](http://purl.obolibrary.org/obo/MONDO_0015270) (Butyrylcholinesterase deficiency), [MONDO:0008983](http://purl.obolibrary.org/obo/MONDO_0008983) (chromosomal instability with tissue-specific Radiosensitivity), [MONDO:0008984](http://purl.obolibrary.org/obo/MONDO_0008984) (ciliary discoordination due to random ciliary orientation), [MONDO:0008985](http://purl.obolibrary.org/obo/MONDO_0008985) (ciliary dyskinesia with transposition of ciliary microtubules), [MONDO:0008986](http://purl.obolibrary.org/obo/MONDO_0008986) (Circumvallate placenta syndrome), [MONDO:0007649](http://purl.obolibrary.org/obo/MONDO_0007649) (gastric Juice Peptides), [MONDO:0008988](http://purl.obolibrary.org/obo/MONDO_0008988) (citrullinemia type I), [MONDO:0007648](http://purl.obolibrary.org/obo/MONDO_0007648) (hereditary diffuse gastric cancer), [MONDO:0008989](http://purl.obolibrary.org/obo/MONDO_0008989) (citrulline transport defect), [MONDO:0007647](http://purl.obolibrary.org/obo/MONDO_0007647) (gastric volvulus, intrathoracic), [MONDO:0007646](http://purl.obolibrary.org/obo/MONDO_0007646) (Gamstorp-Wohlfart syndrome), [MONDO:0007645](http://purl.obolibrary.org/obo/MONDO_0007645) (gastric Sneezing), [MONDO:0007644](http://purl.obolibrary.org/obo/MONDO_0007644) (IgAD1), [MONDO:0007643](http://purl.obolibrary.org/obo/MONDO_0007643) (gamma-a-globulin, defect 1N assembly of), [MONDO:0007641](http://purl.obolibrary.org/obo/MONDO_0007641) (Futcher line), [MONDO:0007640](http://purl.obolibrary.org/obo/MONDO_0007640) (Sorsby's fundus dystrophy), [MONDO:0016599](http://purl.obolibrary.org/obo/MONDO_0016599) (autosomal dominant secondary polycythemia), [MONDO:0015267](http://purl.obolibrary.org/obo/MONDO_0015267) (Feingold syndrome), [MONDO:0019623](http://purl.obolibrary.org/obo/MONDO_0019623) (hereditary angioedema), [MONDO:0016597](http://purl.obolibrary.org/obo/MONDO_0016597) (generalized pustular psoriasis), [MONDO:0016596](http://purl.obolibrary.org/obo/MONDO_0016596) (hyperphosphatasia-intellectual disability syndrome), [MONDO:0008971](http://purl.obolibrary.org/obo/MONDO_0008971) (chondrodysplasia calcificans Metaphysealis), [MONDO:0008972](http://purl.obolibrary.org/obo/MONDO_0008972) (rhizomelic chondrodysplasia punctata type 1), [MONDO:0008974](http://purl.obolibrary.org/obo/MONDO_0008974) (Greenberg dysplasia), [MONDO:0008976](http://purl.obolibrary.org/obo/MONDO_0008976) (chondroitin-6-Sulfaturia, defective cellular immunity, nephrotic syndrome), [MONDO:0007659](http://purl.obolibrary.org/obo/MONDO_0007659) (giant platelet syndrome with thrombocytopenia), [MONDO:0007657](http://purl.obolibrary.org/obo/MONDO_0007657) (giant neutrophil Leukocytes), [MONDO:0007656](http://purl.obolibrary.org/obo/MONDO_0007656) (Gerstmann-Straussler-Scheinker syndrome), [MONDO:0007654](http://purl.obolibrary.org/obo/MONDO_0007654) (genu valgum, st. Helena familial), [MONDO:0007653](http://purl.obolibrary.org/obo/MONDO_0007653) (genochondromatosis), [MONDO:0007652](http://purl.obolibrary.org/obo/MONDO_0007652) (gastric mucosal hypertrophy), [MONDO:0019629](http://purl.obolibrary.org/obo/MONDO_0019629) (sclerocornea (disease)), [MONDO:0019628](http://purl.obolibrary.org/obo/MONDO_0019628) (Rieger anomaly), [MONDO:0015253](http://purl.obolibrary.org/obo/MONDO_0015253) (Diamond-Blackfan anemia), [MONDO:0016583](http://purl.obolibrary.org/obo/MONDO_0016583) (familial intestinal malrotation-facial anomalies syndrome), [MONDO:0008962](http://purl.obolibrary.org/obo/MONDO_0008962) (Griscelli syndrome type 1), [MONDO:0008963](http://purl.obolibrary.org/obo/MONDO_0008963) (Chediak-Higashi syndrome), [MONDO:0007629](http://purl.obolibrary.org/obo/MONDO_0007629) (fragile site 10Q23), [MONDO:0007628](http://purl.obolibrary.org/obo/MONDO_0007628) (foveal hypoplasia 1), [MONDO:0008967](http://purl.obolibrary.org/obo/MONDO_0008967) (congenital bile acid synthesis defect 4), [MONDO:0008968](http://purl.obolibrary.org/obo/MONDO_0008968) (cholestasis with Gallstone, ataxia, and visual disturbance), [MONDO:0007625](http://purl.obolibrary.org/obo/MONDO_0007625) (focal epithelial hyperplasia of the oral mucosa), [MONDO:0008969](http://purl.obolibrary.org/obo/MONDO_0008969) (cholesterol pneumonia), [MONDO:0007623](http://purl.obolibrary.org/obo/MONDO_0007623) (flushing of ears and Somnolence), [MONDO:0007622](http://purl.obolibrary.org/obo/MONDO_0007622) (Flood factor deficiency), [MONDO:0007620](http://purl.obolibrary.org/obo/MONDO_0007620) (fish-eye disease), [MONDO:0019601](http://purl.obolibrary.org/obo/MONDO_0019601) (autosomal recessive axonal hereditary motor and sensory neuropathy), [MONDO:0016578](http://purl.obolibrary.org/obo/MONDO_0016578) (mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies), [MONDO:0019602](http://purl.obolibrary.org/obo/MONDO_0019602) (other inborn metabolic disease), [MONDO:0019600](http://purl.obolibrary.org/obo/MONDO_0019600) (xeroderma pigmentosum), [MONDO:0016575](http://purl.obolibrary.org/obo/MONDO_0016575) (primary ciliary dyskinesia), [MONDO:0015244](http://purl.obolibrary.org/obo/MONDO_0015244) (autosomal recessive cerebellar ataxia), [MONDO:0008950](http://purl.obolibrary.org/obo/MONDO_0008950) (cerebral sclerosis similar to Pelizaeus-Merzbacher disease), [MONDO:0008951](http://purl.obolibrary.org/obo/MONDO_0008951) (Cerebrocortical degeneration of infancy), [MONDO:0008953](http://purl.obolibrary.org/obo/MONDO_0008953) (peroxisome biogenesis disorder 1A (Zellweger)), [MONDO:0008954](http://purl.obolibrary.org/obo/MONDO_0008954) (peroxisome biogenesis disorder 2A (Zellweger)), [MONDO:0007638](http://purl.obolibrary.org/obo/MONDO_0007638) (fucosidase Regulator), [MONDO:0008955](http://purl.obolibrary.org/obo/MONDO_0008955) (Cerebrooculofacioskeletal syndrome 1), [MONDO:0008956](http://purl.obolibrary.org/obo/MONDO_0008956) (congenital neuronal ceroid lipofuscinosis), [MONDO:0008957](http://purl.obolibrary.org/obo/MONDO_0008957) (cervical vertebrae, agenesis of), [MONDO:0007635](http://purl.obolibrary.org/obo/MONDO_0007635) (Frasier syndrome), [MONDO:0007634](http://purl.obolibrary.org/obo/MONDO_0007634) (mental retardation, Fra12A type), [MONDO:0008959](http://purl.obolibrary.org/obo/MONDO_0008959) (Chands), [MONDO:0007633](http://purl.obolibrary.org/obo/MONDO_0007633) (Friedreich ataxia, So-called, with optic atrophy and sensorineural deafness), [MONDO:0007632](http://purl.obolibrary.org/obo/MONDO_0007632) (fragile site, Distamycin a type, rare, Fra(16)(Q22.1)), [MONDO:0007631](http://purl.obolibrary.org/obo/MONDO_0007631) (chromosome 16p12.1 deletion syndrome, 520kb), [MONDO:0019609](http://purl.obolibrary.org/obo/MONDO_0019609) (Zellweger syndrome), [MONDO:0001909](http://purl.obolibrary.org/obo/MONDO_0001909) (renal tubular acidosis), [MONDO:0016168](http://purl.obolibrary.org/obo/MONDO_0016168) (Cryopyrin-associated periodic syndrome), [MONDO:0008541](http://purl.obolibrary.org/obo/MONDO_0008541) (spermatic cord torsion), [MONDO:0009872](http://purl.obolibrary.org/obo/MONDO_0009872) (Bjornstad syndrome), [MONDO:0008542](http://purl.obolibrary.org/obo/MONDO_0008542) (tetralogy of fallot), [MONDO:0008543](http://purl.obolibrary.org/obo/MONDO_0008543) (tetralogy of fallot and glaucoma), [MONDO:0009874](http://purl.obolibrary.org/obo/MONDO_0009874) (Rabson-Mendenhall syndrome), [MONDO:0008545](http://purl.obolibrary.org/obo/MONDO_0008545) (thalassemia, beta+, silent Allele), [MONDO:0016163](http://purl.obolibrary.org/obo/MONDO_0016163) (autosomal dominant cerebellar ataxia type 2), [MONDO:0009877](http://purl.obolibrary.org/obo/MONDO_0009877) (Laron syndrome), [MONDO:0016160](http://purl.obolibrary.org/obo/MONDO_0016160) (X-linked intellectual disability-epilepsy syndrome), [MONDO:0008548](http://purl.obolibrary.org/obo/MONDO_0008548) (Theophylline Biotransformation), [MONDO:0008549](http://purl.obolibrary.org/obo/MONDO_0008549) (thoracic dysostosis, isolated), [MONDO:0007206](http://purl.obolibrary.org/obo/MONDO_0007206) (bone pain, periodic), [MONDO:0010869](http://purl.obolibrary.org/obo/MONDO_0010869) (motor neuron disease with dementia and ophthalmoplegia), [MONDO:0007203](http://purl.obolibrary.org/obo/MONDO_0007203) (blue rubber bleb nevus), [MONDO:0007201](http://purl.obolibrary.org/obo/MONDO_0007201) (blepharophimosis, ptosis, and epicanthus inversus syndrome), [MONDO:0010860](http://purl.obolibrary.org/obo/MONDO_0010860) (autosomal recessive nonsyndromic deafness 3), [MONDO:0016159](http://purl.obolibrary.org/obo/MONDO_0016159) (Gemignani syndrome), [MONDO:0016155](http://purl.obolibrary.org/obo/MONDO_0016155) (qualitative or quantitative defects of protein involved in O-glycosylation of alpha-dystroglycan), [MONDO:0016157](http://purl.obolibrary.org/obo/MONDO_0016157) (qualitative or quantitative defects of fukutin), [MONDO:0009860](http://purl.obolibrary.org/obo/MONDO_0009860) (phenformin 4-hydroxylation), [MONDO:0009861](http://purl.obolibrary.org/obo/MONDO_0009861) (phenylketonuria), [MONDO:0016156](http://purl.obolibrary.org/obo/MONDO_0016156) (qualitative or quantitative defects of FKRP), [MONDO:0008530](http://purl.obolibrary.org/obo/MONDO_0008530) (teeth, odd shapes of), [MONDO:0009862](http://purl.obolibrary.org/obo/MONDO_0009862) (dihydropteridine reductase deficiency), [MONDO:0008531](http://purl.obolibrary.org/obo/MONDO_0008531) (T-complex locus TCP10B), [MONDO:0009863](http://purl.obolibrary.org/obo/MONDO_0009863) (Bh4-deficient hyperphenylalaninemia a), [MONDO:0008532](http://purl.obolibrary.org/obo/MONDO_0008532) (teeth present at birth (disease)), [MONDO:0008533](http://purl.obolibrary.org/obo/MONDO_0008533) (teeth, supernumerary), [MONDO:0009864](http://purl.obolibrary.org/obo/MONDO_0009864) (Phosphoenolpyruvate carboxykinase deficiency, mitochondrial), [MONDO:0009865](http://purl.obolibrary.org/obo/MONDO_0009865) (glycogen storage disease due to phosphoglycerate mutase deficiency), [MONDO:0008535](http://purl.obolibrary.org/obo/MONDO_0008535) (telangiectasia, hereditary hemorrhagic, of Rendu, Osler, and Weber), [MONDO:0009866](http://purl.obolibrary.org/obo/MONDO_0009866) (Phosphoenolpyruvate carboxykinase deficiency, cytosolic), [MONDO:0009867](http://purl.obolibrary.org/obo/MONDO_0009867) (lethal congenital glycogen storage disease of heart), [MONDO:0008536](http://purl.obolibrary.org/obo/MONDO_0008536) (temperature-Sensitive lethal mutation), [MONDO:0009868](http://purl.obolibrary.org/obo/MONDO_0009868) (glycogen storage disease IXb), [MONDO:0010859](http://purl.obolibrary.org/obo/MONDO_0010859) (atrioventricular septal defect 3), [MONDO:0007210](http://purl.obolibrary.org/obo/MONDO_0007210) (Brachmann-de Lange-like facial changes with microcephaly, Metatarsus Adductus, and developmental delay), [MONDO:0010852](http://purl.obolibrary.org/obo/MONDO_0010852) (chromosome 8Q12.1-Q21.2 deletion syndrome), [MONDO:0010853](http://purl.obolibrary.org/obo/MONDO_0010853) (helicobacter pylori infection, susceptibility to), [MONDO:0009850](http://purl.obolibrary.org/obo/MONDO_0009850) (periodontitis, chronic, adult), [MONDO:0009851](http://purl.obolibrary.org/obo/MONDO_0009851) (peripheral neuropathy, ataxia, focal necrotizing encephalopathy, and Spongy degeneration of brain), [MONDO:0009852](http://purl.obolibrary.org/obo/MONDO_0009852) (congenital intrinsic factor deficiency), [MONDO:0008521](http://purl.obolibrary.org/obo/MONDO_0008521) (tarsal-carpal coalition syndrome), [MONDO:0009853](http://purl.obolibrary.org/obo/MONDO_0009853) (Imerslund-Grasbeck syndrome), [MONDO:0008522](http://purl.obolibrary.org/obo/MONDO_0008522) (synovial chondromatosis, familial, with dwarfism), [MONDO:0008523](http://purl.obolibrary.org/obo/MONDO_0008523) (Blau syndrome), [MONDO:0009854](http://purl.obolibrary.org/obo/MONDO_0009854) (Peroneus Tertius muscle, absence of), [MONDO:0008524](http://purl.obolibrary.org/obo/MONDO_0008524) (syringomas, multiple), [MONDO:0009855](http://purl.obolibrary.org/obo/MONDO_0009855) (d-bifunctional protein deficiency), [MONDO:0009856](http://purl.obolibrary.org/obo/MONDO_0009856) (Peters plus syndrome), [MONDO:0008526](http://purl.obolibrary.org/obo/MONDO_0008526) (talonavicular coalition), [MONDO:0008527](http://purl.obolibrary.org/obo/MONDO_0008527) (tarsal coalition), [MONDO:0008528](http://purl.obolibrary.org/obo/MONDO_0008528) (tear protein, anodal), [MONDO:0010848](http://purl.obolibrary.org/obo/MONDO_0010848) (spinocerebellar ataxia type 5), [MONDO:0008529](http://purl.obolibrary.org/obo/MONDO_0008529) (T-cell Subgroups, non-HLA-linked), [MONDO:0010849](http://purl.obolibrary.org/obo/MONDO_0010849) (palmoplantar keratoderma, Bothnian type), [MONDO:0010846](http://purl.obolibrary.org/obo/MONDO_0010846) (EXT3), [MONDO:0010847](http://purl.obolibrary.org/obo/MONDO_0010847) (spinocerebellar ataxia type 4), [MONDO:0010841](http://purl.obolibrary.org/obo/MONDO_0010841) (Waardenburg syndrome type 2B), [MONDO:0010842](http://purl.obolibrary.org/obo/MONDO_0010842) (multiple cutaneous and mucosal venous malformations), [MONDO:0010843](http://purl.obolibrary.org/obo/MONDO_0010843) (DYX2), [MONDO:0018799](http://purl.obolibrary.org/obo/MONDO_0018799) (rare hypercholesterolemia), [MONDO:0009840](http://purl.obolibrary.org/obo/MONDO_0009840) (Partington-Anderson syndrome), [MONDO:0009842](http://purl.obolibrary.org/obo/MONDO_0009842) (Pelger-Huet-like anomaly and episodic fever with abdominal pain), [MONDO:0008511](http://purl.obolibrary.org/obo/MONDO_0008511) (proximal symphalangism (disease)), [MONDO:0008512](http://purl.obolibrary.org/obo/MONDO_0008512) (syndactyly type 1), [MONDO:0009844](http://purl.obolibrary.org/obo/MONDO_0009844) (pellagra-like syndrome), [MONDO:0009846](http://purl.obolibrary.org/obo/MONDO_0009846) (pentosuria), [MONDO:0009847](http://purl.obolibrary.org/obo/MONDO_0009847) (pericardial effusion, chronic), [MONDO:0008518](http://purl.obolibrary.org/obo/MONDO_0008518) (calcaneonavicular coalition), [MONDO:0009849](http://purl.obolibrary.org/obo/MONDO_0009849) (Hyperimmunoglobulinemia d with periodic fever), [MONDO:0010838](http://purl.obolibrary.org/obo/MONDO_0010838) (gonadal agenesis), [MONDO:0004166](http://purl.obolibrary.org/obo/MONDO_0004166) (hereditary fallopian tube carcinoma), [MONDO:0010839](http://purl.obolibrary.org/obo/MONDO_0010839) (autosomal dominant congenital benign spinal muscular atrophy), [MONDO:0004162](http://purl.obolibrary.org/obo/MONDO_0004162) (uterine corpus cellular leiomyoma), [MONDO:0010830](http://purl.obolibrary.org/obo/MONDO_0010830) (neuronal ceroid lipofuscinosis 8), [MONDO:0004161](http://purl.obolibrary.org/obo/MONDO_0004161) (uterine corpus apoplectic leiomyoma), [MONDO:0010832](http://purl.obolibrary.org/obo/MONDO_0010832) (Bardet-Biedl syndrome 3), [MONDO:0019238](http://purl.obolibrary.org/obo/MONDO_0019238) (inborn disorder of pyrimidine metabolism), [MONDO:0008580](http://purl.obolibrary.org/obo/MONDO_0008580) (toes, space between first and second), [MONDO:0019239](http://purl.obolibrary.org/obo/MONDO_0019239) (inborn disorder of serine or glycine metabolism), [MONDO:0008581](http://purl.obolibrary.org/obo/MONDO_0008581) (malposition of teeth with or without hypodontia/oligodontia), [MONDO:0019236](http://purl.obolibrary.org/obo/MONDO_0019236) (inborn disorder of purine metabolism), [MONDO:0019237](http://purl.obolibrary.org/obo/MONDO_0019237) (inborn disorder of pyridoxine metabolism), [MONDO:0008583](http://purl.obolibrary.org/obo/MONDO_0008583) (torticollis (disease)), [MONDO:0019234](http://purl.obolibrary.org/obo/MONDO_0019234) (peroxisome biogenesis disorder), [MONDO:0008584](http://purl.obolibrary.org/obo/MONDO_0008584) (torus palatinus and Torus Mandibularis), [MONDO:0019235](http://purl.obolibrary.org/obo/MONDO_0019235) (inborn disorder of phenylalanin or tyrosine metabolism), [MONDO:0019232](http://purl.obolibrary.org/obo/MONDO_0019232) (inborn disorder of peptide metabolism), [MONDO:0020221](http://purl.obolibrary.org/obo/MONDO_0020221) (secondary glaucoma due to a proliferation and differentiation anomaly), [MONDO:0019233](http://purl.obolibrary.org/obo/MONDO_0019233) (peroxisomal beta-oxidation disorder), [MONDO:0019230](http://purl.obolibrary.org/obo/MONDO_0019230) (inborn disorder of ornithine or proline metabolism), [MONDO:0008589](http://purl.obolibrary.org/obo/MONDO_0008589) (tremor of Intention, ataxia, and lipofuscinosis), [MONDO:0019231](http://purl.obolibrary.org/obo/MONDO_0019231) (inborn disorder of pentose phosphate metabolism), [MONDO:0012607](http://purl.obolibrary.org/obo/MONDO_0012607) (asthma-related Traits, susceptibility to, 5), [MONDO:0012606](http://purl.obolibrary.org/obo/MONDO_0012606) (mycobacterium tuberculosis, susceptibility to, 2), [MONDO:0007248](http://purl.obolibrary.org/obo/MONDO_0007248) (hereditary painful callosities), [MONDO:0007247](http://purl.obolibrary.org/obo/MONDO_0007247) (basal ganglia calcification, idiopathic, childhood-onset), [MONDO:0013937](http://purl.obolibrary.org/obo/MONDO_0013937) (peroxisome biogenesis disorder 6B), [MONDO:0007246](http://purl.obolibrary.org/obo/MONDO_0007246) (calcific aortic disease with immunologic abnormalities, familial), [MONDO:0013938](http://purl.obolibrary.org/obo/MONDO_0013938) (peroxisome biogenesis disorder 7A (Zellweger)), [MONDO:0013939](http://purl.obolibrary.org/obo/MONDO_0013939) (peroxisome biogenesis disorder 7B), [MONDO:0020220](http://purl.obolibrary.org/obo/MONDO_0020220) (Corneoiridogoniodysgenesis), [MONDO:0013933](http://purl.obolibrary.org/obo/MONDO_0013933) (peroxisome biogenesis disorder 5B), [MONDO:0013934](http://purl.obolibrary.org/obo/MONDO_0013934) (combined immunodeficiency due to STK4 deficiency), [MONDO:0007242](http://purl.obolibrary.org/obo/MONDO_0007242) (butyrylesterase 1), [MONDO:0007241](http://purl.obolibrary.org/obo/MONDO_0007241) (bundle branch block, familial isolated complete right), [MONDO:0013935](http://purl.obolibrary.org/obo/MONDO_0013935) (Usher syndrome type 1J), [MONDO:0013936](http://purl.obolibrary.org/obo/MONDO_0013936) (peroxisome biogenesis disorder 6A (Zellweger)), [MONDO:0013930](http://purl.obolibrary.org/obo/MONDO_0013930) (peroxisome biogenesis disorder 4A (Zellweger)), [MONDO:0013931](http://purl.obolibrary.org/obo/MONDO_0013931) (peroxisome biogenesis disorder 4B), [MONDO:0012602](http://purl.obolibrary.org/obo/MONDO_0012602) (autosomal recessive nonsyndromic deafness 24), [MONDO:0013932](http://purl.obolibrary.org/obo/MONDO_0013932) (peroxisome biogenesis disorder 5A (Zellweger)), [MONDO:0020218](http://purl.obolibrary.org/obo/MONDO_0020218) (goniodysgenesis), [MONDO:0019229](http://purl.obolibrary.org/obo/MONDO_0019229) (inborn disorder of ketolysis), [MONDO:0020219](http://purl.obolibrary.org/obo/MONDO_0020219) (corneogoniodysgenesis), [MONDO:0019227](http://purl.obolibrary.org/obo/MONDO_0019227) (inborn disorder of glycerol metabolism), [MONDO:0019228](http://purl.obolibrary.org/obo/MONDO_0019228) (inborn disorder of histidine metabolism), [MONDO:0008570](http://purl.obolibrary.org/obo/MONDO_0008570) (thyrotoxic periodic paralysis, susceptibility to, 1), [MONDO:0019225](http://purl.obolibrary.org/obo/MONDO_0019225) (gluconeogenesis disorder), [MONDO:0019226](http://purl.obolibrary.org/obo/MONDO_0019226) (glucose transport disorder), [MONDO:0010892](http://purl.obolibrary.org/obo/MONDO_0010892) (mitochondrial myopathy and sideroblastic anemia), [MONDO:0008572](http://purl.obolibrary.org/obo/MONDO_0008572) (tibia, hypoplasia or aplasia of, with polydactyly), [MONDO:0008573](http://purl.obolibrary.org/obo/MONDO_0008573) (tibial torsion, bilateral medial), [MONDO:0019223](http://purl.obolibrary.org/obo/MONDO_0019223) (inborn disorder of fatty acid oxidation and ketone body metabolism), [MONDO:0008574](http://purl.obolibrary.org/obo/MONDO_0008574) (Tl antigen), [MONDO:0019224](http://purl.obolibrary.org/obo/MONDO_0019224) (inborn disorder of gamma-aminobutyric acid metabolism), [MONDO:0008575](http://purl.obolibrary.org/obo/MONDO_0008575) (nicotine dependence), [MONDO:0008576](http://purl.obolibrary.org/obo/MONDO_0008576) (toe, fifth, number of phalanges 1N), [MONDO:0019222](http://purl.obolibrary.org/obo/MONDO_0019222) (inborn disorder of methionine cycle and sulfur amino acid metabolism), [MONDO:0008577](http://purl.obolibrary.org/obo/MONDO_0008577) (toe, Misshapen), [MONDO:0008578](http://purl.obolibrary.org/obo/MONDO_0008578) (toe, Rotated fifth), [MONDO:0019220](http://purl.obolibrary.org/obo/MONDO_0019220) (inborn disorder of cobalamin metabolism and transport), [MONDO:0008579](http://purl.obolibrary.org/obo/MONDO_0008579) (toes, Relative length of first and second), [MONDO:0020216](http://purl.obolibrary.org/obo/MONDO_0020216) (secondary dysgenetic glaucoma), [MONDO:0020217](http://purl.obolibrary.org/obo/MONDO_0020217) (secondary dysgenetic glaucoma associated with neural crest cell migration anomaly), [MONDO:0021547](http://purl.obolibrary.org/obo/MONDO_0021547) (amelogenesis imperfecta type 3B), [MONDO:0007258](http://purl.obolibrary.org/obo/MONDO_0007258) (canine teeth, absence of upper permanent), [MONDO:0013927](http://purl.obolibrary.org/obo/MONDO_0013927) (peroxisome biogenesis disorder 3A (Zellweger)), [MONDO:0013929](http://purl.obolibrary.org/obo/MONDO_0013929) (autosomal recessive nonsyndromic deafness 98), [MONDO:0013922](http://purl.obolibrary.org/obo/MONDO_0013922) (microcephalic primordial dwarfism, Dauber type), [MONDO:0010895](http://purl.obolibrary.org/obo/MONDO_0010895) (ABCD syndrome), [MONDO:0010896](http://purl.obolibrary.org/obo/MONDO_0010896) (pigment dispersion syndrome), [MONDO:0007253](http://purl.obolibrary.org/obo/MONDO_0007253) (cancer, familial, with 1N Vitro Radioresistance), [MONDO:0010894](http://purl.obolibrary.org/obo/MONDO_0010894) (maturity-onset diabetes of the young type 3), [MONDO:0013925](http://purl.obolibrary.org/obo/MONDO_0013925) (methylmalonic acidemia with homocystinuria, type cblJ), [MONDO:0010899](http://purl.obolibrary.org/obo/MONDO_0010899) (autosomal dominant nocturnal frontal lobe epilepsy 1), [MONDO:0010898](http://purl.obolibrary.org/obo/MONDO_0010898) (familial temporal lobe epilepsy 1), [MONDO:0019218](http://purl.obolibrary.org/obo/MONDO_0019218) (inborn disorder of bile acid synthesis), [MONDO:0019219](http://purl.obolibrary.org/obo/MONDO_0019219) (inborn disorder of neurotransmitter metabolism and transport), [MONDO:0019216](http://purl.obolibrary.org/obo/MONDO_0019216) (inborn disorder of amino acid absorption and transport), [MONDO:0009890](http://purl.obolibrary.org/obo/MONDO_0009890) (polycystic kidney disease, Potter type i, with Microbrachycephaly, hypertelorism, and Brachymelia), [MONDO:0019217](http://purl.obolibrary.org/obo/MONDO_0019217) (inborn disorder of urea cycle metabolism and ammonia detoxification), [MONDO:0008560](http://purl.obolibrary.org/obo/MONDO_0008560) (thrombophilia due to activated protein C resistance), [MONDO:0019214](http://purl.obolibrary.org/obo/MONDO_0019214) (inborn carbohydrate metabolic disorder), [MONDO:0010880](http://purl.obolibrary.org/obo/MONDO_0010880) (telangiectasia, hereditary hemorrhagic, type 2), [MONDO:0019215](http://purl.obolibrary.org/obo/MONDO_0019215) (classic organic aciduria), [MONDO:0008561](http://purl.obolibrary.org/obo/MONDO_0008561) (thumb deformity (disease)), [MONDO:0019213](http://purl.obolibrary.org/obo/MONDO_0019213) (cerebral organic aciduria), [MONDO:0009894](http://purl.obolibrary.org/obo/MONDO_0009894) (short-rib thoracic dysplasia 6 with or without polydactyly), [MONDO:0008564](http://purl.obolibrary.org/obo/MONDO_0008564) (DiGeorge syndrome), [MONDO:0016184](http://purl.obolibrary.org/obo/MONDO_0016184) (qualitative or quantitative defects of protein O-mannosyltransferase 1), [MONDO:0008565](http://purl.obolibrary.org/obo/MONDO_0008565) (familial thyroglossal duct cyst), [MONDO:0009896](http://purl.obolibrary.org/obo/MONDO_0009896) (polymyoclonus, infantile), [MONDO:0016183](http://purl.obolibrary.org/obo/MONDO_0016183) (qualitative or quantitative defects of protein glycosyltransferase-like), [MONDO:0009897](http://purl.obolibrary.org/obo/MONDO_0009897) (adult polyglucosan body disease), [MONDO:0009898](http://purl.obolibrary.org/obo/MONDO_0009898) (Polysaccharide, storage of unusual), [MONDO:0016185](http://purl.obolibrary.org/obo/MONDO_0016185) (qualitative or quantitative defects of protein O-mannosyltransferase 2), [MONDO:0008568](http://purl.obolibrary.org/obo/MONDO_0008568) (thyroid hormone plasma membrane transport defect), [MONDO:0009899](http://purl.obolibrary.org/obo/MONDO_0009899) (polyhydramnios, chronic idiopathic), [MONDO:0016182](http://purl.obolibrary.org/obo/MONDO_0016182) (qualitative or quantitative defects of protein O-mannose beta1,2N-acetylglucosaminyltransferase), [MONDO:0013919](http://purl.obolibrary.org/obo/MONDO_0013919) (epilepsy, idiopathic generalized, susceptibility to, 12), [MONDO:0007229](http://purl.obolibrary.org/obo/MONDO_0007229) (Brachymetatarsus 4), [MONDO:0007228](http://purl.obolibrary.org/obo/MONDO_0007228) (brachymesomelia-renal syndrome), [MONDO:0013916](http://purl.obolibrary.org/obo/MONDO_0013916) (nephronophthisis 14), [MONDO:0013917](http://purl.obolibrary.org/obo/MONDO_0013917) (nephronophthisis 15), [MONDO:0013918](http://purl.obolibrary.org/obo/MONDO_0013918) (distal tetrasomy 15q), [MONDO:0010885](http://purl.obolibrary.org/obo/MONDO_0010885) (angiokeratoma corporis diffusum with arteriovenous fistulas), [MONDO:0010888](http://purl.obolibrary.org/obo/MONDO_0010888) (endometriosis of uterus), [MONDO:0019207](http://purl.obolibrary.org/obo/MONDO_0019207) (DEND syndrome), [MONDO:0010870](http://purl.obolibrary.org/obo/MONDO_0010870) (tibial muscular dystrophy), [MONDO:0009881](http://purl.obolibrary.org/obo/MONDO_0009881) (pituitary dwarfism with large sella turcica), [MONDO:0009882](http://purl.obolibrary.org/obo/MONDO_0009882) (plasma clot retraction factor, deficiency of), [MONDO:0019201](http://purl.obolibrary.org/obo/MONDO_0019201) (thyrotoxic periodic paralysis), [MONDO:0008552](http://purl.obolibrary.org/obo/MONDO_0008552) (platelet-type bleeding disorder 16), [MONDO:0009884](http://purl.obolibrary.org/obo/MONDO_0009884) (platelet prostacyclin receptor defect), [MONDO:0009886](http://purl.obolibrary.org/obo/MONDO_0009886) (pleoconial myopathy with salt craving), [MONDO:0008556](http://purl.obolibrary.org/obo/MONDO_0008556) (thrombocytopenia, cyclic), [MONDO:0009888](http://purl.obolibrary.org/obo/MONDO_0009888) (polycystic kidney, cataract, and congenital blindness), [MONDO:0009889](http://purl.obolibrary.org/obo/MONDO_0009889) (autosomal recessive polycystic kidney disease), [MONDO:0008559](http://purl.obolibrary.org/obo/MONDO_0008559) (thrombophilia due to thrombin defect), [MONDO:0000600](http://purl.obolibrary.org/obo/MONDO_0000600) (nosophobia), [MONDO:0013908](http://purl.obolibrary.org/obo/MONDO_0013908) (TTPP3), [MONDO:0007239](http://purl.obolibrary.org/obo/MONDO_0007239) (epidermolytic hyperkeratosis), [MONDO:0013909](http://purl.obolibrary.org/obo/MONDO_0013909) (HHV8S), [MONDO:0007237](http://purl.obolibrary.org/obo/MONDO_0007237) (familial juvenile hypertrophy of the breast), [MONDO:0013904](http://purl.obolibrary.org/obo/MONDO_0013904) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8), [MONDO:0007236](http://purl.obolibrary.org/obo/MONDO_0007236) (branchiootorenal syndrome 1), [MONDO:0013905](http://purl.obolibrary.org/obo/MONDO_0013905) (autosomal recessive spinocerebellar ataxia 13), [MONDO:0007235](http://purl.obolibrary.org/obo/MONDO_0007235) (branchiooculofacial syndrome), [MONDO:0013906](http://purl.obolibrary.org/obo/MONDO_0013906) (amelogenesis imperfecta hypomaturation type 2A4), [MONDO:0007234](http://purl.obolibrary.org/obo/MONDO_0007234) (branchial myoclonus with spastic paraparesis and cerebellar ataxia), [MONDO:0007233](http://purl.obolibrary.org/obo/MONDO_0007233) (second branchial cleft anomaly), [MONDO:0007232](http://purl.obolibrary.org/obo/MONDO_0007232) (autosomal dominant brachyolmia), [MONDO:0010873](http://purl.obolibrary.org/obo/MONDO_0010873) (band heterotopia of brain), [MONDO:0010874](http://purl.obolibrary.org/obo/MONDO_0010874) (enteropathy, familial, with villous edema and immunoglobulin G2 deficiency), [MONDO:0010871](http://purl.obolibrary.org/obo/MONDO_0010871) (succinic acidemia), [MONDO:0010872](http://purl.obolibrary.org/obo/MONDO_0010872) (PDDP), [MONDO:0010875](http://purl.obolibrary.org/obo/MONDO_0010875) (Pachydermodactyly, familial), [MONDO:0013970](http://purl.obolibrary.org/obo/MONDO_0013970) (branched-chain keto acid dehydrogenase kinase deficiency), [MONDO:0013971](http://purl.obolibrary.org/obo/MONDO_0013971) (leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome), [MONDO:0013972](http://purl.obolibrary.org/obo/MONDO_0013972) (Perrault syndrome 2), [MONDO:0012641](http://purl.obolibrary.org/obo/MONDO_0012641) (RLS5), [MONDO:0011310](http://purl.obolibrary.org/obo/MONDO_0011310) (long chain fatty acids, defect 1N transport of), [MONDO:0019276](http://purl.obolibrary.org/obo/MONDO_0019276) (inherited epidermolysis bullosa), [MONDO:0019272](http://purl.obolibrary.org/obo/MONDO_0019272) (hereditary palmoplantar keratoderma), [MONDO:0001982](http://purl.obolibrary.org/obo/MONDO_0001982) (Niemann-Pick disease), [MONDO:0011319](http://purl.obolibrary.org/obo/MONDO_0011319) (activator of liver function 1), [MONDO:0013977](http://purl.obolibrary.org/obo/MONDO_0013977) (combined oxidative phosphorylation defect type 13), [MONDO:0012645](http://purl.obolibrary.org/obo/MONDO_0012645) (GLC1N), [MONDO:0012644](http://purl.obolibrary.org/obo/MONDO_0012644) (asphyxiating thoracic dystrophy 2), [MONDO:0013978](http://purl.obolibrary.org/obo/MONDO_0013978) (autosomal recessive nonsyndromic deafness 70), [MONDO:0012643](http://purl.obolibrary.org/obo/MONDO_0012643) (hereditary spastic paraplegia 32), [MONDO:0013979](http://purl.obolibrary.org/obo/MONDO_0013979) (primary ciliary dyskinesia 19), [MONDO:0012642](http://purl.obolibrary.org/obo/MONDO_0012642) (MAFD4), [MONDO:0011311](http://purl.obolibrary.org/obo/MONDO_0011311) (glaucoma 1, open angle, f), [MONDO:0012649](http://purl.obolibrary.org/obo/MONDO_0012649) (FTSD), [MONDO:0011318](http://purl.obolibrary.org/obo/MONDO_0011318) (Tonoki syndrome), [MONDO:0012648](http://purl.obolibrary.org/obo/MONDO_0012648) (isobutyryl-CoA dehydrogenase deficiency), [MONDO:0011317](http://purl.obolibrary.org/obo/MONDO_0011317) (microcephaly, severe, with skeletal anomalies including posterior rib-Gap defects), [MONDO:0012647](http://purl.obolibrary.org/obo/MONDO_0012647) (generalized epilepsy with febrile seizures plus, type 3), [MONDO:0011316](http://purl.obolibrary.org/obo/MONDO_0011316) (osteosclerotic chondrodysplasia, lethal, with intracellular inclusions), [MONDO:0012646](http://purl.obolibrary.org/obo/MONDO_0012646) (GLC1H), [MONDO:0011315](http://purl.obolibrary.org/obo/MONDO_0011315) (Osebold skeletal dysplasia/osteolysis syndrome), [MONDO:0019267](http://purl.obolibrary.org/obo/MONDO_0019267) (vitamin B12-unresponsive methylmalonic acidemia type mut-), [MONDO:0019265](http://purl.obolibrary.org/obo/MONDO_0019265) (diazoxide-resistant focal hyperinsulinism), [MONDO:0019263](http://purl.obolibrary.org/obo/MONDO_0019263) (autosomal erythropoietic protoporphyria), [MONDO:0019264](http://purl.obolibrary.org/obo/MONDO_0019264) (alpha-N-acetylgalactosaminidase deficiency type 3), [MONDO:0019261](http://purl.obolibrary.org/obo/MONDO_0019261) (infantile neuronal ceroid lipofuscinosis), [MONDO:0019262](http://purl.obolibrary.org/obo/MONDO_0019262) (juvenile neuronal ceroid lipofuscinosis), [MONDO:0019260](http://purl.obolibrary.org/obo/MONDO_0019260) (adult neuronal ceroid lipofuscinosis), [MONDO:0011308](http://purl.obolibrary.org/obo/MONDO_0011308) (gracile syndrome), [MONDO:0012639](http://purl.obolibrary.org/obo/MONDO_0012639) (hereditary spastic paraplegia 18), [MONDO:0020250](http://purl.obolibrary.org/obo/MONDO_0020250) (autosomal dominant optic atrophy), [MONDO:0007299](http://purl.obolibrary.org/obo/MONDO_0007299) (Sotos syndrome 1), [MONDO:0007298](http://purl.obolibrary.org/obo/MONDO_0007298) (spinocerebellar ataxia type 29), [MONDO:0007297](http://purl.obolibrary.org/obo/MONDO_0007297) (ADan amyloidosis), [MONDO:0013967](http://purl.obolibrary.org/obo/MONDO_0013967) (peroxisome biogenesis disorder 14B), [MONDO:0013968](http://purl.obolibrary.org/obo/MONDO_0013968) (PGM1-CDG), [MONDO:0007296](http://purl.obolibrary.org/obo/MONDO_0007296) (spinocerebellar ataxia type 31), [MONDO:0011301](http://purl.obolibrary.org/obo/MONDO_0011301) (pseudohypoparathyroidism type 1B), [MONDO:0011300](http://purl.obolibrary.org/obo/MONDO_0011300) (MYP3), [MONDO:0007295](http://purl.obolibrary.org/obo/MONDO_0007295) (rolandic epilepsy), [MONDO:0013969](http://purl.obolibrary.org/obo/MONDO_0013969) (combined oxidative phosphorylation defect type 11), [MONDO:0013962](http://purl.obolibrary.org/obo/MONDO_0013962) (hereditary spastic paraplegia 53), [MONDO:0011306](http://purl.obolibrary.org/obo/MONDO_0011306) (muscular dystrophy, congenital, with cerebellar atrophy), [MONDO:0012637](http://purl.obolibrary.org/obo/MONDO_0012637) (COG1-CDG), [MONDO:0013963](http://purl.obolibrary.org/obo/MONDO_0013963) (autosomal recessive nonsyndromic deafness 93), [MONDO:0007293](http://purl.obolibrary.org/obo/MONDO_0007293) (leukocyte adhesion deficiency 1), [MONDO:0007292](http://purl.obolibrary.org/obo/MONDO_0007292) (celiac artery stenosis from compression by median arcuate ligament of diaphragm), [MONDO:0011305](http://purl.obolibrary.org/obo/MONDO_0011305) (cerebral cavernous malformations 3), [MONDO:0013964](http://purl.obolibrary.org/obo/MONDO_0013964) (Diamond-Blackfan anemia 11), [MONDO:0012636](http://purl.obolibrary.org/obo/MONDO_0012636) (RLS6), [MONDO:0007291](http://purl.obolibrary.org/obo/MONDO_0007291) (familial cerebral cavernous malformation), [MONDO:0011304](http://purl.obolibrary.org/obo/MONDO_0011304) (cerebral cavernous malformation 2), [MONDO:0012635](http://purl.obolibrary.org/obo/MONDO_0012635) (COG8-CDG), [MONDO:0013950](http://purl.obolibrary.org/obo/MONDO_0013950) (peroxisome biogenesis disorder 11B), [MONDO:0019258](http://purl.obolibrary.org/obo/MONDO_0019258) (mild phenylketonuria), [MONDO:0019259](http://purl.obolibrary.org/obo/MONDO_0019259) (classic phenylketonuria), [MONDO:0019256](http://purl.obolibrary.org/obo/MONDO_0019256) (sterol metabolism disorder), [MONDO:0019257](http://purl.obolibrary.org/obo/MONDO_0019257) (hemochromatosis type 2), [MONDO:0019254](http://purl.obolibrary.org/obo/MONDO_0019254) (inborn disorder of purine or pyrimidine metabolism), [MONDO:0021575](http://purl.obolibrary.org/obo/MONDO_0021575) (oocyte maturation defect 4), [MONDO:0019255](http://purl.obolibrary.org/obo/MONDO_0019255) (sphingolipidosis), [MONDO:0021574](http://purl.obolibrary.org/obo/MONDO_0021574) (oocyte maturation defect 3), [MONDO:0019253](http://purl.obolibrary.org/obo/MONDO_0019253) (metabolic disease involving other neurotransmitter deficiency), [MONDO:0019250](http://purl.obolibrary.org/obo/MONDO_0019250) (inborn disorder of biogenic amine metabolism and transport), [MONDO:0019251](http://purl.obolibrary.org/obo/MONDO_0019251) (oligosaccharidosis), [MONDO:0012628](http://purl.obolibrary.org/obo/MONDO_0012628) (CHDS8), [MONDO:0007269](http://purl.obolibrary.org/obo/MONDO_0007269) (dilated cardiomyopathy 1A), [MONDO:0021573](http://purl.obolibrary.org/obo/MONDO_0021573) (oocyte maturation defect 2), [MONDO:0012623](http://purl.obolibrary.org/obo/MONDO_0012623) (MRT4), [MONDO:0012622](http://purl.obolibrary.org/obo/MONDO_0012622) (leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome), [MONDO:0013958](http://purl.obolibrary.org/obo/MONDO_0013958) (Monocyte and dendritic cell deficiency, autosomal recessive), [MONDO:0013951](http://purl.obolibrary.org/obo/MONDO_0013951) (peroxisome biogenesis disorder 12A (Zellweger)), [MONDO:0012627](http://purl.obolibrary.org/obo/MONDO_0012627) (epilepsy, idiopathic generalized, susceptibility to, 13), [MONDO:0007261](http://purl.obolibrary.org/obo/MONDO_0007261) (Carabelli anomaly of maxillary molar teeth), [MONDO:0013952](http://purl.obolibrary.org/obo/MONDO_0013952) (peroxisome biogenesis disorder 13A (Zellweger)), [MONDO:0012626](http://purl.obolibrary.org/obo/MONDO_0012626) (Meckel syndrome, type 4), [MONDO:0007260](http://purl.obolibrary.org/obo/MONDO_0007260) (Car factor deficiency), [MONDO:0013953](http://purl.obolibrary.org/obo/MONDO_0013953) (immunodeficiency 28), [MONDO:0012624](http://purl.obolibrary.org/obo/MONDO_0012624) (acyl-CoA dehydrogenase 9 deficiency), [MONDO:0008590](http://purl.obolibrary.org/obo/MONDO_0008590) (tremor, hereditary essential, 1), [MONDO:0019249](http://purl.obolibrary.org/obo/MONDO_0019249) (mucopolysaccharidosis), [MONDO:0008593](http://purl.obolibrary.org/obo/MONDO_0008593) (trichomegaly), [MONDO:0019248](http://purl.obolibrary.org/obo/MONDO_0019248) (mucolipidosis), [MONDO:0008594](http://purl.obolibrary.org/obo/MONDO_0008594) (FMDF), [MONDO:0019245](http://purl.obolibrary.org/obo/MONDO_0019245) (lipid storage disorder), [MONDO:0008595](http://purl.obolibrary.org/obo/MONDO_0008595) (Trichoepitheliomas, multiple desmoplastic), [MONDO:0019246](http://purl.obolibrary.org/obo/MONDO_0019246) (inborn disorder of lysosomal amino acid transport), [MONDO:0008596](http://purl.obolibrary.org/obo/MONDO_0008596) (trichorhinophalangeal syndrome type i), [MONDO:0019243](http://purl.obolibrary.org/obo/MONDO_0019243) (inborn disorder of energy metabolism), [MONDO:0008597](http://purl.obolibrary.org/obo/MONDO_0008597) (trichorhinophalangeal syndrome, type 3), [MONDO:0019241](http://purl.obolibrary.org/obo/MONDO_0019241) (inborn disorder of the gamma-glutamyl cycle), [MONDO:0019242](http://purl.obolibrary.org/obo/MONDO_0019242) (inborn disorder of branched-chain amino acid metabolism), [MONDO:0019240](http://purl.obolibrary.org/obo/MONDO_0019240) (sterol biosynthesis disorder), [MONDO:0021569](http://purl.obolibrary.org/obo/MONDO_0021569) (Emery-Dreifuss muscular dystrophy 2, autosomal dominant), [MONDO:0012619](http://purl.obolibrary.org/obo/MONDO_0012619) (MRT11), [MONDO:0012618](http://purl.obolibrary.org/obo/MONDO_0012618) (MRT10), [MONDO:0012617](http://purl.obolibrary.org/obo/MONDO_0012617) (MRT9), [MONDO:0013948](http://purl.obolibrary.org/obo/MONDO_0013948) (peroxisome biogenesis disorder 10A (Zellweger)), [MONDO:0013949](http://purl.obolibrary.org/obo/MONDO_0013949) (peroxisome biogenesis disorder 11A (Zellweger)), [MONDO:0013944](http://purl.obolibrary.org/obo/MONDO_0013944) (Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation), [MONDO:0012612](http://purl.obolibrary.org/obo/MONDO_0012612) (mental retardation, autosomal recessive 12), [MONDO:0007275](http://purl.obolibrary.org/obo/MONDO_0007275) (carpal tunnel syndrome), [MONDO:0013945](http://purl.obolibrary.org/obo/MONDO_0013945) (peroxisome biogenesis disorder 9B), [MONDO:0012611](http://purl.obolibrary.org/obo/MONDO_0012611) (polyhydramnios, megalencephaly, and symptomatic epilepsy), [MONDO:0007274](http://purl.obolibrary.org/obo/MONDO_0007274) (carpal displacement), [MONDO:0013947](http://purl.obolibrary.org/obo/MONDO_0013947) (young adult-onset distal hereditary motor neuropathy), [MONDO:0013940](http://purl.obolibrary.org/obo/MONDO_0013940) (primary ciliary dyskinesia 18), [MONDO:0007272](http://purl.obolibrary.org/obo/MONDO_0007272) (hereditary hypercarotenemia and vitamin A deficiency), [MONDO:0012616](http://purl.obolibrary.org/obo/MONDO_0012616) (MRT8), [MONDO:0012615](http://purl.obolibrary.org/obo/MONDO_0012615) (mental retardation, autosomal recessive 7), [MONDO:0013942](http://purl.obolibrary.org/obo/MONDO_0013942) (peroxisome biogenesis disorder 8A (Zellweger)), [MONDO:0012614](http://purl.obolibrary.org/obo/MONDO_0012614) (mental retardation, autosomal recessive 6), [MONDO:0007270](http://purl.obolibrary.org/obo/MONDO_0007270) (cardiomyopathy, familial restrictive, 1), [MONDO:0013943](http://purl.obolibrary.org/obo/MONDO_0013943) (peroxisome biogenesis disorder 8B), [MONDO:0012613](http://purl.obolibrary.org/obo/MONDO_0012613) (mental retardation, autosomal recessive 5), [MONDO:0012681](http://purl.obolibrary.org/obo/MONDO_0012681) (FEB7), [MONDO:0011350](http://purl.obolibrary.org/obo/MONDO_0011350) (autosomal dominant nonsyndromic deafness 17), [MONDO:0009030](http://purl.obolibrary.org/obo/MONDO_0009030) (cranial nerves, recurrent paresis of), [MONDO:0012680](http://purl.obolibrary.org/obo/MONDO_0012680) (nephronophthisis 7), [MONDO:0009032](http://purl.obolibrary.org/obo/MONDO_0009032) (cranioectodermal dysplasia), [MONDO:0012685](http://purl.obolibrary.org/obo/MONDO_0012685) (MAFD5), [MONDO:0010022](http://purl.obolibrary.org/obo/MONDO_0010022) (senile plaque formation), [MONDO:0011353](http://purl.obolibrary.org/obo/MONDO_0011353) (atrial septal defect, secundum, with Various cardiac and Noncardiac defects), [MONDO:0010023](http://purl.obolibrary.org/obo/MONDO_0010023) (combined immunodeficiency due to ZAP70 deficiency), [MONDO:0009035](http://purl.obolibrary.org/obo/MONDO_0009035) (craniometaphyseal dysplasia, autosomal recessive), [MONDO:0010020](http://purl.obolibrary.org/obo/MONDO_0010020) (congenital generalized lipodystrophy type 2), [MONDO:0011352](http://purl.obolibrary.org/obo/MONDO_0011352) (neuroendocrine carcinoma of salivary glands, sensorineural hearing loss, and enamel hypoplasia), [MONDO:0012683](http://purl.obolibrary.org/obo/MONDO_0012683) (pontocerebellar hypoplasia type 6), [MONDO:0011351](http://purl.obolibrary.org/obo/MONDO_0011351) (autosomal recessive nonsyndromic deafness 21), [MONDO:0003727](http://purl.obolibrary.org/obo/MONDO_0003727) (animal phobia), [MONDO:0009037](http://purl.obolibrary.org/obo/MONDO_0009037) (craniosynostosis with anomalies of the cranial base and digits), [MONDO:0000698](http://purl.obolibrary.org/obo/MONDO_0000698) (gamma-amino butyric acid metabolism disorder), [MONDO:0015719](http://purl.obolibrary.org/obo/MONDO_0015719) (severe hemophilia A), [MONDO:0010026](http://purl.obolibrary.org/obo/MONDO_0010026) (short syndrome), [MONDO:0012689](http://purl.obolibrary.org/obo/MONDO_0012689) (premature ovarian failure 5), [MONDO:0011358](http://purl.obolibrary.org/obo/MONDO_0011358) (blue nevi, familial multiple), [MONDO:0010027](http://purl.obolibrary.org/obo/MONDO_0010027) (Free sialic acid storage disease, infantile form), [MONDO:0011357](http://purl.obolibrary.org/obo/MONDO_0011357) (eccrine Syringofibroadenomatosis with eyelid abnormalities), [MONDO:0011356](http://purl.obolibrary.org/obo/MONDO_0011356) (exostosis, Dupuytren subungual), [MONDO:0010024](http://purl.obolibrary.org/obo/MONDO_0010024) (Beemer-Langer syndrome), [MONDO:0012686](http://purl.obolibrary.org/obo/MONDO_0012686) (MAFD6), [MONDO:0010025](http://purl.obolibrary.org/obo/MONDO_0010025) (short stature-obesity syndrome), [MONDO:0010028](http://purl.obolibrary.org/obo/MONDO_0010028) (sialuria), [MONDO:0012670](http://purl.obolibrary.org/obo/MONDO_0012670) (autosomal recessive nonsyndromic deafness 63), [MONDO:0009022](http://purl.obolibrary.org/obo/MONDO_0009022) (corpus callosum, agenesis of), [MONDO:0012674](http://purl.obolibrary.org/obo/MONDO_0012674) (age related macular degeneration 10), [MONDO:0011343](http://purl.obolibrary.org/obo/MONDO_0011343) (follicular atrophoderma, Perioral pigmented, with milia and epidermoid cysts), [MONDO:0011342](http://purl.obolibrary.org/obo/MONDO_0011342) (SLC35A1-CDG), [MONDO:0012672](http://purl.obolibrary.org/obo/MONDO_0012672) (cholelithiasis), [MONDO:0011341](http://purl.obolibrary.org/obo/MONDO_0011341) (microcephaly, facial abnormalities, micromelia, and mental retardation), [MONDO:0010010](http://purl.obolibrary.org/obo/MONDO_0010010) (Schinzel-Giedion syndrome), [MONDO:0012671](http://purl.obolibrary.org/obo/MONDO_0012671) (ETM3), [MONDO:0009026](http://purl.obolibrary.org/obo/MONDO_0009026) (Costello syndrome), [MONDO:0020298](http://purl.obolibrary.org/obo/MONDO_0020298) (Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15), [MONDO:0009027](http://purl.obolibrary.org/obo/MONDO_0009027) (cramps, familial adolescent), [MONDO:0002408](http://purl.obolibrary.org/obo/MONDO_0002408) (bilirubin metabolic disorder), [MONDO:0003736](http://purl.obolibrary.org/obo/MONDO_0003736) (cancerophobia), [MONDO:0009029](http://purl.obolibrary.org/obo/MONDO_0009029) (cranial nerves, congenital paresis of), [MONDO:0015705](http://purl.obolibrary.org/obo/MONDO_0015705) (autosomal recessive centronuclear myopathy), [MONDO:0012678](http://purl.obolibrary.org/obo/MONDO_0012678) (ATFB5), [MONDO:0011346](http://purl.obolibrary.org/obo/MONDO_0011346) (xanthinuria type II), [MONDO:0012677](http://purl.obolibrary.org/obo/MONDO_0012677) (atrial fibrillation, familial, 4), [MONDO:0010013](http://purl.obolibrary.org/obo/MONDO_0010013) (schneckenbecken dysplasia), [MONDO:0011345](http://purl.obolibrary.org/obo/MONDO_0011345) (facial dysmorphism, selective tooth agenesis, and choroid calcification), [MONDO:0011344](http://purl.obolibrary.org/obo/MONDO_0011344) (parotitis, juvenile recurrent), [MONDO:0010019](http://purl.obolibrary.org/obo/MONDO_0010019) (secretory component deficiency), [MONDO:0015701](http://purl.obolibrary.org/obo/MONDO_0015701) (T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency), [MONDO:0010017](http://purl.obolibrary.org/obo/MONDO_0010017) (sea-blue histiocyte syndrome), [MONDO:0015703](http://purl.obolibrary.org/obo/MONDO_0015703) (T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta), [MONDO:0011349](http://purl.obolibrary.org/obo/MONDO_0011349) (Osteoma of cranial vault, familial), [MONDO:0015702](http://purl.obolibrary.org/obo/MONDO_0015702) (T-B+ severe combined immunodeficiency due to CD45 deficiency), [MONDO:0010018](http://purl.obolibrary.org/obo/MONDO_0010018) (second metatarsal-metacarpal syndrome), [MONDO:0013991](http://purl.obolibrary.org/obo/MONDO_0013991) (obesity due to congenital leptin deficiency), [MONDO:0013992](http://purl.obolibrary.org/obo/MONDO_0013992) (obesity due to leptin receptor gene deficiency), [MONDO:0013994](http://purl.obolibrary.org/obo/MONDO_0013994) (Joubert syndrome 20), [MONDO:0011332](http://purl.obolibrary.org/obo/MONDO_0011332) (Dyserythropoiesis, congenital, with Ultrastructurally normal Erythroblast Heterochromatin), [MONDO:0010000](http://purl.obolibrary.org/obo/MONDO_0010000) (rod-cone dystrophy, sensorineural deafness, and Fanconi-type renal dysfunction), [MONDO:0012662](http://purl.obolibrary.org/obo/MONDO_0012662) (Usher syndrome type 2D), [MONDO:0009013](http://purl.obolibrary.org/obo/MONDO_0009013) (convulsive disorder, familial, with Prenatal or early onset), [MONDO:0011330](http://purl.obolibrary.org/obo/MONDO_0011330) (spinocerebellar ataxia type 10), [MONDO:0003703](http://purl.obolibrary.org/obo/MONDO_0003703) (uterine corpus leiomyomatosis), [MONDO:0009017](http://purl.obolibrary.org/obo/MONDO_0009017) (corneal degeneration, band-shaped spheroid), [MONDO:0003704](http://purl.obolibrary.org/obo/MONDO_0003704) (uterine corpus diffuse leiomyomatosis), [MONDO:0003702](http://purl.obolibrary.org/obo/MONDO_0003702) (uterus intravascular leiomyomatosis), [MONDO:0010004](http://purl.obolibrary.org/obo/MONDO_0010004) (EEC syndrome), [MONDO:0012667](http://purl.obolibrary.org/obo/MONDO_0012667) (dilated cardiomyopathy 1W), [MONDO:0012666](http://purl.obolibrary.org/obo/MONDO_0012666) (asthma-related Traits, susceptibility to, 6), [MONDO:0011335](http://purl.obolibrary.org/obo/MONDO_0011335) (spondyloepimetaphyseal dysplasia with multiple dislocations), [MONDO:0010005](http://purl.obolibrary.org/obo/MONDO_0010005) (Saccharopinuria), [MONDO:0010002](http://purl.obolibrary.org/obo/MONDO_0010002) (Rothmund-Thomson syndrome), [MONDO:0011333](http://purl.obolibrary.org/obo/MONDO_0011333) (light fixation seizure syndrome), [MONDO:0010003](http://purl.obolibrary.org/obo/MONDO_0010003) (Rowley-Rosenberg syndrome), [MONDO:0012664](http://purl.obolibrary.org/obo/MONDO_0012664) (spastic ataxia 3), [MONDO:0010008](http://purl.obolibrary.org/obo/MONDO_0010008) (Sarcosinemia), [MONDO:0010009](http://purl.obolibrary.org/obo/MONDO_0010009) (SC phocomelia syndrome), [MONDO:0011339](http://purl.obolibrary.org/obo/MONDO_0011339) (hereditary spastic paraplegia 8), [MONDO:0010006](http://purl.obolibrary.org/obo/MONDO_0010006) (Sandhoff disease), [MONDO:0011338](http://purl.obolibrary.org/obo/MONDO_0011338) (Omenn syndrome), [MONDO:0012668](http://purl.obolibrary.org/obo/MONDO_0012668) (Tented eyebrows), [MONDO:0013998](http://purl.obolibrary.org/obo/MONDO_0013998) (Carpenter syndrome 2), [MONDO:0013980](http://purl.obolibrary.org/obo/MONDO_0013980) (PPKP1B), [MONDO:0013982](http://purl.obolibrary.org/obo/MONDO_0013982) (ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant), [MONDO:0013983](http://purl.obolibrary.org/obo/MONDO_0013983) (ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive), [MONDO:0012652](http://purl.obolibrary.org/obo/MONDO_0012652) (autosomal recessive limb-girdle muscular dystrophy type 2L), [MONDO:0011321](http://purl.obolibrary.org/obo/MONDO_0011321) (expansile bone lesions), [MONDO:0012651](http://purl.obolibrary.org/obo/MONDO_0012651) (spastic ataxia 2), [MONDO:0012650](http://purl.obolibrary.org/obo/MONDO_0012650) (Cernunnos-XLF deficiency), [MONDO:0009004](http://purl.obolibrary.org/obo/MONDO_0009004) (combined inflammatory and immunologic defect), [MONDO:0009009](http://purl.obolibrary.org/obo/MONDO_0009009) (hypoplasminogenemia), [MONDO:0000688](http://purl.obolibrary.org/obo/MONDO_0000688) (organic acidemia), [MONDO:0011325](http://purl.obolibrary.org/obo/MONDO_0011325) (Fanconi anemia complementation group f), [MONDO:0013988](http://purl.obolibrary.org/obo/MONDO_0013988) (CHTD3), [MONDO:0013989](http://purl.obolibrary.org/obo/MONDO_0013989) (epileptic encephalopathy, early infantile, 14), [MONDO:0012655](http://purl.obolibrary.org/obo/MONDO_0012655) (EJM4), [MONDO:0011324](http://purl.obolibrary.org/obo/MONDO_0011324) (hypospadias, hypertelorism, upper 51D coloboma, and mixed-type hearing loss), [MONDO:0011323](http://purl.obolibrary.org/obo/MONDO_0011323) (arhinia, choanal atresia, and microphthalmia), [MONDO:0011322](http://purl.obolibrary.org/obo/MONDO_0011322) (Oroacral syndrome, Verloes-Koulischer type), [MONDO:0013984](http://purl.obolibrary.org/obo/MONDO_0013984) (autosomal recessive nonsyndromic deafness 84B), [MONDO:0013985](http://purl.obolibrary.org/obo/MONDO_0013985) (autosomal recessive nonsyndromic deafness 18B), [MONDO:0012659](http://purl.obolibrary.org/obo/MONDO_0012659) (age related macular degeneration 9), [MONDO:0013986](http://purl.obolibrary.org/obo/MONDO_0013986) (combined oxidative phosphorylation defect type 14), [MONDO:0011326](http://purl.obolibrary.org/obo/MONDO_0011326) (citrullinemia, type Ii, adult-onset), [MONDO:0013987](http://purl.obolibrary.org/obo/MONDO_0013987) (combined oxidative phosphorylation defect type 15), [MONDO:0012657](http://purl.obolibrary.org/obo/MONDO_0012657) (MGS), [MONDO:0011393](http://purl.obolibrary.org/obo/MONDO_0011393) (apolipoprotein A-I deficiency), [MONDO:0014422](http://purl.obolibrary.org/obo/MONDO_0014422) (vesicoureteral reflux 8), [MONDO:0010060](http://purl.obolibrary.org/obo/MONDO_0010060) (infantile onset spinocerebellar ataxia), [MONDO:0011392](http://purl.obolibrary.org/obo/MONDO_0011392) (autosomal recessive nonsyndromic deafness 20), [MONDO:0014423](http://purl.obolibrary.org/obo/MONDO_0014423) (severe combined immunodeficiency due to DNA-PKcs deficiency), [MONDO:0010061](http://purl.obolibrary.org/obo/MONDO_0010061) (autosomal recessive cerebellar ataxia-blindness-deafness syndrome), [MONDO:0009076](http://purl.obolibrary.org/obo/MONDO_0009076) (autosomal recessive nonsyndromic deafness 1A), [MONDO:0011398](http://purl.obolibrary.org/obo/MONDO_0011398) (dystrophic epidermolysis bullosa pruriginosa), [MONDO:0009077](http://purl.obolibrary.org/obo/MONDO_0009077) (deafness, congenital, and familial myoclonic epilepsy), [MONDO:0011397](http://purl.obolibrary.org/obo/MONDO_0011397) (autosomal dominant cerebellar ataxia, deafness and narcolepsy), [MONDO:0009078](http://purl.obolibrary.org/obo/MONDO_0009078) (Jervell and Lange-Nielsen syndrome), [MONDO:0010067](http://purl.obolibrary.org/obo/MONDO_0010067) (Splenoportal vascular anomalies), [MONDO:0010064](http://purl.obolibrary.org/obo/MONDO_0010064) (spastic ataxia-corneal dystrophy syndrome), [MONDO:0011396](http://purl.obolibrary.org/obo/MONDO_0011396) (keratoderma hereditarium mutilans with ichthyosis), [MONDO:0010065](http://purl.obolibrary.org/obo/MONDO_0010065) (spinocerebellar degeneration with slow eye movements), [MONDO:0014428](http://purl.obolibrary.org/obo/MONDO_0014428) (autosomal recessive nonsyndromic deafness 102), [MONDO:0011399](http://purl.obolibrary.org/obo/MONDO_0011399) (alpha thalassemia), [MONDO:0014424](http://purl.obolibrary.org/obo/MONDO_0014424) (congenital deficiency in alpha-fetoprotein), [MONDO:0009081](http://purl.obolibrary.org/obo/MONDO_0009081) (deafness, congenital, with total albinism), [MONDO:0014425](http://purl.obolibrary.org/obo/MONDO_0014425) (hereditary persistence of alpha-fetoprotein), [MONDO:0009083](http://purl.obolibrary.org/obo/MONDO_0009083) (conductive deafness-malformed external ear syndrome), [MONDO:0011383](http://purl.obolibrary.org/obo/MONDO_0011383) (autoimmune lymphoproliferative syndrome type 2A), [MONDO:0011382](http://purl.obolibrary.org/obo/MONDO_0011382) (sickle cell anemia), [MONDO:0014410](http://purl.obolibrary.org/obo/MONDO_0014410) (spinocerebellar ataxia type 37), [MONDO:0009064](http://purl.obolibrary.org/obo/MONDO_0009064) (ocular cystinosis), [MONDO:0011381](http://purl.obolibrary.org/obo/MONDO_0011381) (dominant beta-thalassemia), [MONDO:0014411](http://purl.obolibrary.org/obo/MONDO_0014411) (myopia 24, autosomal dominant), [MONDO:0009065](http://purl.obolibrary.org/obo/MONDO_0009065) (cystinosis, nephropathic), [MONDO:0010050](http://purl.obolibrary.org/obo/MONDO_0010050) (spastic pseudosclerosis), [MONDO:0014412](http://purl.obolibrary.org/obo/MONDO_0014412) (hyperlipoproteinemia, type 1D), [MONDO:0009066](http://purl.obolibrary.org/obo/MONDO_0009066) (juvenile nephropathic cystinosis), [MONDO:0011387](http://purl.obolibrary.org/obo/MONDO_0011387) (PSORS4), [MONDO:0010055](http://purl.obolibrary.org/obo/MONDO_0010055) (spinal muscular atrophy with microcephaly and mental subnormality), [MONDO:0011386](http://purl.obolibrary.org/obo/MONDO_0011386) (Microvascular complications of diabetes, susceptibility to, 1), [MONDO:0009067](http://purl.obolibrary.org/obo/MONDO_0009067) (cystinuria (disease)), [MONDO:0011385](http://purl.obolibrary.org/obo/MONDO_0011385) (lumbar disc degeneration), [MONDO:0009068](http://purl.obolibrary.org/obo/MONDO_0009068) (cytochrome-c oxidase deficiency disease), [MONDO:0010054](http://purl.obolibrary.org/obo/MONDO_0010054) (spinal muscular atrophy with mental retardation), [MONDO:0009069](http://purl.obolibrary.org/obo/MONDO_0009069) (congenital lactic acidosis, Saguenay-Lac-saint-Jean type), [MONDO:0014417](http://purl.obolibrary.org/obo/MONDO_0014417) (spinocerebellar ataxia type 38), [MONDO:0010059](http://purl.obolibrary.org/obo/MONDO_0010059) (spinal muscular atrophy, type I, with congenital bone fractures), [MONDO:0015749](http://purl.obolibrary.org/obo/MONDO_0015749) (6q16 deletion syndrome), [MONDO:0014418](http://purl.obolibrary.org/obo/MONDO_0014418) (myopathy, centronuclear, 5), [MONDO:0011389](http://purl.obolibrary.org/obo/MONDO_0011389) (autosomal dominant nonsyndromic deafness 16), [MONDO:0014414](http://purl.obolibrary.org/obo/MONDO_0014414) (STAT3-related early-onset multisystem autoimmune disease), [MONDO:0009070](http://purl.obolibrary.org/obo/MONDO_0009070) (d-glyceric aciduria), [MONDO:0014415](http://purl.obolibrary.org/obo/MONDO_0014415) (Kallikrein, decreased urinary activity of), [MONDO:0010040](http://purl.obolibrary.org/obo/MONDO_0010040) (ataxia, spastic, childhood-onset, autosomal recessive, with optic atrophy and mental retardation), [MONDO:0010041](http://purl.obolibrary.org/obo/MONDO_0010041) (Charlevoix-Saguenay spastic ataxia), [MONDO:0011371](http://purl.obolibrary.org/obo/MONDO_0011371) (hydroa vacciniforme, familial), [MONDO:0009053](http://purl.obolibrary.org/obo/MONDO_0009053) (ALDH18A1-related de Barsy syndrome), [MONDO:0009054](http://purl.obolibrary.org/obo/MONDO_0009054) (autosomal recessive cutis laxa type 2, classic type), [MONDO:0010044](http://purl.obolibrary.org/obo/MONDO_0010044) (hereditary spastic paraplegia 15), [MONDO:0009056](http://purl.obolibrary.org/obo/MONDO_0009056) (cutis verticis gyrata and mental retardation), [MONDO:0011374](http://purl.obolibrary.org/obo/MONDO_0011374) (autosomal recessive hypercholesterolemia), [MONDO:0010042](http://purl.obolibrary.org/obo/MONDO_0010042) (spastic diplegia and mental retardation), [MONDO:0009057](http://purl.obolibrary.org/obo/MONDO_0009057) (cyanosis and hepatic disease), [MONDO:0009058](http://purl.obolibrary.org/obo/MONDO_0009058) (cystathioninuria (disease)), [MONDO:0010043](http://purl.obolibrary.org/obo/MONDO_0010043) (hereditary spastic paraplegia 17), [MONDO:0011373](http://purl.obolibrary.org/obo/MONDO_0011373) (urinary tract infections, recurrent, susceptibility to), [MONDO:0009059](http://purl.obolibrary.org/obo/MONDO_0009059) (Cysteine Peptiduria), [MONDO:0003748](http://purl.obolibrary.org/obo/MONDO_0003748) (flying phobia), [MONDO:0002413](http://purl.obolibrary.org/obo/MONDO_0002413) (glycogen storage disease I), [MONDO:0002412](http://purl.obolibrary.org/obo/MONDO_0002412) (glycogen storage disease), [MONDO:0003740](http://purl.obolibrary.org/obo/MONDO_0003740) (AIDS phobia), [MONDO:0010048](http://purl.obolibrary.org/obo/MONDO_0010048) (spastic paraplegia with myoclonic epilepsy), [MONDO:0010049](http://purl.obolibrary.org/obo/MONDO_0010049) (spastic paraplegia-glaucoma-intellectual disability syndrome), [MONDO:0010046](http://purl.obolibrary.org/obo/MONDO_0010046) (hereditary spastic paraplegia 23), [MONDO:0011378](http://purl.obolibrary.org/obo/MONDO_0011378) (CFM1), [MONDO:0014409](http://purl.obolibrary.org/obo/MONDO_0014409) (mental retardation, autosomal recessive 44), [MONDO:0011377](http://purl.obolibrary.org/obo/MONDO_0011377) (long QT syndrome 3), [MONDO:0009060](http://purl.obolibrary.org/obo/MONDO_0009060) (cystic disease of lung), [MONDO:0014404](http://purl.obolibrary.org/obo/MONDO_0014404) (Webb-Dattani syndrome), [MONDO:0009061](http://purl.obolibrary.org/obo/MONDO_0009061) (cystic fibrosis), [MONDO:0012692](http://purl.obolibrary.org/obo/MONDO_0012692) (renal tubular acidosis, distal, with nephrocalcinosis, short stature, mental retardation, and distinctive facies), [MONDO:0009040](http://purl.obolibrary.org/obo/MONDO_0009040) (craniosynostosis-mental retardation syndrome of 51N and Gettig), [MONDO:0011360](http://purl.obolibrary.org/obo/MONDO_0011360) (autosomal recessive nonsyndromic deafness 14), [MONDO:0012691](http://purl.obolibrary.org/obo/MONDO_0012691) (leopard syndrome 2), [MONDO:0009041](http://purl.obolibrary.org/obo/MONDO_0009041) (craniosynostosis-mental retardation-clefting syndrome), [MONDO:0012690](http://purl.obolibrary.org/obo/MONDO_0012690) (Noonan syndrome 5), [MONDO:0015721](http://purl.obolibrary.org/obo/MONDO_0015721) (mild hemophilia A), [MONDO:0015720](http://purl.obolibrary.org/obo/MONDO_0015720) (moderately severe hemophilia A), [MONDO:0010033](http://purl.obolibrary.org/obo/MONDO_0010033) (generalized peeling skin syndrome), [MONDO:0012696](http://purl.obolibrary.org/obo/MONDO_0012696) (OTSC4), [MONDO:0009044](http://purl.obolibrary.org/obo/MONDO_0009044) (Crigler-Najjar syndrome), [MONDO:0011364](http://purl.obolibrary.org/obo/MONDO_0011364) (autosomal recessive nonsyndromic deafness 16), [MONDO:0010034](http://purl.obolibrary.org/obo/MONDO_0010034) (anosmia for butyl mercaptan), [MONDO:0012695](http://purl.obolibrary.org/obo/MONDO_0012695) (Meckel syndrome, type 5), [MONDO:0009046](http://purl.obolibrary.org/obo/MONDO_0009046) (Fraser syndrome), [MONDO:0010031](http://purl.obolibrary.org/obo/MONDO_0010031) (Sjogren-Larsson syndrome), [MONDO:0012694](http://purl.obolibrary.org/obo/MONDO_0012694) (Joubert syndrome 7), [MONDO:0011363](http://purl.obolibrary.org/obo/MONDO_0011363) (diabetes mellitus, Noninsulin-dependent, 3), [MONDO:0010032](http://purl.obolibrary.org/obo/MONDO_0010032) (Sjogren-Larsson-like ichthyosis without Cns or eye involvement), [MONDO:0009047](http://purl.obolibrary.org/obo/MONDO_0009047) (cryptorchidism (disease)), [MONDO:0012693](http://purl.obolibrary.org/obo/MONDO_0012693) (glycogen storage disease due to muscle and heart glycogen synthase deficiency), [MONDO:0009048](http://purl.obolibrary.org/obo/MONDO_0009048) (curved nail of fourth toe), [MONDO:0010037](http://purl.obolibrary.org/obo/MONDO_0010037) (sodium-potassium-Atpase activity of red cell), [MONDO:0011369](http://purl.obolibrary.org/obo/MONDO_0011369) (hypercholesterolemia, autosomal dominant, 3), [MONDO:0012699](http://purl.obolibrary.org/obo/MONDO_0012699) (autosomal recessive limb-girdle muscular dystrophy type 2M), [MONDO:0011367](http://purl.obolibrary.org/obo/MONDO_0011367) (Acrodysplasia with ossification abnormalities, short stature, and fibular hypoplasia), [MONDO:0010035](http://purl.obolibrary.org/obo/MONDO_0010035) (Smith-Lemli-Opitz syndrome), [MONDO:0012698](http://purl.obolibrary.org/obo/MONDO_0012698) (Waardenburg syndrome type 2E), [MONDO:0012697](http://purl.obolibrary.org/obo/MONDO_0012697) (OTSC7), [MONDO:0015728](http://purl.obolibrary.org/obo/MONDO_0015728) (distal trisomy 15q), [MONDO:0014464](http://purl.obolibrary.org/obo/MONDO_0014464) (progressive encephalopathy with leukodystrophy due to DECR deficiency), [MONDO:0013133](http://purl.obolibrary.org/obo/MONDO_0013133) (melanoma, cutaneous malignant, susceptibility to, 5), [MONDO:0018823](http://purl.obolibrary.org/obo/MONDO_0018823) (X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome), [MONDO:0013134](http://purl.obolibrary.org/obo/MONDO_0013134) (glaucoma 1, open angle, O), [MONDO:0014465](http://purl.obolibrary.org/obo/MONDO_0014465) (primary ciliary dyskinesia 30), [MONDO:0014466](http://purl.obolibrary.org/obo/MONDO_0014466) (Neu-Laxova syndrome 2), [MONDO:0015797](http://purl.obolibrary.org/obo/MONDO_0015797) (UV-sensitive syndrome), [MONDO:0014467](http://purl.obolibrary.org/obo/MONDO_0014467) (Charcot-Marie-tooth disease recessive intermediate d), [MONDO:0018821](http://purl.obolibrary.org/obo/MONDO_0018821) (X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual disability), [MONDO:0014460](http://purl.obolibrary.org/obo/MONDO_0014460) (nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome), [MONDO:0013131](http://purl.obolibrary.org/obo/MONDO_0013131) (polycystic kidney disease 2), [MONDO:0013132](http://purl.obolibrary.org/obo/MONDO_0013132) (hereditary spastic paraplegia 36), [MONDO:0005508](http://purl.obolibrary.org/obo/MONDO_0005508) (hereditary multiple exostoses), [MONDO:0005501](http://purl.obolibrary.org/obo/MONDO_0005501) (congenital disorder of glycosylation type II), [MONDO:0002474](http://purl.obolibrary.org/obo/MONDO_0002474) (primary hyperoxaluria), [MONDO:0005500](http://purl.obolibrary.org/obo/MONDO_0005500) (congenital disorder of glycosylation type I), [MONDO:0002470](http://purl.obolibrary.org/obo/MONDO_0002470) (photosensitive trichothiodystrophy), [MONDO:0018829](http://purl.obolibrary.org/obo/MONDO_0018829) (familial schizencephaly), [MONDO:0018827](http://purl.obolibrary.org/obo/MONDO_0018827) (familial Chilblain lupus), [MONDO:0014469](http://purl.obolibrary.org/obo/MONDO_0014469) (autosomal recessive nonsyndromic deafness 103), [MONDO:0013138](http://purl.obolibrary.org/obo/MONDO_0013138) (BRV2), [MONDO:0013139](http://purl.obolibrary.org/obo/MONDO_0013139) (neutropenia, severe congenital, 2, autosomal dominant), [MONDO:0013122](http://purl.obolibrary.org/obo/MONDO_0013122) (glaucoma 3, primary congenital, d), [MONDO:0015785](http://purl.obolibrary.org/obo/MONDO_0015785) (Prader-Willi syndrome due to translocation), [MONDO:0010096](http://purl.obolibrary.org/obo/MONDO_0010096) (tardive dyskinesia (disease)), [MONDO:0015784](http://purl.obolibrary.org/obo/MONDO_0015784) (Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2), [MONDO:0018812](http://purl.obolibrary.org/obo/MONDO_0018812) (MSH3-related attenuated familial adenomatous polyposis), [MONDO:0014455](http://purl.obolibrary.org/obo/MONDO_0014455) (cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome), [MONDO:0013124](http://purl.obolibrary.org/obo/MONDO_0013124) (pelvic organ prolapse, susceptibility to, 2), [MONDO:0015787](http://purl.obolibrary.org/obo/MONDO_0015787) (symptomatic form of hemophilia a in female carriers), [MONDO:0010093](http://purl.obolibrary.org/obo/MONDO_0010093) (syndesmodysplasic dwarfism), [MONDO:0015786](http://purl.obolibrary.org/obo/MONDO_0015786) (Prader-Willi syndrome due to imprinting mutation), [MONDO:0010099](http://purl.obolibrary.org/obo/MONDO_0010099) (Tay-Sachs disease AB variant), [MONDO:0015780](http://purl.obolibrary.org/obo/MONDO_0015780) (dyskeratosis congenita), [MONDO:0010097](http://purl.obolibrary.org/obo/MONDO_0010097) (Tatsumi factor deficiency), [MONDO:0015783](http://purl.obolibrary.org/obo/MONDO_0015783) (Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1), [MONDO:0010098](http://purl.obolibrary.org/obo/MONDO_0010098) (taurodontism (disease)), [MONDO:0013121](http://purl.obolibrary.org/obo/MONDO_0013121) (GLC3C), [MONDO:0010091](http://purl.obolibrary.org/obo/MONDO_0010091) (Crisponi syndrome), [MONDO:0005513](http://purl.obolibrary.org/obo/MONDO_0005513) (methylmalonic aciduria and homocystinuria type cblE), [MONDO:0005511](http://purl.obolibrary.org/obo/MONDO_0005511) (janus kinase-3 deficiency), [MONDO:0018817](http://purl.obolibrary.org/obo/MONDO_0018817) (autosomal recessive limb-girdle muscular dystrophy type 2Z), [MONDO:0014457](http://purl.obolibrary.org/obo/MONDO_0014457) (hyperphosphatasia with mental retardation syndrome 5), [MONDO:0014458](http://purl.obolibrary.org/obo/MONDO_0014458) (Fanconi renotubular syndrome 4 with Maturity-onset diabetes of the young), [MONDO:0013127](http://purl.obolibrary.org/obo/MONDO_0013127) (asphyxiating thoracic dystrophy 3), [MONDO:0018814](http://purl.obolibrary.org/obo/MONDO_0018814) (non-severe combined immunodeficiency), [MONDO:0013129](http://purl.obolibrary.org/obo/MONDO_0013129) (cone dystrophy 4), [MONDO:0013111](http://purl.obolibrary.org/obo/MONDO_0013111) (acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins), [MONDO:0010084](http://purl.obolibrary.org/obo/MONDO_0010084) (sucrosuria, hiatus hernia and mental retardation), [MONDO:0014442](http://purl.obolibrary.org/obo/MONDO_0014442) (Bardet-Biedl syndrome 14), [MONDO:0014443](http://purl.obolibrary.org/obo/MONDO_0014443) (Bardet-Biedl syndrome 15), [MONDO:0015776](http://purl.obolibrary.org/obo/MONDO_0015776) (rhizomelic chondrodysplasia punctata), [MONDO:0009097](http://purl.obolibrary.org/obo/MONDO_0009097) (persistent hyperplastic primary vitreous, autosomal recessive), [MONDO:0014444](http://purl.obolibrary.org/obo/MONDO_0014444) (Bardet-Biedl syndrome 16), [MONDO:0010083](http://purl.obolibrary.org/obo/MONDO_0010083) (succinic semialdehyde dehydrogenase deficiency), [MONDO:0009098](http://purl.obolibrary.org/obo/MONDO_0009098) (dextrocardia with unusual facies and microphthalmia), [MONDO:0013114](http://purl.obolibrary.org/obo/MONDO_0013114) (autosomal dominant nonsyndromic deafness 50), [MONDO:0014445](http://purl.obolibrary.org/obo/MONDO_0014445) (Bardet-Biedl syndrome 17), [MONDO:0010088](http://purl.obolibrary.org/obo/MONDO_0010088) (mucosulfatidosis), [MONDO:0010089](http://purl.obolibrary.org/obo/MONDO_0010089) (isolated sulfite oxidase deficiency), [MONDO:0010086](http://purl.obolibrary.org/obo/MONDO_0010086) (sudden infant death syndrome), [MONDO:0014440](http://purl.obolibrary.org/obo/MONDO_0014440) (Bardet-Biedl syndrome 12), [MONDO:0013110](http://purl.obolibrary.org/obo/MONDO_0013110) (neurodegenerative syndrome due to cerebral folate transport deficiency), [MONDO:0014441](http://purl.obolibrary.org/obo/MONDO_0014441) (Bardet-Biedl syndrome 13), [MONDO:0010080](http://purl.obolibrary.org/obo/MONDO_0010080) (familial infantile bilateral striatal necrosis), [MONDO:0002457](http://purl.obolibrary.org/obo/MONDO_0002457) (Treacher-Collins syndrome), [MONDO:0003789](http://purl.obolibrary.org/obo/MONDO_0003789) (hereditary papillary renal cell carcinoma), [MONDO:0010081](http://purl.obolibrary.org/obo/MONDO_0010081) (subaortic stenosis, membranous), [MONDO:0013119](http://purl.obolibrary.org/obo/MONDO_0013119) (autosomal recessive nonsyndromic deafness 77), [MONDO:0018804](http://purl.obolibrary.org/obo/MONDO_0018804) (MYO5B-related progressive familial intrahepatic cholestasis), [MONDO:0014446](http://purl.obolibrary.org/obo/MONDO_0014446) (Bardet-Biedl syndrome 18), [MONDO:0013116](http://purl.obolibrary.org/obo/MONDO_0013116) (congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome), [MONDO:0014447](http://purl.obolibrary.org/obo/MONDO_0014447) (Bardet-Biedl syndrome 19), [MONDO:0014448](http://purl.obolibrary.org/obo/MONDO_0014448) (hyperthyroxinemia, familial Dysalbuminemic), [MONDO:0013117](http://purl.obolibrary.org/obo/MONDO_0013117) (progressive external ophthalmoplegia with mitochondrial Dna deletions, autosomal dominant 5), [MONDO:0018802](http://purl.obolibrary.org/obo/MONDO_0018802) (progressive familial intrahepatic cholestasis type 5), [MONDO:0013118](http://purl.obolibrary.org/obo/MONDO_0013118) (Nijmegen breakage syndrome-like disorder), [MONDO:0018803](http://purl.obolibrary.org/obo/MONDO_0018803) (progressive familial intrahepatic cholestasis type 4), [MONDO:0013100](http://purl.obolibrary.org/obo/MONDO_0013100) (ATFB8), [MONDO:0014431](http://purl.obolibrary.org/obo/MONDO_0014431) (LIPE-related familial partial lipodystrophy), [MONDO:0015762](http://purl.obolibrary.org/obo/MONDO_0015762) (progressive familial intrahepatic cholestasis), [MONDO:0014432](http://purl.obolibrary.org/obo/MONDO_0014432) (Bardet-Biedl syndrome 2), [MONDO:0013101](http://purl.obolibrary.org/obo/MONDO_0013101) (BCC2), [MONDO:0009085](http://purl.obolibrary.org/obo/MONDO_0009085) (deafness-vitiligo-achalasia syndrome), [MONDO:0010074](http://purl.obolibrary.org/obo/MONDO_0010074) (BCYM1B), [MONDO:0014433](http://purl.obolibrary.org/obo/MONDO_0014433) (Bardet-Biedl syndrome 4), [MONDO:0013102](http://purl.obolibrary.org/obo/MONDO_0013102) (BCC3), [MONDO:0009086](http://purl.obolibrary.org/obo/MONDO_0009086) (deafness-small bowel diverticulosis-neuropathy syndrome), [MONDO:0013103](http://purl.obolibrary.org/obo/MONDO_0013103) (epilepsy, idiopathic generalized, susceptibility to, 10), [MONDO:0014434](http://purl.obolibrary.org/obo/MONDO_0014434) (Bardet-Biedl syndrome 5), [MONDO:0010072](http://purl.obolibrary.org/obo/MONDO_0010072) (spondyloepiphyseal dysplasia tarda, autosomal recessive), [MONDO:0009087](http://purl.obolibrary.org/obo/MONDO_0009087) (deafness, neural, congenital moderate), [MONDO:0009088](http://purl.obolibrary.org/obo/MONDO_0009088) (deafness, neural, with atypical atopic dermatitis), [MONDO:0010075](http://purl.obolibrary.org/obo/MONDO_0010075) (spondyloepimetaphyseal dysplasia with joint laxity, type 1, With or without fractures), [MONDO:0014430](http://purl.obolibrary.org/obo/MONDO_0014430) (mental retardation, autosomal recessive 45), [MONDO:0002468](http://purl.obolibrary.org/obo/MONDO_0002468) (hyperimmunoglobulin syndrome), [MONDO:0010070](http://purl.obolibrary.org/obo/MONDO_0010070) (BCYM1A), [MONDO:0006823](http://purl.obolibrary.org/obo/MONDO_0006823) (Klinefelter's syndrome), [MONDO:0014439](http://purl.obolibrary.org/obo/MONDO_0014439) (Bardet-Biedl syndrome 11), [MONDO:0010079](http://purl.obolibrary.org/obo/MONDO_0010079) (Canavan disease), [MONDO:0009090](http://purl.obolibrary.org/obo/MONDO_0009090) (deafness, sensorineural, autosomal-mitochondrial type), [MONDO:0013104](http://purl.obolibrary.org/obo/MONDO_0013104) (BCC4), [MONDO:0014435](http://purl.obolibrary.org/obo/MONDO_0014435) (Bardet-Biedl syndrome 7), [MONDO:0014436](http://purl.obolibrary.org/obo/MONDO_0014436) (Bardet-Biedl syndrome 8), [MONDO:0013105](http://purl.obolibrary.org/obo/MONDO_0013105) (BCC5), [MONDO:0009092](http://purl.obolibrary.org/obo/MONDO_0009092) (Nasu-Hakola disease), [MONDO:0013106](http://purl.obolibrary.org/obo/MONDO_0013106) (BCC6), [MONDO:0014437](http://purl.obolibrary.org/obo/MONDO_0014437) (Bardet-Biedl syndrome 9), [MONDO:0014438](http://purl.obolibrary.org/obo/MONDO_0014438) (Bardet-Biedl syndrome 10), [MONDO:0013107](http://purl.obolibrary.org/obo/MONDO_0013107) (atopic dermatitis 7), [MONDO:0015768](http://purl.obolibrary.org/obo/MONDO_0015768) (trisomy 5p), [MONDO:0018866](http://purl.obolibrary.org/obo/MONDO_0018866) (Aicardi-Goutieres syndrome), [MONDO:0016203](http://purl.obolibrary.org/obo/MONDO_0016203) (hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency), [MONDO:0016202](http://purl.obolibrary.org/obo/MONDO_0016202) (autosomal dominant rhegmatogenous retinal detachment), [MONDO:0013179](http://purl.obolibrary.org/obo/MONDO_0013179) (hereditary spastic paraplegia 44), [MONDO:0018865](http://purl.obolibrary.org/obo/MONDO_0018865) (striate palmoplantar keratoderma), [MONDO:0013173](http://purl.obolibrary.org/obo/MONDO_0013173) (mental retardation, autosomal recessive 13), [MONDO:0013174](http://purl.obolibrary.org/obo/MONDO_0013174) (primary ciliary dyskinesia 13), [MONDO:0013176](http://purl.obolibrary.org/obo/MONDO_0013176) (ichthyosis-short stature-brachydactyly-microspherophakia syndrome), [MONDO:0018861](http://purl.obolibrary.org/obo/MONDO_0018861) (Zellweger-like syndrome without peroxisomal anomalies), [MONDO:0013171](http://purl.obolibrary.org/obo/MONDO_0013171) (purine nucleoside phosphorylase deficiency), [MONDO:0009911](http://purl.obolibrary.org/obo/MONDO_0009911) (prolactin deficiency, isolated), [MONDO:0009912](http://purl.obolibrary.org/obo/MONDO_0009912) (prolactin deficiency with obesity and enlarged testes), [MONDO:0009913](http://purl.obolibrary.org/obo/MONDO_0009913) (prune belly syndrome with pulmonic stenosis, mental retardation, and deafness), [MONDO:0010904](http://purl.obolibrary.org/obo/MONDO_0010904) (Setting-Sun phenomenon, familial benign), [MONDO:0009917](http://purl.obolibrary.org/obo/MONDO_0009917) (autosomal recessive pseudohypoaldosteronism type 1), [MONDO:0009918](http://purl.obolibrary.org/obo/MONDO_0009918) (fundus dystrophy, pseudoinflammatory, recessive form), [MONDO:0010907](http://purl.obolibrary.org/obo/MONDO_0010907) (Hypertryptophanemia), [MONDO:0009919](http://purl.obolibrary.org/obo/MONDO_0009919) (peroxisomal acyl-CoA oxidase deficiency), [MONDO:0010900](http://purl.obolibrary.org/obo/MONDO_0010900) (intrauterine growth retardation with increased mitomycin c sensitivity), [MONDO:0018868](http://purl.obolibrary.org/obo/MONDO_0018868) (metachromatic leukodystrophy), [MONDO:0014497](http://purl.obolibrary.org/obo/MONDO_0014497) (polyendocrine-polyneuropathy syndrome), [MONDO:0013166](http://purl.obolibrary.org/obo/MONDO_0013166) (GABA aminotransferase deficiency), [MONDO:0014498](http://purl.obolibrary.org/obo/MONDO_0014498) (familial cold autoinflammatory syndrome 4), [MONDO:0013168](http://purl.obolibrary.org/obo/MONDO_0013168) (dilated cardiomyopathy 1DD), [MONDO:0018853](http://purl.obolibrary.org/obo/MONDO_0018853) (transgrediens et progrediens palmoplantar keratoderma), [MONDO:0014499](http://purl.obolibrary.org/obo/MONDO_0014499) (mental retardation, autosomal recessive 46), [MONDO:0013169](http://purl.obolibrary.org/obo/MONDO_0013169) (chromosome 5p13 duplication syndrome), [MONDO:0013162](http://purl.obolibrary.org/obo/MONDO_0013162) (autosomal recessive limb-girdle muscular dystrophy type 2N), [MONDO:0018851](http://purl.obolibrary.org/obo/MONDO_0018851) (familial keratoacanthoma), [MONDO:0014493](http://purl.obolibrary.org/obo/MONDO_0014493) (autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency), [MONDO:0013163](http://purl.obolibrary.org/obo/MONDO_0013163) (nephronophthisis-like nephropathy 1), [MONDO:0014494](http://purl.obolibrary.org/obo/MONDO_0014494) (psoriasis 15, pustular, susceptibility to), [MONDO:0013164](http://purl.obolibrary.org/obo/MONDO_0013164) (beta-ureidopropionase deficiency), [MONDO:0014496](http://purl.obolibrary.org/obo/MONDO_0014496) (mitochondrial complex III deficiency nuclear type 9), [MONDO:0013165](http://purl.obolibrary.org/obo/MONDO_0013165) (hereditary spastic paraplegia 45), [MONDO:0014490](http://purl.obolibrary.org/obo/MONDO_0014490) (ketoacidosis due to monocarboxylate transporter-1 deficiency), [MONDO:0014491](http://purl.obolibrary.org/obo/MONDO_0014491) (immunodeficiency 37), [MONDO:0013161](http://purl.obolibrary.org/obo/MONDO_0013161) (autosomal recessive limb-girdle muscular dystrophy type 2O), [MONDO:0014492](http://purl.obolibrary.org/obo/MONDO_0014492) (woolly hair-palmoplantar keratoderma syndrome), [MONDO:0009902](http://purl.obolibrary.org/obo/MONDO_0009902) (cutaneous porphyria), [MONDO:0009904](http://purl.obolibrary.org/obo/MONDO_0009904) (Gitelman syndrome), [MONDO:0009907](http://purl.obolibrary.org/obo/MONDO_0009907) (Prepapillary vascular Loops), [MONDO:0009908](http://purl.obolibrary.org/obo/MONDO_0009908) (dehydratase deficiency), [MONDO:0009909](http://purl.obolibrary.org/obo/MONDO_0009909) (progesterone resistance), [MONDO:0018859](http://purl.obolibrary.org/obo/MONDO_0018859) (Leigh disease), [MONDO:0013155](http://purl.obolibrary.org/obo/MONDO_0013155) (muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3), [MONDO:0013156](http://purl.obolibrary.org/obo/MONDO_0013156) (muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4), [MONDO:0014488](http://purl.obolibrary.org/obo/MONDO_0014488) (diabetes mellitus, Noninsulin-dependent, 5), [MONDO:0013157](http://purl.obolibrary.org/obo/MONDO_0013157) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5), [MONDO:0014489](http://purl.obolibrary.org/obo/MONDO_0014489) (limb-girdle muscular dystrophy due to POMK deficiency), [MONDO:0013158](http://purl.obolibrary.org/obo/MONDO_0013158) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6), [MONDO:0018841](http://purl.obolibrary.org/obo/MONDO_0018841) (congenital bile acid synthesis defect), [MONDO:0013154](http://purl.obolibrary.org/obo/MONDO_0013154) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2), [MONDO:0005529](http://purl.obolibrary.org/obo/MONDO_0005529) (methylmalonic aciduria and homocystinuria type cblG), [MONDO:0005528](http://purl.obolibrary.org/obo/MONDO_0005528) (vitamin metabolic disorder), [MONDO:0005523](http://purl.obolibrary.org/obo/MONDO_0005523) (steroid inherited metabolic disorder), [MONDO:0014475](http://purl.obolibrary.org/obo/MONDO_0014475) (spinocerebellar ataxia type 40), [MONDO:0018834](http://purl.obolibrary.org/obo/MONDO_0018834) (Adenylosuccinate synthetase-like 1-related distal myopathy), [MONDO:0014477](http://purl.obolibrary.org/obo/MONDO_0014477) (epileptic encephalopathy, early infantile, 26), [MONDO:0013147](http://purl.obolibrary.org/obo/MONDO_0013147) (dilated cardiomyopathy 1CC), [MONDO:0014471](http://purl.obolibrary.org/obo/MONDO_0014471) (isolated ATP synthase deficiency), [MONDO:0014472](http://purl.obolibrary.org/obo/MONDO_0014472) (periodic fever-infantile enterocolitis-autoinflammatory syndrome), [MONDO:0014473](http://purl.obolibrary.org/obo/MONDO_0014473) (microcephaly 13, primary, autosomal recessive), [MONDO:0013142](http://purl.obolibrary.org/obo/MONDO_0013142) (neuropathy, hereditary sensory and autonomic, type 2B), [MONDO:0014474](http://purl.obolibrary.org/obo/MONDO_0014474) (autosomal recessive limb-girdle muscular dystrophy type 2U), [MONDO:0014470](http://purl.obolibrary.org/obo/MONDO_0014470) (autosomal dominant nonsyndromic deafness 65), [MONDO:0013149](http://purl.obolibrary.org/obo/MONDO_0013149) (hydrops fetalis, Nonimmune, with gracile bones and dysmorphic features), [MONDO:0017578](http://purl.obolibrary.org/obo/MONDO_0017578) (disorder of thiamine metabolism and transport), [MONDO:0016249](http://purl.obolibrary.org/obo/MONDO_0016249) (hereditary site-specific ovarian cancer syndrome), [MONDO:0016248](http://purl.obolibrary.org/obo/MONDO_0016248) (familial ovarian cancer), [MONDO:0017575](http://purl.obolibrary.org/obo/MONDO_0017575) (mitochondrial neurogastrointestinal encephalomyopathy), [MONDO:0017570](http://purl.obolibrary.org/obo/MONDO_0017570) (leukocyte adhesion deficiency), [MONDO:0009950](http://purl.obolibrary.org/obo/MONDO_0009950) (pyruvate kinase deficiency of red cells), [MONDO:0009951](http://purl.obolibrary.org/obo/MONDO_0009951) (Radiculoneuropathy, fatal neonatal), [MONDO:0009953](http://purl.obolibrary.org/obo/MONDO_0009953) (leukocyte adhesion deficiency type II), [MONDO:0008623](http://purl.obolibrary.org/obo/MONDO_0008623) (Undritz anomaly), [MONDO:0009955](http://purl.obolibrary.org/obo/MONDO_0009955) (rapadilino syndrome), [MONDO:0008625](http://purl.obolibrary.org/obo/MONDO_0008625) (urate-Binding globulin, Decrease 1N), [MONDO:0009956](http://purl.obolibrary.org/obo/MONDO_0009956) (red skin pigment anomaly of new guinea), [MONDO:0008626](http://purl.obolibrary.org/obo/MONDO_0008626) (ureter, bifid or double), [MONDO:0009957](http://purl.obolibrary.org/obo/MONDO_0009957) (Reese retinal dysplasia), [MONDO:0009958](http://purl.obolibrary.org/obo/MONDO_0009958) (adult Refsum disease), [MONDO:0008628](http://purl.obolibrary.org/obo/MONDO_0008628) (ureterocele (disease)), [MONDO:0009959](http://purl.obolibrary.org/obo/MONDO_0009959) (peroxisome biogenesis disorder type 3B), [MONDO:0008629](http://purl.obolibrary.org/obo/MONDO_0008629) (urolithiasis, Uric acid, autosomal dominant), [MONDO:0010940](http://purl.obolibrary.org/obo/MONDO_0010940) (asthma, susceptibility to), [MONDO:0010944](http://purl.obolibrary.org/obo/MONDO_0010944) (mitochondrial import-stimulating factor), [MONDO:0010941](http://purl.obolibrary.org/obo/MONDO_0010941) (ENUR2), [MONDO:0010942](http://purl.obolibrary.org/obo/MONDO_0010942) (Eukaryotic Translation elongation factor 1 alpha-1-like 14), [MONDO:0017569](http://purl.obolibrary.org/obo/MONDO_0017569) (de Barsy syndrome), [MONDO:0018893](http://purl.obolibrary.org/obo/MONDO_0018893) (Cobb syndrome), [MONDO:0018891](http://purl.obolibrary.org/obo/MONDO_0018891) (familial tumoral calcinosis), [MONDO:0009940](http://purl.obolibrary.org/obo/MONDO_0009940) (pycnodysostosis), [MONDO:0009941](http://purl.obolibrary.org/obo/MONDO_0009941) (Pygmy), [MONDO:0008612](http://purl.obolibrary.org/obo/MONDO_0008612) (tuberous sclerosis 1), [MONDO:0008613](http://purl.obolibrary.org/obo/MONDO_0008613) (Tuftsin deficiency), [MONDO:0009944](http://purl.obolibrary.org/obo/MONDO_0009944) (pyloric atresia), [MONDO:0009945](http://purl.obolibrary.org/obo/MONDO_0009945) (pyridoxine-dependent epilepsy), [MONDO:0008614](http://purl.obolibrary.org/obo/MONDO_0008614) (ST3), [MONDO:0008615](http://purl.obolibrary.org/obo/MONDO_0008615) (Tune deafness), [MONDO:0009946](http://purl.obolibrary.org/obo/MONDO_0009946) (hemolytic anemia due to pyrimidine 5' nucleotidase deficiency), [MONDO:0009947](http://purl.obolibrary.org/obo/MONDO_0009947) (glutathione synthetase deficiency with 5-oxoprolinuria), [MONDO:0008616](http://purl.obolibrary.org/obo/MONDO_0008616) (Twinning due to Superfetation), [MONDO:0009948](http://purl.obolibrary.org/obo/MONDO_0009948) (Pyropoikilocytosis, hereditary), [MONDO:0010937](http://purl.obolibrary.org/obo/MONDO_0010937) (isoproterenol-mediated Vasodilatation), [MONDO:0009949](http://purl.obolibrary.org/obo/MONDO_0009949) (pyruvate carboxylase deficiency disease), [MONDO:0010935](http://purl.obolibrary.org/obo/MONDO_0010935) (neuronopathy, distal hereditary motor, type 5A), [MONDO:0010938](http://purl.obolibrary.org/obo/MONDO_0010938) (T-b+ severe combined immunodeficiency due to JAK3 deficiency), [MONDO:0010933](http://purl.obolibrary.org/obo/MONDO_0010933) (autosomal recessive nonsyndromic deafness 4), [MONDO:0016239](http://purl.obolibrary.org/obo/MONDO_0016239) (cystinosis), [MONDO:0013199](http://purl.obolibrary.org/obo/MONDO_0013199) (tuberous sclerosis 2), [MONDO:0016224](http://purl.obolibrary.org/obo/MONDO_0016224) (autosomal dominant proximal spinal muscular atrophy), [MONDO:0013196](http://purl.obolibrary.org/obo/MONDO_0013196) (colorectal cancer, hereditary nonpolyposis, type 8), [MONDO:0018883](http://purl.obolibrary.org/obo/MONDO_0018883) (Berardinelli-Seip congenital lipodystrophy), [MONDO:0013198](http://purl.obolibrary.org/obo/MONDO_0013198) (dilated cardiomyopathy 1EE), [MONDO:0013192](http://purl.obolibrary.org/obo/MONDO_0013192) (SPDA3), [MONDO:0013193](http://purl.obolibrary.org/obo/MONDO_0013193) (thyrotoxic periodic paralysis, susceptibility to, 2), [MONDO:0009931](http://purl.obolibrary.org/obo/MONDO_0009931) (pulmonary atresia-intact ventricular septum syndrome), [MONDO:0013194](http://purl.obolibrary.org/obo/MONDO_0013194) (Pseudopili annulati), [MONDO:0008600](http://purl.obolibrary.org/obo/MONDO_0008600) (trigger thumb), [MONDO:0008601](http://purl.obolibrary.org/obo/MONDO_0008601) (triglyceride storage disease, type 1), [MONDO:0009932](http://purl.obolibrary.org/obo/MONDO_0009932) (pulmonary bullae causing pneumothorax), [MONDO:0008602](http://purl.obolibrary.org/obo/MONDO_0008602) (triglyceride storage disease, type 2), [MONDO:0008604](http://purl.obolibrary.org/obo/MONDO_0008604) (triphalangeal thumb with double phalanges), [MONDO:0008605](http://purl.obolibrary.org/obo/MONDO_0008605) (triphalangeal thumb, Nonopposable), [MONDO:0010926](http://purl.obolibrary.org/obo/MONDO_0010926) (familial hypocalciuric hypercalcemia 3), [MONDO:0009938](http://purl.obolibrary.org/obo/MONDO_0009938) (pulmonic stenosis (disease)), [MONDO:0010923](http://purl.obolibrary.org/obo/MONDO_0010923) (proximal myopathy with focal depletion of mitochondria), [MONDO:0010924](http://purl.obolibrary.org/obo/MONDO_0010924) (D-2-hydroxyglutaric aciduria), [MONDO:0009939](http://purl.obolibrary.org/obo/MONDO_0009939) (pulmonic stenosis and congenital nephrosis), [MONDO:0008608](http://purl.obolibrary.org/obo/MONDO_0008608) (down syndrome), [MONDO:0008609](http://purl.obolibrary.org/obo/MONDO_0008609) (Tristichiasis), [MONDO:0010928](http://purl.obolibrary.org/obo/MONDO_0010928) (dwarfism, familial, with muscle spasms), [MONDO:0010921](http://purl.obolibrary.org/obo/MONDO_0010921) (nasal dermoid cyst), [MONDO:0017545](http://purl.obolibrary.org/obo/MONDO_0017545) (Zygodactyly type 4), [MONDO:0013188](http://purl.obolibrary.org/obo/MONDO_0013188) (cerebellar ataxia, mental retardation, and Dysequilibrium syndrome 3), [MONDO:0017544](http://purl.obolibrary.org/obo/MONDO_0017544) (Zygodactyly type 3), [MONDO:0013189](http://purl.obolibrary.org/obo/MONDO_0013189) (trichotillomania), [MONDO:0018875](http://purl.obolibrary.org/obo/MONDO_0018875) (Li-Fraumeni syndrome), [MONDO:0017543](http://purl.obolibrary.org/obo/MONDO_0017543) (Zygodactyly type 2), [MONDO:0013186](http://purl.obolibrary.org/obo/MONDO_0013186) (Noonan syndrome 6), [MONDO:0013180](http://purl.obolibrary.org/obo/MONDO_0013180) (ASRT8), [MONDO:0013181](http://purl.obolibrary.org/obo/MONDO_0013181) (amelogenesis imperfecta hypomaturation type 2A3), [MONDO:0013182](http://purl.obolibrary.org/obo/MONDO_0013182) (chromosome 17p13.3 duplication syndrome), [MONDO:0010909](http://purl.obolibrary.org/obo/MONDO_0010909) (UV-Sensitive syndrome 1), [MONDO:0009922](http://purl.obolibrary.org/obo/MONDO_0009922) (Pseudouridinuria and mental defect), [MONDO:0009923](http://purl.obolibrary.org/obo/MONDO_0009923) (46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency), [MONDO:0009925](http://purl.obolibrary.org/obo/MONDO_0009925) (pseudoxanthoma elasticum), [MONDO:0010914](http://purl.obolibrary.org/obo/MONDO_0010914) (carnitine palmitoyl transferase II deficiency, severe infantile form), [MONDO:0009926](http://purl.obolibrary.org/obo/MONDO_0009926) (autosomal recessive multiple pterygium syndrome), [MONDO:0010915](http://purl.obolibrary.org/obo/MONDO_0010915) (autosomal dominant nonsyndromic deafness 4A), [MONDO:0010918](http://purl.obolibrary.org/obo/MONDO_0010918) (EIG), [MONDO:0009929](http://purl.obolibrary.org/obo/MONDO_0009929) (neonatal acute respiratory distress due to SP-b deficiency), [MONDO:0010919](http://purl.obolibrary.org/obo/MONDO_0010919) (varicella, severe recurrent), [MONDO:0010916](http://purl.obolibrary.org/obo/MONDO_0010916) (polycystic kidney disease 3), [MONDO:0010910](http://purl.obolibrary.org/obo/MONDO_0010910) (ENUR1), [MONDO:0020306](http://purl.obolibrary.org/obo/MONDO_0020306) (absent tibia-polydactyly syndrome), [MONDO:0019313](http://purl.obolibrary.org/obo/MONDO_0019313) (hereditary lymphedema), [MONDO:0009990](http://purl.obolibrary.org/obo/MONDO_0009990) (Revesz syndrome), [MONDO:0008660](http://purl.obolibrary.org/obo/MONDO_0008660) (autosomal dominant hypophosphatemic rickets), [MONDO:0010980](http://purl.obolibrary.org/obo/MONDO_0010980) (midline malformations, multiple, with limb abnormalities and hypopituitarism), [MONDO:0009992](http://purl.obolibrary.org/obo/MONDO_0009992) (myoglobinuria, acute recurrent, autosomal recessive), [MONDO:0019311](http://purl.obolibrary.org/obo/MONDO_0019311) (woolly hair nevus), [MONDO:0019312](http://purl.obolibrary.org/obo/MONDO_0019312) (Hermansky-Pudlak syndrome), [MONDO:0009995](http://purl.obolibrary.org/obo/MONDO_0009995) (rheumatic fever-related antigen), [MONDO:0019310](http://purl.obolibrary.org/obo/MONDO_0019310) (recessive dystrophic epidermolysis bullosa inversa), [MONDO:0020300](http://purl.obolibrary.org/obo/MONDO_0020300) (autosomal dominant nocturnal frontal lobe epilepsy), [MONDO:0009997](http://purl.obolibrary.org/obo/MONDO_0009997) (Roberts syndrome), [MONDO:0020301](http://purl.obolibrary.org/obo/MONDO_0020301) (Prader-Willi syndrome due to paternal 15q11q13 deletion), [MONDO:0008666](http://purl.obolibrary.org/obo/MONDO_0008666) (volvulus of Midgut), [MONDO:0008667](http://purl.obolibrary.org/obo/MONDO_0008667) (von Hippel-Lindau disease), [MONDO:0020302](http://purl.obolibrary.org/obo/MONDO_0020302) (Angelman syndrome due to maternal 15q11q13 deletion), [MONDO:0020303](http://purl.obolibrary.org/obo/MONDO_0020303) (Angelman syndrome due to paternal uniparental disomy of chromosome 15), [MONDO:0009999](http://purl.obolibrary.org/obo/MONDO_0009999) (autosomal recessive Robinow syndrome), [MONDO:0007329](http://purl.obolibrary.org/obo/MONDO_0007329) (cirrhosis, familial), [MONDO:0007328](http://purl.obolibrary.org/obo/MONDO_0007328) (choroidal osteoma, bilateral), [MONDO:0007327](http://purl.obolibrary.org/obo/MONDO_0007327) (chylomicronemia, familial, due to circulating inhibitor of lipoprotein lipase), [MONDO:0007325](http://purl.obolibrary.org/obo/MONDO_0007325) (choreoathetosis, familial inverted), [MONDO:0007323](http://purl.obolibrary.org/obo/MONDO_0007323) (Chondronectin), [MONDO:0007322](http://purl.obolibrary.org/obo/MONDO_0007322) (chondrodysplasia punctata, tibial-metacarpal type), [MONDO:0007321](http://purl.obolibrary.org/obo/MONDO_0007321) (autosomal dominant chondrodysplasia punctata), [MONDO:0010984](http://purl.obolibrary.org/obo/MONDO_0010984) (Usher syndrome type 1D), [MONDO:0010982](http://purl.obolibrary.org/obo/MONDO_0010982) (ichthyosis-mental retardation syndrome with large Keratohyalin Granules 1N the skin), [MONDO:0010987](http://purl.obolibrary.org/obo/MONDO_0010987) (autosomal recessive nonsyndromic deafness 8), [MONDO:0010985](http://purl.obolibrary.org/obo/MONDO_0010985) (FAME1), [MONDO:0010986](http://purl.obolibrary.org/obo/MONDO_0010986) (autosomal recessive nonsyndromic deafness 9), [MONDO:0019306](http://purl.obolibrary.org/obo/MONDO_0019306) (congenital non-bullous ichthyosiform erythroderma), [MONDO:0019307](http://purl.obolibrary.org/obo/MONDO_0019307) (junctional epidermolysis bullosa non-Herlitz type), [MONDO:0019302](http://purl.obolibrary.org/obo/MONDO_0019302) (mucopolysaccharidosis with skin involvement), [MONDO:0009980](http://purl.obolibrary.org/obo/MONDO_0009980) (retinal telangiectasia and hypogammaglobulinemia), [MONDO:0009982](http://purl.obolibrary.org/obo/MONDO_0009982) (retinitis pigmentosa inversa with deafness), [MONDO:0008651](http://purl.obolibrary.org/obo/MONDO_0008651) (vertebral hypoplasia with lumbar kyphosis), [MONDO:0008653](http://purl.obolibrary.org/obo/MONDO_0008653) (VUR1), [MONDO:0008655](http://purl.obolibrary.org/obo/MONDO_0008655) (vestibulocochlear dysfunction, progressive), [MONDO:0009986](http://purl.obolibrary.org/obo/MONDO_0009986) (retinopathy, pigmentary, and mental retardation), [MONDO:0008656](http://purl.obolibrary.org/obo/MONDO_0008656) (benign paroxysmal positional nystagmus), [MONDO:0009988](http://purl.obolibrary.org/obo/MONDO_0009988) (retinoschisis of fovea), [MONDO:0008657](http://purl.obolibrary.org/obo/MONDO_0008657) (vibratory angioedema), [MONDO:0008658](http://purl.obolibrary.org/obo/MONDO_0008658) (virus Rd114 Rna Complementarity), [MONDO:0008659](http://purl.obolibrary.org/obo/MONDO_0008659) (transcobalamin i deficiency), [MONDO:0007338](http://purl.obolibrary.org/obo/MONDO_0007338) (cleft soft palate), [MONDO:0010978](http://purl.obolibrary.org/obo/MONDO_0010978) (portal vein, cavernous transformation of), [MONDO:0007336](http://purl.obolibrary.org/obo/MONDO_0007336) (isolated cleft palate), [MONDO:0010979](http://purl.obolibrary.org/obo/MONDO_0010979) (Timothy syndrome), [MONDO:0007334](http://purl.obolibrary.org/obo/MONDO_0007334) (autosomal dominant popliteal pterygium syndrome), [MONDO:0007331](http://purl.obolibrary.org/obo/MONDO_0007331) (cleft chin), [MONDO:0010973](http://purl.obolibrary.org/obo/MONDO_0010973) (autosomal dominant nonsyndromic deafness 5), [MONDO:0010970](http://purl.obolibrary.org/obo/MONDO_0010970) (cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies), [MONDO:0010976](http://purl.obolibrary.org/obo/MONDO_0010976) (KRT14-related epidermolysis bullosa simplex), [MONDO:0019308](http://purl.obolibrary.org/obo/MONDO_0019308) (junctional epidermolysis bullosa inversa), [MONDO:0019309](http://purl.obolibrary.org/obo/MONDO_0019309) (late-onset junctional epidermolysis bullosa), [MONDO:0008640](http://purl.obolibrary.org/obo/MONDO_0008640) (vasculitis, lymphocytic, nodular), [MONDO:0009972](http://purl.obolibrary.org/obo/MONDO_0009972) (respiratory Underresponsiveness to hypoxia and Hypercapnia), [MONDO:0009973](http://purl.obolibrary.org/obo/MONDO_0009973) (reticular dysgenesis), [MONDO:0008643](http://purl.obolibrary.org/obo/MONDO_0008643) (veins, pattern of, on anterior thorax), [MONDO:0008644](http://purl.obolibrary.org/obo/MONDO_0008644) (velocardiofacial syndrome), [MONDO:0009976](http://purl.obolibrary.org/obo/MONDO_0009976) (retinal degeneration and epilepsy), [MONDO:0008646](http://purl.obolibrary.org/obo/MONDO_0008646) (long QT syndrome 1), [MONDO:0008648](http://purl.obolibrary.org/obo/MONDO_0008648) (ventricular tachycardia, familial), [MONDO:0008649](http://purl.obolibrary.org/obo/MONDO_0008649) (Venular insufficiency, systemic), [MONDO:0007305](http://purl.obolibrary.org/obo/MONDO_0007305) (cervical vertebral dysplasia (disease)), [MONDO:0010967](http://purl.obolibrary.org/obo/MONDO_0010967) (autosomal recessive nonsyndromic deafness 7), [MONDO:0007304](http://purl.obolibrary.org/obo/MONDO_0007304) (cervical vertebral Bridge), [MONDO:0007303](http://purl.obolibrary.org/obo/MONDO_0007303) (cervical rib), [MONDO:0010968](http://purl.obolibrary.org/obo/MONDO_0010968) (GLC3B), [MONDO:0007302](http://purl.obolibrary.org/obo/MONDO_0007302) (cervical hypertrichosis with Underlying kyphoscoliosis), [MONDO:0010961](http://purl.obolibrary.org/obo/MONDO_0010961) (obesity due to prohormone convertase i deficiency), [MONDO:0010962](http://purl.obolibrary.org/obo/MONDO_0010962) (palmoplantar keratoderma, nonepidermolytic), [MONDO:0010960](http://purl.obolibrary.org/obo/MONDO_0010960) (Protocadherin 3), [MONDO:0010965](http://purl.obolibrary.org/obo/MONDO_0010965) (autosomal recessive nonsyndromic deafness 6), [MONDO:0010963](http://purl.obolibrary.org/obo/MONDO_0010963) (autosomal dominant nonsyndromic deafness 6), [MONDO:0021607](http://purl.obolibrary.org/obo/MONDO_0021607) (eyelid seborrheic keratosis), [MONDO:0008630](http://purl.obolibrary.org/obo/MONDO_0008630) (urinary bladder, Atony of), [MONDO:0009961](http://purl.obolibrary.org/obo/MONDO_0009961) (renal and mullerian duct hypoplasia), [MONDO:0009962](http://purl.obolibrary.org/obo/MONDO_0009962) (Senior-Loken syndrome 1), [MONDO:0008632](http://purl.obolibrary.org/obo/MONDO_0008632) (urticaria, Aquagenic), [MONDO:0008633](http://purl.obolibrary.org/obo/MONDO_0008633) (Muckle-Wells syndrome), [MONDO:0009964](http://purl.obolibrary.org/obo/MONDO_0009964) (short-rib thoracic dysplasia 9 with or without polydactyly), [MONDO:0009965](http://purl.obolibrary.org/obo/MONDO_0009965) (Perlman syndrome), [MONDO:0008634](http://purl.obolibrary.org/obo/MONDO_0008634) (urticaria, familial localized heat), [MONDO:0008635](http://purl.obolibrary.org/obo/MONDO_0008635) (uterine anomalies), [MONDO:0009966](http://purl.obolibrary.org/obo/MONDO_0009966) (NPHP3-related Meckel-like syndrome), [MONDO:0009967](http://purl.obolibrary.org/obo/MONDO_0009967) (renal tubular acidosis 3), [MONDO:0007318](http://purl.obolibrary.org/obo/MONDO_0007318) (Alagille syndrome), [MONDO:0009968](http://purl.obolibrary.org/obo/MONDO_0009968) (renal tubular acidosis, distal, with progressive nerve deafness), [MONDO:0008637](http://purl.obolibrary.org/obo/MONDO_0008637) (bifid uvula), [MONDO:0010958](http://purl.obolibrary.org/obo/MONDO_0010958) (cardiac arrhythmia, Ankyrin-b-related), [MONDO:0007317](http://purl.obolibrary.org/obo/MONDO_0007317) (Chlorpropamide-alcohol flushing), [MONDO:0008639](http://purl.obolibrary.org/obo/MONDO_0008639) (vascular helix of umbilical cord), [MONDO:0007316](http://purl.obolibrary.org/obo/MONDO_0007316) (Arnold-Chiari malformation type i), [MONDO:0010956](http://purl.obolibrary.org/obo/MONDO_0010956) (enamel hypoplasia, cataracts, and aqueductal stenosis), [MONDO:0007315](http://purl.obolibrary.org/obo/MONDO_0007315) (cherubism), [MONDO:0010957](http://purl.obolibrary.org/obo/MONDO_0010957) (Agonadism, 46,Xy, with mental retardation, short stature, retarded bone age, and multiple Extragenital malformations), [MONDO:0007314](http://purl.obolibrary.org/obo/MONDO_0007314) (chemodectoma, Intraabdominal, with cutaneous angiolipomas), [MONDO:0007312](http://purl.obolibrary.org/obo/MONDO_0007312) (Charcot-Marie-tooth disease with ptosis and parkinsonism), [MONDO:0010951](http://purl.obolibrary.org/obo/MONDO_0010951) (dilated cardiomyopathy 1B), [MONDO:0010954](http://purl.obolibrary.org/obo/MONDO_0010954) (Wiskott-Aldrich syndrome, autosomal dominant form), [MONDO:0010955](http://purl.obolibrary.org/obo/MONDO_0010955) (ectodermal dysplasia with mental retardation and syndactyly), [MONDO:0010953](http://purl.obolibrary.org/obo/MONDO_0010953) (Fanconi anemia complementation group E), [MONDO:0019358](http://purl.obolibrary.org/obo/MONDO_0019358) (encephalopathy due to sulfite oxidase deficiency), [MONDO:0000732](http://purl.obolibrary.org/obo/MONDO_0000732) (combined oxidative phosphorylation deficiency), [MONDO:0012729](http://purl.obolibrary.org/obo/MONDO_0012729) (erythrocytosis, familial, 4), [MONDO:0007369](http://purl.obolibrary.org/obo/MONDO_0007369) (hereditary coproporphyria), [MONDO:0006037](http://purl.obolibrary.org/obo/MONDO_0006037) (hydrolethalus syndrome), [MONDO:0007368](http://purl.obolibrary.org/obo/MONDO_0007368) (familial benign copper deficiency), [MONDO:0007367](http://purl.obolibrary.org/obo/MONDO_0007367) (FEB1), [MONDO:0012722](http://purl.obolibrary.org/obo/MONDO_0012722) (Dauwerse-Peters syndrome), [MONDO:0007363](http://purl.obolibrary.org/obo/MONDO_0007363) (congenital contractural arachnodactyly), [MONDO:0012721](http://purl.obolibrary.org/obo/MONDO_0012721) (progressive myoclonic epilepsy type 3), [MONDO:0012720](http://purl.obolibrary.org/obo/MONDO_0012720) (Krabbe disease, atypical, due to saposin a deficiency), [MONDO:0012725](http://purl.obolibrary.org/obo/MONDO_0012725) (lipoprotein glomerulopathy), [MONDO:0012724](http://purl.obolibrary.org/obo/MONDO_0012724) (familial cold autoinflammatory syndrome 2), [MONDO:0008690](http://purl.obolibrary.org/obo/MONDO_0008690) (xeroderma pigmentosum, autosomal dominant, mild), [MONDO:0019349](http://purl.obolibrary.org/obo/MONDO_0019349) (Sotos syndrome), [MONDO:0008691](http://purl.obolibrary.org/obo/MONDO_0008691) (zinc, elevated plasma), [MONDO:0019346](http://purl.obolibrary.org/obo/MONDO_0019346) (sialidosis type 1), [MONDO:0008692](http://purl.obolibrary.org/obo/MONDO_0008692) (abetalipoproteinemia), [MONDO:0019347](http://purl.obolibrary.org/obo/MONDO_0019347) (peeling skin syndrome), [MONDO:0018014](http://purl.obolibrary.org/obo/MONDO_0018014) (transient neonatal multiple acyl-CoA dehydrogenase deficiency), [MONDO:0008696](http://purl.obolibrary.org/obo/MONDO_0008696) (acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome), [MONDO:0019342](http://purl.obolibrary.org/obo/MONDO_0019342) (Seckel syndrome), [MONDO:0008697](http://purl.obolibrary.org/obo/MONDO_0008697) (Acetophenetidin sensitivity), [MONDO:0008698](http://purl.obolibrary.org/obo/MONDO_0008698) (achalasia (disease)), [MONDO:0019341](http://purl.obolibrary.org/obo/MONDO_0019341) (tuberous sclerosis complex), [MONDO:0008699](http://purl.obolibrary.org/obo/MONDO_0008699) (achalasia microcephaly syndrome), [MONDO:0020336](http://purl.obolibrary.org/obo/MONDO_0020336) (autosomal dominant Emery-Dreifuss muscular dystrophy), [MONDO:0012719](http://purl.obolibrary.org/obo/MONDO_0012719) (encephalopathy due to prosaposin deficiency), [MONDO:0012718](http://purl.obolibrary.org/obo/MONDO_0012718) (hypotonia with lactic acidemia and hyperammonemia), [MONDO:0012717](http://purl.obolibrary.org/obo/MONDO_0012717) (renal hypomagnesemia 4), [MONDO:0007378](http://purl.obolibrary.org/obo/MONDO_0007378) (posterior polymorphous corneal dystrophy 1), [MONDO:0012711](http://purl.obolibrary.org/obo/MONDO_0012711) (peripapillary atrophy, beta type), [MONDO:0007373](http://purl.obolibrary.org/obo/MONDO_0007373) (corneal degeneration, Ribbonlike, with deafness), [MONDO:0007371](http://purl.obolibrary.org/obo/MONDO_0007371) (cornea guttata with anterior polar cataracts), [MONDO:0012714](http://purl.obolibrary.org/obo/MONDO_0012714) (early-onset myopathy with fatal cardiomyopathy), [MONDO:0007370](http://purl.obolibrary.org/obo/MONDO_0007370) (coracoclavicular joint, anomalous), [MONDO:0012712](http://purl.obolibrary.org/obo/MONDO_0012712) (DYTCA), [MONDO:0018006](http://purl.obolibrary.org/obo/MONDO_0018006) (adult-onset distal myopathy due to VCP mutation), [MONDO:0008681](http://purl.obolibrary.org/obo/MONDO_0008681) (WAGR syndrome), [MONDO:0019335](http://purl.obolibrary.org/obo/MONDO_0019335) (mild hyperphenylalaninemia), [MONDO:0008682](http://purl.obolibrary.org/obo/MONDO_0008682) (Denys-Drash syndrome), [MONDO:0019336](http://purl.obolibrary.org/obo/MONDO_0019336) (Gardner syndrome), [MONDO:0018005](http://purl.obolibrary.org/obo/MONDO_0018005) (spastic paraplegia-Paget disease of bone syndrome), [MONDO:0018002](http://purl.obolibrary.org/obo/MONDO_0018002) (adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy), [MONDO:0019333](http://purl.obolibrary.org/obo/MONDO_0019333) (autosomal recessive hyperinsulinism due to SUR1 deficiency), [MONDO:0008684](http://purl.obolibrary.org/obo/MONDO_0008684) (wolf-Hirschhorn syndrome), [MONDO:0019334](http://purl.obolibrary.org/obo/MONDO_0019334) (autosomal recessive hyperinsulinism due to Kir6.2 deficiency), [MONDO:0008685](http://purl.obolibrary.org/obo/MONDO_0008685) (Wolff-Parkinson-white syndrome (disease)), [MONDO:0019332](http://purl.obolibrary.org/obo/MONDO_0019332) (punctate palmoplantar keratoderma type 1), [MONDO:0008687](http://purl.obolibrary.org/obo/MONDO_0008687) (Woronets trait), [MONDO:0012707](http://purl.obolibrary.org/obo/MONDO_0012707) (FEB9), [MONDO:0007349](http://purl.obolibrary.org/obo/MONDO_0007349) (familial cold autoinflammatory syndrome 1), [MONDO:0007348](http://purl.obolibrary.org/obo/MONDO_0007348) (Colchicine resistance), [MONDO:0012706](http://purl.obolibrary.org/obo/MONDO_0012706) (familial temporal lobe epilepsy 4), [MONDO:0012705](http://purl.obolibrary.org/obo/MONDO_0012705) (ETL3), [MONDO:0007347](http://purl.obolibrary.org/obo/MONDO_0007347) (CXB3S), [MONDO:0007345](http://purl.obolibrary.org/obo/MONDO_0007345) (aorta coarctation), [MONDO:0007344](http://purl.obolibrary.org/obo/MONDO_0007344) (cluster headache, familial), [MONDO:0012704](http://purl.obolibrary.org/obo/MONDO_0012704) (dilated cardiomyopathy 1X), [MONDO:0010990](http://purl.obolibrary.org/obo/MONDO_0010990) (Cd4/Cd8 T-cell Ratio), [MONDO:0008670](http://purl.obolibrary.org/obo/MONDO_0008670) (Waardenburg syndrome type 1), [MONDO:0010991](http://purl.obolibrary.org/obo/MONDO_0010991) (Laterality defects, autosomal dominant), [MONDO:0008671](http://purl.obolibrary.org/obo/MONDO_0008671) (Waardenburg syndrome type 2A), [MONDO:0008675](http://purl.obolibrary.org/obo/MONDO_0008675) (Freeman-Sheldon syndrome), [MONDO:0020310](http://purl.obolibrary.org/obo/MONDO_0020310) (familial focal epilepsy with variable foci), [MONDO:0019321](http://purl.obolibrary.org/obo/MONDO_0019321) (atypical Werner syndrome), [MONDO:0016295](http://purl.obolibrary.org/obo/MONDO_0016295) (neuronal ceroid lipofuscinosis), [MONDO:0008677](http://purl.obolibrary.org/obo/MONDO_0008677) (Widow's Peak (disease)), [MONDO:0008678](http://purl.obolibrary.org/obo/MONDO_0008678) (Williams syndrome), [MONDO:0007359](http://purl.obolibrary.org/obo/MONDO_0007359) (commissural 51P pits), [MONDO:0007358](http://purl.obolibrary.org/obo/MONDO_0007358) (Comedones, familial Dyskeratotic), [MONDO:0007357](http://purl.obolibrary.org/obo/MONDO_0007357) (colonic varices without portal hypertension), [MONDO:0006025](http://purl.obolibrary.org/obo/MONDO_0006025) (autosomal recessive disease), [MONDO:0007356](http://purl.obolibrary.org/obo/MONDO_0007356) (Lynch syndrome 1), [MONDO:0007354](http://purl.obolibrary.org/obo/MONDO_0007354) (coloboma of optic nerve (disease)), [MONDO:0007352](http://purl.obolibrary.org/obo/MONDO_0007352) (renal coloboma syndrome), [MONDO:0010998](http://purl.obolibrary.org/obo/MONDO_0010998) (ALG3-CDG), [MONDO:0010996](http://purl.obolibrary.org/obo/MONDO_0010996) (HHT3), [MONDO:0011431](http://purl.obolibrary.org/obo/MONDO_0011431) (mass syndrome), [MONDO:0009110](http://purl.obolibrary.org/obo/MONDO_0009110) (dicarboxylic aminoaciduria), [MONDO:0012761](http://purl.obolibrary.org/obo/MONDO_0012761) (chromosome 3q29 microduplication syndrome), [MONDO:0010100](http://purl.obolibrary.org/obo/MONDO_0010100) (Tay-Sachs disease), [MONDO:0009111](http://purl.obolibrary.org/obo/MONDO_0009111) (dihydropyrimidinuria), [MONDO:0009112](http://purl.obolibrary.org/obo/MONDO_0009112) (rhizomelic chondrodysplasia punctata type 2), [MONDO:0012760](http://purl.obolibrary.org/obo/MONDO_0012760) (EIG5), [MONDO:0009113](http://purl.obolibrary.org/obo/MONDO_0009113) (hemolytic anemia due to diphosphoglycerate mutase deficiency), [MONDO:0009114](http://purl.obolibrary.org/obo/MONDO_0009114) (congenital sucrase-isomaltase deficiency), [MONDO:0009115](http://purl.obolibrary.org/obo/MONDO_0009115) (congenital lactase deficiency), [MONDO:0018067](http://purl.obolibrary.org/obo/MONDO_0018067) (Triploidy), [MONDO:0009116](http://purl.obolibrary.org/obo/MONDO_0009116) (lactose intolerance (disease)), [MONDO:0009117](http://purl.obolibrary.org/obo/MONDO_0009117) (Disorganization, mouse, Homolog of), [MONDO:0019393](http://purl.obolibrary.org/obo/MONDO_0019393) (idiopathic malabsorption due to bile acid synthesis defects), [MONDO:0009118](http://purl.obolibrary.org/obo/MONDO_0009118) (disseminated sclerosis with narcolepsy), [MONDO:0009119](http://purl.obolibrary.org/obo/MONDO_0009119) (diverticulosis, small-intestinal), [MONDO:0019391](http://purl.obolibrary.org/obo/MONDO_0019391) (Fanconi anemia), [MONDO:0020380](http://purl.obolibrary.org/obo/MONDO_0020380) (autosomal dominant cerebellar ataxia), [MONDO:0010109](http://purl.obolibrary.org/obo/MONDO_0010109) (tetraamelia with ectodermal dysplasia and lacrimal duct abnormalities), [MONDO:0020384](http://purl.obolibrary.org/obo/MONDO_0020384) (Niemann-Pick disease type E), [MONDO:0012766](http://purl.obolibrary.org/obo/MONDO_0012766) (hereditary spastic paraplegia 37), [MONDO:0010103](http://purl.obolibrary.org/obo/MONDO_0010103) (teeth, fused), [MONDO:0011434](http://purl.obolibrary.org/obo/MONDO_0011434) (PSORS5), [MONDO:0012765](http://purl.obolibrary.org/obo/MONDO_0012765) (LMPH1B), [MONDO:0012764](http://purl.obolibrary.org/obo/MONDO_0012764) (RIDDLE syndrome), [MONDO:0011433](http://purl.obolibrary.org/obo/MONDO_0011433) (anemia, congenital hypoplastic, with multiple Congenital anomalies/mental retardation syndrome), [MONDO:0011439](http://purl.obolibrary.org/obo/MONDO_0011439) (spinocerebellar ataxia type 12), [MONDO:0011438](http://purl.obolibrary.org/obo/MONDO_0011438) (acne (disease)), [MONDO:0012767](http://purl.obolibrary.org/obo/MONDO_0012767) (age related macular degeneration 11), [MONDO:0011436](http://purl.obolibrary.org/obo/MONDO_0011436) (autosomal recessive distal spinal muscular atrophy 1), [MONDO:0010106](http://purl.obolibrary.org/obo/MONDO_0010106) (testes, rudimentary), [MONDO:0012751](http://purl.obolibrary.org/obo/MONDO_0012751) (AAA3), [MONDO:0009101](http://purl.obolibrary.org/obo/MONDO_0009101) (Wolfram syndrome 1), [MONDO:0009102](http://purl.obolibrary.org/obo/MONDO_0009102) (Diaminopentanuria), [MONDO:0019389](http://purl.obolibrary.org/obo/MONDO_0019389) (X-linked recessive intellectual disability-macrocephaly-ciliary dysfunction syndrome), [MONDO:0009104](http://purl.obolibrary.org/obo/MONDO_0009104) (Donnai-Barrow syndrome), [MONDO:0018053](http://purl.obolibrary.org/obo/MONDO_0018053) (trichothiodystrophy), [MONDO:0018054](http://purl.obolibrary.org/obo/MONDO_0018054) (familial atrial fibrillation), [MONDO:0009108](http://purl.obolibrary.org/obo/MONDO_0009108) (hyperdibasic aminoaciduria type 1), [MONDO:0018052](http://purl.obolibrary.org/obo/MONDO_0018052) (hypoplastic tibiae-postaxial polydactyly syndrome), [MONDO:0009109](http://purl.obolibrary.org/obo/MONDO_0009109) (lysinuric protein intolerance), [MONDO:0020370](http://purl.obolibrary.org/obo/MONDO_0020370) (Cogan-Reese syndrome), [MONDO:0020371](http://purl.obolibrary.org/obo/MONDO_0020371) (essential iris atrophy), [MONDO:0011423](http://purl.obolibrary.org/obo/MONDO_0011423) (autosomal recessive limb-girdle muscular dystrophy type 2E), [MONDO:0011422](http://purl.obolibrary.org/obo/MONDO_0011422) (autosomal recessive proximal renal tubular acidosis), [MONDO:0011421](http://purl.obolibrary.org/obo/MONDO_0011421) (mitochondrial complex v (ATP synthase) deficiency, nuclear type 1), [MONDO:0012759](http://purl.obolibrary.org/obo/MONDO_0012759) (camptodactyly syndrome, Guadalajara, type 3), [MONDO:0011428](http://purl.obolibrary.org/obo/MONDO_0011428) (ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3), [MONDO:0011427](http://purl.obolibrary.org/obo/MONDO_0011427) (Ascaris lumbricoides infection, susceptibility to), [MONDO:0011426](http://purl.obolibrary.org/obo/MONDO_0011426) (aceruloplasminemia), [MONDO:0012757](http://purl.obolibrary.org/obo/MONDO_0012757) (lung fibrosis-immunodeficiency-46,XX gonadal dysgenesis syndrome), [MONDO:0012756](http://purl.obolibrary.org/obo/MONDO_0012756) (proximal 16p11.2 microdeletion syndrome), [MONDO:0011425](http://purl.obolibrary.org/obo/MONDO_0011425) (dilated cardiomyopathy 1H), [MONDO:0012740](http://purl.obolibrary.org/obo/MONDO_0012740) (chromosome 22q11.2 deletion syndrome, distal), [MONDO:0020364](http://purl.obolibrary.org/obo/MONDO_0020364) (posterior polymorphous corneal dystrophy), [MONDO:0018045](http://purl.obolibrary.org/obo/MONDO_0018045) (Hoyeraal-Hreidarsson syndrome), [MONDO:0020366](http://purl.obolibrary.org/obo/MONDO_0020366) (congenital glaucoma), [MONDO:0020367](http://purl.obolibrary.org/obo/MONDO_0020367) (juvenile glaucoma), [MONDO:0019374](http://purl.obolibrary.org/obo/MONDO_0019374) (CAMOS syndrome), [MONDO:0020368](http://purl.obolibrary.org/obo/MONDO_0020368) (Axenfeld anomaly), [MONDO:0020369](http://purl.obolibrary.org/obo/MONDO_0020369) (Chandler syndrome), [MONDO:0011419](http://purl.obolibrary.org/obo/MONDO_0011419) (Camera-Marugo-Cohen syndrome), [MONDO:0011418](http://purl.obolibrary.org/obo/MONDO_0011418) (DYX3), [MONDO:0012749](http://purl.obolibrary.org/obo/MONDO_0012749) (mesomelic dysplasia, Camera type), [MONDO:0012744](http://purl.obolibrary.org/obo/MONDO_0012744) (dilated cardiomyopathy 1Y), [MONDO:0007386](http://purl.obolibrary.org/obo/MONDO_0007386) (HCVS), [MONDO:0011410](http://purl.obolibrary.org/obo/MONDO_0011410) (Hirschsprung disease with heart defects, laryngeal anomalies, and preaxial polydactyly), [MONDO:0012748](http://purl.obolibrary.org/obo/MONDO_0012748) (primary ciliary dyskinesia 7), [MONDO:0011417](http://purl.obolibrary.org/obo/MONDO_0011417) (hemochromatosis type 3), [MONDO:0012747](http://purl.obolibrary.org/obo/MONDO_0012747) (glycogen storage disease due to aldolase A deficiency), [MONDO:0012746](http://purl.obolibrary.org/obo/MONDO_0012746) (dilated cardiomyopathy 2A), [MONDO:0011414](http://purl.obolibrary.org/obo/MONDO_0011414) (Peters anomaly (disease)), [MONDO:0012745](http://purl.obolibrary.org/obo/MONDO_0012745) (dilated cardiomyopathy 1Z), [MONDO:0019366](http://purl.obolibrary.org/obo/MONDO_0019366) (Free sialic acid storage disease), [MONDO:0020353](http://purl.obolibrary.org/obo/MONDO_0020353) (von Hippel anomaly), [MONDO:0000762](http://purl.obolibrary.org/obo/MONDO_0000762) (chromosomal duplication syndrome), [MONDO:0011409](http://purl.obolibrary.org/obo/MONDO_0011409) (hepatic fibrosis, severe, susceptibility to, due to schistosoma mansoni infection), [MONDO:0012738](http://purl.obolibrary.org/obo/MONDO_0012738) (long QT syndrome 11), [MONDO:0000761](http://purl.obolibrary.org/obo/MONDO_0000761) (chromosomal deletion syndrome), [MONDO:0007398](http://purl.obolibrary.org/obo/MONDO_0007398) (craniorhiny), [MONDO:0011402](http://purl.obolibrary.org/obo/MONDO_0011402) (congenital cataracts-facial dysmorphism-neuropathy syndrome), [MONDO:0012732](http://purl.obolibrary.org/obo/MONDO_0012732) (tremor, hereditary essential, and idiopathic normal pressure hydrocephalus), [MONDO:0006065](http://purl.obolibrary.org/obo/MONDO_0006065) (lactose intolerance adult type), [MONDO:0011400](http://purl.obolibrary.org/obo/MONDO_0011400) (dilated cardiomyopathy 1G), [MONDO:0012737](http://purl.obolibrary.org/obo/MONDO_0012737) (long QT syndrome 10), [MONDO:0011406](http://purl.obolibrary.org/obo/MONDO_0011406) (cholesteatoma, congenital), [MONDO:0007393](http://purl.obolibrary.org/obo/MONDO_0007393) (Cranioacrofacial syndrome), [MONDO:0012736](http://purl.obolibrary.org/obo/MONDO_0012736) (long QT syndrome 9), [MONDO:0011404](http://purl.obolibrary.org/obo/MONDO_0011404) (Caronte), [MONDO:0007391](http://purl.obolibrary.org/obo/MONDO_0007391) (coxa vara (disease)), [MONDO:0007390](http://purl.obolibrary.org/obo/MONDO_0007390) (Coumarin resistance), [MONDO:0009151](http://purl.obolibrary.org/obo/MONDO_0009151) (cleft lip-palate-ectodermal dysplasia syndrome), [MONDO:0011470](http://purl.obolibrary.org/obo/MONDO_0011470) (hyperlipidemia, combined, 2), [MONDO:0010143](http://purl.obolibrary.org/obo/MONDO_0010143) (lethal restrictive dermopathy), [MONDO:0010141](http://purl.obolibrary.org/obo/MONDO_0010141) (Tiglic acidemia), [MONDO:0011472](http://purl.obolibrary.org/obo/MONDO_0011472) (epidermolysis bullosa simplex due to plakophilin deficiency), [MONDO:0010147](http://purl.obolibrary.org/obo/MONDO_0010147) (tongue, pigmented Fungiform papillae of), [MONDO:0014505](http://purl.obolibrary.org/obo/MONDO_0014505) (epileptic encephalopathy, early infantile, 27), [MONDO:0011478](http://purl.obolibrary.org/obo/MONDO_0011478) (growth and developmental retardation, ocular ptosis, cardiac defect, and anal atresia), [MONDO:0010145](http://purl.obolibrary.org/obo/MONDO_0010145) (tibia, absence of, with congenital deafness), [MONDO:0011477](http://purl.obolibrary.org/obo/MONDO_0011477) (tooth agenesis, selective, 3), [MONDO:0011476](http://purl.obolibrary.org/obo/MONDO_0011476) (MHC class i deficiency), [MONDO:0014501](http://purl.obolibrary.org/obo/MONDO_0014501) (macular degeneration, early-onset), [MONDO:0014503](http://purl.obolibrary.org/obo/MONDO_0014503) (autosomal recessive spinocerebellar ataxia 17), [MONDO:0010149](http://purl.obolibrary.org/obo/MONDO_0010149) (transcobalamin II deficiency), [MONDO:0014504](http://purl.obolibrary.org/obo/MONDO_0014504) (Perrault syndrome 5), [MONDO:0012791](http://purl.obolibrary.org/obo/MONDO_0012791) (mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria), [MONDO:0012790](http://purl.obolibrary.org/obo/MONDO_0012790) (amyotrophic lateral sclerosis type 10), [MONDO:0009142](http://purl.obolibrary.org/obo/MONDO_0009142) (dystonia with Ringbinden), [MONDO:0012795](http://purl.obolibrary.org/obo/MONDO_0012795) (hypophosphatemic rickets and hyperparathyroidism), [MONDO:0009143](http://purl.obolibrary.org/obo/MONDO_0009143) (Meier-Gorlin syndrome 1), [MONDO:0011464](http://purl.obolibrary.org/obo/MONDO_0011464) (spinocerebellar ataxia type 11), [MONDO:0011463](http://purl.obolibrary.org/obo/MONDO_0011463) (polyneuropathy, lethal neonatal, axonal sensorimotor, autosomal recessive), [MONDO:0009145](http://purl.obolibrary.org/obo/MONDO_0009145) (SchC6pf-Schulz-Passarge syndrome), [MONDO:0010130](http://purl.obolibrary.org/obo/MONDO_0010130) (dihydropyrimidine dehydrogenase deficiency), [MONDO:0011461](http://purl.obolibrary.org/obo/MONDO_0011461) (generalized epilepsy with febrile seizures plus, type 2), [MONDO:0012792](http://purl.obolibrary.org/obo/MONDO_0012792) (mitochondrial DNA depletion syndrome 8a), [MONDO:0009147](http://purl.obolibrary.org/obo/MONDO_0009147) (ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive), [MONDO:0009148](http://purl.obolibrary.org/obo/MONDO_0009148) (Rosselli-Gulienetti syndrome), [MONDO:0018097](http://purl.obolibrary.org/obo/MONDO_0018097) (West syndrome), [MONDO:0018098](http://purl.obolibrary.org/obo/MONDO_0018098) (autosomal dominant limb-girdle muscular dystrophy type 1E (DES)), [MONDO:0018096](http://purl.obolibrary.org/obo/MONDO_0018096) (Weill-Marchesani syndrome), [MONDO:0002525](http://purl.obolibrary.org/obo/MONDO_0002525) (inherited lipid metabolism disorder), [MONDO:0018094](http://purl.obolibrary.org/obo/MONDO_0018094) (Waardenburg's syndrome), [MONDO:0002520](http://purl.obolibrary.org/obo/MONDO_0002520) (acute porphyria), [MONDO:0015826](http://purl.obolibrary.org/obo/MONDO_0015826) (autosomal dominant spondylocostal dysostosis), [MONDO:0012798](http://purl.obolibrary.org/obo/MONDO_0012798) (deafness, unilateral, with delayed endolymphatic hydrops), [MONDO:0011467](http://purl.obolibrary.org/obo/MONDO_0011467) (human herpesvirus type 6, Integrated), [MONDO:0015825](http://purl.obolibrary.org/obo/MONDO_0015825) (obesity due to congenital leptin resistance), [MONDO:0010134](http://purl.obolibrary.org/obo/MONDO_0010134) (Pendred syndrome), [MONDO:0012797](http://purl.obolibrary.org/obo/MONDO_0012797) (OTSC8), [MONDO:0011466](http://purl.obolibrary.org/obo/MONDO_0011466) (distal myopathy, Welander type), [MONDO:0011465](http://purl.obolibrary.org/obo/MONDO_0011465) (infundibulocystic basal cell carcinoma), [MONDO:0009131](http://purl.obolibrary.org/obo/MONDO_0009131) (Riley-Day syndrome), [MONDO:0012784](http://purl.obolibrary.org/obo/MONDO_0012784) (autosomal recessive ataxia due to ubiquinone deficiency), [MONDO:0010121](http://purl.obolibrary.org/obo/MONDO_0010121) (thrombocytopenia-absent radius syndrome), [MONDO:0009132](http://purl.obolibrary.org/obo/MONDO_0009132) (dysautonomia-like disorder), [MONDO:0011453](http://purl.obolibrary.org/obo/MONDO_0011453) (ulnar ray dysgenesis with postaxial polydactyly and renal cystic dysplasia), [MONDO:0012783](http://purl.obolibrary.org/obo/MONDO_0012783) (RFT1-CDG), [MONDO:0009133](http://purl.obolibrary.org/obo/MONDO_0009133) (dysequilibrium syndrome), [MONDO:0009134](http://purl.obolibrary.org/obo/MONDO_0009134) (congenital dyserythropoietic anemia type II), [MONDO:0011451](http://purl.obolibrary.org/obo/MONDO_0011451) (cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1), [MONDO:0011450](http://purl.obolibrary.org/obo/MONDO_0011450) (breast-ovarian cancer, familial, susceptibility to, 1), [MONDO:0018088](http://purl.obolibrary.org/obo/MONDO_0018088) (familial Mediterranean fever), [MONDO:0009136](http://purl.obolibrary.org/obo/MONDO_0009136) (dyskeratosis congenita, autosomal recessive 1), [MONDO:0009137](http://purl.obolibrary.org/obo/MONDO_0009137) (dysmyelination with jaundice), [MONDO:0003824](http://purl.obolibrary.org/obo/MONDO_0003824) (hereditary kidney oncocytoma), [MONDO:0018083](http://purl.obolibrary.org/obo/MONDO_0018083) (transient tyrosinemia of the newborn), [MONDO:0011457](http://purl.obolibrary.org/obo/MONDO_0011457) (ataxia-telangiectasia-like disorder), [MONDO:0012788](http://purl.obolibrary.org/obo/MONDO_0012788) (CHDS9), [MONDO:0012787](http://purl.obolibrary.org/obo/MONDO_0012787) (hereditary spastic paraplegia 39), [MONDO:0010126](http://purl.obolibrary.org/obo/MONDO_0010126) (thymic aplasia with fetal death), [MONDO:0011456](http://purl.obolibrary.org/obo/MONDO_0011456) (nephronophthisis 3), [MONDO:0012786](http://purl.obolibrary.org/obo/MONDO_0012786) (juvenile cataract-microcornea-renal glucosuria syndrome), [MONDO:0011455](http://purl.obolibrary.org/obo/MONDO_0011455) (lissencephaly, familial, with cleft palate and cerebellar hypoplasia), [MONDO:0010124](http://purl.obolibrary.org/obo/MONDO_0010124) (thumb, distal hyperextensibility of), [MONDO:0012785](http://purl.obolibrary.org/obo/MONDO_0012785) (IHPS3), [MONDO:0010127](http://purl.obolibrary.org/obo/MONDO_0010127) (thymoma, familial), [MONDO:0012773](http://purl.obolibrary.org/obo/MONDO_0012773) (Hunter-Macdonald syndrome), [MONDO:0009122](http://purl.obolibrary.org/obo/MONDO_0009122) (Dohle bodies and leukemia), [MONDO:0012772](http://purl.obolibrary.org/obo/MONDO_0012772) (Stevenson-Carey syndrome), [MONDO:0009123](http://purl.obolibrary.org/obo/MONDO_0009123) (dopamine beta-hydroxylase deficiency), [MONDO:0012771](http://purl.obolibrary.org/obo/MONDO_0012771) (asthma-related Traits, susceptibility to, 7), [MONDO:0009125](http://purl.obolibrary.org/obo/MONDO_0009125) (dopamine beta-hydroxylase, plasma, Thermolability of), [MONDO:0009127](http://purl.obolibrary.org/obo/MONDO_0009127) (dwarfism, low-birth-weight type, with Unresponsiveness to growth hormone), [MONDO:0009128](http://purl.obolibrary.org/obo/MONDO_0009128) (dwarfism, mental retardation, and eye abnormality), [MONDO:0009129](http://purl.obolibrary.org/obo/MONDO_0009129) (dwarfism, proportionate, with hip dislocation), [MONDO:0018071](http://purl.obolibrary.org/obo/MONDO_0018071) (trisomy 18), [MONDO:0011446](http://purl.obolibrary.org/obo/MONDO_0011446) (myoclonic epilepsy, congenital deafness, macular dystrophy, and psychiatric disorders), [MONDO:0010112](http://purl.obolibrary.org/obo/MONDO_0010112) (thalamic degeneration, symmetric infantile), [MONDO:0012774](http://purl.obolibrary.org/obo/MONDO_0012774) (chromosome 15q13.3 microdeletion syndrome), [MONDO:0010113](http://purl.obolibrary.org/obo/MONDO_0010113) (thalidomide susceptibility), [MONDO:0011443](http://purl.obolibrary.org/obo/MONDO_0011443) (febrile seizures, familial, 4), [MONDO:0010118](http://purl.obolibrary.org/obo/MONDO_0010118) (Threoninemia), [MONDO:0011449](http://purl.obolibrary.org/obo/MONDO_0011449) (Salla disease), [MONDO:0015802](http://purl.obolibrary.org/obo/MONDO_0015802) (autosomal dominant non-syndromic intellectual disability), [MONDO:0011448](http://purl.obolibrary.org/obo/MONDO_0011448) (PPARG-related familial partial lipodystrophy), [MONDO:0010117](http://purl.obolibrary.org/obo/MONDO_0010117) (three M syndrome 1), [MONDO:0010183](http://purl.obolibrary.org/obo/MONDO_0010183) (methylmalonic aciduria and homocystinuria type cblF), [MONDO:0009194](http://purl.obolibrary.org/obo/MONDO_0009194) (chronic Epstein-Barr virus infection syndrome), [MONDO:0014541](http://purl.obolibrary.org/obo/MONDO_0014541) (motor developmental delay due to 14q32.2 paternally expressed gene defect), [MONDO:0013210](http://purl.obolibrary.org/obo/MONDO_0013210) (autosomal recessive nonsyndromic deafness 25), [MONDO:0013211](http://purl.obolibrary.org/obo/MONDO_0013211) (dilated cardiomyopathy 1FF), [MONDO:0010184](http://purl.obolibrary.org/obo/MONDO_0010184) (methylmalonic aciduria and homocystinuria type cblC), [MONDO:0014542](http://purl.obolibrary.org/obo/MONDO_0014542) (congenital myasthenic syndrome 15), [MONDO:0009195](http://purl.obolibrary.org/obo/MONDO_0009195) (erythema of acral regions), [MONDO:0014543](http://purl.obolibrary.org/obo/MONDO_0014543) (congenital myasthenic syndrome 14), [MONDO:0009196](http://purl.obolibrary.org/obo/MONDO_0009196) (Ermine phenotype), [MONDO:0013213](http://purl.obolibrary.org/obo/MONDO_0013213) (CIHL), [MONDO:0010182](http://purl.obolibrary.org/obo/MONDO_0010182) (hypercarotenemia and vitamin a deficiency, autosomal recessive), [MONDO:0010187](http://purl.obolibrary.org/obo/MONDO_0010187) (vitamin K-dependent clotting factors, combined deficiency of, type 1), [MONDO:0010188](http://purl.obolibrary.org/obo/MONDO_0010188) (familial isolated deficiency of vitamin E), [MONDO:0009199](http://purl.obolibrary.org/obo/MONDO_0009199) (Ethanolaminosis), [MONDO:0010185](http://purl.obolibrary.org/obo/MONDO_0010185) (methylmalonic aciduria and homocystinuria type cblD), [MONDO:0014540](http://purl.obolibrary.org/obo/MONDO_0014540) (amelogenesis imperfecta type 1H), [MONDO:0010180](http://purl.obolibrary.org/obo/MONDO_0010180) (autosomal recessive spondylocostal dysostosis), [MONDO:0001222](http://purl.obolibrary.org/obo/MONDO_0001222) (congenital T-cell immunodeficiency), [MONDO:0013219](http://purl.obolibrary.org/obo/MONDO_0013219) (hypophosphatemic rickets, autosomal recessive, 2), [MONDO:0010189](http://purl.obolibrary.org/obo/MONDO_0010189) (vitiligo, progressive, with mental retardation and urethral duplication), [MONDO:0014545](http://purl.obolibrary.org/obo/MONDO_0014545) (progressive myoclonic epilepsy type 8), [MONDO:0013214](http://purl.obolibrary.org/obo/MONDO_0013214) (bile acid malabsorption, primary), [MONDO:0013215](http://purl.obolibrary.org/obo/MONDO_0013215) (autosomal recessive nonsyndromic deafness 79), [MONDO:0014547](http://purl.obolibrary.org/obo/MONDO_0014547) (combined oxidative phosphorylation defect type 24), [MONDO:0013216](http://purl.obolibrary.org/obo/MONDO_0013216) (Diamond-Blackfan anemia 9), [MONDO:0013217](http://purl.obolibrary.org/obo/MONDO_0013217) (Diamond-Blackfan anemia 10), [MONDO:0014548](http://purl.obolibrary.org/obo/MONDO_0014548) (long QT syndrome 14), [MONDO:0010172](http://purl.obolibrary.org/obo/MONDO_0010172) (VACTERL with hydrocephalus), [MONDO:0014530](http://purl.obolibrary.org/obo/MONDO_0014530) (autosomal recessive spinocerebellar ataxia 18), [MONDO:0009183](http://purl.obolibrary.org/obo/MONDO_0009183) (junctional epidermolysis bullosa with pyloric atresia), [MONDO:0009184](http://purl.obolibrary.org/obo/MONDO_0009184) (epidermolysis bullosa with diaphragmatic hernia), [MONDO:0013201](http://purl.obolibrary.org/obo/MONDO_0013201) (Waardenburg syndrome type 4B), [MONDO:0014532](http://purl.obolibrary.org/obo/MONDO_0014532) (autosomal dominant mitochondrial myopathy with exercise intolerance), [MONDO:0010170](http://purl.obolibrary.org/obo/MONDO_0010170) (Usher syndrome type 3A), [MONDO:0013202](http://purl.obolibrary.org/obo/MONDO_0013202) (Waardenburg syndrome type 4C), [MONDO:0010171](http://purl.obolibrary.org/obo/MONDO_0010171) (Usher syndrome type 1C), [MONDO:0009186](http://purl.obolibrary.org/obo/MONDO_0009186) (epilepsy, photogenic, with spastic diplegia and mental retardation), [MONDO:0014533](http://purl.obolibrary.org/obo/MONDO_0014533) (epileptic encephalopathy, early infantile, 28), [MONDO:0010176](http://purl.obolibrary.org/obo/MONDO_0010176) (Joubert syndrome with orofaciodigital defect), [MONDO:0010177](http://purl.obolibrary.org/obo/MONDO_0010177) (retinal ischemic syndrome-digestive tract small vessel hyalinosis-diffuse cerebral calcifications syndrome), [MONDO:0010174](http://purl.obolibrary.org/obo/MONDO_0010174) (Valinemia), [MONDO:0010175](http://purl.obolibrary.org/obo/MONDO_0010175) (van Bogaert-Hozay syndrome), [MONDO:0002561](http://purl.obolibrary.org/obo/MONDO_0002561) (lysosomal storage disease), [MONDO:0013208](http://purl.obolibrary.org/obo/MONDO_0013208) (cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome), [MONDO:0010179](http://purl.obolibrary.org/obo/MONDO_0010179) (isolated right ventricular hypoplasia), [MONDO:0009190](http://purl.obolibrary.org/obo/MONDO_0009190) (epiphyseal dysplasia of femoral head, myopia, and deafness), [MONDO:0014535](http://purl.obolibrary.org/obo/MONDO_0014535) (hyperproinsulinemia), [MONDO:0009192](http://purl.obolibrary.org/obo/MONDO_0009192) (Wolcott-Rallison syndrome), [MONDO:0014536](http://purl.obolibrary.org/obo/MONDO_0014536) (thrombocytopenia 5), [MONDO:0014537](http://purl.obolibrary.org/obo/MONDO_0014537) (nephronophthisis 19), [MONDO:0009193](http://purl.obolibrary.org/obo/MONDO_0009193) (epithelial squamous dysplasia, keratinizing desquamative, of urinary tract), [MONDO:0010161](http://purl.obolibrary.org/obo/MONDO_0010161) (tyrosinemia type i), [MONDO:0009172](http://purl.obolibrary.org/obo/MONDO_0009172) (enterocolitis (disease)), [MONDO:0010162](http://purl.obolibrary.org/obo/MONDO_0010162) (tyrosinemia type III), [MONDO:0011492](http://purl.obolibrary.org/obo/MONDO_0011492) (mandibulofacial dysostosis syndrome, Bauru type), [MONDO:0009174](http://purl.obolibrary.org/obo/MONDO_0009174) (protein-losing enteropathy (disease)), [MONDO:0011491](http://purl.obolibrary.org/obo/MONDO_0011491) (EIG7), [MONDO:0010160](http://purl.obolibrary.org/obo/MONDO_0010160) (tyrosinemia type II), [MONDO:0009176](http://purl.obolibrary.org/obo/MONDO_0009176) (epidermodysplasia verruciformis), [MONDO:0011497](http://purl.obolibrary.org/obo/MONDO_0011497) (hereditary North american indian childhood cirrhosis), [MONDO:0009177](http://purl.obolibrary.org/obo/MONDO_0009177) (late-onset localized junctional epidermolysis bullosa-intellectual disability syndrome), [MONDO:0010166](http://purl.obolibrary.org/obo/MONDO_0010166) (ulnar agenesis and endocardial fibroelastosis), [MONDO:0009178](http://purl.obolibrary.org/obo/MONDO_0009178) (epidermolysis bullosa dystrophica Neurotrophica), [MONDO:0010163](http://purl.obolibrary.org/obo/MONDO_0010163) (Tyrosinosis), [MONDO:0009179](http://purl.obolibrary.org/obo/MONDO_0009179) (recessive dystrophic epidermolysis bullosa), [MONDO:0011494](http://purl.obolibrary.org/obo/MONDO_0011494) (Hyaluronan metabolism, defect 1N), [MONDO:0014527](http://purl.obolibrary.org/obo/MONDO_0014527) (progeroid features-hepatocellular carcinoma predisposition syndrome), [MONDO:0010169](http://purl.obolibrary.org/obo/MONDO_0010169) (Usher syndrome type 2A), [MONDO:0010167](http://purl.obolibrary.org/obo/MONDO_0010167) (Urocanic aciduria (disease)), [MONDO:0010168](http://purl.obolibrary.org/obo/MONDO_0010168) (Usher syndrome type 1), [MONDO:0014523](http://purl.obolibrary.org/obo/MONDO_0014523) (juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome), [MONDO:0009180](http://purl.obolibrary.org/obo/MONDO_0009180) (junctional epidermolysis bullosa, non-Herlitz type), [MONDO:0014524](http://purl.obolibrary.org/obo/MONDO_0014524) (mental retardation, autosomal recessive 47), [MONDO:0014525](http://purl.obolibrary.org/obo/MONDO_0014525) (combined oxidative phosphorylation defect type 23), [MONDO:0009181](http://purl.obolibrary.org/obo/MONDO_0009181) (epidermolysis bullosa simplex with muscular dystrophy), [MONDO:0014526](http://purl.obolibrary.org/obo/MONDO_0014526) (polyglucosan body myopathy type 2), [MONDO:0009182](http://purl.obolibrary.org/obo/MONDO_0009182) (junctional epidermolysis bullosa Herlitz type), [MONDO:0011482](http://purl.obolibrary.org/obo/MONDO_0011482) (dilated cardiomyopathy 1I), [MONDO:0009162](http://purl.obolibrary.org/obo/MONDO_0009162) (Ellis-van Creveld syndrome), [MONDO:0010151](http://purl.obolibrary.org/obo/MONDO_0010151) (tricarboxylic acid cycle, defect of), [MONDO:0009163](http://purl.obolibrary.org/obo/MONDO_0009163) (encephalomalacia, multilocular), [MONDO:0014510](http://purl.obolibrary.org/obo/MONDO_0014510) (severe intellectual disability-epilepsy-cataract syndrome due to fatty acyl-CoA reductase 1 deficiency), [MONDO:0011480](http://purl.obolibrary.org/obo/MONDO_0011480) (autosomal dominant nonsyndromic deafness 20), [MONDO:0014511](http://purl.obolibrary.org/obo/MONDO_0014511) (Charcot-Marie-tooth disease axonal type 2S), [MONDO:0009164](http://purl.obolibrary.org/obo/MONDO_0009164) (encephalopathy, axonal, with necrotizing myopathy, cardiomyopathy, and cataracts), [MONDO:0009165](http://purl.obolibrary.org/obo/MONDO_0009165) (Aicardi-Goutieres syndrome 1), [MONDO:0011485](http://purl.obolibrary.org/obo/MONDO_0011485) (autosomal recessive congenital ichthyosis 5), [MONDO:0010155](http://purl.obolibrary.org/obo/MONDO_0010155) (Dorfman-Chanarin disease), [MONDO:0011483](http://purl.obolibrary.org/obo/MONDO_0011483) (polycystic bone disease), [MONDO:0009169](http://purl.obolibrary.org/obo/MONDO_0009169) (endocardial fibroelastosis), [MONDO:0014516](http://purl.obolibrary.org/obo/MONDO_0014516) (microcephaly and chorioretinopathy 2), [MONDO:0010158](http://purl.obolibrary.org/obo/MONDO_0010158) (T-substance anomaly), [MONDO:0010159](http://purl.obolibrary.org/obo/MONDO_0010159) (constitutional mismatch repair deficiency syndrome), [MONDO:0011489](http://purl.obolibrary.org/obo/MONDO_0011489) (hereditary spastic paraplegia 12), [MONDO:0010156](http://purl.obolibrary.org/obo/MONDO_0010156) (Troyer syndrome), [MONDO:0010157](http://purl.obolibrary.org/obo/MONDO_0010157) (Tryptophanuria with dwarfism), [MONDO:0014519](http://purl.obolibrary.org/obo/MONDO_0014519) (chronic mountain sickness, susceptibility to), [MONDO:0009170](http://purl.obolibrary.org/obo/MONDO_0009170) (endocardial fibroelastosis and coarctation of abdominal aorta), [MONDO:0009171](http://purl.obolibrary.org/obo/MONDO_0009171) (endothelial dystrophy, congenital hereditary, with nail hypoplasia), [MONDO:0013254](http://purl.obolibrary.org/obo/MONDO_0013254) (microcephaly, seizures, and developmental delay), [MONDO:0017610](http://purl.obolibrary.org/obo/MONDO_0017610) (epidermolysis bullosa simplex), [MONDO:0013255](http://purl.obolibrary.org/obo/MONDO_0013255) (arthrogryposis, renal dysfunction, and cholestasis 2), [MONDO:0013256](http://purl.obolibrary.org/obo/MONDO_0013256) (chromosome 15q24 deletion syndrome), [MONDO:0017612](http://purl.obolibrary.org/obo/MONDO_0017612) (junctional epidermolysis bullosa), [MONDO:0013250](http://purl.obolibrary.org/obo/MONDO_0013250) (autosomal recessive nonsyndromic deafness 85), [MONDO:0013251](http://purl.obolibrary.org/obo/MONDO_0013251) (Birbeck granule deficiency), [MONDO:0013252](http://purl.obolibrary.org/obo/MONDO_0013252) (Warsaw breakage syndrome), [MONDO:0013253](http://purl.obolibrary.org/obo/MONDO_0013253) (breast-ovarian cancer, familial, susceptibility to, 3), [MONDO:0014580](http://purl.obolibrary.org/obo/MONDO_0014580) (mental retardation, autosomal dominant 33), [MONDO:0005620](http://purl.obolibrary.org/obo/MONDO_0005620) (cerebral amyloid angiopathy), [MONDO:0017619](http://purl.obolibrary.org/obo/MONDO_0017619) (congenital sucrase-isomaltase deficiency with minimal starch tolerance), [MONDO:0017618](http://purl.obolibrary.org/obo/MONDO_0017618) (congenital sucrase-isomaltase deficiency with starch intolerance), [MONDO:0014589](http://purl.obolibrary.org/obo/MONDO_0014589) (maturity-onset diabetes of the young type 13), [MONDO:0013259](http://purl.obolibrary.org/obo/MONDO_0013259) (Oguchi disease-2), [MONDO:0017614](http://purl.obolibrary.org/obo/MONDO_0017614) (X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome), [MONDO:0018945](http://purl.obolibrary.org/obo/MONDO_0018945) (McLeod neuroacanthocytosis syndrome), [MONDO:0017616](http://purl.obolibrary.org/obo/MONDO_0017616) (X-linked intellectual disability, Schutz type), [MONDO:0013243](http://purl.obolibrary.org/obo/MONDO_0013243) (neuronopathy, distal hereditary motor, type 2C), [MONDO:0014574](http://purl.obolibrary.org/obo/MONDO_0014574) (peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome), [MONDO:0014576](http://purl.obolibrary.org/obo/MONDO_0014576) (Lipoyl transferase 1 deficiency), [MONDO:0018931](http://purl.obolibrary.org/obo/MONDO_0018931) (mucolipidosis type III), [MONDO:0014577](http://purl.obolibrary.org/obo/MONDO_0014577) (short-rib thoracic dysplasia 13 with or without polydactyly), [MONDO:0013240](http://purl.obolibrary.org/obo/MONDO_0013240) (maturity-onset diabetes of the young type 10), [MONDO:0014572](http://purl.obolibrary.org/obo/MONDO_0014572) (autosomal recessive spinocerebellar ataxia 19), [MONDO:0013241](http://purl.obolibrary.org/obo/MONDO_0013241) (spinocerebellar ataxia type 30), [MONDO:0013242](http://purl.obolibrary.org/obo/MONDO_0013242) (maturity-onset diabetes of the young type 11), [MONDO:0017608](http://purl.obolibrary.org/obo/MONDO_0017608) (dystrophic epidermolysis bullosa), [MONDO:0001270](http://purl.obolibrary.org/obo/MONDO_0001270) (stone in bladder diverticulum), [MONDO:0018938](http://purl.obolibrary.org/obo/MONDO_0018938) (mucopolysaccharidosis type 4), [MONDO:0018939](http://purl.obolibrary.org/obo/MONDO_0018939) (muscle-eye-brain disease), [MONDO:0013247](http://purl.obolibrary.org/obo/MONDO_0013247) (Fanconi renotubular syndrome 2), [MONDO:0018937](http://purl.obolibrary.org/obo/MONDO_0018937) (mucopolysaccharidosis type 3), [MONDO:0014579](http://purl.obolibrary.org/obo/MONDO_0014579) (Senior-Loken syndrome 8), [MONDO:0013248](http://purl.obolibrary.org/obo/MONDO_0013248) (Fanconi anemia complementation group O), [MONDO:0013249](http://purl.obolibrary.org/obo/MONDO_0013249) (autosomal recessive nonsyndromic deafness 84A), [MONDO:0018921](http://purl.obolibrary.org/obo/MONDO_0018921) (Meckel syndrome), [MONDO:0014563](http://purl.obolibrary.org/obo/MONDO_0014563) (mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency), [MONDO:0014564](http://purl.obolibrary.org/obo/MONDO_0014564) (congenital bile acid synthesis defect 5), [MONDO:0013234](http://purl.obolibrary.org/obo/MONDO_0013234) (hypokalemic periodic paralysis, type 2), [MONDO:0013235](http://purl.obolibrary.org/obo/MONDO_0013235) (pancreatic cancer, susceptibility to, 2), [MONDO:0014560](http://purl.obolibrary.org/obo/MONDO_0014560) (amelogenesis imperfecta type 1F), [MONDO:0014561](http://purl.obolibrary.org/obo/MONDO_0014561) (3-methylglutaconic aciduria with cataracts, neurologic involvement and neutropenia), [MONDO:0014562](http://purl.obolibrary.org/obo/MONDO_0014562) (neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome), [MONDO:0013236](http://purl.obolibrary.org/obo/MONDO_0013236) (pancreatic cancer, susceptibility to, 3), [MONDO:0014567](http://purl.obolibrary.org/obo/MONDO_0014567) (postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome), [MONDO:0014568](http://purl.obolibrary.org/obo/MONDO_0014568) (hereditary spastic paraplegia 73), [MONDO:0013237](http://purl.obolibrary.org/obo/MONDO_0013237) (mononeuropathy of the median nerve, mild), [MONDO:0013238](http://purl.obolibrary.org/obo/MONDO_0013238) (chromosome 17q23.1-q23.2 deletion syndrome), [MONDO:0013239](http://purl.obolibrary.org/obo/MONDO_0013239) (hereditary spastic paraplegia 41), [MONDO:0018924](http://purl.obolibrary.org/obo/MONDO_0018924) (microphthalmia, Lenz type), [MONDO:0014552](http://purl.obolibrary.org/obo/MONDO_0014552) (lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome), [MONDO:0015884](http://purl.obolibrary.org/obo/MONDO_0015884) (autosomal dominant hypohidrotic ectodermal dysplasia), [MONDO:0018910](http://purl.obolibrary.org/obo/MONDO_0018910) (oculocutaneous albinism), [MONDO:0010194](http://purl.obolibrary.org/obo/MONDO_0010194) (Weill-Marchesani syndrome 1), [MONDO:0013221](http://purl.obolibrary.org/obo/MONDO_0013221) (MMD2), [MONDO:0014553](http://purl.obolibrary.org/obo/MONDO_0014553) (Tenorio syndrome), [MONDO:0018911](http://purl.obolibrary.org/obo/MONDO_0018911) (maturity-onset diabetes of the young (disease)), [MONDO:0013222](http://purl.obolibrary.org/obo/MONDO_0013222) (distal anoctaminopathy), [MONDO:0010192](http://purl.obolibrary.org/obo/MONDO_0010192) (Waardenburg syndrome type 4A), [MONDO:0013224](http://purl.obolibrary.org/obo/MONDO_0013224) (rhabdoid tumor predisposition syndrome 2), [MONDO:0015885](http://purl.obolibrary.org/obo/MONDO_0015885) (rare insulin-resistance syndrome), [MONDO:0014555](http://purl.obolibrary.org/obo/MONDO_0014555) (peeling skin syndrome type a), [MONDO:0010198](http://purl.obolibrary.org/obo/MONDO_0010198) (Wernicke-Korsakoff syndrome), [MONDO:0010196](http://purl.obolibrary.org/obo/MONDO_0010196) (Werner syndrome), [MONDO:0014550](http://purl.obolibrary.org/obo/MONDO_0014550) (long QT syndrome 15), [MONDO:0014551](http://purl.obolibrary.org/obo/MONDO_0014551) (short stature with nonspecific skeletal abnormalities), [MONDO:0010197](http://purl.obolibrary.org/obo/MONDO_0010197) (whistling face syndrome, recessive form), [MONDO:0013220](http://purl.obolibrary.org/obo/MONDO_0013220) (hemochromatosis type 2B), [MONDO:0018919](http://purl.obolibrary.org/obo/MONDO_0018919) (McCune-Albright syndrome), [MONDO:0013225](http://purl.obolibrary.org/obo/MONDO_0013225) (congenital generalized lipodystrophy type 4), [MONDO:0014556](http://purl.obolibrary.org/obo/MONDO_0014556) (congenital contractures of the limbs and face, hypotonia, and developmental delay), [MONDO:0014557](http://purl.obolibrary.org/obo/MONDO_0014557) (ataxia-oculomotor apraxia type 4), [MONDO:0013298](http://purl.obolibrary.org/obo/MONDO_0013298) (chromosome 17q21.31 duplication syndrome), [MONDO:0018988](http://purl.obolibrary.org/obo/MONDO_0018988) (Iridocorneal endothelial syndrome), [MONDO:0016323](http://purl.obolibrary.org/obo/MONDO_0016323) (chronic respiratory distress with surfactant metabolism deficiency), [MONDO:0013299](http://purl.obolibrary.org/obo/MONDO_0013299) (chromosome 6q11-q14 deletion syndrome), [MONDO:0013294](http://purl.obolibrary.org/obo/MONDO_0013294) (atopic dermatitis 8), [MONDO:0013295](http://purl.obolibrary.org/obo/MONDO_0013295) (atopic dermatitis 9), [MONDO:0018982](http://purl.obolibrary.org/obo/MONDO_0018982) (Niemann-Pick disease type C), [MONDO:0013297](http://purl.obolibrary.org/obo/MONDO_0013297) (autosomal dominant limb-girdle muscular dystrophy type 1H), [MONDO:0013291](http://purl.obolibrary.org/obo/MONDO_0013291) (glycogen storage disease XV), [MONDO:0013292](http://purl.obolibrary.org/obo/MONDO_0013292) (chromosome 4q21 deletion syndrome), [MONDO:0003008](http://purl.obolibrary.org/obo/MONDO_0003008) (hereditary renal cell carcinoma), [MONDO:0008704](http://purl.obolibrary.org/obo/MONDO_0008704) (short-limb skeletal dysplasia with severe combined immunodeficiency), [MONDO:0008705](http://purl.obolibrary.org/obo/MONDO_0008705) (acid phosphatase deficiency), [MONDO:0016328](http://purl.obolibrary.org/obo/MONDO_0016328) (fatty acid oxidation and ketogenesis disorder with hypertrophic cardiomyopathy), [MONDO:0016327](http://purl.obolibrary.org/obo/MONDO_0016327) (mitochondrial disease with hypertrophic cardiomyopathy), [MONDO:0016315](http://purl.obolibrary.org/obo/MONDO_0016315) (mucopolysaccharidosis type 2, severe form), [MONDO:0018975](http://purl.obolibrary.org/obo/MONDO_0018975) (neurofibromatosis type 1), [MONDO:0013283](http://purl.obolibrary.org/obo/MONDO_0013283) (immunodeficiency, common variable, 3), [MONDO:0013284](http://purl.obolibrary.org/obo/MONDO_0013284) (immunodeficiency, common variable, 4), [MONDO:0013285](http://purl.obolibrary.org/obo/MONDO_0013285) (immunodeficiency, common variable, 5), [MONDO:0013286](http://purl.obolibrary.org/obo/MONDO_0013286) (immunodeficiency, common variable, 6), [MONDO:0016310](http://purl.obolibrary.org/obo/MONDO_0016310) (Niemann-Pick disease type C, adult neurologic onset), [MONDO:0013281](http://purl.obolibrary.org/obo/MONDO_0013281) (COG4-CDG), [MONDO:0013282](http://purl.obolibrary.org/obo/MONDO_0013282) (alpha 1-antitrypsin deficiency), [MONDO:0016316](http://purl.obolibrary.org/obo/MONDO_0016316) (mucopolysaccharidosis type 2, attenuated form), [MONDO:0016319](http://purl.obolibrary.org/obo/MONDO_0016319) (congenital insensitivity to pain with hyperhidrosis), [MONDO:0018965](http://purl.obolibrary.org/obo/MONDO_0018965) (Alport syndrome), [MONDO:0013277](http://purl.obolibrary.org/obo/MONDO_0013277) (epileptic encephalopathy, early infantile, 5), [MONDO:0018963](http://purl.obolibrary.org/obo/MONDO_0018963) (hereditary methemoglobinemia), [MONDO:0013278](http://purl.obolibrary.org/obo/MONDO_0013278) (lymphedema, hereditary, 1C), [MONDO:0016304](http://purl.obolibrary.org/obo/MONDO_0016304) (classic pantothenate kinase-associated neurodegeneration), [MONDO:0018964](http://purl.obolibrary.org/obo/MONDO_0018964) (homocystinuria without methylmalonic aciduria), [MONDO:0013279](http://purl.obolibrary.org/obo/MONDO_0013279) (long QT syndrome 13), [MONDO:0018961](http://purl.obolibrary.org/obo/MONDO_0018961) (familial melanoma), [MONDO:0013272](http://purl.obolibrary.org/obo/MONDO_0013272) (chromosome 14q11-q22 deletion syndrome), [MONDO:0013273](http://purl.obolibrary.org/obo/MONDO_0013273) (chromosome 16p13.3 duplication syndrome), [MONDO:0017630](http://purl.obolibrary.org/obo/MONDO_0017630) (X-linked complicated spastic paraplegia type 1), [MONDO:0013275](http://purl.obolibrary.org/obo/MONDO_0013275) (hemolytic anemia due to glucophosphate isomerase deficiency), [MONDO:0013270](http://purl.obolibrary.org/obo/MONDO_0013270) (Rett syndrome, congenital variant), [MONDO:0016309](http://purl.obolibrary.org/obo/MONDO_0016309) (Niemann-Pick disease type C, juvenile neurologic onset), [MONDO:0016306](http://purl.obolibrary.org/obo/MONDO_0016306) (Niemann-Pick disease type C, severe perinatal form), [MONDO:0016305](http://purl.obolibrary.org/obo/MONDO_0016305) (atypical pantothenate kinase-associated neurodegeneration), [MONDO:0016308](http://purl.obolibrary.org/obo/MONDO_0016308) (Niemann-Pick disease type C, late infantile neurologic onset), [MONDO:0016307](http://purl.obolibrary.org/obo/MONDO_0016307) (Niemann-Pick disease type C, severe early infantile neurologic onset), [MONDO:0018954](http://purl.obolibrary.org/obo/MONDO_0018954) (Loeys-Dietz syndrome), [MONDO:0017622](http://purl.obolibrary.org/obo/MONDO_0017622) (congenital sucrase-isomaltase deficiency without sucrose intolerance), [MONDO:0014597](http://purl.obolibrary.org/obo/MONDO_0014597) (immunodeficiency 39), [MONDO:0017621](http://purl.obolibrary.org/obo/MONDO_0017621) (congenital sucrase-isomaltase deficiency with starch and lactose intolerance), [MONDO:0013266](http://purl.obolibrary.org/obo/MONDO_0013266) (mental retardation, autosomal dominant 20), [MONDO:0014598](http://purl.obolibrary.org/obo/MONDO_0014598) (epileptic encephalopathy, early infantile, 31), [MONDO:0013267](http://purl.obolibrary.org/obo/MONDO_0013267) (chromosome 16p11.2 deletion syndrome, 220kb), [MONDO:0017624](http://purl.obolibrary.org/obo/MONDO_0017624) (familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis), [MONDO:0014599](http://purl.obolibrary.org/obo/MONDO_0014599) (mental retardation, autosomal dominant 34), [MONDO:0017623](http://purl.obolibrary.org/obo/MONDO_0017623) (PTEN hamartoma tumor syndrome), [MONDO:0013261](http://purl.obolibrary.org/obo/MONDO_0013261) (dilated cardiomyopathy 1R), [MONDO:0018950](http://purl.obolibrary.org/obo/MONDO_0018950) (3-methylcrotonyl-CoA carboxylase deficiency), [MONDO:0014593](http://purl.obolibrary.org/obo/MONDO_0014593) (epileptic encephalopathy, early infantile, 29), [MONDO:0013262](http://purl.obolibrary.org/obo/MONDO_0013262) (dilated cardiomyopathy 1S), [MONDO:0018951](http://purl.obolibrary.org/obo/MONDO_0018951) (distal myopathy with vocal cord weakness), [MONDO:0017620](http://purl.obolibrary.org/obo/MONDO_0017620) (congenital sucrase-isomaltase deficiency without starch intolerance), [MONDO:0014594](http://purl.obolibrary.org/obo/MONDO_0014594) (autosomal dominant nonsyndromic deafness 67), [MONDO:0014595](http://purl.obolibrary.org/obo/MONDO_0014595) (epileptic encephalopathy, early infantile, 30), [MONDO:0013264](http://purl.obolibrary.org/obo/MONDO_0013264) (amyotrophic lateral sclerosis type 12), [MONDO:0013260](http://purl.obolibrary.org/obo/MONDO_0013260) (EOE2), [MONDO:0017629](http://purl.obolibrary.org/obo/MONDO_0017629) (sodium channelopathy-related small fiber neuropathy), [MONDO:0013269](http://purl.obolibrary.org/obo/MONDO_0013269) (autosomal recessive nonsyndromic deafness 91), [MONDO:0017626](http://purl.obolibrary.org/obo/MONDO_0017626) (familial primary hypomagnesemia with normocalcuria), [MONDO:0017625](http://purl.obolibrary.org/obo/MONDO_0017625) (familial primary hypomagnesemia with hypocalcuria), [MONDO:0017699](http://purl.obolibrary.org/obo/MONDO_0017699) (glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form), [MONDO:0016368](http://purl.obolibrary.org/obo/MONDO_0016368) (Rothmund-Thomson syndrome type 1), [MONDO:0017698](http://purl.obolibrary.org/obo/MONDO_0017698) (glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form), [MONDO:0016369](http://purl.obolibrary.org/obo/MONDO_0016369) (Rothmund-Thomson syndrome type 2), [MONDO:0016364](http://purl.obolibrary.org/obo/MONDO_0016364) (Joubert syndrome with ocular defect), [MONDO:0017695](http://purl.obolibrary.org/obo/MONDO_0017695) (glycogen storage disease due to glycogen branching enzyme deficiency, progressive hepatic form), [MONDO:0016363](http://purl.obolibrary.org/obo/MONDO_0016363) (rare hereditary hemochromatosis), [MONDO:0017694](http://purl.obolibrary.org/obo/MONDO_0017694) (glycogen storage disease due to acid maltase deficiency, infantile onset), [MONDO:0015033](http://purl.obolibrary.org/obo/MONDO_0015033) (ABeta amyloidosis, dutch type), [MONDO:0016366](http://purl.obolibrary.org/obo/MONDO_0016366) (maternal phenylketonuria), [MONDO:0017697](http://purl.obolibrary.org/obo/MONDO_0017697) (glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form), [MONDO:0017696](http://purl.obolibrary.org/obo/MONDO_0017696) (glycogen storage disease due to glycogen branching enzyme deficiency, non progressive hepatic form), [MONDO:0017691](http://purl.obolibrary.org/obo/MONDO_0017691) (erythrocyte galactose epimerase deficiency), [MONDO:0017690](http://purl.obolibrary.org/obo/MONDO_0017690) (disorder of galactose metabolism), [MONDO:0017693](http://purl.obolibrary.org/obo/MONDO_0017693) (glycogen storage disease due to glycogen synthase deficiency), [MONDO:0008742](http://purl.obolibrary.org/obo/MONDO_0008742) (autosomal dominant severe congenital neutropenia), [MONDO:0016362](http://purl.obolibrary.org/obo/MONDO_0016362) (attenuated familial adenomatous polyposis), [MONDO:0017692](http://purl.obolibrary.org/obo/MONDO_0017692) (generalized galactose epimerase deficiency), [MONDO:0007408](http://purl.obolibrary.org/obo/MONDO_0007408) (Cryptotia, familial), [MONDO:0008745](http://purl.obolibrary.org/obo/MONDO_0008745) (oculocutaneous albinism type 1A), [MONDO:0008746](http://purl.obolibrary.org/obo/MONDO_0008746) (oculocutaneous albinism type 2), [MONDO:0007406](http://purl.obolibrary.org/obo/MONDO_0007406) (Cryofibrinogenemia, familial primary), [MONDO:0008747](http://purl.obolibrary.org/obo/MONDO_0008747) (oculocutaneous albinism type 3), [MONDO:0008748](http://purl.obolibrary.org/obo/MONDO_0008748) (Hermansky-Pudlak syndrome 1), [MONDO:0007404](http://purl.obolibrary.org/obo/MONDO_0007404) (Cri-du-chat syndrome), [MONDO:0008749](http://purl.obolibrary.org/obo/MONDO_0008749) (pseudohypoparathyroidism type 2), [MONDO:0003049](http://purl.obolibrary.org/obo/MONDO_0003049) (ovarian large-cell neuroendocrine carcinoma), [MONDO:0007403](http://purl.obolibrary.org/obo/MONDO_0007403) (inherited Creutzfeldt-Jakob disease), [MONDO:0007402](http://purl.obolibrary.org/obo/MONDO_0007402) (creatine phosphokinase, elevated serum), [MONDO:0017688](http://purl.obolibrary.org/obo/MONDO_0017688) (disorder of glycolysis), [MONDO:0015025](http://purl.obolibrary.org/obo/MONDO_0015025) (epileptic encephalopathy, early infantile, 51; EIEE51), [MONDO:0017687](http://purl.obolibrary.org/obo/MONDO_0017687) (disorder of neutral amino acid transport), [MONDO:0015027](http://purl.obolibrary.org/obo/MONDO_0015027) (familial isolated hyperparathyroidism), [MONDO:0017689](http://purl.obolibrary.org/obo/MONDO_0017689) (disorder of fructose metabolism), [MONDO:0017684](http://purl.obolibrary.org/obo/MONDO_0017684) (disorder of beta and omega amino acid metabolism), [MONDO:0016353](http://purl.obolibrary.org/obo/MONDO_0016353) (palmoplantar keratoderma-spastic paralysis syndrome), [MONDO:0015021](http://purl.obolibrary.org/obo/MONDO_0015021) (hypotonia, ataxia, and delayed development syndrome; HADDS), [MONDO:0015022](http://purl.obolibrary.org/obo/MONDO_0015022) (intellectual developmental disorder with dysmorphic facies and ptosis; IDDDFP), [MONDO:0017683](http://purl.obolibrary.org/obo/MONDO_0017683) (methylcobalamin deficiency type cblDv1), [MONDO:0017686](http://purl.obolibrary.org/obo/MONDO_0017686) (aminoacylase deficiency), [MONDO:0016354](http://purl.obolibrary.org/obo/MONDO_0016354) (xeroderma pigmentosum-Cockayne syndrome complex), [MONDO:0017685](http://purl.obolibrary.org/obo/MONDO_0017685) (vitamin B12-responsive methylmalonic acidemia, type cblDv2), [MONDO:0017680](http://purl.obolibrary.org/obo/MONDO_0017680) (autosomal recessive disease associated with punctate palmoplantar keratoderma as a major feature), [MONDO:0008730](http://purl.obolibrary.org/obo/MONDO_0008730) (congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency), [MONDO:0015020](http://purl.obolibrary.org/obo/MONDO_0015020) (mental retardation, autosomal recessive 59; MRT59), [MONDO:0008734](http://purl.obolibrary.org/obo/MONDO_0008734) (adrenocortical carcinoma, hereditary), [MONDO:0007418](http://purl.obolibrary.org/obo/MONDO_0007418) (Darwinian tubercle of pinna), [MONDO:0008736](http://purl.obolibrary.org/obo/MONDO_0008736) (peroxisome biogenesis disorder 2B), [MONDO:0007416](http://purl.obolibrary.org/obo/MONDO_0007416) (Balkan nephropathy), [MONDO:0007415](http://purl.obolibrary.org/obo/MONDO_0007415) (mitochondrial complex III deficiency nuclear type 1), [MONDO:0008738](http://purl.obolibrary.org/obo/MONDO_0008738) (aganglionosis, total intestinal), [MONDO:0008739](http://purl.obolibrary.org/obo/MONDO_0008739) (agenesis of cerebral white matter), [MONDO:0007412](http://purl.obolibrary.org/obo/MONDO_0007412) (Beare-Stevenson cutis gyrata syndrome), [MONDO:0007411](http://purl.obolibrary.org/obo/MONDO_0007411) (cutis laxa, autosomal dominant 1), [MONDO:0016346](http://purl.obolibrary.org/obo/MONDO_0016346) (hydrocephalus-obesity-hypogonadism syndrome), [MONDO:0017677](http://purl.obolibrary.org/obo/MONDO_0017677) (focal acral hyperkeratosis), [MONDO:0015014](http://purl.obolibrary.org/obo/MONDO_0015014) (coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness; COMMAD), [MONDO:0015015](http://purl.obolibrary.org/obo/MONDO_0015015) (congenital bile acid synthesis defect 6), [MONDO:0017676](http://purl.obolibrary.org/obo/MONDO_0017676) (marginal papular palmoplantar keratoderma), [MONDO:0017679](http://purl.obolibrary.org/obo/MONDO_0017679) (autosomal dominant disease associated with punctate palmoplantar keratoderma as a major feature), [MONDO:0017678](http://purl.obolibrary.org/obo/MONDO_0017678) (disease with punctate palmoplantar keratoderma as a major feature), [MONDO:0017673](http://purl.obolibrary.org/obo/MONDO_0017673) (isolated focal palmoplantar keratoderma), [MONDO:0015010](http://purl.obolibrary.org/obo/MONDO_0015010) (atypical glycine encephalopathy), [MONDO:0016341](http://purl.obolibrary.org/obo/MONDO_0016341) (lysosomal disease with restrictive cardiomyopathy), [MONDO:0017672](http://purl.obolibrary.org/obo/MONDO_0017672) (focal palmoplantar keratoderma), [MONDO:0015012](http://purl.obolibrary.org/obo/MONDO_0015012) (mucopolysaccharidosis-plus syndrome; MPSPS), [MONDO:0017675](http://purl.obolibrary.org/obo/MONDO_0017675) (punctate palmoplantar keratoderma), [MONDO:0017674](http://purl.obolibrary.org/obo/MONDO_0017674) (disease with focal palmoplantar keratoderma as a major feature), [MONDO:0016340](http://purl.obolibrary.org/obo/MONDO_0016340) (familial restrictive cardiomyopathy), [MONDO:0017671](http://purl.obolibrary.org/obo/MONDO_0017671) (autosomal recessive disease with diffuse palmoplantar keratoderma as a major feature), [MONDO:0008721](http://purl.obolibrary.org/obo/MONDO_0008721) (medium chain acyl-CoA dehydrogenase deficiency), [MONDO:0017670](http://purl.obolibrary.org/obo/MONDO_0017670) (autosomal dominant diffuse mutilating palmoplantar keratoderma), [MONDO:0008722](http://purl.obolibrary.org/obo/MONDO_0008722) (short chain acyl-CoA dehydrogenase deficiency), [MONDO:0008723](http://purl.obolibrary.org/obo/MONDO_0008723) (very long chain acyl-CoA dehydrogenase deficiency), [MONDO:0008725](http://purl.obolibrary.org/obo/MONDO_0008725) (congenital lipoid adrenal hyperplasia due to STAR deficency), [MONDO:0008726](http://purl.obolibrary.org/obo/MONDO_0008726) (Antley-Bixler syndrome with genital anomalies and Disordered steroidogenesis), [MONDO:0008727](http://purl.obolibrary.org/obo/MONDO_0008727) (congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency), [MONDO:0008728](http://purl.obolibrary.org/obo/MONDO_0008728) (classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency), [MONDO:0008729](http://purl.obolibrary.org/obo/MONDO_0008729) (congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency), [MONDO:0015018](http://purl.obolibrary.org/obo/MONDO_0015018) (ichthyosis, congenital, autosomal recessive 12; ARCI12), [MONDO:0015019](http://purl.obolibrary.org/obo/MONDO_0015019) (Yao syndrome; YAOS), [MONDO:0016335](http://purl.obolibrary.org/obo/MONDO_0016335) (mitochondrial disease with dilated cardiomyopathy), [MONDO:0015003](http://purl.obolibrary.org/obo/MONDO_0015003) (dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities; DYTOABG), [MONDO:0017666](http://purl.obolibrary.org/obo/MONDO_0017666) (diffuse palmoplantar keratoderma), [MONDO:0016334](http://purl.obolibrary.org/obo/MONDO_0016334) (neuromuscular disease with dilated cardiomyopathy), [MONDO:0015004](http://purl.obolibrary.org/obo/MONDO_0015004) (dystonia 28, childhood-onset; DYT28), [MONDO:0018999](http://purl.obolibrary.org/obo/MONDO_0018999) (LCAT deficiency), [MONDO:0016337](http://purl.obolibrary.org/obo/MONDO_0016337) (syndrome associated with dilated cardiomyopathy), [MONDO:0018996](http://purl.obolibrary.org/obo/MONDO_0018996) (spinocerebellar ataxia with axonal neuropathy type 2), [MONDO:0015005](http://purl.obolibrary.org/obo/MONDO_0015005) (epilepsy, early-onset, vitamin B6-dependent; EPVB6D), [MONDO:0018997](http://purl.obolibrary.org/obo/MONDO_0018997) (Noonan syndrome), [MONDO:0016336](http://purl.obolibrary.org/obo/MONDO_0016336) (fatty acid oxidation and ketogenesis disorder with dilated cardiomyopathy), [MONDO:0015006](http://purl.obolibrary.org/obo/MONDO_0015006) (epidermolysis bullosa simplex, generalized, with Scarring and hair loss; EBSSH), [MONDO:0017667](http://purl.obolibrary.org/obo/MONDO_0017667) (isolated diffuse palmoplantar keratoderma), [MONDO:0018994](http://purl.obolibrary.org/obo/MONDO_0018994) (Charcot-Marie-tooth disease type X), [MONDO:0016331](http://purl.obolibrary.org/obo/MONDO_0016331) (infantile systemic hyalinosis), [MONDO:0015000](http://purl.obolibrary.org/obo/MONDO_0015000) (epileptic encephalopathy, early infantile, 48; EIEE48), [MONDO:0016333](http://purl.obolibrary.org/obo/MONDO_0016333) (familial dilated cardiomyopathy), [MONDO:0015001](http://purl.obolibrary.org/obo/MONDO_0015001) (atrial fibrillation, familial, 18; ATFB18), [MONDO:0015002](http://purl.obolibrary.org/obo/MONDO_0015002) (epileptic encephalopathy, early infantile, 49; EIEE49), [MONDO:0008710](http://purl.obolibrary.org/obo/MONDO_0008710) (Carpenter syndrome 1), [MONDO:0008713](http://purl.obolibrary.org/obo/MONDO_0008713) (acrodermatitis enteropathica), [MONDO:0008718](http://purl.obolibrary.org/obo/MONDO_0008718) (Morvan syndrome), [MONDO:0008719](http://purl.obolibrary.org/obo/MONDO_0008719) (acrorenal syndrome, autosomal recessive), [MONDO:0015007](http://purl.obolibrary.org/obo/MONDO_0015007) (spastic paraplegia, intellectual disability, nystagmus, and obesity;), [MONDO:0017669](http://purl.obolibrary.org/obo/MONDO_0017669) (disease with diffuse palmoplantar keratoderma as a major feature), [MONDO:0015008](http://purl.obolibrary.org/obo/MONDO_0015008) (amelogenesis imperfecta, type IJ; AI1J), [MONDO:0015009](http://purl.obolibrary.org/obo/MONDO_0015009) (hydrops fetalis, Nonimmune, and/or atrial septal defect, susceptibility to; HFASD), 

**Mapped go classes:** [GO:0060122](http://purl.obolibrary.org/obo/GO_0060122) (inner ear receptor cell stereocilium organization), [GO:0035166](http://purl.obolibrary.org/obo/GO_0035166) (post-embryonic hemopoiesis), [GO:0019915](http://purl.obolibrary.org/obo/GO_0019915) (lipid storage), [GO:0060123](http://purl.obolibrary.org/obo/GO_0060123) (regulation of growth hormone secretion), [GO:0036499](http://purl.obolibrary.org/obo/GO_0036499) (PERK-mediated unfolded protein response), [GO:2000120](http://purl.obolibrary.org/obo/GO_2000120) (positive regulation of sodium-dependent phosphate transport), [GO:0036492](http://purl.obolibrary.org/obo/GO_0036492) (eiF2alpha phosphorylation in response to endoplasmic reticulum stress), [GO:0035162](http://purl.obolibrary.org/obo/GO_0035162) (embryonic hemopoiesis), [GO:1901222](http://purl.obolibrary.org/obo/GO_1901222) (regulation of NIK/NF-kappaB signaling), [GO:0019918](http://purl.obolibrary.org/obo/GO_0019918) (peptidyl-arginine methylation, to symmetrical-dimethyl arginine), [GO:1901224](http://purl.obolibrary.org/obo/GO_1901224) (positive regulation of NIK/NF-kappaB signaling), [GO:0060129](http://purl.obolibrary.org/obo/GO_0060129) (thyroid-stimulating hormone-secreting cell differentiation), [GO:1901223](http://purl.obolibrary.org/obo/GO_1901223) (negative regulation of NIK/NF-kappaB signaling), [GO:0060125](http://purl.obolibrary.org/obo/GO_0060125) (negative regulation of growth hormone secretion), [GO:0006600](http://purl.obolibrary.org/obo/GO_0006600) (creatine metabolic process), [GO:0006601](http://purl.obolibrary.org/obo/GO_0006601) (creatine biosynthetic process), [GO:0061458](http://purl.obolibrary.org/obo/GO_0061458) (reproductive system development), [GO:0060128](http://purl.obolibrary.org/obo/GO_0060128) (corticotropin hormone secreting cell differentiation), [GO:0048485](http://purl.obolibrary.org/obo/GO_0048485) (sympathetic nervous system development), [GO:0050795](http://purl.obolibrary.org/obo/GO_0050795) (regulation of behavior), [GO:0050796](http://purl.obolibrary.org/obo/GO_0050796) (regulation of insulin secretion), [GO:0048484](http://purl.obolibrary.org/obo/GO_0048484) (enteric nervous system development), [GO:0050793](http://purl.obolibrary.org/obo/GO_0050793) (regulation of developmental process), [GO:0050794](http://purl.obolibrary.org/obo/GO_0050794) (regulation of cellular process), [GO:0048489](http://purl.obolibrary.org/obo/GO_0048489) (synaptic vesicle transport), [GO:0048488](http://purl.obolibrary.org/obo/GO_0048488) (synaptic vesicle endocytosis), [GO:0072102](http://purl.obolibrary.org/obo/GO_0072102) (glomerulus morphogenesis), [GO:0048487](http://purl.obolibrary.org/obo/GO_0048487) (beta-tubulin binding), [GO:0050790](http://purl.obolibrary.org/obo/GO_0050790) (regulation of catalytic activity), [GO:0072107](http://purl.obolibrary.org/obo/GO_0072107) (positive regulation of ureteric bud formation), [GO:0098735](http://purl.obolibrary.org/obo/GO_0098735) (positive regulation of the force of heart contraction), [GO:2000111](http://purl.obolibrary.org/obo/GO_2000111) (positive regulation of macrophage apoptotic process), [GO:2000110](http://purl.obolibrary.org/obo/GO_2000110) (negative regulation of macrophage apoptotic process), [GO:0072104](http://purl.obolibrary.org/obo/GO_0072104) (glomerular capillary formation), [GO:2000117](http://purl.obolibrary.org/obo/GO_2000117) (negative regulation of cysteine-type endopeptidase activity), [GO:2000114](http://purl.obolibrary.org/obo/GO_2000114) (regulation of establishment of cell polarity), [GO:0072108](http://purl.obolibrary.org/obo/GO_0072108) (positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis), [GO:0019902](http://purl.obolibrary.org/obo/GO_0019902) (phosphatase binding), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0060112](http://purl.obolibrary.org/obo/GO_0060112) (generation of ovulation cycle rhythm), [GO:0019903](http://purl.obolibrary.org/obo/GO_0019903) (protein phosphatase binding), [GO:0060113](http://purl.obolibrary.org/obo/GO_0060113) (inner ear receptor cell differentiation), [GO:0019905](http://purl.obolibrary.org/obo/GO_0019905) (syntaxin binding), [GO:0019907](http://purl.obolibrary.org/obo/GO_0019907) (cyclin-dependent protein kinase activating kinase holoenzyme complex), [GO:0060118](http://purl.obolibrary.org/obo/GO_0060118) (vestibular receptor cell development), [GO:0060119](http://purl.obolibrary.org/obo/GO_0060119) (inner ear receptor cell development), [GO:0006611](http://purl.obolibrary.org/obo/GO_0006611) (protein export from nucleus), [GO:0006612](http://purl.obolibrary.org/obo/GO_0006612) (protein targeting to membrane), [GO:1902569](http://purl.obolibrary.org/obo/GO_1902569) (negative regulation of activation of Janus kinase activity), [GO:0060117](http://purl.obolibrary.org/obo/GO_0060117) (auditory receptor cell development), [GO:0048496](http://purl.obolibrary.org/obo/GO_0048496) (maintenance of animal organ identity), [GO:0006605](http://purl.obolibrary.org/obo/GO_0006605) (protein targeting), [GO:0048499](http://purl.obolibrary.org/obo/GO_0048499) (synaptic vesicle membrane organization), [GO:0006606](http://purl.obolibrary.org/obo/GO_0006606) (protein import into nucleus), [GO:0098742](http://purl.obolibrary.org/obo/GO_0098742) (cell-cell adhesion via plasma-membrane adhesion molecules), [GO:0006607](http://purl.obolibrary.org/obo/GO_0006607) (NLS-bearing protein import into nucleus), [GO:0097413](http://purl.obolibrary.org/obo/GO_0097413) (Lewy body), [GO:0098743](http://purl.obolibrary.org/obo/GO_0098743) (cell aggregation), [GO:0097418](http://purl.obolibrary.org/obo/GO_0097418) (neurofibrillary tangle), [GO:2000121](http://purl.obolibrary.org/obo/GO_2000121) (regulation of removal of superoxide radicals), [GO:0035148](http://purl.obolibrary.org/obo/GO_0035148) (tube formation), [GO:0048490](http://purl.obolibrary.org/obo/GO_0048490) (anterograde synaptic vesicle transport), [GO:0019911](http://purl.obolibrary.org/obo/GO_0019911) (structural constituent of myelin sheath), [GO:0035143](http://purl.obolibrary.org/obo/GO_0035143) (caudal fin morphogenesis), [GO:0035145](http://purl.obolibrary.org/obo/GO_0035145) (exon-exon junction complex), [GO:0036477](http://purl.obolibrary.org/obo/GO_0036477) (somatodendritic compartment), [GO:1902572](http://purl.obolibrary.org/obo/GO_1902572) (negative regulation of serine-type peptidase activity), [GO:0072125](http://purl.obolibrary.org/obo/GO_0072125) (negative regulation of glomerular mesangial cell proliferation), [GO:0098711](http://purl.obolibrary.org/obo/GO_0098711) (iron ion import across plasma membrane), [GO:0098712](http://purl.obolibrary.org/obo/GO_0098712) (L-glutamate import across plasma membrane), [GO:2000134](http://purl.obolibrary.org/obo/GO_2000134) (negative regulation of G1/S transition of mitotic cell cycle), [GO:0072126](http://purl.obolibrary.org/obo/GO_0072126) (positive regulation of glomerular mesangial cell proliferation), [GO:0098719](http://purl.obolibrary.org/obo/GO_0098719) (sodium ion import across plasma membrane), [GO:0035136](http://purl.obolibrary.org/obo/GO_0035136) (forelimb morphogenesis), [GO:0035137](http://purl.obolibrary.org/obo/GO_0035137) (hindlimb morphogenesis), [GO:0036468](http://purl.obolibrary.org/obo/GO_0036468) (L-dopa decarboxylase activity), [GO:0035138](http://purl.obolibrary.org/obo/GO_0035138) (pectoral fin morphogenesis), [GO:0019900](http://purl.obolibrary.org/obo/GO_0019900) (kinase binding), [GO:0036464](http://purl.obolibrary.org/obo/GO_0036464) (cytoplasmic ribonucleoprotein granule), [GO:0060134](http://purl.obolibrary.org/obo/GO_0060134) (prepulse inhibition), [GO:0060135](http://purl.obolibrary.org/obo/GO_0060135) (maternal process involved in female pregnancy), [GO:0036466](http://purl.obolibrary.org/obo/GO_0036466) (synaptic vesicle recycling via endosome), [GO:1901255](http://purl.obolibrary.org/obo/GO_1901255) (nucleotide-excision repair involved in interstrand cross-link repair), [GO:0036462](http://purl.obolibrary.org/obo/GO_0036462) (TRAIL-activated apoptotic signaling pathway), [GO:0061462](http://purl.obolibrary.org/obo/GO_0061462) (protein localization to lysosome), [GO:0060136](http://purl.obolibrary.org/obo/GO_0060136) (embryonic process involved in female pregnancy), [GO:0060137](http://purl.obolibrary.org/obo/GO_0060137) (maternal process involved in parturition), [GO:0061469](http://purl.obolibrary.org/obo/GO_0061469) (regulation of type B pancreatic cell proliferation), [GO:0060139](http://purl.obolibrary.org/obo/GO_0060139) (positive regulation of apoptotic process by virus), [GO:0047184](http://purl.obolibrary.org/obo/GO_0047184) (1-acylglycerophosphocholine O-acyltransferase activity), [GO:0072114](http://purl.obolibrary.org/obo/GO_0072114) (pronephros morphogenesis), [GO:0072112](http://purl.obolibrary.org/obo/GO_0072112) (glomerular visceral epithelial cell differentiation), [GO:0072111](http://purl.obolibrary.org/obo/GO_0072111) (cell proliferation involved in kidney development), [GO:2000146](http://purl.obolibrary.org/obo/GO_2000146) (negative regulation of cell motility), [GO:2000145](http://purl.obolibrary.org/obo/GO_2000145) (regulation of cell motility), [GO:0098727](http://purl.obolibrary.org/obo/GO_0098727) (maintenance of cell number), [GO:2000144](http://purl.obolibrary.org/obo/GO_2000144) (positive regulation of DNA-templated transcription, initiation), [GO:0072116](http://purl.obolibrary.org/obo/GO_0072116) (pronephros formation), [GO:0106003](http://purl.obolibrary.org/obo/GO_0106003) (amyloid-beta complex), [GO:0036458](http://purl.obolibrary.org/obo/GO_0036458) (hepatocyte growth factor binding), [GO:2000147](http://purl.obolibrary.org/obo/GO_2000147) (positive regulation of cell motility), [GO:0036459](http://purl.obolibrary.org/obo/GO_0036459) (thiol-dependent ubiquitinyl hydrolase activity), [GO:0019957](http://purl.obolibrary.org/obo/GO_0019957) (C-C chemokine binding), [GO:0019956](http://purl.obolibrary.org/obo/GO_0019956) (chemokine binding), [GO:0019959](http://purl.obolibrary.org/obo/GO_0019959) (interleukin-8 binding), [GO:0061410](http://purl.obolibrary.org/obo/GO_0061410) (positive regulation of transcription from RNA polymerase II promoter in response to ethanol), [GO:0006641](http://purl.obolibrary.org/obo/GO_0006641) (triglyceride metabolic process), [GO:1902513](http://purl.obolibrary.org/obo/GO_1902513) (regulation of organelle transport along microtubule), [GO:1902510](http://purl.obolibrary.org/obo/GO_1902510) (regulation of apoptotic DNA fragmentation), [GO:0061419](http://purl.obolibrary.org/obo/GO_0061419) (positive regulation of transcription from RNA polymerase II promoter in response to hypoxia), [GO:0006644](http://purl.obolibrary.org/obo/GO_0006644) (phospholipid metabolic process), [GO:0006642](http://purl.obolibrary.org/obo/GO_0006642) (triglyceride mobilization), [GO:1902514](http://purl.obolibrary.org/obo/GO_1902514) (regulation of calcium ion transmembrane transport via high voltage-gated calcium channel), [GO:0005314](http://purl.obolibrary.org/obo/GO_0005314) (high-affinity glutamate transmembrane transporter activity), [GO:0005313](http://purl.obolibrary.org/obo/GO_0005313) (L-glutamate transmembrane transporter activity), [GO:0032924](http://purl.obolibrary.org/obo/GO_0032924) (activin receptor signaling pathway), [GO:0006637](http://purl.obolibrary.org/obo/GO_0006637) (acyl-CoA metabolic process), [GO:0032922](http://purl.obolibrary.org/obo/GO_0032922) (circadian regulation of gene expression), [GO:0006635](http://purl.obolibrary.org/obo/GO_0006635) (fatty acid beta-oxidation), [GO:0005307](http://purl.obolibrary.org/obo/GO_0005307) (choline:sodium symporter activity), [GO:0050750](http://purl.obolibrary.org/obo/GO_0050750) (low-density lipoprotein particle receptor binding), [GO:0006636](http://purl.obolibrary.org/obo/GO_0006636) (unsaturated fatty acid biosynthetic process), [GO:0005309](http://purl.obolibrary.org/obo/GO_0005309) (creatine:sodium symporter activity), [GO:0032929](http://purl.obolibrary.org/obo/GO_0032929) (negative regulation of superoxide anion generation), [GO:0005308](http://purl.obolibrary.org/obo/GO_0005308) (creatine transmembrane transporter activity), [GO:0032926](http://purl.obolibrary.org/obo/GO_0032926) (negative regulation of activin receptor signaling pathway), [GO:0032927](http://purl.obolibrary.org/obo/GO_0032927) (positive regulation of activin receptor signaling pathway), [GO:0106019](http://purl.obolibrary.org/obo/GO_0106019) (phosphatidylinositol-4,5-bisphosphate phosphatase activity), [GO:0019960](http://purl.obolibrary.org/obo/GO_0019960) (C-X3-C chemokine binding), [GO:0019962](http://purl.obolibrary.org/obo/GO_0019962) (type I interferon binding), [GO:0019966](http://purl.obolibrary.org/obo/GO_0019966) (interleukin-1 binding), [GO:2000171](http://purl.obolibrary.org/obo/GO_2000171) (negative regulation of dendrite development), [GO:0035198](http://purl.obolibrary.org/obo/GO_0035198) (miRNA binding), [GO:2000170](http://purl.obolibrary.org/obo/GO_2000170) (positive regulation of peptidyl-cysteine S-nitrosylation), [GO:0035195](http://purl.obolibrary.org/obo/GO_0035195) (gene silencing by miRNA), [GO:0035196](http://purl.obolibrary.org/obo/GO_0035196) (production of miRNAs involved in gene silencing by miRNA), [GO:2000173](http://purl.obolibrary.org/obo/GO_2000173) (negative regulation of branching morphogenesis of a nerve), [GO:0006650](http://purl.obolibrary.org/obo/GO_0006650) (glycerophospholipid metabolic process), [GO:0006656](http://purl.obolibrary.org/obo/GO_0006656) (phosphatidylcholine biosynthetic process), [GO:0061402](http://purl.obolibrary.org/obo/GO_0061402) (positive regulation of transcription from RNA polymerase II promoter in response to acidic pH), [GO:0005324](http://purl.obolibrary.org/obo/GO_0005324) (long-chain fatty acid transporter activity), [GO:0006654](http://purl.obolibrary.org/obo/GO_0006654) (phosphatidic acid biosynthetic process), [GO:0005316](http://purl.obolibrary.org/obo/GO_0005316) (high-affinity inorganic phosphate:sodium symporter activity), [GO:0006649](http://purl.obolibrary.org/obo/GO_0006649) (phospholipid transfer to membrane), [GO:0032914](http://purl.obolibrary.org/obo/GO_0032914) (positive regulation of transforming growth factor beta1 production), [GO:0005315](http://purl.obolibrary.org/obo/GO_0005315) (inorganic phosphate transmembrane transporter activity), [GO:0032911](http://purl.obolibrary.org/obo/GO_0032911) (negative regulation of transforming growth factor beta1 production), [GO:0006646](http://purl.obolibrary.org/obo/GO_0006646) (phosphatidylethanolamine biosynthetic process), [GO:1903849](http://purl.obolibrary.org/obo/GO_1903849) (positive regulation of aorta morphogenesis), [GO:0032912](http://purl.obolibrary.org/obo/GO_0032912) (negative regulation of transforming growth factor beta2 production), [GO:0005319](http://purl.obolibrary.org/obo/GO_0005319) (lipid transporter activity), [GO:0032916](http://purl.obolibrary.org/obo/GO_0032916) (positive regulation of transforming growth factor beta3 production), [GO:0050768](http://purl.obolibrary.org/obo/GO_0050768) (negative regulation of neurogenesis), [GO:0050769](http://purl.obolibrary.org/obo/GO_0050769) (positive regulation of neurogenesis), [GO:0050766](http://purl.obolibrary.org/obo/GO_0050766) (positive regulation of phagocytosis), [GO:0019953](http://purl.obolibrary.org/obo/GO_0019953) (sexual reproduction), [GO:0050767](http://purl.obolibrary.org/obo/GO_0050767) (regulation of neurogenesis), [GO:0019955](http://purl.obolibrary.org/obo/GO_0019955) (cytokine binding), [GO:0050764](http://purl.obolibrary.org/obo/GO_0050764) (regulation of phagocytosis), [GO:0050765](http://purl.obolibrary.org/obo/GO_0050765) (negative regulation of phagocytosis), [GO:0098707](http://purl.obolibrary.org/obo/GO_0098707) (ferrous iron import across plasma membrane), [GO:0061430](http://purl.obolibrary.org/obo/GO_0061430) (bone trabecula morphogenesis), [GO:0060100](http://purl.obolibrary.org/obo/GO_0060100) (positive regulation of phagocytosis, engulfment), [GO:0019934](http://purl.obolibrary.org/obo/GO_0019934) (cGMP-mediated signaling), [GO:0035188](http://purl.obolibrary.org/obo/GO_0035188) (hatching), [GO:1902530](http://purl.obolibrary.org/obo/GO_1902530) (positive regulation of protein linear polyubiquitination), [GO:1902531](http://purl.obolibrary.org/obo/GO_1902531) (regulation of intracellular signal transduction), [GO:1903862](http://purl.obolibrary.org/obo/GO_1903862) (positive regulation of oxidative phosphorylation), [GO:1903860](http://purl.obolibrary.org/obo/GO_1903860) (negative regulation of dendrite extension), [GO:1901202](http://purl.obolibrary.org/obo/GO_1901202) (negative regulation of extracellular matrix assembly), [GO:0047127](http://purl.obolibrary.org/obo/GO_0047127) (thiomorpholine-carboxylate dehydrogenase activity), [GO:0032909](http://purl.obolibrary.org/obo/GO_0032909) (regulation of transforming growth factor beta2 production), [GO:1902533](http://purl.obolibrary.org/obo/GO_1902533) (positive regulation of intracellular signal transduction), [GO:0006622](http://purl.obolibrary.org/obo/GO_0006622) (protein targeting to lysosome), [GO:0006623](http://purl.obolibrary.org/obo/GO_0006623) (protein targeting to vacuole), [GO:0061436](http://purl.obolibrary.org/obo/GO_0061436) (establishment of skin barrier), [GO:0006620](http://purl.obolibrary.org/obo/GO_0006620) (posttranslational protein targeting to endoplasmic reticulum membrane), [GO:1901207](http://purl.obolibrary.org/obo/GO_1901207) (regulation of heart looping), [GO:0006621](http://purl.obolibrary.org/obo/GO_0006621) (protein retention in ER lumen), [GO:0050773](http://purl.obolibrary.org/obo/GO_0050773) (regulation of dendrite development), [GO:0006616](http://purl.obolibrary.org/obo/GO_0006616) (SRP-dependent cotranslational protein targeting to membrane, translocation), [GO:0047131](http://purl.obolibrary.org/obo/GO_0047131) (saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity), [GO:0050771](http://purl.obolibrary.org/obo/GO_0050771) (negative regulation of axonogenesis), [GO:0006613](http://purl.obolibrary.org/obo/GO_0006613) (cotranslational protein targeting to membrane), [GO:0047130](http://purl.obolibrary.org/obo/GO_0047130) (saccharopine dehydrogenase (NADP+, L-lysine-forming) activity), [GO:0050772](http://purl.obolibrary.org/obo/GO_0050772) (positive regulation of axonogenesis), [GO:0006614](http://purl.obolibrary.org/obo/GO_0006614) (SRP-dependent cotranslational protein targeting to membrane), [GO:0050770](http://purl.obolibrary.org/obo/GO_0050770) (regulation of axonogenesis), [GO:0047134](http://purl.obolibrary.org/obo/GO_0047134) (protein-disulfide reductase activity), [GO:2000178](http://purl.obolibrary.org/obo/GO_2000178) (negative regulation of neural precursor cell proliferation), [GO:2000177](http://purl.obolibrary.org/obo/GO_2000177) (regulation of neural precursor cell proliferation), [GO:0050777](http://purl.obolibrary.org/obo/GO_0050777) (negative regulation of immune response), [GO:0050778](http://purl.obolibrary.org/obo/GO_0050778) (positive regulation of immune response), [GO:0050775](http://purl.obolibrary.org/obo/GO_0050775) (positive regulation of dendrite morphogenesis), [GO:0050776](http://purl.obolibrary.org/obo/GO_0050776) (regulation of immune response), [GO:0035176](http://purl.obolibrary.org/obo/GO_0035176) (social behavior), [GO:2000195](http://purl.obolibrary.org/obo/GO_2000195) (negative regulation of female gonad development), [GO:1901210](http://purl.obolibrary.org/obo/GO_1901210) (regulation of cardiac chamber formation), [GO:0061428](http://purl.obolibrary.org/obo/GO_0061428) (negative regulation of transcription from RNA polymerase II promoter in response to hypoxia), [GO:1901215](http://purl.obolibrary.org/obo/GO_1901215) (negative regulation of neuron death), [GO:0048469](http://purl.obolibrary.org/obo/GO_0048469) (cell maturation), [GO:0061429](http://purl.obolibrary.org/obo/GO_0061429) (positive regulation of transcription from RNA polymerase II promoter by oleic acid), [GO:0047138](http://purl.obolibrary.org/obo/GO_0047138) (aquacobalamin reductase activity), [GO:0048468](http://purl.obolibrary.org/obo/GO_0048468) (cell development), [GO:1901214](http://purl.obolibrary.org/obo/GO_1901214) (regulation of neuron death), [GO:0006633](http://purl.obolibrary.org/obo/GO_0006633) (fatty acid biosynthetic process), [GO:1901216](http://purl.obolibrary.org/obo/GO_1901216) (positive regulation of neuron death), [GO:0061424](http://purl.obolibrary.org/obo/GO_0061424) (positive regulation of peroxisome organization by positive regulation of transcription from RNA polymerase II promoter), [GO:0006631](http://purl.obolibrary.org/obo/GO_0006631) (fatty acid metabolic process), [GO:0061425](http://purl.obolibrary.org/obo/GO_0061425) (positive regulation of ethanol catabolic process by positive regulation of transcription from RNA polymerase II promoter), [GO:0005302](http://purl.obolibrary.org/obo/GO_0005302) (L-tyrosine transmembrane transporter activity), [GO:0006626](http://purl.obolibrary.org/obo/GO_0006626) (protein targeting to mitochondrion), [GO:0006627](http://purl.obolibrary.org/obo/GO_0006627) (protein processing involved in protein targeting to mitochondrion), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0006625](http://purl.obolibrary.org/obo/GO_0006625) (protein targeting to peroxisome), [GO:0048478](http://purl.obolibrary.org/obo/GO_0048478) (replication fork protection), [GO:0048477](http://purl.obolibrary.org/obo/GO_0048477) (oogenesis), [GO:0048476](http://purl.obolibrary.org/obo/GO_0048476) (Holliday junction resolvase complex), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:2000189](http://purl.obolibrary.org/obo/GO_2000189) (positive regulation of cholesterol homeostasis), [GO:2000187](http://purl.obolibrary.org/obo/GO_2000187) (positive regulation of phosphate transmembrane transport), [GO:0019933](http://purl.obolibrary.org/obo/GO_0019933) (cAMP-mediated signaling), [GO:0043626](http://purl.obolibrary.org/obo/GO_0043626) (PCNA complex), [GO:0043625](http://purl.obolibrary.org/obo/GO_0043625) (delta DNA polymerase complex), [GO:0043627](http://purl.obolibrary.org/obo/GO_0043627) (response to estrogen), [GO:0006680](http://purl.obolibrary.org/obo/GO_0006680) (glucosylceramide catabolic process), [GO:0006681](http://purl.obolibrary.org/obo/GO_0006681) (galactosylceramide metabolic process), [GO:0004021](http://purl.obolibrary.org/obo/GO_0004021) (L-alanine:2-oxoglutarate aminotransferase activity), [GO:0005351](http://purl.obolibrary.org/obo/GO_0005351) (sugar:proton symporter activity), [GO:0006685](http://purl.obolibrary.org/obo/GO_0006685) (sphingomyelin catabolic process), [GO:0004020](http://purl.obolibrary.org/obo/GO_0004020) (adenylylsulfate kinase activity), [GO:0006683](http://purl.obolibrary.org/obo/GO_0006683) (galactosylceramide catabolic process), [GO:0006688](http://purl.obolibrary.org/obo/GO_0006688) (glycosphingolipid biosynthetic process), [GO:0043621](http://purl.obolibrary.org/obo/GO_0043621) (protein self-association), [GO:0006689](http://purl.obolibrary.org/obo/GO_0006689) (ganglioside catabolic process), [GO:0005355](http://purl.obolibrary.org/obo/GO_0005355) (glucose transmembrane transporter activity), [GO:0072193](http://purl.obolibrary.org/obo/GO_0072193) (ureter smooth muscle cell differentiation), [GO:0043623](http://purl.obolibrary.org/obo/GO_0043623) (cellular protein complex assembly), [GO:0097493](http://purl.obolibrary.org/obo/GO_0097493) (structural molecule activity conferring elasticity), [GO:0006687](http://purl.obolibrary.org/obo/GO_0006687) (glycosphingolipid metabolic process), [GO:0004018](http://purl.obolibrary.org/obo/GO_0004018) (N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity), [GO:0032968](http://purl.obolibrary.org/obo/GO_0032968) (positive regulation of transcription elongation from RNA polymerase II promoter), [GO:0097484](http://purl.obolibrary.org/obo/GO_0097484) (dendrite extension), [GO:0031638](http://purl.obolibrary.org/obo/GO_0031638) (zymogen activation), [GO:0004017](http://purl.obolibrary.org/obo/GO_0004017) (adenylate kinase activity), [GO:0030307](http://purl.obolibrary.org/obo/GO_0030307) (positive regulation of cell growth), [GO:0032967](http://purl.obolibrary.org/obo/GO_0032967) (positive regulation of collagen biosynthetic process), [GO:0030308](http://purl.obolibrary.org/obo/GO_0030308) (negative regulation of cell growth), [GO:0031639](http://purl.obolibrary.org/obo/GO_0031639) (plasminogen activation), [GO:0072189](http://purl.obolibrary.org/obo/GO_0072189) (ureter development), [GO:0016010](http://purl.obolibrary.org/obo/GO_0016010) (dystrophin-associated glycoprotein complex), [GO:0016011](http://purl.obolibrary.org/obo/GO_0016011) (dystroglycan complex), [GO:0016012](http://purl.obolibrary.org/obo/GO_0016012) (sarcoglycan complex), [GO:0030301](http://purl.obolibrary.org/obo/GO_0030301) (cholesterol transport), [GO:0032964](http://purl.obolibrary.org/obo/GO_0032964) (collagen biosynthetic process), [GO:0030300](http://purl.obolibrary.org/obo/GO_0030300) (regulation of intestinal cholesterol absorption), [GO:0032965](http://purl.obolibrary.org/obo/GO_0032965) (regulation of collagen biosynthetic process), [GO:0032962](http://purl.obolibrary.org/obo/GO_0032962) (positive regulation of inositol trisphosphate biosynthetic process), [GO:0032963](http://purl.obolibrary.org/obo/GO_0032963) (collagen metabolic process), [GO:0042306](http://purl.obolibrary.org/obo/GO_0042306) (regulation of protein import into nucleus), [GO:0042307](http://purl.obolibrary.org/obo/GO_0042307) (positive regulation of protein import into nucleus), [GO:0042309](http://purl.obolibrary.org/obo/GO_0042309) (homoiothermy), [GO:0006691](http://purl.obolibrary.org/obo/GO_0006691) (leukotriene metabolic process), [GO:0004030](http://purl.obolibrary.org/obo/GO_0004030) (aldehyde dehydrogenase [NAD(P)+] activity), [GO:0060196](http://purl.obolibrary.org/obo/GO_0060196) (positive regulation of antisense RNA transcription), [GO:0060197](http://purl.obolibrary.org/obo/GO_0060197) (cloacal septation), [GO:0006695](http://purl.obolibrary.org/obo/GO_0006695) (cholesterol biosynthetic process), [GO:0004032](http://purl.obolibrary.org/obo/GO_0004032) (alditol:NADP+ 1-oxidoreductase activity), [GO:0006696](http://purl.obolibrary.org/obo/GO_0006696) (ergosterol biosynthetic process), [GO:0006693](http://purl.obolibrary.org/obo/GO_0006693) (prostaglandin metabolic process), [GO:0004034](http://purl.obolibrary.org/obo/GO_0004034) (aldose 1-epimerase activity), [GO:0043631](http://purl.obolibrary.org/obo/GO_0043631) (RNA polyadenylation), [GO:0006694](http://purl.obolibrary.org/obo/GO_0006694) (steroid biosynthetic process), [GO:0004033](http://purl.obolibrary.org/obo/GO_0004033) (aldo-keto reductase (NADP) activity), [GO:0042301](http://purl.obolibrary.org/obo/GO_0042301) (phosphate ion binding), [GO:0006699](http://purl.obolibrary.org/obo/GO_0006699) (bile acid biosynthetic process), [GO:0004035](http://purl.obolibrary.org/obo/GO_0004035) (alkaline phosphatase activity), [GO:0072182](http://purl.obolibrary.org/obo/GO_0072182) (regulation of nephron tubule epithelial cell differentiation), [GO:0072181](http://purl.obolibrary.org/obo/GO_0072181) (mesonephric duct formation), [GO:0072180](http://purl.obolibrary.org/obo/GO_0072180) (mesonephric duct morphogenesis), [GO:0004029](http://purl.obolibrary.org/obo/GO_0004029) (aldehyde dehydrogenase (NAD) activity), [GO:0072176](http://purl.obolibrary.org/obo/GO_0072176) (nephric duct development), [GO:0032957](http://purl.obolibrary.org/obo/GO_0032957) (inositol trisphosphate metabolic process), [GO:0032958](http://purl.obolibrary.org/obo/GO_0032958) (inositol phosphate biosynthetic process), [GO:0004028](http://purl.obolibrary.org/obo/GO_0004028) (3-chloroallyl aldehyde dehydrogenase activity), [GO:0072175](http://purl.obolibrary.org/obo/GO_0072175) (epithelial tube formation), [GO:0031624](http://purl.obolibrary.org/obo/GO_0031624) (ubiquitin conjugating enzyme binding), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0032956](http://purl.obolibrary.org/obo/GO_0032956) (regulation of actin cytoskeleton organization), [GO:0072179](http://purl.obolibrary.org/obo/GO_0072179) (nephric duct formation), [GO:0097499](http://purl.obolibrary.org/obo/GO_0097499) (protein localization to non-motile cilium), [GO:0031628](http://purl.obolibrary.org/obo/GO_0031628) (opioid receptor binding), [GO:0032959](http://purl.obolibrary.org/obo/GO_0032959) (inositol trisphosphate biosynthetic process), [GO:0072178](http://purl.obolibrary.org/obo/GO_0072178) (nephric duct morphogenesis), [GO:0072177](http://purl.obolibrary.org/obo/GO_0072177) (mesonephric duct development), [GO:0031629](http://purl.obolibrary.org/obo/GO_0031629) (synaptic vesicle fusion to presynaptic active zone membrane), [GO:0031622](http://purl.obolibrary.org/obo/GO_0031622) (positive regulation of fever generation), [GO:0031623](http://purl.obolibrary.org/obo/GO_0031623) (receptor internalization), [GO:0016004](http://purl.obolibrary.org/obo/GO_0016004) (phospholipase activator activity), [GO:0031620](http://purl.obolibrary.org/obo/GO_0031620) (regulation of fever generation), [GO:0019979](http://purl.obolibrary.org/obo/GO_0019979) (interleukin-4 binding), [GO:0043648](http://purl.obolibrary.org/obo/GO_0043648) (dicarboxylic acid metabolic process), [GO:0005330](http://purl.obolibrary.org/obo/GO_0005330) (dopamine:sodium symporter activity), [GO:0006662](http://purl.obolibrary.org/obo/GO_0006662) (glycerol ether metabolic process), [GO:0042310](http://purl.obolibrary.org/obo/GO_0042310) (vasoconstriction), [GO:0004001](http://purl.obolibrary.org/obo/GO_0004001) (adenosine kinase activity), [GO:0006660](http://purl.obolibrary.org/obo/GO_0006660) (phosphatidylserine catabolic process), [GO:0006661](http://purl.obolibrary.org/obo/GO_0006661) (phosphatidylinositol biosynthetic process), [GO:0004000](http://purl.obolibrary.org/obo/GO_0004000) (adenosine deaminase activity), [GO:0042311](http://purl.obolibrary.org/obo/GO_0042311) (vasodilation), [GO:0004003](http://purl.obolibrary.org/obo/GO_0004003) (ATP-dependent DNA helicase activity), [GO:0097470](http://purl.obolibrary.org/obo/GO_0097470) (ribbon synapse), [GO:0006664](http://purl.obolibrary.org/obo/GO_0006664) (glycolipid metabolic process), [GO:0006665](http://purl.obolibrary.org/obo/GO_0006665) (sphingolipid metabolic process), [GO:0004004](http://purl.obolibrary.org/obo/GO_0004004) (ATP-dependent RNA helicase activity), [GO:0005335](http://purl.obolibrary.org/obo/GO_0005335) (serotonin:sodium symporter activity), [GO:0032947](http://purl.obolibrary.org/obo/GO_0032947) (protein complex scaffold activity), [GO:0031616](http://purl.obolibrary.org/obo/GO_0031616) (spindle pole centrosome), [GO:0005326](http://purl.obolibrary.org/obo/GO_0005326) (neurotransmitter transporter activity), [GO:0098793](http://purl.obolibrary.org/obo/GO_0098793) (presynapse), [GO:0005329](http://purl.obolibrary.org/obo/GO_0005329) (dopamine transmembrane transporter activity), [GO:0098794](http://purl.obolibrary.org/obo/GO_0098794) (postsynapse), [GO:0005328](http://purl.obolibrary.org/obo/GO_0005328) (neurotransmitter:sodium symporter activity), [GO:0006658](http://purl.obolibrary.org/obo/GO_0006658) (phosphatidylserine metabolic process), [GO:0031619](http://purl.obolibrary.org/obo/GO_0031619) (homologous chromosome orientation involved in meiotic metaphase I plate congression), [GO:0097466](http://purl.obolibrary.org/obo/GO_0097466) (ubiquitin-dependent glycoprotein ERAD pathway), [GO:0098797](http://purl.obolibrary.org/obo/GO_0098797) (plasma membrane protein complex), [GO:0031618](http://purl.obolibrary.org/obo/GO_0031618) (nuclear pericentric heterochromatin), [GO:0019985](http://purl.obolibrary.org/obo/GO_0019985) (translesion synthesis), [GO:0032940](http://purl.obolibrary.org/obo/GO_0032940) (secretion by cell), [GO:0042327](http://purl.obolibrary.org/obo/GO_0042327) (positive regulation of phosphorylation), [GO:0018636](http://purl.obolibrary.org/obo/GO_0018636) (phenanthrene 9,10-monooxygenase activity), [GO:0042328](http://purl.obolibrary.org/obo/GO_0042328) (heparan sulfate N-acetylglucosaminyltransferase activity), [GO:0043651](http://purl.obolibrary.org/obo/GO_0043651) (linoleic acid metabolic process), [GO:0006673](http://purl.obolibrary.org/obo/GO_0006673) (inositol phosphoceramide metabolic process), [GO:0043653](http://purl.obolibrary.org/obo/GO_0043653) (mitochondrial fragmentation involved in apoptotic process), [GO:0004012](http://purl.obolibrary.org/obo/GO_0004012) (phospholipid-translocating ATPase activity), [GO:0005343](http://purl.obolibrary.org/obo/GO_0005343) (organic acid:sodium symporter activity), [GO:0043652](http://purl.obolibrary.org/obo/GO_0043652) (engulfment of apoptotic cell), [GO:0006672](http://purl.obolibrary.org/obo/GO_0006672) (ceramide metabolic process), [GO:0042323](http://purl.obolibrary.org/obo/GO_0042323) (negative regulation of circadian sleep/wake cycle, non-REM sleep), [GO:0043654](http://purl.obolibrary.org/obo/GO_0043654) (recognition of apoptotic cell), [GO:0005344](http://purl.obolibrary.org/obo/GO_0005344) (oxygen carrier activity), [GO:0004013](http://purl.obolibrary.org/obo/GO_0004013) (adenosylhomocysteinase activity), [GO:0006678](http://purl.obolibrary.org/obo/GO_0006678) (glucosylceramide metabolic process), [GO:0004016](http://purl.obolibrary.org/obo/GO_0004016) (adenylate cyclase activity), [GO:0042325](http://purl.obolibrary.org/obo/GO_0042325) (regulation of phosphorylation), [GO:0006675](http://purl.obolibrary.org/obo/GO_0006675) (mannosyl-inositol phosphorylceramide metabolic process), [GO:0042326](http://purl.obolibrary.org/obo/GO_0042326) (negative regulation of phosphorylation), [GO:0005337](http://purl.obolibrary.org/obo/GO_0005337) (nucleoside transmembrane transporter activity), [GO:0097473](http://purl.obolibrary.org/obo/GO_0097473) (retinal rod cell apoptotic process), [GO:0072197](http://purl.obolibrary.org/obo/GO_0072197) (ureter morphogenesis), [GO:0032933](http://purl.obolibrary.org/obo/GO_0032933) (SREBP signaling pathway), [GO:0072196](http://purl.obolibrary.org/obo/GO_0072196) (proximal/distal pattern formation involved in pronephric nephron development), [GO:0004008](http://purl.obolibrary.org/obo/GO_0004008) (copper-exporting ATPase activity), [GO:0032934](http://purl.obolibrary.org/obo/GO_0032934) (sterol binding), [GO:0097475](http://purl.obolibrary.org/obo/GO_0097475) (motor neuron migration), [GO:0097477](http://purl.obolibrary.org/obo/GO_0097477) (lateral motor column neuron migration), [GO:0032930](http://purl.obolibrary.org/obo/GO_0032930) (positive regulation of superoxide anion generation), [GO:0019976](http://purl.obolibrary.org/obo/GO_0019976) (interleukin-2 binding), [GO:0031681](http://purl.obolibrary.org/obo/GO_0031681) (G-protein beta-subunit binding), [GO:0005391](http://purl.obolibrary.org/obo/GO_0005391) (sodium:potassium-exchanging ATPase activity), [GO:0030350](http://purl.obolibrary.org/obo/GO_0030350) (iron-responsive element binding), [GO:0004063](http://purl.obolibrary.org/obo/GO_0004063) (aryldialkylphosphatase activity), [GO:0060164](http://purl.obolibrary.org/obo/GO_0060164) (regulation of timing of neuron differentiation), [GO:0004065](http://purl.obolibrary.org/obo/GO_0004065) (arylsulfatase activity), [GO:0004064](http://purl.obolibrary.org/obo/GO_0004064) (arylesterase activity), [GO:1902598](http://purl.obolibrary.org/obo/GO_1902598) (creatine transmembrane transport), [GO:0004066](http://purl.obolibrary.org/obo/GO_0004066) (asparagine synthase (glutamine-hydrolyzing) activity), [GO:0060169](http://purl.obolibrary.org/obo/GO_0060169) (negative regulation of adenosine receptor signaling pathway), [GO:0098780](http://purl.obolibrary.org/obo/GO_0098780) (response to mitochondrial depolarisation), [GO:0098773](http://purl.obolibrary.org/obo/GO_0098773) (skin epidermis development), [GO:0097441](http://purl.obolibrary.org/obo/GO_0097441) (basal dendrite), [GO:0097440](http://purl.obolibrary.org/obo/GO_0097440) (apical dendrite), [GO:0097443](http://purl.obolibrary.org/obo/GO_0097443) (sorting endosome), [GO:0016050](http://purl.obolibrary.org/obo/GO_0016050) (vesicle organization), [GO:0016051](http://purl.obolibrary.org/obo/GO_0016051) (carbohydrate biosynthetic process), [GO:0016052](http://purl.obolibrary.org/obo/GO_0016052) (carbohydrate catabolic process), [GO:0097447](http://purl.obolibrary.org/obo/GO_0097447) (dendritic tree), [GO:0097449](http://purl.obolibrary.org/obo/GO_0097449) (astrocyte projection), [GO:0031673](http://purl.obolibrary.org/obo/GO_0031673) (H zone), [GO:0016055](http://purl.obolibrary.org/obo/GO_0016055) (Wnt signaling pathway), [GO:0031674](http://purl.obolibrary.org/obo/GO_0031674) (I band), [GO:0072149](http://purl.obolibrary.org/obo/GO_0072149) (glomerular visceral epithelial cell fate commitment), [GO:0060170](http://purl.obolibrary.org/obo/GO_0060170) (ciliary membrane), [GO:0030343](http://purl.obolibrary.org/obo/GO_0030343) (vitamin D3 25-hydroxylase activity), [GO:0072148](http://purl.obolibrary.org/obo/GO_0072148) (epithelial cell fate commitment), [GO:0031672](http://purl.obolibrary.org/obo/GO_0031672) (A band), [GO:0030342](http://purl.obolibrary.org/obo/GO_0030342) (1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity), [GO:0060171](http://purl.obolibrary.org/obo/GO_0060171) (stereocilium membrane), [GO:0030345](http://purl.obolibrary.org/obo/GO_0030345) (structural constituent of tooth enamel), [GO:0030346](http://purl.obolibrary.org/obo/GO_0030346) (protein phosphatase 2B binding), [GO:0061485](http://purl.obolibrary.org/obo/GO_0061485) (memory T cell proliferation), [GO:0060155](http://purl.obolibrary.org/obo/GO_0060155) (platelet dense granule organization), [GO:0004070](http://purl.obolibrary.org/obo/GO_0004070) (aspartate carbamoyltransferase activity), [GO:0060157](http://purl.obolibrary.org/obo/GO_0060157) (urinary bladder development), [GO:0031670](http://purl.obolibrary.org/obo/GO_0031670) (cellular response to nutrient), [GO:0060152](http://purl.obolibrary.org/obo/GO_0060152) (microtubule-based peroxisome localization), [GO:0061484](http://purl.obolibrary.org/obo/GO_0061484) (hematopoietic stem cell homeostasis), [GO:0004075](http://purl.obolibrary.org/obo/GO_0004075) (biotin carboxylase activity), [GO:0004078](http://purl.obolibrary.org/obo/GO_0004078) (biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity), [GO:0004077](http://purl.obolibrary.org/obo/GO_0004077) (biotin-[acetyl-CoA-carboxylase] ligase activity), [GO:0004079](http://purl.obolibrary.org/obo/GO_0004079) (biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity), [GO:0060159](http://purl.obolibrary.org/obo/GO_0060159) (regulation of dopamine receptor signaling pathway), [GO:0030337](http://purl.obolibrary.org/obo/GO_0030337) (DNA polymerase processivity factor activity), [GO:0097451](http://purl.obolibrary.org/obo/GO_0097451) (glial limiting end-foot), [GO:0031668](http://purl.obolibrary.org/obo/GO_0031668) (cellular response to extracellular stimulus), [GO:0097453](http://purl.obolibrary.org/obo/GO_0097453) (mesaxon), [GO:0031669](http://purl.obolibrary.org/obo/GO_0031669) (cellular response to nutrient levels), [GO:0097458](http://purl.obolibrary.org/obo/GO_0097458) (neuron part), [GO:0016042](http://purl.obolibrary.org/obo/GO_0016042) (lipid catabolic process), [GO:0016043](http://purl.obolibrary.org/obo/GO_0016043) (cellular component organization), [GO:0032993](http://purl.obolibrary.org/obo/GO_0032993) (protein-DNA complex), [GO:0031663](http://purl.obolibrary.org/obo/GO_0031663) (lipopolysaccharide-mediated signaling pathway), [GO:0032994](http://purl.obolibrary.org/obo/GO_0032994) (protein-lipid complex), [GO:0072138](http://purl.obolibrary.org/obo/GO_0072138) (mesenchymal cell proliferation involved in ureteric bud development), [GO:0030332](http://purl.obolibrary.org/obo/GO_0030332) (cyclin binding), [GO:0032991](http://purl.obolibrary.org/obo/GO_0032991) (macromolecular complex), [GO:0016045](http://purl.obolibrary.org/obo/GO_0016045) (detection of bacterium), [GO:0030331](http://purl.obolibrary.org/obo/GO_0030331) (estrogen receptor binding), [GO:0030334](http://purl.obolibrary.org/obo/GO_0030334) (regulation of cell migration), [GO:0031667](http://purl.obolibrary.org/obo/GO_0031667) (response to nutrient levels), [GO:0030336](http://purl.obolibrary.org/obo/GO_0030336) (negative regulation of cell migration), [GO:0016049](http://purl.obolibrary.org/obo/GO_0016049) (cell growth), [GO:0030335](http://purl.obolibrary.org/obo/GO_0030335) (positive regulation of cell migration), [GO:0005371](http://purl.obolibrary.org/obo/GO_0005371) (tricarboxylate secondary active transmembrane transporter activity), [GO:0004040](http://purl.obolibrary.org/obo/GO_0004040) (amidase activity), [GO:0004043](http://purl.obolibrary.org/obo/GO_0004043) (L-aminoadipate-semialdehyde dehydrogenase activity), [GO:0004042](http://purl.obolibrary.org/obo/GO_0004042) (acetyl-CoA:L-glutamate N-acetyltransferase activity), [GO:0004045](http://purl.obolibrary.org/obo/GO_0004045) (aminoacyl-tRNA hydrolase activity), [GO:0005375](http://purl.obolibrary.org/obo/GO_0005375) (copper ion transmembrane transporter activity), [GO:0072172](http://purl.obolibrary.org/obo/GO_0072172) (mesonephric tubule formation), [GO:0004047](http://purl.obolibrary.org/obo/GO_0004047) (aminomethyltransferase activity), [GO:0004046](http://purl.obolibrary.org/obo/GO_0004046) (aminoacylase activity), [GO:0043602](http://purl.obolibrary.org/obo/GO_0043602) (nitrate catabolic process), [GO:0031659](http://purl.obolibrary.org/obo/GO_0031659) (positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle), [GO:0030327](http://purl.obolibrary.org/obo/GO_0030327) (prenylated protein catabolic process), [GO:0030326](http://purl.obolibrary.org/obo/GO_0030326) (embryonic limb morphogenesis), [GO:0072164](http://purl.obolibrary.org/obo/GO_0072164) (mesonephric tubule development), [GO:0097421](http://purl.obolibrary.org/obo/GO_0097421) (liver regeneration), [GO:0031658](http://purl.obolibrary.org/obo/GO_0031658) (negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle), [GO:0072162](http://purl.obolibrary.org/obo/GO_0072162) (metanephric mesenchymal cell differentiation), [GO:0098754](http://purl.obolibrary.org/obo/GO_0098754) (detoxification), [GO:0016031](http://purl.obolibrary.org/obo/GO_0016031) (tRNA import into mitochondrion), [GO:0032982](http://purl.obolibrary.org/obo/GO_0032982) (myosin filament), [GO:0016032](http://purl.obolibrary.org/obo/GO_0016032) (viral process), [GO:0032983](http://purl.obolibrary.org/obo/GO_0032983) (kainate selective glutamate receptor complex), [GO:0060192](http://purl.obolibrary.org/obo/GO_0060192) (negative regulation of lipase activity), [GO:0032981](http://purl.obolibrary.org/obo/GO_0032981) (mitochondrial respiratory chain complex I assembly), [GO:0097428](http://purl.obolibrary.org/obo/GO_0097428) (protein maturation by iron-sulfur cluster transfer), [GO:0016035](http://purl.obolibrary.org/obo/GO_0016035) (zeta DNA polymerase complex), [GO:0016036](http://purl.obolibrary.org/obo/GO_0016036) (cellular response to phosphate starvation), [GO:0030323](http://purl.obolibrary.org/obo/GO_0030323) (respiratory tube development), [GO:0030322](http://purl.obolibrary.org/obo/GO_0030322) (stabilization of membrane potential), [GO:0030325](http://purl.obolibrary.org/obo/GO_0030325) (adrenal gland development), [GO:0030324](http://purl.obolibrary.org/obo/GO_0030324) (lung development), [GO:0043615](http://purl.obolibrary.org/obo/GO_0043615) (astrocyte cell migration), [GO:1901292](http://purl.obolibrary.org/obo/GO_1901292) (nucleoside phosphate catabolic process), [GO:0060177](http://purl.obolibrary.org/obo/GO_0060177) (regulation of angiotensin metabolic process), [GO:0060178](http://purl.obolibrary.org/obo/GO_0060178) (regulation of exocyst localization), [GO:0043616](http://purl.obolibrary.org/obo/GO_0043616) (keratinocyte proliferation), [GO:0060179](http://purl.obolibrary.org/obo/GO_0060179) (male mating behavior), [GO:0005381](http://purl.obolibrary.org/obo/GO_0005381) (iron ion transmembrane transporter activity), [GO:0043619](http://purl.obolibrary.org/obo/GO_0043619) (regulation of transcription from RNA polymerase II promoter in response to oxidative stress), [GO:0060173](http://purl.obolibrary.org/obo/GO_0060173) (limb development), [GO:0060174](http://purl.obolibrary.org/obo/GO_0060174) (limb bud formation), [GO:0004052](http://purl.obolibrary.org/obo/GO_0004052) (arachidonate 12-lipoxygenase activity), [GO:1901299](http://purl.obolibrary.org/obo/GO_1901299) (negative regulation of hydrogen peroxide-mediated programmed cell death), [GO:0060175](http://purl.obolibrary.org/obo/GO_0060175) (brain-derived neurotrophic factor-activated receptor activity), [GO:0004051](http://purl.obolibrary.org/obo/GO_0004051) (arachidonate 5-lipoxygenase activity), [GO:0005385](http://purl.obolibrary.org/obo/GO_0005385) (zinc ion transmembrane transporter activity), [GO:0005384](http://purl.obolibrary.org/obo/GO_0005384) (manganese ion transmembrane transporter activity), [GO:0004053](http://purl.obolibrary.org/obo/GO_0004053) (arginase activity), [GO:0004056](http://purl.obolibrary.org/obo/GO_0004056) (argininosuccinate lyase activity), [GO:0004055](http://purl.obolibrary.org/obo/GO_0004055) (argininosuccinate synthase activity), [GO:0004058](http://purl.obolibrary.org/obo/GO_0004058) (aromatic-L-amino-acid decarboxylase activity), [GO:0005388](http://purl.obolibrary.org/obo/GO_0005388) (calcium-transporting ATPase activity), [GO:0072160](http://purl.obolibrary.org/obo/GO_0072160) (nephron tubule epithelial cell differentiation), [GO:0031648](http://purl.obolibrary.org/obo/GO_0031648) (protein destabilization), [GO:0030316](http://purl.obolibrary.org/obo/GO_0030316) (osteoclast differentiation), [GO:0032979](http://purl.obolibrary.org/obo/GO_0032979) (protein insertion into mitochondrial membrane from inner side), [GO:0030315](http://purl.obolibrary.org/obo/GO_0030315) (T-tubule), [GO:0031649](http://purl.obolibrary.org/obo/GO_0031649) (heat generation), [GO:0030318](http://purl.obolibrary.org/obo/GO_0030318) (melanocyte differentiation), [GO:0031647](http://purl.obolibrary.org/obo/GO_0031647) (regulation of protein stability), [GO:0032978](http://purl.obolibrary.org/obo/GO_0032978) (protein insertion into membrane from inner side), [GO:0030317](http://purl.obolibrary.org/obo/GO_0030317) (flagellated sperm motility), [GO:0097431](http://purl.obolibrary.org/obo/GO_0097431) (mitotic spindle pole), [GO:0097433](http://purl.obolibrary.org/obo/GO_0097433) (dense body), [GO:0072156](http://purl.obolibrary.org/obo/GO_0072156) (distal tubule morphogenesis), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0097435](http://purl.obolibrary.org/obo/GO_0097435) (supramolecular fiber organization), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0031640](http://purl.obolibrary.org/obo/GO_0031640) (killing of cells of other organism), [GO:0031641](http://purl.obolibrary.org/obo/GO_0031641) (regulation of myelination), [GO:0060180](http://purl.obolibrary.org/obo/GO_0060180) (female mating behavior), [GO:0032972](http://purl.obolibrary.org/obo/GO_0032972) (regulation of muscle filament sliding speed), [GO:0016024](http://purl.obolibrary.org/obo/GO_0016024) (CDP-diacylglycerol biosynthetic process), [GO:0031642](http://purl.obolibrary.org/obo/GO_0031642) (negative regulation of myelination), [GO:0032973](http://purl.obolibrary.org/obo/GO_0032973) (amino acid export), [GO:0030314](http://purl.obolibrary.org/obo/GO_0030314) (junctional membrane complex), [GO:0032974](http://purl.obolibrary.org/obo/GO_0032974) (amino acid transmembrane export from vacuole), [GO:0031643](http://purl.obolibrary.org/obo/GO_0031643) (positive regulation of myelination), [GO:0043584](http://purl.obolibrary.org/obo/GO_0043584) (nose development), [GO:0042254](http://purl.obolibrary.org/obo/GO_0042254) (ribosome biogenesis), [GO:0043587](http://purl.obolibrary.org/obo/GO_0043587) (tongue morphogenesis), [GO:0042255](http://purl.obolibrary.org/obo/GO_0042255) (ribosome assembly), [GO:0043586](http://purl.obolibrary.org/obo/GO_0043586) (tongue development), [GO:0042256](http://purl.obolibrary.org/obo/GO_0042256) (mature ribosome assembly), [GO:0043589](http://purl.obolibrary.org/obo/GO_0043589) (skin morphogenesis), [GO:0043588](http://purl.obolibrary.org/obo/GO_0043588) (skin development), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0001702](http://purl.obolibrary.org/obo/GO_0001702) (gastrulation with mouth forming second), [GO:0001706](http://purl.obolibrary.org/obo/GO_0001706) (endoderm formation), [GO:0031594](http://purl.obolibrary.org/obo/GO_0031594) (neuromuscular junction), [GO:0001707](http://purl.obolibrary.org/obo/GO_0001707) (mesoderm formation), [GO:0001708](http://purl.obolibrary.org/obo/GO_0001708) (cell fate specification), [GO:0001709](http://purl.obolibrary.org/obo/GO_0001709) (cell fate determination), [GO:0030267](http://purl.obolibrary.org/obo/GO_0030267) (glyoxylate reductase (NADP) activity), [GO:0031593](http://purl.obolibrary.org/obo/GO_0031593) (polyubiquitin modification-dependent protein binding), [GO:0030261](http://purl.obolibrary.org/obo/GO_0030261) (chromosome condensation), [GO:0043596](http://purl.obolibrary.org/obo/GO_0043596) (nuclear replication fork), [GO:0042267](http://purl.obolibrary.org/obo/GO_0042267) (natural killer cell mediated cytotoxicity), [GO:0042269](http://purl.obolibrary.org/obo/GO_0042269) (regulation of natural killer cell mediated cytotoxicity), [GO:0001710](http://purl.obolibrary.org/obo/GO_0001710) (mesodermal cell fate commitment), [GO:0042272](http://purl.obolibrary.org/obo/GO_0042272) (nuclear RNA export factor complex), [GO:0042273](http://purl.obolibrary.org/obo/GO_0042273) (ribosomal large subunit biogenesis), [GO:0042274](http://purl.obolibrary.org/obo/GO_0042274) (ribosomal small subunit biogenesis), [GO:0001714](http://purl.obolibrary.org/obo/GO_0001714) (endodermal cell fate specification), [GO:0031588](http://purl.obolibrary.org/obo/GO_0031588) (nucleotide-activated protein kinase complex), [GO:0031581](http://purl.obolibrary.org/obo/GO_0031581) (hemidesmosome assembly), [GO:0030250](http://purl.obolibrary.org/obo/GO_0030250) (guanylate cyclase activator activity), [GO:0042276](http://purl.obolibrary.org/obo/GO_0042276) (error-prone translesion synthesis), [GO:0042277](http://purl.obolibrary.org/obo/GO_0042277) (peptide binding), [GO:0042278](http://purl.obolibrary.org/obo/GO_0042278) (purine nucleoside metabolic process), [GO:0030249](http://purl.obolibrary.org/obo/GO_0030249) (guanylate cyclase regulator activity), [GO:0042281](http://purl.obolibrary.org/obo/GO_0042281) (dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity), [GO:0042283](http://purl.obolibrary.org/obo/GO_0042283) (dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity), [GO:0042285](http://purl.obolibrary.org/obo/GO_0042285) (xylosyltransferase activity), [GO:0030242](http://purl.obolibrary.org/obo/GO_0030242) (autophagy of peroxisome), [GO:0030241](http://purl.obolibrary.org/obo/GO_0030241) (skeletal muscle myosin thick filament assembly), [GO:0031572](http://purl.obolibrary.org/obo/GO_0031572) (G2 DNA damage checkpoint), [GO:0031573](http://purl.obolibrary.org/obo/GO_0031573) (intra-S DNA damage checkpoint), [GO:0030246](http://purl.obolibrary.org/obo/GO_0030246) (carbohydrate binding), [GO:0031578](http://purl.obolibrary.org/obo/GO_0031578) (mitotic spindle orientation checkpoint), [GO:0031579](http://purl.obolibrary.org/obo/GO_0031579) (membrane raft organization), [GO:0030247](http://purl.obolibrary.org/obo/GO_0030247) (polysaccharide binding), [GO:0031571](http://purl.obolibrary.org/obo/GO_0031571) (mitotic G1 DNA damage checkpoint), [GO:0030240](http://purl.obolibrary.org/obo/GO_0030240) (skeletal muscle thin filament assembly), [GO:0042287](http://purl.obolibrary.org/obo/GO_0042287) (MHC protein binding), [GO:0042288](http://purl.obolibrary.org/obo/GO_0042288) (MHC class I protein binding), [GO:0042289](http://purl.obolibrary.org/obo/GO_0042289) (MHC class II protein binding), [GO:0030239](http://purl.obolibrary.org/obo/GO_0030239) (myofibril assembly), [GO:0030238](http://purl.obolibrary.org/obo/GO_0030238) (male sex determination), [GO:0030235](http://purl.obolibrary.org/obo/GO_0030235) (nitric-oxide synthase regulator activity), [GO:0030234](http://purl.obolibrary.org/obo/GO_0030234) (enzyme regulator activity), [GO:0032897](http://purl.obolibrary.org/obo/GO_0032897) (negative regulation of viral transcription), [GO:0043548](http://purl.obolibrary.org/obo/GO_0043548) (phosphatidylinositol 3-kinase binding), [GO:0043541](http://purl.obolibrary.org/obo/GO_0043541) (UDP-N-acetylglucosamine transferase complex), [GO:0000414](http://purl.obolibrary.org/obo/GO_0000414) (regulation of histone H3-K36 methylation), [GO:0043542](http://purl.obolibrary.org/obo/GO_0043542) (endothelial cell migration), [GO:0000413](http://purl.obolibrary.org/obo/GO_0000413) (protein peptidyl-prolyl isomerization), [GO:0043545](http://purl.obolibrary.org/obo/GO_0043545) (molybdopterin cofactor metabolic process), [GO:0043547](http://purl.obolibrary.org/obo/GO_0043547) (positive regulation of GTPase activity), [GO:0001750](http://purl.obolibrary.org/obo/GO_0001750) (photoreceptor outer segment), [GO:0043546](http://purl.obolibrary.org/obo/GO_0043546) (molybdopterin cofactor binding), [GO:0044877](http://purl.obolibrary.org/obo/GO_0044877) (macromolecular complex binding), [GO:0001740](http://purl.obolibrary.org/obo/GO_0001740) (Barr body), [GO:0001741](http://purl.obolibrary.org/obo/GO_0001741) (XY body), [GO:0043550](http://purl.obolibrary.org/obo/GO_0043550) (regulation of lipid kinase activity), [GO:0042220](http://purl.obolibrary.org/obo/GO_0042220) (response to cocaine), [GO:0043552](http://purl.obolibrary.org/obo/GO_0043552) (positive regulation of phosphatidylinositol 3-kinase activity), [GO:0043551](http://purl.obolibrary.org/obo/GO_0043551) (regulation of phosphatidylinositol 3-kinase activity), [GO:0043553](http://purl.obolibrary.org/obo/GO_0043553) (negative regulation of phosphatidylinositol 3-kinase activity), [GO:0000423](http://purl.obolibrary.org/obo/GO_0000423) (mitophagy), [GO:0000422](http://purl.obolibrary.org/obo/GO_0000422) (autophagy of mitochondrion), [GO:0000421](http://purl.obolibrary.org/obo/GO_0000421) (autophagosome membrane), [GO:0001754](http://purl.obolibrary.org/obo/GO_0001754) (eye photoreceptor cell differentiation), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0001756](http://purl.obolibrary.org/obo/GO_0001756) (somitogenesis), [GO:0001757](http://purl.obolibrary.org/obo/GO_0001757) (somite specification), [GO:0043560](http://purl.obolibrary.org/obo/GO_0043560) (insulin receptor substrate binding), [GO:0001758](http://purl.obolibrary.org/obo/GO_0001758) (retinal dehydrogenase activity), [GO:0001759](http://purl.obolibrary.org/obo/GO_0001759) (organ induction), [GO:0030297](http://purl.obolibrary.org/obo/GO_0030297) (transmembrane receptor protein tyrosine kinase activator activity), [GO:0030296](http://purl.obolibrary.org/obo/GO_0030296) (protein tyrosine kinase activator activity), [GO:0030299](http://purl.obolibrary.org/obo/GO_0030299) (intestinal cholesterol absorption), [GO:0030291](http://purl.obolibrary.org/obo/GO_0030291) (protein serine/threonine kinase inhibitor activity), [GO:0030295](http://purl.obolibrary.org/obo/GO_0030295) (protein kinase activator activity), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0043569](http://purl.obolibrary.org/obo/GO_0043569) (negative regulation of insulin-like growth factor receptor signaling pathway), [GO:0097386](http://purl.obolibrary.org/obo/GO_0097386) (glial cell projection), [GO:0043570](http://purl.obolibrary.org/obo/GO_0043570) (maintenance of DNA repeat elements), [GO:0001725](http://purl.obolibrary.org/obo/GO_0001725) (stress fiber), [GO:0001726](http://purl.obolibrary.org/obo/GO_0001726) (ruffle), [GO:0030286](http://purl.obolibrary.org/obo/GO_0030286) (dynein complex), [GO:0001727](http://purl.obolibrary.org/obo/GO_0001727) (lipid kinase activity), [GO:0001729](http://purl.obolibrary.org/obo/GO_0001729) (ceramide kinase activity), [GO:0030280](http://purl.obolibrary.org/obo/GO_0030280) (structural constituent of epidermis), [GO:0030282](http://purl.obolibrary.org/obo/GO_0030282) (bone mineralization), [GO:0000407](http://purl.obolibrary.org/obo/GO_0000407) (phagophore assembly site), [GO:0030284](http://purl.obolibrary.org/obo/GO_0030284) (estrogen receptor activity), [GO:0030283](http://purl.obolibrary.org/obo/GO_0030283) (testosterone dehydrogenase [NAD(P)] activity), [GO:0000406](http://purl.obolibrary.org/obo/GO_0000406) (double-strand/single-strand DNA junction binding), [GO:0000405](http://purl.obolibrary.org/obo/GO_0000405) (bubble DNA binding), [GO:0000404](http://purl.obolibrary.org/obo/GO_0000404) (heteroduplex DNA loop binding), [GO:0043576](http://purl.obolibrary.org/obo/GO_0043576) (regulation of respiratory gaseous exchange), [GO:0000403](http://purl.obolibrary.org/obo/GO_0000403) (Y-form DNA binding), [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration), [GO:0000400](http://purl.obolibrary.org/obo/GO_0000400) (four-way junction DNA binding), [GO:0043577](http://purl.obolibrary.org/obo/GO_0043577) (chemotropism), [GO:0043583](http://purl.obolibrary.org/obo/GO_0043583) (ear development), [GO:0001736](http://purl.obolibrary.org/obo/GO_0001736) (establishment of planar polarity), [GO:0030275](http://purl.obolibrary.org/obo/GO_0030275) (LRR domain binding), [GO:0001738](http://purl.obolibrary.org/obo/GO_0001738) (morphogenesis of a polarized epithelium), [GO:0030277](http://purl.obolibrary.org/obo/GO_0030277) (maintenance of gastrointestinal epithelium), [GO:0030276](http://purl.obolibrary.org/obo/GO_0030276) (clathrin binding), [GO:0030279](http://purl.obolibrary.org/obo/GO_0030279) (negative regulation of ossification), [GO:0030278](http://purl.obolibrary.org/obo/GO_0030278) (regulation of ossification), [GO:0050718](http://purl.obolibrary.org/obo/GO_0050718) (positive regulation of interleukin-1 beta secretion), [GO:0000454](http://purl.obolibrary.org/obo/GO_0000454) (snoRNA guided rRNA pseudouridine synthesis), [GO:0001784](http://purl.obolibrary.org/obo/GO_0001784) (phosphotyrosine residue binding), [GO:0000462](http://purl.obolibrary.org/obo/GO_0000462) (maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)), [GO:0001785](http://purl.obolibrary.org/obo/GO_0001785) (prostaglandin J receptor activity), [GO:0001786](http://purl.obolibrary.org/obo/GO_0001786) (phosphatidylserine binding), [GO:0000460](http://purl.obolibrary.org/obo/GO_0000460) (maturation of 5.8S rRNA), [GO:0001788](http://purl.obolibrary.org/obo/GO_0001788) (antibody-dependent cellular cytotoxicity), [GO:0050715](http://purl.obolibrary.org/obo/GO_0050715) (positive regulation of cytokine secretion), [GO:0050713](http://purl.obolibrary.org/obo/GO_0050713) (negative regulation of interleukin-1 beta secretion), [GO:0050714](http://purl.obolibrary.org/obo/GO_0050714) (positive regulation of protein secretion), [GO:0050711](http://purl.obolibrary.org/obo/GO_0050711) (negative regulation of interleukin-1 secretion), [GO:0050710](http://purl.obolibrary.org/obo/GO_0050710) (negative regulation of cytokine secretion), [GO:0050728](http://purl.obolibrary.org/obo/GO_0050728) (negative regulation of inflammatory response), [GO:0050729](http://purl.obolibrary.org/obo/GO_0050729) (positive regulation of inflammatory response), [GO:0048403](http://purl.obolibrary.org/obo/GO_0048403) (brain-derived neurotrophic factor binding), [GO:0000469](http://purl.obolibrary.org/obo/GO_0000469) (cleavage involved in rRNA processing), [GO:1903815](http://purl.obolibrary.org/obo/GO_1903815) (negative regulation of collecting lymphatic vessel constriction), [GO:0048407](http://purl.obolibrary.org/obo/GO_0048407) (platelet-derived growth factor binding), [GO:0048406](http://purl.obolibrary.org/obo/GO_0048406) (nerve growth factor binding), [GO:0000472](http://purl.obolibrary.org/obo/GO_0000472) (endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)), [GO:0001798](http://purl.obolibrary.org/obo/GO_0001798) (positive regulation of type IIa hypersensitivity), [GO:0000470](http://purl.obolibrary.org/obo/GO_0000470) (maturation of LSU-rRNA), [GO:0050727](http://purl.obolibrary.org/obo/GO_0050727) (regulation of inflammatory response), [GO:0000439](http://purl.obolibrary.org/obo/GO_0000439) (core TFIIH complex), [GO:0000433](http://purl.obolibrary.org/obo/GO_0000433) (negative regulation of transcription from RNA polymerase II promoter by glucose), [GO:0001771](http://purl.obolibrary.org/obo/GO_0001771) (immunological synapse formation), [GO:0001772](http://purl.obolibrary.org/obo/GO_0001772) (immunological synapse), [GO:0050730](http://purl.obolibrary.org/obo/GO_0050730) (regulation of peptidyl-tyrosine phosphorylation), [GO:0001763](http://purl.obolibrary.org/obo/GO_0001763) (morphogenesis of a branching structure), [GO:0001764](http://purl.obolibrary.org/obo/GO_0001764) (neuron migration), [GO:0001766](http://purl.obolibrary.org/obo/GO_0001766) (membrane raft polarization), [GO:0001768](http://purl.obolibrary.org/obo/GO_0001768) (establishment of T cell polarity), [GO:0050733](http://purl.obolibrary.org/obo/GO_0050733) (RS domain binding), [GO:0050731](http://purl.obolibrary.org/obo/GO_0050731) (positive regulation of peptidyl-tyrosine phosphorylation), [GO:0050732](http://purl.obolibrary.org/obo/GO_0050732) (negative regulation of peptidyl-tyrosine phosphorylation), [GO:0000448](http://purl.obolibrary.org/obo/GO_0000448) (cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)), [GO:1903833](http://purl.obolibrary.org/obo/GO_1903833) (positive regulation of cellular response to amino acid starvation), [GO:0000447](http://purl.obolibrary.org/obo/GO_0000447) (endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)), [GO:0000446](http://purl.obolibrary.org/obo/GO_0000446) (nucleoplasmic THO complex), [GO:0000445](http://purl.obolibrary.org/obo/GO_0000445) (THO complex part of transcription export complex), [GO:0001780](http://purl.obolibrary.org/obo/GO_0001780) (neutrophil homeostasis), [GO:0001781](http://purl.obolibrary.org/obo/GO_0001781) (neutrophil apoptotic process), [GO:0001782](http://purl.obolibrary.org/obo/GO_0001782) (B cell homeostasis), [GO:0001783](http://purl.obolibrary.org/obo/GO_0001783) (B cell apoptotic process), [GO:0001774](http://purl.obolibrary.org/obo/GO_0001774) (microglial cell activation), [GO:0001775](http://purl.obolibrary.org/obo/GO_0001775) (cell activation), [GO:1903827](http://purl.obolibrary.org/obo/GO_1903827) (regulation of cellular protein localization), [GO:1903828](http://purl.obolibrary.org/obo/GO_1903828) (negative regulation of cellular protein localization), [GO:0001778](http://purl.obolibrary.org/obo/GO_0001778) (plasma membrane repair), [GO:0001779](http://purl.obolibrary.org/obo/GO_0001779) (natural killer cell differentiation), [GO:0036455](http://purl.obolibrary.org/obo/GO_0036455) (iron-sulfur transferase activity), [GO:0035124](http://purl.obolibrary.org/obo/GO_0035124) (embryonic caudal fin morphogenesis), [GO:0035118](http://purl.obolibrary.org/obo/GO_0035118) (embryonic pectoral fin morphogenesis), [GO:0036449](http://purl.obolibrary.org/obo/GO_0036449) (microtubule minus-end), [GO:0035115](http://purl.obolibrary.org/obo/GO_0035115) (embryonic forelimb morphogenesis), [GO:0035116](http://purl.obolibrary.org/obo/GO_0035116) (embryonic hindlimb morphogenesis), [GO:0036444](http://purl.obolibrary.org/obo/GO_0036444) (mitochondrial calcium uptake), [GO:0036438](http://purl.obolibrary.org/obo/GO_0036438) (maintenance of lens transparency), [GO:0035108](http://purl.obolibrary.org/obo/GO_0035108) (limb morphogenesis), [GO:0036435](http://purl.obolibrary.org/obo/GO_0036435) (K48-linked polyubiquitin modification-dependent protein binding), [GO:2000203](http://purl.obolibrary.org/obo/GO_2000203) (regulation of ribosomal large subunit export from nucleus), [GO:0000478](http://purl.obolibrary.org/obo/GO_0000478) (endonucleolytic cleavage involved in rRNA processing), [GO:0000480](http://purl.obolibrary.org/obo/GO_0000480) (endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)), [GO:2000212](http://purl.obolibrary.org/obo/GO_2000212) (negative regulation of glutamate metabolic process), [GO:0050708](http://purl.obolibrary.org/obo/GO_0050708) (regulation of protein secretion), [GO:0050709](http://purl.obolibrary.org/obo/GO_0050709) (negative regulation of protein secretion), [GO:0050707](http://purl.obolibrary.org/obo/GO_0050707) (regulation of cytokine secretion), [GO:0000495](http://purl.obolibrary.org/obo/GO_0000495) (box H/ACA snoRNA 3'-end processing), [GO:2000228](http://purl.obolibrary.org/obo/GO_2000228) (positive regulation of pancreatic A cell differentiation), [GO:2000222](http://purl.obolibrary.org/obo/GO_2000222) (positive regulation of pseudohyphal growth), [GO:2000221](http://purl.obolibrary.org/obo/GO_2000221) (negative regulation of pseudohyphal growth), [GO:0050702](http://purl.obolibrary.org/obo/GO_0050702) (interleukin-1 beta secretion), [GO:0050700](http://purl.obolibrary.org/obo/GO_0050700) (CARD domain binding), [GO:0050701](http://purl.obolibrary.org/obo/GO_0050701) (interleukin-1 secretion), [GO:0036414](http://purl.obolibrary.org/obo/GO_0036414) (histone citrullination), [GO:2000224](http://purl.obolibrary.org/obo/GO_2000224) (regulation of testosterone biosynthetic process), [GO:0061576](http://purl.obolibrary.org/obo/GO_0061576) (acyl-CoA ceramide synthase complex), [GO:0035282](http://purl.obolibrary.org/obo/GO_0035282) (segmentation), [GO:1903763](http://purl.obolibrary.org/obo/GO_1903763) (gap junction channel activity involved in cell communication by electrical coupling), [GO:1902430](http://purl.obolibrary.org/obo/GO_1902430) (negative regulation of amyloid-beta formation), [GO:1903766](http://purl.obolibrary.org/obo/GO_1903766) (positive regulation of potassium ion export across plasma membrane), [GO:0035280](http://purl.obolibrary.org/obo/GO_0035280) (miRNA loading onto RISC involved in gene silencing by miRNA), [GO:0061578](http://purl.obolibrary.org/obo/GO_0061578) (Lys63-specific deubiquitinase activity), [GO:0006720](http://purl.obolibrary.org/obo/GO_0006720) (isoprenoid metabolic process), [GO:0006714](http://purl.obolibrary.org/obo/GO_0006714) (sesquiterpenoid metabolic process), [GO:0098850](http://purl.obolibrary.org/obo/GO_0098850) (extrinsic component of synaptic vesicle membrane), [GO:0098855](http://purl.obolibrary.org/obo/GO_0098855) (HCN channel complex), [GO:0072221](http://purl.obolibrary.org/obo/GO_0072221) (metanephric distal convoluted tubule development), [GO:0097527](http://purl.obolibrary.org/obo/GO_0097527) (necroptotic signaling pathway), [GO:0035279](http://purl.obolibrary.org/obo/GO_0035279) (mRNA cleavage involved in gene silencing by miRNA), [GO:0060231](http://purl.obolibrary.org/obo/GO_0060231) (mesenchymal to epithelial transition), [GO:0061564](http://purl.obolibrary.org/obo/GO_0061564) (axon development), [GO:0035278](http://purl.obolibrary.org/obo/GO_0035278) (miRNA mediated inhibition of translation), [GO:2000010](http://purl.obolibrary.org/obo/GO_2000010) (positive regulation of protein localization to cell surface), [GO:1902443](http://purl.obolibrary.org/obo/GO_1902443) (negative regulation of ripoptosome assembly involved in necroptotic process), [GO:1903774](http://purl.obolibrary.org/obo/GO_1903774) (positive regulation of viral budding via host ESCRT complex), [GO:0060230](http://purl.obolibrary.org/obo/GO_0060230) (lipoprotein lipase activator activity), [GO:1903772](http://purl.obolibrary.org/obo/GO_1903772) (regulation of viral budding via host ESCRT complex), [GO:0035270](http://purl.obolibrary.org/obo/GO_0035270) (endocrine system development), [GO:0060235](http://purl.obolibrary.org/obo/GO_0060235) (lens induction in camera-type eye), [GO:0060236](http://purl.obolibrary.org/obo/GO_0060236) (regulation of mitotic spindle organization), [GO:0006730](http://purl.obolibrary.org/obo/GO_0006730) (one-carbon metabolic process), [GO:0060237](http://purl.obolibrary.org/obo/GO_0060237) (regulation of fungal-type cell wall organization), [GO:0006725](http://purl.obolibrary.org/obo/GO_0006725) (cellular aromatic compound metabolic process), [GO:2000008](http://purl.obolibrary.org/obo/GO_2000008) (regulation of protein localization to cell surface), [GO:0006729](http://purl.obolibrary.org/obo/GO_0006729) (tetrahydrobiopterin biosynthetic process), [GO:0097535](http://purl.obolibrary.org/obo/GO_0097535) (lymphoid lineage cell migration into thymus), [GO:0072210](http://purl.obolibrary.org/obo/GO_0072210) (metanephric nephron development), [GO:0098869](http://purl.obolibrary.org/obo/GO_0098869) (cellular oxidant detoxification), [GO:0097536](http://purl.obolibrary.org/obo/GO_0097536) (thymus epithelium morphogenesis), [GO:2000001](http://purl.obolibrary.org/obo/GO_2000001) (regulation of DNA damage checkpoint), [GO:0097539](http://purl.obolibrary.org/obo/GO_0097539) (ciliary transition fiber), [GO:0098868](http://purl.obolibrary.org/obo/GO_0098868) (bone growth), [GO:0035268](http://purl.obolibrary.org/obo/GO_0035268) (protein mannosylation), [GO:0035269](http://purl.obolibrary.org/obo/GO_0035269) (protein O-linked mannosylation), [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth), [GO:0060265](http://purl.obolibrary.org/obo/GO_0060265) (positive regulation of respiratory burst involved in inflammatory response), [GO:0035265](http://purl.obolibrary.org/obo/GO_0035265) (organ growth), [GO:0060266](http://purl.obolibrary.org/obo/GO_0060266) (negative regulation of respiratory burst involved in inflammatory response), [GO:0061598](http://purl.obolibrary.org/obo/GO_0061598) (molybdopterin adenylyltransferase activity), [GO:2000021](http://purl.obolibrary.org/obo/GO_2000021) (regulation of ion homeostasis), [GO:2000020](http://purl.obolibrary.org/obo/GO_2000020) (positive regulation of male gonad development), [GO:0060261](http://purl.obolibrary.org/obo/GO_0060261) (positive regulation of transcription initiation from RNA polymerase II promoter), [GO:1903788](http://purl.obolibrary.org/obo/GO_1903788) (positive regulation of glutathione biosynthetic process), [GO:0061599](http://purl.obolibrary.org/obo/GO_0061599) (molybdopterin molybdotransferase activity), [GO:0006700](http://purl.obolibrary.org/obo/GO_0006700) (C21-steroid hormone biosynthetic process), [GO:0097500](http://purl.obolibrary.org/obo/GO_0097500) (receptor localization to non-motile cilium), [GO:0097502](http://purl.obolibrary.org/obo/GO_0097502) (mannosylation), [GO:0098830](http://purl.obolibrary.org/obo/GO_0098830) (presynaptic endosome), [GO:0047293](http://purl.obolibrary.org/obo/GO_0047293) (4-hydroxybenzoate nonaprenyltransferase activity), [GO:0035257](http://purl.obolibrary.org/obo/GO_0035257) (nuclear hormone receptor binding), [GO:2000018](http://purl.obolibrary.org/obo/GO_2000018) (regulation of male gonad development), [GO:0035259](http://purl.obolibrary.org/obo/GO_0035259) (glucocorticoid receptor binding), [GO:0047291](http://purl.obolibrary.org/obo/GO_0047291) (lactosylceramide alpha-2,3-sialyltransferase activity), [GO:0098839](http://purl.obolibrary.org/obo/GO_0098839) (postsynaptic density membrane), [GO:0060253](http://purl.obolibrary.org/obo/GO_0060253) (negative regulation of glial cell proliferation), [GO:0035253](http://purl.obolibrary.org/obo/GO_0035253) (ciliary rootlet), [GO:0035254](http://purl.obolibrary.org/obo/GO_0035254) (glutamate receptor binding), [GO:0035255](http://purl.obolibrary.org/obo/GO_0035255) (ionotropic glutamate receptor binding), [GO:0035256](http://purl.obolibrary.org/obo/GO_0035256) (G-protein coupled glutamate receptor binding), [GO:0061580](http://purl.obolibrary.org/obo/GO_0061580) (colon epithelial cell migration), [GO:0035250](http://purl.obolibrary.org/obo/GO_0035250) (UDP-galactosyltransferase activity), [GO:0060251](http://purl.obolibrary.org/obo/GO_0060251) (regulation of glial cell proliferation), [GO:0035251](http://purl.obolibrary.org/obo/GO_0035251) (UDP-glucosyltransferase activity), [GO:0061582](http://purl.obolibrary.org/obo/GO_0061582) (intestinal epithelial cell migration), [GO:1902462](http://purl.obolibrary.org/obo/GO_1902462) (positive regulation of mesenchymal stem cell proliferation), [GO:0035252](http://purl.obolibrary.org/obo/GO_0035252) (UDP-xylosyltransferase activity), [GO:0060252](http://purl.obolibrary.org/obo/GO_0060252) (positive regulation of glial cell proliferation), [GO:1903799](http://purl.obolibrary.org/obo/GO_1903799) (negative regulation of production of miRNAs involved in gene silencing by miRNA), [GO:1901135](http://purl.obolibrary.org/obo/GO_1901135) (carbohydrate derivative metabolic process), [GO:1901137](http://purl.obolibrary.org/obo/GO_1901137) (carbohydrate derivative biosynthetic process), [GO:0060259](http://purl.obolibrary.org/obo/GO_0060259) (regulation of feeding behavior), [GO:0006703](http://purl.obolibrary.org/obo/GO_0006703) (estrogen biosynthetic process), [GO:0006704](http://purl.obolibrary.org/obo/GO_0006704) (glucocorticoid biosynthetic process), [GO:0098840](http://purl.obolibrary.org/obo/GO_0098840) (protein transport along microtubule), [GO:0006701](http://purl.obolibrary.org/obo/GO_0006701) (progesterone biosynthetic process), [GO:0006702](http://purl.obolibrary.org/obo/GO_0006702) (androgen biosynthetic process), [GO:0006707](http://purl.obolibrary.org/obo/GO_0006707) (cholesterol catabolic process), [GO:0097510](http://purl.obolibrary.org/obo/GO_0097510) (base-excision repair, AP site formation via deaminated base removal), [GO:0006705](http://purl.obolibrary.org/obo/GO_0006705) (mineralocorticoid biosynthetic process), [GO:0097512](http://purl.obolibrary.org/obo/GO_0097512) (cardiac myofibril), [GO:0006706](http://purl.obolibrary.org/obo/GO_0006706) (steroid catabolic process), [GO:0006709](http://purl.obolibrary.org/obo/GO_0006709) (progesterone catabolic process), [GO:0035246](http://purl.obolibrary.org/obo/GO_0035246) (peptidyl-arginine N-methylation), [GO:0097519](http://purl.obolibrary.org/obo/GO_0097519) (DNA recombinase complex), [GO:2000027](http://purl.obolibrary.org/obo/GO_2000027) (regulation of organ morphogenesis), [GO:0035249](http://purl.obolibrary.org/obo/GO_0035249) (synaptic transmission, glutamatergic), [GO:2000026](http://purl.obolibrary.org/obo/GO_2000026) (regulation of multicellular organismal development), [GO:2000043](http://purl.obolibrary.org/obo/GO_2000043) (regulation of cardiac cell fate specification), [GO:2000042](http://purl.obolibrary.org/obo/GO_2000042) (negative regulation of double-strand break repair via homologous recombination), [GO:0061537](http://purl.obolibrary.org/obo/GO_0061537) (glycine secretion, neurotransmission), [GO:0048557](http://purl.obolibrary.org/obo/GO_0048557) (embryonic digestive tract morphogenesis), [GO:1903721](http://purl.obolibrary.org/obo/GO_1903721) (positive regulation of I-kappaB phosphorylation), [GO:0005432](http://purl.obolibrary.org/obo/GO_0005432) (calcium:sodium antiporter activity), [GO:0061534](http://purl.obolibrary.org/obo/GO_0061534) (gamma-aminobutyric acid secretion, neurotransmission), [GO:0004104](http://purl.obolibrary.org/obo/GO_0004104) (cholinesterase activity), [GO:0061535](http://purl.obolibrary.org/obo/GO_0061535) (glutamate secretion, neurotransmission), [GO:0060205](http://purl.obolibrary.org/obo/GO_0060205) (cytoplasmic vesicle lumen), [GO:0004103](http://purl.obolibrary.org/obo/GO_0004103) (choline kinase activity), [GO:0050872](http://purl.obolibrary.org/obo/GO_0050872) (white fat cell differentiation), [GO:0048562](http://purl.obolibrary.org/obo/GO_0048562) (embryonic organ morphogenesis), [GO:0050873](http://purl.obolibrary.org/obo/GO_0050873) (brown fat cell differentiation), [GO:0031715](http://purl.obolibrary.org/obo/GO_0031715) (C5L2 anaphylatoxin chemotactic receptor binding), [GO:0050870](http://purl.obolibrary.org/obo/GO_0050870) (positive regulation of T cell activation), [GO:0048560](http://purl.obolibrary.org/obo/GO_0048560) (establishment of anatomical structure orientation), [GO:0050871](http://purl.obolibrary.org/obo/GO_0050871) (positive regulation of B cell activation), [GO:1903718](http://purl.obolibrary.org/obo/GO_1903718) (cellular response to ammonia), [GO:0031713](http://purl.obolibrary.org/obo/GO_0031713) (B2 bradykinin receptor binding), [GO:0048566](http://purl.obolibrary.org/obo/GO_0048566) (embryonic digestive tract development), [GO:0048565](http://purl.obolibrary.org/obo/GO_0048565) (digestive tract development), [GO:0048563](http://purl.obolibrary.org/obo/GO_0048563) (post-embryonic animal organ morphogenesis), [GO:0098815](http://purl.obolibrary.org/obo/GO_0098815) (modulation of excitatory postsynaptic potential), [GO:2000035](http://purl.obolibrary.org/obo/GO_2000035) (regulation of stem cell division), [GO:0050878](http://purl.obolibrary.org/obo/GO_0050878) (regulation of body fluid levels), [GO:0050877](http://purl.obolibrary.org/obo/GO_0050877) (nervous system process), [GO:0031711](http://purl.obolibrary.org/obo/GO_0031711) (bradykinin receptor binding), [GO:2000054](http://purl.obolibrary.org/obo/GO_2000054) (negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification), [GO:2000052](http://purl.obolibrary.org/obo/GO_2000052) (positive regulation of non-canonical Wnt signaling pathway), [GO:2000051](http://purl.obolibrary.org/obo/GO_2000051) (negative regulation of non-canonical Wnt signaling pathway), [GO:0006772](http://purl.obolibrary.org/obo/GO_0006772) (thiamine metabolic process), [GO:0047238](http://purl.obolibrary.org/obo/GO_0047238) (glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity), [GO:0048568](http://purl.obolibrary.org/obo/GO_0048568) (embryonic organ development), [GO:0006777](http://purl.obolibrary.org/obo/GO_0006777) (Mo-molybdopterin cofactor biosynthetic process), [GO:0004112](http://purl.obolibrary.org/obo/GO_0004112) (cyclic-nucleotide phosphodiesterase activity), [GO:0004115](http://purl.obolibrary.org/obo/GO_0004115) (3',5'-cyclic-AMP phosphodiesterase activity), [GO:0004114](http://purl.obolibrary.org/obo/GO_0004114) (3',5'-cyclic-nucleotide phosphodiesterase activity), [GO:0061525](http://purl.obolibrary.org/obo/GO_0061525) (hindgut development), [GO:0050883](http://purl.obolibrary.org/obo/GO_0050883) (musculoskeletal movement, spinal reflex action), [GO:0005436](http://purl.obolibrary.org/obo/GO_0005436) (sodium:phosphate symporter activity), [GO:0050884](http://purl.obolibrary.org/obo/GO_0050884) (neuromuscular process controlling posture), [GO:0050881](http://purl.obolibrary.org/obo/GO_0050881) (musculoskeletal movement), [GO:0006768](http://purl.obolibrary.org/obo/GO_0006768) (biotin metabolic process), [GO:0048570](http://purl.obolibrary.org/obo/GO_0048570) (notochord morphogenesis), [GO:0050882](http://purl.obolibrary.org/obo/GO_0050882) (voluntary musculoskeletal movement), [GO:0031702](http://purl.obolibrary.org/obo/GO_0031702) (type 1 angiotensin receptor binding), [GO:0098821](http://purl.obolibrary.org/obo/GO_0098821) (BMP receptor activity), [GO:0050880](http://purl.obolibrary.org/obo/GO_0050880) (regulation of blood vessel size), [GO:0004109](http://purl.obolibrary.org/obo/GO_0004109) (coproporphyrinogen oxidase activity), [GO:0031708](http://purl.obolibrary.org/obo/GO_0031708) (endothelin B receptor binding), [GO:0098826](http://purl.obolibrary.org/obo/GO_0098826) (endoplasmic reticulum tubular network membrane), [GO:0050885](http://purl.obolibrary.org/obo/GO_0050885) (neuromuscular process controlling balance), [GO:2000048](http://purl.obolibrary.org/obo/GO_2000048) (negative regulation of cell-cell adhesion mediated by cadherin), [GO:0061551](http://purl.obolibrary.org/obo/GO_0061551) (trigeminal ganglion development), [GO:2000060](http://purl.obolibrary.org/obo/GO_2000060) (positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0060221](http://purl.obolibrary.org/obo/GO_0060221) (retinal rod cell differentiation), [GO:2000065](http://purl.obolibrary.org/obo/GO_2000065) (negative regulation of cortisol biosynthetic process), [GO:0061550](http://purl.obolibrary.org/obo/GO_0061550) (cranial ganglion development), [GO:0060228](http://purl.obolibrary.org/obo/GO_0060228) (phosphatidylcholine-sterol O-acyltransferase activator activity), [GO:0090076](http://purl.obolibrary.org/obo/GO_0090076) (relaxation of skeletal muscle), [GO:0006740](http://purl.obolibrary.org/obo/GO_0006740) (NADPH regeneration), [GO:0060229](http://purl.obolibrary.org/obo/GO_0060229) (lipase activator activity), [GO:0090073](http://purl.obolibrary.org/obo/GO_0090073) (positive regulation of protein homodimerization activity), [GO:0006744](http://purl.obolibrary.org/obo/GO_0006744) (ubiquinone biosynthetic process), [GO:0006741](http://purl.obolibrary.org/obo/GO_0006741) (NADP biosynthetic process), [GO:0090071](http://purl.obolibrary.org/obo/GO_0090071) (negative regulation of ribosome biogenesis), [GO:0005412](http://purl.obolibrary.org/obo/GO_0005412) (glucose:sodium symporter activity), [GO:0090080](http://purl.obolibrary.org/obo/GO_0090080) (positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway), [GO:0050892](http://purl.obolibrary.org/obo/GO_0050892) (intestinal absorption), [GO:0006734](http://purl.obolibrary.org/obo/GO_0006734) (NADH metabolic process), [GO:0050893](http://purl.obolibrary.org/obo/GO_0050893) (sensory processing), [GO:0050890](http://purl.obolibrary.org/obo/GO_0050890) (cognition), [GO:0050891](http://purl.obolibrary.org/obo/GO_0050891) (multicellular organismal water homeostasis), [GO:0006739](http://purl.obolibrary.org/obo/GO_0006739) (NADP metabolic process), [GO:2000058](http://purl.obolibrary.org/obo/GO_2000058) (regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0072205](http://purl.obolibrary.org/obo/GO_0072205) (metanephric collecting duct development), [GO:0072203](http://purl.obolibrary.org/obo/GO_0072203) (cell proliferation involved in metanephros development), [GO:0050896](http://purl.obolibrary.org/obo/GO_0050896) (response to stimulus), [GO:0050897](http://purl.obolibrary.org/obo/GO_0050897) (cobalt ion binding), [GO:2000059](http://purl.obolibrary.org/obo/GO_2000059) (negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0072207](http://purl.obolibrary.org/obo/GO_0072207) (metanephric epithelium development), [GO:0060211](http://purl.obolibrary.org/obo/GO_0060211) (regulation of nuclear-transcribed mRNA poly(A) tail shortening), [GO:0006750](http://purl.obolibrary.org/obo/GO_0006750) (glutathione biosynthetic process), [GO:0060218](http://purl.obolibrary.org/obo/GO_0060218) (hematopoietic stem cell differentiation), [GO:0006751](http://purl.obolibrary.org/obo/GO_0006751) (glutathione catabolic process), [GO:0060219](http://purl.obolibrary.org/obo/GO_0060219) (camera-type eye photoreceptor cell differentiation), [GO:0048589](http://purl.obolibrary.org/obo/GO_0048589) (developmental growth), [GO:0090086](http://purl.obolibrary.org/obo/GO_0090086) (negative regulation of protein deubiquitination), [GO:0006754](http://purl.obolibrary.org/obo/GO_0006754) (ATP biosynthetic process), [GO:0090084](http://purl.obolibrary.org/obo/GO_0090084) (negative regulation of inclusion body assembly), [GO:0060214](http://purl.obolibrary.org/obo/GO_0060214) (endocardium formation), [GO:0060215](http://purl.obolibrary.org/obo/GO_0060215) (primitive hemopoiesis), [GO:0060216](http://purl.obolibrary.org/obo/GO_0060216) (definitive hemopoiesis), [GO:0061547](http://purl.obolibrary.org/obo/GO_0061547) (glycogen synthase activity, transferring glucose-1-phosphate), [GO:1903758](http://purl.obolibrary.org/obo/GO_1903758) (negative regulation of transcription from RNA polymerase II promoter by histone modification), [GO:0090090](http://purl.obolibrary.org/obo/GO_0090090) (negative regulation of canonical Wnt signaling pathway), [GO:0090091](http://purl.obolibrary.org/obo/GO_0090091) (positive regulation of extracellular matrix disassembly), [GO:0048593](http://purl.obolibrary.org/obo/GO_0048593) (camera-type eye morphogenesis), [GO:0048592](http://purl.obolibrary.org/obo/GO_0048592) (eye morphogenesis), [GO:0048599](http://purl.obolibrary.org/obo/GO_0048599) (oocyte development), [GO:0048598](http://purl.obolibrary.org/obo/GO_0048598) (embryonic morphogenesis), [GO:0006749](http://purl.obolibrary.org/obo/GO_0006749) (glutathione metabolic process), [GO:0048597](http://purl.obolibrary.org/obo/GO_0048597) (post-embryonic camera-type eye morphogenesis), [GO:0048596](http://purl.obolibrary.org/obo/GO_0048596) (embryonic camera-type eye morphogenesis), [GO:0042415](http://purl.obolibrary.org/obo/GO_0042415) (norepinephrine metabolic process), [GO:0042416](http://purl.obolibrary.org/obo/GO_0042416) (dopamine biosynthetic process), [GO:0042417](http://purl.obolibrary.org/obo/GO_0042417) (dopamine metabolic process), [GO:0042418](http://purl.obolibrary.org/obo/GO_0042418) (epinephrine biosynthetic process), [GO:1901184](http://purl.obolibrary.org/obo/GO_1901184) (regulation of ERBB signaling pathway), [GO:0005471](http://purl.obolibrary.org/obo/GO_0005471) (ATP:ADP antiporter activity), [GO:0004143](http://purl.obolibrary.org/obo/GO_0004143) (diacylglycerol kinase activity), [GO:0004146](http://purl.obolibrary.org/obo/GO_0004146) (dihydrofolate reductase activity), [GO:0005476](http://purl.obolibrary.org/obo/GO_0005476) (carnitine:acyl carnitine antiporter activity), [GO:0004148](http://purl.obolibrary.org/obo/GO_0004148) (dihydrolipoyl dehydrogenase activity), [GO:0042414](http://purl.obolibrary.org/obo/GO_0042414) (epinephrine metabolic process), [GO:0030426](http://purl.obolibrary.org/obo/GO_0030426) (growth cone), [GO:0004138](http://purl.obolibrary.org/obo/GO_0004138) (deoxyguanosine kinase activity), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0030427](http://purl.obolibrary.org/obo/GO_0030427) (site of polarized growth), [GO:0030429](http://purl.obolibrary.org/obo/GO_0030429) (kynureninase activity), [GO:0016132](http://purl.obolibrary.org/obo/GO_0016132) (brassinosteroid biosynthetic process), [GO:0030422](http://purl.obolibrary.org/obo/GO_0030422) (production of siRNA involved in RNA interference), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0030423](http://purl.obolibrary.org/obo/GO_0030423) (targeting of mRNA for destruction involved in RNA interference), [GO:0042426](http://purl.obolibrary.org/obo/GO_0042426) (choline catabolic process), [GO:0042427](http://purl.obolibrary.org/obo/GO_0042427) (serotonin biosynthetic process), [GO:0042428](http://purl.obolibrary.org/obo/GO_0042428) (serotonin metabolic process), [GO:2000096](http://purl.obolibrary.org/obo/GO_2000096) (positive regulation of Wnt signaling pathway, planar cell polarity pathway), [GO:0004151](http://purl.obolibrary.org/obo/GO_0004151) (dihydroorotase activity), [GO:2000095](http://purl.obolibrary.org/obo/GO_2000095) (regulation of Wnt signaling pathway, planar cell polarity pathway), [GO:0005484](http://purl.obolibrary.org/obo/GO_0005484) (SNAP receptor activity), [GO:0004152](http://purl.obolibrary.org/obo/GO_0004152) (dihydroorotate dehydrogenase activity), [GO:0042420](http://purl.obolibrary.org/obo/GO_0042420) (dopamine catabolic process), [GO:0004155](http://purl.obolibrary.org/obo/GO_0004155) (6,7-dihydropteridine reductase activity), [GO:0042421](http://purl.obolibrary.org/obo/GO_0042421) (norepinephrine biosynthetic process), [GO:0043754](http://purl.obolibrary.org/obo/GO_0043754) (dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity), [GO:0004157](http://purl.obolibrary.org/obo/GO_0004157) (dihydropyrimidinase activity), [GO:0005487](http://purl.obolibrary.org/obo/GO_0005487) (nuclear pore activity), [GO:0042423](http://purl.obolibrary.org/obo/GO_0042423) (catecholamine biosynthetic process), [GO:0042424](http://purl.obolibrary.org/obo/GO_0042424) (catecholamine catabolic process), [GO:0004159](http://purl.obolibrary.org/obo/GO_0004159) (dihydrouracil dehydrogenase (NAD+) activity), [GO:0030414](http://purl.obolibrary.org/obo/GO_0030414) (peptidase inhibitor activity), [GO:0031748](http://purl.obolibrary.org/obo/GO_0031748) (D1 dopamine receptor binding), [GO:0031749](http://purl.obolibrary.org/obo/GO_0031749) (D2 dopamine receptor binding), [GO:0016125](http://purl.obolibrary.org/obo/GO_0016125) (sterol metabolic process), [GO:0016126](http://purl.obolibrary.org/obo/GO_0016126) (sterol biosynthetic process), [GO:0030412](http://purl.obolibrary.org/obo/GO_0030412) (formimidoyltetrahydrofolate cyclodeaminase activity), [GO:0042438](http://purl.obolibrary.org/obo/GO_0042438) (melanin biosynthetic process), [GO:0006780](http://purl.obolibrary.org/obo/GO_0006780) (uroporphyrinogen III biosynthetic process), [GO:0006783](http://purl.obolibrary.org/obo/GO_0006783) (heme biosynthetic process), [GO:0006784](http://purl.obolibrary.org/obo/GO_0006784) (heme a biosynthetic process), [GO:0004122](http://purl.obolibrary.org/obo/GO_0004122) (cystathionine beta-synthase activity), [GO:0005452](http://purl.obolibrary.org/obo/GO_0005452) (inorganic anion exchanger activity), [GO:0006782](http://purl.obolibrary.org/obo/GO_0006782) (protoporphyrinogen IX biosynthetic process), [GO:0004121](http://purl.obolibrary.org/obo/GO_0004121) (cystathionine beta-lyase activity), [GO:0006788](http://purl.obolibrary.org/obo/GO_0006788) (heme oxidation), [GO:0004123](http://purl.obolibrary.org/obo/GO_0004123) (cystathionine gamma-lyase activity), [GO:0004126](http://purl.obolibrary.org/obo/GO_0004126) (cytidine deaminase activity), [GO:0097584](http://purl.obolibrary.org/obo/GO_0097584) (dolichyl-phosphate-mannose-protein mannosyltransferase Pmt5p-Pmt2p dimer complex), [GO:0097583](http://purl.obolibrary.org/obo/GO_0097583) (dolichyl-phosphate-mannose-protein mannosyltransferase Pmt1p-Pmt3p dimer complex), [GO:0006778](http://purl.obolibrary.org/obo/GO_0006778) (porphyrin-containing compound metabolic process), [GO:0097586](http://purl.obolibrary.org/obo/GO_0097586) (dolichyl-phosphate-mannose-protein mannosyltransferase Pmt4p homodimer complex), [GO:0006779](http://purl.obolibrary.org/obo/GO_0006779) (porphyrin-containing compound biosynthetic process), [GO:0004118](http://purl.obolibrary.org/obo/GO_0004118) (cGMP-stimulated cyclic-nucleotide phosphodiesterase activity), [GO:0097585](http://purl.obolibrary.org/obo/GO_0097585) (dolichyl-phosphate-mannose-protein mannosyltransferase Pmt5p-Pmt3p dimer complex), [GO:0097587](http://purl.obolibrary.org/obo/GO_0097587) (MutLgamma complex), [GO:0030407](http://purl.obolibrary.org/obo/GO_0030407) (formimidoyltransferase activity), [GO:0030409](http://purl.obolibrary.org/obo/GO_0030409) (glutamate formimidoyltransferase activity), [GO:0031730](http://purl.obolibrary.org/obo/GO_0031730) (CCR5 chemokine receptor binding), [GO:0042448](http://purl.obolibrary.org/obo/GO_0042448) (progesterone metabolic process), [GO:0006790](http://purl.obolibrary.org/obo/GO_0006790) (sulfur compound metabolic process), [GO:0004133](http://purl.obolibrary.org/obo/GO_0004133) (glycogen debranching enzyme activity), [GO:0042443](http://purl.obolibrary.org/obo/GO_0042443) (phenylethylamine metabolic process), [GO:0006798](http://purl.obolibrary.org/obo/GO_0006798) (polyphosphate catabolic process), [GO:0004135](http://purl.obolibrary.org/obo/GO_0004135) (amylo-alpha-1,6-glucosidase activity), [GO:0042445](http://purl.obolibrary.org/obo/GO_0042445) (hormone metabolic process), [GO:0004134](http://purl.obolibrary.org/obo/GO_0004134) (4-alpha-glucanotransferase activity), [GO:0042446](http://purl.obolibrary.org/obo/GO_0042446) (hormone biosynthetic process), [GO:0006796](http://purl.obolibrary.org/obo/GO_0006796) (phosphate-containing compound metabolic process), [GO:0004137](http://purl.obolibrary.org/obo/GO_0004137) (deoxycytidine kinase activity), [GO:0006797](http://purl.obolibrary.org/obo/GO_0006797) (polyphosphate metabolic process), [GO:0042447](http://purl.obolibrary.org/obo/GO_0042447) (hormone catabolic process), [GO:0004128](http://purl.obolibrary.org/obo/GO_0004128) (cytochrome-b5 reductase activity, acting on NAD(P)H), [GO:0005459](http://purl.obolibrary.org/obo/GO_0005459) (UDP-galactose transmembrane transporter activity), [GO:0004129](http://purl.obolibrary.org/obo/GO_0004129) (cytochrome-c oxidase activity), [GO:0097598](http://purl.obolibrary.org/obo/GO_0097598) (sperm cytoplasmic droplet), [GO:0031727](http://purl.obolibrary.org/obo/GO_0031727) (CCR2 chemokine receptor binding), [GO:0042450](http://purl.obolibrary.org/obo/GO_0042450) (arginine biosynthetic process via ornithine), [GO:0031721](http://purl.obolibrary.org/obo/GO_0031721) (hemoglobin alpha binding), [GO:0031722](http://purl.obolibrary.org/obo/GO_0031722) (hemoglobin beta binding), [GO:0031720](http://purl.obolibrary.org/obo/GO_0031720) (haptoglobin binding), [GO:0060287](http://purl.obolibrary.org/obo/GO_0060287) (epithelial cilium movement involved in determination of left/right asymmetry), [GO:0004180](http://purl.obolibrary.org/obo/GO_0004180) (carboxypeptidase activity), [GO:1902475](http://purl.obolibrary.org/obo/GO_1902475) (L-alpha-amino acid transmembrane transport), [GO:1902476](http://purl.obolibrary.org/obo/GO_1902476) (chloride transmembrane transport), [GO:0004181](http://purl.obolibrary.org/obo/GO_0004181) (metallocarboxypeptidase activity), [GO:1901142](http://purl.obolibrary.org/obo/GO_1901142) (insulin metabolic process), [GO:0060285](http://purl.obolibrary.org/obo/GO_0060285) (cilium-dependent cell motility), [GO:0004185](http://purl.obolibrary.org/obo/GO_0004185) (serine-type carboxypeptidase activity), [GO:0072264](http://purl.obolibrary.org/obo/GO_0072264) (metanephric glomerular endothelium development), [GO:0072262](http://purl.obolibrary.org/obo/GO_0072262) (metanephric glomerular mesangial cell proliferation involved in metanephros development), [GO:0016174](http://purl.obolibrary.org/obo/GO_0016174) (NAD(P)H oxidase activity), [GO:0016175](http://purl.obolibrary.org/obo/GO_0016175) (superoxide-generating NADPH oxidase activity), [GO:0016176](http://purl.obolibrary.org/obo/GO_0016176) (superoxide-generating NADPH oxidase activator activity), [GO:0060290](http://purl.obolibrary.org/obo/GO_0060290) (transdifferentiation), [GO:0060291](http://purl.obolibrary.org/obo/GO_0060291) (long-term synaptic potentiation), [GO:0060292](http://purl.obolibrary.org/obo/GO_0060292) (long term synaptic depression), [GO:0001906](http://purl.obolibrary.org/obo/GO_0001906) (cell killing), [GO:0030466](http://purl.obolibrary.org/obo/GO_0030466) (chromatin silencing at silent mating-type cassette), [GO:0031798](http://purl.obolibrary.org/obo/GO_0031798) (type 1 metabotropic glutamate receptor binding), [GO:0004190](http://purl.obolibrary.org/obo/GO_0004190) (aspartic-type endopeptidase activity), [GO:0060271](http://purl.obolibrary.org/obo/GO_0060271) (cilium assembly), [GO:0060272](http://purl.obolibrary.org/obo/GO_0060272) (embryonic skeletal joint morphogenesis), [GO:0004197](http://purl.obolibrary.org/obo/GO_0004197) (cysteine-type endopeptidase activity), [GO:0004198](http://purl.obolibrary.org/obo/GO_0004198) (calcium-dependent cysteine-type endopeptidase activity), [GO:0097582](http://purl.obolibrary.org/obo/GO_0097582) (dolichyl-phosphate-mannose-protein mannosyltransferase Pmt1p-Pmt2p dimer complex), [GO:0072255](http://purl.obolibrary.org/obo/GO_0072255) (metanephric glomerular mesangial cell development), [GO:0001913](http://purl.obolibrary.org/obo/GO_0001913) (T cell mediated cytotoxicity), [GO:0016165](http://purl.obolibrary.org/obo/GO_0016165) (linoleate 13S-lipoxygenase activity), [GO:0030450](http://purl.obolibrary.org/obo/GO_0030450) (regulation of complement activation, classical pathway), [GO:0001915](http://purl.obolibrary.org/obo/GO_0001915) (negative regulation of T cell mediated cytotoxicity), [GO:0031781](http://purl.obolibrary.org/obo/GO_0031781) (type 3 melanocortin receptor binding), [GO:0001916](http://purl.obolibrary.org/obo/GO_0001916) (positive regulation of T cell mediated cytotoxicity), [GO:0031782](http://purl.obolibrary.org/obo/GO_0031782) (type 4 melanocortin receptor binding), [GO:0001917](http://purl.obolibrary.org/obo/GO_0001917) (photoreceptor inner segment), [GO:0001919](http://purl.obolibrary.org/obo/GO_0001919) (regulation of receptor recycling), [GO:1901166](http://purl.obolibrary.org/obo/GO_1901166) (neural crest cell migration involved in autonomic nervous system development), [GO:0005496](http://purl.obolibrary.org/obo/GO_0005496) (steroid binding), [GO:0004165](http://purl.obolibrary.org/obo/GO_0004165) (dodecenoyl-CoA delta-isomerase activity), [GO:0004168](http://purl.obolibrary.org/obo/GO_0004168) (dolichol kinase activity), [GO:0004169](http://purl.obolibrary.org/obo/GO_0004169) (dolichyl-phosphate-mannose-protein mannosyltransferase activity), [GO:0030447](http://purl.obolibrary.org/obo/GO_0030447) (filamentous growth), [GO:0097542](http://purl.obolibrary.org/obo/GO_0097542) (ciliary tip), [GO:0030449](http://purl.obolibrary.org/obo/GO_0030449) (regulation of complement activation), [GO:0097541](http://purl.obolibrary.org/obo/GO_0097541) (axonemal basal plate), [GO:0097544](http://purl.obolibrary.org/obo/GO_0097544) (ciliary shaft), [GO:0097543](http://purl.obolibrary.org/obo/GO_0097543) (ciliary inversin compartment), [GO:0016150](http://purl.obolibrary.org/obo/GO_0016150) (translation release factor activity, codon nonspecific), [GO:0072289](http://purl.obolibrary.org/obo/GO_0072289) (metanephric nephron tubule formation), [GO:0097546](http://purl.obolibrary.org/obo/GO_0097546) (ciliary base), [GO:0016151](http://purl.obolibrary.org/obo/GO_0016151) (nickel cation binding), [GO:0016153](http://purl.obolibrary.org/obo/GO_0016153) (urocanate hydratase activity), [GO:0016154](http://purl.obolibrary.org/obo/GO_0016154) (pyrimidine-nucleoside phosphorylase activity), [GO:0016139](http://purl.obolibrary.org/obo/GO_0016139) (glycoside catabolic process), [GO:0060297](http://purl.obolibrary.org/obo/GO_0060297) (regulation of sarcomere organization), [GO:0042406](http://purl.obolibrary.org/obo/GO_0042406) (extrinsic component of endoplasmic reticulum membrane), [GO:0042407](http://purl.obolibrary.org/obo/GO_0042407) (cristae formation), [GO:0043739](http://purl.obolibrary.org/obo/GO_0043739) (G/U mismatch-specific uracil-DNA glycosylase activity), [GO:0060294](http://purl.obolibrary.org/obo/GO_0060294) (cilium movement involved in cell motility), [GO:0004170](http://purl.obolibrary.org/obo/GO_0004170) (dUTP diphosphatase activity), [GO:0060296](http://purl.obolibrary.org/obo/GO_0060296) (regulation of cilium beat frequency involved in ciliary motility), [GO:0004175](http://purl.obolibrary.org/obo/GO_0004175) (endopeptidase activity), [GO:0004174](http://purl.obolibrary.org/obo/GO_0004174) (electron-transferring-flavoprotein dehydrogenase activity), [GO:0004177](http://purl.obolibrary.org/obo/GO_0004177) (aminopeptidase activity), [GO:0042402](http://purl.obolibrary.org/obo/GO_0042402) (cellular biogenic amine catabolic process), [GO:0042403](http://purl.obolibrary.org/obo/GO_0042403) (thyroid hormone metabolic process), [GO:0030437](http://purl.obolibrary.org/obo/GO_0030437) (ascospore formation), [GO:0097550](http://purl.obolibrary.org/obo/GO_0097550) (transcriptional preinitiation complex), [GO:0097553](http://purl.obolibrary.org/obo/GO_0097553) (calcium ion transmembrane import into cytosol), [GO:0098885](http://purl.obolibrary.org/obo/GO_0098885) (modification of postsynaptic actin cytoskeleton), [GO:0030431](http://purl.obolibrary.org/obo/GO_0030431) (sleep), [GO:0030433](http://purl.obolibrary.org/obo/GO_0030433) (ubiquitin-dependent ERAD pathway), [GO:0031765](http://purl.obolibrary.org/obo/GO_0031765) (type 2 galanin receptor binding), [GO:0030432](http://purl.obolibrary.org/obo/GO_0030432) (peristalsis), [GO:0031766](http://purl.obolibrary.org/obo/GO_0031766) (type 3 galanin receptor binding), [GO:0030435](http://purl.obolibrary.org/obo/GO_0030435) (sporulation resulting in formation of a cellular spore), [GO:0031763](http://purl.obolibrary.org/obo/GO_0031763) (galanin receptor binding), [GO:0031764](http://purl.obolibrary.org/obo/GO_0031764) (type 1 galanin receptor binding), [GO:0001820](http://purl.obolibrary.org/obo/GO_0001820) (serotonin secretion), [GO:0001821](http://purl.obolibrary.org/obo/GO_0001821) (histamine secretion), [GO:0001822](http://purl.obolibrary.org/obo/GO_0001822) (kidney development), [GO:0042382](http://purl.obolibrary.org/obo/GO_0042382) (paraspeckles), [GO:0016095](http://purl.obolibrary.org/obo/GO_0016095) (polyprenol catabolic process), [GO:0042383](http://purl.obolibrary.org/obo/GO_0042383) (sarcolemma), [GO:0001823](http://purl.obolibrary.org/obo/GO_0001823) (mesonephros development), [GO:0001824](http://purl.obolibrary.org/obo/GO_0001824) (blastocyst development), [GO:0001826](http://purl.obolibrary.org/obo/GO_0001826) (inner cell mass cell differentiation), [GO:0001828](http://purl.obolibrary.org/obo/GO_0001828) (inner cell mass cellular morphogenesis), [GO:0001829](http://purl.obolibrary.org/obo/GO_0001829) (trophectodermal cell differentiation), [GO:0030388](http://purl.obolibrary.org/obo/GO_0030388) (fructose 1,6-bisphosphate metabolic process), [GO:0065004](http://purl.obolibrary.org/obo/GO_0065004) (protein-DNA complex assembly), [GO:0000506](http://purl.obolibrary.org/obo/GO_0000506) (glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex), [GO:0065001](http://purl.obolibrary.org/obo/GO_0065001) (specification of axis polarity), [GO:0030382](http://purl.obolibrary.org/obo/GO_0030382) (sperm mitochondrion organization), [GO:0065002](http://purl.obolibrary.org/obo/GO_0065002) (intracellular protein transmembrane transport), [GO:0000502](http://purl.obolibrary.org/obo/GO_0000502) (proteasome complex), [GO:0000500](http://purl.obolibrary.org/obo/GO_0000500) (RNA polymerase I upstream activating factor complex), [GO:0042391](http://purl.obolibrary.org/obo/GO_0042391) (regulation of membrane potential), [GO:0016082](http://purl.obolibrary.org/obo/GO_0016082) (synaptic vesicle priming), [GO:0042393](http://purl.obolibrary.org/obo/GO_0042393) (histone binding), [GO:0001833](http://purl.obolibrary.org/obo/GO_0001833) (inner cell mass cell proliferation), [GO:0001835](http://purl.obolibrary.org/obo/GO_0001835) (blastocyst hatching), [GO:0001836](http://purl.obolibrary.org/obo/GO_0001836) (release of cytochrome c from mitochondria), [GO:0065010](http://purl.obolibrary.org/obo/GO_0065010) (extracellular membrane-bounded organelle), [GO:0030374](http://purl.obolibrary.org/obo/GO_0030374) (ligand-dependent nuclear receptor transcription coactivator activity), [GO:0001837](http://purl.obolibrary.org/obo/GO_0001837) (epithelial to mesenchymal transition), [GO:0001838](http://purl.obolibrary.org/obo/GO_0001838) (embryonic epithelial tube formation), [GO:0001839](http://purl.obolibrary.org/obo/GO_0001839) (neural plate morphogenesis), [GO:0004081](http://purl.obolibrary.org/obo/GO_0004081) (bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity), [GO:0004080](http://purl.obolibrary.org/obo/GO_0004080) (biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity), [GO:0004082](http://purl.obolibrary.org/obo/GO_0004082) (bisphosphoglycerate mutase activity), [GO:0004085](http://purl.obolibrary.org/obo/GO_0004085) (butyryl-CoA dehydrogenase activity), [GO:0004087](http://purl.obolibrary.org/obo/GO_0004087) (carbamoyl-phosphate synthase (ammonia) activity), [GO:0004089](http://purl.obolibrary.org/obo/GO_0004089) (carbonate dehydratase activity), [GO:0004088](http://purl.obolibrary.org/obo/GO_0004088) (carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity), [GO:0016070](http://purl.obolibrary.org/obo/GO_0016070) (RNA metabolic process), [GO:0001805](http://purl.obolibrary.org/obo/GO_0001805) (positive regulation of type III hypersensitivity), [GO:0016079](http://purl.obolibrary.org/obo/GO_0016079) (synaptic vesicle exocytosis), [GO:0030366](http://purl.obolibrary.org/obo/GO_0030366) (molybdopterin synthase activity), [GO:0031698](http://purl.obolibrary.org/obo/GO_0031698) (beta-2 adrenergic receptor binding), [GO:0004090](http://purl.obolibrary.org/obo/GO_0004090) (carbonyl reductase (NADPH) activity), [GO:0004096](http://purl.obolibrary.org/obo/GO_0004096) (catalase activity), [GO:0004095](http://purl.obolibrary.org/obo/GO_0004095) (carnitine O-palmitoyltransferase activity), [GO:0004098](http://purl.obolibrary.org/obo/GO_0004098) (cerebroside-sulfatase activity), [GO:0004097](http://purl.obolibrary.org/obo/GO_0004097) (catechol oxidase activity), [GO:0001811](http://purl.obolibrary.org/obo/GO_0001811) (negative regulation of type I hypersensitivity), [GO:0001812](http://purl.obolibrary.org/obo/GO_0001812) (positive regulation of type I hypersensitivity), [GO:0016064](http://purl.obolibrary.org/obo/GO_0016064) (immunoglobulin mediated immune response), [GO:0001816](http://purl.obolibrary.org/obo/GO_0001816) (cytokine production), [GO:0031683](http://purl.obolibrary.org/obo/GO_0031683) (G-protein beta/gamma-subunit complex binding), [GO:0001818](http://purl.obolibrary.org/obo/GO_0001818) (negative regulation of cytokine production), [GO:0001819](http://purl.obolibrary.org/obo/GO_0001819) (positive regulation of cytokine production), [GO:0001865](http://purl.obolibrary.org/obo/GO_0001865) (NK T cell differentiation), [GO:0001867](http://purl.obolibrary.org/obo/GO_0001867) (complement activation, lectin pathway), [GO:0001869](http://purl.obolibrary.org/obo/GO_0001869) (negative regulation of complement activation, lectin pathway), [GO:0012510](http://purl.obolibrary.org/obo/GO_0012510) (trans-Golgi network transport vesicle membrane), [GO:0042346](http://purl.obolibrary.org/obo/GO_0042346) (positive regulation of NF-kappaB import into nucleus), [GO:0043679](http://purl.obolibrary.org/obo/GO_0043679) (axon terminus), [GO:0042347](http://purl.obolibrary.org/obo/GO_0042347) (negative regulation of NF-kappaB import into nucleus), [GO:0001881](http://purl.obolibrary.org/obo/GO_0001881) (receptor recycling), [GO:0001882](http://purl.obolibrary.org/obo/GO_0001882) (nucleoside binding), [GO:0001878](http://purl.obolibrary.org/obo/GO_0001878) (response to yeast), [GO:0043686](http://purl.obolibrary.org/obo/GO_0043686) (co-translational protein modification), [GO:0043687](http://purl.obolibrary.org/obo/GO_0043687) (post-translational protein modification), [GO:0042359](http://purl.obolibrary.org/obo/GO_0042359) (vitamin D metabolic process), [GO:0001841](http://purl.obolibrary.org/obo/GO_0001841) (neural tube formation), [GO:0001842](http://purl.obolibrary.org/obo/GO_0001842) (neural fold formation), [GO:0001843](http://purl.obolibrary.org/obo/GO_0001843) (neural tube closure), [GO:0043691](http://purl.obolibrary.org/obo/GO_0043691) (reverse cholesterol transport), [GO:0042360](http://purl.obolibrary.org/obo/GO_0042360) (vitamin E metabolic process), [GO:0001845](http://purl.obolibrary.org/obo/GO_0001845) (phagolysosome assembly), [GO:0001848](http://purl.obolibrary.org/obo/GO_0001848) (complement binding), [GO:0001849](http://purl.obolibrary.org/obo/GO_0001849) (complement component C1q binding), [GO:0042369](http://purl.obolibrary.org/obo/GO_0042369) (vitamin D catabolic process), [GO:0001851](http://purl.obolibrary.org/obo/GO_0001851) (complement component C3b binding), [GO:0012506](http://purl.obolibrary.org/obo/GO_0012506) (vesicle membrane), [GO:0012507](http://purl.obolibrary.org/obo/GO_0012507) (ER to Golgi transport vesicle membrane), [GO:0012505](http://purl.obolibrary.org/obo/GO_0012505) (endomembrane system), [GO:0012501](http://purl.obolibrary.org/obo/GO_0012501) (programmed cell death), [GO:0050839](http://purl.obolibrary.org/obo/GO_0050839) (cell adhesion molecule binding), [GO:0048515](http://purl.obolibrary.org/obo/GO_0048515) (spermatid differentiation), [GO:0090055](http://purl.obolibrary.org/obo/GO_0090055) (positive regulation of chromatin silencing at silent mating-type cassette), [GO:0048514](http://purl.obolibrary.org/obo/GO_0048514) (blood vessel morphogenesis), [GO:0048513](http://purl.obolibrary.org/obo/GO_0048513) (animal organ development), [GO:0090050](http://purl.obolibrary.org/obo/GO_0090050) (positive regulation of cell migration involved in sprouting angiogenesis), [GO:0102490](http://purl.obolibrary.org/obo/GO_0102490) (8-oxo-dGTP phosphohydrolase activity), [GO:0050832](http://purl.obolibrary.org/obo/GO_0050832) (defense response to fungus), [GO:0050833](http://purl.obolibrary.org/obo/GO_0050833) (pyruvate transmembrane transporter activity), [GO:0050830](http://purl.obolibrary.org/obo/GO_0050830) (defense response to Gram-positive bacterium), [GO:0090067](http://purl.obolibrary.org/obo/GO_0090067) (regulation of thalamus size), [GO:0050849](http://purl.obolibrary.org/obo/GO_0050849) (negative regulation of calcium-mediated signaling), [GO:0048524](http://purl.obolibrary.org/obo/GO_0048524) (positive regulation of viral process), [GO:0050840](http://purl.obolibrary.org/obo/GO_0050840) (extracellular matrix binding), [GO:0050847](http://purl.obolibrary.org/obo/GO_0050847) (progesterone receptor signaling pathway), [GO:0050848](http://purl.obolibrary.org/obo/GO_0050848) (regulation of calcium-mediated signaling), [GO:0036513](http://purl.obolibrary.org/obo/GO_0036513) (Derlin-1 retrotranslocation complex), [GO:0090038](http://purl.obolibrary.org/obo/GO_0090038) (negative regulation of protein kinase C signaling), [GO:0090037](http://purl.obolibrary.org/obo/GO_0090037) (positive regulation of protein kinase C signaling), [GO:0061515](http://purl.obolibrary.org/obo/GO_0061515) (myeloid cell development), [GO:0048536](http://purl.obolibrary.org/obo/GO_0048536) (spleen development), [GO:1903701](http://purl.obolibrary.org/obo/GO_1903701) (substantia propria of cornea development), [GO:0048535](http://purl.obolibrary.org/obo/GO_0048535) (lymph node development), [GO:0090031](http://purl.obolibrary.org/obo/GO_0090031) (positive regulation of steroid hormone biosynthetic process), [GO:0048534](http://purl.obolibrary.org/obo/GO_0048534) (hematopoietic or lymphoid organ development), [GO:0001890](http://purl.obolibrary.org/obo/GO_0001890) (placenta development), [GO:0061511](http://purl.obolibrary.org/obo/GO_0061511) (centriole elongation), [GO:0001891](http://purl.obolibrary.org/obo/GO_0001891) (phagocytic cup), [GO:0061512](http://purl.obolibrary.org/obo/GO_0061512) (protein localization to cilium), [GO:0001892](http://purl.obolibrary.org/obo/GO_0001892) (embryonic placenta development), [GO:0048539](http://purl.obolibrary.org/obo/GO_0048539) (bone marrow development), [GO:0061513](http://purl.obolibrary.org/obo/GO_0061513) (glucose 6-phosphate:inorganic phosphate antiporter activity), [GO:0048538](http://purl.obolibrary.org/obo/GO_0048538) (thymus development), [GO:0001893](http://purl.obolibrary.org/obo/GO_0001893) (maternal placenta development), [GO:0001883](http://purl.obolibrary.org/obo/GO_0001883) (purine nucleoside binding), [GO:0050850](http://purl.obolibrary.org/obo/GO_0050850) (positive regulation of calcium-mediated signaling), [GO:0001885](http://purl.obolibrary.org/obo/GO_0001885) (endothelial cell development), [GO:0001886](http://purl.obolibrary.org/obo/GO_0001886) (endothelial cell morphogenesis), [GO:0036508](http://purl.obolibrary.org/obo/GO_0036508) (protein alpha-1,2-demannosylation), [GO:0061519](http://purl.obolibrary.org/obo/GO_0061519) (macrophage homeostasis), [GO:0036509](http://purl.obolibrary.org/obo/GO_0036509) (trimming of terminal mannose on B branch), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0048541](http://purl.obolibrary.org/obo/GO_0048541) (Peyer's patch development), [GO:0050856](http://purl.obolibrary.org/obo/GO_0050856) (regulation of T cell receptor signaling pathway), [GO:0050857](http://purl.obolibrary.org/obo/GO_0050857) (positive regulation of antigen receptor-mediated signaling pathway), [GO:0036500](http://purl.obolibrary.org/obo/GO_0036500) (ATF6-mediated unfolded protein response), [GO:1990948](http://purl.obolibrary.org/obo/GO_1990948) (ubiquitin ligase inhibitor activity), [GO:0050855](http://purl.obolibrary.org/obo/GO_0050855) (regulation of B cell receptor signaling pathway), [GO:0050852](http://purl.obolibrary.org/obo/GO_0050852) (T cell receptor signaling pathway), [GO:0050853](http://purl.obolibrary.org/obo/GO_0050853) (B cell receptor signaling pathway), [GO:0036503](http://purl.obolibrary.org/obo/GO_0036503) (ERAD pathway), [GO:0048546](http://purl.obolibrary.org/obo/GO_0048546) (digestive tract morphogenesis), [GO:1903715](http://purl.obolibrary.org/obo/GO_1903715) (regulation of aerobic respiration), [GO:0048549](http://purl.obolibrary.org/obo/GO_0048549) (positive regulation of pinocytosis), [GO:0001894](http://purl.obolibrary.org/obo/GO_0001894) (tissue homeostasis), [GO:0047220](http://purl.obolibrary.org/obo/GO_0047220) (galactosylxylosylprotein 3-beta-galactosyltransferase activity), [GO:0050862](http://purl.obolibrary.org/obo/GO_0050862) (positive regulation of T cell receptor signaling pathway), [GO:0001895](http://purl.obolibrary.org/obo/GO_0001895) (retina homeostasis), [GO:1903707](http://purl.obolibrary.org/obo/GO_1903707) (negative regulation of hemopoiesis), [GO:0047223](http://purl.obolibrary.org/obo/GO_0047223) (beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity), [GO:0050869](http://purl.obolibrary.org/obo/GO_0050869) (negative regulation of B cell activation), [GO:1990955](http://purl.obolibrary.org/obo/GO_1990955) (G-rich single-stranded DNA binding), [GO:0050868](http://purl.obolibrary.org/obo/GO_0050868) (negative regulation of T cell activation), [GO:0050863](http://purl.obolibrary.org/obo/GO_0050863) (regulation of T cell activation), [GO:0035242](http://purl.obolibrary.org/obo/GO_0035242) (protein-arginine omega-N asymmetric methyltransferase activity), [GO:0035243](http://purl.obolibrary.org/obo/GO_0035243) (protein-arginine omega-N symmetric methyltransferase activity), [GO:0035240](http://purl.obolibrary.org/obo/GO_0035240) (dopamine binding), [GO:0035241](http://purl.obolibrary.org/obo/GO_0035241) (protein-arginine omega-N monomethyltransferase activity), [GO:1990962](http://purl.obolibrary.org/obo/GO_1990962) (drug transport across blood-brain barrier), [GO:1990963](http://purl.obolibrary.org/obo/GO_1990963) (establishment of blood-retinal barrier), [GO:0035239](http://purl.obolibrary.org/obo/GO_0035239) (tube morphogenesis), [GO:0035235](http://purl.obolibrary.org/obo/GO_0035235) (ionotropic glutamate receptor signaling pathway), [GO:0035234](http://purl.obolibrary.org/obo/GO_0035234) (ectopic germ cell programmed cell death), [GO:0050808](http://purl.obolibrary.org/obo/GO_0050808) (synapse organization), [GO:0090026](http://purl.obolibrary.org/obo/GO_0090026) (positive regulation of monocyte chemotaxis), [GO:0090023](http://purl.obolibrary.org/obo/GO_0090023) (positive regulation of neutrophil chemotaxis), [GO:0050805](http://purl.obolibrary.org/obo/GO_0050805) (negative regulation of synaptic transmission), [GO:0050806](http://purl.obolibrary.org/obo/GO_0050806) (positive regulation of synaptic transmission), [GO:0090022](http://purl.obolibrary.org/obo/GO_0090022) (regulation of neutrophil chemotaxis), [GO:0050803](http://purl.obolibrary.org/obo/GO_0050803) (regulation of synapse structure or activity), [GO:0050804](http://purl.obolibrary.org/obo/GO_0050804) (modulation of chemical synaptic transmission), [GO:0035229](http://purl.obolibrary.org/obo/GO_0035229) (positive regulation of glutamate-cysteine ligase activity), [GO:0050801](http://purl.obolibrary.org/obo/GO_0050801) (ion homeostasis), [GO:0035226](http://purl.obolibrary.org/obo/GO_0035226) (glutamate-cysteine ligase catalytic subunit binding), [GO:0050819](http://purl.obolibrary.org/obo/GO_0050819) (negative regulation of coagulation), [GO:0050810](http://purl.obolibrary.org/obo/GO_0050810) (regulation of steroid biosynthetic process), [GO:0090008](http://purl.obolibrary.org/obo/GO_0090008) (hypoblast development), [GO:0050829](http://purl.obolibrary.org/obo/GO_0050829) (defense response to Gram-negative bacterium), [GO:0048505](http://purl.obolibrary.org/obo/GO_0048505) (regulation of timing of cell differentiation), [GO:0048511](http://purl.obolibrary.org/obo/GO_0048511) (rhythmic process), [GO:0050821](http://purl.obolibrary.org/obo/GO_0050821) (protein stabilization), [GO:2000105](http://purl.obolibrary.org/obo/GO_2000105) (positive regulation of DNA-dependent DNA replication), [GO:0050820](http://purl.obolibrary.org/obo/GO_0050820) (positive regulation of coagulation), [GO:0036257](http://purl.obolibrary.org/obo/GO_0036257) (multivesicular body organization), [GO:0036250](http://purl.obolibrary.org/obo/GO_0036250) (peroxisome transport along microtubule), [GO:1904970](http://purl.obolibrary.org/obo/GO_1904970) (brush border assembly), [GO:0048239](http://purl.obolibrary.org/obo/GO_0048239) (negative regulation of DNA recombination at telomere), [GO:0048237](http://purl.obolibrary.org/obo/GO_0048237) (rough endoplasmic reticulum lumen), [GO:1903644](http://purl.obolibrary.org/obo/GO_1903644) (regulation of chaperone-mediated protein folding), [GO:0051885](http://purl.obolibrary.org/obo/GO_0051885) (positive regulation of timing of anagen), [GO:0048240](http://purl.obolibrary.org/obo/GO_0048240) (sperm capacitation), [GO:0048247](http://purl.obolibrary.org/obo/GO_0048247) (lymphocyte chemotaxis), [GO:0048246](http://purl.obolibrary.org/obo/GO_0048246) (macrophage chemotaxis), [GO:0051881](http://purl.obolibrary.org/obo/GO_0051881) (regulation of mitochondrial membrane potential), [GO:0048244](http://purl.obolibrary.org/obo/GO_0048244) (phytanoyl-CoA dioxygenase activity), [GO:2000353](http://purl.obolibrary.org/obo/GO_2000353) (positive regulation of endothelial cell apoptotic process), [GO:2000352](http://purl.obolibrary.org/obo/GO_2000352) (negative regulation of endothelial cell apoptotic process), [GO:0036245](http://purl.obolibrary.org/obo/GO_0036245) (cellular response to menadione), [GO:1904983](http://purl.obolibrary.org/obo/GO_1904983) (glycine import into mitochondrion), [GO:0061205](http://purl.obolibrary.org/obo/GO_0061205) (paramesonephric duct development), [GO:0051895](http://purl.obolibrary.org/obo/GO_0051895) (negative regulation of focal adhesion assembly), [GO:0051896](http://purl.obolibrary.org/obo/GO_0051896) (regulation of protein kinase B signaling), [GO:0051893](http://purl.obolibrary.org/obo/GO_0051893) (regulation of focal adhesion assembly), [GO:0048251](http://purl.obolibrary.org/obo/GO_0048251) (elastic fiber assembly), [GO:0051894](http://purl.obolibrary.org/obo/GO_0051894) (positive regulation of focal adhesion assembly), [GO:0051891](http://purl.obolibrary.org/obo/GO_0051891) (positive regulation of cardioblast differentiation), [GO:0050560](http://purl.obolibrary.org/obo/GO_0050560) (aspartate-tRNA(Asn) ligase activity), [GO:0048257](http://purl.obolibrary.org/obo/GO_0048257) (3'-flap endonuclease activity), [GO:0050561](http://purl.obolibrary.org/obo/GO_0050561) (glutamate-tRNA(Gln) ligase activity), [GO:0048255](http://purl.obolibrary.org/obo/GO_0048255) (mRNA stabilization), [GO:2000366](http://purl.obolibrary.org/obo/GO_2000366) (positive regulation of STAT protein import into nucleus), [GO:0098506](http://purl.obolibrary.org/obo/GO_0098506) (polynucleotide 3' dephosphorylation), [GO:0098504](http://purl.obolibrary.org/obo/GO_0098504) (DNA 3' dephosphorylation involved in DNA repair), [GO:0098505](http://purl.obolibrary.org/obo/GO_0098505) (G-rich strand telomeric DNA binding), [GO:0051899](http://purl.obolibrary.org/obo/GO_0051899) (membrane depolarization), [GO:0098508](http://purl.obolibrary.org/obo/GO_0098508) (endothelial to hematopoietic transition), [GO:0051897](http://purl.obolibrary.org/obo/GO_0051897) (positive regulation of protein kinase B signaling), [GO:0051898](http://purl.obolibrary.org/obo/GO_0051898) (negative regulation of protein kinase B signaling), [GO:0036233](http://purl.obolibrary.org/obo/GO_0036233) (glycine import), [GO:2000381](http://purl.obolibrary.org/obo/GO_2000381) (negative regulation of mesoderm development), [GO:1904999](http://purl.obolibrary.org/obo/GO_1904999) (positive regulation of leukocyte adhesion to arterial endothelial cell), [GO:1902336](http://purl.obolibrary.org/obo/GO_1902336) (positive regulation of retinal ganglion cell axon guidance), [GO:1901006](http://purl.obolibrary.org/obo/GO_1901006) (ubiquinone-6 biosynthetic process), [GO:1904996](http://purl.obolibrary.org/obo/GO_1904996) (positive regulation of leukocyte adhesion to vascular endothelial cell), [GO:0000278](http://purl.obolibrary.org/obo/GO_0000278) (mitotic cell cycle), [GO:0000287](http://purl.obolibrary.org/obo/GO_0000287) (magnesium ion binding), [GO:0048265](http://purl.obolibrary.org/obo/GO_0048265) (response to pain), [GO:0048264](http://purl.obolibrary.org/obo/GO_0048264) (determination of ventral identity), [GO:0048263](http://purl.obolibrary.org/obo/GO_0048263) (determination of dorsal identity), [GO:0000281](http://purl.obolibrary.org/obo/GO_0000281) (mitotic cytokinesis), [GO:0048266](http://purl.obolibrary.org/obo/GO_0048266) (behavioral response to pain), [GO:2000377](http://purl.obolibrary.org/obo/GO_2000377) (regulation of reactive oxygen species metabolic process), [GO:0048261](http://purl.obolibrary.org/obo/GO_0048261) (negative regulation of receptor-mediated endocytosis), [GO:0048260](http://purl.obolibrary.org/obo/GO_0048260) (positive regulation of receptor-mediated endocytosis), [GO:2000379](http://purl.obolibrary.org/obo/GO_2000379) (positive regulation of reactive oxygen species metabolic process), [GO:0036228](http://purl.obolibrary.org/obo/GO_0036228) (protein localization to nuclear inner membrane), [GO:2000378](http://purl.obolibrary.org/obo/GO_2000378) (negative regulation of reactive oxygen species metabolic process), [GO:1903670](http://purl.obolibrary.org/obo/GO_1903670) (regulation of sprouting angiogenesis), [GO:2000391](http://purl.obolibrary.org/obo/GO_2000391) (positive regulation of neutrophil extravasation), [GO:0036221](http://purl.obolibrary.org/obo/GO_0036221) (UTP diphosphatase activity), [GO:0036222](http://purl.obolibrary.org/obo/GO_0036222) (XTP diphosphatase activity), [GO:0036220](http://purl.obolibrary.org/obo/GO_0036220) (ITP diphosphatase activity), [GO:1901017](http://purl.obolibrary.org/obo/GO_1901017) (negative regulation of potassium ion transmembrane transporter activity), [GO:1901016](http://purl.obolibrary.org/obo/GO_1901016) (regulation of potassium ion transmembrane transporter activity), [GO:0000289](http://purl.obolibrary.org/obo/GO_0000289) (nuclear-transcribed mRNA poly(A) tail shortening), [GO:0000288](http://purl.obolibrary.org/obo/GO_0000288) (nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay), [GO:0000294](http://purl.obolibrary.org/obo/GO_0000294) (nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay), [GO:0048278](http://purl.obolibrary.org/obo/GO_0048278) (vesicle docking), [GO:0000291](http://purl.obolibrary.org/obo/GO_0000291) (nuclear-transcribed mRNA catabolic process, exonucleolytic), [GO:0000290](http://purl.obolibrary.org/obo/GO_0000290) (deadenylation-dependent decapping of nuclear-transcribed mRNA), [GO:0036218](http://purl.obolibrary.org/obo/GO_0036218) (dTTP diphosphatase activity), [GO:0036219](http://purl.obolibrary.org/obo/GO_0036219) (GTP diphosphatase activity), [GO:0036217](http://purl.obolibrary.org/obo/GO_0036217) (dGTP diphosphatase activity), [GO:0036294](http://purl.obolibrary.org/obo/GO_0036294) (cellular response to decreased oxygen levels), [GO:0036295](http://purl.obolibrary.org/obo/GO_0036295) (cellular response to increased oxygen levels), [GO:0036297](http://purl.obolibrary.org/obo/GO_0036297) (interstrand cross-link repair), [GO:0006402](http://purl.obolibrary.org/obo/GO_0006402) (mRNA catabolic process), [GO:1904937](http://purl.obolibrary.org/obo/GO_1904937) (sensory neuron migration), [GO:0006400](http://purl.obolibrary.org/obo/GO_0006400) (tRNA modification), [GO:0006401](http://purl.obolibrary.org/obo/GO_0006401) (RNA catabolic process), [GO:0050510](http://purl.obolibrary.org/obo/GO_0050510) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity), [GO:0050518](http://purl.obolibrary.org/obo/GO_0050518) (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase activity), [GO:2000397](http://purl.obolibrary.org/obo/GO_2000397) (positive regulation of ubiquitin-dependent endocytosis), [GO:0019722](http://purl.obolibrary.org/obo/GO_0019722) (calcium-mediated signaling), [GO:0019724](http://purl.obolibrary.org/obo/GO_0019724) (B cell mediated immunity), [GO:0019706](http://purl.obolibrary.org/obo/GO_0019706) (protein-cysteine S-palmitoyltransferase activity), [GO:0006413](http://purl.obolibrary.org/obo/GO_0006413) (translational initiation), [GO:0006414](http://purl.obolibrary.org/obo/GO_0006414) (translational elongation), [GO:0006412](http://purl.obolibrary.org/obo/GO_0006412) (translation), [GO:0048208](http://purl.obolibrary.org/obo/GO_0048208) (COPII vesicle coating), [GO:0006406](http://purl.obolibrary.org/obo/GO_0006406) (mRNA export from nucleus), [GO:0006407](http://purl.obolibrary.org/obo/GO_0006407) (rRNA export from nucleus), [GO:0006405](http://purl.obolibrary.org/obo/GO_0006405) (RNA export from nucleus), [GO:0048213](http://purl.obolibrary.org/obo/GO_0048213) (Golgi vesicle prefusion complex stabilization), [GO:0006409](http://purl.obolibrary.org/obo/GO_0006409) (tRNA export from nucleus), [GO:1904959](http://purl.obolibrary.org/obo/GO_1904959) (regulation of cytochrome-c oxidase activity), [GO:0048219](http://purl.obolibrary.org/obo/GO_0048219) (inter-Golgi cisterna vesicle-mediated transport), [GO:1904949](http://purl.obolibrary.org/obo/GO_1904949) (ATPase complex), [GO:0036269](http://purl.obolibrary.org/obo/GO_0036269) (swimming behavior), [GO:1990904](http://purl.obolibrary.org/obo/GO_1990904) (ribonucleoprotein complex), [GO:0051864](http://purl.obolibrary.org/obo/GO_0051864) (histone demethylase activity (H3-K36 specific)), [GO:0019702](http://purl.obolibrary.org/obo/GO_0019702) (protein-arginine N5-methyltransferase activity), [GO:0051865](http://purl.obolibrary.org/obo/GO_0051865) (protein autoubiquitination), [GO:0036267](http://purl.obolibrary.org/obo/GO_0036267) (invasive filamentous growth), [GO:0036268](http://purl.obolibrary.org/obo/GO_0036268) (swimming), [GO:1902303](http://purl.obolibrary.org/obo/GO_1902303) (negative regulation of potassium ion export), [GO:1902305](http://purl.obolibrary.org/obo/GO_1902305) (regulation of sodium ion transmembrane transport), [GO:0051873](http://purl.obolibrary.org/obo/GO_0051873) (killing by host of symbiont cells), [GO:0051871](http://purl.obolibrary.org/obo/GO_0051871) (dihydrofolic acid binding), [GO:0051870](http://purl.obolibrary.org/obo/GO_0051870) (methotrexate binding), [GO:0051879](http://purl.obolibrary.org/obo/GO_0051879) (Hsp90 protein binding), [GO:0051877](http://purl.obolibrary.org/obo/GO_0051877) (pigment granule aggregation in cell center), [GO:0051875](http://purl.obolibrary.org/obo/GO_0051875) (pigment granule localization), [GO:0050544](http://purl.obolibrary.org/obo/GO_0050544) (arachidonic acid binding), [GO:0051876](http://purl.obolibrary.org/obo/GO_0051876) (pigment granule dispersal), [GO:1990918](http://purl.obolibrary.org/obo/GO_1990918) (double-strand break repair involved in meiotic recombination), [GO:0061298](http://purl.obolibrary.org/obo/GO_0061298) (retina vasculature development in camera-type eye), [GO:1902394](http://purl.obolibrary.org/obo/GO_1902394) (positive regulation of exodeoxyribonuclease activity), [GO:0061299](http://purl.obolibrary.org/obo/GO_0061299) (retina vasculature morphogenesis in camera-type eye), [GO:0061296](http://purl.obolibrary.org/obo/GO_0061296) (negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis), [GO:0005112](http://purl.obolibrary.org/obo/GO_0005112) (Notch binding), [GO:0005114](http://purl.obolibrary.org/obo/GO_0005114) (type II transforming growth factor beta receptor binding), [GO:0097250](http://purl.obolibrary.org/obo/GO_0097250) (mitochondrial respiratory chain supercomplex assembly), [GO:0006446](http://purl.obolibrary.org/obo/GO_0006446) (regulation of translational initiation), [GO:0005113](http://purl.obolibrary.org/obo/GO_0005113) (patched binding), [GO:0032727](http://purl.obolibrary.org/obo/GO_0032727) (positive regulation of interferon-alpha production), [GO:0097242](http://purl.obolibrary.org/obo/GO_0097242) (amyloid-beta clearance), [GO:0005109](http://purl.obolibrary.org/obo/GO_0005109) (frizzled binding), [GO:0006437](http://purl.obolibrary.org/obo/GO_0006437) (tyrosyl-tRNA aminoacylation), [GO:0006438](http://purl.obolibrary.org/obo/GO_0006438) (valyl-tRNA aminoacylation), [GO:0032728](http://purl.obolibrary.org/obo/GO_0032728) (positive regulation of interferon-beta production), [GO:0032729](http://purl.obolibrary.org/obo/GO_0032729) (positive regulation of interferon-gamma production), [GO:0017101](http://purl.obolibrary.org/obo/GO_0017101) (aminoacyl-tRNA synthetase multienzyme complex), [GO:0017102](http://purl.obolibrary.org/obo/GO_0017102) (methionyl glutamyl tRNA synthetase complex), [GO:0032722](http://purl.obolibrary.org/obo/GO_0032722) (positive regulation of chemokine production), [GO:0032720](http://purl.obolibrary.org/obo/GO_0032720) (negative regulation of tumor necrosis factor production), [GO:0019767](http://purl.obolibrary.org/obo/GO_0019767) (IgE receptor activity), [GO:1901077](http://purl.obolibrary.org/obo/GO_1901077) (regulation of relaxation of muscle), [GO:0006450](http://purl.obolibrary.org/obo/GO_0006450) (regulation of translational fidelity), [GO:0005121](http://purl.obolibrary.org/obo/GO_0005121) (Toll binding), [GO:0005123](http://purl.obolibrary.org/obo/GO_0005123) (death receptor binding), [GO:0005125](http://purl.obolibrary.org/obo/GO_0005125) (cytokine activity), [GO:0006457](http://purl.obolibrary.org/obo/GO_0006457) (protein folding), [GO:0006458](http://purl.obolibrary.org/obo/GO_0006458) ('de novo' protein folding), [GO:0044721](http://purl.obolibrary.org/obo/GO_0044721) (protein import into peroxisome matrix, substrate release), [GO:0005127](http://purl.obolibrary.org/obo/GO_0005127) (ciliary neurotrophic factor receptor binding), [GO:0005126](http://purl.obolibrary.org/obo/GO_0005126) (cytokine receptor binding), [GO:0098586](http://purl.obolibrary.org/obo/GO_0098586) (cellular response to virus), [GO:0032715](http://purl.obolibrary.org/obo/GO_0032715) (negative regulation of interleukin-6 production), [GO:0005119](http://purl.obolibrary.org/obo/GO_0005119) (smoothened binding), [GO:0061290](http://purl.obolibrary.org/obo/GO_0061290) (canonical Wnt signaling pathway involved in metanephric kidney development), [GO:0019752](http://purl.obolibrary.org/obo/GO_0019752) (carboxylic acid metabolic process), [GO:0043406](http://purl.obolibrary.org/obo/GO_0043406) (positive regulation of MAP kinase activity), [GO:0043405](http://purl.obolibrary.org/obo/GO_0043405) (regulation of MAP kinase activity), [GO:0043408](http://purl.obolibrary.org/obo/GO_0043408) (regulation of MAPK cascade), [GO:1901086](http://purl.obolibrary.org/obo/GO_1901086) (benzylpenicillin metabolic process), [GO:0043407](http://purl.obolibrary.org/obo/GO_0043407) (negative regulation of MAP kinase activity), [GO:0043409](http://purl.obolibrary.org/obo/GO_0043409) (negative regulation of MAPK cascade), [GO:0006420](http://purl.obolibrary.org/obo/GO_0006420) (arginyl-tRNA aminoacylation), [GO:0006421](http://purl.obolibrary.org/obo/GO_0006421) (asparaginyl-tRNA aminoacylation), [GO:0006424](http://purl.obolibrary.org/obo/GO_0006424) (glutamyl-tRNA aminoacylation), [GO:0043401](http://purl.obolibrary.org/obo/GO_0043401) (steroid hormone mediated signaling pathway), [GO:0043403](http://purl.obolibrary.org/obo/GO_0043403) (skeletal muscle tissue regeneration), [GO:0006423](http://purl.obolibrary.org/obo/GO_0006423) (cysteinyl-tRNA aminoacylation), [GO:0006417](http://purl.obolibrary.org/obo/GO_0006417) (regulation of translation), [GO:0006418](http://purl.obolibrary.org/obo/GO_0006418) (tRNA aminoacylation for protein translation), [GO:0006415](http://purl.obolibrary.org/obo/GO_0006415) (translational termination), [GO:0032703](http://purl.obolibrary.org/obo/GO_0032703) (negative regulation of interleukin-2 production), [GO:0097222](http://purl.obolibrary.org/obo/GO_0097222) (mitochondrial mRNA polyadenylation), [GO:0097225](http://purl.obolibrary.org/obo/GO_0097225) (sperm midpiece), [GO:0006419](http://purl.obolibrary.org/obo/GO_0006419) (alanyl-tRNA aminoacylation), [GO:0097228](http://purl.obolibrary.org/obo/GO_0097228) (sperm principal piece), [GO:0032700](http://purl.obolibrary.org/obo/GO_0032700) (negative regulation of interleukin-17 production), [GO:0019725](http://purl.obolibrary.org/obo/GO_0019725) (cellular homeostasis), [GO:1901094](http://purl.obolibrary.org/obo/GO_1901094) (negative regulation of protein homotetramerization), [GO:1901097](http://purl.obolibrary.org/obo/GO_1901097) (negative regulation of autophagosome maturation), [GO:0043418](http://purl.obolibrary.org/obo/GO_0043418) (homocysteine catabolic process), [GO:1901098](http://purl.obolibrary.org/obo/GO_1901098) (positive regulation of autophagosome maturation), [GO:0006431](http://purl.obolibrary.org/obo/GO_0006431) (methionyl-tRNA aminoacylation), [GO:0006432](http://purl.obolibrary.org/obo/GO_0006432) (phenylalanyl-tRNA aminoacylation), [GO:0043410](http://purl.obolibrary.org/obo/GO_0043410) (positive regulation of MAPK cascade), [GO:0006430](http://purl.obolibrary.org/obo/GO_0006430) (lysyl-tRNA aminoacylation), [GO:0006435](http://purl.obolibrary.org/obo/GO_0006435) (threonyl-tRNA aminoacylation), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0044743](http://purl.obolibrary.org/obo/GO_0044743) (protein transmembrane import into intracellular organelle), [GO:0097241](http://purl.obolibrary.org/obo/GO_0097241) (hematopoietic stem cell migration to bone marrow), [GO:0005105](http://purl.obolibrary.org/obo/GO_0005105) (type 1 fibroblast growth factor receptor binding), [GO:0005104](http://purl.obolibrary.org/obo/GO_0005104) (fibroblast growth factor receptor binding), [GO:0006434](http://purl.obolibrary.org/obo/GO_0006434) (seryl-tRNA aminoacylation), [GO:0006428](http://purl.obolibrary.org/obo/GO_0006428) (isoleucyl-tRNA aminoacylation), [GO:0006429](http://purl.obolibrary.org/obo/GO_0006429) (leucyl-tRNA aminoacylation), [GO:0006426](http://purl.obolibrary.org/obo/GO_0006426) (glycyl-tRNA aminoacylation), [GO:0006427](http://purl.obolibrary.org/obo/GO_0006427) (histidyl-tRNA aminoacylation), [GO:0097233](http://purl.obolibrary.org/obo/GO_0097233) (alveolar lamellar body membrane), [GO:0097236](http://purl.obolibrary.org/obo/GO_0097236) (positive regulation of transcription from RNA polymerase II promoter in response to zinc ion starvation), [GO:0097235](http://purl.obolibrary.org/obo/GO_0097235) (positive regulation of fatty acid beta-oxidation by positive regulation of transcription from RNA polymerase II promoter), [GO:0019731](http://purl.obolibrary.org/obo/GO_0019731) (antibacterial humoral response), [GO:0018401](http://purl.obolibrary.org/obo/GO_0018401) (peptidyl-proline hydroxylation to 4-hydroxy-L-proline), [GO:0032770](http://purl.obolibrary.org/obo/GO_0032770) (positive regulation of monooxygenase activity), [GO:0006486](http://purl.obolibrary.org/obo/GO_0006486) (protein glycosylation), [GO:0005154](http://purl.obolibrary.org/obo/GO_0005154) (epidermal growth factor receptor binding), [GO:1902358](http://purl.obolibrary.org/obo/GO_1902358) (sulfate transmembrane transport), [GO:0006487](http://purl.obolibrary.org/obo/GO_0006487) (protein N-linked glycosylation), [GO:0005158](http://purl.obolibrary.org/obo/GO_0005158) (insulin receptor binding), [GO:0006488](http://purl.obolibrary.org/obo/GO_0006488) (dolichol-linked oligosaccharide biosynthetic process), [GO:0006489](http://purl.obolibrary.org/obo/GO_0006489) (dolichyl diphosphate biosynthetic process), [GO:0005159](http://purl.obolibrary.org/obo/GO_0005159) (insulin-like growth factor receptor binding), [GO:0048286](http://purl.obolibrary.org/obo/GO_0048286) (lung alveolus development), [GO:0097201](http://purl.obolibrary.org/obo/GO_0097201) (negative regulation of transcription from RNA polymerase II promoter in response to stress), [GO:0097200](http://purl.obolibrary.org/obo/GO_0097200) (cysteine-type endopeptidase activity involved in execution phase of apoptosis), [GO:0098535](http://purl.obolibrary.org/obo/GO_0098535) (de novo centriole assembly involved in multi-ciliated epithelial cell differentiation), [GO:0097202](http://purl.obolibrary.org/obo/GO_0097202) (activation of cysteine-type endopeptidase activity), [GO:0098536](http://purl.obolibrary.org/obo/GO_0098536) (deuterosome), [GO:0097205](http://purl.obolibrary.org/obo/GO_0097205) (renal filtration), [GO:0098534](http://purl.obolibrary.org/obo/GO_0098534) (centriole assembly), [GO:0032762](http://purl.obolibrary.org/obo/GO_0032762) (mast cell cytokine production), [GO:0031432](http://purl.obolibrary.org/obo/GO_0031432) (titin binding), [GO:0017144](http://purl.obolibrary.org/obo/GO_0017144) (drug metabolic process), [GO:0032760](http://purl.obolibrary.org/obo/GO_0032760) (positive regulation of tumor necrosis factor production), [GO:0097209](http://purl.obolibrary.org/obo/GO_0097209) (epidermal lamellar body), [GO:0097208](http://purl.obolibrary.org/obo/GO_0097208) (alveolar lamellar body), [GO:0031430](http://purl.obolibrary.org/obo/GO_0031430) (M band), [GO:0030100](http://purl.obolibrary.org/obo/GO_0030100) (regulation of endocytosis), [GO:0017146](http://purl.obolibrary.org/obo/GO_0017146) (NMDA selective glutamate receptor complex), [GO:0017147](http://purl.obolibrary.org/obo/GO_0017147) (Wnt-protein binding), [GO:0031435](http://purl.obolibrary.org/obo/GO_0031435) (mitogen-activated protein kinase kinase kinase binding), [GO:0032767](http://purl.obolibrary.org/obo/GO_0032767) (copper-dependent protein binding), [GO:0017148](http://purl.obolibrary.org/obo/GO_0017148) (negative regulation of translation), [GO:0018478](http://purl.obolibrary.org/obo/GO_0018478) (malonate-semialdehyde dehydrogenase (acetylating) activity), [GO:0031436](http://purl.obolibrary.org/obo/GO_0031436) (BRCA1-BARD1 complex), [GO:0032764](http://purl.obolibrary.org/obo/GO_0032764) (negative regulation of mast cell cytokine production), [GO:0031433](http://purl.obolibrary.org/obo/GO_0031433) (telethonin binding), [GO:0031434](http://purl.obolibrary.org/obo/GO_0031434) (mitogen-activated protein kinase kinase binding), [GO:0030104](http://purl.obolibrary.org/obo/GO_0030104) (water homeostasis), [GO:0017129](http://purl.obolibrary.org/obo/GO_0017129) (triglyceride binding), [GO:0006490](http://purl.obolibrary.org/obo/GO_0006490) (oligosaccharide-lipid intermediate biosynthetic process), [GO:1902362](http://purl.obolibrary.org/obo/GO_1902362) (melanocyte apoptotic process), [GO:1903690](http://purl.obolibrary.org/obo/GO_1903690) (negative regulation of wound healing, spreading of epidermal cells), [GO:0006493](http://purl.obolibrary.org/obo/GO_0006493) (protein O-linked glycosylation), [GO:0005161](http://purl.obolibrary.org/obo/GO_0005161) (platelet-derived growth factor receptor binding), [GO:1902366](http://purl.obolibrary.org/obo/GO_1902366) (regulation of Notch signaling pathway involved in somitogenesis), [GO:0005160](http://purl.obolibrary.org/obo/GO_0005160) (transforming growth factor beta receptor binding), [GO:0006491](http://purl.obolibrary.org/obo/GO_0006491) (N-glycan processing), [GO:0005163](http://purl.obolibrary.org/obo/GO_0005163) (nerve growth factor receptor binding), [GO:0006497](http://purl.obolibrary.org/obo/GO_0006497) (protein lipidation), [GO:0005164](http://purl.obolibrary.org/obo/GO_0005164) (tumor necrosis factor receptor binding), [GO:1902367](http://purl.obolibrary.org/obo/GO_1902367) (negative regulation of Notch signaling pathway involved in somitogenesis), [GO:0005166](http://purl.obolibrary.org/obo/GO_0005166) (neurotrophin p75 receptor binding), [GO:0005169](http://purl.obolibrary.org/obo/GO_0005169) (neurotrophin TRKB receptor binding), [GO:0098542](http://purl.obolibrary.org/obo/GO_0098542) (defense response to other organism), [GO:0031428](http://purl.obolibrary.org/obo/GO_0031428) (box C/D snoRNP complex), [GO:0048298](http://purl.obolibrary.org/obo/GO_0048298) (positive regulation of isotype switching to IgA isotypes), [GO:0031429](http://purl.obolibrary.org/obo/GO_0031429) (box H/ACA snoRNP complex), [GO:0032757](http://purl.obolibrary.org/obo/GO_0032757) (positive regulation of interleukin-8 production), [GO:0097211](http://purl.obolibrary.org/obo/GO_0097211) (cellular response to gonadotropin-releasing hormone), [GO:0031427](http://purl.obolibrary.org/obo/GO_0031427) (response to methotrexate), [GO:0017133](http://purl.obolibrary.org/obo/GO_0017133) (mitochondrial electron transfer flavoprotein complex), [GO:0017134](http://purl.obolibrary.org/obo/GO_0017134) (fibroblast growth factor binding), [GO:0032755](http://purl.obolibrary.org/obo/GO_0032755) (positive regulation of interleukin-6 production), [GO:0031424](http://purl.obolibrary.org/obo/GO_0031424) (keratinization), [GO:0017137](http://purl.obolibrary.org/obo/GO_0017137) (Rab GTPase binding), [GO:0032753](http://purl.obolibrary.org/obo/GO_0032753) (positive regulation of interleukin-4 production), [GO:0031422](http://purl.obolibrary.org/obo/GO_0031422) (RecQ helicase-Topo III complex), [GO:0032754](http://purl.obolibrary.org/obo/GO_0032754) (positive regulation of interleukin-5 production), [GO:0017119](http://purl.obolibrary.org/obo/GO_0017119) (Golgi transport complex), [GO:1902373](http://purl.obolibrary.org/obo/GO_1902373) (negative regulation of mRNA catabolic process), [GO:0006461](http://purl.obolibrary.org/obo/GO_0006461) (protein complex assembly), [GO:0006464](http://purl.obolibrary.org/obo/GO_0006464) (cellular protein modification process), [GO:0006465](http://purl.obolibrary.org/obo/GO_0006465) (signal peptide processing), [GO:0005134](http://purl.obolibrary.org/obo/GO_0005134) (interleukin-2 receptor binding), [GO:0005133](http://purl.obolibrary.org/obo/GO_0005133) (interferon-gamma receptor binding), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0006469](http://purl.obolibrary.org/obo/GO_0006469) (negative regulation of protein kinase activity), [GO:0031418](http://purl.obolibrary.org/obo/GO_0031418) (L-ascorbic acid binding), [GO:0005128](http://purl.obolibrary.org/obo/GO_0005128) (erythropoietin receptor binding), [GO:0031415](http://purl.obolibrary.org/obo/GO_0031415) (NatA complex), [GO:0032747](http://purl.obolibrary.org/obo/GO_0032747) (positive regulation of interleukin-23 production), [GO:0031419](http://purl.obolibrary.org/obo/GO_0031419) (cobalamin binding), [GO:0032740](http://purl.obolibrary.org/obo/GO_0032740) (positive regulation of interleukin-17 production), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0032741](http://purl.obolibrary.org/obo/GO_0032741) (positive regulation of interleukin-18 production), [GO:0017124](http://purl.obolibrary.org/obo/GO_0017124) (SH3 domain binding), [GO:0018454](http://purl.obolibrary.org/obo/GO_0018454) (acetoacetyl-CoA reductase activity), [GO:0031413](http://purl.obolibrary.org/obo/GO_0031413) (regulation of buoyancy), [GO:0017126](http://purl.obolibrary.org/obo/GO_0017126) (nucleologenesis), [GO:0017127](http://purl.obolibrary.org/obo/GO_0017127) (cholesterol transporter activity), [GO:0032743](http://purl.obolibrary.org/obo/GO_0032743) (positive regulation of interleukin-2 production), [GO:0019789](http://purl.obolibrary.org/obo/GO_0019789) (SUMO transferase activity), [GO:0017108](http://purl.obolibrary.org/obo/GO_0017108) (5'-flap endonuclease activity), [GO:0017109](http://purl.obolibrary.org/obo/GO_0017109) (glutamate-cysteine ligase complex), [GO:0006471](http://purl.obolibrary.org/obo/GO_0006471) (protein ADP-ribosylation), [GO:0006470](http://purl.obolibrary.org/obo/GO_0006470) (protein dephosphorylation), [GO:0006475](http://purl.obolibrary.org/obo/GO_0006475) (internal protein amino acid acetylation), [GO:0005143](http://purl.obolibrary.org/obo/GO_0005143) (interleukin-12 receptor binding), [GO:0006476](http://purl.obolibrary.org/obo/GO_0006476) (protein deacetylation), [GO:0006473](http://purl.obolibrary.org/obo/GO_0006473) (protein acetylation), [GO:0006474](http://purl.obolibrary.org/obo/GO_0006474) (N-terminal protein amino acid acetylation), [GO:0006479](http://purl.obolibrary.org/obo/GO_0006479) (protein methylation), [GO:0005149](http://purl.obolibrary.org/obo/GO_0005149) (interleukin-1 receptor binding), [GO:0006477](http://purl.obolibrary.org/obo/GO_0006477) (protein sulfation), [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding), [GO:0032738](http://purl.obolibrary.org/obo/GO_0032738) (positive regulation of interleukin-15 production), [GO:0032735](http://purl.obolibrary.org/obo/GO_0032735) (positive regulation of interleukin-12 production), [GO:0031404](http://purl.obolibrary.org/obo/GO_0031404) (chloride ion binding), [GO:0032736](http://purl.obolibrary.org/obo/GO_0032736) (positive regulation of interleukin-13 production), [GO:0019770](http://purl.obolibrary.org/obo/GO_0019770) (IgG receptor activity), [GO:0017110](http://purl.obolibrary.org/obo/GO_0017110) (nucleoside-diphosphatase activity), [GO:0019773](http://purl.obolibrary.org/obo/GO_0019773) (proteasome core complex, alpha-subunit complex), [GO:0017111](http://purl.obolibrary.org/obo/GO_0017111) (nucleoside-triphosphatase activity), [GO:0019772](http://purl.obolibrary.org/obo/GO_0019772) (low-affinity IgG receptor activity), [GO:0017112](http://purl.obolibrary.org/obo/GO_0017112) (Rab guanyl-nucleotide exchange factor activity), [GO:0017113](http://purl.obolibrary.org/obo/GO_0017113) (dihydropyrimidine dehydrogenase (NADP+) activity), [GO:0032733](http://purl.obolibrary.org/obo/GO_0032733) (positive regulation of interleukin-10 production), [GO:0031402](http://purl.obolibrary.org/obo/GO_0031402) (sodium ion binding), [GO:0031403](http://purl.obolibrary.org/obo/GO_0031403) (lithium ion binding), [GO:0017116](http://purl.obolibrary.org/obo/GO_0017116) (single-stranded DNA-dependent ATP-dependent DNA helicase activity), [GO:0032731](http://purl.obolibrary.org/obo/GO_0032731) (positive regulation of interleukin-1 beta production), [GO:0042019](http://purl.obolibrary.org/obo/GO_0042019) (interleukin-23 binding), [GO:0005070](http://purl.obolibrary.org/obo/GO_0005070) (SH3/SH2 adaptor activity), [GO:0031362](http://purl.obolibrary.org/obo/GO_0031362) (anchored component of external side of plasma membrane), [GO:0032693](http://purl.obolibrary.org/obo/GO_0032693) (negative regulation of interleukin-10 production), [GO:0030031](http://purl.obolibrary.org/obo/GO_0030031) (cell projection assembly), [GO:0032691](http://purl.obolibrary.org/obo/GO_0032691) (negative regulation of interleukin-1 beta production), [GO:0030030](http://purl.obolibrary.org/obo/GO_0030030) (cell projection organization), [GO:0042011](http://purl.obolibrary.org/obo/GO_0042011) (interleukin-16 binding), [GO:0042012](http://purl.obolibrary.org/obo/GO_0042012) (interleukin-16 receptor activity), [GO:0005078](http://purl.obolibrary.org/obo/GO_0005078) (MAP-kinase scaffold activity), [GO:0018393](http://purl.obolibrary.org/obo/GO_0018393) (internal peptidyl-lysine acetylation), [GO:0042020](http://purl.obolibrary.org/obo/GO_0042020) (interleukin-23 receptor activity), [GO:0017064](http://purl.obolibrary.org/obo/GO_0017064) (fatty acid amide hydrolase activity), [GO:0030021](http://purl.obolibrary.org/obo/GO_0030021) (extracellular matrix structural constituent conferring compression resistance), [GO:0030026](http://purl.obolibrary.org/obo/GO_0030026) (cellular manganese ion homeostasis), [GO:0032689](http://purl.obolibrary.org/obo/GO_0032689) (negative regulation of interferon-gamma production), [GO:0030027](http://purl.obolibrary.org/obo/GO_0030027) (lamellipodium), [GO:0070965](http://purl.obolibrary.org/obo/GO_0070965) (positive regulation of neutrophil mediated killing of fungus), [GO:0032688](http://purl.obolibrary.org/obo/GO_0032688) (negative regulation of interferon-beta production), [GO:0005080](http://purl.obolibrary.org/obo/GO_0005080) (protein kinase C binding), [GO:0032682](http://purl.obolibrary.org/obo/GO_0032682) (negative regulation of chemokine production), [GO:0005086](http://purl.obolibrary.org/obo/GO_0005086) (ARF guanyl-nucleotide exchange factor activity), [GO:0032680](http://purl.obolibrary.org/obo/GO_0032680) (regulation of tumor necrosis factor production), [GO:0005085](http://purl.obolibrary.org/obo/GO_0005085) (guanyl-nucleotide exchange factor activity), [GO:0005088](http://purl.obolibrary.org/obo/GO_0005088) (Ras guanyl-nucleotide exchange factor activity), [GO:0005089](http://purl.obolibrary.org/obo/GO_0005089) (Rho guanyl-nucleotide exchange factor activity), [GO:0042026](http://purl.obolibrary.org/obo/GO_0042026) (protein refolding), [GO:0030018](http://purl.obolibrary.org/obo/GO_0030018) (Z disc), [GO:0044690](http://purl.obolibrary.org/obo/GO_0044690) (methionine import), [GO:0044692](http://purl.obolibrary.org/obo/GO_0044692) (exoribonuclease activator activity), [GO:0042030](http://purl.obolibrary.org/obo/GO_0042030) (ATPase inhibitor activity), [GO:0017053](http://purl.obolibrary.org/obo/GO_0017053) (transcriptional repressor complex), [GO:0043362](http://purl.obolibrary.org/obo/GO_0043362) (nucleate erythrocyte maturation), [GO:0030011](http://purl.obolibrary.org/obo/GO_0030011) (maintenance of cell polarity), [GO:0017056](http://purl.obolibrary.org/obo/GO_0017056) (structural constituent of nuclear pore), [GO:0030010](http://purl.obolibrary.org/obo/GO_0030010) (establishment of cell polarity), [GO:0032675](http://purl.obolibrary.org/obo/GO_0032675) (regulation of interleukin-6 production), [GO:0017059](http://purl.obolibrary.org/obo/GO_0017059) (serine C-palmitoyltransferase complex), [GO:0030017](http://purl.obolibrary.org/obo/GO_0030017) (sarcomere), [GO:0031345](http://purl.obolibrary.org/obo/GO_0031345) (negative regulation of cell projection organization), [GO:0030016](http://purl.obolibrary.org/obo/GO_0030016) (myofibril), [GO:0006383](http://purl.obolibrary.org/obo/GO_0006383) (transcription by RNA polymerase III), [GO:0031340](http://purl.obolibrary.org/obo/GO_0031340) (positive regulation of vesicle fusion), [GO:0005053](http://purl.obolibrary.org/obo/GO_0005053) (peroxisome matrix targeting signal-2 binding), [GO:0006382](http://purl.obolibrary.org/obo/GO_0006382) (adenosine to inosine editing), [GO:0005052](http://purl.obolibrary.org/obo/GO_0005052) (peroxisome matrix targeting signal-1 binding), [GO:0097191](http://purl.obolibrary.org/obo/GO_0097191) (extrinsic apoptotic signaling pathway), [GO:0097190](http://purl.obolibrary.org/obo/GO_0097190) (apoptotic signaling pathway), [GO:0097193](http://purl.obolibrary.org/obo/GO_0097193) (intrinsic apoptotic signaling pathway), [GO:0005057](http://purl.obolibrary.org/obo/GO_0005057) (signal transducer activity, downstream of receptor), [GO:0042035](http://purl.obolibrary.org/obo/GO_0042035) (regulation of cytokine biosynthetic process), [GO:0097192](http://purl.obolibrary.org/obo/GO_0097192) (extrinsic apoptotic signaling pathway in absence of ligand), [GO:0097194](http://purl.obolibrary.org/obo/GO_0097194) (execution phase of apoptosis), [GO:0043368](http://purl.obolibrary.org/obo/GO_0043368) (positive T cell selection), [GO:0030008](http://purl.obolibrary.org/obo/GO_0030008) (TRAPP complex), [GO:0030007](http://purl.obolibrary.org/obo/GO_0030007) (cellular potassium ion homeostasis), [GO:0043370](http://purl.obolibrary.org/obo/GO_0043370) (regulation of CD4-positive, alpha-beta T cell differentiation), [GO:0031338](http://purl.obolibrary.org/obo/GO_0031338) (regulation of vesicle fusion), [GO:0031339](http://purl.obolibrary.org/obo/GO_0031339) (negative regulation of vesicle fusion), [GO:0017040](http://purl.obolibrary.org/obo/GO_0017040) (ceramidase activity), [GO:0043372](http://purl.obolibrary.org/obo/GO_0043372) (positive regulation of CD4-positive, alpha-beta T cell differentiation), [GO:0070981](http://purl.obolibrary.org/obo/GO_0070981) (L-asparagine biosynthetic process), [GO:0042043](http://purl.obolibrary.org/obo/GO_0042043) (neurexin family protein binding), [GO:0031333](http://purl.obolibrary.org/obo/GO_0031333) (negative regulation of protein complex assembly), [GO:0017046](http://purl.obolibrary.org/obo/GO_0017046) (peptide hormone binding), [GO:0033993](http://purl.obolibrary.org/obo/GO_0033993) (response to lipid), [GO:0030001](http://purl.obolibrary.org/obo/GO_0030001) (metal ion transport), [GO:0017048](http://purl.obolibrary.org/obo/GO_0017048) (Rho GTPase binding), [GO:0070988](http://purl.obolibrary.org/obo/GO_0070988) (demethylation), [GO:0030004](http://purl.obolibrary.org/obo/GO_0030004) (cellular monovalent inorganic cation homeostasis), [GO:0030003](http://purl.obolibrary.org/obo/GO_0030003) (cellular cation homeostasis), [GO:0031334](http://purl.obolibrary.org/obo/GO_0031334) (positive regulation of protein complex assembly), [GO:0070986](http://purl.obolibrary.org/obo/GO_0070986) (left/right axis specification), [GO:0031335](http://purl.obolibrary.org/obo/GO_0031335) (regulation of sulfur amino acid metabolic process), [GO:0070987](http://purl.obolibrary.org/obo/GO_0070987) (error-free translesion synthesis), [GO:0006390](http://purl.obolibrary.org/obo/GO_0006390) (mitochondrial transcription), [GO:0006391](http://purl.obolibrary.org/obo/GO_0006391) (transcription initiation from mitochondrial promoter), [GO:0042045](http://purl.obolibrary.org/obo/GO_0042045) (epithelial fluid transport), [GO:0006396](http://purl.obolibrary.org/obo/GO_0006396) (RNA processing), [GO:0005068](http://purl.obolibrary.org/obo/GO_0005068) (transmembrane receptor protein tyrosine kinase adaptor activity), [GO:0006397](http://purl.obolibrary.org/obo/GO_0006397) (mRNA processing), [GO:0042048](http://purl.obolibrary.org/obo/GO_0042048) (olfactory behavior), [GO:0097199](http://purl.obolibrary.org/obo/GO_0097199) (cysteine-type endopeptidase activity involved in apoptotic signaling pathway), [GO:0097198](http://purl.obolibrary.org/obo/GO_0097198) (histone H3-K36 trimethylation), [GO:0032658](http://purl.obolibrary.org/obo/GO_0032658) (regulation of interleukin-15 production), [GO:0033989](http://purl.obolibrary.org/obo/GO_0033989) (3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity), [GO:0042051](http://purl.obolibrary.org/obo/GO_0042051) (compound eye photoreceptor development), [GO:0043382](http://purl.obolibrary.org/obo/GO_0043382) (positive regulation of memory T cell differentiation), [GO:0042053](http://purl.obolibrary.org/obo/GO_0042053) (regulation of dopamine metabolic process), [GO:0019693](http://purl.obolibrary.org/obo/GO_0019693) (ribose phosphate metabolic process), [GO:0042054](http://purl.obolibrary.org/obo/GO_0042054) (histone methyltransferase activity), [GO:0031321](http://purl.obolibrary.org/obo/GO_0031321) (ascospore-type prospore assembly), [GO:0070973](http://purl.obolibrary.org/obo/GO_0070973) (protein localization to endoplasmic reticulum exit site), [GO:0070971](http://purl.obolibrary.org/obo/GO_0070971) (endoplasmic reticulum exit site), [GO:0070972](http://purl.obolibrary.org/obo/GO_0070972) (protein localization to endoplasmic reticulum), [GO:0070977](http://purl.obolibrary.org/obo/GO_0070977) (bone maturation), [GO:0017038](http://purl.obolibrary.org/obo/GO_0017038) (protein import), [GO:0031323](http://purl.obolibrary.org/obo/GO_0031323) (regulation of cellular metabolic process), [GO:0070976](http://purl.obolibrary.org/obo/GO_0070976) (TIR domain binding), [GO:0043306](http://purl.obolibrary.org/obo/GO_0043306) (positive regulation of mast cell degranulation), [GO:0030071](http://purl.obolibrary.org/obo/GO_0030071) (regulation of mitotic metaphase/anaphase transition), [GO:0030070](http://purl.obolibrary.org/obo/GO_0030070) (insulin processing), [GO:0030073](http://purl.obolibrary.org/obo/GO_0030073) (insulin secretion), [GO:0030072](http://purl.obolibrary.org/obo/GO_0030072) (peptide hormone secretion), [GO:0045963](http://purl.obolibrary.org/obo/GO_0045963) (negative regulation of dopamine metabolic process), [GO:0043303](http://purl.obolibrary.org/obo/GO_0043303) (mast cell degranulation), [GO:0045967](http://purl.obolibrary.org/obo/GO_0045967) (negative regulation of growth rate), [GO:0043305](http://purl.obolibrary.org/obo/GO_0043305) (negative regulation of mast cell degranulation), [GO:0045964](http://purl.obolibrary.org/obo/GO_0045964) (positive regulation of dopamine metabolic process), [GO:0002830](http://purl.obolibrary.org/obo/GO_0002830) (positive regulation of type 2 immune response), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0001502](http://purl.obolibrary.org/obo/GO_0001502) (cartilage condensation), [GO:0001503](http://purl.obolibrary.org/obo/GO_0001503) (ossification), [GO:0097169](http://purl.obolibrary.org/obo/GO_0097169) (AIM2 inflammasome complex), [GO:0014816](http://purl.obolibrary.org/obo/GO_0014816) (skeletal muscle satellite cell differentiation), [GO:0001505](http://purl.obolibrary.org/obo/GO_0001505) (regulation of neurotransmitter levels), [GO:0031398](http://purl.obolibrary.org/obo/GO_0031398) (positive regulation of protein ubiquitination), [GO:0014814](http://purl.obolibrary.org/obo/GO_0014814) (axon regeneration at neuromuscular junction), [GO:0002839](http://purl.obolibrary.org/obo/GO_0002839) (positive regulation of immune response to tumor cell), [GO:0001508](http://purl.obolibrary.org/obo/GO_0001508) (action potential), [GO:0031396](http://purl.obolibrary.org/obo/GO_0031396) (regulation of protein ubiquitination), [GO:0014812](http://purl.obolibrary.org/obo/GO_0014812) (muscle cell migration), [GO:0031397](http://purl.obolibrary.org/obo/GO_0031397) (negative regulation of protein ubiquitination), [GO:0031390](http://purl.obolibrary.org/obo/GO_0031390) (Ctf18 RFC-like complex), [GO:0030060](http://purl.obolibrary.org/obo/GO_0030060) (L-malate dehydrogenase activity), [GO:0070914](http://purl.obolibrary.org/obo/GO_0070914) (UV-damage excision repair), [GO:0102336](http://purl.obolibrary.org/obo/GO_0102336) (3-oxo-arachidoyl-CoA synthase activity), [GO:0030061](http://purl.obolibrary.org/obo/GO_0030061) (mitochondrial crista), [GO:0102338](http://purl.obolibrary.org/obo/GO_0102338) (3-oxo-lignoceronyl-CoA synthase activity), [GO:0102337](http://purl.obolibrary.org/obo/GO_0102337) (3-oxo-cerotoyl-CoA synthase activity), [GO:0043310](http://purl.obolibrary.org/obo/GO_0043310) (negative regulation of eosinophil degranulation), [GO:0045977](http://purl.obolibrary.org/obo/GO_0045977) (positive regulation of mitotic cell cycle, embryonic), [GO:0097186](http://purl.obolibrary.org/obo/GO_0097186) (amelogenesis), [GO:0043316](http://purl.obolibrary.org/obo/GO_0043316) (cytotoxic T cell degranulation), [GO:0097176](http://purl.obolibrary.org/obo/GO_0097176) (epoxide metabolic process), [GO:0001512](http://purl.obolibrary.org/obo/GO_0001512) (dihydronicotinamide riboside quinone reductase activity), [GO:0001515](http://purl.obolibrary.org/obo/GO_0001515) (opioid peptide activity), [GO:0001516](http://purl.obolibrary.org/obo/GO_0001516) (prostaglandin biosynthetic process), [GO:0001517](http://purl.obolibrary.org/obo/GO_0001517) (N-acetylglucosamine 6-O-sulfotransferase activity), [GO:0014826](http://purl.obolibrary.org/obo/GO_0014826) (vein smooth muscle contraction), [GO:0017099](http://purl.obolibrary.org/obo/GO_0017099) (very-long-chain-acyl-CoA dehydrogenase activity), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0001518](http://purl.obolibrary.org/obo/GO_0001518) (voltage-gated sodium channel complex), [GO:0030057](http://purl.obolibrary.org/obo/GO_0030057) (desmosome), [GO:0014824](http://purl.obolibrary.org/obo/GO_0014824) (artery smooth muscle contraction), [GO:0014823](http://purl.obolibrary.org/obo/GO_0014823) (response to activity), [GO:0030056](http://purl.obolibrary.org/obo/GO_0030056) (hemidesmosome), [GO:0031386](http://purl.obolibrary.org/obo/GO_0031386) (protein tag), [GO:0043328](http://purl.obolibrary.org/obo/GO_0043328) (protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway), [GO:0005092](http://purl.obolibrary.org/obo/GO_0005092) (GDP-dissociation inhibitor activity), [GO:0070947](http://purl.obolibrary.org/obo/GO_0070947) (neutrophil mediated killing of fungus), [GO:0005095](http://purl.obolibrary.org/obo/GO_0005095) (GTPase inhibitor activity), [GO:0030050](http://purl.obolibrary.org/obo/GO_0030050) (vesicle transport along actin filament), [GO:0031384](http://purl.obolibrary.org/obo/GO_0031384) (regulation of initiation of mating projection growth), [GO:0005096](http://purl.obolibrary.org/obo/GO_0005096) (GTPase activator activity), [GO:0045984](http://purl.obolibrary.org/obo/GO_0045984) (negative regulation of pyrimidine nucleobase metabolic process), [GO:0043320](http://purl.obolibrary.org/obo/GO_0043320) (natural killer cell degranulation), [GO:0043325](http://purl.obolibrary.org/obo/GO_0043325) (phosphatidylinositol-3,4-bisphosphate binding), [GO:0097150](http://purl.obolibrary.org/obo/GO_0097150) (neuronal stem cell population maintenance), [GO:0097153](http://purl.obolibrary.org/obo/GO_0097153) (cysteine-type endopeptidase activity involved in apoptotic process), [GO:0045986](http://purl.obolibrary.org/obo/GO_0045986) (negative regulation of smooth muscle contraction), [GO:0045987](http://purl.obolibrary.org/obo/GO_0045987) (positive regulation of smooth muscle contraction), [GO:0097152](http://purl.obolibrary.org/obo/GO_0097152) (mesenchymal cell apoptotic process), [GO:0017080](http://purl.obolibrary.org/obo/GO_0017080) (sodium channel regulator activity), [GO:0017081](http://purl.obolibrary.org/obo/GO_0017081) (chloride channel regulator activity), [GO:0017082](http://purl.obolibrary.org/obo/GO_0017082) (mineralocorticoid receptor activity), [GO:0017084](http://purl.obolibrary.org/obo/GO_0017084) (delta1-pyrroline-5-carboxylate synthetase activity), [GO:0002812](http://purl.obolibrary.org/obo/GO_0002812) (biosynthetic process of antibacterial peptides active against Gram-negative bacteria), [GO:0043330](http://purl.obolibrary.org/obo/GO_0043330) (response to exogenous dsRNA), [GO:0070940](http://purl.obolibrary.org/obo/GO_0070940) (dephosphorylation of RNA polymerase II C-terminal domain), [GO:0030046](http://purl.obolibrary.org/obo/GO_0030046) (parallel actin filament bundle assembly), [GO:0030048](http://purl.obolibrary.org/obo/GO_0030048) (actin filament-based movement), [GO:0002819](http://purl.obolibrary.org/obo/GO_0002819) (regulation of adaptive immune response), [GO:0070945](http://purl.obolibrary.org/obo/GO_0070945) (neutrophil mediated killing of gram-negative bacterium), [GO:0030049](http://purl.obolibrary.org/obo/GO_0030049) (muscle filament sliding), [GO:0070938](http://purl.obolibrary.org/obo/GO_0070938) (contractile ring), [GO:0070935](http://purl.obolibrary.org/obo/GO_0070935) (3'-UTR-mediated mRNA stabilization), [GO:0070936](http://purl.obolibrary.org/obo/GO_0070936) (protein K48-linked ubiquitination), [GO:0030041](http://purl.obolibrary.org/obo/GO_0030041) (actin filament polymerization), [GO:0043332](http://purl.obolibrary.org/obo/GO_0043332) (mating projection tip), [GO:0045995](http://purl.obolibrary.org/obo/GO_0045995) (regulation of embryonic development), [GO:0045994](http://purl.obolibrary.org/obo/GO_0045994) (positive regulation of translational initiation by iron), [GO:0043335](http://purl.obolibrary.org/obo/GO_0043335) (protein unfolding), [GO:0097155](http://purl.obolibrary.org/obo/GO_0097155) (fasciculation of sensory neuron axon), [GO:0014808](http://purl.obolibrary.org/obo/GO_0014808) (release of sequestered calcium ion into cytosol by sarcoplasmic reticulum), [GO:0097159](http://purl.obolibrary.org/obo/GO_0097159) (organic cyclic compound binding), [GO:0014807](http://purl.obolibrary.org/obo/GO_0014807) (regulation of somitogenesis), [GO:0017075](http://purl.obolibrary.org/obo/GO_0017075) (syntaxin-1 binding), [GO:0017076](http://purl.obolibrary.org/obo/GO_0017076) (purine nucleotide binding), [GO:0030033](http://purl.obolibrary.org/obo/GO_0030033) (microvillus assembly), [GO:0002827](http://purl.obolibrary.org/obo/GO_0002827) (positive regulation of T-helper 1 type immune response), [GO:0030032](http://purl.obolibrary.org/obo/GO_0030032) (lamellipodium assembly), [GO:0002828](http://purl.obolibrary.org/obo/GO_0002828) (regulation of type 2 immune response), [GO:0014802](http://purl.obolibrary.org/obo/GO_0014802) (terminal cisterna), [GO:0032695](http://purl.obolibrary.org/obo/GO_0032695) (negative regulation of interleukin-12 production), [GO:0002829](http://purl.obolibrary.org/obo/GO_0002829) (negative regulation of type 2 immune response), [GO:0031369](http://purl.obolibrary.org/obo/GO_0031369) (translation initiation factor binding), [GO:0030036](http://purl.obolibrary.org/obo/GO_0030036) (actin cytoskeleton organization), [GO:1990809](http://purl.obolibrary.org/obo/GO_1990809) (endoplasmic reticulum tubular network membrane organization), [GO:0014861](http://purl.obolibrary.org/obo/GO_0014861) (regulation of skeletal muscle contraction via regulation of action potential), [GO:0001550](http://purl.obolibrary.org/obo/GO_0001550) (ovarian cumulus expansion), [GO:0002881](http://purl.obolibrary.org/obo/GO_0002881) (negative regulation of chronic inflammatory response to non-antigenic stimulus), [GO:0000212](http://purl.obolibrary.org/obo/GO_0000212) (meiotic spindle organization), [GO:0001552](http://purl.obolibrary.org/obo/GO_0001552) (ovarian follicle atresia), [GO:0000221](http://purl.obolibrary.org/obo/GO_0000221) (vacuolar proton-transporting V-type ATPase, V1 domain), [GO:0001542](http://purl.obolibrary.org/obo/GO_0001542) (ovulation from ovarian follicle), [GO:0000220](http://purl.obolibrary.org/obo/GO_0000220) (vacuolar proton-transporting V-type ATPase, V0 domain), [GO:0002876](http://purl.obolibrary.org/obo/GO_0002876) (positive regulation of chronic inflammatory response to antigenic stimulus), [GO:0001547](http://purl.obolibrary.org/obo/GO_0001547) (antral ovarian follicle growth), [GO:0014857](http://purl.obolibrary.org/obo/GO_0014857) (regulation of skeletal muscle cell proliferation), [GO:0051800](http://purl.obolibrary.org/obo/GO_0051800) (phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity), [GO:0000228](http://purl.obolibrary.org/obo/GO_0000228) (nuclear chromosome), [GO:0000226](http://purl.obolibrary.org/obo/GO_0000226) (microtubule cytoskeleton organization), [GO:0000225](http://purl.obolibrary.org/obo/GO_0000225) (N-acetylglucosaminylphosphatidylinositol deacetylase activity), [GO:0002891](http://purl.obolibrary.org/obo/GO_0002891) (positive regulation of immunoglobulin mediated immune response), [GO:0000224](http://purl.obolibrary.org/obo/GO_0000224) (peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity), [GO:0001561](http://purl.obolibrary.org/obo/GO_0001561) (fatty acid alpha-oxidation), [GO:0001553](http://purl.obolibrary.org/obo/GO_0001553) (luteinization), [GO:2000406](http://purl.obolibrary.org/obo/GO_2000406) (positive regulation of T cell migration), [GO:2000405](http://purl.obolibrary.org/obo/GO_2000405) (negative regulation of T cell migration), [GO:2000404](http://purl.obolibrary.org/obo/GO_2000404) (regulation of T cell migration), [GO:0001556](http://purl.obolibrary.org/obo/GO_0001556) (oocyte maturation), [GO:0001558](http://purl.obolibrary.org/obo/GO_0001558) (regulation of cell growth), [GO:0030099](http://purl.obolibrary.org/obo/GO_0030099) (myeloid cell differentiation), [GO:1990812](http://purl.obolibrary.org/obo/GO_1990812) (growth cone filopodium), [GO:0030098](http://purl.obolibrary.org/obo/GO_0030098) (lymphocyte differentiation), [GO:1990816](http://purl.obolibrary.org/obo/GO_1990816) (vacuole-mitochondrion membrane contact site), [GO:0014866](http://purl.obolibrary.org/obo/GO_0014866) (skeletal myofibril assembly), [GO:0030091](http://purl.obolibrary.org/obo/GO_0030091) (protein repair), [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis), [GO:0001530](http://purl.obolibrary.org/obo/GO_0001530) (lipopolysaccharide binding), [GO:0001520](http://purl.obolibrary.org/obo/GO_0001520) (outer dense fiber), [GO:0001522](http://purl.obolibrary.org/obo/GO_0001522) (pseudouridine synthesis), [GO:0001523](http://purl.obolibrary.org/obo/GO_0001523) (retinoid metabolic process), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0001527](http://purl.obolibrary.org/obo/GO_0001527) (microfibril), [GO:1990825](http://purl.obolibrary.org/obo/GO_1990825) (sequence-specific mRNA binding), [GO:0014835](http://purl.obolibrary.org/obo/GO_0014835) (myoblast differentiation involved in skeletal muscle regeneration), [GO:0014832](http://purl.obolibrary.org/obo/GO_0014832) (urinary bladder smooth muscle contraction), [GO:0051823](http://purl.obolibrary.org/obo/GO_0051823) (regulation of synapse structural plasticity), [GO:0014831](http://purl.obolibrary.org/obo/GO_0014831) (gastro-intestinal system smooth muscle contraction), [GO:0014850](http://purl.obolibrary.org/obo/GO_0014850) (response to muscle activity), [GO:0000209](http://purl.obolibrary.org/obo/GO_0000209) (protein polyubiquitination), [GO:0050508](http://purl.obolibrary.org/obo/GO_0050508) (glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity), [GO:0000208](http://purl.obolibrary.org/obo/GO_0000208) (MAPK import into nucleus involved in osmosensory signaling pathway), [GO:0050509](http://purl.obolibrary.org/obo/GO_0050509) (N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity), [GO:1904925](http://purl.obolibrary.org/obo/GO_1904925) (positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization), [GO:0001540](http://purl.obolibrary.org/obo/GO_0001540) (amyloid-beta binding), [GO:1904924](http://purl.obolibrary.org/obo/GO_1904924) (negative regulation of mitophagy in response to mitochondrial depolarization), [GO:0001541](http://purl.obolibrary.org/obo/GO_0001541) (ovarian follicle development), [GO:0002862](http://purl.obolibrary.org/obo/GO_0002862) (negative regulation of inflammatory response to antigenic stimulus), [GO:0001533](http://purl.obolibrary.org/obo/GO_0001533) (cornified envelope), [GO:2000427](http://purl.obolibrary.org/obo/GO_2000427) (positive regulation of apoptotic cell clearance), [GO:0002865](http://purl.obolibrary.org/obo/GO_0002865) (negative regulation of acute inflammatory response to antigenic stimulus), [GO:1990830](http://purl.obolibrary.org/obo/GO_1990830) (cellular response to leukemia inhibitory factor), [GO:0001537](http://purl.obolibrary.org/obo/GO_0001537) (N-acetylgalactosamine 4-O-sulfotransferase activity), [GO:0051835](http://purl.obolibrary.org/obo/GO_0051835) (positive regulation of synapse structural plasticity), [GO:1990837](http://purl.obolibrary.org/obo/GO_1990837) (sequence-specific double-stranded DNA binding), [GO:0014842](http://purl.obolibrary.org/obo/GO_0014842) (regulation of skeletal muscle satellite cell proliferation), [GO:0014841](http://purl.obolibrary.org/obo/GO_0014841) (skeletal muscle satellite cell proliferation), [GO:0050501](http://purl.obolibrary.org/obo/GO_0050501) (hyaluronan synthase activity), [GO:0042056](http://purl.obolibrary.org/obo/GO_0042056) (chemoattractant activity), [GO:0043388](http://purl.obolibrary.org/obo/GO_0043388) (positive regulation of DNA binding), [GO:0042058](http://purl.obolibrary.org/obo/GO_0042058) (regulation of epidermal growth factor receptor signaling pathway), [GO:0042059](http://purl.obolibrary.org/obo/GO_0042059) (negative regulation of epidermal growth factor receptor signaling pathway), [GO:0000255](http://purl.obolibrary.org/obo/GO_0000255) (allantoin metabolic process), [GO:2000439](http://purl.obolibrary.org/obo/GO_2000439) (positive regulation of monocyte extravasation), [GO:0042060](http://purl.obolibrary.org/obo/GO_0042060) (wound healing), [GO:0043392](http://purl.obolibrary.org/obo/GO_0043392) (negative regulation of DNA binding), [GO:2000438](http://purl.obolibrary.org/obo/GO_2000438) (negative regulation of monocyte extravasation), [GO:0000262](http://purl.obolibrary.org/obo/GO_0000262) (mitochondrial chromosome), [GO:1990841](http://purl.obolibrary.org/obo/GO_1990841) (promoter-specific chromatin binding), [GO:0043394](http://purl.obolibrary.org/obo/GO_0043394) (proteoglycan binding), [GO:0043393](http://purl.obolibrary.org/obo/GO_0043393) (regulation of protein binding), [GO:0042063](http://purl.obolibrary.org/obo/GO_0042063) (gliogenesis), [GO:0043395](http://purl.obolibrary.org/obo/GO_0043395) (heparan sulfate proteoglycan binding), [GO:0014898](http://purl.obolibrary.org/obo/GO_0014898) (cardiac muscle hypertrophy in response to stress), [GO:2000435](http://purl.obolibrary.org/obo/GO_2000435) (negative regulation of protein neddylation), [GO:0042069](http://purl.obolibrary.org/obo/GO_0042069) (regulation of catecholamine metabolic process), [GO:0000268](http://purl.obolibrary.org/obo/GO_0000268) (peroxisome targeting sequence binding), [GO:0000266](http://purl.obolibrary.org/obo/GO_0000266) (mitochondrial fission), [GO:0042073](http://purl.obolibrary.org/obo/GO_0042073) (intraciliary transport), [GO:0070991](http://purl.obolibrary.org/obo/GO_0070991) (medium-chain-acyl-CoA dehydrogenase activity), [GO:0000272](http://purl.obolibrary.org/obo/GO_0000272) (polysaccharide catabolic process), [GO:0042074](http://purl.obolibrary.org/obo/GO_0042074) (cell migration involved in gastrulation), [GO:0000271](http://purl.obolibrary.org/obo/GO_0000271) (polysaccharide biosynthetic process), [GO:1990854](http://purl.obolibrary.org/obo/GO_1990854) (vacuole-ER tethering), [GO:0070996](http://purl.obolibrary.org/obo/GO_0070996) (type 1 melanocortin receptor binding), [GO:0070997](http://purl.obolibrary.org/obo/GO_0070997) (neuron death), [GO:0014883](http://purl.obolibrary.org/obo/GO_0014883) (transition between fast and slow fiber), [GO:0014881](http://purl.obolibrary.org/obo/GO_0014881) (regulation of myofibril size), [GO:0042078](http://purl.obolibrary.org/obo/GO_0042078) (germ-line stem cell division), [GO:0001570](http://purl.obolibrary.org/obo/GO_0001570) (vasculogenesis), [GO:0001571](http://purl.obolibrary.org/obo/GO_0001571) (non-tyrosine kinase fibroblast growth factor receptor activity), [GO:0000235](http://purl.obolibrary.org/obo/GO_0000235) (astral microtubule), [GO:0001573](http://purl.obolibrary.org/obo/GO_0001573) (ganglioside metabolic process), [GO:0000242](http://purl.obolibrary.org/obo/GO_0000242) (pericentriolar material), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0001569](http://purl.obolibrary.org/obo/GO_0001569) (branching involved in blood vessel morphogenesis), [GO:1990869](http://purl.obolibrary.org/obo/GO_1990869) (cellular response to chemokine), [GO:2000451](http://purl.obolibrary.org/obo/GO_2000451) (positive regulation of CD8-positive, alpha-beta T cell extravasation), [GO:0014894](http://purl.obolibrary.org/obo/GO_0014894) (response to denervation involved in regulation of muscle adaptation), [GO:0042088](http://purl.obolibrary.org/obo/GO_0042088) (T-helper 1 type immune response), [GO:0000248](http://purl.obolibrary.org/obo/GO_0000248) (C-5 sterol desaturase activity), [GO:0000247](http://purl.obolibrary.org/obo/GO_0000247) (C-8 sterol isomerase activity), [GO:0000246](http://purl.obolibrary.org/obo/GO_0000246) (delta24(24-1) sterol reductase activity), [GO:0000254](http://purl.obolibrary.org/obo/GO_0000254) (C-4 methylsterol oxidase activity), [GO:1990871](http://purl.obolibrary.org/obo/GO_1990871) (Vma12-Vma22 assembly complex), [GO:0000252](http://purl.obolibrary.org/obo/GO_0000252) (C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity), [GO:0042093](http://purl.obolibrary.org/obo/GO_0042093) (T-helper cell differentiation), [GO:0001579](http://purl.obolibrary.org/obo/GO_0001579) (medium-chain fatty acid transport), [GO:0042098](http://purl.obolibrary.org/obo/GO_0042098) (T cell proliferation), [GO:1990879](http://purl.obolibrary.org/obo/GO_1990879) (CST complex), [GO:2000464](http://purl.obolibrary.org/obo/GO_2000464) (positive regulation of astrocyte chemotaxis), [GO:2000463](http://purl.obolibrary.org/obo/GO_2000463) (positive regulation of excitatory postsynaptic potential), [GO:0014889](http://purl.obolibrary.org/obo/GO_0014889) (muscle atrophy), [GO:2000467](http://purl.obolibrary.org/obo/GO_2000467) (positive regulation of glycogen (starch) synthase activity), [GO:0036376](http://purl.obolibrary.org/obo/GO_0036376) (sodium ion export across plasma membrane), [GO:0060002](http://purl.obolibrary.org/obo/GO_0060002) (plus-end directed microfilament motor activity), [GO:0061333](http://purl.obolibrary.org/obo/GO_0061333) (renal tubule morphogenesis), [GO:0060003](http://purl.obolibrary.org/obo/GO_0060003) (copper ion export), [GO:0036372](http://purl.obolibrary.org/obo/GO_0036372) (opsin transport), [GO:1904851](http://purl.obolibrary.org/obo/GO_1904851) (positive regulation of establishment of protein localization to telomere), [GO:0036374](http://purl.obolibrary.org/obo/GO_0036374) (glutathione hydrolase activity), [GO:0060009](http://purl.obolibrary.org/obo/GO_0060009) (Sertoli cell development), [GO:1904854](http://purl.obolibrary.org/obo/GO_1904854) (proteasome core complex binding), [GO:0060005](http://purl.obolibrary.org/obo/GO_0060005) (vestibular reflex), [GO:0061337](http://purl.obolibrary.org/obo/GO_0061337) (cardiac conduction), [GO:0050672](http://purl.obolibrary.org/obo/GO_0050672) (negative regulation of lymphocyte proliferation), [GO:0050673](http://purl.obolibrary.org/obo/GO_0050673) (epithelial cell proliferation), [GO:0048368](http://purl.obolibrary.org/obo/GO_0048368) (lateral mesoderm development), [GO:0050671](http://purl.obolibrary.org/obo/GO_0050671) (positive regulation of lymphocyte proliferation), [GO:0048365](http://purl.obolibrary.org/obo/GO_0048365) (Rac GTPase binding), [GO:2000232](http://purl.obolibrary.org/obo/GO_2000232) (regulation of rRNA processing), [GO:0035037](http://purl.obolibrary.org/obo/GO_0035037) (sperm entry), [GO:2000238](http://purl.obolibrary.org/obo/GO_2000238) (regulation of tRNA export from nucleus), [GO:0050678](http://purl.obolibrary.org/obo/GO_0050678) (regulation of epithelial cell proliferation), [GO:0036368](http://purl.obolibrary.org/obo/GO_0036368) (cone photoresponse recovery), [GO:0050679](http://purl.obolibrary.org/obo/GO_0050679) (positive regulation of epithelial cell proliferation), [GO:2000235](http://purl.obolibrary.org/obo/GO_2000235) (regulation of tRNA processing), [GO:0035035](http://purl.obolibrary.org/obo/GO_0035035) (histone acetyltransferase binding), [GO:2000252](http://purl.obolibrary.org/obo/GO_2000252) (negative regulation of feeding behavior), [GO:2000251](http://purl.obolibrary.org/obo/GO_2000251) (positive regulation of actin cytoskeleton reorganization), [GO:1904861](http://purl.obolibrary.org/obo/GO_1904861) (excitatory synapse assembly), [GO:0036363](http://purl.obolibrary.org/obo/GO_0036363) (transforming growth factor beta activation), [GO:0061325](http://purl.obolibrary.org/obo/GO_0061325) (cell proliferation involved in outflow tract morphogenesis), [GO:0061326](http://purl.obolibrary.org/obo/GO_0061326) (renal tubule development), [GO:0023051](http://purl.obolibrary.org/obo/GO_0023051) (regulation of signaling), [GO:0050681](http://purl.obolibrary.org/obo/GO_0050681) (androgen receptor binding), [GO:0050680](http://purl.obolibrary.org/obo/GO_0050680) (negative regulation of epithelial cell proliferation), [GO:0047045](http://purl.obolibrary.org/obo/GO_0047045) (testosterone 17-beta-dehydrogenase (NADP+) activity), [GO:0050687](http://purl.obolibrary.org/obo/GO_0050687) (negative regulation of defense response to virus), [GO:0050688](http://purl.obolibrary.org/obo/GO_0050688) (regulation of defense response to virus), [GO:0060022](http://purl.obolibrary.org/obo/GO_0060022) (hard palate development), [GO:0035022](http://purl.obolibrary.org/obo/GO_0035022) (positive regulation of Rac protein signal transduction), [GO:0035023](http://purl.obolibrary.org/obo/GO_0035023) (regulation of Rho protein signal transduction), [GO:0060023](http://purl.obolibrary.org/obo/GO_0060023) (soft palate development), [GO:0060024](http://purl.obolibrary.org/obo/GO_0060024) (rhythmic synaptic transmission), [GO:0035024](http://purl.obolibrary.org/obo/GO_0035024) (negative regulation of Rho protein signal transduction), [GO:0061355](http://purl.obolibrary.org/obo/GO_0061355) (Wnt protein secretion), [GO:0035025](http://purl.obolibrary.org/obo/GO_0035025) (positive regulation of Rho protein signal transduction), [GO:0060025](http://purl.obolibrary.org/obo/GO_0060025) (regulation of synaptic activity), [GO:1904874](http://purl.obolibrary.org/obo/GO_1904874) (positive regulation of telomerase RNA localization to Cajal body), [GO:1903543](http://purl.obolibrary.org/obo/GO_1903543) (positive regulation of exosomal secretion), [GO:0061351](http://purl.obolibrary.org/obo/GO_0061351) (neural precursor cell proliferation), [GO:0060020](http://purl.obolibrary.org/obo/GO_0060020) (Bergmann glial cell differentiation), [GO:1904872](http://purl.obolibrary.org/obo/GO_1904872) (regulation of telomerase RNA localization to Cajal body), [GO:0036351](http://purl.obolibrary.org/obo/GO_0036351) (histone H2A-K13 ubiquitination), [GO:0060021](http://purl.obolibrary.org/obo/GO_0060021) (palate development), [GO:1904871](http://purl.obolibrary.org/obo/GO_1904871) (positive regulation of protein localization to Cajal body), [GO:0035021](http://purl.obolibrary.org/obo/GO_0035021) (negative regulation of Rac protein signal transduction), [GO:0036352](http://purl.obolibrary.org/obo/GO_0036352) (histone H2A-K15 ubiquitination), [GO:1903546](http://purl.obolibrary.org/obo/GO_1903546) (protein localization to photoreceptor outer segment), [GO:0060026](http://purl.obolibrary.org/obo/GO_0060026) (convergent extension), [GO:1902219](http://purl.obolibrary.org/obo/GO_1902219) (negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress), [GO:0060027](http://purl.obolibrary.org/obo/GO_0060027) (convergent extension involved in gastrulation), [GO:0060028](http://purl.obolibrary.org/obo/GO_0060028) (convergent extension involved in axis elongation), [GO:0000398](http://purl.obolibrary.org/obo/GO_0000398) (mRNA splicing, via spliceosome), [GO:1904879](http://purl.obolibrary.org/obo/GO_1904879) (positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel), [GO:0048385](http://purl.obolibrary.org/obo/GO_0048385) (regulation of retinoic acid receptor signaling pathway), [GO:0048384](http://purl.obolibrary.org/obo/GO_0048384) (retinoic acid receptor signaling pathway), [GO:0050693](http://purl.obolibrary.org/obo/GO_0050693) (LBD domain binding), [GO:0048388](http://purl.obolibrary.org/obo/GO_0048388) (endosomal lumen acidification), [GO:0047057](http://purl.obolibrary.org/obo/GO_0047057) (vitamin-K-epoxide reductase (warfarin-sensitive) activity), [GO:0050691](http://purl.obolibrary.org/obo/GO_0050691) (regulation of defense response to virus by host), [GO:0048387](http://purl.obolibrary.org/obo/GO_0048387) (negative regulation of retinoic acid receptor signaling pathway), [GO:0072001](http://purl.obolibrary.org/obo/GO_0072001) (renal system development), [GO:0035019](http://purl.obolibrary.org/obo/GO_0035019) (somatic stem cell population maintenance), [GO:0072006](http://purl.obolibrary.org/obo/GO_0072006) (nephron development), [GO:2000254](http://purl.obolibrary.org/obo/GO_2000254) (regulation of male germ cell proliferation), [GO:2000253](http://purl.obolibrary.org/obo/GO_2000253) (positive regulation of feeding behavior), [GO:0048382](http://purl.obolibrary.org/obo/GO_0048382) (mesendoderm development), [GO:0050698](http://purl.obolibrary.org/obo/GO_0050698) (proteoglycan sulfotransferase activity), [GO:0050699](http://purl.obolibrary.org/obo/GO_0050699) (WW domain binding), [GO:0036342](http://purl.obolibrary.org/obo/GO_0036342) (post-anal tail morphogenesis), [GO:1904881](http://purl.obolibrary.org/obo/GO_1904881) (cellular response to hydrogen sulfide), [GO:2000270](http://purl.obolibrary.org/obo/GO_2000270) (negative regulation of fibroblast apoptotic process), [GO:0060011](http://purl.obolibrary.org/obo/GO_0060011) (Sertoli cell proliferation), [GO:0060012](http://purl.obolibrary.org/obo/GO_0060012) (synaptic transmission, glycinergic), [GO:0060013](http://purl.obolibrary.org/obo/GO_0060013) (righting reflex), [GO:0036344](http://purl.obolibrary.org/obo/GO_0036344) (platelet morphogenesis), [GO:0035014](http://purl.obolibrary.org/obo/GO_0035014) (phosphatidylinositol 3-kinase regulator activity), [GO:0060014](http://purl.obolibrary.org/obo/GO_0060014) (granulosa cell differentiation), [GO:1904884](http://purl.obolibrary.org/obo/GO_1904884) (positive regulation of telomerase catalytic core complex assembly), [GO:2000273](http://purl.obolibrary.org/obo/GO_2000273) (positive regulation of receptor activity), [GO:2000272](http://purl.obolibrary.org/obo/GO_2000272) (negative regulation of receptor activity), [GO:1903551](http://purl.obolibrary.org/obo/GO_1903551) (regulation of extracellular exosome assembly), [GO:2000271](http://purl.obolibrary.org/obo/GO_2000271) (positive regulation of fibroblast apoptotic process), [GO:0060019](http://purl.obolibrary.org/obo/GO_0060019) (radial glial cell differentiation), [GO:1904888](http://purl.obolibrary.org/obo/GO_1904888) (cranial skeletal system development), [GO:0023026](http://purl.obolibrary.org/obo/GO_0023026) (MHC class II protein complex binding), [GO:0060017](http://purl.obolibrary.org/obo/GO_0060017) (parathyroid gland development), [GO:0098609](http://purl.obolibrary.org/obo/GO_0098609) (cell-cell adhesion), [GO:0035005](http://purl.obolibrary.org/obo/GO_0035005) (1-phosphatidylinositol-4-phosphate 3-kinase activity), [GO:0036336](http://purl.obolibrary.org/obo/GO_0036336) (dendritic cell migration), [GO:0036337](http://purl.obolibrary.org/obo/GO_0036337) (Fas signaling pathway), [GO:2000269](http://purl.obolibrary.org/obo/GO_2000269) (regulation of fibroblast apoptotic process), [GO:0035088](http://purl.obolibrary.org/obo/GO_0035088) (establishment or maintenance of apical/basal cell polarity), [GO:0019835](http://purl.obolibrary.org/obo/GO_0019835) (cytolysis), [GO:0019838](http://purl.obolibrary.org/obo/GO_0019838) (growth factor binding), [GO:0006520](http://purl.obolibrary.org/obo/GO_0006520) (cellular amino acid metabolic process), [GO:0035082](http://purl.obolibrary.org/obo/GO_0035082) (axoneme assembly), [GO:0032809](http://purl.obolibrary.org/obo/GO_0032809) (neuronal cell body membrane), [GO:0006523](http://purl.obolibrary.org/obo/GO_0006523) (alanine biosynthetic process), [GO:0006524](http://purl.obolibrary.org/obo/GO_0006524) (alanine catabolic process), [GO:0048318](http://purl.obolibrary.org/obo/GO_0048318) (axial mesoderm development), [GO:0006516](http://purl.obolibrary.org/obo/GO_0006516) (glycoprotein catabolic process), [GO:0032803](http://purl.obolibrary.org/obo/GO_0032803) (regulation of low-density lipoprotein particle receptor catabolic process), [GO:0006517](http://purl.obolibrary.org/obo/GO_0006517) (protein deglycosylation), [GO:0006515](http://purl.obolibrary.org/obo/GO_0006515) (protein quality control for misfolded or incompletely synthesized proteins), [GO:0032802](http://purl.obolibrary.org/obo/GO_0032802) (low-density lipoprotein particle receptor catabolic process), [GO:0032807](http://purl.obolibrary.org/obo/GO_0032807) (DNA ligase IV complex), [GO:0032808](http://purl.obolibrary.org/obo/GO_0032808) (lacrimal gland development), [GO:0006518](http://purl.obolibrary.org/obo/GO_0006518) (peptide metabolic process), [GO:0032805](http://purl.obolibrary.org/obo/GO_0032805) (positive regulation of low-density lipoprotein particle receptor catabolic process), [GO:0051969](http://purl.obolibrary.org/obo/GO_0051969) (regulation of transmission of nerve impulse), [GO:2000277](http://purl.obolibrary.org/obo/GO_2000277) (positive regulation of oxidative phosphorylation uncoupler activity), [GO:2000276](http://purl.obolibrary.org/obo/GO_2000276) (negative regulation of oxidative phosphorylation uncoupler activity), [GO:0051967](http://purl.obolibrary.org/obo/GO_0051967) (negative regulation of synaptic transmission, glutamatergic), [GO:0019841](http://purl.obolibrary.org/obo/GO_0019841) (retinol binding), [GO:0051968](http://purl.obolibrary.org/obo/GO_0051968) (positive regulation of synaptic transmission, glutamatergic), [GO:0051965](http://purl.obolibrary.org/obo/GO_0051965) (positive regulation of synapse assembly), [GO:0019843](http://purl.obolibrary.org/obo/GO_0019843) (rRNA binding), [GO:0019842](http://purl.obolibrary.org/obo/GO_0019842) (vitamin binding), [GO:0051966](http://purl.obolibrary.org/obo/GO_0051966) (regulation of synaptic transmission, glutamatergic), [GO:0032800](http://purl.obolibrary.org/obo/GO_0032800) (receptor biosynthetic process), [GO:0050632](http://purl.obolibrary.org/obo/GO_0050632) (propionyl-CoA C2-trimethyltridecanoyltransferase activity), [GO:0051963](http://purl.obolibrary.org/obo/GO_0051963) (regulation of synapse assembly), [GO:2000279](http://purl.obolibrary.org/obo/GO_2000279) (negative regulation of DNA biosynthetic process), [GO:0019825](http://purl.obolibrary.org/obo/GO_0019825) (oxygen binding), [GO:2000291](http://purl.obolibrary.org/obo/GO_2000291) (regulation of myoblast proliferation), [GO:0019827](http://purl.obolibrary.org/obo/GO_0019827) (stem cell population maintenance), [GO:0019829](http://purl.obolibrary.org/obo/GO_0019829) (cation-transporting ATPase activity), [GO:2000293](http://purl.obolibrary.org/obo/GO_2000293) (negative regulation of defecation), [GO:0006531](http://purl.obolibrary.org/obo/GO_0006531) (aspartate metabolic process), [GO:0005200](http://purl.obolibrary.org/obo/GO_0005200) (structural constituent of cytoskeleton), [GO:0006534](http://purl.obolibrary.org/obo/GO_0006534) (cysteine metabolic process), [GO:0005201](http://purl.obolibrary.org/obo/GO_0005201) (extracellular matrix structural constituent), [GO:0006535](http://purl.obolibrary.org/obo/GO_0006535) (cysteine biosynthetic process from serine), [GO:0048329](http://purl.obolibrary.org/obo/GO_0048329) (negative regulation of axial mesodermal cell fate specification), [GO:0006527](http://purl.obolibrary.org/obo/GO_0006527) (arginine catabolic process), [GO:0051973](http://purl.obolibrary.org/obo/GO_0051973) (positive regulation of telomerase activity), [GO:0006525](http://purl.obolibrary.org/obo/GO_0006525) (arginine metabolic process), [GO:0006526](http://purl.obolibrary.org/obo/GO_0006526) (arginine biosynthetic process), [GO:0006529](http://purl.obolibrary.org/obo/GO_0006529) (asparagine biosynthetic process), [GO:0048332](http://purl.obolibrary.org/obo/GO_0048332) (mesoderm morphogenesis), [GO:2000288](http://purl.obolibrary.org/obo/GO_2000288) (positive regulation of myoblast proliferation), [GO:0051974](http://purl.obolibrary.org/obo/GO_0051974) (negative regulation of telomerase activity), [GO:0035066](http://purl.obolibrary.org/obo/GO_0035066) (positive regulation of histone acetylation), [GO:0035067](http://purl.obolibrary.org/obo/GO_0035067) (negative regulation of histone acetylation), [GO:0035068](http://purl.obolibrary.org/obo/GO_0035068) (micro-ribonucleoprotein complex), [GO:0061312](http://purl.obolibrary.org/obo/GO_0061312) (BMP signaling pathway involved in heart development), [GO:0035063](http://purl.obolibrary.org/obo/GO_0035063) (nuclear speck organization), [GO:0035064](http://purl.obolibrary.org/obo/GO_0035064) (methylated histone binding), [GO:0048339](http://purl.obolibrary.org/obo/GO_0048339) (paraxial mesoderm development), [GO:0047006](http://purl.obolibrary.org/obo/GO_0047006) (17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity), [GO:1904831](http://purl.obolibrary.org/obo/GO_1904831) (positive regulation of aortic smooth muscle cell differentiation), [GO:1903507](http://purl.obolibrary.org/obo/GO_1903507) (negative regulation of nucleic acid-templated transcription), [GO:0061316](http://purl.obolibrary.org/obo/GO_0061316) (canonical Wnt signaling pathway involved in heart development), [GO:0048341](http://purl.obolibrary.org/obo/GO_0048341) (paraxial mesoderm formation), [GO:0051984](http://purl.obolibrary.org/obo/GO_0051984) (positive regulation of chromosome segregation), [GO:0050650](http://purl.obolibrary.org/obo/GO_0050650) (chondroitin sulfate proteoglycan biosynthetic process), [GO:0050651](http://purl.obolibrary.org/obo/GO_0050651) (dermatan sulfate proteoglycan biosynthetic process), [GO:0047015](http://purl.obolibrary.org/obo/GO_0047015) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity), [GO:0047012](http://purl.obolibrary.org/obo/GO_0047012) (sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity), [GO:2000298](http://purl.obolibrary.org/obo/GO_2000298) (regulation of Rho-dependent protein serine/threonine kinase activity), [GO:0051987](http://purl.obolibrary.org/obo/GO_0051987) (positive regulation of attachment of spindle microtubules to kinetochore), [GO:0050655](http://purl.obolibrary.org/obo/GO_0050655) (dermatan sulfate proteoglycan metabolic process), [GO:0061300](http://purl.obolibrary.org/obo/GO_0061300) (cerebellum vasculature development), [GO:0019805](http://purl.obolibrary.org/obo/GO_0019805) (quinolinate biosynthetic process), [GO:0035051](http://purl.obolibrary.org/obo/GO_0035051) (cardiocyte differentiation), [GO:0019807](http://purl.obolibrary.org/obo/GO_0019807) (aspartoacylase activity), [GO:0019808](http://purl.obolibrary.org/obo/GO_0019808) (polyamine binding), [GO:0035054](http://purl.obolibrary.org/obo/GO_0035054) (embryonic heart tube anterior/posterior pattern specification), [GO:1903514](http://purl.obolibrary.org/obo/GO_1903514) (release of sequestered calcium ion into cytosol by endoplasmic reticulum), [GO:0061308](http://purl.obolibrary.org/obo/GO_0061308) (cardiac neural crest cell development involved in heart development), [GO:0048348](http://purl.obolibrary.org/obo/GO_0048348) (paraxial mesodermal cell fate specification), [GO:0061309](http://purl.obolibrary.org/obo/GO_0061309) (cardiac neural crest cell development involved in outflow tract morphogenesis), [GO:0035050](http://purl.obolibrary.org/obo/GO_0035050) (embryonic heart tube development), [GO:0047016](http://purl.obolibrary.org/obo/GO_0047016) (cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity), [GO:0061303](http://purl.obolibrary.org/obo/GO_0061303) (cornea development in camera-type eye), [GO:0006513](http://purl.obolibrary.org/obo/GO_0006513) (protein monoubiquitination), [GO:0061304](http://purl.obolibrary.org/obo/GO_0061304) (retinal blood vessel morphogenesis), [GO:0006511](http://purl.obolibrary.org/obo/GO_0006511) (ubiquitin-dependent protein catabolic process), [GO:0006505](http://purl.obolibrary.org/obo/GO_0006505) (GPI anchor metabolic process), [GO:0006506](http://purl.obolibrary.org/obo/GO_0006506) (GPI anchor biosynthetic process), [GO:0050661](http://purl.obolibrary.org/obo/GO_0050661) (NADP binding), [GO:0047020](http://purl.obolibrary.org/obo/GO_0047020) (15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity), [GO:0050662](http://purl.obolibrary.org/obo/GO_0050662) (coenzyme binding), [GO:0006509](http://purl.obolibrary.org/obo/GO_0006509) (membrane protein ectodomain proteolysis), [GO:0051990](http://purl.obolibrary.org/obo/GO_0051990) ((R)-2-hydroxyglutarate dehydrogenase activity), [GO:0050660](http://purl.obolibrary.org/obo/GO_0050660) (flavin adenine dinucleotide binding), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:0047023](http://purl.obolibrary.org/obo/GO_0047023) (androsterone dehydrogenase activity), [GO:0050667](http://purl.obolibrary.org/obo/GO_0050667) (homocysteine metabolic process), [GO:0050668](http://purl.obolibrary.org/obo/GO_0050668) (positive regulation of homocysteine metabolic process), [GO:0050665](http://purl.obolibrary.org/obo/GO_0050665) (hydrogen peroxide biosynthetic process), [GO:0019811](http://purl.obolibrary.org/obo/GO_0019811) (cocaine binding), [GO:0060088](http://purl.obolibrary.org/obo/GO_0060088) (auditory receptor cell stereocilium organization), [GO:0043504](http://purl.obolibrary.org/obo/GO_0043504) (mitochondrial DNA repair), [GO:0043507](http://purl.obolibrary.org/obo/GO_0043507) (positive regulation of JUN kinase activity), [GO:0043506](http://purl.obolibrary.org/obo/GO_0043506) (regulation of JUN kinase activity), [GO:0006560](http://purl.obolibrary.org/obo/GO_0006560) (proline metabolic process), [GO:0043508](http://purl.obolibrary.org/obo/GO_0043508) (negative regulation of JUN kinase activity), [GO:0060086](http://purl.obolibrary.org/obo/GO_0060086) (circadian temperature homeostasis), [GO:1902275](http://purl.obolibrary.org/obo/GO_1902275) (regulation of chromatin organization), [GO:0006563](http://purl.obolibrary.org/obo/GO_0006563) (L-serine metabolic process), [GO:0006564](http://purl.obolibrary.org/obo/GO_0006564) (L-serine biosynthetic process), [GO:0005230](http://purl.obolibrary.org/obo/GO_0005230) (extracellular ligand-gated ion channel activity), [GO:0006561](http://purl.obolibrary.org/obo/GO_0006561) (proline biosynthetic process), [GO:0044830](http://purl.obolibrary.org/obo/GO_0044830) (modulation by host of viral RNA genome replication), [GO:0006562](http://purl.obolibrary.org/obo/GO_0006562) (proline catabolic process), [GO:0097371](http://purl.obolibrary.org/obo/GO_0097371) (MDM2/MDM4 family protein binding), [GO:0043501](http://purl.obolibrary.org/obo/GO_0043501) (skeletal muscle adaptation), [GO:0006568](http://purl.obolibrary.org/obo/GO_0006568) (tryptophan metabolic process), [GO:0005234](http://purl.obolibrary.org/obo/GO_0005234) (extracellularly glutamate-gated ion channel activity), [GO:0006566](http://purl.obolibrary.org/obo/GO_0006566) (threonine metabolic process), [GO:0005227](http://purl.obolibrary.org/obo/GO_0005227) (calcium activated cation channel activity), [GO:0097363](http://purl.obolibrary.org/obo/GO_0097363) (protein O-GlcNAc transferase activity), [GO:0031514](http://purl.obolibrary.org/obo/GO_0031514) (motile cilium), [GO:0006558](http://purl.obolibrary.org/obo/GO_0006558) (L-phenylalanine metabolic process), [GO:0006559](http://purl.obolibrary.org/obo/GO_0006559) (L-phenylalanine catabolic process), [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding), [GO:0031519](http://purl.obolibrary.org/obo/GO_0031519) (PcG protein complex), [GO:0060091](http://purl.obolibrary.org/obo/GO_0060091) (kinocilium), [GO:0019882](http://purl.obolibrary.org/obo/GO_0019882) (antigen processing and presentation), [GO:0060092](http://purl.obolibrary.org/obo/GO_0060092) (regulation of synaptic transmission, glycinergic), [GO:0019885](http://purl.obolibrary.org/obo/GO_0019885) (antigen processing and presentation of endogenous peptide antigen via MHC class I), [GO:0019887](http://purl.obolibrary.org/obo/GO_0019887) (protein kinase regulator activity), [GO:0019886](http://purl.obolibrary.org/obo/GO_0019886) (antigen processing and presentation of exogenous peptide antigen via MHC class II), [GO:0019889](http://purl.obolibrary.org/obo/GO_0019889) (pteridine metabolic process), [GO:0019888](http://purl.obolibrary.org/obo/GO_0019888) (protein phosphatase regulator activity), [GO:0019869](http://purl.obolibrary.org/obo/GO_0019869) (chloride channel inhibitor activity), [GO:0060077](http://purl.obolibrary.org/obo/GO_0060077) (inhibitory synapse), [GO:0060078](http://purl.obolibrary.org/obo/GO_0060078) (regulation of postsynaptic membrane potential), [GO:0043515](http://purl.obolibrary.org/obo/GO_0043515) (kinetochore binding), [GO:0043518](http://purl.obolibrary.org/obo/GO_0043518) (negative regulation of DNA damage response, signal transduction by p53 class mediator), [GO:0060079](http://purl.obolibrary.org/obo/GO_0060079) (excitatory postsynaptic potential), [GO:1902282](http://purl.obolibrary.org/obo/GO_1902282) (voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization), [GO:0043517](http://purl.obolibrary.org/obo/GO_0043517) (positive regulation of DNA damage response, signal transduction by p53 class mediator), [GO:0006570](http://purl.obolibrary.org/obo/GO_0006570) (tyrosine metabolic process), [GO:0060074](http://purl.obolibrary.org/obo/GO_0060074) (synapse maturation), [GO:0006571](http://purl.obolibrary.org/obo/GO_0006571) (tyrosine biosynthetic process), [GO:0060075](http://purl.obolibrary.org/obo/GO_0060075) (regulation of resting membrane potential), [GO:0060076](http://purl.obolibrary.org/obo/GO_0060076) (excitatory synapse), [GO:0006574](http://purl.obolibrary.org/obo/GO_0006574) (valine catabolic process), [GO:0005242](http://purl.obolibrary.org/obo/GO_0005242) (inward rectifier potassium channel activity), [GO:0005244](http://purl.obolibrary.org/obo/GO_0005244) (voltage-gated ion channel activity), [GO:0006572](http://purl.obolibrary.org/obo/GO_0006572) (tyrosine catabolic process), [GO:0005243](http://purl.obolibrary.org/obo/GO_0005243) (gap junction channel activity), [GO:0006573](http://purl.obolibrary.org/obo/GO_0006573) (valine metabolic process), [GO:0005246](http://purl.obolibrary.org/obo/GO_0005246) (calcium channel regulator activity), [GO:0005245](http://purl.obolibrary.org/obo/GO_0005245) (voltage-gated calcium channel activity), [GO:0005248](http://purl.obolibrary.org/obo/GO_0005248) (voltage-gated sodium channel activity), [GO:0005247](http://purl.obolibrary.org/obo/GO_0005247) (voltage-gated chloride channel activity), [GO:0031505](http://purl.obolibrary.org/obo/GO_0031505) (fungal-type cell wall organization), [GO:0032836](http://purl.obolibrary.org/obo/GO_0032836) (glomerular basement membrane development), [GO:0032837](http://purl.obolibrary.org/obo/GO_0032837) (distributive segregation), [GO:0097374](http://purl.obolibrary.org/obo/GO_0097374) (sensory neuron axon guidance), [GO:0032834](http://purl.obolibrary.org/obo/GO_0032834) (positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response), [GO:0031503](http://purl.obolibrary.org/obo/GO_0031503) (protein complex localization), [GO:0072053](http://purl.obolibrary.org/obo/GO_0072053) (renal inner medulla development), [GO:0006569](http://purl.obolibrary.org/obo/GO_0006569) (tryptophan catabolic process), [GO:0032835](http://purl.obolibrary.org/obo/GO_0032835) (glomerulus development), [GO:0019870](http://purl.obolibrary.org/obo/GO_0019870) (potassium channel inhibitor activity), [GO:0031507](http://purl.obolibrary.org/obo/GO_0031507) (heterochromatin assembly), [GO:0032839](http://purl.obolibrary.org/obo/GO_0032839) (dendrite cytoplasm), [GO:0031508](http://purl.obolibrary.org/obo/GO_0031508) (pericentric heterochromatin assembly), [GO:0060080](http://purl.obolibrary.org/obo/GO_0060080) (inhibitory postsynaptic potential), [GO:0060081](http://purl.obolibrary.org/obo/GO_0060081) (membrane hyperpolarization), [GO:0019871](http://purl.obolibrary.org/obo/GO_0019871) (sodium channel inhibitor activity), [GO:0031501](http://purl.obolibrary.org/obo/GO_0031501) (mannosyltransferase complex), [GO:0019878](http://purl.obolibrary.org/obo/GO_0019878) (lysine biosynthetic process via aminoadipic acid), [GO:0032831](http://purl.obolibrary.org/obo/GO_0032831) (positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation), [GO:0120013](http://purl.obolibrary.org/obo/GO_0120013) (intermembrane lipid transfer activity), [GO:0019859](http://purl.obolibrary.org/obo/GO_0019859) (thymine metabolic process), [GO:0120017](http://purl.obolibrary.org/obo/GO_0120017) (intermembrane ceramide transfer activity), [GO:0072091](http://purl.obolibrary.org/obo/GO_0072091) (regulation of stem cell proliferation), [GO:0006541](http://purl.obolibrary.org/obo/GO_0006541) (glutamine metabolic process), [GO:0006542](http://purl.obolibrary.org/obo/GO_0006542) (glutamine biosynthetic process), [GO:0006540](http://purl.obolibrary.org/obo/GO_0006540) (glutamate decarboxylation to succinate), [GO:0043523](http://purl.obolibrary.org/obo/GO_0043523) (regulation of neuron apoptotic process), [GO:0072095](http://purl.obolibrary.org/obo/GO_0072095) (regulation of branch elongation involved in ureteric bud branching), [GO:0006545](http://purl.obolibrary.org/obo/GO_0006545) (glycine biosynthetic process), [GO:0044853](http://purl.obolibrary.org/obo/GO_0044853) (plasma membrane raft), [GO:0005212](http://purl.obolibrary.org/obo/GO_0005212) (structural constituent of eye lens), [GO:0006546](http://purl.obolibrary.org/obo/GO_0006546) (glycine catabolic process), [GO:0043522](http://purl.obolibrary.org/obo/GO_0043522) (leucine zipper domain binding), [GO:0005215](http://purl.obolibrary.org/obo/GO_0005215) (transporter activity), [GO:0043525](http://purl.obolibrary.org/obo/GO_0043525) (positive regulation of neuron apoptotic process), [GO:0043524](http://purl.obolibrary.org/obo/GO_0043524) (negative regulation of neuron apoptotic process), [GO:0006544](http://purl.obolibrary.org/obo/GO_0006544) (glycine metabolic process), [GO:0097350](http://purl.obolibrary.org/obo/GO_0097350) (neutrophil clearance), [GO:0032825](http://purl.obolibrary.org/obo/GO_0032825) (positive regulation of natural killer cell differentiation), [GO:0006538](http://purl.obolibrary.org/obo/GO_0006538) (glutamate catabolic process), [GO:0097342](http://purl.obolibrary.org/obo/GO_0097342) (ripoptosome), [GO:0006536](http://purl.obolibrary.org/obo/GO_0006536) (glutamate metabolic process), [GO:0006537](http://purl.obolibrary.org/obo/GO_0006537) (glutamate biosynthetic process), [GO:0072089](http://purl.obolibrary.org/obo/GO_0072089) (stem cell proliferation), [GO:0019860](http://purl.obolibrary.org/obo/GO_0019860) (uracil metabolic process), [GO:0019863](http://purl.obolibrary.org/obo/GO_0019863) (IgE binding), [GO:0019865](http://purl.obolibrary.org/obo/GO_0019865) (immunoglobulin binding), [GO:0019864](http://purl.obolibrary.org/obo/GO_0019864) (IgG binding), [GO:0043539](http://purl.obolibrary.org/obo/GO_0043539) (protein serine/threonine kinase activator activity), [GO:0035095](http://purl.obolibrary.org/obo/GO_0035095) (behavioral response to nicotine), [GO:0060096](http://purl.obolibrary.org/obo/GO_0060096) (serotonin secretion, neurotransmission), [GO:0060097](http://purl.obolibrary.org/obo/GO_0060097) (cytoskeletal rearrangement involved in phagocytosis, engulfment), [GO:0035097](http://purl.obolibrary.org/obo/GO_0035097) (histone methyltransferase complex), [GO:0120008](http://purl.obolibrary.org/obo/GO_0120008) (positive regulation of glutamatergic neuron differentiation), [GO:0035091](http://purl.obolibrary.org/obo/GO_0035091) (phosphatidylinositol binding), [GO:0006552](http://purl.obolibrary.org/obo/GO_0006552) (leucine catabolic process), [GO:0005220](http://purl.obolibrary.org/obo/GO_0005220) (inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity), [GO:0120009](http://purl.obolibrary.org/obo/GO_0120009) (intermembrane lipid transfer), [GO:0005222](http://purl.obolibrary.org/obo/GO_0005222) (intracellular cAMP activated cation channel activity), [GO:0006550](http://purl.obolibrary.org/obo/GO_0006550) (isoleucine catabolic process), [GO:0043531](http://purl.obolibrary.org/obo/GO_0043531) (ADP binding), [GO:0035094](http://purl.obolibrary.org/obo/GO_0035094) (response to nicotine), [GO:0006556](http://purl.obolibrary.org/obo/GO_0006556) (S-adenosylmethionine biosynthetic process), [GO:0043534](http://purl.obolibrary.org/obo/GO_0043534) (blood vessel endothelial cell migration), [GO:0043536](http://purl.obolibrary.org/obo/GO_0043536) (positive regulation of blood vessel endothelial cell migration), [GO:0006555](http://purl.obolibrary.org/obo/GO_0006555) (methionine metabolic process), [GO:0043535](http://purl.obolibrary.org/obo/GO_0043535) (regulation of blood vessel endothelial cell migration), [GO:0006549](http://purl.obolibrary.org/obo/GO_0006549) (isoleucine metabolic process), [GO:0032814](http://purl.obolibrary.org/obo/GO_0032814) (regulation of natural killer cell activation), [GO:0005216](http://purl.obolibrary.org/obo/GO_0005216) (ion channel activity), [GO:0097352](http://purl.obolibrary.org/obo/GO_0097352) (autophagosome maturation), [GO:0006547](http://purl.obolibrary.org/obo/GO_0006547) (histidine metabolic process), [GO:0072075](http://purl.obolibrary.org/obo/GO_0072075) (metanephric mesenchyme development), [GO:0006548](http://purl.obolibrary.org/obo/GO_0006548) (histidine catabolic process), [GO:0032813](http://purl.obolibrary.org/obo/GO_0032813) (tumor necrosis factor receptor superfamily binding), [GO:0032816](http://purl.obolibrary.org/obo/GO_0032816) (positive regulation of natural killer cell activation), [GO:0032817](http://purl.obolibrary.org/obo/GO_0032817) (regulation of natural killer cell proliferation), [GO:0019852](http://purl.obolibrary.org/obo/GO_0019852) (L-ascorbic acid metabolic process), [GO:0019856](http://purl.obolibrary.org/obo/GO_0019856) (pyrimidine nucleobase biosynthetic process), [GO:0019855](http://purl.obolibrary.org/obo/GO_0019855) (calcium channel inhibitor activity), [GO:0060044](http://purl.obolibrary.org/obo/GO_0060044) (negative regulation of cardiac muscle cell proliferation), [GO:0060045](http://purl.obolibrary.org/obo/GO_0060045) (positive regulation of cardiac muscle cell proliferation), [GO:1902230](http://purl.obolibrary.org/obo/GO_1902230) (negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage), [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle), [GO:0060046](http://purl.obolibrary.org/obo/GO_0060046) (regulation of acrosome reaction), [GO:0060047](http://purl.obolibrary.org/obo/GO_0060047) (heart contraction), [GO:0061371](http://purl.obolibrary.org/obo/GO_0061371) (determination of heart left/right asymmetry), [GO:0060040](http://purl.obolibrary.org/obo/GO_0060040) (retinal bipolar neuron differentiation), [GO:0060041](http://purl.obolibrary.org/obo/GO_0060041) (retina development in camera-type eye), [GO:1903565](http://purl.obolibrary.org/obo/GO_1903565) (negative regulation of protein localization to cilium), [GO:0060042](http://purl.obolibrary.org/obo/GO_0060042) (retina morphogenesis in camera-type eye), [GO:1904894](http://purl.obolibrary.org/obo/GO_1904894) (positive regulation of STAT cascade), [GO:0005272](http://purl.obolibrary.org/obo/GO_0005272) (sodium channel activity), [GO:1902232](http://purl.obolibrary.org/obo/GO_1902232) (regulation of positive thymic T cell selection), [GO:1903568](http://purl.obolibrary.org/obo/GO_1903568) (negative regulation of protein localization to ciliary membrane), [GO:1902237](http://purl.obolibrary.org/obo/GO_1902237) (positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway), [GO:1904899](http://purl.obolibrary.org/obo/GO_1904899) (positive regulation of hepatic stellate cell proliferation), [GO:1902235](http://purl.obolibrary.org/obo/GO_1902235) (regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway), [GO:1902236](http://purl.obolibrary.org/obo/GO_1902236) (negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway), [GO:0060048](http://purl.obolibrary.org/obo/GO_0060048) (cardiac muscle contraction), [GO:0060049](http://purl.obolibrary.org/obo/GO_0060049) (regulation of protein glycosylation), [GO:0032889](http://purl.obolibrary.org/obo/GO_0032889) (regulation of vacuole fusion, non-autophagic), [GO:0030229](http://purl.obolibrary.org/obo/GO_0030229) (very-low-density lipoprotein particle receptor activity), [GO:0097324](http://purl.obolibrary.org/obo/GO_0097324) (melanocyte migration), [GO:0098656](http://purl.obolibrary.org/obo/GO_0098656) (anion transmembrane transport), [GO:0097326](http://purl.obolibrary.org/obo/GO_0097326) (melanocyte adhesion), [GO:0098655](http://purl.obolibrary.org/obo/GO_0098655) (cation transmembrane transport), [GO:0030220](http://purl.obolibrary.org/obo/GO_0030220) (platelet formation), [GO:0030222](http://purl.obolibrary.org/obo/GO_0030222) (eosinophil differentiation), [GO:0061380](http://purl.obolibrary.org/obo/GO_0061380) (superior colliculus development), [GO:0030221](http://purl.obolibrary.org/obo/GO_0030221) (basophil differentiation), [GO:0030224](http://purl.obolibrary.org/obo/GO_0030224) (monocyte differentiation), [GO:0030223](http://purl.obolibrary.org/obo/GO_0030223) (neutrophil differentiation), [GO:0030225](http://purl.obolibrary.org/obo/GO_0030225) (macrophage differentiation), [GO:0032886](http://purl.obolibrary.org/obo/GO_0032886) (regulation of microtubule-based process), [GO:0061365](http://purl.obolibrary.org/obo/GO_0061365) (positive regulation of triglyceride lipase activity), [GO:1903572](http://purl.obolibrary.org/obo/GO_1903572) (positive regulation of protein kinase D signaling), [GO:0060034](http://purl.obolibrary.org/obo/GO_0060034) (notochord cell differentiation), [GO:0005280](http://purl.obolibrary.org/obo/GO_0005280) (amino acid:proton symporter activity), [GO:0060035](http://purl.obolibrary.org/obo/GO_0060035) (notochord cell development), [GO:0060036](http://purl.obolibrary.org/obo/GO_0060036) (notochord cell vacuolation), [GO:0061360](http://purl.obolibrary.org/obo/GO_0061360) (optic chiasma development), [GO:0032880](http://purl.obolibrary.org/obo/GO_0032880) (regulation of protein localization), [GO:0060030](http://purl.obolibrary.org/obo/GO_0060030) (dorsal convergence), [GO:1903573](http://purl.obolibrary.org/obo/GO_1903573) (negative regulation of response to endoplasmic reticulum stress), [GO:0005283](http://purl.obolibrary.org/obo/GO_0005283) (sodium:amino acid symporter activity), [GO:0060037](http://purl.obolibrary.org/obo/GO_0060037) (pharyngeal system development), [GO:0061368](http://purl.obolibrary.org/obo/GO_0061368) (behavioral response to formalin induced pain), [GO:0060038](http://purl.obolibrary.org/obo/GO_0060038) (cardiac muscle cell proliferation), [GO:0060039](http://purl.obolibrary.org/obo/GO_0060039) (pericardium development), [GO:0097340](http://purl.obolibrary.org/obo/GO_0097340) (inhibition of cysteine-type endopeptidase activity), [GO:0030217](http://purl.obolibrary.org/obo/GO_0030217) (T cell differentiation), [GO:0072010](http://purl.obolibrary.org/obo/GO_0072010) (glomerular epithelium development), [GO:0030216](http://purl.obolibrary.org/obo/GO_0030216) (keratinocyte differentiation), [GO:0047086](http://purl.obolibrary.org/obo/GO_0047086) (ketosteroid monooxygenase activity), [GO:0031547](http://purl.obolibrary.org/obo/GO_0031547) (brain-derived neurotrophic factor receptor signaling pathway), [GO:0030219](http://purl.obolibrary.org/obo/GO_0030219) (megakaryocyte differentiation), [GO:0030218](http://purl.obolibrary.org/obo/GO_0030218) (erythrocyte differentiation), [GO:0072015](http://purl.obolibrary.org/obo/GO_0072015) (glomerular visceral epithelial cell development), [GO:0032872](http://purl.obolibrary.org/obo/GO_0032872) (regulation of stress-activated MAPK cascade), [GO:0072019](http://purl.obolibrary.org/obo/GO_0072019) (proximal convoluted tubule development), [GO:0032870](http://purl.obolibrary.org/obo/GO_0032870) (cellular response to hormone stimulus), [GO:0061370](http://purl.obolibrary.org/obo/GO_0061370) (testosterone biosynthetic process), [GO:0030210](http://purl.obolibrary.org/obo/GO_0030210) (heparin biosynthetic process), [GO:0031545](http://purl.obolibrary.org/obo/GO_0031545) (peptidyl-proline 4-dioxygenase activity), [GO:0030213](http://purl.obolibrary.org/obo/GO_0030213) (hyaluronan biosynthetic process), [GO:0030212](http://purl.obolibrary.org/obo/GO_0030212) (hyaluronan metabolic process), [GO:0032874](http://purl.obolibrary.org/obo/GO_0032874) (positive regulation of stress-activated MAPK cascade), [GO:0031543](http://purl.obolibrary.org/obo/GO_0031543) (peptidyl-proline dioxygenase activity), [GO:0030214](http://purl.obolibrary.org/obo/GO_0030214) (hyaluronan catabolic process), [GO:1902251](http://purl.obolibrary.org/obo/GO_1902251) (negative regulation of erythrocyte apoptotic process), [GO:0060068](http://purl.obolibrary.org/obo/GO_0060068) (vagina development), [GO:1902255](http://purl.obolibrary.org/obo/GO_1902255) (positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator), [GO:0044818](http://purl.obolibrary.org/obo/GO_0044818) (mitotic G2/M transition checkpoint), [GO:0061393](http://purl.obolibrary.org/obo/GO_0061393) (positive regulation of transcription from RNA polymerase II promoter in response to osmotic stress), [GO:1902256](http://purl.obolibrary.org/obo/GO_1902256) (regulation of apoptotic process involved in outflow tract morphogenesis), [GO:0006582](http://purl.obolibrary.org/obo/GO_0006582) (melanin metabolic process), [GO:0005251](http://purl.obolibrary.org/obo/GO_0005251) (delayed rectifier potassium channel activity), [GO:1902254](http://purl.obolibrary.org/obo/GO_1902254) (negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator), [GO:0060065](http://purl.obolibrary.org/obo/GO_0060065) (uterus development), [GO:0005250](http://purl.obolibrary.org/obo/GO_0005250) (A-type (transient outward) potassium channel activity), [GO:0006585](http://purl.obolibrary.org/obo/GO_0006585) (dopamine biosynthetic process from tyrosine), [GO:1902257](http://purl.obolibrary.org/obo/GO_1902257) (negative regulation of apoptotic process involved in outflow tract morphogenesis), [GO:0006583](http://purl.obolibrary.org/obo/GO_0006583) (melanin biosynthetic process from tyrosine), [GO:0006584](http://purl.obolibrary.org/obo/GO_0006584) (catecholamine metabolic process), [GO:0005254](http://purl.obolibrary.org/obo/GO_0005254) (chloride channel activity), [GO:0006589](http://purl.obolibrary.org/obo/GO_0006589) (octopamine biosynthetic process), [GO:0006587](http://purl.obolibrary.org/obo/GO_0006587) (serotonin biosynthetic process from tryptophan), [GO:0032869](http://purl.obolibrary.org/obo/GO_0032869) (cellular response to insulin stimulus), [GO:0030206](http://purl.obolibrary.org/obo/GO_0030206) (chondroitin sulfate biosynthetic process), [GO:0005249](http://purl.obolibrary.org/obo/GO_0005249) (voltage-gated potassium channel activity), [GO:0030208](http://purl.obolibrary.org/obo/GO_0030208) (dermatan sulfate biosynthetic process), [GO:0097300](http://purl.obolibrary.org/obo/GO_0097300) (programmed necrotic cell death), [GO:0032868](http://purl.obolibrary.org/obo/GO_0032868) (response to insulin), [GO:0030209](http://purl.obolibrary.org/obo/GO_0030209) (dermatan sulfate catabolic process), [GO:0072045](http://purl.obolibrary.org/obo/GO_0072045) (convergent extension involved in nephron morphogenesis), [GO:0060070](http://purl.obolibrary.org/obo/GO_0060070) (canonical Wnt signaling pathway), [GO:0030200](http://purl.obolibrary.org/obo/GO_0030200) (heparan sulfate proteoglycan catabolic process), [GO:0098636](http://purl.obolibrary.org/obo/GO_0098636) (protein complex involved in cell adhesion), [GO:0060071](http://purl.obolibrary.org/obo/GO_0060071) (Wnt signaling pathway, planar cell polarity pathway), [GO:0060072](http://purl.obolibrary.org/obo/GO_0060072) (large conductance calcium-activated potassium channel activity), [GO:0030201](http://purl.obolibrary.org/obo/GO_0030201) (heparan sulfate proteoglycan metabolic process), [GO:0032866](http://purl.obolibrary.org/obo/GO_0032866) (D-xylose:NADP reductase activity), [GO:0031532](http://purl.obolibrary.org/obo/GO_0031532) (actin cytoskeleton reorganization), [GO:0030204](http://purl.obolibrary.org/obo/GO_0030204) (chondroitin sulfate metabolic process), [GO:0030203](http://purl.obolibrary.org/obo/GO_0030203) (glycosaminoglycan metabolic process), [GO:0061386](http://purl.obolibrary.org/obo/GO_0061386) (closure of optic fissure), [GO:1902262](http://purl.obolibrary.org/obo/GO_1902262) (apoptotic process involved in blood vessel morphogenesis), [GO:0060055](http://purl.obolibrary.org/obo/GO_0060055) (angiogenesis involved in wound healing), [GO:1902261](http://purl.obolibrary.org/obo/GO_1902261) (positive regulation of delayed rectifier potassium channel activity), [GO:0060058](http://purl.obolibrary.org/obo/GO_0060058) (positive regulation of apoptotic process involved in mammary gland involution), [GO:0044829](http://purl.obolibrary.org/obo/GO_0044829) (positive regulation by host of viral genome replication), [GO:0005260](http://purl.obolibrary.org/obo/GO_0005260) (intracellularly ATP-gated chloride channel activity), [GO:0006592](http://purl.obolibrary.org/obo/GO_0006592) (ornithine biosynthetic process), [GO:1903597](http://purl.obolibrary.org/obo/GO_1903597) (negative regulation of gap junction assembly), [GO:0006593](http://purl.obolibrary.org/obo/GO_0006593) (ornithine catabolic process), [GO:0044828](http://purl.obolibrary.org/obo/GO_0044828) (negative regulation by host of viral genome replication), [GO:0060052](http://purl.obolibrary.org/obo/GO_0060052) (neurofilament cytoskeleton organization), [GO:0006590](http://purl.obolibrary.org/obo/GO_0006590) (thyroid hormone generation), [GO:0005262](http://purl.obolibrary.org/obo/GO_0005262) (calcium channel activity), [GO:0061384](http://purl.obolibrary.org/obo/GO_0061384) (heart trabecula morphogenesis), [GO:0060053](http://purl.obolibrary.org/obo/GO_0060053) (neurofilament cytoskeleton), [GO:1903595](http://purl.obolibrary.org/obo/GO_1903595) (positive regulation of histamine secretion by mast cell), [GO:0005261](http://purl.obolibrary.org/obo/GO_0005261) (cation channel activity), [GO:0006591](http://purl.obolibrary.org/obo/GO_0006591) (ornithine metabolic process), [GO:0060054](http://purl.obolibrary.org/obo/GO_0060054) (positive regulation of epithelial cell proliferation involved in wound healing), [GO:0006596](http://purl.obolibrary.org/obo/GO_0006596) (polyamine biosynthetic process), [GO:0006597](http://purl.obolibrary.org/obo/GO_0006597) (spermine biosynthetic process), [GO:0060059](http://purl.obolibrary.org/obo/GO_0060059) (embryonic retina morphogenesis in camera-type eye), [GO:0005267](http://purl.obolibrary.org/obo/GO_0005267) (potassium channel activity), [GO:0031527](http://purl.obolibrary.org/obo/GO_0031527) (filopodium membrane), [GO:0098641](http://purl.obolibrary.org/obo/GO_0098641) (cadherin binding involved in cell-cell adhesion), [GO:0031528](http://purl.obolibrary.org/obo/GO_0031528) (microvillus membrane), [GO:0031526](http://purl.obolibrary.org/obo/GO_0031526) (brush border membrane), [GO:0031529](http://purl.obolibrary.org/obo/GO_0031529) (ruffle organization), [GO:0019894](http://purl.obolibrary.org/obo/GO_0019894) (kinesin binding), [GO:0019896](http://purl.obolibrary.org/obo/GO_0019896) (axonal transport of mitochondrion), [GO:0060060](http://purl.obolibrary.org/obo/GO_0060060) (post-embryonic retina morphogenesis in camera-type eye), [GO:0019898](http://purl.obolibrary.org/obo/GO_0019898) (extrinsic component of membrane), [GO:0019897](http://purl.obolibrary.org/obo/GO_0019897) (extrinsic component of plasma membrane), [GO:0120053](http://purl.obolibrary.org/obo/GO_0120053) (ribitol beta-1,4-xylosyltransferase activity), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), [GO:0030150](http://purl.obolibrary.org/obo/GO_0030150) (protein import into mitochondrial matrix), [GO:0030151](http://purl.obolibrary.org/obo/GO_0030151) (molybdenum ion binding), [GO:0005198](http://purl.obolibrary.org/obo/GO_0005198) (structural molecule activity), [GO:0042132](http://purl.obolibrary.org/obo/GO_0042132) (fructose 1,6-bisphosphate 1-phosphatase activity), [GO:0044794](http://purl.obolibrary.org/obo/GO_0044794) (positive regulation by host of viral process), [GO:0042134](http://purl.obolibrary.org/obo/GO_0042134) (rRNA primary transcript binding), [GO:0042135](http://purl.obolibrary.org/obo/GO_0042135) (neurotransmitter catabolic process), [GO:0042136](http://purl.obolibrary.org/obo/GO_0042136) (neurotransmitter biosynthetic process), [GO:0044798](http://purl.obolibrary.org/obo/GO_0044798) (nuclear transcription factor complex), [GO:1990761](http://purl.obolibrary.org/obo/GO_1990761) (growth cone lamellipodium), [GO:1990763](http://purl.obolibrary.org/obo/GO_1990763) (arrestin family protein binding), [GO:0043473](http://purl.obolibrary.org/obo/GO_0043473) (pigmentation), [GO:0017185](http://purl.obolibrary.org/obo/GO_0017185) (peptidyl-lysine hydroxylation), [GO:0017187](http://purl.obolibrary.org/obo/GO_0017187) (peptidyl-glutamic acid carboxylation), [GO:0017188](http://purl.obolibrary.org/obo/GO_0017188) (aspartate N-acetyltransferase activity), [GO:1990769](http://purl.obolibrary.org/obo/GO_1990769) (proximal neuron projection), [GO:0030145](http://purl.obolibrary.org/obo/GO_0030145) (manganese ion binding), [GO:0031477](http://purl.obolibrary.org/obo/GO_0031477) (myosin VII complex), [GO:0030148](http://purl.obolibrary.org/obo/GO_0030148) (sphingolipid biosynthetic process), [GO:0030141](http://purl.obolibrary.org/obo/GO_0030141) (secretory granule), [GO:0030140](http://purl.obolibrary.org/obo/GO_0030140) (trans-Golgi network transport vesicle), [GO:0042144](http://purl.obolibrary.org/obo/GO_0042144) (vacuole fusion, non-autophagic), [GO:0042147](http://purl.obolibrary.org/obo/GO_0042147) (retrograde transport, endosome to Golgi), [GO:0042149](http://purl.obolibrary.org/obo/GO_0042149) (cellular response to glucose starvation), [GO:0030139](http://purl.obolibrary.org/obo/GO_0030139) (endocytic vesicle), [GO:0014909](http://purl.obolibrary.org/obo/GO_0014909) (smooth muscle cell migration), [GO:0017171](http://purl.obolibrary.org/obo/GO_0017171) (serine hydrolase activity), [GO:0043484](http://purl.obolibrary.org/obo/GO_0043484) (regulation of RNA splicing), [GO:0002923](http://purl.obolibrary.org/obo/GO_0002923) (regulation of humoral immune response mediated by circulating immunoglobulin), [GO:0017174](http://purl.obolibrary.org/obo/GO_0017174) (glycine N-methyltransferase activity), [GO:0002924](http://purl.obolibrary.org/obo/GO_0002924) (negative regulation of humoral immune response mediated by circulating immunoglobulin), [GO:0017176](http://purl.obolibrary.org/obo/GO_0017176) (phosphatidylinositol N-acetylglucosaminyltransferase activity), [GO:0002925](http://purl.obolibrary.org/obo/GO_0002925) (positive regulation of humoral immune response mediated by circulating immunoglobulin), [GO:0031464](http://purl.obolibrary.org/obo/GO_0031464) (Cul4A-RING E3 ubiquitin ligase complex), [GO:0030131](http://purl.obolibrary.org/obo/GO_0030131) (clathrin adaptor complex), [GO:0014902](http://purl.obolibrary.org/obo/GO_0014902) (myotube differentiation), [GO:0017177](http://purl.obolibrary.org/obo/GO_0017177) (glucosidase II complex), [GO:0031465](http://purl.obolibrary.org/obo/GO_0031465) (Cul4B-RING E3 ubiquitin ligase complex), [GO:0032793](http://purl.obolibrary.org/obo/GO_0032793) (positive regulation of CREB transcription factor activity), [GO:0030134](http://purl.obolibrary.org/obo/GO_0030134) (COPII-coated ER to Golgi transport vesicle), [GO:0120072](http://purl.obolibrary.org/obo/GO_0120072) (positive regulation of pyloric antrum smooth muscle contraction), [GO:0031462](http://purl.obolibrary.org/obo/GO_0031462) (Cul2-RING ubiquitin ligase complex), [GO:0032794](http://purl.obolibrary.org/obo/GO_0032794) (GTPase activating protein binding), [GO:0031463](http://purl.obolibrary.org/obo/GO_0031463) (Cul3-RING ubiquitin ligase complex), [GO:0030133](http://purl.obolibrary.org/obo/GO_0030133) (transport vesicle), [GO:0030136](http://purl.obolibrary.org/obo/GO_0030136) (clathrin-coated vesicle), [GO:0032799](http://purl.obolibrary.org/obo/GO_0032799) (low-density lipoprotein receptor particle metabolic process), [GO:0030135](http://purl.obolibrary.org/obo/GO_0030135) (coated vesicle), [GO:0032797](http://purl.obolibrary.org/obo/GO_0032797) (SMN complex), [GO:0030137](http://purl.obolibrary.org/obo/GO_0030137) (COPI-coated vesicle), [GO:0031467](http://purl.obolibrary.org/obo/GO_0031467) (Cul7-RING ubiquitin ligase complex), [GO:0005172](http://purl.obolibrary.org/obo/GO_0005172) (vascular endothelial growth factor receptor binding), [GO:0031461](http://purl.obolibrary.org/obo/GO_0031461) (cullin-RING ubiquitin ligase complex), [GO:0032792](http://purl.obolibrary.org/obo/GO_0032792) (negative regulation of CREB transcription factor activity), [GO:0005174](http://purl.obolibrary.org/obo/GO_0005174) (CD40 receptor binding), [GO:0005173](http://purl.obolibrary.org/obo/GO_0005173) (stem cell factor receptor binding), [GO:0005178](http://purl.obolibrary.org/obo/GO_0005178) (integrin binding), [GO:0043488](http://purl.obolibrary.org/obo/GO_0043488) (regulation of mRNA stability), [GO:0042157](http://purl.obolibrary.org/obo/GO_0042157) (lipoprotein metabolic process), [GO:0042158](http://purl.obolibrary.org/obo/GO_0042158) (lipoprotein biosynthetic process), [GO:0005179](http://purl.obolibrary.org/obo/GO_0005179) (hormone activity), [GO:0042159](http://purl.obolibrary.org/obo/GO_0042159) (lipoprotein catabolic process), [GO:1990782](http://purl.obolibrary.org/obo/GO_1990782) (protein tyrosine kinase binding), [GO:0043491](http://purl.obolibrary.org/obo/GO_0043491) (protein kinase B signaling), [GO:0043490](http://purl.obolibrary.org/obo/GO_0043490) (malate-aspartate shuttle), [GO:0042162](http://purl.obolibrary.org/obo/GO_0042162) (telomeric DNA binding), [GO:0017162](http://purl.obolibrary.org/obo/GO_0017162) (aryl hydrocarbon receptor binding), [GO:0032784](http://purl.obolibrary.org/obo/GO_0032784) (regulation of DNA-templated transcription, elongation), [GO:0030121](http://purl.obolibrary.org/obo/GO_0030121) (AP-1 adaptor complex), [GO:0030120](http://purl.obolibrary.org/obo/GO_0030120) (vesicle coat), [GO:0030123](http://purl.obolibrary.org/obo/GO_0030123) (AP-3 adaptor complex), [GO:0032782](http://purl.obolibrary.org/obo/GO_0032782) (bile acid secretion), [GO:0017168](http://purl.obolibrary.org/obo/GO_0017168) (5-oxoprolinase (ATP-hydrolyzing) activity), [GO:0030122](http://purl.obolibrary.org/obo/GO_0030122) (AP-2 adaptor complex), [GO:0030125](http://purl.obolibrary.org/obo/GO_0030125) (clathrin vesicle coat), [GO:0030124](http://purl.obolibrary.org/obo/GO_0030124) (AP-4 adaptor complex), [GO:0030127](http://purl.obolibrary.org/obo/GO_0030127) (COPII vesicle coat), [GO:0032786](http://purl.obolibrary.org/obo/GO_0032786) (positive regulation of DNA-templated transcription, elongation), [GO:0030126](http://purl.obolibrary.org/obo/GO_0030126) (COPI vesicle coat), [GO:0032780](http://purl.obolibrary.org/obo/GO_0032780) (negative regulation of ATPase activity), [GO:0032781](http://purl.obolibrary.org/obo/GO_0032781) (positive regulation of ATPase activity), [GO:0005184](http://purl.obolibrary.org/obo/GO_0005184) (neuropeptide hormone activity), [GO:0043497](http://purl.obolibrary.org/obo/GO_0043497) (regulation of protein heterodimerization activity), [GO:0042166](http://purl.obolibrary.org/obo/GO_0042166) (acetylcholine binding), [GO:0043496](http://purl.obolibrary.org/obo/GO_0043496) (regulation of protein homodimerization activity), [GO:0042167](http://purl.obolibrary.org/obo/GO_0042167) (heme catabolic process), [GO:0042168](http://purl.obolibrary.org/obo/GO_0042168) (heme metabolic process), [GO:0042169](http://purl.obolibrary.org/obo/GO_0042169) (SH2 domain binding), [GO:0030117](http://purl.obolibrary.org/obo/GO_0030117) (membrane coat), [GO:0031449](http://purl.obolibrary.org/obo/GO_0031449) (regulation of slow-twitch skeletal muscle fiber contraction), [GO:0042171](http://purl.obolibrary.org/obo/GO_0042171) (lysophosphatidic acid acyltransferase activity), [GO:1990798](http://purl.obolibrary.org/obo/GO_1990798) (pancreas regeneration), [GO:0017151](http://purl.obolibrary.org/obo/GO_0017151) (DEAD/H-box RNA helicase binding), [GO:1990799](http://purl.obolibrary.org/obo/GO_1990799) (mitochondrial tRNA wobble position uridine thiolation), [GO:0018484](http://purl.obolibrary.org/obo/GO_0018484) (4-hydroxybenzaldehyde dehydrogenase activity), [GO:0002902](http://purl.obolibrary.org/obo/GO_0002902) (regulation of B cell apoptotic process), [GO:0017153](http://purl.obolibrary.org/obo/GO_0017153) (sodium:dicarboxylate symporter activity), [GO:0042175](http://purl.obolibrary.org/obo/GO_0042175) (nuclear outer membrane-endoplasmic reticulum membrane network), [GO:0017154](http://purl.obolibrary.org/obo/GO_0017154) (semaphorin receptor activity), [GO:0002903](http://purl.obolibrary.org/obo/GO_0002903) (negative regulation of B cell apoptotic process), [GO:0017156](http://purl.obolibrary.org/obo/GO_0017156) (calcium ion regulated exocytosis), [GO:0002906](http://purl.obolibrary.org/obo/GO_0002906) (negative regulation of mature B cell apoptotic process), [GO:0030111](http://purl.obolibrary.org/obo/GO_0030111) (regulation of Wnt signaling pathway), [GO:0017158](http://purl.obolibrary.org/obo/GO_0017158) (regulation of calcium ion-dependent exocytosis), [GO:0031444](http://purl.obolibrary.org/obo/GO_0031444) (slow-twitch skeletal muscle fiber contraction), [GO:0032776](http://purl.obolibrary.org/obo/GO_0032776) (DNA methylation on cytosine), [GO:0030194](http://purl.obolibrary.org/obo/GO_0030194) (positive regulation of blood coagulation), [GO:0030193](http://purl.obolibrary.org/obo/GO_0030193) (regulation of blood coagulation), [GO:0030195](http://purl.obolibrary.org/obo/GO_0030195) (negative regulation of blood coagulation), [GO:0043420](http://purl.obolibrary.org/obo/GO_0043420) (anthranilate metabolic process), [GO:0044753](http://purl.obolibrary.org/obo/GO_0044753) (amphisome), [GO:0043422](http://purl.obolibrary.org/obo/GO_0043422) (protein kinase B binding), [GO:0044754](http://purl.obolibrary.org/obo/GO_0044754) (autolysosome), [GO:0043426](http://purl.obolibrary.org/obo/GO_0043426) (MRF binding), [GO:0043425](http://purl.obolibrary.org/obo/GO_0043425) (bHLH transcription factor binding), [GO:0097286](http://purl.obolibrary.org/obo/GO_0097286) (iron ion import), [GO:0002951](http://purl.obolibrary.org/obo/GO_0002951) (leukotriene-C(4) hydrolase), [GO:0043438](http://purl.obolibrary.org/obo/GO_0043438) (acetoacetic acid metabolic process), [GO:0030183](http://purl.obolibrary.org/obo/GO_0030183) (B cell differentiation), [GO:0030182](http://purl.obolibrary.org/obo/GO_0030182) (neuron differentiation), [GO:0000307](http://purl.obolibrary.org/obo/GO_0000307) (cyclin-dependent protein kinase holoenzyme complex), [GO:0000306](http://purl.obolibrary.org/obo/GO_0000306) (extrinsic component of vacuolar membrane), [GO:0042100](http://purl.obolibrary.org/obo/GO_0042100) (B cell proliferation), [GO:0043433](http://purl.obolibrary.org/obo/GO_0043433) (negative regulation of DNA binding transcription factor activity), [GO:0042101](http://purl.obolibrary.org/obo/GO_0042101) (T cell receptor complex), [GO:0042102](http://purl.obolibrary.org/obo/GO_0042102) (positive regulation of T cell proliferation), [GO:0000303](http://purl.obolibrary.org/obo/GO_0000303) (response to superoxide), [GO:0000302](http://purl.obolibrary.org/obo/GO_0000302) (response to reactive oxygen species), [GO:0042104](http://purl.obolibrary.org/obo/GO_0042104) (positive regulation of activated T cell proliferation), [GO:0043434](http://purl.obolibrary.org/obo/GO_0043434) (response to peptide hormone), [GO:0000301](http://purl.obolibrary.org/obo/GO_0000301) (retrograde transport, vesicle recycling within Golgi), [GO:0042105](http://purl.obolibrary.org/obo/GO_0042105) (alpha-beta T cell receptor complex), [GO:0044770](http://purl.obolibrary.org/obo/GO_0044770) (cell cycle phase transition), [GO:0030176](http://purl.obolibrary.org/obo/GO_0030176) (integral component of endoplasmic reticulum membrane), [GO:0030175](http://purl.obolibrary.org/obo/GO_0030175) (filopodium), [GO:0001639](http://purl.obolibrary.org/obo/GO_0001639) (PLC activating G-protein coupled glutamate receptor activity), [GO:0030178](http://purl.obolibrary.org/obo/GO_0030178) (negative regulation of Wnt signaling pathway), [GO:0030177](http://purl.obolibrary.org/obo/GO_0030177) (positive regulation of Wnt signaling pathway), [GO:0042119](http://purl.obolibrary.org/obo/GO_0042119) (neutrophil activation), [GO:0030170](http://purl.obolibrary.org/obo/GO_0030170) (pyridoxal phosphate binding), [GO:0030172](http://purl.obolibrary.org/obo/GO_0030172) (troponin C binding), [GO:0030174](http://purl.obolibrary.org/obo/GO_0030174) (regulation of DNA-dependent DNA replication initiation), [GO:0030173](http://purl.obolibrary.org/obo/GO_0030173) (integral component of Golgi membrane), [GO:0042110](http://purl.obolibrary.org/obo/GO_0042110) (T cell activation), [GO:0044773](http://purl.obolibrary.org/obo/GO_0044773) (mitotic DNA damage checkpoint), [GO:0044774](http://purl.obolibrary.org/obo/GO_0044774) (mitotic DNA integrity checkpoint), [GO:0042113](http://purl.obolibrary.org/obo/GO_0042113) (B cell activation), [GO:0097272](http://purl.obolibrary.org/obo/GO_0097272) (ammonia homeostasis), [GO:0097271](http://purl.obolibrary.org/obo/GO_0097271) (protein localization to bud neck), [GO:0042116](http://purl.obolibrary.org/obo/GO_0042116) (macrophage activation), [GO:0098597](http://purl.obolibrary.org/obo/GO_0098597) (observational learning), [GO:0097264](http://purl.obolibrary.org/obo/GO_0097264) (self proteolysis), [GO:0098598](http://purl.obolibrary.org/obo/GO_0098598) (learned vocalization behavior or vocal learning), [GO:0002930](http://purl.obolibrary.org/obo/GO_0002930) (trabecular meshwork development), [GO:0002931](http://purl.obolibrary.org/obo/GO_0002931) (response to ischemia), [GO:0097268](http://purl.obolibrary.org/obo/GO_0097268) (cytoophidium), [GO:0044782](http://purl.obolibrary.org/obo/GO_0044782) (cilium organization), [GO:0098599](http://purl.obolibrary.org/obo/GO_0098599) (palmitoyl hydrolase activity), [GO:0002934](http://purl.obolibrary.org/obo/GO_0002934) (desmosome organization), [GO:0014916](http://purl.obolibrary.org/obo/GO_0014916) (regulation of lung blood pressure), [GO:0030165](http://purl.obolibrary.org/obo/GO_0030165) (PDZ domain binding), [GO:0031497](http://purl.obolibrary.org/obo/GO_0031497) (chromatin assembly), [GO:0030166](http://purl.obolibrary.org/obo/GO_0030166) (proteoglycan biosynthetic process), [GO:0031496](http://purl.obolibrary.org/obo/GO_0031496) (positive regulation of mating type switching), [GO:0014911](http://purl.obolibrary.org/obo/GO_0014911) (positive regulation of smooth muscle cell migration), [GO:0002939](http://purl.obolibrary.org/obo/GO_0002939) (tRNA N1-guanine methylation), [GO:0030169](http://purl.obolibrary.org/obo/GO_0030169) (low-density lipoprotein particle binding), [GO:0014910](http://purl.obolibrary.org/obo/GO_0014910) (regulation of smooth muscle cell migration), [GO:0030168](http://purl.obolibrary.org/obo/GO_0030168) (platelet activation), [GO:0042129](http://purl.obolibrary.org/obo/GO_0042129) (regulation of T cell proliferation), [GO:0031490](http://purl.obolibrary.org/obo/GO_0031490) (chromatin DNA binding), [GO:0031493](http://purl.obolibrary.org/obo/GO_0031493) (nucleosomal histone binding), [GO:0030160](http://purl.obolibrary.org/obo/GO_0030160) (GKAP/Homer scaffold activity), [GO:0030163](http://purl.obolibrary.org/obo/GO_0030163) (protein catabolic process), [GO:0031491](http://purl.obolibrary.org/obo/GO_0031491) (nucleosome binding), [GO:0030162](http://purl.obolibrary.org/obo/GO_0030162) (regulation of proteolysis), [GO:0031492](http://purl.obolibrary.org/obo/GO_0031492) (nucleosomal DNA binding), [GO:0043457](http://purl.obolibrary.org/obo/GO_0043457) (regulation of cellular respiration), [GO:0043456](http://purl.obolibrary.org/obo/GO_0043456) (regulation of pentose-phosphate shunt), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0097284](http://purl.obolibrary.org/obo/GO_0097284) (hepatocyte apoptotic process), [GO:0042128](http://purl.obolibrary.org/obo/GO_0042128) (nitrate assimilation), [GO:0097278](http://purl.obolibrary.org/obo/GO_0097278) (complement-dependent cytotoxicity), [GO:0044791](http://purl.obolibrary.org/obo/GO_0044791) (positive regulation by host of viral release from host cell), [GO:0044790](http://purl.obolibrary.org/obo/GO_0044790) (negative regulation by host of viral release from host cell), [GO:0001614](http://purl.obolibrary.org/obo/GO_0001614) (purinergic nucleotide receptor activity), [GO:0043462](http://purl.obolibrary.org/obo/GO_0043462) (regulation of ATPase activity), [GO:0042130](http://purl.obolibrary.org/obo/GO_0042130) (negative regulation of T cell proliferation), [GO:0043461](http://purl.obolibrary.org/obo/GO_0043461) (proton-transporting ATP synthase complex assembly), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0017198](http://purl.obolibrary.org/obo/GO_0017198) (N-terminal peptidyl-serine acetylation), [GO:0001618](http://purl.obolibrary.org/obo/GO_0001618) (virus receptor activity), [GO:0030155](http://purl.obolibrary.org/obo/GO_0030155) (regulation of cell adhesion), [GO:0030158](http://purl.obolibrary.org/obo/GO_0030158) (protein xylosyltransferase activity), [GO:0030157](http://purl.obolibrary.org/obo/GO_0030157) (pancreatic juice secretion), [GO:0031489](http://purl.obolibrary.org/obo/GO_0031489) (myosin V binding), [GO:0030159](http://purl.obolibrary.org/obo/GO_0030159) (receptor signaling complex scaffold activity), [GO:0051928](http://purl.obolibrary.org/obo/GO_0051928) (positive regulation of calcium ion transport), [GO:0001671](http://purl.obolibrary.org/obo/GO_0001671) (ATPase activator activity), [GO:0000333](http://purl.obolibrary.org/obo/GO_0000333) (telomerase catalytic core complex), [GO:0001673](http://purl.obolibrary.org/obo/GO_0001673) (male germ cell nucleus), [GO:0001664](http://purl.obolibrary.org/obo/GO_0001664) (G-protein coupled receptor binding), [GO:0000340](http://purl.obolibrary.org/obo/GO_0000340) (RNA 7-methylguanosine cap binding), [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia), [GO:0001669](http://purl.obolibrary.org/obo/GO_0001669) (acrosomal vesicle), [GO:0051926](http://purl.obolibrary.org/obo/GO_0051926) (negative regulation of calcium ion transport), [GO:0051923](http://purl.obolibrary.org/obo/GO_0051923) (sulfation), [GO:0051924](http://purl.obolibrary.org/obo/GO_0051924) (regulation of calcium ion transport), [GO:0051938](http://purl.obolibrary.org/obo/GO_0051938) (L-glutamate import), [GO:0000349](http://purl.obolibrary.org/obo/GO_0000349) (generation of catalytic spliceosome for first transesterification step), [GO:0001680](http://purl.obolibrary.org/obo/GO_0001680) (tRNA 3'-terminal CCA addition), [GO:0001675](http://purl.obolibrary.org/obo/GO_0001675) (acrosome assembly), [GO:0001676](http://purl.obolibrary.org/obo/GO_0001676) (long-chain fatty acid metabolic process), [GO:0001678](http://purl.obolibrary.org/obo/GO_0001678) (cellular glucose homeostasis), [GO:0051935](http://purl.obolibrary.org/obo/GO_0051935) (glutamate reuptake), [GO:0051932](http://purl.obolibrary.org/obo/GO_0051932) (synaptic transmission, GABAergic), [GO:0051930](http://purl.obolibrary.org/obo/GO_0051930) (regulation of sensory perception of pain), [GO:0001650](http://purl.obolibrary.org/obo/GO_0001650) (fibrillar center), [GO:1990700](http://purl.obolibrary.org/obo/GO_1990700) (nucleolar chromatin organization), [GO:0001649](http://purl.obolibrary.org/obo/GO_0001649) (osteoblast differentiation), [GO:0050614](http://purl.obolibrary.org/obo/GO_0050614) (delta24-sterol reductase activity), [GO:0050613](http://purl.obolibrary.org/obo/GO_0050613) (delta14-sterol reductase activity), [GO:0000329](http://purl.obolibrary.org/obo/GO_0000329) (fungal-type vacuole membrane), [GO:0048306](http://purl.obolibrary.org/obo/GO_0048306) (calcium-dependent protein binding), [GO:0000328](http://purl.obolibrary.org/obo/GO_0000328) (fungal-type vacuole lumen), [GO:0048305](http://purl.obolibrary.org/obo/GO_0048305) (immunoglobulin secretion), [GO:1904800](http://purl.obolibrary.org/obo/GO_1904800) (negative regulation of neuron remodeling), [GO:0048304](http://purl.obolibrary.org/obo/GO_0048304) (positive regulation of isotype switching to IgG isotypes), [GO:0000324](http://purl.obolibrary.org/obo/GO_0000324) (fungal-type vacuole), [GO:0048309](http://purl.obolibrary.org/obo/GO_0048309) (endoplasmic reticulum inheritance), [GO:0000322](http://purl.obolibrary.org/obo/GO_0000322) (storage vacuole), [GO:1904803](http://purl.obolibrary.org/obo/GO_1904803) (regulation of translation involved in cellular response to UV), [GO:0001662](http://purl.obolibrary.org/obo/GO_0001662) (behavioral fear response), [GO:0001654](http://purl.obolibrary.org/obo/GO_0001654) (eye development), [GO:0001655](http://purl.obolibrary.org/obo/GO_0001655) (urogenital system development), [GO:0001656](http://purl.obolibrary.org/obo/GO_0001656) (metanephros development), [GO:0048313](http://purl.obolibrary.org/obo/GO_0048313) (Golgi inheritance), [GO:0001657](http://purl.obolibrary.org/obo/GO_0001657) (ureteric bud development), [GO:0048311](http://purl.obolibrary.org/obo/GO_0048311) (mitochondrion distribution), [GO:0001658](http://purl.obolibrary.org/obo/GO_0001658) (branching involved in ureteric bud morphogenesis), [GO:2000309](http://purl.obolibrary.org/obo/GO_2000309) (positive regulation of tumor necrosis factor (ligand) superfamily member 11 production), [GO:1990712](http://purl.obolibrary.org/obo/GO_1990712) (HFE-transferrin receptor complex), [GO:0001659](http://purl.obolibrary.org/obo/GO_0001659) (temperature homeostasis), [GO:0048310](http://purl.obolibrary.org/obo/GO_0048310) (nucleus inheritance), [GO:0030198](http://purl.obolibrary.org/obo/GO_0030198) (extracellular matrix organization), [GO:0051958](http://purl.obolibrary.org/obo/GO_0051958) (methotrexate transport), [GO:0051959](http://purl.obolibrary.org/obo/GO_0051959) (dynein light intermediate chain binding), [GO:0030199](http://purl.obolibrary.org/obo/GO_0030199) (collagen fibril organization), [GO:2000304](http://purl.obolibrary.org/obo/GO_2000304) (positive regulation of ceramide biosynthetic process), [GO:1990718](http://purl.obolibrary.org/obo/GO_1990718) (axonemal central pair projection), [GO:0023019](http://purl.obolibrary.org/obo/GO_0023019) (signal transduction involved in regulation of gene expression), [GO:0042176](http://purl.obolibrary.org/obo/GO_0042176) (regulation of protein catabolic process), [GO:0042177](http://purl.obolibrary.org/obo/GO_0042177) (negative regulation of protein catabolic process), [GO:0023014](http://purl.obolibrary.org/obo/GO_0023014) (signal transduction by protein phosphorylation), [GO:0023016](http://purl.obolibrary.org/obo/GO_0023016) (signal transduction by trans-phosphorylation), [GO:0023021](http://purl.obolibrary.org/obo/GO_0023021) (termination of signal transduction), [GO:0042180](http://purl.obolibrary.org/obo/GO_0042180) (cellular ketone metabolic process), [GO:0042182](http://purl.obolibrary.org/obo/GO_0042182) (ketone catabolic process), [GO:0000381](http://purl.obolibrary.org/obo/GO_0000381) (regulation of alternative mRNA splicing, via spliceosome), [GO:0000380](http://purl.obolibrary.org/obo/GO_0000380) (alternative mRNA splicing, via spliceosome), [GO:0036328](http://purl.obolibrary.org/obo/GO_0036328) (VEGF-C-activated receptor activity), [GO:2000311](http://purl.obolibrary.org/obo/GO_2000311) (regulation of AMPA receptor activity), [GO:2000310](http://purl.obolibrary.org/obo/GO_2000310) (regulation of NMDA receptor activity), [GO:2000314](http://purl.obolibrary.org/obo/GO_2000314) (negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation), [GO:2000313](http://purl.obolibrary.org/obo/GO_2000313) (regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation), [GO:2000312](http://purl.obolibrary.org/obo/GO_2000312) (regulation of kainate selective glutamate receptor activity), [GO:0000387](http://purl.obolibrary.org/obo/GO_0000387) (spliceosomal snRNP assembly), [GO:2000329](http://purl.obolibrary.org/obo/GO_2000329) (negative regulation of T-helper 17 cell lineage commitment), [GO:1990730](http://purl.obolibrary.org/obo/GO_1990730) (VCP-NSFL1C complex), [GO:0000390](http://purl.obolibrary.org/obo/GO_0000390) (spliceosomal complex disassembly), [GO:0036317](http://purl.obolibrary.org/obo/GO_0036317) (tyrosyl-RNA phosphodiesterase activity), [GO:2000321](http://purl.obolibrary.org/obo/GO_2000321) (positive regulation of T-helper 17 cell differentiation), [GO:2000320](http://purl.obolibrary.org/obo/GO_2000320) (negative regulation of T-helper 17 cell differentiation), [GO:2000324](http://purl.obolibrary.org/obo/GO_2000324) (positive regulation of glucocorticoid receptor signaling pathway), [GO:0036310](http://purl.obolibrary.org/obo/GO_0036310) (annealing helicase activity), [GO:0036312](http://purl.obolibrary.org/obo/GO_0036312) (phosphatidylinositol 3-kinase regulatory subunit binding), [GO:2000340](http://purl.obolibrary.org/obo/GO_2000340) (positive regulation of chemokine (C-X-C motif) ligand 1 production), [GO:0001692](http://purl.obolibrary.org/obo/GO_0001692) (histamine metabolic process), [GO:0001694](http://purl.obolibrary.org/obo/GO_0001694) (histamine biosynthetic process), [GO:0001695](http://purl.obolibrary.org/obo/GO_0001695) (histamine catabolic process), [GO:2000338](http://purl.obolibrary.org/obo/GO_2000338) (regulation of chemokine (C-X-C motif) ligand 1 production), [GO:0051904](http://purl.obolibrary.org/obo/GO_0051904) (pigment granule transport), [GO:0051901](http://purl.obolibrary.org/obo/GO_0051901) (positive regulation of mitochondrial depolarization), [GO:0036302](http://purl.obolibrary.org/obo/GO_0036302) (atrioventricular canal development), [GO:0036303](http://purl.obolibrary.org/obo/GO_0036303) (lymph vessel morphogenesis), [GO:0051900](http://purl.obolibrary.org/obo/GO_0051900) (regulation of mitochondrial depolarization), [GO:0036305](http://purl.obolibrary.org/obo/GO_0036305) (ameloblast differentiation), [GO:2000334](http://purl.obolibrary.org/obo/GO_2000334) (positive regulation of blood microparticle formation), [GO:0051918](http://purl.obolibrary.org/obo/GO_0051918) (negative regulation of fibrinolysis), [GO:0051919](http://purl.obolibrary.org/obo/GO_0051919) (positive regulation of fibrinolysis), [GO:2000350](http://purl.obolibrary.org/obo/GO_2000350) (positive regulation of CD40 signaling pathway), [GO:0000372](http://purl.obolibrary.org/obo/GO_0000372) (Group I intron splicing), [GO:2000349](http://purl.obolibrary.org/obo/GO_2000349) (negative regulation of CD40 signaling pathway), [GO:2000344](http://purl.obolibrary.org/obo/GO_2000344) (positive regulation of acrosome reaction), [GO:2000343](http://purl.obolibrary.org/obo/GO_2000343) (positive regulation of chemokine (C-X-C motif) ligand 2 production), [GO:2000341](http://purl.obolibrary.org/obo/GO_2000341) (regulation of chemokine (C-X-C motif) ligand 2 production), [GO:2000348](http://purl.obolibrary.org/obo/GO_2000348) (regulation of CD40 signaling pathway), [GO:2000347](http://purl.obolibrary.org/obo/GO_2000347) (positive regulation of hepatocyte proliferation), [GO:2000346](http://purl.obolibrary.org/obo/GO_2000346) (negative regulation of hepatocyte proliferation), [GO:2000345](http://purl.obolibrary.org/obo/GO_2000345) (regulation of hepatocyte proliferation), [GO:0016409](http://purl.obolibrary.org/obo/GO_0016409) (palmitoyltransferase activity), [GO:0005750](http://purl.obolibrary.org/obo/GO_0005750) (mitochondrial respiratory chain complex III), [GO:0004421](http://purl.obolibrary.org/obo/GO_0004421) (hydroxymethylglutaryl-CoA synthase activity), [GO:0005751](http://purl.obolibrary.org/obo/GO_0005751) (mitochondrial respiratory chain complex IV), [GO:0004423](http://purl.obolibrary.org/obo/GO_0004423) (iduronate-2-sulfatase activity), [GO:0004422](http://purl.obolibrary.org/obo/GO_0004422) (hypoxanthine phosphoribosyltransferase activity), [GO:0005745](http://purl.obolibrary.org/obo/GO_0005745) (m-AAA complex), [GO:0072583](http://purl.obolibrary.org/obo/GO_0072583) (clathrin-dependent endocytosis), [GO:0005744](http://purl.obolibrary.org/obo/GO_0005744) (mitochondrial inner membrane presequence translocase complex), [GO:0005747](http://purl.obolibrary.org/obo/GO_0005747) (mitochondrial respiratory chain complex I), [GO:0005746](http://purl.obolibrary.org/obo/GO_0005746) (mitochondrial respiratory chain), [GO:0004415](http://purl.obolibrary.org/obo/GO_0004415) (hyalurononglucosaminidase activity), [GO:0005749](http://purl.obolibrary.org/obo/GO_0005749) (mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)), [GO:0030705](http://purl.obolibrary.org/obo/GO_0030705) (cytoskeleton-dependent intracellular transport), [GO:0004418](http://purl.obolibrary.org/obo/GO_0004418) (hydroxymethylbilane synthase activity), [GO:0071253](http://purl.obolibrary.org/obo/GO_0071253) (connexin binding), [GO:0004419](http://purl.obolibrary.org/obo/GO_0004419) (hydroxymethylglutaryl-CoA lyase activity), [GO:0071257](http://purl.obolibrary.org/obo/GO_0071257) (cellular response to electrical stimulus), [GO:0072589](http://purl.obolibrary.org/obo/GO_0072589) (box H/ACA scaRNP complex), [GO:0016410](http://purl.obolibrary.org/obo/GO_0016410) (N-acyltransferase activity), [GO:0016411](http://purl.obolibrary.org/obo/GO_0016411) (acylglycerol O-acyltransferase activity), [GO:0060594](http://purl.obolibrary.org/obo/GO_0060594) (mammary gland specification), [GO:0042703](http://purl.obolibrary.org/obo/GO_0042703) (menstruation), [GO:0060591](http://purl.obolibrary.org/obo/GO_0060591) (chondroblast differentiation), [GO:0005761](http://purl.obolibrary.org/obo/GO_0005761) (mitochondrial ribosome), [GO:0005760](http://purl.obolibrary.org/obo/GO_0005760) (gamma DNA polymerase complex), [GO:0005763](http://purl.obolibrary.org/obo/GO_0005763) (mitochondrial small ribosomal subunit), [GO:0003100](http://purl.obolibrary.org/obo/GO_0003100) (regulation of systemic arterial blood pressure by endothelin), [GO:0005762](http://purl.obolibrary.org/obo/GO_0005762) (mitochondrial large ribosomal subunit), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0042700](http://purl.obolibrary.org/obo/GO_0042700) (luteinizing hormone signaling pathway), [GO:0072572](http://purl.obolibrary.org/obo/GO_0072572) (poly-ADP-D-ribose binding), [GO:0005758](http://purl.obolibrary.org/obo/GO_0005758) (mitochondrial intermembrane space), [GO:0004427](http://purl.obolibrary.org/obo/GO_0004427) (inorganic diphosphatase activity), [GO:0005757](http://purl.obolibrary.org/obo/GO_0005757) (mitochondrial permeability transition pore complex), [GO:0072576](http://purl.obolibrary.org/obo/GO_0072576) (liver morphogenesis), [GO:0005759](http://purl.obolibrary.org/obo/GO_0005759) (mitochondrial matrix), [GO:0072574](http://purl.obolibrary.org/obo/GO_0072574) (hepatocyte proliferation), [GO:0071243](http://purl.obolibrary.org/obo/GO_0071243) (cellular response to arsenic-containing substance), [GO:0072573](http://purl.obolibrary.org/obo/GO_0072573) (tolerance induction to lipopolysaccharide), [GO:0072579](http://purl.obolibrary.org/obo/GO_0072579) (glycine receptor clustering), [GO:0072577](http://purl.obolibrary.org/obo/GO_0072577) (endothelial cell apoptotic process), [GO:0016401](http://purl.obolibrary.org/obo/GO_0016401) (palmitoyl-CoA oxidase activity), [GO:0042713](http://purl.obolibrary.org/obo/GO_0042713) (sperm ejaculation), [GO:0042719](http://purl.obolibrary.org/obo/GO_0042719) (mitochondrial intermembrane space protein transporter complex), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0071280](http://purl.obolibrary.org/obo/GO_0071280) (cellular response to copper ion), [GO:0071281](http://purl.obolibrary.org/obo/GO_0071281) (cellular response to iron ion), [GO:0005732](http://purl.obolibrary.org/obo/GO_0005732) (small nucleolar ribonucleoprotein complex), [GO:0042711](http://purl.obolibrary.org/obo/GO_0042711) (maternal behavior), [GO:0005724](http://purl.obolibrary.org/obo/GO_0005724) (nuclear telomeric heterochromatin), [GO:0071277](http://purl.obolibrary.org/obo/GO_0071277) (cellular response to calcium ion), [GO:0071276](http://purl.obolibrary.org/obo/GO_0071276) (cellular response to cadmium ion), [GO:0034284](http://purl.obolibrary.org/obo/GO_0034284) (response to monosaccharide), [GO:0005741](http://purl.obolibrary.org/obo/GO_0005741) (mitochondrial outer membrane), [GO:0005740](http://purl.obolibrary.org/obo/GO_0005740) (mitochondrial envelope), [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane), [GO:0042721](http://purl.obolibrary.org/obo/GO_0042721) (mitochondrial inner membrane protein insertion complex), [GO:0004411](http://purl.obolibrary.org/obo/GO_0004411) (homogentisate 1,2-dioxygenase activity), [GO:0072594](http://purl.obolibrary.org/obo/GO_0072594) (establishment of protein localization to organelle), [GO:0072593](http://purl.obolibrary.org/obo/GO_0072593) (reactive oxygen species metabolic process), [GO:0004402](http://purl.obolibrary.org/obo/GO_0004402) (histone acetyltransferase activity), [GO:0071260](http://purl.obolibrary.org/obo/GO_0071260) (cellular response to mechanical stimulus), [GO:0005736](http://purl.obolibrary.org/obo/GO_0005736) (DNA-directed RNA polymerase I complex), [GO:0071261](http://purl.obolibrary.org/obo/GO_0071261) (Ssh1 translocon complex), [GO:0004407](http://purl.obolibrary.org/obo/GO_0004407) (histone deacetylase activity), [GO:0071266](http://purl.obolibrary.org/obo/GO_0071266) ('de novo' L-methionine biosynthetic process), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0004408](http://purl.obolibrary.org/obo/GO_0004408) (holocytochrome-c synthase activity), [GO:0071268](http://purl.obolibrary.org/obo/GO_0071268) (homocysteine biosynthetic process), [GO:0016447](http://purl.obolibrary.org/obo/GO_0016447) (somatic recombination of immunoglobulin gene segments), [GO:0060561](http://purl.obolibrary.org/obo/GO_0060561) (apoptotic process involved in morphogenesis), [GO:0015114](http://purl.obolibrary.org/obo/GO_0015114) (phosphate ion transmembrane transporter activity), [GO:0060563](http://purl.obolibrary.org/obo/GO_0060563) (neuroepithelial cell differentiation), [GO:1901660](http://purl.obolibrary.org/obo/GO_1901660) (calcium ion export), [GO:0015111](http://purl.obolibrary.org/obo/GO_0015111) (iodide transmembrane transporter activity), [GO:1902990](http://purl.obolibrary.org/obo/GO_1902990) (mitotic telomere maintenance via semi-conservative replication), [GO:0005790](http://purl.obolibrary.org/obo/GO_0005790) (smooth endoplasmic reticulum), [GO:0061890](http://purl.obolibrary.org/obo/GO_0061890) (positive regulation of astrocyte activation), [GO:1902991](http://purl.obolibrary.org/obo/GO_1902991) (regulation of amyloid precursor protein catabolic process), [GO:0004461](http://purl.obolibrary.org/obo/GO_0004461) (lactose synthase activity), [GO:0005791](http://purl.obolibrary.org/obo/GO_0005791) (rough endoplasmic reticulum), [GO:0003130](http://purl.obolibrary.org/obo/GO_0003130) (BMP signaling pathway involved in heart induction), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0005793](http://purl.obolibrary.org/obo/GO_0005793) (endoplasmic reticulum-Golgi intermediate compartment), [GO:0004465](http://purl.obolibrary.org/obo/GO_0004465) (lipoprotein lipase activity), [GO:0005795](http://purl.obolibrary.org/obo/GO_0005795) (Golgi stack), [GO:0004464](http://purl.obolibrary.org/obo/GO_0004464) (leukotriene-C4 synthase activity), [GO:0060566](http://purl.obolibrary.org/obo/GO_0060566) (positive regulation of DNA-templated transcription, termination), [GO:0004467](http://purl.obolibrary.org/obo/GO_0004467) (long-chain fatty acid-CoA ligase activity), [GO:0005798](http://purl.obolibrary.org/obo/GO_0005798) (Golgi-associated vesicle), [GO:0005797](http://purl.obolibrary.org/obo/GO_0005797) (Golgi medial cisterna), [GO:0004466](http://purl.obolibrary.org/obo/GO_0004466) (long-chain-acyl-CoA dehydrogenase activity), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0004458](http://purl.obolibrary.org/obo/GO_0004458) (D-lactate dehydrogenase (cytochrome) activity), [GO:0005788](http://purl.obolibrary.org/obo/GO_0005788) (endoplasmic reticulum lumen), [GO:0004457](http://purl.obolibrary.org/obo/GO_0004457) (lactate dehydrogenase activity), [GO:0003127](http://purl.obolibrary.org/obo/GO_0003127) (detection of nodal flow), [GO:0003128](http://purl.obolibrary.org/obo/GO_0003128) (heart field specification), [GO:0004459](http://purl.obolibrary.org/obo/GO_0004459) (L-lactate dehydrogenase activity), [GO:0047598](http://purl.obolibrary.org/obo/GO_0047598) (7-dehydrocholesterol reductase activity), [GO:0072542](http://purl.obolibrary.org/obo/GO_0072542) (protein phosphatase activator activity), [GO:0072540](http://purl.obolibrary.org/obo/GO_0072540) (T-helper 17 cell lineage commitment), [GO:0072546](http://purl.obolibrary.org/obo/GO_0072546) (ER membrane protein complex), [GO:0072545](http://purl.obolibrary.org/obo/GO_0072545) (tyrosine binding), [GO:0072544](http://purl.obolibrary.org/obo/GO_0072544) (L-DOPA binding), [GO:0015108](http://purl.obolibrary.org/obo/GO_0015108) (chloride transmembrane transporter activity), [GO:0071219](http://purl.obolibrary.org/obo/GO_0071219) (cellular response to molecule of bacterial origin), [GO:0015106](http://purl.obolibrary.org/obo/GO_0015106) (bicarbonate transmembrane transporter activity), [GO:0030742](http://purl.obolibrary.org/obo/GO_0030742) (GTP-dependent protein binding), [GO:0060550](http://purl.obolibrary.org/obo/GO_0060550) (positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity), [GO:0015126](http://purl.obolibrary.org/obo/GO_0015126) (canalicular bile acid transmembrane transporter activity), [GO:0015125](http://purl.obolibrary.org/obo/GO_0015125) (bile acid transmembrane transporter activity), [GO:0060552](http://purl.obolibrary.org/obo/GO_0060552) (positive regulation of fructose 1,6-bisphosphate metabolic process), [GO:2001022](http://purl.obolibrary.org/obo/GO_2001022) (positive regulation of response to DNA damage stimulus), [GO:1901671](http://purl.obolibrary.org/obo/GO_1901671) (positive regulation of superoxide dismutase activity), [GO:1901673](http://purl.obolibrary.org/obo/GO_1901673) (regulation of mitotic spindle assembly), [GO:0003140](http://purl.obolibrary.org/obo/GO_0003140) (determination of left/right asymmetry in lateral mesoderm), [GO:0060559](http://purl.obolibrary.org/obo/GO_0060559) (positive regulation of calcidiol 1-monooxygenase activity), [GO:0003142](http://purl.obolibrary.org/obo/GO_0003142) (cardiogenic plate morphogenesis), [GO:0003143](http://purl.obolibrary.org/obo/GO_0003143) (embryonic heart tube morphogenesis), [GO:0004476](http://purl.obolibrary.org/obo/GO_0004476) (mannose-6-phosphate isomerase activity), [GO:0061885](http://purl.obolibrary.org/obo/GO_0061885) (positive regulation of mini excitatory postsynaptic potential), [GO:0004475](http://purl.obolibrary.org/obo/GO_0004475) (mannose-1-phosphate guanylyltransferase activity), [GO:0004478](http://purl.obolibrary.org/obo/GO_0004478) (methionine adenosyltransferase activity), [GO:0003146](http://purl.obolibrary.org/obo/GO_0003146) (heart jogging), [GO:0060557](http://purl.obolibrary.org/obo/GO_0060557) (positive regulation of vitamin D biosynthetic process), [GO:0003147](http://purl.obolibrary.org/obo/GO_0003147) (neural crest cell migration involved in heart formation), [GO:0004468](http://purl.obolibrary.org/obo/GO_0004468) (lysine N-acetyltransferase activity, acting on acetyl phosphate as donor), [GO:0003138](http://purl.obolibrary.org/obo/GO_0003138) (primary heart field specification), [GO:0003139](http://purl.obolibrary.org/obo/GO_0003139) (secondary heart field specification), [GO:0046272](http://purl.obolibrary.org/obo/GO_0046272) (stilbene catabolic process), [GO:2001016](http://purl.obolibrary.org/obo/GO_2001016) (positive regulation of skeletal muscle cell differentiation), [GO:0072534](http://purl.obolibrary.org/obo/GO_0072534) (perineuronal net), [GO:0071203](http://purl.obolibrary.org/obo/GO_0071203) (WASH complex), [GO:0016442](http://purl.obolibrary.org/obo/GO_0016442) (RISC complex), [GO:0030730](http://purl.obolibrary.org/obo/GO_0030730) (sequestering of triglyceride), [GO:0016444](http://purl.obolibrary.org/obo/GO_0016444) (somatic cell DNA recombination), [GO:2001013](http://purl.obolibrary.org/obo/GO_2001013) (epithelial cell proliferation involved in renal tubule morphogenesis), [GO:2001014](http://purl.obolibrary.org/obo/GO_2001014) (regulation of skeletal muscle cell differentiation), [GO:0016445](http://purl.obolibrary.org/obo/GO_0016445) (somatic diversification of immunoglobulins), [GO:2001015](http://purl.obolibrary.org/obo/GO_2001015) (negative regulation of skeletal muscle cell differentiation), [GO:0016446](http://purl.obolibrary.org/obo/GO_0016446) (somatic hypermutation of immunoglobulin genes), [GO:0015116](http://purl.obolibrary.org/obo/GO_0015116) (sulfate transmembrane transporter activity), [GO:0030731](http://purl.obolibrary.org/obo/GO_0030731) (guanidinoacetate N-methyltransferase activity), [GO:2001032](http://purl.obolibrary.org/obo/GO_2001032) (regulation of double-strand break repair via nonhomologous end joining), [GO:0060586](http://purl.obolibrary.org/obo/GO_0060586) (multicellular organismal iron ion homeostasis), [GO:0016428](http://purl.obolibrary.org/obo/GO_0016428) (tRNA (cytosine-5-)-methyltransferase activity), [GO:0016429](http://purl.obolibrary.org/obo/GO_0016429) (tRNA (adenine-N1-)-methyltransferase activity), [GO:1901684](http://purl.obolibrary.org/obo/GO_1901684) (arsenate ion transmembrane transport), [GO:0005770](http://purl.obolibrary.org/obo/GO_0005770) (late endosome), [GO:0005771](http://purl.obolibrary.org/obo/GO_0005771) (multivesicular body), [GO:0005774](http://purl.obolibrary.org/obo/GO_0005774) (vacuolar membrane), [GO:0060587](http://purl.obolibrary.org/obo/GO_0060587) (regulation of lipoprotein lipid oxidation), [GO:0005773](http://purl.obolibrary.org/obo/GO_0005773) (vacuole), [GO:0005776](http://purl.obolibrary.org/obo/GO_0005776) (autophagosome), [GO:0004445](http://purl.obolibrary.org/obo/GO_0004445) (inositol-polyphosphate 5-phosphatase activity), [GO:0005775](http://purl.obolibrary.org/obo/GO_0005775) (vacuolar lumen), [GO:0003104](http://purl.obolibrary.org/obo/GO_0003104) (positive regulation of glomerular filtration), [GO:0071230](http://purl.obolibrary.org/obo/GO_0071230) (cellular response to amino acid stimulus), [GO:0004435](http://purl.obolibrary.org/obo/GO_0004435) (phosphatidylinositol phospholipase C activity), [GO:0003105](http://purl.obolibrary.org/obo/GO_0003105) (negative regulation of glomerular filtration), [GO:0005769](http://purl.obolibrary.org/obo/GO_0005769) (early endosome), [GO:0004438](http://purl.obolibrary.org/obo/GO_0004438) (phosphatidylinositol-3-phosphatase activity), [GO:0005768](http://purl.obolibrary.org/obo/GO_0005768) (endosome), [GO:0071233](http://purl.obolibrary.org/obo/GO_0071233) (cellular response to leucine), [GO:0004439](http://purl.obolibrary.org/obo/GO_0004439) (phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity), [GO:0072563](http://purl.obolibrary.org/obo/GO_0072563) (endothelial microparticle), [GO:0071231](http://purl.obolibrary.org/obo/GO_0071231) (cellular response to folic acid), [GO:0072562](http://purl.obolibrary.org/obo/GO_0072562) (blood microparticle), [GO:0030728](http://purl.obolibrary.org/obo/GO_0030728) (ovulation), [GO:2001028](http://purl.obolibrary.org/obo/GO_2001028) (positive regulation of endothelial cell chemotaxis), [GO:0071236](http://purl.obolibrary.org/obo/GO_0071236) (cellular response to antibiotic), [GO:2001025](http://purl.obolibrary.org/obo/GO_2001025) (positive regulation of response to drug), [GO:2001043](http://purl.obolibrary.org/obo/GO_2001043) (positive regulation of cell separation after cytokinesis), [GO:0060575](http://purl.obolibrary.org/obo/GO_0060575) (intestinal epithelial cell differentiation), [GO:1900364](http://purl.obolibrary.org/obo/GO_1900364) (negative regulation of mRNA polyadenylation), [GO:0060571](http://purl.obolibrary.org/obo/GO_0060571) (morphogenesis of an epithelial fold), [GO:0004450](http://purl.obolibrary.org/obo/GO_0004450) (isocitrate dehydrogenase (NADP+) activity), [GO:0030719](http://purl.obolibrary.org/obo/GO_0030719) (P granule organization), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0005782](http://purl.obolibrary.org/obo/GO_0005782) (peroxisomal matrix), [GO:0060577](http://purl.obolibrary.org/obo/GO_0060577) (pulmonary vein morphogenesis), [GO:0005784](http://purl.obolibrary.org/obo/GO_0005784) (Sec61 translocon complex), [GO:1900369](http://purl.obolibrary.org/obo/GO_1900369) (negative regulation of RNA interference), [GO:0060578](http://purl.obolibrary.org/obo/GO_0060578) (superior vena cava morphogenesis), [GO:0005778](http://purl.obolibrary.org/obo/GO_0005778) (peroxisomal membrane), [GO:0005777](http://purl.obolibrary.org/obo/GO_0005777) (peroxisome), [GO:0005779](http://purl.obolibrary.org/obo/GO_0005779) (integral component of peroxisomal membrane), [GO:0004448](http://purl.obolibrary.org/obo/GO_0004448) (isocitrate dehydrogenase activity), [GO:0071222](http://purl.obolibrary.org/obo/GO_0071222) (cellular response to lipopolysaccharide), [GO:0072554](http://purl.obolibrary.org/obo/GO_0072554) (blood vessel lumenization), [GO:0071223](http://purl.obolibrary.org/obo/GO_0071223) (cellular response to lipoteichoic acid), [GO:0071221](http://purl.obolibrary.org/obo/GO_0071221) (cellular response to bacterial lipopeptide), [GO:0072558](http://purl.obolibrary.org/obo/GO_0072558) (NLRP1 inflammasome complex), [GO:0072557](http://purl.obolibrary.org/obo/GO_0072557) (IPAF inflammasome complex), [GO:0071224](http://purl.obolibrary.org/obo/GO_0071224) (cellular response to peptidoglycan), [GO:0016421](http://purl.obolibrary.org/obo/GO_0016421) (CoA carboxylase activity), [GO:0046292](http://purl.obolibrary.org/obo/GO_0046292) (formaldehyde metabolic process), [GO:0016423](http://purl.obolibrary.org/obo/GO_0016423) (tRNA (guanine) methyltransferase activity), [GO:0071229](http://purl.obolibrary.org/obo/GO_0071229) (cellular response to acid chemical), [GO:0072559](http://purl.obolibrary.org/obo/GO_0072559) (NLRP3 inflammasome complex), [GO:2001037](http://purl.obolibrary.org/obo/GO_2001037) (positive regulation of tongue muscle cell differentiation), [GO:2001054](http://purl.obolibrary.org/obo/GO_2001054) (negative regulation of mesenchymal cell apoptotic process), [GO:2001055](http://purl.obolibrary.org/obo/GO_2001055) (positive regulation of mesenchymal cell apoptotic process), [GO:0003170](http://purl.obolibrary.org/obo/GO_0003170) (heart valve development), [GO:0003171](http://purl.obolibrary.org/obo/GO_0003171) (atrioventricular valve development), [GO:0015152](http://purl.obolibrary.org/obo/GO_0015152) (glucose-6-phosphate transmembrane transporter activity), [GO:0042770](http://purl.obolibrary.org/obo/GO_0042770) (signal transduction in response to DNA damage), [GO:0042771](http://purl.obolibrary.org/obo/GO_0042771) (intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:0003174](http://purl.obolibrary.org/obo/GO_0003174) (mitral valve development), [GO:0042773](http://purl.obolibrary.org/obo/GO_0042773) (ATP synthesis coupled electron transport), [GO:0042775](http://purl.obolibrary.org/obo/GO_0042775) (mitochondrial ATP synthesis coupled electron transport), [GO:0042776](http://purl.obolibrary.org/obo/GO_0042776) (mitochondrial ATP synthesis coupled proton transport), [GO:0003179](http://purl.obolibrary.org/obo/GO_0003179) (heart valve morphogenesis), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0042780](http://purl.obolibrary.org/obo/GO_0042780) (tRNA 3'-end processing), [GO:0016493](http://purl.obolibrary.org/obo/GO_0016493) (C-C chemokine receptor activity), [GO:0016495](http://purl.obolibrary.org/obo/GO_0016495) (C-X3-C chemokine receptor activity), [GO:2001046](http://purl.obolibrary.org/obo/GO_2001046) (positive regulation of integrin-mediated signaling pathway), [GO:0042789](http://purl.obolibrary.org/obo/GO_0042789) (mRNA transcription by RNA polymerase II), [GO:0003180](http://purl.obolibrary.org/obo/GO_0003180) (aortic valve morphogenesis), [GO:0000904](http://purl.obolibrary.org/obo/GO_0000904) (cell morphogenesis involved in differentiation), [GO:0003181](http://purl.obolibrary.org/obo/GO_0003181) (atrioventricular valve morphogenesis), [GO:0015165](http://purl.obolibrary.org/obo/GO_0015165) (pyrimidine nucleotide-sugar transmembrane transporter activity), [GO:0000902](http://purl.obolibrary.org/obo/GO_0000902) (cell morphogenesis), [GO:0003183](http://purl.obolibrary.org/obo/GO_0003183) (mitral valve morphogenesis), [GO:0042781](http://purl.obolibrary.org/obo/GO_0042781) (3'-tRNA processing endoribonuclease activity), [GO:0003184](http://purl.obolibrary.org/obo/GO_0003184) (pulmonary valve morphogenesis), [GO:0000900](http://purl.obolibrary.org/obo/GO_0000900) (translation repressor activity, nucleic acid binding), [GO:0003185](http://purl.obolibrary.org/obo/GO_0003185) (sinoatrial valve morphogenesis), [GO:0042787](http://purl.obolibrary.org/obo/GO_0042787) (protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0042788](http://purl.obolibrary.org/obo/GO_0042788) (polysomal ribosome), [GO:0042790](http://purl.obolibrary.org/obo/GO_0042790) (transcription of nucleolar large rRNA by RNA polymerase I), [GO:0016485](http://purl.obolibrary.org/obo/GO_0016485) (protein processing), [GO:0016486](http://purl.obolibrary.org/obo/GO_0016486) (peptide hormone processing), [GO:0016488](http://purl.obolibrary.org/obo/GO_0016488) (farnesol catabolic process), [GO:0052106](http://purl.obolibrary.org/obo/GO_0052106) (quorum sensing involved in interaction with host), [GO:0015137](http://purl.obolibrary.org/obo/GO_0015137) (citrate transmembrane transporter activity), [GO:0015136](http://purl.obolibrary.org/obo/GO_0015136) (sialic acid transmembrane transporter activity), [GO:0003151](http://purl.obolibrary.org/obo/GO_0003151) (outflow tract morphogenesis), [GO:0004485](http://purl.obolibrary.org/obo/GO_0004485) (methylcrotonoyl-CoA carboxylase activity), [GO:0003156](http://purl.obolibrary.org/obo/GO_0003156) (regulation of animal organ formation), [GO:0003157](http://purl.obolibrary.org/obo/GO_0003157) (endocardium development), [GO:0004489](http://purl.obolibrary.org/obo/GO_0004489) (methylenetetrahydrofolate reductase (NAD(P)H) activity), [GO:0003158](http://purl.obolibrary.org/obo/GO_0003158) (endothelium development), [GO:0042799](http://purl.obolibrary.org/obo/GO_0042799) (histone methyltransferase activity (H4-K20 specific)), [GO:0003148](http://purl.obolibrary.org/obo/GO_0003148) (outflow tract septum morphogenesis), [GO:0003149](http://purl.obolibrary.org/obo/GO_0003149) (membranous septum morphogenesis), [GO:0004479](http://purl.obolibrary.org/obo/GO_0004479) (methionyl-tRNA formyltransferase activity), [GO:0016471](http://purl.obolibrary.org/obo/GO_0016471) (vacuolar proton-transporting V-type ATPase complex), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:0015129](http://purl.obolibrary.org/obo/GO_0015129) (lactate transmembrane transporter activity), [GO:0015127](http://purl.obolibrary.org/obo/GO_0015127) (bilirubin transmembrane transporter activity), [GO:0016458](http://purl.obolibrary.org/obo/GO_0016458) (gene silencing), [GO:0016459](http://purl.obolibrary.org/obo/GO_0016459) (myosin complex), [GO:0004490](http://purl.obolibrary.org/obo/GO_0004490) (methylglutaconyl-CoA hydratase activity), [GO:0003160](http://purl.obolibrary.org/obo/GO_0003160) (endocardium morphogenesis), [GO:0015142](http://purl.obolibrary.org/obo/GO_0015142) (tricarboxylic acid transmembrane transporter activity), [GO:0003161](http://purl.obolibrary.org/obo/GO_0003161) (cardiac conduction system development), [GO:0015141](http://purl.obolibrary.org/obo/GO_0015141) (succinate transmembrane transporter activity), [GO:0004491](http://purl.obolibrary.org/obo/GO_0004491) (methylmalonate-semialdehyde dehydrogenase (acylating) activity), [GO:0004494](http://purl.obolibrary.org/obo/GO_0004494) (methylmalonyl-CoA mutase activity), [GO:0004493](http://purl.obolibrary.org/obo/GO_0004493) (methylmalonyl-CoA epimerase activity), [GO:0004496](http://purl.obolibrary.org/obo/GO_0004496) (mevalonate kinase activity), [GO:0003165](http://purl.obolibrary.org/obo/GO_0003165) (Purkinje myocyte development), [GO:0003166](http://purl.obolibrary.org/obo/GO_0003166) (bundle of His development), [GO:0004497](http://purl.obolibrary.org/obo/GO_0004497) (monooxygenase activity), [GO:0004499](http://purl.obolibrary.org/obo/GO_0004499) (N,N-dimethylaniline monooxygenase activity), [GO:0003169](http://purl.obolibrary.org/obo/GO_0003169) (coronary vein morphogenesis), [GO:0016460](http://purl.obolibrary.org/obo/GO_0016460) (myosin II complex), [GO:0016462](http://purl.obolibrary.org/obo/GO_0016462) (pyrophosphatase activity), [GO:0042734](http://purl.obolibrary.org/obo/GO_0042734) (presynaptic membrane), [GO:0042738](http://purl.obolibrary.org/obo/GO_0042738) (exogenous drug catabolic process), [GO:0015197](http://purl.obolibrary.org/obo/GO_0015197) (peptide transporter activity), [GO:0015195](http://purl.obolibrary.org/obo/GO_0015195) (L-threonine transmembrane transporter activity), [GO:0000932](http://purl.obolibrary.org/obo/GO_0000932) (P-body), [GO:0015194](http://purl.obolibrary.org/obo/GO_0015194) (L-serine transmembrane transporter activity), [GO:0015193](http://purl.obolibrary.org/obo/GO_0015193) (L-proline transmembrane transporter activity), [GO:0000930](http://purl.obolibrary.org/obo/GO_0000930) (gamma-tubulin complex), [GO:0042730](http://purl.obolibrary.org/obo/GO_0042730) (fibrinolysis), [GO:0015191](http://purl.obolibrary.org/obo/GO_0015191) (L-methionine transmembrane transporter activity), [GO:0042733](http://purl.obolibrary.org/obo/GO_0042733) (embryonic digit morphogenesis), [GO:0071294](http://purl.obolibrary.org/obo/GO_0071294) (cellular response to zinc ion), [GO:0042745](http://purl.obolibrary.org/obo/GO_0042745) (circadian sleep/wake cycle), [GO:0000940](http://purl.obolibrary.org/obo/GO_0000940) (condensed chromosome outer kinetochore), [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium), [GO:0042743](http://purl.obolibrary.org/obo/GO_0042743) (hydrogen peroxide metabolic process), [GO:0042744](http://purl.obolibrary.org/obo/GO_0042744) (hydrogen peroxide catabolic process), [GO:0071285](http://purl.obolibrary.org/obo/GO_0071285) (cellular response to lithium ion), [GO:0071283](http://purl.obolibrary.org/obo/GO_0071283) (cellular response to iron(III) ion), [GO:0071286](http://purl.obolibrary.org/obo/GO_0071286) (cellular response to magnesium ion), [GO:0042756](http://purl.obolibrary.org/obo/GO_0042756) (drinking behavior), [GO:0042758](http://purl.obolibrary.org/obo/GO_0042758) (long-chain fatty acid catabolic process), [GO:0015179](http://purl.obolibrary.org/obo/GO_0015179) (L-amino acid transmembrane transporter activity), [GO:0042759](http://purl.obolibrary.org/obo/GO_0042759) (long-chain fatty acid biosynthetic process), [GO:0003190](http://purl.obolibrary.org/obo/GO_0003190) (atrioventricular valve formation), [GO:0000915](http://purl.obolibrary.org/obo/GO_0000915) (actomyosin contractile ring assembly), [GO:0003192](http://purl.obolibrary.org/obo/GO_0003192) (mitral valve formation), [GO:0003193](http://purl.obolibrary.org/obo/GO_0003193) (pulmonary valve formation), [GO:0015175](http://purl.obolibrary.org/obo/GO_0015175) (neutral amino acid transmembrane transporter activity), [GO:0015174](http://purl.obolibrary.org/obo/GO_0015174) (basic amino acid transmembrane transporter activity), [GO:0003195](http://purl.obolibrary.org/obo/GO_0003195) (tricuspid valve formation), [GO:0000910](http://purl.obolibrary.org/obo/GO_0000910) (cytokinesis), [GO:0003197](http://purl.obolibrary.org/obo/GO_0003197) (endocardial cushion development), [GO:0015171](http://purl.obolibrary.org/obo/GO_0015171) (amino acid transmembrane transporter activity), [GO:0003198](http://purl.obolibrary.org/obo/GO_0003198) (epithelial to mesenchymal transition involved in endocardial cushion formation), [GO:0042752](http://purl.obolibrary.org/obo/GO_0042752) (regulation of circadian rhythm), [GO:0042755](http://purl.obolibrary.org/obo/GO_0042755) (eating behavior), [GO:0102991](http://purl.obolibrary.org/obo/GO_0102991) (myristoyl-CoA hydrolase activity), [GO:0042769](http://purl.obolibrary.org/obo/GO_0042769) (DNA damage response, detection of DNA damage), [GO:0000928](http://purl.obolibrary.org/obo/GO_0000928) (gamma-tubulin small complex, spindle pole body), [GO:0015188](http://purl.obolibrary.org/obo/GO_0015188) (L-isoleucine transmembrane transporter activity), [GO:0015187](http://purl.obolibrary.org/obo/GO_0015187) (glycine transmembrane transporter activity), [GO:0015186](http://purl.obolibrary.org/obo/GO_0015186) (L-glutamine transmembrane transporter activity), [GO:0000922](http://purl.obolibrary.org/obo/GO_0000922) (spindle pole), [GO:0015184](http://purl.obolibrary.org/obo/GO_0015184) (L-cystine transmembrane transporter activity), [GO:0015183](http://purl.obolibrary.org/obo/GO_0015183) (L-aspartate transmembrane transporter activity), [GO:0042760](http://purl.obolibrary.org/obo/GO_0042760) (very long-chain fatty acid catabolic process), [GO:0042761](http://purl.obolibrary.org/obo/GO_0042761) (very long-chain fatty acid biosynthetic process), [GO:0000920](http://purl.obolibrary.org/obo/GO_0000920) (cell separation after cytokinesis), [GO:0015180](http://purl.obolibrary.org/obo/GO_0015180) (L-alanine transmembrane transporter activity), [GO:0042765](http://purl.obolibrary.org/obo/GO_0042765) (GPI-anchor transamidase complex), [GO:0042766](http://purl.obolibrary.org/obo/GO_0042766) (nucleosome mobilization), [GO:1905144](http://purl.obolibrary.org/obo/GO_1905144) (response to acetylcholine), [GO:0090335](http://purl.obolibrary.org/obo/GO_0090335) (regulation of brown fat cell differentiation), [GO:0090336](http://purl.obolibrary.org/obo/GO_0090336) (positive regulation of brown fat cell differentiation), [GO:0090334](http://purl.obolibrary.org/obo/GO_0090334) (regulation of cell wall (1->3)-beta-D-glucan biosynthetic process), [GO:0090331](http://purl.obolibrary.org/obo/GO_0090331) (negative regulation of platelet aggregation), [GO:1905146](http://purl.obolibrary.org/obo/GO_1905146) (lysosomal protein catabolic process), [GO:0048807](http://purl.obolibrary.org/obo/GO_0048807) (female genitalia morphogenesis), [GO:0090346](http://purl.obolibrary.org/obo/GO_0090346) (cellular organofluorine metabolic process), [GO:0048806](http://purl.obolibrary.org/obo/GO_0048806) (genitalia development), [GO:0090344](http://purl.obolibrary.org/obo/GO_0090344) (negative regulation of cell aging), [GO:0009200](http://purl.obolibrary.org/obo/GO_0009200) (deoxyribonucleoside triphosphate metabolic process), [GO:0090342](http://purl.obolibrary.org/obo/GO_0090342) (regulation of cell aging), [GO:0009202](http://purl.obolibrary.org/obo/GO_0009202) (deoxyribonucleoside triphosphate biosynthetic process), [GO:1905150](http://purl.obolibrary.org/obo/GO_1905150) (regulation of voltage-gated sodium channel activity), [GO:0090316](http://purl.obolibrary.org/obo/GO_0090316) (positive regulation of intracellular protein transport), [GO:0090314](http://purl.obolibrary.org/obo/GO_0090314) (positive regulation of protein targeting to membrane), [GO:0090312](http://purl.obolibrary.org/obo/GO_0090312) (positive regulation of protein deacetylation), [GO:1905168](http://purl.obolibrary.org/obo/GO_1905168) (positive regulation of double-strand break repair via homologous recombination), [GO:0090310](http://purl.obolibrary.org/obo/GO_0090310) (negative regulation of methylation-dependent chromatin silencing), [GO:0048812](http://purl.obolibrary.org/obo/GO_0048812) (neuron projection morphogenesis), [GO:0015095](http://purl.obolibrary.org/obo/GO_0015095) (magnesium ion transmembrane transporter activity), [GO:0015093](http://purl.obolibrary.org/obo/GO_0015093) (ferrous iron transmembrane transporter activity), [GO:0015091](http://purl.obolibrary.org/obo/GO_0015091) (ferric iron transmembrane transporter activity), [GO:0048814](http://purl.obolibrary.org/obo/GO_0048814) (regulation of dendrite morphogenesis), [GO:0048813](http://purl.obolibrary.org/obo/GO_0048813) (dendrite morphogenesis), [GO:0090319](http://purl.obolibrary.org/obo/GO_0090319) (positive regulation of chylomicron remodeling), [GO:1905176](http://purl.obolibrary.org/obo/GO_1905176) (positive regulation of vascular smooth muscle cell dedifferentiation), [GO:0090324](http://purl.obolibrary.org/obo/GO_0090324) (negative regulation of oxidative phosphorylation), [GO:0090321](http://purl.obolibrary.org/obo/GO_0090321) (positive regulation of chylomicron remnant clearance), [GO:0048823](http://purl.obolibrary.org/obo/GO_0048823) (nucleate erythrocyte development), [GO:0048821](http://purl.obolibrary.org/obo/GO_0048821) (erythrocyte development), [GO:0048820](http://purl.obolibrary.org/obo/GO_0048820) (hair follicle maturation), [GO:1902902](http://purl.obolibrary.org/obo/GO_1902902) (negative regulation of autophagosome assembly), [GO:0040038](http://purl.obolibrary.org/obo/GO_0040038) (polar body extrusion after meiotic divisions), [GO:0040037](http://purl.obolibrary.org/obo/GO_0040037) (negative regulation of fibroblast growth factor receptor signaling pathway), [GO:0040036](http://purl.obolibrary.org/obo/GO_0040036) (regulation of fibroblast growth factor receptor signaling pathway), [GO:0035520](http://purl.obolibrary.org/obo/GO_0035520) (monoubiquitinated protein deubiquitination), [GO:0042693](http://purl.obolibrary.org/obo/GO_0042693) (muscle cell fate commitment), [GO:0009236](http://purl.obolibrary.org/obo/GO_0009236) (cobalamin biosynthetic process), [GO:0009235](http://purl.obolibrary.org/obo/GO_0009235) (cobalamin metabolic process), [GO:0042698](http://purl.obolibrary.org/obo/GO_0042698) (ovulation cycle), [GO:0035518](http://purl.obolibrary.org/obo/GO_0035518) (histone H2A monoubiquitination), [GO:0040040](http://purl.obolibrary.org/obo/GO_0040040) (thermosensory behavior), [GO:0010216](http://purl.obolibrary.org/obo/GO_0010216) (maintenance of DNA methylation), [GO:0035517](http://purl.obolibrary.org/obo/GO_0035517) (PR-DUB complex), [GO:0010212](http://purl.obolibrary.org/obo/GO_0010212) (response to ionizing radiation), [GO:0090305](http://purl.obolibrary.org/obo/GO_0090305) (nucleic acid phosphodiester bond hydrolysis), [GO:0090303](http://purl.obolibrary.org/obo/GO_0090303) (positive regulation of wound healing), [GO:0009249](http://purl.obolibrary.org/obo/GO_0009249) (protein lipoylation), [GO:0035509](http://purl.obolibrary.org/obo/GO_0035509) (negative regulation of myosin-light-chain-phosphatase activity), [GO:0010226](http://purl.obolibrary.org/obo/GO_0010226) (response to lithium ion), [GO:0010225](http://purl.obolibrary.org/obo/GO_0010225) (response to UV-C), [GO:0090309](http://purl.obolibrary.org/obo/GO_0090309) (positive regulation of methylation-dependent chromatin silencing), [GO:0010224](http://purl.obolibrary.org/obo/GO_0010224) (response to UV-B), [GO:0090306](http://purl.obolibrary.org/obo/GO_0090306) (spindle assembly involved in meiosis), [GO:0009213](http://purl.obolibrary.org/obo/GO_0009213) (pyrimidine deoxyribonucleoside triphosphate catabolic process), [GO:0009217](http://purl.obolibrary.org/obo/GO_0009217) (purine deoxyribonucleoside triphosphate catabolic process), [GO:0009229](http://purl.obolibrary.org/obo/GO_0009229) (thiamine diphosphate biosynthetic process), [GO:0009272](http://purl.obolibrary.org/obo/GO_0009272) (fungal-type cell wall biogenesis), [GO:0035563](http://purl.obolibrary.org/obo/GO_0035563) (positive regulation of chromatin binding), [GO:0009277](http://purl.obolibrary.org/obo/GO_0009277) (fungal-type cell wall), [GO:0048878](http://purl.obolibrary.org/obo/GO_0048878) (chemical homeostasis), [GO:1901620](http://purl.obolibrary.org/obo/GO_1901620) (regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning), [GO:1902953](http://purl.obolibrary.org/obo/GO_1902953) (positive regulation of ER to Golgi vesicle-mediated transport), [GO:0061857](http://purl.obolibrary.org/obo/GO_0061857) (endoplasmic reticulum stress-induced pre-emptive quality control), [GO:0048877](http://purl.obolibrary.org/obo/GO_0048877) (homeostasis of number of retina cells), [GO:0060527](http://purl.obolibrary.org/obo/GO_0060527) (prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis), [GO:1902950](http://purl.obolibrary.org/obo/GO_1902950) (regulation of dendritic spine maintenance), [GO:0047545](http://purl.obolibrary.org/obo/GO_0047545) (2-hydroxyglutarate dehydrogenase activity), [GO:1901621](http://purl.obolibrary.org/obo/GO_1901621) (negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning), [GO:0048875](http://purl.obolibrary.org/obo/GO_0048875) (chemical homeostasis within a tissue), [GO:0060523](http://purl.obolibrary.org/obo/GO_0060523) (prostate epithelial cord elongation), [GO:0048881](http://purl.obolibrary.org/obo/GO_0048881) (mechanosensory lateral line system development), [GO:0060529](http://purl.obolibrary.org/obo/GO_0060529) (squamous basal epithelial stem cell differentiation involved in prostate gland acinus development), [GO:0048884](http://purl.obolibrary.org/obo/GO_0048884) (neuromast development), [GO:0048883](http://purl.obolibrary.org/obo/GO_0048883) (neuromast primordium migration), [GO:0048882](http://purl.obolibrary.org/obo/GO_0048882) (lateral line development), [GO:0010259](http://purl.obolibrary.org/obo/GO_0010259) (multicellular organism aging), [GO:0034225](http://purl.obolibrary.org/obo/GO_0034225) (regulation of transcription from RNA polymerase II promoter in response to zinc ion starvation), [GO:0034224](http://purl.obolibrary.org/obo/GO_0034224) (cellular response to zinc ion starvation), [GO:0010255](http://purl.obolibrary.org/obo/GO_0010255) (glucose mediated signaling pathway), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0010257](http://purl.obolibrary.org/obo/GO_0010257) (NADH dehydrogenase complex assembly), [GO:0010273](http://purl.obolibrary.org/obo/GO_0010273) (detoxification of copper ion), [GO:0034221](http://purl.obolibrary.org/obo/GO_0034221) (fungal-type cell wall chitin biosynthetic process), [GO:0034220](http://purl.obolibrary.org/obo/GO_0034220) (ion transmembrane transport), [GO:0047555](http://purl.obolibrary.org/obo/GO_0047555) (3',5'-cyclic-GMP phosphodiesterase activity), [GO:0060510](http://purl.obolibrary.org/obo/GO_0060510) (Type II pneumocyte differentiation), [GO:0060513](http://purl.obolibrary.org/obo/GO_0060513) (prostatic bud formation), [GO:0061844](http://purl.obolibrary.org/obo/GO_0061844) (antimicrobial humoral immune response mediated by antimicrobial peptide), [GO:1902966](http://purl.obolibrary.org/obo/GO_1902966) (positive regulation of protein localization to early endosome), [GO:0048890](http://purl.obolibrary.org/obo/GO_0048890) (lateral line ganglion development), [GO:0034214](http://purl.obolibrary.org/obo/GO_0034214) (protein hexamerization), [GO:0035549](http://purl.obolibrary.org/obo/GO_0035549) (positive regulation of interferon-beta secretion), [GO:0035545](http://purl.obolibrary.org/obo/GO_0035545) (determination of left/right asymmetry in nervous system), [GO:0060541](http://purl.obolibrary.org/obo/GO_0060541) (respiratory system development), [GO:0090399](http://purl.obolibrary.org/obo/GO_0090399) (replicative senescence), [GO:0090398](http://purl.obolibrary.org/obo/GO_0090398) (cellular senescence), [GO:0009259](http://purl.obolibrary.org/obo/GO_0009259) (ribonucleotide metabolic process), [GO:1901642](http://purl.obolibrary.org/obo/GO_1901642) (nucleoside transmembrane transport), [GO:0060548](http://purl.obolibrary.org/obo/GO_0060548) (negative regulation of cell death), [GO:0047568](http://purl.obolibrary.org/obo/GO_0047568) (3-oxo-5-beta-steroid 4-dehydrogenase activity), [GO:0048899](http://purl.obolibrary.org/obo/GO_0048899) (anterior lateral line development), [GO:0090394](http://purl.obolibrary.org/obo/GO_0090394) (negative regulation of excitatory postsynaptic potential), [GO:0060546](http://purl.obolibrary.org/obo/GO_0060546) (negative regulation of necroptotic process), [GO:1902977](http://purl.obolibrary.org/obo/GO_1902977) (mitotic DNA replication preinitiation complex assembly), [GO:0072520](http://purl.obolibrary.org/obo/GO_0072520) (seminiferous tubule development), [GO:0034203](http://purl.obolibrary.org/obo/GO_0034203) (glycolipid translocation), [GO:0035539](http://purl.obolibrary.org/obo/GO_0035539) (8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity), [GO:0034205](http://purl.obolibrary.org/obo/GO_0034205) (amyloid-beta formation), [GO:0009262](http://purl.obolibrary.org/obo/GO_0009262) (deoxyribonucleotide metabolic process), [GO:0009266](http://purl.obolibrary.org/obo/GO_0009266) (response to temperature stimulus), [GO:0009263](http://purl.obolibrary.org/obo/GO_0009263) (deoxyribonucleotide biosynthetic process), [GO:0060536](http://purl.obolibrary.org/obo/GO_0060536) (cartilage morphogenesis), [GO:1901653](http://purl.obolibrary.org/obo/GO_1901653) (cellular response to peptide), [GO:0060537](http://purl.obolibrary.org/obo/GO_0060537) (muscle tissue development), [GO:0009268](http://purl.obolibrary.org/obo/GO_0009268) (response to pH), [GO:0060538](http://purl.obolibrary.org/obo/GO_0060538) (skeletal muscle organ development), [GO:0009267](http://purl.obolibrary.org/obo/GO_0009267) (cellular response to starvation), [GO:0060539](http://purl.obolibrary.org/obo/GO_0060539) (diaphragm development), [GO:1901657](http://purl.obolibrary.org/obo/GO_1901657) (glycosyl compound metabolic process), [GO:0035529](http://purl.obolibrary.org/obo/GO_0035529) (NADH pyrophosphatase activity), [GO:0072513](http://purl.obolibrary.org/obo/GO_0072513) (positive regulation of secondary heart field cardioblast proliferation), [GO:0010243](http://purl.obolibrary.org/obo/GO_0010243) (response to organonitrogen compound), [GO:0035522](http://purl.obolibrary.org/obo/GO_0035522) (monoubiquitinated histone H2A deubiquitination), [GO:0035524](http://purl.obolibrary.org/obo/GO_0035524) (proline transmembrane transport), [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:1902906](http://purl.obolibrary.org/obo/GO_1902906) (proteasome storage granule assembly), [GO:0048841](http://purl.obolibrary.org/obo/GO_0048841) (regulation of axon extension involved in axon guidance), [GO:0048840](http://purl.obolibrary.org/obo/GO_0048840) (otolith development), [GO:1902908](http://purl.obolibrary.org/obo/GO_1902908) (regulation of melanosome transport), [GO:0035598](http://purl.obolibrary.org/obo/GO_0035598) (N6-threonylcarbomyladenosine methylthiotransferase activity), [GO:0034260](http://purl.obolibrary.org/obo/GO_0034260) (negative regulation of GTPase activity), [GO:0090389](http://purl.obolibrary.org/obo/GO_0090389) (phagosome-lysosome fusion involved in apoptotic cell clearance), [GO:0035591](http://purl.obolibrary.org/obo/GO_0035591) (signaling adaptor activity), [GO:0048845](http://purl.obolibrary.org/obo/GO_0048845) (venous blood vessel morphogenesis), [GO:0048844](http://purl.obolibrary.org/obo/GO_0048844) (artery morphogenesis), [GO:0048843](http://purl.obolibrary.org/obo/GO_0048843) (negative regulation of axon extension involved in axon guidance), [GO:0048842](http://purl.obolibrary.org/obo/GO_0048842) (positive regulation of axon extension involved in axon guidance), [GO:0005721](http://purl.obolibrary.org/obo/GO_0005721) (pericentric heterochromatin), [GO:0005720](http://purl.obolibrary.org/obo/GO_0005720) (nuclear heterochromatin), [GO:0048846](http://purl.obolibrary.org/obo/GO_0048846) (axon extension involved in axon guidance), [GO:0005712](http://purl.obolibrary.org/obo/GO_0005712) (chiasma), [GO:1902915](http://purl.obolibrary.org/obo/GO_1902915) (negative regulation of protein polyubiquitination), [GO:0034258](http://purl.obolibrary.org/obo/GO_0034258) (nicotinamide riboside transport), [GO:0005719](http://purl.obolibrary.org/obo/GO_0005719) (nuclear euchromatin), [GO:0034257](http://purl.obolibrary.org/obo/GO_0034257) (nicotinamide riboside transmembrane transporter activity), [GO:0035583](http://purl.obolibrary.org/obo/GO_0035583) (sequestering of TGFbeta in extracellular matrix), [GO:0035584](http://purl.obolibrary.org/obo/GO_0035584) (calcium-mediated signaling using intracellular calcium source), [GO:0009298](http://purl.obolibrary.org/obo/GO_0009298) (GDP-mannose biosynthetic process), [GO:0048856](http://purl.obolibrary.org/obo/GO_0048856) (anatomical structure development), [GO:0048854](http://purl.obolibrary.org/obo/GO_0048854) (brain morphogenesis), [GO:0048853](http://purl.obolibrary.org/obo/GO_0048853) (forebrain morphogenesis), [GO:0048858](http://purl.obolibrary.org/obo/GO_0048858) (cell projection morphogenesis), [GO:0060501](http://purl.obolibrary.org/obo/GO_0060501) (positive regulation of epithelial cell proliferation involved in lung morphogenesis), [GO:0048863](http://purl.obolibrary.org/obo/GO_0048863) (stem cell differentiation), [GO:0060509](http://purl.obolibrary.org/obo/GO_0060509) (Type I pneumocyte differentiation), [GO:0034247](http://purl.obolibrary.org/obo/GO_0034247) (snoRNA splicing), [GO:0035579](http://purl.obolibrary.org/obo/GO_0035579) (specific granule membrane), [GO:0035574](http://purl.obolibrary.org/obo/GO_0035574) (histone H4-K20 demethylation), [GO:0090368](http://purl.obolibrary.org/obo/GO_0090368) (regulation of ornithine metabolic process), [GO:0035575](http://purl.obolibrary.org/obo/GO_0035575) (histone demethylase activity (H4-K20 specific)), [GO:0090369](http://purl.obolibrary.org/obo/GO_0090369) (ornithine carbamoyltransferase inhibitor activity), [GO:0034244](http://purl.obolibrary.org/obo/GO_0034244) (negative regulation of transcription elongation from RNA polymerase II promoter), [GO:0090365](http://purl.obolibrary.org/obo/GO_0090365) (regulation of mRNA modification), [GO:0090362](http://purl.obolibrary.org/obo/GO_0090362) (positive regulation of platelet-derived growth factor production), [GO:0048866](http://purl.obolibrary.org/obo/GO_0048866) (stem cell fate specification), [GO:0048865](http://purl.obolibrary.org/obo/GO_0048865) (stem cell fate commitment), [GO:0048864](http://purl.obolibrary.org/obo/GO_0048864) (stem cell development), [GO:0061820](http://purl.obolibrary.org/obo/GO_0061820) (telomeric D-loop disassembly), [GO:1901612](http://purl.obolibrary.org/obo/GO_1901612) (cardiolipin binding), [GO:0046209](http://purl.obolibrary.org/obo/GO_0046209) (nitric oxide metabolic process), [GO:0061821](http://purl.obolibrary.org/obo/GO_0061821) (telomeric D-loop binding), [GO:0048870](http://purl.obolibrary.org/obo/GO_0048870) (cell motility), [GO:1902937](http://purl.obolibrary.org/obo/GO_1902937) (inward rectifier potassium channel complex), [GO:0061827](http://purl.obolibrary.org/obo/GO_0061827) (sperm head), [GO:0048873](http://purl.obolibrary.org/obo/GO_0048873) (homeostasis of number of cells within a tissue), [GO:0048872](http://purl.obolibrary.org/obo/GO_0048872) (homeostasis of number of cells), [GO:0048871](http://purl.obolibrary.org/obo/GO_0048871) (multicellular organismal homeostasis), [GO:0046210](http://purl.obolibrary.org/obo/GO_0046210) (nitric oxide catabolic process), [GO:0034237](http://purl.obolibrary.org/obo/GO_0034237) (protein kinase A regulatory subunit binding), [GO:0035565](http://purl.obolibrary.org/obo/GO_0035565) (regulation of pronephros size), [GO:0010288](http://purl.obolibrary.org/obo/GO_0010288) (response to lead ion), [GO:0035566](http://purl.obolibrary.org/obo/GO_0035566) (regulation of metanephros size), [GO:0016525](http://purl.obolibrary.org/obo/GO_0016525) (negative regulation of angiogenesis), [GO:0042813](http://purl.obolibrary.org/obo/GO_0042813) (Wnt-activated receptor activity), [GO:0016528](http://purl.obolibrary.org/obo/GO_0016528) (sarcoplasm), [GO:0016529](http://purl.obolibrary.org/obo/GO_0016529) (sarcoplasmic reticulum), [GO:0004540](http://purl.obolibrary.org/obo/GO_0004540) (ribonuclease activity), [GO:0005871](http://purl.obolibrary.org/obo/GO_0005871) (kinesin complex), [GO:0003210](http://purl.obolibrary.org/obo/GO_0003210) (cardiac atrium formation), [GO:0071380](http://purl.obolibrary.org/obo/GO_0071380) (cellular response to prostaglandin E stimulus), [GO:0003211](http://purl.obolibrary.org/obo/GO_0003211) (cardiac ventricle formation), [GO:0005875](http://purl.obolibrary.org/obo/GO_0005875) (microtubule associated complex), [GO:0005874](http://purl.obolibrary.org/obo/GO_0005874) (microtubule), [GO:0003203](http://purl.obolibrary.org/obo/GO_0003203) (endocardial cushion morphogenesis), [GO:0004535](http://purl.obolibrary.org/obo/GO_0004535) (poly(A)-specific ribonuclease activity), [GO:0005865](http://purl.obolibrary.org/obo/GO_0005865) (striated muscle thin filament), [GO:0030821](http://purl.obolibrary.org/obo/GO_0030821) (negative regulation of cAMP catabolic process), [GO:0003205](http://purl.obolibrary.org/obo/GO_0003205) (cardiac chamber development), [GO:0005868](http://purl.obolibrary.org/obo/GO_0005868) (cytoplasmic dynein complex), [GO:0045095](http://purl.obolibrary.org/obo/GO_0045095) (keratin filament), [GO:0071371](http://purl.obolibrary.org/obo/GO_0071371) (cellular response to gonadotropin stimulus), [GO:0003206](http://purl.obolibrary.org/obo/GO_0003206) (cardiac chamber morphogenesis), [GO:0030823](http://purl.obolibrary.org/obo/GO_0030823) (regulation of cGMP metabolic process), [GO:0005869](http://purl.obolibrary.org/obo/GO_0005869) (dynactin complex), [GO:0003208](http://purl.obolibrary.org/obo/GO_0003208) (cardiac ventricle morphogenesis), [GO:0071377](http://purl.obolibrary.org/obo/GO_0071377) (cellular response to glucagon stimulus), [GO:0030828](http://purl.obolibrary.org/obo/GO_0030828) (positive regulation of cGMP biosynthetic process), [GO:0045098](http://purl.obolibrary.org/obo/GO_0045098) (type III intermediate filament), [GO:0003209](http://purl.obolibrary.org/obo/GO_0003209) (cardiac atrium morphogenesis), [GO:0071374](http://purl.obolibrary.org/obo/GO_0071374) (cellular response to parathyroid hormone stimulus), [GO:0071375](http://purl.obolibrary.org/obo/GO_0071375) (cellular response to peptide hormone stimulus), [GO:0071379](http://purl.obolibrary.org/obo/GO_0071379) (cellular response to prostaglandin stimulus), [GO:0016532](http://purl.obolibrary.org/obo/GO_0016532) (superoxide dismutase copper chaperone activity), [GO:0042823](http://purl.obolibrary.org/obo/GO_0042823) (pyridoxal phosphate biosynthetic process), [GO:0016514](http://purl.obolibrary.org/obo/GO_0016514) (SWI/SNF complex), [GO:0033093](http://purl.obolibrary.org/obo/GO_0033093) (Weibel-Palade body), [GO:0042825](http://purl.obolibrary.org/obo/GO_0042825) (TAP complex), [GO:0042826](http://purl.obolibrary.org/obo/GO_0042826) (histone deacetylase binding), [GO:0042827](http://purl.obolibrary.org/obo/GO_0042827) (platelet dense granule), [GO:0016519](http://purl.obolibrary.org/obo/GO_0016519) (gastric inhibitory peptide receptor activity), [GO:0030819](http://purl.obolibrary.org/obo/GO_0030819) (positive regulation of cAMP biosynthetic process), [GO:0005880](http://purl.obolibrary.org/obo/GO_0005880) (nuclear microtubule), [GO:0005882](http://purl.obolibrary.org/obo/GO_0005882) (intermediate filament), [GO:0004551](http://purl.obolibrary.org/obo/GO_0004551) (nucleotide diphosphatase activity), [GO:0005881](http://purl.obolibrary.org/obo/GO_0005881) (cytoplasmic microtubule), [GO:0004550](http://purl.obolibrary.org/obo/GO_0004550) (nucleoside diphosphate kinase activity), [GO:0004553](http://purl.obolibrary.org/obo/GO_0004553) (hydrolase activity, hydrolyzing O-glycosyl compounds), [GO:0005884](http://purl.obolibrary.org/obo/GO_0005884) (actin filament), [GO:0003221](http://purl.obolibrary.org/obo/GO_0003221) (right ventricular cardiac muscle tissue morphogenesis), [GO:0005883](http://purl.obolibrary.org/obo/GO_0005883) (neurofilament), [GO:0003222](http://purl.obolibrary.org/obo/GO_0003222) (ventricular trabecula myocardium morphogenesis), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0003223](http://purl.obolibrary.org/obo/GO_0003223) (ventricular compact myocardium morphogenesis), [GO:0004555](http://purl.obolibrary.org/obo/GO_0004555) (alpha,alpha-trehalase activity), [GO:0005885](http://purl.obolibrary.org/obo/GO_0005885) (Arp2/3 protein complex), [GO:0071361](http://purl.obolibrary.org/obo/GO_0071361) (cellular response to ethanol), [GO:0003214](http://purl.obolibrary.org/obo/GO_0003214) (cardiac left ventricle morphogenesis), [GO:0003215](http://purl.obolibrary.org/obo/GO_0003215) (cardiac right ventricle morphogenesis), [GO:0005876](http://purl.obolibrary.org/obo/GO_0005876) (spindle microtubule), [GO:0005879](http://purl.obolibrary.org/obo/GO_0005879) (axonemal microtubule), [GO:0071360](http://purl.obolibrary.org/obo/GO_0071360) (cellular response to exogenous dsRNA), [GO:0070034](http://purl.obolibrary.org/obo/GO_0070034) (telomerase RNA binding), [GO:0003218](http://purl.obolibrary.org/obo/GO_0003218) (cardiac left ventricle formation), [GO:0004549](http://purl.obolibrary.org/obo/GO_0004549) (tRNA-specific ribonuclease activity), [GO:0030814](http://purl.obolibrary.org/obo/GO_0030814) (regulation of cAMP metabolic process), [GO:0071363](http://purl.obolibrary.org/obo/GO_0071363) (cellular response to growth factor stimulus), [GO:0070032](http://purl.obolibrary.org/obo/GO_0070032) (synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex), [GO:0071364](http://purl.obolibrary.org/obo/GO_0071364) (cellular response to epidermal growth factor stimulus), [GO:0070037](http://purl.obolibrary.org/obo/GO_0070037) (rRNA (pseudouridine) methyltransferase activity), [GO:0042834](http://purl.obolibrary.org/obo/GO_0042834) (peptidoglycan binding), [GO:1900272](http://purl.obolibrary.org/obo/GO_1900272) (negative regulation of long-term synaptic potentiation), [GO:0016504](http://purl.obolibrary.org/obo/GO_0016504) (peptidase activator activity), [GO:0016505](http://purl.obolibrary.org/obo/GO_0016505) (peptidase activator activity involved in apoptotic process), [GO:1900271](http://purl.obolibrary.org/obo/GO_1900271) (regulation of long-term synaptic potentiation), [GO:0033089](http://purl.obolibrary.org/obo/GO_0033089) (positive regulation of T cell differentiation in thymus), [GO:1900274](http://purl.obolibrary.org/obo/GO_1900274) (regulation of phospholipase C activity), [GO:1900273](http://purl.obolibrary.org/obo/GO_1900273) (positive regulation of long-term synaptic potentiation), [GO:0016507](http://purl.obolibrary.org/obo/GO_0016507) (mitochondrial fatty acid beta-oxidation multienzyme complex), [GO:0016508](http://purl.obolibrary.org/obo/GO_0016508) (long-chain-enoyl-CoA hydratase activity), [GO:0016509](http://purl.obolibrary.org/obo/GO_0016509) (long-chain-3-hydroxyacyl-CoA dehydrogenase activity), [GO:0033081](http://purl.obolibrary.org/obo/GO_0033081) (regulation of T cell differentiation in thymus), [GO:0004520](http://purl.obolibrary.org/obo/GO_0004520) (endodeoxyribonuclease activity), [GO:0005850](http://purl.obolibrary.org/obo/GO_0005850) (eukaryotic translation initiation factor 2 complex), [GO:0005853](http://purl.obolibrary.org/obo/GO_0005853) (eukaryotic translation elongation factor 1 complex), [GO:0042832](http://purl.obolibrary.org/obo/GO_0042832) (defense response to protozoan), [GO:0005844](http://purl.obolibrary.org/obo/GO_0005844) (polysome), [GO:0070063](http://purl.obolibrary.org/obo/GO_0070063) (RNA polymerase binding), [GO:0070064](http://purl.obolibrary.org/obo/GO_0070064) (proline-rich region binding), [GO:0071395](http://purl.obolibrary.org/obo/GO_0071395) (cellular response to jasmonic acid stimulus), [GO:0070061](http://purl.obolibrary.org/obo/GO_0070061) (fructose binding), [GO:0071392](http://purl.obolibrary.org/obo/GO_0071392) (cellular response to estradiol stimulus), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0071393](http://purl.obolibrary.org/obo/GO_0071393) (cellular response to progesterone stimulus), [GO:0004517](http://purl.obolibrary.org/obo/GO_0004517) (nitric-oxide synthase activity), [GO:0004519](http://purl.obolibrary.org/obo/GO_0004519) (endonuclease activity), [GO:0004518](http://purl.obolibrary.org/obo/GO_0004518) (nuclease activity), [GO:0070069](http://purl.obolibrary.org/obo/GO_0070069) (cytochrome complex), [GO:1900281](http://purl.obolibrary.org/obo/GO_1900281) (positive regulation of CD4-positive, alpha-beta T cell costimulation), [GO:0033077](http://purl.obolibrary.org/obo/GO_0033077) (T cell differentiation in thymus), [GO:0005862](http://purl.obolibrary.org/obo/GO_0005862) (muscle thin filament tropomyosin), [GO:0005861](http://purl.obolibrary.org/obo/GO_0005861) (troponin complex), [GO:0071391](http://purl.obolibrary.org/obo/GO_0071391) (cellular response to estrogen stimulus), [GO:0004530](http://purl.obolibrary.org/obo/GO_0004530) (deoxyribonuclease I activity), [GO:0042843](http://purl.obolibrary.org/obo/GO_0042843) (D-xylose catabolic process), [GO:0005863](http://purl.obolibrary.org/obo/GO_0005863) (striated muscle myosin thick filament), [GO:0071383](http://purl.obolibrary.org/obo/GO_0071383) (cellular response to steroid hormone stimulus), [GO:0004523](http://purl.obolibrary.org/obo/GO_0004523) (RNA-DNA hybrid ribonuclease activity), [GO:0070053](http://purl.obolibrary.org/obo/GO_0070053) (thrombospondin receptor activity), [GO:0071384](http://purl.obolibrary.org/obo/GO_0071384) (cellular response to corticosteroid stimulus), [GO:0070050](http://purl.obolibrary.org/obo/GO_0070050) (neuron cellular homeostasis), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0004525](http://purl.obolibrary.org/obo/GO_0004525) (ribonuclease III activity), [GO:0070051](http://purl.obolibrary.org/obo/GO_0070051) (fibrinogen binding), [GO:0004528](http://purl.obolibrary.org/obo/GO_0004528) (phosphodiesterase I activity), [GO:0005859](http://purl.obolibrary.org/obo/GO_0005859) (muscle myosin complex), [GO:0004527](http://purl.obolibrary.org/obo/GO_0004527) (exonuclease activity), [GO:0005858](http://purl.obolibrary.org/obo/GO_0005858) (axonemal dynein complex), [GO:0070059](http://purl.obolibrary.org/obo/GO_0070059) (intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress), [GO:0034399](http://purl.obolibrary.org/obo/GO_0034399) (nuclear periphery), [GO:0016500](http://purl.obolibrary.org/obo/GO_0016500) (protein-hormone receptor activity), [GO:0016569](http://purl.obolibrary.org/obo/GO_0016569) (covalent chromatin modification), [GO:0015234](http://purl.obolibrary.org/obo/GO_0015234) (thiamine transmembrane transporter activity), [GO:0060684](http://purl.obolibrary.org/obo/GO_0060684) (epithelial-mesenchymal cell signaling), [GO:0015232](http://purl.obolibrary.org/obo/GO_0015232) (heme transporter activity), [GO:1900210](http://purl.obolibrary.org/obo/GO_1900210) (positive regulation of cardiolipin metabolic process), [GO:0015230](http://purl.obolibrary.org/obo/GO_0015230) (FAD transmembrane transporter activity), [GO:0003250](http://purl.obolibrary.org/obo/GO_0003250) (regulation of cell proliferation involved in heart valve morphogenesis), [GO:0004582](http://purl.obolibrary.org/obo/GO_0004582) (dolichyl-phosphate beta-D-mannosyltransferase activity), [GO:1900212](http://purl.obolibrary.org/obo/GO_1900212) (negative regulation of mesenchymal cell apoptotic process involved in metanephros development), [GO:0004584](http://purl.obolibrary.org/obo/GO_0004584) (dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity), [GO:0045047](http://purl.obolibrary.org/obo/GO_0045047) (protein targeting to ER), [GO:0003253](http://purl.obolibrary.org/obo/GO_0003253) (cardiac neural crest cell migration involved in outflow tract morphogenesis), [GO:0004583](http://purl.obolibrary.org/obo/GO_0004583) (dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity), [GO:0003254](http://purl.obolibrary.org/obo/GO_0003254) (regulation of membrane depolarization), [GO:0004585](http://purl.obolibrary.org/obo/GO_0004585) (ornithine carbamoyltransferase activity), [GO:0060687](http://purl.obolibrary.org/obo/GO_0060687) (regulation of branching involved in prostate gland morphogenesis), [GO:1901546](http://purl.obolibrary.org/obo/GO_1901546) (regulation of synaptic vesicle lumen acidification), [GO:1900215](http://purl.obolibrary.org/obo/GO_1900215) (negative regulation of apoptotic process involved in metanephric collecting duct development), [GO:0004588](http://purl.obolibrary.org/obo/GO_0004588) (orotate phosphoribosyltransferase activity), [GO:1900218](http://purl.obolibrary.org/obo/GO_1900218) (negative regulation of apoptotic process involved in metanephric nephron tubule development), [GO:0004587](http://purl.obolibrary.org/obo/GO_0004587) (ornithine-oxo-acid transaminase activity), [GO:0060689](http://purl.obolibrary.org/obo/GO_0060689) (cell differentiation involved in salivary gland development), [GO:0030866](http://purl.obolibrary.org/obo/GO_0030866) (cortical actin cytoskeleton organization), [GO:0004579](http://purl.obolibrary.org/obo/GO_0004579) (dolichyl-diphosphooligosaccharide-protein glycotransferase activity), [GO:0045053](http://purl.obolibrary.org/obo/GO_0045053) (protein retention in Golgi apparatus), [GO:0004578](http://purl.obolibrary.org/obo/GO_0004578) (chitobiosyldiphosphodolichol beta-mannosyltransferase activity), [GO:0030868](http://purl.obolibrary.org/obo/GO_0030868) (smooth endoplasmic reticulum membrane), [GO:0030867](http://purl.obolibrary.org/obo/GO_0030867) (rough endoplasmic reticulum membrane), [GO:0045056](http://purl.obolibrary.org/obo/GO_0045056) (transcytosis), [GO:0071332](http://purl.obolibrary.org/obo/GO_0071332) (cellular response to fructose stimulus), [GO:0071333](http://purl.obolibrary.org/obo/GO_0071333) (cellular response to glucose stimulus), [GO:0030869](http://purl.obolibrary.org/obo/GO_0030869) (RENT complex), [GO:0072663](http://purl.obolibrary.org/obo/GO_0072663) (establishment of protein localization to peroxisome), [GO:0016570](http://purl.obolibrary.org/obo/GO_0016570) (histone modification), [GO:0045055](http://purl.obolibrary.org/obo/GO_0045055) (regulated exocytosis), [GO:0016571](http://purl.obolibrary.org/obo/GO_0016571) (histone methylation), [GO:0071336](http://purl.obolibrary.org/obo/GO_0071336) (regulation of hair follicle cell proliferation), [GO:0016572](http://purl.obolibrary.org/obo/GO_0016572) (histone phosphorylation), [GO:0016573](http://purl.obolibrary.org/obo/GO_0016573) (histone acetylation), [GO:0072666](http://purl.obolibrary.org/obo/GO_0072666) (establishment of protein localization to vacuole), [GO:0016574](http://purl.obolibrary.org/obo/GO_0016574) (histone ubiquitination), [GO:0016575](http://purl.obolibrary.org/obo/GO_0016575) (histone deacetylation), [GO:0030862](http://purl.obolibrary.org/obo/GO_0030862) (positive regulation of polarized epithelial cell differentiation), [GO:0016576](http://purl.obolibrary.org/obo/GO_0016576) (histone dephosphorylation), [GO:0030864](http://purl.obolibrary.org/obo/GO_0030864) (cortical actin cytoskeleton), [GO:0016577](http://purl.obolibrary.org/obo/GO_0016577) (histone demethylation), [GO:0071338](http://purl.obolibrary.org/obo/GO_0071338) (positive regulation of hair follicle cell proliferation), [GO:0015227](http://purl.obolibrary.org/obo/GO_0015227) (acyl carnitine transmembrane transporter activity), [GO:0071339](http://purl.obolibrary.org/obo/GO_0071339) (MLL1 complex), [GO:0030863](http://purl.obolibrary.org/obo/GO_0030863) (cortical cytoskeleton), [GO:0016578](http://purl.obolibrary.org/obo/GO_0016578) (histone deubiquitination), [GO:0015226](http://purl.obolibrary.org/obo/GO_0015226) (carnitine transmembrane transporter activity), [GO:0015247](http://purl.obolibrary.org/obo/GO_0015247) (aminophospholipid transmembrane transporter activity), [GO:0016557](http://purl.obolibrary.org/obo/GO_0016557) (peroxisome membrane biogenesis), [GO:0016558](http://purl.obolibrary.org/obo/GO_0016558) (protein import into peroxisome matrix), [GO:0060672](http://purl.obolibrary.org/obo/GO_0060672) (epithelial cell morphogenesis involved in placental branching), [GO:0016559](http://purl.obolibrary.org/obo/GO_0016559) (peroxisome fission), [GO:0060674](http://purl.obolibrary.org/obo/GO_0060674) (placenta blood vessel development), [GO:1900221](http://purl.obolibrary.org/obo/GO_1900221) (regulation of amyloid-beta clearance), [GO:0004591](http://purl.obolibrary.org/obo/GO_0004591) (oxoglutarate dehydrogenase (succinyl-transferring) activity), [GO:0004590](http://purl.obolibrary.org/obo/GO_0004590) (orotidine-5'-phosphate decarboxylase activity), [GO:0003262](http://purl.obolibrary.org/obo/GO_0003262) (endocardial progenitor cell migration to the midline involved in heart field formation), [GO:0045058](http://purl.obolibrary.org/obo/GO_0045058) (T cell selection), [GO:1902884](http://purl.obolibrary.org/obo/GO_1902884) (positive regulation of response to oxidative stress), [GO:0045059](http://purl.obolibrary.org/obo/GO_0045059) (positive thymic T cell selection), [GO:0004594](http://purl.obolibrary.org/obo/GO_0004594) (pantothenate kinase activity), [GO:1900227](http://purl.obolibrary.org/obo/GO_1900227) (positive regulation of NLRP3 inflammasome complex assembly), [GO:0004596](http://purl.obolibrary.org/obo/GO_0004596) (peptide alpha-N-acetyltransferase activity), [GO:0060676](http://purl.obolibrary.org/obo/GO_0060676) (ureteric bud formation), [GO:1901557](http://purl.obolibrary.org/obo/GO_1901557) (response to fenofibrate), [GO:0060677](http://purl.obolibrary.org/obo/GO_0060677) (ureteric bud elongation), [GO:0030855](http://purl.obolibrary.org/obo/GO_0030855) (epithelial cell differentiation), [GO:0030854](http://purl.obolibrary.org/obo/GO_0030854) (positive regulation of granulocyte differentiation), [GO:0045064](http://purl.obolibrary.org/obo/GO_0045064) (T-helper 2 cell differentiation), [GO:0046395](http://purl.obolibrary.org/obo/GO_0046395) (carboxylic acid catabolic process), [GO:0030857](http://purl.obolibrary.org/obo/GO_0030857) (negative regulation of epithelial cell differentiation), [GO:0045061](http://purl.obolibrary.org/obo/GO_0045061) (thymic T cell selection), [GO:0030856](http://purl.obolibrary.org/obo/GO_0030856) (regulation of epithelial cell differentiation), [GO:0030859](http://purl.obolibrary.org/obo/GO_0030859) (polarized epithelial cell differentiation), [GO:0071321](http://purl.obolibrary.org/obo/GO_0071321) (cellular response to cGMP), [GO:0030858](http://purl.obolibrary.org/obo/GO_0030858) (positive regulation of epithelial cell differentiation), [GO:0071322](http://purl.obolibrary.org/obo/GO_0071322) (cellular response to carbohydrate stimulus), [GO:0045065](http://purl.obolibrary.org/obo/GO_0045065) (cytotoxic T cell differentiation), [GO:0071320](http://purl.obolibrary.org/obo/GO_0071320) (cellular response to cAMP), [GO:0072657](http://purl.obolibrary.org/obo/GO_0072657) (protein localization to membrane), [GO:0016560](http://purl.obolibrary.org/obo/GO_0016560) (protein import into peroxisome matrix, docking), [GO:0072656](http://purl.obolibrary.org/obo/GO_0072656) (maintenance of protein location in mitochondrion), [GO:0016561](http://purl.obolibrary.org/obo/GO_0016561) (protein import into peroxisome matrix, translocation), [GO:0072655](http://purl.obolibrary.org/obo/GO_0072655) (establishment of protein localization to mitochondrion), [GO:0016562](http://purl.obolibrary.org/obo/GO_0016562) (protein import into peroxisome matrix, receptor recycling), [GO:0030851](http://purl.obolibrary.org/obo/GO_0030851) (granulocyte differentiation), [GO:0046390](http://purl.obolibrary.org/obo/GO_0046390) (ribose phosphate biosynthetic process), [GO:0030850](http://purl.obolibrary.org/obo/GO_0030850) (prostate gland development), [GO:0045060](http://purl.obolibrary.org/obo/GO_0045060) (negative thymic T cell selection), [GO:0015238](http://purl.obolibrary.org/obo/GO_0015238) (drug transmembrane transporter activity), [GO:0072659](http://purl.obolibrary.org/obo/GO_0072659) (protein localization to plasma membrane), [GO:0030853](http://purl.obolibrary.org/obo/GO_0030853) (negative regulation of granulocyte differentiation), [GO:0016567](http://purl.obolibrary.org/obo/GO_0016567) (protein ubiquitination), [GO:1902894](http://purl.obolibrary.org/obo/GO_1902894) (negative regulation of pri-miRNA transcription by RNA polymerase II), [GO:1902891](http://purl.obolibrary.org/obo/GO_1902891) (negative regulation of root hair elongation), [GO:0005891](http://purl.obolibrary.org/obo/GO_0005891) (voltage-gated calcium channel complex), [GO:1902897](http://purl.obolibrary.org/obo/GO_1902897) (regulation of postsynaptic density protein 95 clustering), [GO:0004560](http://purl.obolibrary.org/obo/GO_0004560) (alpha-L-fucosidase activity), [GO:0005890](http://purl.obolibrary.org/obo/GO_0005890) (sodium:potassium-exchanging ATPase complex), [GO:0003230](http://purl.obolibrary.org/obo/GO_0003230) (cardiac atrium development), [GO:1902895](http://purl.obolibrary.org/obo/GO_1902895) (positive regulation of pri-miRNA transcription by RNA polymerase II), [GO:0004561](http://purl.obolibrary.org/obo/GO_0004561) (alpha-N-acetylglucosaminidase activity), [GO:0003231](http://purl.obolibrary.org/obo/GO_0003231) (cardiac ventricle development), [GO:0005892](http://purl.obolibrary.org/obo/GO_0005892) (acetylcholine-gated channel complex), [GO:0003232](http://purl.obolibrary.org/obo/GO_0003232) (bulbus arteriosus development), [GO:0004564](http://purl.obolibrary.org/obo/GO_0004564) (beta-fructofuranosidase activity), [GO:0004563](http://purl.obolibrary.org/obo/GO_0004563) (beta-N-acetylhexosaminidase activity), [GO:0004566](http://purl.obolibrary.org/obo/GO_0004566) (beta-glucuronidase activity), [GO:0004565](http://purl.obolibrary.org/obo/GO_0004565) (beta-galactosidase activity), [GO:0004557](http://purl.obolibrary.org/obo/GO_0004557) (alpha-galactosidase activity), [GO:0071351](http://purl.obolibrary.org/obo/GO_0071351) (cellular response to interleukin-18), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0004556](http://purl.obolibrary.org/obo/GO_0004556) (alpha-amylase activity), [GO:0004559](http://purl.obolibrary.org/obo/GO_0004559) (alpha-mannosidase activity), [GO:0004558](http://purl.obolibrary.org/obo/GO_0004558) (alpha-1,4-glucosidase activity), [GO:0072686](http://purl.obolibrary.org/obo/GO_0072686) (mitotic spindle), [GO:0045078](http://purl.obolibrary.org/obo/GO_0045078) (positive regulation of interferon-gamma biosynthetic process), [GO:0003229](http://purl.obolibrary.org/obo/GO_0003229) (ventricular cardiac muscle tissue development), [GO:0071354](http://purl.obolibrary.org/obo/GO_0071354) (cellular response to interleukin-6), [GO:0030847](http://purl.obolibrary.org/obo/GO_0030847) (termination of RNA polymerase II transcription, exosome-dependent), [GO:0045079](http://purl.obolibrary.org/obo/GO_0045079) (negative regulation of chemokine biosynthetic process), [GO:0072684](http://purl.obolibrary.org/obo/GO_0072684) (mitochondrial tRNA 3'-trailer cleavage, endonucleolytic), [GO:0071353](http://purl.obolibrary.org/obo/GO_0071353) (cellular response to interleukin-4), [GO:0071359](http://purl.obolibrary.org/obo/GO_0071359) (cellular response to dsRNA), [GO:0071356](http://purl.obolibrary.org/obo/GO_0071356) (cellular response to tumor necrosis factor), [GO:0070025](http://purl.obolibrary.org/obo/GO_0070025) (carbon monoxide binding), [GO:0072687](http://purl.obolibrary.org/obo/GO_0072687) (meiotic spindle), [GO:0070026](http://purl.obolibrary.org/obo/GO_0070026) (nitric oxide binding), [GO:0045070](http://purl.obolibrary.org/obo/GO_0045070) (positive regulation of viral genome replication), [GO:0016553](http://purl.obolibrary.org/obo/GO_0016553) (base conversion or substitution editing), [GO:0045071](http://purl.obolibrary.org/obo/GO_0045071) (negative regulation of viral genome replication), [GO:0015205](http://purl.obolibrary.org/obo/GO_0015205) (nucleobase transmembrane transporter activity), [GO:0060693](http://purl.obolibrary.org/obo/GO_0060693) (regulation of branching involved in salivary gland morphogenesis), [GO:0042800](http://purl.obolibrary.org/obo/GO_0042800) (histone methyltransferase activity (H3-K4 specific)), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0015222](http://purl.obolibrary.org/obo/GO_0015222) (serotonin transmembrane transporter activity), [GO:0042805](http://purl.obolibrary.org/obo/GO_0042805) (actinin binding), [GO:0015220](http://purl.obolibrary.org/obo/GO_0015220) (choline transmembrane transporter activity), [GO:0042806](http://purl.obolibrary.org/obo/GO_0042806) (fucose binding), [GO:0060691](http://purl.obolibrary.org/obo/GO_0060691) (epithelial cell maturation involved in salivary gland development), [GO:0004571](http://purl.obolibrary.org/obo/GO_0004571) (mannosyl-oligosaccharide 1,2-alpha-mannosidase activity), [GO:0004573](http://purl.obolibrary.org/obo/GO_0004573) (mannosyl-oligosaccharide glucosidase activity), [GO:0060697](http://purl.obolibrary.org/obo/GO_0060697) (positive regulation of phospholipid catabolic process), [GO:0004575](http://purl.obolibrary.org/obo/GO_0004575) (sucrose alpha-glucosidase activity), [GO:0004574](http://purl.obolibrary.org/obo/GO_0004574) (oligo-1,6-glucosidase activity), [GO:0004577](http://purl.obolibrary.org/obo/GO_0004577) (N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity), [GO:0004576](http://purl.obolibrary.org/obo/GO_0004576) (oligosaccharyl transferase activity), [GO:0030833](http://purl.obolibrary.org/obo/GO_0030833) (regulation of actin filament polymerization), [GO:0072671](http://purl.obolibrary.org/obo/GO_0072671) (mitochondria-associated ubiquitin-dependent protein catabolic process), [GO:0005899](http://purl.obolibrary.org/obo/GO_0005899) (insulin receptor complex), [GO:0004568](http://purl.obolibrary.org/obo/GO_0004568) (chitinase activity), [GO:0045086](http://purl.obolibrary.org/obo/GO_0045086) (positive regulation of interleukin-2 biosynthetic process), [GO:0071340](http://purl.obolibrary.org/obo/GO_0071340) (skeletal muscle acetylcholine-gated channel clustering), [GO:0004567](http://purl.obolibrary.org/obo/GO_0004567) (beta-mannosidase activity), [GO:0030832](http://purl.obolibrary.org/obo/GO_0030832) (regulation of actin filament length), [GO:0030835](http://purl.obolibrary.org/obo/GO_0030835) (negative regulation of actin filament depolymerization), [GO:0045083](http://purl.obolibrary.org/obo/GO_0045083) (negative regulation of interleukin-12 biosynthetic process), [GO:0045084](http://purl.obolibrary.org/obo/GO_0045084) (positive regulation of interleukin-12 biosynthetic process), [GO:0045089](http://purl.obolibrary.org/obo/GO_0045089) (positive regulation of innate immune response), [GO:0030837](http://purl.obolibrary.org/obo/GO_0030837) (negative regulation of actin filament polymerization), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0045088](http://purl.obolibrary.org/obo/GO_0045088) (regulation of innate immune response), [GO:0030838](http://purl.obolibrary.org/obo/GO_0030838) (positive regulation of actin filament polymerization), [GO:0071347](http://purl.obolibrary.org/obo/GO_0071347) (cellular response to interleukin-1), [GO:0072679](http://purl.obolibrary.org/obo/GO_0072679) (thymocyte migration), [GO:0070016](http://purl.obolibrary.org/obo/GO_0070016) (armadillo repeat domain binding), [GO:0016540](http://purl.obolibrary.org/obo/GO_0016540) (protein autoprocessing), [GO:0071345](http://purl.obolibrary.org/obo/GO_0071345) (cellular response to cytokine stimulus), [GO:0071346](http://purl.obolibrary.org/obo/GO_0071346) (cellular response to interferon-gamma), [GO:0072676](http://purl.obolibrary.org/obo/GO_0072676) (lymphocyte migration), [GO:0045080](http://purl.obolibrary.org/obo/GO_0045080) (positive regulation of chemokine biosynthetic process), [GO:0015279](http://purl.obolibrary.org/obo/GO_0015279) (store-operated calcium channel activity), [GO:0015278](http://purl.obolibrary.org/obo/GO_0015278) (calcium-release channel activity), [GO:0015277](http://purl.obolibrary.org/obo/GO_0015277) (kainate selective glutamate receptor activity), [GO:0015276](http://purl.obolibrary.org/obo/GO_0015276) (ligand-gated ion channel activity), [GO:0003290](http://purl.obolibrary.org/obo/GO_0003290) (atrial septum secundum morphogenesis), [GO:0015272](http://purl.obolibrary.org/obo/GO_0015272) (ATP-activated inward rectifier potassium channel activity), [GO:0003294](http://purl.obolibrary.org/obo/GO_0003294) (atrial ventricular junction remodeling), [GO:0042891](http://purl.obolibrary.org/obo/GO_0042891) (antibiotic transport), [GO:0015271](http://purl.obolibrary.org/obo/GO_0015271) (outward rectifier potassium channel activity), [GO:0042895](http://purl.obolibrary.org/obo/GO_0042895) (antibiotic transmembrane transporter activity), [GO:0052213](http://purl.obolibrary.org/obo/GO_0052213) (interaction with symbiont via secreted substance involved in symbiotic interaction), [GO:0090502](http://purl.obolibrary.org/obo/GO_0090502) (RNA phosphodiester bond hydrolysis, endonucleolytic), [GO:0090503](http://purl.obolibrary.org/obo/GO_0090503) (RNA phosphodiester bond hydrolysis, exonucleolytic), [GO:0090501](http://purl.obolibrary.org/obo/GO_0090501) (RNA phosphodiester bond hydrolysis), [GO:0015280](http://purl.obolibrary.org/obo/GO_0015280) (ligand-gated sodium channel activity), [GO:0030899](http://purl.obolibrary.org/obo/GO_0030899) (calcium-dependent ATPase activity), [GO:0030898](http://purl.obolibrary.org/obo/GO_0030898) (actin-dependent ATPase activity), [GO:0030891](http://purl.obolibrary.org/obo/GO_0030891) (VCB complex), [GO:0030890](http://purl.obolibrary.org/obo/GO_0030890) (positive regulation of B cell proliferation), [GO:0030893](http://purl.obolibrary.org/obo/GO_0030893) (meiotic cohesin complex), [GO:0030894](http://purl.obolibrary.org/obo/GO_0030894) (replisome), [GO:0090504](http://purl.obolibrary.org/obo/GO_0090504) (epiboly), [GO:0030897](http://purl.obolibrary.org/obo/GO_0030897) (HOPS complex), [GO:0003274](http://purl.obolibrary.org/obo/GO_0003274) (endocardial cushion fusion), [GO:0003279](http://purl.obolibrary.org/obo/GO_0003279) (cardiac septum development), [GO:0030889](http://purl.obolibrary.org/obo/GO_0030889) (negative regulation of B cell proliferation), [GO:0016591](http://purl.obolibrary.org/obo/GO_0016591) (DNA-directed RNA polymerase II, holoenzyme), [GO:0016592](http://purl.obolibrary.org/obo/GO_0016592) (mediator complex), [GO:0016594](http://purl.obolibrary.org/obo/GO_0016594) (glycine binding), [GO:0016595](http://purl.obolibrary.org/obo/GO_0016595) (glutamate binding), [GO:0030881](http://purl.obolibrary.org/obo/GO_0030881) (beta-2-microglobulin binding), [GO:0016596](http://purl.obolibrary.org/obo/GO_0016596) (thienylcyclohexylpiperidine binding), [GO:0016597](http://purl.obolibrary.org/obo/GO_0016597) (amino acid binding), [GO:0015248](http://purl.obolibrary.org/obo/GO_0015248) (sterol transporter activity), [GO:0016579](http://purl.obolibrary.org/obo/GO_0016579) (protein deubiquitination), [GO:0015269](http://purl.obolibrary.org/obo/GO_0015269) (calcium-activated potassium channel activity), [GO:0015266](http://purl.obolibrary.org/obo/GO_0015266), [GO:0003281](http://purl.obolibrary.org/obo/GO_0003281) (ventricular septum development), [GO:0003283](http://purl.obolibrary.org/obo/GO_0003283) (atrial septum development), [GO:0003284](http://purl.obolibrary.org/obo/GO_0003284) (septum primum development), [GO:0003289](http://purl.obolibrary.org/obo/GO_0003289) (atrial septum primum morphogenesis), [GO:0030877](http://purl.obolibrary.org/obo/GO_0030877) (beta-catenin destruction complex), [GO:0030879](http://purl.obolibrary.org/obo/GO_0030879) (mammary gland development), [GO:0030878](http://purl.obolibrary.org/obo/GO_0030878) (thyroid gland development), [GO:0016580](http://purl.obolibrary.org/obo/GO_0016580) (Sin3 complex), [GO:0016581](http://purl.obolibrary.org/obo/GO_0016581) (NuRD complex), [GO:0016584](http://purl.obolibrary.org/obo/GO_0016584) (nucleosome positioning), [GO:0030870](http://purl.obolibrary.org/obo/GO_0030870) (Mre11 complex), [GO:0016589](http://purl.obolibrary.org/obo/GO_0016589) (NURF complex), [GO:0042851](http://purl.obolibrary.org/obo/GO_0042851) (L-alanine metabolic process), [GO:0070093](http://purl.obolibrary.org/obo/GO_0070093) (negative regulation of glucagon secretion), [GO:0042853](http://purl.obolibrary.org/obo/GO_0042853) (L-alanine catabolic process), [GO:0070085](http://purl.obolibrary.org/obo/GO_0070085) (glycosylation), [GO:0070086](http://purl.obolibrary.org/obo/GO_0070086) (ubiquitin-dependent endocytosis), [GO:0070087](http://purl.obolibrary.org/obo/GO_0070087) (chromo shadow domain binding), [GO:0042866](http://purl.obolibrary.org/obo/GO_0042866) (pyruvate biosynthetic process), [GO:0009405](http://purl.obolibrary.org/obo/GO_0009405) (pathogenesis), [GO:0009404](http://purl.obolibrary.org/obo/GO_0009404) (toxin metabolic process), [GO:0070080](http://purl.obolibrary.org/obo/GO_0070080) (titin Z domain binding), [GO:0070072](http://purl.obolibrary.org/obo/GO_0070072) (vacuolar proton-transporting V-type ATPase complex assembly), [GO:0102867](http://purl.obolibrary.org/obo/GO_0102867) (molybdenum cofactor sulfurtransferase activity), [GO:0015299](http://purl.obolibrary.org/obo/GO_0015299) (solute:proton antiporter activity), [GO:0015297](http://purl.obolibrary.org/obo/GO_0015297) (antiporter activity), [GO:0015295](http://purl.obolibrary.org/obo/GO_0015295) (solute:proton symporter activity), [GO:0015293](http://purl.obolibrary.org/obo/GO_0015293) (symporter activity), [GO:0015292](http://purl.obolibrary.org/obo/GO_0015292) (uniporter activity), [GO:0042883](http://purl.obolibrary.org/obo/GO_0042883) (cysteine transport), [GO:0070094](http://purl.obolibrary.org/obo/GO_0070094) (positive regulation of glucagon secretion), [GO:0070095](http://purl.obolibrary.org/obo/GO_0070095) (fructose-6-phosphate binding), [GO:0070098](http://purl.obolibrary.org/obo/GO_0070098) (chemokine-mediated signaling pathway), [GO:0048919](http://purl.obolibrary.org/obo/GO_0048919) (posterior lateral line neuromast development), [GO:1905023](http://purl.obolibrary.org/obo/GO_1905023) (positive regulation of threonine-tRNA ligase activity), [GO:0048916](http://purl.obolibrary.org/obo/GO_0048916) (posterior lateral line development), [GO:0000979](http://purl.obolibrary.org/obo/GO_0000979) (RNA polymerase II core promoter sequence-specific DNA binding), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0000977](http://purl.obolibrary.org/obo/GO_0000977) (RNA polymerase II regulatory region sequence-specific DNA binding), [GO:0009314](http://purl.obolibrary.org/obo/GO_0009314) (response to radiation), [GO:0000976](http://purl.obolibrary.org/obo/GO_0000976) (transcription regulatory region sequence-specific DNA binding), [GO:0009313](http://purl.obolibrary.org/obo/GO_0009313) (oligosaccharide catabolic process), [GO:0009312](http://purl.obolibrary.org/obo/GO_0009312) (oligosaccharide biosynthetic process), [GO:0052182](http://purl.obolibrary.org/obo/GO_0052182) (modification by host of symbiont morphology or physiology via secreted substance), [GO:0009311](http://purl.obolibrary.org/obo/GO_0009311) (oligosaccharide metabolic process), [GO:0000973](http://purl.obolibrary.org/obo/GO_0000973) (posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery), [GO:0000972](http://purl.obolibrary.org/obo/GO_0000972) (transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery), [GO:0000980](http://purl.obolibrary.org/obo/GO_0000980) (RNA polymerase II distal enhancer sequence-specific DNA binding), [GO:0009308](http://purl.obolibrary.org/obo/GO_0009308) (amine metabolic process), [GO:1905020](http://purl.obolibrary.org/obo/GO_1905020) (positive regulation of methionine-tRNA ligase activity), [GO:1905037](http://purl.obolibrary.org/obo/GO_1905037) (autophagosome organization), [GO:0000989](http://purl.obolibrary.org/obo/GO_0000989) (transcription factor activity, transcription factor binding), [GO:0048922](http://purl.obolibrary.org/obo/GO_0048922) (posterior lateral line neuromast deposition), [GO:0000988](http://purl.obolibrary.org/obo/GO_0000988) (transcription factor activity, protein binding), [GO:0000987](http://purl.obolibrary.org/obo/GO_0000987) (proximal promoter sequence-specific DNA binding), [GO:0048920](http://purl.obolibrary.org/obo/GO_0048920) (posterior lateral line neuromast primordium migration), [GO:0000983](http://purl.obolibrary.org/obo/GO_0000983) (transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding), [GO:0048925](http://purl.obolibrary.org/obo/GO_0048925) (lateral line system development), [GO:0000982](http://purl.obolibrary.org/obo/GO_0000982) (transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0048923](http://purl.obolibrary.org/obo/GO_0048923) (posterior lateral line neuromast hair cell differentiation), [GO:0000990](http://purl.obolibrary.org/obo/GO_0000990) (transcription factor activity, core RNA polymerase binding), [GO:0000958](http://purl.obolibrary.org/obo/GO_0000958) (mitochondrial mRNA catabolic process), [GO:0000957](http://purl.obolibrary.org/obo/GO_0000957) (mitochondrial RNA catabolic process), [GO:0048936](http://purl.obolibrary.org/obo/GO_0048936) (peripheral nervous system neuron axonogenesis), [GO:0048935](http://purl.obolibrary.org/obo/GO_0048935) (peripheral nervous system neuron development), [GO:0009303](http://purl.obolibrary.org/obo/GO_0009303) (rRNA transcription), [GO:0000965](http://purl.obolibrary.org/obo/GO_0000965) (mitochondrial RNA 3'-end processing), [GO:0000964](http://purl.obolibrary.org/obo/GO_0000964) (mitochondrial RNA 5'-end processing), [GO:0047617](http://purl.obolibrary.org/obo/GO_0047617) (acyl-CoA hydrolase activity), [GO:0000962](http://purl.obolibrary.org/obo/GO_0000962) (positive regulation of mitochondrial RNA catabolic process), [GO:0009306](http://purl.obolibrary.org/obo/GO_0009306) (protein secretion), [GO:0009305](http://purl.obolibrary.org/obo/GO_0009305) (protein biotinylation), [GO:0047620](http://purl.obolibrary.org/obo/GO_0047620) (acylglycerol kinase activity), [GO:1905050](http://purl.obolibrary.org/obo/GO_1905050) (positive regulation of metallopeptidase activity), [GO:0035640](http://purl.obolibrary.org/obo/GO_0035640) (exploration behavior), [GO:0008023](http://purl.obolibrary.org/obo/GO_0008023) (transcription elongation factor complex), [GO:0090410](http://purl.obolibrary.org/obo/GO_0090410) (malonate catabolic process), [GO:0008022](http://purl.obolibrary.org/obo/GO_0008022) (protein C-terminus binding), [GO:0009353](http://purl.obolibrary.org/obo/GO_0009353) (mitochondrial oxoglutarate dehydrogenase complex), [GO:0008021](http://purl.obolibrary.org/obo/GO_0008021) (synaptic vesicle), [GO:0008020](http://purl.obolibrary.org/obo/GO_0008020) (G-protein coupled photoreceptor activity), [GO:0008026](http://purl.obolibrary.org/obo/GO_0008026) (ATP-dependent helicase activity), [GO:0008028](http://purl.obolibrary.org/obo/GO_0008028) (monocarboxylic acid transmembrane transporter activity), [GO:0010332](http://purl.obolibrary.org/obo/GO_0010332) (response to gamma radiation), [GO:0035631](http://purl.obolibrary.org/obo/GO_0035631) (CD40 receptor complex), [GO:0090419](http://purl.obolibrary.org/obo/GO_0090419) (negative regulation of transcription involved in G2/M transition of mitotic cell cycle), [GO:0035633](http://purl.obolibrary.org/obo/GO_0035633) (maintenance of permeability of blood-brain barrier), [GO:0035634](http://purl.obolibrary.org/obo/GO_0035634) (response to stilbenoid), [GO:0035630](http://purl.obolibrary.org/obo/GO_0035630) (bone mineralization involved in bone maturation), [GO:0008033](http://purl.obolibrary.org/obo/GO_0008033) (tRNA processing), [GO:0008038](http://purl.obolibrary.org/obo/GO_0008038) (neuron recognition), [GO:0009368](http://purl.obolibrary.org/obo/GO_0009368) (endopeptidase Clp complex), [GO:0008037](http://purl.obolibrary.org/obo/GO_0008037) (cell recognition), [GO:0008035](http://purl.obolibrary.org/obo/GO_0008035) (high-density lipoprotein particle binding), [GO:0035625](http://purl.obolibrary.org/obo/GO_0035625) (epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway), [GO:0035627](http://purl.obolibrary.org/obo/GO_0035627) (ceramide transport), [GO:0035621](http://purl.obolibrary.org/obo/GO_0035621) (ER to Golgi ceramide transport), [GO:0090427](http://purl.obolibrary.org/obo/GO_0090427) (activation of meiosis), [GO:0035622](http://purl.obolibrary.org/obo/GO_0035622) (intrahepatic bile duct development), [GO:0035623](http://purl.obolibrary.org/obo/GO_0035623) (renal glucose absorption), [GO:1905006](http://purl.obolibrary.org/obo/GO_1905006) (negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation), [GO:0009331](http://purl.obolibrary.org/obo/GO_0009331) (glycerol-3-phosphate dehydrogenase complex), [GO:1905007](http://purl.obolibrary.org/obo/GO_1905007) (positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation), [GO:0008009](http://purl.obolibrary.org/obo/GO_0008009) (chemokine activity), [GO:0000993](http://purl.obolibrary.org/obo/GO_0000993) (RNA polymerase II core binding), [GO:0035612](http://purl.obolibrary.org/obo/GO_0035612) (AP-2 adaptor complex binding), [GO:1905017](http://purl.obolibrary.org/obo/GO_1905017) (positive regulation of isoleucine-tRNA ligase activity), [GO:0008016](http://purl.obolibrary.org/obo/GO_0008016) (regulation of heart contraction), [GO:0008015](http://purl.obolibrary.org/obo/GO_0008015) (blood circulation), [GO:0008013](http://purl.obolibrary.org/obo/GO_0008013) (beta-catenin binding), [GO:0008017](http://purl.obolibrary.org/obo/GO_0008017) (microtubule binding), [GO:0048901](http://purl.obolibrary.org/obo/GO_0048901) (anterior lateral line neuromast development), [GO:0090409](http://purl.obolibrary.org/obo/GO_0090409) (malonyl-CoA synthetase activity), [GO:0035600](http://purl.obolibrary.org/obo/GO_0035600) (tRNA methylthiolation), [GO:0008063](http://purl.obolibrary.org/obo/GO_0008063) (Toll signaling pathway), [GO:0010385](http://purl.obolibrary.org/obo/GO_0010385) (double-stranded methylated DNA binding), [GO:0008061](http://purl.obolibrary.org/obo/GO_0008061) (chitin binding), [GO:0034354](http://purl.obolibrary.org/obo/GO_0034354) ('de novo' NAD biosynthetic process from tryptophan), [GO:0008066](http://purl.obolibrary.org/obo/GO_0008066) (glutamate receptor activity), [GO:0008065](http://purl.obolibrary.org/obo/GO_0008065) (establishment of blood-nerve barrier), [GO:0009396](http://purl.obolibrary.org/obo/GO_0009396) (folic acid-containing compound biosynthetic process), [GO:0034351](http://purl.obolibrary.org/obo/GO_0034351) (negative regulation of glial cell apoptotic process), [GO:0009395](http://purl.obolibrary.org/obo/GO_0009395) (phospholipid catabolic process), [GO:0008064](http://purl.obolibrary.org/obo/GO_0008064) (regulation of actin polymerization or depolymerization), [GO:0045005](http://purl.obolibrary.org/obo/GO_0045005) (DNA-dependent DNA replication maintenance of fidelity), [GO:0046337](http://purl.obolibrary.org/obo/GO_0046337) (phosphatidylethanolamine metabolic process), [GO:0045003](http://purl.obolibrary.org/obo/GO_0045003) (double-strand break repair via synthesis-dependent strand annealing), [GO:0045004](http://purl.obolibrary.org/obo/GO_0045004) (DNA replication proofreading), [GO:0060644](http://purl.obolibrary.org/obo/GO_0060644) (mammary gland epithelial cell differentiation), [GO:0046340](http://purl.obolibrary.org/obo/GO_0046340) (diacylglycerol catabolic process), [GO:0045010](http://purl.obolibrary.org/obo/GO_0045010) (actin nucleation), [GO:0033014](http://purl.obolibrary.org/obo/GO_0033014) (tetrapyrrole biosynthetic process), [GO:0035676](http://purl.obolibrary.org/obo/GO_0035676) (anterior lateral line neuromast hair cell development), [GO:0035677](http://purl.obolibrary.org/obo/GO_0035677) (posterior lateral line neuromast hair cell development), [GO:0033017](http://purl.obolibrary.org/obo/GO_0033017) (sarcoplasmic reticulum membrane), [GO:0035678](http://purl.obolibrary.org/obo/GO_0035678) (neuromast hair cell morphogenesis), [GO:0008074](http://purl.obolibrary.org/obo/GO_0008074) (guanylate cyclase complex, soluble), [GO:0035673](http://purl.obolibrary.org/obo/GO_0035673) (oligopeptide transmembrane transporter activity), [GO:0035674](http://purl.obolibrary.org/obo/GO_0035674) (tricarboxylic acid transmembrane transport), [GO:0008078](http://purl.obolibrary.org/obo/GO_0008078) (mesodermal cell migration), [GO:0010390](http://purl.obolibrary.org/obo/GO_0010390) (histone monoubiquitination), [GO:0034341](http://purl.obolibrary.org/obo/GO_0034341) (response to interferon-gamma), [GO:0033010](http://purl.obolibrary.org/obo/GO_0033010) (paranodal junction), [GO:0008076](http://purl.obolibrary.org/obo/GO_0008076) (voltage-gated potassium channel complex), [GO:0034340](http://purl.obolibrary.org/obo/GO_0034340) (response to type I interferon), [GO:0045019](http://purl.obolibrary.org/obo/GO_0045019) (negative regulation of nitric oxide biosynthetic process), [GO:0046352](http://purl.obolibrary.org/obo/GO_0046352) (disaccharide catabolic process), [GO:0045022](http://purl.obolibrary.org/obo/GO_0045022) (early endosome to late endosome transport), [GO:0033005](http://purl.obolibrary.org/obo/GO_0033005) (positive regulation of mast cell activation), [GO:0034334](http://purl.obolibrary.org/obo/GO_0034334) (adherens junction maintenance), [GO:0033002](http://purl.obolibrary.org/obo/GO_0033002) (muscle cell proliferation), [GO:0034333](http://purl.obolibrary.org/obo/GO_0034333) (adherens junction assembly), [GO:0035665](http://purl.obolibrary.org/obo/GO_0035665) (TIRAP-dependent toll-like receptor 4 signaling pathway), [GO:0010389](http://purl.obolibrary.org/obo/GO_0010389) (regulation of G2/M transition of mitotic cell cycle), [GO:0035666](http://purl.obolibrary.org/obo/GO_0035666) (TRIF-dependent toll-like receptor signaling pathway), [GO:0035662](http://purl.obolibrary.org/obo/GO_0035662) (Toll-like receptor 4 binding), [GO:0060662](http://purl.obolibrary.org/obo/GO_0060662) (salivary gland cavitation), [GO:0035663](http://purl.obolibrary.org/obo/GO_0035663) (Toll-like receptor 2 binding), [GO:0008045](http://purl.obolibrary.org/obo/GO_0008045) (motor neuron axon guidance), [GO:0034332](http://purl.obolibrary.org/obo/GO_0034332) (adherens junction organization), [GO:1902850](http://purl.obolibrary.org/obo/GO_1902850) (microtubule cytoskeleton organization involved in mitosis), [GO:0009374](http://purl.obolibrary.org/obo/GO_0009374) (biotin binding), [GO:0008043](http://purl.obolibrary.org/obo/GO_0008043) (intracellular ferritin complex), [GO:0045027](http://purl.obolibrary.org/obo/GO_0045027) (DNA end binding), [GO:0008049](http://purl.obolibrary.org/obo/GO_0008049) (male courtship behavior), [GO:0060669](http://purl.obolibrary.org/obo/GO_0060669) (embryonic placenta morphogenesis), [GO:0008048](http://purl.obolibrary.org/obo/GO_0008048) (calcium sensitive guanylate cyclase activator activity), [GO:0046359](http://purl.obolibrary.org/obo/GO_0046359) (butyrate catabolic process), [GO:0008047](http://purl.obolibrary.org/obo/GO_0008047) (enzyme activator activity), [GO:0046356](http://purl.obolibrary.org/obo/GO_0046356) (acetyl-CoA catabolic process), [GO:0009378](http://purl.obolibrary.org/obo/GO_0009378) (four-way junction helicase activity), [GO:0045025](http://purl.obolibrary.org/obo/GO_0045025) (mitochondrial degradosome), [GO:1901522](http://purl.obolibrary.org/obo/GO_1901522) (positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus), [GO:1902857](http://purl.obolibrary.org/obo/GO_1902857) (positive regulation of non-motile cilium assembly), [GO:0060664](http://purl.obolibrary.org/obo/GO_0060664) (epithelial cell proliferation involved in salivary gland morphogenesis), [GO:0060665](http://purl.obolibrary.org/obo/GO_0060665) (regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling), [GO:1902855](http://purl.obolibrary.org/obo/GO_1902855) (regulation of non-motile cilium assembly), [GO:0071310](http://purl.obolibrary.org/obo/GO_0071310) (cellular response to organic substance), [GO:0045033](http://purl.obolibrary.org/obo/GO_0045033) (peroxisome inheritance), [GO:0072643](http://purl.obolibrary.org/obo/GO_0072643) (interferon-gamma secretion), [GO:0071318](http://purl.obolibrary.org/obo/GO_0071318) (cellular response to ATP), [GO:0034329](http://purl.obolibrary.org/obo/GO_0034329) (cell junction assembly), [GO:0035655](http://purl.obolibrary.org/obo/GO_0035655) (interleukin-18-mediated signaling pathway), [GO:0071316](http://purl.obolibrary.org/obo/GO_0071316) (cellular response to nicotine), [GO:0008052](http://purl.obolibrary.org/obo/GO_0008052) (sensory organ boundary specification), [GO:1902860](http://purl.obolibrary.org/obo/GO_1902860) (propionyl-CoA biosynthetic process), [GO:0010370](http://purl.obolibrary.org/obo/GO_0010370) (perinucleolar chromocenter), [GO:0008053](http://purl.obolibrary.org/obo/GO_0008053) (mitochondrial fusion), [GO:0009384](http://purl.obolibrary.org/obo/GO_0009384) (N-acylmannosamine kinase activity), [GO:1901532](http://purl.obolibrary.org/obo/GO_1901532) (regulation of hematopoietic progenitor cell differentiation), [GO:0045039](http://purl.obolibrary.org/obo/GO_0045039) (protein import into mitochondrial inner membrane), [GO:1901534](http://purl.obolibrary.org/obo/GO_1901534) (positive regulation of hematopoietic progenitor cell differentiation), [GO:0008057](http://purl.obolibrary.org/obo/GO_0008057) (eye pigment granule organization), [GO:1901536](http://purl.obolibrary.org/obo/GO_1901536) (negative regulation of DNA demethylation), [GO:0045041](http://purl.obolibrary.org/obo/GO_0045041) (protein import into mitochondrial intermembrane space), [GO:1901529](http://purl.obolibrary.org/obo/GO_1901529) (positive regulation of anion channel activity), [GO:0046373](http://purl.obolibrary.org/obo/GO_0046373) (L-arabinose metabolic process), [GO:0071300](http://purl.obolibrary.org/obo/GO_0071300) (cellular response to retinoic acid), [GO:0045046](http://purl.obolibrary.org/obo/GO_0045046) (protein import into peroxisome membrane), [GO:0010369](http://purl.obolibrary.org/obo/GO_0010369) (chromocenter), [GO:0035646](http://purl.obolibrary.org/obo/GO_0035646) (endosome to melanosome transport), [GO:0034312](http://purl.obolibrary.org/obo/GO_0034312) (diol biosynthetic process), [GO:0035649](http://purl.obolibrary.org/obo/GO_0035649) (Nrd1 complex), [GO:0035643](http://purl.obolibrary.org/obo/GO_0035643) (L-DOPA receptor activity), [GO:0035645](http://purl.obolibrary.org/obo/GO_0035645) (enteric smooth muscle cell differentiation), [GO:0033063](http://purl.obolibrary.org/obo/GO_0033063) (Rad51B-Rad51C-Rad51D-XRCC2 complex), [GO:0034394](http://purl.obolibrary.org/obo/GO_0034394) (protein localization to cell surface), [GO:0034393](http://purl.obolibrary.org/obo/GO_0034393) (positive regulation of smooth muscle cell apoptotic process), [GO:1905065](http://purl.obolibrary.org/obo/GO_1905065) (positive regulation of vascular smooth muscle cell differentiation), [GO:0034398](http://purl.obolibrary.org/obo/GO_0034398) (telomere tethering at nuclear periphery), [GO:0034395](http://purl.obolibrary.org/obo/GO_0034395) (regulation of transcription from RNA polymerase II promoter in response to iron), [GO:0060602](http://purl.obolibrary.org/obo/GO_0060602) (branch elongation of an epithelium), [GO:0090494](http://purl.obolibrary.org/obo/GO_0090494) (dopamine uptake), [GO:0004500](http://purl.obolibrary.org/obo/GO_0004500) (dopamine beta-monooxygenase activity), [GO:0005822](http://purl.obolibrary.org/obo/GO_0005822) (inner plaque of spindle pole body), [GO:0005824](http://purl.obolibrary.org/obo/GO_0005824) (outer plaque of spindle pole body), [GO:0005828](http://purl.obolibrary.org/obo/GO_0005828) (kinetochore microtubule), [GO:0005827](http://purl.obolibrary.org/obo/GO_0005827) (polar microtubule), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0033059](http://purl.obolibrary.org/obo/GO_0033059) (cellular pigmentation), [GO:0034389](http://purl.obolibrary.org/obo/GO_0034389) (lipid particle organization), [GO:0034388](http://purl.obolibrary.org/obo/GO_0034388) (Pwp2p-containing subcomplex of 90S preribosome), [GO:1905064](http://purl.obolibrary.org/obo/GO_1905064) (negative regulation of vascular smooth muscle cell differentiation), [GO:0034383](http://purl.obolibrary.org/obo/GO_0034383) (low-density lipoprotein particle clearance), [GO:0034382](http://purl.obolibrary.org/obo/GO_0034382) (chylomicron remnant clearance), [GO:0034381](http://purl.obolibrary.org/obo/GO_0034381) (plasma lipoprotein particle clearance), [GO:0034380](http://purl.obolibrary.org/obo/GO_0034380) (high-density lipoprotein particle assembly), [GO:0034386](http://purl.obolibrary.org/obo/GO_0034386) (4-aminobutyrate:2-oxoglutarate transaminase activity), [GO:0034384](http://purl.obolibrary.org/obo/GO_0034384) (high-density lipoprotein particle clearance), [GO:0005840](http://purl.obolibrary.org/obo/GO_0005840) (ribosome), [GO:0004511](http://purl.obolibrary.org/obo/GO_0004511) (tyrosine 3-monooxygenase activity), [GO:0004510](http://purl.obolibrary.org/obo/GO_0004510) (tryptophan 5-monooxygenase activity), [GO:0005833](http://purl.obolibrary.org/obo/GO_0005833) (hemoglobin complex), [GO:0005832](http://purl.obolibrary.org/obo/GO_0005832) (chaperonin-containing T-complex), [GO:0005834](http://purl.obolibrary.org/obo/GO_0005834) (heterotrimeric G-protein complex), [GO:0004503](http://purl.obolibrary.org/obo/GO_0004503) (monophenol monooxygenase activity), [GO:0004505](http://purl.obolibrary.org/obo/GO_0004505) (phenylalanine 4-monooxygenase activity), [GO:0005839](http://purl.obolibrary.org/obo/GO_0005839) (proteasome core complex), [GO:0004508](http://purl.obolibrary.org/obo/GO_0004508) (steroid 17-alpha-monooxygenase activity), [GO:0004507](http://purl.obolibrary.org/obo/GO_0004507) (steroid 11-beta-monooxygenase activity), [GO:0034379](http://purl.obolibrary.org/obo/GO_0034379) (very-low-density lipoprotein particle assembly), [GO:0004509](http://purl.obolibrary.org/obo/GO_0004509) (steroid 21-monooxygenase activity), [GO:0034377](http://purl.obolibrary.org/obo/GO_0034377) (plasma lipoprotein particle assembly), [GO:1905075](http://purl.obolibrary.org/obo/GO_1905075) (positive regulation of occluding junction disassembly), [GO:0034372](http://purl.obolibrary.org/obo/GO_0034372) (very-low-density lipoprotein particle remodeling), [GO:0034371](http://purl.obolibrary.org/obo/GO_0034371) (chylomicron remodeling), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0034370](http://purl.obolibrary.org/obo/GO_0034370) (triglyceride-rich lipoprotein particle remodeling), [GO:0008089](http://purl.obolibrary.org/obo/GO_0008089) (anterograde axonal transport), [GO:0034375](http://purl.obolibrary.org/obo/GO_0034375) (high-density lipoprotein particle remodeling), [GO:0008088](http://purl.obolibrary.org/obo/GO_0008088) (axo-dendritic transport), [GO:0034374](http://purl.obolibrary.org/obo/GO_0034374) (low-density lipoprotein particle remodeling), [GO:0060627](http://purl.obolibrary.org/obo/GO_0060627) (regulation of vesicle-mediated transport), [GO:0061953](http://purl.obolibrary.org/obo/GO_0061953) (mRNA (adenine-N1-)-methyltransferase activity), [GO:0060623](http://purl.obolibrary.org/obo/GO_0060623) (regulation of chromosome condensation), [GO:1902807](http://purl.obolibrary.org/obo/GO_1902807) (negative regulation of cell cycle G1/S phase transition), [GO:0005802](http://purl.obolibrary.org/obo/GO_0005802) (trans-Golgi network), [GO:0005801](http://purl.obolibrary.org/obo/GO_0005801) (cis-Golgi network), [GO:0046321](http://purl.obolibrary.org/obo/GO_0046321) (positive regulation of fatty acid oxidation), [GO:0046322](http://purl.obolibrary.org/obo/GO_0046322) (negative regulation of fatty acid oxidation), [GO:1902808](http://purl.obolibrary.org/obo/GO_1902808) (positive regulation of cell cycle G1/S phase transition), [GO:0046320](http://purl.obolibrary.org/obo/GO_0046320) (regulation of fatty acid oxidation), [GO:0072602](http://purl.obolibrary.org/obo/GO_0072602) (interleukin-4 secretion), [GO:0034368](http://purl.obolibrary.org/obo/GO_0034368) (protein-lipid complex remodeling), [GO:0034366](http://purl.obolibrary.org/obo/GO_0034366) (spherical high-density lipoprotein particle), [GO:0008081](http://purl.obolibrary.org/obo/GO_0008081) (phosphoric diester hydrolase activity), [GO:0072606](http://purl.obolibrary.org/obo/GO_0072606) (interleukin-8 secretion), [GO:0008080](http://purl.obolibrary.org/obo/GO_0008080) (N-acetyltransferase activity), [GO:0072604](http://purl.obolibrary.org/obo/GO_0072604) (interleukin-6 secretion), [GO:0034361](http://purl.obolibrary.org/obo/GO_0034361) (very-low-density lipoprotein particle), [GO:0033030](http://purl.obolibrary.org/obo/GO_0033030) (negative regulation of neutrophil apoptotic process), [GO:0008094](http://purl.obolibrary.org/obo/GO_0008094) (DNA-dependent ATPase activity), [GO:1905098](http://purl.obolibrary.org/obo/GO_1905098) (negative regulation of guanyl-nucleotide exchange factor activity), [GO:0008093](http://purl.obolibrary.org/obo/GO_0008093) (cytoskeletal adaptor activity), [GO:0034364](http://purl.obolibrary.org/obo/GO_0034364) (high-density lipoprotein particle), [GO:0035690](http://purl.obolibrary.org/obo/GO_0035690) (cellular response to drug), [GO:0033033](http://purl.obolibrary.org/obo/GO_0033033) (negative regulation of myeloid cell apoptotic process), [GO:0033032](http://purl.obolibrary.org/obo/GO_0033032) (regulation of myeloid cell apoptotic process), [GO:0034363](http://purl.obolibrary.org/obo/GO_0034363) (intermediate-density lipoprotein particle), [GO:0034362](http://purl.obolibrary.org/obo/GO_0034362) (low-density lipoprotein particle), [GO:0008097](http://purl.obolibrary.org/obo/GO_0008097) (5S rRNA binding), [GO:0046325](http://purl.obolibrary.org/obo/GO_0046325) (negative regulation of glucose import), [GO:0060613](http://purl.obolibrary.org/obo/GO_0060613) (fat pad development), [GO:0046326](http://purl.obolibrary.org/obo/GO_0046326) (positive regulation of glucose import), [GO:0046323](http://purl.obolibrary.org/obo/GO_0046323) (glucose import), [GO:0046324](http://purl.obolibrary.org/obo/GO_0046324) (regulation of glucose import), [GO:0046329](http://purl.obolibrary.org/obo/GO_0046329) (negative regulation of JNK cascade), [GO:0046327](http://purl.obolibrary.org/obo/GO_0046327) (glycerol biosynthetic process from pyruvate), [GO:0060612](http://purl.obolibrary.org/obo/GO_0060612) (adipose tissue development), [GO:0046328](http://purl.obolibrary.org/obo/GO_0046328) (regulation of JNK cascade), [GO:0005811](http://purl.obolibrary.org/obo/GO_0005811) (lipid droplet), [GO:1902817](http://purl.obolibrary.org/obo/GO_1902817) (negative regulation of protein localization to microtubule), [GO:0005813](http://purl.obolibrary.org/obo/GO_0005813) (centrosome), [GO:0005815](http://purl.obolibrary.org/obo/GO_0005815) (microtubule organizing center), [GO:0046332](http://purl.obolibrary.org/obo/GO_0046332) (SMAD binding), [GO:0005814](http://purl.obolibrary.org/obo/GO_0005814) (centriole), [GO:0045002](http://purl.obolibrary.org/obo/GO_0045002) (double-strand break repair via single-strand annealing), [GO:0046333](http://purl.obolibrary.org/obo/GO_0046333) (octopamine metabolic process), [GO:0046330](http://purl.obolibrary.org/obo/GO_0046330) (positive regulation of JNK cascade), [GO:0005816](http://purl.obolibrary.org/obo/GO_0005816) (spindle pole body), [GO:0046331](http://purl.obolibrary.org/obo/GO_0046331) (lateral inhibition), [GO:0005819](http://purl.obolibrary.org/obo/GO_0005819) (spindle), [GO:0033026](http://purl.obolibrary.org/obo/GO_0033026) (negative regulation of mast cell apoptotic process), [GO:0034356](http://purl.obolibrary.org/obo/GO_0034356) (NAD biosynthesis via nicotinamide riboside salvage pathway), [GO:0008092](http://purl.obolibrary.org/obo/GO_0008092) (cytoskeletal protein binding), [GO:0035686](http://purl.obolibrary.org/obo/GO_0035686) (sperm fibrous sheath), [GO:0008091](http://purl.obolibrary.org/obo/GO_0008091) (spectrin), [GO:0008090](http://purl.obolibrary.org/obo/GO_0008090) (retrograde axonal transport), [GO:0034359](http://purl.obolibrary.org/obo/GO_0034359) (mature chylomicron), [GO:0060363](http://purl.obolibrary.org/obo/GO_0060363) (cranial suture morphogenesis), [GO:1900131](http://purl.obolibrary.org/obo/GO_1900131) (negative regulation of lipid binding), [GO:1900133](http://purl.obolibrary.org/obo/GO_1900133) (regulation of renin secretion into blood stream), [GO:0006842](http://purl.obolibrary.org/obo/GO_0006842) (tricarboxylic acid transport), [GO:0006843](http://purl.obolibrary.org/obo/GO_0006843) (mitochondrial citrate transport), [GO:0072341](http://purl.obolibrary.org/obo/GO_0072341) (modified amino acid binding), [GO:0098971](http://purl.obolibrary.org/obo/GO_0098971) (anterograde dendritic transport of neurotransmitter receptor complex), [GO:0006836](http://purl.obolibrary.org/obo/GO_0006836) (neurotransmitter transport), [GO:0098970](http://purl.obolibrary.org/obo/GO_0098970) (postsynaptic neurotransmitter receptor diffusion trapping), [GO:0005504](http://purl.obolibrary.org/obo/GO_0005504) (fatty acid binding), [GO:0071013](http://purl.obolibrary.org/obo/GO_0071013) (catalytic step 2 spliceosome), [GO:0005507](http://purl.obolibrary.org/obo/GO_0005507) (copper ion binding), [GO:0072345](http://purl.obolibrary.org/obo/GO_0072345) (NAADP-sensitive calcium-release channel activity), [GO:0006839](http://purl.obolibrary.org/obo/GO_0006839) (mitochondrial transport), [GO:0046068](http://purl.obolibrary.org/obo/GO_0046068) (cGMP metabolic process), [GO:0005506](http://purl.obolibrary.org/obo/GO_0005506) (iron ion binding), [GO:0046069](http://purl.obolibrary.org/obo/GO_0046069) (cGMP catabolic process), [GO:0072344](http://purl.obolibrary.org/obo/GO_0072344) (rescue of stalled ribosome), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0006837](http://purl.obolibrary.org/obo/GO_0006837) (serotonin transport), [GO:2001209](http://purl.obolibrary.org/obo/GO_2001209) (positive regulation of transcription elongation from RNA polymerase I promoter), [GO:0071011](http://purl.obolibrary.org/obo/GO_0071011) (precatalytic spliceosome), [GO:2001204](http://purl.obolibrary.org/obo/GO_2001204) (regulation of osteoclast development), [GO:2001205](http://purl.obolibrary.org/obo/GO_2001205) (negative regulation of osteoclast development), [GO:2001206](http://purl.obolibrary.org/obo/GO_2001206) (positive regulation of osteoclast development), [GO:2001200](http://purl.obolibrary.org/obo/GO_2001200) (positive regulation of dendritic cell differentiation), [GO:0046061](http://purl.obolibrary.org/obo/GO_0046061) (dATP catabolic process), [GO:0047391](http://purl.obolibrary.org/obo/GO_0047391) (alkylglycerophosphoethanolamine phosphodiesterase activity), [GO:0034063](http://purl.obolibrary.org/obo/GO_0034063) (stress granule assembly), [GO:0018812](http://purl.obolibrary.org/obo/GO_0018812) (3-hydroxyacyl-CoA dehydratase activity), [GO:0035397](http://purl.obolibrary.org/obo/GO_0035397) (helper T cell enhancement of adaptive immune response), [GO:0034067](http://purl.obolibrary.org/obo/GO_0034067) (protein localization to Golgi apparatus), [GO:0060351](http://purl.obolibrary.org/obo/GO_0060351) (cartilage development involved in endochondral bone morphogenesis), [GO:0006850](http://purl.obolibrary.org/obo/GO_0006850) (mitochondrial pyruvate transmembrane transport), [GO:1900145](http://purl.obolibrary.org/obo/GO_1900145) (regulation of nodal signaling pathway involved in determination of left/right asymmetry), [GO:0005521](http://purl.obolibrary.org/obo/GO_0005521) (lamin binding), [GO:0005520](http://purl.obolibrary.org/obo/GO_0005520) (insulin-like growth factor binding), [GO:0098990](http://purl.obolibrary.org/obo/GO_0098990) (AMPA selective glutamate receptor signaling pathway), [GO:1900149](http://purl.obolibrary.org/obo/GO_1900149) (positive regulation of Schwann cell migration), [GO:0061689](http://purl.obolibrary.org/obo/GO_0061689) (tricellular tight junction), [GO:0005523](http://purl.obolibrary.org/obo/GO_0005523) (tropomyosin binding), [GO:0006851](http://purl.obolibrary.org/obo/GO_0006851) (mitochondrial calcium ion transmembrane transport), [GO:0005522](http://purl.obolibrary.org/obo/GO_0005522) (profilin binding), [GO:0005513](http://purl.obolibrary.org/obo/GO_0005513) (detection of calcium ion), [GO:0005516](http://purl.obolibrary.org/obo/GO_0005516) (calmodulin binding), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0005518](http://purl.obolibrary.org/obo/GO_0005518) (collagen binding), [GO:0072334](http://purl.obolibrary.org/obo/GO_0072334) (UDP-galactose transmembrane transport), [GO:0072332](http://purl.obolibrary.org/obo/GO_0072332) (intrinsic apoptotic signaling pathway by p53 class mediator), [GO:2001214](http://purl.obolibrary.org/obo/GO_2001214) (positive regulation of vasculogenesis), [GO:0071004](http://purl.obolibrary.org/obo/GO_0071004) (U2-type prespliceosome), [GO:0098989](http://purl.obolibrary.org/obo/GO_0098989) (NMDA selective glutamate receptor signaling pathway), [GO:0046070](http://purl.obolibrary.org/obo/GO_0046070) (dGTP metabolic process), [GO:2001213](http://purl.obolibrary.org/obo/GO_2001213) (negative regulation of vasculogenesis), [GO:0060385](http://purl.obolibrary.org/obo/GO_0060385) (axonogenesis involved in innervation), [GO:0035385](http://purl.obolibrary.org/obo/GO_0035385) (Roundabout signaling pathway), [GO:1900153](http://purl.obolibrary.org/obo/GO_1900153) (positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay), [GO:0060381](http://purl.obolibrary.org/obo/GO_0060381) (positive regulation of single-stranded telomeric DNA binding), [GO:1900152](http://purl.obolibrary.org/obo/GO_1900152) (negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay), [GO:0034056](http://purl.obolibrary.org/obo/GO_0034056) (estrogen response element binding), [GO:0060383](http://purl.obolibrary.org/obo/GO_0060383) (positive regulation of DNA strand elongation), [GO:0060384](http://purl.obolibrary.org/obo/GO_0060384) (innervation), [GO:0006820](http://purl.obolibrary.org/obo/GO_0006820) (anion transport), [GO:0060389](http://purl.obolibrary.org/obo/GO_0060389) (pathway-restricted SMAD protein phosphorylation), [GO:0006821](http://purl.obolibrary.org/obo/GO_0006821) (chloride transport), [GO:0006813](http://purl.obolibrary.org/obo/GO_0006813) (potassium ion transport), [GO:0006814](http://purl.obolibrary.org/obo/GO_0006814) (sodium ion transport), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:0006812](http://purl.obolibrary.org/obo/GO_0006812) (cation transport), [GO:0046085](http://purl.obolibrary.org/obo/GO_0046085) (adenosine metabolic process), [GO:0006817](http://purl.obolibrary.org/obo/GO_0006817) (phosphate ion transport), [GO:2001229](http://purl.obolibrary.org/obo/GO_2001229) (negative regulation of response to gamma radiation), [GO:0097623](http://purl.obolibrary.org/obo/GO_0097623) (potassium ion export across plasma membrane), [GO:0006816](http://purl.obolibrary.org/obo/GO_0006816) (calcium ion transport), [GO:0071034](http://purl.obolibrary.org/obo/GO_0071034) (CUT catabolic process), [GO:2001225](http://purl.obolibrary.org/obo/GO_2001225) (regulation of chloride transport), [GO:0060391](http://purl.obolibrary.org/obo/GO_0060391) (positive regulation of SMAD protein import into nucleus), [GO:0046083](http://purl.obolibrary.org/obo/GO_0046083) (adenine metabolic process), [GO:2001223](http://purl.obolibrary.org/obo/GO_2001223) (negative regulation of neuron migration), [GO:2001224](http://purl.obolibrary.org/obo/GO_2001224) (positive regulation of neuron migration), [GO:1901491](http://purl.obolibrary.org/obo/GO_1901491) (negative regulation of lymphangiogenesis), [GO:0060374](http://purl.obolibrary.org/obo/GO_0060374) (mast cell differentiation), [GO:0043813](http://purl.obolibrary.org/obo/GO_0043813) (phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity), [GO:2001240](http://purl.obolibrary.org/obo/GO_2001240) (negative regulation of extrinsic apoptotic signaling pathway in absence of ligand), [GO:2001241](http://purl.obolibrary.org/obo/GO_2001241) (positive regulation of extrinsic apoptotic signaling pathway in absence of ligand), [GO:0035376](http://purl.obolibrary.org/obo/GO_0035376) (sterol import), [GO:2001242](http://purl.obolibrary.org/obo/GO_2001242) (regulation of intrinsic apoptotic signaling pathway), [GO:1901492](http://purl.obolibrary.org/obo/GO_1901492) (positive regulation of lymphangiogenesis), [GO:0035377](http://purl.obolibrary.org/obo/GO_0035377) (transepithelial water transport), [GO:1900164](http://purl.obolibrary.org/obo/GO_1900164) (nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry), [GO:0034046](http://purl.obolibrary.org/obo/GO_0034046) (poly(G) binding), [GO:1900163](http://purl.obolibrary.org/obo/GO_1900163) (positive regulation of phospholipid scramblase activity), [GO:0060371](http://purl.obolibrary.org/obo/GO_0060371) (regulation of atrial cardiac muscle cell membrane depolarization), [GO:0035371](http://purl.obolibrary.org/obo/GO_0035371) (microtubule plus-end), [GO:0034045](http://purl.obolibrary.org/obo/GO_0034045) (phagophore assembly site membrane), [GO:0035372](http://purl.obolibrary.org/obo/GO_0035372) (protein localization to microtubule), [GO:0060372](http://purl.obolibrary.org/obo/GO_0060372) (regulation of atrial cardiac muscle cell membrane repolarization), [GO:0060373](http://purl.obolibrary.org/obo/GO_0060373) (regulation of ventricular cardiac muscle cell membrane depolarization), [GO:0005501](http://purl.obolibrary.org/obo/GO_0005501) (retinoid binding), [GO:0006824](http://purl.obolibrary.org/obo/GO_0006824) (cobalt ion transport), [GO:0006825](http://purl.obolibrary.org/obo/GO_0006825) (copper ion transport), [GO:0072350](http://purl.obolibrary.org/obo/GO_0072350) (tricarboxylic acid metabolic process), [GO:0006828](http://purl.obolibrary.org/obo/GO_0006828) (manganese ion transport), [GO:0098964](http://purl.obolibrary.org/obo/GO_0098964) (anterograde dendritic transport of messenger ribonucleoprotein complex), [GO:0006829](http://purl.obolibrary.org/obo/GO_0006829) (zinc II ion transport), [GO:0006826](http://purl.obolibrary.org/obo/GO_0006826) (iron ion transport), [GO:0098963](http://purl.obolibrary.org/obo/GO_0098963) (dendritic transport of messenger ribonucleoprotein complex), [GO:2001236](http://purl.obolibrary.org/obo/GO_2001236) (regulation of extrinsic apoptotic signaling pathway), [GO:0071028](http://purl.obolibrary.org/obo/GO_0071028) (nuclear mRNA surveillance), [GO:2001237](http://purl.obolibrary.org/obo/GO_2001237) (negative regulation of extrinsic apoptotic signaling pathway), [GO:0072358](http://purl.obolibrary.org/obo/GO_0072358) (cardiovascular system development), [GO:2001238](http://purl.obolibrary.org/obo/GO_2001238) (positive regulation of extrinsic apoptotic signaling pathway), [GO:2001233](http://purl.obolibrary.org/obo/GO_2001233) (regulation of apoptotic signaling pathway), [GO:2001234](http://purl.obolibrary.org/obo/GO_2001234) (negative regulation of apoptotic signaling pathway), [GO:2001235](http://purl.obolibrary.org/obo/GO_2001235) (positive regulation of apoptotic signaling pathway), [GO:0046092](http://purl.obolibrary.org/obo/GO_0046092) (deoxycytidine metabolic process), [GO:0016206](http://purl.obolibrary.org/obo/GO_0016206) (catechol O-methyltransferase activity), [GO:2001252](http://purl.obolibrary.org/obo/GO_2001252) (positive regulation of chromosome organization), [GO:0016208](http://purl.obolibrary.org/obo/GO_0016208) (AMP binding), [GO:0060322](http://purl.obolibrary.org/obo/GO_0060322) (head development), [GO:0016209](http://purl.obolibrary.org/obo/GO_0016209) (antioxidant activity), [GO:0047349](http://purl.obolibrary.org/obo/GO_0047349) (D-ribitol-5-phosphate cytidylyltransferase activity), [GO:0006882](http://purl.obolibrary.org/obo/GO_0006882) (cellular zinc ion homeostasis), [GO:0006883](http://purl.obolibrary.org/obo/GO_0006883) (cellular sodium ion homeostasis), [GO:0048679](http://purl.obolibrary.org/obo/GO_0048679) (regulation of axon regeneration), [GO:0048678](http://purl.obolibrary.org/obo/GO_0048678) (response to axon injury), [GO:0006880](http://purl.obolibrary.org/obo/GO_0006880) (intracellular sequestering of iron ion), [GO:0046015](http://purl.obolibrary.org/obo/GO_0046015) (regulation of transcription by glucose), [GO:0048677](http://purl.obolibrary.org/obo/GO_0048677) (axon extension involved in regeneration), [GO:0006886](http://purl.obolibrary.org/obo/GO_0006886) (intracellular protein transport), [GO:0060323](http://purl.obolibrary.org/obo/GO_0060323) (head morphogenesis), [GO:0004222](http://purl.obolibrary.org/obo/GO_0004222) (metalloendopeptidase activity), [GO:0006887](http://purl.obolibrary.org/obo/GO_0006887) (exocytosis), [GO:0060324](http://purl.obolibrary.org/obo/GO_0060324) (face development), [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis), [GO:0060326](http://purl.obolibrary.org/obo/GO_0060326) (cell chemotaxis), [GO:0006885](http://purl.obolibrary.org/obo/GO_0006885) (regulation of pH), [GO:0006879](http://purl.obolibrary.org/obo/GO_0006879) (cellular iron ion homeostasis), [GO:0005547](http://purl.obolibrary.org/obo/GO_0005547) (phosphatidylinositol-3,4,5-trisphosphate binding), [GO:0046020](http://purl.obolibrary.org/obo/GO_0046020) (negative regulation of transcription from RNA polymerase II promoter by pheromones), [GO:0005546](http://purl.obolibrary.org/obo/GO_0005546) (phosphatidylinositol-4,5-bisphosphate binding), [GO:0030502](http://purl.obolibrary.org/obo/GO_0030502) (negative regulation of bone mineralization), [GO:0048681](http://purl.obolibrary.org/obo/GO_0048681) (negative regulation of axon regeneration), [GO:0030505](http://purl.obolibrary.org/obo/GO_0030505) (inorganic diphosphate transport), [GO:0006878](http://purl.obolibrary.org/obo/GO_0006878) (cellular copper ion homeostasis), [GO:0048680](http://purl.obolibrary.org/obo/GO_0048680) (positive regulation of axon regeneration), [GO:0005548](http://purl.obolibrary.org/obo/GO_0005548) (phospholipid transporter activity), [GO:0030507](http://purl.obolibrary.org/obo/GO_0030507) (spectrin binding), [GO:0030506](http://purl.obolibrary.org/obo/GO_0030506) (ankyrin binding), [GO:0072300](http://purl.obolibrary.org/obo/GO_0072300) (positive regulation of metanephric glomerulus development), [GO:0030509](http://purl.obolibrary.org/obo/GO_0030509) (BMP signaling pathway), [GO:0031838](http://purl.obolibrary.org/obo/GO_0031838) (haptoglobin-hemoglobin complex), [GO:0072305](http://purl.obolibrary.org/obo/GO_0072305) (negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis), [GO:0050999](http://purl.obolibrary.org/obo/GO_0050999) (regulation of nitric-oxide synthase activity), [GO:2001243](http://purl.obolibrary.org/obo/GO_2001243) (negative regulation of intrinsic apoptotic signaling pathway), [GO:0050998](http://purl.obolibrary.org/obo/GO_0050998) (nitric-oxide synthase binding), [GO:2001244](http://purl.obolibrary.org/obo/GO_2001244) (positive regulation of intrinsic apoptotic signaling pathway), [GO:0030501](http://purl.obolibrary.org/obo/GO_0030501) (positive regulation of bone mineralization), [GO:0050995](http://purl.obolibrary.org/obo/GO_0050995) (negative regulation of lipid catabolic process), [GO:0072307](http://purl.obolibrary.org/obo/GO_0072307) (regulation of metanephric nephron tubule epithelial cell differentiation), [GO:0030500](http://purl.obolibrary.org/obo/GO_0030500) (regulation of bone mineralization), [GO:0050996](http://purl.obolibrary.org/obo/GO_0050996) (positive regulation of lipid catabolic process), [GO:0060311](http://purl.obolibrary.org/obo/GO_0060311) (negative regulation of elastin catabolic process), [GO:0006890](http://purl.obolibrary.org/obo/GO_0006890) (retrograde vesicle-mediated transport, Golgi to ER), [GO:1900100](http://purl.obolibrary.org/obo/GO_1900100) (positive regulation of plasma cell differentiation), [GO:0006893](http://purl.obolibrary.org/obo/GO_0006893) (Golgi to plasma membrane transport), [GO:1900102](http://purl.obolibrary.org/obo/GO_1900102) (negative regulation of endoplasmic reticulum unfolded protein response), [GO:0060317](http://purl.obolibrary.org/obo/GO_0060317) (cardiac epithelial to mesenchymal transition), [GO:1900101](http://purl.obolibrary.org/obo/GO_1900101) (regulation of endoplasmic reticulum unfolded protein response), [GO:0006891](http://purl.obolibrary.org/obo/GO_0006891) (intra-Golgi vesicle-mediated transport), [GO:0006892](http://purl.obolibrary.org/obo/GO_0006892) (post-Golgi vesicle-mediated transport), [GO:1900103](http://purl.obolibrary.org/obo/GO_1900103) (positive regulation of endoplasmic reticulum unfolded protein response), [GO:0060319](http://purl.obolibrary.org/obo/GO_0060319) (primitive erythrocyte differentiation), [GO:0006897](http://purl.obolibrary.org/obo/GO_0006897) (endocytosis), [GO:0060312](http://purl.obolibrary.org/obo/GO_0060312) (regulation of blood vessel remodeling), [GO:1900106](http://purl.obolibrary.org/obo/GO_1900106) (positive regulation of hyaluranon cable assembly), [GO:0006898](http://purl.obolibrary.org/obo/GO_0006898) (receptor-mediated endocytosis), [GO:0006895](http://purl.obolibrary.org/obo/GO_0006895) (Golgi to endosome transport), [GO:0060314](http://purl.obolibrary.org/obo/GO_0060314) (regulation of ryanodine-sensitive calcium-release channel activity), [GO:0006896](http://purl.obolibrary.org/obo/GO_0006896) (Golgi to vacuole transport), [GO:0060315](http://purl.obolibrary.org/obo/GO_0060315) (negative regulation of ryanodine-sensitive calcium-release channel activity), [GO:0061646](http://purl.obolibrary.org/obo/GO_0061646) (positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization), [GO:0006888](http://purl.obolibrary.org/obo/GO_0006888) (ER to Golgi vesicle-mediated transport), [GO:0048698](http://purl.obolibrary.org/obo/GO_0048698) (negative regulation of collateral sprouting in absence of injury), [GO:0098943](http://purl.obolibrary.org/obo/GO_0098943) (neurotransmitter receptor transport, postsynaptic endosome to lysosome), [GO:0048696](http://purl.obolibrary.org/obo/GO_0048696) (regulation of collateral sprouting in absence of injury), [GO:0046033](http://purl.obolibrary.org/obo/GO_0046033) (AMP metabolic process), [GO:0046034](http://purl.obolibrary.org/obo/GO_0046034) (ATP metabolic process), [GO:2001258](http://purl.obolibrary.org/obo/GO_2001258) (negative regulation of cation channel activity), [GO:2001259](http://purl.obolibrary.org/obo/GO_2001259) (positive regulation of cation channel activity), [GO:0031821](http://purl.obolibrary.org/obo/GO_0031821) (G-protein coupled serotonin receptor binding), [GO:0016202](http://purl.obolibrary.org/obo/GO_0016202) (regulation of striated muscle tissue development), [GO:2001256](http://purl.obolibrary.org/obo/GO_2001256) (regulation of store-operated calcium entry), [GO:0016203](http://purl.obolibrary.org/obo/GO_0016203) (muscle attachment), [GO:0034097](http://purl.obolibrary.org/obo/GO_0034097) (response to cytokine), [GO:0060341](http://purl.obolibrary.org/obo/GO_0060341) (regulation of cellular localization), [GO:2001275](http://purl.obolibrary.org/obo/GO_2001275) (positive regulation of glucose import in response to insulin stimulus), [GO:1900111](http://purl.obolibrary.org/obo/GO_1900111) (positive regulation of histone H3-K9 dimethylation), [GO:0034098](http://purl.obolibrary.org/obo/GO_0034098) (VCP-NPL4-UFD1 AAA ATPase complex), [GO:0060340](http://purl.obolibrary.org/obo/GO_0060340) (positive regulation of type I interferon-mediated signaling pathway), [GO:0060349](http://purl.obolibrary.org/obo/GO_0060349) (bone morphogenesis), [GO:0046039](http://purl.obolibrary.org/obo/GO_0046039) (GTP metabolic process), [GO:0090197](http://purl.obolibrary.org/obo/GO_0090197) (positive regulation of chemokine secretion), [GO:0048699](http://purl.obolibrary.org/obo/GO_0048699) (generation of neurons), [GO:0046038](http://purl.obolibrary.org/obo/GO_0046038) (GMP catabolic process), [GO:1902775](http://purl.obolibrary.org/obo/GO_1902775) (mitochondrial large ribosomal subunit assembly), [GO:0090193](http://purl.obolibrary.org/obo/GO_0090193) (positive regulation of glomerulus development), [GO:0060345](http://purl.obolibrary.org/obo/GO_0060345) (spleen trabecula formation), [GO:0006865](http://purl.obolibrary.org/obo/GO_0006865) (amino acid transport), [GO:0060346](http://purl.obolibrary.org/obo/GO_0060346) (bone trabecula formation), [GO:0060347](http://purl.obolibrary.org/obo/GO_0060347) (heart trabecula formation), [GO:0090191](http://purl.obolibrary.org/obo/GO_0090191) (negative regulation of branching involved in ureteric bud morphogenesis), [GO:0005534](http://purl.obolibrary.org/obo/GO_0005534) (galactose binding), [GO:0060348](http://purl.obolibrary.org/obo/GO_0060348) (bone development), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0006857](http://purl.obolibrary.org/obo/GO_0006857) (oligopeptide transport), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0006858](http://purl.obolibrary.org/obo/GO_0006858) (extracellular transport), [GO:0006855](http://purl.obolibrary.org/obo/GO_0006855) (drug transmembrane transport), [GO:0047372](http://purl.obolibrary.org/obo/GO_0047372) (acylglycerol lipase activity), [GO:0046040](http://purl.obolibrary.org/obo/GO_0046040) (IMP metabolic process), [GO:0098910](http://purl.obolibrary.org/obo/GO_0098910) (regulation of atrial cardiac muscle cell action potential), [GO:0005528](http://purl.obolibrary.org/obo/GO_0005528) (FK506 binding), [GO:0072321](http://purl.obolibrary.org/obo/GO_0072321) (chaperone-mediated protein transport), [GO:2001269](http://purl.obolibrary.org/obo/GO_2001269) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway), [GO:0098914](http://purl.obolibrary.org/obo/GO_0098914) (membrane repolarization during atrial cardiac muscle cell action potential), [GO:0098911](http://purl.obolibrary.org/obo/GO_0098911) (regulation of ventricular cardiac muscle cell action potential), [GO:0098912](http://purl.obolibrary.org/obo/GO_0098912) (membrane depolarization during atrial cardiac muscle cell action potential), [GO:0098915](http://purl.obolibrary.org/obo/GO_0098915) (membrane repolarization during ventricular cardiac muscle cell action potential), [GO:0034085](http://purl.obolibrary.org/obo/GO_0034085) (establishment of sister chromatid cohesion), [GO:0060333](http://purl.obolibrary.org/obo/GO_0060333) (interferon-gamma-mediated signaling pathway), [GO:1900122](http://purl.obolibrary.org/obo/GO_1900122) (positive regulation of receptor binding), [GO:1900121](http://purl.obolibrary.org/obo/GO_1900121) (negative regulation of receptor binding), [GO:0034087](http://purl.obolibrary.org/obo/GO_0034087) (establishment of mitotic sister chromatid cohesion), [GO:0060338](http://purl.obolibrary.org/obo/GO_0060338) (regulation of type I interferon-mediated signaling pathway), [GO:0060339](http://purl.obolibrary.org/obo/GO_0060339) (negative regulation of type I interferon-mediated signaling pathway), [GO:0005540](http://purl.obolibrary.org/obo/GO_0005540) (hyaluronic acid binding), [GO:0005543](http://purl.obolibrary.org/obo/GO_0005543) (phospholipid binding), [GO:1900128](http://purl.obolibrary.org/obo/GO_1900128) (regulation of G-protein activated inward rectifier potassium channel activity), [GO:0006875](http://purl.obolibrary.org/obo/GO_0006875) (cellular metal ion homeostasis), [GO:0006876](http://purl.obolibrary.org/obo/GO_0006876) (cellular cadmium ion homeostasis), [GO:0060335](http://purl.obolibrary.org/obo/GO_0060335) (positive regulation of interferon-gamma-mediated signaling pathway), [GO:0005542](http://purl.obolibrary.org/obo/GO_0005542) (folic acid binding), [GO:1900127](http://purl.obolibrary.org/obo/GO_1900127) (positive regulation of hyaluronan biosynthetic process), [GO:0006873](http://purl.obolibrary.org/obo/GO_0006873) (cellular ion homeostasis), [GO:0060336](http://purl.obolibrary.org/obo/GO_0060336) (negative regulation of interferon-gamma-mediated signaling pathway), [GO:0005545](http://purl.obolibrary.org/obo/GO_0005545) (1-phosphatidylinositol binding), [GO:0005544](http://purl.obolibrary.org/obo/GO_0005544) (calcium-dependent phospholipid binding), [GO:0006874](http://purl.obolibrary.org/obo/GO_0006874) (cellular calcium ion homeostasis), [GO:0060337](http://purl.obolibrary.org/obo/GO_0060337) (type I interferon signaling pathway), [GO:0005536](http://purl.obolibrary.org/obo/GO_0005536) (glucose binding), [GO:0006868](http://purl.obolibrary.org/obo/GO_0006868) (glutamine transport), [GO:0006869](http://purl.obolibrary.org/obo/GO_0006869) (lipid transport), [GO:0005537](http://purl.obolibrary.org/obo/GO_0005537) (mannose binding), [GO:0005539](http://purl.obolibrary.org/obo/GO_0005539) (glycosaminoglycan binding), [GO:2001294](http://purl.obolibrary.org/obo/GO_2001294) (malonyl-CoA catabolic process), [GO:0042537](http://purl.obolibrary.org/obo/GO_0042537) (benzene-containing compound metabolic process), [GO:2001295](http://purl.obolibrary.org/obo/GO_2001295) (malonyl-CoA biosynthetic process), [GO:0005592](http://purl.obolibrary.org/obo/GO_0005592) (collagen type XI trimer), [GO:0042531](http://purl.obolibrary.org/obo/GO_0042531) (positive regulation of tyrosine phosphorylation of STAT protein), [GO:0042532](http://purl.obolibrary.org/obo/GO_0042532) (negative regulation of tyrosine phosphorylation of STAT protein), [GO:0042535](http://purl.obolibrary.org/obo/GO_0042535) (positive regulation of tumor necrosis factor biosynthetic process), [GO:0030547](http://purl.obolibrary.org/obo/GO_0030547) (receptor inhibitor activity), [GO:0030549](http://purl.obolibrary.org/obo/GO_0030549) (acetylcholine receptor activator activity), [GO:0016250](http://purl.obolibrary.org/obo/GO_0016250) (N-sulfoglucosamine sulfohydrolase activity), [GO:0031870](http://purl.obolibrary.org/obo/GO_0031870) (thromboxane A2 receptor binding), [GO:0016255](http://purl.obolibrary.org/obo/GO_0016255) (attachment of GPI anchor to protein), [GO:0030540](http://purl.obolibrary.org/obo/GO_0030540) (female genitalia development), [GO:0016256](http://purl.obolibrary.org/obo/GO_0016256) (N-glycan processing to lysosome), [GO:2001287](http://purl.obolibrary.org/obo/GO_2001287) (negative regulation of caveolin-mediated endocytosis), [GO:0030544](http://purl.obolibrary.org/obo/GO_0030544) (Hsp70 protein binding), [GO:0016239](http://purl.obolibrary.org/obo/GO_0016239) (positive regulation of macroautophagy), [GO:0042541](http://purl.obolibrary.org/obo/GO_0042541) (hemoglobin biosynthetic process), [GO:0042542](http://purl.obolibrary.org/obo/GO_0042542) (response to hydrogen peroxide), [GO:0030538](http://purl.obolibrary.org/obo/GO_0030538) (embryonic genitalia morphogenesis), [GO:0030539](http://purl.obolibrary.org/obo/GO_0030539) (male genitalia development), [GO:0016240](http://purl.obolibrary.org/obo/GO_0016240) (autophagosome membrane docking), [GO:0016241](http://purl.obolibrary.org/obo/GO_0016241) (regulation of macroautophagy), [GO:0031860](http://purl.obolibrary.org/obo/GO_0031860) (telomeric 3' overhang formation), [GO:0016242](http://purl.obolibrary.org/obo/GO_0016242) (negative regulation of macroautophagy), [GO:0030532](http://purl.obolibrary.org/obo/GO_0030532) (small nuclear ribonucleoprotein complex), [GO:0030534](http://purl.obolibrary.org/obo/GO_0030534) (adult behavior), [GO:0016247](http://purl.obolibrary.org/obo/GO_0016247) (channel regulator activity), [GO:0042558](http://purl.obolibrary.org/obo/GO_0042558) (pteridine-containing compound metabolic process), [GO:0042559](http://purl.obolibrary.org/obo/GO_0042559) (pteridine-containing compound biosynthetic process), [GO:0016229](http://purl.obolibrary.org/obo/GO_0016229) (steroid dehydrogenase activity), [GO:0102704](http://purl.obolibrary.org/obo/GO_0102704) (GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity), [GO:0042551](http://purl.obolibrary.org/obo/GO_0042551) (neuron maturation), [GO:0042552](http://purl.obolibrary.org/obo/GO_0042552) (myelination), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0042554](http://purl.obolibrary.org/obo/GO_0042554) (superoxide anion generation), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0042555](http://purl.obolibrary.org/obo/GO_0042555) (MCM complex), [GO:0005578](http://purl.obolibrary.org/obo/GO_0005578) (proteinaceous extracellular matrix), [GO:0005577](http://purl.obolibrary.org/obo/GO_0005577) (fibrinogen complex), [GO:0030529](http://purl.obolibrary.org/obo/GO_0030529) (intracellular ribonucleoprotein complex), [GO:0043890](http://purl.obolibrary.org/obo/GO_0043890) (N-acetylgalactosamine-6-sulfatase activity), [GO:0016231](http://purl.obolibrary.org/obo/GO_0016231) (beta-N-acetylglucosaminidase activity), [GO:0016233](http://purl.obolibrary.org/obo/GO_0016233) (telomere capping), [GO:0016234](http://purl.obolibrary.org/obo/GO_0016234) (inclusion body), [GO:0030521](http://purl.obolibrary.org/obo/GO_0030521) (androgen receptor signaling pathway), [GO:0016235](http://purl.obolibrary.org/obo/GO_0016235) (aggresome), [GO:0030520](http://purl.obolibrary.org/obo/GO_0030520) (intracellular estrogen receptor signaling pathway), [GO:0016236](http://purl.obolibrary.org/obo/GO_0016236) (macroautophagy), [GO:0031852](http://purl.obolibrary.org/obo/GO_0031852) (mu-type opioid receptor binding), [GO:0016237](http://purl.obolibrary.org/obo/GO_0016237) (lysosomal microautophagy), [GO:0030522](http://purl.obolibrary.org/obo/GO_0030522) (intracellular receptor signaling pathway), [GO:0005581](http://purl.obolibrary.org/obo/GO_0005581) (collagen trimer), [GO:0004252](http://purl.obolibrary.org/obo/GO_0004252) (serine-type endopeptidase activity), [GO:0005583](http://purl.obolibrary.org/obo/GO_0005583) (fibrillar collagen trimer), [GO:0042562](http://purl.obolibrary.org/obo/GO_0042562) (hormone binding), [GO:0005585](http://purl.obolibrary.org/obo/GO_0005585) (collagen type II trimer), [GO:0005587](http://purl.obolibrary.org/obo/GO_0005587) (collagen type IV trimer), [GO:0005586](http://purl.obolibrary.org/obo/GO_0005586) (collagen type III trimer), [GO:0030514](http://purl.obolibrary.org/obo/GO_0030514) (negative regulation of BMP signaling pathway), [GO:0030513](http://purl.obolibrary.org/obo/GO_0030513) (positive regulation of BMP signaling pathway), [GO:0005579](http://purl.obolibrary.org/obo/GO_0005579) (membrane attack complex), [GO:0030516](http://purl.obolibrary.org/obo/GO_0030516) (regulation of axon extension), [GO:0030515](http://purl.obolibrary.org/obo/GO_0030515) (snoRNA binding), [GO:0030518](http://purl.obolibrary.org/obo/GO_0030518) (intracellular steroid hormone receptor signaling pathway), [GO:0030517](http://purl.obolibrary.org/obo/GO_0030517) (negative regulation of axon extension), [GO:0031848](http://purl.obolibrary.org/obo/GO_0031848) (protection from non-homologous end joining at telomere), [GO:0031849](http://purl.obolibrary.org/obo/GO_0031849) (olfactory receptor binding), [GO:0016222](http://purl.obolibrary.org/obo/GO_0016222) (procollagen-proline 4-dioxygenase complex), [GO:0030510](http://purl.obolibrary.org/obo/GO_0030510) (regulation of BMP signaling pathway), [GO:0030512](http://purl.obolibrary.org/obo/GO_0030512) (negative regulation of transforming growth factor beta receptor signaling pathway), [GO:0030511](http://purl.obolibrary.org/obo/GO_0030511) (positive regulation of transforming growth factor beta receptor signaling pathway), [GO:0016226](http://purl.obolibrary.org/obo/GO_0016226) (iron-sulfur cluster assembly), [GO:0072385](http://purl.obolibrary.org/obo/GO_0072385) (minus-end-directed organelle transport along microtubule), [GO:0097682](http://purl.obolibrary.org/obo/GO_0097682) (intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity), [GO:0072384](http://purl.obolibrary.org/obo/GO_0072384) (organelle transport along microtubule), [GO:0016290](http://purl.obolibrary.org/obo/GO_0016290) (palmitoyl-CoA hydrolase activity), [GO:0072382](http://purl.obolibrary.org/obo/GO_0072382) (minus-end-directed vesicle transport along microtubule), [GO:0072389](http://purl.obolibrary.org/obo/GO_0072389) (flavin adenine dinucleotide catabolic process), [GO:0097689](http://purl.obolibrary.org/obo/GO_0097689) (iron channel activity), [GO:0016298](http://purl.obolibrary.org/obo/GO_0016298) (lipase activity), [GO:0030586](http://purl.obolibrary.org/obo/GO_0030586) ([methionine synthase] reductase activity), [GO:1900182](http://purl.obolibrary.org/obo/GO_1900182) (positive regulation of protein localization to nucleus), [GO:0060396](http://purl.obolibrary.org/obo/GO_0060396) (growth hormone receptor signaling pathway), [GO:0060397](http://purl.obolibrary.org/obo/GO_0060397) (JAK-STAT cascade involved in growth hormone signaling pathway), [GO:0060399](http://purl.obolibrary.org/obo/GO_0060399) (positive regulation of growth hormone receptor signaling pathway), [GO:1900186](http://purl.obolibrary.org/obo/GO_1900186) (negative regulation of clathrin-dependent endocytosis), [GO:0000706](http://purl.obolibrary.org/obo/GO_0000706) (meiotic DNA double-strand break processing), [GO:0060394](http://purl.obolibrary.org/obo/GO_0060394) (negative regulation of pathway-restricted SMAD protein phosphorylation), [GO:0060395](http://purl.obolibrary.org/obo/GO_0060395) (SMAD protein signal transduction), [GO:0000703](http://purl.obolibrary.org/obo/GO_0000703) (oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity), [GO:0000701](http://purl.obolibrary.org/obo/GO_0000701) (purine-specific mismatch base pair DNA N-glycosylase activity), [GO:0042500](http://purl.obolibrary.org/obo/GO_0042500) (aspartic endopeptidase activity, intramembrane cleaving), [GO:0097694](http://purl.obolibrary.org/obo/GO_0097694) (establishment of RNA localization to telomere), [GO:0071042](http://purl.obolibrary.org/obo/GO_0071042) (nuclear polyadenylation-dependent mRNA catabolic process), [GO:0030579](http://purl.obolibrary.org/obo/GO_0030579) (ubiquitin-dependent SMAD protein catabolic process), [GO:0071041](http://purl.obolibrary.org/obo/GO_0071041) (antisense RNA transcript catabolic process), [GO:0097695](http://purl.obolibrary.org/obo/GO_0097695) (establishment of macromolecular complex localization to telomere), [GO:0072378](http://purl.obolibrary.org/obo/GO_0072378) (blood coagulation, fibrin clot formation), [GO:0071044](http://purl.obolibrary.org/obo/GO_0071044) (histone mRNA catabolic process), [GO:0030574](http://purl.obolibrary.org/obo/GO_0030574) (collagen catabolic process), [GO:0016287](http://purl.obolibrary.org/obo/GO_0016287) (glycerone-phosphate O-acyltransferase activity), [GO:0030573](http://purl.obolibrary.org/obo/GO_0030573) (bile acid catabolic process), [GO:1900180](http://purl.obolibrary.org/obo/GO_1900180) (regulation of protein localization to nucleus), [GO:1900194](http://purl.obolibrary.org/obo/GO_1900194) (negative regulation of oocyte maturation), [GO:0043849](http://purl.obolibrary.org/obo/GO_0043849) (Ras palmitoyltransferase activity), [GO:0098993](http://purl.obolibrary.org/obo/GO_0098993) (anchored component of synaptic vesicle membrane), [GO:0071073](http://purl.obolibrary.org/obo/GO_0071073) (positive regulation of phospholipid biosynthetic process), [GO:0071074](http://purl.obolibrary.org/obo/GO_0071074) (eukaryotic initiation factor eIF2 binding), [GO:0016274](http://purl.obolibrary.org/obo/GO_0016274) (protein-arginine N-methyltransferase activity), [GO:0016277](http://purl.obolibrary.org/obo/GO_0016277) ([myelin basic protein]-arginine N-methyltransferase activity), [GO:0016279](http://purl.obolibrary.org/obo/GO_0016279) (protein-lysine N-methyltransferase activity), [GO:0004298](http://purl.obolibrary.org/obo/GO_0004298) (threonine-type endopeptidase activity), [GO:0071071](http://purl.obolibrary.org/obo/GO_0071071) (regulation of phospholipid biosynthetic process), [GO:0097680](http://purl.obolibrary.org/obo/GO_0097680) (double-strand break repair via classical nonhomologous end joining), [GO:0072393](http://purl.obolibrary.org/obo/GO_0072393) (microtubule anchoring at microtubule organizing center), [GO:0097676](http://purl.obolibrary.org/obo/GO_0097676) (histone H3-K36 dimethylation), [GO:0016263](http://purl.obolibrary.org/obo/GO_0016263) (glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity), [GO:0016264](http://purl.obolibrary.org/obo/GO_0016264) (gap junction assembly), [GO:0030552](http://purl.obolibrary.org/obo/GO_0030552) (cAMP binding), [GO:0016267](http://purl.obolibrary.org/obo/GO_0016267) (O-glycan processing, core 1), [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding), [GO:0030553](http://purl.obolibrary.org/obo/GO_0030553) (cGMP binding), [GO:0001942](http://purl.obolibrary.org/obo/GO_0001942) (hair follicle development), [GO:0001944](http://purl.obolibrary.org/obo/GO_0001944) (vasculature development), [GO:0001945](http://purl.obolibrary.org/obo/GO_0001945) (lymph vessel development), [GO:0001946](http://purl.obolibrary.org/obo/GO_0001946) (lymphangiogenesis), [GO:0001947](http://purl.obolibrary.org/obo/GO_0001947) (heart looping), [GO:0090107](http://purl.obolibrary.org/obo/GO_0090107) (regulation of high-density lipoprotein particle assembly), [GO:0090104](http://purl.obolibrary.org/obo/GO_0090104) (pancreatic epsilon cell differentiation), [GO:0090102](http://purl.obolibrary.org/obo/GO_0090102) (cochlea development), [GO:0090103](http://purl.obolibrary.org/obo/GO_0090103) (cochlea morphogenesis), [GO:0001951](http://purl.obolibrary.org/obo/GO_0001951) (intestinal D-glucose absorption), [GO:0001952](http://purl.obolibrary.org/obo/GO_0001952) (regulation of cell-matrix adhesion), [GO:0001953](http://purl.obolibrary.org/obo/GO_0001953) (negative regulation of cell-matrix adhesion), [GO:0001954](http://purl.obolibrary.org/obo/GO_0001954) (positive regulation of cell-matrix adhesion), [GO:0001956](http://purl.obolibrary.org/obo/GO_0001956) (positive regulation of neurotransmitter secretion), [GO:0001957](http://purl.obolibrary.org/obo/GO_0001957) (intramembranous ossification), [GO:0001958](http://purl.obolibrary.org/obo/GO_0001958) (endochondral ossification), [GO:0030497](http://purl.obolibrary.org/obo/GO_0030497) (fatty acid elongation), [GO:0030496](http://purl.obolibrary.org/obo/GO_0030496) (midbody), [GO:0030491](http://purl.obolibrary.org/obo/GO_0030491) (heteroduplex formation), [GO:0030490](http://purl.obolibrary.org/obo/GO_0030490) (maturation of SSU-rRNA), [GO:0030492](http://purl.obolibrary.org/obo/GO_0030492) (hemoglobin binding), [GO:0016192](http://purl.obolibrary.org/obo/GO_0016192) (vesicle-mediated transport), [GO:0001920](http://purl.obolibrary.org/obo/GO_0001920) (negative regulation of receptor recycling), [GO:0001921](http://purl.obolibrary.org/obo/GO_0001921) (positive regulation of receptor recycling), [GO:0001922](http://purl.obolibrary.org/obo/GO_0001922) (B-1 B cell homeostasis), [GO:0016197](http://purl.obolibrary.org/obo/GO_0016197) (endosomal transport), [GO:0016199](http://purl.obolibrary.org/obo/GO_0016199) (axon midline choice point recognition), [GO:0030488](http://purl.obolibrary.org/obo/GO_0030488) (tRNA methylation), [GO:0050908](http://purl.obolibrary.org/obo/GO_0050908) (detection of light stimulus involved in visual perception), [GO:0050909](http://purl.obolibrary.org/obo/GO_0050909) (sensory perception of taste), [GO:0050905](http://purl.obolibrary.org/obo/GO_0050905) (neuromuscular process), [GO:0016182](http://purl.obolibrary.org/obo/GO_0016182) (synaptic vesicle budding from endosome), [GO:0001932](http://purl.obolibrary.org/obo/GO_0001932) (regulation of protein phosphorylation), [GO:0001933](http://purl.obolibrary.org/obo/GO_0001933) (negative regulation of protein phosphorylation), [GO:0001934](http://purl.obolibrary.org/obo/GO_0001934) (positive regulation of protein phosphorylation), [GO:0016185](http://purl.obolibrary.org/obo/GO_0016185) (synaptic vesicle budding from presynaptic endocytic zone membrane), [GO:0001935](http://purl.obolibrary.org/obo/GO_0001935) (endothelial cell proliferation), [GO:0030473](http://purl.obolibrary.org/obo/GO_0030473) (nuclear migration along microtubule), [GO:0001936](http://purl.obolibrary.org/obo/GO_0001936) (regulation of endothelial cell proliferation), [GO:0030472](http://purl.obolibrary.org/obo/GO_0030472) (mitotic spindle organization in nucleus), [GO:0001937](http://purl.obolibrary.org/obo/GO_0001937) (negative regulation of endothelial cell proliferation), [GO:0050900](http://purl.obolibrary.org/obo/GO_0050900) (leukocyte migration), [GO:0001938](http://purl.obolibrary.org/obo/GO_0001938) (positive regulation of endothelial cell proliferation), [GO:0030474](http://purl.obolibrary.org/obo/GO_0030474) (spindle pole body duplication), [GO:0050901](http://purl.obolibrary.org/obo/GO_0050901) (leukocyte tethering or rolling), [GO:0030476](http://purl.obolibrary.org/obo/GO_0030476) (ascospore wall assembly), [GO:0030479](http://purl.obolibrary.org/obo/GO_0030479) (actin cortical patch), [GO:0043783](http://purl.obolibrary.org/obo/GO_0043783) (oxidoreductase activity, oxidizing metal ions with flavin as acceptor), [GO:0001991](http://purl.obolibrary.org/obo/GO_0001991) (regulation of systemic arterial blood pressure by circulatory renin-angiotensin), [GO:0001988](http://purl.obolibrary.org/obo/GO_0001988) (positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure), [GO:0042461](http://purl.obolibrary.org/obo/GO_0042461) (photoreceptor cell development), [GO:0042462](http://purl.obolibrary.org/obo/GO_0042462) (eye photoreceptor cell development), [GO:0009008](http://purl.obolibrary.org/obo/GO_0009008) (DNA-methyltransferase activity), [GO:0001993](http://purl.obolibrary.org/obo/GO_0001993) (regulation of systemic arterial blood pressure by norepinephrine-epinephrine), [GO:0042470](http://purl.obolibrary.org/obo/GO_0042470) (melanosome), [GO:0001998](http://purl.obolibrary.org/obo/GO_0001998) (angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure), [GO:0042471](http://purl.obolibrary.org/obo/GO_0042471) (ear morphogenesis), [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis), [GO:0042473](http://purl.obolibrary.org/obo/GO_0042473) (outer ear morphogenesis), [GO:0042474](http://purl.obolibrary.org/obo/GO_0042474) (middle ear morphogenesis), [GO:0042475](http://purl.obolibrary.org/obo/GO_0042475) (odontogenesis of dentin-containing tooth), [GO:0042476](http://purl.obolibrary.org/obo/GO_0042476) (odontogenesis), [GO:0001970](http://purl.obolibrary.org/obo/GO_0001970) (positive regulation of activation of membrane attack complex), [GO:0001960](http://purl.obolibrary.org/obo/GO_0001960) (negative regulation of cytokine-mediated signaling pathway), [GO:0001963](http://purl.obolibrary.org/obo/GO_0001963) (synaptic transmission, dopaminergic), [GO:0001964](http://purl.obolibrary.org/obo/GO_0001964) (startle response), [GO:0042481](http://purl.obolibrary.org/obo/GO_0042481) (regulation of odontogenesis), [GO:0001965](http://purl.obolibrary.org/obo/GO_0001965) (G-protein alpha-subunit binding), [GO:0001966](http://purl.obolibrary.org/obo/GO_0001966) (thigmotaxis), [GO:0042482](http://purl.obolibrary.org/obo/GO_0042482) (positive regulation of odontogenesis), [GO:0001967](http://purl.obolibrary.org/obo/GO_0001967) (suckling behavior), [GO:0001968](http://purl.obolibrary.org/obo/GO_0001968) (fibronectin binding), [GO:0042487](http://purl.obolibrary.org/obo/GO_0042487) (regulation of odontogenesis of dentin-containing tooth), [GO:0001980](http://purl.obolibrary.org/obo/GO_0001980) (regulation of systemic arterial blood pressure by ischemic conditions), [GO:0001971](http://purl.obolibrary.org/obo/GO_0001971) (negative regulation of activation of membrane attack complex), [GO:0001972](http://purl.obolibrary.org/obo/GO_0001972) (retinoic acid binding), [GO:0001973](http://purl.obolibrary.org/obo/GO_0001973) (adenosine receptor signaling pathway), [GO:0001974](http://purl.obolibrary.org/obo/GO_0001974) (blood vessel remodeling), [GO:0042490](http://purl.obolibrary.org/obo/GO_0042490) (mechanoreceptor differentiation), [GO:0042491](http://purl.obolibrary.org/obo/GO_0042491) (inner ear auditory receptor cell differentiation), [GO:0001975](http://purl.obolibrary.org/obo/GO_0001975) (response to amphetamine), [GO:0042493](http://purl.obolibrary.org/obo/GO_0042493) (response to drug), [GO:0009032](http://purl.obolibrary.org/obo/GO_0009032) (thymidine phosphorylase activity), [GO:1902710](http://purl.obolibrary.org/obo/GO_1902710) (GABA receptor complex), [GO:0022006](http://purl.obolibrary.org/obo/GO_0022006) (zona limitans intrathalamica formation), [GO:0048635](http://purl.obolibrary.org/obo/GO_0048635) (negative regulation of muscle organ development), [GO:1902711](http://purl.obolibrary.org/obo/GO_1902711) (GABA-A receptor complex), [GO:0061615](http://purl.obolibrary.org/obo/GO_0061615) (glycolytic process through fructose-6-phosphate), [GO:0022008](http://purl.obolibrary.org/obo/GO_0022008) (neurogenesis), [GO:0048633](http://purl.obolibrary.org/obo/GO_0048633) (positive regulation of skeletal muscle tissue growth), [GO:0090171](http://purl.obolibrary.org/obo/GO_0090171) (chondrocyte morphogenesis), [GO:0061611](http://purl.obolibrary.org/obo/GO_0061611) (mannose to fructose-6-phosphate metabolic process), [GO:0048639](http://purl.obolibrary.org/obo/GO_0048639) (positive regulation of developmental growth), [GO:0022010](http://purl.obolibrary.org/obo/GO_0022010) (central nervous system myelination), [GO:0022011](http://purl.obolibrary.org/obo/GO_0022011) (myelination in peripheral nervous system), [GO:0048643](http://purl.obolibrary.org/obo/GO_0048643) (positive regulation of skeletal muscle tissue development), [GO:0061618](http://purl.obolibrary.org/obo/GO_0061618) (sublamina densa), [GO:0048642](http://purl.obolibrary.org/obo/GO_0048642) (negative regulation of skeletal muscle tissue development), [GO:0061619](http://purl.obolibrary.org/obo/GO_0061619) (glycolytic process from mannose through fructose-6-phosphate), [GO:0048641](http://purl.obolibrary.org/obo/GO_0048641) (regulation of skeletal muscle tissue development), [GO:0048640](http://purl.obolibrary.org/obo/GO_0048640) (negative regulation of developmental growth), [GO:0050957](http://purl.obolibrary.org/obo/GO_0050957) (equilibrioception), [GO:0050953](http://purl.obolibrary.org/obo/GO_0050953) (sensory perception of light stimulus), [GO:0035312](http://purl.obolibrary.org/obo/GO_0035312) (5'-3' exodeoxyribonuclease activity), [GO:0050954](http://purl.obolibrary.org/obo/GO_0050954) (sensory perception of mechanical stimulus), [GO:0035315](http://purl.obolibrary.org/obo/GO_0035315) (hair cell differentiation), [GO:0098908](http://purl.obolibrary.org/obo/GO_0098908) (regulation of neuronal action potential), [GO:0010033](http://purl.obolibrary.org/obo/GO_0010033) (response to organic substance), [GO:0098909](http://purl.obolibrary.org/obo/GO_0098909) (regulation of cardiac muscle cell action potential involved in regulation of contraction), [GO:0090188](http://purl.obolibrary.org/obo/GO_0090188) (negative regulation of pancreatic juice secretion), [GO:1902721](http://purl.obolibrary.org/obo/GO_1902721) (negative regulation of prolactin secretion), [GO:0048646](http://purl.obolibrary.org/obo/GO_0048646) (anatomical structure formation involved in morphogenesis), [GO:0048645](http://purl.obolibrary.org/obo/GO_0048645) (animal organ formation), [GO:0009048](http://purl.obolibrary.org/obo/GO_0009048) (dosage compensation by inactivation of X chromosome), [GO:0048644](http://purl.obolibrary.org/obo/GO_0048644) (muscle organ morphogenesis), [GO:1902723](http://purl.obolibrary.org/obo/GO_1902723) (negative regulation of skeletal muscle satellite cell proliferation), [GO:0090181](http://purl.obolibrary.org/obo/GO_0090181) (regulation of cholesterol metabolic process), [GO:0090190](http://purl.obolibrary.org/obo/GO_0090190) (positive regulation of branching involved in ureteric bud morphogenesis), [GO:0047323](http://purl.obolibrary.org/obo/GO_0047323) ([3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity), [GO:0061609](http://purl.obolibrary.org/obo/GO_0061609) (fructose-1-phosphate aldolase activity), [GO:0035307](http://purl.obolibrary.org/obo/GO_0035307) (positive regulation of protein dephosphorylation), [GO:0050966](http://purl.obolibrary.org/obo/GO_0050966) (detection of mechanical stimulus involved in sensory perception of pain), [GO:0098900](http://purl.obolibrary.org/obo/GO_0098900) (regulation of action potential), [GO:0098906](http://purl.obolibrary.org/obo/GO_0098906) (regulation of Purkinje myocyte action potential), [GO:0035301](http://purl.obolibrary.org/obo/GO_0035301) (Hedgehog signaling complex), [GO:0050965](http://purl.obolibrary.org/obo/GO_0050965) (detection of temperature stimulus involved in sensory perception of pain), [GO:0098904](http://purl.obolibrary.org/obo/GO_0098904) (regulation of AV node cell action potential), [GO:0035303](http://purl.obolibrary.org/obo/GO_0035303) (regulation of dephosphorylation), [GO:0098905](http://purl.obolibrary.org/obo/GO_0098905) (regulation of bundle of His cell action potential), [GO:0010025](http://purl.obolibrary.org/obo/GO_0010025) (wax biosynthetic process), [GO:0061630](http://purl.obolibrary.org/obo/GO_0061630) (ubiquitin protein ligase activity), [GO:0060300](http://purl.obolibrary.org/obo/GO_0060300) (regulation of cytokine activity), [GO:0009013](http://purl.obolibrary.org/obo/GO_0009013) (succinate-semialdehyde dehydrogenase [NAD(P)+] activity), [GO:0090158](http://purl.obolibrary.org/obo/GO_0090158) (endoplasmic reticulum membrane organization), [GO:0090153](http://purl.obolibrary.org/obo/GO_0090153) (regulation of sphingolipid biosynthetic process), [GO:0060306](http://purl.obolibrary.org/obo/GO_0060306) (regulation of membrane repolarization), [GO:0060307](http://purl.obolibrary.org/obo/GO_0060307) (regulation of ventricular cardiac muscle cell membrane repolarization), [GO:0061632](http://purl.obolibrary.org/obo/GO_0061632) (RNA lariat debranching enzyme activator activity), [GO:0090150](http://purl.obolibrary.org/obo/GO_0090150) (establishment of protein localization to membrane), [GO:0060302](http://purl.obolibrary.org/obo/GO_0060302) (negative regulation of cytokine activity), [GO:0009019](http://purl.obolibrary.org/obo/GO_0009019) (tRNA (guanine-N1-)-methyltransferase activity), [GO:0061635](http://purl.obolibrary.org/obo/GO_0061635) (regulation of protein complex stability), [GO:0060304](http://purl.obolibrary.org/obo/GO_0060304) (regulation of phosphatidylinositol dephosphorylation), [GO:0048659](http://purl.obolibrary.org/obo/GO_0048659) (smooth muscle cell proliferation), [GO:0048661](http://purl.obolibrary.org/obo/GO_0048661) (positive regulation of smooth muscle cell proliferation), [GO:0048660](http://purl.obolibrary.org/obo/GO_0048660) (regulation of smooth muscle cell proliferation), [GO:1902728](http://purl.obolibrary.org/obo/GO_1902728) (positive regulation of growth factor dependent skeletal muscle satellite cell proliferation), [GO:0048665](http://purl.obolibrary.org/obo/GO_0048665) (neuron fate specification), [GO:0048664](http://purl.obolibrary.org/obo/GO_0048664) (neuron fate determination), [GO:0048663](http://purl.obolibrary.org/obo/GO_0048663) (neuron fate commitment), [GO:0048662](http://purl.obolibrary.org/obo/GO_0048662) (negative regulation of smooth muscle cell proliferation), [GO:0050973](http://purl.obolibrary.org/obo/GO_0050973) (detection of mechanical stimulus involved in equilibrioception), [GO:0050974](http://purl.obolibrary.org/obo/GO_0050974) (detection of mechanical stimulus involved in sensory perception), [GO:0061620](http://purl.obolibrary.org/obo/GO_0061620) (glycolytic process through glucose-6-phosphate), [GO:0009022](http://purl.obolibrary.org/obo/GO_0009022) (tRNA nucleotidyltransferase activity), [GO:0048669](http://purl.obolibrary.org/obo/GO_0048669) (collateral sprouting in absence of injury), [GO:0061625](http://purl.obolibrary.org/obo/GO_0061625) (glycolytic process through fructose-1-phosphate), [GO:0061626](http://purl.obolibrary.org/obo/GO_0061626) (pharyngeal arch artery morphogenesis), [GO:0048668](http://purl.obolibrary.org/obo/GO_0048668) (collateral sprouting), [GO:0046007](http://purl.obolibrary.org/obo/GO_0046007) (negative regulation of activated T cell proliferation), [GO:1902741](http://purl.obolibrary.org/obo/GO_1902741) (positive regulation of interferon-alpha secretion), [GO:0048667](http://purl.obolibrary.org/obo/GO_0048667) (cell morphogenesis involved in neuron differentiation), [GO:0048666](http://purl.obolibrary.org/obo/GO_0048666) (neuron development), [GO:1902742](http://purl.obolibrary.org/obo/GO_1902742) (apoptotic process involved in development), [GO:0090160](http://purl.obolibrary.org/obo/GO_0090160) (Golgi to lysosome transport), [GO:0061621](http://purl.obolibrary.org/obo/GO_0061621) (canonical glycolysis), [GO:0090161](http://purl.obolibrary.org/obo/GO_0090161) (Golgi ribbon formation), [GO:0061623](http://purl.obolibrary.org/obo/GO_0061623) (glycolytic process from galactose), [GO:1902746](http://purl.obolibrary.org/obo/GO_1902746) (regulation of lens fiber cell differentiation), [GO:0061624](http://purl.obolibrary.org/obo/GO_0061624) (fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate), [GO:0048672](http://purl.obolibrary.org/obo/GO_0048672) (positive regulation of collateral sprouting), [GO:0050982](http://purl.obolibrary.org/obo/GO_0050982) (detection of mechanical stimulus), [GO:0048671](http://purl.obolibrary.org/obo/GO_0048671) (negative regulation of collateral sprouting), [GO:0048670](http://purl.obolibrary.org/obo/GO_0048670) (regulation of collateral sprouting), [GO:0061629](http://purl.obolibrary.org/obo/GO_0061629) (RNA polymerase II sequence-specific DNA binding transcription factor binding), [GO:0048675](http://purl.obolibrary.org/obo/GO_0048675) (axon extension), [GO:0010008](http://purl.obolibrary.org/obo/GO_0010008) (endosome membrane), [GO:0010002](http://purl.obolibrary.org/obo/GO_0010002) (cardioblast differentiation), [GO:0010001](http://purl.obolibrary.org/obo/GO_0010001) (glial cell differentiation), [GO:0090139](http://purl.obolibrary.org/obo/GO_0090139) (mitochondrial DNA packaging), [GO:0009074](http://purl.obolibrary.org/obo/GO_0009074) (aromatic amino acid family catabolic process), [GO:0009072](http://purl.obolibrary.org/obo/GO_0009072) (aromatic amino acid family metabolic process), [GO:0090135](http://purl.obolibrary.org/obo/GO_0090135) (actin filament branching), [GO:0035360](http://purl.obolibrary.org/obo/GO_0035360) (positive regulation of peroxisome proliferator activated receptor signaling pathway), [GO:0050918](http://purl.obolibrary.org/obo/GO_0050918) (positive chemotaxis), [GO:0090136](http://purl.obolibrary.org/obo/GO_0090136) (epithelial cell-cell adhesion), [GO:0090131](http://purl.obolibrary.org/obo/GO_0090131) (mesenchyme migration), [GO:0090132](http://purl.obolibrary.org/obo/GO_0090132) (epithelium migration), [GO:0035356](http://purl.obolibrary.org/obo/GO_0035356) (cellular triglyceride homeostasis), [GO:0050910](http://purl.obolibrary.org/obo/GO_0050910) (detection of mechanical stimulus involved in sensory perception of sound), [GO:0009070](http://purl.obolibrary.org/obo/GO_0009070) (serine family amino acid biosynthetic process), [GO:0035357](http://purl.obolibrary.org/obo/GO_0035357) (peroxisome proliferator activated receptor signaling pathway), [GO:0035359](http://purl.obolibrary.org/obo/GO_0035359) (negative regulation of peroxisome proliferator activated receptor signaling pathway), [GO:0009086](http://purl.obolibrary.org/obo/GO_0009086) (methionine biosynthetic process), [GO:0009085](http://purl.obolibrary.org/obo/GO_0009085) (lysine biosynthetic process), [GO:0048609](http://purl.obolibrary.org/obo/GO_0048609) (multicellular organismal reproductive process), [GO:0009083](http://purl.obolibrary.org/obo/GO_0009083) (branched-chain amino acid catabolic process), [GO:0048608](http://purl.obolibrary.org/obo/GO_0048608) (reproductive structure development), [GO:0035350](http://purl.obolibrary.org/obo/GO_0035350) (FAD transmembrane transport), [GO:0009088](http://purl.obolibrary.org/obo/GO_0009088) (threonine biosynthetic process), [GO:0009087](http://purl.obolibrary.org/obo/GO_0009087) (methionine catabolic process), [GO:0050927](http://purl.obolibrary.org/obo/GO_0050927) (positive regulation of positive chemotaxis), [GO:0090140](http://purl.obolibrary.org/obo/GO_0090140) (regulation of mitochondrial fission), [GO:0090141](http://purl.obolibrary.org/obo/GO_0090141) (positive regulation of mitochondrial fission), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0022038](http://purl.obolibrary.org/obo/GO_0022038) (corpus callosum development), [GO:0006801](http://purl.obolibrary.org/obo/GO_0006801) (superoxide metabolic process), [GO:0006807](http://purl.obolibrary.org/obo/GO_0006807) (nitrogen compound metabolic process), [GO:0006805](http://purl.obolibrary.org/obo/GO_0006805) (xenobiotic metabolic process), [GO:0006808](http://purl.obolibrary.org/obo/GO_0006808) (regulation of nitrogen utilization), [GO:0006809](http://purl.obolibrary.org/obo/GO_0006809) (nitric oxide biosynthetic process), [GO:0050921](http://purl.obolibrary.org/obo/GO_0050921) (positive regulation of chemotaxis), [GO:0009081](http://purl.obolibrary.org/obo/GO_0009081) (branched-chain amino acid metabolic process), [GO:0010042](http://purl.obolibrary.org/obo/GO_0010042) (response to manganese ion), [GO:0009052](http://purl.obolibrary.org/obo/GO_0009052) (pentose-phosphate shunt, non-oxidative branch), [GO:0090118](http://purl.obolibrary.org/obo/GO_0090118) (receptor-mediated endocytosis involved in cholesterol transport), [GO:0010044](http://purl.obolibrary.org/obo/GO_0010044) (response to aluminum ion), [GO:0009051](http://purl.obolibrary.org/obo/GO_0009051) (pentose-phosphate shunt, oxidative branch), [GO:0010043](http://purl.obolibrary.org/obo/GO_0010043) (response to zinc ion), [GO:0048619](http://purl.obolibrary.org/obo/GO_0048619) (embryonic hindgut morphogenesis), [GO:0090116](http://purl.obolibrary.org/obo/GO_0090116) (C-5 methylation of cytosine), [GO:0090114](http://purl.obolibrary.org/obo/GO_0090114) (COPII-coated vesicle budding), [GO:0009055](http://purl.obolibrary.org/obo/GO_0009055) (electron transfer activity), [GO:0010040](http://purl.obolibrary.org/obo/GO_0010040) (response to iron(II) ion), [GO:0022028](http://purl.obolibrary.org/obo/GO_0022028) (tangential migration from the subventricular zone to the olfactory bulb), [GO:0090110](http://purl.obolibrary.org/obo/GO_0090110) (cargo loading into COPII-coated vesicle), [GO:0009058](http://purl.obolibrary.org/obo/GO_0009058) (biosynthetic process), [GO:0048617](http://purl.obolibrary.org/obo/GO_0048617) (embryonic foregut morphogenesis), [GO:0022027](http://purl.obolibrary.org/obo/GO_0022027) (interkinetic nuclear migration), [GO:0010039](http://purl.obolibrary.org/obo/GO_0010039) (response to iron ion), [GO:0050935](http://purl.obolibrary.org/obo/GO_0050935) (iridophore differentiation), [GO:0035338](http://purl.obolibrary.org/obo/GO_0035338) (long-chain fatty-acyl-CoA biosynthetic process), [GO:0010038](http://purl.obolibrary.org/obo/GO_0010038) (response to metal ion), [GO:0050936](http://purl.obolibrary.org/obo/GO_0050936) (xanthophore differentiation), [GO:0035339](http://purl.obolibrary.org/obo/GO_0035339) (SPOTS complex), [GO:0010035](http://purl.obolibrary.org/obo/GO_0010035) (response to inorganic substance), [GO:0050931](http://purl.obolibrary.org/obo/GO_0050931) (pigment cell differentiation), [GO:0035335](http://purl.obolibrary.org/obo/GO_0035335) (peptidyl-tyrosine dephosphorylation), [GO:0010037](http://purl.obolibrary.org/obo/GO_0010037) (response to carbon dioxide), [GO:0035336](http://purl.obolibrary.org/obo/GO_0035336) (long-chain fatty-acyl-CoA metabolic process), [GO:0050930](http://purl.obolibrary.org/obo/GO_0050930) (induction of positive chemotaxis), [GO:0035330](http://purl.obolibrary.org/obo/GO_0035330) (regulation of hippo signaling), [GO:0009063](http://purl.obolibrary.org/obo/GO_0009063) (cellular amino acid catabolic process), [GO:0090129](http://purl.obolibrary.org/obo/GO_0090129) (positive regulation of synapse maturation), [GO:0009062](http://purl.obolibrary.org/obo/GO_0009062) (fatty acid catabolic process), [GO:0009061](http://purl.obolibrary.org/obo/GO_0009061) (anaerobic respiration), [GO:0048625](http://purl.obolibrary.org/obo/GO_0048625) (myoblast fate commitment), [GO:0048632](http://purl.obolibrary.org/obo/GO_0048632) (negative regulation of skeletal muscle tissue growth), [GO:0035327](http://purl.obolibrary.org/obo/GO_0035327) (transcriptionally active chromatin), [GO:0035329](http://purl.obolibrary.org/obo/GO_0035329) (hippo signaling), [GO:0009060](http://purl.obolibrary.org/obo/GO_0009060) (aerobic respiration), [GO:0010046](http://purl.obolibrary.org/obo/GO_0010046) (response to mycotoxin), [GO:0010045](http://purl.obolibrary.org/obo/GO_0010045) (response to nickel cation), [GO:0035325](http://purl.obolibrary.org/obo/GO_0035325) (Toll-like receptor binding), [GO:0035326](http://purl.obolibrary.org/obo/GO_0035326) (enhancer binding), [GO:0060485](http://purl.obolibrary.org/obo/GO_0060485) (mesenchyme development), [GO:0060486](http://purl.obolibrary.org/obo/GO_0060486) (Clara cell differentiation), [GO:0060487](http://purl.obolibrary.org/obo/GO_0060487) (lung epithelial cell differentiation), [GO:0034198](http://purl.obolibrary.org/obo/GO_0034198) (cellular response to amino acid starvation), [GO:0034197](http://purl.obolibrary.org/obo/GO_0034197) (triglyceride transport), [GO:1901342](http://purl.obolibrary.org/obo/GO_1901342) (regulation of vasculature development), [GO:1900015](http://purl.obolibrary.org/obo/GO_1900015) (regulation of cytokine production involved in inflammatory response), [GO:0004300](http://purl.obolibrary.org/obo/GO_0004300) (enoyl-CoA hydratase activity), [GO:1900017](http://purl.obolibrary.org/obo/GO_1900017) (positive regulation of cytokine production involved in inflammatory response), [GO:0034191](http://purl.obolibrary.org/obo/GO_0034191) (apolipoprotein A-I receptor binding), [GO:0034190](http://purl.obolibrary.org/obo/GO_0034190) (apolipoprotein receptor binding), [GO:0004301](http://purl.obolibrary.org/obo/GO_0004301) (epoxide hydrolase activity), [GO:0006956](http://purl.obolibrary.org/obo/GO_0006956) (complement activation), [GO:0046185](http://purl.obolibrary.org/obo/GO_0046185) (aldehyde catabolic process), [GO:0006957](http://purl.obolibrary.org/obo/GO_0006957) (complement activation, alternative pathway), [GO:0005623](http://purl.obolibrary.org/obo/GO_0005623) (cell), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0005628](http://purl.obolibrary.org/obo/GO_0005628) (prospore membrane), [GO:0006958](http://purl.obolibrary.org/obo/GO_0006958) (complement activation, classical pathway), [GO:0006959](http://purl.obolibrary.org/obo/GO_0006959) (humoral immune response), [GO:0034185](http://purl.obolibrary.org/obo/GO_0034185) (apolipoprotein binding), [GO:0034184](http://purl.obolibrary.org/obo/GO_0034184) (positive regulation of maintenance of mitotic sister chromatid cohesion), [GO:0034189](http://purl.obolibrary.org/obo/GO_0034189) (very-low-density lipoprotein particle binding), [GO:1900020](http://purl.obolibrary.org/obo/GO_1900020) (positive regulation of protein kinase C activity), [GO:0060471](http://purl.obolibrary.org/obo/GO_0060471) (cortical granule exocytosis), [GO:0034186](http://purl.obolibrary.org/obo/GO_0034186) (apolipoprotein A-I binding), [GO:0006970](http://purl.obolibrary.org/obo/GO_0006970) (response to osmotic stress), [GO:0006971](http://purl.obolibrary.org/obo/GO_0006971) (hypotonic response), [GO:0005640](http://purl.obolibrary.org/obo/GO_0005640) (nuclear outer membrane), [GO:1902686](http://purl.obolibrary.org/obo/GO_1902686) (mitochondrial outer membrane permeabilization involved in programmed cell death), [GO:1900027](http://purl.obolibrary.org/obo/GO_1900027) (regulation of ruffle assembly), [GO:1900026](http://purl.obolibrary.org/obo/GO_1900026) (positive regulation of substrate adhesion-dependent cell spreading), [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus), [GO:0004311](http://purl.obolibrary.org/obo/GO_0004311) (farnesyltranstransferase activity), [GO:1900029](http://purl.obolibrary.org/obo/GO_1900029) (positive regulation of ruffle assembly), [GO:0005642](http://purl.obolibrary.org/obo/GO_0005642) (annulate lamellae), [GO:0006975](http://purl.obolibrary.org/obo/GO_0006975) (DNA damage induced protein phosphorylation), [GO:0005641](http://purl.obolibrary.org/obo/GO_0005641) (nuclear envelope lumen), [GO:0006972](http://purl.obolibrary.org/obo/GO_0006972) (hyperosmotic response), [GO:0005643](http://purl.obolibrary.org/obo/GO_0005643) (nuclear pore), [GO:0005635](http://purl.obolibrary.org/obo/GO_0005635) (nuclear envelope), [GO:0031901](http://purl.obolibrary.org/obo/GO_0031901) (early endosome membrane), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0031902](http://purl.obolibrary.org/obo/GO_0031902) (late endosome membrane), [GO:0006968](http://purl.obolibrary.org/obo/GO_0006968) (cellular defense response), [GO:0004303](http://purl.obolibrary.org/obo/GO_0004303) (estradiol 17-beta-dehydrogenase activity), [GO:0005637](http://purl.obolibrary.org/obo/GO_0005637) (nuclear inner membrane), [GO:0004305](http://purl.obolibrary.org/obo/GO_0004305) (ethanolamine kinase activity), [GO:0005639](http://purl.obolibrary.org/obo/GO_0005639) (integral component of nuclear inner membrane), [GO:0004308](http://purl.obolibrary.org/obo/GO_0004308) (exo-alpha-sialidase activity), [GO:0005638](http://purl.obolibrary.org/obo/GO_0005638) (lamin filament), [GO:0004309](http://purl.obolibrary.org/obo/GO_0004309) (exopolyphosphatase activity), [GO:0043923](http://purl.obolibrary.org/obo/GO_0043923) (positive regulation by host of viral transcription), [GO:0006941](http://purl.obolibrary.org/obo/GO_0006941) (striated muscle contraction), [GO:0006942](http://purl.obolibrary.org/obo/GO_0006942) (regulation of striated muscle contraction), [GO:0006940](http://purl.obolibrary.org/obo/GO_0006940) (regulation of smooth muscle contraction), [GO:0006935](http://purl.obolibrary.org/obo/GO_0006935) (chemotaxis), [GO:0005604](http://purl.obolibrary.org/obo/GO_0005604) (basement membrane), [GO:0006933](http://purl.obolibrary.org/obo/GO_0006933) (negative regulation of cell adhesion involved in substrate-bound cell migration), [GO:0071157](http://purl.obolibrary.org/obo/GO_0071157) (negative regulation of cell cycle arrest), [GO:0005605](http://purl.obolibrary.org/obo/GO_0005605) (basal lamina), [GO:0006939](http://purl.obolibrary.org/obo/GO_0006939) (smooth muscle contraction), [GO:0006936](http://purl.obolibrary.org/obo/GO_0006936) (muscle contraction), [GO:0006937](http://purl.obolibrary.org/obo/GO_0006937) (regulation of muscle contraction), [GO:0097746](http://purl.obolibrary.org/obo/GO_0097746) (regulation of blood vessel diameter), [GO:0097745](http://purl.obolibrary.org/obo/GO_0097745) (mitochondrial tRNA 5'-end processing), [GO:0071158](http://purl.obolibrary.org/obo/GO_0071158) (positive regulation of cell cycle arrest), [GO:2001107](http://purl.obolibrary.org/obo/GO_2001107) (negative regulation of Rho guanyl-nucleotide exchange factor activity), [GO:0097749](http://purl.obolibrary.org/obo/GO_0097749) (membrane tubulation), [GO:0035497](http://purl.obolibrary.org/obo/GO_0035497) (cAMP response element binding), [GO:0042605](http://purl.obolibrary.org/obo/GO_0042605) (peptide antigen binding), [GO:1901373](http://purl.obolibrary.org/obo/GO_1901373) (lipid hydroperoxide transport), [GO:0035493](http://purl.obolibrary.org/obo/GO_0035493) (SNARE complex assembly), [GO:0042608](http://purl.obolibrary.org/obo/GO_0042608) (T cell receptor binding), [GO:1901379](http://purl.obolibrary.org/obo/GO_1901379) (regulation of potassium ion transmembrane transport), [GO:0006952](http://purl.obolibrary.org/obo/GO_0006952) (defense response), [GO:0006953](http://purl.obolibrary.org/obo/GO_0006953) (acute-phase response), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0071141](http://purl.obolibrary.org/obo/GO_0071141) (SMAD protein complex), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005614](http://purl.obolibrary.org/obo/GO_0005614) (interstitial matrix), [GO:0097752](http://purl.obolibrary.org/obo/GO_0097752) (regulation of DNA stability), [GO:0097755](http://purl.obolibrary.org/obo/GO_0097755) (positive regulation of blood vessel diameter), [GO:0006948](http://purl.obolibrary.org/obo/GO_0006948) (induction by virus of host cell-cell fusion), [GO:0097756](http://purl.obolibrary.org/obo/GO_0097756) (negative regulation of blood vessel diameter), [GO:0016327](http://purl.obolibrary.org/obo/GO_0016327) (apicolateral plasma membrane), [GO:0061772](http://purl.obolibrary.org/obo/GO_0061772) (drug transport across blood-nerve barrier), [GO:0060441](http://purl.obolibrary.org/obo/GO_0060441) (epithelial tube branching involved in lung morphogenesis), [GO:0016328](http://purl.obolibrary.org/obo/GO_0016328) (lateral plasma membrane), [GO:0060442](http://purl.obolibrary.org/obo/GO_0060442) (branching involved in prostate gland morphogenesis), [GO:1902630](http://purl.obolibrary.org/obo/GO_1902630) (regulation of membrane hyperpolarization), [GO:0004340](http://purl.obolibrary.org/obo/GO_0004340) (glucokinase activity), [GO:0005673](http://purl.obolibrary.org/obo/GO_0005673) (transcription factor TFIIE complex), [GO:0048798](http://purl.obolibrary.org/obo/GO_0048798) (swim bladder inflation), [GO:0003011](http://purl.obolibrary.org/obo/GO_0003011) (involuntary skeletal muscle contraction), [GO:0003012](http://purl.obolibrary.org/obo/GO_0003012) (muscle system process), [GO:0005675](http://purl.obolibrary.org/obo/GO_0005675) (holo TFIIH complex), [GO:0060445](http://purl.obolibrary.org/obo/GO_0060445) (branching involved in salivary gland morphogenesis), [GO:0003014](http://purl.obolibrary.org/obo/GO_0003014) (renal system process), [GO:0004346](http://purl.obolibrary.org/obo/GO_0004346) (glucose-6-phosphatase activity), [GO:0005677](http://purl.obolibrary.org/obo/GO_0005677) (chromatin silencing complex), [GO:1902636](http://purl.obolibrary.org/obo/GO_1902636) (kinociliary basal body), [GO:0004345](http://purl.obolibrary.org/obo/GO_0004345) (glucose-6-phosphate dehydrogenase activity), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0003006](http://purl.obolibrary.org/obo/GO_0003006) (developmental process involved in reproduction), [GO:0004336](http://purl.obolibrary.org/obo/GO_0004336) (galactosylceramidase activity), [GO:0031957](http://purl.obolibrary.org/obo/GO_0031957) (very long-chain fatty acid-CoA ligase activity), [GO:1903959](http://purl.obolibrary.org/obo/GO_1903959) (regulation of anion transmembrane transport), [GO:0003007](http://purl.obolibrary.org/obo/GO_0003007) (heart morphogenesis), [GO:0006998](http://purl.obolibrary.org/obo/GO_0006998) (nuclear envelope organization), [GO:0031954](http://purl.obolibrary.org/obo/GO_0031954) (positive regulation of protein autophosphorylation), [GO:0006999](http://purl.obolibrary.org/obo/GO_0006999) (nuclear pore organization), [GO:0005669](http://purl.obolibrary.org/obo/GO_0005669) (transcription factor TFIID complex), [GO:0003009](http://purl.obolibrary.org/obo/GO_0003009) (skeletal muscle contraction), [GO:0097720](http://purl.obolibrary.org/obo/GO_0097720) (calcineurin-mediated signaling), [GO:0046146](http://purl.obolibrary.org/obo/GO_0046146) (tetrahydrobiopterin metabolic process), [GO:0031959](http://purl.obolibrary.org/obo/GO_0031959) (mineralocorticoid receptor signaling pathway), [GO:0072425](http://purl.obolibrary.org/obo/GO_0072425) (signal transduction involved in G2 DNA damage checkpoint), [GO:0016331](http://purl.obolibrary.org/obo/GO_0016331) (morphogenesis of embryonic epithelium), [GO:0097726](http://purl.obolibrary.org/obo/GO_0097726) (LEM domain binding), [GO:0031953](http://purl.obolibrary.org/obo/GO_0031953) (negative regulation of protein autophosphorylation), [GO:0097729](http://purl.obolibrary.org/obo/GO_0097729) (9+2 motile cilium), [GO:2001140](http://purl.obolibrary.org/obo/GO_2001140) (positive regulation of phospholipid transport), [GO:0060430](http://purl.obolibrary.org/obo/GO_0060430) (lung saccule development), [GO:2001141](http://purl.obolibrary.org/obo/GO_2001141) (regulation of RNA biosynthetic process), [GO:0061762](http://purl.obolibrary.org/obo/GO_0061762) (CAMKK-AMPK signaling cascade), [GO:0015002](http://purl.obolibrary.org/obo/GO_0015002) (heme-copper terminal oxidase activity), [GO:0005680](http://purl.obolibrary.org/obo/GO_0005680) (anaphase-promoting complex), [GO:0005682](http://purl.obolibrary.org/obo/GO_0005682) (U5 snRNP), [GO:0004351](http://purl.obolibrary.org/obo/GO_0004351) (glutamate decarboxylase activity), [GO:0005681](http://purl.obolibrary.org/obo/GO_0005681) (spliceosomal complex), [GO:0004350](http://purl.obolibrary.org/obo/GO_0004350) (glutamate-5-semialdehyde dehydrogenase activity), [GO:1903976](http://purl.obolibrary.org/obo/GO_1903976) (negative regulation of glial cell migration), [GO:0060438](http://purl.obolibrary.org/obo/GO_0060438) (trachea development), [GO:0004353](http://purl.obolibrary.org/obo/GO_0004353) (glutamate dehydrogenase [NAD(P)+] activity), [GO:0005684](http://purl.obolibrary.org/obo/GO_0005684) (U2-type spliceosomal complex), [GO:0004352](http://purl.obolibrary.org/obo/GO_0004352) (glutamate dehydrogenase (NAD+) activity), [GO:0005686](http://purl.obolibrary.org/obo/GO_0005686) (U2 snRNP), [GO:0005685](http://purl.obolibrary.org/obo/GO_0005685) (U1 snRNP), [GO:0004357](http://purl.obolibrary.org/obo/GO_0004357) (glutamate-cysteine ligase activity), [GO:0005687](http://purl.obolibrary.org/obo/GO_0005687) (U4 snRNP), [GO:1901317](http://purl.obolibrary.org/obo/GO_1901317) (regulation of flagellated sperm motility), [GO:0004356](http://purl.obolibrary.org/obo/GO_0004356) (glutamate-ammonia ligase activity), [GO:0003016](http://purl.obolibrary.org/obo/GO_0003016) (respiratory system process), [GO:0004348](http://purl.obolibrary.org/obo/GO_0004348) (glucosylceramidase activity), [GO:0047484](http://purl.obolibrary.org/obo/GO_0047484) (regulation of response to osmotic stress), [GO:0004347](http://purl.obolibrary.org/obo/GO_0004347) (glucose-6-phosphate isomerase activity), [GO:0031943](http://purl.obolibrary.org/obo/GO_0031943) (regulation of glucocorticoid metabolic process), [GO:0004349](http://purl.obolibrary.org/obo/GO_0004349) (glutamate 5-kinase activity), [GO:0097731](http://purl.obolibrary.org/obo/GO_0097731) (9+0 non-motile cilium), [GO:0097730](http://purl.obolibrary.org/obo/GO_0097730) (non-motile cilium), [GO:0046154](http://purl.obolibrary.org/obo/GO_0046154) (rhodopsin metabolic process), [GO:0097733](http://purl.obolibrary.org/obo/GO_0097733) (photoreceptor cell cilium), [GO:0047485](http://purl.obolibrary.org/obo/GO_0047485) (protein N-terminus binding), [GO:0031941](http://purl.obolibrary.org/obo/GO_0031941) (filamentous actin), [GO:0016322](http://purl.obolibrary.org/obo/GO_0016322) (neuron remodeling), [GO:0016323](http://purl.obolibrary.org/obo/GO_0016323) (basolateral plasma membrane), [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane), [GO:2001135](http://purl.obolibrary.org/obo/GO_2001135) (regulation of endocytic recycling), [GO:0060463](http://purl.obolibrary.org/obo/GO_0060463) (lung lobe morphogenesis), [GO:0060460](http://purl.obolibrary.org/obo/GO_0060460) (left lung morphogenesis), [GO:1903980](http://purl.obolibrary.org/obo/GO_1903980) (positive regulation of microglial cell activation), [GO:1903984](http://purl.obolibrary.org/obo/GO_1903984) (positive regulation of TRAIL-activated apoptotic signaling pathway), [GO:0004322](http://purl.obolibrary.org/obo/GO_0004322) (ferroxidase activity), [GO:0060466](http://purl.obolibrary.org/obo/GO_0060466) (activation of meiosis involved in egg activation), [GO:0005652](http://purl.obolibrary.org/obo/GO_0005652) (nuclear lamina), [GO:0061798](http://purl.obolibrary.org/obo/GO_0061798) (GTP 3',8'-cyclase activity), [GO:0006986](http://purl.obolibrary.org/obo/GO_0006986) (response to unfolded protein), [GO:0061799](http://purl.obolibrary.org/obo/GO_0061799) (cyclic pyranopterin monophosphate synthase activity), [GO:1903988](http://purl.obolibrary.org/obo/GO_1903988) (ferrous iron export across plasma membrane), [GO:0006983](http://purl.obolibrary.org/obo/GO_0006983) (ER overload response), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0006978](http://purl.obolibrary.org/obo/GO_0006978) (DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator), [GO:0006979](http://purl.obolibrary.org/obo/GO_0006979) (response to oxidative stress), [GO:0031932](http://purl.obolibrary.org/obo/GO_0031932) (TORC2 complex), [GO:0006977](http://purl.obolibrary.org/obo/GO_0006977) (DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest), [GO:0046167](http://purl.obolibrary.org/obo/GO_0046167) (glycerol-3-phosphate biosynthetic process), [GO:0047499](http://purl.obolibrary.org/obo/GO_0047499) (calcium-independent phospholipase A2 activity), [GO:0031938](http://purl.obolibrary.org/obo/GO_0031938) (regulation of chromatin silencing at telomere), [GO:0031939](http://purl.obolibrary.org/obo/GO_0031939) (negative regulation of chromatin silencing at telomere), [GO:0071110](http://purl.obolibrary.org/obo/GO_0071110) (histone biotinylation), [GO:0031936](http://purl.obolibrary.org/obo/GO_0031936) (negative regulation of chromatin silencing), [GO:0046166](http://purl.obolibrary.org/obo/GO_0046166) (glyceraldehyde-3-phosphate biosynthetic process), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0016311](http://purl.obolibrary.org/obo/GO_0016311) (dephosphorylation), [GO:0031931](http://purl.obolibrary.org/obo/GO_0031931) (TORC1 complex), [GO:0016314](http://purl.obolibrary.org/obo/GO_0016314) (phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity), [GO:0060452](http://purl.obolibrary.org/obo/GO_0060452) (positive regulation of cardiac muscle contraction), [GO:0031929](http://purl.obolibrary.org/obo/GO_0031929) (TOR signaling), [GO:0006990](http://purl.obolibrary.org/obo/GO_0006990) (positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response), [GO:0005662](http://purl.obolibrary.org/obo/GO_0005662) (DNA replication factor A complex), [GO:1900004](http://purl.obolibrary.org/obo/GO_1900004) (negative regulation of serine-type endopeptidase activity), [GO:0004333](http://purl.obolibrary.org/obo/GO_0004333) (fumarate hydratase activity), [GO:0005664](http://purl.obolibrary.org/obo/GO_0005664) (nuclear origin of replication recognition complex), [GO:0006996](http://purl.obolibrary.org/obo/GO_0006996) (organelle organization), [GO:0006997](http://purl.obolibrary.org/obo/GO_0006997) (nucleus organization), [GO:0003002](http://purl.obolibrary.org/obo/GO_0003002) (regionalization), [GO:0004332](http://purl.obolibrary.org/obo/GO_0004332) (fructose-bisphosphate aldolase activity), [GO:1900006](http://purl.obolibrary.org/obo/GO_1900006) (positive regulation of dendrite development), [GO:0005666](http://purl.obolibrary.org/obo/GO_0005666) (DNA-directed RNA polymerase III complex), [GO:0004335](http://purl.obolibrary.org/obo/GO_0004335) (galactokinase activity), [GO:1903999](http://purl.obolibrary.org/obo/GO_1903999) (negative regulation of eating behavior), [GO:1901339](http://purl.obolibrary.org/obo/GO_1901339) (regulation of store-operated calcium channel activity), [GO:0006995](http://purl.obolibrary.org/obo/GO_0006995) (cellular response to nitrogen starvation), [GO:0004334](http://purl.obolibrary.org/obo/GO_0004334) (fumarylacetoacetase activity), [GO:0005657](http://purl.obolibrary.org/obo/GO_0005657) (replication fork), [GO:0004325](http://purl.obolibrary.org/obo/GO_0004325) (ferrochelatase activity), [GO:0005656](http://purl.obolibrary.org/obo/GO_0005656) (nuclear pre-replicative complex), [GO:0006987](http://purl.obolibrary.org/obo/GO_0006987) (activation of signaling protein activity involved in unfolded protein response), [GO:0005658](http://purl.obolibrary.org/obo/GO_0005658) (alpha DNA polymerase:primase complex), [GO:0072431](http://purl.obolibrary.org/obo/GO_0072431) (signal transduction involved in mitotic G1 DNA damage checkpoint), [GO:0097712](http://purl.obolibrary.org/obo/GO_0097712) (vesicle targeting, trans-Golgi to periciliary membrane compartment), [GO:0071104](http://purl.obolibrary.org/obo/GO_0071104) (response to interleukin-9), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0016303](http://purl.obolibrary.org/obo/GO_0016303) (1-phosphatidylinositol-3-kinase activity), [GO:0097718](http://purl.obolibrary.org/obo/GO_0097718) (disordered domain specific binding), [GO:0071108](http://purl.obolibrary.org/obo/GO_0071108) (protein K48-linked deubiquitination), [GO:0015036](http://purl.obolibrary.org/obo/GO_0015036) (disulfide oxidoreductase activity), [GO:0015035](http://purl.obolibrary.org/obo/GO_0015035) (protein disulfide oxidoreductase activity), [GO:2001170](http://purl.obolibrary.org/obo/GO_2001170) (negative regulation of ATP biosynthetic process), [GO:0004382](http://purl.obolibrary.org/obo/GO_0004382) (guanosine-diphosphatase activity), [GO:2001171](http://purl.obolibrary.org/obo/GO_2001171) (positive regulation of ATP biosynthetic process), [GO:0039003](http://purl.obolibrary.org/obo/GO_0039003) (pronephric field specification), [GO:0015031](http://purl.obolibrary.org/obo/GO_0015031) (protein transport), [GO:0015030](http://purl.obolibrary.org/obo/GO_0015030) (Cajal body), [GO:0004383](http://purl.obolibrary.org/obo/GO_0004383) (guanylate cyclase activity), [GO:0004386](http://purl.obolibrary.org/obo/GO_0004386) (helicase activity), [GO:0003056](http://purl.obolibrary.org/obo/GO_0003056) (regulation of vascular smooth muscle contraction), [GO:0043985](http://purl.obolibrary.org/obo/GO_0043985) (histone H4-R3 methylation), [GO:0003059](http://purl.obolibrary.org/obo/GO_0003059) (positive regulation of the force of heart contraction by epinephrine), [GO:0030667](http://purl.obolibrary.org/obo/GO_0030667) (secretory granule membrane), [GO:0031998](http://purl.obolibrary.org/obo/GO_0031998) (regulation of fatty acid beta-oxidation), [GO:0031999](http://purl.obolibrary.org/obo/GO_0031999) (negative regulation of fatty acid beta-oxidation), [GO:0030669](http://purl.obolibrary.org/obo/GO_0030669) (clathrin-coated endocytic vesicle membrane), [GO:0030660](http://purl.obolibrary.org/obo/GO_0030660) (Golgi-associated vesicle membrane), [GO:0030663](http://purl.obolibrary.org/obo/GO_0030663) (COPI-coated vesicle membrane), [GO:0031994](http://purl.obolibrary.org/obo/GO_0031994) (insulin-like growth factor I binding), [GO:0030665](http://purl.obolibrary.org/obo/GO_0030665) (clathrin-coated vesicle membrane), [GO:2001186](http://purl.obolibrary.org/obo/GO_2001186) (negative regulation of CD8-positive, alpha-beta T cell activation), [GO:0040001](http://purl.obolibrary.org/obo/GO_0040001) (establishment of mitotic spindle localization), [GO:0004392](http://purl.obolibrary.org/obo/GO_0004392) (heme oxygenase (decyclizing) activity), [GO:0042660](http://purl.obolibrary.org/obo/GO_0042660) (positive regulation of cell fate specification), [GO:0042661](http://purl.obolibrary.org/obo/GO_0042661) (regulation of mesodermal cell fate specification), [GO:0042662](http://purl.obolibrary.org/obo/GO_0042662) (negative regulation of mesodermal cell fate specification), [GO:0043994](http://purl.obolibrary.org/obo/GO_0043994) (histone acetyltransferase activity (H3-K23 specific)), [GO:0004396](http://purl.obolibrary.org/obo/GO_0004396) (hexokinase activity), [GO:0042663](http://purl.obolibrary.org/obo/GO_0042663) (regulation of endodermal cell fate specification), [GO:0043996](http://purl.obolibrary.org/obo/GO_0043996) (histone acetyltransferase activity (H4-K8 specific)), [GO:0042664](http://purl.obolibrary.org/obo/GO_0042664) (negative regulation of endodermal cell fate specification), [GO:0040008](http://purl.obolibrary.org/obo/GO_0040008) (regulation of growth), [GO:0043995](http://purl.obolibrary.org/obo/GO_0043995) (histone acetyltransferase activity (H4-K5 specific)), [GO:0004398](http://purl.obolibrary.org/obo/GO_0004398) (histidine decarboxylase activity), [GO:0040007](http://purl.obolibrary.org/obo/GO_0040007) (growth), [GO:0003069](http://purl.obolibrary.org/obo/GO_0003069) (acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure), [GO:0042667](http://purl.obolibrary.org/obo/GO_0042667) (auditory receptor cell fate specification), [GO:0031987](http://purl.obolibrary.org/obo/GO_0031987) (locomotion involved in locomotory behavior), [GO:0030659](http://purl.obolibrary.org/obo/GO_0030659) (cytoplasmic vesicle membrane), [GO:0030658](http://purl.obolibrary.org/obo/GO_0030658) (transport vesicle membrane), [GO:0042670](http://purl.obolibrary.org/obo/GO_0042670) (retinal cone cell differentiation), [GO:0016361](http://purl.obolibrary.org/obo/GO_0016361) (activin receptor activity, type I), [GO:0031981](http://purl.obolibrary.org/obo/GO_0031981) (nuclear lumen), [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle), [GO:0016363](http://purl.obolibrary.org/obo/GO_0016363) (nuclear matrix), [GO:0031985](http://purl.obolibrary.org/obo/GO_0031985) (Golgi cisterna), [GO:2001178](http://purl.obolibrary.org/obo/GO_2001178) (positive regulation of mediator complex assembly), [GO:0031983](http://purl.obolibrary.org/obo/GO_0031983) (vesicle lumen), [GO:0015016](http://purl.obolibrary.org/obo/GO_0015016) ([heparan sulfate]-glucosamine N-sulfotransferase activity), [GO:0040015](http://purl.obolibrary.org/obo/GO_0040015) (negative regulation of multicellular organism growth), [GO:0040014](http://purl.obolibrary.org/obo/GO_0040014) (regulation of multicellular organism growth), [GO:0015014](http://purl.obolibrary.org/obo/GO_0015014) (heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process), [GO:0015012](http://purl.obolibrary.org/obo/GO_0015012) (heparan sulfate proteoglycan biosynthetic process), [GO:0040011](http://purl.obolibrary.org/obo/GO_0040011) (locomotion), [GO:0004360](http://purl.obolibrary.org/obo/GO_0004360) (glutamine-fructose-6-phosphate transaminase (isomerizing) activity), [GO:0004361](http://purl.obolibrary.org/obo/GO_0004361) (glutaryl-CoA dehydrogenase activity), [GO:0004364](http://purl.obolibrary.org/obo/GO_0004364) (glutathione transferase activity), [GO:0003032](http://purl.obolibrary.org/obo/GO_0003032) (detection of oxygen), [GO:0005694](http://purl.obolibrary.org/obo/GO_0005694) (chromosome), [GO:0004363](http://purl.obolibrary.org/obo/GO_0004363) (glutathione synthase activity), [GO:0005697](http://purl.obolibrary.org/obo/GO_0005697) (telomerase holoenzyme complex), [GO:0040019](http://purl.obolibrary.org/obo/GO_0040019) (positive regulation of embryonic development), [GO:0040018](http://purl.obolibrary.org/obo/GO_0040018) (positive regulation of multicellular organism growth), [GO:0004368](http://purl.obolibrary.org/obo/GO_0004368) (glycerol-3-phosphate dehydrogenase activity), [GO:0004367](http://purl.obolibrary.org/obo/GO_0004367) (glycerol-3-phosphate dehydrogenase [NAD+] activity), [GO:0040017](http://purl.obolibrary.org/obo/GO_0040017) (positive regulation of locomotion), [GO:0003029](http://purl.obolibrary.org/obo/GO_0003029) (detection of hypoxic conditions in blood by carotid body chemoreceptor signaling), [GO:0030641](http://purl.obolibrary.org/obo/GO_0030641) (regulation of cellular pH), [GO:0030644](http://purl.obolibrary.org/obo/GO_0030644) (cellular chloride ion homeostasis), [GO:0016358](http://purl.obolibrary.org/obo/GO_0016358) (dendrite development), [GO:0030643](http://purl.obolibrary.org/obo/GO_0030643) (cellular phosphate ion homeostasis), [GO:0015026](http://purl.obolibrary.org/obo/GO_0015026) (coreceptor activity), [GO:0016338](http://purl.obolibrary.org/obo/GO_0016338) (calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules), [GO:0004370](http://purl.obolibrary.org/obo/GO_0004370) (glycerol kinase activity), [GO:0015020](http://purl.obolibrary.org/obo/GO_0015020) (glucuronosyltransferase activity), [GO:0004373](http://purl.obolibrary.org/obo/GO_0004373) (glycogen (starch) synthase activity), [GO:0004375](http://purl.obolibrary.org/obo/GO_0004375) (glycine dehydrogenase (decarboxylating) activity), [GO:0004377](http://purl.obolibrary.org/obo/GO_0004377) (GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity), [GO:0004376](http://purl.obolibrary.org/obo/GO_0004376) (glycolipid mannosyltransferase activity), [GO:0004378](http://purl.obolibrary.org/obo/GO_0004378) (GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity), [GO:0031965](http://purl.obolibrary.org/obo/GO_0031965) (nuclear membrane), [GO:0031966](http://purl.obolibrary.org/obo/GO_0031966) (mitochondrial membrane), [GO:0016342](http://purl.obolibrary.org/obo/GO_0016342) (catenin complex), [GO:0015019](http://purl.obolibrary.org/obo/GO_0015019) (heparan-alpha-glucosaminide N-acetyltransferase activity), [GO:0015018](http://purl.obolibrary.org/obo/GO_0015018) (galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity), [GO:1901381](http://purl.obolibrary.org/obo/GO_1901381) (positive regulation of potassium ion transmembrane transport), [GO:0042613](http://purl.obolibrary.org/obo/GO_0042613) (MHC class II protein complex), [GO:1901380](http://purl.obolibrary.org/obo/GO_1901380) (negative regulation of potassium ion transmembrane transport), [GO:0042615](http://purl.obolibrary.org/obo/GO_0042615) (CD154 receptor binding), [GO:1900052](http://purl.obolibrary.org/obo/GO_1900052) (regulation of retinoic acid biosynthetic process), [GO:0015078](http://purl.obolibrary.org/obo/GO_0015078) (hydrogen ion transmembrane transporter activity), [GO:1901385](http://purl.obolibrary.org/obo/GO_1901385) (regulation of voltage-gated calcium channel activity), [GO:0043949](http://purl.obolibrary.org/obo/GO_0043949) (regulation of cAMP-mediated signaling), [GO:1900053](http://purl.obolibrary.org/obo/GO_1900053) (negative regulation of retinoic acid biosynthetic process), [GO:0003094](http://purl.obolibrary.org/obo/GO_0003094) (glomerular filtration), [GO:0015075](http://purl.obolibrary.org/obo/GO_0015075) (ion transmembrane transporter activity), [GO:0000813](http://purl.obolibrary.org/obo/GO_0000813) (ESCRT I complex), [GO:1901386](http://purl.obolibrary.org/obo/GO_1901386) (negative regulation of voltage-gated calcium channel activity), [GO:0015074](http://purl.obolibrary.org/obo/GO_0015074) (DNA integration), [GO:0042612](http://purl.obolibrary.org/obo/GO_0042612) (MHC class I protein complex), [GO:0042626](http://purl.obolibrary.org/obo/GO_0042626) (ATPase activity, coupled to transmembrane movement of substances), [GO:0042627](http://purl.obolibrary.org/obo/GO_0042627) (chylomicron), [GO:0042629](http://purl.obolibrary.org/obo/GO_0042629) (mast cell granule), [GO:0015087](http://purl.obolibrary.org/obo/GO_0015087) (cobalt ion transmembrane transporter activity), [GO:0015086](http://purl.obolibrary.org/obo/GO_0015086) (cadmium ion transmembrane transporter activity), [GO:0015085](http://purl.obolibrary.org/obo/GO_0015085) (calcium ion transmembrane transporter activity), [GO:0043950](http://purl.obolibrary.org/obo/GO_0043950) (positive regulation of cAMP-mediated signaling), [GO:0000821](http://purl.obolibrary.org/obo/GO_0000821) (regulation of arginine metabolic process), [GO:0015081](http://purl.obolibrary.org/obo/GO_0015081) (sodium ion transmembrane transporter activity), [GO:0042622](http://purl.obolibrary.org/obo/GO_0042622) (photoreceptor outer segment membrane), [GO:0042623](http://purl.obolibrary.org/obo/GO_0042623) (ATPase activity, coupled), [GO:0071162](http://purl.obolibrary.org/obo/GO_0071162) (CMG complex), [GO:0072492](http://purl.obolibrary.org/obo/GO_0072492) (host cell mitochondrial intermembrane space), [GO:0071168](http://purl.obolibrary.org/obo/GO_0071168) (protein localization to chromatin), [GO:0072498](http://purl.obolibrary.org/obo/GO_0072498) (embryonic skeletal joint development), [GO:0071166](http://purl.obolibrary.org/obo/GO_0071166) (ribonucleoprotein complex localization), [GO:0030695](http://purl.obolibrary.org/obo/GO_0030695) (GTPase regulator activity), [GO:0043967](http://purl.obolibrary.org/obo/GO_0043967) (histone H4 acetylation), [GO:0042636](http://purl.obolibrary.org/obo/GO_0042636) (negative regulation of hair cycle), [GO:0043966](http://purl.obolibrary.org/obo/GO_0043966) (histone H3 acetylation), [GO:0042637](http://purl.obolibrary.org/obo/GO_0042637) (catagen), [GO:0039023](http://purl.obolibrary.org/obo/GO_0039023) (pronephric duct morphogenesis), [GO:0003071](http://purl.obolibrary.org/obo/GO_0003071) (renal system process involved in regulation of systemic arterial blood pressure), [GO:0039022](http://purl.obolibrary.org/obo/GO_0039022) (pronephric duct development), [GO:0003073](http://purl.obolibrary.org/obo/GO_0003073) (regulation of systemic arterial blood pressure), [GO:0030690](http://purl.obolibrary.org/obo/GO_0030690) (Noc1p-Noc2p complex), [GO:0039021](http://purl.obolibrary.org/obo/GO_0039021) (pronephric glomerulus development), [GO:0039020](http://purl.obolibrary.org/obo/GO_0039020) (pronephric nephron tubule development), [GO:0042632](http://purl.obolibrary.org/obo/GO_0042632) (cholesterol homeostasis), [GO:0042633](http://purl.obolibrary.org/obo/GO_0042633) (hair cycle), [GO:0030686](http://purl.obolibrary.org/obo/GO_0030686) (90S preribosome), [GO:0039019](http://purl.obolibrary.org/obo/GO_0039019) (pronephric nephron development), [GO:0030687](http://purl.obolibrary.org/obo/GO_0030687) (preribosome, large subunit precursor), [GO:0000808](http://purl.obolibrary.org/obo/GO_0000808) (origin recognition complex), [GO:0015068](http://purl.obolibrary.org/obo/GO_0015068) (glycine amidinotransferase activity), [GO:1900087](http://purl.obolibrary.org/obo/GO_1900087) (positive regulation of G1/S transition of mitotic cell cycle), [GO:0003081](http://purl.obolibrary.org/obo/GO_0003081) (regulation of systemic arterial blood pressure by renin-angiotensin), [GO:0015067](http://purl.obolibrary.org/obo/GO_0015067) (amidinotransferase activity), [GO:1900086](http://purl.obolibrary.org/obo/GO_1900086) (positive regulation of peptidyl-tyrosine autophosphorylation), [GO:0003084](http://purl.obolibrary.org/obo/GO_0003084) (positive regulation of systemic arterial blood pressure), [GO:0000802](http://purl.obolibrary.org/obo/GO_0000802) (transverse filament), [GO:0003085](http://purl.obolibrary.org/obo/GO_0003085) (negative regulation of systemic arterial blood pressure), [GO:0000801](http://purl.obolibrary.org/obo/GO_0000801) (central element), [GO:0000800](http://purl.obolibrary.org/obo/GO_0000800) (lateral element), [GO:0042640](http://purl.obolibrary.org/obo/GO_0042640) (anagen), [GO:0042643](http://purl.obolibrary.org/obo/GO_0042643) (actomyosin, actin portion), [GO:0042645](http://purl.obolibrary.org/obo/GO_0042645) (mitochondrial nucleoid), [GO:0030678](http://purl.obolibrary.org/obo/GO_0030678) (mitochondrial ribonuclease P complex), [GO:0030670](http://purl.obolibrary.org/obo/GO_0030670) (phagocytic vesicle membrane), [GO:0030673](http://purl.obolibrary.org/obo/GO_0030673) (axolemma), [GO:0030672](http://purl.obolibrary.org/obo/GO_0030672) (synaptic vesicle membrane), [GO:0030674](http://purl.obolibrary.org/obo/GO_0030674) (protein binding, bridging), [GO:0039008](http://purl.obolibrary.org/obo/GO_0039008) (pronephric nephron tubule morphogenesis), [GO:0030676](http://purl.obolibrary.org/obo/GO_0030676) (Rac guanyl-nucleotide exchange factor activity), [GO:0090212](http://purl.obolibrary.org/obo/GO_0090212) (negative regulation of establishment of blood-brain barrier), [GO:0000735](http://purl.obolibrary.org/obo/GO_0000735) (removal of nonhomologous ends), [GO:0000733](http://purl.obolibrary.org/obo/GO_0000733) (DNA strand renaturation), [GO:0000732](http://purl.obolibrary.org/obo/GO_0000732) (strand displacement), [GO:0000731](http://purl.obolibrary.org/obo/GO_0000731) (DNA synthesis involved in DNA repair), [GO:0090218](http://purl.obolibrary.org/obo/GO_0090218) (positive regulation of lipid kinase activity), [GO:0000749](http://purl.obolibrary.org/obo/GO_0000749) (response to pheromone involved in conjugation with cellular fusion), [GO:0000747](http://purl.obolibrary.org/obo/GO_0000747) (conjugation with cellular fusion), [GO:0090222](http://purl.obolibrary.org/obo/GO_0090222) (centrosome-templated microtubule nucleation), [GO:0000743](http://purl.obolibrary.org/obo/GO_0000743) (nuclear migration involved in conjugation with cellular fusion), [GO:0000742](http://purl.obolibrary.org/obo/GO_0000742) (karyogamy involved in conjugation with cellular fusion), [GO:0000741](http://purl.obolibrary.org/obo/GO_0000741) (karyogamy), [GO:0000715](http://purl.obolibrary.org/obo/GO_0000715) (nucleotide-excision repair, DNA damage recognition), [GO:0000712](http://purl.obolibrary.org/obo/GO_0000712) (resolution of meiotic recombination intermediates), [GO:0000710](http://purl.obolibrary.org/obo/GO_0000710) (meiotic mismatch repair), [GO:0048709](http://purl.obolibrary.org/obo/GO_0048709) (oligodendrocyte differentiation), [GO:0048708](http://purl.obolibrary.org/obo/GO_0048708) (astrocyte differentiation), [GO:0000729](http://purl.obolibrary.org/obo/GO_0000729) (DNA double-strand break processing), [GO:0090201](http://purl.obolibrary.org/obo/GO_0090201) (negative regulation of release of cytochrome c from mitochondria), [GO:0000727](http://purl.obolibrary.org/obo/GO_0000727) (double-strand break repair via break-induced replication), [GO:0090200](http://purl.obolibrary.org/obo/GO_0090200) (positive regulation of release of cytochrome c from mitochondria), [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis), [GO:0000724](http://purl.obolibrary.org/obo/GO_0000724) (double-strand break repair via homologous recombination), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0000723](http://purl.obolibrary.org/obo/GO_0000723) (telomere maintenance), [GO:0000722](http://purl.obolibrary.org/obo/GO_0000722) (telomere maintenance via recombination), [GO:0048706](http://purl.obolibrary.org/obo/GO_0048706) (embryonic skeletal system development), [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis), [GO:0048704](http://purl.obolibrary.org/obo/GO_0048704) (embryonic skeletal system morphogenesis), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0030594](http://purl.obolibrary.org/obo/GO_0030594) (neurotransmitter receptor activity), [GO:0030593](http://purl.obolibrary.org/obo/GO_0030593) (neutrophil chemotaxis), [GO:0030595](http://purl.obolibrary.org/obo/GO_0030595) (leukocyte chemotaxis), [GO:0090209](http://purl.obolibrary.org/obo/GO_0090209) (negative regulation of triglyceride metabolic process), [GO:0090207](http://purl.obolibrary.org/obo/GO_0090207) (regulation of triglyceride metabolic process), [GO:0090208](http://purl.obolibrary.org/obo/GO_0090208) (positive regulation of triglyceride metabolic process), [GO:0009116](http://purl.obolibrary.org/obo/GO_0009116) (nucleoside metabolic process), [GO:0042572](http://purl.obolibrary.org/obo/GO_0042572) (retinol metabolic process), [GO:0000779](http://purl.obolibrary.org/obo/GO_0000779) (condensed chromosome, centromeric region), [GO:0000778](http://purl.obolibrary.org/obo/GO_0000778) (condensed nuclear chromosome kinetochore), [GO:0009115](http://purl.obolibrary.org/obo/GO_0009115) (xanthine catabolic process), [GO:0000777](http://purl.obolibrary.org/obo/GO_0000777) (condensed chromosome kinetochore), [GO:0042574](http://purl.obolibrary.org/obo/GO_0042574) (retinal metabolic process), [GO:0000776](http://purl.obolibrary.org/obo/GO_0000776) (kinetochore), [GO:0009113](http://purl.obolibrary.org/obo/GO_0009113) (purine nucleobase biosynthetic process), [GO:0000775](http://purl.obolibrary.org/obo/GO_0000775) (chromosome, centromeric region), [GO:0042577](http://purl.obolibrary.org/obo/GO_0042577) (lipid phosphatase activity), [GO:0000774](http://purl.obolibrary.org/obo/GO_0000774) (adenyl-nucleotide exchange factor activity), [GO:0042578](http://purl.obolibrary.org/obo/GO_0042578) (phosphoric ester hydrolase activity), [GO:0009117](http://purl.obolibrary.org/obo/GO_0009117) (nucleotide metabolic process), [GO:0000781](http://purl.obolibrary.org/obo/GO_0000781) (chromosome, telomeric region), [GO:0000780](http://purl.obolibrary.org/obo/GO_0000780) (condensed nuclear chromosome, centromeric region), [GO:0042582](http://purl.obolibrary.org/obo/GO_0042582) (azurophil granule), [GO:0000786](http://purl.obolibrary.org/obo/GO_0000786) (nucleosome), [GO:0000785](http://purl.obolibrary.org/obo/GO_0000785) (chromatin), [GO:0042588](http://purl.obolibrary.org/obo/GO_0042588) (zymogen granule), [GO:0000784](http://purl.obolibrary.org/obo/GO_0000784) (nuclear chromosome, telomeric region), [GO:0000783](http://purl.obolibrary.org/obo/GO_0000783) (nuclear telomere cap complex), [GO:0000793](http://purl.obolibrary.org/obo/GO_0000793) (condensed chromosome), [GO:0000792](http://purl.obolibrary.org/obo/GO_0000792) (heterochromatin), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0042590](http://purl.obolibrary.org/obo/GO_0042590) (antigen processing and presentation of exogenous peptide antigen via MHC class I), [GO:0042592](http://purl.obolibrary.org/obo/GO_0042592) (homeostatic process), [GO:0042593](http://purl.obolibrary.org/obo/GO_0042593) (glucose homeostasis), [GO:0010107](http://purl.obolibrary.org/obo/GO_0010107) (potassium ion import), [GO:0042594](http://purl.obolibrary.org/obo/GO_0042594) (response to starvation), [GO:0042596](http://purl.obolibrary.org/obo/GO_0042596) (fear response), [GO:0000755](http://purl.obolibrary.org/obo/GO_0000755) (cytogamy), [GO:0000754](http://purl.obolibrary.org/obo/GO_0000754) (adaptation of signaling pathway by response to pheromone involved in conjugation with cellular fusion), [GO:0042597](http://purl.obolibrary.org/obo/GO_0042597) (periplasmic space), [GO:0000753](http://purl.obolibrary.org/obo/GO_0000753) (cell morphogenesis involved in conjugation with cellular fusion), [GO:0042599](http://purl.obolibrary.org/obo/GO_0042599) (lamellar body), [GO:0000750](http://purl.obolibrary.org/obo/GO_0000750) (pheromone-dependent signal transduction involved in conjugation with cellular fusion), [GO:0009101](http://purl.obolibrary.org/obo/GO_0009101) (glycoprotein biosynthetic process), [GO:0009100](http://purl.obolibrary.org/obo/GO_0009100) (glycoprotein metabolic process), [GO:0009102](http://purl.obolibrary.org/obo/GO_0009102) (biotin biosynthetic process), [GO:0009108](http://purl.obolibrary.org/obo/GO_0009108) (coenzyme biosynthetic process), [GO:0009107](http://purl.obolibrary.org/obo/GO_0009107) (lipoate biosynthetic process), [GO:0009152](http://purl.obolibrary.org/obo/GO_0009152) (purine ribonucleotide biosynthetic process), [GO:0035441](http://purl.obolibrary.org/obo/GO_0035441) (cell migration involved in vasculogenesis), [GO:0010142](http://purl.obolibrary.org/obo/GO_0010142) (farnesyl diphosphate biosynthetic process, mevalonate pathway), [GO:0009156](http://purl.obolibrary.org/obo/GO_0009156) (ribonucleoside monophosphate biosynthetic process), [GO:0009154](http://purl.obolibrary.org/obo/GO_0009154) (purine ribonucleotide catabolic process), [GO:1903920](http://purl.obolibrary.org/obo/GO_1903920) (positive regulation of actin filament severing), [GO:0090297](http://purl.obolibrary.org/obo/GO_0090297) (positive regulation of mitochondrial DNA replication), [GO:0048755](http://purl.obolibrary.org/obo/GO_0048755) (branching morphogenesis of a nerve), [GO:0060406](http://purl.obolibrary.org/obo/GO_0060406) (positive regulation of penile erection), [GO:0060407](http://purl.obolibrary.org/obo/GO_0060407) (negative regulation of penile erection), [GO:0048754](http://purl.obolibrary.org/obo/GO_0048754) (branching morphogenesis of an epithelial tube), [GO:0047429](http://purl.obolibrary.org/obo/GO_0047429) (nucleoside-triphosphate diphosphatase activity), [GO:0061732](http://purl.obolibrary.org/obo/GO_0061732) (mitochondrial acetyl-CoA biosynthetic process from pyruvate), [GO:0060402](http://purl.obolibrary.org/obo/GO_0060402) (calcium ion transport into cytosol), [GO:0061739](http://purl.obolibrary.org/obo/GO_0061739) (protein lipidation involved in autophagosome assembly), [GO:0046101](http://purl.obolibrary.org/obo/GO_0046101) (hypoxanthine biosynthetic process), [GO:0048762](http://purl.obolibrary.org/obo/GO_0048762) (mesenchymal cell differentiation), [GO:1903919](http://purl.obolibrary.org/obo/GO_1903919) (negative regulation of actin filament severing), [GO:0046100](http://purl.obolibrary.org/obo/GO_0046100) (hypoxanthine metabolic process), [GO:0034109](http://purl.obolibrary.org/obo/GO_0034109) (homotypic cell-cell adhesion), [GO:0035434](http://purl.obolibrary.org/obo/GO_0035434) (copper ion transmembrane transport), [GO:0010133](http://purl.obolibrary.org/obo/GO_0010133) (proline catabolic process to glutamate), [GO:0035435](http://purl.obolibrary.org/obo/GO_0035435) (phosphate ion transmembrane transport), [GO:0034101](http://purl.obolibrary.org/obo/GO_0034101) (erythrocyte homeostasis), [GO:0009165](http://purl.obolibrary.org/obo/GO_0009165) (nucleotide biosynthetic process), [GO:1902600](http://purl.obolibrary.org/obo/GO_1902600) (hydrogen ion transmembrane transport), [GO:0046103](http://purl.obolibrary.org/obo/GO_0046103) (inosine biosynthetic process), [GO:0009168](http://purl.obolibrary.org/obo/GO_0009168) (purine ribonucleoside monophosphate biosynthetic process), [GO:0046104](http://purl.obolibrary.org/obo/GO_0046104) (thymidine metabolic process), [GO:1903935](http://purl.obolibrary.org/obo/GO_1903935) (response to sodium arsenite), [GO:0048769](http://purl.obolibrary.org/obo/GO_0048769) (sarcomerogenesis), [GO:0061723](http://purl.obolibrary.org/obo/GO_0061723) (glycophagy), [GO:1902603](http://purl.obolibrary.org/obo/GO_1902603) (carnitine transmembrane transport), [GO:0048771](http://purl.obolibrary.org/obo/GO_0048771) (tissue remodeling), [GO:0048773](http://purl.obolibrary.org/obo/GO_0048773) (erythrophore differentiation), [GO:0047442](http://purl.obolibrary.org/obo/GO_0047442) (17-alpha-hydroxyprogesterone aldolase activity), [GO:0046111](http://purl.obolibrary.org/obo/GO_0046111) (xanthine biosynthetic process), [GO:0035426](http://purl.obolibrary.org/obo/GO_0035426) (extracellular matrix-cell signaling), [GO:0061750](http://purl.obolibrary.org/obo/GO_0061750) (acid sphingomyelin phosphodiesterase activity), [GO:0060420](http://purl.obolibrary.org/obo/GO_0060420) (regulation of heart growth), [GO:0090279](http://purl.obolibrary.org/obo/GO_0090279) (regulation of calcium ion import), [GO:0090276](http://purl.obolibrary.org/obo/GO_0090276) (regulation of peptide hormone secretion), [GO:0090277](http://purl.obolibrary.org/obo/GO_0090277) (positive regulation of peptide hormone secretion), [GO:0060426](http://purl.obolibrary.org/obo/GO_0060426) (lung vasculature development), [GO:0090275](http://purl.obolibrary.org/obo/GO_0090275) (negative regulation of somatostatin secretion), [GO:0060428](http://purl.obolibrary.org/obo/GO_0060428) (lung epithelium development), [GO:0060429](http://purl.obolibrary.org/obo/GO_0060429) (epithelium development), [GO:0046115](http://purl.obolibrary.org/obo/GO_0046115) (guanosine catabolic process), [GO:0060422](http://purl.obolibrary.org/obo/GO_0060422) (peptidyl-dipeptidase inhibitor activity), [GO:0000795](http://purl.obolibrary.org/obo/GO_0000795) (synaptonemal complex), [GO:0000794](http://purl.obolibrary.org/obo/GO_0000794) (condensed nuclear chromosome), [GO:0060425](http://purl.obolibrary.org/obo/GO_0060425) (lung morphogenesis), [GO:0061756](http://purl.obolibrary.org/obo/GO_0061756) (leukocyte adhesion to vascular endothelial cell), [GO:1902608](http://purl.obolibrary.org/obo/GO_1902608) (positive regulation of large conductance calcium-activated potassium channel activity), [GO:0048786](http://purl.obolibrary.org/obo/GO_0048786) (presynaptic active zone), [GO:0048785](http://purl.obolibrary.org/obo/GO_0048785) (hatching gland development), [GO:0046122](http://purl.obolibrary.org/obo/GO_0046122) (purine deoxyribonucleoside metabolic process), [GO:0035418](http://purl.obolibrary.org/obo/GO_0035418) (protein localization to synapse), [GO:0035411](http://purl.obolibrary.org/obo/GO_0035411) (catenin import into nucleus), [GO:0035414](http://purl.obolibrary.org/obo/GO_0035414) (negative regulation of catenin import into nucleus), [GO:0009141](http://purl.obolibrary.org/obo/GO_0009141) (nucleoside triphosphate metabolic process), [GO:0035410](http://purl.obolibrary.org/obo/GO_0035410) (dihydrotestosterone 17-beta-dehydrogenase activity), [GO:0009143](http://purl.obolibrary.org/obo/GO_0009143) (nucleoside triphosphate catabolic process), [GO:0090287](http://purl.obolibrary.org/obo/GO_0090287) (regulation of cellular response to growth factor stimulus), [GO:0060415](http://purl.obolibrary.org/obo/GO_0060415) (muscle tissue morphogenesis), [GO:1902622](http://purl.obolibrary.org/obo/GO_1902622) (regulation of neutrophil migration), [GO:0090286](http://purl.obolibrary.org/obo/GO_0090286) (cytoskeletal anchoring at nuclear membrane), [GO:0048787](http://purl.obolibrary.org/obo/GO_0048787) (presynaptic active zone membrane), [GO:0090281](http://purl.obolibrary.org/obo/GO_0090281) (negative regulation of calcium ion import), [GO:0060411](http://purl.obolibrary.org/obo/GO_0060411) (cardiac septum morphogenesis), [GO:0060412](http://purl.obolibrary.org/obo/GO_0060412) (ventricular septum morphogenesis), [GO:0090282](http://purl.obolibrary.org/obo/GO_0090282) (positive regulation of transcription involved in G2/M transition of mitotic cell cycle), [GO:1903955](http://purl.obolibrary.org/obo/GO_1903955) (positive regulation of protein targeting to mitochondrion), [GO:0060413](http://purl.obolibrary.org/obo/GO_0060413) (atrial septum morphogenesis), [GO:0090280](http://purl.obolibrary.org/obo/GO_0090280) (positive regulation of calcium ion import), [GO:0060414](http://purl.obolibrary.org/obo/GO_0060414) (aorta smooth muscle tissue morphogenesis), [GO:0048793](http://purl.obolibrary.org/obo/GO_0048793) (pronephros development), [GO:0048791](http://purl.obolibrary.org/obo/GO_0048791) (calcium ion-regulated exocytosis of neurotransmitter), [GO:1902617](http://purl.obolibrary.org/obo/GO_1902617) (response to fluoride), [GO:1902618](http://purl.obolibrary.org/obo/GO_1902618) (cellular response to fluoride), [GO:0048797](http://purl.obolibrary.org/obo/GO_0048797) (swim bladder formation), [GO:0060419](http://purl.obolibrary.org/obo/GO_0060419) (heart growth), [GO:0048795](http://purl.obolibrary.org/obo/GO_0048795) (swim bladder morphogenesis), [GO:0048794](http://purl.obolibrary.org/obo/GO_0048794) (swim bladder development), [GO:0035403](http://purl.obolibrary.org/obo/GO_0035403) (histone kinase activity (H3-T6 specific)), [GO:0090259](http://purl.obolibrary.org/obo/GO_0090259) (regulation of retinal ganglion cell axon guidance), [GO:0010181](http://purl.obolibrary.org/obo/GO_0010181) (FMN binding), [GO:0048713](http://purl.obolibrary.org/obo/GO_0048713) (regulation of oligodendrocyte differentiation), [GO:0048712](http://purl.obolibrary.org/obo/GO_0048712) (negative regulation of astrocyte differentiation), [GO:0048711](http://purl.obolibrary.org/obo/GO_0048711) (positive regulation of astrocyte differentiation), [GO:0048715](http://purl.obolibrary.org/obo/GO_0048715) (negative regulation of oligodendrocyte differentiation), [GO:0048714](http://purl.obolibrary.org/obo/GO_0048714) (positive regulation of oligodendrocyte differentiation), [GO:0006913](http://purl.obolibrary.org/obo/GO_0006913) (nucleocytoplasmic transport), [GO:0006910](http://purl.obolibrary.org/obo/GO_0006910) (phagocytosis, recognition), [GO:0006911](http://purl.obolibrary.org/obo/GO_0006911) (phagocytosis, engulfment), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0034148](http://purl.obolibrary.org/obo/GO_0034148) (negative regulation of toll-like receptor 5 signaling pathway), [GO:0006919](http://purl.obolibrary.org/obo/GO_0006919) (activation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0035477](http://purl.obolibrary.org/obo/GO_0035477) (regulation of angioblast cell migration involved in selective angioblast sprouting), [GO:0035478](http://purl.obolibrary.org/obo/GO_0035478) (chylomicron binding), [GO:0009190](http://purl.obolibrary.org/obo/GO_0009190) (cyclic nucleotide biosynthetic process), [GO:0035479](http://purl.obolibrary.org/obo/GO_0035479) (angioblast cell migration from lateral mesoderm to midline), [GO:0034141](http://purl.obolibrary.org/obo/GO_0034141) (positive regulation of toll-like receptor 3 signaling pathway), [GO:0035473](http://purl.obolibrary.org/obo/GO_0035473) (lipase binding), [GO:0035474](http://purl.obolibrary.org/obo/GO_0035474) (selective angioblast sprouting), [GO:0034140](http://purl.obolibrary.org/obo/GO_0034140) (negative regulation of toll-like receptor 3 signaling pathway), [GO:0035475](http://purl.obolibrary.org/obo/GO_0035475) (angioblast cell migration involved in selective angioblast sprouting), [GO:0034145](http://purl.obolibrary.org/obo/GO_0034145) (positive regulation of toll-like receptor 4 signaling pathway), [GO:0035470](http://purl.obolibrary.org/obo/GO_0035470) (positive regulation of vascular wound healing), [GO:0090265](http://purl.obolibrary.org/obo/GO_0090265) (positive regulation of immune complex clearance by monocytes and macrophages), [GO:0090263](http://purl.obolibrary.org/obo/GO_0090263) (positive regulation of canonical Wnt signaling pathway), [GO:0006924](http://purl.obolibrary.org/obo/GO_0006924) (activation-induced cell death of T cells), [GO:0048731](http://purl.obolibrary.org/obo/GO_0048731) (system development), [GO:0048730](http://purl.obolibrary.org/obo/GO_0048730) (epidermis morphogenesis), [GO:0006925](http://purl.obolibrary.org/obo/GO_0006925) (inflammatory cell apoptotic process), [GO:0034138](http://purl.obolibrary.org/obo/GO_0034138) (toll-like receptor 3 signaling pathway), [GO:0034137](http://purl.obolibrary.org/obo/GO_0034137) (positive regulation of toll-like receptor 2 signaling pathway), [GO:0006929](http://purl.obolibrary.org/obo/GO_0006929) (substrate-dependent cell migration), [GO:0035469](http://purl.obolibrary.org/obo/GO_0035469) (determination of pancreatic left/right asymmetry), [GO:0035462](http://purl.obolibrary.org/obo/GO_0035462) (determination of left/right asymmetry in diencephalon), [GO:0090238](http://purl.obolibrary.org/obo/GO_0090238) (positive regulation of arachidonic acid secretion), [GO:0010165](http://purl.obolibrary.org/obo/GO_0010165) (response to X-ray), [GO:0034134](http://purl.obolibrary.org/obo/GO_0034134) (toll-like receptor 2 signaling pathway), [GO:0061713](http://purl.obolibrary.org/obo/GO_0061713) (anterior neural tube closure), [GO:0061714](http://purl.obolibrary.org/obo/GO_0061714) (folic acid receptor activity), [GO:0048733](http://purl.obolibrary.org/obo/GO_0048733) (sebaceous gland development), [GO:0048732](http://purl.obolibrary.org/obo/GO_0048732) (gland development), [GO:0048739](http://purl.obolibrary.org/obo/GO_0048739) (cardiac muscle fiber development), [GO:0048738](http://purl.obolibrary.org/obo/GO_0048738) (cardiac muscle tissue development), [GO:0061712](http://purl.obolibrary.org/obo/GO_0061712) (tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase), [GO:0048741](http://purl.obolibrary.org/obo/GO_0048741) (skeletal muscle fiber development), [GO:0034127](http://purl.obolibrary.org/obo/GO_0034127) (regulation of MyD88-independent toll-like receptor signaling pathway), [GO:0034124](http://purl.obolibrary.org/obo/GO_0034124) (regulation of MyD88-dependent toll-like receptor signaling pathway), [GO:0035455](http://purl.obolibrary.org/obo/GO_0035455) (response to interferon-alpha), [GO:0035456](http://purl.obolibrary.org/obo/GO_0035456) (response to interferon-beta), [GO:0010155](http://purl.obolibrary.org/obo/GO_0010155) (regulation of proton transport), [GO:0035457](http://purl.obolibrary.org/obo/GO_0035457) (cellular response to interferon-alpha), [GO:0035458](http://purl.obolibrary.org/obo/GO_0035458) (cellular response to interferon-beta), [GO:0090245](http://purl.obolibrary.org/obo/GO_0090245) (axis elongation involved in somitogenesis), [GO:0034122](http://purl.obolibrary.org/obo/GO_0034122) (negative regulation of toll-like receptor signaling pathway), [GO:0010172](http://purl.obolibrary.org/obo/GO_0010172) (embryonic body morphogenesis), [GO:0034121](http://purl.obolibrary.org/obo/GO_0034121) (regulation of toll-like receptor signaling pathway), [GO:0010171](http://purl.obolibrary.org/obo/GO_0010171) (body morphogenesis), [GO:0090244](http://purl.obolibrary.org/obo/GO_0090244) (Wnt signaling pathway involved in somitogenesis), [GO:0061702](http://purl.obolibrary.org/obo/GO_0061702) (inflammasome complex), [GO:0090241](http://purl.obolibrary.org/obo/GO_0090241) (negative regulation of histone H4 acetylation), [GO:0048745](http://purl.obolibrary.org/obo/GO_0048745) (smooth muscle tissue development), [GO:0048743](http://purl.obolibrary.org/obo/GO_0048743) (positive regulation of skeletal muscle fiber development), [GO:0048749](http://purl.obolibrary.org/obo/GO_0048749) (compound eye development), [GO:0061700](http://purl.obolibrary.org/obo/GO_0061700) (GATOR2 complex), [GO:0048747](http://purl.obolibrary.org/obo/GO_0048747) (muscle fiber development), [GO:1903912](http://purl.obolibrary.org/obo/GO_1903912) (negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation), [GO:1903904](http://purl.obolibrary.org/obo/GO_1903904) (negative regulation of establishment of T cell polarity), [GO:1903905](http://purl.obolibrary.org/obo/GO_1903905) (positive regulation of establishment of T cell polarity), [GO:0048753](http://purl.obolibrary.org/obo/GO_0048753) (pigment granule organization), [GO:0006906](http://purl.obolibrary.org/obo/GO_0006906) (vesicle fusion), [GO:0048752](http://purl.obolibrary.org/obo/GO_0048752) (semicircular canal morphogenesis), [GO:0061708](http://purl.obolibrary.org/obo/GO_0061708) (tRNA-5-taurinomethyluridine 2-sulfurtransferase), [GO:0006903](http://purl.obolibrary.org/obo/GO_0006903) (vesicle targeting), [GO:0006904](http://purl.obolibrary.org/obo/GO_0006904) (vesicle docking involved in exocytosis), [GO:0061709](http://purl.obolibrary.org/obo/GO_0061709) (reticulophagy), [GO:0006909](http://purl.obolibrary.org/obo/GO_0006909) (phagocytosis), [GO:0034116](http://purl.obolibrary.org/obo/GO_0034116) (positive regulation of heterotypic cell-cell adhesion), [GO:0034115](http://purl.obolibrary.org/obo/GO_0034115) (negative regulation of heterotypic cell-cell adhesion), [GO:0006907](http://purl.obolibrary.org/obo/GO_0006907) (pinocytosis), [GO:0034113](http://purl.obolibrary.org/obo/GO_0034113) (heterotypic cell-cell adhesion), [GO:0009181](http://purl.obolibrary.org/obo/GO_0009181) (purine ribonucleoside diphosphate catabolic process), [GO:0016887](http://purl.obolibrary.org/obo/GO_0016887) (ATPase activity), [GO:0002244](http://purl.obolibrary.org/obo/GO_0002244) (hematopoietic progenitor cell differentiation), [GO:0002237](http://purl.obolibrary.org/obo/GO_0002237) (response to molecule of bacterial origin), [GO:0002238](http://purl.obolibrary.org/obo/GO_0002238) (response to molecule of fungal origin), [GO:0016890](http://purl.obolibrary.org/obo/GO_0016890) (site-specific endodeoxyribonuclease activity, specific for altered base), [GO:0016891](http://purl.obolibrary.org/obo/GO_0016891) (endoribonuclease activity, producing 5'-phosphomonoesters), [GO:0016878](http://purl.obolibrary.org/obo/GO_0016878) (acid-thiol ligase activity), [GO:0015562](http://purl.obolibrary.org/obo/GO_0015562) (efflux transmembrane transporter activity), [GO:0002250](http://purl.obolibrary.org/obo/GO_0002250) (adaptive immune response), [GO:0002253](http://purl.obolibrary.org/obo/GO_0002253) (activation of immune response), [GO:0002246](http://purl.obolibrary.org/obo/GO_0002246) (wound healing involved in inflammatory response), [GO:0070392](http://purl.obolibrary.org/obo/GO_0070392) (detection of lipoteichoic acid), [GO:0016885](http://purl.obolibrary.org/obo/GO_0016885) (ligase activity, forming carbon-carbon bonds), [GO:0016866](http://purl.obolibrary.org/obo/GO_0016866) (intramolecular transferase activity), [GO:0016868](http://purl.obolibrary.org/obo/GO_0016868) (intramolecular transferase activity, phosphotransferases), [GO:1905601](http://purl.obolibrary.org/obo/GO_1905601) (negative regulation of receptor-mediated endocytosis involved in cholesterol transport), [GO:0004875](http://purl.obolibrary.org/obo/GO_0004875) (complement receptor activity), [GO:0002215](http://purl.obolibrary.org/obo/GO_0002215) (defense response to nematode), [GO:0002218](http://purl.obolibrary.org/obo/GO_0002218) (activation of innate immune response), [GO:0004879](http://purl.obolibrary.org/obo/GO_0004879) (nuclear receptor activity), [GO:0016874](http://purl.obolibrary.org/obo/GO_0016874) (ligase activity), [GO:0016857](http://purl.obolibrary.org/obo/GO_0016857) (racemase and epimerase activity, acting on carbohydrates and derivatives), [GO:0004890](http://purl.obolibrary.org/obo/GO_0004890) (GABA-A receptor activity), [GO:0002230](http://purl.obolibrary.org/obo/GO_0002230) (positive regulation of defense response to virus by host), [GO:0004896](http://purl.obolibrary.org/obo/GO_0004896) (cytokine receptor activity), [GO:0002224](http://purl.obolibrary.org/obo/GO_0002224) (toll-like receptor signaling pathway), [GO:0004887](http://purl.obolibrary.org/obo/GO_0004887) (thyroid hormone receptor activity), [GO:0004888](http://purl.obolibrary.org/obo/GO_0004888) (transmembrane signaling receptor activity), [GO:0002281](http://purl.obolibrary.org/obo/GO_0002281) (macrophage activation involved in immune response), [GO:0002282](http://purl.obolibrary.org/obo/GO_0002282) (microglial cell activation involved in immune response), [GO:0002283](http://purl.obolibrary.org/obo/GO_0002283) (neutrophil activation involved in immune response), [GO:0093001](http://purl.obolibrary.org/obo/GO_0093001) (glycolysis from storage polysaccharide through glucose-1-phosphate), [GO:0002286](http://purl.obolibrary.org/obo/GO_0002286) (T cell activation involved in immune response), [GO:0071696](http://purl.obolibrary.org/obo/GO_0071696) (ectodermal placode development), [GO:0070365](http://purl.obolibrary.org/obo/GO_0070365) (hepatocyte differentiation), [GO:0044088](http://purl.obolibrary.org/obo/GO_0044088) (regulation of vacuole organization), [GO:0071699](http://purl.obolibrary.org/obo/GO_0071699) (olfactory placode morphogenesis), [GO:0070369](http://purl.obolibrary.org/obo/GO_0070369) (beta-catenin-TCF7L2 complex), [GO:0071698](http://purl.obolibrary.org/obo/GO_0071698) (olfactory placode development), [GO:0071681](http://purl.obolibrary.org/obo/GO_0071681) (cellular response to indole-3-methanol), [GO:0071688](http://purl.obolibrary.org/obo/GO_0071688) (striated muscle myosin thick filament assembly), [GO:0070358](http://purl.obolibrary.org/obo/GO_0070358) (actin polymerization-dependent cell motility), [GO:0044092](http://purl.obolibrary.org/obo/GO_0044092) (negative regulation of molecular function), [GO:0002260](http://purl.obolibrary.org/obo/GO_0002260) (lymphocyte homeostasis), [GO:0002262](http://purl.obolibrary.org/obo/GO_0002262) (myeloid cell homeostasis), [GO:0002265](http://purl.obolibrary.org/obo/GO_0002265) (astrocyte activation involved in immune response), [GO:0070382](http://purl.obolibrary.org/obo/GO_0070382) (exocytic vesicle), [GO:0038202](http://purl.obolibrary.org/obo/GO_0038202) (TORC1 signaling), [GO:0039530](http://purl.obolibrary.org/obo/GO_0039530) (MDA-5 signaling pathway), [GO:0002275](http://purl.obolibrary.org/obo/GO_0002275) (myeloid cell activation involved in immune response), [GO:0002276](http://purl.obolibrary.org/obo/GO_0002276) (basophil activation involved in immune response), [GO:0002277](http://purl.obolibrary.org/obo/GO_0002277) (myeloid dendritic cell activation involved in immune response), [GO:0070371](http://purl.obolibrary.org/obo/GO_0070371) (ERK1 and ERK2 cascade), [GO:0002268](http://purl.obolibrary.org/obo/GO_0002268) (follicular dendritic cell differentiation), [GO:0070372](http://purl.obolibrary.org/obo/GO_0070372) (regulation of ERK1 and ERK2 cascade), [GO:0070375](http://purl.obolibrary.org/obo/GO_0070375) (ERK5 cascade), [GO:0070373](http://purl.obolibrary.org/obo/GO_0070373) (negative regulation of ERK1 and ERK2 cascade), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:1903007](http://purl.obolibrary.org/obo/GO_1903007) (positive regulation of Lys63-specific deubiquitinase activity), [GO:1903006](http://purl.obolibrary.org/obo/GO_1903006) (positive regulation of protein K63-linked deubiquitination), [GO:0009712](http://purl.obolibrary.org/obo/GO_0009712) (catechol-containing compound metabolic process), [GO:0051246](http://purl.obolibrary.org/obo/GO_0051246) (regulation of protein metabolic process), [GO:0051247](http://purl.obolibrary.org/obo/GO_0051247) (positive regulation of protein metabolic process), [GO:1903010](http://purl.obolibrary.org/obo/GO_1903010) (regulation of bone development), [GO:1904343](http://purl.obolibrary.org/obo/GO_1904343) (positive regulation of colon smooth muscle contraction), [GO:0051260](http://purl.obolibrary.org/obo/GO_0051260) (protein homooligomerization), [GO:0052591](http://purl.obolibrary.org/obo/GO_0052591) (sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity), [GO:1904349](http://purl.obolibrary.org/obo/GO_1904349) (positive regulation of small intestine smooth muscle contraction), [GO:0052590](http://purl.obolibrary.org/obo/GO_0052590) (sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity), [GO:0009725](http://purl.obolibrary.org/obo/GO_0009725) (response to hormone), [GO:1990254](http://purl.obolibrary.org/obo/GO_1990254) (keratin filament binding), [GO:0051258](http://purl.obolibrary.org/obo/GO_0051258) (protein polymerization), [GO:0051256](http://purl.obolibrary.org/obo/GO_0051256) (mitotic spindle midzone assembly), [GO:0010705](http://purl.obolibrary.org/obo/GO_0010705) (meiotic DNA double-strand break processing involved in reciprocal meiotic recombination), [GO:0010701](http://purl.obolibrary.org/obo/GO_0010701) (positive regulation of norepinephrine secretion), [GO:0051259](http://purl.obolibrary.org/obo/GO_0051259) (protein oligomerization), [GO:1903022](http://purl.obolibrary.org/obo/GO_1903022) (positive regulation of phosphodiesterase activity, acting on 3'-phosphoglycolate-terminated DNA strands), [GO:1904352](http://purl.obolibrary.org/obo/GO_1904352) (positive regulation of protein catabolic process in the vacuole), [GO:1903025](http://purl.obolibrary.org/obo/GO_1903025) (regulation of RNA polymerase II regulatory region sequence-specific DNA binding), [GO:1904356](http://purl.obolibrary.org/obo/GO_1904356) (regulation of telomere maintenance via telomere lengthening), [GO:1904355](http://purl.obolibrary.org/obo/GO_1904355) (positive regulation of telomere capping), [GO:0051271](http://purl.obolibrary.org/obo/GO_0051271) (negative regulation of cellular component movement), [GO:0051272](http://purl.obolibrary.org/obo/GO_0051272) (positive regulation of cellular component movement), [GO:0051270](http://purl.obolibrary.org/obo/GO_0051270) (regulation of cellular component movement), [GO:1904358](http://purl.obolibrary.org/obo/GO_1904358) (positive regulation of telomere maintenance via telomere lengthening), [GO:1990266](http://purl.obolibrary.org/obo/GO_1990266) (neutrophil migration), [GO:0051267](http://purl.obolibrary.org/obo/GO_0051267) (CP2 mannose-ethanolamine phosphotransferase activity), [GO:0051262](http://purl.obolibrary.org/obo/GO_0051262) (protein tetramerization), [GO:1903036](http://purl.obolibrary.org/obo/GO_1903036) (positive regulation of response to wounding), [GO:0051280](http://purl.obolibrary.org/obo/GO_0051280) (negative regulation of release of sequestered calcium ion into cytosol), [GO:1903038](http://purl.obolibrary.org/obo/GO_1903038) (negative regulation of leukocyte cell-cell adhesion), [GO:0051281](http://purl.obolibrary.org/obo/GO_0051281) (positive regulation of release of sequestered calcium ion into cytosol), [GO:0051279](http://purl.obolibrary.org/obo/GO_0051279) (regulation of release of sequestered calcium ion into cytosol), [GO:0051276](http://purl.obolibrary.org/obo/GO_0051276) (chromosome organization), [GO:0008422](http://purl.obolibrary.org/obo/GO_0008422) (beta-glucosidase activity), [GO:0008420](http://purl.obolibrary.org/obo/GO_0008420) (CTD phosphatase activity), [GO:0009758](http://purl.obolibrary.org/obo/GO_0009758) (carbohydrate utilization), [GO:0009757](http://purl.obolibrary.org/obo/GO_0009757) (hexose mediated signaling), [GO:0008426](http://purl.obolibrary.org/obo/GO_0008426) (protein kinase C inhibitor activity), [GO:0009755](http://purl.obolibrary.org/obo/GO_0009755) (hormone-mediated signaling pathway), [GO:1905627](http://purl.obolibrary.org/obo/GO_1905627) (regulation of serotonin biosynthetic process), [GO:0034707](http://purl.obolibrary.org/obo/GO_0034707) (chloride channel complex), [GO:0034706](http://purl.obolibrary.org/obo/GO_0034706) (sodium channel complex), [GO:0010739](http://purl.obolibrary.org/obo/GO_0010739) (positive regulation of protein kinase A signaling), [GO:0009749](http://purl.obolibrary.org/obo/GO_0009749) (response to glucose), [GO:0034705](http://purl.obolibrary.org/obo/GO_0034705) (potassium channel complex), [GO:0034704](http://purl.obolibrary.org/obo/GO_0034704) (calcium channel complex), [GO:0008417](http://purl.obolibrary.org/obo/GO_0008417) (fucosyltransferase activity), [GO:0010738](http://purl.obolibrary.org/obo/GO_0010738) (regulation of protein kinase A signaling), [GO:0010737](http://purl.obolibrary.org/obo/GO_0010737) (protein kinase A signaling), [GO:0010734](http://purl.obolibrary.org/obo/GO_0010734) (negative regulation of protein glutathionylation), [GO:0051209](http://purl.obolibrary.org/obo/GO_0051209) (release of sequestered calcium ion into cytosol), [GO:0010730](http://purl.obolibrary.org/obo/GO_0010730) (negative regulation of hydrogen peroxide biosynthetic process), [GO:0051204](http://purl.obolibrary.org/obo/GO_0051204) (protein insertion into mitochondrial membrane), [GO:0051205](http://purl.obolibrary.org/obo/GO_0051205) (protein insertion into membrane), [GO:1905631](http://purl.obolibrary.org/obo/GO_1905631) (cellular response to glyceraldehyde), [GO:0008432](http://purl.obolibrary.org/obo/GO_0008432) (JUN kinase binding), [GO:0007100](http://purl.obolibrary.org/obo/GO_0007100) (mitotic centrosome separation), [GO:1905634](http://purl.obolibrary.org/obo/GO_1905634) (regulation of protein localization to chromatin), [GO:0008431](http://purl.obolibrary.org/obo/GO_0008431) (vitamin E binding), [GO:0051213](http://purl.obolibrary.org/obo/GO_0051213) (dioxygenase activity), [GO:0008429](http://purl.obolibrary.org/obo/GO_0008429) (phosphatidylethanolamine binding), [GO:0010749](http://purl.obolibrary.org/obo/GO_0010749) (regulation of nitric oxide mediated signal transduction), [GO:0010748](http://purl.obolibrary.org/obo/GO_0010748) (negative regulation of plasma membrane long-chain fatty acid transport), [GO:0051219](http://purl.obolibrary.org/obo/GO_0051219) (phosphoprotein binding), [GO:0010744](http://purl.obolibrary.org/obo/GO_0010744) (positive regulation of macrophage derived foam cell differentiation), [GO:0052548](http://purl.obolibrary.org/obo/GO_0052548) (regulation of endopeptidase activity), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:1904315](http://purl.obolibrary.org/obo/GO_1904315) (transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential), [GO:0008403](http://purl.obolibrary.org/obo/GO_0008403) (25-hydroxycholecalciferol-24-hydroxylase activity), [GO:0010718](http://purl.obolibrary.org/obo/GO_0010718) (positive regulation of epithelial to mesenchymal transition), [GO:0051225](http://purl.obolibrary.org/obo/GO_0051225) (spindle assembly), [GO:0051222](http://purl.obolibrary.org/obo/GO_0051222) (positive regulation of protein transport), [GO:0010719](http://purl.obolibrary.org/obo/GO_0010719) (negative regulation of epithelial to mesenchymal transition), [GO:0010714](http://purl.obolibrary.org/obo/GO_0010714) (positive regulation of collagen metabolic process), [GO:0010712](http://purl.obolibrary.org/obo/GO_0010712) (regulation of collagen metabolic process), [GO:0051229](http://purl.obolibrary.org/obo/GO_0051229) (meiotic spindle disassembly), [GO:1904322](http://purl.obolibrary.org/obo/GO_1904322) (cellular response to forskolin), [GO:0009743](http://purl.obolibrary.org/obo/GO_0009743) (response to carbohydrate), [GO:0008412](http://purl.obolibrary.org/obo/GO_0008412) (4-hydroxybenzoate octaprenyltransferase activity), [GO:0008410](http://purl.obolibrary.org/obo/GO_0008410) (CoA-transferase activity), [GO:0008413](http://purl.obolibrary.org/obo/GO_0008413) (8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity), [GO:0008409](http://purl.obolibrary.org/obo/GO_0008409) (5'-3' exonuclease activity), [GO:0008408](http://purl.obolibrary.org/obo/GO_0008408) (3'-5' exonuclease activity), [GO:0051233](http://purl.obolibrary.org/obo/GO_0051233) (spindle midzone), [GO:0008406](http://purl.obolibrary.org/obo/GO_0008406) (gonad development), [GO:0010725](http://purl.obolibrary.org/obo/GO_0010725) (regulation of primitive erythrocyte differentiation), [GO:0010724](http://purl.obolibrary.org/obo/GO_0010724) (regulation of definitive erythrocyte differentiation), [GO:0010727](http://purl.obolibrary.org/obo/GO_0010727) (negative regulation of hydrogen peroxide metabolic process), [GO:0010722](http://purl.obolibrary.org/obo/GO_0010722) (regulation of ferrochelatase activity), [GO:0051237](http://purl.obolibrary.org/obo/GO_0051237) (maintenance of RNA location), [GO:0046619](http://purl.obolibrary.org/obo/GO_0046619) (optic placode formation involved in camera-type eye formation), [GO:0046618](http://purl.obolibrary.org/obo/GO_0046618) (drug export), [GO:0007010](http://purl.obolibrary.org/obo/GO_0007010) (cytoskeleton organization), [GO:0008340](http://purl.obolibrary.org/obo/GO_0008340) (determination of adult lifespan), [GO:0007014](http://purl.obolibrary.org/obo/GO_0007014) (actin ubiquitination), [GO:0007015](http://purl.obolibrary.org/obo/GO_0007015) (actin filament organization), [GO:0008345](http://purl.obolibrary.org/obo/GO_0008345) (larval locomotory behavior), [GO:0008344](http://purl.obolibrary.org/obo/GO_0008344) (adult locomotory behavior), [GO:0008343](http://purl.obolibrary.org/obo/GO_0008343) (adult feeding behavior), [GO:0007018](http://purl.obolibrary.org/obo/GO_0007018) (microtubule-based movement), [GO:0008349](http://purl.obolibrary.org/obo/GO_0008349) (MAP kinase kinase kinase kinase activity), [GO:0007016](http://purl.obolibrary.org/obo/GO_0007016) (cytoskeletal anchoring at plasma membrane), [GO:0008347](http://purl.obolibrary.org/obo/GO_0008347) (glial cell migration), [GO:0007017](http://purl.obolibrary.org/obo/GO_0007017) (microtubule-based process), [GO:0010659](http://purl.obolibrary.org/obo/GO_0010659) (cardiac muscle cell apoptotic process), [GO:0019001](http://purl.obolibrary.org/obo/GO_0019001) (guanyl nucleotide binding), [GO:0019003](http://purl.obolibrary.org/obo/GO_0019003) (GDP binding), [GO:0019002](http://purl.obolibrary.org/obo/GO_0019002) (GMP binding), [GO:0035955](http://purl.obolibrary.org/obo/GO_0035955) (negative regulation of dipeptide transport by negative regulation of transcription from RNA polymerase II promoter), [GO:0019005](http://purl.obolibrary.org/obo/GO_0019005) (SCF ubiquitin ligase complex), [GO:0010656](http://purl.obolibrary.org/obo/GO_0010656) (negative regulation of muscle cell apoptotic process), [GO:0034626](http://purl.obolibrary.org/obo/GO_0034626) (fatty acid elongation, polyunsaturated fatty acid), [GO:0034625](http://purl.obolibrary.org/obo/GO_0034625) (fatty acid elongation, monounsaturated fatty acid), [GO:0035952](http://purl.obolibrary.org/obo/GO_0035952) (negative regulation of oligopeptide transport by negative regulation of transcription from RNA polymerase II promoter), [GO:0019008](http://purl.obolibrary.org/obo/GO_0019008) (molybdopterin synthase complex), [GO:0010652](http://purl.obolibrary.org/obo/GO_0010652) (positive regulation of cell communication by chemical coupling), [GO:0046628](http://purl.obolibrary.org/obo/GO_0046628) (positive regulation of insulin receptor signaling pathway), [GO:0008353](http://purl.obolibrary.org/obo/GO_0008353) (RNA polymerase II carboxy-terminal domain kinase activity), [GO:0007021](http://purl.obolibrary.org/obo/GO_0007021) (tubulin complex assembly), [GO:0009682](http://purl.obolibrary.org/obo/GO_0009682) (induced systemic resistance), [GO:0007020](http://purl.obolibrary.org/obo/GO_0007020) (microtubule nucleation), [GO:0046622](http://purl.obolibrary.org/obo/GO_0046622) (positive regulation of organ growth), [GO:0007026](http://purl.obolibrary.org/obo/GO_0007026) (negative regulation of microtubule depolymerization), [GO:0047953](http://purl.obolibrary.org/obo/GO_0047953) (glycerol 2-dehydrogenase (NADP+) activity), [GO:0060912](http://purl.obolibrary.org/obo/GO_0060912) (cardiac cell fate specification), [GO:0046620](http://purl.obolibrary.org/obo/GO_0046620) (regulation of organ growth), [GO:0007023](http://purl.obolibrary.org/obo/GO_0007023) (post-chaperonin tubulin folding pathway), [GO:0008354](http://purl.obolibrary.org/obo/GO_0008354) (germ cell migration), [GO:0046621](http://purl.obolibrary.org/obo/GO_0046621) (negative regulation of organ growth), [GO:0060913](http://purl.obolibrary.org/obo/GO_0060913) (cardiac cell fate determination), [GO:0007029](http://purl.obolibrary.org/obo/GO_0007029) (endoplasmic reticulum organization), [GO:0046627](http://purl.obolibrary.org/obo/GO_0046627) (negative regulation of insulin receptor signaling pathway), [GO:0046624](http://purl.obolibrary.org/obo/GO_0046624) (sphingolipid transporter activity), [GO:0007028](http://purl.obolibrary.org/obo/GO_0007028) (cytoplasm organization), [GO:0034618](http://purl.obolibrary.org/obo/GO_0034618) (arginine binding), [GO:0034617](http://purl.obolibrary.org/obo/GO_0034617) (tetrahydrobiopterin binding), [GO:0035947](http://purl.obolibrary.org/obo/GO_0035947) (regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter), [GO:0060914](http://purl.obolibrary.org/obo/GO_0060914) (heart formation), [GO:0010669](http://purl.obolibrary.org/obo/GO_0010669) (epithelial structure maintenance), [GO:0010666](http://purl.obolibrary.org/obo/GO_0010666) (positive regulation of cardiac muscle cell apoptotic process), [GO:0010668](http://purl.obolibrary.org/obo/GO_0010668) (ectodermal cell differentiation), [GO:0010667](http://purl.obolibrary.org/obo/GO_0010667) (negative regulation of cardiac muscle cell apoptotic process), [GO:0034614](http://purl.obolibrary.org/obo/GO_0034614) (cellular response to reactive oxygen species), [GO:0034613](http://purl.obolibrary.org/obo/GO_0034613) (cellular protein localization), [GO:0010664](http://purl.obolibrary.org/obo/GO_0010664) (negative regulation of striated muscle cell apoptotic process), [GO:0034612](http://purl.obolibrary.org/obo/GO_0034612) (response to tumor necrosis factor), [GO:0009651](http://purl.obolibrary.org/obo/GO_0009651) (response to salt stress), [GO:0022626](http://purl.obolibrary.org/obo/GO_0022626) (cytosolic ribosome), [GO:0008320](http://purl.obolibrary.org/obo/GO_0008320) (protein transmembrane transporter activity), [GO:0022627](http://purl.obolibrary.org/obo/GO_0022627) (cytosolic small ribosomal subunit), [GO:0009650](http://purl.obolibrary.org/obo/GO_0009650) (UV protection), [GO:0008324](http://purl.obolibrary.org/obo/GO_0008324) (cation transmembrane transporter activity), [GO:0046633](http://purl.obolibrary.org/obo/GO_0046633) (alpha-beta T cell proliferation), [GO:0009653](http://purl.obolibrary.org/obo/GO_0009653) (anatomical structure morphogenesis), [GO:0047963](http://purl.obolibrary.org/obo/GO_0047963) (glycine N-choloyltransferase activity), [GO:0046631](http://purl.obolibrary.org/obo/GO_0046631) (alpha-beta T cell activation), [GO:0022625](http://purl.obolibrary.org/obo/GO_0022625) (cytosolic large ribosomal subunit), [GO:0009652](http://purl.obolibrary.org/obo/GO_0009652) (thigmotropism), [GO:0046632](http://purl.obolibrary.org/obo/GO_0046632) (alpha-beta T cell differentiation), [GO:0099132](http://purl.obolibrary.org/obo/GO_0099132) (ATP hydrolysis coupled cation transmembrane transport), [GO:0008328](http://purl.obolibrary.org/obo/GO_0008328) (ionotropic glutamate receptor complex), [GO:0099133](http://purl.obolibrary.org/obo/GO_0099133) (ATP hydrolysis coupled anion transmembrane transport), [GO:0046638](http://purl.obolibrary.org/obo/GO_0046638) (positive regulation of alpha-beta T cell differentiation), [GO:0008327](http://purl.obolibrary.org/obo/GO_0008327) (methyl-CpG binding), [GO:0046635](http://purl.obolibrary.org/obo/GO_0046635) (positive regulation of alpha-beta T cell activation), [GO:0099131](http://purl.obolibrary.org/obo/GO_0099131) (ATP hydrolysis coupled ion transmembrane transport), [GO:0034605](http://purl.obolibrary.org/obo/GO_0034605) (cellular response to heat), [GO:0060947](http://purl.obolibrary.org/obo/GO_0060947) (cardiac vascular smooth muscle cell differentiation), [GO:0046641](http://purl.obolibrary.org/obo/GO_0046641) (positive regulation of alpha-beta T cell proliferation), [GO:0060948](http://purl.obolibrary.org/obo/GO_0060948) (cardiac vascular smooth muscle cell development), [GO:0010632](http://purl.obolibrary.org/obo/GO_0010632) (regulation of epithelial cell migration), [GO:0010634](http://purl.obolibrary.org/obo/GO_0010634) (positive regulation of epithelial cell migration), [GO:0034604](http://purl.obolibrary.org/obo/GO_0034604) (pyruvate dehydrogenase (NAD+) activity), [GO:0034602](http://purl.obolibrary.org/obo/GO_0034602) (oxoglutarate dehydrogenase (NAD+) activity), [GO:0008331](http://purl.obolibrary.org/obo/GO_0008331) (high voltage-gated calcium channel activity), [GO:0022615](http://purl.obolibrary.org/obo/GO_0022615) (protein to membrane docking), [GO:0007000](http://purl.obolibrary.org/obo/GO_0007000) (nucleolus organization), [GO:0022617](http://purl.obolibrary.org/obo/GO_0022617) (extracellular matrix disassembly), [GO:0022612](http://purl.obolibrary.org/obo/GO_0022612) (gland morphogenesis), [GO:0007004](http://purl.obolibrary.org/obo/GO_0007004) (telomere maintenance via telomerase), [GO:0008333](http://purl.obolibrary.org/obo/GO_0008333) (endosome to lysosome transport), [GO:0008332](http://purl.obolibrary.org/obo/GO_0008332) (low voltage-gated calcium channel activity), [GO:0007007](http://purl.obolibrary.org/obo/GO_0007007) (inner mitochondrial membrane organization), [GO:0046649](http://purl.obolibrary.org/obo/GO_0046649) (lymphocyte activation), [GO:0007005](http://purl.obolibrary.org/obo/GO_0007005) (mitochondrion organization), [GO:0007006](http://purl.obolibrary.org/obo/GO_0007006) (mitochondrial membrane organization), [GO:0060931](http://purl.obolibrary.org/obo/GO_0060931) (sinoatrial node cell development), [GO:0046651](http://purl.obolibrary.org/obo/GO_0046651) (lymphocyte proliferation), [GO:0035927](http://purl.obolibrary.org/obo/GO_0035927) (RNA import into mitochondrion), [GO:0035928](http://purl.obolibrary.org/obo/GO_0035928) (rRNA import into mitochondrion), [GO:0010644](http://purl.obolibrary.org/obo/GO_0010644) (cell communication by electrical coupling), [GO:0035922](http://purl.obolibrary.org/obo/GO_0035922) (foramen ovale closure), [GO:0010643](http://purl.obolibrary.org/obo/GO_0010643) (cell communication by chemical coupling), [GO:0035924](http://purl.obolibrary.org/obo/GO_0035924) (cellular response to vascular endothelial growth factor stimulus), [GO:0007050](http://purl.obolibrary.org/obo/GO_0007050) (cell cycle arrest), [GO:0008381](http://purl.obolibrary.org/obo/GO_0008381) (mechanosensitive ion channel activity), [GO:0007051](http://purl.obolibrary.org/obo/GO_0007051) (spindle organization), [GO:0008380](http://purl.obolibrary.org/obo/GO_0008380) (RNA splicing), [GO:1904251](http://purl.obolibrary.org/obo/GO_1904251) (regulation of bile acid metabolic process), [GO:0008385](http://purl.obolibrary.org/obo/GO_0008385) (IkappaB kinase complex), [GO:0034672](http://purl.obolibrary.org/obo/GO_0034672) (anterior/posterior pattern specification involved in pronephros development), [GO:0007052](http://purl.obolibrary.org/obo/GO_0007052) (mitotic spindle organization), [GO:0008384](http://purl.obolibrary.org/obo/GO_0008384) (IkappaB kinase activity), [GO:0034670](http://purl.obolibrary.org/obo/GO_0034670) (chemotaxis to arachidonic acid), [GO:0007059](http://purl.obolibrary.org/obo/GO_0007059) (chromosome segregation), [GO:0051170](http://purl.obolibrary.org/obo/GO_0051170) (nuclear import), [GO:0020027](http://purl.obolibrary.org/obo/GO_0020027) (hemoglobin metabolic process), [GO:0051169](http://purl.obolibrary.org/obo/GO_0051169) (nuclear transport), [GO:0035998](http://purl.obolibrary.org/obo/GO_0035998) (7,8-dihydroneopterin 3'-triphosphate biosynthetic process), [GO:0033334](http://purl.obolibrary.org/obo/GO_0033334) (fin morphogenesis), [GO:0035999](http://purl.obolibrary.org/obo/GO_0035999) (tetrahydrofolate interconversion), [GO:0033333](http://purl.obolibrary.org/obo/GO_0033333) (fin development), [GO:0019048](http://purl.obolibrary.org/obo/GO_0019048) (modulation by virus of host morphology or physiology), [GO:0032007](http://purl.obolibrary.org/obo/GO_0032007) (negative regulation of TOR signaling), [GO:0033339](http://purl.obolibrary.org/obo/GO_0033339) (pectoral fin development), [GO:0035994](http://purl.obolibrary.org/obo/GO_0035994) (response to muscle stretch), [GO:0032008](http://purl.obolibrary.org/obo/GO_0032008) (positive regulation of TOR signaling), [GO:0035995](http://purl.obolibrary.org/obo/GO_0035995) (detection of muscle stretch), [GO:0010694](http://purl.obolibrary.org/obo/GO_0010694) (positive regulation of alkaline phosphatase activity), [GO:0032006](http://purl.obolibrary.org/obo/GO_0032006) (regulation of TOR signaling), [GO:0034667](http://purl.obolibrary.org/obo/GO_0034667) (integrin alpha3-beta1 complex), [GO:1905596](http://purl.obolibrary.org/obo/GO_1905596) (negative regulation of low-density lipoprotein particle receptor binding), [GO:0008392](http://purl.obolibrary.org/obo/GO_0008392) (arachidonic acid epoxygenase activity), [GO:0007062](http://purl.obolibrary.org/obo/GO_0007062) (sister chromatid cohesion), [GO:1904263](http://purl.obolibrary.org/obo/GO_1904263) (positive regulation of TORC1 signaling), [GO:1905594](http://purl.obolibrary.org/obo/GO_1905594) (resveratrol binding), [GO:0008391](http://purl.obolibrary.org/obo/GO_0008391) (arachidonic acid monooxygenase activity), [GO:0035993](http://purl.obolibrary.org/obo/GO_0035993) (deltoid tuberosity development), [GO:1904262](http://purl.obolibrary.org/obo/GO_1904262) (negative regulation of TORC1 signaling), [GO:0008390](http://purl.obolibrary.org/obo/GO_0008390) (testosterone 16-alpha-hydroxylase activity), [GO:0007065](http://purl.obolibrary.org/obo/GO_0007065) (male meiosis sister chromatid cohesion), [GO:0032000](http://purl.obolibrary.org/obo/GO_0032000) (positive regulation of fatty acid beta-oxidation), [GO:0007066](http://purl.obolibrary.org/obo/GO_0007066) (female meiosis sister chromatid cohesion), [GO:0008396](http://purl.obolibrary.org/obo/GO_0008396) (oxysterol 7-alpha-hydroxylase activity), [GO:0008395](http://purl.obolibrary.org/obo/GO_0008395) (steroid hydroxylase activity), [GO:1905598](http://purl.obolibrary.org/obo/GO_1905598) (negative regulation of low-density lipoprotein receptor activity), [GO:0007064](http://purl.obolibrary.org/obo/GO_0007064) (mitotic sister chromatid cohesion), [GO:0051181](http://purl.obolibrary.org/obo/GO_0051181) (cofactor transport), [GO:0020018](http://purl.obolibrary.org/obo/GO_0020018) (ciliary pocket membrane), [GO:0051180](http://purl.obolibrary.org/obo/GO_0051180) (vitamin transport), [GO:0019031](http://purl.obolibrary.org/obo/GO_0019031) (viral envelope), [GO:0035987](http://purl.obolibrary.org/obo/GO_0035987) (endodermal cell differentiation), [GO:0035988](http://purl.obolibrary.org/obo/GO_0035988) (chondrocyte proliferation), [GO:0035989](http://purl.obolibrary.org/obo/GO_0035989) (tendon development), [GO:0033328](http://purl.obolibrary.org/obo/GO_0033328) (peroxisome membrane targeting sequence binding), [GO:0033327](http://purl.obolibrary.org/obo/GO_0033327) (Leydig cell differentiation), [GO:0035984](http://purl.obolibrary.org/obo/GO_0035984) (cellular response to trichostatin A), [GO:1905590](http://purl.obolibrary.org/obo/GO_1905590) (fibronectin fibril organization), [GO:0035985](http://purl.obolibrary.org/obo/GO_0035985) (senescence-associated heterochromatin focus), [GO:0008360](http://purl.obolibrary.org/obo/GO_0008360) (regulation of cell shape), [GO:0034651](http://purl.obolibrary.org/obo/GO_0034651) (cortisol biosynthetic process), [GO:0007032](http://purl.obolibrary.org/obo/GO_0007032) (endosome organization), [GO:0034650](http://purl.obolibrary.org/obo/GO_0034650) (cortisol metabolic process), [GO:0007033](http://purl.obolibrary.org/obo/GO_0007033) (vacuole organization), [GO:0007030](http://purl.obolibrary.org/obo/GO_0007030) (Golgi organization), [GO:0008361](http://purl.obolibrary.org/obo/GO_0008361) (regulation of cell size), [GO:0007031](http://purl.obolibrary.org/obo/GO_0007031) (peroxisome organization), [GO:0020003](http://purl.obolibrary.org/obo/GO_0020003) (symbiont-containing vacuole), [GO:0060900](http://purl.obolibrary.org/obo/GO_0060900) (embryonic camera-type eye formation), [GO:0007034](http://purl.obolibrary.org/obo/GO_0007034) (vacuolar transport), [GO:0008366](http://purl.obolibrary.org/obo/GO_0008366) (axon ensheathment), [GO:0007035](http://purl.obolibrary.org/obo/GO_0007035) (vacuolar acidification), [GO:0060907](http://purl.obolibrary.org/obo/GO_0060907) (positive regulation of macrophage cytokine production), [GO:0034649](http://purl.obolibrary.org/obo/GO_0034649) (histone demethylase activity (H3-monomethyl-K4 specific)), [GO:1990226](http://purl.obolibrary.org/obo/GO_1990226) (histone methyltransferase binding), [GO:0051186](http://purl.obolibrary.org/obo/GO_0051186) (cofactor metabolic process), [GO:0034644](http://purl.obolibrary.org/obo/GO_0034644) (cellular response to UV), [GO:0033313](http://purl.obolibrary.org/obo/GO_0033313) (meiotic cell cycle checkpoint), [GO:0035977](http://purl.obolibrary.org/obo/GO_0035977) (protein deglycosylation involved in glycoprotein catabolic process), [GO:0035973](http://purl.obolibrary.org/obo/GO_0035973) (aggrephagy), [GO:0007040](http://purl.obolibrary.org/obo/GO_0007040) (lysosome organization), [GO:0010693](http://purl.obolibrary.org/obo/GO_0010693) (negative regulation of alkaline phosphatase activity), [GO:0035970](http://purl.obolibrary.org/obo/GO_0035970) (peptidyl-threonine dephosphorylation), [GO:0008375](http://purl.obolibrary.org/obo/GO_0008375) (acetylglucosaminyltransferase activity), [GO:0007043](http://purl.obolibrary.org/obo/GO_0007043) (cell-cell junction assembly), [GO:0008374](http://purl.obolibrary.org/obo/GO_0008374) (O-acyltransferase activity), [GO:0007044](http://purl.obolibrary.org/obo/GO_0007044) (cell-substrate junction assembly), [GO:0007041](http://purl.obolibrary.org/obo/GO_0007041) (lysosomal transport), [GO:0008373](http://purl.obolibrary.org/obo/GO_0008373) (sialyltransferase activity), [GO:0007042](http://purl.obolibrary.org/obo/GO_0007042) (lysosomal lumen acidification), [GO:1904288](http://purl.obolibrary.org/obo/GO_1904288) (BAT3 complex binding), [GO:0008379](http://purl.obolibrary.org/obo/GO_0008379) (thioredoxin peroxidase activity), [GO:0008378](http://purl.obolibrary.org/obo/GO_0008378) (galactosyltransferase activity), [GO:0046601](http://purl.obolibrary.org/obo/GO_0046601) (positive regulation of centriole replication), [GO:0008376](http://purl.obolibrary.org/obo/GO_0008376) (acetylgalactosaminyltransferase activity), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:1990234](http://purl.obolibrary.org/obo/GO_1990234) (transferase complex), [GO:0034638](http://purl.obolibrary.org/obo/GO_0034638) (phosphatidylcholine catabolic process), [GO:0019012](http://purl.obolibrary.org/obo/GO_0019012) (virion), [GO:1990239](http://purl.obolibrary.org/obo/GO_1990239) (steroid hormone binding), [GO:0034633](http://purl.obolibrary.org/obo/GO_0034633) (retinol transport), [GO:0035965](http://purl.obolibrary.org/obo/GO_0035965) (cardiolipin acyl-chain remodeling), [GO:0019013](http://purl.obolibrary.org/obo/GO_0019013) (viral nucleocapsid), [GO:0033300](http://purl.obolibrary.org/obo/GO_0033300) (dehydroascorbic acid transmembrane transporter activity), [GO:1904283](http://purl.obolibrary.org/obo/GO_1904283) (negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I), [GO:0033306](http://purl.obolibrary.org/obo/GO_0033306) (phytol metabolic process), [GO:0007094](http://purl.obolibrary.org/obo/GO_0007094) (mitotic spindle assembly checkpoint), [GO:0007095](http://purl.obolibrary.org/obo/GO_0007095) (mitotic G2 DNA damage checkpoint), [GO:0007093](http://purl.obolibrary.org/obo/GO_0007093) (mitotic cell cycle checkpoint), [GO:0007098](http://purl.obolibrary.org/obo/GO_0007098) (centrosome cycle), [GO:0007099](http://purl.obolibrary.org/obo/GO_0007099) (centriole replication), [GO:0032055](http://purl.obolibrary.org/obo/GO_0032055) (negative regulation of translation in response to stress), [GO:0007096](http://purl.obolibrary.org/obo/GO_0007096) (regulation of exit from mitosis), [GO:0032052](http://purl.obolibrary.org/obo/GO_0032052) (bile acid binding), [GO:0016805](http://purl.obolibrary.org/obo/GO_0016805) (dipeptidase activity), [GO:0007097](http://purl.obolibrary.org/obo/GO_0007097) (nuclear migration), [GO:0046697](http://purl.obolibrary.org/obo/GO_0046697) (decidualization), [GO:0004812](http://purl.obolibrary.org/obo/GO_0004812) (aminoacyl-tRNA ligase activity), [GO:0004814](http://purl.obolibrary.org/obo/GO_0004814) (arginine-tRNA ligase activity), [GO:0004813](http://purl.obolibrary.org/obo/GO_0004813) (alanine-tRNA ligase activity), [GO:0004816](http://purl.obolibrary.org/obo/GO_0004816) (asparagine-tRNA ligase activity), [GO:0004815](http://purl.obolibrary.org/obo/GO_0004815) (aspartate-tRNA ligase activity), [GO:0070324](http://purl.obolibrary.org/obo/GO_0070324) (thyroid hormone binding), [GO:0004818](http://purl.obolibrary.org/obo/GO_0004818) (glutamate-tRNA ligase activity), [GO:0032048](http://purl.obolibrary.org/obo/GO_0032048) (cardiolipin metabolic process), [GO:0070325](http://purl.obolibrary.org/obo/GO_0070325) (lipoprotein particle receptor binding), [GO:0004817](http://purl.obolibrary.org/obo/GO_0004817) (cysteine-tRNA ligase activity), [GO:0070328](http://purl.obolibrary.org/obo/GO_0070328) (triglyceride homeostasis), [GO:0007091](http://purl.obolibrary.org/obo/GO_0007091) (metaphase/anaphase transition of mitotic cell cycle), [GO:0032049](http://purl.obolibrary.org/obo/GO_0032049) (cardiolipin biosynthetic process), [GO:0070326](http://purl.obolibrary.org/obo/GO_0070326) (very-low-density lipoprotein particle receptor binding), [GO:0070327](http://purl.obolibrary.org/obo/GO_0070327) (thyroid hormone transport), [GO:0032040](http://purl.obolibrary.org/obo/GO_0032040) (small-subunit processome), [GO:0060993](http://purl.obolibrary.org/obo/GO_0060993) (kidney morphogenesis), [GO:0032041](http://purl.obolibrary.org/obo/GO_0032041) (NAD-dependent histone deacetylase activity (H3-K14 specific)), [GO:0032042](http://purl.obolibrary.org/obo/GO_0032042) (mitochondrial DNA metabolic process), [GO:0060998](http://purl.obolibrary.org/obo/GO_0060998) (regulation of dendritic spine development), [GO:0060999](http://purl.obolibrary.org/obo/GO_0060999) (positive regulation of dendritic spine development), [GO:0060994](http://purl.obolibrary.org/obo/GO_0060994) (regulation of transcription from RNA polymerase II promoter involved in kidney development), [GO:0060996](http://purl.obolibrary.org/obo/GO_0060996) (dendritic spine development), [GO:0060997](http://purl.obolibrary.org/obo/GO_0060997) (dendritic spine morphogenesis), [GO:0004821](http://purl.obolibrary.org/obo/GO_0004821) (histidine-tRNA ligase activity), [GO:0004820](http://purl.obolibrary.org/obo/GO_0004820) (glycine-tRNA ligase activity), [GO:0004823](http://purl.obolibrary.org/obo/GO_0004823) (leucine-tRNA ligase activity), [GO:0019074](http://purl.obolibrary.org/obo/GO_0019074) (viral RNA genome packaging), [GO:0004822](http://purl.obolibrary.org/obo/GO_0004822) (isoleucine-tRNA ligase activity), [GO:0004825](http://purl.obolibrary.org/obo/GO_0004825) (methionine-tRNA ligase activity), [GO:0004824](http://purl.obolibrary.org/obo/GO_0004824) (lysine-tRNA ligase activity), [GO:0004826](http://purl.obolibrary.org/obo/GO_0004826) (phenylalanine-tRNA ligase activity), [GO:0032036](http://purl.obolibrary.org/obo/GO_0032036) (myosin heavy chain binding), [GO:0004829](http://purl.obolibrary.org/obo/GO_0004829) (threonine-tRNA ligase activity), [GO:0070314](http://purl.obolibrary.org/obo/GO_0070314) (G1 to G0 transition), [GO:0019079](http://purl.obolibrary.org/obo/GO_0019079) (viral genome replication), [GO:0004828](http://purl.obolibrary.org/obo/GO_0004828) (serine-tRNA ligase activity), [GO:0033365](http://purl.obolibrary.org/obo/GO_0033365) (protein localization to organelle), [GO:0070315](http://purl.obolibrary.org/obo/GO_0070315) (G1 to G0 transition involved in cell differentiation), [GO:0032038](http://purl.obolibrary.org/obo/GO_0032038) (myosin II heavy chain binding), [GO:0032039](http://purl.obolibrary.org/obo/GO_0032039) (integrator complex), [GO:0033364](http://purl.obolibrary.org/obo/GO_0033364) (mast cell secretory granule organization), [GO:0034694](http://purl.obolibrary.org/obo/GO_0034694) (response to prostaglandin), [GO:0033363](http://purl.obolibrary.org/obo/GO_0033363) (secretory granule organization), [GO:0007074](http://purl.obolibrary.org/obo/GO_0007074) (positive regulation of transcription involved in exit from mitosis, from RNA polymerase II promoter), [GO:0007079](http://purl.obolibrary.org/obo/GO_0007079) (mitotic chromosome movement towards spindle pole), [GO:0071674](http://purl.obolibrary.org/obo/GO_0071674) (mononuclear cell migration), [GO:0032025](http://purl.obolibrary.org/obo/GO_0032025) (response to cobalt ion), [GO:0032026](http://purl.obolibrary.org/obo/GO_0032026) (response to magnesium ion), [GO:0019068](http://purl.obolibrary.org/obo/GO_0019068) (virion assembly), [GO:0071678](http://purl.obolibrary.org/obo/GO_0071678) (olfactory bulb axon guidance), [GO:0032024](http://purl.obolibrary.org/obo/GO_0032024) (positive regulation of insulin secretion), [GO:0034685](http://purl.obolibrary.org/obo/GO_0034685) (integrin alphav-beta6 complex), [GO:0032029](http://purl.obolibrary.org/obo/GO_0032029) (myosin tail binding), [GO:0032027](http://purl.obolibrary.org/obo/GO_0032027) (myosin light chain binding), [GO:0071679](http://purl.obolibrary.org/obo/GO_0071679) (commissural neuron axon guidance), [GO:0007084](http://purl.obolibrary.org/obo/GO_0007084) (mitotic nuclear envelope reassembly), [GO:0033353](http://purl.obolibrary.org/obo/GO_0033353) (S-adenosylmethionine cycle), [GO:0007088](http://purl.obolibrary.org/obo/GO_0007088) (regulation of mitotic nuclear division), [GO:0007089](http://purl.obolibrary.org/obo/GO_0007089) (traversing start control point of mitotic cell cycle), [GO:0020037](http://purl.obolibrary.org/obo/GO_0020037) (heme binding), [GO:0004801](http://purl.obolibrary.org/obo/GO_0004801) (sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity), [GO:0019051](http://purl.obolibrary.org/obo/GO_0019051) (induction by virus of host apoptotic process), [GO:0004802](http://purl.obolibrary.org/obo/GO_0004802) (transketolase activity), [GO:0070330](http://purl.obolibrary.org/obo/GO_0070330) (aromatase activity), [GO:0004807](http://purl.obolibrary.org/obo/GO_0004807) (triose-phosphate isomerase activity), [GO:0004806](http://purl.obolibrary.org/obo/GO_0004806) (triglyceride lipase activity), [GO:0033344](http://purl.obolibrary.org/obo/GO_0033344) (cholesterol efflux), [GO:0071664](http://purl.obolibrary.org/obo/GO_0071664) (catenin-TCF7L2 complex), [GO:0007080](http://purl.obolibrary.org/obo/GO_0007080) (mitotic metaphase plate congression), [GO:0032094](http://purl.obolibrary.org/obo/GO_0032094) (response to food), [GO:0032095](http://purl.obolibrary.org/obo/GO_0032095) (regulation of response to food), [GO:0032092](http://purl.obolibrary.org/obo/GO_0032092) (positive regulation of protein binding), [GO:0071617](http://purl.obolibrary.org/obo/GO_0071617) (lysophospholipid acyltransferase activity), [GO:0032098](http://purl.obolibrary.org/obo/GO_0032098) (regulation of appetite), [GO:0032099](http://purl.obolibrary.org/obo/GO_0032099) (negative regulation of appetite), [GO:0016849](http://purl.obolibrary.org/obo/GO_0016849) (phosphorus-oxygen lyase activity), [GO:0045324](http://purl.obolibrary.org/obo/GO_0045324) (late endosome to vacuole transport), [GO:0046655](http://purl.obolibrary.org/obo/GO_0046655) (folic acid metabolic process), [GO:0046656](http://purl.obolibrary.org/obo/GO_0046656) (folic acid biosynthetic process), [GO:0046653](http://purl.obolibrary.org/obo/GO_0046653) (tetrahydrofolate metabolic process), [GO:0060968](http://purl.obolibrary.org/obo/GO_0060968) (regulation of gene silencing), [GO:0046654](http://purl.obolibrary.org/obo/GO_0046654) (tetrahydrofolate biosynthetic process), [GO:0004861](http://purl.obolibrary.org/obo/GO_0004861) (cyclin-dependent protein serine/threonine kinase inhibitor activity), [GO:0032090](http://purl.obolibrary.org/obo/GO_0032090) (Pyrin domain binding), [GO:0004860](http://purl.obolibrary.org/obo/GO_0004860) (protein kinase inhibitor activity), [GO:0032091](http://purl.obolibrary.org/obo/GO_0032091) (negative regulation of protein binding), [GO:0045329](http://purl.obolibrary.org/obo/GO_0045329) (carnitine biosynthetic process), [GO:0046658](http://purl.obolibrary.org/obo/GO_0046658) (anchored component of plasma membrane), [GO:0004862](http://purl.obolibrary.org/obo/GO_0004862) (cAMP-dependent protein kinase inhibitor activity), [GO:0004854](http://purl.obolibrary.org/obo/GO_0004854) (xanthine dehydrogenase activity), [GO:0004853](http://purl.obolibrary.org/obo/GO_0004853) (uroporphyrinogen decarboxylase activity), [GO:0004855](http://purl.obolibrary.org/obo/GO_0004855) (xanthine oxidase activity), [GO:0045332](http://purl.obolibrary.org/obo/GO_0045332) (phospholipid translocation), [GO:0004857](http://purl.obolibrary.org/obo/GO_0004857) (enzyme inhibitor activity), [GO:0004859](http://purl.obolibrary.org/obo/GO_0004859) (phospholipase inhibitor activity), [GO:0016853](http://purl.obolibrary.org/obo/GO_0016853) (isomerase activity), [GO:0015501](http://purl.obolibrary.org/obo/GO_0015501) (glutamate:sodium symporter activity), [GO:0032088](http://purl.obolibrary.org/obo/GO_0032088) (negative regulation of NF-kappaB transcription factor activity), [GO:0045335](http://purl.obolibrary.org/obo/GO_0045335) (phagocytic vesicle), [GO:0046666](http://purl.obolibrary.org/obo/GO_0046666) (retinal cell programmed cell death), [GO:0045333](http://purl.obolibrary.org/obo/GO_0045333) (cellular respiration), [GO:0060956](http://purl.obolibrary.org/obo/GO_0060956) (endocardial cell differentiation), [GO:0045334](http://purl.obolibrary.org/obo/GO_0045334) (clathrin-coated endocytic vesicle), [GO:0004872](http://purl.obolibrary.org/obo/GO_0004872) (receptor activity), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0046668](http://purl.obolibrary.org/obo/GO_0046668) (regulation of retinal cell programmed cell death), [GO:1900746](http://purl.obolibrary.org/obo/GO_1900746) (regulation of vascular endothelial growth factor signaling pathway), [GO:1900745](http://purl.obolibrary.org/obo/GO_1900745) (positive regulation of p38MAPK cascade), [GO:0004865](http://purl.obolibrary.org/obo/GO_0004865) (protein serine/threonine phosphatase inhibitor activity), [GO:0004864](http://purl.obolibrary.org/obo/GO_0004864) (protein phosphatase inhibitor activity), [GO:0004867](http://purl.obolibrary.org/obo/GO_0004867) (serine-type endopeptidase inhibitor activity), [GO:0004866](http://purl.obolibrary.org/obo/GO_0004866) (endopeptidase inhibitor activity), [GO:0045342](http://purl.obolibrary.org/obo/GO_0045342) (MHC class II biosynthetic process), [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity), [GO:0060958](http://purl.obolibrary.org/obo/GO_0060958) (endocardial cell development), [GO:0045340](http://purl.obolibrary.org/obo/GO_0045340) (mercury ion binding), [GO:0071600](http://purl.obolibrary.org/obo/GO_0071600) (otic vesicle morphogenesis), [GO:0032079](http://purl.obolibrary.org/obo/GO_0032079) (positive regulation of endodeoxyribonuclease activity), [GO:0071603](http://purl.obolibrary.org/obo/GO_0071603) (endothelial cell-cell adhesion), [GO:0071639](http://purl.obolibrary.org/obo/GO_0071639) (positive regulation of monocyte chemotactic protein-1 production), [GO:0070309](http://purl.obolibrary.org/obo/GO_0070309) (lens fiber cell morphogenesis), [GO:0060982](http://purl.obolibrary.org/obo/GO_0060982) (coronary artery morphogenesis), [GO:0032077](http://purl.obolibrary.org/obo/GO_0032077) (positive regulation of deoxyribonuclease activity), [GO:0016829](http://purl.obolibrary.org/obo/GO_0016829) (lyase activity), [GO:0046677](http://purl.obolibrary.org/obo/GO_0046677) (response to antibiotic), [GO:0060988](http://purl.obolibrary.org/obo/GO_0060988) (lipid tube assembly), [GO:0046676](http://purl.obolibrary.org/obo/GO_0046676) (negative regulation of insulin secretion), [GO:0045345](http://purl.obolibrary.org/obo/GO_0045345) (positive regulation of MHC class I biosynthetic process), [GO:0045348](http://purl.obolibrary.org/obo/GO_0045348) (positive regulation of MHC class II biosynthetic process), [GO:0004832](http://purl.obolibrary.org/obo/GO_0004832) (valine-tRNA ligase activity), [GO:1900747](http://purl.obolibrary.org/obo/GO_1900747) (negative regulation of vascular endothelial growth factor signaling pathway), [GO:0004831](http://purl.obolibrary.org/obo/GO_0004831) (tyrosine-tRNA ligase activity), [GO:0004833](http://purl.obolibrary.org/obo/GO_0004833) (tryptophan 2,3-dioxygenase activity), [GO:0046684](http://purl.obolibrary.org/obo/GO_0046684) (response to pyrethroid), [GO:0046685](http://purl.obolibrary.org/obo/GO_0046685) (response to arsenic-containing substance), [GO:0044020](http://purl.obolibrary.org/obo/GO_0044020) (histone methyltransferase activity (H4-R3 specific)), [GO:0045351](http://purl.obolibrary.org/obo/GO_0045351) (type I interferon biosynthetic process), [GO:0004838](http://purl.obolibrary.org/obo/GO_0004838) (L-tyrosine:2-oxoglutarate aminotransferase activity), [GO:0070300](http://purl.obolibrary.org/obo/GO_0070300) (phosphatidic acid binding), [GO:0071632](http://purl.obolibrary.org/obo/GO_0071632) (optomotor response), [GO:0070301](http://purl.obolibrary.org/obo/GO_0070301) (cellular response to hydrogen peroxide), [GO:0070306](http://purl.obolibrary.org/obo/GO_0070306) (lens fiber cell differentiation), [GO:0070307](http://purl.obolibrary.org/obo/GO_0070307) (lens fiber cell development), [GO:0071635](http://purl.obolibrary.org/obo/GO_0071635) (negative regulation of transforming growth factor beta production), [GO:0016830](http://purl.obolibrary.org/obo/GO_0016830) (carbon-carbon lyase activity), [GO:0016831](http://purl.obolibrary.org/obo/GO_0016831) (carboxy-lyase activity), [GO:0016810](http://purl.obolibrary.org/obo/GO_0016810) (hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds), [GO:0016811](http://purl.obolibrary.org/obo/GO_0016811) (hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides), [GO:0016812](http://purl.obolibrary.org/obo/GO_0016812) (hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides), [GO:0033391](http://purl.obolibrary.org/obo/GO_0033391) (chromatoid body), [GO:0060971](http://purl.obolibrary.org/obo/GO_0060971) (embryonic heart tube left/right pattern formation), [GO:0071629](http://purl.obolibrary.org/obo/GO_0071629) (cytoplasm protein quality control by the ubiquitin-proteasome system), [GO:0016813](http://purl.obolibrary.org/obo/GO_0016813) (hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines), [GO:0016814](http://purl.obolibrary.org/obo/GO_0016814) (hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines), [GO:0016817](http://purl.obolibrary.org/obo/GO_0016817) (hydrolase activity, acting on acid anhydrides), [GO:0046688](http://purl.obolibrary.org/obo/GO_0046688) (response to copper ion), [GO:0016818](http://purl.obolibrary.org/obo/GO_0016818) (hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides), [GO:0060976](http://purl.obolibrary.org/obo/GO_0060976) (coronary vasculature development), [GO:0046689](http://purl.obolibrary.org/obo/GO_0046689) (response to mercury ion), [GO:0060977](http://purl.obolibrary.org/obo/GO_0060977) (coronary vasculature morphogenesis), [GO:0046686](http://purl.obolibrary.org/obo/GO_0046686) (response to cadmium ion), [GO:0060978](http://purl.obolibrary.org/obo/GO_0060978) (angiogenesis involved in coronary vascular morphogenesis), [GO:0044026](http://purl.obolibrary.org/obo/GO_0044026) (DNA hypermethylation), [GO:0060979](http://purl.obolibrary.org/obo/GO_0060979) (vasculogenesis involved in coronary vascular morphogenesis), [GO:0060972](http://purl.obolibrary.org/obo/GO_0060972) (left/right pattern formation), [GO:0044029](http://purl.obolibrary.org/obo/GO_0044029) (hypomethylation of CpG island), [GO:0060973](http://purl.obolibrary.org/obo/GO_0060973) (cell migration involved in heart development), [GO:0004852](http://purl.obolibrary.org/obo/GO_0004852) (uroporphyrinogen-III synthase activity), [GO:0060975](http://purl.obolibrary.org/obo/GO_0060975) (cardioblast migration to the midline involved in heart field formation), [GO:0004843](http://purl.obolibrary.org/obo/GO_0004843) (thiol-dependent ubiquitin-specific protease activity), [GO:0046691](http://purl.obolibrary.org/obo/GO_0046691) (intracellular canaliculus), [GO:0004842](http://purl.obolibrary.org/obo/GO_0004842) (ubiquitin-protein transferase activity), [GO:0044030](http://purl.obolibrary.org/obo/GO_0044030) (regulation of DNA methylation), [GO:0004844](http://purl.obolibrary.org/obo/GO_0004844) (uracil DNA N-glycosylase activity), [GO:0046696](http://purl.obolibrary.org/obo/GO_0046696) (lipopolysaccharide receptor complex), [GO:0071627](http://purl.obolibrary.org/obo/GO_0071627) (integral component of fungal-type vacuolar membrane), [GO:0071625](http://purl.obolibrary.org/obo/GO_0071625) (vocalization behavior), [GO:0015671](http://purl.obolibrary.org/obo/GO_0015671) (oxygen transport), [GO:0015670](http://purl.obolibrary.org/obo/GO_0015670) (carbon dioxide transport), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0002360](http://purl.obolibrary.org/obo/GO_0002360) (T cell lineage commitment), [GO:0003692](http://purl.obolibrary.org/obo/GO_0003692) (left-handed Z-DNA binding), [GO:0003697](http://purl.obolibrary.org/obo/GO_0003697) (single-stranded DNA binding), [GO:0003688](http://purl.obolibrary.org/obo/GO_0003688) (DNA replication origin binding), [GO:0001034](http://purl.obolibrary.org/obo/GO_0001034) (RNA polymerase III transcription factor activity, sequence-specific DNA binding), [GO:0002358](http://purl.obolibrary.org/obo/GO_0002358) (B cell homeostatic proliferation), [GO:0016997](http://purl.obolibrary.org/obo/GO_0016997) (alpha-sialidase activity), [GO:0016998](http://purl.obolibrary.org/obo/GO_0016998) (cell wall macromolecule catabolic process), [GO:0016999](http://purl.obolibrary.org/obo/GO_0016999) (antibiotic metabolic process), [GO:0015682](http://purl.obolibrary.org/obo/GO_0015682) (ferric iron transport), [GO:0002371](http://purl.obolibrary.org/obo/GO_0002371) (dendritic cell cytokine production), [GO:0002374](http://purl.obolibrary.org/obo/GO_0002374) (cytokine secretion involved in immune response), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0002377](http://purl.obolibrary.org/obo/GO_0002377) (immunoglobulin production), [GO:0001046](http://purl.obolibrary.org/obo/GO_0001046) (core promoter sequence-specific DNA binding), [GO:0002369](http://purl.obolibrary.org/obo/GO_0002369) (T cell cytokine production), [GO:0001042](http://purl.obolibrary.org/obo/GO_0001042) (RNA polymerase I core binding), [GO:0052629](http://purl.obolibrary.org/obo/GO_0052629) (phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity), [GO:0015679](http://purl.obolibrary.org/obo/GO_0015679) (plasma membrane copper ion transport), [GO:0015677](http://purl.obolibrary.org/obo/GO_0015677) (copper ion import), [GO:0015651](http://purl.obolibrary.org/obo/GO_0015651) (quaternary ammonium group transmembrane transporter activity), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0002344](http://purl.obolibrary.org/obo/GO_0002344) (B cell affinity maturation), [GO:0051301](http://purl.obolibrary.org/obo/GO_0051301) (cell division), [GO:0051302](http://purl.obolibrary.org/obo/GO_0051302) (regulation of cell division), [GO:0001012](http://purl.obolibrary.org/obo/GO_0001012) (RNA polymerase II regulatory region DNA binding), [GO:0051300](http://purl.obolibrary.org/obo/GO_0051300) (spindle pole body organization), [GO:0004998](http://purl.obolibrary.org/obo/GO_0004998) (transferrin receptor activity), [GO:0016992](http://purl.obolibrary.org/obo/GO_0016992) (lipoate synthase activity), [GO:0051306](http://purl.obolibrary.org/obo/GO_0051306) (mitotic sister chromatid separation), [GO:0015662](http://purl.obolibrary.org/obo/GO_0015662) (ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism), [GO:0016979](http://purl.obolibrary.org/obo/GO_0016979) (lipoate-protein ligase activity), [GO:0003680](http://purl.obolibrary.org/obo/GO_0003680) (AT DNA binding), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0001018](http://purl.obolibrary.org/obo/GO_0001018) (mitochondrial promoter sequence-specific DNA binding), [GO:0003684](http://purl.obolibrary.org/obo/GO_0003684) (damaged DNA binding), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0003678](http://purl.obolibrary.org/obo/GO_0003678) (DNA helicase activity), [GO:0051310](http://purl.obolibrary.org/obo/GO_0051310) (metaphase plate congression), [GO:0051315](http://purl.obolibrary.org/obo/GO_0051315) (attachment of mitotic spindle microtubules to kinetochore), [GO:0070481](http://purl.obolibrary.org/obo/GO_0070481) (nuclear-transcribed mRNA catabolic process, non-stop decay), [GO:0001078](http://purl.obolibrary.org/obo/GO_0001078) (transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0001075](http://purl.obolibrary.org/obo/GO_0001075) (transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly), [GO:0070483](http://purl.obolibrary.org/obo/GO_0070483) (detection of hypoxia), [GO:0070474](http://purl.obolibrary.org/obo/GO_0070474) (positive regulation of uterine smooth muscle contraction), [GO:0001085](http://purl.obolibrary.org/obo/GO_0001085) (RNA polymerase II transcription factor binding), [GO:0070475](http://purl.obolibrary.org/obo/GO_0070475) (rRNA base methylation), [GO:0070478](http://purl.obolibrary.org/obo/GO_0070478) (nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay), [GO:0015698](http://purl.obolibrary.org/obo/GO_0015698) (inorganic anion transport), [GO:0015697](http://purl.obolibrary.org/obo/GO_0015697) (quaternary ammonium group transport), [GO:0015696](http://purl.obolibrary.org/obo/GO_0015696) (ammonium transport), [GO:0015694](http://purl.obolibrary.org/obo/GO_0015694) (mercury ion transport), [GO:0015693](http://purl.obolibrary.org/obo/GO_0015693) (magnesium ion transport), [GO:0015691](http://purl.obolibrary.org/obo/GO_0015691) (cadmium ion transport), [GO:0002381](http://purl.obolibrary.org/obo/GO_0002381) (immunoglobulin production involved in immunoglobulin mediated immune response), [GO:0002385](http://purl.obolibrary.org/obo/GO_0002385) (mucosal immune response), [GO:0001047](http://purl.obolibrary.org/obo/GO_0001047) (core promoter binding), [GO:0002378](http://purl.obolibrary.org/obo/GO_0002378) (immunoglobulin biosynthetic process), [GO:0001056](http://purl.obolibrary.org/obo/GO_0001056) (RNA polymerase III activity), [GO:0001054](http://purl.obolibrary.org/obo/GO_0001054) (RNA polymerase I activity), [GO:0001068](http://purl.obolibrary.org/obo/GO_0001068) (transcription regulatory region RNA binding), [GO:0070492](http://purl.obolibrary.org/obo/GO_0070492) (oligosaccharide binding), [GO:0070491](http://purl.obolibrary.org/obo/GO_0070491) (repressing transcription factor binding), [GO:0070495](http://purl.obolibrary.org/obo/GO_0070495) (negative regulation of thrombin-activated receptor signaling pathway), [GO:0070498](http://purl.obolibrary.org/obo/GO_0070498) (interleukin-1-mediated signaling pathway), [GO:0051371](http://purl.obolibrary.org/obo/GO_0051371) (muscle alpha-actinin binding), [GO:0008504](http://purl.obolibrary.org/obo/GO_0008504) (monoamine transmembrane transporter activity), [GO:1990130](http://purl.obolibrary.org/obo/GO_1990130) (GATOR1 complex), [GO:0008502](http://purl.obolibrary.org/obo/GO_0008502) (melatonin receptor activity), [GO:0010817](http://purl.obolibrary.org/obo/GO_0010817) (regulation of hormone levels), [GO:0010816](http://purl.obolibrary.org/obo/GO_0010816) (calcitonin catabolic process), [GO:0009826](http://purl.obolibrary.org/obo/GO_0009826) (unidimensional cell growth), [GO:0052696](http://purl.obolibrary.org/obo/GO_0052696) (flavonoid glucuronidation), [GO:0051365](http://purl.obolibrary.org/obo/GO_0051365) (cellular response to potassium ion starvation), [GO:1990124](http://purl.obolibrary.org/obo/GO_1990124) (messenger ribonucleoprotein complex), [GO:0052697](http://purl.obolibrary.org/obo/GO_0052697) (xenobiotic glucuronidation), [GO:0010812](http://purl.obolibrary.org/obo/GO_0010812) (negative regulation of cell-substrate adhesion), [GO:0052692](http://purl.obolibrary.org/obo/GO_0052692) (raffinose alpha-galactosidase activity), [GO:0010815](http://purl.obolibrary.org/obo/GO_0010815) (bradykinin catabolic process), [GO:0010814](http://purl.obolibrary.org/obo/GO_0010814) (substance P catabolic process), [GO:0010811](http://purl.obolibrary.org/obo/GO_0010811) (positive regulation of cell-substrate adhesion), [GO:0086002](http://purl.obolibrary.org/obo/GO_0086002) (cardiac muscle cell action potential involved in contraction), [GO:0086001](http://purl.obolibrary.org/obo/GO_0086001) (cardiac muscle cell action potential), [GO:0086006](http://purl.obolibrary.org/obo/GO_0086006) (voltage-gated sodium channel activity involved in cardiac muscle cell action potential), [GO:0086007](http://purl.obolibrary.org/obo/GO_0086007) (voltage-gated calcium channel activity involved in cardiac muscle cell action potential), [GO:0086004](http://purl.obolibrary.org/obo/GO_0086004) (regulation of cardiac muscle cell contraction), [GO:0086005](http://purl.obolibrary.org/obo/GO_0086005) (ventricular cardiac muscle cell action potential), [GO:0008511](http://purl.obolibrary.org/obo/GO_0008511) (sodium:potassium:chloride symporter activity), [GO:0008510](http://purl.obolibrary.org/obo/GO_0008510) (sodium:bicarbonate symporter activity), [GO:0086008](http://purl.obolibrary.org/obo/GO_0086008) (voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization), [GO:0086009](http://purl.obolibrary.org/obo/GO_0086009) (membrane repolarization), [GO:0051380](http://purl.obolibrary.org/obo/GO_0051380) (norepinephrine binding), [GO:0008514](http://purl.obolibrary.org/obo/GO_0008514) (organic anion transmembrane transporter activity), [GO:0051378](http://purl.obolibrary.org/obo/GO_0051378) (serotonin binding), [GO:0050046](http://purl.obolibrary.org/obo/GO_0050046) (lathosterol oxidase activity), [GO:0010828](http://purl.obolibrary.org/obo/GO_0010828) (positive regulation of glucose transport), [GO:0008508](http://purl.obolibrary.org/obo/GO_0008508) (bile acid:sodium symporter activity), [GO:0051379](http://purl.obolibrary.org/obo/GO_0051379) (epinephrine binding), [GO:0008506](http://purl.obolibrary.org/obo/GO_0008506) (sucrose:proton symporter activity), [GO:0051377](http://purl.obolibrary.org/obo/GO_0051377) (mannose-ethanolamine phosphotransferase activity), [GO:1990136](http://purl.obolibrary.org/obo/GO_1990136) (linoleate 9S-lipoxygenase activity), [GO:1990138](http://purl.obolibrary.org/obo/GO_1990138) (neuron projection extension), [GO:0010826](http://purl.obolibrary.org/obo/GO_0010826) (negative regulation of centrosome duplication), [GO:0008509](http://purl.obolibrary.org/obo/GO_0008509) (anion transmembrane transporter activity), [GO:0051373](http://purl.obolibrary.org/obo/GO_0051373) (FATZ binding), [GO:0010825](http://purl.obolibrary.org/obo/GO_0010825) (positive regulation of centrosome duplication), [GO:0010820](http://purl.obolibrary.org/obo/GO_0010820) (positive regulation of T cell chemotaxis), [GO:0010822](http://purl.obolibrary.org/obo/GO_0010822) (positive regulation of mitochondrion organization), [GO:0010821](http://purl.obolibrary.org/obo/GO_0010821) (regulation of mitochondrion organization), [GO:0086010](http://purl.obolibrary.org/obo/GO_0086010) (membrane depolarization during action potential), [GO:1904231](http://purl.obolibrary.org/obo/GO_1904231) (positive regulation of succinate dehydrogenase activity), [GO:1904234](http://purl.obolibrary.org/obo/GO_1904234) (positive regulation of aconitate hydratase activity), [GO:1905564](http://purl.obolibrary.org/obo/GO_1905564) (positive regulation of vascular endothelial cell proliferation), [GO:0051393](http://purl.obolibrary.org/obo/GO_0051393) (alpha-actinin binding), [GO:0050061](http://purl.obolibrary.org/obo/GO_0050061) (long-chain-aldehyde dehydrogenase activity), [GO:1990145](http://purl.obolibrary.org/obo/GO_1990145) (maintenance of translational fidelity), [GO:0051388](http://purl.obolibrary.org/obo/GO_0051388) (positive regulation of neurotrophin TRK receptor signaling pathway), [GO:0001097](http://purl.obolibrary.org/obo/GO_0001097) (TFIIH-class transcription factor binding), [GO:0051386](http://purl.obolibrary.org/obo/GO_0051386) (regulation of neurotrophin TRK receptor signaling pathway), [GO:0001096](http://purl.obolibrary.org/obo/GO_0001096) (TFIIF-class transcription factor binding), [GO:0051384](http://purl.obolibrary.org/obo/GO_0051384) (response to glucocorticoid), [GO:0001094](http://purl.obolibrary.org/obo/GO_0001094) (TFIID-class transcription factor binding), [GO:0001093](http://purl.obolibrary.org/obo/GO_0001093) (TFIIB-class transcription factor binding), [GO:1905574](http://purl.obolibrary.org/obo/GO_1905574) (ganglioside GM2 binding), [GO:1905573](http://purl.obolibrary.org/obo/GO_1905573) (ganglioside GM1 binding), [GO:1905572](http://purl.obolibrary.org/obo/GO_1905572) (ganglioside GM1 transport to membrane), [GO:1905577](http://purl.obolibrary.org/obo/GO_1905577) (ganglioside GP1c binding), [GO:1905576](http://purl.obolibrary.org/obo/GO_1905576) (ganglioside GT1b binding), [GO:1905575](http://purl.obolibrary.org/obo/GO_1905575) (ganglioside GM3 binding), [GO:0050072](http://purl.obolibrary.org/obo/GO_0050072) (m7G(5')pppN diphosphatase activity), [GO:1990163](http://purl.obolibrary.org/obo/GO_1990163) (ATP-dependent four-way junction helicase activity), [GO:1990165](http://purl.obolibrary.org/obo/GO_1990165) (single-strand break-containing DNA binding), [GO:0010801](http://purl.obolibrary.org/obo/GO_0010801) (negative regulation of peptidyl-threonine phosphorylation), [GO:0010804](http://purl.obolibrary.org/obo/GO_0010804) (negative regulation of tumor necrosis factor-mediated signaling pathway), [GO:0010800](http://purl.obolibrary.org/obo/GO_0010800) (positive regulation of peptidyl-threonine phosphorylation), [GO:0008540](http://purl.obolibrary.org/obo/GO_0008540) (proteasome regulatory particle, base subcomplex), [GO:0022848](http://purl.obolibrary.org/obo/GO_0022848) (acetylcholine-gated cation-selective channel activity), [GO:0021517](http://purl.obolibrary.org/obo/GO_0021517) (ventral spinal cord development), [GO:0007212](http://purl.obolibrary.org/obo/GO_0007212) (dopamine receptor signaling pathway), [GO:0008544](http://purl.obolibrary.org/obo/GO_0008544) (epidermis development), [GO:0021511](http://purl.obolibrary.org/obo/GO_0021511) (spinal cord patterning), [GO:0008543](http://purl.obolibrary.org/obo/GO_0008543) (fibroblast growth factor receptor signaling pathway), [GO:0007213](http://purl.obolibrary.org/obo/GO_0007213) (G-protein coupled acetylcholine receptor signaling pathway), [GO:0022843](http://purl.obolibrary.org/obo/GO_0022843) (voltage-gated cation channel activity), [GO:0007210](http://purl.obolibrary.org/obo/GO_0007210) (serotonin receptor signaling pathway), [GO:0008542](http://purl.obolibrary.org/obo/GO_0008542) (visual learning), [GO:0021513](http://purl.obolibrary.org/obo/GO_0021513) (spinal cord dorsal/ventral patterning), [GO:0021514](http://purl.obolibrary.org/obo/GO_0021514) (ventral spinal cord interneuron differentiation), [GO:0007216](http://purl.obolibrary.org/obo/GO_0007216) (G-protein coupled glutamate receptor signaling pathway), [GO:1990174](http://purl.obolibrary.org/obo/GO_1990174) (phosphodiesterase decapping endonuclease activity), [GO:0007214](http://purl.obolibrary.org/obo/GO_0007214) (gamma-aminobutyric acid signaling pathway), [GO:0022840](http://purl.obolibrary.org/obo/GO_0022840) (leak channel activity), [GO:0021510](http://purl.obolibrary.org/obo/GO_0021510) (spinal cord development), [GO:0022841](http://purl.obolibrary.org/obo/GO_0022841) (potassium ion leak channel activity), [GO:0007215](http://purl.obolibrary.org/obo/GO_0007215) (glutamate receptor signaling pathway), [GO:0051321](http://purl.obolibrary.org/obo/GO_0051321) (meiotic cell cycle), [GO:0052652](http://purl.obolibrary.org/obo/GO_0052652) (cyclic purine nucleotide metabolic process), [GO:0007208](http://purl.obolibrary.org/obo/GO_0007208) (phospholipase C-activating serotonin receptor signaling pathway), [GO:0052651](http://purl.obolibrary.org/obo/GO_0052651) (monoacylglycerol catabolic process), [GO:0010859](http://purl.obolibrary.org/obo/GO_0010859) (calcium-dependent cysteine-type endopeptidase inhibitor activity), [GO:0019201](http://purl.obolibrary.org/obo/GO_0019201) (nucleotide kinase activity), [GO:0019200](http://purl.obolibrary.org/obo/GO_0019200) (carbohydrate kinase activity), [GO:0019205](http://purl.obolibrary.org/obo/GO_0019205) (nucleobase-containing compound kinase activity), [GO:0019206](http://purl.obolibrary.org/obo/GO_0019206) (nucleoside kinase activity), [GO:0052657](http://purl.obolibrary.org/obo/GO_0052657) (guanine phosphoribosyltransferase activity), [GO:0021508](http://purl.obolibrary.org/obo/GO_0021508) (floor plate formation), [GO:0007220](http://purl.obolibrary.org/obo/GO_0007220) (Notch receptor processing), [GO:0009881](http://purl.obolibrary.org/obo/GO_0009881) (photoreceptor activity), [GO:0009880](http://purl.obolibrary.org/obo/GO_0009880) (embryonic pattern specification), [GO:0021506](http://purl.obolibrary.org/obo/GO_0021506) (anterior neuropore closure), [GO:1990180](http://purl.obolibrary.org/obo/GO_1990180) (mitochondrial tRNA 3'-end processing), [GO:0007223](http://purl.obolibrary.org/obo/GO_0007223) (Wnt signaling pathway, calcium modulating pathway), [GO:0007224](http://purl.obolibrary.org/obo/GO_0007224) (smoothened signaling pathway), [GO:0021501](http://purl.obolibrary.org/obo/GO_0021501) (prechordal plate formation), [GO:0022832](http://purl.obolibrary.org/obo/GO_0022832) (voltage-gated channel activity), [GO:1905515](http://purl.obolibrary.org/obo/GO_1905515) (non-motile cilium assembly), [GO:1990182](http://purl.obolibrary.org/obo/GO_1990182) (exosomal secretion), [GO:0008559](http://purl.obolibrary.org/obo/GO_0008559) (xenobiotic transmembrane transporting ATPase activity), [GO:0007227](http://purl.obolibrary.org/obo/GO_0007227) (signal transduction downstream of smoothened), [GO:0009889](http://purl.obolibrary.org/obo/GO_0009889) (regulation of biosynthetic process), [GO:0009888](http://purl.obolibrary.org/obo/GO_0009888) (tissue development), [GO:0009887](http://purl.obolibrary.org/obo/GO_0009887) (animal organ morphogenesis), [GO:1905517](http://purl.obolibrary.org/obo/GO_1905517) (macrophage migration), [GO:0007218](http://purl.obolibrary.org/obo/GO_0007218) (neuropeptide signaling pathway), [GO:0007219](http://purl.obolibrary.org/obo/GO_0007219) (Notch signaling pathway), [GO:0010868](http://purl.obolibrary.org/obo/GO_0010868) (negative regulation of triglyceride biosynthetic process), [GO:0010867](http://purl.obolibrary.org/obo/GO_0010867) (positive regulation of triglyceride biosynthetic process), [GO:0010863](http://purl.obolibrary.org/obo/GO_0010863) (positive regulation of phospholipase C activity), [GO:0010866](http://purl.obolibrary.org/obo/GO_0010866) (regulation of triglyceride biosynthetic process), [GO:0010862](http://purl.obolibrary.org/obo/GO_0010862) (positive regulation of pathway-restricted SMAD protein phosphorylation), [GO:0022824](http://purl.obolibrary.org/obo/GO_0022824) (transmitter-gated ion channel activity), [GO:1990190](http://purl.obolibrary.org/obo/GO_1990190) (peptide-glutamate-N-acetyltransferase activity), [GO:0022820](http://purl.obolibrary.org/obo/GO_0022820) (potassium ion symporter activity), [GO:0008521](http://purl.obolibrary.org/obo/GO_0008521) (acetyl-CoA transmembrane transporter activity), [GO:0008526](http://purl.obolibrary.org/obo/GO_0008526) (phosphatidylinositol transporter activity), [GO:0008525](http://purl.obolibrary.org/obo/GO_0008525) (phosphatidylcholine transporter activity), [GO:0010839](http://purl.obolibrary.org/obo/GO_0010839) (negative regulation of keratinocyte proliferation), [GO:0008519](http://purl.obolibrary.org/obo/GO_0008519) (ammonium transmembrane transporter activity), [GO:1990189](http://purl.obolibrary.org/obo/GO_1990189) (peptide-serine-N-acetyltransferase activity), [GO:0010838](http://purl.obolibrary.org/obo/GO_0010838) (positive regulation of keratinocyte proliferation), [GO:0051346](http://purl.obolibrary.org/obo/GO_0051346) (negative regulation of hydrolase activity), [GO:0008517](http://purl.obolibrary.org/obo/GO_0008517) (folic acid transmembrane transporter activity), [GO:0051344](http://purl.obolibrary.org/obo/GO_0051344) (negative regulation of cyclic-nucleotide phosphodiesterase activity), [GO:0010835](http://purl.obolibrary.org/obo/GO_0010835) (regulation of protein ADP-ribosylation), [GO:0110008](http://purl.obolibrary.org/obo/GO_0110008) (ncRNA deadenylation), [GO:0010837](http://purl.obolibrary.org/obo/GO_0010837) (regulation of keratinocyte proliferation), [GO:0010836](http://purl.obolibrary.org/obo/GO_0010836) (negative regulation of protein ADP-ribosylation), [GO:0010831](http://purl.obolibrary.org/obo/GO_0010831) (positive regulation of myotube differentiation), [GO:0010830](http://purl.obolibrary.org/obo/GO_0010830) (regulation of myotube differentiation), [GO:0010832](http://purl.obolibrary.org/obo/GO_0010832) (negative regulation of myotube differentiation), [GO:0051349](http://purl.obolibrary.org/obo/GO_0051349) (positive regulation of lyase activity), [GO:0051347](http://purl.obolibrary.org/obo/GO_0051347) (positive regulation of transferase activity), [GO:0051348](http://purl.obolibrary.org/obo/GO_0051348) (negative regulation of transferase activity), [GO:0007202](http://purl.obolibrary.org/obo/GO_0007202) (activation of phospholipase C activity), [GO:0007200](http://purl.obolibrary.org/obo/GO_0007200) (phospholipase C-activating G-protein coupled receptor signaling pathway), [GO:0008535](http://purl.obolibrary.org/obo/GO_0008535) (respiratory chain complex IV assembly), [GO:0007204](http://purl.obolibrary.org/obo/GO_0007204) (positive regulation of cytosolic calcium ion concentration), [GO:0008534](http://purl.obolibrary.org/obo/GO_0008534) (oxidized purine nucleobase lesion DNA N-glycosylase activity), [GO:0051353](http://purl.obolibrary.org/obo/GO_0051353) (positive regulation of oxidoreductase activity), [GO:0051351](http://purl.obolibrary.org/obo/GO_0051351) (positive regulation of ligase activity), [GO:0010842](http://purl.obolibrary.org/obo/GO_0010842) (retina layer formation), [GO:0052689](http://purl.obolibrary.org/obo/GO_0052689) (carboxylic ester hydrolase activity), [GO:0009790](http://purl.obolibrary.org/obo/GO_0009790) (embryo development), [GO:0045409](http://purl.obolibrary.org/obo/GO_0045409) (negative regulation of interleukin-6 biosynthetic process), [GO:0007131](http://purl.obolibrary.org/obo/GO_0007131) (reciprocal meiotic recombination), [GO:0009792](http://purl.obolibrary.org/obo/GO_0009792) (embryo development ending in birth or egg hatching), [GO:0009791](http://purl.obolibrary.org/obo/GO_0009791) (post-embryonic development), [GO:0007130](http://purl.obolibrary.org/obo/GO_0007130) (synaptonemal complex assembly), [GO:0009798](http://purl.obolibrary.org/obo/GO_0009798) (axis specification), [GO:0008466](http://purl.obolibrary.org/obo/GO_0008466) (glycogenin glucosyltransferase activity), [GO:0008465](http://purl.obolibrary.org/obo/GO_0008465) (glycerate dehydrogenase activity), [GO:0008469](http://purl.obolibrary.org/obo/GO_0008469) (histone-arginine N-methyltransferase activity), [GO:0110024](http://purl.obolibrary.org/obo/GO_0110024) (positive regulation of cardiac muscle myoblast proliferation), [GO:0008470](http://purl.obolibrary.org/obo/GO_0008470) (isovaleryl-CoA dehydrogenase activity), [GO:0010792](http://purl.obolibrary.org/obo/GO_0010792) (DNA double-strand break processing involved in repair via single-strand annealing), [GO:0008474](http://purl.obolibrary.org/obo/GO_0008474) (palmitoyl-(protein) hydrolase activity), [GO:0007140](http://purl.obolibrary.org/obo/GO_0007140) (male meiotic nuclear division), [GO:0007141](http://purl.obolibrary.org/obo/GO_0007141) (male meiosis I), [GO:0045410](http://purl.obolibrary.org/obo/GO_0045410) (positive regulation of interleukin-6 biosynthetic process), [GO:0007144](http://purl.obolibrary.org/obo/GO_0007144) (female meiosis I), [GO:0045416](http://purl.obolibrary.org/obo/GO_0045416) (positive regulation of interleukin-8 biosynthetic process), [GO:0045415](http://purl.obolibrary.org/obo/GO_0045415) (negative regulation of interleukin-8 biosynthetic process), [GO:1904184](http://purl.obolibrary.org/obo/GO_1904184) (positive regulation of pyruvate dehydrogenase activity), [GO:1904183](http://purl.obolibrary.org/obo/GO_1904183) (negative regulation of pyruvate dehydrogenase activity), [GO:0045429](http://purl.obolibrary.org/obo/GO_0045429) (positive regulation of nitric oxide biosynthetic process), [GO:0046755](http://purl.obolibrary.org/obo/GO_0046755) (viral budding), [GO:0008443](http://purl.obolibrary.org/obo/GO_0008443) (phosphofructokinase activity), [GO:0008449](http://purl.obolibrary.org/obo/GO_0008449) (N-acetylglucosamine-6-sulfatase activity), [GO:0007117](http://purl.obolibrary.org/obo/GO_0007117) (budding cell bud growth), [GO:0007118](http://purl.obolibrary.org/obo/GO_0007118) (budding cell apical bud growth), [GO:0034728](http://purl.obolibrary.org/obo/GO_0034728) (nucleosome organization), [GO:0034727](http://purl.obolibrary.org/obo/GO_0034727) (piecemeal microautophagy of the nucleus), [GO:0010759](http://purl.obolibrary.org/obo/GO_0010759) (positive regulation of macrophage chemotaxis), [GO:1901919](http://purl.obolibrary.org/obo/GO_1901919) (positive regulation of exoribonuclease activity), [GO:0071711](http://purl.obolibrary.org/obo/GO_0071711) (basement membrane organization), [GO:0034720](http://purl.obolibrary.org/obo/GO_0034720) (histone H3-K4 demethylation), [GO:0019101](http://purl.obolibrary.org/obo/GO_0019101) (female somatic sex determination), [GO:0019104](http://purl.obolibrary.org/obo/GO_0019104) (DNA N-glycosylase activity), [GO:0071712](http://purl.obolibrary.org/obo/GO_0071712) (ER-associated misfolded protein catabolic process), [GO:0010751](http://purl.obolibrary.org/obo/GO_0010751) (negative regulation of nitric oxide mediated signal transduction), [GO:0007120](http://purl.obolibrary.org/obo/GO_0007120) (axial cellular bud site selection), [GO:0007121](http://purl.obolibrary.org/obo/GO_0007121) (bipolar cellular bud site selection), [GO:0007124](http://purl.obolibrary.org/obo/GO_0007124) (pseudohyphal growth), [GO:0008456](http://purl.obolibrary.org/obo/GO_0008456) (alpha-N-acetylgalactosaminidase activity), [GO:0009786](http://purl.obolibrary.org/obo/GO_0009786) (regulation of asymmetric cell division), [GO:0008455](http://purl.obolibrary.org/obo/GO_0008455) (alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity), [GO:0008453](http://purl.obolibrary.org/obo/GO_0008453) (alanine-glyoxylate transaminase activity), [GO:0007128](http://purl.obolibrary.org/obo/GO_0007128) (meiotic prophase I), [GO:0007129](http://purl.obolibrary.org/obo/GO_0007129) (synapsis), [GO:0008459](http://purl.obolibrary.org/obo/GO_0008459) (chondroitin 6-sulfotransferase activity), [GO:0045437](http://purl.obolibrary.org/obo/GO_0045437) (uridine nucleosidase activity), [GO:0007119](http://purl.obolibrary.org/obo/GO_0007119) (budding cell isotropic bud growth), [GO:0010765](http://purl.obolibrary.org/obo/GO_0010765) (positive regulation of sodium ion transport), [GO:0010766](http://purl.obolibrary.org/obo/GO_0010766) (negative regulation of sodium ion transport), [GO:0034714](http://purl.obolibrary.org/obo/GO_0034714) (type III transforming growth factor beta receptor binding), [GO:0034713](http://purl.obolibrary.org/obo/GO_0034713) (type I transforming growth factor beta receptor binding), [GO:0071704](http://purl.obolibrary.org/obo/GO_0071704) (organic substance metabolic process), [GO:0071701](http://purl.obolibrary.org/obo/GO_0071701) (regulation of MAPK export from nucleus), [GO:0010763](http://purl.obolibrary.org/obo/GO_0010763) (positive regulation of fibroblast migration), [GO:0034711](http://purl.obolibrary.org/obo/GO_0034711) (inhibin binding), [GO:0010762](http://purl.obolibrary.org/obo/GO_0010762) (regulation of fibroblast migration), [GO:0007171](http://purl.obolibrary.org/obo/GO_0007171) (activation of transmembrane receptor protein tyrosine kinase activity), [GO:0007175](http://purl.obolibrary.org/obo/GO_0007175) (negative regulation of epidermal growth factor-activated receptor activity), [GO:0007176](http://purl.obolibrary.org/obo/GO_0007176) (regulation of epidermal growth factor-activated receptor activity), [GO:0007173](http://purl.obolibrary.org/obo/GO_0007173) (epidermal growth factor receptor signaling pathway), [GO:0007179](http://purl.obolibrary.org/obo/GO_0007179) (transforming growth factor beta receptor signaling pathway), [GO:0051291](http://purl.obolibrary.org/obo/GO_0051291) (protein heterooligomerization), [GO:0007178](http://purl.obolibrary.org/obo/GO_0007178) (transmembrane receptor protein serine/threonine kinase signaling pathway), [GO:0051292](http://purl.obolibrary.org/obo/GO_0051292) (nuclear pore complex assembly), [GO:0051290](http://purl.obolibrary.org/obo/GO_0051290) (protein heterotetramerization), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0051286](http://purl.obolibrary.org/obo/GO_0051286) (cell tip), [GO:0051287](http://purl.obolibrary.org/obo/GO_0051287) (NAD binding), [GO:0051284](http://purl.obolibrary.org/obo/GO_0051284) (positive regulation of sequestering of calcium ion), [GO:0019166](http://purl.obolibrary.org/obo/GO_0019166) (trans-2-enoyl-CoA reductase (NADPH) activity), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0032120](http://purl.obolibrary.org/obo/GO_0032120) (ascospore-type prospore membrane assembly), [GO:0007187](http://purl.obolibrary.org/obo/GO_0007187) (G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger), [GO:0007184](http://purl.obolibrary.org/obo/GO_0007184) (SMAD protein import into nucleus), [GO:0007188](http://purl.obolibrary.org/obo/GO_0007188) (adenylate cyclase-modulating G-protein coupled receptor signaling pathway), [GO:0007189](http://purl.obolibrary.org/obo/GO_0007189) (adenylate cyclase-activating G-protein coupled receptor signaling pathway), [GO:2000969](http://purl.obolibrary.org/obo/GO_2000969) (positive regulation of AMPA receptor activity), [GO:0032119](http://purl.obolibrary.org/obo/GO_0032119) (sequestering of zinc ion), [GO:0051298](http://purl.obolibrary.org/obo/GO_0051298) (centrosome duplication), [GO:0004904](http://purl.obolibrary.org/obo/GO_0004904) (interferon receptor activity), [GO:0004903](http://purl.obolibrary.org/obo/GO_0004903) (growth hormone receptor activity), [GO:0004905](http://purl.obolibrary.org/obo/GO_0004905) (type I interferon receptor activity), [GO:0034774](http://purl.obolibrary.org/obo/GO_0034774) (secretory granule lumen), [GO:0019158](http://purl.obolibrary.org/obo/GO_0019158) (mannokinase activity), [GO:0046718](http://purl.obolibrary.org/obo/GO_0046718) (viral entry into host cell), [GO:0046716](http://purl.obolibrary.org/obo/GO_0046716) (muscle cell cellular homeostasis), [GO:0008484](http://purl.obolibrary.org/obo/GO_0008484) (sulfuric ester hydrolase activity), [GO:0007154](http://purl.obolibrary.org/obo/GO_0007154) (cell communication), [GO:1904158](http://purl.obolibrary.org/obo/GO_1904158) (axonemal central apparatus assembly), [GO:0008483](http://purl.obolibrary.org/obo/GO_0008483) (transaminase activity), [GO:0034770](http://purl.obolibrary.org/obo/GO_0034770) (histone H4-K20 methylation), [GO:0008482](http://purl.obolibrary.org/obo/GO_0008482) (sulfite oxidase activity), [GO:0007157](http://purl.obolibrary.org/obo/GO_0007157) (heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules), [GO:0007158](http://purl.obolibrary.org/obo/GO_0007158) (neuron cell-cell adhesion), [GO:0008488](http://purl.obolibrary.org/obo/GO_0008488) (gamma-glutamyl carboxylase activity), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0007156](http://purl.obolibrary.org/obo/GO_0007156) (homophilic cell adhesion via plasma membrane adhesion molecules), [GO:0007159](http://purl.obolibrary.org/obo/GO_0007159) (leukocyte cell-cell adhesion), [GO:1990108](http://purl.obolibrary.org/obo/GO_1990108) (protein linear deubiquitination), [GO:0034765](http://purl.obolibrary.org/obo/GO_0034765) (regulation of ion transmembrane transport), [GO:2000973](http://purl.obolibrary.org/obo/GO_2000973) (regulation of pro-B cell differentiation), [GO:0010794](http://purl.obolibrary.org/obo/GO_0010794) (regulation of dolichol biosynthetic process), [GO:0010793](http://purl.obolibrary.org/obo/GO_0010793) (regulation of mRNA export from nucleus), [GO:0010796](http://purl.obolibrary.org/obo/GO_0010796) (regulation of multivesicular body size), [GO:0034766](http://purl.obolibrary.org/obo/GO_0034766) (negative regulation of ion transmembrane transport), [GO:0010795](http://purl.obolibrary.org/obo/GO_0010795) (regulation of ubiquinone biosynthetic process), [GO:0007160](http://purl.obolibrary.org/obo/GO_0007160) (cell-matrix adhesion), [GO:0007164](http://purl.obolibrary.org/obo/GO_0007164) (establishment of tissue polarity), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0034760](http://purl.obolibrary.org/obo/GO_0034760) (negative regulation of iron ion transmembrane transport), [GO:0008495](http://purl.obolibrary.org/obo/GO_0008495) (protoheme IX farnesyltransferase activity), [GO:0007162](http://purl.obolibrary.org/obo/GO_0007162) (negative regulation of cell adhesion), [GO:0007163](http://purl.obolibrary.org/obo/GO_0007163) (establishment or maintenance of cell polarity), [GO:0007168](http://purl.obolibrary.org/obo/GO_0007168) (receptor guanylyl cyclase signaling pathway), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:0008499](http://purl.obolibrary.org/obo/GO_0008499) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0007167](http://purl.obolibrary.org/obo/GO_0007167) (enzyme linked receptor protein signaling pathway), [GO:0046725](http://purl.obolibrary.org/obo/GO_0046725) (negative regulation by virus of viral protein levels in host cell), [GO:0046726](http://purl.obolibrary.org/obo/GO_0046726) (positive regulation by virus of viral protein levels in host cell), [GO:0046724](http://purl.obolibrary.org/obo/GO_0046724) (oxalic acid secretion), [GO:2000987](http://purl.obolibrary.org/obo/GO_2000987) (positive regulation of behavioral fear response), [GO:2000984](http://purl.obolibrary.org/obo/GO_2000984) (negative regulation of ATP citrate synthase activity), [GO:2000980](http://purl.obolibrary.org/obo/GO_2000980) (regulation of inner ear receptor cell differentiation), [GO:0034755](http://purl.obolibrary.org/obo/GO_0034755) (iron ion transmembrane transport), [GO:0016922](http://purl.obolibrary.org/obo/GO_0016922) (ligand-dependent nuclear receptor binding), [GO:0016925](http://purl.obolibrary.org/obo/GO_0016925) (protein sumoylation), [GO:1901981](http://purl.obolibrary.org/obo/GO_1901981) (phosphatidylinositol phosphate binding), [GO:1901985](http://purl.obolibrary.org/obo/GO_1901985) (positive regulation of protein acetylation), [GO:0004931](http://purl.obolibrary.org/obo/GO_0004931) (extracellularly ATP-gated cation channel activity), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0004935](http://purl.obolibrary.org/obo/GO_0004935) (adrenergic receptor activity), [GO:0071773](http://purl.obolibrary.org/obo/GO_0071773) (cellular response to BMP stimulus), [GO:0045494](http://purl.obolibrary.org/obo/GO_0045494) (photoreceptor cell maintenance), [GO:0004936](http://purl.obolibrary.org/obo/GO_0004936) (alpha-adrenergic receptor activity), [GO:0070445](http://purl.obolibrary.org/obo/GO_0070445) (regulation of oligodendrocyte progenitor proliferation), [GO:0004938](http://purl.obolibrary.org/obo/GO_0004938) (alpha2-adrenergic receptor activity), [GO:0033499](http://purl.obolibrary.org/obo/GO_0033499) (galactose catabolic process via UDP-galactose), [GO:0070444](http://purl.obolibrary.org/obo/GO_0070444) (oligodendrocyte progenitor proliferation), [GO:0070447](http://purl.obolibrary.org/obo/GO_0070447) (positive regulation of oligodendrocyte progenitor proliferation), [GO:0033490](http://purl.obolibrary.org/obo/GO_0033490) (cholesterol biosynthetic process via lathosterol), [GO:1901990](http://purl.obolibrary.org/obo/GO_1901990) (regulation of mitotic cell cycle phase transition), [GO:0032165](http://purl.obolibrary.org/obo/GO_0032165) (prospore septin filament array), [GO:0016917](http://purl.obolibrary.org/obo/GO_0016917) (GABA receptor activity), [GO:0016918](http://purl.obolibrary.org/obo/GO_0016918) (retinal binding), [GO:1901998](http://purl.obolibrary.org/obo/GO_1901998) (toxin transport), [GO:0004950](http://purl.obolibrary.org/obo/GO_0004950) (chemokine receptor activity), [GO:0004941](http://purl.obolibrary.org/obo/GO_0004941) (beta2-adrenergic receptor activity), [GO:0070431](http://purl.obolibrary.org/obo/GO_0070431) (nucleotide-binding oligomerization domain containing 2 signaling pathway), [GO:0071763](http://purl.obolibrary.org/obo/GO_0071763) (nuclear membrane organization), [GO:0070433](http://purl.obolibrary.org/obo/GO_0070433) (negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway), [GO:0007193](http://purl.obolibrary.org/obo/GO_0007193) (adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway), [GO:0007194](http://purl.obolibrary.org/obo/GO_0007194) (negative regulation of adenylate cyclase activity), [GO:0007191](http://purl.obolibrary.org/obo/GO_0007191) (adenylate cyclase-activating dopamine receptor signaling pathway), [GO:0032154](http://purl.obolibrary.org/obo/GO_0032154) (cleavage furrow), [GO:0007198](http://purl.obolibrary.org/obo/GO_0007198) (adenylate cyclase-inhibiting serotonin receptor signaling pathway), [GO:0016903](http://purl.obolibrary.org/obo/GO_0016903) (oxidoreductase activity, acting on the aldehyde or oxo group of donors), [GO:0007195](http://purl.obolibrary.org/obo/GO_0007195) (adenylate cyclase-inhibiting dopamine receptor signaling pathway), [GO:0007196](http://purl.obolibrary.org/obo/GO_0007196) (adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway), [GO:0071791](http://purl.obolibrary.org/obo/GO_0071791) (chemokine (C-C motif) ligand 5 binding), [GO:0044183](http://purl.obolibrary.org/obo/GO_0044183) (protein binding involved in protein folding), [GO:0019187](http://purl.obolibrary.org/obo/GO_0019187) (beta-1,4-mannosyltransferase activity), [GO:0032147](http://purl.obolibrary.org/obo/GO_0032147) (activation of protein kinase activity), [GO:0071799](http://purl.obolibrary.org/obo/GO_0071799) (cellular response to prostaglandin D stimulus), [GO:0071797](http://purl.obolibrary.org/obo/GO_0071797) (LUBAC complex), [GO:0007190](http://purl.obolibrary.org/obo/GO_0007190) (activation of adenylate cyclase activity), [GO:0032148](http://purl.obolibrary.org/obo/GO_0032148) (activation of protein kinase B activity), [GO:0070469](http://purl.obolibrary.org/obo/GO_0070469) (respiratory chain), [GO:0032142](http://purl.obolibrary.org/obo/GO_0032142) (single guanine insertion binding), [GO:0032143](http://purl.obolibrary.org/obo/GO_0032143) (single thymine insertion binding), [GO:0004920](http://purl.obolibrary.org/obo/GO_0004920) (interleukin-10 receptor activity), [GO:0004924](http://purl.obolibrary.org/obo/GO_0004924) (oncostatin-M receptor activity), [GO:0004925](http://purl.obolibrary.org/obo/GO_0004925) (prolactin receptor activity), [GO:0071782](http://purl.obolibrary.org/obo/GO_0071782) (endoplasmic reticulum tubular network), [GO:0032135](http://purl.obolibrary.org/obo/GO_0032135) (DNA insertion or deletion binding), [GO:0071787](http://purl.obolibrary.org/obo/GO_0071787) (endoplasmic reticulum tubular network formation), [GO:0071786](http://purl.obolibrary.org/obo/GO_0071786) (endoplasmic reticulum tubular network organization), [GO:0032139](http://purl.obolibrary.org/obo/GO_0032139) (dinucleotide insertion or deletion binding), [GO:0032137](http://purl.obolibrary.org/obo/GO_0032137) (guanine/thymine mispair binding), [GO:0032138](http://purl.obolibrary.org/obo/GO_0032138) (single base insertion or deletion binding), [GO:0070409](http://purl.obolibrary.org/obo/GO_0070409) (carbamoyl phosphate biosynthetic process), [GO:0015631](http://purl.obolibrary.org/obo/GO_0015631) (tubulin binding), [GO:0015630](http://purl.obolibrary.org/obo/GO_0015630) (microtubule cytoskeleton), [GO:0045445](http://purl.obolibrary.org/obo/GO_0045445) (myoblast differentiation), [GO:0046777](http://purl.obolibrary.org/obo/GO_0046777) (protein autophosphorylation), [GO:0045446](http://purl.obolibrary.org/obo/GO_0045446) (endothelial cell differentiation), [GO:0004980](http://purl.obolibrary.org/obo/GO_0004980) (melanocyte-stimulating hormone receptor activity), [GO:0045444](http://purl.obolibrary.org/obo/GO_0045444) (fat cell differentiation), [GO:0002320](http://purl.obolibrary.org/obo/GO_0002320) (lymphoid progenitor cell differentiation), [GO:0004977](http://purl.obolibrary.org/obo/GO_0004977) (melanocortin receptor activity), [GO:0002314](http://purl.obolibrary.org/obo/GO_0002314) (germinal center B cell differentiation), [GO:0002315](http://purl.obolibrary.org/obo/GO_0002315) (marginal zone B cell differentiation), [GO:0002316](http://purl.obolibrary.org/obo/GO_0002316) (follicular B cell differentiation), [GO:0045453](http://purl.obolibrary.org/obo/GO_0045453) (bone resorption), [GO:0002318](http://purl.obolibrary.org/obo/GO_0002318) (myeloid progenitor cell differentiation), [GO:0071732](http://purl.obolibrary.org/obo/GO_0071732) (cellular response to nitric oxide), [GO:0015629](http://purl.obolibrary.org/obo/GO_0015629) (actin cytoskeleton), [GO:0071733](http://purl.obolibrary.org/obo/GO_0071733) (transcriptional activation by promoter-enhancer looping), [GO:0070402](http://purl.obolibrary.org/obo/GO_0070402) (NADPH binding), [GO:0071731](http://purl.obolibrary.org/obo/GO_0071731) (response to nitric oxide), [GO:0016971](http://purl.obolibrary.org/obo/GO_0016971) (flavin-linked sulfhydryl oxidase activity), [GO:0016972](http://purl.obolibrary.org/obo/GO_0016972) (thiol oxidase activity), [GO:0016973](http://purl.obolibrary.org/obo/GO_0016973) (poly(A)+ mRNA export from nucleus), [GO:0071734](http://purl.obolibrary.org/obo/GO_0071734) (biotin-[pyruvate-carboxylase] ligase activity), [GO:0070403](http://purl.obolibrary.org/obo/GO_0070403) (NAD+ binding), [GO:0070404](http://purl.obolibrary.org/obo/GO_0070404) (NADH binding), [GO:0015643](http://purl.obolibrary.org/obo/GO_0015643) (toxic substance binding), [GO:0045454](http://purl.obolibrary.org/obo/GO_0045454) (cell redox homeostasis), [GO:0004991](http://purl.obolibrary.org/obo/GO_0004991) (parathyroid hormone receptor activity), [GO:0046785](http://purl.obolibrary.org/obo/GO_0046785) (microtubule polymerization), [GO:0004993](http://purl.obolibrary.org/obo/GO_0004993) (G-protein coupled serotonin receptor activity), [GO:0002331](http://purl.obolibrary.org/obo/GO_0002331) (pre-B cell allelic exclusion), [GO:0046790](http://purl.obolibrary.org/obo/GO_0046790) (virion binding), [GO:0004985](http://purl.obolibrary.org/obo/GO_0004985) (opioid receptor activity), [GO:0002326](http://purl.obolibrary.org/obo/GO_0002326) (B cell lineage commitment), [GO:0002327](http://purl.obolibrary.org/obo/GO_0002327) (immature B cell differentiation), [GO:0044130](http://purl.obolibrary.org/obo/GO_0044130) (negative regulation of growth of symbiont in host), [GO:0002328](http://purl.obolibrary.org/obo/GO_0002328) (pro-B cell differentiation), [GO:0071726](http://purl.obolibrary.org/obo/GO_0071726) (cellular response to diacyl bacterial lipopeptide), [GO:0070429](http://purl.obolibrary.org/obo/GO_0070429) (negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway), [GO:1901962](http://purl.obolibrary.org/obo/GO_1901962) (S-adenosyl-L-methionine transmembrane transport), [GO:0004962](http://purl.obolibrary.org/obo/GO_0004962) (endothelin receptor activity), [GO:0045471](http://purl.obolibrary.org/obo/GO_0045471) (response to ethanol), [GO:0004952](http://purl.obolibrary.org/obo/GO_0004952) (dopamine neurotransmitter receptor activity), [GO:0044140](http://purl.obolibrary.org/obo/GO_0044140) (negative regulation of growth of symbiont on or near host surface), [GO:0004957](http://purl.obolibrary.org/obo/GO_0004957) (prostaglandin E receptor activity), [GO:0045475](http://purl.obolibrary.org/obo/GO_0045475) (locomotor rhythm), [GO:0004956](http://purl.obolibrary.org/obo/GO_0004956) (prostaglandin D receptor activity), [GO:0032183](http://purl.obolibrary.org/obo/GO_0032183) (SUMO binding), [GO:0032180](http://purl.obolibrary.org/obo/GO_0032180) (ubiquinone biosynthetic process from tyrosine), [GO:0016934](http://purl.obolibrary.org/obo/GO_0016934) (extracellularly glycine-gated chloride channel activity), [GO:0070419](http://purl.obolibrary.org/obo/GO_0070419) (nonhomologous end joining complex), [GO:0032181](http://purl.obolibrary.org/obo/GO_0032181) (dinucleotide repeat insertion binding), [GO:0032186](http://purl.obolibrary.org/obo/GO_0032186) (cellular bud neck septin ring organization), [GO:0016936](http://purl.obolibrary.org/obo/GO_0016936) (galactoside binding), [GO:0016937](http://purl.obolibrary.org/obo/GO_0016937) (short-branched-chain-acyl-CoA dehydrogenase activity), [GO:0032184](http://purl.obolibrary.org/obo/GO_0032184) (SUMO polymer binding), [GO:0044146](http://purl.obolibrary.org/obo/GO_0044146) (negative regulation of growth of symbiont involved in interaction with host), [GO:0004971](http://purl.obolibrary.org/obo/GO_0004971) (AMPA glutamate receptor activity), [GO:0004970](http://purl.obolibrary.org/obo/GO_0004970) (ionotropic glutamate receptor activity), [GO:0002302](http://purl.obolibrary.org/obo/GO_0002302) (CD8-positive, alpha-beta T cell differentiation involved in immune response), [GO:0004966](http://purl.obolibrary.org/obo/GO_0004966) (galanin receptor activity), [GO:0004965](http://purl.obolibrary.org/obo/GO_0004965) (G-protein coupled GABA receptor activity), [GO:0004967](http://purl.obolibrary.org/obo/GO_0004967) (glucagon receptor activity), [GO:0002309](http://purl.obolibrary.org/obo/GO_0002309) (T cell proliferation involved in immune response), [GO:0070412](http://purl.obolibrary.org/obo/GO_0070412) (R-SMAD binding), [GO:0015616](http://purl.obolibrary.org/obo/GO_0015616) (DNA translocase activity), [GO:0070410](http://purl.obolibrary.org/obo/GO_0070410) (co-SMAD binding), [GO:0070411](http://purl.obolibrary.org/obo/GO_0070411) (I-SMAD binding), [GO:0070417](http://purl.obolibrary.org/obo/GO_0070417) (cellular response to cold), [GO:0016941](http://purl.obolibrary.org/obo/GO_0016941) (natriuretic peptide receptor activity), [GO:1990090](http://purl.obolibrary.org/obo/GO_1990090) (cellular response to nerve growth factor stimulus), [GO:1990091](http://purl.obolibrary.org/obo/GO_1990091) (sodium-dependent self proteolysis), [GO:0005991](http://purl.obolibrary.org/obo/GO_0005991) (trehalose metabolic process), [GO:0004663](http://purl.obolibrary.org/obo/GO_0004663) (Rab geranylgeranyltransferase activity), [GO:0005993](http://purl.obolibrary.org/obo/GO_0005993) (trehalose catabolic process), [GO:0003333](http://purl.obolibrary.org/obo/GO_0003333) (amino acid transmembrane transport), [GO:0003334](http://purl.obolibrary.org/obo/GO_0003334) (keratinocyte development), [GO:0002003](http://purl.obolibrary.org/obo/GO_0002003) (angiotensin maturation), [GO:0071493](http://purl.obolibrary.org/obo/GO_0071493) (cellular response to UV-B), [GO:0004656](http://purl.obolibrary.org/obo/GO_0004656) (procollagen-proline 4-dioxygenase activity), [GO:0005987](http://purl.obolibrary.org/obo/GO_0005987) (sucrose catabolic process), [GO:0004655](http://purl.obolibrary.org/obo/GO_0004655) (porphobilinogen synthase activity), [GO:0071494](http://purl.obolibrary.org/obo/GO_0071494) (cellular response to UV-C), [GO:0005986](http://purl.obolibrary.org/obo/GO_0005986) (sucrose biosynthetic process), [GO:0070160](http://purl.obolibrary.org/obo/GO_0070160) (occluding junction), [GO:0005989](http://purl.obolibrary.org/obo/GO_0005989) (lactose biosynthetic process), [GO:0004658](http://purl.obolibrary.org/obo/GO_0004658) (propionyl-CoA carboxylase activity), [GO:0004657](http://purl.obolibrary.org/obo/GO_0004657) (proline dehydrogenase activity), [GO:0071492](http://purl.obolibrary.org/obo/GO_0071492) (cellular response to UV-A), [GO:0030947](http://purl.obolibrary.org/obo/GO_0030947) (regulation of vascular endothelial growth factor receptor signaling pathway), [GO:0070166](http://purl.obolibrary.org/obo/GO_0070166) (enamel mineralization), [GO:0004659](http://purl.obolibrary.org/obo/GO_0004659) (prenyltransferase activity), [GO:0071498](http://purl.obolibrary.org/obo/GO_0071498) (cellular response to fluid shear stress), [GO:0030949](http://purl.obolibrary.org/obo/GO_0030949) (positive regulation of vascular endothelial growth factor receptor signaling pathway), [GO:0071499](http://purl.obolibrary.org/obo/GO_0071499) (cellular response to laminar fluid shear stress), [GO:0016651](http://purl.obolibrary.org/obo/GO_0016651) (oxidoreductase activity, acting on NAD(P)H), [GO:0070169](http://purl.obolibrary.org/obo/GO_0070169) (positive regulation of biomineral tissue development), [GO:0016653](http://purl.obolibrary.org/obo/GO_0016653) (oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor), [GO:0016655](http://purl.obolibrary.org/obo/GO_0016655) (oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor), [GO:0015321](http://purl.obolibrary.org/obo/GO_0015321) (sodium-dependent phosphate transmembrane transporter activity), [GO:0016638](http://purl.obolibrary.org/obo/GO_0016638) (oxidoreductase activity, acting on the CH-NH2 group of donors), [GO:0016639](http://purl.obolibrary.org/obo/GO_0016639) (oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0003341](http://purl.obolibrary.org/obo/GO_0003341) (cilium movement), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:0003342](http://purl.obolibrary.org/obo/GO_0003342) (proepicardium development), [GO:0003344](http://purl.obolibrary.org/obo/GO_0003344) (pericardium morphogenesis), [GO:0004675](http://purl.obolibrary.org/obo/GO_0004675) (transmembrane receptor protein serine/threonine kinase activity), [GO:0071482](http://purl.obolibrary.org/obo/GO_0071482) (cellular response to light stimulus), [GO:0070152](http://purl.obolibrary.org/obo/GO_0070152) (mitochondrial isoleucyl-tRNA aminoacylation), [GO:0071480](http://purl.obolibrary.org/obo/GO_0071480) (cellular response to gamma radiation), [GO:0003337](http://purl.obolibrary.org/obo/GO_0003337) (mesenchymal to epithelial transition involved in metanephros morphogenesis), [GO:0070150](http://purl.obolibrary.org/obo/GO_0070150) (mitochondrial glycyl-tRNA aminoacylation), [GO:0004668](http://purl.obolibrary.org/obo/GO_0004668) (protein-arginine deiminase activity), [GO:0003338](http://purl.obolibrary.org/obo/GO_0003338) (metanephros morphogenesis), [GO:0071486](http://purl.obolibrary.org/obo/GO_0071486) (cellular response to high light intensity), [GO:0002009](http://purl.obolibrary.org/obo/GO_0002009) (morphogenesis of an epithelium), [GO:0070156](http://purl.obolibrary.org/obo/GO_0070156) (mitochondrial phenylalanyl-tRNA aminoacylation), [GO:0070154](http://purl.obolibrary.org/obo/GO_0070154) (mitochondrial lysyl-tRNA aminoacylation), [GO:0070159](http://purl.obolibrary.org/obo/GO_0070159) (mitochondrial threonyl-tRNA aminoacylation), [GO:0015319](http://purl.obolibrary.org/obo/GO_0015319) (sodium:inorganic phosphate symporter activity), [GO:0070158](http://purl.obolibrary.org/obo/GO_0070158) (mitochondrial seryl-tRNA aminoacylation), [GO:0016641](http://purl.obolibrary.org/obo/GO_0016641) (oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor), [GO:0016624](http://purl.obolibrary.org/obo/GO_0016624) (oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor), [GO:0016627](http://purl.obolibrary.org/obo/GO_0016627) (oxidoreductase activity, acting on the CH-CH group of donors), [GO:0016628](http://purl.obolibrary.org/obo/GO_0016628) (oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor), [GO:0003310](http://purl.obolibrary.org/obo/GO_0003310) (pancreatic A cell differentiation), [GO:0005971](http://purl.obolibrary.org/obo/GO_0005971) (ribonucleoside-diphosphate reductase complex), [GO:0003311](http://purl.obolibrary.org/obo/GO_0003311) (pancreatic D cell differentiation), [GO:0004643](http://purl.obolibrary.org/obo/GO_0004643) (phosphoribosylaminoimidazolecarboxamide formyltransferase activity), [GO:0042953](http://purl.obolibrary.org/obo/GO_0042953) (lipoprotein transport), [GO:0004634](http://purl.obolibrary.org/obo/GO_0004634) (phosphopyruvate hydratase activity), [GO:0070184](http://purl.obolibrary.org/obo/GO_0070184) (mitochondrial tyrosyl-tRNA aminoacylation), [GO:0005964](http://purl.obolibrary.org/obo/GO_0005964) (phosphorylase kinase complex), [GO:0005967](http://purl.obolibrary.org/obo/GO_0005967) (mitochondrial pyruvate dehydrogenase complex), [GO:0070182](http://purl.obolibrary.org/obo/GO_0070182) (DNA polymerase binding), [GO:0003305](http://purl.obolibrary.org/obo/GO_0003305) (cell migration involved in heart jogging), [GO:0003306](http://purl.obolibrary.org/obo/GO_0003306) (Wnt signaling pathway involved in heart development), [GO:0005968](http://purl.obolibrary.org/obo/GO_0005968) (Rab-protein geranylgeranyltransferase complex), [GO:0003308](http://purl.obolibrary.org/obo/GO_0003308) (negative regulation of Wnt signaling pathway involved in heart development), [GO:0003309](http://purl.obolibrary.org/obo/GO_0003309) (type B pancreatic cell differentiation), [GO:0070187](http://purl.obolibrary.org/obo/GO_0070187) (shelterin complex), [GO:0016631](http://purl.obolibrary.org/obo/GO_0016631) (enoyl-[acyl-carrier-protein] reductase activity), [GO:0015301](http://purl.obolibrary.org/obo/GO_0015301) (anion:anion antiporter activity), [GO:0033194](http://purl.obolibrary.org/obo/GO_0033194) (response to hydroperoxide), [GO:0016614](http://purl.obolibrary.org/obo/GO_0016614) (oxidoreductase activity, acting on CH-OH group of donors), [GO:0016615](http://purl.obolibrary.org/obo/GO_0016615) (malate dehydrogenase activity), [GO:0016616](http://purl.obolibrary.org/obo/GO_0016616) (oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor), [GO:0033198](http://purl.obolibrary.org/obo/GO_0033198) (response to ATP), [GO:0033197](http://purl.obolibrary.org/obo/GO_0033197) (response to vitamin E), [GO:0016618](http://purl.obolibrary.org/obo/GO_0016618) (hydroxypyruvate reductase activity), [GO:0030917](http://purl.obolibrary.org/obo/GO_0030917) (midbrain-hindbrain boundary development), [GO:0005980](http://purl.obolibrary.org/obo/GO_0005980) (glycogen catabolic process), [GO:0004652](http://purl.obolibrary.org/obo/GO_0004652) (polynucleotide adenylyltransferase activity), [GO:0003322](http://purl.obolibrary.org/obo/GO_0003322) (pancreatic A cell development), [GO:0004654](http://purl.obolibrary.org/obo/GO_0004654) (polyribonucleotide nucleotidyltransferase activity), [GO:0003323](http://purl.obolibrary.org/obo/GO_0003323) (type B pancreatic cell development), [GO:0030910](http://purl.obolibrary.org/obo/GO_0030910) (olfactory placode formation), [GO:0004645](http://purl.obolibrary.org/obo/GO_0004645) (phosphorylase activity), [GO:0070173](http://purl.obolibrary.org/obo/GO_0070173) (regulation of enamel mineralization), [GO:0005975](http://purl.obolibrary.org/obo/GO_0005975) (carbohydrate metabolic process), [GO:0003314](http://purl.obolibrary.org/obo/GO_0003314) (heart rudiment morphogenesis), [GO:0005978](http://purl.obolibrary.org/obo/GO_0005978) (glycogen biosynthetic process), [GO:0003315](http://purl.obolibrary.org/obo/GO_0003315) (heart rudiment formation), [GO:0004647](http://purl.obolibrary.org/obo/GO_0004647) (phosphoserine phosphatase activity), [GO:0005977](http://purl.obolibrary.org/obo/GO_0005977) (glycogen metabolic process), [GO:0030911](http://purl.obolibrary.org/obo/GO_0030911) (TPR domain binding), [GO:0070172](http://purl.obolibrary.org/obo/GO_0070172) (positive regulation of tooth mineralization), [GO:0005979](http://purl.obolibrary.org/obo/GO_0005979) (regulation of glycogen biosynthetic process), [GO:0003318](http://purl.obolibrary.org/obo/GO_0003318) (cell migration to the midline involved in heart development), [GO:0004648](http://purl.obolibrary.org/obo/GO_0004648) (O-phospho-L-serine:2-oxoglutarate aminotransferase activity), [GO:0030913](http://purl.obolibrary.org/obo/GO_0030913) (paranodal junction assembly), [GO:0070175](http://purl.obolibrary.org/obo/GO_0070175) (positive regulation of enamel mineralization), [GO:0030916](http://purl.obolibrary.org/obo/GO_0030916) (otic vesicle formation), [GO:0003319](http://purl.obolibrary.org/obo/GO_0003319) (cardioblast migration to the midline involved in heart rudiment formation), [GO:0030915](http://purl.obolibrary.org/obo/GO_0030915) (Smc5-Smc6 complex), [GO:0016620](http://purl.obolibrary.org/obo/GO_0016620) (oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor), [GO:0015350](http://purl.obolibrary.org/obo/GO_0015350) (methotrexate transmembrane transporter activity), [GO:0003370](http://purl.obolibrary.org/obo/GO_0003370) (cell-cell adhesion involved in mesendodermal cell migration), [GO:0002040](http://purl.obolibrary.org/obo/GO_0002040) (sprouting angiogenesis), [GO:0002042](http://purl.obolibrary.org/obo/GO_0002042) (cell migration involved in sprouting angiogenesis), [GO:0045168](http://purl.obolibrary.org/obo/GO_0045168) (cell-cell signaling involved in cell fate commitment), [GO:0003374](http://purl.obolibrary.org/obo/GO_0003374) (dynamin family protein polymerization involved in mitochondrial fission), [GO:0002043](http://purl.obolibrary.org/obo/GO_0002043) (blood vessel endothelial cell proliferation involved in sprouting angiogenesis), [GO:0002044](http://purl.obolibrary.org/obo/GO_0002044) (blood vessel endothelial cell migration involved in intussusceptive angiogenesis), [GO:0003376](http://purl.obolibrary.org/obo/GO_0003376) (sphingosine-1-phosphate signaling pathway), [GO:0002046](http://purl.obolibrary.org/obo/GO_0002046) (opsin binding), [GO:0002037](http://purl.obolibrary.org/obo/GO_0002037) (negative regulation of L-glutamate transport), [GO:0004699](http://purl.obolibrary.org/obo/GO_0004699) (calcium-independent protein kinase C activity), [GO:0002038](http://purl.obolibrary.org/obo/GO_0002038) (positive regulation of L-glutamate transport), [GO:0002039](http://purl.obolibrary.org/obo/GO_0002039) (p53 binding), [GO:0045171](http://purl.obolibrary.org/obo/GO_0045171) (intercellular bridge), [GO:0045177](http://purl.obolibrary.org/obo/GO_0045177) (apical part of cell), [GO:0045178](http://purl.obolibrary.org/obo/GO_0045178) (basal part of cell), [GO:0070121](http://purl.obolibrary.org/obo/GO_0070121) (Kupffer's vesicle development), [GO:0045176](http://purl.obolibrary.org/obo/GO_0045176) (apical protein localization), [GO:0070126](http://purl.obolibrary.org/obo/GO_0070126) (mitochondrial translational termination), [GO:0070127](http://purl.obolibrary.org/obo/GO_0070127) (tRNA aminoacylation for mitochondrial protein translation), [GO:0071455](http://purl.obolibrary.org/obo/GO_0071455) (cellular response to hyperoxia), [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia), [GO:0070125](http://purl.obolibrary.org/obo/GO_0070125) (mitochondrial translational elongation), [GO:0030983](http://purl.obolibrary.org/obo/GO_0030983) (mismatched DNA binding), [GO:0015349](http://purl.obolibrary.org/obo/GO_0015349) (thyroid hormone transmembrane transporter activity), [GO:0071459](http://purl.obolibrary.org/obo/GO_0071459) (protein localization to chromosome, centromeric region), [GO:0070129](http://purl.obolibrary.org/obo/GO_0070129) (regulation of mitochondrial translation), [GO:0015347](http://purl.obolibrary.org/obo/GO_0015347) (sodium-independent organic anion transmembrane transporter activity), [GO:0014037](http://purl.obolibrary.org/obo/GO_0014037) (Schwann cell differentiation), [GO:0014036](http://purl.obolibrary.org/obo/GO_0014036) (neural crest cell fate specification), [GO:0014033](http://purl.obolibrary.org/obo/GO_0014033) (neural crest cell differentiation), [GO:0042903](http://purl.obolibrary.org/obo/GO_0042903) (tubulin deacetylase activity), [GO:0014032](http://purl.obolibrary.org/obo/GO_0014032) (neural crest cell development), [GO:0014031](http://purl.obolibrary.org/obo/GO_0014031) (mesenchymal cell development), [GO:0003382](http://purl.obolibrary.org/obo/GO_0003382) (epithelial cell morphogenesis), [GO:0002052](http://purl.obolibrary.org/obo/GO_0002052) (positive regulation of neuroblast proliferation), [GO:0002053](http://purl.obolibrary.org/obo/GO_0002053) (positive regulation of mesenchymal cell proliferation), [GO:0002055](http://purl.obolibrary.org/obo/GO_0002055) (adenine binding), [GO:0002058](http://purl.obolibrary.org/obo/GO_0002058) (uracil binding), [GO:0045184](http://purl.obolibrary.org/obo/GO_0045184) (establishment of protein localization), [GO:0003379](http://purl.obolibrary.org/obo/GO_0003379) (establishment of cell polarity involved in gastrulation cell migration), [GO:0030976](http://purl.obolibrary.org/obo/GO_0030976) (thiamine pyrophosphate binding), [GO:0030975](http://purl.obolibrary.org/obo/GO_0030975) (thiamine binding), [GO:0071442](http://purl.obolibrary.org/obo/GO_0071442) (positive regulation of histone H3-K14 acetylation), [GO:0045188](http://purl.obolibrary.org/obo/GO_0045188) (regulation of circadian sleep/wake cycle, non-REM sleep), [GO:0042908](http://purl.obolibrary.org/obo/GO_0042908) (xenobiotic transport), [GO:0071447](http://purl.obolibrary.org/obo/GO_0071447) (cellular response to hydroperoxide), [GO:0030970](http://purl.obolibrary.org/obo/GO_0030970) (retrograde protein transport, ER to cytosol), [GO:0016684](http://purl.obolibrary.org/obo/GO_0016684) (oxidoreductase activity, acting on peroxide as acceptor), [GO:0030971](http://purl.obolibrary.org/obo/GO_0030971) (receptor tyrosine kinase binding), [GO:0014029](http://purl.obolibrary.org/obo/GO_0014029) (neural crest formation), [GO:0030974](http://purl.obolibrary.org/obo/GO_0030974) (thiamine pyrophosphate transmembrane transport), [GO:0014003](http://purl.obolibrary.org/obo/GO_0014003) (oligodendrocyte development), [GO:0016668](http://purl.obolibrary.org/obo/GO_0016668) (oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor), [GO:0014002](http://purl.obolibrary.org/obo/GO_0014002) (astrocyte development), [GO:0003350](http://purl.obolibrary.org/obo/GO_0003350) (pulmonary myocardium development), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:0003351](http://purl.obolibrary.org/obo/GO_0003351) (epithelial cilium movement), [GO:0004683](http://purl.obolibrary.org/obo/GO_0004683) (calmodulin-dependent protein kinase activity), [GO:0003352](http://purl.obolibrary.org/obo/GO_0003352) (regulation of cilium movement), [GO:0002021](http://purl.obolibrary.org/obo/GO_0002021) (response to dietary excess), [GO:0002024](http://purl.obolibrary.org/obo/GO_0002024) (diet induced thermogenesis), [GO:0003356](http://purl.obolibrary.org/obo/GO_0003356) (regulation of cilium beat frequency), [GO:0002025](http://purl.obolibrary.org/obo/GO_0002025) (norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure), [GO:0071472](http://purl.obolibrary.org/obo/GO_0071472) (cellular response to salt stress), [GO:0070141](http://purl.obolibrary.org/obo/GO_0070141) (response to UV-A), [GO:0003347](http://purl.obolibrary.org/obo/GO_0003347) (epicardial cell to mesenchymal cell transition), [GO:0004677](http://purl.obolibrary.org/obo/GO_0004677) (DNA-dependent protein kinase activity), [GO:0002017](http://purl.obolibrary.org/obo/GO_0002017) (regulation of blood volume by renal aldosterone), [GO:0071470](http://purl.obolibrary.org/obo/GO_0071470) (cellular response to osmotic stress), [GO:0004679](http://purl.obolibrary.org/obo/GO_0004679) (AMP-activated protein kinase activity), [GO:0071475](http://purl.obolibrary.org/obo/GO_0071475) (cellular hyperosmotic salinity response), [GO:0070144](http://purl.obolibrary.org/obo/GO_0070144) (mitochondrial arginyl-tRNA aminoacylation), [GO:0030968](http://purl.obolibrary.org/obo/GO_0030968) (endoplasmic reticulum unfolded protein response), [GO:0071476](http://purl.obolibrary.org/obo/GO_0071476) (cellular hypotonic response), [GO:0070145](http://purl.obolibrary.org/obo/GO_0070145) (mitochondrial asparaginyl-tRNA aminoacylation), [GO:0045198](http://purl.obolibrary.org/obo/GO_0045198) (establishment of epithelial cell apical/basal polarity), [GO:0070143](http://purl.obolibrary.org/obo/GO_0070143) (mitochondrial alanyl-tRNA aminoacylation), [GO:0071474](http://purl.obolibrary.org/obo/GO_0071474) (cellular hyperosmotic response), [GO:0071479](http://purl.obolibrary.org/obo/GO_0071479) (cellular response to ionizing radiation), [GO:0016671](http://purl.obolibrary.org/obo/GO_0016671) (oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor), [GO:0070149](http://purl.obolibrary.org/obo/GO_0070149) (mitochondrial glutamyl-tRNA aminoacylation), [GO:0070146](http://purl.obolibrary.org/obo/GO_0070146) (mitochondrial aspartyl-tRNA aminoacylation), [GO:0071478](http://purl.obolibrary.org/obo/GO_0071478) (cellular response to radiation), [GO:0030961](http://purl.obolibrary.org/obo/GO_0030961) (peptidyl-arginine hydroxylation), [GO:0045190](http://purl.obolibrary.org/obo/GO_0045190) (isotype switching), [GO:0014015](http://purl.obolibrary.org/obo/GO_0014015) (positive regulation of gliogenesis), [GO:0042923](http://purl.obolibrary.org/obo/GO_0042923) (neuropeptide binding), [GO:0014013](http://purl.obolibrary.org/obo/GO_0014013) (regulation of gliogenesis), [GO:0014010](http://purl.obolibrary.org/obo/GO_0014010) (Schwann cell proliferation), [GO:0003360](http://purl.obolibrary.org/obo/GO_0003360) (brainstem development), [GO:0004694](http://purl.obolibrary.org/obo/GO_0004694) (eukaryotic translation initiation factor 2alpha kinase activity), [GO:0002031](http://purl.obolibrary.org/obo/GO_0002031) (G-protein coupled receptor internalization), [GO:0004693](http://purl.obolibrary.org/obo/GO_0004693) (cyclin-dependent protein serine/threonine kinase activity), [GO:0002032](http://purl.obolibrary.org/obo/GO_0002032) (desensitization of G-protein coupled receptor protein signaling pathway by arrestin), [GO:0002033](http://purl.obolibrary.org/obo/GO_0002033) (angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure), [GO:0004698](http://purl.obolibrary.org/obo/GO_0004698) (calcium-dependent protein kinase C activity), [GO:0004697](http://purl.obolibrary.org/obo/GO_0004697) (protein kinase C activity), [GO:0002026](http://purl.obolibrary.org/obo/GO_0002026) (regulation of the force of heart contraction), [GO:0004689](http://purl.obolibrary.org/obo/GO_0004689) (phosphorylase kinase activity), [GO:0071460](http://purl.obolibrary.org/obo/GO_0071460) (cellular response to cell-matrix adhesion), [GO:0030954](http://purl.obolibrary.org/obo/GO_0030954) (astral microtubule nucleation), [GO:0002027](http://purl.obolibrary.org/obo/GO_0002027) (regulation of heart rate), [GO:0030953](http://purl.obolibrary.org/obo/GO_0030953) (astral microtubule organization), [GO:0002028](http://purl.obolibrary.org/obo/GO_0002028) (regulation of sodium ion transport), [GO:0030955](http://purl.obolibrary.org/obo/GO_0030955) (potassium ion binding), [GO:0071465](http://purl.obolibrary.org/obo/GO_0071465) (cellular response to desiccation), [GO:0030957](http://purl.obolibrary.org/obo/GO_0030957) (Tat protein binding), [GO:0070131](http://purl.obolibrary.org/obo/GO_0070131) (positive regulation of mitochondrial translation), [GO:0071468](http://purl.obolibrary.org/obo/GO_0071468) (cellular response to acidic pH), [GO:0071466](http://purl.obolibrary.org/obo/GO_0071466) (cellular response to xenobiotic stimulus), [GO:0016661](http://purl.obolibrary.org/obo/GO_0016661) (oxidoreductase activity, acting on other nitrogenous compounds as donors), [GO:0071467](http://purl.obolibrary.org/obo/GO_0071467) (cellular response to pH), [GO:0014005](http://purl.obolibrary.org/obo/GO_0014005) (microglia development), [GO:0038037](http://purl.obolibrary.org/obo/GO_0038037) (G-protein coupled receptor dimeric complex), [GO:0014069](http://purl.obolibrary.org/obo/GO_0014069) (postsynaptic density), [GO:0038036](http://purl.obolibrary.org/obo/GO_0038036) (sphingosine-1-phosphate receptor activity), [GO:0014068](http://purl.obolibrary.org/obo/GO_0014068) (positive regulation of phosphatidylinositol 3-kinase signaling), [GO:0014067](http://purl.obolibrary.org/obo/GO_0014067) (negative regulation of phosphatidylinositol 3-kinase signaling), [GO:0038038](http://purl.obolibrary.org/obo/GO_0038038) (G-protein coupled receptor homodimeric complex), [GO:0038033](http://purl.obolibrary.org/obo/GO_0038033) (positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway), [GO:0014066](http://purl.obolibrary.org/obo/GO_0014066) (regulation of phosphatidylinositol 3-kinase signaling), [GO:0014065](http://purl.obolibrary.org/obo/GO_0014065) (phosphatidylinositol 3-kinase signaling), [GO:0002082](http://purl.obolibrary.org/obo/GO_0002082) (regulation of oxidative phosphorylation), [GO:0014064](http://purl.obolibrary.org/obo/GO_0014064) (positive regulation of serotonin secretion), [GO:0002083](http://purl.obolibrary.org/obo/GO_0002083) (4-hydroxybenzoate decaprenyltransferase activity), [GO:0002084](http://purl.obolibrary.org/obo/GO_0002084) (protein depalmitoylation), [GO:0014062](http://purl.obolibrary.org/obo/GO_0014062) (regulation of serotonin secretion), [GO:0014061](http://purl.obolibrary.org/obo/GO_0014061) (regulation of norepinephrine secretion), [GO:0038031](http://purl.obolibrary.org/obo/GO_0038031) (non-canonical Wnt signaling pathway via JNK cascade), [GO:0002086](http://purl.obolibrary.org/obo/GO_0002086) (diaphragm contraction), [GO:0002088](http://purl.obolibrary.org/obo/GO_0002088) (lens development in camera-type eye), [GO:0002089](http://purl.obolibrary.org/obo/GO_0002089) (lens morphogenesis in camera-type eye), [GO:1990001](http://purl.obolibrary.org/obo/GO_1990001) (inhibition of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0051005](http://purl.obolibrary.org/obo/GO_0051005) (negative regulation of lipoprotein lipase activity), [GO:0051000](http://purl.obolibrary.org/obo/GO_0051000) (positive regulation of nitric-oxide synthase activity), [GO:0051001](http://purl.obolibrary.org/obo/GO_0051001) (negative regulation of nitric-oxide synthase activity), [GO:0051006](http://purl.obolibrary.org/obo/GO_0051006) (positive regulation of lipoprotein lipase activity), [GO:1904100](http://purl.obolibrary.org/obo/GO_1904100) (positive regulation of protein O-linked glycosylation), [GO:0038026](http://purl.obolibrary.org/obo/GO_0038026) (reelin-mediated signaling pathway), [GO:1905431](http://purl.obolibrary.org/obo/GO_1905431) (microcystin transport), [GO:0038028](http://purl.obolibrary.org/obo/GO_0038028) (insulin receptor signaling pathway via phosphatidylinositol 3-kinase), [GO:0002090](http://purl.obolibrary.org/obo/GO_0002090) (regulation of receptor internalization), [GO:0002091](http://purl.obolibrary.org/obo/GO_0002091) (negative regulation of receptor internalization), [GO:0002092](http://purl.obolibrary.org/obo/GO_0002092) (positive regulation of receptor internalization), [GO:0038021](http://purl.obolibrary.org/obo/GO_0038021) (leptin receptor activity), [GO:0002093](http://purl.obolibrary.org/obo/GO_0002093) (auditory receptor cell morphogenesis), [GO:1904106](http://purl.obolibrary.org/obo/GO_1904106) (protein localization to microvillus), [GO:0014070](http://purl.obolibrary.org/obo/GO_0014070) (response to organic cyclic compound), [GO:0002098](http://purl.obolibrary.org/obo/GO_0002098) (tRNA wobble uridine modification), [GO:1904109](http://purl.obolibrary.org/obo/GO_1904109) (positive regulation of cholesterol import), [GO:0051015](http://purl.obolibrary.org/obo/GO_0051015) (actin filament binding), [GO:0051016](http://purl.obolibrary.org/obo/GO_0051016) (barbed-end actin filament capping), [GO:0051014](http://purl.obolibrary.org/obo/GO_0051014) (actin filament severing), [GO:0051019](http://purl.obolibrary.org/obo/GO_0051019) (mitogen-activated protein kinase binding), [GO:0038018](http://purl.obolibrary.org/obo/GO_0038018) (Wnt receptor catabolic process), [GO:0051017](http://purl.obolibrary.org/obo/GO_0051017) (actin filament bundle assembly), [GO:0051018](http://purl.obolibrary.org/obo/GO_0051018) (protein kinase A binding), [GO:0015379](http://purl.obolibrary.org/obo/GO_0015379) (potassium:chloride symporter activity), [GO:0014047](http://purl.obolibrary.org/obo/GO_0014047) (glutamate secretion), [GO:0015378](http://purl.obolibrary.org/obo/GO_0015378) (sodium:chloride symporter activity), [GO:0015377](http://purl.obolibrary.org/obo/GO_0015377) (cation:chloride symporter activity), [GO:0014045](http://purl.obolibrary.org/obo/GO_0014045) (establishment of endothelial blood-brain barrier), [GO:0038016](http://purl.obolibrary.org/obo/GO_0038016) (insulin receptor internalization), [GO:0015375](http://purl.obolibrary.org/obo/GO_0015375) (glycine:sodium symporter activity), [GO:1904115](http://purl.obolibrary.org/obo/GO_1904115) (axon cytoplasm), [GO:0014044](http://purl.obolibrary.org/obo/GO_0014044) (Schwann cell development), [GO:0014043](http://purl.obolibrary.org/obo/GO_0014043) (negative regulation of neuron maturation), [GO:0014042](http://purl.obolibrary.org/obo/GO_0014042) (positive regulation of neuron maturation), [GO:0002060](http://purl.obolibrary.org/obo/GO_0002060) (purine nucleobase binding), [GO:0002062](http://purl.obolibrary.org/obo/GO_0002062) (chondrocyte differentiation), [GO:0002063](http://purl.obolibrary.org/obo/GO_0002063) (chondrocyte development), [GO:0002064](http://purl.obolibrary.org/obo/GO_0002064) (epithelial cell development), [GO:1904117](http://purl.obolibrary.org/obo/GO_1904117) (cellular response to vasopressin), [GO:1990030](http://purl.obolibrary.org/obo/GO_1990030) (pericellular basket), [GO:0002067](http://purl.obolibrary.org/obo/GO_0002067) (glandular epithelial cell differentiation), [GO:0051026](http://purl.obolibrary.org/obo/GO_0051026) (chiasma assembly), [GO:1990023](http://purl.obolibrary.org/obo/GO_1990023) (mitotic spindle midzone), [GO:0002059](http://purl.obolibrary.org/obo/GO_0002059) (thymine binding), [GO:0051024](http://purl.obolibrary.org/obo/GO_0051024) (positive regulation of immunoglobulin secretion), [GO:0051022](http://purl.obolibrary.org/obo/GO_0051022) (Rho GDP-dissociation inhibitor binding), [GO:0051023](http://purl.obolibrary.org/obo/GO_0051023) (regulation of immunoglobulin secretion), [GO:1990029](http://purl.obolibrary.org/obo/GO_1990029) (vasomotion), [GO:0051020](http://purl.obolibrary.org/obo/GO_0051020) (GTPase binding), [GO:0051028](http://purl.obolibrary.org/obo/GO_0051028) (mRNA transport), [GO:0015369](http://purl.obolibrary.org/obo/GO_0015369) (calcium:proton antiporter activity), [GO:0014059](http://purl.obolibrary.org/obo/GO_0014059) (regulation of dopamine secretion), [GO:1904121](http://purl.obolibrary.org/obo/GO_1904121) (phosphatidylethanolamine transporter activity), [GO:0014056](http://purl.obolibrary.org/obo/GO_0014056) (regulation of acetylcholine secretion, neurotransmission), [GO:0015386](http://purl.obolibrary.org/obo/GO_0015386) (potassium:proton antiporter activity), [GO:0002070](http://purl.obolibrary.org/obo/GO_0002070) (epithelial cell maturation), [GO:0015385](http://purl.obolibrary.org/obo/GO_0015385) (sodium:proton antiporter activity), [GO:0038002](http://purl.obolibrary.org/obo/GO_0038002) (endocrine signaling), [GO:0038001](http://purl.obolibrary.org/obo/GO_0038001) (paracrine signaling), [GO:0002072](http://purl.obolibrary.org/obo/GO_0002072) (optic cup morphogenesis involved in camera-type eye development), [GO:0014051](http://purl.obolibrary.org/obo/GO_0014051) (gamma-aminobutyric acid secretion), [GO:0002074](http://purl.obolibrary.org/obo/GO_0002074) (extraocular skeletal muscle development), [GO:0002076](http://purl.obolibrary.org/obo/GO_0002076) (osteoblast development), [GO:1990042](http://purl.obolibrary.org/obo/GO_1990042) (glycerol dehydrogenase [NAD(P)+] activity), [GO:0030990](http://purl.obolibrary.org/obo/GO_0030990) (intraciliary transport particle), [GO:0030992](http://purl.obolibrary.org/obo/GO_0030992) (intraciliary transport particle B), [GO:0030991](http://purl.obolibrary.org/obo/GO_0030991) (intraciliary transport particle A), [GO:0090606](http://purl.obolibrary.org/obo/GO_0090606) (single-species surface biofilm formation), [GO:0042976](http://purl.obolibrary.org/obo/GO_0042976) (activation of Janus kinase activity), [GO:1990051](http://purl.obolibrary.org/obo/GO_1990051) (activation of protein kinase C activity), [GO:0042974](http://purl.obolibrary.org/obo/GO_0042974) (retinoic acid receptor binding), [GO:0042975](http://purl.obolibrary.org/obo/GO_0042975) (peroxisome proliferator activated receptor binding), [GO:0042987](http://purl.obolibrary.org/obo/GO_0042987) (amyloid precursor protein catabolic process), [GO:0042989](http://purl.obolibrary.org/obo/GO_0042989) (sequestering of actin monomers), [GO:0038066](http://purl.obolibrary.org/obo/GO_0038066) (p38MAPK cascade), [GO:0038061](http://purl.obolibrary.org/obo/GO_0038061) (NIK/NF-kappaB signaling), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0038063](http://purl.obolibrary.org/obo/GO_0038063) (collagen-activated tyrosine kinase receptor signaling pathway), [GO:0042982](http://purl.obolibrary.org/obo/GO_0042982) (amyloid precursor protein metabolic process), [GO:0042985](http://purl.obolibrary.org/obo/GO_0042985) (negative regulation of amyloid precursor protein biosynthetic process), [GO:0070195](http://purl.obolibrary.org/obo/GO_0070195) (growth hormone receptor complex), [GO:0010508](http://purl.obolibrary.org/obo/GO_0010508) (positive regulation of autophagy), [GO:0070193](http://purl.obolibrary.org/obo/GO_0070193) (synaptonemal complex organization), [GO:0010507](http://purl.obolibrary.org/obo/GO_0010507) (negative regulation of autophagy), [GO:0070197](http://purl.obolibrary.org/obo/GO_0070197) (meiotic attachment of telomere to nuclear envelope), [GO:0010506](http://purl.obolibrary.org/obo/GO_0010506) (regulation of autophagy), [GO:0070198](http://purl.obolibrary.org/obo/GO_0070198) (protein localization to chromosome, telomeric region), [GO:0010501](http://purl.obolibrary.org/obo/GO_0010501) (RNA secondary structure unwinding), [GO:1990070](http://purl.obolibrary.org/obo/GO_1990070) (TRAPPI protein complex), [GO:1990071](http://purl.obolibrary.org/obo/GO_1990071) (TRAPPII protein complex), [GO:1990072](http://purl.obolibrary.org/obo/GO_1990072) (TRAPPIII protein complex), [GO:0042992](http://purl.obolibrary.org/obo/GO_0042992) (negative regulation of transcription factor import into nucleus), [GO:0042993](http://purl.obolibrary.org/obo/GO_0042993) (positive regulation of transcription factor import into nucleus), [GO:0038052](http://purl.obolibrary.org/obo/GO_0038052) (RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding), [GO:0042994](http://purl.obolibrary.org/obo/GO_0042994) (cytoplasmic sequestering of transcription factor), [GO:1990074](http://purl.obolibrary.org/obo/GO_1990074) (polyuridylation-dependent mRNA catabolic process), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:1990075](http://purl.obolibrary.org/obo/GO_1990075) (periciliary membrane compartment), [GO:0038044](http://purl.obolibrary.org/obo/GO_0038044) (transforming growth factor-beta secretion), [GO:0038042](http://purl.obolibrary.org/obo/GO_0038042) (dimeric G-protein coupled receptor signaling pathway), [GO:0047708](http://purl.obolibrary.org/obo/GO_0047708) (biotinidase activity), [GO:0090575](http://purl.obolibrary.org/obo/GO_0090575) (RNA polymerase II transcription factor complex), [GO:0022408](http://purl.obolibrary.org/obo/GO_0022408) (negative regulation of cell-cell adhesion), [GO:0022409](http://purl.obolibrary.org/obo/GO_0022409) (positive regulation of cell-cell adhesion), [GO:0008104](http://purl.obolibrary.org/obo/GO_0008104) (protein localization), [GO:0009435](http://purl.obolibrary.org/obo/GO_0009435) (NAD biosynthetic process), [GO:0008108](http://purl.obolibrary.org/obo/GO_0008108) (UDP-glucose:hexose-1-phosphate uridylyltransferase activity), [GO:0009437](http://purl.obolibrary.org/obo/GO_0009437) (carnitine metabolic process), [GO:0022400](http://purl.obolibrary.org/obo/GO_0022400) (regulation of rhodopsin mediated signaling pathway), [GO:0009436](http://purl.obolibrary.org/obo/GO_0009436) (glyoxylate catabolic process), [GO:0035716](http://purl.obolibrary.org/obo/GO_0035716) (chemokine (C-C motif) ligand 12 binding), [GO:0035717](http://purl.obolibrary.org/obo/GO_0035717) (chemokine (C-C motif) ligand 7 binding), [GO:0035712](http://purl.obolibrary.org/obo/GO_0035712) (T-helper 2 cell activation), [GO:0035713](http://purl.obolibrary.org/obo/GO_0035713) (response to nitrogen dioxide), [GO:0035714](http://purl.obolibrary.org/obo/GO_0035714) (cellular response to nitrogen dioxide), [GO:0035715](http://purl.obolibrary.org/obo/GO_0035715) (chemokine (C-C motif) ligand 2 binding), [GO:0008113](http://purl.obolibrary.org/obo/GO_0008113) (peptide-methionine (S)-S-oxide reductase activity), [GO:0009443](http://purl.obolibrary.org/obo/GO_0009443) (pyridoxal 5'-phosphate salvage), [GO:0008119](http://purl.obolibrary.org/obo/GO_0008119) (thiopurine S-methyltransferase activity), [GO:0009448](http://purl.obolibrary.org/obo/GO_0009448) (gamma-aminobutyric acid metabolic process), [GO:0035709](http://purl.obolibrary.org/obo/GO_0035709) (memory T cell activation), [GO:0035705](http://purl.obolibrary.org/obo/GO_0035705) (T-helper 17 cell chemotaxis), [GO:0010424](http://purl.obolibrary.org/obo/GO_0010424) (DNA methylation on cytosine within a CG sequence), [GO:0035701](http://purl.obolibrary.org/obo/GO_0035701) (hematopoietic stem cell migration), [GO:1904060](http://purl.obolibrary.org/obo/GO_1904060) (negative regulation of locomotor rhythm), [GO:0090557](http://purl.obolibrary.org/obo/GO_0090557) (establishment of endothelial intestinal barrier), [GO:0090555](http://purl.obolibrary.org/obo/GO_0090555) (phosphatidylethanolamine-translocating ATPase activity), [GO:0090554](http://purl.obolibrary.org/obo/GO_0090554) (phosphatidylcholine-translocating ATPase activity), [GO:0009411](http://purl.obolibrary.org/obo/GO_0009411) (response to UV), [GO:0009410](http://purl.obolibrary.org/obo/GO_0009410) (response to xenobiotic stimulus), [GO:0060704](http://purl.obolibrary.org/obo/GO_0060704) (acinar cell differentiation involved in salivary gland development), [GO:1901800](http://purl.obolibrary.org/obo/GO_1901800) (positive regulation of proteasomal protein catabolic process), [GO:0009416](http://purl.obolibrary.org/obo/GO_0009416) (response to light stimulus), [GO:0047726](http://purl.obolibrary.org/obo/GO_0047726) (iron-cytochrome-c reductase activity), [GO:0047724](http://purl.obolibrary.org/obo/GO_0047724) (inosine nucleosidase activity), [GO:0060709](http://purl.obolibrary.org/obo/GO_0060709) (glycogen cell differentiation involved in embryonic placenta development), [GO:0009409](http://purl.obolibrary.org/obo/GO_0009409) (response to cold), [GO:0009408](http://purl.obolibrary.org/obo/GO_0009408) (response to heat), [GO:0060706](http://purl.obolibrary.org/obo/GO_0060706) (cell differentiation involved in embryonic placenta development), [GO:0060707](http://purl.obolibrary.org/obo/GO_0060707) (trophoblast giant cell differentiation), [GO:0090559](http://purl.obolibrary.org/obo/GO_0090559) (regulation of membrane permeability), [GO:1904086](http://purl.obolibrary.org/obo/GO_1904086) (regulation of epiboly involved in gastrulation with mouth forming second), [GO:0046403](http://purl.obolibrary.org/obo/GO_0046403) (polynucleotide 3'-phosphatase activity), [GO:1901810](http://purl.obolibrary.org/obo/GO_1901810) (beta-carotene metabolic process), [GO:0046404](http://purl.obolibrary.org/obo/GO_0046404) (ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity), [GO:1901805](http://purl.obolibrary.org/obo/GO_1901805) (beta-glucoside catabolic process), [GO:0010460](http://purl.obolibrary.org/obo/GO_0010460) (positive regulation of heart rate), [GO:0008140](http://purl.obolibrary.org/obo/GO_0008140) (cAMP response element binding protein binding), [GO:0090533](http://purl.obolibrary.org/obo/GO_0090533) (cation-transporting ATPase complex), [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding), [GO:0033100](http://purl.obolibrary.org/obo/GO_0033100) (NuA3 histone acetyltransferase complex), [GO:0008143](http://purl.obolibrary.org/obo/GO_0008143) (poly(A) binding), [GO:0008142](http://purl.obolibrary.org/obo/GO_0008142) (oxysterol binding), [GO:0008146](http://purl.obolibrary.org/obo/GO_0008146) (sulfotransferase activity), [GO:0034421](http://purl.obolibrary.org/obo/GO_0034421) (post-translational protein acetylation), [GO:0010458](http://purl.obolibrary.org/obo/GO_0010458) (exit from mitosis), [GO:0035753](http://purl.obolibrary.org/obo/GO_0035753) (maintenance of DNA trinucleotide repeats), [GO:0034427](http://purl.obolibrary.org/obo/GO_0034427) (nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'), [GO:0010452](http://purl.obolibrary.org/obo/GO_0010452) (histone H3-K36 methylation), [GO:0035754](http://purl.obolibrary.org/obo/GO_0035754) (B cell chemotaxis), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0010470](http://purl.obolibrary.org/obo/GO_0010470) (regulation of gastrulation), [GO:1904021](http://purl.obolibrary.org/obo/GO_1904021) (negative regulation of G-protein coupled receptor internalization), [GO:0035751](http://purl.obolibrary.org/obo/GO_0035751) (regulation of lysosomal lumen pH), [GO:0008154](http://purl.obolibrary.org/obo/GO_0008154) (actin polymerization or depolymerization), [GO:0090543](http://purl.obolibrary.org/obo/GO_0090543) (Flemming body), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0008158](http://purl.obolibrary.org/obo/GO_0008158) (hedgehog receptor activity), [GO:0008156](http://purl.obolibrary.org/obo/GO_0008156) (negative regulation of DNA replication), [GO:0034418](http://purl.obolibrary.org/obo/GO_0034418) (urate biosynthetic process), [GO:0035749](http://purl.obolibrary.org/obo/GO_0035749) (myelin sheath adaxonal region), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0035745](http://purl.obolibrary.org/obo/GO_0035745) (T-helper 2 cell cytokine production), [GO:0010467](http://purl.obolibrary.org/obo/GO_0010467) (gene expression), [GO:0035748](http://purl.obolibrary.org/obo/GO_0035748) (myelin sheath abaxonal region), [GO:0010469](http://purl.obolibrary.org/obo/GO_0010469) (regulation of receptor activity), [GO:0010464](http://purl.obolibrary.org/obo/GO_0010464) (regulation of mesenchymal cell proliferation), [GO:0010463](http://purl.obolibrary.org/obo/GO_0010463) (mesenchymal cell proliferation), [GO:0010466](http://purl.obolibrary.org/obo/GO_0010466) (negative regulation of peptidase activity), [GO:0034414](http://purl.obolibrary.org/obo/GO_0034414) (tRNA 3'-trailer cleavage, endonucleolytic), [GO:0010465](http://purl.obolibrary.org/obo/GO_0010465) (nerve growth factor receptor activity), [GO:0008121](http://purl.obolibrary.org/obo/GO_0008121) (ubiquinol-cytochrome-c reductase activity), [GO:1904036](http://purl.obolibrary.org/obo/GO_1904036) (negative regulation of epithelial cell apoptotic process), [GO:0009451](http://purl.obolibrary.org/obo/GO_0009451) (RNA modification), [GO:0009450](http://purl.obolibrary.org/obo/GO_0009450) (gamma-aminobutyric acid catabolic process), [GO:0008124](http://purl.obolibrary.org/obo/GO_0008124) (4-alpha-hydroxytetrahydrobiopterin dehydratase activity), [GO:0008127](http://purl.obolibrary.org/obo/GO_0008127) (quercetin 2,3-dioxygenase activity), [GO:0035735](http://purl.obolibrary.org/obo/GO_0035735) (intraciliary transport involved in cilium assembly), [GO:1904030](http://purl.obolibrary.org/obo/GO_1904030) (negative regulation of cyclin-dependent protein kinase activity), [GO:0034405](http://purl.obolibrary.org/obo/GO_0034405) (response to fluid shear stress), [GO:1904042](http://purl.obolibrary.org/obo/GO_1904042) (negative regulation of cystathionine beta-synthase activity), [GO:0090521](http://purl.obolibrary.org/obo/GO_0090521) (glomerular visceral epithelial cell migration), [GO:0008131](http://purl.obolibrary.org/obo/GO_0008131) (primary amine oxidase activity), [GO:1904047](http://purl.obolibrary.org/obo/GO_1904047) (S-adenosyl-L-methionine binding), [GO:0008137](http://purl.obolibrary.org/obo/GO_0008137) (NADH dehydrogenase (ubiquinone) activity), [GO:0022414](http://purl.obolibrary.org/obo/GO_0022414) (reproductive process), [GO:0008135](http://purl.obolibrary.org/obo/GO_0008135) (translation factor activity, RNA binding), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0008139](http://purl.obolibrary.org/obo/GO_0008139) (nuclear localization sequence binding), [GO:0008138](http://purl.obolibrary.org/obo/GO_0008138) (protein tyrosine/serine/threonine phosphatase activity), [GO:1990000](http://purl.obolibrary.org/obo/GO_1990000) (amyloid fibril formation), [GO:0035729](http://purl.obolibrary.org/obo/GO_0035729) (cellular response to hepatocyte growth factor stimulus), [GO:0035723](http://purl.obolibrary.org/obo/GO_0035723) (interleukin-15-mediated signaling pathway), [GO:0035725](http://purl.obolibrary.org/obo/GO_0035725) (sodium ion transmembrane transport), [GO:0010447](http://purl.obolibrary.org/obo/GO_0010447) (response to acidic pH), [GO:0035720](http://purl.obolibrary.org/obo/GO_0035720) (intraciliary anterograde transport), [GO:0035721](http://purl.obolibrary.org/obo/GO_0035721) (intraciliary retrograde transport), [GO:1905370](http://purl.obolibrary.org/obo/GO_1905370) (serine-type endopeptidase complex), [GO:0035722](http://purl.obolibrary.org/obo/GO_0035722) (interleukin-12-mediated signaling pathway), [GO:0008184](http://purl.obolibrary.org/obo/GO_0008184) (glycogen phosphorylase activity), [GO:0060760](http://purl.obolibrary.org/obo/GO_0060760) (positive regulation of response to cytokine stimulus), [GO:0033144](http://purl.obolibrary.org/obo/GO_0033144) (negative regulation of intracellular steroid hormone receptor signaling pathway), [GO:0034475](http://purl.obolibrary.org/obo/GO_0034475) (U4 snRNA 3'-end processing), [GO:0008188](http://purl.obolibrary.org/obo/GO_0008188) (neuropeptide receptor activity), [GO:0008187](http://purl.obolibrary.org/obo/GO_0008187) (poly-pyrimidine tract binding), [GO:0034473](http://purl.obolibrary.org/obo/GO_0034473) (U1 snRNA 3'-end processing), [GO:0008186](http://purl.obolibrary.org/obo/GO_0008186) (RNA-dependent ATPase activity), [GO:0033141](http://purl.obolibrary.org/obo/GO_0033141) (positive regulation of peptidyl-serine phosphorylation of STAT protein), [GO:0034472](http://purl.obolibrary.org/obo/GO_0034472) (snRNA 3'-end processing), [GO:0047787](http://purl.obolibrary.org/obo/GO_0047787) (delta4-3-oxosteroid 5beta-reductase activity), [GO:0045124](http://purl.obolibrary.org/obo/GO_0045124) (regulation of bone resorption), [GO:0045128](http://purl.obolibrary.org/obo/GO_0045128) (negative regulation of reciprocal meiotic recombination), [GO:0046459](http://purl.obolibrary.org/obo/GO_0046459) (short-chain fatty acid metabolic process), [GO:0046461](http://purl.obolibrary.org/obo/GO_0046461) (neutral lipid catabolic process), [GO:0005901](http://purl.obolibrary.org/obo/GO_0005901) (caveola), [GO:0005903](http://purl.obolibrary.org/obo/GO_0005903) (brush border), [GO:0046464](http://purl.obolibrary.org/obo/GO_0046464) (acylglycerol catabolic process), [GO:0005902](http://purl.obolibrary.org/obo/GO_0005902) (microvillus), [GO:0045134](http://purl.obolibrary.org/obo/GO_0045134) (uridine-diphosphatase activity), [GO:0005905](http://purl.obolibrary.org/obo/GO_0005905) (clathrin-coated pit), [GO:0045132](http://purl.obolibrary.org/obo/GO_0045132) (meiotic chromosome segregation), [GO:0033135](http://purl.obolibrary.org/obo/GO_0033135) (regulation of peptidyl-serine phosphorylation), [GO:0008180](http://purl.obolibrary.org/obo/GO_0008180) (COP9 signalosome), [GO:0010499](http://purl.obolibrary.org/obo/GO_0010499) (proteasomal ubiquitin-independent protein catabolic process), [GO:0033138](http://purl.obolibrary.org/obo/GO_0033138) (positive regulation of peptidyl-serine phosphorylation), [GO:0035799](http://purl.obolibrary.org/obo/GO_0035799) (ureter maturation), [GO:0010498](http://purl.obolibrary.org/obo/GO_0010498) (proteasomal protein catabolic process), [GO:0008195](http://purl.obolibrary.org/obo/GO_0008195) (phosphatidate phosphatase activity), [GO:0035793](http://purl.obolibrary.org/obo/GO_0035793) (positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway), [GO:0060750](http://purl.obolibrary.org/obo/GO_0060750) (epithelial cell proliferation involved in mammary gland duct elongation), [GO:0035794](http://purl.obolibrary.org/obo/GO_0035794) (positive regulation of mitochondrial membrane permeability), [GO:0008199](http://purl.obolibrary.org/obo/GO_0008199) (ferric iron binding), [GO:0034464](http://purl.obolibrary.org/obo/GO_0034464) (BBSome), [GO:0008198](http://purl.obolibrary.org/obo/GO_0008198) (ferrous iron binding), [GO:0035791](http://purl.obolibrary.org/obo/GO_0035791) (platelet-derived growth factor receptor-beta signaling pathway), [GO:0033130](http://purl.obolibrary.org/obo/GO_0033130) (acetylcholine receptor binding), [GO:0046469](http://purl.obolibrary.org/obo/GO_0046469) (platelet activating factor metabolic process), [GO:0046466](http://purl.obolibrary.org/obo/GO_0046466) (membrane lipid catabolic process), [GO:0045136](http://purl.obolibrary.org/obo/GO_0045136) (development of secondary sexual characteristics), [GO:0060754](http://purl.obolibrary.org/obo/GO_0060754) (positive regulation of mast cell chemotaxis), [GO:0046471](http://purl.obolibrary.org/obo/GO_0046471) (phosphatidylglycerol metabolic process), [GO:0045141](http://purl.obolibrary.org/obo/GO_0045141) (meiotic telomere clustering), [GO:0005912](http://purl.obolibrary.org/obo/GO_0005912) (adherens junction), [GO:0005911](http://purl.obolibrary.org/obo/GO_0005911) (cell-cell junction), [GO:0046470](http://purl.obolibrary.org/obo/GO_0046470) (phosphatidylcholine metabolic process), [GO:0046475](http://purl.obolibrary.org/obo/GO_0046475) (glycerophospholipid catabolic process), [GO:0045144](http://purl.obolibrary.org/obo/GO_0045144) (meiotic sister chromatid segregation), [GO:0005913](http://purl.obolibrary.org/obo/GO_0005913) (cell-cell adherens junction), [GO:0046473](http://purl.obolibrary.org/obo/GO_0046473) (phosphatidic acid metabolic process), [GO:0005916](http://purl.obolibrary.org/obo/GO_0005916) (fascia adherens), [GO:0046474](http://purl.obolibrary.org/obo/GO_0046474) (glycerophospholipid biosynthetic process), [GO:0045143](http://purl.obolibrary.org/obo/GO_0045143) (homologous chromosome segregation), [GO:0034456](http://purl.obolibrary.org/obo/GO_0034456) (UTP-C complex), [GO:0071400](http://purl.obolibrary.org/obo/GO_0071400) (cellular response to oleic acid), [GO:0034455](http://purl.obolibrary.org/obo/GO_0034455) (t-UTP complex), [GO:0034454](http://purl.obolibrary.org/obo/GO_0034454) (microtubule anchoring at centrosome), [GO:0071406](http://purl.obolibrary.org/obo/GO_0071406) (cellular response to methylmercury), [GO:0008191](http://purl.obolibrary.org/obo/GO_0008191) (metalloendopeptidase inhibitor activity), [GO:0071407](http://purl.obolibrary.org/obo/GO_0071407) (cellular response to organic cyclic compound), [GO:0033128](http://purl.obolibrary.org/obo/GO_0033128) (negative regulation of histone phosphorylation), [GO:0071404](http://purl.obolibrary.org/obo/GO_0071404) (cellular response to low-density lipoprotein particle stimulus), [GO:0071405](http://purl.obolibrary.org/obo/GO_0071405) (cellular response to methanol), [GO:0010482](http://purl.obolibrary.org/obo/GO_0010482) (regulation of epidermal cell division), [GO:0010481](http://purl.obolibrary.org/obo/GO_0010481) (epidermal cell division), [GO:0010484](http://purl.obolibrary.org/obo/GO_0010484) (H3 histone acetyltransferase activity), [GO:0035783](http://purl.obolibrary.org/obo/GO_0035783) (CD4-positive, alpha-beta T cell costimulation), [GO:0034453](http://purl.obolibrary.org/obo/GO_0034453) (microtubule anchoring), [GO:0034452](http://purl.obolibrary.org/obo/GO_0034452) (dynactin binding), [GO:0034451](http://purl.obolibrary.org/obo/GO_0034451) (centriolar satellite), [GO:0033120](http://purl.obolibrary.org/obo/GO_0033120) (positive regulation of RNA splicing), [GO:0060789](http://purl.obolibrary.org/obo/GO_0060789) (hair follicle placode formation), [GO:0008168](http://purl.obolibrary.org/obo/GO_0008168) (methyltransferase activity), [GO:0046477](http://purl.obolibrary.org/obo/GO_0046477) (glycosylceramide catabolic process), [GO:0060788](http://purl.obolibrary.org/obo/GO_0060788) (ectodermal placode formation), [GO:0045155](http://purl.obolibrary.org/obo/GO_0045155) (electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity), [GO:0046486](http://purl.obolibrary.org/obo/GO_0046486) (glycerolipid metabolic process), [GO:0046487](http://purl.obolibrary.org/obo/GO_0046487) (glyoxylate metabolic process), [GO:0071432](http://purl.obolibrary.org/obo/GO_0071432) (peptide mating pheromone maturation involved in conjugation with cellular fusion), [GO:0045153](http://purl.obolibrary.org/obo/GO_0045153) (electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity), [GO:0034446](http://purl.obolibrary.org/obo/GO_0034446) (substrate adhesion-dependent cell spreading), [GO:0071435](http://purl.obolibrary.org/obo/GO_0071435) (potassium ion export), [GO:0071433](http://purl.obolibrary.org/obo/GO_0071433) (cell wall repair), [GO:0070102](http://purl.obolibrary.org/obo/GO_0070102) (interleukin-6-mediated signaling pathway), [GO:0035774](http://purl.obolibrary.org/obo/GO_0035774) (positive regulation of insulin secretion involved in cellular response to glucose stimulus), [GO:0071439](http://purl.obolibrary.org/obo/GO_0071439) (clathrin complex), [GO:0033119](http://purl.obolibrary.org/obo/GO_0033119) (negative regulation of RNA splicing), [GO:0035775](http://purl.obolibrary.org/obo/GO_0035775) (pronephric glomerulus morphogenesis), [GO:0035776](http://purl.obolibrary.org/obo/GO_0035776) (pronephric proximal tubule development), [GO:0071438](http://purl.obolibrary.org/obo/GO_0071438) (invadopodium membrane), [GO:0035777](http://purl.obolibrary.org/obo/GO_0035777) (pronephric distal tubule development), [GO:0033116](http://purl.obolibrary.org/obo/GO_0033116) (endoplasmic reticulum-Golgi intermediate compartment membrane), [GO:0060770](http://purl.obolibrary.org/obo/GO_0060770) (negative regulation of epithelial cell proliferation involved in prostate gland development), [GO:0035770](http://purl.obolibrary.org/obo/GO_0035770) (ribonucleoprotein granule), [GO:0035771](http://purl.obolibrary.org/obo/GO_0035771) (interleukin-4-mediated signaling pathway), [GO:0008171](http://purl.obolibrary.org/obo/GO_0008171) (O-methyltransferase activity), [GO:0010494](http://purl.obolibrary.org/obo/GO_0010494) (cytoplasmic stress granule), [GO:0008170](http://purl.obolibrary.org/obo/GO_0008170) (N-methyltransferase activity), [GO:0008177](http://purl.obolibrary.org/obo/GO_0008177) (succinate dehydrogenase (ubiquinone) activity), [GO:0034441](http://purl.obolibrary.org/obo/GO_0034441) (plasma lipoprotein particle oxidation), [GO:0034440](http://purl.obolibrary.org/obo/GO_0034440) (lipid oxidation), [GO:0046488](http://purl.obolibrary.org/obo/GO_0046488) (phosphatidylinositol metabolic process), [GO:1901897](http://purl.obolibrary.org/obo/GO_1901897) (regulation of relaxation of cardiac muscle), [GO:0008179](http://purl.obolibrary.org/obo/GO_0008179) (adenylate cyclase binding), [GO:0045162](http://purl.obolibrary.org/obo/GO_0045162) (clustering of voltage-gated sodium channels), [GO:0046491](http://purl.obolibrary.org/obo/GO_0046491) (L-methylmalonyl-CoA metabolic process), [GO:0071420](http://purl.obolibrary.org/obo/GO_0071420) (cellular response to histamine), [GO:0046498](http://purl.obolibrary.org/obo/GO_0046498) (S-adenosylhomocysteine metabolic process), [GO:0071421](http://purl.obolibrary.org/obo/GO_0071421) (manganese ion transmembrane transport), [GO:0045165](http://purl.obolibrary.org/obo/GO_0045165) (cell fate commitment), [GO:0046496](http://purl.obolibrary.org/obo/GO_0046496) (nicotinamide nucleotide metabolic process), [GO:0034435](http://purl.obolibrary.org/obo/GO_0034435) (cholesterol esterification), [GO:0035767](http://purl.obolibrary.org/obo/GO_0035767) (endothelial cell chemotaxis), [GO:0071425](http://purl.obolibrary.org/obo/GO_0071425) (hematopoietic stem cell proliferation), [GO:0033101](http://purl.obolibrary.org/obo/GO_0033101) (cellular bud membrane), [GO:0033108](http://purl.obolibrary.org/obo/GO_0033108) (mitochondrial respiratory chain complex assembly), [GO:0010485](http://purl.obolibrary.org/obo/GO_0010485) (H4 histone acetyltransferase activity), [GO:0071426](http://purl.obolibrary.org/obo/GO_0071426) (ribonucleoprotein complex export from nucleus), [GO:0072757](http://purl.obolibrary.org/obo/GO_0072757) (cellular response to camptothecin), [GO:0016601](http://purl.obolibrary.org/obo/GO_0016601) (Rac protein signal transduction), [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0016605](http://purl.obolibrary.org/obo/GO_0016605) (PML body), [GO:0016607](http://purl.obolibrary.org/obo/GO_0016607) (nuclear speck), [GO:0033185](http://purl.obolibrary.org/obo/GO_0033185) (dolichol-phosphate-mannose synthase complex), [GO:0033180](http://purl.obolibrary.org/obo/GO_0033180) (proton-transporting V-type ATPase, V1 domain), [GO:0046415](http://purl.obolibrary.org/obo/GO_0046415) (urate metabolic process), [GO:0005952](http://purl.obolibrary.org/obo/GO_0005952) (cAMP-dependent protein kinase complex), [GO:0004620](http://purl.obolibrary.org/obo/GO_0004620) (phospholipase activity), [GO:0005943](http://purl.obolibrary.org/obo/GO_0005943) (phosphatidylinositol 3-kinase complex, class IA), [GO:0005942](http://purl.obolibrary.org/obo/GO_0005942) (phosphatidylinositol 3-kinase complex), [GO:0004611](http://purl.obolibrary.org/obo/GO_0004611) (phosphoenolpyruvate carboxykinase activity), [GO:0030901](http://purl.obolibrary.org/obo/GO_0030901) (midbrain development), [GO:0004614](http://purl.obolibrary.org/obo/GO_0004614) (phosphoglucomutase activity), [GO:0005945](http://purl.obolibrary.org/obo/GO_0005945) (6-phosphofructokinase complex), [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development), [GO:0005944](http://purl.obolibrary.org/obo/GO_0005944) (phosphatidylinositol 3-kinase complex, class IB), [GO:0004613](http://purl.obolibrary.org/obo/GO_0004613) (phosphoenolpyruvate carboxykinase (GTP) activity), [GO:0030903](http://purl.obolibrary.org/obo/GO_0030903) (notochord development), [GO:0005947](http://purl.obolibrary.org/obo/GO_0005947) (mitochondrial alpha-ketoglutarate dehydrogenase complex), [GO:0030902](http://purl.obolibrary.org/obo/GO_0030902) (hindbrain development), [GO:0047751](http://purl.obolibrary.org/obo/GO_0047751) (cholestenone 5-alpha-reductase activity), [GO:0004615](http://purl.obolibrary.org/obo/GO_0004615) (phosphomannomutase activity), [GO:0060729](http://purl.obolibrary.org/obo/GO_0060729) (intestinal epithelial structure maintenance), [GO:0047750](http://purl.obolibrary.org/obo/GO_0047750) (cholestenol delta-isomerase activity), [GO:0004618](http://purl.obolibrary.org/obo/GO_0004618) (phosphoglycerate kinase activity), [GO:0030904](http://purl.obolibrary.org/obo/GO_0030904) (retromer complex), [GO:0004617](http://purl.obolibrary.org/obo/GO_0004617) (phosphoglycerate dehydrogenase activity), [GO:0004619](http://purl.obolibrary.org/obo/GO_0004619) (phosphoglycerate mutase activity), [GO:0033179](http://purl.obolibrary.org/obo/GO_0033179) (proton-transporting V-type ATPase, V0 domain), [GO:0060715](http://purl.obolibrary.org/obo/GO_0060715) (syncytiotrophoblast cell differentiation involved in labyrinthine layer development), [GO:0004630](http://purl.obolibrary.org/obo/GO_0004630) (phospholipase D activity), [GO:0005960](http://purl.obolibrary.org/obo/GO_0005960) (glycine cleavage complex), [GO:0046426](http://purl.obolibrary.org/obo/GO_0046426) (negative regulation of JAK-STAT cascade), [GO:0003300](http://purl.obolibrary.org/obo/GO_0003300) (cardiac muscle hypertrophy), [GO:0060710](http://purl.obolibrary.org/obo/GO_0060710) (chorio-allantoic fusion), [GO:0047757](http://purl.obolibrary.org/obo/GO_0047757) (chondroitin-glucuronate 5-epimerase activity), [GO:0046427](http://purl.obolibrary.org/obo/GO_0046427) (positive regulation of JAK-STAT cascade), [GO:0060711](http://purl.obolibrary.org/obo/GO_0060711) (labyrinthine layer development), [GO:0003301](http://purl.obolibrary.org/obo/GO_0003301) (physiological cardiac muscle hypertrophy), [GO:0004623](http://purl.obolibrary.org/obo/GO_0004623) (phospholipase A2 activity), [GO:0004622](http://purl.obolibrary.org/obo/GO_0004622) (lysophospholipase activity), [GO:0005956](http://purl.obolibrary.org/obo/GO_0005956) (protein kinase CK2 complex), [GO:0005955](http://purl.obolibrary.org/obo/GO_0005955) (calcineurin complex), [GO:0060716](http://purl.obolibrary.org/obo/GO_0060716) (labyrinthine layer blood vessel development), [GO:0005958](http://purl.obolibrary.org/obo/GO_0005958) (DNA-dependent protein kinase-DNA ligase 4 complex), [GO:0060717](http://purl.obolibrary.org/obo/GO_0060717) (chorion development), [GO:0004629](http://purl.obolibrary.org/obo/GO_0004629) (phospholipase C activity), [GO:0033169](http://purl.obolibrary.org/obo/GO_0033169) (histone H3-K9 demethylation), [GO:0016600](http://purl.obolibrary.org/obo/GO_0016600) (flotillin complex), [GO:0033162](http://purl.obolibrary.org/obo/GO_0033162) (melanosome membrane), [GO:0033160](http://purl.obolibrary.org/obo/GO_0033160) (positive regulation of protein import into nucleus, translocation), [GO:0060740](http://purl.obolibrary.org/obo/GO_0060740) (prostate gland epithelium morphogenesis), [GO:0034497](http://purl.obolibrary.org/obo/GO_0034497) (protein localization to phagophore assembly site), [GO:0033164](http://purl.obolibrary.org/obo/GO_0033164) (glycolipid 6-alpha-mannosyltransferase activity), [GO:0045104](http://purl.obolibrary.org/obo/GO_0045104) (intermediate filament cytoskeleton organization), [GO:0060745](http://purl.obolibrary.org/obo/GO_0060745) (mammary gland branching involved in pregnancy), [GO:0090594](http://purl.obolibrary.org/obo/GO_0090594) (inflammatory response to wounding), [GO:1901841](http://purl.obolibrary.org/obo/GO_1901841) (regulation of high voltage-gated calcium channel activity), [GO:0046434](http://purl.obolibrary.org/obo/GO_0046434) (organophosphate catabolic process), [GO:0060748](http://purl.obolibrary.org/obo/GO_0060748) (tertiary branching involved in mammary gland duct morphogenesis), [GO:0045109](http://purl.obolibrary.org/obo/GO_0045109) (intermediate filament organization), [GO:0060742](http://purl.obolibrary.org/obo/GO_0060742) (epithelial cell differentiation involved in prostate gland development), [GO:1901843](http://purl.obolibrary.org/obo/GO_1901843) (positive regulation of high voltage-gated calcium channel activity), [GO:0005930](http://purl.obolibrary.org/obo/GO_0005930) (axoneme), [GO:0005921](http://purl.obolibrary.org/obo/GO_0005921) (gap junction), [GO:0047770](http://purl.obolibrary.org/obo/GO_0047770) (carboxylate reductase activity), [GO:1901836](http://purl.obolibrary.org/obo/GO_1901836) (regulation of transcription of nucleolar large rRNA by RNA polymerase I), [GO:0005923](http://purl.obolibrary.org/obo/GO_0005923) (bicellular tight junction), [GO:0005922](http://purl.obolibrary.org/obo/GO_0005922) (connexin complex), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0060749](http://purl.obolibrary.org/obo/GO_0060749) (mammary gland alveolus development), [GO:0045111](http://purl.obolibrary.org/obo/GO_0045111) (intermediate filament cytoskeleton), [GO:0005927](http://purl.obolibrary.org/obo/GO_0005927) (muscle tendon junction), [GO:0045110](http://purl.obolibrary.org/obo/GO_0045110) (intermediate filament bundle assembly), [GO:0005929](http://purl.obolibrary.org/obo/GO_0005929) (cilium), [GO:0033159](http://purl.obolibrary.org/obo/GO_0033159) (negative regulation of protein import into nucleus, translocation), [GO:0072721](http://purl.obolibrary.org/obo/GO_0072721) (cellular response to dithiothreitol), [GO:0033157](http://purl.obolibrary.org/obo/GO_0033157) (regulation of intracellular protein transport), [GO:0033151](http://purl.obolibrary.org/obo/GO_0033151) (V(D)J recombination), [GO:0072719](http://purl.obolibrary.org/obo/GO_0072719) (cellular response to cisplatin), [GO:0033153](http://purl.obolibrary.org/obo/GO_0033153) (T cell receptor V(D)J recombination), [GO:0033152](http://purl.obolibrary.org/obo/GO_0033152) (immunoglobulin V(D)J recombination), [GO:0060734](http://purl.obolibrary.org/obo/GO_0060734) (regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation), [GO:0060736](http://purl.obolibrary.org/obo/GO_0060736) (prostate gland growth), [GO:0060731](http://purl.obolibrary.org/obo/GO_0060731) (positive regulation of intestinal epithelial structure maintenance), [GO:0004610](http://purl.obolibrary.org/obo/GO_0004610) (phosphoacetylglucosamine mutase activity), [GO:0060732](http://purl.obolibrary.org/obo/GO_0060732) (positive regulation of inositol phosphate biosynthetic process), [GO:0046449](http://purl.obolibrary.org/obo/GO_0046449) (creatinine metabolic process), [GO:0005940](http://purl.obolibrary.org/obo/GO_0005940) (septin ring), [GO:0004601](http://purl.obolibrary.org/obo/GO_0004601) (peroxidase activity), [GO:0005934](http://purl.obolibrary.org/obo/GO_0005934) (cellular bud tip), [GO:0005933](http://purl.obolibrary.org/obo/GO_0005933) (cellular bud), [GO:0004602](http://purl.obolibrary.org/obo/GO_0004602) (glutathione peroxidase activity), [GO:0005935](http://purl.obolibrary.org/obo/GO_0005935) (cellular bud neck), [GO:0045123](http://purl.obolibrary.org/obo/GO_0045123) (cellular extravasation), [GO:0047783](http://purl.obolibrary.org/obo/GO_0047783) (corticosterone 18-monooxygenase activity), [GO:0005938](http://purl.obolibrary.org/obo/GO_0005938) (cell cortex), [GO:0045120](http://purl.obolibrary.org/obo/GO_0045120) (pronucleus), [GO:0004607](http://purl.obolibrary.org/obo/GO_0004607) (phosphatidylcholine-sterol O-acyltransferase activity), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0005937](http://purl.obolibrary.org/obo/GO_0005937) (mating projection), [GO:0046452](http://purl.obolibrary.org/obo/GO_0046452) (dihydrofolate metabolic process), [GO:0033147](http://purl.obolibrary.org/obo/GO_0033147) (negative regulation of intracellular estrogen receptor signaling pathway), [GO:0072711](http://purl.obolibrary.org/obo/GO_0072711) (cellular response to hydroxyurea), [GO:0033146](http://purl.obolibrary.org/obo/GO_0033146) (regulation of intracellular estrogen receptor signaling pathway), [GO:0034476](http://purl.obolibrary.org/obo/GO_0034476) (U5 snRNA 3'-end processing), [GO:0033149](http://purl.obolibrary.org/obo/GO_0033149) (FFAT motif binding), [GO:0016768](http://purl.obolibrary.org/obo/GO_0016768) (spermine synthase activity), [GO:0015432](http://purl.obolibrary.org/obo/GO_0015432) (bile acid-exporting ATPase activity), [GO:0015431](http://purl.obolibrary.org/obo/GO_0015431) (glutathione S-conjugate-exporting ATPase activity), [GO:0004781](http://purl.obolibrary.org/obo/GO_0004781) (sulfate adenylyltransferase (ATP) activity), [GO:0004784](http://purl.obolibrary.org/obo/GO_0004784) (superoxide dismutase activity), [GO:0002121](http://purl.obolibrary.org/obo/GO_0002121) (inter-male aggressive behavior), [GO:0070290](http://purl.obolibrary.org/obo/GO_0070290) (N-acylphosphatidylethanolamine-specific phospholipase D activity), [GO:0002124](http://purl.obolibrary.org/obo/GO_0002124) (territorial aggressive behavior), [GO:0004777](http://purl.obolibrary.org/obo/GO_0004777) (succinate-semialdehyde dehydrogenase (NAD+) activity), [GO:0004776](http://purl.obolibrary.org/obo/GO_0004776) (succinate-CoA ligase (GDP-forming) activity), [GO:0070287](http://purl.obolibrary.org/obo/GO_0070287) (ferritin receptor activity), [GO:0070285](http://purl.obolibrary.org/obo/GO_0070285) (pigment cell development), [GO:0070286](http://purl.obolibrary.org/obo/GO_0070286) (axonemal dynein complex assembly), [GO:0016772](http://purl.obolibrary.org/obo/GO_0016772) (transferase activity, transferring phosphorus-containing groups), [GO:0016773](http://purl.obolibrary.org/obo/GO_0016773) (phosphotransferase activity, alcohol group as acceptor), [GO:0016776](http://purl.obolibrary.org/obo/GO_0016776) (phosphotransferase activity, phosphate group as acceptor), [GO:0016755](http://purl.obolibrary.org/obo/GO_0016755) (transferase activity, transferring amino-acyl groups), [GO:0016757](http://purl.obolibrary.org/obo/GO_0016757) (transferase activity, transferring glycosyl groups), [GO:0016758](http://purl.obolibrary.org/obo/GO_0016758) (transferase activity, transferring hexosyl groups), [GO:0015440](http://purl.obolibrary.org/obo/GO_0015440) (peptide-transporting ATPase activity), [GO:0002133](http://purl.obolibrary.org/obo/GO_0002133) (polycystin complex), [GO:0004797](http://purl.obolibrary.org/obo/GO_0004797) (thymidine kinase activity), [GO:0002134](http://purl.obolibrary.org/obo/GO_0002134) (UTP binding), [GO:0004796](http://purl.obolibrary.org/obo/GO_0004796) (thromboxane-A synthase activity), [GO:0004788](http://purl.obolibrary.org/obo/GO_0004788) (thiamine diphosphokinase activity), [GO:0070273](http://purl.obolibrary.org/obo/GO_0070273) (phosphatidylinositol-4-phosphate binding), [GO:0002127](http://purl.obolibrary.org/obo/GO_0002127) (tRNA wobble base cytosine methylation), [GO:0070274](http://purl.obolibrary.org/obo/GO_0070274) (RES complex), [GO:0016763](http://purl.obolibrary.org/obo/GO_0016763) (transferase activity, transferring pentosyl groups), [GO:0016765](http://purl.obolibrary.org/obo/GO_0016765) (transferase activity, transferring alkyl or aryl (other than methyl) groups), [GO:0016746](http://purl.obolibrary.org/obo/GO_0016746) (transferase activity, transferring acyl groups), [GO:0016747](http://purl.obolibrary.org/obo/GO_0016747) (transferase activity, transferring acyl groups other than amino-acyl groups), [GO:0004760](http://purl.obolibrary.org/obo/GO_0004760) (serine-pyruvate transaminase activity), [GO:0003433](http://purl.obolibrary.org/obo/GO_0003433) (chondrocyte development involved in endochondral bone morphogenesis), [GO:0002102](http://purl.obolibrary.org/obo/GO_0002102) (podosome), [GO:0004755](http://purl.obolibrary.org/obo/GO_0004755) (saccharopine dehydrogenase (NADP+, L-glutamate-forming) activity), [GO:0004757](http://purl.obolibrary.org/obo/GO_0004757) (sepiapterin reductase activity), [GO:0004758](http://purl.obolibrary.org/obo/GO_0004758) (serine C-palmitoyltransferase activity), [GO:0004771](http://purl.obolibrary.org/obo/GO_0004771) (sterol esterase activity), [GO:0004773](http://purl.obolibrary.org/obo/GO_0004773) (steryl-sulfatase activity), [GO:0004775](http://purl.obolibrary.org/obo/GO_0004775) (succinate-CoA ligase (ADP-forming) activity), [GO:0004774](http://purl.obolibrary.org/obo/GO_0004774) (succinate-CoA ligase activity), [GO:0070294](http://purl.obolibrary.org/obo/GO_0070294) (renal sodium ion absorption), [GO:0004768](http://purl.obolibrary.org/obo/GO_0004768) (stearoyl-CoA 9-desaturase activity), [GO:0004767](http://purl.obolibrary.org/obo/GO_0004767) (sphingomyelin phosphodiesterase activity), [GO:0070293](http://purl.obolibrary.org/obo/GO_0070293) (renal absorption), [GO:0004769](http://purl.obolibrary.org/obo/GO_0004769) (steroid delta-isomerase activity), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0016742](http://purl.obolibrary.org/obo/GO_0016742) (hydroxymethyl-, formyl- and related transferase activity), [GO:0016743](http://purl.obolibrary.org/obo/GO_0016743) (carboxyl- or carbamoyltransferase activity), [GO:0002161](http://purl.obolibrary.org/obo/GO_0002161) (aminoacyl-tRNA editing activity), [GO:1900454](http://purl.obolibrary.org/obo/GO_1900454) (positive regulation of long term synaptic depression), [GO:0002162](http://purl.obolibrary.org/obo/GO_0002162) (dystroglycan binding), [GO:0045294](http://purl.obolibrary.org/obo/GO_0045294) (alpha-catenin binding), [GO:0002159](http://purl.obolibrary.org/obo/GO_0002159) (desmosome assembly), [GO:0045295](http://purl.obolibrary.org/obo/GO_0045295) (gamma-catenin binding), [GO:0045292](http://purl.obolibrary.org/obo/GO_0045292) (mRNA cis splicing, via spliceosome), [GO:0045298](http://purl.obolibrary.org/obo/GO_0045298) (tubulin complex), [GO:0070243](http://purl.obolibrary.org/obo/GO_0070243) (regulation of thymocyte apoptotic process), [GO:0070244](http://purl.obolibrary.org/obo/GO_0070244) (negative regulation of thymocyte apoptotic process), [GO:0045299](http://purl.obolibrary.org/obo/GO_0045299) (otolith mineralization), [GO:0045296](http://purl.obolibrary.org/obo/GO_0045296) (cadherin binding), [GO:0071578](http://purl.obolibrary.org/obo/GO_0071578) (zinc II ion transmembrane import), [GO:0071579](http://purl.obolibrary.org/obo/GO_0071579) (regulation of zinc ion transport), [GO:0071577](http://purl.obolibrary.org/obo/GO_0071577) (zinc II ion transmembrane transport), [GO:0038109](http://purl.obolibrary.org/obo/GO_0038109) (Kit signaling pathway), [GO:0038108](http://purl.obolibrary.org/obo/GO_0038108) (negative regulation of appetite by leptin-mediated signaling pathway), [GO:0016799](http://purl.obolibrary.org/obo/GO_0016799) (hydrolase activity, hydrolyzing N-glycosyl compounds), [GO:0015485](http://purl.obolibrary.org/obo/GO_0015485) (cholesterol binding), [GO:0038100](http://purl.obolibrary.org/obo/GO_0038100) (nodal binding), [GO:1901796](http://purl.obolibrary.org/obo/GO_1901796) (regulation of signal transduction by p53 class mediator), [GO:1901798](http://purl.obolibrary.org/obo/GO_1901798) (positive regulation of signal transduction by p53 class mediator), [GO:1901799](http://purl.obolibrary.org/obo/GO_1901799) (negative regulation of proteasomal protein catabolic process), [GO:0002178](http://purl.obolibrary.org/obo/GO_0002178) (palmitoyltransferase complex), [GO:0071560](http://purl.obolibrary.org/obo/GO_0071560) (cellular response to transforming growth factor beta stimulus), [GO:0070232](http://purl.obolibrary.org/obo/GO_0070232) (regulation of T cell apoptotic process), [GO:0070233](http://purl.obolibrary.org/obo/GO_0070233) (negative regulation of T cell apoptotic process), [GO:0070230](http://purl.obolibrary.org/obo/GO_0070230) (positive regulation of lymphocyte apoptotic process), [GO:0071561](http://purl.obolibrary.org/obo/GO_0071561) (nucleus-vacuole junction), [GO:0070231](http://purl.obolibrary.org/obo/GO_0070231) (T cell apoptotic process), [GO:0070236](http://purl.obolibrary.org/obo/GO_0070236) (negative regulation of activation-induced cell death of T cells), [GO:0070237](http://purl.obolibrary.org/obo/GO_0070237) (positive regulation of activation-induced cell death of T cells), [GO:0071566](http://purl.obolibrary.org/obo/GO_0071566) (UFM1 activating enzyme activity), [GO:0071569](http://purl.obolibrary.org/obo/GO_0071569) (protein ufmylation), [GO:0016788](http://purl.obolibrary.org/obo/GO_0016788) (hydrolase activity, acting on ester bonds), [GO:0015450](http://purl.obolibrary.org/obo/GO_0015450) (P-P-bond-hydrolysis-driven protein transmembrane transporter activity), [GO:0002141](http://purl.obolibrary.org/obo/GO_0002141) (stereocilia ankle link), [GO:0002142](http://purl.obolibrary.org/obo/GO_0002142) (stereocilia ankle link complex), [GO:0002143](http://purl.obolibrary.org/obo/GO_0002143) (tRNA wobble position uridine thiolation), [GO:0070262](http://purl.obolibrary.org/obo/GO_0070262) (peptidyl-serine dephosphorylation), [GO:0070260](http://purl.obolibrary.org/obo/GO_0070260) (5'-tyrosyl-DNA phosphodiesterase activity), [GO:0071596](http://purl.obolibrary.org/obo/GO_0071596) (ubiquitin-dependent protein catabolic process via the N-end rule pathway), [GO:0070265](http://purl.obolibrary.org/obo/GO_0070265) (necrotic cell death), [GO:0070266](http://purl.obolibrary.org/obo/GO_0070266) (necroptotic process), [GO:0016790](http://purl.obolibrary.org/obo/GO_0016790) (thiolester hydrolase activity), [GO:0016791](http://purl.obolibrary.org/obo/GO_0016791) (phosphatase activity), [GO:0070269](http://purl.obolibrary.org/obo/GO_0070269) (pyroptosis), [GO:0071598](http://purl.obolibrary.org/obo/GO_0071598) (neuronal ribonucleoprotein granule), [GO:0016793](http://purl.obolibrary.org/obo/GO_0016793) (triphosphoric monoester hydrolase activity), [GO:0071599](http://purl.obolibrary.org/obo/GO_0071599) (otic vesicle development), [GO:0070268](http://purl.obolibrary.org/obo/GO_0070268) (cornification), [GO:0016798](http://purl.obolibrary.org/obo/GO_0016798) (hydrolase activity, acting on glycosyl bonds), [GO:0015467](http://purl.obolibrary.org/obo/GO_0015467) (G-protein activated inward rectifier potassium channel activity), [GO:0016779](http://purl.obolibrary.org/obo/GO_0016779) (nucleotidyltransferase activity), [GO:0015464](http://purl.obolibrary.org/obo/GO_0015464) (acetylcholine receptor activity), [GO:0015462](http://purl.obolibrary.org/obo/GO_0015462) (ATPase-coupled protein transmembrane transporter activity), [GO:0002151](http://purl.obolibrary.org/obo/GO_0002151) (G-quadruplex RNA binding), [GO:0002152](http://purl.obolibrary.org/obo/GO_0002152) (bile acid conjugation), [GO:0071585](http://purl.obolibrary.org/obo/GO_0071585) (detoxification of cadmium ion), [GO:0071586](http://purl.obolibrary.org/obo/GO_0071586) (CAAX-box protein processing), [GO:0070252](http://purl.obolibrary.org/obo/GO_0070252) (actin-mediated cell contraction), [GO:0016780](http://purl.obolibrary.org/obo/GO_0016780) (phosphotransferase activity, for other substituted phosphate groups), [GO:0070256](http://purl.obolibrary.org/obo/GO_0070256) (negative regulation of mucus secretion), [GO:0016783](http://purl.obolibrary.org/obo/GO_0016783) (sulfurtransferase activity), [GO:0070257](http://purl.obolibrary.org/obo/GO_0070257) (positive regulation of mucus secretion), [GO:0015459](http://purl.obolibrary.org/obo/GO_0015459) (potassium channel regulator activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0051124](http://purl.obolibrary.org/obo/GO_0051124) (synaptic growth at neuromuscular junction), [GO:0051122](http://purl.obolibrary.org/obo/GO_0051122) (hepoxilin biosynthetic process), [GO:0051120](http://purl.obolibrary.org/obo/GO_0051120) (hepoxilin A3 synthase activity), [GO:0051131](http://purl.obolibrary.org/obo/GO_0051131) (chaperone-mediated protein complex assembly), [GO:0051138](http://purl.obolibrary.org/obo/GO_0051138) (positive regulation of NK T cell differentiation), [GO:0051139](http://purl.obolibrary.org/obo/GO_0051139) (metal ion:proton antiporter activity), [GO:0038132](http://purl.obolibrary.org/obo/GO_0038132) (neuregulin binding), [GO:0002181](http://purl.obolibrary.org/obo/GO_0002181) (cytoplasmic translation), [GO:0038133](http://purl.obolibrary.org/obo/GO_0038133) (ERBB2-ERBB3 signaling pathway), [GO:0051150](http://purl.obolibrary.org/obo/GO_0051150) (regulation of smooth muscle cell differentiation), [GO:0015491](http://purl.obolibrary.org/obo/GO_0015491) (cation:cation antiporter activity), [GO:0002189](http://purl.obolibrary.org/obo/GO_0002189) (ribose phosphate diphosphokinase complex), [GO:0051147](http://purl.obolibrary.org/obo/GO_0051147) (regulation of muscle cell differentiation), [GO:0051145](http://purl.obolibrary.org/obo/GO_0051145) (smooth muscle cell differentiation), [GO:0051146](http://purl.obolibrary.org/obo/GO_0051146) (striated muscle cell differentiation), [GO:0090722](http://purl.obolibrary.org/obo/GO_0090722) (receptor-receptor interaction), [GO:0038127](http://purl.obolibrary.org/obo/GO_0038127) (ERBB signaling pathway), [GO:1905333](http://purl.obolibrary.org/obo/GO_1905333) (regulation of gastric motility), [GO:0002196](http://purl.obolibrary.org/obo/GO_0002196) (Ser-tRNA(Ala) hydrolase activity), [GO:0002199](http://purl.obolibrary.org/obo/GO_0002199) (zona pellucida receptor complex), [GO:0051156](http://purl.obolibrary.org/obo/GO_0051156) (glucose 6-phosphate metabolic process), [GO:0051154](http://purl.obolibrary.org/obo/GO_0051154) (negative regulation of striated muscle cell differentiation), [GO:0090729](http://purl.obolibrary.org/obo/GO_0090729) (toxin activity), [GO:0090724](http://purl.obolibrary.org/obo/GO_0090724) (central region of growth cone), [GO:0022604](http://purl.obolibrary.org/obo/GO_0022604) (regulation of cell morphogenesis), [GO:0008301](http://purl.obolibrary.org/obo/GO_0008301) (DNA binding, bending), [GO:0038195](http://purl.obolibrary.org/obo/GO_0038195) (urokinase plasminogen activator signaling pathway), [GO:0008306](http://purl.obolibrary.org/obo/GO_0008306) (associative learning), [GO:0038190](http://purl.obolibrary.org/obo/GO_0038190) (VEGF-activated neuropilin signaling pathway), [GO:0009636](http://purl.obolibrary.org/obo/GO_0009636) (response to toxic substance), [GO:0008305](http://purl.obolibrary.org/obo/GO_0008305) (integrin complex), [GO:0038191](http://purl.obolibrary.org/obo/GO_0038191) (neuropilin binding), [GO:0035914](http://purl.obolibrary.org/obo/GO_0035914) (skeletal muscle cell differentiation), [GO:0035910](http://purl.obolibrary.org/obo/GO_0035910) (ascending aorta morphogenesis), [GO:0010613](http://purl.obolibrary.org/obo/GO_0010613) (positive regulation of cardiac muscle hypertrophy), [GO:0035912](http://purl.obolibrary.org/obo/GO_0035912) (dorsal aorta morphogenesis), [GO:0089711](http://purl.obolibrary.org/obo/GO_0089711) (L-glutamate transmembrane transport), [GO:0089712](http://purl.obolibrary.org/obo/GO_0089712) (L-aspartate transmembrane transport), [GO:0038189](http://purl.obolibrary.org/obo/GO_0038189) (neuropilin signaling pathway), [GO:0008312](http://purl.obolibrary.org/obo/GO_0008312) (7S RNA binding), [GO:0008310](http://purl.obolibrary.org/obo/GO_0008310) (single-stranded DNA 3'-5' exodeoxyribonuclease activity), [GO:0009648](http://purl.obolibrary.org/obo/GO_0009648) (photoperiodism), [GO:0038180](http://purl.obolibrary.org/obo/GO_0038180) (nerve growth factor signaling pathway), [GO:0035907](http://purl.obolibrary.org/obo/GO_0035907) (dorsal aorta development), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0035909](http://purl.obolibrary.org/obo/GO_0035909) (aorta morphogenesis), [GO:0008307](http://purl.obolibrary.org/obo/GO_0008307) (structural constituent of muscle), [GO:0010626](http://purl.obolibrary.org/obo/GO_0010626) (negative regulation of Schwann cell proliferation), [GO:0035904](http://purl.obolibrary.org/obo/GO_0035904) (aorta development), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0010623](http://purl.obolibrary.org/obo/GO_0010623) (programmed cell death involved in cell development), [GO:0009611](http://purl.obolibrary.org/obo/GO_0009611) (response to wounding), [GO:0009615](http://purl.obolibrary.org/obo/GO_0009615) (response to virus), [GO:0009612](http://purl.obolibrary.org/obo/GO_0009612) (response to mechanical stimulus), [GO:0051103](http://purl.obolibrary.org/obo/GO_0051103) (DNA ligation involved in DNA repair), [GO:0009607](http://purl.obolibrary.org/obo/GO_0009607) (response to biotic stimulus), [GO:0051101](http://purl.obolibrary.org/obo/GO_0051101) (regulation of DNA binding), [GO:0051102](http://purl.obolibrary.org/obo/GO_0051102) (DNA ligation involved in DNA recombination), [GO:0038161](http://purl.obolibrary.org/obo/GO_0038161) (prolactin signaling pathway), [GO:0038162](http://purl.obolibrary.org/obo/GO_0038162) (erythropoietin-mediated signaling pathway), [GO:0010608](http://purl.obolibrary.org/obo/GO_0010608) (posttranscriptional regulation of gene expression), [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium), [GO:0010603](http://purl.obolibrary.org/obo/GO_0010603) (regulation of cytoplasmic mRNA processing body assembly), [GO:0010606](http://purl.obolibrary.org/obo/GO_0010606) (positive regulation of cytoplasmic mRNA processing body assembly), [GO:0051117](http://purl.obolibrary.org/obo/GO_0051117) (ATPase binding), [GO:0060800](http://purl.obolibrary.org/obo/GO_0060800) (regulation of cell differentiation involved in embryonic placenta development), [GO:0051096](http://purl.obolibrary.org/obo/GO_0051096) (positive regulation of helicase activity), [GO:0051091](http://purl.obolibrary.org/obo/GO_0051091) (positive regulation of DNA binding transcription factor activity), [GO:0051092](http://purl.obolibrary.org/obo/GO_0051092) (positive regulation of NF-kappaB transcription factor activity), [GO:0051090](http://purl.obolibrary.org/obo/GO_0051090) (regulation of DNA binding transcription factor activity), [GO:0034508](http://purl.obolibrary.org/obo/GO_0034508) (centromere complex assembly), [GO:0008219](http://purl.obolibrary.org/obo/GO_0008219) (cell death), [GO:0060804](http://purl.obolibrary.org/obo/GO_0060804) (positive regulation of Wnt signaling pathway by BMP signaling pathway), [GO:0051087](http://purl.obolibrary.org/obo/GO_0051087) (chaperone binding), [GO:0060807](http://purl.obolibrary.org/obo/GO_0060807) (regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification), [GO:0034501](http://purl.obolibrary.org/obo/GO_0034501) (protein localization to kinetochore), [GO:0034505](http://purl.obolibrary.org/obo/GO_0034505) (tooth mineralization), [GO:0034504](http://purl.obolibrary.org/obo/GO_0034504) (protein localization to nucleus), [GO:0034502](http://purl.obolibrary.org/obo/GO_0034502) (protein localization to chromosome), [GO:0046501](http://purl.obolibrary.org/obo/GO_0046501) (protoporphyrinogen IX metabolic process), [GO:0008236](http://purl.obolibrary.org/obo/GO_0008236) (serine-type peptidase activity), [GO:0099040](http://purl.obolibrary.org/obo/GO_0099040) (ceramide translocation), [GO:0009566](http://purl.obolibrary.org/obo/GO_0009566) (fertilization), [GO:0046502](http://purl.obolibrary.org/obo/GO_0046502) (uroporphyrinogen III metabolic process), [GO:0008234](http://purl.obolibrary.org/obo/GO_0008234) (cysteine-type peptidase activity), [GO:0008233](http://purl.obolibrary.org/obo/GO_0008233) (peptidase activity), [GO:0046500](http://purl.obolibrary.org/obo/GO_0046500) (S-adenosylmethionine metabolic process), [GO:0008239](http://purl.obolibrary.org/obo/GO_0008239) (dipeptidyl-peptidase activity), [GO:0008238](http://purl.obolibrary.org/obo/GO_0008238) (exopeptidase activity), [GO:0008237](http://purl.obolibrary.org/obo/GO_0008237) (metallopeptidase activity), [GO:0099038](http://purl.obolibrary.org/obo/GO_0099038) (ceramide-translocating ATPase activity), [GO:0075044](http://purl.obolibrary.org/obo/GO_0075044) (autophagy of host cells involved in interaction with symbiont), [GO:0051099](http://purl.obolibrary.org/obo/GO_0051099) (positive regulation of binding), [GO:0047840](http://purl.obolibrary.org/obo/GO_0047840) (dCTP diphosphatase activity), [GO:0035827](http://purl.obolibrary.org/obo/GO_0035827) (rubidium ion transmembrane transporter activity), [GO:0035829](http://purl.obolibrary.org/obo/GO_0035829) (renal rubidium ion absorption), [GO:0010544](http://purl.obolibrary.org/obo/GO_0010544) (negative regulation of platelet activation), [GO:0038098](http://purl.obolibrary.org/obo/GO_0038098) (sequestering of BMP from receptor via BMP binding), [GO:0008203](http://purl.obolibrary.org/obo/GO_0008203) (cholesterol metabolic process), [GO:0046512](http://purl.obolibrary.org/obo/GO_0046512) (sphingosine biosynthetic process), [GO:0008202](http://purl.obolibrary.org/obo/GO_0008202) (steroid metabolic process), [GO:0046513](http://purl.obolibrary.org/obo/GO_0046513) (ceramide biosynthetic process), [GO:0090671](http://purl.obolibrary.org/obo/GO_0090671) (telomerase RNA localization to Cajal body), [GO:0008201](http://purl.obolibrary.org/obo/GO_0008201) (heparin binding), [GO:0060825](http://purl.obolibrary.org/obo/GO_0060825) (fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation), [GO:0038096](http://purl.obolibrary.org/obo/GO_0038096) (Fc-gamma receptor signaling pathway involved in phagocytosis), [GO:0008207](http://purl.obolibrary.org/obo/GO_0008207) (C21-steroid hormone metabolic process), [GO:0038091](http://purl.obolibrary.org/obo/GO_0038091) (positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway), [GO:0008206](http://purl.obolibrary.org/obo/GO_0008206) (bile acid metabolic process), [GO:0038093](http://purl.obolibrary.org/obo/GO_0038093) (Fc receptor signaling pathway), [GO:0046514](http://purl.obolibrary.org/obo/GO_0046514) (ceramide catabolic process), [GO:0060821](http://purl.obolibrary.org/obo/GO_0060821) (inactivation of X chromosome by DNA methylation), [GO:0038092](http://purl.obolibrary.org/obo/GO_0038092) (nodal signaling pathway), [GO:0010519](http://purl.obolibrary.org/obo/GO_0010519) (negative regulation of phospholipase activity), [GO:0035815](http://purl.obolibrary.org/obo/GO_0035815) (positive regulation of renal sodium excretion), [GO:0060828](http://purl.obolibrary.org/obo/GO_0060828) (regulation of canonical Wnt signaling pathway), [GO:0010518](http://purl.obolibrary.org/obo/GO_0010518) (positive regulation of phospholipase activity), [GO:0010512](http://purl.obolibrary.org/obo/GO_0010512) (negative regulation of phosphatidylinositol biosynthetic process), [GO:0035811](http://purl.obolibrary.org/obo/GO_0035811) (negative regulation of urine volume), [GO:0010513](http://purl.obolibrary.org/obo/GO_0010513) (positive regulation of phosphatidylinositol biosynthetic process), [GO:0035814](http://purl.obolibrary.org/obo/GO_0035814) (negative regulation of renal sodium excretion), [GO:0035810](http://purl.obolibrary.org/obo/GO_0035810) (positive regulation of urine volume), [GO:0008210](http://purl.obolibrary.org/obo/GO_0008210) (estrogen metabolic process), [GO:0038084](http://purl.obolibrary.org/obo/GO_0038084) (vascular endothelial growth factor signaling pathway), [GO:0038083](http://purl.obolibrary.org/obo/GO_0038083) (peptidyl-tyrosine autophosphorylation), [GO:0038085](http://purl.obolibrary.org/obo/GO_0038085) (vascular endothelial growth factor binding), [GO:0008211](http://purl.obolibrary.org/obo/GO_0008211) (glucocorticoid metabolic process), [GO:0046527](http://purl.obolibrary.org/obo/GO_0046527) (glucosyltransferase activity), [GO:0008217](http://purl.obolibrary.org/obo/GO_0008217) (regulation of blood pressure), [GO:0046525](http://purl.obolibrary.org/obo/GO_0046525) (xylosylprotein 4-beta-galactosyltransferase activity), [GO:0008215](http://purl.obolibrary.org/obo/GO_0008215) (spermine metabolic process), [GO:0008209](http://purl.obolibrary.org/obo/GO_0008209) (androgen metabolic process), [GO:0046530](http://purl.obolibrary.org/obo/GO_0046530) (photoreceptor cell differentiation), [GO:0010526](http://purl.obolibrary.org/obo/GO_0010526) (negative regulation of transposition, RNA-mediated), [GO:0035800](http://purl.obolibrary.org/obo/GO_0035800) (deubiquitinase activator activity), [GO:0010523](http://purl.obolibrary.org/obo/GO_0010523) (negative regulation of calcium ion transport into cytosol), [GO:1905290](http://purl.obolibrary.org/obo/GO_1905290) (negative regulation of CAMKK-AMPK signaling cascade), [GO:0035802](http://purl.obolibrary.org/obo/GO_0035802) (adrenal cortex formation), [GO:0010525](http://purl.obolibrary.org/obo/GO_0010525) (regulation of transposition, RNA-mediated), [GO:0010524](http://purl.obolibrary.org/obo/GO_0010524) (positive regulation of calcium ion transport into cytosol), [GO:0010521](http://purl.obolibrary.org/obo/GO_0010521) (telomerase inhibitor activity), [GO:0010520](http://purl.obolibrary.org/obo/GO_0010520) (regulation of reciprocal meiotic recombination), [GO:0035880](http://purl.obolibrary.org/obo/GO_0035880) (embryonic nail plate morphogenesis), [GO:0035881](http://purl.obolibrary.org/obo/GO_0035881) (amacrine cell differentiation), [GO:0008260](http://purl.obolibrary.org/obo/GO_0008260) (3-oxoacid CoA-transferase activity), [GO:0090657](http://purl.obolibrary.org/obo/GO_0090657) (telomeric loop disassembly), [GO:0008265](http://purl.obolibrary.org/obo/GO_0008265) (Mo-molybdopterin cofactor sulfurase activity), [GO:0034551](http://purl.obolibrary.org/obo/GO_0034551) (mitochondrial respiratory chain complex III assembly), [GO:0008266](http://purl.obolibrary.org/obo/GO_0008266) (poly(U) RNA binding), [GO:0051044](http://purl.obolibrary.org/obo/GO_0051044) (positive regulation of membrane protein ectodomain proteolysis), [GO:0051042](http://purl.obolibrary.org/obo/GO_0051042) (negative regulation of calcium-independent cell-cell adhesion), [GO:0035877](http://purl.obolibrary.org/obo/GO_0035877) (death effector domain binding), [GO:0035878](http://purl.obolibrary.org/obo/GO_0035878) (nail development), [GO:0035879](http://purl.obolibrary.org/obo/GO_0035879) (plasma membrane lactate transport), [GO:0010574](http://purl.obolibrary.org/obo/GO_0010574) (regulation of vascular endothelial growth factor production), [GO:0035873](http://purl.obolibrary.org/obo/GO_0035873) (lactate transmembrane transport), [GO:0033218](http://purl.obolibrary.org/obo/GO_0033218) (amide binding), [GO:0033216](http://purl.obolibrary.org/obo/GO_0033216) (ferric iron import), [GO:0010575](http://purl.obolibrary.org/obo/GO_0010575) (positive regulation of vascular endothelial growth factor production), [GO:0090659](http://purl.obolibrary.org/obo/GO_0090659) (walking behavior), [GO:0010592](http://purl.obolibrary.org/obo/GO_0010592) (positive regulation of lamellipodium assembly), [GO:0008272](http://purl.obolibrary.org/obo/GO_0008272) (sulfate transport), [GO:0008271](http://purl.obolibrary.org/obo/GO_0008271) (secondary active sulfate transmembrane transporter activity), [GO:0010591](http://purl.obolibrary.org/obo/GO_0010591) (regulation of lamellipodium assembly), [GO:0035870](http://purl.obolibrary.org/obo/GO_0035870) (dITP diphosphatase activity), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0035871](http://purl.obolibrary.org/obo/GO_0035871) (protein K11-linked deubiquitination), [GO:0090666](http://purl.obolibrary.org/obo/GO_0090666) (scaRNA localization to Cajal body), [GO:0033210](http://purl.obolibrary.org/obo/GO_0033210) (leptin-mediated signaling pathway), [GO:0090661](http://purl.obolibrary.org/obo/GO_0090661) (box H/ACA telomerase RNP complex), [GO:0008273](http://purl.obolibrary.org/obo/GO_0008273) (calcium, potassium:sodium antiporter activity), [GO:0090660](http://purl.obolibrary.org/obo/GO_0090660) (cerebrospinal fluid circulation), [GO:0008277](http://purl.obolibrary.org/obo/GO_0008277) (regulation of G-protein coupled receptor protein signaling pathway), [GO:0051059](http://purl.obolibrary.org/obo/GO_0051059) (NF-kappaB binding), [GO:0033209](http://purl.obolibrary.org/obo/GO_0033209) (tumor necrosis factor-mediated signaling pathway), [GO:0051057](http://purl.obolibrary.org/obo/GO_0051057) (positive regulation of small GTPase mediated signal transduction), [GO:0051058](http://purl.obolibrary.org/obo/GO_0051058) (negative regulation of small GTPase mediated signal transduction), [GO:0051056](http://purl.obolibrary.org/obo/GO_0051056) (regulation of small GTPase mediated signal transduction), [GO:0051054](http://purl.obolibrary.org/obo/GO_0051054) (positive regulation of DNA metabolic process), [GO:0035869](http://purl.obolibrary.org/obo/GO_0035869) (ciliary transition zone), [GO:0090669](http://purl.obolibrary.org/obo/GO_0090669) (telomerase RNA stabilization), [GO:0010587](http://purl.obolibrary.org/obo/GO_0010587) (miRNA catabolic process), [GO:0033204](http://purl.obolibrary.org/obo/GO_0033204) (ribonuclease P RNA binding), [GO:1905243](http://purl.obolibrary.org/obo/GO_1905243) (cellular response to 3,3',5-triiodo-L-thyronine), [GO:0035861](http://purl.obolibrary.org/obo/GO_0035861) (site of double-strand break), [GO:0090630](http://purl.obolibrary.org/obo/GO_0090630) (activation of GTPase activity), [GO:0008241](http://purl.obolibrary.org/obo/GO_0008241) (peptidyl-dipeptidase activity), [GO:0008240](http://purl.obolibrary.org/obo/GO_0008240) (tripeptidyl-peptidase activity), [GO:0035859](http://purl.obolibrary.org/obo/GO_0035859) (Seh1-associated complex), [GO:0051066](http://purl.obolibrary.org/obo/GO_0051066) (dihydrobiopterin metabolic process), [GO:0010559](http://purl.obolibrary.org/obo/GO_0010559) (regulation of glycoprotein biosynthetic process), [GO:0035855](http://purl.obolibrary.org/obo/GO_0035855) (megakaryocyte development), [GO:0035854](http://purl.obolibrary.org/obo/GO_0035854) (eosinophil fate commitment), [GO:0008250](http://purl.obolibrary.org/obo/GO_0008250) (oligosaccharyltransferase complex), [GO:0090646](http://purl.obolibrary.org/obo/GO_0090646) (mitochondrial tRNA processing), [GO:0010572](http://purl.obolibrary.org/obo/GO_0010572) (positive regulation of platelet activation), [GO:0035850](http://purl.obolibrary.org/obo/GO_0035850) (epithelial cell differentiation involved in kidney development), [GO:0008253](http://purl.obolibrary.org/obo/GO_0008253) (5'-nucleotidase activity), [GO:0009589](http://purl.obolibrary.org/obo/GO_0009589) (detection of UV), [GO:0051082](http://purl.obolibrary.org/obo/GO_0051082) (unfolded protein binding), [GO:0034517](http://purl.obolibrary.org/obo/GO_0034517) (ribophagy), [GO:0035844](http://purl.obolibrary.org/obo/GO_0035844) (cloaca development), [GO:0035845](http://purl.obolibrary.org/obo/GO_0035845) (photoreceptor cell outer segment organization), [GO:0010569](http://purl.obolibrary.org/obo/GO_0010569) (regulation of double-strand break repair via homologous recombination), [GO:0034516](http://purl.obolibrary.org/obo/GO_0034516) (response to vitamin B6), [GO:0034515](http://purl.obolibrary.org/obo/GO_0034515) (proteasome storage granule), [GO:0090647](http://purl.obolibrary.org/obo/GO_0090647) (modulation of age-related behavioral decline), [GO:0034513](http://purl.obolibrary.org/obo/GO_0034513) (box H/ACA snoRNA binding), [GO:0010564](http://purl.obolibrary.org/obo/GO_0010564) (regulation of cell cycle process), [GO:0033260](http://purl.obolibrary.org/obo/GO_0033260) (nuclear DNA replication), [GO:0070209](http://purl.obolibrary.org/obo/GO_0070209) (ASTRA complex), [GO:0034590](http://purl.obolibrary.org/obo/GO_0034590) (L-hydroxyproline transmembrane transporter activity), [GO:0033265](http://purl.obolibrary.org/obo/GO_0033265) (choline binding), [GO:1901741](http://purl.obolibrary.org/obo/GO_1901741) (positive regulation of myoblast fusion), [GO:0046579](http://purl.obolibrary.org/obo/GO_0046579) (positive regulation of Ras protein signal transduction), [GO:0046577](http://purl.obolibrary.org/obo/GO_0046577) (long-chain-alcohol oxidase activity), [GO:0046581](http://purl.obolibrary.org/obo/GO_0046581) (intercellular canaliculus), [GO:1900407](http://purl.obolibrary.org/obo/GO_1900407) (regulation of cellular response to oxidative stress), [GO:0046580](http://purl.obolibrary.org/obo/GO_0046580) (negative regulation of Ras protein signal transduction), [GO:0045254](http://purl.obolibrary.org/obo/GO_0045254) (pyruvate dehydrogenase complex), [GO:0070200](http://purl.obolibrary.org/obo/GO_0070200) (establishment of protein localization to telomere), [GO:0045252](http://purl.obolibrary.org/obo/GO_0045252) (oxoglutarate dehydrogenase complex), [GO:0095500](http://purl.obolibrary.org/obo/GO_0095500) (acetylcholine receptor signaling pathway), [GO:0034589](http://purl.obolibrary.org/obo/GO_0034589) (hydroxyproline transport), [GO:0033257](http://purl.obolibrary.org/obo/GO_0033257) (Bcl3/NF-kappaB2 complex), [GO:0070201](http://purl.obolibrary.org/obo/GO_0070201) (regulation of establishment of protein localization), [GO:0033256](http://purl.obolibrary.org/obo/GO_0033256) (I-kappaB/NF-kappaB complex), [GO:0070207](http://purl.obolibrary.org/obo/GO_0070207) (protein homotrimerization), [GO:0071539](http://purl.obolibrary.org/obo/GO_0071539) (protein localization to centrosome), [GO:0070208](http://purl.obolibrary.org/obo/GO_0070208) (protein heterotrimerization), [GO:0070206](http://purl.obolibrary.org/obo/GO_0070206) (protein trimerization), [GO:0060872](http://purl.obolibrary.org/obo/GO_0060872) (semicircular canal development), [GO:1901750](http://purl.obolibrary.org/obo/GO_1901750) (leukotriene D4 biosynthetic process), [GO:0046588](http://purl.obolibrary.org/obo/GO_0046588) (negative regulation of calcium-dependent cell-cell adhesion), [GO:1900425](http://purl.obolibrary.org/obo/GO_1900425) (negative regulation of defense response to bacterium), [GO:0060876](http://purl.obolibrary.org/obo/GO_0060876) (semicircular canal formation), [GO:0045261](http://purl.obolibrary.org/obo/GO_0045261) (proton-transporting ATP synthase complex, catalytic core F(1)), [GO:0004702](http://purl.obolibrary.org/obo/GO_0004702) (signal transducer, downstream of receptor, with serine/threonine kinase activity), [GO:0046597](http://purl.obolibrary.org/obo/GO_0046597) (negative regulation of viral entry into host cell), [GO:0004703](http://purl.obolibrary.org/obo/GO_0004703) (G-protein coupled receptor kinase activity), [GO:0045263](http://purl.obolibrary.org/obo/GO_0045263) (proton-transporting ATP synthase complex, coupling factor F(o)), [GO:0004708](http://purl.obolibrary.org/obo/GO_0004708) (MAP kinase kinase activity), [GO:0004709](http://purl.obolibrary.org/obo/GO_0004709) (MAP kinase kinase kinase activity), [GO:0071526](http://purl.obolibrary.org/obo/GO_0071526) (semaphorin-plexin signaling pathway), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0008282](http://purl.obolibrary.org/obo/GO_0008282) (inward rectifying potassium channel), [GO:0008281](http://purl.obolibrary.org/obo/GO_0008281) (sulfonylurea receptor activity), [GO:0008286](http://purl.obolibrary.org/obo/GO_0008286) (insulin receptor signaling pathway), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0008289](http://purl.obolibrary.org/obo/GO_0008289) (lipid binding), [GO:0046598](http://purl.obolibrary.org/obo/GO_0046598) (positive regulation of viral entry into host cell), [GO:0099093](http://purl.obolibrary.org/obo/GO_0099093) (mitochondrial calcium release), [GO:0046599](http://purl.obolibrary.org/obo/GO_0046599) (regulation of centriole replication), [GO:1900436](http://purl.obolibrary.org/obo/GO_1900436) (positive regulation of filamentous growth of a population of unicellular organisms in response to starvation), [GO:0045273](http://purl.obolibrary.org/obo/GO_0045273) (respiratory chain complex II), [GO:0045277](http://purl.obolibrary.org/obo/GO_0045277) (respiratory chain complex IV), [GO:0045275](http://purl.obolibrary.org/obo/GO_0045275) (respiratory chain complex III), [GO:0071557](http://purl.obolibrary.org/obo/GO_0071557) (histone H3-K27 demethylation), [GO:0033234](http://purl.obolibrary.org/obo/GO_0033234) (negative regulation of protein sumoylation), [GO:0071555](http://purl.obolibrary.org/obo/GO_0071555) (cell wall organization), [GO:0010596](http://purl.obolibrary.org/obo/GO_0010596) (negative regulation of endothelial cell migration), [GO:0010595](http://purl.obolibrary.org/obo/GO_0010595) (positive regulation of endothelial cell migration), [GO:0071558](http://purl.obolibrary.org/obo/GO_0071558) (histone demethylase activity (H3-K27 specific)), [GO:0070228](http://purl.obolibrary.org/obo/GO_0070228) (regulation of lymphocyte apoptotic process), [GO:0035898](http://purl.obolibrary.org/obo/GO_0035898) (parathyroid hormone secretion), [GO:0008294](http://purl.obolibrary.org/obo/GO_0008294) (calcium- and calmodulin-responsive adenylate cyclase activity), [GO:0008292](http://purl.obolibrary.org/obo/GO_0008292) (acetylcholine biosynthetic process), [GO:0008298](http://purl.obolibrary.org/obo/GO_0008298) (intracellular mRNA localization), [GO:0008297](http://purl.obolibrary.org/obo/GO_0008297) (single-stranded DNA exodeoxyribonuclease activity), [GO:0033231](http://purl.obolibrary.org/obo/GO_0033231) (carbohydrate export), [GO:0008296](http://purl.obolibrary.org/obo/GO_0008296) (3'-5'-exodeoxyribonuclease activity), [GO:0008299](http://purl.obolibrary.org/obo/GO_0008299) (isoprenoid biosynthetic process), [GO:0060896](http://purl.obolibrary.org/obo/GO_0060896) (neural plate pattern specification), [GO:1900449](http://purl.obolibrary.org/obo/GO_1900449) (regulation of glutamate receptor signaling pathway), [GO:0060898](http://purl.obolibrary.org/obo/GO_0060898) (eye field cell fate commitment involved in camera-type eye formation), [GO:0045281](http://purl.obolibrary.org/obo/GO_0045281) (succinate dehydrogenase complex), [GO:0070210](http://purl.obolibrary.org/obo/GO_0070210) (Rpd3L-Expanded complex), [GO:0071542](http://purl.obolibrary.org/obo/GO_0071542) (dopaminergic neuron differentiation), [GO:0070211](http://purl.obolibrary.org/obo/GO_0070211) (Snt2C complex), [GO:0035889](http://purl.obolibrary.org/obo/GO_0035889) (otolith tethering), [GO:0034553](http://purl.obolibrary.org/obo/GO_0034553) (mitochondrial respiratory chain complex II assembly), [GO:0071549](http://purl.obolibrary.org/obo/GO_0071549) (cellular response to dexamethasone stimulus), [GO:0035886](http://purl.obolibrary.org/obo/GO_0035886) (vascular smooth muscle cell differentiation), [GO:0071548](http://purl.obolibrary.org/obo/GO_0071548) (response to dexamethasone), [GO:0016723](http://purl.obolibrary.org/obo/GO_0016723) (oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor), [GO:0016726](http://purl.obolibrary.org/obo/GO_0016726) (oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor), [GO:0099073](http://purl.obolibrary.org/obo/GO_0099073) (mitochondrion-derived vesicle), [GO:0045203](http://purl.obolibrary.org/obo/GO_0045203) (integral component of cell outer membrane), [GO:0060844](http://purl.obolibrary.org/obo/GO_0060844) (arterial endothelial cell fate commitment), [GO:0047865](http://purl.obolibrary.org/obo/GO_0047865) (dimethylglycine dehydrogenase activity), [GO:0045202](http://purl.obolibrary.org/obo/GO_0045202) (synapse), [GO:0060847](http://purl.obolibrary.org/obo/GO_0060847) (endothelial cell fate specification), [GO:0060840](http://purl.obolibrary.org/obo/GO_0060840) (artery development), [GO:0046538](http://purl.obolibrary.org/obo/GO_0046538) (2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity), [GO:0004740](http://purl.obolibrary.org/obo/GO_0004740) (pyruvate dehydrogenase (acetyl-transferring) kinase activity), [GO:0060841](http://purl.obolibrary.org/obo/GO_0060841) (venous blood vessel development), [GO:0046539](http://purl.obolibrary.org/obo/GO_0046539) (histamine N-methyltransferase activity), [GO:0004742](http://purl.obolibrary.org/obo/GO_0004742) (dihydrolipoyllysine-residue acetyltransferase activity), [GO:0060842](http://purl.obolibrary.org/obo/GO_0060842) (arterial endothelial cell differentiation), [GO:0004741](http://purl.obolibrary.org/obo/GO_0004741) ([pyruvate dehydrogenase (lipoamide)] phosphatase activity), [GO:0004733](http://purl.obolibrary.org/obo/GO_0004733) (pyridoxamine-phosphate oxidase activity), [GO:0003401](http://purl.obolibrary.org/obo/GO_0003401) (axis elongation), [GO:0004735](http://purl.obolibrary.org/obo/GO_0004735) (pyrroline-5-carboxylate reductase activity), [GO:0003404](http://purl.obolibrary.org/obo/GO_0003404) (optic vesicle morphogenesis), [GO:0045211](http://purl.obolibrary.org/obo/GO_0045211) (postsynaptic membrane), [GO:0003406](http://purl.obolibrary.org/obo/GO_0003406) (retinal pigment epithelium development), [GO:0060849](http://purl.obolibrary.org/obo/GO_0060849) (regulation of transcription involved in lymphatic endothelial cell fate commitment), [GO:0004736](http://purl.obolibrary.org/obo/GO_0004736) (pyruvate carboxylase activity), [GO:0004739](http://purl.obolibrary.org/obo/GO_0004739) (pyruvate dehydrogenase (acetyl-transferring) activity), [GO:0003407](http://purl.obolibrary.org/obo/GO_0003407) (neural retina development), [GO:0046540](http://purl.obolibrary.org/obo/GO_0046540) (U4/U6 x U5 tri-snRNP complex), [GO:0004738](http://purl.obolibrary.org/obo/GO_0004738) (pyruvate dehydrogenase activity), [GO:0003409](http://purl.obolibrary.org/obo/GO_0003409) (optic cup structural organization), [GO:0033299](http://purl.obolibrary.org/obo/GO_0033299) (secretion of lysosomal enzymes), [GO:0016712](http://purl.obolibrary.org/obo/GO_0016712) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen), [GO:0033292](http://purl.obolibrary.org/obo/GO_0033292) (T-tubule organization), [GO:0016714](http://purl.obolibrary.org/obo/GO_0016714) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen), [GO:0099080](http://purl.obolibrary.org/obo/GO_0099080) (supramolecular complex), [GO:0016715](http://purl.obolibrary.org/obo/GO_0016715) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen), [GO:0016716](http://purl.obolibrary.org/obo/GO_0016716) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen), [GO:0045214](http://purl.obolibrary.org/obo/GO_0045214) (sarcomere organization), [GO:0099083](http://purl.obolibrary.org/obo/GO_0099083) (retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission), [GO:0060836](http://purl.obolibrary.org/obo/GO_0060836) (lymphatic endothelial cell differentiation), [GO:0046549](http://purl.obolibrary.org/obo/GO_0046549) (retinal cone cell development), [GO:0004751](http://purl.obolibrary.org/obo/GO_0004751) (ribose-5-phosphate isomerase activity), [GO:0060830](http://purl.obolibrary.org/obo/GO_0060830) (ciliary receptor clustering involved in smoothened signaling pathway), [GO:0003420](http://purl.obolibrary.org/obo/GO_0003420) (regulation of growth plate cartilage chondrocyte proliferation), [GO:0045216](http://purl.obolibrary.org/obo/GO_0045216) (cell-cell junction organization), [GO:0060831](http://purl.obolibrary.org/obo/GO_0060831) (smoothened signaling pathway involved in dorsal/ventral neural tube patterning), [GO:0004753](http://purl.obolibrary.org/obo/GO_0004753) (saccharopine dehydrogenase activity), [GO:0046548](http://purl.obolibrary.org/obo/GO_0046548) (retinal rod cell development), [GO:0045217](http://purl.obolibrary.org/obo/GO_0045217) (cell-cell junction maintenance), [GO:0004743](http://purl.obolibrary.org/obo/GO_0004743) (pyruvate kinase activity), [GO:0003413](http://purl.obolibrary.org/obo/GO_0003413) (chondrocyte differentiation involved in endochondral bone morphogenesis), [GO:0004745](http://purl.obolibrary.org/obo/GO_0004745) (retinol dehydrogenase activity), [GO:0003416](http://purl.obolibrary.org/obo/GO_0003416) (endochondral bone growth), [GO:0060837](http://purl.obolibrary.org/obo/GO_0060837) (blood vessel endothelial cell differentiation), [GO:0004748](http://purl.obolibrary.org/obo/GO_0004748) (ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor), [GO:0045221](http://purl.obolibrary.org/obo/GO_0045221) (negative regulation of FasL biosynthetic process), [GO:0060838](http://purl.obolibrary.org/obo/GO_0060838) (lymphatic endothelial cell fate commitment), [GO:0004749](http://purl.obolibrary.org/obo/GO_0004749) (ribose phosphate diphosphokinase activity), [GO:0016701](http://purl.obolibrary.org/obo/GO_0016701) (oxidoreductase activity, acting on single donors with incorporation of molecular oxygen), [GO:0016702](http://purl.obolibrary.org/obo/GO_0016702) (oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen), [GO:0033280](http://purl.obolibrary.org/obo/GO_0033280) (response to vitamin D), [GO:0016705](http://purl.obolibrary.org/obo/GO_0016705) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen), [GO:0016706](http://purl.obolibrary.org/obo/GO_0016706) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors), [GO:0046556](http://purl.obolibrary.org/obo/GO_0046556) (alpha-L-arabinofuranosidase activity), [GO:0016709](http://purl.obolibrary.org/obo/GO_0016709) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen), [GO:0046554](http://purl.obolibrary.org/obo/GO_0046554) (malate dehydrogenase (NADP+) activity), [GO:0004720](http://purl.obolibrary.org/obo/GO_0004720) (protein-lysine 6-oxidase activity), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0004712](http://purl.obolibrary.org/obo/GO_0004712) (protein serine/threonine/tyrosine kinase activity), [GO:0004715](http://purl.obolibrary.org/obo/GO_0004715) (non-membrane spanning protein tyrosine kinase activity), [GO:0004714](http://purl.obolibrary.org/obo/GO_0004714) (transmembrane receptor protein tyrosine kinase activity), [GO:0004716](http://purl.obolibrary.org/obo/GO_0004716) (signal transducer, downstream of receptor, with protein tyrosine kinase activity), [GO:0033278](http://purl.obolibrary.org/obo/GO_0033278) (cell proliferation in midbrain), [GO:0033277](http://purl.obolibrary.org/obo/GO_0033277) (abortive mitotic cell cycle), [GO:0071514](http://purl.obolibrary.org/obo/GO_0071514) (genetic imprinting), [GO:0071507](http://purl.obolibrary.org/obo/GO_0071507) (MAPK cascade involved in conjugation with cellular fusion), [GO:0033270](http://purl.obolibrary.org/obo/GO_0033270) (paranode region of axon), [GO:0071508](http://purl.obolibrary.org/obo/GO_0071508) (activation of MAPK activity involved in conjugation with cellular fusion), [GO:0033275](http://purl.obolibrary.org/obo/GO_0033275) (actin-myosin filament sliding), [GO:0060855](http://purl.obolibrary.org/obo/GO_0060855) (venous endothelial cell migration involved in lymph vessel development), [GO:0060856](http://purl.obolibrary.org/obo/GO_0060856) (establishment of blood-brain barrier), [GO:0045234](http://purl.obolibrary.org/obo/GO_0045234) (protein palmitoleylation), [GO:0060852](http://purl.obolibrary.org/obo/GO_0060852) (regulation of transcription involved in venous endothelial cell fate commitment), [GO:0004731](http://purl.obolibrary.org/obo/GO_0004731) (purine-nucleoside phosphorylase activity), [GO:0045239](http://purl.obolibrary.org/obo/GO_0045239) (tricarboxylic acid cycle enzyme complex), [GO:0003400](http://purl.obolibrary.org/obo/GO_0003400) (regulation of COPII vesicle coating), [GO:0060854](http://purl.obolibrary.org/obo/GO_0060854) (branching involved in lymph vessel morphogenesis), [GO:0004722](http://purl.obolibrary.org/obo/GO_0004722) (protein serine/threonine phosphatase activity), [GO:1901727](http://purl.obolibrary.org/obo/GO_1901727) (positive regulation of histone deacetylase activity), [GO:0004721](http://purl.obolibrary.org/obo/GO_0004721) (phosphoprotein phosphatase activity), [GO:0004724](http://purl.obolibrary.org/obo/GO_0004724) (magnesium-dependent protein serine/threonine phosphatase activity), [GO:0004726](http://purl.obolibrary.org/obo/GO_0004726) (non-membrane spanning protein tyrosine phosphatase activity), [GO:0004725](http://purl.obolibrary.org/obo/GO_0004725) (protein tyrosine phosphatase activity), [GO:0045244](http://purl.obolibrary.org/obo/GO_0045244) (succinate-CoA ligase complex (GDP-forming)), [GO:0034599](http://purl.obolibrary.org/obo/GO_0034599) (cellular response to oxidative stress), [GO:0033268](http://purl.obolibrary.org/obo/GO_0033268) (node of Ranvier), [GO:0004729](http://purl.obolibrary.org/obo/GO_0004729) (oxygen-dependent protoporphyrinogen oxidase activity), [GO:0071506](http://purl.obolibrary.org/obo/GO_0071506) (cellular response to mycophenolic acid), [GO:0051642](http://purl.obolibrary.org/obo/GO_0051642) (centrosome localization), [GO:0000066](http://purl.obolibrary.org/obo/GO_0000066) (mitochondrial ornithine transport), [GO:0000064](http://purl.obolibrary.org/obo/GO_0000064) (L-ornithine transmembrane transporter activity), [GO:0000062](http://purl.obolibrary.org/obo/GO_0000062) (fatty-acyl-CoA binding), [GO:0048002](http://purl.obolibrary.org/obo/GO_0048002) (antigen processing and presentation of peptide antigen), [GO:0000060](http://purl.obolibrary.org/obo/GO_0000060) (protein import into nucleus, translocation), [GO:0051648](http://purl.obolibrary.org/obo/GO_0051648) (vesicle localization), [GO:0051646](http://purl.obolibrary.org/obo/GO_0051646) (mitochondrion localization), [GO:2000594](http://purl.obolibrary.org/obo/GO_2000594) (positive regulation of metanephric DCT cell differentiation), [GO:0050313](http://purl.obolibrary.org/obo/GO_0050313) (sulfur dioxygenase activity), [GO:0051647](http://purl.obolibrary.org/obo/GO_0051647) (nucleus localization), [GO:0051645](http://purl.obolibrary.org/obo/GO_0051645) (Golgi localization), [GO:2000597](http://purl.obolibrary.org/obo/GO_2000597) (positive regulation of optic nerve formation), [GO:0036003](http://purl.obolibrary.org/obo/GO_0036003) (positive regulation of transcription from RNA polymerase II promoter in response to stress), [GO:0048009](http://purl.obolibrary.org/obo/GO_0048009) (insulin-like growth factor receptor signaling pathway), [GO:0048008](http://purl.obolibrary.org/obo/GO_0048008) (platelet-derived growth factor receptor signaling pathway), [GO:0048007](http://purl.obolibrary.org/obo/GO_0048007) (antigen processing and presentation, exogenous lipid antigen via MHC class Ib), [GO:1903413](http://purl.obolibrary.org/obo/GO_1903413) (cellular response to bile acid), [GO:0048012](http://purl.obolibrary.org/obo/GO_0048012) (hepatocyte growth factor receptor signaling pathway), [GO:0048011](http://purl.obolibrary.org/obo/GO_0048011) (neurotrophin TRK receptor signaling pathway), [GO:0000077](http://purl.obolibrary.org/obo/GO_0000077) (DNA damage checkpoint), [GO:0048010](http://purl.obolibrary.org/obo/GO_0048010) (vascular endothelial growth factor receptor signaling pathway), [GO:0000076](http://purl.obolibrary.org/obo/GO_0000076) (DNA replication checkpoint), [GO:0048016](http://purl.obolibrary.org/obo/GO_0048016) (inositol phosphate-mediated signaling), [GO:0051650](http://purl.obolibrary.org/obo/GO_0051650) (establishment of vesicle localization), [GO:0048015](http://purl.obolibrary.org/obo/GO_0048015) (phosphatidylinositol-mediated signaling), [GO:0048013](http://purl.obolibrary.org/obo/GO_0048013) (ephrin receptor signaling pathway), [GO:0000070](http://purl.obolibrary.org/obo/GO_0000070) (mitotic sister chromatid segregation), [GO:0051656](http://purl.obolibrary.org/obo/GO_0051656) (establishment of organelle localization), [GO:1903421](http://purl.obolibrary.org/obo/GO_1903421) (regulation of synaptic vesicle recycling), [GO:0048018](http://purl.obolibrary.org/obo/GO_0048018) (receptor ligand activity), [GO:1903423](http://purl.obolibrary.org/obo/GO_1903423) (positive regulation of synaptic vesicle recycling), [GO:0048017](http://purl.obolibrary.org/obo/GO_0048017) (inositol lipid-mediated signaling), [GO:1904754](http://purl.obolibrary.org/obo/GO_1904754) (positive regulation of vascular associated smooth muscle cell migration), [GO:0000038](http://purl.obolibrary.org/obo/GO_0000038) (very long-chain fatty acid metabolic process), [GO:1903427](http://purl.obolibrary.org/obo/GO_1903427) (negative regulation of reactive oxygen species biosynthetic process), [GO:1903428](http://purl.obolibrary.org/obo/GO_1903428) (positive regulation of reactive oxygen species biosynthetic process), [GO:0000045](http://purl.obolibrary.org/obo/GO_0000045) (autophagosome assembly), [GO:0048023](http://purl.obolibrary.org/obo/GO_0048023) (positive regulation of melanin biosynthetic process), [GO:0002699](http://purl.obolibrary.org/obo/GO_0002699) (positive regulation of immune effector process), [GO:0048020](http://purl.obolibrary.org/obo/GO_0048020) (CCR chemokine receptor binding), [GO:0000042](http://purl.obolibrary.org/obo/GO_0000042) (protein targeting to Golgi), [GO:0048027](http://purl.obolibrary.org/obo/GO_0048027) (mRNA 5'-UTR binding), [GO:0051660](http://purl.obolibrary.org/obo/GO_0051660) (establishment of centrosome localization), [GO:0048026](http://purl.obolibrary.org/obo/GO_0048026) (positive regulation of mRNA splicing, via spliceosome), [GO:0048025](http://purl.obolibrary.org/obo/GO_0048025) (negative regulation of mRNA splicing, via spliceosome), [GO:0048024](http://purl.obolibrary.org/obo/GO_0048024) (regulation of mRNA splicing, via spliceosome), [GO:0051666](http://purl.obolibrary.org/obo/GO_0051666) (actin cortical patch localization), [GO:1903431](http://purl.obolibrary.org/obo/GO_1903431) (positive regulation of cell maturation), [GO:0048029](http://purl.obolibrary.org/obo/GO_0048029) (monosaccharide binding), [GO:1903435](http://purl.obolibrary.org/obo/GO_1903435) (positive regulation of constitutive secretory pathway), [GO:0000049](http://purl.obolibrary.org/obo/GO_0000049) (tRNA binding), [GO:1902109](http://purl.obolibrary.org/obo/GO_1902109) (negative regulation of mitochondrial membrane permeability involved in apoptotic process), [GO:0000048](http://purl.obolibrary.org/obo/GO_0000048) (peptidyltransferase activity), [GO:1903438](http://purl.obolibrary.org/obo/GO_1903438) (positive regulation of mitotic cytokinetic process), [GO:0048034](http://purl.obolibrary.org/obo/GO_0048034) (heme O biosynthetic process), [GO:0000056](http://purl.obolibrary.org/obo/GO_0000056) (ribosomal small subunit export from nucleus), [GO:0000055](http://purl.obolibrary.org/obo/GO_0000055) (ribosomal large subunit export from nucleus), [GO:0000053](http://purl.obolibrary.org/obo/GO_0000053) (argininosuccinate metabolic process), [GO:0048038](http://purl.obolibrary.org/obo/GO_0048038) (quinone binding), [GO:0000052](http://purl.obolibrary.org/obo/GO_0000052) (citrulline metabolic process), [GO:0048037](http://purl.obolibrary.org/obo/GO_0048037) (cofactor binding), [GO:0000050](http://purl.obolibrary.org/obo/GO_0000050) (urea cycle), [GO:0036057](http://purl.obolibrary.org/obo/GO_0036057) (slit diaphragm), [GO:0008821](http://purl.obolibrary.org/obo/GO_0008821) (crossover junction endodeoxyribonuclease activity), [GO:0008817](http://purl.obolibrary.org/obo/GO_0008817) (cob(I)yrinic acid a,c-diamide adenosyltransferase activity), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0051604](http://purl.obolibrary.org/obo/GO_0051604) (protein maturation), [GO:0051602](http://purl.obolibrary.org/obo/GO_0051602) (response to electrical stimulus), [GO:0051603](http://purl.obolibrary.org/obo/GO_0051603) (proteolysis involved in cellular protein catabolic process), [GO:0080182](http://purl.obolibrary.org/obo/GO_0080182) (histone H3-K4 trimethylation), [GO:0036042](http://purl.obolibrary.org/obo/GO_0036042) (long-chain fatty acyl-CoA binding), [GO:1904706](http://purl.obolibrary.org/obo/GO_1904706) (negative regulation of vascular smooth muscle cell proliferation), [GO:0008832](http://purl.obolibrary.org/obo/GO_0008832) (dGTPase activity), [GO:0007501](http://purl.obolibrary.org/obo/GO_0007501) (mesodermal cell fate specification), [GO:0051610](http://purl.obolibrary.org/obo/GO_0051610) (serotonin uptake), [GO:0008828](http://purl.obolibrary.org/obo/GO_0008828) (dATP pyrophosphohydrolase activity), [GO:0036038](http://purl.obolibrary.org/obo/GO_0036038) (MKS complex), [GO:0080154](http://purl.obolibrary.org/obo/GO_0080154) (regulation of fertilization), [GO:0036033](http://purl.obolibrary.org/obo/GO_0036033) (mediator complex binding), [GO:1904715](http://purl.obolibrary.org/obo/GO_1904715) (negative regulation of chaperone-mediated autophagy), [GO:0000079](http://purl.obolibrary.org/obo/GO_0000079) (regulation of cyclin-dependent protein serine/threonine kinase activity), [GO:1904709](http://purl.obolibrary.org/obo/GO_1904709) (negative regulation of granulosa cell apoptotic process), [GO:0000086](http://purl.obolibrary.org/obo/GO_0000086) (G2/M transition of mitotic cell cycle), [GO:1904707](http://purl.obolibrary.org/obo/GO_1904707) (positive regulation of vascular smooth muscle cell proliferation), [GO:0000083](http://purl.obolibrary.org/obo/GO_0000083) (regulation of transcription involved in G1/S transition of mitotic cell cycle), [GO:0000082](http://purl.obolibrary.org/obo/GO_0000082) (G1/S transition of mitotic cell cycle), [GO:0008802](http://purl.obolibrary.org/obo/GO_0008802) (betaine-aldehyde dehydrogenase activity), [GO:0000096](http://purl.obolibrary.org/obo/GO_0000096) (sulfur amino acid metabolic process), [GO:0000095](http://purl.obolibrary.org/obo/GO_0000095) (S-adenosyl-L-methionine transmembrane transporter activity), [GO:0061056](http://purl.obolibrary.org/obo/GO_0061056) (sclerotome development), [GO:0045806](http://purl.obolibrary.org/obo/GO_0045806) (negative regulation of endocytosis), [GO:0019516](http://purl.obolibrary.org/obo/GO_0019516) (lactate oxidation), [GO:0061052](http://purl.obolibrary.org/obo/GO_0061052) (negative regulation of cell growth involved in cardiac muscle cell development), [GO:0061053](http://purl.obolibrary.org/obo/GO_0061053) (somite development), [GO:0045807](http://purl.obolibrary.org/obo/GO_0045807) (positive regulation of endocytosis), [GO:0061055](http://purl.obolibrary.org/obo/GO_0061055) (myotome development), [GO:0021830](http://purl.obolibrary.org/obo/GO_0021830) (interneuron migration from the subpallium to the cortex), [GO:0036092](http://purl.obolibrary.org/obo/GO_0036092) (phosphatidylinositol-3-phosphate biosynthetic process), [GO:0021831](http://purl.obolibrary.org/obo/GO_0021831) (embryonic olfactory bulb interneuron precursor migration), [GO:0036094](http://purl.obolibrary.org/obo/GO_0036094) (small molecule binding), [GO:1903489](http://purl.obolibrary.org/obo/GO_1903489) (positive regulation of lactation), [GO:0007530](http://purl.obolibrary.org/obo/GO_0007530) (sex determination), [GO:0007535](http://purl.obolibrary.org/obo/GO_0007535) (donor selection), [GO:0008865](http://purl.obolibrary.org/obo/GO_0008865) (fructokinase activity), [GO:0007533](http://purl.obolibrary.org/obo/GO_0007533) (mating type switching), [GO:0006203](http://purl.obolibrary.org/obo/GO_0006203) (dGTP catabolic process), [GO:0007528](http://purl.obolibrary.org/obo/GO_0007528) (neuromuscular junction development), [GO:0097001](http://purl.obolibrary.org/obo/GO_0097001) (ceramide binding), [GO:0007529](http://purl.obolibrary.org/obo/GO_0007529) (establishment of synaptic specificity at neuromuscular junction), [GO:0033814](http://purl.obolibrary.org/obo/GO_0033814) (propanoyl-CoA C-acyltransferase activity), [GO:0097002](http://purl.obolibrary.org/obo/GO_0097002) (mitochondrial inner boundary membrane), [GO:0097006](http://purl.obolibrary.org/obo/GO_0097006) (regulation of plasma lipoprotein particle levels), [GO:0097009](http://purl.obolibrary.org/obo/GO_0097009) (energy homeostasis), [GO:0061061](http://purl.obolibrary.org/obo/GO_0061061) (muscle structure development), [GO:0021828](http://purl.obolibrary.org/obo/GO_0021828) (gonadotrophin-releasing hormone neuronal migration to the hypothalamus), [GO:1902164](http://purl.obolibrary.org/obo/GO_1902164) (positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator), [GO:0045814](http://purl.obolibrary.org/obo/GO_0045814) (negative regulation of gene expression, epigenetic), [GO:0061048](http://purl.obolibrary.org/obo/GO_0061048) (negative regulation of branching involved in lung morphogenesis), [GO:1902167](http://purl.obolibrary.org/obo/GO_1902167) (positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:0006212](http://purl.obolibrary.org/obo/GO_0006212) (uracil catabolic process), [GO:0006210](http://purl.obolibrary.org/obo/GO_0006210) (thymine catabolic process), [GO:0006213](http://purl.obolibrary.org/obo/GO_0006213) (pyrimidine nucleoside metabolic process), [GO:0006214](http://purl.obolibrary.org/obo/GO_0006214) (thymidine catabolic process), [GO:0006208](http://purl.obolibrary.org/obo/GO_0006208) (pyrimidine nucleobase catabolic process), [GO:0097011](http://purl.obolibrary.org/obo/GO_0097011) (cellular response to granulocyte macrophage colony-stimulating factor stimulus), [GO:0006206](http://purl.obolibrary.org/obo/GO_0006206) (pyrimidine nucleobase metabolic process), [GO:0006207](http://purl.obolibrary.org/obo/GO_0006207) ('de novo' pyrimidine nucleobase biosynthetic process), [GO:0061051](http://purl.obolibrary.org/obo/GO_0061051) (positive regulation of cell growth involved in cardiac muscle cell development), [GO:0019510](http://purl.obolibrary.org/obo/GO_0019510) (S-adenosylhomocysteine catabolic process), [GO:0021819](http://purl.obolibrary.org/obo/GO_0021819) (layer formation in cerebral cortex), [GO:1902178](http://purl.obolibrary.org/obo/GO_1902178) (fibroblast growth factor receptor apoptotic signaling pathway), [GO:0061074](http://purl.obolibrary.org/obo/GO_0061074) (regulation of neural retina development), [GO:1902176](http://purl.obolibrary.org/obo/GO_1902176) (negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway), [GO:0036076](http://purl.obolibrary.org/obo/GO_0036076) (ligamentous ossification), [GO:0061077](http://purl.obolibrary.org/obo/GO_0061077) (chaperone-mediated protein folding), [GO:0045820](http://purl.obolibrary.org/obo/GO_0045820) (negative regulation of glycolytic process), [GO:0045823](http://purl.obolibrary.org/obo/GO_0045823) (positive regulation of heart contraction), [GO:0045824](http://purl.obolibrary.org/obo/GO_0045824) (negative regulation of innate immune response), [GO:0045821](http://purl.obolibrary.org/obo/GO_0045821) (positive regulation of glycolytic process), [GO:0007512](http://purl.obolibrary.org/obo/GO_0007512) (adult heart development), [GO:0045822](http://purl.obolibrary.org/obo/GO_0045822) (negative regulation of heart contraction), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0099641](http://purl.obolibrary.org/obo/GO_0099641) (anterograde axonal protein transport), [GO:0099645](http://purl.obolibrary.org/obo/GO_0099645) (neurotransmitter receptor localization to postsynaptic specialization membrane), [GO:0045838](http://purl.obolibrary.org/obo/GO_0045838) (positive regulation of membrane potential), [GO:0045839](http://purl.obolibrary.org/obo/GO_0045839) (negative regulation of mitotic nuclear division), [GO:0036064](http://purl.obolibrary.org/obo/GO_0036064) (ciliary basal body), [GO:0036066](http://purl.obolibrary.org/obo/GO_0036066) (protein O-linked fucosylation), [GO:1902188](http://purl.obolibrary.org/obo/GO_1902188) (positive regulation of viral release from host cell), [GO:0045830](http://purl.obolibrary.org/obo/GO_0045830) (positive regulation of isotype switching), [GO:0007520](http://purl.obolibrary.org/obo/GO_0007520) (myoblast fusion), [GO:0036060](http://purl.obolibrary.org/obo/GO_0036060) (slit diaphragm assembly), [GO:0007521](http://purl.obolibrary.org/obo/GO_0007521) (muscle cell fate determination), [GO:0021800](http://purl.obolibrary.org/obo/GO_0021800) (cerebral cortex tangential migration), [GO:0045834](http://purl.obolibrary.org/obo/GO_0045834) (positive regulation of lipid metabolic process), [GO:0007525](http://purl.obolibrary.org/obo/GO_0007525) (somatic muscle development), [GO:0045835](http://purl.obolibrary.org/obo/GO_0045835) (negative regulation of meiotic nuclear division), [GO:0007522](http://purl.obolibrary.org/obo/GO_0007522) (visceral muscle development), [GO:0045833](http://purl.obolibrary.org/obo/GO_0045833) (negative regulation of lipid metabolic process), [GO:0008853](http://purl.obolibrary.org/obo/GO_0008853) (exodeoxyribonuclease III activity), [GO:0007517](http://purl.obolibrary.org/obo/GO_0007517) (muscle organ development), [GO:0007519](http://purl.obolibrary.org/obo/GO_0007519) (skeletal muscle tissue development), [GO:0061072](http://purl.obolibrary.org/obo/GO_0061072) (iris morphogenesis), [GO:0061073](http://purl.obolibrary.org/obo/GO_0061073) (ciliary body morphogenesis), [GO:0085020](http://purl.obolibrary.org/obo/GO_0085020) (protein K6-linked ubiquitination), [GO:0061014](http://purl.obolibrary.org/obo/GO_0061014) (positive regulation of mRNA catabolic process), [GO:0007571](http://purl.obolibrary.org/obo/GO_0007571) (age-dependent general metabolic decline), [GO:0006241](http://purl.obolibrary.org/obo/GO_0006241) (CTP biosynthetic process), [GO:0021879](http://purl.obolibrary.org/obo/GO_0021879) (forebrain neuron differentiation), [GO:0061010](http://purl.obolibrary.org/obo/GO_0061010) (gall bladder development), [GO:1903441](http://purl.obolibrary.org/obo/GO_1903441) (protein localization to ciliary membrane), [GO:1903445](http://purl.obolibrary.org/obo/GO_1903445) (protein transport from ciliary membrane to plasma membrane), [GO:0048039](http://purl.obolibrary.org/obo/GO_0048039) (ubiquinone binding), [GO:0021871](http://purl.obolibrary.org/obo/GO_0021871) (forebrain regionalization), [GO:0061017](http://purl.obolibrary.org/obo/GO_0061017) (hepatoblast differentiation), [GO:1903449](http://purl.obolibrary.org/obo/GO_1903449) (androst-4-ene-3,17-dione biosynthetic process), [GO:0032528](http://purl.obolibrary.org/obo/GO_0032528) (microvillus organization), [GO:0032526](http://purl.obolibrary.org/obo/GO_0032526) (response to retinoic acid), [GO:0032527](http://purl.obolibrary.org/obo/GO_0032527) (protein exit from endoplasmic reticulum), [GO:0051683](http://purl.obolibrary.org/obo/GO_0051683) (establishment of Golgi localization), [GO:0048048](http://purl.obolibrary.org/obo/GO_0048048) (embryonic eye morphogenesis), [GO:0018230](http://purl.obolibrary.org/obo/GO_0018230) (peptidyl-L-cysteine S-palmitoylation), [GO:0019563](http://purl.obolibrary.org/obo/GO_0019563) (glycerol catabolic process), [GO:0019568](http://purl.obolibrary.org/obo/GO_0019568) (arabinose catabolic process), [GO:0032525](http://purl.obolibrary.org/obo/GO_0032525) (somite rostral/caudal axis specification), [GO:0061002](http://purl.obolibrary.org/obo/GO_0061002) (negative regulation of dendritic spine morphogenesis), [GO:1904781](http://purl.obolibrary.org/obo/GO_1904781) (positive regulation of protein localization to centrosome), [GO:0061003](http://purl.obolibrary.org/obo/GO_0061003) (positive regulation of dendritic spine morphogenesis), [GO:1904784](http://purl.obolibrary.org/obo/GO_1904784) (NLRP1 inflammasome complex assembly), [GO:0061009](http://purl.obolibrary.org/obo/GO_0061009) (common bile duct development), [GO:0007586](http://purl.obolibrary.org/obo/GO_0007586) (digestion), [GO:0007584](http://purl.obolibrary.org/obo/GO_0007584) (response to nutrient), [GO:0007585](http://purl.obolibrary.org/obo/GO_0007585) (respiratory gaseous exchange), [GO:1903457](http://purl.obolibrary.org/obo/GO_1903457) (lactate catabolic process), [GO:0061005](http://purl.obolibrary.org/obo/GO_0061005) (cell differentiation involved in kidney development), [GO:0006259](http://purl.obolibrary.org/obo/GO_0006259) (DNA metabolic process), [GO:0021860](http://purl.obolibrary.org/obo/GO_0021860) (pyramidal neuron development), [GO:0007588](http://purl.obolibrary.org/obo/GO_0007588) (excretion), [GO:0061007](http://purl.obolibrary.org/obo/GO_0061007) (hepaticobiliary system process), [GO:0061008](http://purl.obolibrary.org/obo/GO_0061008) (hepaticobiliary system development), [GO:0006258](http://purl.obolibrary.org/obo/GO_0006258) (UDP-glucose catabolic process), [GO:0051693](http://purl.obolibrary.org/obo/GO_0051693) (actin filament capping), [GO:0032510](http://purl.obolibrary.org/obo/GO_0032510) (endosome to lysosome transport via multivesicular body sorting pathway), [GO:0032511](http://purl.obolibrary.org/obo/GO_0032511) (late endosome to vacuole transport via multivesicular body sorting pathway), [GO:0061034](http://purl.obolibrary.org/obo/GO_0061034) (olfactory bulb mitral cell layer development), [GO:0061035](http://purl.obolibrary.org/obo/GO_0061035) (regulation of cartilage development), [GO:0019538](http://purl.obolibrary.org/obo/GO_0019538) (protein metabolic process), [GO:0061036](http://purl.obolibrary.org/obo/GO_0061036) (positive regulation of cartilage development), [GO:0061037](http://purl.obolibrary.org/obo/GO_0061037) (negative regulation of cartilage development), [GO:0061031](http://purl.obolibrary.org/obo/GO_0061031) (endodermal digestive tract morphogenesis), [GO:0061032](http://purl.obolibrary.org/obo/GO_0061032) (visceral serous pericardium development), [GO:0006222](http://purl.obolibrary.org/obo/GO_0006222) (UMP biosynthetic process), [GO:0021852](http://purl.obolibrary.org/obo/GO_0021852) (pyramidal neuron migration), [GO:0021853](http://purl.obolibrary.org/obo/GO_0021853) (cerebral cortex GABAergic interneuron migration), [GO:0021854](http://purl.obolibrary.org/obo/GO_0021854) (hypothalamus development), [GO:1904798](http://purl.obolibrary.org/obo/GO_1904798) (positive regulation of core promoter binding), [GO:0021855](http://purl.obolibrary.org/obo/GO_0021855) (hypothalamus cell migration), [GO:1903468](http://purl.obolibrary.org/obo/GO_1903468) (positive regulation of DNA replication initiation), [GO:0006221](http://purl.obolibrary.org/obo/GO_0006221) (pyrimidine nucleotide biosynthetic process), [GO:0008887](http://purl.obolibrary.org/obo/GO_0008887) (glycerate kinase activity), [GO:0048066](http://purl.obolibrary.org/obo/GO_0048066) (developmental pigmentation), [GO:0032507](http://purl.obolibrary.org/obo/GO_0032507) (maintenance of protein location in cell), [GO:0007548](http://purl.obolibrary.org/obo/GO_0007548) (sex differentiation), [GO:0032508](http://purl.obolibrary.org/obo/GO_0032508) (DNA duplex unwinding), [GO:0048069](http://purl.obolibrary.org/obo/GO_0048069) (eye pigmentation), [GO:0099606](http://purl.obolibrary.org/obo/GO_0099606) (microtubule plus-end directed mitotic chromosome migration), [GO:0099607](http://purl.obolibrary.org/obo/GO_0099607) (lateral attachment of mitotic spindle microtubules to kinetochore), [GO:0099604](http://purl.obolibrary.org/obo/GO_0099604) (ligand-gated calcium channel activity), [GO:0032502](http://purl.obolibrary.org/obo/GO_0032502) (developmental process), [GO:0018216](http://purl.obolibrary.org/obo/GO_0018216) (peptidyl-arginine methylation), [GO:0019547](http://purl.obolibrary.org/obo/GO_0019547) (arginine catabolic process to ornithine), [GO:0061024](http://purl.obolibrary.org/obo/GO_0061024) (membrane organization), [GO:0061025](http://purl.obolibrary.org/obo/GO_0061025) (membrane fusion), [GO:0061026](http://purl.obolibrary.org/obo/GO_0061026) (cardiac muscle tissue regeneration), [GO:0021846](http://purl.obolibrary.org/obo/GO_0021846) (cell proliferation in forebrain), [GO:0007565](http://purl.obolibrary.org/obo/GO_0007565) (female pregnancy), [GO:0007568](http://purl.obolibrary.org/obo/GO_0007568) (aging), [GO:0061028](http://purl.obolibrary.org/obo/GO_0061028) (establishment of endothelial barrier), [GO:0007569](http://purl.obolibrary.org/obo/GO_0007569) (cell aging), [GO:0061029](http://purl.obolibrary.org/obo/GO_0061029) (eyelid development in camera-type eye), [GO:0007566](http://purl.obolibrary.org/obo/GO_0007566) (embryo implantation), [GO:0007567](http://purl.obolibrary.org/obo/GO_0007567) (parturition), [GO:0006228](http://purl.obolibrary.org/obo/GO_0006228) (UTP biosynthetic process), [GO:0048076](http://purl.obolibrary.org/obo/GO_0048076) (regulation of compound eye pigmentation), [GO:0033829](http://purl.obolibrary.org/obo/GO_0033829) (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity), [GO:0019531](http://purl.obolibrary.org/obo/GO_0019531) (oxalate transmembrane transporter activity), [GO:0048070](http://purl.obolibrary.org/obo/GO_0048070) (regulation of developmental pigmentation), [GO:0019530](http://purl.obolibrary.org/obo/GO_0019530) (taurine metabolic process), [GO:0099615](http://purl.obolibrary.org/obo/GO_0099615) ((D)-2-hydroxyglutarate-pyruvate transhydrogenase activity), [GO:0019532](http://purl.obolibrary.org/obo/GO_0019532) (oxalate transport), [GO:0019534](http://purl.obolibrary.org/obo/GO_0019534) (toxin transmembrane transporter activity), [GO:0018205](http://purl.obolibrary.org/obo/GO_0018205) (peptidyl-lysine modification), [GO:0070728](http://purl.obolibrary.org/obo/GO_0070728) (leucine binding), [GO:0006163](http://purl.obolibrary.org/obo/GO_0006163) (purine nucleotide metabolic process), [GO:0032450](http://purl.obolibrary.org/obo/GO_0032450) (maltose alpha-glucosidase activity), [GO:0006164](http://purl.obolibrary.org/obo/GO_0006164) (purine nucleotide biosynthetic process), [GO:0031120](http://purl.obolibrary.org/obo/GO_0031120) (snRNA pseudouridine synthesis), [GO:0032451](http://purl.obolibrary.org/obo/GO_0032451) (demethylase activity), [GO:0007492](http://purl.obolibrary.org/obo/GO_0007492) (endoderm development), [GO:0006161](http://purl.obolibrary.org/obo/GO_0006161) (deoxyguanosine catabolic process), [GO:0007493](http://purl.obolibrary.org/obo/GO_0007493) (endodermal cell fate determination), [GO:0006167](http://purl.obolibrary.org/obo/GO_0006167) (AMP biosynthetic process), [GO:0007498](http://purl.obolibrary.org/obo/GO_0007498) (mesoderm development), [GO:0007499](http://purl.obolibrary.org/obo/GO_0007499) (ectoderm and mesoderm interaction), [GO:0006168](http://purl.obolibrary.org/obo/GO_0006168) (adenine salvage), [GO:0045765](http://purl.obolibrary.org/obo/GO_0045765) (regulation of angiogenesis), [GO:0021798](http://purl.obolibrary.org/obo/GO_0021798) (forebrain dorsal/ventral pattern formation), [GO:0043103](http://purl.obolibrary.org/obo/GO_0043103) (hypoxanthine salvage), [GO:0006165](http://purl.obolibrary.org/obo/GO_0006165) (nucleoside diphosphate phosphorylation), [GO:0045762](http://purl.obolibrary.org/obo/GO_0045762) (positive regulation of adenylate cyclase activity), [GO:0006166](http://purl.obolibrary.org/obo/GO_0006166) (purine ribonucleoside salvage), [GO:0007497](http://purl.obolibrary.org/obo/GO_0007497) (posterior midgut development), [GO:0021794](http://purl.obolibrary.org/obo/GO_0021794) (thalamus development), [GO:0021795](http://purl.obolibrary.org/obo/GO_0021795) (cerebral cortex cell migration), [GO:0045766](http://purl.obolibrary.org/obo/GO_0045766) (positive regulation of angiogenesis), [GO:0006169](http://purl.obolibrary.org/obo/GO_0006169) (adenosine salvage), [GO:0021796](http://purl.obolibrary.org/obo/GO_0021796) (cerebral cortex regionalization), [GO:0032449](http://purl.obolibrary.org/obo/GO_0032449) (CBM complex), [GO:0031118](http://purl.obolibrary.org/obo/GO_0031118) (rRNA pseudouridine synthesis), [GO:0031119](http://purl.obolibrary.org/obo/GO_0031119) (tRNA pseudouridine synthesis), [GO:0019483](http://purl.obolibrary.org/obo/GO_0019483) (beta-alanine biosynthetic process), [GO:0019482](http://purl.obolibrary.org/obo/GO_0019482) (beta-alanine metabolic process), [GO:0019484](http://purl.obolibrary.org/obo/GO_0019484) (beta-alanine catabolic process), [GO:0032443](http://purl.obolibrary.org/obo/GO_0032443) (regulation of ergosterol biosynthetic process), [GO:0031113](http://purl.obolibrary.org/obo/GO_0031113) (regulation of microtubule polymerization), [GO:0031110](http://purl.obolibrary.org/obo/GO_0031110) (regulation of microtubule polymerization or depolymerization), [GO:0070724](http://purl.obolibrary.org/obo/GO_0070724) (BMP receptor complex), [GO:0031116](http://purl.obolibrary.org/obo/GO_0031116) (positive regulation of microtubule polymerization), [GO:0032447](http://purl.obolibrary.org/obo/GO_0032447) (protein urmylation), [GO:0031117](http://purl.obolibrary.org/obo/GO_0031117) (positive regulation of microtubule depolymerization), [GO:0032445](http://purl.obolibrary.org/obo/GO_0032445) (fructose import), [GO:0070723](http://purl.obolibrary.org/obo/GO_0070723) (response to cholesterol), [GO:0031115](http://purl.obolibrary.org/obo/GO_0031115) (negative regulation of microtubule polymerization), [GO:0006171](http://purl.obolibrary.org/obo/GO_0006171) (cAMP biosynthetic process), [GO:0070715](http://purl.obolibrary.org/obo/GO_0070715) (sodium-dependent organic cation transport), [GO:0006175](http://purl.obolibrary.org/obo/GO_0006175) (dATP biosynthetic process), [GO:0006172](http://purl.obolibrary.org/obo/GO_0006172) (ADP biosynthetic process), [GO:0006178](http://purl.obolibrary.org/obo/GO_0006178) (guanine salvage), [GO:0045776](http://purl.obolibrary.org/obo/GO_0045776) (negative regulation of blood pressure), [GO:0043111](http://purl.obolibrary.org/obo/GO_0043111) (replication fork arrest), [GO:0045773](http://purl.obolibrary.org/obo/GO_0045773) (positive regulation of axon extension), [GO:0043114](http://purl.obolibrary.org/obo/GO_0043114) (regulation of vascular permeability), [GO:0043113](http://purl.obolibrary.org/obo/GO_0043113) (receptor clustering), [GO:0021782](http://purl.obolibrary.org/obo/GO_0021782) (glial cell development), [GO:0045779](http://purl.obolibrary.org/obo/GO_0045779) (negative regulation of bone resorption), [GO:0045777](http://purl.obolibrary.org/obo/GO_0045777) (positive regulation of blood pressure), [GO:0045778](http://purl.obolibrary.org/obo/GO_0045778) (positive regulation of ossification), [GO:0043117](http://purl.obolibrary.org/obo/GO_0043117) (positive regulation of vascular permeability), [GO:0031109](http://purl.obolibrary.org/obo/GO_0031109) (microtubule polymerization or depolymerization), [GO:0032438](http://purl.obolibrary.org/obo/GO_0032438) (melanosome organization), [GO:0019470](http://purl.obolibrary.org/obo/GO_0019470) (4-hydroxyproline catabolic process), [GO:0045780](http://purl.obolibrary.org/obo/GO_0045780) (positive regulation of bone resorption), [GO:0043121](http://purl.obolibrary.org/obo/GO_0043121) (neurotrophin binding), [GO:0043120](http://purl.obolibrary.org/obo/GO_0043120) (tumor necrosis factor binding), [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration), [GO:0032432](http://purl.obolibrary.org/obo/GO_0032432) (actin filament bundle), [GO:0031102](http://purl.obolibrary.org/obo/GO_0031102) (neuron projection regeneration), [GO:0032433](http://purl.obolibrary.org/obo/GO_0032433) (filopodium tip), [GO:0033762](http://purl.obolibrary.org/obo/GO_0033762) (response to glucagon), [GO:0031100](http://purl.obolibrary.org/obo/GO_0031100) (animal organ regeneration), [GO:0019477](http://purl.obolibrary.org/obo/GO_0019477) (L-lysine catabolic process), [GO:0032436](http://purl.obolibrary.org/obo/GO_0032436) (positive regulation of proteasomal ubiquitin-dependent protein catabolic process), [GO:0018149](http://purl.obolibrary.org/obo/GO_0018149) (peptide cross-linking), [GO:0032437](http://purl.obolibrary.org/obo/GO_0032437) (cuticular plate), [GO:0031106](http://purl.obolibrary.org/obo/GO_0031106) (septin ring organization), [GO:0031103](http://purl.obolibrary.org/obo/GO_0031103) (axon regeneration), [GO:0032434](http://purl.obolibrary.org/obo/GO_0032434) (regulation of proteasomal ubiquitin-dependent protein catabolic process), [GO:0032435](http://purl.obolibrary.org/obo/GO_0032435) (negative regulation of proteasomal ubiquitin-dependent protein catabolic process), [GO:0031104](http://purl.obolibrary.org/obo/GO_0031104) (dendrite regeneration), [GO:0043123](http://purl.obolibrary.org/obo/GO_0043123) (positive regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0045786](http://purl.obolibrary.org/obo/GO_0045786) (negative regulation of cell cycle), [GO:0021775](http://purl.obolibrary.org/obo/GO_0021775) (smoothened signaling pathway involved in ventral spinal cord interneuron specification), [GO:0006145](http://purl.obolibrary.org/obo/GO_0006145) (purine nucleobase catabolic process), [GO:0043122](http://purl.obolibrary.org/obo/GO_0043122) (regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0045787](http://purl.obolibrary.org/obo/GO_0045787) (positive regulation of cell cycle), [GO:0021776](http://purl.obolibrary.org/obo/GO_0021776) (smoothened signaling pathway involved in spinal cord motor neuron cell fate specification), [GO:0045785](http://purl.obolibrary.org/obo/GO_0045785) (positive regulation of cell adhesion), [GO:0006144](http://purl.obolibrary.org/obo/GO_0006144) (purine nucleobase metabolic process), [GO:0043124](http://purl.obolibrary.org/obo/GO_0043124) (negative regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0021778](http://purl.obolibrary.org/obo/GO_0021778) (oligodendrocyte cell fate specification), [GO:0044458](http://purl.obolibrary.org/obo/GO_0044458) (motile cilium assembly), [GO:0006149](http://purl.obolibrary.org/obo/GO_0006149) (deoxyinosine catabolic process), [GO:0021772](http://purl.obolibrary.org/obo/GO_0021772) (olfactory bulb development), [GO:0043129](http://purl.obolibrary.org/obo/GO_0043129) (surfactant homeostasis), [GO:0021773](http://purl.obolibrary.org/obo/GO_0021773) (striatal medium spiny neuron differentiation), [GO:0006148](http://purl.obolibrary.org/obo/GO_0006148) (inosine catabolic process), [GO:0043128](http://purl.obolibrary.org/obo/GO_0043128) (positive regulation of 1-phosphatidylinositol 4-kinase activity), [GO:0032429](http://purl.obolibrary.org/obo/GO_0032429) (regulation of phospholipase A2 activity), [GO:0045793](http://purl.obolibrary.org/obo/GO_0045793) (positive regulation of cell size), [GO:0043130](http://purl.obolibrary.org/obo/GO_0043130) (ubiquitin binding), [GO:1990666](http://purl.obolibrary.org/obo/GO_1990666) (PCSK9-LDLR complex), [GO:1990667](http://purl.obolibrary.org/obo/GO_1990667) (PCSK9-AnxA2 complex), [GO:0045792](http://purl.obolibrary.org/obo/GO_0045792) (negative regulation of cell size), [GO:0032421](http://purl.obolibrary.org/obo/GO_0032421) (stereocilium bundle), [GO:0070742](http://purl.obolibrary.org/obo/GO_0070742) (C2H2 zinc finger domain binding), [GO:0055102](http://purl.obolibrary.org/obo/GO_0055102) (lipase inhibitor activity), [GO:0019464](http://purl.obolibrary.org/obo/GO_0019464) (glycine decarboxylation via glycine cleavage system), [GO:0055103](http://purl.obolibrary.org/obo/GO_0055103) (ligase regulator activity), [GO:0070740](http://purl.obolibrary.org/obo/GO_0070740) (tubulin-glutamic acid ligase activity), [GO:0032420](http://purl.obolibrary.org/obo/GO_0032420) (stereocilium), [GO:0032425](http://purl.obolibrary.org/obo/GO_0032425) (positive regulation of mismatch repair), [GO:0032426](http://purl.obolibrary.org/obo/GO_0032426) (stereocilium tip), [GO:0032423](http://purl.obolibrary.org/obo/GO_0032423) (regulation of mismatch repair), [GO:0018119](http://purl.obolibrary.org/obo/GO_0018119) (peptidyl-cysteine S-nitrosylation), [GO:0006150](http://purl.obolibrary.org/obo/GO_0006150) (hypoxanthine oxidation), [GO:0045797](http://purl.obolibrary.org/obo/GO_0045797) (positive regulation of intestinal cholesterol absorption), [GO:0021764](http://purl.obolibrary.org/obo/GO_0021764) (amygdala development), [GO:0006157](http://purl.obolibrary.org/obo/GO_0006157) (deoxyadenosine catabolic process), [GO:0021766](http://purl.obolibrary.org/obo/GO_0021766) (hippocampus development), [GO:0006154](http://purl.obolibrary.org/obo/GO_0006154) (adenosine catabolic process), [GO:0043138](http://purl.obolibrary.org/obo/GO_0043138) (3'-5' DNA helicase activity), [GO:0043137](http://purl.obolibrary.org/obo/GO_0043137) (DNA replication, removal of RNA primer), [GO:0021762](http://purl.obolibrary.org/obo/GO_0021762) (substantia nigra development), [GO:0021763](http://purl.obolibrary.org/obo/GO_0021763) (subthalamic nucleus development), [GO:0043139](http://purl.obolibrary.org/obo/GO_0043139) (5'-3' DNA helicase activity), [GO:0032418](http://purl.obolibrary.org/obo/GO_0032418) (lysosome localization), [GO:0032417](http://purl.obolibrary.org/obo/GO_0032417) (positive regulation of sodium:proton antiporter activity), [GO:0043141](http://purl.obolibrary.org/obo/GO_0043141) (ATP-dependent 5'-3' DNA helicase activity), [GO:0043140](http://purl.obolibrary.org/obo/GO_0043140) (ATP-dependent 3'-5' DNA helicase activity), [GO:0043143](http://purl.obolibrary.org/obo/GO_0043143) (regulation of translation by machinery localization), [GO:0043142](http://purl.obolibrary.org/obo/GO_0043142) (single-stranded DNA-dependent ATPase activity), [GO:0055113](http://purl.obolibrary.org/obo/GO_0055113) (epiboly involved in gastrulation with mouth forming second), [GO:0032411](http://purl.obolibrary.org/obo/GO_0032411) (positive regulation of transporter activity), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0055117](http://purl.obolibrary.org/obo/GO_0055117) (regulation of cardiac muscle contraction), [GO:0033745](http://purl.obolibrary.org/obo/GO_0033745) (L-methionine-(R)-S-oxide reductase activity), [GO:0018126](http://purl.obolibrary.org/obo/GO_0018126) (protein hydroxylation), [GO:0070734](http://purl.obolibrary.org/obo/GO_0070734) (histone H3-K27 methylation), [GO:0055119](http://purl.obolibrary.org/obo/GO_0055119) (relaxation of cardiac muscle), [GO:0033743](http://purl.obolibrary.org/obo/GO_0033743) (peptide-methionine (R)-S-oxide reductase activity), [GO:0045726](http://purl.obolibrary.org/obo/GO_0045726) (positive regulation of integrin biosynthetic process), [GO:0045727](http://purl.obolibrary.org/obo/GO_0045727) (positive regulation of translation), [GO:0032494](http://purl.obolibrary.org/obo/GO_0032494) (response to peptidoglycan), [GO:0032495](http://purl.obolibrary.org/obo/GO_0032495) (response to muramyl dipeptide), [GO:0031161](http://purl.obolibrary.org/obo/GO_0031161) (phosphatidylinositol catabolic process), [GO:1902078](http://purl.obolibrary.org/obo/GO_1902078) (positive regulation of lateral motor column neuron migration), [GO:0099590](http://purl.obolibrary.org/obo/GO_0099590) (neurotransmitter receptor internalization), [GO:0045721](http://purl.obolibrary.org/obo/GO_0045721) (negative regulation of gluconeogenesis), [GO:0045724](http://purl.obolibrary.org/obo/GO_0045724) (positive regulation of cilium assembly), [GO:0045725](http://purl.obolibrary.org/obo/GO_0045725) (positive regulation of glycogen biosynthetic process), [GO:0045722](http://purl.obolibrary.org/obo/GO_0045722) (positive regulation of gluconeogenesis), [GO:0045723](http://purl.obolibrary.org/obo/GO_0045723) (positive regulation of fatty acid biosynthetic process), [GO:1990683](http://purl.obolibrary.org/obo/GO_1990683) (DNA double-strand break attachment to nuclear envelope), [GO:0015909](http://purl.obolibrary.org/obo/GO_0015909) (long-chain fatty acid transport), [GO:0015908](http://purl.obolibrary.org/obo/GO_0015908) (fatty acid transport), [GO:0003923](http://purl.obolibrary.org/obo/GO_0003923) (GPI-anchor transamidase activity), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:0032488](http://purl.obolibrary.org/obo/GO_0032488) (Cdc42 protein signal transduction), [GO:1902072](http://purl.obolibrary.org/obo/GO_1902072) (negative regulation of hypoxia-inducible factor-1alpha signaling pathway), [GO:0045739](http://purl.obolibrary.org/obo/GO_0045739) (positive regulation of DNA repair), [GO:0032480](http://purl.obolibrary.org/obo/GO_0032480) (negative regulation of type I interferon production), [GO:0045737](http://purl.obolibrary.org/obo/GO_0045737) (positive regulation of cyclin-dependent protein serine/threonine kinase activity), [GO:0032481](http://purl.obolibrary.org/obo/GO_0032481) (positive regulation of type I interferon production), [GO:0045732](http://purl.obolibrary.org/obo/GO_0045732) (positive regulation of protein catabolic process), [GO:0045730](http://purl.obolibrary.org/obo/GO_0045730) (respiratory burst), [GO:0045736](http://purl.obolibrary.org/obo/GO_0045736) (negative regulation of cyclin-dependent protein serine/threonine kinase activity), [GO:2000607](http://purl.obolibrary.org/obo/GO_2000607) (negative regulation of cell proliferation involved in mesonephros development), [GO:1990696](http://purl.obolibrary.org/obo/GO_1990696) (USH2 complex), [GO:1990698](http://purl.obolibrary.org/obo/GO_1990698) (palmitoleoyltransferase activity), [GO:0003934](http://purl.obolibrary.org/obo/GO_0003934) (GTP cyclohydrolase I activity), [GO:0015918](http://purl.obolibrary.org/obo/GO_0015918) (sterol transport), [GO:0015917](http://purl.obolibrary.org/obo/GO_0015917) (aminophospholipid transport), [GO:0002606](http://purl.obolibrary.org/obo/GO_0002606) (positive regulation of dendritic cell antigen processing and presentation), [GO:0003937](http://purl.obolibrary.org/obo/GO_0003937) (IMP cyclohydrolase activity), [GO:0031145](http://purl.obolibrary.org/obo/GO_0031145) (anaphase-promoting complex-dependent catabolic process), [GO:0015914](http://purl.obolibrary.org/obo/GO_0015914) (phospholipid transport), [GO:0031146](http://purl.obolibrary.org/obo/GO_0031146) (SCF-dependent proteasomal ubiquitin-dependent protein catabolic process), [GO:0032474](http://purl.obolibrary.org/obo/GO_0032474) (otolith morphogenesis), [GO:2000601](http://purl.obolibrary.org/obo/GO_2000601) (positive regulation of Arp2/3 complex-mediated actin nucleation), [GO:0032475](http://purl.obolibrary.org/obo/GO_0032475) (otolith formation), [GO:0015910](http://purl.obolibrary.org/obo/GO_0015910) (peroxisomal long-chain fatty acid import), [GO:0006182](http://purl.obolibrary.org/obo/GO_0006182) (cGMP biosynthetic process), [GO:0032472](http://purl.obolibrary.org/obo/GO_0032472) (Golgi calcium ion transport), [GO:0006183](http://purl.obolibrary.org/obo/GO_0006183) (GTP biosynthetic process), [GO:0006189](http://purl.obolibrary.org/obo/GO_0006189) ('de novo' IMP biosynthetic process), [GO:0045742](http://purl.obolibrary.org/obo/GO_0045742) (positive regulation of epidermal growth factor receptor signaling pathway), [GO:0045743](http://purl.obolibrary.org/obo/GO_0045743) (positive regulation of fibroblast growth factor receptor signaling pathway), [GO:0045740](http://purl.obolibrary.org/obo/GO_0045740) (positive regulation of DNA replication), [GO:0006188](http://purl.obolibrary.org/obo/GO_0006188) (IMP biosynthetic process), [GO:0099572](http://purl.obolibrary.org/obo/GO_0099572) (postsynaptic specialization), [GO:0045746](http://purl.obolibrary.org/obo/GO_0045746) (negative regulation of Notch signaling pathway), [GO:0045747](http://purl.obolibrary.org/obo/GO_0045747) (positive regulation of Notch signaling pathway), [GO:0045744](http://purl.obolibrary.org/obo/GO_0045744) (negative regulation of G-protein coupled receptor protein signaling pathway), [GO:0045745](http://purl.obolibrary.org/obo/GO_0045745) (positive regulation of G-protein coupled receptor protein signaling pathway), [GO:0099565](http://purl.obolibrary.org/obo/GO_0099565) (chemical synaptic transmission, postsynaptic), [GO:2000617](http://purl.obolibrary.org/obo/GO_2000617) (positive regulation of histone H3-K9 acetylation), [GO:0099566](http://purl.obolibrary.org/obo/GO_0099566) (regulation of postsynaptic cytosolic calcium ion concentration), [GO:0099563](http://purl.obolibrary.org/obo/GO_0099563) (modification of synaptic structure), [GO:0099568](http://purl.obolibrary.org/obo/GO_0099568) (cytoplasmic region), [GO:0032465](http://purl.obolibrary.org/obo/GO_0032465) (regulation of cytokinesis), [GO:0031134](http://purl.obolibrary.org/obo/GO_0031134) (sister chromatid biorientation), [GO:0032463](http://purl.obolibrary.org/obo/GO_0032463) (negative regulation of protein homooligomerization), [GO:2000611](http://purl.obolibrary.org/obo/GO_2000611) (positive regulation of thyroid hormone generation), [GO:0003906](http://purl.obolibrary.org/obo/GO_0003906) (DNA-(apurinic or apyrimidinic site) lyase activity), [GO:0032464](http://purl.obolibrary.org/obo/GO_0032464) (positive regulation of protein homooligomerization), [GO:0031133](http://purl.obolibrary.org/obo/GO_0031133) (regulation of axon diameter), [GO:0032469](http://purl.obolibrary.org/obo/GO_0032469) (endoplasmic reticulum calcium ion homeostasis), [GO:0031138](http://purl.obolibrary.org/obo/GO_0031138) (negative regulation of conjugation with cellular fusion), [GO:0003909](http://purl.obolibrary.org/obo/GO_0003909) (DNA ligase activity), [GO:0032467](http://purl.obolibrary.org/obo/GO_0032467) (positive regulation of cytokinesis), [GO:0070700](http://purl.obolibrary.org/obo/GO_0070700) (BMP receptor binding), [GO:0032468](http://purl.obolibrary.org/obo/GO_0032468) (Golgi calcium ion homeostasis), [GO:0044428](http://purl.obolibrary.org/obo/GO_0044428) (nuclear part), [GO:0006193](http://purl.obolibrary.org/obo/GO_0006193) (ITP catabolic process), [GO:0045759](http://purl.obolibrary.org/obo/GO_0045759) (negative regulation of action potential), [GO:0032461](http://purl.obolibrary.org/obo/GO_0032461) (positive regulation of protein oligomerization), [GO:0033791](http://purl.obolibrary.org/obo/GO_0033791) (3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity), [GO:0006195](http://purl.obolibrary.org/obo/GO_0006195) (purine nucleotide catabolic process), [GO:0032460](http://purl.obolibrary.org/obo/GO_0032460) (negative regulation of protein oligomerization), [GO:0006198](http://purl.obolibrary.org/obo/GO_0006198) (cAMP catabolic process), [GO:0045751](http://purl.obolibrary.org/obo/GO_0045751) (negative regulation of Toll signaling pathway), [GO:0099583](http://purl.obolibrary.org/obo/GO_0099583) (neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration), [GO:0018160](http://purl.obolibrary.org/obo/GO_0018160) (peptidyl-pyrromethane cofactor linkage), [GO:0003910](http://purl.obolibrary.org/obo/GO_0003910) (DNA ligase (ATP) activity), [GO:0045760](http://purl.obolibrary.org/obo/GO_0045760) (positive regulation of action potential), [GO:2000627](http://purl.obolibrary.org/obo/GO_2000627) (positive regulation of miRNA catabolic process), [GO:2000620](http://purl.obolibrary.org/obo/GO_2000620) (positive regulation of histone H4-K16 acetylation), [GO:0032454](http://purl.obolibrary.org/obo/GO_0032454) (histone demethylase activity (H3-K9 specific)), [GO:0031124](http://purl.obolibrary.org/obo/GO_0031124) (mRNA 3'-end processing), [GO:0032452](http://purl.obolibrary.org/obo/GO_0032452) (histone demethylase activity), [GO:0031122](http://purl.obolibrary.org/obo/GO_0031122) (cytoplasmic microtubule organization), [GO:0032453](http://purl.obolibrary.org/obo/GO_0032453) (histone demethylase activity (H3-K4 specific)), [GO:0032456](http://purl.obolibrary.org/obo/GO_0032456) (endocytic recycling), [GO:0031126](http://purl.obolibrary.org/obo/GO_0031126) (snoRNA 3'-end processing), [GO:0033787](http://purl.obolibrary.org/obo/GO_0033787) (cyanocobalamin reductase (cyanide-eliminating) activity), [GO:0080130](http://purl.obolibrary.org/obo/GO_0080130) (L-phenylalanine:2-oxoglutarate aminotransferase activity), [GO:0001308](http://purl.obolibrary.org/obo/GO_0001308) (negative regulation of chromatin silencing involved in replicative cell aging), [GO:0001306](http://purl.obolibrary.org/obo/GO_0001306) (age-dependent response to oxidative stress), [GO:0001302](http://purl.obolibrary.org/obo/GO_0001302) (replicative cell aging), [GO:0001300](http://purl.obolibrary.org/obo/GO_0001300) (chronological cell aging), [GO:0002631](http://purl.obolibrary.org/obo/GO_0002631) (regulation of granuloma formation), [GO:0003962](http://purl.obolibrary.org/obo/GO_0003962) (cystathionine gamma-synthase activity), [GO:0002632](http://purl.obolibrary.org/obo/GO_0002632) (negative regulation of granuloma formation), [GO:0043194](http://purl.obolibrary.org/obo/GO_0043194) (axon initial segment), [GO:0003964](http://purl.obolibrary.org/obo/GO_0003964) (RNA-directed DNA polymerase activity), [GO:0002634](http://purl.obolibrary.org/obo/GO_0002634) (regulation of germinal center formation), [GO:0043196](http://purl.obolibrary.org/obo/GO_0043196) (varicosity), [GO:0043195](http://purl.obolibrary.org/obo/GO_0043195) (terminal bouton), [GO:0002636](http://purl.obolibrary.org/obo/GO_0002636) (positive regulation of germinal center formation), [GO:0043198](http://purl.obolibrary.org/obo/GO_0043198) (dendritic shaft), [GO:2000637](http://purl.obolibrary.org/obo/GO_2000637) (positive regulation of gene silencing by miRNA), [GO:0002637](http://purl.obolibrary.org/obo/GO_0002637) (regulation of immunoglobulin production), [GO:0043197](http://purl.obolibrary.org/obo/GO_0043197) (dendritic spine), [GO:0002638](http://purl.obolibrary.org/obo/GO_0002638) (negative regulation of immunoglobulin production), [GO:0002639](http://purl.obolibrary.org/obo/GO_0002639) (positive regulation of immunoglobulin production), [GO:2000630](http://purl.obolibrary.org/obo/GO_2000630) (positive regulation of miRNA metabolic process), [GO:0052906](http://purl.obolibrary.org/obo/GO_0052906) (tRNA (guanine(37)-N(1))-methyltransferase activity), [GO:0043199](http://purl.obolibrary.org/obo/GO_0043199) (sulfate binding), [GO:0080146](http://purl.obolibrary.org/obo/GO_0080146) (L-cysteine desulfhydrase activity), [GO:0001315](http://purl.obolibrary.org/obo/GO_0001315) (age-dependent response to reactive oxygen species), [GO:0003974](http://purl.obolibrary.org/obo/GO_0003974) (UDP-N-acetylglucosamine 4-epimerase activity), [GO:0001320](http://purl.obolibrary.org/obo/GO_0001320) (age-dependent response to reactive oxygen species involved in chronological cell aging), [GO:0003975](http://purl.obolibrary.org/obo/GO_0003975) (UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity), [GO:0003976](http://purl.obolibrary.org/obo/GO_0003976) (UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity), [GO:0003978](http://purl.obolibrary.org/obo/GO_0003978) (UDP-glucose 4-epimerase activity), [GO:2000647](http://purl.obolibrary.org/obo/GO_2000647) (negative regulation of stem cell proliferation), [GO:2000648](http://purl.obolibrary.org/obo/GO_2000648) (positive regulation of stem cell proliferation), [GO:2000649](http://purl.obolibrary.org/obo/GO_2000649) (regulation of sodium ion transmembrane transporter activity), [GO:0052905](http://purl.obolibrary.org/obo/GO_0052905) (tRNA (guanine(9)-N(1))-methyltransferase activity), [GO:0052917](http://purl.obolibrary.org/obo/GO_0052917) (dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity), [GO:0080111](http://purl.obolibrary.org/obo/GO_0080111) (DNA demethylation), [GO:0052918](http://purl.obolibrary.org/obo/GO_0052918) (dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity), [GO:0003940](http://purl.obolibrary.org/obo/GO_0003940) (L-iduronidase activity), [GO:0003942](http://purl.obolibrary.org/obo/GO_0003942) (N-acetyl-gamma-glutamyl-phosphate reductase activity), [GO:0003943](http://purl.obolibrary.org/obo/GO_0003943) (N-acetylgalactosamine-4-sulfatase activity), [GO:0003945](http://purl.obolibrary.org/obo/GO_0003945) (N-acetyllactosamine synthase activity), [GO:0015929](http://purl.obolibrary.org/obo/GO_0015929) (hexosaminidase activity), [GO:0015928](http://purl.obolibrary.org/obo/GO_0015928) (fucosidase activity), [GO:2000653](http://purl.obolibrary.org/obo/GO_2000653) (regulation of genetic imprinting), [GO:0003948](http://purl.obolibrary.org/obo/GO_0003948) (N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity), [GO:0015926](http://purl.obolibrary.org/obo/GO_0015926) (glucosidase activity), [GO:0031179](http://purl.obolibrary.org/obo/GO_0031179) (peptide modification), [GO:2000650](http://purl.obolibrary.org/obo/GO_2000650) (negative regulation of sodium ion transmembrane transporter activity), [GO:2000670](http://purl.obolibrary.org/obo/GO_2000670) (positive regulation of dendritic cell apoptotic process), [GO:0031174](http://purl.obolibrary.org/obo/GO_0031174) (lifelong otolith mineralization), [GO:0031175](http://purl.obolibrary.org/obo/GO_0031175) (neuron projection development), [GO:0052928](http://purl.obolibrary.org/obo/GO_0052928) (CTP:3'-cytidine-tRNA cytidylyltransferase activity), [GO:0052929](http://purl.obolibrary.org/obo/GO_0052929) (ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity), [GO:0003951](http://purl.obolibrary.org/obo/GO_0003951) (NAD+ kinase activity), [GO:0003954](http://purl.obolibrary.org/obo/GO_0003954) (NADH dehydrogenase activity), [GO:0002625](http://purl.obolibrary.org/obo/GO_0002625) (regulation of T cell antigen processing and presentation), [GO:0002626](http://purl.obolibrary.org/obo/GO_0002626) (negative regulation of T cell antigen processing and presentation), [GO:0003958](http://purl.obolibrary.org/obo/GO_0003958) (NADPH-hemoprotein reductase activity), [GO:0015937](http://purl.obolibrary.org/obo/GO_0015937) (coenzyme A biosynthetic process), [GO:2000664](http://purl.obolibrary.org/obo/GO_2000664) (positive regulation of interleukin-5 secretion), [GO:0052926](http://purl.obolibrary.org/obo/GO_0052926) (dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity), [GO:0052927](http://purl.obolibrary.org/obo/GO_0052927) (CTP:tRNA cytidylyltransferase activity), [GO:0015936](http://purl.obolibrary.org/obo/GO_0015936) (coenzyme A metabolic process), [GO:0032499](http://purl.obolibrary.org/obo/GO_0032499) (detection of peptidoglycan), [GO:0032496](http://purl.obolibrary.org/obo/GO_0032496) (response to lipopolysaccharide), [GO:0015935](http://purl.obolibrary.org/obo/GO_0015935) (small ribosomal subunit), [GO:2000667](http://purl.obolibrary.org/obo/GO_2000667) (positive regulation of interleukin-13 secretion), [GO:0015934](http://purl.obolibrary.org/obo/GO_0015934) (large ribosomal subunit), [GO:0032497](http://purl.obolibrary.org/obo/GO_0032497) (detection of lipopolysaccharide), [GO:0052925](http://purl.obolibrary.org/obo/GO_0052925) (dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity), [GO:0015992](http://purl.obolibrary.org/obo/GO_0015992) (proton transport), [GO:0015991](http://purl.obolibrary.org/obo/GO_0015991) (ATP hydrolysis coupled proton transport), [GO:0015990](http://purl.obolibrary.org/obo/GO_0015990) (electron transport coupled proton transport), [GO:0055131](http://purl.obolibrary.org/obo/GO_0055131) (C3HC4-type RING finger domain binding), [GO:0002682](http://purl.obolibrary.org/obo/GO_0002682) (regulation of immune system process), [GO:0043149](http://purl.obolibrary.org/obo/GO_0043149) (stress fiber assembly), [GO:0000016](http://purl.obolibrary.org/obo/GO_0000016) (lactase activity), [GO:0000015](http://purl.obolibrary.org/obo/GO_0000015) (phosphopyruvate hydratase complex), [GO:0000014](http://purl.obolibrary.org/obo/GO_0000014) (single-stranded DNA endodeoxyribonuclease activity), [GO:0002684](http://purl.obolibrary.org/obo/GO_0002684) (positive regulation of immune system process), [GO:0000023](http://purl.obolibrary.org/obo/GO_0000023) (maltose metabolic process), [GO:0002677](http://purl.obolibrary.org/obo/GO_0002677) (negative regulation of chronic inflammatory response), [GO:2000679](http://purl.obolibrary.org/obo/GO_2000679) (positive regulation of transcription regulatory region DNA binding), [GO:0002679](http://purl.obolibrary.org/obo/GO_0002679) (respiratory burst involved in defense response), [GO:0070761](http://purl.obolibrary.org/obo/GO_0070761) (pre-snoRNP complex), [GO:0043154](http://purl.obolibrary.org/obo/GO_0043154) (negative regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0043153](http://purl.obolibrary.org/obo/GO_0043153) (entrainment of circadian clock by photoperiod), [GO:0055123](http://purl.obolibrary.org/obo/GO_0055123) (digestive system development), [GO:2000675](http://purl.obolibrary.org/obo/GO_2000675) (negative regulation of type B pancreatic cell apoptotic process), [GO:0070765](http://purl.obolibrary.org/obo/GO_0070765) (gamma-secretase complex), [GO:2000676](http://purl.obolibrary.org/obo/GO_2000676) (positive regulation of type B pancreatic cell apoptotic process), [GO:2000678](http://purl.obolibrary.org/obo/GO_2000678) (negative regulation of transcription regulatory region DNA binding), [GO:2000671](http://purl.obolibrary.org/obo/GO_2000671) (regulation of motor neuron apoptotic process), [GO:2000672](http://purl.obolibrary.org/obo/GO_2000672) (negative regulation of motor neuron apoptotic process), [GO:0055129](http://purl.obolibrary.org/obo/GO_0055129) (L-proline biosynthetic process), [GO:0015986](http://purl.obolibrary.org/obo/GO_0015986) (ATP synthesis coupled proton transport), [GO:0002690](http://purl.obolibrary.org/obo/GO_0002690) (positive regulation of leukocyte chemotaxis), [GO:0002691](http://purl.obolibrary.org/obo/GO_0002691) (regulation of cellular extravasation), [GO:0000028](http://purl.obolibrary.org/obo/GO_0000028) (ribosomal small subunit assembly), [GO:0000027](http://purl.obolibrary.org/obo/GO_0000027) (ribosomal large subunit assembly), [GO:0000026](http://purl.obolibrary.org/obo/GO_0000026) (alpha-1,2-mannosyltransferase activity), [GO:0000025](http://purl.obolibrary.org/obo/GO_0000025) (maltose catabolic process), [GO:0002686](http://purl.obolibrary.org/obo/GO_0002686) (negative regulation of leukocyte migration), [GO:0002687](http://purl.obolibrary.org/obo/GO_0002687) (positive regulation of leukocyte migration), [GO:0000033](http://purl.obolibrary.org/obo/GO_0000033) (alpha-1,3-mannosyltransferase activity), [GO:0043161](http://purl.obolibrary.org/obo/GO_0043161) (proteasome-mediated ubiquitin-dependent protein catabolic process), [GO:0000032](http://purl.obolibrary.org/obo/GO_0000032) (cell wall mannoprotein biosynthetic process), [GO:0000030](http://purl.obolibrary.org/obo/GO_0000030) (mannosyltransferase activity), [GO:0043162](http://purl.obolibrary.org/obo/GO_0043162) (ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway), [GO:1990616](http://purl.obolibrary.org/obo/GO_1990616) (magnesium ion export from mitochondrion), [GO:2000683](http://purl.obolibrary.org/obo/GO_2000683) (regulation of cellular response to X-ray), [GO:0043169](http://purl.obolibrary.org/obo/GO_0043169) (cation binding), [GO:0043168](http://purl.obolibrary.org/obo/GO_0043168) (anion binding), [GO:0003991](http://purl.obolibrary.org/obo/GO_0003991) (acetylglutamate kinase activity), [GO:0001324](http://purl.obolibrary.org/obo/GO_0001324) (age-dependent response to oxidative stress involved in chronological cell aging), [GO:0003993](http://purl.obolibrary.org/obo/GO_0003993) (acid phosphatase activity), [GO:0003994](http://purl.obolibrary.org/obo/GO_0003994) (aconitate hydratase activity), [GO:0000001](http://purl.obolibrary.org/obo/GO_0000001) (mitochondrion inheritance), [GO:0003985](http://purl.obolibrary.org/obo/GO_0003985) (acetyl-CoA C-acetyltransferase activity), [GO:0043171](http://purl.obolibrary.org/obo/GO_0043171) (peptide catabolic process), [GO:0003988](http://purl.obolibrary.org/obo/GO_0003988) (acetyl-CoA C-acyltransferase activity), [GO:0003989](http://purl.obolibrary.org/obo/GO_0003989) (acetyl-CoA carboxylase activity), [GO:0043176](http://purl.obolibrary.org/obo/GO_0043176) (amine binding), [GO:0070781](http://purl.obolibrary.org/obo/GO_0070781) (response to biotin), [GO:0015966](http://purl.obolibrary.org/obo/GO_0015966) (diadenosine tetraphosphate biosynthetic process), [GO:0000009](http://purl.obolibrary.org/obo/GO_0000009) (alpha-1,6-mannosyltransferase activity), [GO:0043178](http://purl.obolibrary.org/obo/GO_0043178) (alcohol binding), [GO:0000002](http://purl.obolibrary.org/obo/GO_0000002) (mitochondrial genome maintenance), [GO:0002674](http://purl.obolibrary.org/obo/GO_0002674) (negative regulation of acute inflammatory response), [GO:0003995](http://purl.obolibrary.org/obo/GO_0003995) (acyl-CoA dehydrogenase activity), [GO:0000012](http://purl.obolibrary.org/obo/GO_0000012) (single strand break repair), [GO:0043181](http://purl.obolibrary.org/obo/GO_0043181) (vacuolar sequestering), [GO:0000011](http://purl.obolibrary.org/obo/GO_0000011) (vacuole inheritance), [GO:0000010](http://purl.obolibrary.org/obo/GO_0000010) (trans-hexaprenyltranstransferase activity), [GO:0043183](http://purl.obolibrary.org/obo/GO_0043183) (vascular endothelial growth factor receptor 1 binding), [GO:0003997](http://purl.obolibrary.org/obo/GO_0003997) (acyl-CoA oxidase activity), [GO:0002667](http://purl.obolibrary.org/obo/GO_0002667) (regulation of T cell anergy), [GO:0003999](http://purl.obolibrary.org/obo/GO_0003999) (adenine phosphoribosyltransferase activity), [GO:0043185](http://purl.obolibrary.org/obo/GO_0043185) (vascular endothelial growth factor receptor 3 binding), [GO:0002669](http://purl.obolibrary.org/obo/GO_0002669) (positive regulation of T cell anergy), [GO:0070772](http://purl.obolibrary.org/obo/GO_0070772) (PAS complex), [GO:0043184](http://purl.obolibrary.org/obo/GO_0043184) (vascular endothelial growth factor receptor 2 binding), [GO:0043186](http://purl.obolibrary.org/obo/GO_0043186) (P granule), [GO:0070779](http://purl.obolibrary.org/obo/GO_0070779) (D-aspartate import), [GO:0015976](http://purl.obolibrary.org/obo/GO_0015976) (carbon utilization), [GO:2000483](http://purl.obolibrary.org/obo/GO_2000483) (negative regulation of interleukin-8 secretion), [GO:0000178](http://purl.obolibrary.org/obo/GO_0000178) (exosome (RNase complex)), [GO:0050431](http://purl.obolibrary.org/obo/GO_0050431) (transforming growth factor beta binding), [GO:0000187](http://purl.obolibrary.org/obo/GO_0000187) (activation of MAPK activity), [GO:0051764](http://purl.obolibrary.org/obo/GO_0051764) (actin crosslink formation), [GO:0000186](http://purl.obolibrary.org/obo/GO_0000186) (activation of MAPKK activity), [GO:0000185](http://purl.obolibrary.org/obo/GO_0000185) (activation of MAPKKK activity), [GO:0000184](http://purl.obolibrary.org/obo/GO_0000184) (nuclear-transcribed mRNA catabolic process, nonsense-mediated decay), [GO:0000183](http://purl.obolibrary.org/obo/GO_0000183) (chromatin silencing at rDNA), [GO:0000182](http://purl.obolibrary.org/obo/GO_0000182) (rDNA binding), [GO:0036126](http://purl.obolibrary.org/obo/GO_0036126) (sperm flagellum), [GO:0050435](http://purl.obolibrary.org/obo/GO_0050435) (amyloid-beta metabolic process), [GO:2000473](http://purl.obolibrary.org/obo/GO_2000473) (positive regulation of hematopoietic stem cell migration), [GO:0050434](http://purl.obolibrary.org/obo/GO_0050434) (positive regulation of viral transcription), [GO:0036122](http://purl.obolibrary.org/obo/GO_0036122) (BMP binding), [GO:2000491](http://purl.obolibrary.org/obo/GO_2000491) (positive regulation of hepatic stellate cell activation), [GO:0036120](http://purl.obolibrary.org/obo/GO_0036120) (cellular response to platelet-derived growth factor stimulus), [GO:2000490](http://purl.obolibrary.org/obo/GO_2000490) (negative regulation of hepatic stellate cell activation), [GO:0051775](http://purl.obolibrary.org/obo/GO_0051775) (response to redox state), [GO:0050444](http://purl.obolibrary.org/obo/GO_0050444) (aquacobalamin reductase (NADPH) activity), [GO:0000196](http://purl.obolibrary.org/obo/GO_0000196) (MAPK cascade involved in cell wall organization or biogenesis), [GO:0051770](http://purl.obolibrary.org/obo/GO_0051770) (positive regulation of nitric-oxide synthase biosynthetic process), [GO:0036117](http://purl.obolibrary.org/obo/GO_0036117) (hyaluranon cable), [GO:2000486](http://purl.obolibrary.org/obo/GO_2000486) (negative regulation of glutamine transport), [GO:0036111](http://purl.obolibrary.org/obo/GO_0036111) (very long-chain fatty-acyl-CoA metabolic process), [GO:0036112](http://purl.obolibrary.org/obo/GO_0036112) (medium-chain fatty-acyl-CoA metabolic process), [GO:1904632](http://purl.obolibrary.org/obo/GO_1904632) (cellular response to glucoside), [GO:1905962](http://purl.obolibrary.org/obo/GO_1905962) (glutamatergic neuron differentiation), [GO:1904630](http://purl.obolibrary.org/obo/GO_1904630) (cellular response to diterpene), [GO:1903307](http://purl.obolibrary.org/obo/GO_1903307) (positive regulation of regulated secretory pathway), [GO:1904637](http://purl.obolibrary.org/obo/GO_1904637) (cellular response to ionomycin), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0000165](http://purl.obolibrary.org/obo/GO_0000165) (MAPK cascade), [GO:0048143](http://purl.obolibrary.org/obo/GO_0048143) (astrocyte activation), [GO:0000164](http://purl.obolibrary.org/obo/GO_0000164) (protein phosphatase type 1 complex), [GO:0051781](http://purl.obolibrary.org/obo/GO_0051781) (positive regulation of cell division), [GO:0048148](http://purl.obolibrary.org/obo/GO_0048148) (behavioral response to cocaine), [GO:0048147](http://purl.obolibrary.org/obo/GO_0048147) (negative regulation of fibroblast proliferation), [GO:0051782](http://purl.obolibrary.org/obo/GO_0051782) (negative regulation of cell division), [GO:0048146](http://purl.obolibrary.org/obo/GO_0048146) (positive regulation of fibroblast proliferation), [GO:0000160](http://purl.obolibrary.org/obo/GO_0000160) (phosphorelay signal transduction system), [GO:0051780](http://purl.obolibrary.org/obo/GO_0051780) (behavioral response to nutrient), [GO:0048145](http://purl.obolibrary.org/obo/GO_0048145) (regulation of fibroblast proliferation), [GO:0036105](http://purl.obolibrary.org/obo/GO_0036105) (peroxisome membrane class-1 targeting sequence binding), [GO:0051787](http://purl.obolibrary.org/obo/GO_0051787) (misfolded protein binding), [GO:1904646](http://purl.obolibrary.org/obo/GO_1904646) (cellular response to amyloid-beta), [GO:1904645](http://purl.obolibrary.org/obo/GO_1904645) (response to amyloid-beta), [GO:0048149](http://purl.obolibrary.org/obo/GO_0048149) (behavioral response to ethanol), [GO:1903319](http://purl.obolibrary.org/obo/GO_1903319) (positive regulation of protein maturation), [GO:0000169](http://purl.obolibrary.org/obo/GO_0000169) (activation of MAPK activity involved in osmosensory signaling pathway), [GO:0000175](http://purl.obolibrary.org/obo/GO_0000175) (3'-5'-exoribonuclease activity), [GO:0051795](http://purl.obolibrary.org/obo/GO_0051795) (positive regulation of timing of catagen), [GO:0051793](http://purl.obolibrary.org/obo/GO_0051793) (medium-chain fatty acid catabolic process), [GO:0051791](http://purl.obolibrary.org/obo/GO_0051791) (medium-chain fatty acid metabolic process), [GO:0051798](http://purl.obolibrary.org/obo/GO_0051798) (positive regulation of hair follicle development), [GO:0021915](http://purl.obolibrary.org/obo/GO_0021915) (neural tube development), [GO:0021918](http://purl.obolibrary.org/obo/GO_0021918) (regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment), [GO:0021912](http://purl.obolibrary.org/obo/GO_0021912) (regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification), [GO:0021913](http://purl.obolibrary.org/obo/GO_0021913) (regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification), [GO:0021914](http://purl.obolibrary.org/obo/GO_0021914) (negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning), [GO:0008940](http://purl.obolibrary.org/obo/GO_0008940) (nitrate reductase activity), [GO:0007612](http://purl.obolibrary.org/obo/GO_0007612) (learning), [GO:0007613](http://purl.obolibrary.org/obo/GO_0007613) (memory), [GO:0007610](http://purl.obolibrary.org/obo/GO_0007610) (behavior), [GO:0007611](http://purl.obolibrary.org/obo/GO_0007611) (learning or memory), [GO:0008941](http://purl.obolibrary.org/obo/GO_0008941) (nitric oxide dioxygenase activity), [GO:0007605](http://purl.obolibrary.org/obo/GO_0007605) (sensory perception of sound), [GO:0007606](http://purl.obolibrary.org/obo/GO_0007606) (sensory perception of chemical stimulus), [GO:0007603](http://purl.obolibrary.org/obo/GO_0007603) (phototransduction, visible light), [GO:0008934](http://purl.obolibrary.org/obo/GO_0008934) (inositol monophosphate 1-phosphatase activity), [GO:0007608](http://purl.obolibrary.org/obo/GO_0007608) (sensory perception of smell), [GO:0051726](http://purl.obolibrary.org/obo/GO_0051726) (regulation of cell cycle), [GO:0051721](http://purl.obolibrary.org/obo/GO_0051721) (protein phosphatase 2A binding), [GO:0021904](http://purl.obolibrary.org/obo/GO_0021904) (dorsal/ventral neural tube patterning), [GO:0021905](http://purl.obolibrary.org/obo/GO_0021905) (forebrain-midbrain boundary formation), [GO:0021902](http://purl.obolibrary.org/obo/GO_0021902) (commitment of neuronal cell to specific neuron type in forebrain), [GO:0021903](http://purl.obolibrary.org/obo/GO_0021903) (rostrocaudal neural tube patterning), [GO:0007623](http://purl.obolibrary.org/obo/GO_0007623) (circadian rhythm), [GO:0007616](http://purl.obolibrary.org/obo/GO_0007616) (long-term memory), [GO:0007617](http://purl.obolibrary.org/obo/GO_0007617) (mating behavior), [GO:1905908](http://purl.obolibrary.org/obo/GO_1905908) (positive regulation of amyloid fibril formation), [GO:0007614](http://purl.obolibrary.org/obo/GO_0007614) (short-term memory), [GO:1905907](http://purl.obolibrary.org/obo/GO_1905907) (negative regulation of amyloid fibril formation), [GO:1905906](http://purl.obolibrary.org/obo/GO_1905906) (regulation of amyloid fibril formation), [GO:0036159](http://purl.obolibrary.org/obo/GO_0036159) (inner dynein arm assembly), [GO:0036157](http://purl.obolibrary.org/obo/GO_0036157) (outer dynein arm), [GO:0036158](http://purl.obolibrary.org/obo/GO_0036158) (outer dynein arm assembly), [GO:1905923](http://purl.obolibrary.org/obo/GO_1905923) (positive regulation of acetylcholine biosynthetic process), [GO:1905920](http://purl.obolibrary.org/obo/GO_1905920) (positive regulation of CoA-transferase activity), [GO:0048103](http://purl.obolibrary.org/obo/GO_0048103) (somatic stem cell division), [GO:0048102](http://purl.obolibrary.org/obo/GO_0048102) (autophagic cell death), [GO:0075713](http://purl.obolibrary.org/obo/GO_0075713) (establishment of integrated proviral latency), [GO:0036146](http://purl.obolibrary.org/obo/GO_0036146) (cellular response to mycotoxin), [GO:0007601](http://purl.obolibrary.org/obo/GO_0007601) (visual perception), [GO:0007602](http://purl.obolibrary.org/obo/GO_0007602) (phototransduction), [GO:0007600](http://purl.obolibrary.org/obo/GO_0007600) (sensory perception), [GO:0050421](http://purl.obolibrary.org/obo/GO_0050421) (nitrite reductase (NO-forming) activity), [GO:0050428](http://purl.obolibrary.org/obo/GO_0050428) (3'-phosphoadenosine 5'-phosphosulfate biosynthetic process), [GO:0050427](http://purl.obolibrary.org/obo/GO_0050427) (3'-phosphoadenosine 5'-phosphosulfate metabolic process), [GO:0051754](http://purl.obolibrary.org/obo/GO_0051754) (meiotic sister chromatid cohesion, centromeric), [GO:0045926](http://purl.obolibrary.org/obo/GO_0045926) (negative regulation of growth), [GO:0019637](http://purl.obolibrary.org/obo/GO_0019637) (organophosphate metabolic process), [GO:1904693](http://purl.obolibrary.org/obo/GO_1904693) (midbrain morphogenesis), [GO:0045927](http://purl.obolibrary.org/obo/GO_0045927) (positive regulation of growth), [GO:0061178](http://purl.obolibrary.org/obo/GO_0061178) (regulation of insulin secretion involved in cellular response to glucose stimulus), [GO:0061179](http://purl.obolibrary.org/obo/GO_0061179) (negative regulation of insulin secretion involved in cellular response to glucose stimulus), [GO:0021955](http://purl.obolibrary.org/obo/GO_0021955) (central nervous system neuron axonogenesis), [GO:1902035](http://purl.obolibrary.org/obo/GO_1902035) (positive regulation of hematopoietic stem cell proliferation), [GO:1902036](http://purl.obolibrary.org/obo/GO_1902036) (regulation of hematopoietic stem cell differentiation), [GO:0021956](http://purl.obolibrary.org/obo/GO_0021956) (central nervous system interneuron axonogenesis), [GO:1903364](http://purl.obolibrary.org/obo/GO_1903364) (positive regulation of cellular protein catabolic process), [GO:1902033](http://purl.obolibrary.org/obo/GO_1902033) (regulation of hematopoietic stem cell proliferation), [GO:0021952](http://purl.obolibrary.org/obo/GO_0021952) (central nervous system projection neuron axonogenesis), [GO:1902037](http://purl.obolibrary.org/obo/GO_1902037) (negative regulation of hematopoietic stem cell differentiation), [GO:0021953](http://purl.obolibrary.org/obo/GO_0021953) (central nervous system neuron differentiation), [GO:0021954](http://purl.obolibrary.org/obo/GO_0021954) (central nervous system neuron development), [GO:1902038](http://purl.obolibrary.org/obo/GO_1902038) (positive regulation of hematopoietic stem cell differentiation), [GO:0006325](http://purl.obolibrary.org/obo/GO_0006325) (chromatin organization), [GO:0045921](http://purl.obolibrary.org/obo/GO_0045921) (positive regulation of exocytosis), [GO:0033934](http://purl.obolibrary.org/obo/GO_0033934) (glucan 1,4-alpha-maltotriohydrolase activity), [GO:0032609](http://purl.obolibrary.org/obo/GO_0032609) (interferon-gamma production), [GO:0032607](http://purl.obolibrary.org/obo/GO_0032607) (interferon-alpha production), [GO:0032608](http://purl.obolibrary.org/obo/GO_0032608) (interferon-beta production), [GO:0061180](http://purl.obolibrary.org/obo/GO_0061180) (mammary gland epithelium development), [GO:0097129](http://purl.obolibrary.org/obo/GO_0097129) (cyclin D2-CDK4 complex), [GO:0061181](http://purl.obolibrary.org/obo/GO_0061181) (regulation of chondrocyte development), [GO:0018315](http://purl.obolibrary.org/obo/GO_0018315) (molybdenum incorporation into molybdenum-molybdopterin complex), [GO:0019646](http://purl.obolibrary.org/obo/GO_0019646) (aerobic electron transport chain), [GO:1903373](http://purl.obolibrary.org/obo/GO_1903373) (positive regulation of endoplasmic reticulum tubular network organization), [GO:1902042](http://purl.obolibrary.org/obo/GO_1902042) (negative regulation of extrinsic apoptotic signaling pathway via death domain receptors), [GO:0045937](http://purl.obolibrary.org/obo/GO_0045937) (positive regulation of phosphate metabolic process), [GO:1902043](http://purl.obolibrary.org/obo/GO_1902043) (positive regulation of extrinsic apoptotic signaling pathway via death domain receptors), [GO:1902041](http://purl.obolibrary.org/obo/GO_1902041) (regulation of extrinsic apoptotic signaling pathway via death domain receptors), [GO:1903377](http://purl.obolibrary.org/obo/GO_1903377) (negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway), [GO:0005000](http://purl.obolibrary.org/obo/GO_0005000) (vasopressin receptor activity), [GO:0045930](http://purl.obolibrary.org/obo/GO_0045930) (negative regulation of mitotic cell cycle), [GO:0021941](http://purl.obolibrary.org/obo/GO_0021941) (negative regulation of cerebellar granule cell precursor proliferation), [GO:0006333](http://purl.obolibrary.org/obo/GO_0006333) (chromatin assembly or disassembly), [GO:0021942](http://purl.obolibrary.org/obo/GO_0021942) (radial glia guided migration of Purkinje cell), [GO:0021943](http://purl.obolibrary.org/obo/GO_0021943) (formation of radial glial scaffolds), [GO:0005004](http://purl.obolibrary.org/obo/GO_0005004) (GPI-linked ephrin receptor activity), [GO:0006337](http://purl.obolibrary.org/obo/GO_0006337) (nucleosome disassembly), [GO:0005003](http://purl.obolibrary.org/obo/GO_0005003) (ephrin receptor activity), [GO:0045931](http://purl.obolibrary.org/obo/GO_0045931) (positive regulation of mitotic cell cycle), [GO:0006334](http://purl.obolibrary.org/obo/GO_0006334) (nucleosome assembly), [GO:0044615](http://purl.obolibrary.org/obo/GO_0044615) (nuclear pore nuclear basket), [GO:0070903](http://purl.obolibrary.org/obo/GO_0070903) (mitochondrial tRNA thio-modification), [GO:0061196](http://purl.obolibrary.org/obo/GO_0061196) (fungiform papilla development), [GO:0061197](http://purl.obolibrary.org/obo/GO_0061197) (fungiform papilla morphogenesis), [GO:0021935](http://purl.obolibrary.org/obo/GO_0021935) (cerebellar granule cell precursor tangential migration), [GO:0045940](http://purl.obolibrary.org/obo/GO_0045940) (positive regulation of steroid metabolic process), [GO:0007631](http://purl.obolibrary.org/obo/GO_0007631) (feeding behavior), [GO:0021930](http://purl.obolibrary.org/obo/GO_0021930) (cerebellar granule cell precursor proliferation), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0006303](http://purl.obolibrary.org/obo/GO_0006303) (double-strand break repair via nonhomologous end joining), [GO:0007634](http://purl.obolibrary.org/obo/GO_0007634) (optokinetic behavior), [GO:0044611](http://purl.obolibrary.org/obo/GO_0044611) (nuclear pore inner ring), [GO:0045945](http://purl.obolibrary.org/obo/GO_0045945) (positive regulation of transcription by RNA polymerase III), [GO:0007635](http://purl.obolibrary.org/obo/GO_0007635) (chemosensory behavior), [GO:0006304](http://purl.obolibrary.org/obo/GO_0006304) (DNA modification), [GO:0006301](http://purl.obolibrary.org/obo/GO_0006301) (postreplication repair), [GO:0007632](http://purl.obolibrary.org/obo/GO_0007632) (visual behavior), [GO:0044613](http://purl.obolibrary.org/obo/GO_0044613) (nuclear pore central transport channel), [GO:0008963](http://purl.obolibrary.org/obo/GO_0008963) (phospho-N-acetylmuramoyl-pentapeptide-transferase activity), [GO:0006302](http://purl.obolibrary.org/obo/GO_0006302) (double-strand break repair), [GO:0045943](http://purl.obolibrary.org/obo/GO_0045943) (positive regulation of transcription by RNA polymerase I), [GO:0007628](http://purl.obolibrary.org/obo/GO_0007628) (adult walking behavior), [GO:0007625](http://purl.obolibrary.org/obo/GO_0007625) (grooming behavior), [GO:0007626](http://purl.obolibrary.org/obo/GO_0007626) (locomotory behavior), [GO:0097101](http://purl.obolibrary.org/obo/GO_0097101) (blood vessel endothelial cell fate specification), [GO:0097104](http://purl.obolibrary.org/obo/GO_0097104) (postsynaptic membrane assembly), [GO:0033919](http://purl.obolibrary.org/obo/GO_0033919) (glucan 1,3-alpha-glucosidase activity), [GO:0097105](http://purl.obolibrary.org/obo/GO_0097105) (presynaptic membrane assembly), [GO:0097108](http://purl.obolibrary.org/obo/GO_0097108) (hedgehog family protein binding), [GO:0097107](http://purl.obolibrary.org/obo/GO_0097107) (postsynaptic density assembly), [GO:0070901](http://purl.obolibrary.org/obo/GO_0070901) (mitochondrial tRNA methylation), [GO:0061188](http://purl.obolibrary.org/obo/GO_0061188) (negative regulation of chromatin silencing at rDNA), [GO:0006310](http://purl.obolibrary.org/obo/GO_0006310) (DNA recombination), [GO:0006311](http://purl.obolibrary.org/obo/GO_0006311) (meiotic gene conversion), [GO:0008970](http://purl.obolibrary.org/obo/GO_0008970) (phosphatidylcholine 1-acylhydrolase activity), [GO:0045950](http://purl.obolibrary.org/obo/GO_0045950) (negative regulation of mitotic recombination), [GO:0045956](http://purl.obolibrary.org/obo/GO_0045956) (positive regulation of calcium ion-dependent exocytosis), [GO:0045953](http://purl.obolibrary.org/obo/GO_0045953) (negative regulation of natural killer cell mediated cytotoxicity), [GO:0006312](http://purl.obolibrary.org/obo/GO_0006312) (mitotic recombination), [GO:0097120](http://purl.obolibrary.org/obo/GO_0097120) (receptor localization to synapse), [GO:0045954](http://purl.obolibrary.org/obo/GO_0045954) (positive regulation of natural killer cell mediated cytotoxicity), [GO:0007638](http://purl.obolibrary.org/obo/GO_0007638) (mechanosensory behavior), [GO:0097110](http://purl.obolibrary.org/obo/GO_0097110) (scaffold protein binding), [GO:0097112](http://purl.obolibrary.org/obo/GO_0097112) (gamma-aminobutyric acid receptor clustering), [GO:0006306](http://purl.obolibrary.org/obo/GO_0006306) (DNA methylation), [GO:0097114](http://purl.obolibrary.org/obo/GO_0097114) (NMDA glutamate receptor clustering), [GO:0006309](http://purl.obolibrary.org/obo/GO_0006309) (apoptotic DNA fragmentation), [GO:0097119](http://purl.obolibrary.org/obo/GO_0097119) (postsynaptic density protein 95 clustering), [GO:0061193](http://purl.obolibrary.org/obo/GO_0061193) (taste bud development), [GO:1903392](http://purl.obolibrary.org/obo/GO_1903392) (negative regulation of adherens junction organization), [GO:0061133](http://purl.obolibrary.org/obo/GO_0061133) (endopeptidase activator activity), [GO:0061136](http://purl.obolibrary.org/obo/GO_0061136) (regulation of proteasomal protein catabolic process), [GO:0021999](http://purl.obolibrary.org/obo/GO_0021999) (neural plate anterior/posterior regionalization), [GO:0006361](http://purl.obolibrary.org/obo/GO_0006361) (transcription initiation from RNA polymerase I promoter), [GO:0006362](http://purl.obolibrary.org/obo/GO_0006362) (transcription elongation from RNA polymerase I promoter), [GO:0005031](http://purl.obolibrary.org/obo/GO_0005031) (tumor necrosis factor-activated receptor activity), [GO:0061131](http://purl.obolibrary.org/obo/GO_0061131) (pancreas field specification), [GO:0005030](http://purl.obolibrary.org/obo/GO_0005030) (neurotrophin receptor activity), [GO:1904651](http://purl.obolibrary.org/obo/GO_1904651) (positive regulation of fat cell apoptotic process), [GO:0006366](http://purl.obolibrary.org/obo/GO_0006366) (transcription by RNA polymerase II), [GO:0006363](http://purl.obolibrary.org/obo/GO_0006363) (termination of RNA polymerase I transcription), [GO:0006364](http://purl.obolibrary.org/obo/GO_0006364) (rRNA processing), [GO:0006369](http://purl.obolibrary.org/obo/GO_0006369) (termination of RNA polymerase II transcription), [GO:0061138](http://purl.obolibrary.org/obo/GO_0061138) (morphogenesis of a branching epithelium), [GO:0006367](http://purl.obolibrary.org/obo/GO_0006367) (transcription initiation from RNA polymerase II promoter), [GO:0006368](http://purl.obolibrary.org/obo/GO_0006368) (transcription elongation from RNA polymerase II promoter), [GO:1904659](http://purl.obolibrary.org/obo/GO_1904659) (glucose transmembrane transport), [GO:1903329](http://purl.obolibrary.org/obo/GO_1903329) (regulation of iron-sulfur cluster assembly), [GO:0032648](http://purl.obolibrary.org/obo/GO_0032648) (regulation of interferon-beta production), [GO:0048169](http://purl.obolibrary.org/obo/GO_0048169) (regulation of long-term neuronal synaptic plasticity), [GO:0048168](http://purl.obolibrary.org/obo/GO_0048168) (regulation of neuronal synaptic plasticity), [GO:0048167](http://purl.obolibrary.org/obo/GO_0048167) (regulation of synaptic plasticity), [GO:0019682](http://purl.obolibrary.org/obo/GO_0019682) (glyceraldehyde-3-phosphate metabolic process), [GO:0017022](http://purl.obolibrary.org/obo/GO_0017022) (myosin binding), [GO:0032642](http://purl.obolibrary.org/obo/GO_0032642) (regulation of chemokine production), [GO:0032640](http://purl.obolibrary.org/obo/GO_0032640) (tumor necrosis factor production), [GO:0017025](http://purl.obolibrary.org/obo/GO_0017025) (TBP-class protein binding), [GO:0031314](http://purl.obolibrary.org/obo/GO_0031314) (extrinsic component of mitochondrial inner membrane), [GO:0031315](http://purl.obolibrary.org/obo/GO_0031315) (extrinsic component of mitochondrial outer membrane), [GO:0031313](http://purl.obolibrary.org/obo/GO_0031313) (extrinsic component of endosome membrane), [GO:0005041](http://purl.obolibrary.org/obo/GO_0005041) (low-density lipoprotein receptor activity), [GO:1902001](http://purl.obolibrary.org/obo/GO_1902001) (fatty acid transmembrane transport), [GO:0005044](http://purl.obolibrary.org/obo/GO_0005044) (scavenger receptor activity), [GO:0021984](http://purl.obolibrary.org/obo/GO_0021984) (adenohypophysis development), [GO:1904669](http://purl.obolibrary.org/obo/GO_1904669) (ATP export), [GO:0006376](http://purl.obolibrary.org/obo/GO_0006376) (mRNA splice site selection), [GO:1904668](http://purl.obolibrary.org/obo/GO_1904668) (positive regulation of ubiquitin protein ligase activity), [GO:0021985](http://purl.obolibrary.org/obo/GO_0021985) (neurohypophysis development), [GO:0021986](http://purl.obolibrary.org/obo/GO_0021986) (habenula development), [GO:1902004](http://purl.obolibrary.org/obo/GO_1902004) (positive regulation of amyloid-beta formation), [GO:1904667](http://purl.obolibrary.org/obo/GO_1904667) (negative regulation of ubiquitin protein ligase activity), [GO:0021987](http://purl.obolibrary.org/obo/GO_0021987) (cerebral cortex development), [GO:0005048](http://purl.obolibrary.org/obo/GO_0005048) (signal sequence binding), [GO:0021982](http://purl.obolibrary.org/obo/GO_0021982) (pineal gland development), [GO:0006378](http://purl.obolibrary.org/obo/GO_0006378) (mRNA polyadenylation), [GO:0021983](http://purl.obolibrary.org/obo/GO_0021983) (pituitary gland development), [GO:0031307](http://purl.obolibrary.org/obo/GO_0031307) (integral component of mitochondrial outer membrane), [GO:0031305](http://purl.obolibrary.org/obo/GO_0031305) (integral component of mitochondrial inner membrane), [GO:0050482](http://purl.obolibrary.org/obo/GO_0050482) (arachidonic acid secretion), [GO:0031309](http://purl.obolibrary.org/obo/GO_0031309) (integral component of nuclear outer membrane), [GO:0033962](http://purl.obolibrary.org/obo/GO_0033962) (cytoplasmic mRNA processing body assembly), [GO:0019674](http://purl.obolibrary.org/obo/GO_0019674) (NAD metabolic process), [GO:0033961](http://purl.obolibrary.org/obo/GO_0033961) (cis-stilbene-oxide hydrolase activity), [GO:0019673](http://purl.obolibrary.org/obo/GO_0019673) (GDP-mannose metabolic process), [GO:0018345](http://purl.obolibrary.org/obo/GO_0018345) (protein palmitoylation), [GO:0019676](http://purl.obolibrary.org/obo/GO_0019676) (ammonia assimilation cycle), [GO:0018344](http://purl.obolibrary.org/obo/GO_0018344) (protein geranylgeranylation), [GO:0017015](http://purl.obolibrary.org/obo/GO_0017015) (regulation of transforming growth factor beta receptor signaling pathway), [GO:0031303](http://purl.obolibrary.org/obo/GO_0031303) (integral component of endosome membrane), [GO:0048172](http://purl.obolibrary.org/obo/GO_0048172) (regulation of short-term neuronal synaptic plasticity), [GO:0031304](http://purl.obolibrary.org/obo/GO_0031304) (intrinsic component of mitochondrial inner membrane), [GO:0032635](http://purl.obolibrary.org/obo/GO_0032635) (interleukin-6 production), [GO:0031301](http://purl.obolibrary.org/obo/GO_0031301) (integral component of organelle membrane), [GO:0032632](http://purl.obolibrary.org/obo/GO_0032632) (interleukin-3 production), [GO:0048170](http://purl.obolibrary.org/obo/GO_0048170) (positive regulation of long-term neuronal synaptic plasticity), [GO:0032633](http://purl.obolibrary.org/obo/GO_0032633) (interleukin-4 production), [GO:0061156](http://purl.obolibrary.org/obo/GO_0061156) (pulmonary artery morphogenesis), [GO:1902010](http://purl.obolibrary.org/obo/GO_1902010) (negative regulation of translation in response to endoplasmic reticulum stress), [GO:0021978](http://purl.obolibrary.org/obo/GO_0021978) (telencephalon regionalization), [GO:1904674](http://purl.obolibrary.org/obo/GO_1904674) (positive regulation of somatic stem cell population maintenance), [GO:0061153](http://purl.obolibrary.org/obo/GO_0061153) (trachea gland development), [GO:0045906](http://purl.obolibrary.org/obo/GO_0045906) (negative regulation of vasoconstriction), [GO:0021979](http://purl.obolibrary.org/obo/GO_0021979) (hypothalamus cell differentiation), [GO:0045907](http://purl.obolibrary.org/obo/GO_0045907) (positive regulation of vasoconstriction), [GO:0061154](http://purl.obolibrary.org/obo/GO_0061154) (endothelial tube morphogenesis), [GO:1902017](http://purl.obolibrary.org/obo/GO_1902017) (regulation of cilium assembly), [GO:1903348](http://purl.obolibrary.org/obo/GO_1903348) (positive regulation of bicellular tight junction assembly), [GO:1903347](http://purl.obolibrary.org/obo/GO_1903347) (negative regulation of bicellular tight junction assembly), [GO:0006342](http://purl.obolibrary.org/obo/GO_0006342) (chromatin silencing), [GO:0006348](http://purl.obolibrary.org/obo/GO_0006348) (chromatin silencing at telomere), [GO:0045901](http://purl.obolibrary.org/obo/GO_0045901) (positive regulation of translational elongation), [GO:0006346](http://purl.obolibrary.org/obo/GO_0006346) (methylation-dependent chromatin silencing), [GO:0048188](http://purl.obolibrary.org/obo/GO_0048188) (Set1C/COMPASS complex), [GO:0005008](http://purl.obolibrary.org/obo/GO_0005008) (hepatocyte growth factor-activated receptor activity), [GO:0005007](http://purl.obolibrary.org/obo/GO_0005007) (fibroblast growth factor-activated receptor activity), [GO:0006338](http://purl.obolibrary.org/obo/GO_0006338) (chromatin remodeling), [GO:0048185](http://purl.obolibrary.org/obo/GO_0048185) (activin binding), [GO:0019661](http://purl.obolibrary.org/obo/GO_0019661) (glucose catabolic process to lactate via pyruvate), [GO:0032623](http://purl.obolibrary.org/obo/GO_0032623) (interleukin-2 production), [GO:0017005](http://purl.obolibrary.org/obo/GO_0017005) (3'-tyrosyl-DNA phosphodiesterase activity), [GO:0032621](http://purl.obolibrary.org/obo/GO_0032621) (interleukin-18 production), [GO:0061144](http://purl.obolibrary.org/obo/GO_0061144) (alveolar secondary septum development), [GO:0045916](http://purl.obolibrary.org/obo/GO_0045916) (negative regulation of complement activation), [GO:1903352](http://purl.obolibrary.org/obo/GO_1903352) (L-ornithine transmembrane transport), [GO:0061146](http://purl.obolibrary.org/obo/GO_0061146) (Peyer's patch morphogenesis), [GO:0045919](http://purl.obolibrary.org/obo/GO_0045919) (positive regulation of cytolysis), [GO:0021966](http://purl.obolibrary.org/obo/GO_0021966) (corticospinal neuron axon guidance), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0005020](http://purl.obolibrary.org/obo/GO_0005020) (stem cell factor receptor activity), [GO:1904685](http://purl.obolibrary.org/obo/GO_1904685) (positive regulation of metalloendopeptidase activity), [GO:0045918](http://purl.obolibrary.org/obo/GO_0045918) (negative regulation of cytolysis), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0005021](http://purl.obolibrary.org/obo/GO_0005021) (vascular endothelial growth factor-activated receptor activity), [GO:0006352](http://purl.obolibrary.org/obo/GO_0006352) (DNA-templated transcription, initiation), [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity), [GO:0006353](http://purl.obolibrary.org/obo/GO_0006353) (DNA-templated transcription, termination), [GO:0005026](http://purl.obolibrary.org/obo/GO_0005026) (transforming growth factor beta receptor activity, type II), [GO:0006359](http://purl.obolibrary.org/obo/GO_0006359) (regulation of transcription by RNA polymerase III), [GO:0005025](http://purl.obolibrary.org/obo/GO_0005025) (transforming growth factor beta receptor activity, type I), [GO:0006356](http://purl.obolibrary.org/obo/GO_0006356) (regulation of transcription by RNA polymerase I), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0045910](http://purl.obolibrary.org/obo/GO_0045910) (negative regulation of DNA recombination), [GO:0006349](http://purl.obolibrary.org/obo/GO_0006349) (regulation of gene expression by genetic imprinting), [GO:0032615](http://purl.obolibrary.org/obo/GO_0032615) (interleukin-12 production), [GO:0032613](http://purl.obolibrary.org/obo/GO_0032613) (interleukin-10 production), [GO:0048194](http://purl.obolibrary.org/obo/GO_0048194) (Golgi vesicle budding), [GO:0032610](http://purl.obolibrary.org/obo/GO_0032610) (interleukin-1 alpha production), [GO:0048193](http://purl.obolibrary.org/obo/GO_0048193) (Golgi vesicle transport), [GO:0032611](http://purl.obolibrary.org/obo/GO_0032611) (interleukin-1 beta production), [GO:0006281](http://purl.obolibrary.org/obo/GO_0006281) (DNA repair), [GO:0043229](http://purl.obolibrary.org/obo/GO_0043229) (intracellular organelle), [GO:0070848](http://purl.obolibrary.org/obo/GO_0070848) (response to growth factor), [GO:0006284](http://purl.obolibrary.org/obo/GO_0006284) (base-excision repair), [GO:0006285](http://purl.obolibrary.org/obo/GO_0006285) (base-excision repair, AP site formation), [GO:0032570](http://purl.obolibrary.org/obo/GO_0032570) (response to progesterone), [GO:0006283](http://purl.obolibrary.org/obo/GO_0006283) (transcription-coupled nucleotide-excision repair), [GO:0006289](http://purl.obolibrary.org/obo/GO_0006289) (nucleotide-excision repair), [GO:0097091](http://purl.obolibrary.org/obo/GO_0097091) (synaptic vesicle clustering), [GO:0097094](http://purl.obolibrary.org/obo/GO_0097094) (craniofacial suture morphogenesis), [GO:0006287](http://purl.obolibrary.org/obo/GO_0006287) (base-excision repair, gap-filling), [GO:0097095](http://purl.obolibrary.org/obo/GO_0097095) (frontonasal suture morphogenesis), [GO:0045887](http://purl.obolibrary.org/obo/GO_0045887) (positive regulation of synaptic growth at neuromuscular junction), [GO:0097089](http://purl.obolibrary.org/obo/GO_0097089) (methyl-branched fatty acid metabolic process), [GO:0018271](http://purl.obolibrary.org/obo/GO_0018271) (biotin-protein ligase activity), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:1990523](http://purl.obolibrary.org/obo/GO_1990523) (bone regeneration), [GO:0018272](http://purl.obolibrary.org/obo/GO_0018272) (protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0031234](http://purl.obolibrary.org/obo/GO_0031234) (extrinsic component of cytoplasmic side of plasma membrane), [GO:0070842](http://purl.obolibrary.org/obo/GO_0070842) (aggresome assembly), [GO:0018279](http://purl.obolibrary.org/obo/GO_0018279) (protein N-linked glycosylation via asparagine), [GO:0031231](http://purl.obolibrary.org/obo/GO_0031231) (intrinsic component of peroxisomal membrane), [GO:0070840](http://purl.obolibrary.org/obo/GO_0070840) (dynein complex binding), [GO:0031232](http://purl.obolibrary.org/obo/GO_0031232) (extrinsic component of external side of plasma membrane), [GO:0070843](http://purl.obolibrary.org/obo/GO_0070843) (misfolded protein transport), [GO:0031235](http://purl.obolibrary.org/obo/GO_0031235) (intrinsic component of the cytoplasmic side of the plasma membrane), [GO:0032567](http://purl.obolibrary.org/obo/GO_0032567) (dGTP binding), [GO:0070839](http://purl.obolibrary.org/obo/GO_0070839) (divalent metal ion export), [GO:0070836](http://purl.obolibrary.org/obo/GO_0070836) (caveola assembly), [GO:0006290](http://purl.obolibrary.org/obo/GO_0006290) (pyrimidine dimer repair), [GO:0070837](http://purl.obolibrary.org/obo/GO_0070837) (dehydroascorbic acid transport), [GO:0006295](http://purl.obolibrary.org/obo/GO_0006295) (nucleotide-excision repair, DNA incision, 3'-to lesion), [GO:0006296](http://purl.obolibrary.org/obo/GO_0006296) (nucleotide-excision repair, DNA incision, 5'-to lesion), [GO:0006294](http://purl.obolibrary.org/obo/GO_0006294) (nucleotide-excision repair, preincision complex assembly), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0006297](http://purl.obolibrary.org/obo/GO_0006297) (nucleotide-excision repair, DNA gap filling), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0006298](http://purl.obolibrary.org/obo/GO_0006298) (mismatch repair), [GO:0043236](http://purl.obolibrary.org/obo/GO_0043236) (laminin binding), [GO:0045899](http://purl.obolibrary.org/obo/GO_0045899) (positive regulation of RNA polymerase II transcriptional preinitiation complex assembly), [GO:0031228](http://purl.obolibrary.org/obo/GO_0031228) (intrinsic component of Golgi membrane), [GO:1990531](http://purl.obolibrary.org/obo/GO_1990531) (Lem3p-Dnf1p complex), [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding), [GO:0043240](http://purl.obolibrary.org/obo/GO_0043240) (Fanconi anaemia nuclear complex), [GO:1990535](http://purl.obolibrary.org/obo/GO_1990535) (neuron projection maintenance), [GO:0043242](http://purl.obolibrary.org/obo/GO_0043242) (negative regulation of protein complex disassembly), [GO:0070830](http://purl.obolibrary.org/obo/GO_0070830) (bicellular tight junction assembly), [GO:0033885](http://purl.obolibrary.org/obo/GO_0033885) (10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity), [GO:0070831](http://purl.obolibrary.org/obo/GO_0070831) (basement membrane assembly), [GO:0031226](http://purl.obolibrary.org/obo/GO_0031226) (intrinsic component of plasma membrane), [GO:0031227](http://purl.obolibrary.org/obo/GO_0031227) (intrinsic component of endoplasmic reticulum membrane), [GO:0032558](http://purl.obolibrary.org/obo/GO_0032558) (adenyl deoxyribonucleotide binding), [GO:0031224](http://purl.obolibrary.org/obo/GO_0031224) (intrinsic component of membrane), [GO:0031225](http://purl.obolibrary.org/obo/GO_0031225) (anchored component of membrane), [GO:0070869](http://purl.obolibrary.org/obo/GO_0070869) (heterochromatin assembly involved in chromatin silencing), [GO:0006260](http://purl.obolibrary.org/obo/GO_0006260) (DNA replication), [GO:0006261](http://purl.obolibrary.org/obo/GO_0006261) (DNA-dependent DNA replication), [GO:0006266](http://purl.obolibrary.org/obo/GO_0006266) (DNA ligation), [GO:0043244](http://purl.obolibrary.org/obo/GO_0043244) (regulation of protein complex disassembly), [GO:0043243](http://purl.obolibrary.org/obo/GO_0043243) (positive regulation of protein complex disassembly), [GO:0006267](http://purl.obolibrary.org/obo/GO_0006267) (pre-replicative complex assembly involved in nuclear cell cycle DNA replication), [GO:0021897](http://purl.obolibrary.org/obo/GO_0021897) (forebrain astrocyte development), [GO:0007595](http://purl.obolibrary.org/obo/GO_0007595) (lactation), [GO:0006264](http://purl.obolibrary.org/obo/GO_0006264) (mitochondrial DNA replication), [GO:0007596](http://purl.obolibrary.org/obo/GO_0007596) (blood coagulation), [GO:0006265](http://purl.obolibrary.org/obo/GO_0006265) (DNA topological change), [GO:0043248](http://purl.obolibrary.org/obo/GO_0043248) (proteasome assembly), [GO:0043247](http://purl.obolibrary.org/obo/GO_0043247) (telomere maintenance in response to DNA damage), [GO:0007599](http://purl.obolibrary.org/obo/GO_0007599) (hemostasis), [GO:0006268](http://purl.obolibrary.org/obo/GO_0006268) (DNA unwinding involved in DNA replication), [GO:0043249](http://purl.obolibrary.org/obo/GO_0043249) (erythrocyte maturation), [GO:0021895](http://purl.obolibrary.org/obo/GO_0021895) (cerebral cortex neuron differentiation), [GO:0097067](http://purl.obolibrary.org/obo/GO_0097067) (cellular response to thyroid hormone stimulus), [GO:0097066](http://purl.obolibrary.org/obo/GO_0097066) (response to thyroid hormone), [GO:0070860](http://purl.obolibrary.org/obo/GO_0070860) (RNA polymerase I core factor complex), [GO:0043252](http://purl.obolibrary.org/obo/GO_0043252) (sodium-independent organic anion transport), [GO:0031211](http://purl.obolibrary.org/obo/GO_0031211) (endoplasmic reticulum palmitoyltransferase complex), [GO:0032543](http://purl.obolibrary.org/obo/GO_0032543) (mitochondrial translation), [GO:0032541](http://purl.obolibrary.org/obo/GO_0032541) (cortical endoplasmic reticulum), [GO:0031210](http://purl.obolibrary.org/obo/GO_0031210) (phosphatidylcholine binding), [GO:0070867](http://purl.obolibrary.org/obo/GO_0070867) (mating projection tip membrane), [GO:0033878](http://purl.obolibrary.org/obo/GO_0033878) (hormone-sensitive lipase activity), [GO:0031214](http://purl.obolibrary.org/obo/GO_0031214) (biomineral tissue development), [GO:0006270](http://purl.obolibrary.org/obo/GO_0006270) (DNA replication initiation), [GO:0070859](http://purl.obolibrary.org/obo/GO_0070859) (positive regulation of bile acid biosynthetic process), [GO:0006273](http://purl.obolibrary.org/obo/GO_0006273) (lagging strand elongation), [GO:0021889](http://purl.obolibrary.org/obo/GO_0021889) (olfactory bulb interneuron differentiation), [GO:0006272](http://purl.obolibrary.org/obo/GO_0006272) (leading strand elongation), [GO:0043254](http://purl.obolibrary.org/obo/GO_0043254) (regulation of protein complex assembly), [GO:0006278](http://purl.obolibrary.org/obo/GO_0006278) (RNA-dependent DNA biosynthetic process), [GO:0006275](http://purl.obolibrary.org/obo/GO_0006275) (regulation of DNA replication), [GO:0006276](http://purl.obolibrary.org/obo/GO_0006276) (plasmid maintenance), [GO:0097084](http://purl.obolibrary.org/obo/GO_0097084) (vascular smooth muscle cell development), [GO:0006279](http://purl.obolibrary.org/obo/GO_0006279) (premeiotic DNA replication), [GO:0021884](http://purl.obolibrary.org/obo/GO_0021884) (forebrain neuron development), [GO:0031207](http://purl.obolibrary.org/obo/GO_0031207) (Sec62/Sec63 complex), [GO:0043262](http://purl.obolibrary.org/obo/GO_0043262) (adenosine-diphosphatase activity), [GO:0018242](http://purl.obolibrary.org/obo/GO_0018242) (protein O-linked glycosylation via serine), [GO:0044594](http://purl.obolibrary.org/obo/GO_0044594) (17-beta-hydroxysteroid dehydrogenase (NAD+) activity), [GO:0070852](http://purl.obolibrary.org/obo/GO_0070852) (cell body fiber), [GO:0032532](http://purl.obolibrary.org/obo/GO_0032532) (regulation of microvillus length), [GO:0031201](http://purl.obolibrary.org/obo/GO_0031201) (SNARE complex), [GO:0070851](http://purl.obolibrary.org/obo/GO_0070851) (growth factor receptor binding), [GO:0032535](http://purl.obolibrary.org/obo/GO_0032535) (regulation of cellular component size), [GO:0031204](http://purl.obolibrary.org/obo/GO_0031204) (posttranslational protein targeting to membrane, translocation), [GO:0031205](http://purl.obolibrary.org/obo/GO_0031205) (endoplasmic reticulum Sec complex), [GO:0032534](http://purl.obolibrary.org/obo/GO_0032534) (regulation of microvillus assembly), [GO:0031284](http://purl.obolibrary.org/obo/GO_0031284) (positive regulation of guanylate cyclase activity), [GO:0031282](http://purl.obolibrary.org/obo/GO_0031282) (regulation of guanylate cyclase activity), [GO:0061098](http://purl.obolibrary.org/obo/GO_0061098) (positive regulation of protein tyrosine kinase activity), [GO:0045842](http://purl.obolibrary.org/obo/GO_0045842) (positive regulation of mitotic metaphase/anaphase transition), [GO:0097050](http://purl.obolibrary.org/obo/GO_0097050) (type B pancreatic cell apoptotic process), [GO:0045840](http://purl.obolibrary.org/obo/GO_0045840) (positive regulation of mitotic nuclear division), [GO:0045843](http://purl.obolibrary.org/obo/GO_0045843) (negative regulation of striated muscle tissue development), [GO:0097053](http://purl.obolibrary.org/obo/GO_0097053) (L-kynurenine catabolic process), [GO:0002711](http://purl.obolibrary.org/obo/GO_0002711) (positive regulation of T cell mediated immunity), [GO:0097049](http://purl.obolibrary.org/obo/GO_0097049) (motor neuron apoptotic process), [GO:1990569](http://purl.obolibrary.org/obo/GO_1990569) (UDP-N-acetylglucosamine transmembrane transport), [GO:1903281](http://purl.obolibrary.org/obo/GO_1903281) (positive regulation of calcium:sodium antiporter activity), [GO:0045859](http://purl.obolibrary.org/obo/GO_0045859) (regulation of protein kinase activity), [GO:0061085](http://purl.obolibrary.org/obo/GO_0061085) (regulation of histone H3-K27 methylation), [GO:0031274](http://purl.obolibrary.org/obo/GO_0031274) (positive regulation of pseudopodium assembly), [GO:0061088](http://purl.obolibrary.org/obo/GO_0061088) (regulation of sequestering of zinc ion), [GO:0097061](http://purl.obolibrary.org/obo/GO_0097061) (dendritic spine organization), [GO:0097060](http://purl.obolibrary.org/obo/GO_0097060) (synaptic membrane), [GO:0045851](http://purl.obolibrary.org/obo/GO_0045851) (pH reduction), [GO:0044524](http://purl.obolibrary.org/obo/GO_0044524) (protein sulfhydration), [GO:0097062](http://purl.obolibrary.org/obo/GO_0097062) (dendritic spine maintenance), [GO:0097064](http://purl.obolibrary.org/obo/GO_0097064) (ncRNA export from nucleus), [GO:1990573](http://purl.obolibrary.org/obo/GO_1990573) (potassium ion import across plasma membrane), [GO:0097056](http://purl.obolibrary.org/obo/GO_0097056) (selenocysteinyl-tRNA(Sec) biosynthetic process), [GO:0097058](http://purl.obolibrary.org/obo/GO_0097058) (CRLF-CLCF1 complex), [GO:0045860](http://purl.obolibrary.org/obo/GO_0045860) (positive regulation of protein kinase activity), [GO:0014707](http://purl.obolibrary.org/obo/GO_0014707) (branchiomeric skeletal muscle development), [GO:0002725](http://purl.obolibrary.org/obo/GO_0002725) (negative regulation of T cell cytokine production), [GO:0002726](http://purl.obolibrary.org/obo/GO_0002726) (positive regulation of T cell cytokine production), [GO:0014706](http://purl.obolibrary.org/obo/GO_0014706) (striated muscle tissue development), [GO:0061092](http://purl.obolibrary.org/obo/GO_0061092) (positive regulation of phospholipid translocation), [GO:0014704](http://purl.obolibrary.org/obo/GO_0014704) (intercalated disc), [GO:0031267](http://purl.obolibrary.org/obo/GO_0031267) (small GTPase binding), [GO:0031264](http://purl.obolibrary.org/obo/GO_0031264) (death-inducing signaling complex), [GO:0002729](http://purl.obolibrary.org/obo/GO_0002729) (positive regulation of natural killer cell cytokine production), [GO:0031265](http://purl.obolibrary.org/obo/GO_0031265) (CD95 death-inducing signaling complex), [GO:0014701](http://purl.obolibrary.org/obo/GO_0014701) (junctional sarcoplasmic reticulum membrane), [GO:0061090](http://purl.obolibrary.org/obo/GO_0061090) (positive regulation of sequestering of zinc ion), [GO:0044539](http://purl.obolibrary.org/obo/GO_0044539) (long-chain fatty acid import), [GO:0043208](http://purl.obolibrary.org/obo/GO_0043208) (glycosphingolipid binding), [GO:0032590](http://purl.obolibrary.org/obo/GO_0032590) (dendrite membrane), [GO:0043209](http://purl.obolibrary.org/obo/GO_0043209) (myelin sheath), [GO:0032593](http://purl.obolibrary.org/obo/GO_0032593) (insulin-responsive compartment), [GO:0070829](http://purl.obolibrary.org/obo/GO_0070829) (heterochromatin maintenance), [GO:0031261](http://purl.obolibrary.org/obo/GO_0031261) (DNA replication preinitiation complex), [GO:0032592](http://purl.obolibrary.org/obo/GO_0032592) (integral component of mitochondrial membrane), [GO:0043200](http://purl.obolibrary.org/obo/GO_0043200) (response to amino acid), [GO:0044530](http://purl.obolibrary.org/obo/GO_0044530) (supraspliceosomal complex), [GO:0043202](http://purl.obolibrary.org/obo/GO_0043202) (lysosomal lumen), [GO:0045861](http://purl.obolibrary.org/obo/GO_0045861) (negative regulation of proteolysis), [GO:0045862](http://purl.obolibrary.org/obo/GO_0045862) (positive regulation of proteolysis), [GO:0043204](http://purl.obolibrary.org/obo/GO_0043204) (perikaryon), [GO:0043203](http://purl.obolibrary.org/obo/GO_0043203) (axon hillock), [GO:1990592](http://purl.obolibrary.org/obo/GO_1990592) (protein K69-linked ufmylation), [GO:1990584](http://purl.obolibrary.org/obo/GO_1990584) (cardiac Troponin complex), [GO:1990589](http://purl.obolibrary.org/obo/GO_1990589) (ATF4-CREB1 transcription factor complex), [GO:0044540](http://purl.obolibrary.org/obo/GO_0044540) (L-cystine L-cysteine-lyase (deaminating)), [GO:0097028](http://purl.obolibrary.org/obo/GO_0097028) (dendritic cell differentiation), [GO:0032587](http://purl.obolibrary.org/obo/GO_0032587) (ruffle membrane), [GO:0031256](http://purl.obolibrary.org/obo/GO_0031256) (leading edge membrane), [GO:0018298](http://purl.obolibrary.org/obo/GO_0018298) (protein-chromophore linkage), [GO:0031253](http://purl.obolibrary.org/obo/GO_0031253) (cell projection membrane), [GO:0032585](http://purl.obolibrary.org/obo/GO_0032585) (multivesicular body membrane), [GO:0070821](http://purl.obolibrary.org/obo/GO_0070821) (tertiary granule membrane), [GO:0032588](http://purl.obolibrary.org/obo/GO_0032588) (trans-Golgi network membrane), [GO:0031258](http://purl.obolibrary.org/obo/GO_0031258) (lamellipodium membrane), [GO:0043218](http://purl.obolibrary.org/obo/GO_0043218) (compact myelin), [GO:0070814](http://purl.obolibrary.org/obo/GO_0070814) (hydrogen sulfide biosynthetic process), [GO:0031252](http://purl.obolibrary.org/obo/GO_0031252) (cell leading edge), [GO:0032580](http://purl.obolibrary.org/obo/GO_0032580) (Golgi cisterna membrane), [GO:0032581](http://purl.obolibrary.org/obo/GO_0032581) (ER-dependent peroxisome organization), [GO:0045875](http://purl.obolibrary.org/obo/GO_0045875) (negative regulation of sister chromatid cohesion), [GO:0044546](http://purl.obolibrary.org/obo/GO_0044546) (NLRP3 inflammasome complex assembly), [GO:0043215](http://purl.obolibrary.org/obo/GO_0043215) (daunorubicin transport), [GO:0045879](http://purl.obolibrary.org/obo/GO_0045879) (negative regulation of smoothened signaling pathway), [GO:0097042](http://purl.obolibrary.org/obo/GO_0097042) (extrinsic component of fungal-type vacuolar membrane), [GO:0097034](http://purl.obolibrary.org/obo/GO_0097034) (mitochondrial respiratory chain complex IV biogenesis), [GO:0097033](http://purl.obolibrary.org/obo/GO_0097033) (mitochondrial respiratory chain complex III biogenesis), [GO:0097036](http://purl.obolibrary.org/obo/GO_0097036) (regulation of plasma membrane sterol distribution), [GO:0097038](http://purl.obolibrary.org/obo/GO_0097038) (perinuclear endoplasmic reticulum), [GO:1990599](http://purl.obolibrary.org/obo/GO_1990599) (3' overhang single-stranded DNA endodeoxyribonuclease activity), [GO:0018283](http://purl.obolibrary.org/obo/GO_0018283) (iron incorporation into metallo-sulfur cluster), [GO:0097037](http://purl.obolibrary.org/obo/GO_0097037) (heme export), [GO:0043220](http://purl.obolibrary.org/obo/GO_0043220) (Schmidt-Lanterman incisure), [GO:2000505](http://purl.obolibrary.org/obo/GO_2000505) (regulation of energy homeostasis), [GO:0045880](http://purl.obolibrary.org/obo/GO_0045880) (positive regulation of smoothened signaling pathway), [GO:0097039](http://purl.obolibrary.org/obo/GO_0097039) (protein linear polyubiquitination), [GO:0032575](http://purl.obolibrary.org/obo/GO_0032575) (ATP-dependent 5'-3' RNA helicase activity), [GO:2000502](http://purl.obolibrary.org/obo/GO_2000502) (negative regulation of natural killer cell chemotaxis), [GO:0070813](http://purl.obolibrary.org/obo/GO_0070813) (hydrogen sulfide metabolic process), [GO:0014741](http://purl.obolibrary.org/obo/GO_0014741) (negative regulation of muscle hypertrophy), [GO:0102009](http://purl.obolibrary.org/obo/GO_0102009) (proline dipeptidase activity), [GO:0102007](http://purl.obolibrary.org/obo/GO_0102007) (acyl-L-homoserine-lactone lactonohydrolase activity), [GO:0002761](http://purl.obolibrary.org/obo/GO_0002761) (regulation of myeloid leukocyte differentiation), [GO:0002755](http://purl.obolibrary.org/obo/GO_0002755) (MyD88-dependent toll-like receptor signaling pathway), [GO:0002757](http://purl.obolibrary.org/obo/GO_0002757) (immune response-activating signal transduction), [GO:0014734](http://purl.obolibrary.org/obo/GO_0014734) (skeletal muscle hypertrophy), [GO:0014732](http://purl.obolibrary.org/obo/GO_0014732) (skeletal muscle atrophy), [GO:0000104](http://purl.obolibrary.org/obo/GO_0000104) (succinate dehydrogenase activity), [GO:0000103](http://purl.obolibrary.org/obo/GO_0000103) (sulfate assimilation), [GO:0000102](http://purl.obolibrary.org/obo/GO_0000102) (L-methionine secondary active transmembrane transporter activity), [GO:0000101](http://purl.obolibrary.org/obo/GO_0000101) (sulfur amino acid transport), [GO:0000111](http://purl.obolibrary.org/obo/GO_0000111) (nucleotide-excision repair factor 2 complex), [GO:0002763](http://purl.obolibrary.org/obo/GO_0002763) (positive regulation of myeloid leukocyte differentiation), [GO:0000110](http://purl.obolibrary.org/obo/GO_0000110) (nucleotide-excision repair factor 1 complex), [GO:2000525](http://purl.obolibrary.org/obo/GO_2000525) (positive regulation of T cell costimulation), [GO:0002768](http://purl.obolibrary.org/obo/GO_0002768) (immune response-regulating cell surface receptor signaling pathway), [GO:0051707](http://purl.obolibrary.org/obo/GO_0051707) (response to other organism), [GO:0001405](http://purl.obolibrary.org/obo/GO_0001405) (presequence translocase-associated import motor), [GO:0001403](http://purl.obolibrary.org/obo/GO_0001403) (invasive growth in response to glucose limitation), [GO:0001402](http://purl.obolibrary.org/obo/GO_0001402) (signal transduction involved in filamentous growth), [GO:0002740](http://purl.obolibrary.org/obo/GO_0002740) (negative regulation of cytokine secretion involved in immune response), [GO:0002731](http://purl.obolibrary.org/obo/GO_0002731) (negative regulation of dendritic cell cytokine production), [GO:0014719](http://purl.obolibrary.org/obo/GO_0014719) (skeletal muscle satellite cell activation), [GO:0014718](http://purl.obolibrary.org/obo/GO_0014718) (positive regulation of satellite cell activation involved in skeletal muscle regeneration), [GO:0031297](http://purl.obolibrary.org/obo/GO_0031297) (replication fork processing), [GO:0031298](http://purl.obolibrary.org/obo/GO_0031298) (replication fork protection complex), [GO:0051702](http://purl.obolibrary.org/obo/GO_0051702) (interaction with symbiont), [GO:0031292](http://purl.obolibrary.org/obo/GO_0031292) (gene conversion at mating-type locus, DNA double-strand break processing), [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance), [GO:0031295](http://purl.obolibrary.org/obo/GO_0031295) (T cell costimulation), [GO:0031296](http://purl.obolibrary.org/obo/GO_0031296) (B cell costimulation), [GO:0031293](http://purl.obolibrary.org/obo/GO_0031293) (membrane protein intracellular domain proteolysis), [GO:0051718](http://purl.obolibrary.org/obo/GO_0051718) (DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates), [GO:0002741](http://purl.obolibrary.org/obo/GO_0002741) (positive regulation of cytokine secretion involved in immune response), [GO:0014728](http://purl.obolibrary.org/obo/GO_0014728) (regulation of the force of skeletal muscle contraction), [GO:2000543](http://purl.obolibrary.org/obo/GO_2000543) (positive regulation of gastrulation), [GO:0051717](http://purl.obolibrary.org/obo/GO_0051717) (inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity), [GO:0051712](http://purl.obolibrary.org/obo/GO_0051712) (positive regulation of killing of cells of other organism), [GO:2000560](http://purl.obolibrary.org/obo/GO_2000560) (positive regulation of CD24 biosynthetic process), [GO:0044597](http://purl.obolibrary.org/obo/GO_0044597) (daunorubicin metabolic process), [GO:0043266](http://purl.obolibrary.org/obo/GO_0043266) (regulation of potassium ion transport), [GO:0043265](http://purl.obolibrary.org/obo/GO_0043265) (ectoplasm), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0043268](http://purl.obolibrary.org/obo/GO_0043268) (positive regulation of potassium ion transport), [GO:0044599](http://purl.obolibrary.org/obo/GO_0044599) (AP-5 adaptor complex), [GO:0043267](http://purl.obolibrary.org/obo/GO_0043267) (negative regulation of potassium ion transport), [GO:0000138](http://purl.obolibrary.org/obo/GO_0000138) (Golgi trans cisterna), [GO:0044598](http://purl.obolibrary.org/obo/GO_0044598) (doxorubicin metabolic process), [GO:0000137](http://purl.obolibrary.org/obo/GO_0000137) (Golgi cis cisterna), [GO:0000142](http://purl.obolibrary.org/obo/GO_0000142) (cellular bud neck contractile ring), [GO:0043270](http://purl.obolibrary.org/obo/GO_0043270) (positive regulation of ion transport), [GO:0070881](http://purl.obolibrary.org/obo/GO_0070881) (regulation of proline transport), [GO:0043274](http://purl.obolibrary.org/obo/GO_0043274) (phospholipase binding), [GO:0070880](http://purl.obolibrary.org/obo/GO_0070880) (fungal-type cell wall beta-glucan biosynthetic process), [GO:0070886](http://purl.obolibrary.org/obo/GO_0070886) (positive regulation of calcineurin-NFAT signaling cascade), [GO:0070883](http://purl.obolibrary.org/obo/GO_0070883) (pre-miRNA binding), [GO:2000552](http://purl.obolibrary.org/obo/GO_2000552) (negative regulation of T-helper 2 cell cytokine production), [GO:0070888](http://purl.obolibrary.org/obo/GO_0070888) (E-box binding), [GO:2000553](http://purl.obolibrary.org/obo/GO_2000553) (positive regulation of T-helper 2 cell cytokine production), [GO:2000570](http://purl.obolibrary.org/obo/GO_2000570) (positive regulation of T-helper 2 cell activation), [GO:0043277](http://purl.obolibrary.org/obo/GO_0043277) (apoptotic cell clearance), [GO:0043276](http://purl.obolibrary.org/obo/GO_0043276) (anoikis), [GO:0043278](http://purl.obolibrary.org/obo/GO_0043278) (response to morphine), [GO:0000149](http://purl.obolibrary.org/obo/GO_0000149) (SNARE binding), [GO:0000146](http://purl.obolibrary.org/obo/GO_0000146) (microfilament motor activity), [GO:0043280](http://purl.obolibrary.org/obo/GO_0043280) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0000155](http://purl.obolibrary.org/obo/GO_0000155) (phosphorelay sensor kinase activity), [GO:0000154](http://purl.obolibrary.org/obo/GO_0000154) (rRNA modification), [GO:0043282](http://purl.obolibrary.org/obo/GO_0043282) (pharyngeal muscle development), [GO:0043281](http://purl.obolibrary.org/obo/GO_0043281) (regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0000151](http://purl.obolibrary.org/obo/GO_0000151) (ubiquitin ligase complex), [GO:0070873](http://purl.obolibrary.org/obo/GO_0070873) (regulation of glycogen metabolic process), [GO:2000568](http://purl.obolibrary.org/obo/GO_2000568) (positive regulation of memory T cell activation), [GO:0000118](http://purl.obolibrary.org/obo/GO_0000118) (histone deacetylase complex), [GO:0000112](http://purl.obolibrary.org/obo/GO_0000112) (nucleotide-excision repair factor 3 complex), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0043291](http://purl.obolibrary.org/obo/GO_0043291) (RAVE complex), [GO:0043292](http://purl.obolibrary.org/obo/GO_0043292) (contractile fiber), [GO:0043295](http://purl.obolibrary.org/obo/GO_0043295) (glutathione binding), [GO:0043297](http://purl.obolibrary.org/obo/GO_0043297) (apical junction assembly), [GO:0043296](http://purl.obolibrary.org/obo/GO_0043296) (apical junction complex), [GO:2000572](http://purl.obolibrary.org/obo/GO_2000572) (positive regulation of interleukin-4-dependent isotype switching to IgE isotypes), [GO:2000573](http://purl.obolibrary.org/obo/GO_2000573) (positive regulation of DNA biosynthetic process), [GO:0102077](http://purl.obolibrary.org/obo/GO_0102077) (oleamide hydrolase activity), [GO:2000591](http://purl.obolibrary.org/obo/GO_2000591) (positive regulation of metanephric mesenchymal cell migration), [GO:0000123](http://purl.obolibrary.org/obo/GO_0000123) (histone acetyltransferase complex), [GO:0000132](http://purl.obolibrary.org/obo/GO_0000132) (establishment of mitotic spindle orientation), [GO:0000131](http://purl.obolibrary.org/obo/GO_0000131) (incipient cellular bud site), [GO:0002787](http://purl.obolibrary.org/obo/GO_0002787) (negative regulation of antibacterial peptide production), [GO:0102084](http://purl.obolibrary.org/obo/GO_0102084) (L-dopa O-methyltransferase activity), [GO:0070892](http://purl.obolibrary.org/obo/GO_0070892) (lipoteichoic acid receptor activity), [GO:0070891](http://purl.obolibrary.org/obo/GO_0070891) (lipoteichoic acid binding), [GO:2000583](http://purl.obolibrary.org/obo/GO_2000583) (regulation of platelet-derived growth factor receptor-alpha signaling pathway), [GO:0070898](http://purl.obolibrary.org/obo/GO_0070898) (RNA polymerase III transcriptional preinitiation complex assembly), [GO:0070899](http://purl.obolibrary.org/obo/GO_0070899) (mitochondrial tRNA wobble uridine modification), [GO:0002481](http://purl.obolibrary.org/obo/GO_0002481) (antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent), [GO:0001147](http://purl.obolibrary.org/obo/GO_0001147) (transcription termination site sequence-specific DNA binding), [GO:0051409](http://purl.obolibrary.org/obo/GO_0051409) (response to nitrosative stress), [GO:0051402](http://purl.obolibrary.org/obo/GO_0051402) (neuron apoptotic process), [GO:0051403](http://purl.obolibrary.org/obo/GO_0051403) (stress-activated MAPK cascade), [GO:1904504](http://purl.obolibrary.org/obo/GO_1904504) (positive regulation of lipophagy), [GO:0001158](http://purl.obolibrary.org/obo/GO_0001158) (enhancer sequence-specific DNA binding), [GO:1904506](http://purl.obolibrary.org/obo/GO_1904506) (negative regulation of telomere maintenance in response to DNA damage), [GO:0001162](http://purl.obolibrary.org/obo/GO_0001162) (RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding), [GO:0001161](http://purl.obolibrary.org/obo/GO_0001161) (intronic transcription regulatory region sequence-specific DNA binding), [GO:0052745](http://purl.obolibrary.org/obo/GO_0052745) (inositol phosphate phosphatase activity), [GO:0015798](http://purl.obolibrary.org/obo/GO_0015798) (myo-inositol transport), [GO:0015770](http://purl.obolibrary.org/obo/GO_0015770) (sucrose transport), [GO:1904515](http://purl.obolibrary.org/obo/GO_1904515) (positive regulation of TORC2 signaling), [GO:0003796](http://purl.obolibrary.org/obo/GO_0003796) (lysozyme activity), [GO:0003786](http://purl.obolibrary.org/obo/GO_0003786) (actin lateral binding), [GO:0002455](http://purl.obolibrary.org/obo/GO_0002455) (humoral immune response mediated by circulating immunoglobulin), [GO:0001133](http://purl.obolibrary.org/obo/GO_0001133) (RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding), [GO:0002456](http://purl.obolibrary.org/obo/GO_0002456) (T cell mediated immunity), [GO:0051428](http://purl.obolibrary.org/obo/GO_0051428) (peptide hormone receptor binding), [GO:0051427](http://purl.obolibrary.org/obo/GO_0051427) (hormone receptor binding), [GO:0051425](http://purl.obolibrary.org/obo/GO_0051425) (PTB domain binding), [GO:1904526](http://purl.obolibrary.org/obo/GO_1904526) (regulation of microtubule binding), [GO:0002474](http://purl.obolibrary.org/obo/GO_0002474) (antigen processing and presentation of peptide antigen via MHC class I), [GO:0001135](http://purl.obolibrary.org/obo/GO_0001135) (transcription factor activity, RNA polymerase II transcription factor recruiting), [GO:1904527](http://purl.obolibrary.org/obo/GO_1904527) (negative regulation of microtubule binding), [GO:0051434](http://purl.obolibrary.org/obo/GO_0051434) (BH3 domain binding), [GO:0002467](http://purl.obolibrary.org/obo/GO_0002467) (germinal center formation), [GO:0002468](http://purl.obolibrary.org/obo/GO_0002468) (dendritic cell antigen processing and presentation), [GO:0051430](http://purl.obolibrary.org/obo/GO_0051430) (corticotropin-releasing hormone receptor 1 binding), [GO:0001198](http://purl.obolibrary.org/obo/GO_0001198) (negative regulation of mating-type specific transcription from RNA polymerase II promoter), [GO:0001195](http://purl.obolibrary.org/obo/GO_0001195) (maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase III promoter), [GO:0001191](http://purl.obolibrary.org/obo/GO_0001191) (transcriptional repressor activity, RNA polymerase II transcription factor binding), [GO:0001190](http://purl.obolibrary.org/obo/GO_0001190) (transcriptional activator activity, RNA polymerase II transcription factor binding), [GO:0010909](http://purl.obolibrary.org/obo/GO_0010909) (positive regulation of heparan sulfate proteoglycan biosynthetic process), [GO:0009922](http://purl.obolibrary.org/obo/GO_0009922) (fatty acid elongase activity), [GO:0010907](http://purl.obolibrary.org/obo/GO_0010907) (positive regulation of glucose metabolic process), [GO:0009914](http://purl.obolibrary.org/obo/GO_0009914) (hormone transport), [GO:0009913](http://purl.obolibrary.org/obo/GO_0009913) (epidermal cell differentiation), [GO:0010906](http://purl.obolibrary.org/obo/GO_0010906) (regulation of glucose metabolic process), [GO:0009918](http://purl.obolibrary.org/obo/GO_0009918) (sterol delta7 reductase activity), [GO:0010902](http://purl.obolibrary.org/obo/GO_0010902) (positive regulation of very-low-density lipoprotein particle remodeling), [GO:0009917](http://purl.obolibrary.org/obo/GO_0009917) (sterol 5-alpha reductase activity), [GO:1905802](http://purl.obolibrary.org/obo/GO_1905802) (regulation of cellular response to manganese ion), [GO:0001168](http://purl.obolibrary.org/obo/GO_0001168) (transcription factor activity, RNA polymerase I upstream control element sequence-specific binding), [GO:1903244](http://purl.obolibrary.org/obo/GO_1903244) (positive regulation of cardiac muscle hypertrophy in response to stress), [GO:0051491](http://purl.obolibrary.org/obo/GO_0051491) (positive regulation of filopodium assembly), [GO:0009952](http://purl.obolibrary.org/obo/GO_0009952) (anterior/posterior pattern specification), [GO:0051492](http://purl.obolibrary.org/obo/GO_0051492) (regulation of stress fiber assembly), [GO:0009950](http://purl.obolibrary.org/obo/GO_0009950) (dorsal/ventral axis specification), [GO:0051490](http://purl.obolibrary.org/obo/GO_0051490) (negative regulation of filopodium assembly), [GO:0008625](http://purl.obolibrary.org/obo/GO_0008625) (extrinsic apoptotic signaling pathway via death domain receptors), [GO:0009956](http://purl.obolibrary.org/obo/GO_0009956) (radial pattern formation), [GO:0009954](http://purl.obolibrary.org/obo/GO_0009954) (proximal/distal pattern formation), [GO:0009953](http://purl.obolibrary.org/obo/GO_0009953) (dorsal/ventral pattern formation), [GO:0008622](http://purl.obolibrary.org/obo/GO_0008622) (epsilon DNA polymerase complex), [GO:0009948](http://purl.obolibrary.org/obo/GO_0009948) (anterior/posterior axis specification), [GO:0008615](http://purl.obolibrary.org/obo/GO_0008615) (pyridoxine biosynthetic process), [GO:0010933](http://purl.obolibrary.org/obo/GO_0010933) (positive regulation of macrophage tolerance induction), [GO:0051482](http://purl.obolibrary.org/obo/GO_0051482) (positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway), [GO:0010936](http://purl.obolibrary.org/obo/GO_0010936) (negative regulation of macrophage cytokine production), [GO:0046906](http://purl.obolibrary.org/obo/GO_0046906) (tetrapyrrole binding), [GO:1903251](http://purl.obolibrary.org/obo/GO_1903251) (multi-ciliated epithelial cell differentiation), [GO:0046907](http://purl.obolibrary.org/obo/GO_0046907) (intracellular transport), [GO:0008631](http://purl.obolibrary.org/obo/GO_0008631) (intrinsic apoptotic signaling pathway in response to oxidative stress), [GO:0008630](http://purl.obolibrary.org/obo/GO_0008630) (intrinsic apoptotic signaling pathway in response to DNA damage), [GO:0009967](http://purl.obolibrary.org/obo/GO_0009967) (positive regulation of signal transduction), [GO:0009966](http://purl.obolibrary.org/obo/GO_0009966) (regulation of signal transduction), [GO:0046902](http://purl.obolibrary.org/obo/GO_0046902) (regulation of mitochondrial membrane permeability), [GO:0008635](http://purl.obolibrary.org/obo/GO_0008635) (activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c), [GO:0051497](http://purl.obolibrary.org/obo/GO_0051497) (negative regulation of stress fiber assembly), [GO:0008627](http://purl.obolibrary.org/obo/GO_0008627) (intrinsic apoptotic signaling pathway in response to osmotic stress), [GO:0009957](http://purl.obolibrary.org/obo/GO_0009957) (epidermal cell fate specification), [GO:0051496](http://purl.obolibrary.org/obo/GO_0051496) (positive regulation of stress fiber assembly), [GO:0010944](http://purl.obolibrary.org/obo/GO_0010944) (negative regulation of transcription by competitive promoter binding), [GO:0051493](http://purl.obolibrary.org/obo/GO_0051493) (regulation of cytoskeleton organization), [GO:0010947](http://purl.obolibrary.org/obo/GO_0010947) (negative regulation of meiotic joint molecule formation), [GO:0010941](http://purl.obolibrary.org/obo/GO_0010941) (regulation of cell death), [GO:0010942](http://purl.obolibrary.org/obo/GO_0010942) (positive regulation of cell death), [GO:0046914](http://purl.obolibrary.org/obo/GO_0046914) (transition metal ion binding), [GO:0046915](http://purl.obolibrary.org/obo/GO_0046915) (transition metal ion transmembrane transporter activity), [GO:0022904](http://purl.obolibrary.org/obo/GO_0022904) (respiratory electron transport chain), [GO:0022900](http://purl.obolibrary.org/obo/GO_0022900) (electron transport chain), [GO:0008603](http://purl.obolibrary.org/obo/GO_0008603) (cAMP-dependent protein kinase regulator activity), [GO:0010916](http://purl.obolibrary.org/obo/GO_0010916) (negative regulation of very-low-density lipoprotein particle clearance), [GO:0009925](http://purl.obolibrary.org/obo/GO_0009925) (basal plasma membrane), [GO:0010918](http://purl.obolibrary.org/obo/GO_0010918) (positive regulation of mitochondrial membrane potential), [GO:0046928](http://purl.obolibrary.org/obo/GO_0046928) (regulation of neurotransmitter secretion), [GO:0086100](http://purl.obolibrary.org/obo/GO_0086100) (endothelin receptor signaling pathway), [GO:0046929](http://purl.obolibrary.org/obo/GO_0046929) (negative regulation of neurotransmitter secretion), [GO:0008610](http://purl.obolibrary.org/obo/GO_0008610) (lipid biosynthetic process), [GO:0008611](http://purl.obolibrary.org/obo/GO_0008611) (ether lipid biosynthetic process), [GO:0046922](http://purl.obolibrary.org/obo/GO_0046922) (peptide-O-fucosyltransferase activity), [GO:0010923](http://purl.obolibrary.org/obo/GO_0010923) (negative regulation of phosphatase activity), [GO:0050185](http://purl.obolibrary.org/obo/GO_0050185) (phosphatidylinositol deacylase activity), [GO:0010922](http://purl.obolibrary.org/obo/GO_0010922) (positive regulation of phosphatase activity), [GO:0008609](http://purl.obolibrary.org/obo/GO_0008609) (alkylglycerone-phosphate synthase activity), [GO:0008608](http://purl.obolibrary.org/obo/GO_0008608) (attachment of spindle microtubules to kinetochore), [GO:0010921](http://purl.obolibrary.org/obo/GO_0010921) (regulation of phosphatase activity), [GO:0019318](http://purl.obolibrary.org/obo/GO_0019318) (hexose metabolic process), [GO:0021636](http://purl.obolibrary.org/obo/GO_0021636) (trigeminal nerve morphogenesis), [GO:1903202](http://purl.obolibrary.org/obo/GO_1903202) (negative regulation of oxidative stress-induced cell death), [GO:0006002](http://purl.obolibrary.org/obo/GO_0006002) (fructose 6-phosphate metabolic process), [GO:1903206](http://purl.obolibrary.org/obo/GO_1903206) (negative regulation of hydrogen peroxide-induced cell death), [GO:0021633](http://purl.obolibrary.org/obo/GO_0021633) (optic nerve structural organization), [GO:0006000](http://purl.obolibrary.org/obo/GO_0006000) (fructose metabolic process), [GO:1904535](http://purl.obolibrary.org/obo/GO_1904535) (positive regulation of telomeric loop disassembly), [GO:0021634](http://purl.obolibrary.org/obo/GO_0021634) (optic nerve formation), [GO:0009994](http://purl.obolibrary.org/obo/GO_0009994) (oocyte differentiation), [GO:1903204](http://purl.obolibrary.org/obo/GO_1903204) (negative regulation of oxidative stress-induced neuron death), [GO:0006006](http://purl.obolibrary.org/obo/GO_0006006) (glucose metabolic process), [GO:1903209](http://purl.obolibrary.org/obo/GO_1903209) (positive regulation of oxidative stress-induced cell death), [GO:0007338](http://purl.obolibrary.org/obo/GO_0007338) (single fertilization), [GO:0006004](http://purl.obolibrary.org/obo/GO_0006004) (fucose metabolic process), [GO:0021631](http://purl.obolibrary.org/obo/GO_0021631) (optic nerve morphogenesis), [GO:0051444](http://purl.obolibrary.org/obo/GO_0051444) (negative regulation of ubiquitin-protein transferase activity), [GO:0033617](http://purl.obolibrary.org/obo/GO_0033617) (mitochondrial respiratory chain complex IV assembly), [GO:0033615](http://purl.obolibrary.org/obo/GO_0033615) (mitochondrial proton-transporting ATP synthase complex assembly), [GO:0010977](http://purl.obolibrary.org/obo/GO_0010977) (negative regulation of neuron projection development), [GO:0033619](http://purl.obolibrary.org/obo/GO_0033619) (membrane protein proteolysis), [GO:0019322](http://purl.obolibrary.org/obo/GO_0019322) (pentose biosynthetic process), [GO:0010976](http://purl.obolibrary.org/obo/GO_0010976) (positive regulation of neuron projection development), [GO:0010975](http://purl.obolibrary.org/obo/GO_0010975) (regulation of neuron projection development), [GO:0010970](http://purl.obolibrary.org/obo/GO_0010970) (transport along microtubule), [GO:0033613](http://purl.obolibrary.org/obo/GO_0033613) (activating transcription factor binding), [GO:0010972](http://purl.obolibrary.org/obo/GO_0010972) (negative regulation of G2/M transition of mitotic cell cycle), [GO:0051446](http://purl.obolibrary.org/obo/GO_0051446) (positive regulation of meiotic cell cycle), [GO:0010971](http://purl.obolibrary.org/obo/GO_0010971) (positive regulation of G2/M transition of mitotic cell cycle), [GO:0051447](http://purl.obolibrary.org/obo/GO_0051447) (negative regulation of meiotic cell cycle), [GO:0007341](http://purl.obolibrary.org/obo/GO_0007341) (penetration of zona pellucida), [GO:1905872](http://purl.obolibrary.org/obo/GO_1905872) (negative regulation of protein localization to cell leading edge), [GO:0021628](http://purl.obolibrary.org/obo/GO_0021628) (olfactory nerve formation), [GO:0006013](http://purl.obolibrary.org/obo/GO_0006013) (mannose metabolic process), [GO:0006014](http://purl.obolibrary.org/obo/GO_0006014) (D-ribose metabolic process), [GO:0006011](http://purl.obolibrary.org/obo/GO_0006011) (UDP-glucose metabolic process), [GO:0021623](http://purl.obolibrary.org/obo/GO_0021623) (oculomotor nerve formation), [GO:0006012](http://purl.obolibrary.org/obo/GO_0006012) (galactose metabolic process), [GO:0007343](http://purl.obolibrary.org/obo/GO_0007343) (egg activation), [GO:0006015](http://purl.obolibrary.org/obo/GO_0006015) (5-phosphoribose 1-diphosphate biosynthetic process), [GO:0007346](http://purl.obolibrary.org/obo/GO_0007346) (regulation of mitotic cell cycle), [GO:0051453](http://purl.obolibrary.org/obo/GO_0051453) (regulation of intracellular pH), [GO:0007339](http://purl.obolibrary.org/obo/GO_0007339) (binding of sperm to zona pellucida), [GO:0033605](http://purl.obolibrary.org/obo/GO_0033605) (positive regulation of catecholamine secretion), [GO:0051451](http://purl.obolibrary.org/obo/GO_0051451) (myoblast migration), [GO:0010989](http://purl.obolibrary.org/obo/GO_0010989) (negative regulation of low-density lipoprotein particle clearance), [GO:0051452](http://purl.obolibrary.org/obo/GO_0051452) (intracellular pH reduction), [GO:0033609](http://purl.obolibrary.org/obo/GO_0033609) (oxalate metabolic process), [GO:0051450](http://purl.obolibrary.org/obo/GO_0051450) (myoblast proliferation), [GO:0010987](http://purl.obolibrary.org/obo/GO_0010987) (negative regulation of high-density lipoprotein particle clearance), [GO:0033602](http://purl.obolibrary.org/obo/GO_0033602) (negative regulation of dopamine secretion), [GO:0010980](http://purl.obolibrary.org/obo/GO_0010980) (positive regulation of vitamin D 24-hydroxylase activity), [GO:0051457](http://purl.obolibrary.org/obo/GO_0051457) (maintenance of protein location in nucleus), [GO:0033600](http://purl.obolibrary.org/obo/GO_0033600) (negative regulation of mammary gland epithelial cell proliferation), [GO:0021615](http://purl.obolibrary.org/obo/GO_0021615) (glossopharyngeal nerve morphogenesis), [GO:0008643](http://purl.obolibrary.org/obo/GO_0008643) (carbohydrate transport), [GO:0021610](http://purl.obolibrary.org/obo/GO_0021610) (facial nerve morphogenesis), [GO:0008641](http://purl.obolibrary.org/obo/GO_0008641) (ubiquitin-like modifier activating enzyme activity), [GO:0021612](http://purl.obolibrary.org/obo/GO_0021612) (facial nerve structural organization), [GO:0009972](http://purl.obolibrary.org/obo/GO_0009972) (cytidine deamination), [GO:0008645](http://purl.obolibrary.org/obo/GO_0008645) (hexose transport), [GO:0052795](http://purl.obolibrary.org/obo/GO_0052795) (exo-alpha-(2->6)-sialidase activity), [GO:0051464](http://purl.obolibrary.org/obo/GO_0051464) (positive regulation of cortisol secretion), [GO:0008637](http://purl.obolibrary.org/obo/GO_0008637) (apoptotic mitochondrial changes), [GO:0052796](http://purl.obolibrary.org/obo/GO_0052796) (exo-alpha-(2->8)-sialidase activity), [GO:0009968](http://purl.obolibrary.org/obo/GO_0009968) (negative regulation of signal transduction), [GO:0010956](http://purl.obolibrary.org/obo/GO_0010956) (negative regulation of calcidiol 1-monooxygenase activity), [GO:0052794](http://purl.obolibrary.org/obo/GO_0052794) (exo-alpha-(2->3)-sialidase activity), [GO:0051463](http://purl.obolibrary.org/obo/GO_0051463) (negative regulation of cortisol secretion), [GO:0010951](http://purl.obolibrary.org/obo/GO_0010951) (negative regulation of endopeptidase activity), [GO:1903232](http://purl.obolibrary.org/obo/GO_1903232) (melanosome assembly), [GO:0051480](http://purl.obolibrary.org/obo/GO_0051480) (regulation of cytosolic calcium ion concentration), [GO:0008654](http://purl.obolibrary.org/obo/GO_0008654) (phospholipid biosynthetic process), [GO:1903238](http://purl.obolibrary.org/obo/GO_1903238) (positive regulation of leukocyte tethering or rolling), [GO:0051481](http://purl.obolibrary.org/obo/GO_0051481) (negative regulation of cytosolic calcium ion concentration), [GO:0007323](http://purl.obolibrary.org/obo/GO_0007323) (peptide pheromone maturation), [GO:0008652](http://purl.obolibrary.org/obo/GO_0008652) (cellular amino acid biosynthetic process), [GO:1905899](http://purl.obolibrary.org/obo/GO_1905899) (regulation of smooth muscle tissue development), [GO:0021602](http://purl.obolibrary.org/obo/GO_0021602) (cranial nerve morphogenesis), [GO:0009982](http://purl.obolibrary.org/obo/GO_0009982) (pseudouridine synthase activity), [GO:1905898](http://purl.obolibrary.org/obo/GO_1905898) (positive regulation of response to endoplasmic reticulum stress), [GO:0009987](http://purl.obolibrary.org/obo/GO_0009987) (cellular process), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0010966](http://purl.obolibrary.org/obo/GO_0010966) (regulation of phosphate transport), [GO:0010969](http://purl.obolibrary.org/obo/GO_0010969) (regulation of pheromone-dependent signal transduction involved in conjugation with cellular fusion), [GO:0010963](http://purl.obolibrary.org/obo/GO_0010963) (regulation of L-arginine import), [GO:0010961](http://purl.obolibrary.org/obo/GO_0010961) (cellular magnesium ion homeostasis), [GO:0010960](http://purl.obolibrary.org/obo/GO_0010960) (magnesium ion homeostasis), [GO:0086077](http://purl.obolibrary.org/obo/GO_0086077) (gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling), [GO:0086078](http://purl.obolibrary.org/obo/GO_0086078) (gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling), [GO:0007252](http://purl.obolibrary.org/obo/GO_0007252) (I-kappaB phosphorylation), [GO:0021559](http://purl.obolibrary.org/obo/GO_0021559) (trigeminal nerve development), [GO:0008584](http://purl.obolibrary.org/obo/GO_0008584) (male gonad development), [GO:0033540](http://purl.obolibrary.org/obo/GO_0033540) (fatty acid beta-oxidation using acyl-CoA oxidase), [GO:0007250](http://purl.obolibrary.org/obo/GO_0007250) (activation of NF-kappaB-inducing kinase activity), [GO:0008582](http://purl.obolibrary.org/obo/GO_0008582) (regulation of synaptic growth at neuromuscular junction), [GO:0007256](http://purl.obolibrary.org/obo/GO_0007256) (activation of JNKK activity), [GO:0021555](http://purl.obolibrary.org/obo/GO_0021555) (midbrain-hindbrain boundary morphogenesis), [GO:0008588](http://purl.obolibrary.org/obo/GO_0008588) (release of cytoplasmic sequestered NF-kappaB), [GO:0007257](http://purl.obolibrary.org/obo/GO_0007257) (activation of JUN kinase activity), [GO:0046854](http://purl.obolibrary.org/obo/GO_0046854) (phosphatidylinositol phosphorylation), [GO:0021556](http://purl.obolibrary.org/obo/GO_0021556) (central nervous system formation), [GO:0007254](http://purl.obolibrary.org/obo/GO_0007254) (JNK cascade), [GO:0008585](http://purl.obolibrary.org/obo/GO_0008585) (female gonad development), [GO:0021551](http://purl.obolibrary.org/obo/GO_0021551) (central nervous system morphogenesis), [GO:0046855](http://purl.obolibrary.org/obo/GO_0046855) (inositol phosphate dephosphorylation), [GO:0007258](http://purl.obolibrary.org/obo/GO_0007258) (JUN phosphorylation), [GO:0046856](http://purl.obolibrary.org/obo/GO_0046856) (phosphatidylinositol dephosphorylation), [GO:0007259](http://purl.obolibrary.org/obo/GO_0007259) (JAK-STAT cascade), [GO:0008589](http://purl.obolibrary.org/obo/GO_0008589) (regulation of smoothened signaling pathway), [GO:0021554](http://purl.obolibrary.org/obo/GO_0021554) (optic nerve development), [GO:0033539](http://purl.obolibrary.org/obo/GO_0033539) (fatty acid beta-oxidation using acyl-CoA dehydrogenase), [GO:1900925](http://purl.obolibrary.org/obo/GO_1900925) (positive regulation of glycine import), [GO:0019240](http://purl.obolibrary.org/obo/GO_0019240) (citrulline biosynthetic process), [GO:1990402](http://purl.obolibrary.org/obo/GO_1990402) (embryonic liver development), [GO:1990403](http://purl.obolibrary.org/obo/GO_1990403) (embryonic brain development), [GO:0019242](http://purl.obolibrary.org/obo/GO_0019242) (methylglyoxal biosynthetic process), [GO:0010897](http://purl.obolibrary.org/obo/GO_0010897) (negative regulation of triglyceride catabolic process), [GO:1990405](http://purl.obolibrary.org/obo/GO_1990405) (protein antigen binding), [GO:0019244](http://purl.obolibrary.org/obo/GO_0019244) (lactate biosynthetic process from pyruvate), [GO:0032202](http://purl.obolibrary.org/obo/GO_0032202) (telomere assembly), [GO:0010898](http://purl.obolibrary.org/obo/GO_0010898) (positive regulation of triglyceride catabolic process), [GO:0071813](http://purl.obolibrary.org/obo/GO_0071813) (lipoprotein particle binding), [GO:0032205](http://purl.obolibrary.org/obo/GO_0032205) (negative regulation of telomere maintenance), [GO:0010893](http://purl.obolibrary.org/obo/GO_0010893) (positive regulation of steroid biosynthetic process), [GO:0019249](http://purl.obolibrary.org/obo/GO_0019249) (lactate biosynthetic process), [GO:0032206](http://purl.obolibrary.org/obo/GO_0032206) (positive regulation of telomere maintenance), [GO:0086087](http://purl.obolibrary.org/obo/GO_0086087) (voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization), [GO:0032203](http://purl.obolibrary.org/obo/GO_0032203) (telomere formation via telomerase), [GO:0071812](http://purl.obolibrary.org/obo/GO_0071812) (positive regulation of fever generation by positive regulation of prostaglandin secretion), [GO:0010894](http://purl.obolibrary.org/obo/GO_0010894) (negative regulation of steroid biosynthetic process), [GO:0071806](http://purl.obolibrary.org/obo/GO_0071806) (protein transmembrane transport), [GO:0044209](http://purl.obolibrary.org/obo/GO_0044209) (AMP salvage), [GO:0044208](http://purl.obolibrary.org/obo/GO_0044208) ('de novo' AMP biosynthetic process), [GO:0007260](http://purl.obolibrary.org/obo/GO_0007260) (tyrosine phosphorylation of STAT protein), [GO:0071804](http://purl.obolibrary.org/obo/GO_0071804) (cellular potassium ion transport), [GO:0071805](http://purl.obolibrary.org/obo/GO_0071805) (potassium ion transmembrane transport), [GO:0086089](http://purl.obolibrary.org/obo/GO_0086089) (voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization), [GO:0007263](http://purl.obolibrary.org/obo/GO_0007263) (nitric oxide mediated signal transduction), [GO:0021549](http://purl.obolibrary.org/obo/GO_0021549) (cerebellum development), [GO:0007264](http://purl.obolibrary.org/obo/GO_0007264) (small GTPase mediated signal transduction), [GO:0008594](http://purl.obolibrary.org/obo/GO_0008594) (photoreceptor cell morphogenesis), [GO:0008593](http://purl.obolibrary.org/obo/GO_0008593) (regulation of Notch signaling pathway), [GO:0007267](http://purl.obolibrary.org/obo/GO_0007267) (cell-cell signaling), [GO:0007268](http://purl.obolibrary.org/obo/GO_0007268) (chemical synaptic transmission), [GO:0007265](http://purl.obolibrary.org/obo/GO_0007265) (Ras protein signal transduction), [GO:0007266](http://purl.obolibrary.org/obo/GO_0007266) (Rho protein signal transduction), [GO:2000808](http://purl.obolibrary.org/obo/GO_2000808) (negative regulation of synaptic vesicle clustering), [GO:0044205](http://purl.obolibrary.org/obo/GO_0044205) ('de novo' UMP biosynthetic process), [GO:0021542](http://purl.obolibrary.org/obo/GO_0021542) (dentate gyrus development), [GO:0007269](http://purl.obolibrary.org/obo/GO_0007269) (neurotransmitter secretion), [GO:0021543](http://purl.obolibrary.org/obo/GO_0021543) (pallium development), [GO:2000806](http://purl.obolibrary.org/obo/GO_2000806) (positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled), [GO:0045540](http://purl.obolibrary.org/obo/GO_0045540) (regulation of cholesterol biosynthetic process), [GO:0019230](http://purl.obolibrary.org/obo/GO_0019230) (proprioception), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0045541](http://purl.obolibrary.org/obo/GO_0045541) (negative regulation of cholesterol biosynthetic process), [GO:0086090](http://purl.obolibrary.org/obo/GO_0086090) (voltage-gated potassium channel activity involved in SA node cell action potential repolarization), [GO:2000802](http://purl.obolibrary.org/obo/GO_2000802) (positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation), [GO:1990414](http://purl.obolibrary.org/obo/GO_1990414) (replication-born double-strand break repair via sister chromatid exchange), [GO:0044210](http://purl.obolibrary.org/obo/GO_0044210) ('de novo' CTP biosynthetic process), [GO:0046870](http://purl.obolibrary.org/obo/GO_0046870) (cadmium ion binding), [GO:1990415](http://purl.obolibrary.org/obo/GO_1990415) (Pex17p-Pex14p docking complex), [GO:1990416](http://purl.obolibrary.org/obo/GO_1990416) (cellular response to brain-derived neurotrophic factor stimulus), [GO:0033522](http://purl.obolibrary.org/obo/GO_0033522) (histone H2A ubiquitination), [GO:0019233](http://purl.obolibrary.org/obo/GO_0019233) (sensory perception of pain), [GO:0019236](http://purl.obolibrary.org/obo/GO_0019236) (response to pheromone), [GO:0086091](http://purl.obolibrary.org/obo/GO_0086091) (regulation of heart rate by cardiac conduction), [GO:1990418](http://purl.obolibrary.org/obo/GO_1990418) (response to insulin-like growth factor stimulus), [GO:0086092](http://purl.obolibrary.org/obo/GO_0086092) (regulation of the force of heart contraction by cardiac conduction), [GO:0019237](http://purl.obolibrary.org/obo/GO_0019237) (centromeric DNA binding), [GO:0071803](http://purl.obolibrary.org/obo/GO_0071803) (positive regulation of podosome assembly), [GO:0019239](http://purl.obolibrary.org/obo/GO_0019239) (deaminase activity), [GO:0070508](http://purl.obolibrary.org/obo/GO_0070508) (cholesterol import), [GO:0070509](http://purl.obolibrary.org/obo/GO_0070509) (calcium ion import), [GO:0071837](http://purl.obolibrary.org/obo/GO_0071837) (HMG box domain binding), [GO:0070506](http://purl.obolibrary.org/obo/GO_0070506) (high-density lipoprotein particle receptor activity), [GO:0010880](http://purl.obolibrary.org/obo/GO_0010880) (regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum), [GO:0070507](http://purl.obolibrary.org/obo/GO_0070507) (regulation of microtubule cytoskeleton organization), [GO:0071838](http://purl.obolibrary.org/obo/GO_0071838) (cell proliferation in bone marrow), [GO:0086056](http://purl.obolibrary.org/obo/GO_0086056) (voltage-gated calcium channel activity involved in AV node cell action potential), [GO:0021537](http://purl.obolibrary.org/obo/GO_0021537) (telencephalon development), [GO:0021538](http://purl.obolibrary.org/obo/GO_0021538) (epithalamus development), [GO:0007231](http://purl.obolibrary.org/obo/GO_0007231) (osmosensory signaling pathway), [GO:0009892](http://purl.obolibrary.org/obo/GO_0009892) (negative regulation of metabolic process), [GO:0021539](http://purl.obolibrary.org/obo/GO_0021539) (subthalamus development), [GO:0086059](http://purl.obolibrary.org/obo/GO_0086059) (voltage-gated calcium channel activity involved SA node cell action potential), [GO:0009897](http://purl.obolibrary.org/obo/GO_0009897) (external side of plasma membrane), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0021533](http://purl.obolibrary.org/obo/GO_0021533) (cell differentiation in hindbrain), [GO:0046875](http://purl.obolibrary.org/obo/GO_0046875) (ephrin receptor binding), [GO:0008565](http://purl.obolibrary.org/obo/GO_0008565) (protein transporter activity), [GO:0045545](http://purl.obolibrary.org/obo/GO_0045545) (syndecan binding), [GO:0046873](http://purl.obolibrary.org/obo/GO_0046873) (metal ion transmembrane transporter activity), [GO:0045542](http://purl.obolibrary.org/obo/GO_0045542) (positive regulation of cholesterol biosynthetic process), [GO:0021536](http://purl.obolibrary.org/obo/GO_0021536) (diencephalon development), [GO:0008569](http://purl.obolibrary.org/obo/GO_0008569) (ATP-dependent microtubule motor activity, minus-end-directed), [GO:0044218](http://purl.obolibrary.org/obo/GO_0044218) (other organism cell membrane), [GO:0009898](http://purl.obolibrary.org/obo/GO_0009898) (cytoplasmic side of plasma membrane), [GO:0021532](http://purl.obolibrary.org/obo/GO_0021532) (neural tube patterning), [GO:0045547](http://purl.obolibrary.org/obo/GO_0045547) (dehydrodolichyl diphosphate synthase activity), [GO:0007229](http://purl.obolibrary.org/obo/GO_0007229) (integrin-mediated signaling pathway), [GO:2000811](http://purl.obolibrary.org/obo/GO_2000811) (negative regulation of anoikis), [GO:0046883](http://purl.obolibrary.org/obo/GO_0046883) (regulation of hormone secretion), [GO:0019221](http://purl.obolibrary.org/obo/GO_0019221) (cytokine-mediated signaling pathway), [GO:0019220](http://purl.obolibrary.org/obo/GO_0019220) (regulation of phosphate metabolic process), [GO:0045550](http://purl.obolibrary.org/obo/GO_0045550) (geranylgeranyl reductase activity), [GO:1990426](http://purl.obolibrary.org/obo/GO_1990426) (mitotic recombination-dependent replication fork processing), [GO:0046881](http://purl.obolibrary.org/obo/GO_0046881) (positive regulation of follicle-stimulating hormone secretion), [GO:0010875](http://purl.obolibrary.org/obo/GO_0010875) (positive regulation of cholesterol efflux), [GO:0086060](http://purl.obolibrary.org/obo/GO_0086060) (voltage-gated sodium channel activity involved in AV node cell action potential), [GO:0019222](http://purl.obolibrary.org/obo/GO_0019222) (regulation of metabolic process), [GO:0086061](http://purl.obolibrary.org/obo/GO_0086061) (voltage-gated sodium channel activity involved in bundle of His cell action potential), [GO:0010874](http://purl.obolibrary.org/obo/GO_0010874) (regulation of cholesterol efflux), [GO:1990429](http://purl.obolibrary.org/obo/GO_1990429) (peroxisomal importomer complex), [GO:0019227](http://purl.obolibrary.org/obo/GO_0019227) (neuronal action potential propagation), [GO:0086064](http://purl.obolibrary.org/obo/GO_0086064) (cell communication by electrical coupling involved in cardiac conduction), [GO:0019226](http://purl.obolibrary.org/obo/GO_0019226) (transmission of nerve impulse), [GO:0086065](http://purl.obolibrary.org/obo/GO_0086065) (cell communication involved in cardiac conduction), [GO:0010873](http://purl.obolibrary.org/obo/GO_0010873) (positive regulation of cholesterol esterification), [GO:0086062](http://purl.obolibrary.org/obo/GO_0086062) (voltage-gated sodium channel activity involved in Purkinje myocyte action potential), [GO:0019229](http://purl.obolibrary.org/obo/GO_0019229) (regulation of vasoconstriction), [GO:0019228](http://purl.obolibrary.org/obo/GO_0019228) (neuronal action potential), [GO:0086063](http://purl.obolibrary.org/obo/GO_0086063) (voltage-gated sodium channel activity involved in SA node cell action potential), [GO:0019209](http://purl.obolibrary.org/obo/GO_0019209) (kinase activator activity), [GO:0019208](http://purl.obolibrary.org/obo/GO_0019208) (phosphatase regulator activity), [GO:0010891](http://purl.obolibrary.org/obo/GO_0010891) (negative regulation of sequestering of triglyceride), [GO:0086067](http://purl.obolibrary.org/obo/GO_0086067) (AV node cell to bundle of His cell communication), [GO:0010890](http://purl.obolibrary.org/obo/GO_0010890) (positive regulation of sequestering of triglyceride), [GO:0022857](http://purl.obolibrary.org/obo/GO_0022857) (transmembrane transporter activity), [GO:0021527](http://purl.obolibrary.org/obo/GO_0021527) (spinal cord association neuron differentiation), [GO:0021529](http://purl.obolibrary.org/obo/GO_0021529) (spinal cord oligodendrocyte cell differentiation), [GO:0021522](http://purl.obolibrary.org/obo/GO_0021522) (spinal cord motor neuron differentiation), [GO:0046887](http://purl.obolibrary.org/obo/GO_0046887) (positive regulation of hormone secretion), [GO:0021523](http://purl.obolibrary.org/obo/GO_0021523) (somatic motor neuron differentiation), [GO:0008574](http://purl.obolibrary.org/obo/GO_0008574) (ATP-dependent microtubule motor activity, plus-end-directed), [GO:0044224](http://purl.obolibrary.org/obo/GO_0044224) (juxtaparanode region of axon), [GO:0007249](http://purl.obolibrary.org/obo/GO_0007249) (I-kappaB kinase/NF-kappaB signaling), [GO:0022851](http://purl.obolibrary.org/obo/GO_0022851) (GABA-gated chloride ion channel activity), [GO:0046888](http://purl.obolibrary.org/obo/GO_0046888) (negative regulation of hormone secretion), [GO:0021520](http://purl.obolibrary.org/obo/GO_0021520) (spinal cord motor neuron cell fate specification), [GO:1990440](http://purl.obolibrary.org/obo/GO_1990440) (positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress), [GO:0046889](http://purl.obolibrary.org/obo/GO_0046889) (positive regulation of lipid biosynthetic process), [GO:0021521](http://purl.obolibrary.org/obo/GO_0021521) (ventral spinal cord interneuron specification), [GO:2000822](http://purl.obolibrary.org/obo/GO_2000822) (regulation of behavioral fear response), [GO:1990435](http://purl.obolibrary.org/obo/GO_1990435) (upper tip-link density), [GO:0010886](http://purl.obolibrary.org/obo/GO_0010886) (positive regulation of cholesterol storage), [GO:0019212](http://purl.obolibrary.org/obo/GO_0019212) (phosphatase inhibitor activity), [GO:0019211](http://purl.obolibrary.org/obo/GO_0019211) (phosphatase activator activity), [GO:0010888](http://purl.obolibrary.org/obo/GO_0010888) (negative regulation of lipid storage), [GO:0019213](http://purl.obolibrary.org/obo/GO_0019213) (deacetylase activity), [GO:0019216](http://purl.obolibrary.org/obo/GO_0019216) (regulation of lipid metabolic process), [GO:0086075](http://purl.obolibrary.org/obo/GO_0086075) (gap junction channel activity involved in cardiac conduction electrical coupling), [GO:0010882](http://purl.obolibrary.org/obo/GO_0010882) (regulation of cardiac muscle contraction by calcium ion signaling), [GO:0033504](http://purl.obolibrary.org/obo/GO_0033504) (floor plate development), [GO:0019215](http://purl.obolibrary.org/obo/GO_0019215) (intermediate filament binding), [GO:0086076](http://purl.obolibrary.org/obo/GO_0086076) (gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling), [GO:0033503](http://purl.obolibrary.org/obo/GO_0033503) (HULC complex), [GO:0010881](http://purl.obolibrary.org/obo/GO_0010881) (regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion), [GO:0010884](http://purl.obolibrary.org/obo/GO_0010884) (positive regulation of lipid storage), [GO:0086073](http://purl.obolibrary.org/obo/GO_0086073) (bundle of His cell-Purkinje myocyte adhesion involved in cell communication), [GO:0019217](http://purl.obolibrary.org/obo/GO_0019217) (regulation of fatty acid metabolic process), [GO:0007292](http://purl.obolibrary.org/obo/GO_0007292) (female gamete generation), [GO:0086036](http://purl.obolibrary.org/obo/GO_0086036) (regulation of cardiac muscle cell membrane potential), [GO:0007296](http://purl.obolibrary.org/obo/GO_0007296) (vitellogenesis), [GO:0032252](http://purl.obolibrary.org/obo/GO_0032252) (secretory granule localization), [GO:0086037](http://purl.obolibrary.org/obo/GO_0086037) (sodium:potassium-exchanging ATPase activity involved in regulation of cardiac muscle cell membrane potential), [GO:0021599](http://purl.obolibrary.org/obo/GO_0021599) (abducens nerve formation), [GO:1990450](http://purl.obolibrary.org/obo/GO_1990450) (linear polyubiquitin binding), [GO:0050080](http://purl.obolibrary.org/obo/GO_0050080) (malonyl-CoA decarboxylase activity), [GO:0019287](http://purl.obolibrary.org/obo/GO_0019287) (isopentenyl diphosphate biosynthetic process, mevalonate pathway), [GO:0033577](http://purl.obolibrary.org/obo/GO_0033577) (protein glycosylation in endoplasmic reticulum), [GO:0033574](http://purl.obolibrary.org/obo/GO_0033574) (response to testosterone), [GO:0086043](http://purl.obolibrary.org/obo/GO_0086043) (bundle of His cell action potential), [GO:1904491](http://purl.obolibrary.org/obo/GO_1904491) (protein localization to ciliary transition zone), [GO:0086041](http://purl.obolibrary.org/obo/GO_0086041) (voltage-gated potassium channel activity involved in SA node cell action potential depolarization), [GO:0033578](http://purl.obolibrary.org/obo/GO_0033578) (protein glycosylation in Golgi), [GO:0086046](http://purl.obolibrary.org/obo/GO_0086046) (membrane depolarization during SA node cell action potential), [GO:0086047](http://purl.obolibrary.org/obo/GO_0086047) (membrane depolarization during Purkinje myocyte cell action potential), [GO:0086044](http://purl.obolibrary.org/obo/GO_0086044) (atrial cardiac muscle cell to AV node cell communication by electrical coupling), [GO:0046827](http://purl.obolibrary.org/obo/GO_0046827) (positive regulation of protein export from nucleus), [GO:0086045](http://purl.obolibrary.org/obo/GO_0086045) (membrane depolarization during AV node cell action potential), [GO:0033572](http://purl.obolibrary.org/obo/GO_0033572) (transferrin transport), [GO:0086048](http://purl.obolibrary.org/obo/GO_0086048) (membrane depolarization during bundle of His cell action potential), [GO:0033570](http://purl.obolibrary.org/obo/GO_0033570) (transferrin transmembrane transporter activity), [GO:0021588](http://purl.obolibrary.org/obo/GO_0021588) (cerebellum formation), [GO:0046825](http://purl.obolibrary.org/obo/GO_0046825) (regulation of protein export from nucleus), [GO:0021587](http://purl.obolibrary.org/obo/GO_0021587) (cerebellum morphogenesis), [GO:0021591](http://purl.obolibrary.org/obo/GO_0021591) (ventricular system development), [GO:0021592](http://purl.obolibrary.org/obo/GO_0021592) (fourth ventricle development), [GO:0021593](http://purl.obolibrary.org/obo/GO_0021593) (rhombomere morphogenesis), [GO:0019276](http://purl.obolibrary.org/obo/GO_0019276) (UDP-N-acetylgalactosamine metabolic process), [GO:0021590](http://purl.obolibrary.org/obo/GO_0021590) (cerebellum maturation), [GO:1990459](http://purl.obolibrary.org/obo/GO_1990459) (transferrin receptor binding), [GO:0086050](http://purl.obolibrary.org/obo/GO_0086050) (membrane repolarization during bundle of His cell action potential), [GO:0032232](http://purl.obolibrary.org/obo/GO_0032232) (negative regulation of actin filament bundle assembly), [GO:0033564](http://purl.obolibrary.org/obo/GO_0033564) (anterior/posterior axon guidance), [GO:0032233](http://purl.obolibrary.org/obo/GO_0032233) (positive regulation of actin filament bundle assembly), [GO:0086053](http://purl.obolibrary.org/obo/GO_0086053) (AV node cell to bundle of His cell communication by electrical coupling), [GO:0086054](http://purl.obolibrary.org/obo/GO_0086054) (bundle of His cell to Purkinje myocyte communication by electrical coupling), [GO:0034899](http://purl.obolibrary.org/obo/GO_0034899) (trimethylamine monooxygenase activity), [GO:0032237](http://purl.obolibrary.org/obo/GO_0032237) (activation of store-operated calcium channel activity), [GO:0033567](http://purl.obolibrary.org/obo/GO_0033567) (DNA replication, Okazaki fragment processing), [GO:0086052](http://purl.obolibrary.org/obo/GO_0086052) (membrane repolarization during SA node cell action potential), [GO:0007270](http://purl.obolibrary.org/obo/GO_0007270) (neuron-neuron synaptic transmission), [GO:0086013](http://purl.obolibrary.org/obo/GO_0086013) (membrane repolarization during cardiac muscle cell action potential), [GO:0046839](http://purl.obolibrary.org/obo/GO_0046839) (phospholipid dephosphorylation), [GO:0086014](http://purl.obolibrary.org/obo/GO_0086014) (atrial cardiac muscle cell action potential), [GO:0007271](http://purl.obolibrary.org/obo/GO_0007271) (synaptic transmission, cholinergic), [GO:0086011](http://purl.obolibrary.org/obo/GO_0086011) (membrane repolarization during action potential), [GO:0086012](http://purl.obolibrary.org/obo/GO_0086012) (membrane depolarization during cardiac muscle cell action potential), [GO:0046838](http://purl.obolibrary.org/obo/GO_0046838) (phosphorylated carbohydrate dephosphorylation), [GO:0007274](http://purl.obolibrary.org/obo/GO_0007274) (neuromuscular synaptic transmission), [GO:0032230](http://purl.obolibrary.org/obo/GO_0032230) (positive regulation of synaptic transmission, GABAergic), [GO:0033561](http://purl.obolibrary.org/obo/GO_0033561) (regulation of water loss via skin), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0086018](http://purl.obolibrary.org/obo/GO_0086018) (SA node cell to atrial cardiac muscle cell signaling), [GO:0086015](http://purl.obolibrary.org/obo/GO_0086015) (SA node cell action potential), [GO:0086016](http://purl.obolibrary.org/obo/GO_0086016) (AV node cell action potential), [GO:0007276](http://purl.obolibrary.org/obo/GO_0007276) (gamete generation), [GO:0046835](http://purl.obolibrary.org/obo/GO_0046835) (carbohydrate phosphorylation), [GO:0045504](http://purl.obolibrary.org/obo/GO_0045504) (dynein heavy chain binding), [GO:0045505](http://purl.obolibrary.org/obo/GO_0045505) (dynein intermediate chain binding), [GO:0021575](http://purl.obolibrary.org/obo/GO_0021575) (hindbrain morphogenesis), [GO:0045503](http://purl.obolibrary.org/obo/GO_0045503) (dynein light chain binding), [GO:0046834](http://purl.obolibrary.org/obo/GO_0046834) (lipid phosphorylation), [GO:0032229](http://purl.obolibrary.org/obo/GO_0032229) (negative regulation of synaptic transmission, GABAergic), [GO:1990467](http://purl.obolibrary.org/obo/GO_1990467) (NuA3a histone acetyltransferase complex), [GO:1990468](http://purl.obolibrary.org/obo/GO_1990468) (NuA3b histone acetyltransferase complex), [GO:0019265](http://purl.obolibrary.org/obo/GO_0019265) (glycine biosynthetic process, by transamination of glyoxylate), [GO:0033555](http://purl.obolibrary.org/obo/GO_0033555) (multicellular organismal response to stress), [GO:0032224](http://purl.obolibrary.org/obo/GO_0032224) (positive regulation of synaptic transmission, cholinergic), [GO:2000852](http://purl.obolibrary.org/obo/GO_2000852) (regulation of corticosterone secretion), [GO:0033552](http://purl.obolibrary.org/obo/GO_0033552) (response to vitamin B3), [GO:0032222](http://purl.obolibrary.org/obo/GO_0032222) (regulation of synaptic transmission, cholinergic), [GO:0032227](http://purl.obolibrary.org/obo/GO_0032227) (negative regulation of synaptic transmission, dopaminergic), [GO:0032228](http://purl.obolibrary.org/obo/GO_0032228) (regulation of synaptic transmission, GABAergic), [GO:0033558](http://purl.obolibrary.org/obo/GO_0033558) (protein deacetylase activity), [GO:0032225](http://purl.obolibrary.org/obo/GO_0032225) (regulation of synaptic transmission, dopaminergic), [GO:0007281](http://purl.obolibrary.org/obo/GO_0007281) (germ cell development), [GO:0046848](http://purl.obolibrary.org/obo/GO_0046848) (hydroxyapatite binding), [GO:0046849](http://purl.obolibrary.org/obo/GO_0046849) (bone remodeling), [GO:0086023](http://purl.obolibrary.org/obo/GO_0086023) (adrenergic receptor signaling pathway involved in heart process), [GO:0007286](http://purl.obolibrary.org/obo/GO_0007286) (spermatid development), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0007284](http://purl.obolibrary.org/obo/GO_0007284) (spermatogonial cell division), [GO:0086027](http://purl.obolibrary.org/obo/GO_0086027) (AV node cell to bundle of His cell signaling), [GO:0022898](http://purl.obolibrary.org/obo/GO_0022898) (regulation of transmembrane transporter activity), [GO:0021569](http://purl.obolibrary.org/obo/GO_0021569) (rhombomere 3 development), [GO:0007288](http://purl.obolibrary.org/obo/GO_0007288) (sperm axoneme assembly), [GO:0021562](http://purl.obolibrary.org/obo/GO_0021562) (vestibulocochlear nerve development), [GO:1990481](http://purl.obolibrary.org/obo/GO_1990481) (mRNA pseudouridine synthesis), [GO:0046847](http://purl.obolibrary.org/obo/GO_0046847) (filopodium assembly), [GO:0021570](http://purl.obolibrary.org/obo/GO_0021570) (rhombomere 4 development), [GO:0021571](http://purl.obolibrary.org/obo/GO_0021571) (rhombomere 5 development), [GO:0032218](http://purl.obolibrary.org/obo/GO_0032218) (riboflavin transport), [GO:0021572](http://purl.obolibrary.org/obo/GO_0021572) (rhombomere 6 development), [GO:0046850](http://purl.obolibrary.org/obo/GO_0046850) (regulation of bone remodeling), [GO:0019254](http://purl.obolibrary.org/obo/GO_0019254) (carnitine metabolic process, CoA-linked), [GO:0032212](http://purl.obolibrary.org/obo/GO_0032212) (positive regulation of telomere maintenance via telomerase), [GO:0034875](http://purl.obolibrary.org/obo/GO_0034875) (caffeine oxidase activity), [GO:0019255](http://purl.obolibrary.org/obo/GO_0019255) (glucose 1-phosphate metabolic process), [GO:0032210](http://purl.obolibrary.org/obo/GO_0032210) (regulation of telomere maintenance via telomerase), [GO:0032211](http://purl.obolibrary.org/obo/GO_0032211) (negative regulation of telomere maintenance via telomerase), [GO:0032216](http://purl.obolibrary.org/obo/GO_0032216) (glucosaminyl-phosphotidylinositol O-acyltransferase activity), [GO:0032217](http://purl.obolibrary.org/obo/GO_0032217) (riboflavin transmembrane transporter activity), [GO:0044279](http://purl.obolibrary.org/obo/GO_0044279) (other organism membrane), [GO:0003730](http://purl.obolibrary.org/obo/GO_0003730) (mRNA 3'-UTR binding), [GO:0003720](http://purl.obolibrary.org/obo/GO_0003720) (telomerase activity), [GO:0003721](http://purl.obolibrary.org/obo/GO_0003721) (telomerase RNA reverse transcriptase activity), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0003724](http://purl.obolibrary.org/obo/GO_0003724) (RNA helicase activity), [GO:0003725](http://purl.obolibrary.org/obo/GO_0003725) (double-stranded RNA binding), [GO:0070563](http://purl.obolibrary.org/obo/GO_0070563) (negative regulation of vitamin D receptor signaling pathway), [GO:0003726](http://purl.obolibrary.org/obo/GO_0003726) (double-stranded RNA adenosine deaminase activity), [GO:0015707](http://purl.obolibrary.org/obo/GO_0015707) (nitrite transport), [GO:0003727](http://purl.obolibrary.org/obo/GO_0003727) (single-stranded RNA binding), [GO:0071897](http://purl.obolibrary.org/obo/GO_0071897) (DNA biosynthetic process), [GO:0032289](http://purl.obolibrary.org/obo/GO_0032289) (central nervous system myelin formation), [GO:0015705](http://purl.obolibrary.org/obo/GO_0015705) (iodide transport), [GO:0003729](http://purl.obolibrary.org/obo/GO_0003729) (mRNA binding), [GO:0070567](http://purl.obolibrary.org/obo/GO_0070567) (cytidylyltransferase activity), [GO:0032287](http://purl.obolibrary.org/obo/GO_0032287) (peripheral nervous system myelin maintenance), [GO:0071895](http://purl.obolibrary.org/obo/GO_0071895) (odontoblast differentiation), [GO:0015701](http://purl.obolibrary.org/obo/GO_0015701) (bicarbonate transport), [GO:2000872](http://purl.obolibrary.org/obo/GO_2000872) (positive regulation of progesterone secretion), [GO:0032281](http://purl.obolibrary.org/obo/GO_0032281) (AMPA glutamate receptor complex), [GO:0032286](http://purl.obolibrary.org/obo/GO_0032286) (central nervous system myelin maintenance), [GO:0044292](http://purl.obolibrary.org/obo/GO_0044292) (dendrite terminus), [GO:0044291](http://purl.obolibrary.org/obo/GO_0044291) (cell-cell contact zone), [GO:0044294](http://purl.obolibrary.org/obo/GO_0044294) (dendritic growth cone), [GO:0003735](http://purl.obolibrary.org/obo/GO_0003735) (structural constituent of ribosome), [GO:0044295](http://purl.obolibrary.org/obo/GO_0044295) (axonal growth cone), [GO:0071880](http://purl.obolibrary.org/obo/GO_0071880) (adenylate cyclase-activating adrenergic receptor signaling pathway), [GO:0044297](http://purl.obolibrary.org/obo/GO_0044297) (cell body), [GO:0015718](http://purl.obolibrary.org/obo/GO_0015718) (monocarboxylic acid transport), [GO:0070555](http://purl.obolibrary.org/obo/GO_0070555) (response to interleukin-1), [GO:0071886](http://purl.obolibrary.org/obo/GO_0071886) (1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding), [GO:0032279](http://purl.obolibrary.org/obo/GO_0032279) (asymmetric synapse), [GO:0015712](http://purl.obolibrary.org/obo/GO_0015712) (hexose phosphate transport), [GO:0015711](http://purl.obolibrary.org/obo/GO_0015711) (organic anion transport), [GO:0070557](http://purl.obolibrary.org/obo/GO_0070557) (PCNA-p21 complex), [GO:0071889](http://purl.obolibrary.org/obo/GO_0071889) (14-3-3 protein binding), [GO:0032270](http://purl.obolibrary.org/obo/GO_0032270) (positive regulation of cellular protein metabolic process), [GO:0044299](http://purl.obolibrary.org/obo/GO_0044299) (C-fiber), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0070584](http://purl.obolibrary.org/obo/GO_0070584) (mitochondrion morphogenesis), [GO:0003705](http://purl.obolibrary.org/obo/GO_0003705) (transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding), [GO:0070588](http://purl.obolibrary.org/obo/GO_0070588) (calcium ion transmembrane transport), [GO:0033599](http://purl.obolibrary.org/obo/GO_0033599) (regulation of mammary gland epithelial cell proliferation), [GO:0032268](http://purl.obolibrary.org/obo/GO_0032268) (regulation of cellular protein metabolic process), [GO:0003707](http://purl.obolibrary.org/obo/GO_0003707) (steroid hormone receptor activity), [GO:0033597](http://purl.obolibrary.org/obo/GO_0033597) (mitotic checkpoint complex), [GO:0070586](http://purl.obolibrary.org/obo/GO_0070586) (cell-cell adhesion involved in gastrulation), [GO:0070587](http://purl.obolibrary.org/obo/GO_0070587) (regulation of cell-cell adhesion involved in gastrulation), [GO:0032266](http://purl.obolibrary.org/obo/GO_0032266) (phosphatidylinositol-3-phosphate binding), [GO:0033596](http://purl.obolibrary.org/obo/GO_0033596) (TSC1-TSC2 complex), [GO:0032269](http://purl.obolibrary.org/obo/GO_0032269) (negative regulation of cellular protein metabolic process), [GO:0032264](http://purl.obolibrary.org/obo/GO_0032264) (IMP salvage), [GO:0032261](http://purl.obolibrary.org/obo/GO_0032261) (purine nucleotide salvage), [GO:0033593](http://purl.obolibrary.org/obo/GO_0033593) (BRCA2-MAGE-D1 complex), [GO:0033592](http://purl.obolibrary.org/obo/GO_0033592) (RNA strand annealing activity), [GO:0003712](http://purl.obolibrary.org/obo/GO_0003712) (transcription cofactor activity), [GO:0003713](http://purl.obolibrary.org/obo/GO_0003713) (transcription coactivator activity), [GO:0070573](http://purl.obolibrary.org/obo/GO_0070573) (metallodipeptidase activity), [GO:0070574](http://purl.obolibrary.org/obo/GO_0070574) (cadmium ion transmembrane transport), [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity), [GO:0033588](http://purl.obolibrary.org/obo/GO_0033588) (Elongator holoenzyme complex), [GO:0070578](http://purl.obolibrary.org/obo/GO_0070578) (RISC-loading complex), [GO:0032258](http://purl.obolibrary.org/obo/GO_0032258) (protein localization by the Cvt pathway), [GO:0032259](http://purl.obolibrary.org/obo/GO_0032259) (methylation), [GO:0070528](http://purl.obolibrary.org/obo/GO_0070528) (protein kinase C signaling), [GO:0044233](http://purl.obolibrary.org/obo/GO_0044233) (ER-mitochondrion membrane contact site), [GO:0044236](http://purl.obolibrary.org/obo/GO_0044236) (multicellular organism metabolic process), [GO:0001106](http://purl.obolibrary.org/obo/GO_0001106) (RNA polymerase II transcription corepressor activity), [GO:0001105](http://purl.obolibrary.org/obo/GO_0001105) (RNA polymerase II transcription coactivator activity), [GO:0044237](http://purl.obolibrary.org/obo/GO_0044237) (cellular metabolic process), [GO:0001104](http://purl.obolibrary.org/obo/GO_0001104) (RNA polymerase II transcription cofactor activity), [GO:0001103](http://purl.obolibrary.org/obo/GO_0001103) (RNA polymerase II repressing transcription factor binding), [GO:0003774](http://purl.obolibrary.org/obo/GO_0003774) (motor activity), [GO:0001102](http://purl.obolibrary.org/obo/GO_0001102) (RNA polymerase II activating transcription factor binding), [GO:0002443](http://purl.obolibrary.org/obo/GO_0002443) (leukocyte mediated immunity), [GO:0002434](http://purl.obolibrary.org/obo/GO_0002434) (immune complex clearance), [GO:0044241](http://purl.obolibrary.org/obo/GO_0044241) (lipid digestion), [GO:0071850](http://purl.obolibrary.org/obo/GO_0071850) (mitotic cell cycle arrest), [GO:0002438](http://purl.obolibrary.org/obo/GO_0002438) (acute inflammatory response to antigenic stimulus), [GO:0002439](http://purl.obolibrary.org/obo/GO_0002439) (chronic inflammatory response to antigenic stimulus), [GO:0044242](http://purl.obolibrary.org/obo/GO_0044242) (cellular lipid catabolic process), [GO:0070522](http://purl.obolibrary.org/obo/GO_0070522) (ERCC4-ERCC1 complex), [GO:0015746](http://purl.obolibrary.org/obo/GO_0015746) (citrate transport), [GO:0070527](http://purl.obolibrary.org/obo/GO_0070527) (platelet aggregation), [GO:0071855](http://purl.obolibrary.org/obo/GO_0071855) (neuropeptide receptor binding), [GO:0015744](http://purl.obolibrary.org/obo/GO_0015744) (succinate transport), [GO:0071848](http://purl.obolibrary.org/obo/GO_0071848) (positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling), [GO:0015760](http://purl.obolibrary.org/obo/GO_0015760) (glucose-6-phosphate transport), [GO:0045577](http://purl.obolibrary.org/obo/GO_0045577) (regulation of B cell differentiation), [GO:0045578](http://purl.obolibrary.org/obo/GO_0045578) (negative regulation of B cell differentiation), [GO:0045576](http://purl.obolibrary.org/obo/GO_0045576) (mast cell activation), [GO:0044249](http://purl.obolibrary.org/obo/GO_0044249) (cellular biosynthetic process), [GO:0045579](http://purl.obolibrary.org/obo/GO_0045579) (positive regulation of B cell differentiation), [GO:0003785](http://purl.obolibrary.org/obo/GO_0003785) (actin monomer binding), [GO:0045580](http://purl.obolibrary.org/obo/GO_0045580) (regulation of T cell differentiation), [GO:0002446](http://purl.obolibrary.org/obo/GO_0002446) (neutrophil mediated immunity), [GO:0003777](http://purl.obolibrary.org/obo/GO_0003777) (microtubule motor activity), [GO:0003779](http://purl.obolibrary.org/obo/GO_0003779) (actin binding), [GO:0045582](http://purl.obolibrary.org/obo/GO_0045582) (positive regulation of T cell differentiation), [GO:0039706](http://purl.obolibrary.org/obo/GO_0039706) (co-receptor binding), [GO:0070512](http://purl.obolibrary.org/obo/GO_0070512) (positive regulation of histone H4-K20 methylation), [GO:0015758](http://purl.obolibrary.org/obo/GO_0015758) (glucose transport), [GO:0071847](http://purl.obolibrary.org/obo/GO_0071847) (TNFSF11-mediated signaling pathway), [GO:0070513](http://purl.obolibrary.org/obo/GO_0070513) (death domain binding), [GO:0015755](http://purl.obolibrary.org/obo/GO_0015755) (fructose transport), [GO:0045588](http://purl.obolibrary.org/obo/GO_0045588) (positive regulation of gamma-delta T cell differentiation), [GO:0045589](http://purl.obolibrary.org/obo/GO_0045589) (regulation of regulatory T cell differentiation), [GO:0044255](http://purl.obolibrary.org/obo/GO_0044255) (cellular lipid metabolic process), [GO:0044257](http://purl.obolibrary.org/obo/GO_0044257) (cellular protein catabolic process), [GO:0003743](http://purl.obolibrary.org/obo/GO_0003743) (translation initiation factor activity), [GO:0045590](http://purl.obolibrary.org/obo/GO_0045590) (negative regulation of regulatory T cell differentiation), [GO:0071871](http://purl.obolibrary.org/obo/GO_0071871) (response to epinephrine), [GO:0003746](http://purl.obolibrary.org/obo/GO_0003746) (translation elongation factor activity), [GO:0045595](http://purl.obolibrary.org/obo/GO_0045595) (regulation of cell differentiation), [GO:0070540](http://purl.obolibrary.org/obo/GO_0070540) (stearic acid binding), [GO:0044262](http://purl.obolibrary.org/obo/GO_0044262) (cellular carbohydrate metabolic process), [GO:0045596](http://purl.obolibrary.org/obo/GO_0045596) (negative regulation of cell differentiation), [GO:0003747](http://purl.obolibrary.org/obo/GO_0003747) (translation release factor activity), [GO:0071872](http://purl.obolibrary.org/obo/GO_0071872) (cellular response to epinephrine stimulus), [GO:0044265](http://purl.obolibrary.org/obo/GO_0044265) (cellular macromolecule catabolic process), [GO:0071875](http://purl.obolibrary.org/obo/GO_0071875) (adrenergic receptor signaling pathway), [GO:0070544](http://purl.obolibrary.org/obo/GO_0070544) (histone H3-K36 demethylation), [GO:0070542](http://purl.obolibrary.org/obo/GO_0070542) (response to fatty acid), [GO:0070543](http://purl.obolibrary.org/obo/GO_0070543) (response to linoleic acid), [GO:0071874](http://purl.obolibrary.org/obo/GO_0071874) (cellular response to norepinephrine stimulus), [GO:0015723](http://purl.obolibrary.org/obo/GO_0015723) (bilirubin transport), [GO:0015722](http://purl.obolibrary.org/obo/GO_0015722) (canalicular bile acid transport), [GO:0015721](http://purl.obolibrary.org/obo/GO_0015721) (bile acid and bile salt transport), [GO:0045599](http://purl.obolibrary.org/obo/GO_0045599) (negative regulation of fat cell differentiation), [GO:0044267](http://purl.obolibrary.org/obo/GO_0044267) (cellular protein metabolic process), [GO:0045597](http://purl.obolibrary.org/obo/GO_0045597) (positive regulation of cell differentiation), [GO:0045598](http://purl.obolibrary.org/obo/GO_0045598) (regulation of fat cell differentiation), [GO:0044268](http://purl.obolibrary.org/obo/GO_0044268) (multicellular organismal protein metabolic process), [GO:0003755](http://purl.obolibrary.org/obo/GO_0003755) (peptidyl-prolyl cis-trans isomerase activity), [GO:0044271](http://purl.obolibrary.org/obo/GO_0044271) (cellular nitrogen compound biosynthetic process), [GO:0003756](http://purl.obolibrary.org/obo/GO_0003756) (protein disulfide isomerase activity), [GO:0070530](http://purl.obolibrary.org/obo/GO_0070530) (K63-linked polyubiquitin modification-dependent protein binding), [GO:0071864](http://purl.obolibrary.org/obo/GO_0071864) (positive regulation of cell proliferation in bone marrow), [GO:0015739](http://purl.obolibrary.org/obo/GO_0015739) (sialic acid transport), [GO:0070534](http://purl.obolibrary.org/obo/GO_0070534) (protein K63-linked ubiquitination), [GO:0032298](http://purl.obolibrary.org/obo/GO_0032298) (positive regulation of DNA-dependent DNA replication initiation), [GO:0070531](http://purl.obolibrary.org/obo/GO_0070531) (BRCA1-A complex), [GO:0032299](http://purl.obolibrary.org/obo/GO_0032299) (ribonuclease H2 complex), [GO:0070538](http://purl.obolibrary.org/obo/GO_0070538) (oleic acid binding), [GO:0070535](http://purl.obolibrary.org/obo/GO_0070535) (histone H2A K63-linked ubiquitination), [GO:0015732](http://purl.obolibrary.org/obo/GO_0015732) (prostaglandin transport), [GO:0070536](http://purl.obolibrary.org/obo/GO_0070536) (protein K63-linked deubiquitination), [GO:0052856](http://purl.obolibrary.org/obo/GO_0052856) (NADHX epimerase activity), [GO:0052857](http://purl.obolibrary.org/obo/GO_0052857) (NADPHX epimerase activity), [GO:0051533](http://purl.obolibrary.org/obo/GO_0051533) (positive regulation of NFAT protein import into nucleus), [GO:0103073](http://purl.obolibrary.org/obo/GO_0103073) (anandamide amidohydrolase activity), [GO:0051538](http://purl.obolibrary.org/obo/GO_0051538) (3 iron, 4 sulfur cluster binding), [GO:0051539](http://purl.obolibrary.org/obo/GO_0051539) (4 iron, 4 sulfur cluster binding), [GO:0051536](http://purl.obolibrary.org/obo/GO_0051536) (iron-sulfur cluster binding), [GO:0051537](http://purl.obolibrary.org/obo/GO_0051537) (2 iron, 2 sulfur cluster binding), [GO:0015893](http://purl.obolibrary.org/obo/GO_0015893) (drug transport), [GO:0051542](http://purl.obolibrary.org/obo/GO_0051542) (elastin biosynthetic process), [GO:1905719](http://purl.obolibrary.org/obo/GO_1905719) (protein localization to perinuclear region of cytoplasm), [GO:0002579](http://purl.obolibrary.org/obo/GO_0002579) (positive regulation of antigen processing and presentation), [GO:0140018](http://purl.obolibrary.org/obo/GO_0140018) (regulation of cytoplasmic translational fidelity), [GO:0015889](http://purl.obolibrary.org/obo/GO_0015889) (cobalamin transport), [GO:0051548](http://purl.obolibrary.org/obo/GO_0051548) (negative regulation of keratinocyte migration), [GO:0015888](http://purl.obolibrary.org/obo/GO_0015888) (thiamine transport), [GO:0051546](http://purl.obolibrary.org/obo/GO_0051546) (keratinocyte migration), [GO:0015886](http://purl.obolibrary.org/obo/GO_0015886) (heme transport), [GO:1904408](http://purl.obolibrary.org/obo/GO_1904408) (melatonin binding), [GO:0002588](http://purl.obolibrary.org/obo/GO_0002588) (positive regulation of antigen processing and presentation of peptide antigen via MHC class II), [GO:0055093](http://purl.obolibrary.org/obo/GO_0055093) (response to hyperoxia), [GO:0055096](http://purl.obolibrary.org/obo/GO_0055096) (low-density lipoprotein particle mediated signaling), [GO:0055090](http://purl.obolibrary.org/obo/GO_0055090) (acylglycerol homeostasis), [GO:0055091](http://purl.obolibrary.org/obo/GO_0055091) (phospholipid homeostasis), [GO:0008700](http://purl.obolibrary.org/obo/GO_0008700) (4-hydroxy-2-oxoglutarate aldolase activity), [GO:0055092](http://purl.obolibrary.org/obo/GO_0055092) (sterol homeostasis), [GO:0052816](http://purl.obolibrary.org/obo/GO_0052816) (long-chain acyl-CoA hydrolase activity), [GO:0052817](http://purl.obolibrary.org/obo/GO_0052817) (very long chain acyl-CoA hydrolase activity), [GO:0052814](http://purl.obolibrary.org/obo/GO_0052814) (medium-chain-aldehyde dehydrogenase activity), [GO:0052815](http://purl.obolibrary.org/obo/GO_0052815) (medium-chain acyl-CoA hydrolase activity), [GO:0008705](http://purl.obolibrary.org/obo/GO_0008705) (methionine synthase activity), [GO:0140059](http://purl.obolibrary.org/obo/GO_0140059) (dendrite arborization), [GO:0052834](http://purl.obolibrary.org/obo/GO_0052834) (inositol monophosphate phosphatase activity), [GO:0052832](http://purl.obolibrary.org/obo/GO_0052832) (inositol monophosphate 3-phosphatase activity), [GO:0052833](http://purl.obolibrary.org/obo/GO_0052833) (inositol monophosphate 4-phosphatase activity), [GO:0140052](http://purl.obolibrary.org/obo/GO_0140052) (cellular response to oxidised low-density lipoprotein particle stimulus), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:1904457](http://purl.obolibrary.org/obo/GO_1904457) (positive regulation of neuronal action potential), [GO:0099551](http://purl.obolibrary.org/obo/GO_0099551) (trans-synaptic signaling by neuropeptide, modulating synaptic transmission), [GO:0007412](http://purl.obolibrary.org/obo/GO_0007412) (axon target recognition), [GO:0007413](http://purl.obolibrary.org/obo/GO_0007413) (axonal fasciculation), [GO:0007406](http://purl.obolibrary.org/obo/GO_0007406) (negative regulation of neuroblast proliferation), [GO:0007409](http://purl.obolibrary.org/obo/GO_0007409) (axonogenesis), [GO:0019402](http://purl.obolibrary.org/obo/GO_0019402) (galactitol metabolic process), [GO:0021707](http://purl.obolibrary.org/obo/GO_0021707) (cerebellar granule cell differentiation), [GO:0021702](http://purl.obolibrary.org/obo/GO_0021702) (cerebellar Purkinje cell differentiation), [GO:1903136](http://purl.obolibrary.org/obo/GO_1903136) (cuprous ion binding), [GO:0021703](http://purl.obolibrary.org/obo/GO_0021703) (locus ceruleus development), [GO:1904465](http://purl.obolibrary.org/obo/GO_1904465) (negative regulation of matrix metallopeptidase secretion), [GO:0050291](http://purl.obolibrary.org/obo/GO_0050291) (sphingosine N-acyltransferase activity), [GO:0007422](http://purl.obolibrary.org/obo/GO_0007422) (peripheral nervous system development), [GO:1904469](http://purl.obolibrary.org/obo/GO_1904469) (positive regulation of tumor necrosis factor secretion), [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development), [GO:1990381](http://purl.obolibrary.org/obo/GO_1990381) (ubiquitin-specific protease binding), [GO:0008757](http://purl.obolibrary.org/obo/GO_0008757) (S-adenosylmethionine-dependent methyltransferase activity), [GO:0007423](http://purl.obolibrary.org/obo/GO_0007423) (sensory organ development), [GO:0007416](http://purl.obolibrary.org/obo/GO_0007416) (synapse assembly), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:1903142](http://purl.obolibrary.org/obo/GO_1903142) (positive regulation of establishment of endothelial barrier), [GO:1903140](http://purl.obolibrary.org/obo/GO_1903140) (regulation of establishment of endothelial barrier), [GO:1903146](http://purl.obolibrary.org/obo/GO_1903146) (regulation of autophagy of mitochondrion), [GO:1904478](http://purl.obolibrary.org/obo/GO_1904478) (regulation of intestinal absorption), [GO:1990391](http://purl.obolibrary.org/obo/GO_1990391) (DNA repair complex), [GO:1990393](http://purl.obolibrary.org/obo/GO_1990393) (3M complex), [GO:0045703](http://purl.obolibrary.org/obo/GO_0045703) (ketoreductase activity), [GO:0099526](http://purl.obolibrary.org/obo/GO_0099526) (presynapse to nucleus signaling pathway), [GO:0045717](http://purl.obolibrary.org/obo/GO_0045717) (negative regulation of fatty acid biosynthetic process), [GO:0045719](http://purl.obolibrary.org/obo/GO_0045719) (negative regulation of glycogen biosynthetic process), [GO:0007402](http://purl.obolibrary.org/obo/GO_0007402) (ganglion mother cell fate determination), [GO:0099530](http://purl.obolibrary.org/obo/GO_0099530) (G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential), [GO:0099536](http://purl.obolibrary.org/obo/GO_0099536) (synaptic signaling), [GO:0018108](http://purl.obolibrary.org/obo/GO_0018108) (peptidyl-tyrosine phosphorylation), [GO:0019439](http://purl.obolibrary.org/obo/GO_0019439) (aromatic compound catabolic process), [GO:0006120](http://purl.obolibrary.org/obo/GO_0006120) (mitochondrial electron transport, NADH to ubiquinone), [GO:0021759](http://purl.obolibrary.org/obo/GO_0021759) (globus pallidus development), [GO:0006123](http://purl.obolibrary.org/obo/GO_0006123) (mitochondrial electron transport, cytochrome c to oxygen), [GO:0021754](http://purl.obolibrary.org/obo/GO_0021754) (facial nucleus development), [GO:0006121](http://purl.obolibrary.org/obo/GO_0006121) (mitochondrial electron transport, succinate to ubiquinone), [GO:0006122](http://purl.obolibrary.org/obo/GO_0006122) (mitochondrial electron transport, ubiquinol to cytochrome c), [GO:0021756](http://purl.obolibrary.org/obo/GO_0021756) (striatum development), [GO:0021750](http://purl.obolibrary.org/obo/GO_0021750) (vestibular nucleus development), [GO:1904417](http://purl.obolibrary.org/obo/GO_1904417) (positive regulation of xenophagy), [GO:0032407](http://purl.obolibrary.org/obo/GO_0032407) (MutSalpha complex binding), [GO:0032405](http://purl.obolibrary.org/obo/GO_0032405) (MutLalpha complex binding), [GO:0051563](http://purl.obolibrary.org/obo/GO_0051563) (smooth endoplasmic reticulum calcium ion homeostasis), [GO:0006119](http://purl.obolibrary.org/obo/GO_0006119) (oxidative phosphorylation), [GO:0019441](http://purl.obolibrary.org/obo/GO_0019441) (tryptophan catabolic process to kynurenine), [GO:0051560](http://purl.obolibrary.org/obo/GO_0051560) (mitochondrial calcium ion homeostasis), [GO:0032400](http://purl.obolibrary.org/obo/GO_0032400) (melanosome localization), [GO:0019442](http://purl.obolibrary.org/obo/GO_0019442) (tryptophan catabolic process to acetyl-CoA), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0051569](http://purl.obolibrary.org/obo/GO_0051569) (regulation of histone H3-K4 methylation), [GO:0051567](http://purl.obolibrary.org/obo/GO_0051567) (histone H3-K9 methylation), [GO:0051568](http://purl.obolibrary.org/obo/GO_0051568) (histone H3-K4 methylation), [GO:0032402](http://purl.obolibrary.org/obo/GO_0032402) (melanosome transport), [GO:0019448](http://purl.obolibrary.org/obo/GO_0019448) (L-cysteine catabolic process), [GO:1904427](http://purl.obolibrary.org/obo/GO_1904427) (positive regulation of calcium ion transmembrane transport), [GO:1904426](http://purl.obolibrary.org/obo/GO_1904426) (positive regulation of GTP binding), [GO:0006139](http://purl.obolibrary.org/obo/GO_0006139) (nucleobase-containing compound metabolic process), [GO:0021740](http://purl.obolibrary.org/obo/GO_0021740) (principal sensory nucleus of trigeminal nerve development), [GO:0051574](http://purl.obolibrary.org/obo/GO_0051574) (positive regulation of histone H3-K9 methylation), [GO:0051575](http://purl.obolibrary.org/obo/GO_0051575) (5'-deoxyribose-5-phosphate lyase activity), [GO:0051572](http://purl.obolibrary.org/obo/GO_0051572) (negative regulation of histone H3-K4 methylation), [GO:0051573](http://purl.obolibrary.org/obo/GO_0051573) (negative regulation of histone H3-K9 methylation), [GO:0019430](http://purl.obolibrary.org/obo/GO_0019430) (removal of superoxide radicals), [GO:0051570](http://purl.obolibrary.org/obo/GO_0051570) (regulation of histone H3-K9 methylation), [GO:0051571](http://purl.obolibrary.org/obo/GO_0051571) (positive regulation of histone H3-K4 methylation), [GO:0019432](http://purl.obolibrary.org/obo/GO_0019432) (triglyceride biosynthetic process), [GO:0018101](http://purl.obolibrary.org/obo/GO_0018101) (protein citrullination), [GO:0019433](http://purl.obolibrary.org/obo/GO_0019433) (triglyceride catabolic process), [GO:0018105](http://purl.obolibrary.org/obo/GO_0018105) (peptidyl-serine phosphorylation), [GO:0018107](http://purl.obolibrary.org/obo/GO_0018107) (peptidyl-threonine phosphorylation), [GO:0033721](http://purl.obolibrary.org/obo/GO_0033721) (aldehyde dehydrogenase (NADP+) activity), [GO:1904430](http://purl.obolibrary.org/obo/GO_1904430) (negative regulation of t-circle formation), [GO:1904434](http://purl.obolibrary.org/obo/GO_1904434) (positive regulation of ferrous iron binding), [GO:0006101](http://purl.obolibrary.org/obo/GO_0006101) (citrate metabolic process), [GO:1904437](http://purl.obolibrary.org/obo/GO_1904437) (positive regulation of transferrin receptor binding), [GO:0051591](http://purl.obolibrary.org/obo/GO_0051591) (response to cAMP), [GO:0006102](http://purl.obolibrary.org/obo/GO_0006102) (isocitrate metabolic process), [GO:0008761](http://purl.obolibrary.org/obo/GO_0008761) (UDP-N-acetylglucosamine 2-epimerase activity), [GO:0006105](http://purl.obolibrary.org/obo/GO_0006105) (succinate metabolic process), [GO:0006106](http://purl.obolibrary.org/obo/GO_0006106) (fumarate metabolic process), [GO:0006103](http://purl.obolibrary.org/obo/GO_0006103) (2-oxoglutarate metabolic process), [GO:0006104](http://purl.obolibrary.org/obo/GO_0006104) (succinyl-CoA metabolic process), [GO:0007435](http://purl.obolibrary.org/obo/GO_0007435) (salivary gland morphogenesis), [GO:0050254](http://purl.obolibrary.org/obo/GO_0050254) (rhodopsin kinase activity), [GO:0051586](http://purl.obolibrary.org/obo/GO_0051586) (positive regulation of dopamine uptake involved in synaptic transmission), [GO:0051583](http://purl.obolibrary.org/obo/GO_0051583) (dopamine uptake involved in synaptic transmission), [GO:0050253](http://purl.obolibrary.org/obo/GO_0050253) (retinyl-palmitate esterase activity), [GO:1904440](http://purl.obolibrary.org/obo/GO_1904440) (positive regulation of ferrous iron import across plasma membrane), [GO:0019408](http://purl.obolibrary.org/obo/GO_0019408) (dolichol biosynthetic process), [GO:1905776](http://purl.obolibrary.org/obo/GO_1905776) (positive regulation of DNA helicase activity), [GO:1905774](http://purl.obolibrary.org/obo/GO_1905774) (regulation of DNA helicase activity), [GO:1905773](http://purl.obolibrary.org/obo/GO_1905773) (8-hydroxy-2'-deoxyguanosine DNA binding), [GO:0006112](http://purl.obolibrary.org/obo/GO_0006112) (energy reserve metabolic process), [GO:0006110](http://purl.obolibrary.org/obo/GO_0006110) (regulation of glycolytic process), [GO:1904447](http://purl.obolibrary.org/obo/GO_1904447) (folic acid import across plasma membrane), [GO:0006111](http://purl.obolibrary.org/obo/GO_0006111) (regulation of gluconeogenesis), [GO:0006116](http://purl.obolibrary.org/obo/GO_0006116) (NADH oxidation), [GO:0006114](http://purl.obolibrary.org/obo/GO_0006114) (glycerol biosynthetic process), [GO:0006107](http://purl.obolibrary.org/obo/GO_0006107) (oxaloacetate metabolic process), [GO:0051597](http://purl.obolibrary.org/obo/GO_0051597) (response to methylmercury), [GO:0006108](http://purl.obolibrary.org/obo/GO_0006108) (malate metabolic process), [GO:0051592](http://purl.obolibrary.org/obo/GO_0051592) (response to calcium ion), [GO:0051593](http://purl.obolibrary.org/obo/GO_0051593) (response to folic acid), [GO:0019413](http://purl.obolibrary.org/obo/GO_0019413) (acetate biosynthetic process), [GO:0033700](http://purl.obolibrary.org/obo/GO_0033700) (phospholipid efflux), [GO:1903087](http://purl.obolibrary.org/obo/GO_1903087) (mitotic spindle pole body duplication), [GO:0071939](http://purl.obolibrary.org/obo/GO_0071939) (vitamin A import), [GO:0045649](http://purl.obolibrary.org/obo/GO_0045649) (regulation of macrophage differentiation), [GO:0006042](http://purl.obolibrary.org/obo/GO_0006042) (glucosamine biosynthetic process), [GO:0034991](http://purl.obolibrary.org/obo/GO_0034991) (nuclear meiotic cohesin complex), [GO:0032330](http://purl.obolibrary.org/obo/GO_0032330) (regulation of chondrocyte differentiation), [GO:0034990](http://purl.obolibrary.org/obo/GO_0034990) (nuclear mitotic cohesin complex), [GO:0006047](http://purl.obolibrary.org/obo/GO_0006047) (UDP-N-acetylglucosamine metabolic process), [GO:0046975](http://purl.obolibrary.org/obo/GO_0046975) (histone methyltransferase activity (H3-K36 specific)), [GO:0046972](http://purl.obolibrary.org/obo/GO_0046972) (histone acetyltransferase activity (H4-K16 specific)), [GO:0006044](http://purl.obolibrary.org/obo/GO_0006044) (N-acetylglucosamine metabolic process), [GO:0021678](http://purl.obolibrary.org/obo/GO_0021678) (third ventricle development), [GO:0021679](http://purl.obolibrary.org/obo/GO_0021679) (cerebellar molecular layer development), [GO:0045647](http://purl.obolibrary.org/obo/GO_0045647) (negative regulation of erythrocyte differentiation), [GO:0045648](http://purl.obolibrary.org/obo/GO_0045648) (positive regulation of erythrocyte differentiation), [GO:0046979](http://purl.obolibrary.org/obo/GO_0046979) (TAP2 binding), [GO:0006048](http://purl.obolibrary.org/obo/GO_0006048) (UDP-N-acetylglucosamine biosynthetic process), [GO:0021675](http://purl.obolibrary.org/obo/GO_0021675) (nerve development), [GO:0045646](http://purl.obolibrary.org/obo/GO_0045646) (regulation of erythrocyte differentiation), [GO:0021680](http://purl.obolibrary.org/obo/GO_0021680) (cerebellar Purkinje cell layer development), [GO:0021681](http://purl.obolibrary.org/obo/GO_0021681) (cerebellar granular layer development), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0045651](http://purl.obolibrary.org/obo/GO_0045651) (positive regulation of macrophage differentiation), [GO:0044320](http://purl.obolibrary.org/obo/GO_0044320) (cellular response to leptin stimulus), [GO:0019363](http://purl.obolibrary.org/obo/GO_0019363) (pyridine nucleotide biosynthetic process), [GO:0071930](http://purl.obolibrary.org/obo/GO_0071930) (negative regulation of transcription involved in G1/S transition of mitotic cell cycle), [GO:0019368](http://purl.obolibrary.org/obo/GO_0019368) (fatty acid elongation, unsaturated fatty acid), [GO:0034982](http://purl.obolibrary.org/obo/GO_0034982) (mitochondrial protein processing), [GO:0019367](http://purl.obolibrary.org/obo/GO_0019367) (fatty acid elongation, saturated fatty acid), [GO:0071934](http://purl.obolibrary.org/obo/GO_0071934) (thiamine transmembrane transport), [GO:0019369](http://purl.obolibrary.org/obo/GO_0019369) (arachidonic acid metabolic process), [GO:0032324](http://purl.obolibrary.org/obo/GO_0032324) (molybdopterin cofactor biosynthetic process), [GO:0034987](http://purl.obolibrary.org/obo/GO_0034987) (immunoglobulin receptor binding), [GO:0034986](http://purl.obolibrary.org/obo/GO_0034986) (iron chaperone activity), [GO:0070602](http://purl.obolibrary.org/obo/GO_0070602) (regulation of centromeric sister chromatid cohesion), [GO:1903082](http://purl.obolibrary.org/obo/GO_1903082) (positive regulation of C-C chemokine receptor CCR7 signaling pathway), [GO:0006054](http://purl.obolibrary.org/obo/GO_0006054) (N-acetylneuraminate metabolic process), [GO:0044322](http://purl.obolibrary.org/obo/GO_0044322) (endoplasmic reticulum quality control compartment), [GO:0007389](http://purl.obolibrary.org/obo/GO_0007389) (pattern specification process), [GO:0044321](http://purl.obolibrary.org/obo/GO_0044321) (response to leptin), [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity), [GO:0021667](http://purl.obolibrary.org/obo/GO_0021667) (rhombomere 6 morphogenesis), [GO:0007386](http://purl.obolibrary.org/obo/GO_0007386) (compartment pattern specification), [GO:0045652](http://purl.obolibrary.org/obo/GO_0045652) (regulation of megakaryocyte differentiation), [GO:0046984](http://purl.obolibrary.org/obo/GO_0046984) (regulation of hemoglobin biosynthetic process), [GO:0044323](http://purl.obolibrary.org/obo/GO_0044323) (retinoic acid-responsive element binding), [GO:0044326](http://purl.obolibrary.org/obo/GO_0044326) (dendritic spine neck), [GO:0045658](http://purl.obolibrary.org/obo/GO_0045658) (regulation of neutrophil differentiation), [GO:0044325](http://purl.obolibrary.org/obo/GO_0044325) (ion channel binding), [GO:0045656](http://purl.obolibrary.org/obo/GO_0045656) (negative regulation of monocyte differentiation), [GO:0044327](http://purl.obolibrary.org/obo/GO_0044327) (dendritic spine head), [GO:0021664](http://purl.obolibrary.org/obo/GO_0021664) (rhombomere 5 morphogenesis), [GO:0045657](http://purl.obolibrary.org/obo/GO_0045657) (positive regulation of monocyte differentiation), [GO:0021670](http://purl.obolibrary.org/obo/GO_0021670) (lateral ventricle development), [GO:0045661](http://purl.obolibrary.org/obo/GO_0045661) (regulation of myoblast differentiation), [GO:0045662](http://purl.obolibrary.org/obo/GO_0045662) (negative regulation of myoblast differentiation), [GO:0045660](http://purl.obolibrary.org/obo/GO_0045660) (positive regulation of neutrophil differentiation), [GO:0018024](http://purl.obolibrary.org/obo/GO_0018024) (histone-lysine N-methyltransferase activity), [GO:0018023](http://purl.obolibrary.org/obo/GO_0018023) (peptidyl-lysine trimethylation), [GO:0018026](http://purl.obolibrary.org/obo/GO_0018026) (peptidyl-lysine monomethylation), [GO:0032310](http://purl.obolibrary.org/obo/GO_0032310) (prostaglandin secretion), [GO:0019358](http://purl.obolibrary.org/obo/GO_0019358) (nicotinate nucleotide salvage), [GO:0034976](http://purl.obolibrary.org/obo/GO_0034976) (response to endoplasmic reticulum stress), [GO:0034975](http://purl.obolibrary.org/obo/GO_0034975) (protein folding in endoplasmic reticulum), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0070628](http://purl.obolibrary.org/obo/GO_0070628) (proteasome binding), [GO:0006020](http://purl.obolibrary.org/obo/GO_0006020) (inositol metabolic process), [GO:0006021](http://purl.obolibrary.org/obo/GO_0006021) (inositol biosynthetic process), [GO:0008681](http://purl.obolibrary.org/obo/GO_0008681) (2-octaprenyl-6-methoxyphenol hydroxylase activity), [GO:0021654](http://purl.obolibrary.org/obo/GO_0021654) (rhombomere boundary formation), [GO:0045665](http://purl.obolibrary.org/obo/GO_0045665) (negative regulation of neuron differentiation), [GO:0006024](http://purl.obolibrary.org/obo/GO_0006024) (glycosaminoglycan biosynthetic process), [GO:0044333](http://purl.obolibrary.org/obo/GO_0044333) (Wnt signaling pathway involved in digestive tract morphogenesis), [GO:0045666](http://purl.obolibrary.org/obo/GO_0045666) (positive regulation of neuron differentiation), [GO:0044332](http://purl.obolibrary.org/obo/GO_0044332) (Wnt signaling pathway involved in dorsal/ventral axis specification), [GO:0043001](http://purl.obolibrary.org/obo/GO_0043001) (Golgi to plasma membrane protein transport), [GO:0045663](http://purl.obolibrary.org/obo/GO_0045663) (positive regulation of myoblast differentiation), [GO:0045664](http://purl.obolibrary.org/obo/GO_0045664) (regulation of neuron differentiation), [GO:0044334](http://purl.obolibrary.org/obo/GO_0044334) (canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition), [GO:0045669](http://purl.obolibrary.org/obo/GO_0045669) (positive regulation of osteoblast differentiation), [GO:0021650](http://purl.obolibrary.org/obo/GO_0021650) (vestibulocochlear nerve formation), [GO:0043005](http://purl.obolibrary.org/obo/GO_0043005) (neuron projection), [GO:0044336](http://purl.obolibrary.org/obo/GO_0044336) (canonical Wnt signaling pathway involved in negative regulation of apoptotic process), [GO:0006029](http://purl.obolibrary.org/obo/GO_0006029) (proteoglycan metabolic process), [GO:0043008](http://purl.obolibrary.org/obo/GO_0043008) (ATP-dependent protein binding), [GO:0045667](http://purl.obolibrary.org/obo/GO_0045667) (regulation of osteoblast differentiation), [GO:0006027](http://purl.obolibrary.org/obo/GO_0006027) (glycosaminoglycan catabolic process), [GO:0045668](http://purl.obolibrary.org/obo/GO_0045668) (negative regulation of osteoblast differentiation), [GO:0043007](http://purl.obolibrary.org/obo/GO_0043007) (maintenance of rDNA), [GO:1900825](http://purl.obolibrary.org/obo/GO_1900825) (regulation of membrane depolarization during cardiac muscle cell action potential), [GO:0034969](http://purl.obolibrary.org/obo/GO_0034969) (histone arginine methylation), [GO:0034968](http://purl.obolibrary.org/obo/GO_0034968) (histone lysine methylation), [GO:0045672](http://purl.obolibrary.org/obo/GO_0045672) (positive regulation of osteoclast differentiation), [GO:0010999](http://purl.obolibrary.org/obo/GO_0010999) (regulation of eIF2 alpha phosphorylation by heme), [GO:0045670](http://purl.obolibrary.org/obo/GO_0045670) (regulation of osteoclast differentiation), [GO:1990304](http://purl.obolibrary.org/obo/GO_1990304) (MUB1-RAD6-UBR2 ubiquitin ligase complex), [GO:0044342](http://purl.obolibrary.org/obo/GO_0044342) (type B pancreatic cell proliferation), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:0044341](http://purl.obolibrary.org/obo/GO_0044341) (sodium-dependent phosphate transport), [GO:0045671](http://purl.obolibrary.org/obo/GO_0045671) (negative regulation of osteoclast differentiation), [GO:0032300](http://purl.obolibrary.org/obo/GO_0032300) (mismatch repair complex), [GO:0033632](http://purl.obolibrary.org/obo/GO_0033632) (regulation of cell-cell adhesion mediated by integrin), [GO:0019344](http://purl.obolibrary.org/obo/GO_0019344) (cysteine biosynthetic process), [GO:0010996](http://purl.obolibrary.org/obo/GO_0010996) (response to auditory stimulus), [GO:0034963](http://purl.obolibrary.org/obo/GO_0034963) (box C/D snoRNA processing), [GO:0032301](http://purl.obolibrary.org/obo/GO_0032301) (MutSalpha complex), [GO:0019343](http://purl.obolibrary.org/obo/GO_0019343) (cysteine biosynthetic process via cystathionine), [GO:0071953](http://purl.obolibrary.org/obo/GO_0071953) (elastic fiber), [GO:0033630](http://purl.obolibrary.org/obo/GO_0033630) (positive regulation of cell adhesion mediated by integrin), [GO:0019346](http://purl.obolibrary.org/obo/GO_0019346) (transsulfuration), [GO:0010998](http://purl.obolibrary.org/obo/GO_0010998) (regulation of translational initiation by eIF2 alpha phosphorylation), [GO:0010997](http://purl.obolibrary.org/obo/GO_0010997) (anaphase-promoting complex binding), [GO:0071951](http://purl.obolibrary.org/obo/GO_0071951) (conversion of methionyl-tRNA to N-formyl-methionyl-tRNA), [GO:0019348](http://purl.obolibrary.org/obo/GO_0019348) (dolichol metabolic process), [GO:0034967](http://purl.obolibrary.org/obo/GO_0034967) (Set3 complex), [GO:0070626](http://purl.obolibrary.org/obo/GO_0070626) ((S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity), [GO:0071954](http://purl.obolibrary.org/obo/GO_0071954) (chemokine (C-C motif) ligand 11 production), [GO:0032302](http://purl.obolibrary.org/obo/GO_0032302) (MutSbeta complex), [GO:0034964](http://purl.obolibrary.org/obo/GO_0034964) (box H/ACA snoRNA processing), [GO:0071949](http://purl.obolibrary.org/obo/GO_0071949) (FAD binding), [GO:0071947](http://purl.obolibrary.org/obo/GO_0071947) (protein deubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0006032](http://purl.obolibrary.org/obo/GO_0006032) (chitin catabolic process), [GO:0055001](http://purl.obolibrary.org/obo/GO_0055001) (muscle cell development), [GO:0044344](http://purl.obolibrary.org/obo/GO_0044344) (cellular response to fibroblast growth factor stimulus), [GO:0021644](http://purl.obolibrary.org/obo/GO_0021644) (vagus nerve morphogenesis), [GO:0043015](http://purl.obolibrary.org/obo/GO_0043015) (gamma-tubulin binding), [GO:0043014](http://purl.obolibrary.org/obo/GO_0043014) (alpha-tubulin binding), [GO:0007368](http://purl.obolibrary.org/obo/GO_0007368) (determination of left/right symmetry), [GO:0007369](http://purl.obolibrary.org/obo/GO_0007369) (gastrulation), [GO:0033629](http://purl.obolibrary.org/obo/GO_0033629) (negative regulation of cell adhesion mediated by integrin), [GO:0033628](http://purl.obolibrary.org/obo/GO_0033628) (regulation of cell adhesion mediated by integrin), [GO:0034959](http://purl.obolibrary.org/obo/GO_0034959) (endothelin maturation), [GO:0033627](http://purl.obolibrary.org/obo/GO_0033627) (cell adhesion mediated by integrin), [GO:0044351](http://purl.obolibrary.org/obo/GO_0044351) (macropinocytosis), [GO:1990314](http://purl.obolibrary.org/obo/GO_1990314) (cellular response to insulin-like growth factor stimulus), [GO:0043022](http://purl.obolibrary.org/obo/GO_0043022) (ribosome binding), [GO:2000703](http://purl.obolibrary.org/obo/GO_2000703) (negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation), [GO:0043021](http://purl.obolibrary.org/obo/GO_0043021) (ribonucleoprotein complex binding), [GO:1990316](http://purl.obolibrary.org/obo/GO_1990316) (Atg1/ULK1 kinase complex), [GO:0018002](http://purl.obolibrary.org/obo/GO_0018002) (N-terminal peptidyl-glutamic acid acetylation), [GO:0071942](http://purl.obolibrary.org/obo/GO_0071942) (XPC complex), [GO:0071940](http://purl.obolibrary.org/obo/GO_0071940) (fungal-type cell wall assembly), [GO:0033623](http://purl.obolibrary.org/obo/GO_0033623) (regulation of integrin activation), [GO:0071944](http://purl.obolibrary.org/obo/GO_0071944) (cell periphery), [GO:0033622](http://purl.obolibrary.org/obo/GO_0033622) (integrin activation), [GO:0070613](http://purl.obolibrary.org/obo/GO_0070613) (regulation of protein processing), [GO:0045607](http://purl.obolibrary.org/obo/GO_0045607) (regulation of inner ear auditory receptor cell differentiation), [GO:0006082](http://purl.obolibrary.org/obo/GO_0006082) (organic acid metabolic process), [GO:0006083](http://purl.obolibrary.org/obo/GO_0006083) (acetate metabolic process), [GO:0046939](http://purl.obolibrary.org/obo/GO_0046939) (nucleotide phosphorylation), [GO:0006081](http://purl.obolibrary.org/obo/GO_0006081) (cellular aldehyde metabolic process), [GO:0045606](http://purl.obolibrary.org/obo/GO_0045606) (positive regulation of epidermal cell differentiation), [GO:0006086](http://purl.obolibrary.org/obo/GO_0006086) (acetyl-CoA biosynthetic process from pyruvate), [GO:0032374](http://purl.obolibrary.org/obo/GO_0032374) (regulation of cholesterol transport), [GO:0006084](http://purl.obolibrary.org/obo/GO_0006084) (acetyl-CoA metabolic process), [GO:0006085](http://purl.obolibrary.org/obo/GO_0006085) (acetyl-CoA biosynthetic process), [GO:0045600](http://purl.obolibrary.org/obo/GO_0045600) (positive regulation of fat cell differentiation), [GO:0006089](http://purl.obolibrary.org/obo/GO_0006089) (lactate metabolic process), [GO:0045603](http://purl.obolibrary.org/obo/GO_0045603) (positive regulation of endothelial cell differentiation), [GO:0046934](http://purl.obolibrary.org/obo/GO_0046934) (phosphatidylinositol-4,5-bisphosphate 3-kinase activity), [GO:0046935](http://purl.obolibrary.org/obo/GO_0046935) (1-phosphatidylinositol-3-kinase regulator activity), [GO:0045601](http://purl.obolibrary.org/obo/GO_0045601) (regulation of endothelial cell differentiation), [GO:0046933](http://purl.obolibrary.org/obo/GO_0046933) (proton-transporting ATP synthase activity, rotational mechanism), [GO:0045602](http://purl.obolibrary.org/obo/GO_0045602) (negative regulation of endothelial cell differentiation), [GO:2000719](http://purl.obolibrary.org/obo/GO_2000719) (negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric), [GO:0032366](http://purl.obolibrary.org/obo/GO_0032366) (intracellular sterol transport), [GO:0032367](http://purl.obolibrary.org/obo/GO_0032367) (intracellular cholesterol transport), [GO:0032364](http://purl.obolibrary.org/obo/GO_0032364) (oxygen homeostasis), [GO:0031034](http://purl.obolibrary.org/obo/GO_0031034) (myosin filament assembly), [GO:0033699](http://purl.obolibrary.org/obo/GO_0033699) (DNA 5'-adenosine monophosphate hydrolase activity), [GO:0045618](http://purl.obolibrary.org/obo/GO_0045618) (positive regulation of keratinocyte differentiation), [GO:0046949](http://purl.obolibrary.org/obo/GO_0046949) (fatty-acyl-CoA biosynthetic process), [GO:0033690](http://purl.obolibrary.org/obo/GO_0033690) (positive regulation of osteoblast proliferation), [GO:0045619](http://purl.obolibrary.org/obo/GO_0045619) (regulation of lymphocyte differentiation), [GO:0006094](http://purl.obolibrary.org/obo/GO_0006094) (gluconeogenesis), [GO:1904385](http://purl.obolibrary.org/obo/GO_1904385) (cellular response to angiotensin), [GO:1903052](http://purl.obolibrary.org/obo/GO_1903052) (positive regulation of proteolysis involved in cellular protein catabolic process), [GO:0006091](http://purl.obolibrary.org/obo/GO_0006091) (generation of precursor metabolites and energy), [GO:0045617](http://purl.obolibrary.org/obo/GO_0045617) (negative regulation of keratinocyte differentiation), [GO:1903053](http://purl.obolibrary.org/obo/GO_1903053) (regulation of extracellular matrix organization), [GO:0006097](http://purl.obolibrary.org/obo/GO_0006097) (glyoxylate cycle), [GO:0006098](http://purl.obolibrary.org/obo/GO_0006098) (pentose-phosphate shunt), [GO:0033693](http://purl.obolibrary.org/obo/GO_0033693) (neurofilament bundle assembly), [GO:0031032](http://purl.obolibrary.org/obo/GO_0031032) (actomyosin structure organization), [GO:0033692](http://purl.obolibrary.org/obo/GO_0033692) (cellular polysaccharide biosynthetic process), [GO:1903056](http://purl.obolibrary.org/obo/GO_1903056) (regulation of melanosome organization), [GO:1904388](http://purl.obolibrary.org/obo/GO_1904388) (negative regulation of ncRNA transcription associated with protein coding gene TSS/TES), [GO:0006096](http://purl.obolibrary.org/obo/GO_0006096) (glycolytic process), [GO:0033691](http://purl.obolibrary.org/obo/GO_0033691) (sialic acid binding), [GO:0006099](http://purl.obolibrary.org/obo/GO_0006099) (tricarboxylic acid cycle), [GO:2000727](http://purl.obolibrary.org/obo/GO_2000727) (positive regulation of cardiac muscle cell differentiation), [GO:0003810](http://purl.obolibrary.org/obo/GO_0003810) (protein-glutamine gamma-glutamyltransferase activity), [GO:2000729](http://purl.obolibrary.org/obo/GO_2000729) (positive regulation of mesenchymal cell proliferation involved in ureter development), [GO:0019395](http://purl.obolibrary.org/obo/GO_0019395) (fatty acid oxidation), [GO:0018063](http://purl.obolibrary.org/obo/GO_0018063) (cytochrome c-heme linkage), [GO:2000726](http://purl.obolibrary.org/obo/GO_2000726) (negative regulation of cardiac muscle cell differentiation), [GO:0032355](http://purl.obolibrary.org/obo/GO_0032355) (response to estradiol), [GO:0033686](http://purl.obolibrary.org/obo/GO_0033686) (positive regulation of luteinizing hormone secretion), [GO:0032353](http://purl.obolibrary.org/obo/GO_0032353) (negative regulation of hormone biosynthetic process), [GO:0031023](http://purl.obolibrary.org/obo/GO_0031023) (microtubule organizing center organization), [GO:1904382](http://purl.obolibrary.org/obo/GO_1904382) (mannose trimming involved in glycoprotein ERAD pathway), [GO:0006090](http://purl.obolibrary.org/obo/GO_0006090) (pyruvate metabolic process), [GO:0032357](http://purl.obolibrary.org/obo/GO_0032357) (oxidized purine DNA binding), [GO:1904380](http://purl.obolibrary.org/obo/GO_1904380) (endoplasmic reticulum mannose trimming), [GO:0045627](http://purl.obolibrary.org/obo/GO_0045627) (positive regulation of T-helper 1 cell differentiation), [GO:0046959](http://purl.obolibrary.org/obo/GO_0046959) (habituation), [GO:0033683](http://purl.obolibrary.org/obo/GO_0033683) (nucleotide-excision repair, DNA incision), [GO:0032350](http://purl.obolibrary.org/obo/GO_0032350) (regulation of hormone metabolic process), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0006068](http://purl.obolibrary.org/obo/GO_0006068) (ethanol catabolic process), [GO:0045621](http://purl.obolibrary.org/obo/GO_0045621) (positive regulation of lymphocyte differentiation), [GO:0046952](http://purl.obolibrary.org/obo/GO_0046952) (ketone body catabolic process), [GO:0046950](http://purl.obolibrary.org/obo/GO_0046950) (cellular ketone body metabolic process), [GO:0045620](http://purl.obolibrary.org/obo/GO_0045620) (negative regulation of lymphocyte differentiation), [GO:0007398](http://purl.obolibrary.org/obo/GO_0007398) (ectoderm development), [GO:0006067](http://purl.obolibrary.org/obo/GO_0006067) (ethanol metabolic process), [GO:0046951](http://purl.obolibrary.org/obo/GO_0046951) (ketone body biosynthetic process), [GO:0045626](http://purl.obolibrary.org/obo/GO_0045626) (negative regulation of T-helper 1 cell differentiation), [GO:0021695](http://purl.obolibrary.org/obo/GO_0021695) (cerebellar cortex development), [GO:0021697](http://purl.obolibrary.org/obo/GO_0021697) (cerebellar cortex formation), [GO:2000734](http://purl.obolibrary.org/obo/GO_2000734) (negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation), [GO:2000737](http://purl.obolibrary.org/obo/GO_2000737) (negative regulation of stem cell differentiation), [GO:0019388](http://purl.obolibrary.org/obo/GO_0019388) (galactose catabolic process), [GO:0018057](http://purl.obolibrary.org/obo/GO_0018057) (peptidyl-lysine oxidation), [GO:0031013](http://purl.obolibrary.org/obo/GO_0031013) (troponin I binding), [GO:0031014](http://purl.obolibrary.org/obo/GO_0031014) (troponin T binding), [GO:0032342](http://purl.obolibrary.org/obo/GO_0032342) (aldosterone biosynthetic process), [GO:0033674](http://purl.obolibrary.org/obo/GO_0033674) (positive regulation of kinase activity), [GO:0031011](http://purl.obolibrary.org/obo/GO_0031011) (Ino80 complex), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:0033673](http://purl.obolibrary.org/obo/GO_0033673) (negative regulation of kinase activity), [GO:1903061](http://purl.obolibrary.org/obo/GO_1903061) (positive regulation of protein lipidation), [GO:0031017](http://purl.obolibrary.org/obo/GO_0031017) (exocrine pancreas development), [GO:0032348](http://purl.obolibrary.org/obo/GO_0032348) (negative regulation of aldosterone biosynthetic process), [GO:0031018](http://purl.obolibrary.org/obo/GO_0031018) (endocrine pancreas development), [GO:0071910](http://purl.obolibrary.org/obo/GO_0071910) (determination of liver left/right asymmetry), [GO:0031016](http://purl.obolibrary.org/obo/GO_0031016) (pancreas development), [GO:0006071](http://purl.obolibrary.org/obo/GO_0006071) (glycerol metabolic process), [GO:0044308](http://purl.obolibrary.org/obo/GO_0044308) (axonal spine), [GO:1903076](http://purl.obolibrary.org/obo/GO_1903076) (regulation of protein localization to plasma membrane), [GO:0006072](http://purl.obolibrary.org/obo/GO_0006072) (glycerol-3-phosphate metabolic process), [GO:0044307](http://purl.obolibrary.org/obo/GO_0044307) (dendritic branch), [GO:0045638](http://purl.obolibrary.org/obo/GO_0045638) (negative regulation of myeloid cell differentiation), [GO:0045639](http://purl.obolibrary.org/obo/GO_0045639) (positive regulation of myeloid cell differentiation), [GO:0071909](http://purl.obolibrary.org/obo/GO_0071909) (determination of stomach left/right asymmetry), [GO:1903078](http://purl.obolibrary.org/obo/GO_1903078) (positive regulation of protein localization to plasma membrane), [GO:0071907](http://purl.obolibrary.org/obo/GO_0071907) (determination of digestive tract left/right asymmetry), [GO:0071908](http://purl.obolibrary.org/obo/GO_0071908) (determination of intestine left/right asymmetry), [GO:0046961](http://purl.obolibrary.org/obo/GO_0046961) (proton-transporting ATPase activity, rotational mechanism), [GO:0045630](http://purl.obolibrary.org/obo/GO_0045630) (positive regulation of T-helper 2 cell differentiation), [GO:0044302](http://purl.obolibrary.org/obo/GO_0044302) (dentate gyrus mossy fiber), [GO:0046967](http://purl.obolibrary.org/obo/GO_0046967) (cytosol to ER transport), [GO:0044304](http://purl.obolibrary.org/obo/GO_0044304) (main axon), [GO:0045636](http://purl.obolibrary.org/obo/GO_0045636) (positive regulation of melanocyte differentiation), [GO:0045637](http://purl.obolibrary.org/obo/GO_0045637) (regulation of myeloid cell differentiation), [GO:0046965](http://purl.obolibrary.org/obo/GO_0046965) (retinoid X receptor binding), [GO:0044306](http://purl.obolibrary.org/obo/GO_0044306) (neuron projection terminus), [GO:0046966](http://purl.obolibrary.org/obo/GO_0046966) (thyroid hormone receptor binding), [GO:0021691](http://purl.obolibrary.org/obo/GO_0021691) (cerebellar Purkinje cell layer maturation), [GO:0021692](http://purl.obolibrary.org/obo/GO_0021692) (cerebellar Purkinje cell layer morphogenesis), [GO:0019370](http://purl.obolibrary.org/obo/GO_0019370) (leukotriene biosynthetic process), [GO:0019373](http://purl.obolibrary.org/obo/GO_0019373) (epoxygenase P450 pathway), [GO:1990357](http://purl.obolibrary.org/obo/GO_1990357) (terminal web), [GO:0019372](http://purl.obolibrary.org/obo/GO_0019372) (lipoxygenase pathway), [GO:0019377](http://purl.obolibrary.org/obo/GO_0019377) (glycolipid catabolic process), [GO:2000741](http://purl.obolibrary.org/obo/GO_2000741) (positive regulation of mesenchymal stem cell differentiation), [GO:0019379](http://purl.obolibrary.org/obo/GO_0019379) (sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin)), [GO:0032331](http://purl.obolibrary.org/obo/GO_0032331) (negative regulation of chondrocyte differentiation), [GO:0031000](http://purl.obolibrary.org/obo/GO_0031000) (response to caffeine), [GO:0034993](http://purl.obolibrary.org/obo/GO_0034993) (LINC complex), [GO:0032332](http://purl.obolibrary.org/obo/GO_0032332) (positive regulation of chondrocyte differentiation), [GO:0071901](http://purl.obolibrary.org/obo/GO_0071901) (negative regulation of protein serine/threonine kinase activity), [GO:0071902](http://purl.obolibrary.org/obo/GO_0071902) (positive regulation of protein serine/threonine kinase activity), [GO:1903071](http://purl.obolibrary.org/obo/GO_1903071) (positive regulation of ER-associated ubiquitin-dependent protein catabolic process), [GO:0031083](http://purl.obolibrary.org/obo/GO_0031083) (BLOC-1 complex), [GO:0031086](http://purl.obolibrary.org/obo/GO_0031086) (nuclear-transcribed mRNA catabolic process, deadenylation-independent decay), [GO:0031087](http://purl.obolibrary.org/obo/GO_0031087) (deadenylation-independent decapping of nuclear-transcribed mRNA), [GO:0031084](http://purl.obolibrary.org/obo/GO_0031084) (BLOC-2 complex), [GO:0031085](http://purl.obolibrary.org/obo/GO_0031085) (BLOC-3 complex), [GO:0055056](http://purl.obolibrary.org/obo/GO_0055056) (D-glucose transmembrane transporter activity), [GO:0043068](http://purl.obolibrary.org/obo/GO_0043068) (positive regulation of programmed cell death), [GO:0043067](http://purl.obolibrary.org/obo/GO_0043067) (regulation of programmed cell death), [GO:0043069](http://purl.obolibrary.org/obo/GO_0043069) (negative regulation of programmed cell death), [GO:0080019](http://purl.obolibrary.org/obo/GO_0080019) (fatty-acyl-CoA reductase (alcohol-forming) activity), [GO:0003841](http://purl.obolibrary.org/obo/GO_0003841) (1-acylglycerol-3-phosphate O-acyltransferase activity), [GO:0003842](http://purl.obolibrary.org/obo/GO_0003842) (1-pyrroline-5-carboxylate dehydrogenase activity), [GO:0003844](http://purl.obolibrary.org/obo/GO_0003844) (1,4-alpha-glucan branching enzyme activity), [GO:0003847](http://purl.obolibrary.org/obo/GO_0003847) (1-alkyl-2-acetylglycerophosphocholine esterase activity), [GO:0015828](http://purl.obolibrary.org/obo/GO_0015828) (tyrosine transport), [GO:0002517](http://purl.obolibrary.org/obo/GO_0002517) (T cell tolerance induction), [GO:2000753](http://purl.obolibrary.org/obo/GO_2000753) (positive regulation of glucosylceramide catabolic process), [GO:0015826](http://purl.obolibrary.org/obo/GO_0015826) (threonine transport), [GO:0031077](http://purl.obolibrary.org/obo/GO_0031077) (post-embryonic camera-type eye development), [GO:0015825](http://purl.obolibrary.org/obo/GO_0015825) (L-serine transport), [GO:2000755](http://purl.obolibrary.org/obo/GO_2000755) (positive regulation of sphingomyelin catabolic process), [GO:0015824](http://purl.obolibrary.org/obo/GO_0015824) (proline transport), [GO:0015821](http://purl.obolibrary.org/obo/GO_0015821) (methionine transport), [GO:0031071](http://purl.obolibrary.org/obo/GO_0031071) (cysteine desulfurase activity), [GO:0031072](http://purl.obolibrary.org/obo/GO_0031072) (heat shock protein binding), [GO:0015840](http://purl.obolibrary.org/obo/GO_0015840) (urea transport), [GO:0055062](http://purl.obolibrary.org/obo/GO_0055062) (phosphate ion homeostasis), [GO:0055064](http://purl.obolibrary.org/obo/GO_0055064) (chloride ion homeostasis), [GO:0031076](http://purl.obolibrary.org/obo/GO_0031076) (embryonic camera-type eye development), [GO:0031073](http://purl.obolibrary.org/obo/GO_0031073) (cholesterol 26-hydroxylase activity), [GO:0080025](http://purl.obolibrary.org/obo/GO_0080025) (phosphatidylinositol-3,5-bisphosphate binding), [GO:0003860](http://purl.obolibrary.org/obo/GO_0003860) (3-hydroxyisobutyryl-CoA hydrolase activity), [GO:0002521](http://purl.obolibrary.org/obo/GO_0002521) (leukocyte differentiation), [GO:0003854](http://purl.obolibrary.org/obo/GO_0003854) (3-beta-hydroxy-delta5-steroid dehydrogenase activity), [GO:0002523](http://purl.obolibrary.org/obo/GO_0002523) (leukocyte migration involved in inflammatory response), [GO:0043083](http://purl.obolibrary.org/obo/GO_0043083) (synaptic cleft), [GO:0043086](http://purl.obolibrary.org/obo/GO_0043086) (negative regulation of catalytic activity), [GO:2000767](http://purl.obolibrary.org/obo/GO_2000767) (positive regulation of cytoplasmic translation), [GO:0070672](http://purl.obolibrary.org/obo/GO_0070672) (response to interleukin-15), [GO:0070673](http://purl.obolibrary.org/obo/GO_0070673) (response to interleukin-18), [GO:0043085](http://purl.obolibrary.org/obo/GO_0043085) (positive regulation of catalytic activity), [GO:0003857](http://purl.obolibrary.org/obo/GO_0003857) (3-hydroxyacyl-CoA dehydrogenase activity), [GO:0002526](http://purl.obolibrary.org/obo/GO_0002526) (acute inflammatory response), [GO:0070670](http://purl.obolibrary.org/obo/GO_0070670) (response to interleukin-4), [GO:0043087](http://purl.obolibrary.org/obo/GO_0043087) (regulation of GTPase activity), [GO:0015838](http://purl.obolibrary.org/obo/GO_0015838) (amino-acid betaine transport), [GO:0031069](http://purl.obolibrary.org/obo/GO_0031069) (hair follicle morphogenesis), [GO:0055059](http://purl.obolibrary.org/obo/GO_0055059) (asymmetric neuroblast division), [GO:0070679](http://purl.obolibrary.org/obo/GO_0070679) (inositol 1,4,5 trisphosphate binding), [GO:0032391](http://purl.obolibrary.org/obo/GO_0032391) (photoreceptor connecting cilium), [GO:0055071](http://purl.obolibrary.org/obo/GO_0055071) (manganese ion homeostasis), [GO:0031060](http://purl.obolibrary.org/obo/GO_0031060) (regulation of histone methylation), [GO:0055072](http://purl.obolibrary.org/obo/GO_0055072) (iron ion homeostasis), [GO:0032392](http://purl.obolibrary.org/obo/GO_0032392) (DNA geometric change), [GO:2000780](http://purl.obolibrary.org/obo/GO_2000780) (negative regulation of double-strand break repair), [GO:0055074](http://purl.obolibrary.org/obo/GO_0055074) (calcium ion homeostasis), [GO:0055075](http://purl.obolibrary.org/obo/GO_0055075) (potassium ion homeostasis), [GO:0032395](http://purl.obolibrary.org/obo/GO_0032395) (MHC class II receptor activity), [GO:0031065](http://purl.obolibrary.org/obo/GO_0031065) (positive regulation of histone deacetylation), [GO:0055077](http://purl.obolibrary.org/obo/GO_0055077) (gap junction hemi-channel activity), [GO:0031062](http://purl.obolibrary.org/obo/GO_0031062) (positive regulation of histone methylation), [GO:0055078](http://purl.obolibrary.org/obo/GO_0055078) (sodium ion homeostasis), [GO:0031063](http://purl.obolibrary.org/obo/GO_0031063) (regulation of histone deacetylation), [GO:0055070](http://purl.obolibrary.org/obo/GO_0055070) (copper ion homeostasis), [GO:0018095](http://purl.obolibrary.org/obo/GO_0018095) (protein polyglutamylation), [GO:2000778](http://purl.obolibrary.org/obo/GO_2000778) (positive regulation of interleukin-6 secretion), [GO:0003823](http://purl.obolibrary.org/obo/GO_0003823) (antigen binding), [GO:0015809](http://purl.obolibrary.org/obo/GO_0015809) (arginine transport), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:2000779](http://purl.obolibrary.org/obo/GO_2000779) (regulation of double-strand break repair), [GO:0015808](http://purl.obolibrary.org/obo/GO_0015808) (L-alanine transport), [GO:0015807](http://purl.obolibrary.org/obo/GO_0015807) (L-amino acid transport), [GO:0003826](http://purl.obolibrary.org/obo/GO_0003826) (alpha-ketoacid dehydrogenase activity), [GO:0032388](http://purl.obolibrary.org/obo/GO_0032388) (positive regulation of intracellular transport), [GO:2000774](http://purl.obolibrary.org/obo/GO_2000774) (positive regulation of cellular senescence), [GO:0015805](http://purl.obolibrary.org/obo/GO_0015805) (S-adenosyl-L-methionine transport), [GO:0015804](http://purl.obolibrary.org/obo/GO_0015804) (neutral amino acid transport), [GO:0032389](http://purl.obolibrary.org/obo/GO_0032389) (MutLalpha complex), [GO:0055069](http://purl.obolibrary.org/obo/GO_0055069) (zinc ion homeostasis), [GO:0032386](http://purl.obolibrary.org/obo/GO_0032386) (regulation of intracellular transport), [GO:0015803](http://purl.obolibrary.org/obo/GO_0015803) (branched-chain amino acid transport), [GO:0031056](http://purl.obolibrary.org/obo/GO_0031056) (regulation of histone modification), [GO:0032387](http://purl.obolibrary.org/obo/GO_0032387) (negative regulation of intracellular transport), [GO:0043091](http://purl.obolibrary.org/obo/GO_0043091) (L-arginine import), [GO:2000772](http://purl.obolibrary.org/obo/GO_2000772) (regulation of cellular senescence), [GO:2000773](http://purl.obolibrary.org/obo/GO_2000773) (negative regulation of cellular senescence), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0031053](http://purl.obolibrary.org/obo/GO_0031053) (primary miRNA processing), [GO:0031054](http://purl.obolibrary.org/obo/GO_0031054) (pre-miRNA processing), [GO:0032385](http://purl.obolibrary.org/obo/GO_0032385) (positive regulation of intracellular cholesterol transport), [GO:0055088](http://purl.obolibrary.org/obo/GO_0055088) (lipid homeostasis), [GO:0032383](http://purl.obolibrary.org/obo/GO_0032383) (regulation of intracellular cholesterol transport), [GO:0055089](http://purl.obolibrary.org/obo/GO_0055089) (fatty acid homeostasis), [GO:0080008](http://purl.obolibrary.org/obo/GO_0080008) (Cul4-RING E3 ubiquitin ligase complex), [GO:0055081](http://purl.obolibrary.org/obo/GO_0055081) (anion homeostasis), [GO:0080009](http://purl.obolibrary.org/obo/GO_0080009) (mRNA methylation), [GO:0003831](http://purl.obolibrary.org/obo/GO_0003831) (beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity), [GO:0003834](http://purl.obolibrary.org/obo/GO_0003834) (beta-carotene 15,15'-monooxygenase activity), [GO:0015819](http://purl.obolibrary.org/obo/GO_0015819) (lysine transport), [GO:0002504](http://purl.obolibrary.org/obo/GO_0002504) (antigen processing and presentation of peptide or polysaccharide antigen via MHC class II), [GO:0003837](http://purl.obolibrary.org/obo/GO_0003837) (beta-ureidopropionase activity), [GO:0015816](http://purl.obolibrary.org/obo/GO_0015816) (glycine transport), [GO:2000785](http://purl.obolibrary.org/obo/GO_2000785) (regulation of autophagosome assembly), [GO:2000786](http://purl.obolibrary.org/obo/GO_2000786) (positive regulation of autophagosome assembly), [GO:0031047](http://purl.obolibrary.org/obo/GO_0031047) (gene silencing by RNA), [GO:0032375](http://purl.obolibrary.org/obo/GO_0032375) (negative regulation of cholesterol transport), [GO:0032376](http://purl.obolibrary.org/obo/GO_0032376) (positive regulation of cholesterol transport), [GO:0015813](http://purl.obolibrary.org/obo/GO_0015813) (L-glutamate transport), [GO:0070697](http://purl.obolibrary.org/obo/GO_0070697) (activin receptor binding), [GO:0015811](http://purl.obolibrary.org/obo/GO_0015811) (L-cystine transport), [GO:0015810](http://purl.obolibrary.org/obo/GO_0015810) (aspartate transport), [GO:0015872](http://purl.obolibrary.org/obo/GO_0015872) (dopamine transport), [GO:0015871](http://purl.obolibrary.org/obo/GO_0015871) (choline transport), [GO:0055010](http://purl.obolibrary.org/obo/GO_0055010) (ventricular cardiac muscle tissue morphogenesis), [GO:0055012](http://purl.obolibrary.org/obo/GO_0055012) (ventricular cardiac muscle cell differentiation), [GO:0043024](http://purl.obolibrary.org/obo/GO_0043024) (ribosomal small subunit binding), [GO:0001228](http://purl.obolibrary.org/obo/GO_0001228) (transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0045685](http://purl.obolibrary.org/obo/GO_0045685) (regulation of glial cell differentiation), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0001227](http://purl.obolibrary.org/obo/GO_0001227) (transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0043028](http://purl.obolibrary.org/obo/GO_0043028) (cysteine-type endopeptidase regulator activity involved in apoptotic process), [GO:0043027](http://purl.obolibrary.org/obo/GO_0043027) (cysteine-type endopeptidase inhibitor activity involved in apoptotic process), [GO:0001225](http://purl.obolibrary.org/obo/GO_0001225) (RNA polymerase II transcription coactivator binding), [GO:0001223](http://purl.obolibrary.org/obo/GO_0001223) (transcription coactivator binding), [GO:0043029](http://purl.obolibrary.org/obo/GO_0043029) (T cell homeostasis), [GO:0003886](http://purl.obolibrary.org/obo/GO_0003886) (DNA (cytosine-5-)-methyltransferase activity), [GO:0003887](http://purl.obolibrary.org/obo/GO_0003887) (DNA-directed DNA polymerase activity), [GO:0043032](http://purl.obolibrary.org/obo/GO_0043032) (positive regulation of macrophage activation), [GO:0055002](http://purl.obolibrary.org/obo/GO_0055002) (striated muscle cell development), [GO:0055003](http://purl.obolibrary.org/obo/GO_0055003) (cardiac myofibril assembly), [GO:0055004](http://purl.obolibrary.org/obo/GO_0055004) (atrial cardiac myofibril assembly), [GO:0055005](http://purl.obolibrary.org/obo/GO_0055005) (ventricular cardiac myofibril assembly), [GO:0015868](http://purl.obolibrary.org/obo/GO_0015868) (purine ribonucleotide transport), [GO:0015867](http://purl.obolibrary.org/obo/GO_0015867) (ATP transport), [GO:0055007](http://purl.obolibrary.org/obo/GO_0055007) (cardiac muscle cell differentiation), [GO:2000793](http://purl.obolibrary.org/obo/GO_2000793) (cell proliferation involved in heart valve development), [GO:0015866](http://purl.obolibrary.org/obo/GO_0015866) (ADP transport), [GO:0055008](http://purl.obolibrary.org/obo/GO_0055008) (cardiac muscle tissue morphogenesis), [GO:0055009](http://purl.obolibrary.org/obo/GO_0055009) (atrial cardiac muscle tissue morphogenesis), [GO:0015884](http://purl.obolibrary.org/obo/GO_0015884) (folic acid transport), [GO:0015883](http://purl.obolibrary.org/obo/GO_0015883) (FAD transport), [GO:0015881](http://purl.obolibrary.org/obo/GO_0015881) (creatine transport), [GO:0043034](http://purl.obolibrary.org/obo/GO_0043034) (costamere), [GO:0043039](http://purl.obolibrary.org/obo/GO_0043039) (tRNA aminoacylation), [GO:0002572](http://purl.obolibrary.org/obo/GO_0002572) (pro-T cell differentiation), [GO:0002573](http://purl.obolibrary.org/obo/GO_0002573) (myeloid leukocyte differentiation), [GO:0002575](http://purl.obolibrary.org/obo/GO_0002575) (basophil chemotaxis), [GO:0003896](http://purl.obolibrary.org/obo/GO_0003896) (DNA primase activity), [GO:0002566](http://purl.obolibrary.org/obo/GO_0002566) (somatic diversification of immune receptors via somatic mutation), [GO:0003899](http://purl.obolibrary.org/obo/GO_0003899) (DNA-directed 5'-3' RNA polymerase activity), [GO:0043044](http://purl.obolibrary.org/obo/GO_0043044) (ATP-dependent chromatin remodeling), [GO:0044375](http://purl.obolibrary.org/obo/GO_0044375) (regulation of peroxisome size), [GO:0043043](http://purl.obolibrary.org/obo/GO_0043043) (peptide biosynthetic process), [GO:0055013](http://purl.obolibrary.org/obo/GO_0055013) (cardiac muscle cell development), [GO:0070633](http://purl.obolibrary.org/obo/GO_0070633) (transepithelial transport), [GO:0055015](http://purl.obolibrary.org/obo/GO_0055015) (ventricular cardiac muscle cell development), [GO:0055016](http://purl.obolibrary.org/obo/GO_0055016) (hypochord development), [GO:0015879](http://purl.obolibrary.org/obo/GO_0015879) (carnitine transport), [GO:0015876](http://purl.obolibrary.org/obo/GO_0015876) (acetyl-CoA transport), [GO:0070635](http://purl.obolibrary.org/obo/GO_0070635) (nicotinamide riboside hydrolase activity), [GO:0015851](http://purl.obolibrary.org/obo/GO_0015851) (nucleobase transport), [GO:0015850](http://purl.obolibrary.org/obo/GO_0015850) (organic hydroxy compound transport), [GO:0001208](http://purl.obolibrary.org/obo/GO_0001208) (histone H2A-H2B dimer displacement), [GO:0043046](http://purl.obolibrary.org/obo/GO_0043046) (DNA methylation involved in gamete generation), [GO:0043045](http://purl.obolibrary.org/obo/GO_0043045) (DNA methylation involved in embryo development), [GO:0001206](http://purl.obolibrary.org/obo/GO_0001206) (transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding), [GO:0043048](http://purl.obolibrary.org/obo/GO_0043048) (dolichyl monophosphate biosynthetic process), [GO:0043047](http://purl.obolibrary.org/obo/GO_0043047) (single-stranded telomeric DNA binding), [GO:0001205](http://purl.obolibrary.org/obo/GO_0001205) (transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding), [GO:0003870](http://purl.obolibrary.org/obo/GO_0003870) (5-aminolevulinate synthase activity), [GO:0043049](http://purl.obolibrary.org/obo/GO_0043049) (otic placode formation), [GO:0002540](http://purl.obolibrary.org/obo/GO_0002540) (leukotriene production involved in inflammatory response), [GO:0003872](http://purl.obolibrary.org/obo/GO_0003872) (6-phosphofructokinase activity), [GO:0002532](http://purl.obolibrary.org/obo/GO_0002532) (production of molecular mediator involved in inflammatory response), [GO:0044380](http://purl.obolibrary.org/obo/GO_0044380) (protein localization to cytoskeleton), [GO:0003863](http://purl.obolibrary.org/obo/GO_0003863) (3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity), [GO:0003865](http://purl.obolibrary.org/obo/GO_0003865) (3-oxo-5-alpha-steroid 4-dehydrogenase activity), [GO:0003867](http://purl.obolibrary.org/obo/GO_0003867) (4-aminobutyrate transaminase activity), [GO:0003868](http://purl.obolibrary.org/obo/GO_0003868) (4-hydroxyphenylpyruvate dioxygenase activity), [GO:0002539](http://purl.obolibrary.org/obo/GO_0002539) (prostaglandin production involved in inflammatory response), [GO:0055025](http://purl.obolibrary.org/obo/GO_0055025) (positive regulation of cardiac muscle tissue development), [GO:0031099](http://purl.obolibrary.org/obo/GO_0031099) (regeneration), [GO:0055026](http://purl.obolibrary.org/obo/GO_0055026) (negative regulation of cardiac muscle tissue development), [GO:0070664](http://purl.obolibrary.org/obo/GO_0070664) (negative regulation of leukocyte proliferation), [GO:0015846](http://purl.obolibrary.org/obo/GO_0015846) (polyamine transport), [GO:0070669](http://purl.obolibrary.org/obo/GO_0070669) (response to interleukin-2), [GO:0015844](http://purl.obolibrary.org/obo/GO_0015844) (monoamine transport), [GO:0015842](http://purl.obolibrary.org/obo/GO_0015842) (aminergic neurotransmitter loading into synaptic vesicle), [GO:0070668](http://purl.obolibrary.org/obo/GO_0070668) (positive regulation of mast cell proliferation), [GO:0031094](http://purl.obolibrary.org/obo/GO_0031094) (platelet dense tubular network), [GO:0031091](http://purl.obolibrary.org/obo/GO_0031091) (platelet alpha granule), [GO:0031092](http://purl.obolibrary.org/obo/GO_0031092) (platelet alpha granule membrane), [GO:0031098](http://purl.obolibrary.org/obo/GO_0031098) (stress-activated protein kinase signaling cascade), [GO:0044387](http://purl.obolibrary.org/obo/GO_0044387) (negative regulation of protein kinase activity by regulation of protein phosphorylation), [GO:0043056](http://purl.obolibrary.org/obo/GO_0043056) (forward locomotion), [GO:0044389](http://purl.obolibrary.org/obo/GO_0044389) (ubiquitin-like protein ligase binding), [GO:0031090](http://purl.obolibrary.org/obo/GO_0031090) (organelle membrane), [GO:0002551](http://purl.obolibrary.org/obo/GO_0002551) (mast cell chemotaxis), [GO:0003883](http://purl.obolibrary.org/obo/GO_0003883) (CTP synthase activity), [GO:0043060](http://purl.obolibrary.org/obo/GO_0043060) (meiotic metaphase I plate congression), [GO:0003874](http://purl.obolibrary.org/obo/GO_0003874) (6-pyruvoyltetrahydropterin synthase activity), [GO:0001221](http://purl.obolibrary.org/obo/GO_0001221) (transcription cofactor binding), [GO:0003876](http://purl.obolibrary.org/obo/GO_0003876) (AMP deaminase activity), [GO:0003877](http://purl.obolibrary.org/obo/GO_0003877) (ATP adenylyltransferase activity), [GO:0070650](http://purl.obolibrary.org/obo/GO_0070650) (actin filament bundle distribution), [GO:0002548](http://purl.obolibrary.org/obo/GO_0002548) (monocyte chemotaxis), [GO:0070651](http://purl.obolibrary.org/obo/GO_0070651) (nonfunctional rRNA decay), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0071985](http://purl.obolibrary.org/obo/GO_0071985) (multivesicular body sorting pathway), [GO:0015858](http://purl.obolibrary.org/obo/GO_0015858) (nucleoside transport), [GO:0055037](http://purl.obolibrary.org/obo/GO_0055037) (recycling endosome), [GO:0031088](http://purl.obolibrary.org/obo/GO_0031088) (platelet dense granule membrane), [GO:0055038](http://purl.obolibrary.org/obo/GO_0055038) (recycling endosome membrane), [GO:0070653](http://purl.obolibrary.org/obo/GO_0070653) (high-density lipoprotein particle receptor binding), [GO:0071988](http://purl.obolibrary.org/obo/GO_0071988) (protein localization to spindle pole body), 

**Class expressions from DL-Learner:**

- Thing 94.29%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 73.44%
- [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) 59.15%
- [GO:0009987](http://purl.obolibrary.org/obo/GO_0009987) (cellular process) 56.27%
- [GO:0065007](http://purl.obolibrary.org/obo/GO_0065007) (biological regulation) 54.20%
- [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity) 53.47%
- [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) 51.84%
- [GO:0044464](http://purl.obolibrary.org/obo/GO_0044464) (cell part) 51.19%
- [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process) 50.81%
- [GO:0071704](http://purl.obolibrary.org/obo/GO_0071704) (organic substance metabolic process) 50.62%
- [GO:0044237](http://purl.obolibrary.org/obo/GO_0044237) (cellular metabolic process) 50.59%
- [GO:0004553](http://purl.obolibrary.org/obo/GO_0004553) (hydrolase activity, hydrolyzing O-glycosyl compounds) 50.28%
- [GO:0043177](http://purl.obolibrary.org/obo/GO_0043177) (organic acid binding) 50.23%
- [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding) 50.23%
- [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus) 50.22%


